PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	HALL, CA; BEGLEY, JA				HALL, CA; BEGLEY, JA			CONGENITAL DEFICIENCY OF HUMAN R-TYPE BINDING-PROTEINS OF COBALAMIN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									VET ADM HOSP,HEMATOL RES LAB,ALBANY,NY 12208; UNION UNIV,ALBANY MED COLL,DEPT MED,ALBANY,NY 12208	Albany Medical College; Union College								Allen R H, 1975, Prog Hematol, V9, P57; ALLEN RH, 1976, BRIT J HAEMATOL, V33, P161, DOI 10.1111/j.1365-2141.1976.tb03527.x; BEGLEY JA, 1975, BLOOD, V45, P287; BEGLEY JA, 1975, BLOOD, V45, P281; BENSON RE, 1972, P SOC EXP BIOL MED, V139, P1096, DOI 10.3181/00379727-139-36306; CARMEL R, 1969, BLOOD-J HEMATOL, V33, P1; FINKLER AE, 1970, BIOCHIM BIOPHYS ACTA, V200, P151, DOI 10.1016/0005-2795(70)90053-X; GRASBECK R, 1975, BRIT J HAEMATOL    S, V31, P103; HAKAMI N, 1971, NEW ENGL J MED, V285, P1163, DOI 10.1056/NEJM197111182852103; HALL CA, 1975, BLOOD, V46, P648; HALL CA, 1975, J CLIN INVEST, V56, P1125, DOI 10.1172/JCI108187; HALL CA, 1976, SCAND J HAEMATOL, V16, P176; HALL CA, 1973, GASTROENTEROLOGY, V65, P684; HALL CA, IN PRESS; HITZIG WH, 1974, J PEDIATR-US, V85, P622, DOI 10.1016/S0022-3476(74)80503-2; MORELLI TA, 1977, J LAB CLIN MED, V89, P645; MORELLI TA, 1977, CLIN CHIM ACTA, V77, P365, DOI 10.1016/0009-8981(77)90242-X; RAPAZZO ME, 1970, BRIT J HAEMATOL, V18, P425; ROSENBERG LE, 1975, P NATL ACAD SCI USA, V72, P4617, DOI 10.1073/pnas.72.11.4617; STENMAN UH, 1975, SCAND J HAEMATOL, V14, P91	20	37	37	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1977	29	6					619	626						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EC270	930926				2022-12-18	WOS:A1977EC27000010
J	MIGEON, BR; SPRENKLE, JA; LIEBAERS, I; SCOTT, JF; NEUFELD, EF				MIGEON, BR; SPRENKLE, JA; LIEBAERS, I; SCOTT, JF; NEUFELD, EF			X-LINKED HUNTER SYNDROME - HETEROZYGOUS PHENOTYPE IN CELL-CULTURE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205; NIAMDD,BETHESDA,MD 20014	Johns Hopkins University								BOOTH CW, 1974, PEDIATRICS, V53, P396; BOOTH CW, 1973, NEW ENGL J MED, V288, P636; CANTZ M, 1972, J BIOL CHEM, V247, P5456; Cantz M, 1972, METHOD ENZYMOL, V28, P884; CAPOBIANCHI MR, 1976, EXPERIENTIA, V32, P459, DOI 10.1007/BF01920795; DANES BS, 1967, J EXP MED, V126, P509, DOI 10.1084/jem.126.3.509; DONNELLY PV, 1975, PEDIATRICS, V56, P429; FRATANTONI JC, 1968, SCIENCE, V162, P570, DOI 10.1126/science.162.3853.570; LIEBAERS I, 1976, PEDIATR RES, V10, P733, DOI 10.1203/00006450-197610080-00007; LIEBAERS I, 1977, J PEDIATR-US, V90, P423, DOI 10.1016/S0022-3476(77)80707-5; LYON MF, 1962, AM J HUM GENET, V14, P135; MCKUSICK VA, 1972, HERITABLE DISORDERS, P521; MIGEON BR, 1968, SCIENCE, V160, P425, DOI 10.1126/science.160.3826.425; NEUFELD E, 1972, COMMUNICATION, P226; NEUFELD EF, 1975, ANNU REV BIOCHEM, V44, P357, DOI 10.1146/annurev.bi.44.070175.002041; NEUFELD EF, 1977, AM J HUM GENET, V29, P455; NEUFELD EF, 1976, CURRENT TRENDS SPHIN, P253	17	37	37	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1977	29	5					448	454						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DV673	409283				2022-12-18	WOS:A1977DV67300003
J	RATTAZZI, MC; BROWN, JA; DAVIDSON, RG; SHOWS, TB				RATTAZZI, MC; BROWN, JA; DAVIDSON, RG; SHOWS, TB			STUDIES ON COMPLEMENTATION OF BETA-HEXOSAMINIDASE DEFICIENCY IN HUMAN GM2 GANGLIOSIDOSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									SUNY, CHILDRENS HOSP, DEPT PEDIAT, DIV HUMAN GENET, BUFFALO, NY 14222 USA; ROSWELL PK MEM INST, DEPT EXPTL BIOL, BUFFALO, NY 14203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; SUNY Maritime College; Roswell Park Cancer Institute								BARTHOLOMEW WR, 1974, INT ARCH ALLER A IMM, V46, P512, DOI 10.1159/000231154; CARROLL M, 1973, BIOCHEM J, V131, P91, DOI 10.1042/bj1310091; CATCHESIDE DG, 1958, COLD SPRING HARB SYM, V23, P137, DOI 10.1101/SQB.1958.023.01.017; CRICK FHC, 1964, J MOL BIOL, V8, P161, DOI 10.1016/S0022-2836(64)80156-X; DESNICK RJ, 1972, SPHINGOLIPIDS SPHING, P351; Fincham J.R.S., 1966, GENETIC COMPLEMENTAT; GALJAARD H, 1974, EXP CELL RES, V87, P444, DOI 10.1016/0014-4827(74)90515-1; GOLDSTON.A, 1971, FEBS LETT, V13, P68, DOI 10.1016/0014-5793(71)80667-1; HARZER K, 1971, KLIN WOCHENSCHR, V49, P1189, DOI 10.1007/BF01732464; IKONNE JU, 1975, AM J HUM GENET, V27, P639; KABACK MM, 1972, METHOD ENZYMOL, V28, P862; KOPROWSKI H, 1967, P NATL ACAD SCI USA, V58, P127, DOI 10.1073/pnas.58.1.127; LALLEY PA, 1974, P NATL ACAD SCI USA, V71, P1569, DOI 10.1073/pnas.71.4.1569; LEABACK DH, 1961, BIOCHEM J, V78, P151, DOI 10.1042/bj0780151; LI YT, 1973, J BIOL CHEM, V248, P7512; Miggiano V, 1969, Wistar Inst Symp Monogr, V9, P61; OKADA S, 1972, PEDIATR RES, V6, P606; OKADA S, 1969, SCIENCE, V165, P698, DOI 10.1126/science.165.3894.698; OKADA S, 1971, AM J HUM GENET, V23, P55; RATTAZZI MC, 1974, AM J HUM GENET, V26, pA71; RATTAZZI MC, 1975, ISOZYMES, V2, P439; RATTAZZI MC, 1972, ANTENATAL DIAGNOSIS, P207; ROBINSON D, 1968, BIOCHEM J, V107, P321, DOI 10.1042/bj1070321; ROPERS HH, 1975, HUMANGENETIK, V26, P117; SANDHOFF K, 1971, J NEUROCHEM, V18, P2469, DOI 10.1111/j.1471-4159.1971.tb00204.x; SANDHOFF K, 1971, H-S Z PHYSIOL CHEM, V352, P1119, DOI 10.1515/bchm2.1971.352.2.1119; SANDHOFF K, 1968, LIFE SCI, V7, P278; Slome D, 1933, J GENET, V27, P363, DOI 10.1007/BF02981749; SRIVASTA.SK, 1974, J BIOL CHEM, V249, P2043; SRIVASTA.SK, 1974, J BIOL CHEM, V249, P2049; SRIVASTA.SK, 1974, J BIOL CHEM, V249, P2054; SUZUKI Y, 1971, NEUROLOGY, V21, P313, DOI 10.1212/WNL.21.4.313; TALLMAN JF, 1974, J BIOL CHEM, V249, P3489; THOMAS GH, 1974, NATURE, V250, P580, DOI 10.1038/250580a0; WADDELL WJ, 1956, J LAB CLIN MED, V48, P311; WENGER DA, 1972, ARCH BIOCHEM BIOPHYS, V153, P116, DOI 10.1016/0003-9861(72)90427-4	36	37	37	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1976	28	2					143	154						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	BJ476	817596				2022-12-18	WOS:A1976BJ47600004
J	CRANDALL, BF; CARREL, RE; HOWARD, J; SCHROEDER, WA; MULLER, H				CRANDALL, BF; CARREL, RE; HOWARD, J; SCHROEDER, WA; MULLER, H			TRISOMY 13 WITH A 13-X TRANSLOCATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF, SCH MED, DEPT PSYCHIAT, LOS ANGELES, CA 90024 USA; CALTECH, DIV CHEM & CHEM ENGN, PASADENA, CA 91109 USA; UNIV CALIF, SCH MED, DEPT PEDIAT, LOS ANGELES, CA 90024 USA	University of California System; University of California Los Angeles; California Institute of Technology; University of California System; University of California Los Angeles								CASPERSSON T, 1970, EXP CELL RES, V62, P490, DOI 10.1016/0014-4827(70)90586-0; CEPPELLINI R, 1964, 2 INT C INT MED C, P199; COHEN MM, 1972, AM J HUM GENET, V24, P583; DOZY AM, 1968, J CHROMATOGR, V32, P723, DOI 10.1016/S0021-9673(01)80551-3; HUEHNS ER, 1964, P NATL ACAD SCI USA, V51, P89, DOI 10.1073/pnas.51.1.89; HUISMAN THJ, 1965, J CHROMATOGR, V19, P160, DOI 10.1016/S0021-9673(01)99434-8; OHNO S., 1962, CYTOGENETICS, V1, P129, DOI 10.1159/000129725; OHNO S, 1969, COMPARATIVE MAMMALIA; SARTO GE, 1973, AM J HUM GENET, V25, P262; SCHMID W., 1963, CYTOGENETICS [BASEL], V2, P175, DOI 10.1159/000129778; SCHROEDER WA, 1970, ANAL BIOCHEM, V35, P235, DOI 10.1016/0003-2697(70)90030-8; SCHROEDER WA, 1971, PEDIATR RES, V5, P493, DOI 10.1203/00006450-197109000-00008; SCHROEDER WA, 1968, P NATL ACAD SCI USA, V60, P537, DOI 10.1073/pnas.60.2.537; SEABRIGH.M, 1971, LANCET, V2, P971; SEABRIGHT M, 1973, CHROMOSOMA, V40, P333, DOI 10.1007/BF00399426; SEARLE AG, 1971, MUTAT RES, V12, P411, DOI 10.1016/0027-5107(71)90091-1; SNODGRASS GJ, 1966, ARCH DIS CHILD, V41, P250, DOI 10.1136/adc.41.217.250; TAYLOR A I, 1968, Journal of Medical Genetics, V5, P227, DOI 10.1136/jmg.5.3.227; THELEN TH, 1971, AM J HUM GENET, V23, P410; WILSON MG, 1973, AM J HUM GENET, V25, P57; WILSON MG, 1967, NEW ENGL J MED, V277, P953, DOI 10.1056/NEJM196711022771804	21	37	37	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1974	26	3					385	392						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	T0991	4133276				2022-12-18	WOS:A1974T099100008
J	GOLDSTEIN, JL; HARROD, MJE; BROWN, MS				GOLDSTEIN, JL; HARROD, MJE; BROWN, MS			HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA - SPECIFICITY OF BIOCHEMICAL DEFECT IN CULTURED-CELLS AND FEASIBILITY OF PRENATAL DETECTION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TEXAS, SW MED SCH, DEPT INTERN MED, DIV MED GENET, DALLAS, TX 75235 USA; UNIV TEXAS, SW MED SCH, DEPT INTERN MED, DIV GASTROENTEROL, DALLAS, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas								BROWN MS, 1973, FED PROC, V32, P2168; BROWN MS, 1973, P NATL ACAD SCI USA, V70, P2162, DOI 10.1073/pnas.70.7.2162; BROWN MS, 1973, J BIOL CHEM, V248, P4731; FREDRICKSON DS, 1972, METABOLIC BASIN INHE; GOLDSTEIN J L, 1972, Birth Defects Original Article Series, V8, P202; GOLDSTEIN JL, 1973, P NATL ACAD SCI USA, V70, P2804, DOI 10.1073/pnas.70.10.2804; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; KHACHADURIAN AK, 1964, AM J MED, V37, P402, DOI 10.1016/0002-9343(64)90196-2; KHACHADURIAN AK, 1973, NUTR METAB, V15, P132; LOWRY OH, 1951, J BIOL CHEM, V193, P265; NADLER HL, 1970, NEW ENGL J MED, V282, P596, DOI 10.1056/NEJM197003122821105; NEVIN N. C., 1968, J MED GENET, V5, P9, DOI 10.1136/jmg.5.1.9; SCHROTT HG, 1972, ANN INTERN MED, V76, P711, DOI 10.7326/0003-4819-76-5-711	13	37	37	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1974	26	2					199	206						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	S7582	4362800				2022-12-18	WOS:A1974S758200009
J	MEISLER, M; RATTAZZI, MC				MEISLER, M; RATTAZZI, MC			IMMUNOLOGICAL STUDIES OF BETA GALACTOSIDASE IN NORMAL HUMAN LIVER AND IN GM1 GANGLIOSIDOSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									SUNY Buffalo, DEPT BIOCHEM, BUFFALO, NY 14214 USA; SUNY Buffalo, CHILDRENS HOSP, DEPT PEDIAT, BUFFALO, NY 14222 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo								BARTHOLOMEW WR, 1974, INT ARCH ALLER A IMM, V46, P512, DOI 10.1159/000231154; CARROLL M, 1973, BIOCHEM J, V131, P91, DOI 10.1042/bj1310091; FELTON J, 1974, J BIOL CHEM, V249, P3267; FOLCH J, 1957, J BIOL CHEM, V226, P497; HARTMAN BK, 1969, ANAL BIOCHEM, V30, P391, DOI 10.1016/0003-2697(69)90132-8; HO MW, 1971, CLIN CHIM ACTA, V32, P443; HO MW, 1969, SCIENCE, V165, P611, DOI 10.1126/science.165.3893.611; KINT JA, 1973, SCIENCE, V181, P352, DOI 10.1126/science.181.4097.352; MEISLER M, IN PRESS; MEISLER M, 1972, METHOD ENZYMOL, V28, P820; NORDEN AGW, 1973, ARCH BIOCHEM BIOPHYS, V159, P383, DOI 10.1016/0003-9861(73)90465-7; OBRIEN JS, 1972, ADV HUM GENET, P39; OBRIEN JS, 1969, LANCET, V2, P805; OBRIEN JS, 1971, LIPID STORAGE DISEAS, P225; OCKERMAN PA, 1968, SCAND J CLIN LAB INV, V22, P199, DOI 10.3109/00365516809166488; OKADA S, 1968, SCIENCE, V160, P1002, DOI 10.1126/science.160.3831.1002; RATTAZZI MC, 1972, ANTENATAL DIAGNOSIS, P207; SINGER HS, 1972, AM J HUM GENET, V24, P454; SRIVASTA.SK, 1974, J BIOL CHEM, V249, P2054; SRIVASTAVA SK, 1973, NATURE, V241, P463, DOI 10.1038/241463a0; SUZUKI Y, 1974, J BIOL CHEM, V249, P2113	21	37	37	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1974	26	6					683	691						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	V0911	4216265				2022-12-18	WOS:A1974V091100003
J	CHUNG, CS; NISWANDER, JD; RUNCK, DW; BILBEN, SE; KAU, MCW				CHUNG, CS; NISWANDER, JD; RUNCK, DW; BILBEN, SE; KAU, MCW			GENETIC AND EPIDEMIOLOGIC STUDIES OF ORAL CHARACTERISTICS IN HAWAIIS SCHOOLCHILDREN .2. MALOCCLUSION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ANDERSON GM, 1960, PRACTICAL ORTHODONTI, P738; ANGLE JL, 1944, HUM BIOL, V16, P283; Bachrach F.H., 1927, BR DENT J, V21, P1293; BEGG PR, 1954, AM J ORTHOD DENTOFAC, V40, P298, DOI 10.1016/0002-9416(54)90092-5; BEGG PR, 1954, AM J ORTHOD DENTOFAC, V40, P373, DOI 10.1016/0002-9416(54)90035-4; BEGG PR, 1954, AM J ORTHOD DENTOFAC, V40, P517, DOI 10.1016/0002-9416(54)90103-7; BEGG PR, 1954, AM J ORTHOD DENTOFAC, V40, P462, DOI 10.1016/0002-9416(54)90118-9; BURIAN C, 1969, GENETICS PROGRAM LIB, P38; CHING GHS, 1970, THESIS U HAWAII; CHUNG CS, 1970, J DENT RES, V49, P1374, DOI 10.1177/00220345700490063801; EMRICH RE, 1965, J DENT RES, V44, P947, DOI 10.1177/00220345650440053301; Graber TM, 1967, ORTHODONTICS PRINCIP; Grainger R. M., 1967, ORTHODONTIC TREATMEN; GREWE JM, 1968, J DENT RES, V47, P302, DOI 10.1177/00220345680470021701; HOROWITZ S. L., 1960, ANGLE ORTHODONT, V30, P1; HUNT EE, 1959, COLD SPRING HARB SYM, V24, P245, DOI 10.1101/SQB.1959.024.01.024; Johnson AL, 1940, AM J ORTHOD ORAL SUR, V26, P627; KROGMAN WM, 1938, Z RASSENKUNDE, V9, P41; LUNDSTROM A., 1955, AMER JOUR ORTHODONT, V41, P910, DOI 10.1016/0002-9416(55)90127-5; Mills J. R. E., 1963, P29; MILLS LF, 1966, J DENT RES, V45, P332, DOI 10.1177/00220345660450022001; MORRISON DF, 1967, MULTIVARIATE STATIST; MORTON NE, 1967, GENETICS INTERRACIAL; NEWMAN G V, 1952, U S Armed Forces Med J, V3, P1653; NISWANDER JD, 1963, AM J PHYS ANTHROPOL, V21, P569, DOI 10.1002/ajpa.1330210413; NISWANDER JD, 1967, AM J HUM GENET, V19, P543; Schull WJ, 1965, EFFECTS INBREEDING J; Stockard Charles Rupert, 1941, GENETIC ENDOCRINE BA; TENCZAR P, 1966, SCIENCE, V152, P1398, DOI 10.1126/science.152.3727.1398	29	37	37	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1971	23	5					471	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	K4744	5092597				2022-12-18	WOS:A1971K474400005
J	PANTELAKIS, SN; KARAKLIS, AG; ALEXIOU, D; VARDAS, E; VALAES, T				PANTELAKIS, SN; KARAKLIS, AG; ALEXIOU, D; VARDAS, E; VALAES, T			RED CELL ENZYMES IN TRISOMY-21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALTER AA, 1962, J CLIN INVEST, V41, P1341; BAIKIE AG, 1965, LANCET, V1, P412; BARTELS H, 1968, LANCET, V1, P820; BECKMAN L, 1966, MONOGRAPHS HUMAN GEN, P1; BENDER K, 1967, HUMANGENETIK, V4, P85, DOI 10.1007/BF00291253; BEUTLER E, 1964, BLOOD, V24, P160, DOI 10.1182/blood.V24.2.160.160; BREWER GJ, 1964, J LAB CLIN MED, V64, P601; BUCHER T, 1955, METHOD ENZYMOL, V1, P435, DOI 10.1016/0076-6879(55)01071-9; CARTER ND, 1968, ACTA GENET STAT MED, V18, P109; CARTWRIGHT GE, 1958, DIAGNOSTIC LABORATOR; DONNELL GN, 1965, LANCET, V1, P553; GERALD PS, 1967, J PEDIATR-US, V70, P172, DOI 10.1016/S0022-3476(67)80411-6; GLOCK GE, 1953, BIOCHEM J, V55, P400, DOI 10.1042/bj0550400; GOLDBERG CAJ, 1958, CLIN CHEM, V4, P484; HERRING RM, 1967, LANCET, V1, P1157; HSIA DY, 1964, NEW ENGL J MED, V270, P1085; HSIA DYY, 1965, CLIN RES, V12, P216; HUENNEKENS FM, 1957, J BIOL CHEM, V227, P261; KRIVIT W, 1956, AMA J DIS CHILD, V91, P218, DOI 10.1001/archpedi.1956.02060020220002; Kubowitz F, 1943, BIOCHEM Z, V314, P94; LENNOX B, 1962, LANCET, V2, P991; LING KH, 1955, METHOD ENZYMOL, V1, P306, DOI 10.1016/0076-6879(55)01042-2; MALAMOS B, 1962, BRIT J HAEMATOL, V8, P5, DOI 10.1111/j.1365-2141.1962.tb06489.x; MARKS PA, 1958, P NATL ACAD SCI USA, V44, P529, DOI 10.1073/pnas.44.6.529; MELLMAN WJ, 1964, LANCET, V2, P674; MITTWOCH U, 1957, J MENT DEFIC RES, V1, P26; MOORHEAD PS, 1960, EXP CELL RES, V20, P613, DOI 10.1016/0014-4827(60)90138-5; NADLER HL, 1967, AM J HUM GENET, V19, P94; NAIMAN JL, 1965, LANCET, V1, P821; NG WG, 1964, CLIN CHIM ACTA, V10, P337; OSULLIVAN MA, 1963, NEW ENGL J MED, V268, P1168, DOI 10.1056/NEJM196305232682106; PANTELAKIS SN, IN PRESS; PORTER IH, 1964, LANCET, V1, P895; RENWICK JH, 1969, BRIT MED BULL, V25, P65, DOI 10.1093/oxfordjournals.bmb.a070673; ROSNER F, 1965, NEW ENGL J MED, V273, P1356, DOI 10.1056/NEJM196512162732503; SCHUPPISSER R, 1967, SCHWEIZ MED WSCHR, V97, P1540; SHIH LY, 1965, LANCET, V2, P746; SLEIN MW, 1950, J BIOL CHEM, V186, P763; STADLER GR, 1965, LANCET, V1, P768; TANAKA KR, 1962, BLOOD, V19, P267, DOI 10.1182/blood.V19.3.267.267; TARLOV AR, 1961, J LAB CLIN MED, V58, P204; TRUBOWITZ S, 1962, LANCET, V2, P486; VOGELL W, 1959, BIOCHEM Z, V332, P81; VONEULER H, 1934, CHEMIE ENZYME, V2; WEBER W W, 1965, J Med Genet, V2, P112, DOI 10.1136/jmg.2.2.112; ZINKHAM WH, 1958, B JOHNS HOPKINS HOSP, V102, P169	46	37	38	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1970	22	2					184	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	F9213	4244917				2022-12-18	WOS:A1970F921300006
J	HEALEY, LA; SKEITH, MD; DECKER, JL; BAYANISI.PS				HEALEY, LA; SKEITH, MD; DECKER, JL; BAYANISI.PS			HYPERURICEMIA IN FILIPINOS - INTERACTION OF HEREDITY AND ENVIRONMENT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		DECKER JL, 1962, ARTHRITIS RHEUM, V5, P144, DOI 10.1002/art.1780050203; DECKER JL, 1959, NEW ENGL J MED, V261, P805, DOI 10.1056/NEJM195910152611609; DYEN I, 1965, INT J AMER LING   S1, V31, P31; HEALEY LA, 1966, ARTHRITIS RHEUM, V9, P288, DOI 10.1002/art.1780090204; KELLGREN JH, 1963, EPIDEMIOLOGY CHRO ED, V1, P170; LIDDLE L, 1959, J LAB CLIN MED, V54, P903; MANAHAN LA, 1963, P AUSTRAL RHEUM C, P20; MIKKELSEN WM, 1965, AM J MED, V39, P242, DOI 10.1016/0002-9343(65)90048-3; NUGENT CA, 1959, J CLIN INVEST, V38, P1890, DOI 10.1172/JCI103966; ROSENBLATT G, 1966, PAC MED SURG, V74, P312; SEEGMILLER JE, 1962, J CLIN INVEST, V41, P1094, DOI 10.1172/JCI104560; STEUERMANN N, 1963, EPIDEMIOL CHRON, V1, P170	12	37	37	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1967	19	2					81	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	91653	6022241				2022-12-18	WOS:A19679165300001
J	FRASER, GR; GIBLETT, ER; MOTULSKY, AG				FRASER, GR; GIBLETT, ER; MOTULSKY, AG			POPULATION GENETIC STUDIES IN CONGO .3. BLOOD GROUPS (ABO MNSS RH JSA)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALLISON AC, 1953, UNPUBLISHED OBSERVAT; Dankmeijer J, 1938, AM J PHYS ANTHROPOL, V23, P377, DOI 10.1002/ajpa.1330230402; GIBLETT ER, 1966, AM J HUM GENET, V18, P553; GIBLETT ER, 1957, J LAB CLIN MED, V49, P433; GIBLETT ER, 1959, BRIT J HAEMATOL, V5, P319, DOI 10.1111/j.1365-2141.1959.tb04040.x; HIERNAUX J, 1962, ANN SOC BELG MED TRO, V2, P145; HUBINONT PO, 1953, ANN EUGENIC, V18, P13; HUBINONT PO, 1949, NATURE, V164, P323, DOI 10.1038/164323c0; JADIN J, 1963, Ann Soc Belg Med Trop (1920), V43, P437; JADIN J, 1935, MEM I ROY COLON  SNM, V4, P1; JADIN J, 1940, MEM I ROY COLON  SNM, V10, P1; JADIN J, 1952, B SEANCES I ROY COLO, V23, P1116; LAMBOTTE-LEGRAND J, 1950, Ann Soc Belg Med Trop (1920), V30, P547; MOTULSKY AG, 1966, AM J HUM GENET, V18, P514; Mourant A., 1954, DISTRIBUTION HUMAN B; RACE RR, 1962, BLOOD GROUPS MAN; WOOLF B, 1957, ANN HUM GENET, V21, P397, DOI 10.1111/j.1469-1809.1972.tb00293.x	17	37	37	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1966	18	6					546	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	86655	4959344				2022-12-18	WOS:A19668665500004
J	AZEVEDO, E; KRIEGER, H; MI, MP; MORTON, NE				AZEVEDO, E; KRIEGER, H; MI, MP; MORTON, NE			PTC TASTE SENSITIVITY AND ENDEMIC GOITER IN BRAZIL	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BEIGUELMAN B., 1962, REV BRASIL BIOL, V22, P93; BRAND N, 1963, ANN HUM GENET, V26, P321, DOI 10.1111/j.1469-1809.1963.tb01328.x; CLEMENTS FW, 1960, BRIT MED BULL, V16, P133, DOI 10.1093/oxfordjournals.bmb.a069812; FRASER GR, 1961, LANCET, V1, P964; HARRIS H, 1950, ANN EUGENIC, V15, P24, DOI 10.1111/j.1469-1809.1949.tb02419.x; HARRIS H, 1949, LANCET, V257, P1038; HOLLINGSWORTH DR, 1963, J CLIN ENDOCR METAB, V23, P961; KITCHIN FD, 1959, BMJ-BRIT MED J, V1, P1069, DOI 10.1136/bmj.1.5129.1069; MEMORIA JMP, 1959, ANAIS REUNIAO BRASIL, P74; MORTON NE, IN PRESS; SALDANHA PH, 1962, HUM BIOL, V34, P179; SHEPARD TH, 1960, SCIENCE, V131, P929, DOI 10.1126/science.131.3404.929	12	37	38	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1965	17	1					87	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	61289	14255559				2022-12-18	WOS:A19656128900010
J	JOHNSON, CC; GORLIN, RJ; ANDERSON, VE				JOHNSON, CC; GORLIN, RJ; ANDERSON, VE			TORUS MANDIBULARIS - A GENETIC STUDY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BERNIER JL, 1955, MANAGEMENT ORAL DISE; COURTURIER P, 1958, DENT ABSTR, V3, P662; DIXON W, 1957, INTRODUCTION STATIST; Drennan MR, 1937, J ANAT, V72, P66; Furst CM, 1908, VERH AN GES, V22, P295; Hooton EA, 1918, AM J PHYS ANTHROPOL, V1, P53, DOI 10.1002/ajpa.1330010104; Hrdlicka A, 1940, AM J PHYS ANTHROPOL, V27, P1, DOI 10.1002/ajpa.1330270127; Johnson O.M., 1959, J PROSTHET DENT, V9, P975; KOLAS S, 1953, ORAL SURG ORAL MED O, V6, P1134, DOI 10.1016/0030-4220(53)90225-4; KRAHL VE, 1949, ANAT REC, V103, P477; LASKER G W, 1947, Hum Biol, V19, P217; Matthews GP, 1933, J DENT RES, V13, P245; Moorrees CFA, 1952, AM J PHYS ANTHROP-NE, V10, P319, DOI 10.1002/ajpa.1330100317; SUZUKI M, 1960, AM J PHYS ANTHROPOL, V18, P263, DOI 10.1002/ajpa.1330180404; WEIMAN JP, 1947, BONE BONES; WITKOP CJ, 1961, GENETICS DENTAL HEAL, P105; WITKOP CJ, 1961, GENETICS DENTAL HEAL, P102; WITKOP CJ, 1961, GENETICS DENTAL HEAL, P44; [No title captured]	19	37	41	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1965	17	5					433	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	67851	14334743				2022-12-18	WOS:A19656785100008
J	SHAW, MW; COHEN, MM; HILDEBRA.HM				SHAW, MW; COHEN, MM; HILDEBRA.HM			A FAMILIAL 4/5 RECIPROCAL TRANSLOCATION RESULTTING IN PARTIAL TRISOMY B	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BOOK JA, 1963, PATHOL BIOL, V11, P1159; BRAY PF, 1964, JAMA-J AM MED ASSOC, V187, P566; BURNHAM CR, 1962, DISCUSSIONS CYTOGENE, P66; COHEN M. M., 1963, CYTOGENETICS [BASEL], V2, P271, DOI 10.1159/000129786; COHEN MM, 1963, P NATL ACAD SCI USA, V50, P16, DOI 10.1073/pnas.50.1.16; COHEN MM, 1964, J CELL BIOL, V23, P386, DOI 10.1083/jcb.23.2.386; DEGROUCHY, 1964, ANN GENET, V7, pG13; EDWARDS JH, 1962, ANN HUM GENET, V26, P163, DOI 10.1111/j.1469-1809.1962.tb01323.x; FERGUSON-SMITH M. A., 1962, CYTO GENETICS [BASEL], V1, P325, DOI 10.1159/000129743; GAGNON JACQUES, 1963, UNION MED CANADA, V92, P311; GERMAN J, 1964, J CELL BIOL, V20, P37, DOI 10.1083/jcb.20.1.37; GUSTAVSON KH, 1964, ACTA PAEDIATR, V53, P172, DOI 10.1111/j.1651-2227.1964.tb07224.x; HIRSCHHORN K, 1961, PERSONAL COMMUNICATI; KOENIG EU, 1962, YALE J BIOL MED, V35, P189; KROOTH RS, 1961, J EXP MED, V113, P1155, DOI 10.1084/jem.113.6.1155; LEJEUNE, 1964, CR ACAD SCI, V258, P5767; LEJEUNE, 1964, SEMAINE HOSPITAUX, V40, P1069; LEJEUNE J, 1963, CR HEBD ACAD SCI, V257, P3098; SAKSELA E., 1962, CYTOGENETICS [BASEL], V1, P225, DOI 10.1159/000129733; SASAKI MS, 1963, AM J HUM GENET, V15, P24; SHAW M, IN PRESS; WALLACE, 1964, S AFR MED J, V38, P352	22	37	37	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1965	17	1					54	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	61289	14255557				2022-12-18	WOS:A19656128900008
J	MAKINO, S; SASAKI, M				MAKINO, S; SASAKI, M			A STUDY OF SOMATIC CHROMOSOMES IN A JAPANESE POPULATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		CHANG CP, 1959, JPN J HUM GENET, V4, P196; CHU EHY, 1959, AM J HUM GENET, V11, P63; FORD CE, 1959, NATURE, V183, P1030, DOI 10.1038/1831030a0; FORD CE, 1959, LANCET, V1, P711; FORD CE, 1959, LANCET, V1, P709; FORD CE, 1956, NATURE, V178, P1020, DOI 10.1038/1781020a0; FRACCARO M, 1959, LANCET, V1, P886; HSU T. C., 1957, JOUR NATL CANCER INST, V19, P867; HSU TC, 1953, J HERED, V44, P23, DOI 10.1093/oxfordjournals.jhered.a106344; HUNGERFORD DA, 1959, AM J HUM GENET, V11, P215; JACOBS PA, 1959, LANCET, V1, P710; KODANI M, 1958, AM J HUM GENET, V10, P125; KODANI M, 1957, P NATL ACAD SCI USA, V43, P285, DOI 10.1073/pnas.43.3.285; LEJEUNE J, 1959, CR HEBD ACAD SCI, V248, P602; LEJEUNE J, 1959, ANN GENET-PARIS, V1, P41; LEVAN A, 1959, HEREDITAS, V45, P665; MAKINO S, 1959, Z Krebsforsch, V63, P184, DOI 10.1007/BF00531590; MAKINO S., 1960, PROC JAPANESE ACAD, V36, P156; MAKINO S., 1959, PROC JAPANESE ACAD, V35, P99; MAKINO S, 1956, REVIEW CHROMOSOME NU; Painter TS, 1923, J EXP ZOOL, V37, P291, DOI 10.1002/jez.1400370303; PUCK TT, 1960, P SOC EXP BIOL MED, V103, P192; SASAKI M, 1961, CHROMOSOMA, V11, P514, DOI 10.1007/BF00328672; SASAKI MOTOMICHI, 1960, TEXAS REPTS BIOL AND MED, V18, P493; STERN C, 1959, J MED EDUC, V34, P301; Tjio J. H., 1956, HEREDITAS, V42, P1, DOI [10.1007/978-94-011-6621-8_13, DOI 10.1111/J.1601-5223.1956.TB03010.X]; TJIO JH, 1959, P NATL ACAD SCI USA, V45, P1008, DOI 10.1073/pnas.45.7.1008; TJIO JH, 1958, P NATL ACAD SCI USA, V44, P1229, DOI 10.1073/pnas.44.12.1229; WINIWARTERHVON, 1912, ARCH BIOL, V27, P91	29	37	38	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1961	13	1					47	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2959A	13765632				2022-12-18	WOS:A19612959A00014
J	ROSENFIELD, RE; HABER, GV				ROSENFIELD, RE; HABER, GV			RH BLOOD FACTOR, RHI (CE), AND ITS RELATIONSHIP TO HR (CE)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		CEPPELLINI R, 1955, P NATL ACAD SCI USA, V41, P283, DOI 10.1073/pnas.41.5.283; JONES AR, 1954, BLOOD, V9, P117, DOI 10.1182/blood.V9.2.117.117; LEWIS EB, 1945, GENETICS, V30, P137; MOURANT AE, 1957, BRIT MED J, V2, P461, DOI 10.1136/bmj.2.5042.461; RACE RR, 1954, NATURE, V174, P460; ROSENFIELD RE, 1953, BRIT MED J, V1, P975, DOI 10.1136/bmj.1.4817.975; ROSENFIELD RE, UNPUBLISHED; SANGER R, 1953, P NATL ACAD SCI USA, V39, P824, DOI 10.1073/pnas.39.8.824; Wiener Alexander S., 1943, PROC SOC EXP BIOL AND MED, V54, P316; WIENER AS, 1954, RH HR BLOOD TYPES; WIENER AS, 1954, RH HR SYLLABUS; WIENER AS, 1958, COMMUNICATION; WIENER AS, 1958, HEREDITY BLOOD GROUP	13	37	37	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1958	10	4					474	480						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA221	13606120				2022-12-18	WOS:A1958WA22100005
J	GRAHAM, JB				GRAHAM, JB			BIOCHEMICAL GENETICS OF BLOOD COAGULATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review																		AGGELER PM, 1952, P SOC EXP BIOL MED, V79, P692; ALEXANDER B, 1954, BLOOD, V9, P843, DOI 10.1182/blood.V9.9.843.843; ALEXANDER B, 1952, AM J MED, V13, P255, DOI 10.1016/0002-9343(52)90281-7; ALEXANDER B, 1949, SCIENCE, V109, P545, DOI 10.1126/science.109.2839.545; Andreassen Mogens, 1943, OPERA EX DOMO BIOL HEREDITARIAE HUMANAE UNIV HAFNIENSIS, V6, P1; BERGSAGEL DE, 1954, BLOOD, V9, P866, DOI 10.1182/blood.V9.9.866.866; BIDWELL E, 1955, BRIT J HAEMATOL, V1, P35, DOI 10.1111/j.1365-2141.1955.tb05485.x; BIGGS R, 1953, J PHYSIOL-LONDON, V122, P538, DOI 10.1113/jphysiol.1953.sp005019; BIGGS R, 1953, J CLIN PATHOL, V6, P23, DOI 10.1136/jcp.6.1.23; BIGGS R, 1952, BRIT MED J, V2, P1378, DOI 10.1136/bmj.2.4799.1378; BRENNAN MJ, 1952, AM J CLIN PATHOL, V22, P150; BRINK AJ, 1952, Q J MED, V21, P19; BRINKHOUS KM, 1954, JAMA-J AM MED ASSOC, V154, P481, DOI 10.1001/jama.1954.02940400019005; Brinkhous KM, 1939, AM J MED SCI, V198, P509, DOI 10.1097/00000441-193910000-00008; BRINKHOUS KM, 1950, SCIENCE, V111, P723, DOI 10.1126/science.111.2896.723; BRINKHOUS KM, 1947, P SOC EXP BIOL MED, V66, P117; BRINKHOUS KM, 1952, FED PROC, V11, P409; BRINKHOUS KM, 1955, THROMBOSIS EMBOLISM, V1, P428; BRINKHOUS KM, ARCH PATH; BULLOCH W, 1912, TREASURY HUMAN INHER, V1, P169; CRAMER R, 1953, ACTA HAEMATOL-BASEL, V10, P65, DOI 10.1159/000204410; DEVRIES A, 1951, ACTA HAEMATOL-BASEL, V5, P129, DOI 10.1159/000203820; FAETH W H, 1953, Conn State Med J, V17, P664; FAHEY JL, 1948, P SOC EXP BIOL MED, V69, P491, DOI 10.3181/00379727-69-16765; FAHEY JL, 1948, AM J PHYSIOL, V154, P122, DOI 10.1152/ajplegacy.1948.154.1.122; FANTL P, 1946, NATURE, V158, P708, DOI 10.1038/158708a0; FANTL P, 1954, MED J AUSTRALIA, P925; FERRY JD, 1954, PHYSIOL REV, V34, P753, DOI 10.1152/physrev.1954.34.4.753; FIELD RA, 1946, CORNELL VET, V36, P285; FLUCKIGER P, 1954, SCHWEIZ MED WSCHR, V84, P1127; FRANK E, 1950, ACTA HAEMATOL-BASEL, V3, P70, DOI 10.1159/000203550; FRICK PG, 1954, PEDIATRICS, V13, P44; FRICK PG, 1954, J LAB CLIN MED, V43, P860; GITLIN D, 1953, BLOOD, V8, P679, DOI 10.1182/blood.V8.8.679.679; GRAHAM JB, 1953, AM J MED SCI, V225, P46; GRAHAM JB, 1951, P SOC EXP BIOL MED, V77, P294; GRAHAM JB, 1949, J EXP MED, V90, P97, DOI 10.1084/jem.90.2.97; GRAHAM JB, 1951, AM J PHYSIOL, V164, P710, DOI 10.1152/ajplegacy.1951.164.3.710; GRAHAM JB, 1955, FED PROC, V14, P404; GRAHAM JB, B SUBCOMMITTEE BLOOD; GROSS JB, UNPUBLISHED; IMRIE A H, 1953, Glasgow Med J, V34, P481; ISRAELS MCG, 1951, LANCET, V260, P1375; KINGSLEY CS, 1954, Q J MED, V23, P323; KOLLER F, 1954, BLOOD, V9, P286, DOI 10.1182/blood.V9.3.286.286; KOLLER F, 1955, THROMBOSIS EMBOLISM, V1, P122; KOLLER F, 1955, THROMBOSIS EMBOLISM, V1, P1206; LANGDELL RD, 1953, J LAB CLIN MED, V41, P637; LANGDELL RD, 1955, P SOC EXP BIOL MED, V88, P212; LEWIS JH, 1953, P SOC EXP BIOL MED, V84, P651; LEWIS JH, 1954, AMA AM J DIS CHILD, V88, P711, DOI 10.1001/archpedi.1954.02050100713002; LEWIS JH, 1953, P SOC EXP BIOL MED, V82, P445; LONG LEOPOLD A., 1955, ACTA HAEMATOL, V13, P242; LORAND L, 1955, P SOC EXP BIOL MED, V89, P45; LORAND L, 1954, PHYSIOL REV, V34, P742, DOI 10.1152/physrev.1954.34.4.742; LORAND L, 1953, SCIENCE, V118, P515, DOI 10.1126/science.118.3070.515; MACFARLANE RG, 1954, LANCET, V1, P1316; MACMILLAN RL, 1953, CAN MED ASSOC J, V69, P623; MADDEN RE, 1952, J BIOL CHEM, V196, P641; MCCORMICK HM, 1949, P SOC EXP BIOL MED, V70, P501; MERSKEY C, 1951, Q J MED, V20, P299; MILSTONE JH, 1952, MEDICINE, V31, P411, DOI 10.1097/00005792-195212000-00004; Moravitz P., 1904, DTSCH ARCH KLINISCHE, V79, P1; Morawitz P, 1904, DTSCH ARCH KLIN MED, V79, P432; OLWIN JH, 1949, J LAB CLIN MED, V34, P806; Owen CA, 1939, P SOC EXP BIOL MED, V41, P181; OWREN PA, 1953, AM J MED, V14, P201, DOI 10.1016/0002-9343(53)90019-9; OWREN PA, 1947, LANCET, V252, P446; OWREN PA, 1947, J CHR GUNDERSON OSLO; Patek AJ, 1937, J CLIN INVEST, V16, P113, DOI 10.1172/JCI100829; PAVLOVSKY A, 1947, BLOOD, V2, P185, DOI 10.1182/blood.V2.2.185.185; PENICK GD, 1951, P SOC EXP BIOL MED, V78, P732; POOL JG, 1954, P SOC EXP BIOL MED, V87, P54; POOLE JCF, 1953, LANCET, V264, P122; PRICHARD RW, 1954, AMA AM J DIS CHILD, V88, P703, DOI 10.1001/archpedi.1954.02050100705001; QUICK AJ, 1955, ARCH INTERN MED, V95, P2, DOI 10.1001/archinte.1955.00250070018002; QUICK AJ, 1947, LANCET, V253, P379; Quick AJ, 1943, AM J PHYSIOL, V140, P0212, DOI 10.1152/ajplegacy.1943.140.2.212; Rabe F., 1920, ARCH KLIN MED, V132, P240; RAMOT B, 1955, J LAB CLIN MED, V46, P80; RATNOFF OD, 1955, J CLIN INVEST, V34, P602, DOI 10.1172/JCI103109; Risak E, 1935, Z KLIN MED, V128, P605; ROSENTHAL MC, 1954, AM J MED, V16, P153, DOI 10.1016/0002-9343(54)90330-7; ROSENTHAL RL, 1954, AM J MED, V17, P57, DOI 10.1016/0002-9343(54)90144-8; ROSENTHAL RL, 1955, BLOOD, V10, P120, DOI 10.1182/blood.V10.2.120.120; ROSENTHAL RL, 1953, P SOC EXP BIOL MED, V82, P171; SACKS MS, 1955, J LAB CLIN MED, V46, P98; SCHULMAN I, 1952, BLOOD, V7, P794, DOI 10.1182/blood.V7.8.794.794; SEEGERS WH, 1955, AM J CLIN PATHOL, V25, P983; SEEGERS WH, 1955, FED PROC, V14, P278; SHULMAN S, 1953, J AM CHEM SOC, V75, P5846, DOI 10.1021/ja01119a021; SISE HS, 1955, P SOC EXP BIOL MED, V89, P81; SJOLIN KE, 1954, ACTA PATHOL MIC SC, V35, P512; SOULIER JP, 1953, NEW ENGL J MED, V249, P547, DOI 10.1056/NEJM195310012491401; SPAET TH, 1954, J CLIN INVEST, V33, P1095, DOI 10.1172/JCI102982; SPAET TH, 1953, P SOC EXP BIOL MED, V84, P314; STEFANINI M, 1950, P SOC EXP BIOL MED, V74, P370; STOHLMAN F, 1951, J LAB CLIN MED, V38, P842; SYKES EM, 1948, P SOC EXP BIOL MED, V67, P506; Tidrick RT, 1943, SURGERY, V14, P191; TOCANTINS LM, 1951, 4TH C BLOOD CLOTT AL, P82; VANCREVELD S, 1953, LANCET, V264, P823; VANDENBROUCKE J, 1954, ACTA HAEMATOL-BASEL, V12, P87, DOI 10.1159/000204605; VERSTRAETE M, 1953, REV BELG PATH MED EX, V23, P201; VOLWILER W, 1955, J CLIN INVEST, V34, P1126, DOI 10.1172/JCI103162; WAGNER RH, 1954, FED PROC, V13, P445; WARE AG, 1947, SCIENCE, V106, P618, DOI 10.1126/science.106.2764.618-a	107	37	37	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1956	8	2					63	79						17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF069	13313517				2022-12-18	WOS:A1956WF06900001
J	STEINBERG, AG; SHWACHMAN, H; ALLEN, FH; DOOLEY, RR				STEINBERG, AG; SHWACHMAN, H; ALLEN, FH; DOOLEY, RR			LINKAGE STUDIES WITH CYSTIC FIBROSIS OF THE PANCREAS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ANDERSEN DH, 1946, AM J DIS CHILD, V72, P62, DOI 10.1001/archpedi.1946.02020300069004; CARTER CO, 1953, FIBROCYSTIC DISEASE; Finney DJ, 1940, ANN EUGENIC, V10, P171, DOI 10.1111/j.1469-1809.1940.tb02246.x; Fisher R. A., 1935, ANN EUGEN, V6, P187; Fisher RA, 1935, ANN EUGENIC, V6, P339, DOI 10.1111/j.1469-1809.1935.tb02116.x; GRUNEBERG H, 1952, GENETICS MOUSE; LOWE CU, 1949, AM J DIS CHILD, V78, P349, DOI 10.1001/archpedi.1949.02030050362008; SHWACHMAN H, 1955, ADV PEDIATRICS, V7; SMITH CAB, 1953, J R STAT SOC B, V15, P153; SMITH CAB, 1954, ANN EUGENIC, V18, P278	10	37	40	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1956	8	3					162	176						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF070	13362224				2022-12-18	WOS:A1956WF07000005
J	WOOLF, CM; STEPHENS, FE; MULAIK, DD; GILBERT, RE				WOOLF, CM; STEPHENS, FE; MULAIK, DD; GILBERT, RE			AN INVESTIGATION OF THE FREQUENCY OF CONSANGUINEOUS MARRIAGES AMONG THE MORMONS AND THEIR RELATIVES IN THE UNITED-STATES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ARNER GBL, 1908, STUDIES HIST EC PUBL, V31; Bell J, 1940, ANN EUGENIC, V10, P370; BOOK JA, 1956, ANN HUM GENET, V20, P239, DOI 10.1111/j.1469-1809.1956.tb01369.x; BUZZATITRAVERSO A, 1950, COLD SPRING HARB SYM, V15, P13, DOI 10.1101/SQB.1950.015.01.004; Dahlberg G, 1929, GENETICS, V14, P421; DAHLBERG GUNNAR, 1938, PROC ROY SOC EDINBURGH, V58, P213; Evans R. J., 1937, CENTURY MORMONISM GR; FREIREMAIA N, 1952, AM J HUM GENET, V4, P194; GLASS B, 1954, ADV GENET, V6, P95, DOI 10.1016/S0065-2660(08)60128-5; Haldane JBS, 1939, ANN EUGENIC, V9, P321, DOI 10.1111/j.1469-1809.1939.tb02217.x; HALDANE JBS, 1947, ANN EUGENIC, V14, P35, DOI 10.1111/j.1469-1809.1947.tb02377.x; HERNDON C. NASH, 1954, EUGENICS QUART, V1, P53; HERNDON CN, 1952, 1952 M AM SOC HUM GE; Hogben LT, 1946, INTRO MATH GENETICS; KILPATRICK S J, 1955, Ulster Med J, V24, P113; Lenz Fritz, 1919, M NCHENER MEDIZINISC, V66, P1340; Li CC., 1955, POPULATION GENETICS; MACKAY RV, 1951, LAW MARRIAGE DIVORCE; MORTON NE, 1955, ANN HUM GENET, V20, P116; MULDER W, 1955, UTAH HIST Q, V23, P233; MULDER W, 1956, SWEDISH PIONEER HIST, V7, P1; NEEL JV, 1949, AM J HUM GENET, V1, P156; NEEL JV, 1952, AM NAT, V86, P129, DOI 10.1086/281718; Orel Herbert, 1932, ARCHIV RASSENUND GES, V26, P249; SANGHVI LD, 1954, EUGEN QUART, V1, P235; Schull WJ, 1953, AM ANTHROPOL, V55, P74, DOI 10.1525/aa.1953.55.1.02a00060; SPUHLER J. N., 1953, HUMAN BIOL, V25, P295; Stern C., 1950, PRINCIPLES HUMAN GEN; SUTTER J, 1948, POPULATION, V4, P607; VERSCHUER OF, 1954, Z MORPHOL ANTHR, V46, P293; Weinberg W, 1920, Z GESAMTE NEUROL PSY, V59, P39, DOI 10.1007/BF02901078; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872; WULZ G, 1952, ARCH RASSENB, V17, P82; 1955, STAT ABSTR US	34	37	37	1	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1956	8	4					236	252						17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF071	13394567				2022-12-18	WOS:A1956WF07100003
J	STECHER, RM; HERSH, AH; HAUSER, H				STECHER, RM; HERSH, AH; HAUSER, H			HEBERDENS NODES - THE FAMILY HISTORY AND RADIOGRAPHIC APPEARANCE OF A LARGE FAMILY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		STECHER R M, 1946, Arch Phys Med Rehabil, V27, P409; Stecher RM, 1944, J CLIN INVEST, V23, P699, DOI 10.1172/JCI101540; Stecher RM, 1940, NEW ENGL J MED, V222, P300, DOI 10.1056/NEJM194002222220802; STECHER RM, 1946, J LAB CLIN MED, V31, P687; STECHER RM, 1947, AM J MED SCI, V213, P181, DOI 10.1097/00000441-194721320-00009; STECHER RM, 1949, J LAB CLIN MED, V34, P1193; STECHER RM, 1948, AM J ROENTGENOL, V59, P326	7	37	37	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1953	5	1					46	60						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XW629	13050609				2022-12-18	WOS:A1953XW62900004
J	STEPHENS, FE; PERKOFF, GT; DOLOWITZ, DA; TYLER, FH				STEPHENS, FE; PERKOFF, GT; DOLOWITZ, DA; TYLER, FH			PARTIALLY SEX-LINKED DOMINANT INHERITANCE OF INTERSTITIAL PYELONEPHRITIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Eason J, 1924, LANCET, V2, P639; Guthrie LG, 1902, LANCET, V1, P1243; Haldane JBS, 1936, ANN EUGENIC, V7, P28, DOI 10.1111/j.1469-1809.1936.tb02127.x; KIDD J, 1882, PRACTITIONER, V29, P104; PERKOFF GT, 1951, ARCH INTERN MED, V88, P191, DOI 10.1001/archinte.1951.03810080059006; Rinkoff SS, 1939, J AMER MED ASSOC, V113, P661, DOI 10.1001/jama.1939.02800330027007; Weiss S, 1939, MEDICINE, V18, P221, DOI 10.1097/00005792-193909000-00001	7	37	37	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1951	3	4					303	313						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XS395	14933359				2022-12-18	WOS:A1951XS39500001
J	Kosmicki, JA; Horowitz, JE; Banerjee, N; Lanche, R; Marcketta, A; Maxwell, E; Bai, XD; Sun, D; Backman, JD; Sharma, D; Kury, FSP; Kang, HM; O'Dushlaine, C; Yadav, A; Mansfield, AJ; Li, AH; Watanabe, K; Gurski, L; McCarthy, SE; Locke, AE; Khalid, S; O'Keeffe, S; Mbatchou, J; Chazara, O; Huang, YF; Kvikstad, E; O'Neill, A; Nioi, P; Parker, MM; Petrovski, S; Runz, H; Szustakowski, JD; Wang, QL; Wong, E; Cordova-Palomera, A; Smith, EN; Szalma, S; Zheng, XW; Esmaeeli, S; Davis, JW; Lai, YP; Chen, X; Justice, AE; Leader, JB; Mirshahi, T; Carey, DJ; Verma, A; Sirugo, G; Ritchie, MD; Rader, DJ; Povysil, G; Goldstein, DB; Kiryluk, K; Pairo-Castineira, E; Rawlik, K; Pasko, D; Walker, S; Meynert, A; Kousathanas, A; Moutsianas, L; Tenesa, A; Caulfield, M; Scott, R; Wilson, JF; Baillie, JK; Butler-Laporte, G; Nakanishi, T; Lathrop, M; Richards, JB; Jones, M; Balasubramanian, S; Salerno, W; Shuldiner, AR; Marchini, J; Overton, JD; Habegger, L; Cantor, MN; Reid, JG; Baras, A; Abecasis, GR; Ferreira, MAR				Kosmicki, Jack A.; Horowitz, Julie E.; Banerjee, Nilanjana; Lanche, Rouel; Marcketta, Anthony; Maxwell, Evan; Bai, Xiaodong; Sun, Dylan; Backman, Joshua D.; Sharma, Deepika; Kury, Fabricio S. P.; Kang, Hyun M.; O'Dushlaine, Colm; Yadav, Ashish; Mansfield, Adam J.; Li, Alexander H.; Watanabe, Kyoko; Gurski, Lauren; McCarthy, Shane E.; Locke, Adam E.; Khalid, Shareef; O'Keeffe, Sean; Mbatchou, Joelle; Chazara, Olympe; Huang, Yunfeng; Kvikstad, Erika; O'Neill, Amanda; Nioi, Paul; Parker, Meg M.; Petrovski, Slave; Runz, Heiko; Szustakowski, Joseph D.; Wang, Quanli; Wong, Emily; Cordova-Palomera, Aldo; Smith, Erin N.; Szalma, Sandor; Zheng, Xiuwen; Esmaeeli, Sahar; Davis, Justin W.; Lai, Yi-Pin; Chen, Xing; Justice, Anne E.; Leader, Joseph B.; Mirshahi, Tooraj; Carey, David J.; Verma, Anurag; Sirugo, Giorgio; Ritchie, Marylyn D.; Rader, Daniel J.; Povysil, Gundula; Goldstein, David B.; Kiryluk, Krzysztof; Pairo-Castineira, Erola; Rawlik, Konrad; Pasko, Dorota; Walker, Susan; Meynert, Alison; Kousathanas, Athanasios; Moutsianas, Loukas; Tenesa, Albert; Caulfield, Mark; Scott, Richard; Wilson, James F.; Baillie, J. Kenneth; Butler-Laporte, Guillaume; Nakanishi, Tomoko; Lathrop, Mark; Richards, J. Brent; Jones, Marcus; Balasubramanian, Suganthi; Salerno, William; Shuldiner, Alan R.; Marchini, Jonathan; Overton, John D.; Habegger, Lukas; Cantor, Michael N.; Reid, Jeffrey G.; Baras, Aris; Abecasis, Goncalo R.; Ferreira, Manuel A. R.		Regeneron Genetics Ctr; UKB Exome Sequencing Consortium	Pan-ancestry exome-wide association analyses of COVID-19 outcomes in 586,157 individuals	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEW-YORK-CITY; SARS-COV-2	Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19), a respiratory illness that can result in hospitalization or death. We used exome sequence data to investigate associations between rare genetic variants and seven COVID-19 outcomes in 586,157 individuals, including 20,952 with COVID-19. After accounting for multiple testing, we did not identify any clear associations with rare variants either exome wide or when specifically focusing on (1) 13 interferon pathway genes in which rare deleterious variants have been reported in individuals with severe COVID-19, (2) 281 genes located in susceptibility loci identified by the COVID-19 Host Genetics Initiative, or (3) 32 additional genes of immunologic relevance and/or therapeutic potential. Our analyses indicate there are no significant associations with rare protein-coding variants with detectable effect sizes at our current sample sizes. Analyses will be updated as additional data become available, and results are publicly available through the Regeneron Genetics Center COVID-19 Results Browser.	[Kosmicki, Jack A.; Horowitz, Julie E.; Banerjee, Nilanjana; Lanche, Rouel; Marcketta, Anthony; Maxwell, Evan; Bai, Xiaodong; Sun, Dylan; Backman, Joshua D.; Sharma, Deepika; Kury, Fabricio S. P.; Kang, Hyun M.; O'Dushlaine, Colm; Yadav, Ashish; Mansfield, Adam J.; Li, Alexander H.; Gurski, Lauren; McCarthy, Shane E.; Locke, Adam E.; Khalid, Shareef; O'Keeffe, Sean; Mbatchou, Joelle; Jones, Marcus; Balasubramanian, Suganthi; Salerno, William; Shuldiner, Alan R.; Marchini, Jonathan; Overton, John D.; Habegger, Lukas; Cantor, Michael N.; Reid, Jeffrey G.; Baras, Aris; Abecasis, Goncalo R.; Ferreira, Manuel A. R.] Regeneron Genet Ctr, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA; [Chazara, Olympe; O'Neill, Amanda; Petrovski, Slave; Wang, Quanli] AstraZeneca, Ctr Genom Res, Discovery Sci, BioPharmaceut R&D, Cambridge CB2 0AA, England; [Huang, Yunfeng; Runz, Heiko] Biogen Inc, 300 Binney St, Cambridge, MA 02142 USA; [Nioi, Paul; Parker, Meg M.] Alnylam Pharmaceut, 675 West Kendall St, Cambridge, MA 02142 USA; [Kvikstad, Erika; Szustakowski, Joseph D.] Bristol Myers Squibb, Route 206 & Prov Line Rd, Princeton, NJ 08543 USA; [Wong, Emily; Cordova-Palomera, Aldo; Smith, Erin N.; Szalma, Sandor] Takeda Calif Inc, 9625 Towne Ctr Dr, San Diego, CA 92121 USA; [Zheng, Xiuwen; Esmaeeli, Sahar; Davis, Justin W.] AbbVie Inc, 1 N Waukegan Rd, N Chicago, IL 60064 USA; [Lai, Yi-Pin; Chen, Xing] Pfizer Inc, 1 Portland St, Cambridge, MA 02139 USA; [Justice, Anne E.; Leader, Joseph B.; Mirshahi, Tooraj; Carey, David J.] Geisinger, Danville, PA 17822 USA; [Verma, Anurag; Sirugo, Giorgio; Ritchie, Marylyn D.; Rader, Daniel J.] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Watanabe, Kyoko; Povysil, Gundula; Goldstein, David B.; Kiryluk, Krzysztof] Columbia Univ, Irving Med Ctr, Inst Genom Med, New York, NY 10032 USA; [Goldstein, David B.] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; [Kiryluk, Krzysztof] Columbia Univ, Vagelos Coll Phys & Surg, Dept Med, Div Nephrol, New York, NY 10032 USA; [Pairo-Castineira, Erola; Rawlik, Konrad; Tenesa, Albert; Baillie, J. Kenneth] Univ Edinburgh, Roslin Inst, Edinburgh EH25 9RG, Midlothian, Scotland; [Pairo-Castineira, Erola; Meynert, Alison; Tenesa, Albert; Wilson, James F.; Baillie, J. Kenneth] Univ Edinburgh, Western Gen Hosp, Inst Genet & Canc, MRC Human Genet Unit, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland; [Pasko, Dorota; Walker, Susan; Kousathanas, Athanasios; Moutsianas, Loukas; Caulfield, Mark; Scott, Richard] Genom England, London EC1M 6BQ, England; [Tenesa, Albert; Wilson, James F.] Usher Inst Populat Hlth Sci & Informat, Ctr Global Hlth Res, Teviot Pl, Edinburgh EH8 9AG, Midlothian, Scotland; [Caulfield, Mark] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England; [Scott, Richard] Great Ormond St Hosp Children NHS Fdn Trust, London WC1N 3JH, England; [Baillie, J. Kenneth] Royal Infirm Edinburgh NHS Trust, Intens Care Unit, 54 Little France Dr, Edinburgh EH16 5SA, Midlothian, Scotland; [Butler-Laporte, Guillaume; Nakanishi, Tomoko; Richards, J. Brent] Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Butler-Laporte, Guillaume; Richards, J. Brent] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ H3A 0G4, Canada; [Nakanishi, Tomoko; Lathrop, Mark; Richards, J. Brent] McGill Univ, Dept Human Genet, Montreal, PQ H3A 0G4, Canada; [Nakanishi, Tomoko] Kyoto Univ, Grad Sch Med, Kyoto McGill Int Collaborat Sch Genom Med, Kyoto 6068501, Japan; [Lathrop, Mark] McGill Univ, Canada Canadian Ctr Computat Genom, Montreal, PQ H3A 0G4, Canada; [Richards, J. Brent] Kings Coll London, Dept Twins Res, London WC2R 2LS, England	Regeneron; AstraZeneca; Biogen; Bristol-Myers Squibb; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals USA Inc. (TPUSA); Takeda California Inc; AbbVie; Pfizer; University of Pennsylvania; Pennsylvania Medicine; Columbia University; NewYork-Presbyterian Hospital; Columbia University; Columbia University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of London; Queen Mary University London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Royal Infirmary of Edinburgh; University of Edinburgh; Lady Davis Institute; McGill University; McGill University; McGill University; Kyoto University; McGill University; University of London; King's College London	Abecasis, GR; Ferreira, MAR (corresponding author), Regeneron Genet Ctr, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA.	goncalo.abecasis@regeneron.com; manuel.ferreira@regeneron.com	Wilson, James F/A-5704-2009; Huang, Yunfeng/AAE-5589-2022; Szustakowski, Joseph/HGB-2712-2022; Baillie, John Kenneth/F-3124-2011; Baillie, Kenneth/AEK-6650-2022	Wilson, James F/0000-0001-5751-9178; Baillie, John Kenneth/0000-0001-5258-793X; Baillie, Kenneth/0000-0001-5258-793X; Szalma, Sandor/0000-0001-7591-3902; Mbatchou, Joelle/0000-0002-2245-3743; Tenesa, Albert/0000-0003-4884-4475; Verma, Anurag/0000-0002-5063-9107; Zheng, Xiuwen/0000-0002-1390-0708; Nakanishi, Tomoko/0000-0001-9510-5646				Atkins JL, 2020, J GERONTOL A-BIOL, V75, P2224, DOI 10.1093/gerona/glaa183; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Bastard P, 2020, SCIENCE, V370, P423, DOI 10.1126/science.abd4585; COVID-19 Host genetics initiative, 2021, NATURE, V600, P472, DOI [10.1038/s41586-021-03767-x, DOI 10.1038/S41586-021-03767-X]; Cummings Matthew J, 2020, medRxiv, DOI [10.1016/S0140-6736(20)31189-2, 10.1101/2020.04.15.20067157]; Ellinghaus D, 2020, NEW ENGL J MED, V383, P1522, DOI 10.1056/NEJMoa2020283; Fallerini C, 2021, ELIFE, V10, DOI 10.7554/eLife.67569; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Horowitz J.E., 2020, MEDRXIV; Kimball A, 2020, MMWR-MORBID MORTAL W, V69, P377, DOI 10.15585/mmwr.mm6913e1; Kosmicki J.A., 2020, MEDRXIV; Lee S, 2012, AM J HUM GENET, V91, P224, DOI 10.1016/j.ajhg.2012.06.007; Mbatchou J, 2021, NAT GENET, V53, P1097, DOI 10.1038/s41588-021-00870-7; Moreno-Eutimio MA, 2020, MICROBES INFECT, V22, P226, DOI 10.1016/j.micinf.2020.04.009; Nchioua R, 2020, MBIO, V11, DOI 10.1128/mBio.01930-20; Pairo-Castineira E, 2021, NATURE, V591, P92, DOI 10.1038/s41586-020-03065-y; Povysil G, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI147834; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Shelton JF, 2021, NAT GENET, V53, P801, DOI 10.1038/s41588-021-00854-7; van der Made CI, 2020, JAMA-J AM MED ASSOC, V324, P663, DOI 10.1001/jama.2020.13719; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Zhang BG, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01912; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017; Zhu YP, 2011, P NATL ACAD SCI USA, V108, P15834, DOI 10.1073/pnas.1101676108	27	36	35	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 1	2021	108	7					1350	1355		10.1016/j.ajhg.2021.017	http://dx.doi.org/10.1016/j.ajhg.2021.017			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TC9NQ	34115965				2022-12-18	WOS:000668964500014
J	Liu, CY; He, XJ; Liu, WJ; Yang, SM; Wang, LB; Li, WY; Wu, H; Tang, SY; Ni, XQ; Wang, JX; Gao, Y; Tian, SX; Zhang, L; Cong, JS; Zhang, ZH; Tan, Q; Zhang, JJ; Li, H; Zhong, YD; Lv, MR; Li, JS; Jin, L; Cao, YX; Zhang, F				Liu, Chunyu; He, Xiaojin; Liu, Wangjie; Yang, Shenmin; Wang, Lingbo; Li, Weiyu; Wu, Huan; Tang, Shuyan; Ni, Xiaoqing; Wang, Jiaxiong; Gao, Yang; Tian, Shixiong; Zhang, Lin; Cong, Jiangshan; Zhang, Zhihua; Tan, Qing; Zhang, Jingjing; Li, Hong; Zhong, Yading; Lv, Mingrong; Li, Jinsong; Jin, Li; Cao, Yunxia; Zhang, Feng			Bi-allelic Mutations in TTC29 Cause Male Subfertility with Asthenoteratospermia in Humans and Mice	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIPLE MORPHOLOGICAL ABNORMALITIES; WORLD-HEALTH-ORGANIZATION; MALE-INFERTILITY; SPERM FLAGELLA; MALE-FERTILITY; PROTEIN; CILIA; GENERATION; TRANSPORT; COMPLEX	As a type of severe asthenoteratospermia, multiple morphological abnormalities of the flagella (MMAF) are characterized by the presence of immotile spermatozoa with severe flagellar malformations. MMAF is a genetically heterogeneous disorder, and the known MMAF-associated genes can only account for approximately 60% of human MMAF cases. Here we conducted whole-exome sequencing and identified bi-allelic truncating mutations of the TTC29 (tetratricopeptide repeat domain 29) gene in three (3.8%) unrelated cases from a cohort of 80 MMAF-affected Han Chinese men. TTC29 is preferentially expressed in the testis, and TTC29 protein contains the tetratricopeptide repeat domains that play an important role in cilia- and flagella-associated functions. All of the men harboring TTC29 mutations presented a typical MMAF phenotype and dramatic disorganization in axonemal and/or other peri-axonemal structures. Immunofluorescence assays of spermatozoa from men harboring TTC29 mutations showed deficiency of TTC29 and remarkably reduced staining of intraflagellar-transport-complex-B-associated proteins (TTC30A and IFT52). We also generated a TtC29-mutated mouse model through the use of CRISPR-Cas9 technology. Remarkably, TtC29-mutated male mice also presented reduced sperm motility, abnormal flagellar ultrastructure, and male subfertility. Furthermore, intracytoplasmic sperm injections performed for TtC29-mutated mice and men harboring TTC29 mutations consistently acquired satisfactory outcomes. Collectively, our experimental observations in humans and mice suggest that bi-allelic mutations in TTC29, as an important genetic pathogeny, can induce MMAF-related asthenoteratospermia. Our study also provided effective guidance for clinical diagnosis and assisted reproduction treatments.	[Liu, Chunyu; Liu, Wangjie; Wang, Lingbo; Li, Weiyu; Tang, Shuyan; Tian, Shixiong; Cong, Jiangshan; Jin, Li; Zhang, Feng] Fudan Univ, Shanghai Inst Planned Parenthood Res, NHC Key Lab Reprod Regulat,Sch Life Sci, Obstet & Gynecol Hosp,State Key Lab Genet Engn, Shanghai 200011, Peoples R China; [Liu, Chunyu; Liu, Wangjie; Li, Weiyu; Tang, Shuyan; Tian, Shixiong; Cong, Jiangshan; Zhang, Feng] Shanghai Key Lab Female Reprod Endocrine Related, Shanghai 200011, Peoples R China; [Liu, Chunyu; Liu, Wangjie; Li, Weiyu; Tian, Shixiong; Zhang, Feng] Nanjing Med Univ, Sch Publ Hlth, Ctr Global Hlth, State Key Lab Reprod Med, Nanjing 211166, Jiangsu, Peoples R China; [He, Xiaojin; Wu, Huan; Ni, Xiaoqing; Gao, Yang; Tan, Qing; Zhang, Jingjing; Lv, Mingrong; Cao, Yunxia] Anhui Med Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Reprod Med Ctr, Hefei 230022, Anhui, Peoples R China; [He, Xiaojin; Wu, Huan; Ni, Xiaoqing; Gao, Yang; Tan, Qing; Zhang, Jingjing; Lv, Mingrong; Cao, Yunxia] Anhui Med Univ, Anhui Prov Key Lab Reprod Hlth & Genet, Hefei 230022, Anhui, Peoples R China; [He, Xiaojin; Wu, Huan; Ni, Xiaoqing; Gao, Yang; Tan, Qing; Zhang, Jingjing; Lv, Mingrong; Cao, Yunxia] Anhui Med Univ, NHC Key Lab Study Abnormal Gametes & Reprod Tract, Hefei 230022, Anhui, Peoples R China; [Yang, Shenmin] Nanjing Med Univ, Affiliated Suzhou Hosp, State Key Lab Reprod Med, Suzhou 215002, Peoples R China; [Yang, Shenmin; Wang, Jiaxiong; Li, Hong] Suzhou Municipal Hosp, Suzhou 215002, Peoples R China; [Wang, Lingbo; Zhang, Lin; Li, Jinsong] Univ Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci,State Key Lab Cel, Shanghai Key Lab Mol Androl,Chinese Acad Sci, Shanghai 200031, Peoples R China; [Zhang, Zhihua] Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hefei 230022, Anhui, Peoples R China; [Zhong, Yading] Anhui Med Univ, Affiliated Hosp 1, Dept Radiol, Hefei 230022, Anhui, Peoples R China	Fudan University; Nanjing Medical University; Anhui Medical University; Anhui Medical University; Anhui Medical University; Nanjing Medical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Anhui Medical University; Anhui Medical University	Zhang, F (corresponding author), Fudan Univ, Shanghai Inst Planned Parenthood Res, NHC Key Lab Reprod Regulat,Sch Life Sci, Obstet & Gynecol Hosp,State Key Lab Genet Engn, Shanghai 200011, Peoples R China.; Zhang, F (corresponding author), Shanghai Key Lab Female Reprod Endocrine Related, Shanghai 200011, Peoples R China.; Zhang, F (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Ctr Global Hlth, State Key Lab Reprod Med, Nanjing 211166, Jiangsu, Peoples R China.; Cao, YX (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Reprod Med Ctr, Hefei 230022, Anhui, Peoples R China.; Cao, YX (corresponding author), Anhui Med Univ, Anhui Prov Key Lab Reprod Hlth & Genet, Hefei 230022, Anhui, Peoples R China.; Cao, YX (corresponding author), Anhui Med Univ, NHC Key Lab Study Abnormal Gametes & Reprod Tract, Hefei 230022, Anhui, Peoples R China.	caoyunxia6@126.com; zhangfeng@fudan.edu.cn	liu, chunyu/GWQ-9357-2022; Wu, Huan/AAL-7095-2021; Li, Weiyu/AAP-1712-2021; Tang, Shuyan/K-9582-2018; Wang, Jiaxiong/AAE-6781-2020; Zhang, Feng/C-7735-2009; zhang, zh/GWV-4677-2022; Li, Jin/GYQ-5363-2022	liu, chunyu/0000-0002-6732-3758; Tang, Shuyan/0000-0003-2701-1976; Wang, Jiaxiong/0000-0002-2819-165X; Zhang, Feng/0000-0003-4556-8276; He, Xiao-Jin/0000-0001-5919-8478; Wang, Lingbo/0000-0002-0962-8457	National Natural Science Foundation of China [31625015, 31521003, 81601340]; Special Foundation for Development of Science and Technology of Anhui Province [2017070802D150]; Jiangsu Commission of Health [H2018050]; Foundation of the Education Department of Anhui Province [KJ2016A370]; Shanghai Medical Center of Key Programs for Female Reproductive Diseases [2017ZZ01016]; Shanghai Municipal Science and Technology Major Project [2017SHZDZX01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Foundation for Development of Science and Technology of Anhui Province; Jiangsu Commission of Health; Foundation of the Education Department of Anhui Province; Shanghai Medical Center of Key Programs for Female Reproductive Diseases; Shanghai Municipal Science and Technology Major Project	We would like to thank the families for participating and supporting this study. We also thank the Center of Cryo-electron Microscopy at Zhejiang University for technical support. This work was supported by National Natural Science Foundation of China (grant numbers 31625015, 31521003, and 81601340), Special Foundation for Development of Science and Technology of Anhui Province (2017070802D150), Jiangsu Commission of Health (H2018050), Foundation of the Education Department of Anhui Province (KJ2016A370), Shanghai Medical Center of Key Programs for Female Reproductive Diseases (2017ZZ01016), and Shanghai Municipal Science and Technology Major Project (2017SHZDZX01).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Allan RK, 2011, CELL STRESS CHAPERON, V16, P353, DOI 10.1007/s12192-010-0248-0; Amiri-Yekta A, 2016, HUM REPROD, V31, P2872, DOI 10.1093/humrep/dew262; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Auger J, 2016, HUM REPROD, V31, P10, DOI 10.1093/humrep/dev251; Auguste Y, 2018, AM J HUM GENET, V103, P413, DOI 10.1016/j.ajhg.2018.07.013; Baccetti B, 2005, HUM REPROD, V20, P2790, DOI 10.1093/humrep/dei126; Ben Khelifa M, 2014, AM J HUM GENET, V94, P95, DOI 10.1016/j.ajhg.2013.11.017; Brazelton WJ, 2001, CURR BIOL, V11, P1591, DOI 10.1016/S0960-9822(01)00485-7; Chemes HE, 2012, ASIAN J ANDROL, V14, P14, DOI 10.1038/aja.2011.168; Chung MI, 2014, ELIFE, V3, DOI 10.7554/eLife.01439; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cooper TG, 2010, HUM REPROD UPDATE, V16, P231, DOI 10.1093/humupd/dmp048; Coutton C, 2019, AM J HUM GENET, V104, P331, DOI 10.1016/j.ajhg.2018.12.013; Coutton C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02792-7; Coutton C, 2015, HUM REPROD UPDATE, V21, P455, DOI 10.1093/humupd/dmv020; Dong FN, 2018, AM J HUM GENET, V102, P636, DOI 10.1016/j.ajhg.2018.03.007; Dupont MA, 2019, HUM MOL GENET, V28, P2720, DOI 10.1093/hmg/ddz091; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; Fujihara Y, 2012, DEVELOPMENT, V139, P3583, DOI 10.1242/dev.081778; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guan Mo, 2014, Curr Protoc Mouse Biol, V4, P67, DOI 10.1002/9780470942390.mo140059; Haycraft CJ, 2003, EXP CELL RES, V284, P251, DOI 10.1016/S0014-4827(02)00089-7; Hou YQ, 2007, J CELL BIOL, V176, P653, DOI 10.1083/jcb.200608041; Ishikawa H, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a021998; JONES E, 2019, J NUCL MED S1, V60; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kherraf ZE, 2018, AM J HUM GENET, V103, P400, DOI 10.1016/j.ajhg.2018.07.014; Knowles MR, 2016, CLIN CHEST MED, V37, P449, DOI 10.1016/j.ccm.2016.04.008; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; LIU C, 2019, J MED GENET, DOI DOI 10.1136/JMEDGENET-2019-106011; Liu WJ, 2019, AM J HUM GENET, V104, P738, DOI 10.1016/j.ajhg.2019.02.020; Lores P, 2018, HUM MOL GENET, V27, P1196, DOI 10.1093/hmg/ddy034; Lu YG, 2019, BIOL REPROD, V101, P501, DOI 10.1093/biolre/ioz103; Martinez G, 2018, HUM REPROD, V33, P1973, DOI 10.1093/humrep/dey264; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; PALERMO G, 1992, LANCET, V340, P17, DOI 10.1016/0140-6736(92)92425-F; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Ramalingam M, 2014, OBSTET GYNAECOL REPR, V24, P326, DOI DOI 10.1016/J.OGRM.2014.08.006; Robay A, 2018, ARAB J UROL, V16, P53, DOI 10.1016/j.aju.2017.12.003; Rosenbaum J, 2002, CURR BIOL, V12, pR125, DOI 10.1016/S0960-9822(02)00703-0; Scholey JM, 2003, ANNU REV CELL DEV BI, V19, P423, DOI 10.1146/annurev.cellbio.19.111401.091318; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Sha YW, 2017, GENE, V633, P48, DOI 10.1016/j.gene.2017.08.033; Shen Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08182-x; Shi L, 2019, BIOL REPROD, V101, P188, DOI 10.1093/biolre/ioz071; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Takei R, 2018, BIOL OPEN, V7, DOI 10.1242/bio.033241; Tang SY, 2017, AM J HUM GENET, V100, P854, DOI 10.1016/j.ajhg.2017.04.012; Tournaye H, 2017, LANCET DIABETES ENDO, V5, P544, DOI 10.1016/S2213-8587(16)30040-7; Wambergue C, 2016, HUM REPROD, V31, P1164, DOI 10.1093/humrep/dew083; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang LB, 2017, CELL RES, V27, P815, DOI 10.1038/cr.2017.58; Wang YX, 2014, FERTIL STERIL, V101, P945, DOI 10.1016/j.fertnstert.2013.12.047; Yang SM, 2015, ASIAN J ANDROL, V17, P513, DOI 10.4103/1008-682X.146100; Yin QQ, 2018, BIOL REPROD, V98, P28, DOI 10.1093/biolre/iox128; Zhang WJ, 2016, HUM MOL GENET, V25, P4012, DOI 10.1093/hmg/ddw241; Zhang Y, 2018, CYTOSKELETON, V75, P70, DOI 10.1002/cm.21427; Zhang Y, 2017, DEV BIOL, V432, P125, DOI 10.1016/j.ydbio.2017.09.023	63	36	39	5	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 5	2019	105	6					1168	1181		10.1016/j.ajhg.2019.10.010	http://dx.doi.org/10.1016/j.ajhg.2019.10.010			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JT4BB	31735294	Green Published, Bronze			2022-12-18	WOS:000500935400008
J	Richard, EM; Polla, DL; Assir, MZ; Contreras, M; Shahzad, M; Khan, AA; Razzaq, A; Akram, J; Tarar, MN; Blanpied, TA; Ahmed, ZM; Abou Jamra, R; Wieczorek, D; van Bokhoven, H; Riazuddin, S; Riazuddin, S				Richard, Elodie M.; Polla, Daniel L.; Assir, Muhammad Zaman; Contreras, Minerva; Shahzad, Mohsin; Khan, Asma A.; Razzaq, Attia; Akram, Javed; Tarar, Moazzam N.; Blanpied, Thomas A.; Ahmed, Zubair M.; Abou Jamra, Rami; Wieczorek, Dagmar; van Bokhoven, Hans; Riazuddin, Sheikh; Riazuddin, Saima			Bi-allelic Variants in METTL5 Cause Autosomal-Recessive Intellectual Disability and Microcephaly	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							METHYLTRANSFERASE; MUTATIONS; GENE; ZEBRAFISH; IDENTIFICATION; GENOMICS; NSUN2	Intellectual disability (ID) is a genetically and clinically heterogeneous disorder, characterized by limited cognitive abilities and impaired adaptive behaviors. In recent years, exome sequencing (ES) has been instrumental in deciphering the genetic etiology of ID. Here, through ES of a large cohort of individuals with ID, we identified two bi-allelic frameshift variants in METIL5, c.344_345delGA (p.Arg115Asnfs*19) and c.571_572delAA (p.Lys191Valfs*10), in families of Pakistani and Yemenite origin. Both of these variants were segregating with moderate to severe ID, microcephaly, and various facial dysmorphisms, in an autosomal-recessive fashion. METTL5 is a member of the methyltransferase-like protein family, which encompasses proteins with a seven-beta-strand methyltransferase domain. We found METIL5 expression in various substructures of rodent and human brains and METTL5 protein to be enriched in the nucleus and synapses of the hippocampal neurons. Functional studies of these truncating variants in transiently transfected orthologous cells and cultured hippocampal rat neurons revealed no effect on the localization of METTL5 but alter its level of expression. Our in silico analysis and 3D modeling simulation predict disruption of METTL5 function by both variants. Finally, mettl5 knockdown in zebrafish resulted in microcephaly, recapitulating the human phenotype. This study provides evidence that biallelic variants in METTL5 cause ID and microcephaly in humans and highlights the essential role of METTL5 in brain development and neuronal function.	[Richard, Elodie M.; Ahmed, Zubair M.; Riazuddin, Saima] Univ Maryland, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Baltimore, MD 21201 USA; [Polla, Daniel L.; Razzaq, Attia; van Bokhoven, Hans] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Donders Inst Brain Cognit & Behav, NL-6500 HE Nijmegen, Netherlands; [Polla, Daniel L.] Minist Educ Brazil, CAPES Fdn, BR-DF700400 Brasilia, DF, Brazil; [Assir, Muhammad Zaman; Shahzad, Mohsin; Akram, Javed; Riazuddin, Sheikh] Shaheed Zulfiqar Ali Bhutto Med Univ, Ctr Genet Dis, Pakistan Inst Med Sci, Islamabad 44000, Pakistan; [Assir, Muhammad Zaman] Univ Hlth Sci, Allama Iqbal Med Coll, Lahore 54550, Pakistan; [Assir, Muhammad Zaman; Shahzad, Mohsin; Akram, Javed; Tarar, Moazzam N.; Riazuddin, Sheikh] Univ Hlth Sci, Allama Iqbal Med Coll, Jinnah Burn & Reconstruct Surg Ctr, Lahore 54550, Pakistan; [Contreras, Minerva; Blanpied, Thomas A.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Khan, Asma A.; Razzaq, Attia; Riazuddin, Sheikh] Univ Punjab, Natl Ctr Excellence Mol Biol, Lahore 53700, Pakistan; [Akram, Javed] Univ Hlth Sci, Lahore 54000, Pakistan; [Abou Jamra, Rami] Univ Med Ctr Leipzig, Inst Human Genet, Leipzig, Germany; [Abou Jamra, Rami; Wieczorek, Dagmar] Univ Duisburg Essen, Univ Klinikum Essen, Inst Humangenet, D-45147 Essen, Germany	University System of Maryland; University of Maryland Baltimore; Radboud University Nijmegen; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Pakistan Institute of Medical Sciences; University of Health Science - Pakistan; University of Health Science - Pakistan; University System of Maryland; University of Maryland Baltimore; National Center of Excellence in Molecular Biology - Pakistan; University of Punjab; University of Health Science - Pakistan; Leipzig University; University of Duisburg Essen	Riazuddin, S (corresponding author), Univ Maryland, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Baltimore, MD 21201 USA.; Riazuddin, S (corresponding author), Shaheed Zulfiqar Ali Bhutto Med Univ, Ctr Genet Dis, Pakistan Inst Med Sci, Islamabad 44000, Pakistan.; Riazuddin, S (corresponding author), Univ Hlth Sci, Allama Iqbal Med Coll, Jinnah Burn & Reconstruct Surg Ctr, Lahore 54550, Pakistan.; Riazuddin, S (corresponding author), Univ Punjab, Natl Ctr Excellence Mol Biol, Lahore 53700, Pakistan.	riazuddin@aimrc.org; sriazuddin@som.umaryland.edu	Bokhoven, J.H.L.M. van van/H-8015-2014; Wieczorek, Dagmar/AAU-6008-2021; Abou Jamra, Rami/AAC-8192-2019; Khan, Asma Al/AAH-5277-2021; Polla, Daniel L./B-3887-2015	Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Wieczorek, Dagmar/0000-0003-2812-6492; Abou Jamra, Rami/0000-0002-1542-1399; Polla, Daniel L./0000-0002-5552-3488; Shahzad, Mohsin/0000-0003-1537-3195; Blanpied, Thomas/0000-0003-4957-557X	NIH [R01NS107428]; EU [241995]; DFG [AB 3939/2-2]; NRPU Projects from Higher Education commission of Pakistan; CAPES Fellowship [99999.013311/2013-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS107428] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU(European Commission); DFG(German Research Foundation (DFG)); NRPU Projects from Higher Education commission of Pakistan; CAPES Fellowship(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH R01NS107428 (to Saima Riazuddin), the EU FP7 Large-Scale Integrating Project Genetic and Epigenetic Networks in Cognitive Dysfunction (241995) (to H.v.B.), the DFG (AB 3939/2-2) (to R.A.J.), and NRPU Projects from Higher Education commission of Pakistan (to M.S. and J.A.). D.L.P. is recipient of a CAPES Fellowship (99999.013311/2013-01).	Abbasi-Moheb L, 2012, AM J HUM GENET, V90, P847, DOI 10.1016/j.ajhg.2012.03.021; Alcina A, 2013, J MED GENET, V50, P25, DOI 10.1136/jmedgenet-2012-101085; Anazi S, 2017, MOL PSYCHIATR, V22, P615, DOI 10.1038/mp.2016.113; Bernkopf M, 2014, HUM MOL GENET, V23, P4015, DOI 10.1093/hmg/ddu115; Cai XL, 2018, CANCER LETT, V415, P11, DOI 10.1016/j.canlet.2017.11.018; Chen MN, 2018, HEPATOLOGY, V67, P2254, DOI 10.1002/hep.29683; Davarniya B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129631; Franke C, 2015, METHODS MOL BIOL, V1314, P63, DOI 10.1007/978-1-4939-2718-0_8; Freude K, 2004, AM J HUM GENET, V75, P305, DOI 10.1086/422507; Gatza ML, 2014, NAT GENET, V46, P1051, DOI 10.1038/ng.3073; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Harripaul R, 2018, MOL PSYCHIATR, V23, P973, DOI 10.1038/mp.2017.60; Harripaul Ricardo, 2017, Cold Spring Harb Perspect Med, V7, DOI 10.1101/cshperspect.a026864; Hu H, 2019, MOD RHEUMATOL, V29, P836, DOI [10.1038/s41380-017-0012-2, 10.1080/14397595.2018.1519103]; Huang J, 2014, J BONE MINER RES, V29, P1531, DOI 10.1002/jbmr.2200; Iwase S, 2017, J NEUROSCI, V37, P10773, DOI 10.1523/JNEUROSCI.1840-17.2017; Jobst-Schwan T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191503; Kashevarova AA, 2018, AM J MED GENET A, V176, P2395, DOI 10.1002/ajmg.a.40478; Kashevarova AA, 2014, GENE, V536, P145, DOI 10.1016/j.gene.2013.11.029; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Khan MA, 2012, AM J HUM GENET, V90, P856, DOI 10.1016/j.ajhg.2012.03.023; Kleefstra T, 2006, AM J HUM GENET, V79, P370, DOI 10.1086/505693; Kleefstra T, 2014, NEUROPHARMACOLOGY, V80, P83, DOI 10.1016/j.neuropharm.2013.12.025; Koranda JL, 2018, NEURON, V99, P283, DOI 10.1016/j.neuron.2018.06.007; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Lebrun N, 2018, EUR J HUM GENET, V26, P107, DOI 10.1038/s41431-017-0033-y; Lesbirel S, 2019, BBA-GENE REGUL MECH, V1862, P319, DOI 10.1016/j.bbagrm.2018.09.008; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Liu S, 2019, CELL, V176, P491, DOI 10.1016/j.cell.2018.11.038; Malla S, 2019, BBA-GENE REGUL MECH, V1862, P394, DOI 10.1016/j.bbagrm.2018.10.013; Maulik PK, 2011, RES DEV DISABIL, V32, P419, DOI 10.1016/j.ridd.2010.12.018; McKenzie K, 2015, RES DEV DISABIL, V37, P31, DOI 10.1016/j.ridd.2014.11.001; Merkurjev D, 2018, NAT NEUROSCI, V21, P1004, DOI 10.1038/s41593-018-0173-6; Meyer KD, 2019, BBA-GENE REGUL MECH, V1862, P301, DOI 10.1016/j.bbagrm.2018.10.006; Musante L, 2014, TRENDS GENET, V30, P32, DOI 10.1016/j.tig.2013.09.008; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Obholzer N, 2008, J NEUROSCI, V28, P2110, DOI 10.1523/JNEUROSCI.5230-07.2008; Parashar NC, 2018, BIOCHIMIE, V144, P56, DOI 10.1016/j.biochi.2017.10.014; Reiff RE, 2014, HUM MOL GENET, V23, P3456, DOI 10.1093/hmg/ddu054; Reuter MS, 2017, JAMA PSYCHIAT, V74, P293, DOI 10.1001/jamapsychiatry.2016.3798; Riazuddin S, 2017, MOL PSYCHIATR, V22, P1604, DOI 10.1038/mp.2016.109; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Robinson PN, 2008, AM J HUM GENET, V83, P610, DOI 10.1016/j.ajhg.2008.09.017; Schalock RL, 2007, INTELLECT DEV DISAB, V45, P116, DOI 10.1352/1934-9556(2007)45[116:TROMRU]2.0.CO;2; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Tatton-Brown K, 2014, NAT GENET, V46, P385, DOI 10.1038/ng.2917; Thisse B, 2004, METHOD CELL BIOL, V77, P505; Trujillano D, 2017, EUR J HUM GENET, V25, P176, DOI 10.1038/ejhg.2016.146; Vissers LELM, 2016, NAT REV GENET, V17, P9, DOI 10.1038/nrg3999; Wang CX, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2004880; Wang Y, 2018, NAT NEUROSCI, V21, P195, DOI 10.1038/s41593-017-0057-1; Warda AS, 2017, EMBO REP, V18, P2004, DOI 10.15252/embr.201744940; Yao B, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01195-y; Yeon SY, 2018, PATHOL ONCOL RES, V24, P617, DOI 10.1007/s12253-017-0287-2; Yousaf R, 2018, J CLIN INVEST, V128, P1509, DOI 10.1172/JCI97350; Zhang ZY, 2018, CELL RES, V28, P1050, DOI 10.1038/s41422-018-0092-9	58	36	37	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 3	2019	105	4					869	878		10.1016/j.ajhg.2019.09.007	http://dx.doi.org/10.1016/j.ajhg.2019.09.007			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC0EX	31564433	Green Published, Bronze			2022-12-18	WOS:000488953400016
J	Nagpal, S; Meng, XR; Epstein, MP; Tsoi, LC; Patrick, M; Gibson, G; De Jager, PL; Bennett, DA; Wingo, AP; Wingo, TS; Yang, JJ				Nagpal, Sini; Meng, Xiaoran; Epstein, Michael P.; Tsoi, Lam C.; Patrick, Matthew; Gibson, Greg; De Jager, Philip L.; Bennett, David A.; Wingo, Aliza P.; Wingo, Thomas S.; Yang, Jingjing			TIGAR: An Improved Bayesian Tool for Transcriptomic Data Imputation Enhances Gene Mapping of Complex Traits	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; VARIATIONAL INFERENCE; VARIABLE SELECTION; SUSCEPTIBILITY LOCI; RUSH MEMORY; REGRESSION; VARIANTS; MODEL; GWAS; MAP	The transcriptome-wide association studies (TWASs) that test for association between the study trait and the imputed gene expression levels from cis-acting expression quantitative trait loci (cis-eQTL) genotypes have successfully enhanced the discovery of genetic risk loci for complex traits. By using the gene expression imputation models fitted from reference datasets that have both genetic and transcriptomic data, TWASs facilitate gene-based tests with GWAS data while accounting for the reference transcriptomic data. The existing TWAS tools like PrediXcan and FUSION use parametric imputation models that have limitations for modeling the complex genetic architecture of transcriptomic data. Therefore, to improve on this, we employ a nonparametric Bayesian method that was originally proposed for genetic prediction of complex traits, which assumes a data-driven nonparametric prior for cis-eQTL effect sizes. The nonparametric Bayesian method is flexible and general because it includes both of the parametric imputation models used by PrediXcan and FUSION as special cases. Our simulation studies showed that the nonparametric Bayesian model improved both imputation R-2 for transcriptomic data and the TWAS power over PrediXcan when >= 1% cis-SNPs co-regulate gene expression and gene expression heritability <= 0.2. In real applications, the nonparametric Bayesian method fitted transcriptomic imputation models for 57.8% more genes over PrediXcan, thus improving the power of follow-up TWASs. We implement both parametric PrediXcan and nonparametric Bayesian methods in a convenient software tool "TIGAR" (Transcriptome-Integrated Genetic Association Resource), which imputes transcriptomic data and performs subsequent TWASs using individual-level or summary-level GWAS data.	[Nagpal, Sini; Gibson, Greg] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Meng, Xiaoran; Epstein, Michael P.] Emory Univ, Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA; [Meng, Xiaoran; Epstein, Michael P.; Wingo, Thomas S.; Yang, Jingjing] Emory Univ, Sch Med, Dept Human Genet, Ctr Computat & Quantitat Genet, Atlanta, GA 30322 USA; [Tsoi, Lam C.] Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA; [Tsoi, Lam C.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Tsoi, Lam C.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Patrick, Matthew] Univ Michigan, Sch Med, Dept Dermatol, Ann Arbor, MI 48109 USA; [De Jager, Philip L.] Columbia Univ, Neurol Inst, Med Ctr, New York, NY 10032 USA; [Bennett, David A.] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; [Wingo, Aliza P.] Atlanta VA Med Ctr, Div Mental Hlth, Decatur, GA USA; [Wingo, Aliza P.] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; [Wingo, Thomas S.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA	University System of Georgia; Georgia Institute of Technology; Emory University; Emory University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Columbia University; Rush University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center; Emory University; Emory University	Yang, JJ (corresponding author), Emory Univ, Sch Med, Dept Human Genet, Ctr Computat & Quantitat Genet, Atlanta, GA 30322 USA.	jingjing.yang@emory.edu	Wingo, Thomas/AEM-2481-2022	Wingo, Thomas/0000-0002-7679-6282; Tsoi, Lam Cheung/0000-0003-1627-5722; Nagpal, Sini/0000-0002-6624-6228	Department of Human Genetics at Emory University School of Medicine; National Institutes of Health (NIH) [R01AG056533]; NIH [R01GM11796, K01AR072129]; Dermatology Foundation; Arthritis National Research Foundation; National Psoriasis Foundation [K01AR072129]; NIA [P30AG10161, R01AG15819, R01AG17917, R01AG30146, R01AG36836, U01AG32984, U01AG46152]; Illinois Department of Public Health; Translational Genomics Research Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR072129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG056533, P50AG025688, R01AG015819, R01AG017917] Funding Source: NIH RePORTER	Department of Human Genetics at Emory University School of Medicine; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dermatology Foundation; Arthritis National Research Foundation(National Research Foundation of Korea); National Psoriasis Foundation; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Illinois Department of Public Health; Translational Genomics Research Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	J.Y. was supported by the startup funding from Department of Human Genetics at Emory University School of Medicine. A.P.W. and T.S.W. were supported by National Institutes of Health (NIH) R01AG056533. M.P.E. was supported by NIH R01GM11796. L.C.T. was supported by the Dermatology Foundation, the Arthritis National Research Foundation, the National Psoriasis Foundation, and NIH K01AR072129. ROS/MAP study data were provided by the Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL. Data collection was supported through funding by NIA grants P30AG10161, R01AG15819, R01AG17917, R01AG30146, R01AG36836, U01AG32984, and U01AG46152, the Illinois Department of Public Health, and the Translational Genomics Research Institute. In addition, we thank Thanneer Perumal and Benjamin Logsdon for performing quality control of the ROS/MAP RNA-sequencing data and for creating the brain cell type proportions.	Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Battle A, 2014, GENOME RES, V24, P14, DOI 10.1101/gr.155192.113; Bennett DA, 2018, J ALZHEIMERS DIS, V64, pS161, DOI 10.3233/JAD-179939; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P646; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P628; Blei DM, 2006, BAYESIAN ANAL, V1, P121, DOI 10.1214/06-BA104; Blei DM, 2017, J AM STAT ASSOC, V112, P859, DOI 10.1080/01621459.2017.1285773; Carbonetto P, 2012, BAYESIAN ANAL, V7, P73, DOI 10.1214/12-BA703; Casella G, 2001, Biostatistics, V2, P485, DOI 10.1093/biostatistics/2.4.485; De Jager PL, 2014, NAT NEUROSCI, V17, P1156, DOI 10.1038/nn.3786; De Jager PL, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.033; Di Lucca MA, 2013, BAYESIAN ANAL, V8, P63, DOI 10.1214/13-BA803; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Gamazon ER, 2015, NAT GENET, V47, P1091, DOI 10.1038/ng.3367; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Guan YT, 2011, ANN APPL STAT, V5, P1780, DOI 10.1214/11-AOAS455; Gusev A, 2016, NAT GENET, V48, P245, DOI 10.1038/ng.3506; Hoerl AE, 2000, TECHNOMETRICS, V42, P80, DOI 10.2307/1271436; Hu YM, 2019, NAT GENET, V51, P568, DOI 10.1038/s41588-019-0345-7; Huan TX, 2015, HUM GENET, V134, P343, DOI 10.1007/s00439-014-1524-3; Huang QY, 2015, J GENET GENOMICS, V42, P87, DOI 10.1016/j.jgg.2015.02.001; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li Q, 2010, BAYESIAN ANAL, V5, P151, DOI 10.1214/10-BA506; Lloyd-Jones LR, 2017, AM J HUM GENET, V100, P371, DOI 10.1016/j.ajhg.2017.01.026; Mancuso N, 2017, AM J HUM GENET, V100, P473, DOI 10.1016/j.ajhg.2017.01.031; Martin AR, 2017, AM J HUM GENET, V100, P635, DOI 10.1016/j.ajhg.2017.03.004; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Ng B, 2017, NAT NEUROSCI, V20, P1418, DOI 10.1038/nn.4632; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; O'Reilly PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034861; Reitz C, 2015, FUTUR NEUROL, V10, P547, DOI 10.2217/fnl.15.42; Reitz C, 2014, FUTUR NEUROL, V9, P119, DOI 10.2217/FNL.14.1; Sims R, 2017, NAT GENET, V49, P1373, DOI 10.1038/ng.3916; Su YR, 2018, AM J HUM GENET, V102, P904, DOI 10.1016/j.ajhg.2018.03.019; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tsoi LC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15382; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wu L, 2018, NAT GENET, V50, P968, DOI 10.1038/s41588-018-0132-x; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JJ, 2017, AM J HUM GENET, V101, P404, DOI 10.1016/j.ajhg.2017.08.002; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Yuan XZ, 2017, J ALZHEIMERS DIS, V58, P303, DOI 10.3233/JAD-170061; Zeng P, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00470-2; Zhou X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003264; Zhu ZH, 2016, NAT GENET, V48, P481, DOI 10.1038/ng.3538; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	49	36	36	2	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2019	105	2					258	266		10.1016/j.ajhg.2019.05.018	http://dx.doi.org/10.1016/j.ajhg.2019.05.018			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IM5GK	31230719	Green Published, Bronze, Green Submitted			2022-12-18	WOS:000478022200003
J	Wang, CC; Ortiz-Gonzalez, XR; Yum, SW; Gill, SM; White, A; Kelter, E; Seaver, LH; Lee, S; Wiley, G; Gaffney, PM; Wierenga, KJ; Rasband, MN				Wang, Chih-Chuan; Ortiz-Gonzalez, Xilma R.; Yum, Sabrina W.; Gill, Sara M.; White, Amy; Kelter, Erin; Seaver, Laurie H.; Lee, Sansan; Wiley, Graham; Gaffney, Patrick M.; Wierenga, Klaas J.; Rasband, Matthew N.			beta IV Spectrinopathies Cause Profound Intellectual Disability, Congenital Hypotonia, and Motor Axonal Neuropathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PERIPHERAL NERVOUS-SYSTEM; INITIAL SEGMENTS; ANKYRIN-G; WEST SYNDROME; RANVIER; NODES; HYPOMYELINATION; MUTATIONS; SPECTRINS; CHANNELS	beta IV spectrin links ankyrinG (AnkG) and clustered ion channels at axon initial segments (AISs) and nodes of Ranvier to the axonal cytoskeleton. Here, we report bi-allelic pathogenic SPTBN4 variants (three homozygous and two compound heterozygous) that cause a severe neurological syndrome that includes congenital hypotonia, intellectual disability, and motor axonal and auditory neuropathy. We introduced these variants into beta IV spectrin, expressed these in neurons, and found that 5/7 were loss-of-function variants disrupting AIS localization or abolishing phosphoinositide binding. Nerve biopsies from an individual with a loss-of-function variant had reduced nodal Na+ channels and no nodal KCNQ2 K+ channels. Modeling the disease in mice revealed that although ankyrinR (AnkR) and beta I spectrin can cluster Nathorn channels and partially compensate for the loss of AnkG and beta IV spectrin at nodes of Ranvier, AnkR and beta I spectrin cannot cluster KCNQ2- and KCNQ3-subunit-containing K+ channels. Our findings define a class of spectrinopathies and reveal the molecular pathologies causing nervous-system dysfunction.	[Wang, Chih-Chuan; Rasband, Matthew N.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Wang, Chih-Chuan; Rasband, Matthew N.] Baylor Coll Med, Integrat Mol & Biomed Sci Grad Program, Houston, TX 77030 USA; [Ortiz-Gonzalez, Xilma R.; Yum, Sabrina W.] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Ortiz-Gonzalez, Xilma R.; Yum, Sabrina W.] Childrens Hosp Philadelphia, Dept Pediat, Div Neurol, Philadelphia, PA 19104 USA; [Gill, Sara M.; White, Amy] Childrens Hosp Philadelphia, Dept Audiol, Philadelphia, PA 19104 USA; [Kelter, Erin] Women & Childrens Hosp Buffalo, Buffalo, NY 14203 USA; [Seaver, Laurie H.] MSU Coll Human Med, Dept Pediat & Human Dev, Spectrum Hlth Med Genet, Grand Rapids, MI 49503 USA; [Lee, Sansan] Hawaii Community Genet, Honolulu, HI 96814 USA; [Wiley, Graham; Gaffney, Patrick M.] Oklahoma Med Res Fdn, Div Genom & Data Sci, Arthrit & Clin Immunol Res Program, Oklahoma City, OK 73104 USA; [Wierenga, Klaas J.] Oklahoma Univ, Hlth Sci Ctr, Dept Pediat, Oklahoma City, OK 73104 USA	Baylor College of Medicine; Baylor College of Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Women & Children's Hospital of Buffalo; Michigan State University; Michigan State University College of Human Medicine; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center	Rasband, MN (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.; Rasband, MN (corresponding author), Baylor Coll Med, Integrat Mol & Biomed Sci Grad Program, Houston, TX 77030 USA.; Wierenga, KJ (corresponding author), Oklahoma Univ, Hlth Sci Ctr, Dept Pediat, Oklahoma City, OK 73104 USA.	klaas-wierenga@ouhsc.edu; rasband@bcm.edu	Ortiz-Gonzalez, Xilma/AAD-2211-2021	Ortiz-Gonzalez, Xilma/0000-0002-1710-4696; Gaffney, Patrick/0000-0002-1580-869X; Yum, Sabrina/0000-0002-5243-5546	National Institutes of Health [NS044916, NS069688, AR056360, AR063124, AI082714, GM110766, NS049453]; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Robert Wood Johnson Harold Amos Faculty Development Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082714] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056360, R01AR063124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K12NS049453, R01NS069688, R01NS044916, R37NS044916] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Robert Wood Johnson Harold Amos Faculty Development Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by grants NS044916 (M.N.R.), NS069688 (M.N.R.), AR056360 (P.M.G.), AR063124 (P.M.G.), AI082714 (P.M.G.), GM110766 (P.M.G), and NS049453 (X.O.G.) from the National Institutes of Health and the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (M.N.R.). We thank Ed Cooper for helpful discussions of AnkR and KCNQ2 and KCNQ3 interactions, and Peter Kang and Stephanie Sacharow for the evaluations of individuals A.III.1 and A.III.2. We thank Brian Harding (CHOP) for the muscle pathology photomicrographs. We thank Jun-Xian Zhang and JIan Li (University of Pennsylvania) for preparation of teased fibers from the human sural nerve biopsy. We thank Avni Santani and Addie Nesbitt at the CHOP Division of Genomics Diagnostics and Katherine Helbig at Ambry Genetics for clinical exome interpretation and referrals. X.O.G. is supported by the Robert Wood Johnson Harold Amos Faculty Development Award.	Amor V, 2017, ELIFE, V6, DOI 10.7554/eLife.21392; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Berghs S, 2000, J CELL BIOL, V151, P985, DOI 10.1083/jcb.151.5.985; D'Este E, 2017, P NATL ACAD SCI USA, V114, pE191, DOI 10.1073/pnas.1619553114; Delaunay J, 2007, BLOOD REV, V21, P1, DOI 10.1016/j.blre.2006.03.005; Devaux JJ, 2010, J PHYSIOL-LONDON, V588, P4719, DOI 10.1113/jphysiol.2010.196022; Devaux JJ, 2004, J NEUROSCI, V24, P1236, DOI 10.1523/JNEUROSCI.4512-03.2004; Hedstrom KL, 2007, J CELL BIOL, V178, P875, DOI 10.1083/jcb.200705119; Hedstrom KL, 2008, J CELL BIOL, V183, P635, DOI 10.1083/jcb.200806112; Ho TSY, 2014, NAT NEUROSCI, V17, P1664, DOI 10.1038/nn.3859; Ikeda Y, 2006, NAT GENET, V38, P184, DOI 10.1038/ng1728; Jenkins PM, 2013, J BIOL CHEM, V288, P14018, DOI 10.1074/jbc.M113.454439; King CH, 2014, J COMP NEUROL, V522, P3262, DOI 10.1002/cne.23595; Knierim E, 2017, HUM GENET, V136, P903, DOI 10.1007/s00439-017-1814-7; Komada M, 2002, J CELL BIOL, V156, P337, DOI 10.1083/jcb.200110003; Kuijpers M, 2016, NEURON, V89, P461, DOI 10.1016/j.neuron.2016.01.022; Lacas-Gervais S, 2004, J CELL BIOL, V166, P983, DOI 10.1083/jcb.200408007; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lemmon MA, 2007, BIOCHEM SOC SYMP, V74, P81, DOI 10.1042/BSS2007c08; Leterrier C, 2015, CELL REP, V13, P2781, DOI 10.1016/j.celrep.2015.11.051; Ogawa Y, 2006, J NEUROSCI, V26, P5230, DOI 10.1523/JNEUROSCI.0425-06.2006; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; Parkinson NJ, 2001, NAT GENET, V29, P61, DOI 10.1038/ng710; Saitsu H, 2010, AM J HUM GENET, V86, P881, DOI 10.1016/j.ajhg.2010.04.013; SPEICHER DW, 1992, J BIOL CHEM, V267, P14775; Susuki K, 2013, NEURON, V78, P469, DOI 10.1016/j.neuron.2013.03.005; Tohyama J, 2015, J HUM GENET, V60, P167, DOI 10.1038/jhg.2015.5; Wang C, 2014, ELIFE, V3, DOI 10.7554/eLife.04353; Writzl K, 2012, EPILEPSIA, V53, pe106, DOI 10.1111/j.1528-1167.2012.03437.x; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; Yang Y, 2004, J NEUROSCI, V24, P7230, DOI 10.1523/JNEUROSCI.2125-04.2004; Yang Y, 2007, J CELL BIOL, V176, P509, DOI 10.1083/jcb.200610128; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	33	36	36	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 7	2018	102	6					1158	1168		10.1016/j.ajhg.2018.04.012	http://dx.doi.org/10.1016/j.ajhg.2018.04.012			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GJ0LP	29861105	Bronze, Green Published			2022-12-18	WOS:000434946200012
J	Gardeitchik, T; Mohamed, M; Ruzzenente, B; Karall, D; Guerrero-Castillo, S; Dalloyaux, D; van den Brand, M; van Kraaij, S; van Asbeck, E; Assouline, Z; Rio, M; de Lonlay, P; Scholl-Buergi, S; Wolthuis, DFGJ; Hoischen, A; Rodenburg, RJ; Sperl, W; Urban, Z; Brandt, U; Mayr, JA; Wong, S; de Brouwer, APM; Nijtmans, L; Munnich, A; Rotig, A; Wevers, RA; Metodiev, MD; Morava, E				Gardeitchik, Thatjana; Mohamed, Miski; Ruzzenente, Benedetta; Karall, Daniela; Guerrero-Castillo, Sergio; Dalloyaux, Daisy; van den Brand, Mariel; van Kraaij, Sanne; van Asbeck, Ellyze; Assouline, Zahra; Rio, Marlene; de Lonlay, Pascale; Scholl-Buergi, Sabine; Wolthuis, David F. G. J.; Hoischen, Alexander; Rodenburg, Richard J.; Sperl, Wolfgang; Urban, Zsolt; Brandt, Ulrich; Mayr, Johannes A.; Wong, Sunnie; de Brouwer, Arjan P. M.; Nijtmans, Leo; Munnich, Arnold; Rotig, Agnes; Wevers, Ron A.; Metodiev, Metodi D.; Morava, Eva			Bi-allelic Mutations in the Mitochondrial Ribosomal Protein MRPS2 Cause Sensorineural Hearing Loss, Hypoglycemia, and Multiple OXPHOS Complex Deficiencies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECESSIVE CUTIS LAXA; SUBUNIT; RNA; CARDIOMYOPATHY; ALDH18A1; DISEASE	Biogenesis of the mitochondrial oxidative phosphorylation system, which produces the bulk of ATP for almost all eukaryotic cells, depends on the translation of 13 mtDNA-encoded polypeptides by mitochondria-specific ribosomes in the mitochondrial matrix. These mitoribosomes are dual-origin ribonucleoprotein complexes, which contain mtDNA-encoded rRNAs and tRNAs and similar to 80 nucleus-encoded proteins. An increasing number of gene mutations that impair mitoribosomal function and result in multiple OXPHOS deficiencies are being linked to human mitochondrial diseases. Using exome sequencing in two unrelated subjects presenting with sensorineural hearing impairment, mild developmental delay, hypoglycemia, and a combined OXPHOS deficiency, we identified mutations in the gene encoding the mitochondrial ribosomal protein S2, which has not previously been implicated in disease. Characterization of subjects' fibroblasts revealed a decrease in the steady-state amounts of mutant MRPS2, and this decrease was shown by complexome profiling to prevent the assembly of the small mitoribosomal subunit. In turn, mitochondrial translation was inhibited, resulting in a combined OXPHOS deficiency detectable in subjects' muscle and liver biopsies as well as in cultured skin fibroblasts. Reintroduction of wild-type MRPS2 restored mitochondrial translation and OXPHOS assembly. The combination of lactic acidemia, hypoglycemia, and sensorineural hearing loss, especially in the presence of a combined OXPHOS deficiency, should raise suspicion for a ribosomal-subunit-related mitochondrial defect, and clinical recognition could allow for a targeted diagnostic approach. The identification of MRPS2 as an additional gene related to mitochondrial disease further expands the genetic and phenotypic spectra of OXPHOS deficiencies caused by impaired mitochondrial translation.	[Gardeitchik, Thatjana; Mohamed, Miski; Guerrero-Castillo, Sergio; Dalloyaux, Daisy; van den Brand, Mariel; van Kraaij, Sanne; van Asbeck, Ellyze; Wolthuis, David F. G. J.; Brandt, Ulrich; Nijtmans, Leo] Radboud Univ Nijmegen, Med Ctr, Dept Pediat, NL-6500 HB Nijmegen, Netherlands; [Gardeitchik, Thatjana; Hoischen, Alexander; de Brouwer, Arjan P. M.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Ruzzenente, Benedetta; Munnich, Arnold; Rotig, Agnes; Metodiev, Metodi D.] Univ Paris 05, INSERM, U1163, Sorbonne Paris Cite,Inst Imagine, F-75015 Paris, France; [Karall, Daniela; Scholl-Buergi, Sabine; Sperl, Wolfgang] Med Univ Innsbruck, Pediat Clin, Inherited Metab Disorders, A-6020 Innsbruck, Austria; [Guerrero-Castillo, Sergio; van den Brand, Mariel; Rodenburg, Richard J.; Brandt, Ulrich; Nijtmans, Leo] Radboud Ctr Mitochondrial Med, Dept Pediat, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [Guerrero-Castillo, Sergio; van Kraaij, Sanne; Rodenburg, Richard J.; Brandt, Ulrich; Wevers, Ron A.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Translat Metab Lab, NL-6500 HB Nijmegen, Netherlands; [Assouline, Zahra; Rio, Marlene; Munnich, Arnold] Hop Necker Enfants Malad, Dept Pediat, F-75015 Paris, France; [Assouline, Zahra; Rio, Marlene; Munnich, Arnold] Hop Necker Enfants Malad, Dept Neurol, F-75015 Paris, France; [Assouline, Zahra; Rio, Marlene; Munnich, Arnold] Hop Necker Enfants Malad, Dept Genet, F-75015 Paris, France; [Urban, Zsolt] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Mayr, Johannes A.] Paracelsus Med Univ, Dept Pediat, Salzburg, Austria; [Wong, Sunnie] Tulane Univ, Hayward Genet Ctr, New Orleans, LA 70112 USA; [de Brouwer, Arjan P. M.] Donders Inst Brain Cognit & Behav, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [Morava, Eva] Mayo Clin, Dept Clin Genom, Rochester, MN 55905 USA; [de Lonlay, Pascale] Univ Paris 05, Hop Necker Enfants Malad, AP HP, Reference Ctr Inherited Metab Dis,Inst Imagine, F-75015 Paris, France	Radboud University Nijmegen; Radboud University Nijmegen; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Medical University of Innsbruck; Radboud University Nijmegen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Paracelsus Private Medical University; Tulane University; Radboud University Nijmegen; Mayo Clinic; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Metodiev, MD (corresponding author), Univ Paris 05, INSERM, U1163, Sorbonne Paris Cite,Inst Imagine, F-75015 Paris, France.; Morava, E (corresponding author), Mayo Clin, Dept Clin Genom, Rochester, MN 55905 USA.	metodi.metodiev@inserm.fr; emoravakozicz@tulane.edu	Rodenburg, Richard/N-3579-2014; Metodiev, Metodi/C-4780-2015; de Brouwer, Arjan PM/P-5949-2015; Guerrero-Castillo, Sergio/T-1515-2019; Wevers, Ron A./H-8116-2014; Hoischen, Alexander/D-1282-2013; Ruzzenente, Benedetta/H-4793-2017; Guerrero-Castillo, Sergio/E-2285-2016; Brandt, Ulrich/C-4406-2008; Hoischen, Alexander/AGF-7293-2022; Brandt, Ulrich/GLV-1242-2022; Dalloyaux, Daisy/L-7379-2016; ROTIG, AGNES/G-9592-2017; Urban, Zsolt/A-2018-2013	Rodenburg, Richard/0000-0001-5227-3527; Metodiev, Metodi/0000-0002-9596-2434; Guerrero-Castillo, Sergio/0000-0002-6630-0562; Wevers, Ron A./0000-0003-2278-9746; Hoischen, Alexander/0000-0002-8072-4476; Ruzzenente, Benedetta/0000-0001-7366-114X; Guerrero-Castillo, Sergio/0000-0002-6630-0562; Brandt, Ulrich/0000-0003-1869-6811; Hoischen, Alexander/0000-0002-8072-4476; Brandt, Ulrich/0000-0003-1869-6811; ROTIG, AGNES/0000-0003-0589-0703; Urban, Zsolt/0000-0003-3890-1843	Dutch Metakids foundation; Netherlands Organisation for Scientific Research (NWO) [017.008.052]; E-Rare project GENOMIT [01GM1207]; National Institutes of Health [HL090648]; Association Francais contre les Myopathies [19876]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090648] Funding Source: NIH RePORTER	Dutch Metakids foundation; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); E-Rare project GENOMIT; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Association Francais contre les Myopathies(Association Francaise contre les Myopathies); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank the subjects and their parents for their participation. This study was financially supported by the Dutch Metakids foundation (2012, M.M.), the Netherlands Organisation for Scientific Research (2011, NWO project 017.008.052, M.M.), the E-Rare project GENOMIT (01GM1207, A.R.), the National Institutes of Health (HL090648, Z.U.), and the Association Francais contre les Myopathies (19876, M.D.M). B.R., A.R., and M.D.M would like to acknowledge the technical assistance with cell culture from Ms. Coralie Zangarelli. Exome sequencing of subject 2 was done in collaboration with the Centre National de Genotypage.	Amunts A, 2015, SCIENCE, V348, P95, DOI 10.1126/science.aaa1193; Aseev LV, 2008, RNA, V14, P1882, DOI 10.1261/rna.1099108; Baertling F, 2015, NEUROGENETICS, V16, P237, DOI 10.1007/s10048-015-0440-6; Berk DR, 2012, J AM ACAD DERMATOL, V66, DOI 10.1016/j.jaad.2011.01.004; Bicknell LS, 2008, EUR J HUM GENET, V16, P1176, DOI 10.1038/ejhg.2008.91; Brodersen DE, 2002, J MOL BIOL, V316, P725, DOI 10.1006/jmbi.2001.5359; Dimopoulou A, 2013, MOL GENET METAB, V110, P352, DOI 10.1016/j.ymgme.2013.08.009; Distelmaier F, 2015, NEUROGENETICS, V16, P319, DOI 10.1007/s10048-015-0444-2; Galmiche L, 2011, HUM MUTAT, V32, P1225, DOI 10.1002/humu.21562; Gardeitchik T, 2014, EUR J HUM GENET, V22, P888, DOI 10.1038/ejhg.2013.154; Gilissen C, 2010, AM J HUM GENET, V87, P418, DOI 10.1016/j.ajhg.2010.08.004; Greber BJ, 2014, NATURE, V515, P283, DOI 10.1038/nature13895; Greber BJ, 2014, NATURE, V505, P515, DOI 10.1038/nature12890; Haque ME, 2008, MITOCHONDRION, V8, P254, DOI 10.1016/j.mito.2008.04.004; Heide H, 2012, CELL METAB, V16, P538, DOI 10.1016/j.cmet.2012.08.009; Kaminishi T, 2007, STRUCTURE, V15, P289, DOI 10.1016/j.str.2006.12.008; Kaushal PS, 2014, P NATL ACAD SCI USA, V111, P7284, DOI 10.1073/pnas.1401657111; Kohda M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005679; Lake NJ, 2017, AM J HUM GENET, V101, P239, DOI 10.1016/j.ajhg.2017.07.005; LAUGHREA M, 1978, J MOL BIOL, V122, P109, DOI 10.1016/0022-2836(78)90111-0; Menezes MJ, 2015, HUM MOL GENET, V24, P2297, DOI 10.1093/hmg/ddu747; Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282; Mohamed M, 2011, J INHERIT METAB DIS, V34, P907, DOI 10.1007/s10545-011-9305-9; Morava E, 2009, EUR J HUM GENET, V17, P1099, DOI 10.1038/ejhg.2009.22; Pearce S, 2013, MOL CELL NEUROSCI, V55, P1, DOI 10.1016/j.mcn.2012.08.013; Reversade B, 2009, NAT GENET, V41, P1016, DOI 10.1038/ng.413; Rorbach J, 2016, P NATL ACAD SCI USA, V113, P12198, DOI 10.1073/pnas.1609338113; Saada A, 2007, J MED GENET, V44, P784, DOI 10.1136/jmg.2007.053116; Serre V, 2013, BBA-MOL BASIS DIS, V1832, P1304, DOI 10.1016/j.bbadis.2013.04.014; Smits P, 2011, EUR J HUM GENET, V19, P394, DOI 10.1038/ejhg.2010.214; Wessels HJCT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068340; Wolthuis DFGJ, 2014, EUR J PAEDIATR NEURO, V18, P511, DOI 10.1016/j.ejpn.2014.01.003	32	36	37	3	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 5	2018	102	4					685	695		10.1016/j.ajhg.2018.02.012	http://dx.doi.org/10.1016/j.ajhg.2018.02.012			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GB8QQ	29576219	Bronze, Green Published			2022-12-18	WOS:000429340800014
J	Zarouchlioti, C; Sanchez-Pintado, B; Tear, NJH; Klein, P; Liskova, P; Dulla, K; Semo, M; Vugler, AA; Muthusamy, K; Dudakova, L; Levis, HJ; Skalicka, P; Hysi, P; Cheetham, ME; Tuft, SJ; Adamson, P; Hardcastle, AJ; Davidson, AE				Zarouchlioti, Christina; Sanchez-Pintado, Beatriz; Tear, Nathaniel J. Hafford; Klein, Pontus; Liskova, Petra; Dulla, Kalyan; Semo, Ma'ayan; Vugler, Anthony A.; Muthusamy, Kirithika; Dudakova, Lubica; Levis, Hannah J.; Skalicka, Pavlina; Hysi, Pirro; Cheetham, Michael E.; Tuft, Stephen J.; Adamson, Peter; Hardcastle, Alison J.; Davidson, Alice E.			Antisense Therapy for a Common Corneal Dystrophy Ameliorates TCF4 Repeat Expansion-Mediated Toxicity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CTG18.1 TRINUCLEOTIDE REPEAT; TRANSCRIPTION FACTOR; MOUSE MODELS; RNA TOXICITY; NUCLEAR-RNA; OLIGONUCLEOTIDES; GENE; ASSOCIATION; DISEASE; GUTTATA	Fuchs endothelial corneal dystrophy (FECD) is a common disease for which corneal transplantation is the only treatment option in advanced stages, and alternative treatment strategies are urgently required. Expansion (>= 50 copies) of a non-coding trinucleotide repeat in TCF4 confers >76-fold risk for FECD in our large cohort of affected individuals. An FECD subject-derived corneal endothelial cell (CEC) model was developed to probe disease mechanism and investigate therapeutic approaches. The CEC model demonstrated that the repeat expansion leads to nuclear RNA foci, with the sequestration of splicing factor proteins (MBNL1 and MBNL2) to the foci and altered mRNA processing. Antisense oligonucleotide (ASO) treatment led to a significant reduction in the incidence of nuclear foci, MBNL1 recruitment to the foci, and downstream aberrant splicing events, suggesting functional rescue. This proof-of-concept study highlights the potential of a targeted ASO therapy to treat the accessible and tractable corneal tissue affected by this repeat expansion-mediated disease.	[Zarouchlioti, Christina; Sanchez-Pintado, Beatriz; Tear, Nathaniel J. Hafford; Semo, Ma'ayan; Vugler, Anthony A.; Muthusamy, Kirithika; Cheetham, Michael E.; Tuft, Stephen J.; Hardcastle, Alison J.; Davidson, Alice E.] UCL Inst Ophthalmol, London ECIV 9EL, England; [Klein, Pontus; Dulla, Kalyan; Adamson, Peter] ProQR Therapeut, Zernikedreef 9, NL-2333 CK Leiden, Netherlands; [Liskova, Petra; Dudakova, Lubica; Skalicka, Pavlina] Charles Univ Prague, Fac Med 1, Dept Paediat & Adolescent Med, Res Unit Rare Dis, Ke Karlovu 2, Prague 12808, Czech Republic; [Liskova, Petra; Dudakova, Lubica; Skalicka, Pavlina] Gen Univ Hosp Prague, Ke Karlovu 2, Prague 12808, Czech Republic; [Liskova, Petra; Skalicka, Pavlina] Charles Univ Prague, Fac Med 1, Dept Ophthalmol, U Nemocnice 2, Prague, Czech Republic; [Liskova, Petra; Skalicka, Pavlina] Gen Univ Hosp Prague, U Nemocnice 2, Prague, Czech Republic; [Muthusamy, Kirithika; Tuft, Stephen J.] Moorfields Eye Hosp, London EC1V 2PD, England; [Levis, Hannah J.] Univ Liverpool, Inst Aging & Chron Dis, Liverpool L7 8TX, Merseyside, England; [Hysi, Pirro] Kings Coll London, Dept Ophthalmol & Twin Res, London SE1 7EH, England	University of London; University College London; Charles University Prague; Charles University Prague; General University Hospital Prague; Charles University Prague; General University Hospital Prague; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Liverpool; University of London; King's College London	Davidson, AE (corresponding author), UCL Inst Ophthalmol, London ECIV 9EL, England.	alice.davidson@ucl.ac.uk	Liskova, Petra/C-9680-2011; Dulla, Kalyan/AAM-3582-2021; Levis, Hannah/AAH-6556-2019; Dudakova, Lubica/F-4781-2017	Liskova, Petra/0000-0001-7834-8486; Dudakova, Lubica/0000-0003-4718-8955; Hysi, Pirro/0000-0001-5752-2510; Levis, Hannah/0000-0002-3923-1178; Skalicka, Pavlina/0000-0002-7403-3433; Cheetham, Michael/0000-0001-6429-654X; Hafford-Tear, Nathaniel/0000-0001-8564-5198; Semo, Ma'ayan/0000-0002-3890-721X; Hardcastle, Alison/0000-0002-0038-6770	Fight for Sight Early Career Investigator Award; Academy of Medical Sciences; Wellcome Trust; ProQR Therapeutics; UNCE [204064]; GA UK [250361/2017]; SVV [260367/2017]; National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital National Health Service Foundation Trust and UCL Institute of Ophthalmology;  [PROGRES-Q26/LF1];  [GACR 17-12355S]; Academy of Medical Sciences (AMS) [SBF001\\1010] Funding Source: researchfish; Rosetrees Trust [M311-F1] Funding Source: researchfish; Fight for Sight [1588/89] Funding Source: researchfish	Fight for Sight Early Career Investigator Award; Academy of Medical Sciences(Academy of Medical Sciences (AMS)); Wellcome Trust(Wellcome TrustEuropean Commission); ProQR Therapeutics; UNCE; GA UK; SVV; National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital National Health Service Foundation Trust and UCL Institute of Ophthalmology; ; ; Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Rosetrees Trust(Rosetrees Trust); Fight for Sight	We would like to thank all affected individuals for participating in this research. We would also like to acknowledge Dr. Charles A. Thornton for generously providing the MBNL1 (A2764) antibody used in this study and Miracles for Sight Eye bank for providing control corneal tissue. We thank Prof. Andrew Webster and Dr. Valentina Cipriani for granting access to AMDDNA samples and Prof. Veronica van Heyningen for providing a critical appraisal of the manuscript. This work was funded by Fight for Sight Early Career Investigator Award (A.E.D.), Academy of Medical Sciences (A.E.D.), The National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital National Health Service Foundation Trust and UCL Institute of Ophthalmology, Rosetrees Trust (A.E.D. and A.J.H.), Wellcome Trust (M.E.C.), and ProQR Therapeutics. L.D., P.S., and P.L. were supported by PROGRES-Q26/LF1 and GACR 17-12355S. L.D. and P.L. were further supported by UNCE 204064 and P.S. by GA UK 250361/2017 and SVV 260367/2017. A patent has been filed by ProQR with UK and European patent offices (1517565) describing a method of treating FECD. P.A. is a listed inventor on this patent. P.K., K.D., and P.A. are all employees of ProQR Therapeutics. This work was supported in part by a grant from ProQR Therapeutics.	Afshari NA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14898; Amiel J, 2007, AM J HUM GENET, V80, P988, DOI 10.1086/515582; Baratz KH, 2010, NEW ENGL J MED, V363, P1016, DOI 10.1056/NEJMoa1007064; Bartakova A, 2016, INVEST OPHTH VIS SCI, V57, P2749, DOI 10.1167/iovs.15-18826; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Carter DA., 2016, WORKING STEM CELLS, P143; Charizanis K, 2012, NEURON, V75, P437, DOI 10.1016/j.neuron.2012.05.029; Ciesiolka A, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00097; Ding V, 2014, MABS-AUSTIN, V6, P1439, DOI 10.4161/mabs.36249; Du HQ, 2010, NAT STRUCT MOL BIOL, V17, P187, DOI 10.1038/nsmb.1720; Du JT, 2015, J BIOL CHEM, V290, P5979, DOI 10.1074/jbc.M114.621607; Eghrari AO, 2015, PROG MOL BIOL TRANSL, V134, P79, DOI 10.1016/bs.pmbts.2015.04.005; Garanto A, 2016, HUM MOL GENET, V25, P2552, DOI 10.1093/hmg/ddw118; Gerard X, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.24; Gipson IK, 2013, INVEST OPHTH VIS SCI, V54, DOI 10.1167/iovs.13-12840; Golchet G, 2000, Optometry, V71, P318; Goldberg RA, 2014, CLIN OPHTHALMOL, V8, P1761, DOI 10.2147/OPTH.S68217; Gonzalez-Barriga A, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.9; He ZG, 2016, SCI REP-UK, V6, DOI 10.1038/srep29047; Henry SP, 2001, INVEST OPHTH VIS SCI, V42, P2646; Holt I, 2009, AM J PATHOL, V174, P216, DOI 10.2353/ajpath.2009.080520; Jain A, 2017, NATURE, V546, P243, DOI 10.1038/nature22386; Jiang J, 2016, NEURON, V90, P535, DOI 10.1016/j.neuron.2016.04.006; Kitagawa K, 2002, OPHTHALMIC RES, V34, P135, DOI 10.1159/000063656; Konieczny P, 2018, RNA BIOL, V15, P1, DOI 10.1080/15476286.2017.1384119; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; Lentz JJ, 2013, NAT MED, V19, P345, DOI 10.1038/nm.3106; Lin XY, 2006, HUM MOL GENET, V15, P2087, DOI 10.1093/hmg/ddl132; LORENZETTI DW, 1967, AM J OPHTHALMOL, V64, P1155, DOI 10.1016/0002-9394(67)93073-5; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Mootha VV, 2017, INVEST OPHTH VIS SCI, V58, P4579, DOI 10.1167/iovs.17-22350; Mootha VV, 2015, INVEST OPHTH VIS SCI, V56, P2003, DOI 10.1167/iovs.14-16222; Mootha VV, 2014, INVEST OPHTH VIS SCI, V55, P33, DOI 10.1167/iovs.13-12611; Mulders SAM, 2009, P NATL ACAD SCI USA, V106, P13915, DOI 10.1073/pnas.0905780106; Murray SF, 2015, INVEST OPHTH VIS SCI, V56, P6362, DOI 10.1167/iovs.15-16400; Parfitt DA, 2016, CELL STEM CELL, V18, P769, DOI 10.1016/j.stem.2016.03.021; Peh GSL, 2015, CELL TRANSPLANT, V24, P287, DOI 10.3727/096368913X675719; Peh Gary S L, 2013, BMC Res Notes, V6, P176, DOI 10.1186/1756-0500-6-176; Peh GSL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028310; Schoch KM, 2017, NEURON, V94, P1056, DOI 10.1016/j.neuron.2017.04.010; Scoles DR, 2017, NATURE, V544, P362, DOI 10.1038/nature22044; Soliman AZ, 2015, JAMA OPHTHALMOL, V133, P1386, DOI 10.1001/jamaophthalmol.2015.3430; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Vasanth S, 2015, INVEST OPHTH VIS SCI, V56, P4531, DOI 10.1167/iovs.14-16122; Vedana G, 2016, CLIN OPHTHALMOL, V10, P321, DOI 10.2147/OPTH.S83467; Wheeler TM, 2012, NATURE, V488, P111, DOI 10.1038/nature11362; Wieben ED, 2017, INVEST OPHTH VIS SCI, V58, P343, DOI 10.1167/iovs.16-20900; Wieben ED, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049083; Xing C, 2014, INVEST OPHTH VIS SCI, V55, P7073, DOI 10.1167/iovs.14-15390; Zoega GM, 2006, OPHTHALMOLOGY, V113, P565, DOI 10.1016/j.ophtha.2005.12.014; Zweier C, 2007, AM J HUM GENET, V80, P994, DOI 10.1086/515583	52	36	38	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 5	2018	102	4					528	539		10.1016/j.ajhg.2018.02.010	http://dx.doi.org/10.1016/j.ajhg.2018.02.010			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GB8QQ	29526280	hybrid, Green Published			2022-12-18	WOS:000429340800002
J	Coram, MA; Fang, HY; Candille, SI; Assimes, TL; Tang, H				Coram, Marc A.; Fang, Huaying; Candille, Sophie I.; Assimes, Themistocles L.; Tang, Hua			Leveraging Multi-ethnic Evidence for Risk Assessment of Quantitative Traits in Minority Populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; COMPLEX TRAITS; HUMAN HEIGHT; MIXED-MODEL; PREDICTION; LOCI; HERITABILITY; ARCHITECTURE; PLEIOTROPY; COMPONENTS	An essential component of precision medicine is the ability to predict an individual's risk of disease based on genetic and non-genetic factors. For complex traits and diseases, assessing the risk due to genetic factors is challenging because it requires knowledge of both the identity of variants that influence the trait and their corresponding allelic effects. Although the set of risk variants and their allelic effects may vary between populations, a large proportion of these variants were identified based on studies in populations of European descent. Heterogeneity in genetic architecture underlying complex traits and diseases, while broadly acknowledged, remains poorly characterized. Ignoring such heterogeneity likely reduces predictive accuracy for minority individuals. In this study, we propose an approach, called XP-BLUP, which ameliorates this ethnic disparity by combining trans-ethnic and ethnic-specific information. We build a polygenic model for complex traits that distinguishes candidate trait-relevant variants from the rest of the genome. The set of candidate variants are selected based on studies in any human population, yet the allelic effects are evaluated in a population-specific fashion. Simulation studies and real data analyses demonstrate that XP-BLUP adaptively utilizes trans-ethnic information and can substantially improve predictive accuracy in minority populations. At the same time, our study highlights the importance of the continued expansion of minority cohorts.	[Coram, Marc A.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Fang, Huaying; Candille, Sophie I.; Tang, Hua] Stanford Univ, Med Ctr, Dept Genet, Stanford, CA 94305 USA; [Assimes, Themistocles L.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Assimes, Themistocles L.] Stanford Univ, Sch Med, Cardiovasc Inst, Stanford, CA 94305 USA; [Coram, Marc A.] Google Inc, Mountain View, CA 94043 USA	Stanford University; Stanford University; Stanford University; Stanford University; Google Incorporated	Tang, H (corresponding author), Stanford Univ, Med Ctr, Dept Genet, Stanford, CA 94305 USA.	huatang@stanford.edu	Assimes, Themistocles Leonard/D-9696-2015	Assimes, Themistocles Leonard/0000-0003-2349-0009; Coram, Marc/0000-0002-8877-2501; Fang, Huaying/0000-0002-7693-8260	US NIH [R01 GM073059]; National Heart, Lung, and Blood Institute, NIH, US Department of Health and Human Services [HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, HHSN271201100004C]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073059] Funding Source: NIH RePORTER	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute, NIH, US Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by US NIH grant R01 GM073059 (M.A,C., H.F., S.I.C., H.T.). M.A.C. is an employee of Google, Inc. We thank three anonymous reviewers for their constructive comments and the Genetics Bioinformatics Service Center at Stanford University for computational resources. The WHI program is funded by the National Heart, Lung, and Blood Institute, NIH, US Department of Health and Human Services through contracts HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, and HHSN271201100004C.	Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Canela-Xandri O, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10162; Carlson CS, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001661; Carty CL, 2012, HUM MOL GENET, V21, P711, DOI 10.1093/hmg/ddr489; Coram MA, 2015, AM J HUM GENET, V96, P740, DOI 10.1016/j.ajhg.2015.03.008; Coram MA, 2013, AM J HUM GENET, V92, P904, DOI 10.1016/j.ajhg.2013.04.025; CORBEIL RR, 1976, TECHNOMETRICS, V18, P31, DOI 10.2307/1267913; de los Campos G, 2010, NAT REV GENET, V11, P880, DOI 10.1038/nrg2898; Dumitrescu L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002138; Erbe M, 2012, J DAIRY SCI, V95, P4114, DOI 10.3168/jds.2011-5019; Franceschini N, 2013, AM J HUM GENET, V93, P545, DOI 10.1016/j.ajhg.2013.07.010; Golan D, 2014, P NATL ACAD SCI USA, V111, pE5272, DOI 10.1073/pnas.1419064111; Golan D, 2014, AM J HUM GENET, V95, P383, DOI 10.1016/j.ajhg.2014.09.007; Guan YT, 2011, ANN APPL STAT, V5, P1780, DOI 10.1214/11-AOAS455; Hastie TJ, 2011, ELEMENTS STAT LEARNI; HENDERSON CR, 1975, BIOMETRICS, V31, P423, DOI 10.2307/2529430; Li C, 2014, HUM GENET, V133, P639, DOI 10.1007/s00439-013-1401-5; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Makowsky R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002051; McCulloch C.E., 2001, GEN LINEAR MIXED MOD; Meuwissen THE, 2001, GENETICS, V157, P1819; Okser S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004754; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Shi JX, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006493; Solovieff N, 2013, NAT REV GENET, V14, P483, DOI 10.1038/nrg3461; Speed D, 2014, GENOME RES, V24, P1550, DOI 10.1101/gr.169375.113; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Wacholder S, 2010, NEW ENGL J MED, V362, P986, DOI 10.1056/NEJMoa0907727; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Wray NR, 2013, NAT REV GENET, V14, P507, DOI 10.1038/nrg3457; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zhou X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003264	37	36	37	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 3	2017	101	2					218	226		10.1016/j.ajhg.2017.06.015	http://dx.doi.org/10.1016/j.ajhg.2017.06.015			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FC5BD	28757202	Bronze, Green Published			2022-12-18	WOS:000406854800006
J	Halim, D; Brosens, E; Muller, F; Wangler, MF; Beaudet, AL; Lupski, JR; Akdemir, ZHC; Doukas, M; Stoop, HJ; de Graaf, BM; Brouwer, RWW; van Ijcken, WFJ; Oury, JF; Rosenblatt, J; Burns, AJ; Tibboel, D; Hofstra, RMW; Alves, MM				Halim, Danny; Brosens, Erwin; Muller, Francoise; Wangler, Michael F.; Beaudet, Arthur L.; Lupski, James R.; Akdemir, Zeynep H. Coban; Doukas, Michael; Stoop, Hans J.; de Graaf, Bianca M.; Brouwer, Rutger W. W.; van Ijcken, Wilfred F. J.; Oury, Jean-Francois; Rosenblatt, Jonathan; Burns, Alan J.; Tibboel, Dick; Hofstra, Robert M. W.; Alves, Maria M.			Loss-of-Function Variants in MYLK Cause Recessive Megacystis Microcolon Intestinal Hypoperistalsis Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LIGHT-CHAIN KINASE; AORTIC DISSECTIONS; MUTATIONS; MICE	Megacystis microcolon intestinal hypoperistalsis syndrome (MMIHS) is a congenital disorder characterized by loss of smooth muscle contraction in the bladder and intestine. To date, three genes are known to be involved in MMIHS pathogenesis: ACTG2, MYH11, and LMOD1. However, for approximately 10% of affected individuals, the genetic cause of the disease is unknown, suggesting that other loci are most likely involved. Here, we report on three MMIHS-affected subjects from two consanguineous families with no variants in the known MMIHS-associated genes. By performing homozygosity mapping and whole-exome sequencing, we found homozygous variants in myosin light chain kinase (MYLK) in both families. We identified a 7 bp duplication (c.3838_3844dupGAAAGCG [p.Glu1282_Glyfs*51]) in one family and a putative splice-site variant (c.3985_5C>A) in the other. Expression studies and splicing assays indicated that both variants affect normal MYLK expression. Because MYLK encodes an important kinase required for myosin activation and subsequent interaction with actin filaments, it is likely that in its absence, contraction of smooth muscle cells is impaired. The existence of a conditional-Mylk-knockout mouse model with severe gut dysmotility and abnormal function of the bladder supports the involvement of this gene in MMIHS pathogenesis. In aggregate, our findings implicate MYLK as a gene involved in the recessive form of MMIHS, confirming that this disease of the visceral organs is heterogeneous with a myopathic origin.	[Halim, Danny; Brosens, Erwin; de Graaf, Bianca M.; Burns, Alan J.; Hofstra, Robert M. W.; Alves, Maria M.] Erasmus Univ, Med Ctr, Dept Clin Genet, NL-3000 CA Rotterdam, Netherlands; [Muller, Francoise] Hop Univ Robert Debre, Biochim Prenatale, F-75019 Paris, France; [Wangler, Michael F.; Beaudet, Arthur L.; Lupski, James R.; Akdemir, Zeynep H. Coban] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Wangler, Michael F.; Beaudet, Arthur L.; Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Beaudet, Arthur L.; Lupski, James R.] Texas Childens Hosp, Houston, TX 77030 USA; [Lupski, James R.; Akdemir, Zeynep H. Coban] Baylor Coll Med, Baylor Hopkins Ctr Mendelian Genom, Houston, TX 77030 USA; [Lupski, James R.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Doukas, Michael; Stoop, Hans J.] Erasmus Univ, Med Ctr, Dept Pathol, NL-3000 CA Rotterdam, Netherlands; [Brouwer, Rutger W. W.; van Ijcken, Wilfred F. J.] Erasmus Univ, Med Ctr, Erasmus Ctr Biom, NL-3000 CA Rotterdam, Netherlands; [Oury, Jean-Francois; Rosenblatt, Jonathan] Hop Univ Robert Debre, Dept Obstet & Gynecol, F-75019 Paris, France; [Burns, Alan J.; Hofstra, Robert M. W.] UCL, UCL Great Ormond St Inst Child Hlth, Birth Defects Res Ctr, Stem Cells & Regenerat Med, London WC1N 1EH, England; [Tibboel, Dick] Erasmus Univ, Med Ctr, Dept Pediat Surg, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; University of London; University College London; Erasmus University Rotterdam; Erasmus MC	Hofstra, RMW; Alves, MM (corresponding author), Erasmus Univ, Med Ctr, Dept Clin Genet, NL-3000 CA Rotterdam, Netherlands.; Hofstra, RMW (corresponding author), UCL, UCL Great Ormond St Inst Child Hlth, Birth Defects Res Ctr, Stem Cells & Regenerat Med, London WC1N 1EH, England.	r.hofstra@erasmusmc.nl; m.alves@erasmusmc.nl	Brouwer, Rutger/AAI-4731-2021; van ijcken, willem/N-9805-2018; Alves, Maria/AAB-2054-2019; Burns, Alan/AAC-1266-2022; Brosens, Erwin/AAP-1913-2020; Burns, Alan J/C-4988-2008; Wangler, Michael/H-6368-2019	van ijcken, willem/0000-0002-0421-8301; Brosens, Erwin/0000-0001-8235-4010; Wangler, Michael/0000-0001-5245-5910; Burns, Alan/0000-0002-1725-1071; Brouwer, Rutger/0000-0001-7524-6230	National Human Genome Research Institute; National Heart, Lung, and Blood Institute [UM1 HG006542]; Stitching Sophia Kinderziekenhuis Fonds [S15-30]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006542, UM1HG006542] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Stitching Sophia Kinderziekenhuis Fonds; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors would like to thank the two families described in this manuscript for their cooperation and willingness to be part of this study. The authors would also like to thank Dr. Raj Kapur for his help with the analysis of the immunohistochemistry data and Tom de Vries Lentsch for making Figure S5. This work received funding from the National Human Genome Research Institute and the National Heart, Lung, and Blood Institute (UM1 HG006542) to the Baylor-Hopkins Center for Mendelian Genomics and from the Stitching Sophia Kinderziekenhuis Fonds (S15-30) to R.M.W.H. and M.M.A.	BERDON WE, 1976, AM J ROENTGENOL, V126, P957, DOI 10.2214/ajr.126.5.957; Fishilevich S, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw030; Gauthier J, 2015, EUR J HUM GENET, V23, P1266, DOI 10.1038/ejhg.2014.256; Halim D, 2017, P NATL ACAD SCI USA, V114, pE2739, DOI 10.1073/pnas.1620507114; Halim D, 2016, HUM MOL GENET, V25, P571, DOI 10.1093/hmg/ddv497; Hamamy H, 2012, J COMMUN GENET, V3, P185, DOI 10.1007/s12687-011-0072-y; Hamamy H, 2011, GENET MED, V13, P841, DOI 10.1097/GIM.0b013e318217477f; Hannuksela M, 2016, BMC MED GENET, V17, DOI 10.1186/s12881-016-0326-y; He WQ, 2008, GASTROENTEROLOGY, V135, P610, DOI 10.1053/j.gastro.2008.05.032; Hong F, 2011, ARCH BIOCHEM BIOPHYS, V510, P135, DOI 10.1016/j.abb.2011.04.018; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Matera I, 2016, EUR J HUM GENET, V24, P1211, DOI 10.1038/ejhg.2015.275; Somlyo AV, 2004, J MUSCLE RES CELL M, V25, P241, DOI 10.1023/B:JURE.0000038362.84697.c0; Szpiech ZA, 2013, AM J HUM GENET, V93, P90, DOI 10.1016/j.ajhg.2013.05.003; Thorson W, 2014, HUM GENET, V133, P737, DOI 10.1007/s00439-013-1406-0; Tuzovic L, 2015, FETAL DIAGN THER, V38, P296, DOI 10.1159/000381638; Van Der Werf CS, 2012, GASTROENTEROLOGY, V142, P453, DOI 10.1053/j.gastro.2011.11.038; Wang L, 2010, AM J HUM GENET, V87, P701, DOI 10.1016/j.ajhg.2010.10.006; Wangler MF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004258; Wymer KM, 2016, J PEDIATR SURG, V51, P1565, DOI 10.1016/j.jpedsurg.2016.06.011	21	36	36	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 6	2017	101	1					123	129		10.1016/j.ajhg.2017.05.011	http://dx.doi.org/10.1016/j.ajhg.2017.05.011			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EZ7FK	28602422	Green Published, Bronze			2022-12-18	WOS:000404886800010
J	Carrat, GR; Hu, M; Nguyen-Tu, MS; Chabosseau, P; Gaulton, KJ; van de Bunt, M; Siddiq, A; Falchi, M; Thurner, M; Canouil, M; Pattou, F; Leclerc, I; Pullen, TJ; Cane, MC; Prabhala, P; Greenwald, W; Schulte, A; Marchetti, P; Ibberson, M; MacDonald, PE; Fox, JEM; Gloyn, AL; Froguel, P; Solimena, M; McCarthy, MI; Rutter, GA				Carrat, Gaelle R.; Hu, Ming; Nguyen-Tu, Marie-Sophie; Chabosseau, Pauline; Gaulton, Kyle J.; van de Bunt, Martijn; Siddiq, Afshan; Falchi, Mario; Thurner, Matthias; Canouil, Mickael; Pattou, Francois; Leclerc, Isabelle; Pullen, Timothy J.; Cane, Matthew C.; Prabhala, Priyanka; Greenwald, William; Schulte, Anke; Marchetti, Piero; Ibberson, Mark; MacDonald, Patrick E.; Fox, Jocelyn E. Manning; Gloyn, Anna L.; Froguel, Philippe; Solimena, Michele; McCarthy, Mark I.; Rutter, Guy A.			Decreased STARD10 Expression Is Associated with Defective Insulin Secretion in Humans and Mice	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; BETA-CELL FAILURE; GENETIC ARCHITECTURE; PANCREATIC-ISLETS; GLYCEMIC TRAITS; GTTT-REPEAT; TYPE-2; GLUCOSE; INSIGHTS; VARIANTS	Genetic variants near ARAP1 (CENTD2) and STARD10 influence type 2 diabetes (T2D) risk. The risk alleles impair glucose-induced insulin secretion and, paradoxically but characteristically, are associated with decreased proinsulin:insulin ratios, indicating improved proinsulin conversion. Neither the identity of the causal variants nor the gene(s) through which risk is conferred have been firmly established. Whereas ARAP1 encodes a GTPase activating protein, STARD10 is a member of the steroidogenic acute regulatory protein (StAR)-related lipid transfer protein family. By integrating genetic fine-mapping and epigenomic annotation data and performing promoter-reporter and chromatin conformational capture (3C) studies in 3 cell lines, we localize the causal variant(s) at this locus to a 5 kb region that overlaps a stretch-enhancer active in islets. This region contains several highly correlated T2D-risk variants, including the rs140130268 indel. Expression QTL analysis of islet transcriptomes from three independent subject groups demonstrated that T2D-risk allele carriers displayed reduced levels of STARD10 mRNA, with no concomitant change in ARAP1 mRNA levels. Correspondingly, beta-cell-selective deletion of StarD10 in mice led to impaired glucose-stimulated Ca2+-dynamics and insulin secretion and recapitulated the pattern of improved proinsulin processing observed at the human GWAS signal. Conversely, overexpression of StarD10 in the adult beta cell improved glucose tolerance in high fat-fed animals. In contrast, manipulation of Arap1 in 13 cells had no impact on insulin secretion or proinsulin conversion in mice. This convergence of human and murine data provides compelling evidence that the T2D risk associated with variation at this locus is mediated through reduction in STARD10 expression in the 13 cell.	[Carrat, Gaelle R.; Hu, Ming; Nguyen-Tu, Marie-Sophie; Chabosseau, Pauline; Leclerc, Isabelle; Pullen, Timothy J.; Cane, Matthew C.; Prabhala, Priyanka; Rutter, Guy A.] Imperial Coll London, Hammersmith Hosp, Sect Cell Biol & Funct Genom, Dept Med, du Cane Rd, London W12 0NN, England; [Gaulton, Kyle J.; van de Bunt, Martijn; Thurner, Matthias; Greenwald, William; Gloyn, Anna L.; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England; [Gaulton, Kyle J.; Greenwald, William] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [van de Bunt, Martijn; Thurner, Matthias; Gloyn, Anna L.; McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [Siddiq, Afshan; Falchi, Mario; Froguel, Philippe] Imperial Coll London, Dept Genom Common Dis, London W12 0NN, England; [Falchi, Mario] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Canouil, Mickael; Pattou, Francois; Froguel, Philippe] EGID, F-59045 Lille, France; [Canouil, Mickael; Pattou, Francois; Froguel, Philippe] Lille Univ, F-59655 Villeneuve Dascq, France; [Schulte, Anke] Sanofi Aventis Deutschland GmbH, D-65926 Frankfurt, Germany; [Marchetti, Piero] Univ Pisa, Dept Endocrinol & Metab, I-56126 Pisa, Italy; [Ibberson, Mark] SIB, Vital IT Grp, CH-1015 Lausanne, Switzerland; [MacDonald, Patrick E.; Fox, Jocelyn E. Manning] Univ Alberta, Alberta Diabet Inst Islet Core, Edmonton, AB T6G 2E1, Canada; [MacDonald, Patrick E.; Fox, Jocelyn E. Manning] Univ Alberta, Dept Pharmacol, Edmonton, AB T6G 2E1, Canada; [Gloyn, Anna L.; McCarthy, Mark I.] Churchill Hosp, Oxford NIHR Biomed Res Ctr, Old Rd, Oxford OX3 7LJ, England; [Solimena, Michele] Univ Hosp, Paul Langerhans Inst, Helmholtz Ctr Munich, D-01307 Dresden, Germany; [Solimena, Michele] Tech Univ Dresden, Fac Med, D-01307 Dresden, Germany; [Solimena, Michele] German Ctr Diabet Res DZD eV, D-85764 Neuherberg, Germany; [Solimena, Michele] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Imperial College London; University of Oxford; Wellcome Centre for Human Genetics; University of California System; University of California San Diego; University of Oxford; Imperial College London; University of London; King's College London; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Sanofi-Aventis; University of Pisa; Swiss Institute of Bioinformatics; University of Alberta; University of Alberta; University of Oxford; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Max Planck Society	Rutter, GA (corresponding author), Imperial Coll London, Hammersmith Hosp, Sect Cell Biol & Funct Genom, Dept Med, du Cane Rd, London W12 0NN, England.	g.rutter@imperial.ac.uk	Solimena, Michele/E-1275-2011; Solimena, Michele/GVS-5990-2022; Pattou, Francois/O-6151-2017; Canouil, Mickaël/L-6657-2018; FROGUEL, Philippe/O-6799-2017; Pullen, Timothy/H-2143-2011; McCarthy, Mark/M-3763-2015	Pattou, Francois/0000-0001-8388-3766; Canouil, Mickaël/0000-0002-3396-4549; FROGUEL, Philippe/0000-0003-2972-0784; Gloyn, Anna/0000-0003-1205-1844; MacDonald, Patrick/0000-0002-5439-6288; Siddiq, Afshan/0000-0002-9110-1434; van de Bunt, Martijn/0000-0002-6744-6125; Rutter, Guy/0000-0001-6360-0343; Carrat, Gaelle/0000-0003-1189-3441; Falchi, Mario/0000-0002-5646-1004; Ibberson, Mark/0000-0003-3152-5670; Pullen, Timothy/0000-0002-6853-5701; McCarthy, Mark/0000-0002-4393-0510; Greenwald, William/0000-0002-6274-1571; Leclerc, Isabelle/0000-0003-0044-7921	Wellcome Trust Senior Investigator Award [WT098424AIA]; MRC Programme [MR/J0003042/1, MR/L020149/1]; Biotechnology and Biological Sciences Research Council [BB/J015873/1]; Diabetes UK [BDA/11/0004210, BDA/15/0005275]; Imperial Confidence in Concept (ICiC) grants; Royal Society Wolfson Research Merit Award; Societe Francophone du Diabete; MRC Experimental Challenge grant [MR/L020149/1]; Innovative Medicines Initiative Joint Undertaking [155005]; European Union's Seventh Framework Programme (FP7); European Federation of Pharmaceutical Industries and Associations (EFPIA) companies; Wellcome Trust [090532, 098381, 106130]; NIH (US) [U01-DK105535, R01-MH101814]; Oxford NIHR Biomedical Research Centre; Novo Nordisk postdoctoral fellowship; Alberta Diabetes Foundation; University of Alberta; Killam Annual Professorship [20162017]; NIH [P30-DK063491]; University of Oxford; MRC [MR/L020149/1, MR/K001981/1] Funding Source: UKRI; Medical Research Council [MR/K001981/1, MR/L020149/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10099] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK105535, P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101814] Funding Source: NIH RePORTER	Wellcome Trust Senior Investigator Award(Wellcome Trust); MRC Programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Diabetes UK(Diabetes UK); Imperial Confidence in Concept (ICiC) grants; Royal Society Wolfson Research Merit Award(Royal Society of London); Societe Francophone du Diabete; MRC Experimental Challenge grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Innovative Medicines Initiative Joint Undertaking; European Union's Seventh Framework Programme (FP7); European Federation of Pharmaceutical Industries and Associations (EFPIA) companies; Wellcome Trust(Wellcome Trust); NIH (US)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oxford NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Novo Nordisk postdoctoral fellowship; Alberta Diabetes Foundation; University of Alberta(University of Alberta); Killam Annual Professorship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Oxford; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	G.A.R. was supported by a Wellcome Trust Senior Investigator Award (WT098424AIA), an MRC Programme (MR/J0003042/1), Biotechnology and Biological Sciences Research Council (BB/J015873/1), Diabetes UK (BDA/11/0004210, BDA/15/0005275), Imperial Confidence in Concept (ICiC) grants, and a Royal Society Wolfson Research Merit Award. G.R.C. received a Fellowship from the Societe Francophone du Diabete. This work was also supported by an MRC Experimental Challenge grant (MR/L020149/1) to the DIVA consortium and by the Innovative Medicines Initiative Joint Undertaking under grant agreement 155005 (IMIDIA), resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and European Federation of Pharmaceutical Industries and Associations (EFPIA) companies. We thank Raphael Scharfmann (Inserm U1016, Universite Paris Descartes, Paris, France) for advice on the use of EndoC-beta H1 cells and Professor Timothy Frayling (University of Exeter) for re-analysis of data from the MAGIC consortium. A.L.G. is a Wellcome Trust Senior Fellow in Basic Biomedical Science (095101/Z/10/Z). M.I.M. is a Wellcome Trust Senior Investigator and received Wellcome Trust grants 090532, 098381, and 106130, NIH (US) awards U01-DK105535 and R01-MH101814, MRC Programme MR/L020149/1, and funds from the Oxford NIHR Biomedical Research Centre. M.v.d.B. is supported by a Novo Nordisk postdoctoral fellowship run in partnership with the University of Oxford. Human islet isolation in Edmonton was funded in part by the Alberta Diabetes Foundation and the University of Alberta. P.E.M. was supported by a 20162017 Killam Annual Professorship. K.J.G. is supported by NIH grant P30-DK063491.	Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Ashcroft FM, 2013, NAT REV ENDOCRINOL, V9, P660, DOI 10.1038/nrendo.2013.166; Blodgett DM, 2015, DIABETES, V64, P3172, DOI 10.2337/db15-0039; Brouwers B, 2014, CELL METAB, V20, P979, DOI 10.1016/j.cmet.2014.11.004; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Caiazzo R, 2014, ANN SURG, V260, P893, DOI 10.1097/SLA.0000000000000945; Cuthbert EJ, 2008, AM J PHYSIOL-CELL PH, V294, pC263, DOI 10.1152/ajpcell.00292.2007; Del Guerra S, 2005, DIABETES, V54, P727, DOI 10.2337/diabetes.54.3.727; Delaneau O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4934; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Dimas AS, 2014, DIABETES, V63, P2158, DOI 10.2337/db13-0949; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fadista J, 2014, P NATL ACAD SCI USA, V111, P13924, DOI 10.1073/pnas.1402665111; Franzen O, 2016, SCIENCE, V353, P827, DOI 10.1126/science.aad6970; Fuchsberger C, 2016, NATURE, V536, P41, DOI 10.1038/nature18642; Gaulton KJ, 2015, NAT GENET, V47, P1415, DOI 10.1038/ng.3437; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Halban PA, 2014, DIABETES CARE, V37, P1751, DOI 10.2337/dc14-0396; Hay D, 2016, NAT GENET, V48, P895, DOI 10.1038/ng.3605; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Ito M, 2013, BBA-MOL CELL BIOL L, V1831, P459, DOI 10.1016/j.bbalip.2012.11.008; Jonsson A, 2013, DIABETES, V62, P2978, DOI 10.2337/db12-1627; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; Kone M, 2014, FASEB J, V28, P4972, DOI 10.1096/fj.14-257667; Kulzer JR, 2014, AM J HUM GENET, V94, P186, DOI 10.1016/j.ajhg.2013.12.011; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lawrence JTR, 2003, P NATL ACAD SCI USA, V100, P13320, DOI 10.1073/pnas.2232129100; Locke JM, 2015, DIABETES, V64, P1484, DOI 10.2337/db14-0957; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Marullo L, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0551-8; Matschinsky FM, 1997, CHEM BIOL, V4, P249, DOI 10.1016/S1074-5521(97)90068-5; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Milo-Landesman D, 2001, CELL TRANSPLANT, V10, P645; Mohlke KL, 2015, HUM MOL GENET, V24, pR85, DOI 10.1093/hmg/ddv264; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nielsen T, 2011, DIABETOLOGIA, V54, P1052, DOI 10.1007/s00125-011-2054-3; Nolan CJ, 2016, DIABETES, V65, P352, DOI 10.2337/dbi15-0020; Olayioye MA, 2005, J BIOL CHEM, V280, P27436, DOI 10.1074/jbc.M413330200; Ongen H, 2016, BIOINFORMATICS, V32, P1479, DOI 10.1093/bioinformatics/btv722; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Pasquali L, 2014, NAT GENET, V46, P136, DOI 10.1038/ng.2870; Pickrell JK, 2014, AM J HUM GENET, V94, P559, DOI 10.1016/j.ajhg.2014.03.004; Prescott NJ, 2010, HUM MOL GENET, V19, P1828, DOI 10.1093/hmg/ddq041; Pullen TJ, 2012, DIABETES, V61, P1719, DOI 10.2337/db11-1531; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ravassard P, 2011, J CLIN INVEST, V121, P3589, DOI 10.1172/JCI58447; Ravier MA, 2010, METHODS MOL BIOL, V633, P171, DOI 10.1007/978-1-59745-019-5_12; Rezazadeh M, 2015, J MOL NEUROSCI, V56, P593, DOI 10.1007/s12031-015-0542-5; Rezazadeh M, 2015, PROG NEURO-PSYCHOPH, V56, P161, DOI 10.1016/j.pnpbp.2014.09.001; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Rutter GA, 2014, DIABETIC MED, V31, P1480, DOI 10.1111/dme.12579; Rutter GA, 2004, DIABETOLOGIA, V47, P1861, DOI 10.1007/s00125-004-1541-1; RUTTER GA, 1993, J BIOL CHEM, V268, P22385; Rutter GA, 2008, FRONT HORM RES, V36, P118, DOI 10.1159/000115360; Rutter GA, 2015, BIOCHEM J, V466, P203, DOI 10.1042/BJ20141384; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Stegle O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000770; Steiner D. E., 1990, INSULIN, P67; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; Tarasov AI, 2012, CELL CALCIUM, V52, P28, DOI 10.1016/j.ceca.2012.03.003; THORENS B, 1988, CELL, V55, P281, DOI 10.1016/0092-8674(88)90051-7; Thorens B, 2015, DIABETOLOGIA, V58, P558, DOI 10.1007/s00125-014-3468-5; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; van de Bunt MV, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005694; van de Geijn B, 2015, NAT METHODS, V12, P1061, DOI [10.1038/NMETH.3582, 10.1038/nmeth.3582]; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wakefield J, 2007, AM J HUM GENET, V81, P208, DOI 10.1086/519024; Yamanaka M, 2000, BIOL REPROD, V62, P1694, DOI 10.1095/biolreprod62.6.1694	78	36	37	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 2	2017	100	2					238	256		10.1016/j.ajhg.2017.01.011	http://dx.doi.org/10.1016/j.ajhg.2017.01.011			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EJ6TP	28132686	Green Published, hybrid			2022-12-18	WOS:000393352000006
J	Miyake, N; Fukai, R; Ohba, C; Chihara, T; Miura, M; Shimizu, H; Kakita, A; Imagawa, E; Shiina, M; Ogata, K; Okuno-Yuguchi, J; Fueki, N; Ogiso, Y; Suzumura, H; Watabe, Y; Imataka, G; Leong, HY; Fattal-Valevski, A; Kramer, U; Miyatake, S; Kato, M; Okamoto, N; Sato, Y; Mitsuhashi, S; Nishino, I; Kaneko, N; Nishiyama, A; Tamura, T; Mizuguchi, T; Nakashima, M; Tanaka, F; Saitsu, H; Matsumoto, N				Miyake, Noriko; Fukai, Ryoko; Ohba, Chihiro; Chihara, Takahiro; Miura, Masayuki; Shimizu, Hiroshi; Kakita, Akiyoshi; Imagawa, Eri; Shiina, Masaaki; Ogata, Kazuhiro; Okuno-Yuguchi, Jiu; Fueki, Noboru; Ogiso, Yoshifumi; Suzumura, Hiroshi; Watabe, Yoshiyuki; Imataka, George; Leong, Huey Yin; Fattal-Valevski, Aviva; Kramer, Uri; Miyatake, Satoko; Kato, Mitsuhiro; Okamoto, Nobuhiko; Sato, Yoshinori; Mitsuhashi, Satomi; Nishino, Ichizo; Kaneko, Naofumi; Nishiyama, Akira; Tamura, Tomohiko; Mizuguchi, Takeshi; Nakashima, Mitsuko; Tanaka, Fumiaki; Saitsu, Hirotomo; Matsumoto, Naomichi			Biallelic TBCD Mutations Cause Early-Onset Neurodegenerative Encephalopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM; KINKY-HAIR DISEASE; FOLDING COFACTOR D; NEURONAL MORPHOGENESIS; WIRING SPECIFICITY; TUBULIN; TRANSPORT; GROWTH; DEGENERATION; MITOCHONDRIA	We describe four families with affected siblings showing unique clinical features: early-onset (before 1 year of age) progressive diffuse brain atrophy with regression, postnatal microcephaly, postnatal growth retardation, muscle weakness/atrophy, and respiratory failure. By whole-exome sequencing, we identified biallelic TBCD mutations in eight affected individuals from the four families. TBCD encodes TBCD (tubulin folding co-factor D), which is one of five tubulin-specific chaperones playing a pivotal role in microtubule assembly in all cells. A total of seven mutations were found: five missense mutations, one nonsense, and one splice site mutation resulting in a frame shift. In vitro cell experiments revealed the impaired binding between most mutant TBCD proteins and ARL2, TBCE, and J3-tubulin. The in vivo experiments using olfactory projection neurons in Drosophila melanogaster indicated that the TBCD mutations caused loss of function. The wide range of clinical severity seen in this neurodegenerative encephalopathy may result from the residual function of mutant TBCD proteins. Furthermore, the autopsied brain from one deceased individual showed characteristic neurodegenerative findings: cactus and somatic sprout formations in the residual Purkinje cells in the cerebellum, which are also seen in some diseases associated with mitochondrial impairment. Defects of microtubule formation caused by TBCD mutations may underlie the pathomechanism of this neurodegenerative encephalopathy.	[Miyake, Noriko; Fukai, Ryoko; Ohba, Chihiro; Imagawa, Eri; Miyatake, Satoko; Mizuguchi, Takeshi; Nakashima, Mitsuko; Matsumoto, Naomichi] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa 2360004, Japan; [Fukai, Ryoko; Ohba, Chihiro; Tanaka, Fumiaki] Yokohama City Univ, Grad Sch Med, Dept Neurol & Stroke Med, Yokohama, Kanagawa 2360004, Japan; [Chihara, Takahiro] Hiroshima Univ, Grad Sch Sci, Dept Biol Sci, Hiroshima 7398526, Japan; [Miura, Masayuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Genet, Tokyo 1130033, Japan; [Miura, Masayuki] Japan Agcy Med Res & Dev, Agcy Med Res & Dev, Core Res Evolut Med Sci & Technol AMED CREST, Tokyo 1000004, Japan; [Shimizu, Hiroshi; Kakita, Akiyoshi] Niigata Univ, Brain Res Inst, Dept Pathol, Niigata 9518585, Japan; [Shiina, Masaaki; Ogata, Kazuhiro] Yokohama City Univ, Grad Sch Med, Dept Biochem, Yokohama, Kanagawa 2360004, Japan; [Okuno-Yuguchi, Jiu] Nagano Childrens Hosp, Dept Neuropediat, Azumino 3998205, Japan; [Fueki, Noboru] Nagano Childrens Hosp, Div Rehabil, Azumino 3998205, Japan; [Ogiso, Yoshifumi] Nagano Childrens Hosp, Dept Clin Pathol, Azumino 3998288, Japan; [Suzumura, Hiroshi; Watabe, Yoshiyuki; Imataka, George] Dokkyo Med Univ, Sch Med, Dept Pediat, Mibu, Tochigi 3210293, Japan; [Leong, Huey Yin] Hosp Kuala Lumpur, Dept Genet, Kuala Lumpur 50586, Malaysia; [Fattal-Valevski, Aviva; Kramer, Uri] Tel Aviv Univ, Sackler Fac Med, Pediat Neurol Unit, Tel Aviv Sourasky Med Ctr, IL-6997801 Tel Aviv, Israel; [Kato, Mitsuhiro] Showa Univ, Sch Med, Dept Pediat, Tokyo 1428666, Japan; [Okamoto, Nobuhiko] Osaka Med Ctr, Dept Med Genet, Osaka 5941101, Japan; [Okamoto, Nobuhiko] Res Inst Maternal & Child Hlth, Osaka 5941101, Japan; [Sato, Yoshinori] Yokohama City Univ, Grad Sch Med, Dept Mol Biol, Yokohama, Kanagawa 2360004, Japan; [Mitsuhashi, Satomi; Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Tokyo 1878502, Japan; [Mitsuhashi, Satomi; Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Med Genome Ctr, Dept Med Genome Dev, Tokyo 1878551, Japan; [Kaneko, Naofumi; Nishiyama, Akira; Tamura, Tomohiko] Yokohama City Univ, Grad Sch Med, Dept Immunol, Yokohama, Kanagawa 2360004, Japan; [Saitsu, Hirotomo] Hamamatsu Univ Sch Med, Dept Biochem, Hamamatsu, Shizuoka 4313192, Japan	Yokohama City University; Yokohama City University; Hiroshima University; University of Tokyo; Niigata University; Yokohama City University; Dokkyo Medical University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Showa University; Osaka Medical Center for Cancer & Cardiovascular Diseases; Yokohama City University; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; Yokohama City University; Hamamatsu University School of Medicine	Miyake, N; Matsumoto, N (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa 2360004, Japan.	nmiyake@yokohama-cu.ac.jp; naomat@yokohama-cu.ac.jp	Chihara, Takahiro/G-7639-2019; Nishino, Ichizo/G-2676-2010; Imataka, George/GQQ-4372-2022; Saitsu, Hirotomo/AAM-7131-2021; Imataka, George/GPF-4347-2022	Chihara, Takahiro/0000-0001-9989-3619; Nishino, Ichizo/0000-0001-9452-112X; Imataka, George/0000-0002-7691-0460; Imataka, George/0000-0002-7691-0460; Shimizu, Hiroshi/0000-0002-4869-502X; Saitsu, Hirotomo/0000-0003-0723-0960; Kato, Mitsuhiro/0000-0003-1485-8553	grants for Research on Measures for Intractable Diseases; Comprehensive Research on Disability Health and Welfare, the Strategic Research Program for Brain Science; Initiative on Rare and Undiagnosed Diseases in Pediatrics and Initiative on Rare and Undiagnosed Diseases for Adults from the Japan Agency for Medical Research and Development; Ministry of Education, Science, Sports and Culture of Japan; Japan Society for the Promotion of Science; Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems from the Japan Science and Technology Agency; Takeda Science Foundation; Yokohama Foundation for Advancement of Medical Science; Hayashi Memorial Foundation for Female Natural Scientists; Grants-in-Aid for Scientific Research [15H04375] Funding Source: KAKEN	grants for Research on Measures for Intractable Diseases; Comprehensive Research on Disability Health and Welfare, the Strategic Research Program for Brain Science; Initiative on Rare and Undiagnosed Diseases in Pediatrics and Initiative on Rare and Undiagnosed Diseases for Adults from the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems from the Japan Science and Technology Agency; Takeda Science Foundation(Takeda Science Foundation (TSF)); Yokohama Foundation for Advancement of Medical Science; Hayashi Memorial Foundation for Female Natural Scientists(Hayashi Memorial Foundation for Female Natural Scientists); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors appreciate the participation of all the affected individuals and their families in this study. This work was supported by grants for Research on Measures for Intractable Diseases; Comprehensive Research on Disability Health and Welfare, the Strategic Research Program for Brain Science; Initiative on Rare and Undiagnosed Diseases in Pediatrics and Initiative on Rare and Undiagnosed Diseases for Adults from the Japan Agency for Medical Research and Development; Grants-in-Aid for Scientific Research on Innovative Areas (Transcription Cycle and Comprehensive Brain Science Network) from the Ministry of Education, Science, Sports and Culture of Japan; Grants-in-Aid for Scientific Research (B and C) and Challenging Exploratory Research from the Japan Society for the Promotion of Science; Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems from the Japan Science and Technology Agency; the Takeda Science Foundation; the Yokohama Foundation for Advancement of Medical Science; and the Hayashi Memorial Foundation for Female Natural Scientists.	Bhamidipati A, 2000, J CELL BIOL, V149, P1087, DOI 10.1083/jcb.149.5.1087; CLANCY RR, 1989, ANN NEUROL, V25, P185, DOI 10.1002/ana.410250213; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Davis AF, 1996, J CELL BIOL, V135, P883, DOI 10.1083/jcb.135.4.883; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Devine MJ, 2016, NEUROBIOL DIS, V90, P27, DOI 10.1016/j.nbd.2015.12.008; Fournier D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079894; GRAFSTEIN B, 1980, PHYSIOL REV, V60, P1167, DOI 10.1152/physrev.1980.60.4.1167; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; HIRANO A, 1977, ARCH NEUROL-CHICAGO, V34, P52, DOI 10.1001/archneur.1977.00500130072014; Hollenbeck Peter J., 1996, Frontiers in Bioscience (online), V1, pD91; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI [10.1242/jcs.02745, 10.1242/jcs.053850]; Jefferis GSXE, 2006, SEMIN CELL DEV BIOL, V17, P50, DOI 10.1016/j.semcdb.2005.12.002; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lewis SA, 1997, TRENDS CELL BIOL, V7, P479, DOI 10.1016/S0962-8924(97)01168-9; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Lin MY, 2015, EXP CELL RES, V334, P35, DOI 10.1016/j.yexcr.2015.01.004; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Miyake N, 2015, AM J HUM GENET, V97, P555, DOI 10.1016/j.ajhg.2015.08.013; Mori O, 2000, ACTA NEUROPATHOL, V100, P712, DOI 10.1007/s004010000209; Nithianantham S, 2015, ELIFE, V4, DOI 10.7554/eLife.08811; Nogales E, 2001, ANNU REV BIOPH BIOM, V30, P397, DOI 10.1146/annurev.biophys.30.1.397; Ohi R., 2016, F1000RES, V5; OKEDA R, 1991, ACTA NEUROPATHOL, V81, P450, DOI 10.1007/BF00293467; Okumura M, 2015, J NEUROSCI, V35, P1979, DOI 10.1523/JNEUROSCI.0973-14.2015; Owada K, 2005, NEUROLOGY, V65, P629, DOI 10.1212/01.wnl.0000173065.75680.e2; Padidela R, 2009, J CLIN ENDOCR METAB, V94, P2686, DOI 10.1210/jc.2008-2788; Parvari R, 2002, NAT GENET, V32, P448, DOI 10.1038/ng1012; Rossi L, 2004, NEUROCHEM RES, V29, P493, DOI 10.1023/B:NERE.0000014820.99232.8a; Ruthel G, 2003, J NEUROSCI, V23, P8618; Sakuma C, 2015, SCI REP-UK, V5, DOI 10.1038/srep17769; Sakuma C, 2014, GENES GENET SYST, V89, P17, DOI 10.1266/ggs.89.17; SANJAD SA, 1991, ARCH DIS CHILD, V66, P193, DOI 10.1136/adc.66.2.193; Sato N, 2009, AM J HUM GENET, V85, P544, DOI 10.1016/j.ajhg.2009.09.019; Sheng ZH, 2012, NAT REV NEUROSCI, V13, P77, DOI 10.1038/nrn3156; Tanahashi C, 2000, ACTA NEUROPATHOL, V99, P31, DOI 10.1007/PL00007403; Tian GL, 1997, J CELL BIOL, V138, P821, DOI 10.1083/jcb.138.4.821; Tian GL, 1999, J BIOL CHEM, V274, P24054, DOI 10.1074/jbc.274.34.24054; Tian GL, 2013, METHOD CELL BIOL, V115, P155, DOI 10.1016/B978-0-12-407757-7.00011-6; Volpe JJ., 2008, NEUROLOGY NEWBORN, P347	41	36	41	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 6	2016	99	4					950	961		10.1016/j.ajhg.2016.08.005	http://dx.doi.org/10.1016/j.ajhg.2016.08.005			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DY7UB	27666374	Green Published, Bronze			2022-12-18	WOS:000385333700016
J	Nikopoulos, K; Farinelli, P; Giangreco, B; Tsika, C; Royer-Bertrand, B; Mbefo, MK; Bedoni, N; Kjellstrom, U; El Zaoui, I; Di Gioia, SA; Balzano, S; Cisarova, K; Messina, A; Decembrini, S; Plainis, S; Blazaki, SV; Khan, MI; Micheal, S; Boldt, K; Ueffing, M; Moulin, AP; Cremers, FPM; Roepman, R; Arsenijevic, Y; Tsilimbaris, MK; Andreasson, S; Rivolta, C				Nikopoulos, Konstantinos; Farinelli, Pietro; Giangreco, Basilio; Tsika, Chrysanthi; Royer-Bertrand, Beryl; Mbefo, Martial K.; Bedoni, Nicola; Kjellstrom, Ulrika; El Zaoui, Ikram; Di Gioia, Silvio Alessandro; Balzano, Sara; Cisarova, Katarina; Messina, Andrea; Decembrini, Sarah; Plainis, Sotiris; Blazaki, Styliani V.; Khan, Muhammad Imran; Micheal, Shazia; Boldt, Karsten; Ueffing, Marius; Moulin, Alexandre P.; Cremers, Frans P. M.; Roepman, Ronald; Arsenijevic, Yvan; Tsilimbaris, Miltiadis K.; Andreasson, Sten; Rivolta, Carlo			Mutations in CEP78 Cause Cone-Rod Dystrophy and Hearing Loss Associated with Primary-Cilia Defects	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RETINITIS-PIGMENTOSA; BIEDL-SYNDROME; GENE; DEGENERATION; CILIOPATHIES; CENTROSOME; COMPLEX; LENGTH; MODEL; ALMS1	Cone-rod degeneration (CRD) belongs to the disease spectrum of retinal degenerations, a group of hereditary disorders characterized by an extreme clinical and genetic heterogeneity. It mainly differentiates from other retinal dystrophies, and in particular from the more frequent disease retinitis pigmentosa, because cone photoreceptors degenerate at a higher rate than rod photoreceptors, causing severe deficiency of central vision. After exome analysis of a cohort of individuals with CRD, we identified biallelic mutations in the orphan gene CEP78 in three subjects from two families: one from Greece and another from Sweden. The Greek subject, from the island of Crete, was homozygous for the c.499+1G>T (IVS3+1G>T) mutation in intron 3. The Swedish subjects, two siblings, were compound heterozygotes for the nearby mutation c.499+5G>A (IVS3+5G>A) and for the frameshift-causing variant c.633delC (p.Trp212Glyfs*18). In addition to CRD, these three individuals had hearing loss or hearing deficit. Immunostaining highlighted the presence of CEP78 in the inner segments of retinal photoreceptors, predominantly of cones, and at the base of the primary cilium of fibroblasts. Interaction studies also showed that CEP78 binds to FAM161A, another ciliary protein associated with retinal degeneration. Finally, analysis of skin fibroblasts derived from affected individuals revealed abnormal ciliary morphology, as compared to that of control cells. Altogether, our data strongly suggest that mutations in CEP78 cause a previously undescribed clinical entity of a ciliary nature characterized by blindness and deafness but clearly distinct from Usher syndrome, a condition for which visual impairment is due to retinitis pigmentosa.	[Nikopoulos, Konstantinos; Farinelli, Pietro; Royer-Bertrand, Beryl; Bedoni, Nicola; El Zaoui, Ikram; Di Gioia, Silvio Alessandro; Balzano, Sara; Cisarova, Katarina; Rivolta, Carlo] Univ Lausanne, Dept Computat Biol, Unit Med Genet, CH-1011 Lausanne, Switzerland; [Giangreco, Basilio] Univ Lausanne Hosp, Dept Psychiat, Ctr Psychiat Neurosci, CH-1008 Lausanne, Switzerland; [Tsika, Chrysanthi; Plainis, Sotiris; Blazaki, Styliani V.; Tsilimbaris, Miltiadis K.] Univ Crete, Sch Med, Dept Ophthalmol, Iraklion 71003, Greece; [Royer-Bertrand, Beryl] Univ Lausanne Hosp, Ctr Mol Dis, CH-1011 Lausanne, Switzerland; [Mbefo, Martial K.; Decembrini, Sarah; Arsenijevic, Yvan] Jules Gonin Ophthalm Hosp, Unit Gene Therapy & Stem Cell Biol, CH-1004 Lausanne, Switzerland; [Kjellstrom, Ulrika; Andreasson, Sten] Lund Univ, Skane Univ Hosp, Dept Ophthalmol, S-20502 Lund, Sweden; [Messina, Andrea] Univ Lausanne Hosp, Serv Endocrinol Diabet & Metab, CH-1011 Lausanne, Switzerland; [Khan, Muhammad Imran; Micheal, Shazia; Cremers, Frans P. M.; Roepman, Ronald] Radboud Univ Nijmegen Med Ctr, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [Khan, Muhammad Imran; Micheal, Shazia; Cremers, Frans P. M.; Roepman, Ronald] Radboud Univ Nijmegen Med Ctr, Radboud Inst Mol Life Sci, NL-6525 GA Nijmegen, Netherlands; [Boldt, Karsten; Ueffing, Marius] Univ Tubingen, Inst Ophthalm Res, Med Proteome Ctr, D-72074 Tubingen, Germany; [Moulin, Alexandre P.] Jules Gonin Ophthalm Hosp, Dept Ophthalmol, CH-1004 Lausanne, Switzerland; [Cremers, Frans P. M.] Radboud Univ Nijmegen, Donders Ctr Neurosci, NL-6525 EN Nijmegen, Netherlands	University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Crete; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Lund University; Skane University Hospital; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Radboud University Nijmegen; Radboud University Nijmegen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Radboud University Nijmegen	Rivolta, C (corresponding author), Univ Lausanne, Dept Computat Biol, Unit Med Genet, CH-1011 Lausanne, Switzerland.	carlo.rivolta@unil.ch	Farinelli, Pietro/G-8000-2017; Roepman, Ronald/B-1339-2014	Farinelli, Pietro/0000-0002-4242-3090; Roepman, Ronald/0000-0002-5178-8163; Tsilimbaris, Miltiadis/0000-0002-0130-1150; Nikopoulos, Konstantinos/0000-0002-1856-2752; Rivolta, Carlo/0000-0002-0733-9950; Khan, Muhammad Imran/0000-0003-0276-5480; Arsenijevic, Yvan/0000-0001-6960-1291; Di Gioia, Silvio Alessandro/0000-0002-7235-5682; Cisarova, Katarina/0000-0003-2711-0480; Plainis, Sotiris/0000-0002-8304-5073; Messina, Andrea/0000-0002-2393-1874	Swiss National Science Foundation [156260]; European Community's Seventh Framework Programmes FP7 [241955]; Netherlands Organization for Scientific Research [NWO Vici-865.12.005]; Rotterdamse Stichting Blindenbelangen; Stichting Blindenhulp; Stichting A.F. Deutman Researchfonds Oogheelkunde; Stichting voor Ooglijders; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; Landelijke Stichting voor Blinden en Slechtzienden; Stichting Retina Nederland Fonds; Novartis fund through UitZicht	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Community's Seventh Framework Programmes FP7; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Rotterdamse Stichting Blindenbelangen; Stichting Blindenhulp; Stichting A.F. Deutman Researchfonds Oogheelkunde; Stichting voor Ooglijders; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; Landelijke Stichting voor Blinden en Slechtzienden; Stichting Retina Nederland Fonds; Novartis fund through UitZicht	This work was supported by the Swiss National Science Foundation (grant #156260, to C.R.), by the European Community's Seventh Framework Programmes FP7/2009 under grant agreement #241955 (SYSCILIA) to R.R. and M.U., by the Netherlands Organization for Scientific Research (NWO Vici-865.12.005 to R.R), and by the Rotterdamse Stichting Blindenbelangen, the Stichting Blindenhulp, the Stichting A.F. Deutman Researchfonds Oogheelkunde, and the Stichting voor Ooglijders (to F.P.M.C. and M.I.K.). F.P.M.C. and M.I.K. were also supported by the following foundations: the Algemene Nederlandse Vereniging ter Voorkoming van Blindheid, the Landelijke Stichting voor Blinden en Slechtzienden, the Stichting Retina Nederland Fonds, and the Novartis fund, contributed through UitZicht. We would also like to acknowledge Drs. Andrea Superti-Furga and Luisa Bonafe from the Center for Molecular Diseases of the Lausanne University Hospital, Dr. Frauke Coppieters from the Ghent University Hospital, Dr. Guy Van Camp from the University of Antwerp, and Dr. Isabelle Schrauwen from the Translational Genomics Research Institute in Phoenix.	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Armour EA, 2012, AM J PHYSIOL-RENAL, V303, pF584, DOI 10.1152/ajprenal.00141.2012; Azimzadeh J, 2012, SCIENCE, V335, P461, DOI 10.1126/science.1214457; Bachmann-Gagescu R, 2015, J MED GENET, V52, P514, DOI 10.1136/jmedgenet-2015-103087; Bandah-Rozenfeld D, 2010, AM J HUM GENET, V87, P382, DOI 10.1016/j.ajhg.2010.07.022; BARD LA, 1978, ARCH OPHTHALMOL-CHIC, V96, P278; Berger W, 2010, PROG RETIN EYE RES, V29, P335, DOI 10.1016/j.preteyeres.2010.03.004; BERSON EL, 1993, INVEST OPHTH VIS SCI, V34, P1659; BERSON EL, 1968, ARCH OPHTHALMOL-CHIC, V80, P68; Cruickshanks KJ, 1998, AM J EPIDEMIOL, V148, P879; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Di Gioia S.A., 2013, THESIS; Di Gioia SA, 2012, HUM MOL GENET, V21, P5174, DOI 10.1093/hmg/dds368; Hamel CP, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-7; Han Y, 2012, GENE, V499, P318, DOI 10.1016/j.gene.2012.02.042; Hildebrandt F, 2007, J AM SOC NEPHROL, V18, P1855, DOI 10.1681/ASN.2006121344; Jakobsen L, 2011, EMBO J, V30, P1520, DOI 10.1038/emboj.2011.63; Jerger J, 1993, J Am Acad Audiol, V4, P42; Koenig R, 2003, DEV OPHTHALMOL, V37, P126; KRAUSS HR, 1982, ARCH OPHTHALMOL-CHIC, V100, P1784; Langmann T, 2010, AM J HUM GENET, V87, P376, DOI 10.1016/j.ajhg.2010.07.018; Lazar CH, 2015, HUM MUTAT, V36, P836, DOI 10.1002/humu.22822; Lenassi E, 2015, EUR J HUM GENET, V23, P1318, DOI 10.1038/ejhg.2014.283; Marshall JD, 2015, HUM MUTAT, V36, P660, DOI 10.1002/humu.22796; Marshall JD, 2011, CURR GENOMICS, V12, P225, DOI 10.2174/138920211795677912; Marshall JD, 2005, ARCH INTERN MED, V165, P675, DOI 10.1001/archinte.165.6.675; Mokrzan EM, 2007, NEPHRON EXP NEPHROL, V106, P88, DOI 10.1159/000103021; Moon H, 2014, P NATL ACAD SCI USA, V111, P8541, DOI 10.1073/pnas.1323161111; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Rivolta C, 2000, AM J HUM GENET, V66, P1975, DOI 10.1086/302926; Roosing S, 2014, PROG RETIN EYE RES, V42, P1, DOI 10.1016/j.preteyeres.2014.05.001; Royer-Bertrand B, 2015, SCI REP-UK, V5, DOI 10.1038/srep17154; Schrauwen I, 2016, HEARING RES, V333, P266, DOI 10.1016/j.heares.2015.08.013; Waters AM, 2011, PEDIATR NEPHROL, V26, P1039, DOI 10.1007/s00467-010-1731-7; WILSON DJ, 1987, ARCH OPHTHALMOL-CHIC, V105, P651; Wright AF, 2010, NAT REV GENET, V11, P273, DOI 10.1038/nrg2717; Zhang SSM, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-48	37	36	39	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 1	2016	99	3					770	776		10.1016/j.ajhg.2016.07.009	http://dx.doi.org/10.1016/j.ajhg.2016.07.009			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DV7KM	27588451	Green Published, Bronze, Green Accepted			2022-12-18	WOS:000383114800023
J	Duyzend, MH; Nuttle, X; Coe, BP; Baker, C; Nickerson, DA; Bernier, R; Eichler, EE				Duyzend, Michael H.; Nuttle, Xander; Coe, Bradley P.; Baker, Carl; Nickerson, Deborah A.; Bernier, Raphael; Eichler, Evan E.			Maternal Modifiers and Parent-of-Origin Bias of the Autism-Associated 16p11.2 CNV	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COPY NUMBER VARIANTS; MICRODELETION; DELETION; COMMON; GENES; DUPLICATIONS; VARIABILITY; PHENOTYPES; TOP3-BETA; MUTATIONS	Recurrent deletions and duplications at chromosomal region 16p11.2 are a major genetic contributor to autism but also associate with a wider range of pediatric diagnoses, including intellectual disability, coordination disorder, and language disorder. In order to investigate the potential genetic basis for phenotype variability, we assessed the parent of origin of the 16p11.2 copy-number variant (CNV) and the presence of additional CNVs in 126 families for which detailed phenotype data were available. Among de novo cases, we found a strong maternal bias for the origin of deletions (59/66, 89.4% of cases, p = 2.38 x 10(-11)), the strongest such effect so far observed for a CNV associated with a microdeletion syndrome. In contrast to de novo events, we observed no transmission bias for inherited 16p11.2 CNVs, consistent with a female meiotic hotspot of unequal crossover driving this maternal bias. We analyzed this 16p11.2 CNV cohort for the presence of secondary CNVs and found a significant maternal transmission bias for secondary deletions (32 maternal versus 14 paternal, p = 1.14 x 10(-2)). Of the secondary deletions that disrupted a gene, 82% were either maternally inherited or de novo (p = 4.3 x 10(-3)). Nine probands carry secondary CNVs that disrupt genes associated with autism and/or intellectual disability risk variants. Our findings demonstrate a strong bias toward maternal origin of 16p11.2 de novo deletions as well as a maternal transmission bias for secondary deletions that contribute to the clinical outcome on a background sensitized by the 16p11.2 CNV.	[Duyzend, Michael H.; Nuttle, Xander; Coe, Bradley P.; Baker, Carl; Nickerson, Deborah A.; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Bernier, Raphael] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Eichler, Evan E.] Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.	eee@gs.washington.edu	Coe, Bradley/A-2878-2009	Duyzend, Michael/0000-0002-3941-6447; Coe, Bradley/0000-0001-8471-4016	US National Institute of Mental Health [1F30MH105055-01]; Simons Foundation; US National Science Foundation Graduate Research Fellowship [DGE-1256082]; Simons Foundation Autism Research Initiative [294112]; NIH [R01MH101221]; MRC [G1001799, MR/N01104X/1] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101221, F30MH105055] Funding Source: NIH RePORTER; Medical Research Council [G1001799, MR/N01104X/1] Funding Source: researchfish	US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Simons Foundation; US National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Simons Foundation Autism Research Initiative; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank F. Hormozdiari, K. Steinman, and T. Brown for useful discussion and edits to the manuscript. We thank all of the families at the participating Simons VIP and SSC sites, as well as the Simons VIP and SSC consortia. We appreciate access to phenotypic data on SFARI Base. Approved researchers can obtain the Simons VIP population dataset described in this study by contacting the Simons Foundation Autism Research Initiative. A full list of the investigators who contributed to the generation of the WTCCC data is available from http://www.wtccc.org.uk/. M.H.D. was supported by US National Institute of Mental Health grant no. 1F30MH105055-01 and by the Simons Foundation, and X.N. was supported by a US National Science Foundation Graduate Research Fellowship (grant no. DGE-1256082). This work was supported by the Simons Foundation Autism Research Initiative grant no. 294112 (E.E.E.) and NIH grant no. R01MH101221 (E.E.E.). E.E.E. is an investigator of the Howard Hughes Medical Institute.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Baran Y, 2015, GENOME RES, V25, P927, DOI 10.1101/gr.192278.115; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Brys G, 2004, J COMPUT GRAPH STAT, V13, P996, DOI 10.1198/106186004X12632; Coe BP, 2014, NAT GENET, V46, P1063, DOI 10.1038/ng.3092; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Delio M, 2013, AM J HUM GENET, V92, P439, DOI 10.1016/j.ajhg.2013.01.018; Eliot C., 2007, DIFFERENTIAL ABILITI; Girirajan S, 2012, NEW ENGL J MED, V367, P1321, DOI 10.1056/NEJMoa1200395; Girirajan S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002334; Girirajan S, 2010, HUM MOL GENET, V19, pR176, DOI 10.1093/hmg/ddq366; Girirajan S, 2010, NAT GENET, V42, P203, DOI 10.1038/ng.534; Hanson E, 2015, BIOL PSYCHIAT, V77, P785, DOI 10.1016/j.biopsych.2014.04.021; Hao YY, 2004, NAT CELL BIOL, V6, P849, DOI 10.1038/ncb1159; Hehir-Kwa JY, 2011, J MED GENET, V48, P776, DOI 10.1136/jmedgenet-2011-100147; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jacquemont S, 2014, AM J HUM GENET, V94, P415, DOI 10.1016/j.ajhg.2014.02.001; Jacquemont S, 2011, NATURE, V478, P97, DOI 10.1038/nature10406; Kaminsky EB, 2011, GENET MED, V13, P777, DOI 10.1097/GIM.0b013e31822c79f9; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Krumm N, 2015, NAT GENET, V47, P582, DOI 10.1038/ng.3303; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Lopez-Correa C, 2001, HUM MOL GENET, V10, P1387, DOI 10.1093/hmg/10.13.1387; Luedi PP, 2007, GENOME RES, V17, P1723, DOI 10.1101/gr.6584707; Mannik K, 2015, JAMA-J AM MED ASSOC, V313, P2044, DOI 10.1001/jama.2015.4845; Maillard AM, 2015, MOL PSYCHIATR, V20, P140, DOI 10.1038/mp.2014.145; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Miyashita A, 2007, HUM MOL GENET, V16, P2854, DOI 10.1093/hmg/ddm244; Moreno-De-Luca A, 2015, JAMA PSYCHIAT, V72, P119, DOI 10.1001/jamapsychiatry.2014.2147; Mullen E. M., 1995, MULLEN SCALES EARLY; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Qureshi AY, 2014, J NEUROSCI, V34, P11199, DOI 10.1523/JNEUROSCI.1366-14.2014; Reinthaler EM, 2014, HUM MOL GENET, V23, P6069, DOI 10.1093/hmg/ddu306; Rosenfeld JA, 2010, J NEURODEV DISORD, V2, P26, DOI 10.1007/s11689-009-9037-4; Sanders SJ, 2015, NEURON, V87, P1215, DOI 10.1016/j.neuron.2015.09.016; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Shinawi M, 2010, J MED GENET, V47, P332, DOI 10.1136/jmg.2009.073015; Simons VIP Consortium, 2012, NEURON, V73, P1063, DOI 10.1016/j.neuron.2012.02.014; Steinberg S, 2014, MOL PSYCHIATR, V19, P108, DOI 10.1038/mp.2012.157; Stessman HA, 2014, CELL, V156, P872, DOI 10.1016/j.cell.2014.02.002; Stoll G, 2013, NAT NEUROSCI, V16, P1228, DOI 10.1038/nn.3484; Sudmant PH, 2015, SCIENCE, V349, DOI 10.1126/science.aab3761; Walters RG, 2010, NATURE, V463, P671, DOI 10.1038/nature08727; Wang JB, 2012, CELL, V150, P402, DOI 10.1016/j.cell.2012.06.030; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Wang T, 2011, DEV CELL, V21, P431, DOI 10.1016/j.devcel.2011.07.007; Wechsler D, 1999, WECHSLER ABBREVIATED; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Wu N, 2015, NEW ENGL J MED, V372, P341, DOI 10.1056/NEJMoa1406829; Xu DY, 2013, NAT NEUROSCI, V16, P1238, DOI 10.1038/nn.3479; Zufferey F, 2012, J MED GENET, V49, P660, DOI 10.1136/jmedgenet-2012-101203	57	36	38	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 7	2016	98	1					45	57		10.1016/j.ajhg.2015.11.017	http://dx.doi.org/10.1016/j.ajhg.2015.11.017			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DA8JL	26749307	Green Published, Bronze			2022-12-18	WOS:000368050800004
J	Ayub, Q; Mezzavilla, M; Pagani, L; Haber, M; Mohyuddin, A; Khaliq, S; Mehdi, SQ; Tyler-Smith, C				Ayub, Qasim; Mezzavilla, Massimo; Pagani, Luca; Haber, Marc; Mohyuddin, Aisha; Khaliq, Shagufta; Mehdi, Syed Qasim; Tyler-Smith, Chris			The Kalash Genetic Isolate: Ancient Divergence, Drift, and Selection	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN-POPULATIONS; HIGH-ALTITUDE; HUMAN GENOMES; HISTORY; PAKISTAN; SNP; ADAPTATION; COMPONENTS; LANDSCAPE; ALLELES	The Kalash represent an enigmatic isolated population of Indo-European speakers who have been living for centuries in the Hindu Kush mountain ranges of present-day Pakistan. Previous Y chromosome and mitochondrial DNA markers provided no support for their claimed Greek descent following Alexander III of Macedon's invasion of this region, and analysis of autosomal loci provided evidence of a strong genetic bottleneck. To understand their origins and demography further, we genotyped 23 unrelated Kalash samples on the Illumina HumanOmni2.5M-8 BeadChip and sequenced one male individual at high coverage on an Illumina HiSeq 2000. Comparison with published data from ancient hunter-gatherers and European farmers showed that the Kalash share genetic drift with the Paleolithic Siberian hunter-gatherers and might represent an extremely drifted ancient northern Eurasian population that also contributed to European and Near Eastern ancestry. Since the split from other South Asian populations, the Kalash have maintained a low long-term effective population size (2,319-2,603) and experienced no detectable gene flow from their geographic neighbors in Pakistan or from other extant Eurasian populations. The mean time of divergence between the Kalash and other populations currently residing in this region was estimated to be 11,800 (95% confidence interval = 10,600-12,600) years ago, and thus they represent present-day descendants of some of the earliest migrants into the Indian sub-continent from West Asia.	[Ayub, Qasim; Mezzavilla, Massimo; Pagani, Luca; Haber, Marc; Tyler-Smith, Chris] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; [Mezzavilla, Massimo] Univ Trieste, Inst Maternal & Child IRCCS Burlo Garofolo, I-34137 Trieste, Italy; [Pagani, Luca] Univ Cambridge, Div Biol Anthropol, Cambridge CB2 1QH, England; [Mohyuddin, Aisha] Shifa Tameer E Millat Univ, Shifa Coll Med, Biochem Sect, Islamabad 44000, Pakistan; [Khaliq, Shagufta] Univ Hlth Sci, Dept Human Genet Mol Biol, Lahore 54000, Pakistan; [Mehdi, Syed Qasim] Sindh Inst Urol & Transplantat, Ctr Human Genet & Mol Med, Karachi 74200, Pakistan	Wellcome Trust Sanger Institute; University of Trieste; University of Cambridge; Shifa College of Medicine; University of Health Science - Pakistan; Dow University of Health Sciences	Ayub, Q (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SA, Cambs, England.	qa1@sanger.ac.uk	Mezzavilla, Massimo/AAL-8225-2020; Haber, Marc/Y-5090-2019; Mehdi, Syed Qasim/L-2385-2015; Pagani, Luca/G-8511-2017; Mezzavilla, Massimo/J-2948-2018	Mezzavilla, Massimo/0000-0002-9000-4595; Haber, Marc/0000-0003-1000-1448; Pagani, Luca/0000-0002-6639-524X; Mezzavilla, Massimo/0000-0002-9000-4595; Ayub, Qasim/0000-0003-3291-0917	Wellcome Trust [098051]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust (098051). We thank Anna di Rienzo at the University of Chicago and Cynthia Beall at Case Western Reserve University for access to the Sherpa genotypes.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Ayub Qasim, 2009, Briefings in Functional Genomics & Proteomics, V8, P395, DOI 10.1093/bfgp/elp015; Behar DM, 2010, NATURE, V466, P238, DOI 10.1038/nature09103; Cann HM, 2002, SCIENCE, V296, P261; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Enattah NS, 2007, AM J HUM GENET, V81, P615, DOI 10.1086/520705; Firasat S, 2007, EUR J HUM GENET, V15, P121, DOI 10.1038/sj.ejhg.5201726; Giannoulatou E, 2008, BIOINFORMATICS, V24, P2209, DOI 10.1093/bioinformatics/btn386; Haak W., 2015, NATURE; Hellenthal G, 2014, SCIENCE, V343, P747, DOI 10.1126/science.1243518; Huerta-Sanchez E, 2013, MOL BIOL EVOL, V30, P1877, DOI 10.1093/molbev/mst089; Jeong CW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4281; Keller A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1701; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; LINES M, 1999, KALASHA PEOPLE N W P; Loh PR, 2013, GENETICS, V193, P1233, DOI 10.1534/genetics.112.147330; Ma F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054685; MacArthur DG, 2007, EXERC SPORT SCI REV, V35, P30, DOI 10.1097/JES.0b013e31802d8874; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Mansoor A, 2004, HUM GENET, V114, P484, DOI 10.1007/s00439-004-1094-x; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Metspalu M, 2011, AM J HUM GENET, V89, P731, DOI 10.1016/j.ajhg.2011.11.010; Mezzavilla M., 2015, J COMPUT SCI SYST BI, V8, P1, DOI [10.4172/jcsb.1000168, DOI 10.4172/JCSB.1000168]; Moorjani P, 2013, AM J HUM GENET, V93, P422, DOI 10.1016/j.ajhg.2013.07.006; O'Connell J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004234; Olalde I, 2014, NATURE, V507, P225, DOI 10.1038/nature12960; Peng B, 2005, BIOINFORMATICS, V21, P3686, DOI 10.1093/bioinformatics/bti584; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Qamar R, 2002, AM J HUM GENET, V70, P1107, DOI 10.1086/339929; Quintana-Murci L, 2004, AM J HUM GENET, V74, P827, DOI 10.1086/383236; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Schiffels S, 2014, NAT GENET, V46, P919, DOI 10.1038/ng.3015; Shi WT, 2010, MOL BIOL EVOL, V27, P385, DOI 10.1093/molbev/msp243; Storfer A, 2007, HEREDITY, V98, P128, DOI 10.1038/sj.hdy.6800917; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Yunusbayev B, 2012, MOL BIOL EVOL, V29, P359, DOI 10.1093/molbev/msr221	42	36	36	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 7	2015	96	5					775	783		10.1016/j.ajhg.2015.03.012	http://dx.doi.org/10.1016/j.ajhg.2015.03.012			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CH7AZ	25937445	Green Published, hybrid			2022-12-18	WOS:000354189300008
J	Singh, A; Compe, E; Le May, N; Egly, JM				Singh, Amita; Compe, Emanuel; Le May, Nicolas; Egly, Jean-Marc			TFIIH Subunit Alterations Causing Xeroderma Pigmentosum and Trichothiodystrophy Specifically Disturb Several Steps during Transcription	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NUCLEOTIDE-EXCISION-REPAIR; C-TERMINAL DOMAIN; DNA-REPAIR; FACTOR-IIH; NUCLEAR RECEPTORS; COCKAYNE-SYNDROME; GENE; MUTATIONS; COMPLEX; XPD	Mutations in genes encoding the ERCC3 (XPB), ERCC2 (XPD), and GTF2H5 (p8 or TTD-A) subunits of the transcription and DNA-repair factor TFIIH lead to three autosomal-recessive disorders: xeroderma pigmentosum (XP), XP associated with Cockayne syndrome (XP/CS), and trichothiodystrophy (TTD). Although these diseases were originally associated with defects in DNA repair, transcription deficiencies might be also implicated. By using retinoic acid receptor beta isoform 2 (RARB2) as a model in several cells bearing mutations in genes encoding TFIIH subunits, we observed that (1) the recruitment of the TFIIH complex was altered at the activated RARB2 promoter, (2) TFIIH participated in the recruitment of nucleotide excision repair (NER) factors during transcription in a manner different from that observed during NER, and (3) the different TFIIH variants disturbed transcription by having distinct consequences on post-translational modifications of histones, DNA-break induction, DNA demethylation, and gene-loop formation. The transition from heterochromatin to euchromatin was disrupted depending on the variant, illustrating the fact that TFIIH, by contributing to NER factor recruitment, orchestrates chromatin remodeling. The subtle transcriptional differences found between various TFIIH variants thus participate in the phenotypic variability observed among XP, XP/CS, and TTD individuals.	[Singh, Amita; Compe, Emanuel; Le May, Nicolas; Egly, Jean-Marc] Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire, Genome Express & Repair Team, Dept Funct Genom & Canc,CNRS,INSERM, F-67404 Illkirch Graffenstaden, CU Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Le May, N (corresponding author), Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire, Genome Express & Repair Team, Dept Funct Genom & Canc,CNRS,INSERM, BP 163, F-67404 Illkirch Graffenstaden, CU Strasbourg, France.	nlemay@igbmc.fr; egly@igbmc.fr	Compe, Emmanuel/U-1071-2019; Le May, Nicolas/O-1275-2016; Le May, Nicolas/R-4656-2019; Compe, Emmanuel/N-8718-2016	Le May, Nicolas/0000-0002-0172-8752; Compe, Emmanuel/0000-0002-9189-7444	European Research Council Advanced Scientists; l'Association de la Recherche contre le Cancer; l'Agence Nationale de Recherche; la Ligue Nationale contre le Cancer "Equipe Labellisee Ligue"; l'Association Nationale des Membres de l'Ordre National du Merite ANMONM; Korean National Research Foundation; Advanced European Research Council; la Ligue Nationale contre le Cancer	European Research Council Advanced Scientists; l'Association de la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); l'Agence Nationale de Recherche(French National Research Agency (ANR)); la Ligue Nationale contre le Cancer "Equipe Labellisee Ligue"; l'Association Nationale des Membres de l'Ordre National du Merite ANMONM; Korean National Research Foundation(National Research Foundation of Korea); Advanced European Research Council(European Research Council (ERC)); la Ligue Nationale contre le Cancer(Ligue nationale contre le cancer)	We thank F. Coin for fruitful discussion, T. Sexton and F. Costanzo for critical reading of the manuscript, C. Braun for help in in vitro experiments, and the Institute of Genetics and Molecular and Cellular Biology Cell Culture Facility. This study was supported by grants from the European Research Council Advanced Scientists, l'Association de la Recherche contre le Cancer, l'Agence Nationale de Recherche, la Ligue Nationale contre le Cancer "Equipe Labellisee Ligue," l'Association Nationale des Membres de l'Ordre National du Merite ANMONM, and the Korean National Research Foundation for international collaboration (Global Research Laboratory program). A.S. was supported by Advanced European Research Council grant and by la Ligue Nationale contre le Cancer fellowship for young scientists.	Akoulitchev S, 2000, NATURE, V407, P102, DOI 10.1038/35024111; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bradford PT, 2011, J MED GENET, V48, P168, DOI 10.1136/jmg.2010.083022; Brooks PJ, 2008, DNA REPAIR, V7, P834, DOI 10.1016/j.dnarep.2008.01.017; BROUGHTON BC, 1994, NAT GENET, V7, P189, DOI 10.1038/ng0694-189; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Cleaver JE, 2005, DNA REPAIR, V4, P285, DOI 10.1016/j.dnarep.2004.09.005; Coin F, 2006, MOL CELL, V21, P215, DOI 10.1016/j.molcel.2005.10.024; Coin F, 1998, NAT GENET, V20, P184, DOI 10.1038/2491; Coin F, 1999, EMBO J, V18, P1357, DOI 10.1093/emboj/18.5.1357; Coin F, 2008, MOL CELL, V31, P9, DOI 10.1016/j.molcel.2008.04.024; Coin F, 2007, MOL CELL, V26, P245, DOI 10.1016/j.molcel.2007.03.009; Compe E, 2012, NAT REV MOL CELL BIO, V13, P343, DOI 10.1038/nrm3350; Drapkin R, 1996, P NATL ACAD SCI USA, V93, P6488, DOI 10.1073/pnas.93.13.6488; Dubaele S, 2003, MOL CELL, V11, P1635, DOI 10.1016/S1097-2765(03)00182-5; Dubois MF, 1997, NUCLEIC ACIDS RES, V25, P694, DOI 10.1093/nar/25.4.694; Dvir A, 1997, P NATL ACAD SCI USA, V94, P9006, DOI 10.1073/pnas.94.17.9006; Esnault C, 2008, MOL CELL, V31, P337, DOI 10.1016/j.molcel.2008.06.021; FEAVER WJ, 1991, CELL, V67, P1223, DOI 10.1016/0092-8674(91)90298-D; FEAVER WJ, 1993, CELL, V75, P1379, DOI 10.1016/0092-8674(93)90624-Y; Giglia-Mari G, 2004, NAT GENET, V36, P714, DOI 10.1038/ng1387; Giglia-Mari G, 2006, PLOS BIOL, V4, P952, DOI 10.1371/journal.pbio.0040156; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Holstege FCP, 1996, EMBO J, V15, P1666, DOI 10.1002/j.1460-2075.1996.tb00512.x; Itin PH, 2001, J AM ACAD DERMATOL, V44, P891, DOI 10.1067/mjd.2001.114294; Ito S, 2007, MOL CELL, V26, P231, DOI 10.1016/j.molcel.2007.03.013; Ito S, 2010, MOL CELL, V39, P632, DOI 10.1016/j.molcel.2010.07.029; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Kalveram B, 2011, J VIROL, V85, P6234, DOI 10.1128/JVI.02255-10; Keriel A, 2002, CELL, V109, P125, DOI 10.1016/S0092-8674(02)00692-X; Kim M, 2009, J BIOL CHEM, V284, P26421, DOI 10.1074/jbc.M109.028993; Le May N, 2004, CELL, V116, P541, DOI 10.1016/S0092-8674(04)00132-1; Le May N, 2012, MOL CELL, V47, P622, DOI 10.1016/j.molcel.2012.05.050; Le May N, 2010, MOL CELL, V38, P54, DOI 10.1016/j.molcel.2010.03.004; LEHMANN AR, 1989, CARCINOGENESIS, V10, P1353, DOI 10.1093/carcin/10.8.1353; LU H, 1992, NATURE, V358, P641, DOI 10.1038/358641a0; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; OHKUMA Y, 1994, NATURE, V368, P160, DOI 10.1038/368160a0; Reardon JT, 1996, P NATL ACAD SCI USA, V93, P6482, DOI 10.1073/pnas.93.13.6482; Riou L, 1999, HUM MOL GENET, V8, P1125, DOI 10.1093/hmg/8.6.1125; RochetteEgly C, 1997, CELL, V90, P97, DOI 10.1016/S0092-8674(00)80317-7; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; Scharer OD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012609; Schmitz KM, 2009, MOL CELL, V33, P344, DOI 10.1016/j.molcel.2009.01.015; SCOTT RJ, 1993, J AM ACAD DERMATOL, V29, P883, DOI 10.1016/0190-9622(93)70263-S; STEFANINI M, 1992, MUTAT RES, V273, P119, DOI 10.1016/0921-8777(92)90073-C; STEFANINI M, 1993, AM J HUM GENET, V53, P817; TAKAYAMA K, 1995, CANCER RES, V55, P5656; Taylor EM, 1997, P NATL ACAD SCI USA, V94, P8658, DOI 10.1073/pnas.94.16.8658; Traboulsi H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004732; Vernimmen D, 2007, EMBO J, V26, P2041, DOI 10.1038/sj.emboj.7601654; Wang H, 2012, GENOME RES, V22, P1680, DOI 10.1101/gr.136101.111; Weeda G, 1997, NUCLEIC ACIDS RES, V25, P2274, DOI 10.1093/nar/25.12.2274; Williams K, 2012, EMBO REP, V13, P28, DOI 10.1038/embor.2011.233; Winkler GS, 1998, J BIOL CHEM, V273, P1092, DOI 10.1074/jbc.273.2.1092; Yokoi M, 2000, J BIOL CHEM, V275, P9870, DOI 10.1074/jbc.275.13.9870; Zentner GE, 2013, NAT STRUCT MOL BIOL, V20, P259, DOI 10.1038/nsmb.2470; Zurita M, 2003, TRENDS GENET, V19, P578, DOI 10.1016/j.tig.2003.08.005	58	36	37	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 5	2015	96	2					194	207		10.1016/j.ajhg.2014.12.012	http://dx.doi.org/10.1016/j.ajhg.2014.12.012			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CA9WY	25620205	Green Published, Bronze			2022-12-18	WOS:000349276700002
J	Arbiza, L; Gottipati, S; Siepel, A; Keinan, A				Arbiza, Leonardo; Gottipati, Srikanth; Siepel, Adam; Keinan, Alon			Contrasting X-Linked and Autosomal Diversity across 14 Human Populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALLELE FREQUENCY-SPECTRUM; GENOME-WIDE PATTERNS; DROSOPHILA-MELANOGASTER; SEX-CHROMOSOMES; DEMOGRAPHIC HISTORY; GENETIC INFERENCE; EVOLUTION; SELECTION; SIZE; ADMIXTURE	Contrasting the genetic diversity of the human X chromosome (X) and autosomes has facilitated understanding historical differences between males and females and the influence of natural selection. Previous studies based on smaller data sets have left questions regarding how empirical patterns extend to additional populations and which forces can explain them. Here, we address these questions by analyzing the ratio of X-to-autosomal (X/A) nucleotide diversity with the complete genomes of 569 females from 14 populations. Results show that X/A diversity is similar within each continental group but notably lower in European (EUR) and East Asian (ASN) populations than in African (AFR) populations. X/A diversity increases in all populations with increasing distance from genes, highlighting the stronger impact of diversity-reducing selection on X than on the autosomes. However, relative X/A diversity (between. two populations) is invariant with distance from genes, suggesting that selection does not drive the relative reduction in X/A diversity in non-Africans (0.842 +/- 0.012 for EUR-to-AFR and 0.820 +/- 0.032 for ASN-to-AFR comparisons). Finally, an array of models with varying population bottlenecks, expansions, and migration from the latest studies of human demographic history account for about half of the observed reduction in relative X/A diversity from the expected value of 1. They predict values between 0.91 and 0.94 for EUR-to-AFR comparisons and between 0.91 and 0.92 for ASN-to-AFR comparisons. Further reductions can be predicted by more extreme demographic events in excess of those captured by. the latest studies but, in the absence of these, also by historical sex-biased demographic events or other processes.	[Arbiza, Leonardo; Gottipati, Srikanth; Siepel, Adam; Keinan, Alon] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA	Cornell University	Keinan, A (corresponding author), Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA.	ak735@cornell.edu		Siepel, Adam/0000-0002-3557-7219; Keinan, Alon/0000-0002-9760-1122	NIH [R01-HG006849, U01-HG005715, R01-GM102192]; Ellison Medical Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006849, U01HG005715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102192] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Diana Chang and Aaron Sams for comments and discussions on earlier versions of the manuscript. This work was supported in part by NIH grants R01-HG006849 (A.K.), U01-HG005715 (A.K.), and R01-GM102192 (A.S.) and by an award from the Ellison Medical Foundation (A.K.).	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amato R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007927; Andolfatto P, 2001, MOL BIOL EVOL, V18, P279, DOI 10.1093/oxfordjournals.molbev.a003804; Bachtrog D, 2011, CURR BIOL, V21, pR685, DOI 10.1016/j.cub.2011.08.027; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bedoya G, 2006, P NATL ACAD SCI USA, V103, P7234, DOI 10.1073/pnas.0508716103; Begun DJ, 2007, PLOS BIOL, V5, P2534, DOI 10.1371/journal.pbio.0050310; BEGUN DJ, 1993, NATURE, V365, P548, DOI 10.1038/365548a0; BEGUN DJ, 1995, MOL BIOL EVOL, V12, P382; Begun DJ, 2000, P NATL ACAD SCI USA, V97, P5960, DOI 10.1073/pnas.97.11.5960; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Betancourt AJ, 2004, GENETICS, V168, P2261, DOI 10.1534/genetics.104.030999; Betzig L, 2012, EVOL HUM BEHAV, V33, P309, DOI 10.1016/j.evolhumbehav.2011.10.008; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Bryc K, 2010, P NATL ACAD SCI USA, V107, P8954, DOI 10.1073/pnas.0914618107; Burgess R, 2008, MOL BIOL EVOL, V25, P1979, DOI 10.1093/molbev/msn148; Bustamante CD, 2009, NAT GENET, V41, P8, DOI 10.1038/ng0109-8; Casto AM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r10; CHARLESWORTH B, 1987, AM NAT, V130, P113, DOI 10.1086/284701; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Corl A, 2012, EVOLUTION, V66, P2138, DOI 10.1111/j.1558-5646.2012.01586.x; Crawford Jacob E., 2012, Frontiers in Genetics, V3, P66, DOI 10.3389/fgene.2012.00066; Eberle MA, 2000, GENET EPIDEMIOL, V19, pS29, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI5>3.0.CO;2-P; Ellegren H, 2009, TRENDS GENET, V25, P278, DOI 10.1016/j.tig.2009.04.005; Emery LS, 2010, AM J HUM GENET, V87, P848, DOI 10.1016/j.ajhg.2010.10.021; Evans BJ, 2013, GENETICS, V193, P545, DOI 10.1534/genetics.112.146258; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gazave E, 2014, P NATL ACAD SCI USA, V111, P757, DOI 10.1073/pnas.1310398110; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Gottipati S, 2011, NAT GENET, V43, P741, DOI 10.1038/ng.877; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Haddrill PR, 2005, GENOME RES, V15, P790, DOI 10.1101/gr.3541005; Hammer MF, 2004, GENETICS, V167, P1841, DOI 10.1534/genetics.103.025361; Hammer MF, 2010, NAT GENET, V42, P830, DOI 10.1038/ng.651; Hammer MF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000202; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Heyer E, 2012, MOL ECOL, V21, P597, DOI 10.1111/j.1365-294X.2011.05406.x; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; JUKES T H, 1969, P21; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; Keinan A, 2010, MOL BIOL EVOL, V27, P2312, DOI 10.1093/molbev/msq117; Keinan A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000886; Keinan A, 2009, NAT GENET, V41, P66, DOI 10.1038/ng.303; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Kidd JM, 2012, AM J HUM GENET, V91, P660, DOI 10.1016/j.ajhg.2012.08.025; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Labuda D, 2010, AM J HUM GENET, V86, P353, DOI 10.1016/j.ajhg.2010.01.029; Lahiri S. N., 2003, RESAMPLING METHODS D; Lambert CA, 2010, AM J HUM GENET, V86, P34, DOI 10.1016/j.ajhg.2009.12.002; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Liu RY, 1992, EXPLORING LIMITS BOO, P225; Locke DP, 2011, NATURE, V469, P529, DOI 10.1038/nature09687; Lohmueller KE, 2010, AM J HUM GENET, V86, P978, DOI 10.1016/j.ajhg.2010.03.021; Mank JE, 2010, EVOLUTION, V64, P663, DOI 10.1111/j.1558-5646.2009.00853.x; Marth GT, 2004, GENETICS, V166, P351, DOI 10.1534/genetics.166.1.351; McVicker G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000471; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Pool JE, 2007, EVOLUTION, V61, P3001, DOI 10.1111/j.1558-5646.2007.00238.x; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Scally A, 2012, NATURE, V483, P169, DOI 10.1038/nature10842; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Siepel A, 2009, GENOME RES, V19, P1929, DOI 10.1101/gr.084228.108; Sun JX, 2012, NAT GENET, V44, P1161, DOI 10.1038/ng.2398; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Vicoso B, 2009, EVOLUTION, V63, P2413, DOI 10.1111/j.1558-5646.2009.00719.x; Voight BF, 2005, P NATL ACAD SCI USA, V102, P18508, DOI 10.1073/pnas.0507325102; Wall JD, 2002, GENETICS, V162, P203; Wilder JA, 2004, MOL BIOL EVOL, V21, P2047, DOI 10.1093/molbev/msh214; Xu K, 2012, EVOLUTION, V66, P1751, DOI 10.1111/j.1558-5646.2011.01556.x	80	36	36	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 5	2014	94	6					827	844		10.1016/j.ajhg.2014.04.011	http://dx.doi.org/10.1016/j.ajhg.2014.04.011			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AJ0HK	24836452	hybrid, Green Published			2022-12-18	WOS:000337331200004
J	Tummala, H; Kirwan, M; Walne, AJ; Hossain, U; Jackson, N; Pondarre, C; Plagnol, V; Vulliamy, T; Dokal, I				Tummala, Hemanth; Kirwan, Michael; Walne, Amanda J.; Hossain, Upal; Jackson, Nicholas; Pondarre, Corinne; Plagnol, Vincent; Vulliamy, Tom; Dokal, Inderjeet			ERCC6L2 Mutations Link a Distinct Bone-Marrow-Failure Syndrome to DNA Repair and Mitochondrial Function	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NUCLEOTIDE EXCISION-REPAIR; COCKAYNE-SYNDROME; CLINICAL-MANIFESTATIONS; XERODERMA-PIGMENTOSUM; OXIDATIVE STRESS; FANCONI-ANEMIA; CSB PROTEIN; DYSFUNCTION	Exome sequencing was performed in three index cases with bone marrow failure and neurological dysfunction and whose Parents are first-degree cousins. Homozygous truncating mutations were identified in ERCC6L2 in two of the individuals. Both of these mutations affect the subcellular localization and stability of ERCC6L2. We show here that knockdown of ERCC6L2 in human A549 cells significantly reduced their viability upon exposure to the DNA-damaging agents mitomycin C and Irofulven, but not etoposide and camptothecin, suggesting a role in nucleotide excision repair. ERCC6L2-knockdown cells also displayed H2AX phosphorylation, which significantly increased upon genotoxic stress, suggesting an early DNA-damage response. Intriguingly, ERCC6L2 was seen to translocate to the mitochondria and the nucleus in response to DNA damage, and ERCC6L2 knockdown induced intracellular reactive Oxygen species (ROS). Treatment with the ROS scavenger N-acetyl cysteine attenuated the Irofulven-induced cytotoxicity in ERCC6L2-knockdown cells and abolished ERCCGL2 traffic to the mitochondria and nucleus in response to this DNA-damaging agent. Collectively, these observations identify a distinct bone-marrow-failure syndrome due to mutations in ERCC6L2, a gene implicated in DNA repair and mitochondrial function.	[Tummala, Hemanth; Kirwan, Michael; Walne, Amanda J.; Hossain, Upal; Vulliamy, Tom; Dokal, Inderjeet] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London E1 2AT, England; [Jackson, Nicholas] Univ Hosp, Dept Haematol, Coventry CV2 2DX, W Midlands, England; [Pondarre, Corinne] Univ Lyon 1, Inst Pediat Hematol & Oncol, F-69008 Lyon, France; [Plagnol, Vincent] UCL, Genet Inst, London WC1E 6BT, England; [Hossain, Upal; Dokal, Inderjeet] Barts Hlth NHS Trust, London E1 1BB, England	University of London; Queen Mary University London; University of Warwick; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of London; University College London; Barts Health NHS Trust	Vulliamy, T (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London E1 2AT, England.	t.vulliamy@qmul.ac.uk	Tummala, Hemanth/ABC-8367-2020; Jackson, Nicholas/A-4609-2016	Tummala, Hemanth/0000-0002-1413-745X; Dokal, Inderjeet/0000-0003-4462-4782; Plagnol, Vincent/0000-0002-5597-9215	Wellcome Trust; Medical Research Council; MRC [MR/K000292/1] Funding Source: UKRI; Medical Research Council [MR/K000292/1] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank the families and clinicians who contributed to this research, as well as Martine French for providing bone marrow slides. This work was funded by The Wellcome Trust and Medical Research Council. We would also like to thank Gary Warnes and Ann Wheeler for support and technical assistance in fluorescence-activated cell sorting and imaging.	Aamann MD, 2010, FASEB J, V24, P2334, DOI 10.1096/fj.09-147991; Berquist BR, 2012, NUCLEIC ACIDS RES, V40, P8392, DOI 10.1093/nar/gks565; Brooks PJ, 2013, DNA REPAIR, V12, P656, DOI 10.1016/j.dnarep.2013.04.018; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Dokal I, 2011, HEMATOL-AM SOC HEMAT, P480, DOI 10.1182/asheducation-2011.1.480; Dokal I, 2010, HAEMATOL-HEMATOL J, V95, P1236, DOI 10.3324/haematol.2010.025619; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Hayashi M, 2008, ADV EXP MED BIOL, V637, P120; Holden Paul, 2009, BMC Res Notes, V2, P243, DOI 10.1186/1756-0500-2-243; IYER VN, 1963, P NATL ACAD SCI USA, V50, P355, DOI 10.1073/pnas.50.2.355; Kamenisch Y, 2013, MECH AGEING DEV, V134, P270, DOI 10.1016/j.mad.2013.03.005; Kashiyama K, 2013, AM J HUM GENET, V92, P807, DOI 10.1016/j.ajhg.2013.04.007; Kirwan M, 2011, BRIT J HAEMATOL, V153, P634, DOI 10.1111/j.1365-2141.2011.08679.x; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Koeppel F, 2004, CLIN CANCER RES, V10, P5604, DOI 10.1158/1078-0432.CCR-04-0442; Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863; Kraemer KH, 2007, NEUROSCIENCE, V145, P1388, DOI 10.1016/j.neuroscience.2006.12.020; Kumari U, 2014, ONCOGENE, V33, P165, DOI 10.1038/onc.2012.583; Lans H, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-4; Laugel V, 2010, HUM MUTAT, V31, P113, DOI 10.1002/humu.21154; Licht CL, 2003, AM J HUM GENET, V73, P1217, DOI 10.1086/380399; Lovejoy CA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002772; Mallery DL, 1998, AM J HUM GENET, V62, P77, DOI 10.1086/301686; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Pang QS, 2011, BLOOD, V118, P2932, DOI 10.1182/blood-2011-07-367755; Pereboeva L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076473; Ratnakumar K, 2013, EPIGENETICS-US, V8, P3, DOI 10.4161/epi.23271; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Ryan DP, 2011, CURR OPIN CHEM BIOL, V15, P649, DOI 10.1016/j.cbpa.2011.07.022; Sahin E, 2012, NAT REV MOL CELL BIO, V13, P397, DOI 10.1038/nrm3352; Savage SA, 2010, GENET MED, V12, P753, DOI 10.1097/GIM.0b013e3181f415b5; Scheibye-Knudsen M, 2012, J EXP MED, V209, P855, DOI 10.1084/jem.20111721; Shtessel L, 2011, NUCLEUS-PHILA, V2, P24, DOI 10.4161/nucl.2.1.13993; Trushina E, 2007, NEUROSCIENCE, V145, P1233, DOI 10.1016/j.neuroscience.2006.10.056; Velez-Cruz R, 2013, MECH AGEING DEV, V134, P234, DOI 10.1016/j.mad.2013.03.004; Walne AJ, 2009, BRIT J HAEMATOL, V145, P164, DOI 10.1111/j.1365-2141.2009.07598.x; Weidenheim KM, 2009, MECH AGEING DEV, V130, P619, DOI 10.1016/j.mad.2009.07.006; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; Young NS, 2010, BIOL BLOOD MARROW TR, V16, pS119, DOI 10.1016/j.bbmt.2009.09.013; Zheng HY, 2003, MOL CELL BIOL, V23, P754, DOI 10.1128/MCB.23.2.754-761.2003	41	36	38	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 6	2014	94	2					246	256		10.1016/j.ajhg.2014.01.007	http://dx.doi.org/10.1016/j.ajhg.2014.01.007			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AA9NF	24507776	Bronze, Green Published			2022-12-18	WOS:000331419500008
J	[Anonymous]				[Anonymous]			Estimation of SNP Heritability from Dense Genotype Data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							COMMON SNPS; ASSOCIATION ANALYSIS; SCHIZOPHRENIA; PROPORTION						Lee, Sang Hong/A-2569-2011; Visscher, Peter/ABB-6151-2020; Wray, Naomi/C-8639-2015; Chen, Guo-Bo/C-2435-2009	Lee, Sang Hong/0000-0001-9701-2718; Visscher, Peter/0000-0002-2143-8760; Wray, Naomi/0000-0001-7421-3357; Goddard, Michael/0000-0001-9917-7946; Chen, Guo-Bo/0000-0001-5475-8237; ripke, stephan/0000-0003-3622-835X	NIMH NIH HHS [R01 MH077139] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077139] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Amin N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001274; Hayes BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001139; Lee SH, 2012, BIOINFORMATICS, V28, P2540, DOI 10.1093/bioinformatics/bts474; Lee SH, 2013, HUM MOL GENET, V22, P832, DOI 10.1093/hmg/dds491; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Lee SH, 2006, GENET SEL EVOL, V38, P25, DOI 10.1051/gse:2005025; Leutenegger AL, 2003, AM J HUM GENET, V73, P516, DOI 10.1086/378207; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Speed D, 2012, AM J HUM GENET, V91, P1011, DOI 10.1016/j.ajhg.2012.10.010; Stahl EA, 2012, NAT GENET, V44, P483, DOI 10.1038/ng.2232; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zaitlen N, 2012, HUM GENET, V131, P1655, DOI 10.1007/s00439-012-1199-6; Zhou X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003264	15	36	36	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 5	2013	93	6					1151	1155		10.1016/j.ajhg.2013.10.015	http://dx.doi.org/10.1016/j.ajhg.2013.10.015			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	273FS	24314550	Green Published, Bronze			2022-12-18	WOS:000328521300015
J	Yoon, SR; Choi, SK; Eboreime, J; Gelb, BD; Calabrese, P; Arnheim, N				Yoon, Song-Ro; Choi, Soo-Kung; Eboreime, Jordan; Gelb, Bruce D.; Calabrese, Peter; Arnheim, Norman			Age-Dependent Germ line Mosaicism of the Most Common Noonan Syndrome Mutation Shows the Signature of Germ line Selection	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CELL SELF-RENEWAL; STEM-CELLS; PTPN11; SHP2; SPERMATOGONIA; RET; SPERMATOGENESIS; ADVANTAGE; GENETICS; STAT3	Noonan syndrome (NS) is among the most common Mendelian genetic diseases (similar to 1/2,000 live births). Most cases (50%-84%) are sporadic, and new mutations are virtually always paternally derived. More than 47 different sites of NS de novo missense mutations are known in the PTPN11 gene that codes for the protein tyrosine phosphatase SHP-2. Surprisingly, many of these mutations are recurrent with nucleotide substitution rates substantially greater than the genome average; the most common mutation, c.922A>G, is at least 2,400 times greater. We examined the spatial distribution of the c.922A>G mutation in testes from 15 unaffected men and found that the mutations were not uniformly distributed across each testis as would be expected for a mutation hot spot but were highly clustered and showed an age-dependent germline mosaicism. Computational modeling that used different stem cell division schemes confirmed that the data were inconsistent with hypermutation, but consistent with germline selection: mutated spermatogonial stem cells gained an advantage that allowed them to increase in frequency. SHP-2 interacts with the transcriptional activator STAT3. Given STAT3's function in mouse spermatogonial stem cells, we suggest that this interaction might explain the mutant's selective advantage by means of repression of stem cell differentiation signals. Repression of STAT3 activity by cyclin D1 might also play a previously unrecognized role in providing a germline-selective advantage to spermatogonia for the recurrent mutations in the receptor tyrosine kinases that cause Apert syndrome and MEN2B. Looking at recurrent mutations driven by germline selection in different gene families can help highlight common causal signaling pathways.	[Yoon, Song-Ro; Choi, Soo-Kung; Eboreime, Jordan; Calabrese, Peter; Arnheim, Norman] Univ So Calif, Mol & Computat Biol Program, Los Angeles, CA 90089 USA; [Gelb, Bruce D.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, Dept Pediat, New York, NY 10029 USA; [Gelb, Bruce D.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, Dept Genet & Genom Sci, New York, NY 10029 USA	University of Southern California; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Calabrese, P (corresponding author), Univ So Calif, Mol & Computat Biol Program, Los Angeles, CA 90089 USA.	petercal@usc.edu; amheim@usc.edu		Arnheim, Norman/0000-0003-1247-1347	National Institute of General Medical Sciences [R01GM36745]; National Heart, Lung and Blood Institute of the National Institutes of Health [HL071207]; GeneDx; Correlegan; Prevention Genetics; Lab Corp; Baylor College of Medicine; Harvard/Partners; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036745] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Heart, Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); GeneDx; Correlegan; Prevention Genetics; Lab Corp; Baylor College of Medicine; Harvard/Partners; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the National Institute of General Medical Sciences under award number R01GM36745 (N.A. and P.C.) and the National Heart, Lung and Blood Institute under award number HL071207 (B.D.G.) of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences, National Heart, Lung and Blood Institute, or National Institutes of Health. One of the authors (B.D.G.) has the following conflict of interest: royalty payments for PTPN11 mutation testing for Noonan syndrome from GeneDx, Correlegan, Prevention Genetics, Lab Corp, Baylor College of Medicine and Harvard/Partners. We thank Jon Oatley for helpful discussions and Thomas Myers for Tma31FS DNA polymerase. (Research samples of Tma31FS can be obtained from Dr. Thomas W. Myers, thomas. myers@roche.com, Director, Program in Core Research, Roche Molecular Systems, 4300 Hacienda Drive, Pleasanton, CA 94588.)	Arighi E, 2005, CYTOKINE GROWTH F R, V16, P441, DOI 10.1016/j.cytogfr.2005.05.010; Arnheim N, 2009, NAT REV GENET, V10, P478, DOI 10.1038/nrg2529; Benjamin G., 2010, HDB CELL SIGNALING, P771; Bertola DR, 2006, GENET TEST, V10, P186, DOI 10.1089/gte.2006.10.186; Choi SK, 2008, P NATL ACAD SCI USA, V105, P10143, DOI 10.1073/pnas.0801267105; Choi SK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002420; Dance M, 2008, CELL SIGNAL, V20, P453, DOI 10.1016/j.cellsig.2007.10.002; Dolan C. R., 1993, GENEREVIEWS; Ehmcke J, 2006, REPRODUCTION, V132, P673, DOI 10.1530/rep.1.01081; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Germain D, 2007, CLIN CANCER RES, V13, P5665, DOI 10.1158/1078-0432.CCR-06-2491; Goriely A, 2003, SCIENCE, V301, P643, DOI 10.1126/science.1085710; Goriely A, 2012, AM J HUM GENET, V90, P175, DOI 10.1016/j.ajhg.2011.12.017; Grossmann KS, 2010, ADV CANCER RES, V106, P53, DOI 10.1016/S0065-230X(10)06002-1; He ZP, 2012, METHODS MOL BIOL, V825, P45, DOI 10.1007/978-1-61779-436-0_4; He ZP, 2010, BIOL REPROD, V82, P363, DOI 10.1095/biolreprod.109.078550; HELLER CG, 1963, SCIENCE, V140, P184, DOI 10.1126/science.140.3563.184; Ishii K, 2012, DEVELOPMENT, V139, P1734, DOI 10.1242/dev.076539; JOHNSON L, 1986, J ANDROL, V7, P331; Jongmans M, 2005, AM J MED GENET A, V134A, P165, DOI 10.1002/ajmg.a.30598; Jongmans M, 2004, HORM RES, V62, P56, DOI 10.1159/000080500; Kaucher AV, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097386; Klein AM, 2011, DEVELOPMENT, V138, P3103, DOI 10.1242/dev.060103; Klein AM, 2010, CELL STEM CELL, V7, P214, DOI 10.1016/j.stem.2010.05.017; Knoblich JA, 2010, NAT REV MOL CELL BIO, V11, P849, DOI 10.1038/nrm3010; Kontaridis MI, 2006, J BIOL CHEM, V281, P6785, DOI 10.1074/jbc.M513068200; Lee J, 2009, CELL STEM CELL, V5, P76, DOI 10.1016/j.stem.2009.04.020; Liu Q, 2004, BIOTECHNIQUES, V36, P156, DOI 10.2144/04361DD03; MENDEZ HMM, 1985, AM J MED GENET, V21, P493, DOI 10.1002/ajmg.1320210312; Mohi MG, 2007, CURR OPIN GENET DEV, V17, P23, DOI 10.1016/j.gde.2006.12.011; NISTAL M, 1987, J ANDROL, V8, P64; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Oatley JM, 2010, BIOL REPROD, V83, P427, DOI 10.1095/biolreprod.109.083352; Otto SP, 1998, GENETICA, V102-3, P507, DOI 10.1023/A:1017074823337; Qin J, 2007, PLOS BIOL, V5, P1912, DOI 10.1371/journal.pbio.0050224; Roberts AE, 2001, GENEREVIEWS, P1993; Robin NH, 1998, GENEREVIEWS; Runeberg-Roos P, 2007, ANN MED, V39, P572, DOI 10.1080/07853890701646256; Savitt J, 2012, STEM CELLS, V30, P732, DOI 10.1002/stem.1028; Spradling A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002642; Tartaglia M, 2005, ANNU REV GENOM HUM G, V6, P45, DOI 10.1146/annurev.genom.6.080604.162305; Tartaglia M, 2004, AM J HUM GENET, V75, P492, DOI 10.1086/423493; Tartaglia M, 2010, MOL SYNDROMOL, V1, P2, DOI 10.1159/000276766; Tartaglia M., 2008, INBORN ERRORS DEV, P620; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Wells SA, 2009, CLIN CANCER RES, V15, P7119, DOI 10.1158/1078-0432.CCR-08-2742; Wu X, 2009, P NATL ACAD SCI USA, V106, P21672, DOI 10.1073/pnas.0912432106; Yoon SR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000558; Yoshida S, 2010, DEV GROWTH DIFFER, V52, P311, DOI 10.1111/j.1440-169X.2010.01174.x; Zhang WJ, 2009, J BIOL CHEM, V284, P22353, DOI 10.1074/jbc.M109.020495	50	36	42	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 6	2013	92	6					917	926		10.1016/j.ajhg.2013.05.001	http://dx.doi.org/10.1016/j.ajhg.2013.05.001			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164MX	23726368	Green Published, Bronze			2022-12-18	WOS:000320415300008
J	Below, JE; Earl, DL; Shively, KM; McMillin, MJ; Smith, JD; Turner, EH; Stephan, MJ; Al-Gazali, LI; Hertecant, JL; Chitayat, D; Unger, S; Cohn, DH; Krakow, D; Swanson, JM; Faustman, EM; Shendure, J; Nickerson, DA; Bamshad, MJ				Below, Jennifer E.; Earl, Dawn L.; Shively, Kathryn M.; McMillin, Margaret J.; Smith, Joshua D.; Turner, Emily H.; Stephan, Mark J.; Al-Gazali, Lihadh I.; Hertecant, Jozef L.; Chitayat, David; Unger, Sheila; Cohn, Daniel H.; Krakow, Deborah; Swanson, James M.; Faustman, Elaine M.; Shendure, Jay; Nickerson, Deborah A.; Bamshad, Michael J.		Univ Washington	Whole-Genome Analysis Reveals that Mutations in Inositol Polyphosphate Phosphatase-like 1 Cause Opsismodysplasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTOSOMAL RECESSIVE INHERITANCE; SHIP2	Opsismodysplasia is a rare, autosomal-recessive skeletal dysplasia characterized by short stature, characteristic facial features, and in some cases severe renal phosphate wasting. We used linkage analysis and whole-genome sequencing of a consanguineous trio to discover that mutations in inositol polyphosphate phosphatase-like 1 (INPPL1) cause opsismodysplasia with or without renal phosphate wasting. Evaluation of 12 families with opsismodysplasia revealed that INPPL1 mutations explain similar to 60% of cases overall, including both of the families in our cohort with more than one affected child and 50% of the simplex cases.	[Below, Jennifer E.; Smith, Joshua D.; Turner, Emily H.; Shendure, Jay; Nickerson, Deborah A.; Bamshad, Michael J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Earl, Dawn L.; Bamshad, Michael J.] Seattle Childrens Hosp, Div Med Genet, Seattle, WA 98105 USA; [Earl, Dawn L.; Shively, Kathryn M.; McMillin, Margaret J.; Bamshad, Michael J.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Stephan, Mark J.] Madigan Army Med Ctr, Dept Pediat, Tacoma, WA 98431 USA; [Al-Gazali, Lihadh I.; Hertecant, Jozef L.] United Arab Emirates Univ, Dept Pediat, Al Ain, U Arab Emirates; [Chitayat, David] Univ Toronto, Mt Sinai Hosp, Prenatal Diag & Med Genet Program, Dept Obstet & Gynecol, Toronto, ON M5G 1Z5, Canada; [Unger, Sheila] Univ Lausanne, Ctr Hos Univ Vaudois, Dept Genet, CH-1011 Lausanne, Switzerland; [Cohn, Daniel H.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Cohn, Daniel H.; Krakow, Deborah] Univ Calif Los Angeles, Dept Orthopaed Surg, Los Angeles, CA 90095 USA; [Krakow, Deborah] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Swanson, James M.] Univ Calif Irvine, Dept Pediat, Irvine, CA 92697 USA; [Faustman, Elaine M.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Madigan Army Medical Center; United Arab Emirates University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Lausanne; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Irvine; University of Washington; University of Washington Seattle	Bamshad, MJ (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	mbamshad@uw.edu	unger, sheila/E-9177-2015; Krakow, Deborah/B-5778-2009; Below, Jennifer E/W-2179-2018; Shendure, Jay/AAU-3684-2021	Krakow, Deborah/0000-0001-9906-4968; Below, Jennifer E/0000-0002-1346-1872; Turner, Emily/0000-0001-9040-9229; Unger, Sheila/0000-0002-9539-8941; Shendure, Jay/0000-0002-1516-1865; Faustman, Elaine/0000-0002-3085-6403; Below, Jennifer/0000-0002-6372-6402	National Institutes of Health/National Human Genome Research Institute [1U54HG006493, 1RC2HG005608]; National Institute of Child Health and Development [HD22657, HHSN27500503415C, HHSN267200700023C]; National Institute of Dental and Craniofacial Research [DE019567]; Life Sciences Discovery Fund [2065508, 0905001]; Washington Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD048895] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006493, RC2HG005608, UM1HG006493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019567] Funding Source: NIH RePORTER	National Institutes of Health/National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Life Sciences Discovery Fund; Washington Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank the families for their participation and support. We thank Thomas Markello, Michael Bober, Arti Pandya, and J. Edward Spence for referral of subjects and Kathryn Millar, Ants Toi, and Sarah Keating for their assistance. Our work was supported in part by grants from the National Institutes of Health/National Human Genome Research Institute (1U54HG006493 and 1RC2HG005608 to M.J.B., DAN., and J.S.), the National Institute of Child Health and Development (HD22657 to D.H.C. and D.K., HHSN27500503415C to J.M.S., and HHSN267200700023C to E.M.F.), the National Institute of Dental and Craniofacial Research (DE019567 to D.H.C. and D.K.), the Life Sciences Discovery Fund (2065508 and 0905001), and the Washington Research Foundation.	BEEMER FA, 1994, AM J MED GENET, V49, P344, DOI 10.1002/ajmg.1320490321; Clement S, 2001, NATURE, V409, P92, DOI 10.1038/35051094; Cormier-Daire V, 2003, J MED GENET, V40, P195, DOI 10.1136/jmg.40.3.195; Dubois E, 2012, CELL SIGNAL, V24, P1971, DOI 10.1016/j.cellsig.2012.06.012; Erneux C, 2011, J CELL BIOCHEM, V112, P2203, DOI 10.1002/jcb.23146; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; MAROTEAUX P, 1984, AM J MED GENET, V19, P171, DOI 10.1002/ajmg.1320190117; SANTOS HG, 1995, CLIN DYSMORPHOL, V4, P222; Sleeman MW, 2005, NAT MED, V11, P199, DOI 10.1038/nm1178; Tyler K, 1999, AM J MED GENET, V83, P47, DOI 10.1002/(SICI)1096-8628(19990305)83:1<47::AID-AJMG9>3.0.CO;2-5; Zonana J, 1977, Birth Defects Orig Artic Ser, V13, P155	11	36	40	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN 10	2013	92	1					137	143		10.1016/j.ajhg.2012.11.011	http://dx.doi.org/10.1016/j.ajhg.2012.11.011			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	073RA	23273567	Green Published, Bronze			2022-12-18	WOS:000313759000015
J	Erez, A; Shchelochkov, OA; Plon, SE; Scaglia, F; Lee, B				Erez, Ayelet; Shchelochkov, Oleg A.; Plon, Sharon E.; Scaglia, Fernando; Lee, Brendan			Insights into the Pathogenesis and Treatment of Cancer from Inborn Errors of Metabolism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							GLYCOGEN-STORAGE-DISEASE; ACUTE INTERMITTENT PORPHYRIA; MITOCHONDRIAL-DNA DEPLETION; TYROSINEMIA TYPE-I; RAGGED-RED FIBERS; ARGININE DEIMINASE TREATMENT; ISOCITRATE DEHYDROGENASE 1; GLIOMA-DERIVED MUTATIONS; PRIMARY LIVER-CARCINOMA; ADULT GAUCHER-DISEASE	Mutations in genes that play fundamental roles in metabolic pathways have been found to also play a role in tumor development and susceptibility to cancer. At the same time, significant progress has been made in the treatment of patients with inborn errors of metabolism (IEM),(1) resulting in increased longevity and the unmasking of cancer predisposition, frequently hepatocellular carcinoma, in these conditions. These patients offer a potential opportunity to deepen our understanding of how intermediary metabolism impacts tumorigenesis. We provide an overview from the perspective of cancers in patients affected with IEM and discuss how dysregulation of these specific metabolic pathways might contribute to the mechanisms of cancer development and treatment.	[Erez, Ayelet; Shchelochkov, Oleg A.; Plon, Sharon E.; Scaglia, Fernando; Lee, Brendan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Plon, Sharon E.; Lee, Brendan] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Erez, Ayelet; Plon, Sharon E.; Scaglia, Fernando; Lee, Brendan] Texas Childrens Hosp, Houston, TX 77030 USA; [Lee, Brendan] Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Scaglia, F (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	fscaglia@bcm.edu; blee@bcm.edu			National Institutes of Health/ National Institute of General Medical Sciences [DK081735-01A1, GM07526]; National Urea Cycle Foundation; Cancer Prevention Institute of Texas; Gustavus and Louise Pfeiffer Research Foundation;  [CA138836-01];  [TR01 GM090310]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD061221] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA138836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK081735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090310, T32GM007526] Funding Source: NIH RePORTER	National Institutes of Health/ National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Urea Cycle Foundation; Cancer Prevention Institute of Texas; Gustavus and Louise Pfeiffer Research Foundation; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	S.E.P. is supported by CA138836-01. A.E. is supported by DK081735-01A1, National Institutes of Health/ National Institute of General Medical Sciences T32 contract grant number GM07526 and by the National Urea Cycle Foundation Research Fellowship. O.A.S. received support through the 2009 National Urea Cycle Foundation Research Fellowship. B.L. is supported in part by the Cancer Prevention Institute of Texas and TR01 GM090310. F.S. is supported by the Gustavus and Louise Pfeiffer Research Foundation Figures were produced by using Servier Medical Art.	Abboud R T, 2001, Can Respir J, V8, P81; Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143; Alexander FE, 2001, CANCER RES, V61, P2542; ALSHAK NS, 1994, ARCH PATHOL LAB MED, V118, P88; Andersen KF, 2011, CANCER TREAT REV, V37, P111, DOI 10.1016/j.ctrv.2010.07.002; Andersson C, 1996, J INTERN MED, V240, P195, DOI 10.1046/j.1365-2796.1996.21847000.x; Argon A, 2002, GYNECOL ONCOL, V85, P362, DOI 10.1006/gyno.2002.6608; ARORA KK, 1988, J BIOL CHEM, V263, P17422; Ascierto PA, 2005, J CLIN ONCOL, V23, P7660, DOI 10.1200/JCO.2005.02.0933; Balreira A, 2005, BRIT J HAEMATOL, V129, P667, DOI 10.1111/j.1365-2141.2005.05503.x; Bandsma RHJ, 2002, EUR J PEDIATR, V161, pS65, DOI 10.1007/s00431-002-1007-8; Barger JF, 2010, ENDOCR-RELAT CANCER, V17, pR287, DOI 10.1677/ERC-10-0106; Bayley JP, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-20; Baysal BE, 2002, J MED GENET, V39, P178, DOI 10.1136/jmg.39.3.178; Bertram Heidi C, 2003, Arch Pathol Lab Med, V127, pe242; Blanco J, 2005, PATHOL RES PRACT, V200, P857, DOI 10.1016/j.prp.2004.09.003; Bohm P, 2001, CANCER, V91, P457; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Broedbaek K, 2009, FREE RADICAL BIO MED, V47, P1230, DOI 10.1016/j.freeradbiomed.2009.08.004; Bruno C, 2004, NEUROLOGY, V63, P1053, DOI 10.1212/01.WNL.0000138429.11433.0D; BRUSILOW SW, 2009, METABOLIC MOL BASES, pCH8; Bulaj ZJ, 2000, BLOOD, V95, P1565, DOI 10.1182/blood.V95.5.1565.005k42_1565_1571; BURDON RH, 1995, FREE RADICAL BIO MED, V18, P775, DOI 10.1016/0891-5849(94)00198-S; Burnichon N, 2010, HUM MOL GENET, V19, P3011, DOI 10.1093/hmg/ddq206; Cao XH, 2008, CLIN CANCER RES, V14, P1831, DOI 10.1158/1078-0432.CCR-07-1607; Cassiman D, 2007, J INHERIT METAB DIS, V30, P830, DOI 10.1007/s10545-007-0648-1; Chace DH, 2002, ANNU REV GENOM HUM G, V3, P17, DOI 10.1146/annurev.genom.3.022502.103213; Chappell S, 2006, HUM MUTAT, V27, P103, DOI 10.1002/humu.20275; Chou JY, 2008, HUM MUTAT, V29, P921, DOI 10.1002/humu.20772; Compston JE, 2002, J ENDOCRINOL, V173, DOI 10.1677/joe.0.1730387; Connor KM, 2005, J BIOL CHEM, V280, P16916, DOI 10.1074/jbc.M410690200; CRYSTAL RG, 1990, J CLIN INVEST, V85, P1343, DOI 10.1172/JCI114578; Dallabona C, 2010, HUM MOL GENET, V19, P1098, DOI 10.1093/hmg/ddp581; Dang LN, 2010, TRENDS MOL MED, V16, P387, DOI 10.1016/j.molmed.2010.07.002; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; de Bie P, 2007, J MED GENET, V44, P673, DOI 10.1136/jmg.2007.052746; de Fost M, 2006, BLOOD CELL MOL DIS, V36, P53, DOI 10.1016/j.bcmd.2005.08.004; de Moor RA, 2000, ARCH DIS CHILD, V82, P479, DOI 10.1136/adc.82.6.479; Demo E, 2007, J HEPATOL, V46, P492, DOI 10.1016/j.jhep.2006.09.022; Di Rocco M, 2008, MOL GENET METAB, V93, P398, DOI 10.1016/j.ymgme.2007.10.134; DICHIRO G, 1982, NEUROLOGY, V32, P1323, DOI 10.1212/WNL.32.12.1323; Dillon BJ, 2004, CANCER-AM CANCER SOC, V100, P826, DOI 10.1002/cncr.20057; Dimmock D, 2009, MOL GENET METAB, V96, P44, DOI 10.1016/j.ymgme.2008.10.007; Dimmock DP, 2008, LIVER TRANSPLANT, V14, P1480, DOI 10.1002/lt.21556; Douki T, 1998, CHEM RES TOXICOL, V11, P150, DOI 10.1021/tx970157d; Dragani TA, 2010, J HEPATOL, V52, P252, DOI 10.1016/j.jhep.2009.11.015; El-Hattab AW, 2010, MOL GENET METAB, V99, P300, DOI 10.1016/j.ymgme.2009.10.003; Endo Y, 2006, J HUM GENET, V51, P958, DOI 10.1007/s10038-006-0045-x; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Franchini M, 2005, ANN HEMATOL, V84, P347, DOI 10.1007/s00277-005-1006-8; Franco LM, 2005, J INHERIT METAB DIS, V28, P153, DOI 10.1007/s10545-005-7500-2; Frank J, 2010, BEST PRACT RES CL GA, V24, P735, DOI 10.1016/j.bpg.2010.07.002; Fu YJ, 2010, BIOCHEM BIOPH RES CO, V397, P127, DOI 10.1016/j.bbrc.2010.05.115; FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3; Gannon PO, 2011, INT J CANCER, V128, P2326, DOI 10.1002/ijc.25577; Garber K, 2010, J NATL CANCER I, V102, P926, DOI 10.1093/jnci/djq262; Gimenez-Roqueplo AP, 2006, ANN NY ACAD SCI, V1073, P112, DOI 10.1196/annals.1353.012; Gogvadze V, 2009, APOPTOSIS, V14, P624, DOI 10.1007/s10495-009-0323-0; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Grompe M, 2001, SEMIN LIVER DIS, V21, P563, DOI 10.1055/s-2001-19035; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; Guzy RD, 2008, MOL CELL BIOL, V28, P718, DOI 10.1128/MCB.01338-07; Hagiwara N, 2003, INTERNAL MED, V42, P978, DOI 10.2169/internalmedicine.42.978; HARDELL L, 1984, BRIT J CANCER, V50, P389, DOI 10.1038/bjc.1984.188; Harrison SA, 2005, MED CLIN N AM, V89, P391, DOI 10.1016/j.mcna.2004.08.005; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Herrick AL, 2005, BEST PRACT RES CL GA, V19, P235, DOI 10.1016/j.bpg.2004.10.006; Holme E, 2000, Clin Liver Dis, V4, P805, DOI 10.1016/S1089-3261(05)70142-2; HOLME E, 1993, AM J HUM GENET, V52, P551; Hsiao HP, 2009, J CLIN ENDOCR METAB, V94, P2930, DOI 10.1210/jc.2009-0516; Hughes DA, 2009, AM J HEMATOL, V84, P199, DOI 10.1002/ajh.21375; Huster D, 2010, BEST PRACT RES CL GA, V24, P531, DOI 10.1016/j.bpg.2010.07.014; Ito T, 2000, DIGEST DIS SCI, V45, P2203, DOI 10.1023/A:1026439913915; Izzo F, 2004, J CLIN ONCOL, V22, P1815, DOI 10.1200/JCO.2004.11.120; Jmoudiak M, 2005, BRIT J HAEMATOL, V129, P178, DOI 10.1111/j.1365-2141.2004.05351.x; Jorquera R, 1997, BIOCHEM BIOPH RES CO, V232, P42, DOI 10.1006/bbrc.1997.6220; Kaelin WG, 2009, CANCER CELL, V16, P180, DOI 10.1016/j.ccr.2009.08.013; Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913; Ke PY, 2005, GENE DEV, V19, P1920, DOI 10.1101/gad.1322905; KENNY GE, 1963, J INFECT DIS, V112, P7, DOI 10.1093/infdis/112.1.7; Kew M D, 1990, Hepatology, V11, P1086, DOI 10.1002/hep.1840110629; Kim RH, 2009, CANCER RES, V69, P700, DOI 10.1158/0008-5472.CAN-08-3157; Kimura A, 2010, HEPATOL RES, V40, P295, DOI 10.1111/j.1872-034X.2009.00594.x; Kishnani PS, 2009, HUM MOL GENET, V18, P4781, DOI 10.1093/hmg/ddp441; Klaunig JE, 2010, TOXICOL PATHOL, V38, P96, DOI 10.1177/0192623309356453; Kloosterhof NK, 2011, LANCET ONCOL, V12, P83, DOI 10.1016/S1470-2045(10)70053-X; Kobayashi E, 2010, MOL CANCER THER, V9, P535, DOI 10.1158/1535-7163.MCT-09-0774; Kobayashi K, 1999, NAT GENET, V22, P159, DOI 10.1038/9667; Kohnlein T, 2008, AM J MED, V121, P3, DOI 10.1016/j.amjmed.2007.07.025; Kok KF, 2007, NETH J MED, V65, P160; Kowdley K V, 1995, Liver Transpl Surg, V1, P237, DOI 10.1002/lt.500010408; KRAEMER PM, 1964, P SOC EXP BIOL MED, V117, P910, DOI 10.3181/00379727-117-29734; Kulawiec M, 2008, CANCER BIOL THER, V7, P1732, DOI 10.4161/cbt.7.11.6729; KUNZ BA, 1991, ANNU REV GENET, V25, P339, DOI 10.1146/annurev.ge.25.120191.002011; KUNZ BA, 1988, MUTAT RES, V200, P133, DOI 10.1016/0027-5107(88)90076-0; KUSHNER JP, 1976, J CLIN INVEST, V58, P1089, DOI 10.1172/JCI108560; Labrune P, 2002, EUR J PEDIATR, V161, pS53, DOI 10.1007/s00431-002-1004-y; Lagarde SM, 2008, ANN SURG ONCOL, V15, P3459, DOI 10.1245/s10434-008-0165-y; Lanpher B, 2006, NAT REV GENET, V7, P449, DOI 10.1038/nrg1880; Lee PJ, 2002, EUR J PEDIATR, V161, pS46; Lee S, 2005, CANCER CELL, V8, P155, DOI 10.1016/j.ccr.2005.06.015; LEI KJ, 1993, SCIENCE, V262, P580, DOI 10.1126/science.8211187; Leone JP, 2008, ANTICANCER RES, V28, P3937; Linehan WM, 2010, NAT REV UROL, V7, P277, DOI 10.1038/nrurol.2010.47; Linet MS, 1999, AM J EPIDEMIOL, V149, P1010; LITHNER F, 1984, ACTA MED SCAND, V215, P271; Litten JB, 2008, ONCOLOGIST, V13, P812, DOI 10.1634/theoncologist.2008-0011; Lopez LC, 2009, HUM MOL GENET, V18, P714, DOI 10.1093/hmg/ddn401; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Maher ER, 2002, HUM MOL GENET, V11, P2347, DOI 10.1093/hmg/11.20.2347; MANABE S, 1985, J EXP MED, V162, P1060, DOI 10.1084/jem.162.3.1060; Manekeller S, 2010, Z GASTROENTEROL, V48, P1211, DOI 10.1055/s-0029-1245204; Marhenke S, 2008, HEPATOLOGY, V48, P487, DOI 10.1002/hep.22391; Marsden D, 2006, J PEDIATR-US, V148, P577, DOI 10.1016/j.jpeds.2005.12.021; MASUDA R, 1988, JPN J CANCER RES, V79, P828, DOI 10.1111/j.1349-7006.1988.tb00044.x; Mathupala SP, 2009, SEMIN CANCER BIOL, V19, P17, DOI 10.1016/j.semcancer.2008.11.006; MCGLYNN KA, 1995, P NATL ACAD SCI USA, V92, P2384, DOI 10.1073/pnas.92.6.2384; Mehta A, 2010, QJM-INT J MED, V103, P641, DOI 10.1093/qjmed/hcq117; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Moroni I, 2004, NEUROLOGY, V62, P1882, DOI 10.1212/01.WNL.0000125335.21381.87; Nagasaka H, 2009, MOL GENET METAB, V97, P21, DOI 10.1016/j.ymgme.2009.01.009; Naito A, 2008, CANCER SCI, V99, P1584, DOI 10.1111/j.1349-7006.2008.00879.x; Nance CS, 2006, ARCH NEUROL-CHICAGO, V63, P453, DOI 10.1001/archneur.63.3.453; NELSON RL, 1995, CANCER, V76, P875, DOI 10.1002/1097-0142(19950901)76:5<875::AID-CNCR2820760523>3.0.CO;2-Q; Ozen H, 2007, WORLD J GASTROENTERO, V13, P2541; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Onal IK, 2009, ACTA GASTRO-ENT BELG, V72, P377; Osborne NJ, 2010, HEPATOLOGY, V51, P1311, DOI 10.1002/hep.23448; Ozisik PA, 2002, PEDIATR NEUROSURG, V37, P22, DOI 10.1159/000065097; Palmieri C, 2004, QJM-INT J MED, V97, P115, DOI 10.1093/qjmed/hch027; Pastorino JG, 2008, J BIOENERG BIOMEMBR, V40, P171, DOI 10.1007/s10863-008-9148-8; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Penta JS, 2001, MUTAT RES-REV MUTAT, V488, P119, DOI 10.1016/S1383-5742(01)00053-9; Perlmutter DH, 2002, J CLIN INVEST, V110, P1579, DOI 10.1172/JCI200216787; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Pitkanen ST, 2000, ANN MED, V32, P530, DOI 10.3109/07853890008998832; Pollard PJ, 2005, HUM MOL GENET, V14, P2231, DOI 10.1093/hmg/ddi227; Preston TJ, 2001, J BIOL CHEM, V276, P9558, DOI 10.1074/jbc.M004617200; Puy H, 1998, HUM GENET, V103, P570, DOI 10.1007/s004390050871; Rake JP, 2002, EUR J PEDIATR, V161, pS20, DOI 10.1007/s00431-002-0999-4; Ralph SJ, 2010, MOL ASPECTS MED, V31, P145, DOI 10.1016/j.mam.2010.02.008; Reitman ZJ, 2010, JNCI-J NATL CANCER I, V102, P932, DOI 10.1093/jnci/djq187; Ricketts CJ, 2010, HUM MUTAT, V31, P41, DOI 10.1002/humu.21136; ROBB L, 1995, P NATL ACAD SCI USA, V92, P7075, DOI 10.1073/pnas.92.15.7075; Rogers RE, 2010, PEDIATR DEVEL PATHOL, V13, P408, DOI 10.2350/09-12-0768-CR.1; Saheki T, 2002, J HUM GENET, V47, P333, DOI 10.1007/s100380200046; Savas N, 2006, PEDIATR TRANSPLANT, V10, P639, DOI 10.1111/j.1399-3046.2006.00562.x; Scheers I, 2005, J PEDIATR-US, V146, P414, DOI 10.1016/j.jpeds.2004.10.023; SCHIMKE RT, 1966, J BIOL CHEM, V241, P2228; Schoffer K, 2006, MUSCLE NERVE, V33, P142, DOI 10.1002/mus.20406; Schwartz IV, 2008, J PEDIAT-BRAZIL, V84, pS8, DOI 10.1590/S0021-75572008000500003; Scott L, 2000, BRIT J CANCER, V83, P800, DOI 10.1054/bjoc.2000.1353; Severi T, 2007, CHEM-BIOL INTERACT, V168, P128, DOI 10.1016/j.cbi.2007.03.006; Shen JJ, 1996, J CLIN INVEST, V98, P352, DOI 10.1172/JCI118799; Shen LJ, 2006, CANCER LETT, V231, P30, DOI 10.1016/j.canlet.2005.01.007; Shidara Y, 2005, CANCER RES, V65, P1655, DOI 10.1158/0008-5472.CAN-04-2012; Shimizu S, 2004, INT J BIOCHEM CELL B, V36, P114, DOI 10.1016/S1357-2725(03)00170-5; Siciliano M, 2000, J CLIN GASTROENTEROL, V31, P80, DOI 10.1097/00004836-200007000-00020; Slane BG, 2006, CANCER RES, V66, P7615, DOI 10.1158/0008-5472.CAN-06-0833; Smeitink J, 2010, NEW ENGL J MED, V362, P1144, DOI 10.1056/NEJMcibr0912922; Soeda J, 2008, J CLIN GASTROENTEROL, V42, P855, DOI 10.1097/01.mcg.0000225683.29841.9c; SOLAINI G, 2010, BIOCH BIOPH IN PRESS, DOI DOI 10.1016/J.BBA-BIO.2010.09.003; Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765; StLouis M, 1997, HUM MUTAT, V9, P291, DOI 10.1002/(SICI)1098-1004(1997)9:4<291::AID-HUMU1>3.0.CO;2-9; Stratakis CA, 2009, J INTERN MED, V266, P43, DOI 10.1111/j.1365-2796.2009.02110.x; Sun XZ, 2003, ANTIOXID REDOX SIGN, V5, P655, DOI 10.1089/152308603770310338; Suzuki H, 1998, BIOCHEM BIOPH RES CO, V249, P542, DOI 10.1006/bbrc.1998.9181; Taddei TH, 2009, AM J HEMATOL, V84, P208, DOI 10.1002/ajh.21362; Teckman JH, 2004, AM J PHYSIOL-GASTR L, V286, pG851, DOI 10.1152/ajpgi.00175.2003; Teive HAG, 2008, MOVEMENT DISORD, V23, P1191, DOI 10.1002/mds.21990; Tischler AS, 2008, ARCH PATHOL LAB MED, V132, P1272, DOI 10.1043/1543-2165(2008)132[1272:PAEPU]2.0.CO;2; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Topcu M, 2004, HUM MOL GENET, V13, P2803, DOI 10.1093/hmg/ddh300; Toyokuni S, 2009, CANCER SCI, V100, P9, DOI 10.1111/j.1349-7006.2008.01001.x; TYTELL AA, 1960, EXP CELL RES, V20, P84, DOI 10.1016/0014-4827(60)90225-1; Van Schaftingen E, 2009, J INHERIT METAB DIS, V32, P135, DOI 10.1007/s10545-008-1042-3; VANSPRONSEN FJ, 1994, HEPATOLOGY, V20, P1187, DOI 10.1002/hep.1840200513; Verschoor ML, 2010, CAN J PHYSIOL PHARM, V88, P204, DOI 10.1139/Y09-135; VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z; Waisbren SE, 2003, JAMA-J AM MED ASSOC, V290, P2564, DOI 10.1001/jama.290.19.2564; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Walshe JM, 2003, QJM-INT J MED, V96, P657, DOI 10.1093/qjmed/hcg114; Wang JL, 2000, P NATL ACAD SCI USA, V97, P7124, DOI 10.1073/pnas.97.13.7124; Wang RY, 2007, GENET MED, V9, P34, DOI 10.1097/GIM.0b013e31802d8321; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Wasserman E, 1997, ANN ONCOL, V8, P1049, DOI 10.1023/A:1008261821434; WEINBERG AG, 1976, J PEDIATR-US, V88, P434, DOI 10.1016/S0022-3476(76)80259-4; WILKINSON ML, 1983, GUT, V24, P767, DOI 10.1136/gut.24.8.767; WU JS, 1994, NAT GENET, V7, P541, DOI 10.1038/ng0894-541; Xu RL, 2005, SEMIN LIVER DIS, V25, P226, DOI 10.1055/s-2005-871201; Yin PH, 2004, BRIT J CANCER, V90, P2390, DOI 10.1038/sj.bjc.6601838; YONEDA M, 1990, BIOCHEM INT, V21, P789; Young CD, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1852; Zacharski LR, 2008, JNCI-J NATL CANCER I, V100, P996, DOI 10.1093/jnci/djn209; Zhang XD, 2009, ANTICANCER RES, V29, P1443; Zhang YQ, 2009, MED SCI MONITOR, V15, pRA1; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944; Zytkovicz TH, 2001, CLIN CHEM, V47, P1945	201	36	39	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 8	2011	88	4					402	421		10.1016/j.ajhg.2011.03.005	http://dx.doi.org/10.1016/j.ajhg.2011.03.005			20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	752BY	21473982	Green Published, Bronze			2022-12-18	WOS:000289664300001
J	McLarren, KW; Severson, TM; du Souich, C; Stockton, DW; Kratz, LE; Cunningham, D; Hendson, G; Morin, RD; Wu, D; Paul, JE; An, JH; Nelson, TN; Chou, A; DeBarber, AE; Merkens, LS; Michaud, JL; Waters, PJ; Yin, JY; McGillivray, B; Demos, M; Rouleau, GA; Grzeschik, KH; Smith, R; Tarpey, PS; Shears, D; Schwartz, CE; Gecz, J; Stratton, MR; Arbour, L; Hurlburt, J; Van Allen, MI; Herman, GE; Zhao, YJ; Moore, R; Kelley, RI; Jones, SJM; Steiner, RD; Raymond, FL; Marra, MA; Boerkoel, CF				McLarren, Keith W.; Severson, Tesa M.; du Souich, Christele; Stockton, David W.; Kratz, Lisa E.; Cunningham, David; Hendson, Glenda; Morin, Ryan D.; Wu, Diane; Paul, Jessica E.; An, Jianghong; Nelson, Tanya N.; Chou, Athena; DeBarber, Andrea E.; Merkens, Louise S.; Michaud, Jacques L.; Waters, Paula J.; Yin, Jingyi; McGillivray, Barbara; Demos, Michelle; Rouleau, Guy A.; Grzeschik, Karl-Heinz; Smith, Raffaella; Tarpey, Patrick S.; Shears, Debbie; Schwartz, Charles E.; Gecz, Jozef; Stratton, Michael R.; Arbour, Laura; Hurlburt, Jane; Van Allen, Margot I.; Herman, Gail E.; Zhao, Yongjun; Moore, Richard; Kelley, Richard I.; Jones, Steven J. M.; Steiner, Robert D.; Raymond, F. Lucy; Marra, Marco A.; Boerkoel, Cornelius F.			Hypomorphic Temperature-Sensitive Alleles of NSDHL Cause CK Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LEMLI-OPITZ SYNDROME; INTELLECTUAL DISABILITY; CHOLESTEROL-METABOLISM; MASS-SPECTROMETRY; CHILD-SYNDROME; MODEL; GENE; EMBRYOS; GENOME; 24S-HYDROXYCHOLESTEROL	CK syndrome (CKS) is an X-linked recessive intellectual disability syndrome characterized by dysmorphism, cortical brain malformations, and an asthenic build. Through an X chromosome single-nucleotide variant scan in the first reported family, we identified linkage to a 5 Mb region on Xq28. Sequencing of this region detected a segregating 3 bp deletion (c.696_698del [p.Lys232del]) in exon 7 of NAD (P) dependent steroid dehydrogenase-like (NSDHL), a gene that encodes an enzyme in the cholesterol biosynthesis pathway. We also found that males with intellectual disability in another reported family with an NSDHL mutation (c.1098 dup [p.Arg367SerfsX33]) have CKS. These two mutations, which alter protein folding, show temperature-sensitive protein stability and complementation in Erg26-deficient yeast. As described for the allelic disorder CHILD syndrome, cells and cerebrospinal fluid from CKS patients have increased methyl sterol levels. We hypothesize that methyl sterol accumulation, not only cholesterol deficiency, causes CKS, given that cerebrospinal fluid cholesterol, plasma cholesterol, and plasma 24S-hydroxycholesterol levels are normal in males with CKS. In summary, CKS expands the spectrum of cholesterol-related disorders and insight into the role of cholesterol in human development.	[McLarren, Keith W.; du Souich, Christele; Chou, Athena; Yin, Jingyi; McGillivray, Barbara; Arbour, Laura; Hurlburt, Jane; Van Allen, Margot I.; Boerkoel, Cornelius F.] Dept Med Genet, Vancouver, BC V6H 3N1, Canada; [McLarren, Keith W.; du Souich, Christele; Chou, Athena; Yin, Jingyi; McGillivray, Barbara; Arbour, Laura; Hurlburt, Jane; Van Allen, Margot I.; Boerkoel, Cornelius F.] Prov Med Genet Program, Vancouver, BC V6H 3N1, Canada; [McLarren, Keith W.; du Souich, Christele; Chou, Athena; McGillivray, Barbara; Van Allen, Margot I.; Boerkoel, Cornelius F.] Univ British Columbia, Child & Family Res Inst, Vancouver, BC V5Z 4H4, Canada; [McLarren, Keith W.; du Souich, Christele; McGillivray, Barbara; Boerkoel, Cornelius F.] Rare Dis Fdn, Vancouver, BC V6H 3N1, Canada; [Severson, Tesa M.; Morin, Ryan D.; Wu, Diane; Paul, Jessica E.; An, Jianghong; Zhao, Yongjun; Moore, Richard; Jones, Steven J. M.; Marra, Marco A.] British Columbia Canc Agcy, Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada; [Severson, Tesa M.; Morin, Ryan D.; Wu, Diane; Paul, Jessica E.; An, Jianghong; Zhao, Yongjun; Moore, Richard; Jones, Steven J. M.; Marra, Marco A.] Univ British Columbia, Dept Med Genet, Vancouver, BC V5Z 1L3, Canada; [Stockton, David W.] Wayne State Univ, Sch Med, Carman & Ann Adams Dept Pediat, Div Genet & Metab Disorders, Detroit, MI 48201 USA; [Kratz, Lisa E.; Kelley, Richard I.] Johns Hopkins Univ, Kennedy Krieger Inst, Baltimore, MD 21205 USA; [Cunningham, David; Herman, Gail E.] Nationwide Childrens Hosp, Res Inst, Columbus, OH 43205 USA; [Cunningham, David; Herman, Gail E.] Ohio State Univ, Dept Pediat, Columbus, OH 43205 USA; [Hendson, Glenda; Nelson, Tanya N.; Waters, Paula J.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6H 3N1, Canada; [DeBarber, Andrea E.] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97239 USA; [Merkens, Louise S.] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97239 USA; [Michaud, Jacques L.; Rouleau, Guy A.] CHU Montreal, St Justine Res Ctr, Montreal, PQ H3T 1C5, Canada; [Demos, Michelle] Univ British Columbia, Dept Pediat, Div Neurol, Vancouver, BC V6H 3N1, Canada; [Grzeschik, Karl-Heinz] Univ Marburg, Dept Human Genet, D-35037 Marburg, Germany; [Smith, Raffaella; Tarpey, Patrick S.; Stratton, Michael R.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Shears, Debbie] Churchill Hosp, Dept Clin Genet, Oxford OX3 7LJ, England; [Schwartz, Charles E.] Greenwood Genet Ctr, JC Self Res Inst, Greenwood, SC 29646 USA; [Gecz, Jozef] Womens & Childrens Hosp, SA Pathol, Adelaide, SA 5006, Australia; [Gecz, Jozef] Univ Adelaide, Dept Paediat, Adelaide, SA 5006, Australia; [Jones, Steven J. M.] Simon Fraser Univ, Dept Mol Biol & Biochem, Vancouver, BC V5A 1S6, Canada; [Steiner, Robert D.] Oregon Hlth & Sci Univ, Doernbecher Childrens Hosp, Child Dev & Rehabil Ctr, Dept Pediat, Portland, OR 97239 USA; [Steiner, Robert D.] Oregon Hlth & Sci Univ, Doernbecher Childrens Hosp, Child Dev & Rehabil Ctr, Dept Mol & Med Genet, Portland, OR 97239 USA; [Raymond, F. Lucy] Cambridge Inst Med Res, Cambridge CB2 0XY, England	Child & Family Research Institute; University of British Columbia; British Columbia Cancer Agency; University of British Columbia; Wayne State University; Johns Hopkins University; Kennedy Krieger Institute; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University of British Columbia; Oregon Health & Science University; Oregon Health & Science University; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; University of British Columbia; Philipps University Marburg; Wellcome Trust Sanger Institute; University of Oxford; Greenwood Genetic Center; SA Pathology; Womens & Childrens Hospital Australia; University of Adelaide; Simon Fraser University; Oregon Health & Science University; Oregon Health & Science University; University of Cambridge	Boerkoel, CF (corresponding author), Dept Med Genet, Vancouver, BC V6H 3N1, Canada.	boerkoel@interchange.ubc.ca	Boerkoel, Cornelius Franciscus/AFW-4948-2022; Jones, Steven J/C-3621-2009; Steiner, Robert D./AAJ-5756-2020; Morin, Ryan/AAE-7824-2019; Marra, Marco A/B-5987-2008; Gecz, Jozef/X-3469-2019	Boerkoel, Cornelius Franciscus/0000-0003-3097-241X; Jones, Steven J/0000-0003-3394-2208; Steiner, Robert D./0000-0003-4177-4590; Morin, Ryan/0000-0003-2932-7800; Marra, Marco A/0000-0001-7146-7175; Gecz, Jozef/0000-0002-7884-6861; Nelson, Tanya/0000-0001-5344-3516; Arbour, Laura/0000-0002-9589-0880	British Columbia Children's Foundation; Scottish Rite Foundation; Child & Family Research Institute Establishment Award; BC Clinical Genomics Network of the Michael Smith Foundation for Health Research; Reseau de Medecine Genetique Appliquee of Quebec	British Columbia Children's Foundation; Scottish Rite Foundation; Child & Family Research Institute Establishment Award; BC Clinical Genomics Network of the Michael Smith Foundation for Health Research; Reseau de Medecine Genetique Appliquee of Quebec	The authors thank Daniel Goldowitz, Jan M. Friedman, Ken Inoue, David Cooke, Martin Bard, and Rosemarie Rupps for critical review of this manuscript. We thank Colin Ross for genotyping support, Daniel Goldowitz for mouse tissues, and the family for their collaboration. This work was supported in part by a British Columbia Children's Foundation Telethon Award (C.D.S.), a Scottish Rite Foundation Award (C.D.S.), a Child & Family Research Institute Establishment Award (C.F.B.), the BC Clinical Genomics Network of the Michael Smith Foundation for Health Research (C.F.B.), and the Reseau de Medecine Genetique Appliquee of Quebec (J.L.M. and G.A.R.). C.F.B., S.J.M.J., and M.A.M. are scholars of the Michael Smith Foundation for Health Research.	*1000 GEN, 1000 GEN PROJ; [Anonymous], ONLINE MENDELIAN INH; [Anonymous], DBSNP; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Bornholdt D, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.024448; Caldas H, 2003, HUM MOL GENET, V12, P2981, DOI 10.1093/hmg/ddg321; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Cooper MK, 2003, NAT GENET, V33, P508, DOI 10.1038/ng1134; Cunningham D, 2009, MOL GENET METAB, V98, P356, DOI 10.1016/j.ymgme.2009.06.016; DeBarber AE, 2008, ANAL BIOCHEM, V381, P151, DOI 10.1016/j.ab.2008.05.037; Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI 10.1194/jlr.R400004-JLR200; du Souich C, 2009, AM J MED GENET A, V149A, P2469, DOI 10.1002/ajmg.a.33071; Engelking LJ, 2006, J CLIN INVEST, V116, P2356, DOI 10.1172/JCI28988; Evers BM, 2010, J INVEST DERMATOL, V130, P1237, DOI 10.1038/jid.2009.442; Fliesler SJ, 2010, ADV EXP MED BIOL, V664, P481, DOI 10.1007/978-1-4419-1399-9_55; Gachotte D, 1998, P NATL ACAD SCI USA, V95, P13794, DOI 10.1073/pnas.95.23.13794; Gaoua W, 1999, J LIPID RES, V40, P456; Gecz J, 2009, TRENDS GENET, V25, P308, DOI 10.1016/j.tig.2009.05.002; *GGC, XLMR UPD JUL 2010; Golomb BA, 2000, J PSYCHIATR RES, V34, P301, DOI 10.1016/S0022-3956(00)00024-8; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; HAPPLE R, 1980, EUR J PEDIATR, V134, P27, DOI 10.1007/BF00442399; Jiang FL, 2006, HUM MOL GENET, V15, P3293, DOI 10.1093/hmg/ddl405; KANDUTSCH AA, 1960, J BIOL CHEM, V235, P2256; Kelley RI, 2000, J MED GENET, V37, P321, DOI 10.1136/jmg.37.5.321; KELLEY RI, 1995, CLIN CHIM ACTA, V236, P45, DOI 10.1016/0009-8981(95)06038-4; KELLEY RI, 2001, ONLINE METABOLIC MOL; Korade Z, 2010, J LIPID RES, V51, P3259, DOI 10.1194/jlr.M009365; Lalovic A, 2004, AM J PSYCHIAT, V161, P2123, DOI 10.1176/appi.ajp.161.11.2123; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Liu XY, 1999, NAT GENET, V22, P182, DOI 10.1038/9700; Lucas ME, 2003, MOL GENET METAB, V80, P227, DOI 10.1016/S1096-7192(03)00137-9; Lutjohann D, 2003, PHARMACOPSYCHIATRY, V36, pS102; Mo C, 2002, P NATL ACAD SCI USA, V99, P9739, DOI 10.1073/pnas.112202799; PIECHOTA W, 1992, EUR J OBSTET GYN R B, V45, P27, DOI 10.1016/0028-2243(92)90190-A; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Stevenson RE, 2009, DEV DISABIL RES REV, V15, P361, DOI 10.1002/ddrr.81; *SWISS MOD, SWISS MOD SERV; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wassif CA, 2001, HUM MOL GENET, V10, P555, DOI 10.1093/hmg/10.6.555; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884	44	36	39	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 10	2010	87	6					905	914		10.1016/j.ajhg.2010.11.004	http://dx.doi.org/10.1016/j.ajhg.2010.11.004			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	698AT	21129721	Bronze, Green Published			2022-12-18	WOS:000285564600019
J	Isidor, B; Pichon, O; Redon, R; Day-Salvatore, D; Hamel, A; Siwicka, KA; Bitner-Glindzicz, M; Heymann, D; Kjellen, L; Kraus, C; Leroy, JG; Mortier, GR; Rauch, A; Verloes, A; David, A; Le Caignec, C				Isidor, Bertrand; Pichon, Olivier; Redon, Richard; Day-Salvatore, Debra; Hamel, Antoine; Siwicka, Karolina A.; Bitner-Glindzicz, Maria; Heymann, Dominique; Kjellen, Lena; Kraus, Cornelia; Leroy, Jules G.; Mortier, Geert R.; Rauch, Anita; Verloes, Alain; David, Albert; Le Caignec, Cedric			Mesomelia-Synostoses Syndrome Results from Deletion of SULF1 and SLCO5A1 Genes at 8q13	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEPARAN-SULFATE; MENTAL-RETARDATION; RECEPTOR ACTIVATOR; DYSPLASIA; QSULF1; HAPLOINSUFFICIENCY; REARRANGEMENTS; INDUCTION; ANOMALIES; MECHANISM	Mesomelia-synostoses syndrome (MSS) or mesomelic dysplasia with acral synostoses Verloes-David-Pfeiffer type is a rare autosomal-dominant disorder characterized by mesomelic limb shortening, acral synostoses, and multiple congenital malformations. So far, five patients in four unrelated families have been reported worldwide with MMS. By using whole-genome oligonucleotide array CGH, we have identified an interstitial deletion at 8q13 in all patients. The deletions vary from 582 Kb to 738 Kb in size, but invariably encompass only two genes: SULF1, encoding the heparan sulfate 6-O-endosulfatase 1, and SLCO5A1, encoding the solute carrier organic anion transporter family member 5A1. SULF1 acts as a regulator of numerous growth factors in skeletal embryonic development whereas the function of SLCO5A1 is yet unknown. Breakpoint sequence analyses performed in two families showed nonrecurrent deletions. Real-time quantitative RT-PCR analysis showed the highest levels of SULF1 transcripts in human osteoblasts and cartilage whereas SLCO5A1 was highly expressed in human fetal and adult brain and heart. Our results strongly suggest that haploinsufficiency of SULF1 contributes to this mesomelic chondrodysplasia, highlighting the critical role of endosulfatase in human skeletal development. Codeletion of SULF1 and SLCO5A1-which does not result from a low-copy repeats (LCRs)-mediated recombination event in at least two families-was found in all patients, so we suggest that haploinsufficiency of SULF1 combined with haploinsufficiency of SLCO5A1 (or the altered expression of a neighboring gene through position effect) could be necessary in the pathogenesis of MSS.	[Isidor, Bertrand; Pichon, Olivier; Redon, Richard; David, Albert; Le Caignec, Cedric] CHU Nantes, Serv Genet Med, F-44093 Nantes, France; [Redon, Richard; Le Caignec, Cedric] INSERM, UMR915, Inst Thorax, F-44007 Nantes, France; [Redon, Richard; Le Caignec, Cedric] CNRS, ERL3147, F-44007 Nantes, France; [Redon, Richard; Le Caignec, Cedric] Univ Nantes, F-44035 Nantes, France; [Day-Salvatore, Debra] St Peters Univ Hosp, Inst Med Genet, New Brunswick, NJ 08901 USA; [Hamel, Antoine] CHU Nantes, Serv Orthoped Pediat, F-44093 Nantes, France; [Siwicka, Karolina A.] Med Univ Gdansk, Dept Orthopaed Surg, PL-80210 Gdansk, Poland; [Siwicka, Karolina A.] Nagoya Univ, Grad Sch Med, Dept Orthopaed Surg, Nagoya, Aichi 4668550, Japan; [Bitner-Glindzicz, Maria] UCL, Inst Child Hlth, London WC1N 1EH, England; [Heymann, Dominique] INSERM, Fac Med, UMR S957, F-44035 Nantes, France; [Kjellen, Lena] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Kraus, Cornelia] Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany; [Leroy, Jules G.] Ghent Univ Hosp, Dept Med Genet, B-9000 Ghent, Belgium; [Mortier, Geert R.] Univ Antwerp Hosp, Dept Med Genet, B-2610 Antwerp, Belgium; [Rauch, Anita] Univ Zurich, Inst Med Genet, CH-8603 Schwerzenbach, Switzerland; [Verloes, Alain] Robert Debre Univ Hosp, Dept Clin Genet, F-75019 Paris, France; [Verloes, Alain] Robert Debre Univ Hosp, INSERM, U676, F-75019 Paris, France	Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Centre National de la Recherche Scientifique (CNRS); Nantes Universite; Saint Peter's University Hospital; Nantes Universite; CHU de Nantes; Fahrenheit Universities; Medical University Gdansk; Nagoya University; University of London; University College London; Institut National de la Sante et de la Recherche Medicale (Inserm); Uppsala University; University of Erlangen Nuremberg; Ghent University; Ghent University Hospital; University of Antwerp; University of Zurich; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Le Caignec, C (corresponding author), CHU Nantes, Serv Genet Med, F-44093 Nantes, France.	cedric.lecaignec@chu-nantes.fr	Rauch, Anita/C-5568-2014; Hamel, Antoine/ABA-6745-2021; Redon, Richard/F-3303-2014; Isidor, Bertrand/AAJ-3456-2021; Heymann, Dominique/AAC-6014-2019; Hamel, Antoine/AAH-7437-2020; /AAK-8500-2021; Isidor, Bertrand/L-2435-2015; Bitner-Glindzicz, Maria/A-4231-2009; Le Caignec, Cedric/K-8467-2015; Mortier, Geert/D-2542-2012; Kjellen, Lena/F-1362-2011; VERLOES, Alain/E-7287-2014	Rauch, Anita/0000-0003-2930-3163; Hamel, Antoine/0000-0003-3348-9060; Redon, Richard/0000-0001-7751-2280; Isidor, Bertrand/0000-0001-6480-126X; Heymann, Dominique/0000-0001-7777-0669; Isidor, Bertrand/0000-0001-6480-126X; Le Caignec, Cedric/0000-0002-0598-653X; Mortier, Geert/0000-0001-9871-4578; VERLOES, Alain/0000-0003-4819-0264				Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Chipoy C, 2004, J BONE MINER RES, V19, P1850, DOI 10.1359/JBMR.040817; Day-Salvatore D, 1998, AM J MED GENET, V80, P309, DOI 10.1002/(SICI)1096-8628(19981204)80:4<309::AID-AJMG2>3.0.CO;2-J; de Smith AJ, 2007, HUM MOL GENET, V16, P2783, DOI 10.1093/hmg/ddm208; Duplomb L, 2008, ENDOCRINOLOGY, V149, P3688, DOI 10.1210/en.2007-1719; Grimaud E, 2003, AM J PATHOL, V163, P2021, DOI 10.1016/S0002-9440(10)63560-2; Holst CR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000575; Isidor B, 2009, AM J MED GENET A, V149A, P2220, DOI 10.1002/ajmg.a.32926; Lai Jin-Ping, 2008, J Gastrointest Cancer, V39, P149, DOI 10.1007/s12029-009-9058-y; Le Meur N, 2010, J MED GENET, V47, P22, DOI 10.1136/jmg.2009.069732; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Leroy JG, 2003, PEDIATR PATHOL MOL M, V22, P23, DOI 10.1080/15227950307693; LEROY JG, 2001, P GREENWOOD GENETIC, V20, P149; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Pfeiffer R A, 1995, Clin Dysmorphol, V4, P38; Ratzka A, 2008, DEV DYNAM, V237, P339, DOI 10.1002/dvdy.21423; Shears DJ, 2004, AM J MED GENET A, V128A, P6, DOI 10.1002/ajmg.a.20640; Siwicka KA, 2008, J PEDIATR ORTHOP B, V17, P271, DOI 10.1097/BPB.0b013e32830cc3c8; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Superti-Furga A, 2007, AM J MED GENET A, V143A, P1, DOI 10.1002/ajmg.a.31483; VERLOES A, 1995, AM J MED GENET, V55, P205, DOI 10.1002/ajmg.1320550211; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Viviano BL, 2004, J BIOL CHEM, V279, P5604, DOI 10.1074/jbc.M310691200; Wang SW, 2004, P NATL ACAD SCI USA, V101, P4833, DOI 10.1073/pnas.0401028101; Zweier C, 2007, AM J HUM GENET, V80, P994, DOI 10.1086/515583	27	36	36	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 9	2010	87	1					95	100		10.1016/j.ajhg.2010.05.012	http://dx.doi.org/10.1016/j.ajhg.2010.05.012			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	627HD	20602915	Green Published, Bronze			2022-12-18	WOS:000280029200009
J	Hattacharjee, S; Wang, ZM; Ciampa, J; Kraft, P; Chanock, S; Yu, K; Chatterjee, N				Hattacharjee, Samsiddhi; Wang, Zhaoming; Ciampa, Julia; Kraft, Peter; Chanock, Stephen; Yu, Kai; Chatterjee, Nilanjan			Using Principal Components of Genetic Variation for Robust and Powerful Detection of Gene-Gene Interactions in Case-Control and Case-Only Studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; POPULATION STRATIFICATION; ENVIRONMENT INDEPENDENCE; MODELS; SUSCEPTIBILITY; SELECTION; ALLELES; RISK	Many popular methods for exploring gene-gene interactions, including the case-only approach, rely on the key assumption that physically distant loci are in linkage equilibrium in the underlying population. These methods utilize the presence of correlation between unlinked loci in a disease-enriched sample as evidence of interactions among the loci in the etiology of the disease. We use data from the CGEMS case-control genome-wide association study of breast cancer to demonstrate empirically that the case-only and related methods have the potential to create large-scale false positives because of the presence Of Population stratification (PS) that creates long-range linkage disequilibrium in the genome. We show that the bias can be removed by considering parametric and nonparametric methods that assume gene-gene independence between unlinked loci, not in the entire population, but only conditional on Population substructure that can be uncovered based on the principal components of a suitably large panel of PS markers. Applications in the CGEMS study as well as simulated data show that the proposed methods are robust to the presence of population stratification and are yet much more powerful, relative to standard logistic regression methods that are also commonly used as robust alternatives to the case-only type methods.	[Hattacharjee, Samsiddhi; Ciampa, Julia; Yu, Kai; Chatterjee, Nilanjan] NCI, Biostat Branch, Div Canc Epidemiol & Genet, NIH, Rockville, MD 20852 USA; [Wang, Zhaoming] NCI, Adv Technol Ctr, NIH, Rockville, MD 20852 USA; [Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Chanock, Stephen] NCI, Lab Translat Genom, Div Canc Epidemiol & Genet, NIH, Gaithersburg, MD 20877 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Chatterjee, N (corresponding author), NCI, Biostat Branch, Div Canc Epidemiol & Genet, NIH, Rockville, MD 20852 USA.	chattern@mail.nih.gov	Wang, Zhaoming/R-5527-2018	Wang, Zhaoming/0000-0001-7556-3869; Bhattacharjee, Samsiddhi/0000-0002-8549-1130	National Cancer Institute Intramural Program; National Heart, Lung, and Blood Institute; NIH [P01 CA87969]; NATIONAL CANCER INSTITUTE [P01CA087969, ZIACP010181] Funding Source: NIH RePORTER	National Cancer Institute Intramural Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors would like to acknowledge Dr. Jay Sethuraman for helpful discussions on matching algorithms and Dr. B.J. Stone for proof reading and editing the manuscript. The research of S.B., J.C., K.Y., S.C., and N.C. was supported by the National Cancer Institute Intramural Program and a Gene-Environment Initiative (GEI) grant from the National Heart, Lung, and Blood Institute. The research of P.K. was Supported by NIH P01 CA87969. We would also like to thank three anonymous reviewers for their helpful comments to improve the manuscript. This Study utilized the high-performance Computational capabilities of the StatPro Linux cluster at the National Cancer Institute and the Bio-wulf Linux cluster at the National Institutes of Health, Bethesda, MD.	Breslow NE, 1980, STATISTICAL METHODS, V1, P247; Chapman J, 2007, GENET EPIDEMIOL, V31, P894, DOI 10.1002/gepi.20250; Chatterjee N, 2005, BIOMETRIKA, V92, P399, DOI 10.1093/biomet/92.2.399; Chatterjee N, 2005, GENET EPIDEMIOL, V28, P138, DOI 10.1002/gepi.20049; Chatterjee N, 2006, AM J HUM GENET, V79, P1002, DOI 10.1086/509704; Epstein MP, 2007, AM J HUM GENET, V80, P921, DOI 10.1086/516842; Gerbault P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006369; Guan WH, 2009, GENET EPIDEMIOL, V33, P508, DOI 10.1002/gepi.20403; Hosmer D. W., 2000, APPL LOGISTIC REGRES, V2nd; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Khoury MJ, 1996, AM J EPIDEMIOL, V144, P207; Kooperberg C, 2005, GENET EPIDEMIOL, V28, P157, DOI 10.1002/gepi.20042; Kraft P, 2007, HUM HERED, V63, P111, DOI 10.1159/000099183; Lee AB, 2010, GENET EPIDEMIOL, V34, P51, DOI 10.1002/gepi.20434; Luca D, 2008, AM J HUM GENET, V82, P453, DOI 10.1016/j.ajhg.2007.11.003; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Millstein J, 2006, AM J HUM GENET, V78, P15, DOI 10.1086/498850; Moore JH, 2009, AM J HUM GENET, V85, P309, DOI 10.1016/j.ajhg.2009.08.006; Park MY, 2008, BIOSTATISTICS, V9, P30, DOI 10.1093/biostatistics/kxm010; PIEGORSCH WW, 1994, STAT MED, V13, P153, DOI 10.1002/sim.4780130206; PRENTICE RL, 1979, BIOMETRIKA, V66, P403, DOI 10.1093/biomet/66.3.403; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Song MS, 2009, GENET EPIDEMIOL, V33, P386, DOI 10.1002/gepi.20392; Tang WW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000464; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Yu K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002551; Zhang Y, 2007, NAT GENET, V39, P1167, DOI 10.1038/ng2110; Zhao JY, 2006, AM J HUM GENET, V79, P831, DOI 10.1086/508571	29	36	37	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 12	2010	86	3					331	342		10.1016/j.ajhg.2010.01.026	http://dx.doi.org/10.1016/j.ajhg.2010.01.026			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	570LG	20206333	Green Published, Bronze			2022-12-18	WOS:000275678800005
J	Rozen, S; Marszalek, JD; Alagappan, RK; Skaletsky, H; Page, DC				Rozen, Steve; Marszalek, Janet D.; Alagappan, Raaji K.; Skaletsky, Helen; Page, David C.			Remarkably Little Variation in Proteins Encoded by the Y Chromosome's Single-Copy Genes, Implying Effective Purifying Selection	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEQUENCE VARIATION; POLYMORPHISMS; POPULATION; DELETIONS; MUTATION; SEX	Y-linked single-nucleotide polymorphisms (SNPs) have served as powerful tools for reconstructing the worldwide genealogy of human Y chromosomes and for illuminating patrilineal relationships among modern human populations. However, there has been 110 systematic, worldwide survey of sequence variation within the protein-coding genes of the Y chromosome. Here we,report and analyze coding sequence variation among the 16 single-copy "X-degenerate" genes of the Y chromosome. We examined variation in these genes in 105 men representing worldwide diversity, resequencing in each man an average of 27 kb of coding DNA, 40 kb of intronic DNA and, for comparison, 15 kb of DNA in single-copy Y-chromosomal pseudogenes. There is remarkably little variation in X-degenerate protein sequences: two chromosomes drawn at random differ on average by a single amino acid, with half of these differences arising from a single, conservative Asp -> Glu mutation that occurred similar to 50,000 years ago. Further analysis showed that nucleotide diversity and the proportion of variant sites are significantly lower for nonsynonymous sites than for synonymous sites, introns, or pseudogenes. These differences imply that natural selection has operated effectively in preserving the amino acid sequences of the Y chromosome's X-degenerate proteins during the last similar to 100,000 years of human history. Thus our findings are at odds with prominent accounts of the human Y chromosome's imminent demise.	[Rozen, Steve; Marszalek, Janet D.; Alagappan, Raaji K.; Skaletsky, Helen; Page, David C.] MIT, Howard Hughes Med Inst, Whitehead Inst, Cambridge, MA 02142 USA; [Rozen, Steve; Marszalek, Janet D.; Alagappan, Raaji K.; Skaletsky, Helen; Page, David C.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Rozen, Steve] Duke NUS Grad Med Sch, Singapore 169857, Singapore	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); National University of Singapore	Page, DC (corresponding author), MIT, Howard Hughes Med Inst, Whitehead Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dcpage@wi.mit.edu	Rozen, Steven G./J-5939-2013	Rozen, Steven G./0000-0002-4288-0056	National Institutes of Health; Howard Hughes Medical Institute	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank Laura Brown, Gail Farino, Vicki Frazzoni, and Loreall Pooler for technical assistance; Christine Disteche, Alan Donnenfeld, Nathan Ellis, TreforJenkins, Michael Hammer, Robert Oates, Pasquale Patrizio, Sherman Silber, jean Weissenbach, and Brian Whitmire for human samples and cell lines; Andrew Clark for consultation on population genetic analysis; Michael Hammer and Peter Underhill for advice and guidance in genealogical studies; and D. Winston Bellott, Michelle Carmell, Greg Dokshin, Mark Gill, Jennifer Hughes, Jacob Mueller, Tatyana Pyntikova, and Shirleen Soh for comments on the manuscript. Supported by the National Institutes of Health and the Howard Hughes Medical Institute.	Aitken RJ, 2002, NATURE, V415, P963, DOI 10.1038/415963a; Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Cadenas AM, 2007, FORENSIC SCI INT, V166, P155, DOI 10.1016/j.forsciint.2006.05.002; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; Hartl D., 2007, PRINCIPLES POPULATIO; Hughes JF, 2005, NATURE, V437, P101, DOI 10.1038/nature04101; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Jobling MA, 2007, HUM MOL GENET, V16, P307, DOI 10.1093/hmg/ddl465; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Kashyap VK, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-37; Repping S, 2006, NAT GENET, V38, P463, DOI 10.1038/ng1754; Repping S, 2003, NAT GENET, V35, P247, DOI 10.1038/ng1250; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Santos FR, 1998, NAT GENET, V18, P103, DOI 10.1038/ng0298-103; Shen PD, 2000, P NATL ACAD SCI USA, V97, P7354, DOI 10.1073/pnas.97.13.7354; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Sykes B, 2004, ADAMS CURSE; Tyler-Smith C, 2006, NAT GENET, V38, P141, DOI 10.1038/ng0206-141; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685	20	36	37	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 11	2009	85	6					923	928		10.1016/j.ajhg.2009.11.011	http://dx.doi.org/10.1016/j.ajhg.2009.11.011			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	533BN	20004767	Bronze, Green Submitted, Green Published			2022-12-18	WOS:000272797100017
J	Robert-Richard, E; Moreau-Gaudry, F; Lalanne, M; Lamrissi-Garcia, I; Cario-Andre, M; Guyonnet-Duperat, V; Taine, L; Ged, C; de Verneuil, H				Robert-Richard, Elodie; Moreau-Gaudry, Francois; Lalanne, Magalie; Lamrissi-Garcia, Isabelle; Cario-Andre, Muriel; Guyonnet-Duperat, Veronique; Taine, Laurence; Ged, Cecile; de Verneuil, Hubert			Effective gene therapy of mice with congenital erythropoietic porphyria is facilitated by a survival advantage of corrected erythroid cells	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BONE-MARROW-TRANSPLANTATION; SEVERE COMBINED IMMUNODEFICIENCY; III SYNTHASE GENE; GAMMA-GLOBIN GENE; MOUSE MODEL; BETA-THALASSEMIA; HEMATOPOIETIC-CELLS; LENTIVIRAL VECTOR; CD34(+) CELLS; MURINE MODEL	Achieving long-term expression of a therapeutic gene in a given hematopoietic lineage remains an important goal of gene therapy. Congenital erythropoietic porphyria (CEP) is a severe autosomal-recessive disorder characterized by a deficiency in uroporphyrinogen III synthase (UROS), the fourth enzyme of the heme biosynthetic pathway. We used a recently obtained murine model to check the feasibility of gene therapy in this disease. Lentivirus-mediated transfer of the human UROS cDNA into hematopoietic stem cells (HSCs) from Uros(mut248) mice resulted in a complete and long-term enzymatic, metabolic, and phenotypic correction of the disease, favored by a survival advantage of corrected red blood cells. These results demonstrate that the cure of this mouse model of CEP at a moderate transduction level supports the proof of concept of a gene therapy in this disease by transplantation of genetically modified hematopoietic stem cells.	[Robert-Richard, Elodie; Moreau-Gaudry, Francois; Lalanne, Magalie; Lamrissi-Garcia, Isabelle; Cario-Andre, Muriel; Guyonnet-Duperat, Veronique; Taine, Laurence; Ged, Cecile; de Verneuil, Hubert] Inst Fed Rech 66, INSERM, U876, F-33000 Bordeaux, France; [Robert-Richard, Elodie; Moreau-Gaudry, Francois; Lalanne, Magalie; Lamrissi-Garcia, Isabelle; Cario-Andre, Muriel; Guyonnet-Duperat, Veronique; Taine, Laurence; Ged, Cecile; de Verneuil, Hubert] Univ Bordeaux 2, F-33000 Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	de Verneuil, H (corresponding author), Inst Fed Rech 66, INSERM, U876, F-33000 Bordeaux, France.	verneuil@u-bordeaux2.fr	Cario, Muriel/AAM-2633-2020	Cario, Muriel/0000-0003-0462-5684; Moreau-Gaudry, Francois/0000-0003-1813-3939; richard, elodie/0000-0003-3778-1210; GED, Cecile/0000-0001-7257-8264				Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104; Aiuti A, 2002, NAT MED, V8, P423, DOI 10.1038/nm0502-423; Anderson K.E., 2001, METABOLIC MOL BASES, P2961; Baum C, 2007, MOL THER, V15, P1401, DOI 10.1038/sj.mt.6300263; Bishop DF, 2006, AM J HUM GENET, V78, P645, DOI 10.1086/502667; Case SS, 1999, P NATL ACAD SCI USA, V96, P2988, DOI 10.1073/pnas.96.6.2988; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; DEVERNEUIL H, 1995, ARCH PEDIATRIE, V2, P755, DOI 10.1016/0929-693X(96)81246-2; DEYBACH JC, 1990, BLOOD, V75, P1763; Dunbar CE, 1998, HUM GENE THER, V9, P2629, DOI 10.1089/10430349850019463; Dupuis-Girod S, 2005, EUR J PEDIATR, V164, P104, DOI 10.1007/s00431-004-1575-x; Fischer A, 2004, NEW ENGL J MED, V350, P2526; Fontanellas A, 1996, EUR J HUM GENET, V4, P274; Fontanellas A, 2001, GENE THER, V8, P618, DOI 10.1038/sj.gt.3301427; Fontanellas A, 2000, HEPATOLOGY, V32, P73, DOI 10.1053/jhep.2000.8531; Fritsch C, 1998, SKIN PHARMACOL APPL, V11, P358, DOI 10.1159/000029858; Fritsch C, 1997, J AM ACAD DERMATOL, V36, P594, DOI 10.1016/S0190-9622(97)70249-4; Gaspar HB, 2006, MOL THER, V14, P505, DOI 10.1016/j.ymthe.2006.06.007; Gaspar HB, 2004, LANCET, V364, P2181, DOI 10.1016/S0140-6736(04)17590-9; Ged C, 2006, GENOMICS, V87, P84, DOI 10.1016/j.ygeno.2005.08.018; Geronimi F, 2003, STEM CELLS, V21, P472, DOI 10.1634/stemcells.21-4-472; Geronimi F, 2003, J MOL MED, V81, P310, DOI 10.1007/s00109-003-0438-7; Harada FA, 2001, J AM ACAD DERMATOL, V45, P279, DOI 10.1067/mjd.2001.114730; KAUFFMAN L, 1991, LANCET, V337, P1510, DOI 10.1016/0140-6736(91)93198-I; Lagarde C, 1998, ANN DERMATOL VENER, V125, P114; LIM CK, 1984, CLIN CHIM ACTA, V139, P55, DOI 10.1016/0009-8981(84)90192-X; Malech HL, 1997, P NATL ACAD SCI USA, V94, P12133, DOI 10.1073/pnas.94.22.12133; Malik P, 2005, ANN NY ACAD SCI, V1054, P238, DOI 10.1196/annals.1345.030; Moreau-Gaudry F, 2001, BLOOD, V98, P2664, DOI 10.1182/blood.V98.9.2664; MOREAUGAUDRY F, 1995, BLOOD, V85, P1449, DOI 10.1182/blood.V85.6.1449.bloodjournal8561449; Muul LM, 2003, BLOOD, V101, P2563, DOI 10.1182/blood-2002-09-2800; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Pawliuk R, 1999, NAT MED, V5, P768, DOI 10.1038/10488; Persons DA, 2001, BLOOD, V97, P3275, DOI 10.1182/blood.V97.10.3275; Phillips JD, 2007, BLOOD, V109, P2618, DOI 10.1182/blood-2006-06-022848; Puthenveetil G, 2004, BLOOD, V104, P3445, DOI 10.1182/blood-2004-04-1427; Ren SC, 1996, BLOOD, V87, P2518, DOI 10.1182/blood.V87.6.2518.bloodjournal8762518; Richard E, 2004, GENE THER, V11, P1638, DOI 10.1038/sj.gt.3302335; Richard E, 2001, MOL THER, V4, P331, DOI 10.1006/mthe.2001.0467; Richard RE, 2004, BLOOD, V103, P4432, DOI 10.1182/blood-2003-10-3705; Rivella S, 2003, BLOOD, V101, P2932, DOI 10.1182/blood-2002-10-3305; Robert-Richard E, 2007, MOL THER, V15, P173, DOI 10.1038/sj.mt.6300030; ROMEO G, 1969, P NATL ACAD SCI USA, V63, P856, DOI 10.1073/pnas.63.3.856; Sabatino DE, 2000, P NATL ACAD SCI USA, V97, P13294, DOI 10.1073/pnas.230453097; Schmidt M, 2003, NAT MED, V9, P463, DOI 10.1038/nm844; Shady AA, 2002, BRIT J HAEMATOL, V117, P980, DOI 10.1046/j.1365-2141.2002.03558.x; Shaw PH, 2001, BONE MARROW TRANSPL, V27, P101, DOI 10.1038/sj.bmt.1702738; Tezcan I, 1998, BLOOD, V92, P4053, DOI 10.1182/blood.V92.11.4053.423k38_4053_4058; Thomas C, 1996, J PEDIATR-US, V129, P453, DOI 10.1016/S0022-3476(96)70082-3; Trobridge G, 2005, HUM GENE THER, V16, P1355, DOI 10.1089/hum.2005.16.1355; Urbinati F, 2005, HUM GENE THER, V16, P594, DOI 10.1089/hum.2005.16.594; Verneuil de H, 2003, PORPHYRIN HDB, V14, P43; XU WM, 1995, J CLIN INVEST, V95, P905, DOI 10.1172/JCI117742; ZixKieffer I, 1996, BONE MARROW TRANSPL, V18, P217	54	36	36	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2008	82	1					113	124		10.1016/j.ajhg.2007.09.007	http://dx.doi.org/10.1016/j.ajhg.2007.09.007			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NM	18179890	Bronze, Green Published			2022-12-18	WOS:000253223800012
J	Lin, DY; Huang, BE				Lin, D. Y.; Huang, B. E.			The use of inferred haplotypes in downstream analyses	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							GENOTYPE DATA; ASSOCIATION; PHASE; INFORMATION; INFERENCE		Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Lin, DY (corresponding author), Univ N Carolina, Dept Biostat, McGavran Greenberg Hall,CB 7420, Chapel Hill, NC 27599 USA.	lin@bios.unc.edu	Huang, Bevan/A-5949-2009	Huang, Bevan/0000-0002-1981-5838	NCI NIH HHS [T32 CA106209] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA106209] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Cordell HJ, 2006, GENET EPIDEMIOL, V30, P259, DOI 10.1002/gepi.20142; DEMPSTER AP, 1983, INCOMPLETE DATA SAMP, V2, P3; Epstein MP, 2003, AM J HUM GENET, V73, P1316, DOI 10.1086/380204; Fallin D, 2000, AM J HUM GENET, V67, P947, DOI 10.1086/303069; French B, 2006, GENET EPIDEMIOL, V30, P485, DOI 10.1002/gepi.20161; Kraft P, 2005, GENET EPIDEMIOL, V28, P261, DOI 10.1002/gepi.20061; Lin DY, 2005, GENET EPIDEMIOL, V29, P299, DOI 10.1002/gepi.20098; Lin DY, 2006, J AM STAT ASSOC, V101, P89, DOI 10.1198/016214505000000808; Marchini J, 2006, AM J HUM GENET, V78, P437, DOI 10.1086/500808; Morris AP, 2004, AM J HUM GENET, V74, P945, DOI 10.1086/420773; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Spinka C, 2005, GENET EPIDEMIOL, V29, P108, DOI 10.1002/gepi.20085	12	36	39	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2007	80	3					577	579		10.1086/512201	http://dx.doi.org/10.1086/512201			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	139AB	17380613	Bronze, Green Published			2022-12-18	WOS:000244403300020
J	Saunders, MA; Good, JM; Lawrence, EC; Ferrell, RE; Li, WH; Nachman, MW				Saunders, Matthew A.; Good, Jeffrey M.; Lawrence, Elizabeth C.; Ferrell, Robert E.; Li, Wen-Hsiung; Nachman, Michael W.			Human adaptive evolution at myostatin (GDF8), a regulator of muscle growth	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECENT POSITIVE SELECTION; HUMAN GENOME; SEQUENCE; GENE; POLYMORPHISMS; EXPRESSION; PROPEPTIDE; MUTATIONS; CATTLE; DOMAIN	Myostatin (GDF8) is a negative regulator of muscle growth in mammals, and loss-of-function mutations are associated with increased skeletal-muscle mass in mice, cattle, and humans. Here, we show that positive natural selection has acted on human nucleotide variation at GDF8, since the observed ratio of nonsynonymous: synonymous changes among humans is significantly greater than expected under the neutral model and is strikingly different from patterns observed across mammalian orders. Furthermore, extended haplotypes around GDF8 suggest that two amino acid variants have been subject to recent positive selection. Both mutations are rare among non-Africans yet are at frequencies of up to 31% in sub-Saharan Africans. These signatures of selection at the molecular level suggest that human variation at GDF8 is associated with functional differences.	Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15260 USA	University of Chicago; University of Arizona; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Saunders, MA (corresponding author), Univ Chicago, Dept Ecol & Evolut, 1101 E 57th St, Chicago, IL 60637 USA.	saunders@uchicago.edu		Li, Wen-Hsiung/0000-0003-1086-1456				Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bogdanovich S, 2005, FASEB J, V19, P543, DOI 10.1096/fj.04-2796com; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Cavalli-Sforza LL, 2005, NAT REV GENET, V6, P333, DOI 10.1038/nrg1579; Currat M, 2006, SCIENCE, V313, P172, DOI 10.1126/science.1122712; Ferrell RE, 1999, GENOMICS, V62, P203, DOI 10.1006/geno.1999.5984; Gonzalez-Cadavid NF, 1998, P NATL ACAD SCI USA, V95, P14938, DOI 10.1073/pnas.95.25.14938; Gordon ES, 2005, INT J BIOCHEM CELL B, V37, P2064, DOI 10.1016/j.biocel.2005.05.005; HUGHES AL, 1989, P NATL ACAD SCI USA, V86, P958, DOI 10.1073/pnas.86.3.958; Jiang MS, 2004, BIOCHEM BIOPH RES CO, V315, P525, DOI 10.1016/j.bbrc.2004.01.085; Kambadur R, 1997, GENOME RES, V7, P910, DOI 10.1101/gr.7.9.910; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Ma K, 2001, AM J PHYSIOL-ENDOC M, V281, pE1128, DOI 10.1152/ajpendo.2001.281.6.E1128; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Saunders MA, 2005, GENETICS, V171, P1219, DOI 10.1534/genetics.105.048140; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tellgren A, 2004, MOL PHYLOGENET EVOL, V33, P782, DOI 10.1016/j.ympev.2004.07.004; Thomis MAI, 2004, EUR J APPL PHYSIOL, V92, P267, DOI 10.1007/s00421-004-1093-6; Toomajian C, 2003, GENETICS, V165, P287; Verrelli BC, 2002, AM J HUM GENET, V71, P1112, DOI 10.1086/344345; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wells JCK, 2006, BIOL REV, V81, P183, DOI 10.1017/S1464793105006974; Yang JZ, 2001, MOL REPROD DEV, V60, P351, DOI 10.1002/mrd.1097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yingling JM, 2004, NAT REV DRUG DISCOV, V3, P1011, DOI 10.1038/nrd1580	31	36	43	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2006	79	6					1089	1097		10.1086/509707	http://dx.doi.org/10.1086/509707			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106WB	17186467	Bronze, Green Published			2022-12-18	WOS:000242131600010
J	Ferreira, MAR; O'Gorman, L; Le Souef, P; Burton, PR; Toelle, BG; Robertson, CF; Visscher, PM; Martin, NG; Duffy, DL				Ferreira, MAR; O'Gorman, L; Le Souef, P; Burton, PR; Toelle, BG; Robertson, CF; Visscher, PM; Martin, NG; Duffy, DL			Robust estimation of experimentwise P values applied to a genome scan of multiple asthma traits identifies a new region of significant linkage on chromosome 20q13	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IMMUNOGLOBULIN-E LEVELS; EXHALED NITRIC-OXIDE; QUANTITATIVE TRAITS; WIDE SEARCH; SUSCEPTIBILITY GENE; BRONCHIAL HYPERRESPONSIVENESS; FOUNDER POPULATION; POSITIONAL CLONING; JAPANESE FAMILIES; CHILDHOOD ASTHMA	Over 30 genomic regions show linkage to asthma traits. Six asthma genes have been cloned, but the putative loci in many linked regions have not been identified. To search for asthma susceptibility loci, we performed genomewide univariate linkage analyses of seven asthma traits, using 202 Australian families ascertained through a twin proband. House-dust mite sensitivity (Dpter) exceeded the empirical threshold for significant linkage at 102 cM on chromosome 20q13, near marker D20S173 (empirical pointwise P = .00001 and genomewide P = .005, both uncorrected for multiple-trait testing). Atopy, bronchial hyperresponsiveness (BHR), and forced expiratory volume in 1s (FEV1) were also linked to this region. In addition, 16 regions were linked to at least one trait at the suggestive level, including 12q24, which has consistently shown linkage to asthma traits in other studies. Some regions were expected to be false-positives arising from multiple-trait testing. To address this, we developed a new approach to estimate genomewide significance that accounts for multiple-trait testing and for correlation between traits and that does not require a Bonferroni correction. With this approach, Dpter remained significantly linked to 20q13 (empirical genomewide P = .042), and airway obstruction remained linked to 12q24 at the suggestive level. Finally, we extended this method to show that the linkage of Dpter, atopy, BHR, FEV1 1, asthma, and airway obstruction to chromosome 20q13 is unlikely to be due to chance and may result from a quantitative trait locus in this region that affects several of these traits.	Queensland Inst Med Res, Brisbane, Qld 4029, Australia; Princess Margaret Hosp Children, Dept Resp Med, Perth, WA, Australia; Woolcock Inst Med Res, Sydney, NSW, Australia; Royal Childrens Hosp, Dept Resp Med, Melbourne, Vic, Australia	QIMR Berghofer Medical Research Institute; University of Western Australia; University of Sydney; Woolcock Institute of Medical Research; Royal Children's Hospital Melbourne	Ferreira, MAR (corresponding author), Queensland Inst Med Res, PO Royal Brisbane Hosp, Brisbane, Qld 4029, Australia.	manuelF@qimr.edu.au	Le Souef, Peter N/H-5256-2014; Visscher, Peter/ABB-6151-2020; Duffy, David L/B-7392-2013; Ferreira, Manuel A R/D-3609-2013; Toelle, Brett G/B-1531-2008	Visscher, Peter/0000-0002-2143-8760; Duffy, David L/0000-0001-7227-632X; Ferreira, Manuel A R/0000-0001-9059-1825; Toelle, Brett G/0000-0002-7375-0019; Le Souef, Peter/0000-0003-0930-1654; Martin, Nicholas/0000-0003-4069-8020				Abecasis GR, 2005, AM J HUM GENET, V77, P754, DOI 10.1086/497345; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Ali M, 2003, PEDIAT ALLERG IMM-UK, V14, P261, DOI 10.1034/j.1399-3038.2003.00065.x; Allen M, 2003, NAT GENET, V35, P258, DOI 10.1038/ng1256; Allison DB, 1998, AM J HUM GENET, V63, P1190, DOI 10.1086/302038; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Amos CI, 2001, HUM HERED, V51, P133, DOI 10.1159/000053334; AMOS CI, 1990, AM J HUM GENET, V47, P247; Beekman M, 2003, EUR J HUM GENET, V11, P845, DOI 10.1038/sj.ejhg.5201053; Blangero J, 1997, GENET EPIDEMIOL, V14, P959, DOI 10.1002/(SICI)1098-2272(1997)14:6<959::AID-GEPI66>3.0.CO;2-K; Blumenthal MN, 2004, GENES IMMUN, V5, P226, DOI 10.1038/sj.gene.6364063; Blumenthal MN, 2004, HUM GENET, V114, P157, DOI 10.1007/s00439-003-1030-5; Bouzigon E, 2004, HUM MOL GENET, V13, P3103, DOI 10.1093/hmg/ddh340; DANIELS SE, 1996, NATURE, V383, P250; de Andrade M, 1997, GENET EPIDEMIOL, V14, P773, DOI 10.1002/(SICI)1098-2272(1997)14:6<773::AID-GEPI35>3.0.CO;2-L; Dizier MH, 2000, AM J RESP CRIT CARE, V162, P1812, DOI 10.1164/ajrccm.162.5.2002113; Dudbridge F, 2004, AM J HUM GENET, V75, P424, DOI 10.1086/423738; Eaves LJ, 1996, BEHAV GENET, V26, P519, DOI 10.1007/BF02359757; Evans DM, 2004, J ALLERGY CLIN IMMUN, V114, P826, DOI 10.1016/j.jaci.2004.05.060; Evans DM, 2004, BEHAV GENET, V34, P135, DOI 10.1023/B:BEGE.0000013727.15845.f8; FERREIRA MAR, IN PRESS ALLERGY; Gao PS, 2000, BIOCHEM BIOPH RES CO, V267, P761, DOI 10.1006/bbrc.1999.2030; Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471; Grasemann H, 1999, CLIN EXP ALLERGY, V29, P39; Haagerup A, 2002, ALLERGY, V57, P680, DOI 10.1034/j.1398-9995.2002.23523.x; Hakonarson H, 2002, AM J HUM GENET, V71, P483, DOI 10.1086/342205; Hoh J, 2001, GENOME RES, V11, P2115, DOI 10.1101/gr.204001; Holberg CJ, 2001, J ALLERGY CLIN IMMUN, V108, P772, DOI 10.1067/mai.2001.119158; Kirk K M, 2000, Twin Res, V3, P299, DOI 10.1375/136905200320565274; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kong X, 2004, AM J HUM GENET, V75, P1143, DOI 10.1086/426405; Koppelman GH, 2002, J ALLERGY CLIN IMMUN, V109, P498, DOI 10.1067/mai.2002.122235; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kurz T, 2005, ALLERGY, V60, P192, DOI 10.1111/j.1398-9995.2005.00646.x; Laitinen T, 2001, NAT GENET, V28, P87, DOI 10.1038/88319; Laitinen T, 2004, SCIENCE, V304, P300, DOI 10.1126/science.1090010; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Marlow AJ, 2003, AM J HUM GENET, V72, P561, DOI 10.1086/368201; Martin N, 1997, NAT GENET, V17, P387, DOI 10.1038/ng1297-387; Mathias RA, 2001, GENET EPIDEMIOL, V20, P340, DOI 10.1002/gepi.5; Meyers DA, 2005, J ALLERGY CLIN IMMUN, V115, P1169, DOI 10.1016/j.jaci.2005.01.070; Nicolae D, 2005, AM J HUM GENET, V76, P349, DOI 10.1086/427763; Noguchi E, 2005, AM J RESP CRIT CARE, V172, P183, DOI 10.1164/rccm.200409-1223OC; Ober C, 2000, AM J HUM GENET, V67, P1154, DOI 10.1016/S0002-9297(07)62946-2; Olswold C, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S57; Postma DS, 2005, AM J RESP CRIT CARE, V172, P446, DOI 10.1164/rccm.200407-864OC; Shao CC, 2004, J HUM GENET, V49, P115, DOI 10.1007/s10038-003-0118-z; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878; Wechsler ME, 2000, AM J RESP CRIT CARE, V162, P2043, DOI 10.1164/ajrccm.162.6.2003089; Whitfield JB, 2000, AM J HUM GENET, V66, P1246, DOI 10.1086/302862; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; Williams JT, 1999, AM J HUM GENET, V65, P1134, DOI 10.1086/302570; Williams JT, 1999, AM J HUM GENET, V65, P1148, DOI 10.1086/302571; Wjst M, 1999, GENOMICS, V58, P1, DOI 10.1006/geno.1999.5806; Xu JF, 2001, AM J HUM GENET, V68, P1437, DOI 10.1086/320589; Xu JF, 2000, AM J HUM GENET, V67, P1163, DOI 10.1086/321190; Xu X, 2001, AM J HUM GENET, V69, P1271, DOI 10.1086/324650; Yokouchi Y, 2000, GENOMICS, V66, P152, DOI 10.1006/geno.2000.6201; Yokouchi Y, 2002, GENES IMMUN, V3, P9, DOI 10.1038/sj.gene.6363815; Zhang YM, 2003, NAT GENET, V34, P181, DOI 10.1038/ng1166	60	36	37	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2005	77	6					1075	1085		10.1086/497997	http://dx.doi.org/10.1086/497997			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	983OE	16380917	Green Published, Bronze			2022-12-18	WOS:000233241200015
J	Rademakers, R; Cruts, M; Sleegers, K; Dermaut, B; Theuns, J; Aulchenko, Y; Weckx, S; De Pooter, T; Van den Broeck, M; Corsmit, E; De Rijk, P; Del-Favero, J; van Swieten, J; van Duijn, CM; Van Broeckhoven, C				Rademakers, R; Cruts, M; Sleegers, K; Dermaut, B; Theuns, J; Aulchenko, Y; Weckx, S; De Pooter, T; Van den Broeck, M; Corsmit, E; De Rijk, P; Del-Favero, J; van Swieten, J; van Duijn, CM; Van Broeckhoven, C			Linkage and association studies identify a novel locus for Alzheimer disease at 7q36 in a Dutch population-based sample	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRECURSOR PROTEIN GENE; APOLIPOPROTEIN-E; MISSENSE MUTATIONS; TYPE-4 ALLELE; DEMENTIA; ROTTERDAM; RISK; PRESENILIN-1; SUBSTITUTION; HISTORY	We obtained conclusive linkage of Alzheimer disease (AD) with a candidate region of 19.7 cM at 7q36 in an extended multiplex family, family 1270, ascertained in a population-based study of early-onset AD in the northern Netherlands. Single-nucleotide polymorphism and haplotype association analyses of a Dutch patient-control sample further supported the linkage at 7q36. In addition, we identified a shared haplotype at 7q36 between family 1270 and three of six multiplex AD-affected families from the same geographical region, which is indicative of a founder effect and defines a priority region of 9.3 cM. Mutation analysis of coding exons of 29 candidate genes identified one linked synonymous mutation, g.3803OG -> C in exon 10, that affected codon 626 of the PAX transactivation domain interacting protein gene (PAXIP1). It remains to be determined whether PAXIP1 has a functional role in the expression of AD in family 1270 or whether another mutation at this locus explains the observed linkage and sharing. Together, our linkage data from the informative family 1270 and the association data in the population-based early-onset AD patient-control sample strongly support the identification of a novel AD locus at 7q36 and re-emphasize the genetic heterogeneity of AD.	Univ Antwerp VIB, Dept Mol Genet, B-2610 Antwerp, Belgium; Univ Hosp Dijkzigt, Dept Epidemiol & Biostat, Erasmus Sch Ctr, NL-3015 GD Rotterdam, Netherlands; Univ Hosp Dijkzigt, Dept Neurol, NL-3015 GD Rotterdam, Netherlands	Flanders Institute for Biotechnology (VIB); University of Antwerp; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Van Broeckhoven, C (corresponding author), Univ Antwerp VIB, Dept Mol Genet, Campus Drie Eiken,Bldg 5,Room 1-10,Univ Pl 1, B-2610 Antwerp, Belgium.	christine.vanbroeckhoven@ua.ac.be	Cruts, Marc/J-6161-2013; Van Broeckhoven, Christine/M-7853-2019; De Rijk, Peter/GXH-9837-2022; Aulchenko, Yurii/M-8270-2013; Weckx, Stefan/ABB-5390-2021; Van Broeckhoven, Christine/G-8362-2017; Weckx, Stefan/J-4254-2014; Weckx, Stefan/AAF-8996-2019; Dermaut, Bart/AAM-2483-2020	Cruts, Marc/0000-0002-1338-992X; Van Broeckhoven, Christine/0000-0003-0183-7665; De Rijk, Peter/0000-0001-8558-9288; Aulchenko, Yurii/0000-0002-7899-1575; Van Broeckhoven, Christine/0000-0003-0183-7665; Weckx, Stefan/0000-0002-1380-8610; Del Favero, jurgen/0000-0002-7427-7489; Theuns, Jessie/0000-0001-5087-7650; Van Duijn, Cornelia/0000-0002-2374-9204				Ashley-Koch AE, 2005, NEUROSCI LETT, V379, P199, DOI 10.1016/j.neulet.2004.12.065; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cruts M, 1998, HUM MOL GENET, V7, P43, DOI 10.1093/hmg/7.1.43; Cruts M, 1998, HUM MUTAT, V11, P183, DOI 10.1002/(SICI)1098-1004(1998)11:3<183::AID-HUMU1>3.3.CO;2-M; Daw EW, 2000, AM J HUM GENET, V66, P196, DOI 10.1086/302710; Dermaut B, 2003, ANN NEUROL, V53, P409, DOI 10.1002/ana.10507; Dermaut B, 1999, AM J HUM GENET, V64, P290, DOI 10.1086/302200; Dermaut B, 2000, J NEUROL, V247, P364, DOI 10.1007/s004150050603; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Hillier LW, 2003, NATURE, V424, P157, DOI 10.1038/nature01782; HOFMAN A, 1989, NEUROLOGY, V39, P1589, DOI 10.1212/WNL.39.12.1589; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; Honig LS, 2001, AGING CLIN EXP RES, V13, P171, DOI 10.1007/BF03351476; Jimenez-Escrig A, 2005, BRAIN, V128, P1707, DOI 10.1093/brain/awh501; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; OTT A, 1995, BRIT MED J, V310, P970, DOI 10.1136/bmj.310.6985.970; Ott A, 1998, AM J EPIDEMIOL, V147, P574; Pericak-Vance MA, 2000, EXP GERONTOL, V35, P1343, DOI 10.1016/S0531-5565(00)00196-0; Rademakers R, 2003, HUM MUTAT, V22, P409, DOI 10.1002/humu.10269; Rademakers R, 2002, MOL PSYCHIATR, V7, P1064, DOI 10.1038/sj.mp.4001198; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Roks G, 1999, NEUROSCI LETT, V277, P137, DOI 10.1016/S0304-3940(99)00861-7; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Slooter AJC, 1998, ARCH NEUROL-CHICAGO, V55, P964, DOI 10.1001/archneur.55.7.964; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; VANDUIJN CM, 1994, NAT GENET, V7, P74, DOI 10.1038/ng0594-74; VANDUIJN CM, 1994, AM J HUM GENET, V55, P714; VANDUIJN CM, 1991, LANCET, V337, P978, DOI 10.1016/0140-6736(91)91611-W; Weckx S, 2005, BIOINFORMATICS, V21, P385, DOI 10.1093/bioinformatics/bti006	34	36	40	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2005	77	4					643	652		10.1086/491749	http://dx.doi.org/10.1086/491749			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	967QS	16175510	Green Published, Bronze			2022-12-18	WOS:000232106900012
J	Lemmers, RJLF; van Overveld, PGM; Sandkuijl, LA; Vrieling, H; Padberg, GW; Frants, RR; van der Maarel, SM				Lemmers, RJLF; van Overveld, PGM; Sandkuijl, LA; Vrieling, H; Padberg, GW; Frants, RR; van der Maarel, SM			Mechanism and timing of mitotic rearrangements in the subtelomeric D4Z4 repeat involved in facioscapulohumeral muscular dystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							STRAND-BREAK REPAIR; GENE CONVERSION; HUMAN MINISATELLITES; 4Q35 REARRANGEMENTS; MENTAL-RETARDATION; DNA REARRANGEMENTS; CROSSING-OVER; GAP REPAIR; FSHD; RECOMBINATION	Autosomal dominant facioscapulohumeral muscular dystrophy (FSHD1A) is associated with contractions of the polymorphic D4Z4 repeat on chromosome 4qter. Almost half of new FSHD mutations occur postfertilization, resulting in somatic mosaicism for D4Z4. Detailed D4Z4 analysis of 11 mosaic individuals with FSHD revealed a mosaic mixture of a contracted FSHD-sized allele and the unchanged ancestral allele in 8 cases, which is suggestive of a mitotic gene conversion without crossover. However, in 3 cases, the D4Z4 rearrangement resulted in two different-sized D4Z4 repeats, indicative of a gene conversion with crossover. In all cases, DNA markers proximal and distal to D4Z4 showed no allelic exchanges, suggesting that all rearrangements were intrachromosomal. We propose that D4Z4 rearrangements occur via a synthesis-dependent strand annealing model that relatively frequently allows for crossovers. Furthermore, the distribution of different cell populations in mosaic patients with FSHD suggests that mosaicism here results from D4Z4 rearrangements occurring during the first few zygotic cell divisions after fertilization.	Leiden Univ, Med Ctr, Ctr Human & Clin Genet, Dept Human & Clin Genet, NL-2333 AL Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Toxicogenet, NL-2333 AL Leiden, Netherlands; Univ Med Ctr Nijmegen, Dept Neurol, Nijmegen, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen	van der Maarel, SM (corresponding author), Leiden Univ, Med Ctr, Ctr Human & Clin Genet, Dept Human & Clin Genet, Wassenaarseweg 72, NL-2333 AL Leiden, Netherlands.	maarel@lumc.nl	Vrieling, Harry/ABC-8068-2020; Padberg, G.W.A.M./H-8079-2014; van der Maarel, Silvere/X-3631-2018	van der Maarel, Silvere/0000-0001-8103-711X; Vrieling, Harry/0000-0002-3034-2664; van Overveld, Petra GM/0000-0003-0216-5004				BROUWER OF, 1991, NEUROLOGY, V41, P1878, DOI 10.1212/WNL.41.12.1878; Deidda G, 1996, J MED GENET, V33, P361, DOI 10.1136/jmg.33.5.361; FRANCIS F, 1994, SIGHT SOUND, V4, P3; Funakoshi M, 1998, NEUROLOGY, V50, P1791, DOI 10.1212/WNL.50.6.1791; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; Galluzzi G, 1999, NEUROMUSCULAR DISORD, V9, P190, DOI 10.1016/S0960-8966(98)00116-3; HEWITT JE, 1994, HUM MOL GENET, V3, P1287, DOI 10.1093/hmg/3.8.1287; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; JEFFREYS AJ, 1994, NAT GENET, V6, P136, DOI 10.1038/ng0294-136; Jeffreys AJ, 1998, EMBO J, V17, P4147, DOI 10.1093/emboj/17.14.4147; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; Kohler J, 1996, HUM GENET, V98, P485, DOI 10.1007/s004390050244; LEMMERS RJL, IN PRESS ANN NEUROL; Lemmers RJLF, 2002, NAT GENET, V32, P235, DOI 10.1038/ng999; Lernmers RJLF, 2001, ANN NEUROL, V50, P816, DOI 10.1002/ana.10057; Liao DQ, 1999, AM J HUM GENET, V64, P24, DOI 10.1086/302221; Lunt P W, 1998, Neuromuscul Disord, V8, P126, DOI 10.1016/S0960-8966(98)00012-1; LUNT PW, 1995, HUM MOL GENET, V4, P951, DOI 10.1093/hmg/4.5.951; Matsumura T, 2002, BMC NEUROL, V2, DOI 10.1186/1471-2377-2-7; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; McLay DW, 2003, REPRODUCTION, V125, P625, DOI 10.1530/rep.0.1250625; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Miura K, 1998, NEUROPEDIATRICS, V29, P239, DOI 10.1055/s-2007-973568; NASSIF N, 1994, MOL CELL BIOL, V14, P1613, DOI 10.1128/MCB.14.3.1613; Okada T, 2002, HUM GENET, V110, P302, DOI 10.1007/s00439-002-0698-2; ORRWEAVER TL, 1983, P NATL ACAD SCI-BIOL, V80, P4417, DOI 10.1073/pnas.80.14.4417; PADBERG GW, 1995, MUSCLE NERVE, pS73; PADBERG GW, 1995, MUSCLE NERVE, pS81, DOI 10.1002/mus.880181315; Padberg GW, 1982, THESIS LEIDEN U LEID; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Paques F, 1998, MOL CELL BIOL, V18, P2045, DOI 10.1128/MCB.18.4.2045; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Tawil R, 1996, ANN NEUROL, V39, P744, DOI 10.1002/ana.410390610; UPADHYAYA M, 1995, MUSCLE NERVE, pS45; van der Maarel SM, 2000, AM J HUM GENET, V66, P26, DOI 10.1086/302730; van der Maarel SM, 1999, J MED GENET, V36, P823; van Geel M, 2002, GENOMICS, V79, P210, DOI 10.1006/geno.2002.6690; van Overveld PGM, 2000, HUM MOL GENET, V9, P2879; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; vanDeutekom JCT, 1996, HUM MOL GENET, V5, P1997, DOI 10.1093/hmg/5.12.1997; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; WRIGHT TJ, 1993, HUM MOL GENET, V2, P1673, DOI 10.1093/hmg/2.10.1673; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; ZATZ M, 1995, AM J HUM GENET, V56, P99; Zatz M, 1998, AM J MED GENET, V77, P155, DOI 10.1002/(SICI)1096-8628(19980501)77:2<155::AID-AJMG9>3.3.CO;2-G	45	36	40	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2004	75	1					44	53		10.1086/422175	http://dx.doi.org/10.1086/422175			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	829FG	15154112	Green Published, Bronze			2022-12-18	WOS:000222031300006
J	Yao, YG; Macaulay, V; Kivisild, T; Zhang, YP; Bandelt, HJ				Yao, YG; Macaulay, V; Kivisild, T; Zhang, YP; Bandelt, HJ			To trust or not to trust an idiosyncratic mitochondrial data set	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							DIVERSITY; SEQUENCE; NETWORK		Yunnan Univ, Lab Conservat & Utilizat Bioresource, Kunming 650091, Yunnan, Peoples R China; Chinese Acad Sci, Kunming Inst Zool, Kunming 650223, Yunnan, Peoples R China; Univ Oxford, Dept Stat, Oxford OX1 3TG, England; Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; Univ Hamburg, Fachbereich Math, Hamburg, Germany	Yunnan University; Chinese Academy of Sciences; Kunming Institute of Zoology; University of Oxford; University of Tartu; University of Hamburg	Yao, YG (corresponding author), Chinese Acad Sci, Kunming Inst Zool, 32 Jiaochang Donglu, Kunming 650223, Yunnan, Peoples R China.	ygyaozh@yahoo.com	Kivisild, Toomas/P-5889-2017; Yao, Yong-Gang/AAH-2303-2021	Kivisild, Toomas/0000-0002-6297-7808; Yao, Yong-Gang/0000-0002-2955-0693				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 2001, INT J LEGAL MED, V115, P64, DOI 10.1007/s004140100228; Bandelt HJ, 2002, AM J HUM GENET, V71, P1150, DOI 10.1086/344397; Derbeneva OA, 2002, AM J HUM GENET, V71, P415, DOI 10.1086/341720; Finnila S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591; Herrnstadt, 2002, AM J HUM GENET, V71, P448; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Kivisild T, 2002, MOL BIOL EVOL, V19, P1737, DOI 10.1093/oxfordjournals.molbev.a003996; Maca-Meyer N, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-13; Macaulay V, 1999, P ROY SOC B-BIOL SCI, V266, P2037, DOI 10.1098/rspb.1999.0883; Richards M, 2001, AM J HUM GENET, V68, P1315, DOI 10.1086/320615; Silva WA, 2002, AM J HUM GENET, V71, P187, DOI 10.1086/341358; Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511	15	36	39	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2003	72	5					1341	1346		10.1086/375119	http://dx.doi.org/10.1086/375119			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671PZ	12772699	Green Published, Bronze			2022-12-18	WOS:000182474400029
J	Camp, NJ; Tavtigian, SV				Camp, NJ; Tavtigian, SV			Meta-analysis of associations of the Ser217Leu and Ala541Thr variants in ELAC2 (HPC2) and prostate cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							SUSCEPTIBILITY GENE; HPC2/ELAC2; HEREDITARY		Univ Utah, Sch Med, Dept Med Informat, Salt Lake City, UT 84108 USA; Int Agcy Res Canc, Genet Canc Susceptibil Unit, F-69372 Lyon, France	Utah System of Higher Education; University of Utah; World Health Organization; International Agency for Research on Cancer (IARC)	Camp, NJ (corresponding author), Univ Utah, Sch Med, Dept Med Informat, 391 Chipeta Way,Suite D, Salt Lake City, UT 84108 USA.							Kirkwood B., 1988, BR K ESSENTIALS MED; Lillienfeld A. M., 1980, FDN EPIDEMIOLOGY; Rebbeck TR, 2000, AM J HUM GENET, V67, P1014, DOI 10.1086/303096; Rokman A, 2001, CANCER RES, V61, P6038; Suarez BK, 2001, CANCER RES, V61, P4982; Tavtigian SV, 2001, NAT GENET, V27, P172, DOI 10.1038/84808; Vesprini D, 2001, AM J HUM GENET, V68, P912, DOI 10.1086/319502; Wang L, 2001, CANCER RES, V61, P6494; Xu JF, 2001, AM J HUM GENET, V68, P901, DOI 10.1086/319513	9	36	40	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2002	71	6					1475	1478		10.1086/344516	http://dx.doi.org/10.1086/344516			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621KD	12515253	Bronze, Green Published			2022-12-18	WOS:000179586800023
J	Ducroq, D; Rozet, JM; Gerber, S; Perrault, I; Barbet, F; Hanein, S; Hakiki, S; Dufier, JL; Munnich, A; Hamel, C; Kaplan, J				Ducroq, D; Rozet, JM; Gerber, S; Perrault, I; Barbet, F; Hanein, S; Hakiki, S; Dufier, JL; Munnich, A; Hamel, C; Kaplan, J			The ABCA4 gene in autosomal recessive cone-rod dystrophies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							STARGARDT-DISEASE; TRANSPORTER GENE; RETINITIS-PIGMENTOSA; MUTATIONS; LOCUS; EXON		Hop Enfants Malad, Unite Rech Handicaps Genet Enfant, F-75743 Paris 15, France; Hop Necker Enfants Malad, Serv Ophtalmol, Paris, France; INSERM, U254, Montpellier, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Kaplan, J (corresponding author), Hop Enfants Malad, Unite Rech Handicaps Genet Enfant, 149 Rue Sevres, F-75743 Paris 15, France.		hanein, sylvain/AAG-4933-2019; ROZET, Jean-Michel/E-5737-2016; KAPLAN, Josseline/I-2622-2017; perrault, isabelle/H-3047-2017	hanein, sylvain/0000-0001-5817-6330; ROZET, Jean-Michel/0000-0001-7951-7886; GERBER, Sylvie/0000-0002-6827-1769; KAPLAN, Josseline/0000-0002-1849-8658; perrault, isabelle/0000-0002-8560-1379				Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Cremers FPM, 1998, HUM MOL GENET, V7, P355, DOI 10.1093/hmg/7.3.355; Danciger M, 2001, INVEST OPHTH VIS SCI, V42, P2458; Gerber S, 1998, GENOMICS, V48, P139, DOI 10.1006/geno.1997.5164; Klevering BJ, 2002, INVEST OPHTH VIS SCI, V43, P1980; Lauderdale J, 2000, P NATL ACAD SCI USA, V97, P13755, DOI 10.1073/pnas.240398797; Lewis RA, 1999, AM J HUM GENET, V64, P422, DOI 10.1086/302251; Martinelli M, 2001, OPT ENG, V40, P142, DOI 10.1117/1.1330703; Maugeri A, 2000, AM J HUM GENET, V67, P960, DOI 10.1086/303079; Rivera A, 2000, AM J HUM GENET, V67, P800, DOI 10.1086/303090; Rozet JM, 1999, J MED GENET, V36, P447; Rozet JM, 1998, EUR J HUM GENET, V6, P291, DOI 10.1038/sj.ejhg.5200221; Vervoort R, 2000, NAT GENET, V25, P462, DOI 10.1038/78182; Yatsenko AN, 2001, HUM GENET, V108, P346, DOI 10.1007/s004390100493	14	36	39	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2002	71	6					1480	1482		10.1086/344829	http://dx.doi.org/10.1086/344829			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621KD	12515255	Green Published, Bronze			2022-12-18	WOS:000179586800025
J	Hodge, SE; Vieland, VJ; Greenberg, DA				Hodge, SE; Vieland, VJ; Greenberg, DA			HLODs remain powerful tools for detection of linkage in the presence of genetic heterogeneity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							LOD SCORES; 2-LOCUS MODELS; STRATEGIES		Columbia Univ, Dept Psychiat, NYSPI, Unit 24, New York, NY 10032 USA; Columbia Univ, Dept Biostat, Div Stat Genet, New York, NY USA; New York State Psychiat Inst & Hosp, Div Clin Genet Epidemiol, New York, NY 10032 USA; Columbia Univ, Genome Ctr, New York, NY USA; Univ Iowa, Coll Publ Hlth, Dept Biostat, Div Stat Genet, Iowa City, IA USA; Univ Iowa, Coll Med, Dept Psychiat, Iowa City, IA 52242 USA	Columbia University; Columbia University; New York State Psychiatry Institute; Columbia University; University of Iowa; University of Iowa	Hodge, SE (corresponding author), Columbia Univ, Dept Psychiat, NYSPI, Unit 24, 1051 Riverside Dr, New York, NY 10032 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031775, R55DK031813, R01DK031813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052841, R01MH048858, R55MH052841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027941] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-31775, R01 DK031775, R01 DK031813, DK31813] Funding Source: Medline; NIMH NIH HHS [R01 MH052841, MH52841, R01 MH048858, MH-48858] Funding Source: Medline; NINDS NIH HHS [R01 NS027941, NS27941] Funding Source: Medline; PHS HHS [K02-01432] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Abreu PC, 1999, AM J HUM GENET, V65, P847, DOI 10.1086/302536; ABREU PC, IN PRESS GENET EPIDE; Durner M, 1999, AM J HUM GENET, V64, P281, DOI 10.1086/302181; DURNER M, 1992, AM J HUM GENET, V51, P859; DURNER M, 1992, AM J MED GENET, V42, P271, DOI 10.1002/ajmg.1320420302; FARAWAY JJ, 1993, GENET EPIDEMIOL, V10, P75, DOI 10.1002/gepi.1370100108; GOLDIN LR, 1992, GENET EPIDEMIOL, V9, P61, DOI 10.1002/gepi.1370090107; GOLDIN LR, 1993, AM J HUM GENET, V53, P908; Greenberg DA, 2001, GENET EPIDEMIOL, V21, P299, DOI 10.1002/gepi.1036; HODGE SE, 1983, AM J HUM GENET, V35, P1139; HOLMANS P, 1993, AM J HUM GENET, V52, P362; Huang J, 2001, HUM HERED, V52, P217, DOI 10.1159/000053379; Huang J, 2001, HUM HERED, V51, P217, DOI 10.1159/000053345; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; OTT J, 1983, ANN HUM GENET, V47, P311, DOI 10.1111/j.1469-1809.1983.tb01001.x; RISCH N, 1990, AM J HUM GENET, V46, P242; Vieland VJ, 2001, HUM HERED, V51, P199, DOI 10.1159/000053343; VIELAND VJ, IN PRESS HUM HERED; Whittemore AS, 2001, AM J HUM GENET, V68, P457, DOI 10.1086/318186	19	36	36	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2002	70	2					556	558		10.1086/338923	http://dx.doi.org/10.1086/338923			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	511FQ	11791217	Green Published, Bronze			2022-12-18	WOS:000173254300028
J	Dagenais, SL; Adam, AN; Innis, JW; Glover, TW				Dagenais, SL; Adam, AN; Innis, JW; Glover, TW			A novel frameshift mutation in exon 23 of ATP7A (MNK) results in occipital horn syndrome and not in Menkes disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COPPER-TRANSPORTING ATPASE; C-TERMINAL TRUNCATIONS; SPLICE-SITE MUTATIONS; TRANS-GOLGI NETWORK; LINKED CUTIS LAXA; CANDIDATE GENE; INTRACELLULAR-LOCALIZATION; PLASMA-MEMBRANE; DI-LEUCINE; PROTEIN	Menkes disease and occipital horn syndrome (OHS) are allelic, X-linked recessive copper-deficiency disorders resulting from mutations in ATP7A, or MNK. Classic Menkes disease has a severe phenotype, with death in early childhood, whereas OHS has a milder phenotype, with, mainly, connective-tissue abnormalities. Data suggest that steady-state localization of ATP7A to the trans-Golgi network (TGN) is necessary for proper activity of lysyl oxidase, which is the predominant cuproenzyme whose activity is deficient in OHS and which is essential for maintenance of connective-tissue integrity. Recently, it was reported that ATP7A-transcript levels as low as 2%-5% of normal are sufficient to result in the milder phenotype, OHS, rather than the phenotype of Menkes disease. In contrast to previously reported cases of OHS, we describe a case of OHS in which, because of a frameshift mutation, no normal ATP7A is produced. Although abundant levels of mutant transcript are present, there are substantially reduced levels of the truncated protein, which lacks the key dileucine motif L1487L1488. It has been demonstrated that the dileucine motif L1487L1488 functions as an endocytic signal for ATP7A cycling between the TGN and the plasma membrane. The present report is the first to describe an ATP7A truncation that results in OHS rather than in Menkes disease. The data from the present report support the concepts that (1) OHS results from lower levels of functional ATP7A and (2) ATP7A does not require the dileucine motif to function in copper efflux.	Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Dagenais, SL (corresponding author), Univ Michigan, Dept Human Genet, 4909 Buhl,Box 0618, Ann Arbor, MI 48109 USA.				NIDDK NIH HHS [DK44130] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R55DK044130, R01DK044130] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ambrosini L, 1999, HUM MOL GENET, V8, P1547, DOI 10.1093/hmg/8.8.1547; BYERS PH, 1980, NEW ENGL J MED, V303, P61, DOI 10.1056/NEJM198007103030201; Camakaris J, 1999, BIOCHEM BIOPH RES CO, V261, P225, DOI 10.1006/bbrc.1999.1073; CHELLY J, 1993, NAT GENET, V3, P14, DOI 10.1038/ng0193-14; DAS S, 1994, AM J HUM GENET, V55, P883; DAS S, 1995, AM J HUM GENET, V56, P570; DIERICK HA, 1995, GENOMICS, V28, P462, DOI 10.1006/geno.1995.1175; Dierick HA, 1997, HUM MOL GENET, V6, P409, DOI 10.1093/hmg/6.3.409; Francis MJ, 1999, J CELL SCI, V112, P1721; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Gu YH, 2001, AM J MED GENET, V99, P217, DOI 10.1002/1096-8628(2001)9999:9999<::AID-AJMG1167>3.0.CO;2-R; Haardt M, 1999, J BIOL CHEM, V274, P21873, DOI 10.1074/jbc.274.31.21873; Harris ED, 2000, ANNU REV NUTR, V20, P291, DOI 10.1146/annurev.nutr.20.1.291; KAINULAINEN K, 1992, P NATL ACAD SCI USA, V89, P5917, DOI 10.1073/pnas.89.13.5917; Kaler SG, 1998, PEDIATR DEVEL PATHOL, V1, P85, DOI 10.1007/s100249900011; KALER SG, 1994, NAT GENET, V8, P195, DOI 10.1038/ng1094-195; KAPUR S, 1987, AM J MED GENET, V26, P503, DOI 10.1002/ajmg.1320260230; La Fontaine S, 1998, HUM MOL GENET, V7, P1293, DOI 10.1093/hmg/7.8.1293; Lazoff S G, 1975, Birth Defects Orig Artic Ser, V11, P71; Levinson B, 1996, HUM MOL GENET, V5, P1737, DOI 10.1093/hmg/5.11.1737; LEVINSON B, 1993, NAT GENET, V3, P6, DOI 10.1038/ng0193-6; Lord JM, 2000, SEMIN CELL DEV BIOL, V11, P159; MENKES JH, 1988, BRAIN DEV-JPN, V10, P77, DOI 10.1016/S0387-7604(88)80074-3; MENKES JH, 1962, PEDIATRICS, V29, P764; MERCER JFB, 1993, NAT GENET, V3, P20, DOI 10.1038/ng0193-20; Moller LB, 2000, AM J HUM GENET, V66, P1211, DOI 10.1086/302857; PEDERSEN PL, 1987, TRENDS BIOCHEM SCI, V12, P146, DOI 10.1016/0968-0004(87)90071-5; Petris MJ, 1996, EMBO J, V15, P6084, DOI 10.1002/j.1460-2075.1996.tb00997.x; Petris MJ, 1998, HUM MOL GENET, V7, P2063, DOI 10.1093/hmg/7.13.2063; Petrucelli A, 1999, GLOBAL TELEPH, V7, P8; Qi M, 1998, HUM MOL GENET, V7, P465, DOI 10.1093/hmg/7.3.465; Ronce N, 1997, AM J HUM GENET, V61, P233; Thermann R, 1998, EMBO J, V17, P3484, DOI 10.1093/emboj/17.12.3484; TSUKAHARA M, 1994, CLIN GENET, V45, P32; TUMER Z, 1995, GENOMICS, V26, P437, DOI 10.1016/0888-7543(95)80160-N; VERGA V, 1991, AM J HUM GENET, V48, P1133; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; Yamaguchi Y, 1996, P NATL ACAD SCI USA, V93, P14030, DOI 10.1073/pnas.93.24.14030; Zhang JX, 1997, MOL BIOL CELL, V8, P1943, DOI 10.1091/mbc.8.10.1943	39	36	38	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2001	69	2					420	427		10.1086/321290	http://dx.doi.org/10.1086/321290			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XN	11431706	Green Published, Bronze			2022-12-18	WOS:000170108200016
J	Gjetting, T; Petersen, M; Guldberg, P; Guttler, F				Gjetting, T; Petersen, M; Guldberg, P; Guttler, F			Missense mutations in the N-terminal domain of human phenylalanine hydroxylase interfere with binding of regulatory phenylalanine	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOTYPE-PHENOTYPE CORRELATIONS; MUTASE-PREPHENATE DEHYDRATASE; ESCHERICHIA-COLI; STRUCTURAL BASIS; FEEDBACK INHIBITION; CRYSTAL-STRUCTURE; GENE PAH; PHENYLKETONURIA; PROTEIN; MECHANISM	Hyperphenylalaninemia due to a deficiency of phenylalanine hydroxylase (PAH) is an autosomal recessive disorder caused by >400 mutations in the PAH gene. Recent work has suggested that the majority of PAH missense mutations impair enzyme activity by causing increased protein instability and aggregation. In this study, we describe an alternative mechanism by which some PAH mutations may render PAH defective. Database searches were used to identify regions in the N-terminal domain of PAH with homology to the regulatory domain of prephenate dehydratase (PDH), the rate-limiting enzyme in the bacterial phenylalanine biosynthesis pathway. Naturally occurring N-terminal PAH mutations are distributed in a nonrandom pattern and cluster within residues 46-48 (GAL) and 65-69 (IESRP), two motifs highly conserved in PDH. To examine whether N-terminal PAH mutations affect the ability of PAH to bind phenylalanine at the regulatory domain, wild-type and five mutant (G46S, A47V, T63P/H64N, I65T, and R68S) forms of the N-terminal domain (residues 2-120) of human PAH were expressed as fusion proteins in Escherichia coli. Binding studies showed that the wild-type form of this domain specifically binds phenylalanine, whereas all mutations abolished or significantly reduced this phenylalanine-binding capacity. Our data suggest that impairment of phenylalanine-mediated activation of PAH may be an important disease-causing mechanism of some N-terminal PAH mutations, which may explain some well-documented genotype-phenotype discrepancies in PAH deficiency.	John F Kennedy Inst, DK-2600 Glostrup, Denmark		Guttler, F (corresponding author), John F Kennedy Inst, Gl Landevej 7, DK-2600 Glostrup, Denmark.		Gjetting, Torben/A-6066-2012					Bjorgo E, 1998, EUR J BIOCHEM, V257, P1, DOI 10.1046/j.1432-1327.1998.2570001.x; Davis MD, 1997, P NATL ACAD SCI USA, V94, P491, DOI 10.1073/pnas.94.2.491; Eiken HG, 1996, HUM MUTAT, V7, P228, DOI 10.1002/(SICI)1098-1004(1996)7:3<228::AID-HUMU7>3.0.CO;2-6; Erlandsen H, 1997, NAT STRUCT BIOL, V4, P995, DOI 10.1038/nsb1297-995; Erlandsen H, 1999, MOL GENET METAB, V68, P103, DOI 10.1006/mgme.1999.2922; Fusetti F, 1998, J BIOL CHEM, V273, P16962, DOI 10.1074/jbc.273.27.16962; Gjetting T, 2001, MOL GENET METAB, V72, P132, DOI 10.1006/mgme.2000.3118; Goodwill KE, 1997, NAT STRUCT BIOL, V4, P578, DOI 10.1038/nsb0797-578; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guldberg P, 1998, AM J HUM GENET, V63, P71, DOI 10.1086/301920; Harlow E LD, 1988, ANTIBODIES LAB MANUA; HUFTON SE, 1995, BIOCHEM J, V311, P353, DOI 10.1042/bj3110353; Jennings IG, 2000, EUR J HUM GENET, V8, P683, DOI 10.1038/sj.ejhg.5200518; Jennings IG, 2001, FEBS LETT, V488, P196, DOI 10.1016/S0014-5793(00)02426-1; KAUFMAN S, 1993, ADV ENZYMOL RAMB, V67, P77; Kayaalp E, 1997, AM J HUM GENET, V61, P1309, DOI 10.1086/301638; Kleppe R, 1999, J BIOL CHEM, V274, P33251, DOI 10.1074/jbc.274.47.33251; Knappskog PM, 1996, HUM MUTAT, V8, P236, DOI 10.1002/(SICI)1098-1004(1996)8:3<236::AID-HUMU7>3.0.CO;2-7; Kobe B, 1999, NAT STRUCT BIOL, V6, P442, DOI 10.1038/8247; MARTINEZ A, 1995, BIOCHEM J, V306, P589, DOI 10.1042/bj3060589; NECKAMEYER WS, 1992, J BIOL CHEM, V267, P4199; NELMS J, 1992, APPL ENVIRON MICROB, V58, P2592, DOI 10.1128/AEM.58.8.2592-2598.1992; OKANO Y, 1991, NEW ENGL J MED, V324, P1232, DOI 10.1056/NEJM199105023241802; Pohnert G, 1999, BIOCHEMISTRY-US, V38, P12212, DOI 10.1021/bi991134w; Scriver CR, 1999, TRENDS GENET, V15, P267, DOI 10.1016/S0168-9525(99)01761-8; Scriver CR, 2000, HUM MUTAT, V15, P99, DOI 10.1002/(SICI)1098-1004(200001)15:1<99::AID-HUMU18>3.0.CO;2-P; SCRIVER CR, 2001, METABOLIC MOL BASES, P1667; SHIMAN R, 1990, J BIOL CHEM, V265, P11633; SHIMAN R, 1980, J BIOL CHEM, V255, P29; Wang GA, 2001, P NATL ACAD SCI USA, V98, P1537, DOI 10.1073/pnas.031561698; Waters PJ, 1999, J INHERIT METAB DIS, V22, P208, DOI 10.1023/A:1005533825980; Waters PJ, 1998, HUM MUTAT, V12, P344, DOI 10.1002/(SICI)1098-1004(1998)12:5<344::AID-HUMU8>3.0.CO;2-D; Waters PJ, 1998, HUM MUTAT, V11, P4; Waters PJ, 2000, MOL GENET METAB, V69, P101, DOI 10.1006/mgme.2000.2965; Zhang S, 1998, J BIOL CHEM, V273, P6248, DOI 10.1074/jbc.273.11.6248	35	36	37	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2001	68	6					1353	1360		10.1086/320604	http://dx.doi.org/10.1086/320604			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	439DB	11326337	Green Published, Bronze			2022-12-18	WOS:000169094600006
J	Tiller, GE; Hannig, VL; Dozier, D; Carrel, L; Trevarthen, KC; Wilcox, WR; Mundlos, S; Haines, JL; Gedeon, AK; Gecz, J				Tiller, GE; Hannig, VL; Dozier, D; Carrel, L; Trevarthen, KC; Wilcox, WR; Mundlos, S; Haines, JL; Gedeon, AK; Gecz, J			A recurrent RNA-splicing mutation in the SEDL gene causes X-linked spondyloepiphyseal dysplasia tarda	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIPLE EPIPHYSEAL DYSPLASIA; EXON-SKIPPING MUTATION; OSTEOGENESIS IMPERFECTA; VESICLE DOCKING; FAMILY; DEFICIENCY; SEQUENCE; IDENTIFICATION; EXPRESSION; PROTEIN	Spondyloepiphyseal dysplasia tarda (SEDL) is a genetically heterogeneous disorder characterized by mild-to-moderate short stature and early-onset osteoarthritis. Both autosomal and X-linked forms have been described. Elsewhere, we have reported the identification of the gene for the X-linked recessive form, which maps to Xp22.2. We now report characterization of an exon-skipping mutation (IVS3+5G -->A at the intron 3 splice-donor site) in two unrelated families with SEDL. Using reverse transcriptase (RT)-PCR, we demonstrated that the mutation resulted in elimination of the first 31 codons of the open reading frame. The mutation was not detected in 120 control X chromosomes. Articular cartilage from an adult who had SEDL and carried this mutation contained chondrocytes with abundant Golgi complexes and dilated rough endoplasmic reticulum (ER). RT-PCR experiments using mouse/human cell hybrids revealed that the SEDL gene escapes X inactivation. Homologues of the SEDL gene include a transcribed retropseudogene on chromosome 19, as well as expressed genes in mouse, rat, Drosophila melanogaster Caenorhabditis elegans, and Saccharomyces cerevisiae. The latter homologue, p20, has a putative role in vesicular transport from ER to Golgi complex. These data suggest that SEDL mutations may perturb an intracellular pathway that is important for cartilage homeostasis.	Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Program Human Genet, Nashville, TN 37212 USA; Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Ctr Human Genet, Cleveland, OH 44106 USA; Cedars Sinai Burns & Allen Res Inst, Steven Spielberg Pediat Res Ctr, Los Angeles, CA USA; Univ Calif Los Angeles, Sch Med, Dept Pediat, Los Angeles, CA 90024 USA; Max Planck Inst Mol Genet, Berlin, Germany; Univ Adelaide, Women & Child Hosp, Adelaide, SA, Australia	Vanderbilt University; Vanderbilt University; Vanderbilt University; Case Western Reserve University; Case Western Reserve University; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Max Planck Society; University of Adelaide	Tiller, GE (corresponding author), Vanderbilt Univ, Med Ctr, Div Med Genet, DD2205 MCN, Nashville, TN 37232 USA.		Mundlos, Stefan/ABH-9585-2020; Haines, Jonathan/C-3374-2012; Gedeon, Agi/G-7890-2011; Gecz, Jozef/X-3469-2019	Haines, Jonathan/0000-0002-4351-4728; Gecz, Jozef/0000-0002-7884-6861; Mundlos, Stefan/0000-0002-9788-3166	NIAMS NIH HHS [R01 AR045477] Funding Source: Medline; NICHD NIH HHS [P01 HD022657] Funding Source: Medline	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Barrowman J, 2000, EMBO J, V19, P862, DOI 10.1093/emboj/19.5.862; BONADIO J, 1990, J BIOL CHEM, V265, P2262; Brodie SG, 1998, AM J MED GENET, V80, P247; Brown CJ, 1997, AM J HUM GENET, V60, P1333, DOI 10.1086/515488; BRUENING W, 1992, NAT GENET, V1, P144, DOI 10.1038/ng0592-144; Carrel L, 1999, P NATL ACAD SCI USA, V96, P14440, DOI 10.1073/pnas.96.25.14440; Carrier L, 1997, CIRC RES, V80, P427, DOI 10.1161/01.res.0000435859.24609.b3; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DEBOER M, 1992, PRENATAL DIAG, V12, P773, DOI 10.1002/pd.1970120910; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DURIEZ B, 1994, FEBS LETT, V346, P165, DOI 10.1016/0014-5793(94)00457-9; GANGULY A, 1991, J BIOL CHEM, V266, P12035; Gecz J, 2000, GENOMICS, V69, P242, DOI 10.1006/geno.2000.6326; Gedeon AK, 1999, NAT GENET, V22, P400, DOI 10.1038/11976; Gedeon AK, 2001, AM J HUM GENET, V68, P1386, DOI 10.1086/320592; GIBBS RA, 1989, P NATL ACAD SCI USA, V86, P1919, DOI 10.1073/pnas.86.6.1919; HEUERTZ S, 1995, HUM GENET, V96, P407, DOI 10.1007/BF00191797; Jacobsen AW, 1939, J AMER MED ASSOC, V113, P121, DOI 10.1001/jama.1939.02800270021006; Ketterling RP, 1999, HUM MUTAT, V13, P221, DOI 10.1002/(SICI)1098-1004(1999)13:3<221::AID-HUMU6>3.3.CO;2-L; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; LAPOUMEROULIE C, 1986, BIOCHEM BIOPH RES CO, V139, P709, DOI 10.1016/S0006-291X(86)80048-1; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Milleding P, 1998, INT J PROSTHODONT, V11, P21; Mumm S, 2000, J CLIN ENDOCR METAB, V85, P3343, DOI 10.1210/jc.85.9.3343; Nichols WC, 1999, AM J HUM GENET, V64, P1493, DOI 10.1086/302433; PFEIFFER RA, 1992, PEDIATR RADIOL, V22, P83, DOI 10.1007/BF02011299; Pritzker KPH, 1998, OSTEOARTHRITIS, P50; REITSMA PH, 1994, J CLIN INVEST, V93, P486, DOI 10.1172/JCI116997; RIMOIN DL, 1994, HUM GENET, V93, P236, DOI 10.1007/BF00212015; Sacher M, 1998, EMBO J, V17, P2494, DOI 10.1093/emboj/17.9.2494; SCHANTZ K, 1988, ACTA ORTHOP SCAND, V59, P716, DOI 10.3109/17453678809149433; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Spayde EC, 2000, MATRIX BIOL, V19, P121, DOI 10.1016/S0945-053X(00)00055-X; SZPIROTAPIA S, 1988, HUM GENET, V81, P61, DOI 10.1007/BF00283731; TAYBI H, 1996, RADIOLOGY SYNDROMES, P926; THAKKERVARIA S, 1995, HUM MUTAT, V6, P116, DOI 10.1002/humu.1380060204; TILLER GE, 1995, AM J HUM GENET, V56, P388; Whyte MP, 1999, MEDICINE, V78, P9, DOI 10.1097/00005792-199901000-00002; WYNNEDAVIES R, 1985, J BONE JOINT SURG BR, V67, P133, DOI 10.1302/0301-620X.67B1.3155744; Yamaguchi H, 1997, J CLIN ENDOCR METAB, V82, P1934, DOI 10.1210/jc.82.6.1934; Zhang MQ, 1998, HUM MOL GENET, V7, P919, DOI 10.1093/hmg/7.5.919	41	36	41	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2001	68	6					1398	1407		10.1086/320594	http://dx.doi.org/10.1086/320594			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	439DB	11326333	Bronze, Green Published			2022-12-18	WOS:000169094600010
J	Bock, CH; Cunningham, JM; McDonnell, SK; Schaid, DJ; Peterson, BJ; Pavlic, RJ; Schroeder, JJ; Klein, J; French, AJ; Marks, A; Thibodeau, SN; Lange, EM; Cooney, KA				Bock, CH; Cunningham, JM; McDonnell, SK; Schaid, DJ; Peterson, BJ; Pavlic, RJ; Schroeder, JJ; Klein, J; French, AJ; Marks, A; Thibodeau, SN; Lange, EM; Cooney, KA			Analysis of the prostate cancer-susceptibility locus HPC20 in 172 families affected by prostate cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; INHERITANCE; HISTORY; GENE	A recent study of hereditary prostate cancer has provided evidence for a prostate cancer-susceptibility locus, HPC20, which maps to 20q13. To assess further the potential contribution of this locus to prostate cancer susceptibility, we studied 172 unrelated families affected by prostate cancer, using 17 polymorphic markers across a 98.5-cM segment of chromosome 20 that contains the candidate region. Parametric analysis, allowing for heterogeneity, resulted in an overall HLOD score of 0.09 (P = .39) at D20S171, under the assumption of linkage in 6% of families. Mode-of-inheritance-free analysis of the entire data set resulted in a maximal Z(lr) score of 0.76 (LOD 0.13; P = .22) at the same location. The strongest evidence for linkage was seen in the subset of 16 black families (LOD 0.86; Z(lr) = 1.99; P = .23) between markers D20S893 and D20S120, near the putative location of HPC20. Although some positive results were observed, our linkage study does not provide statistically significant support for the existence of a prostate cancer-susceptibility locus HPC20 at 20q13.	Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI 48109 USA; Ann Arbor Dept Vet Affairs Med Ctr, Ann Arbor, MI USA; Mayo Clin & Mayo Fdn, Dept Lab Med & Pathol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Rochester, MN 55905 USA; Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Mayo Clinic; Mayo Clinic; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Cooney, KA (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, 7310 CCGC,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	kcooney@umich.edu		Cooney, Kathleen/0000-0003-3831-6943; McDonnell, Shannon/0000-0001-6201-369X	NCI NIH HHS [P50 CA069568, N01 CA015083, R01 CA079596, P30 CA015083, P50 CA69568, R01 CA072818, CA79596] Funding Source: Medline; NHGRI NIH HHS [T32 HG000040, T32 HG00040] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA079596, P30CA015083, P50CA069568, R01CA072818] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000040] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Berry R, 2000, AM J HUM GENET, V67, P82, DOI 10.1086/302994; Berthon P, 1998, AM J HUM GENET, V62, P1416, DOI 10.1086/301879; CARTER BS, 1992, P NATL ACAD SCI USA, V89, P3367, DOI 10.1073/pnas.89.8.3367; CARTER BS, 1993, J UROLOGY, V150, P797, DOI 10.1016/S0022-5347(17)35617-3; Chan JM, 1998, SEMIN CANCER BIOL, V8, P263, DOI 10.1006/scbi.1998.0075; Cooney KA, 1997, J NATL CANCER I, V89, P955, DOI 10.1093/jnci/89.13.955; FARAWAY JJ, 1993, GENET EPIDEMIOL, V10, P75, DOI 10.1002/gepi.1370100108; Gibbs M, 1999, AM J HUM GENET, V64, P776, DOI 10.1086/302287; Greenlee RT, 2000, CA-CANCER J CLIN, V50, P7, DOI 10.3322/canjclin.50.1.7; Gronberg H, 1997, AM J EPIDEMIOL, V146, P552, DOI 10.1093/oxfordjournals.aje.a009313; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lange EM, 1999, CLIN CANCER RES, V5, P4013; MONROE KR, 1995, NAT MED, V1, P827, DOI 10.1038/nm0895-827; NAROD SA, 1995, NAT MED, V1, P99, DOI 10.1038/nm0295-99; Parkin DM, 1998, SEMIN CANCER BIOL, V8, P219, DOI 10.1006/scbi.1998.0080; PLOUGHMAN LM, 1989, AM J HUM GENET, V44, P543; Schaid DJ, 1998, AM J HUM GENET, V62, P1425, DOI 10.1086/301862; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; STEINBERG GD, 1990, PROSTATE, V17, P337, DOI 10.1002/pros.2990170409; SUAREZ BK, 1994, GENETIC APPROACHES M; Tavtigian SV, 2000, AM J HUM GENET, V67, P11; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; Xu JF, 1998, NAT GENET, V20, P175, DOI 10.1038/2477	24	36	36	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2001	68	3					795	801		10.1086/318797	http://dx.doi.org/10.1086/318797			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	402ND	11179028	Green Published, Bronze			2022-12-18	WOS:000166994200025
J	Alders, M; Ryan, A; Hodges, M; Bliek, J; Feinberg, AP; Privitera, O; Westerveld, A; Little, PFR; Mannens, M				Alders, M; Ryan, A; Hodges, M; Bliek, J; Feinberg, AP; Privitera, O; Westerveld, A; Little, PFR; Mannens, M			Disruption of a novel imprinted zinc-finger gene, ZNF215, in Beckwith-Wiedemann syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSCRIPTIONAL REPRESSION; HOMEOBOX GENE; P57(KIP2); PROTEIN; DIFFERENTIATION; BREAKPOINTS; MUTATIONS; LACKING; KVLQT1; TUMORS	The genetics of Beckwith-Wiedemann syndrome (BWS) is complex and is thought to involve multiple genes. It is known that three regions on chromosome 11p15 (BWSCR1, BWSCR2, and BWSCR3) may play a role in the development of BWS. BWSCR2 is defined by two BWS breakpoints. Here we describe the cloning and sequence analysis of 73 kb containing BWSCR2. Within this region, we detected a novel zinc-finger gene, ZNF215. We show that two of its five alternatively spliced transcripts are disrupted by both BWSCR2 breakpoints. Parts of the 3' end of these splice forms are transcribed from the antisense strand of a second zinc-finger gene, ZNF214. We show that ZNF215 is imprinted in a tissue-specific manner.	Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Human Genet, NL-1105 AZ Amsterdam, Netherlands; Univ London Imperial Coll Sci Technol & Med, Dept Biochem, London, England; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Azienda Osped Legnano, Lab Citogenet, Legnano, Italy	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Imperial College London; Johns Hopkins University	Mannens, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.	m.a.mannens@amc.uva.nl	Little, Peter. F.R./C-9971-2009; Hodges, Matthew/GZB-0433-2022; Feinberg, Andrew/AAY-7666-2020	Feinberg, Andrew/0000-0002-8364-1991; Hodges, Matthew David John/0000-0002-6815-751X	NATIONAL CANCER INSTITUTE [R01CA054358, R37CA054358] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA054358, CA54358] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Brown DR, 1996, ADVANCES IN SWINE IN BIOMEDICAL RESEARCH, VOLS 1 AND 2, P5; DeBaun MR, 1998, J PEDIATR-US, V132, P398, DOI 10.1016/S0022-3476(98)70008-3; Eggenschwiler J, 1997, GENE DEV, V11, P3128, DOI 10.1101/gad.11.23.3128; FIDLEROVA H, 1994, CYTOGENET CELL GENET, V65, P203, DOI 10.1159/000133632; Fujima S, 1998, INT J COMPUT FLUID D, V9, P209, DOI 10.1080/10618569808940853; Hatada I, 1996, NAT GENET, V14, P171, DOI 10.1038/ng1096-171; HONG YS, 1995, GENE, V159, P209, DOI 10.1016/0378-1119(95)92712-G; HOOVERS JMN, 1992, GENOMICS, V12, P254, DOI 10.1016/0888-7543(92)90372-Y; Hoovers JMN, 1995, P NATL ACAD SCI USA, V92, P12456, DOI 10.1073/pnas.92.26.12456; IVENS AC, 1994, DNA CLONING COMPLEX, P1; Joyce JA, 1997, HUM MOL GENET, V6, P1543, DOI 10.1093/hmg/6.9.1543; KOUFOS A, 1989, AM J HUM GENET, V44, P711; LAROSA GJ, 1988, MOL CELL BIOL, V8, P3906, DOI 10.1128/MCB.8.9.3906; Lee MP, 1997, AM J HUM GENET, V61, P304, DOI 10.1086/514858; Lee MP, 1997, NAT GENET, V15, P181, DOI 10.1038/ng0297-181; Mannens M., 1994, European Journal of Human Genetics, V2, P3; MARGOLIN JF, 1994, P NATL ACAD SCI USA, V91, P4509, DOI 10.1073/pnas.91.10.4509; OKeefe D, 1997, AM J HUM GENET, V61, P295, DOI 10.1086/514854; PETTENATI MJ, 1986, HUM GENET, V74, P143, DOI 10.1007/BF00282078; PING AJ, 1989, AM J HUM GENET, V44, P720; REDEKER E, 1995, CYTOGENET CELL GENET, V68, P222, DOI 10.1159/000133917; REDEKER E, 1994, GENOMICS, V21, P538, DOI 10.1006/geno.1994.1312; REIK W, 1995, HUM MOL GENET, V4, P2379, DOI 10.1093/hmg/4.12.2379; SHEN WF, 1991, NUCLEIC ACIDS RES, V19, P539, DOI 10.1093/nar/19.3.539; Smilinich NJ, 1999, P NATL ACAD SCI USA, V96, P8064, DOI 10.1073/pnas.96.14.8064; Sun FL, 1997, NATURE, V389, P809, DOI 10.1038/39797; Weksberg R, 1996, MED PEDIATR ONCOL, V27, P462, DOI 10.1002/(SICI)1096-911X(199611)27:5<462::AID-MPO13>3.0.CO;2-C; WEKSBERG R, 1993, NAT GENET, V5, P143, DOI 10.1038/ng1093-143; WIEDEMANN HR, 1983, EUR J PEDIATR, V141, P129, DOI 10.1007/BF00496807; WILLIAMS AJ, 1995, J BIOL CHEM, V270, P22143, DOI 10.1074/jbc.270.38.22143; WITZGALL R, 1994, P NATL ACAD SCI USA, V91, P4514, DOI 10.1073/pnas.91.10.4514; Yan Y, 1997, GENE DEV, V11, P973, DOI 10.1101/gad.11.8.973; Zhang PM, 1997, NATURE, V387, P151, DOI 10.1038/387151a0	33	36	41	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2000	66	5					1473	1484		10.1086/302892	http://dx.doi.org/10.1086/302892			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QT	10762538	Bronze, Green Published			2022-12-18	WOS:000088373700001
J	Zara, F; Gennaro, E; Stabile, M; Carbone, I; Malacarne, M; Majello, L; Santangelo, R; de Falco, FA; Bricarelli, FD				Zara, F; Gennaro, E; Stabile, M; Carbone, I; Malacarne, M; Majello, L; Santangelo, R; de Falco, FA; Bricarelli, FD			Mapping of a locus for a familial autosomal recessive idiopathic myoclonic epilepsy of infancy to chromosome 16p13	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POTASSIUM CHANNEL GENE; INFANTILE CONVULSIONS; CHLORIDE CHANNEL; LINKAGE; BENIGN; MUTATION; LOCALIZATION; EXCHANGER; CHILDHOOD; SEIZURES	Myoclonic epilepsies with onset in infancy and childhood are clinically and etiologically heterogeneous. Although genetic factors are thought to play an important role, to date very little is known about the etiology of these disorders. We ascertained a large Italian pedigree segregating a recessive idiopathic myoclonic epilepsy that starts in early infancy as myoclonic seizures, febrile convulsions, and tonic-clonic seizures. We typed 304 microsatellite markers spanning the 22 autosomes and mapped the locus on chromosome 16p13 by linkage analysis. A maximum LOD score of 4.48 was obtained for marker D16S3027 at recombination fraction 0. Haylotype analysis placed the critical region within a 3.4-cM interval between D16S3024 and D16S423. The present report constitutes the first example of an idiopathic epilepsy that is inherited as an autosomal recessive trait.	EO Ospedali Galliera, Lab Genet Umana, I-16128 Genoa, Italy; Osped Loreto Mare, Dipartimento Sci Neurol, Naples, Italy; Osped Loreto Mare, Gen Med Serv, Naples, Italy	Ente Ospedaliero Ospedali Galliera	Zara, F (corresponding author), EO Ospedali Galliera, Lab Genet Umana, Via Volta 10R, I-16128 Genoa, Italy.	f.zara@galliera.it	de Falco, Fabrizio Antonio/A-7343-2011; Malacarne, Michela/AAA-7569-2020; Zara, Federico/U-3477-2017; gennaro, elena/ABC-2425-2020	Zara, Federico/0000-0001-9744-5222; De Falco, Fabrizio/0000-0001-5065-1678				Aicardi J, 1986, Adv Neurol, V43, P11; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; Brandt S, 1995, FEBS LETT, V377, P15, DOI 10.1016/0014-5793(95)01298-2; BRANT SR, 1995, AM J PHYSIOL-CELL PH, V269, pC198, DOI 10.1152/ajpcell.1995.269.1.C198; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Cox GA, 1997, CELL, V91, P139, DOI 10.1016/S0092-8674(01)80016-7; Dalla Bernardina B, 1982, Rev Electroencephalogr Neurophysiol Clin, V12, P21; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DRAVET C, 1992, EPILEPSY RES, P131; Dravet Charlotte, 1992, P75; Elmslie FV, 1997, HUM MOL GENET, V6, P1329, DOI 10.1093/hmg/6.8.1329; FEJERMAN N, 1991, REV NEUROL-FRANCE, V147, P782; Fong GCY, 1998, AM J HUM GENET, V63, P1117, DOI 10.1086/302066; FUJIWARA T, 1990, EPILEPSIA, V31, P281, DOI 10.1111/j.1528-1157.1990.tb05377.x; Gennaro E, 1999, EPILEPSIA, V40, P1799, DOI 10.1111/j.1528-1157.1999.tb01601.x; Guerruni R, 1997, EPILEPSY COMPREHENSI, P2285; Guipponi M, 1997, HUM MOL GENET, V6, P473, DOI 10.1093/hmg/6.3.473; JEAVONS PM, 1977, DEV MED CHILD NEUROL, V19, P3; Kedra D, 1998, HUM GENET, V103, P131, DOI 10.1007/s004390050795; LATHROP GM, 1985, AM J HUM GENET, V37, P482; Lin YP, 1998, NEUROPEDIATRICS, V29, P268, DOI 10.1055/s-2007-973573; LIU AW, 1995, AM J HUM GENET, V57, P368; LOMBROSO CT, 1990, J CLIN NEUROPHYSIOL, V7, P380, DOI 10.1097/00004691-199007000-00005; Mikami M, 1999, AM J HUM GENET, V65, P745, DOI 10.1086/302535; Minassian BA, 1995, CLIN NEUROSCI, V3, P223; OTTMAN R, 1995, NAT GENET, V10, P56, DOI 10.1038/ng0595-56; Plaster NM, 1999, NEUROLOGY, V53, P1180, DOI 10.1212/WNL.53.6.1180; Pusch M, 1995, NEURON, V15, P1455, DOI 10.1016/0896-6273(95)90023-3; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; STEINLEIN OK, 1995, NAT GENET, V11, P201, DOI 10.1038/ng1095-201; TOURNIERLASSERVE E, 1993, NAT GENET, V3, P256, DOI 10.1038/ng0393-256; VIGEVANO F, 1997, EPILEPSY COMPREHENSI, P2267; Wallace RH, 1998, NAT GENET, V19, P366, DOI 10.1038/1252; Xiong L, 1999, AM J HUM GENET, V65, P1698, DOI 10.1086/302649; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010	39	36	40	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2000	66	5					1552	1557		10.1086/302876	http://dx.doi.org/10.1086/302876			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QT	10741954	Bronze, Green Published			2022-12-18	WOS:000088373700009
J	Bolk, S; Puffenberger, EG; Hudson, J; Morton, DH; Chakravarti, A				Bolk, S; Puffenberger, EG; Hudson, J; Morton, DH; Chakravarti, A			Elevated frequency and allelic heterogeneity of congenital nephrotic syndrome, Finnish type, in the Old Order Mennonites	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							HAPLOTYPE ANALYSIS; LOCUS		Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Ctr Human Genet, Cleveland, OH USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; Clin Special Children, Strasburg, PA USA; Res Genet, Huntsville, AL USA	Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland	Chakravarti, A (corresponding author), Case Western Reserve Univ, Sch Med, Dept Genet, BRB 721,10900 Euclid Ave, Cleveland, OH 44106 USA.			Puffenberger, Erik/0000-0002-6388-9148	NICHD NIH HHS [R37 HD028088, R01 HD028088] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; CHAKRAVARTI A, 1978, AM J HUM GENET, V30, P256; Fuchshuber A, 1996, PEDIATR NEPHROL, V10, P135; Guez S, 1998, PEDIATR NEPHROL, V12, P130, DOI 10.1007/s004670050420; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Lenkkeri U, 1999, AM J HUM GENET, V64, P51, DOI 10.1086/302182; Mannikko M, 1996, J AM SOC NEPHROL, V7, P2700; MANNIKKO M, 1995, AM J HUM GENET, V57, P1377; NORIO R, 1966, ANN PAEDIATR FENN S, V12, P27; PUFFETT D, 1994, MUSIC ANAL, V13, P3; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1111/j.1574-6968.1999.tb13575.x	11	36	37	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1999	65	6					1785	1790		10.1086/302687	http://dx.doi.org/10.1086/302687			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	266CF	10577936	Green Published, Bronze			2022-12-18	WOS:000084282500037
J	Katsanis, N; Lewis, RA; Stockton, DW; Mai, PMT; Baird, L; Beales, PL; Leppert, M; Lupski, JR				Katsanis, N; Lewis, RA; Stockton, DW; Mai, PMT; Baird, L; Beales, PL; Leppert, M; Lupski, JR			Delineation of the critical interval of Bardet-Biedl Syndrome 1 (BBS1) to a small region of 11q13, through linkage and haplotype analysis of 91 pedigrees	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BARDET-BIEDL-SYNDROME; SYNDROME LOCUS; HETEROGENEITY; FAMILIES	Bardet-Biedl syndrome (BBS) is a genetically heterogeneous recessive disease characterized primarily by atypical retinitis pigmentosa, obesity, polydactyly, hypogenitalism, and mental retardation. Despite the presence of at least five loci in the human genome, on chromosomes 2q, 3p, 11q, 15q and 16q, as many as 50% of the mutations appear to map to the BBS1 locus on 11q13. The recessive mode of inheritance and the genetic heterogeneity of the syndrome, as well as the inability to distinguish between different genetic loci by phenotypic analyses, have hindered efforts to delineate the 11q13 region as a first step toward cloning the mutated gene. To circumvent these difficulties, we collected a large number of BBS pedigrees of primarily North American and European origin and performed genetic analysis, using microsatellites from all known BBS genomic regions. Heterogeneity analysis established a 40.5% contribution of the 11q13 locus to BBS, and haplotype construction on 11q-linked pedigrees revealed several informative recombinants, defining the BBS1 critical interval between D11S4205 and D11S913, a genetic distance of 2.9 cM, equivalent to similar to 2.6 Mb. Loss of identity by descent in two consanguineous pedigrees was also observed in the region, potentially refining the region to 1.8 Mb between D11S1883 and D11S4944. The identification of multiple recombinants at the same position forms the basis for physical mapping efforts, coupled with mutation analysis of candidate genes, to identify the gene for BBS1.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA; Baylor Coll Med, Cullen Eye Inst, Houston, TX 77030 USA; Texas Childrens Hosp, Houston, TX 77030 USA; Guys Hosp, Kings Guys & St Thomas Sch Med, Div Med & Mol Genet, London SE1 9RT, England; Univ Utah, Eccles Inst Human Genet, Salt Lake City, UT USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Utah System of Higher Education; University of Utah	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Room 609E,1 Baylor Plaza, Houston, TX 77030 USA.	jlupski@bcm.tmc.edu	Katsanis, Nicholas/E-1837-2012; Beales, Philip L/C-7367-2009	Katsanis, Nicholas/0000-0002-2480-0171	NATIONAL EYE INSTITUTE [R01EY011600, R29EY011600, R01EY011780] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY011780, R29 EY011600, EY11780, R01 EY011600, EY11600] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Wellcome Trust(Wellcome TrustEuropean Commission)		ANDERSON KL, 1996, THESIS BAYLOR COLL M; Beales PL, 1997, J MED GENET, V34, P92, DOI 10.1136/jmg.34.2.92; Bruford EA, 1997, GENOMICS, V41, P93, DOI 10.1006/geno.1997.4613; CARMI R, 1995, AM J MED GENET, V59, P199, DOI 10.1002/ajmg.1320590216; CARMI R, 1995, HUM MOL GENET, V4, P9, DOI 10.1093/hmg/4.1.9; Cooper PR, 1997, GENOMICS, V41, P185, DOI 10.1006/geno.1997.4660; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; FARAG TI, 1988, CLIN GENET, V33, P78; Guru SC, 1997, GENOMICS, V42, P436, DOI 10.1006/geno.1997.4783; Kitamura E, 1997, DNA Res, V4, P281, DOI 10.1093/dnares/4.4.281; KWITEKBLACK AE, 1993, NAT GENET, V5, P392, DOI 10.1038/ng1293-392; LEPPERT M, 1994, NAT GENET, V7, P108, DOI 10.1038/ng0594-108; LEWIS RA, 1990, GENOMICS, V7, P250, DOI 10.1016/0888-7543(90)90547-8; OTT J, 1983, ANN HUM GENET, V47, P311, DOI 10.1111/j.1469-1809.1983.tb01001.x; SHEFFIELD VC, 1994, HUM MOL GENET, V3, P1331, DOI 10.1093/hmg/3.8.1331; Stockton DW, 1998, HUM GENET, V103, P328, DOI 10.1007/s004390050825; Young TL, 1998, AM J MED GENET, V78, P461, DOI 10.1002/(SICI)1096-8628(19980806)78:5<461::AID-AJMG12>3.0.CO;2-D; Young TL, 1999, AM J HUM GENET, V64, P900, DOI 10.1086/302301; Young TL, 1999, AM J HUM GENET, V65, P1680, DOI 10.1086/302686	19	36	38	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1999	65	6					1672	1679		10.1086/302684	http://dx.doi.org/10.1086/302684			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	266CF	10577921	Green Published, Bronze			2022-12-18	WOS:000084282500022
J	Ellis, NA; Proytcheva, M; Sanz, MM; Ye, TZ; German, J				Ellis, NA; Proytcheva, M; Sanz, MM; Ye, TZ; German, J			Transfection of BLM into cultured bloom syndrome cells reduces the sister-chromatid exchange rate toward normal	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								The gene BLM, mutated in Bloom syndrome (BS), encodes the nuclear protein BLM, which when absent, as it is from most BS cells, results in genomic instability. A manifestation of this instability is an excessive rate of sister-chromatid exchange (SCE). Here we describe the effects on this abnormal cellular phenotype of stable transfection of normal BLM cDNAs into two types of BS cells, SV40-transformed fibroblasts and Epstein-Barr virus (EBV)-transformed lymphoblastoid cells. Clones of BLM-transfected fibroblasts produced normal amounts of BLM by western blot analysis and displayed a normal nuclear localization of the protein by immunofluorescence microscopy. They had a mean of 24 SCEs/46 chromosomes, in contrast to the mean of 69 SCEs in controls transfected only with the vector. BLM-transfected fibroblast clones that expressed highest levels of the BLM protein had lowest levels of SCE. The lymphoblastoid cells transfected with BLM had SCE frequencies of 22 and 42 in two separate experiments in which two different selectable markers were used, in contrast to 57 and 58 in vector-transfected cells; in this type cell, however, the BLM protein was below the level detectable by western blot analysis. These experiments prove that BLM cDNA encodes a functional protein capable of restoring to or toward normal the uniquely characteristic high-SCE phenotype of BS cells.	Mem Sloan Kettering Canc Ctr, Dept Human Genet, New York, NY 10021 USA; Cornell Univ, Coll Med, Dept Microbiol, New York, NY USA; Cornell Univ, Coll Med, Dept Pediat, New York, NY USA; Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Yeshiva University; Albert Einstein College of Medicine	Ellis, NA (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Human Genet, 1250 York Ave, New York, NY 10021 USA.				NCI NIH HHS [CA50897] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA050897] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ausubel F., 1999, CURRENT PROTOCOLS MO; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; GERMAN J, 1993, MEDICINE, V72, P393, DOI 10.1097/00005792-199311000-00003; GERMAN J, 1977, AM J HUM GENET, V29, P248; GERMAN J, 1996, AM J HUM GENET S, V59, pA2; GERMAN J, IN PRESS METABOLIC M; Giesler T, 1997, SOMAT CELL MOLEC GEN, V23, P303, DOI 10.1007/BF02674278; HARLOW E, 1988, ANTIBODIES LAB MANUA, P363; MCDANIEL LD, 1992, P NATL ACAD SCI USA, V89, P7968, DOI 10.1073/pnas.89.17.7968; Neff NF, 1999, MOL BIOL CELL, V10, P665, DOI 10.1091/mbc.10.3.665; STRATHDEE CA, 1992, NATURE, V356, P763, DOI 10.1038/356763a0	11	36	36	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1999	65	5					1368	1374		10.1086/302616	http://dx.doi.org/10.1086/302616			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	252YZ	10521302	Bronze, Green Published			2022-12-18	WOS:000083531000018
J	Somerville, MJ; Sprysak, KA; Hicks, M; Elyas, BG; Vicen-Wyhony, L				Somerville, MJ; Sprysak, KA; Hicks, M; Elyas, BG; Vicen-Wyhony, L			An HFE intronic variant promotes misdiagnosis of hereditary hemochromatosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							MUTATIONS; GENE		Univ Alberta, Dept Med Genet, Edmonton, AB T6G 2H7, Canada	University of Alberta	Somerville, MJ (corresponding author), Univ Alberta, Dept Med Genet, 8-26 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.							Baty D, 1998, J CLIN PATHOL, V51, P73, DOI 10.1136/jcp.51.1.73; Bulaj ZJ, 1996, NEW ENGL J MED, V335, P1799, DOI 10.1056/NEJM199612123352403; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Jazwinska EC, 1996, NAT GENET, V14, P249, DOI 10.1038/ng1196-249; MerryweatherClarke AT, 1997, J MED GENET, V34, P275, DOI 10.1136/jmg.34.4.275	5	36	36	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1999	65	3					924	926		10.1086/302550	http://dx.doi.org/10.1086/302550			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233KQ	10441599	Green Published, Bronze			2022-12-18	WOS:000082426400038
J	Chitnis, S; Derom, C; Vlietinck, R; Derom, R; Monteiro, J; Gregersen, PK				Chitnis, S; Derom, C; Vlietinck, R; Derom, R; Monteiro, J; Gregersen, PK			X chromosome-inactivation patterns confirm the late timing of monoamniotic-MZ twinning	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									NYU, Div Biol & Human Genet, N Shore Univ Hosp, Sch Med, Manhasset, NY 11030 USA; Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium	New York University; Northwell Health; North Shore University Hospital; KU Leuven	Gregersen, PK (corresponding author), NYU, Div Biol & Human Genet, N Shore Univ Hosp, Sch Med, 350 Community Dr, Manhasset, NY 11030 USA.	peterg@nshs.edu		Derom, Catherine/0000-0001-5574-796X				ALLEN RC, 1992, AM J HUM GENET, V51, P1229; DEROM C, 1988, NEW ENGL J MED, V319, P119; Derom R., 1995, MULTIPLE PREGNANCY E, P113; LOOS R, 1999, TWIN RES, V1, P167; Monteiro J, 1998, AM J HUM GENET, V63, P339, DOI 10.1086/301978; PERGAMENT E, 1994, HUM REPROD, V9, P1730, DOI 10.1093/oxfordjournals.humrep.a138783; PUCK JM, 1992, AM J HUM GENET, V50, P742	7	36	36	2	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1999	65	2					570	571		10.1086/302502	http://dx.doi.org/10.1086/302502			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	223JA	10417301	Bronze, Green Published			2022-12-18	WOS:000081836900034
J	Reilly, PR				Reilly, PR			Rethinking risks to human subjects in genetic research	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material									Shriver Ctr Mental Retardat Inc, Waltham, MA 02452 USA		Reilly, PR (corresponding author), Shriver Ctr Mental Retardat Inc, 200 Trapelo Rd, Waltham, MA 02452 USA.							Annas George J., 1992, NAZI DOCTORS NUREMBE; BEECHER HK, 1966, NEW ENGL J MED, V274, P1354, DOI 10.1056/NEJM196606162742405; BILLINGS PR, 1992, AM J HUM GENET, V50, P476; CLAYTON EW, 1995, JAMA-J AM MED ASSOC, V274, P1786, DOI 10.1001/jama.274.22.1786; Dobzhanzky T., 1973, GENETIC DIVERSITY HU; FOSTER M, 1998, AM J HUM GENET, V63; Friedlaender J. S., 1996, CULTURAL SURVIVAL Q, V20, P22; Geller Lisa N, 1996, Sci Eng Ethics, V2, P71, DOI 10.1007/BF02639319; JONE SJH, 1981, BAD BLOOD TUSKEGEE S; McKeigue PM, 1997, AM J HUM GENET, V60, P188; *NIH, 1961, HDB UT NORM VOL CLIN; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; TAUBES G, 1995, SCIENCE, V270, P1112, DOI 10.1126/science.270.5239.1112; The National Comission for the Protection of Human Subjects of Biomedical and Behavioral Research, 1979, BELM REP ETH PRINC G; *UN ED SCI CULTR O, 1997, DECL HUM GEN; Wadman M, 1998, NATURE, V392, P851, DOI 10.1038/31764; WALDMAN L, 1998, NY TIMES        0426; 1974, FED REG         0530, V39, P18914	18	36	36	1	2	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1998	63	3					682	685		10.1086/302028	http://dx.doi.org/10.1086/302028			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	119VN	9718358	Green Published, Bronze			2022-12-18	WOS:000075919000003
J	Knowles, JA; Rao, PA; Cox-Matise, T; Loth, JE; de Jesus, GM; Levine, L; Das, K; Penchaszadeh, GK; Alexander, JR; Lerer, B; Endicott, J; Ott, J; Gilliam, TC; Baron, M				Knowles, JA; Rao, PA; Cox-Matise, T; Loth, JE; de Jesus, GM; Levine, L; Das, K; Penchaszadeh, GK; Alexander, JR; Lerer, B; Endicott, J; Ott, J; Gilliam, TC; Baron, M			No evidence for significant linkage between bipolar affective disorder and chromosome 18 pericentromeric markers in a large series of multiplex extended pedigrees	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OLD-ORDER AMISH; DIAGNOSTIC CRITERIA; VULNERABILITY LOCUS; DNA MARKERS; ILLNESS; DISEQUILIBRIUM; RELIABILITY; ASSOCIATION; HISTORY; TRAITS	Bipolar affective disorder (BP) is a major neuropsychiatric disorder with high heritability and complex inheritance. Previously reported linkage between BP and DNA markers in the pericentromeric region of chromosome 18, with a parent-of-origin effect (linkage was present in pedigrees with paternal transmission and absent in pedigrees with exclusive maternal inheritance), has been a focus of interest in human genetics. We reexamined the evidence in one of the largest samples reported to date (1,013 genotyped individuals in 53 unilineal multiplex pedigrees), using 10 highly polymorphic markers and a range of parametric and nonparametric analyses. There was no evidence for significant linkage between BP and chromosome 18 pericentromeric markers in the sample as a whole, nor was there evidence for significant parent-of-origin effect (pedigrees with paternal transmission were not differentially linked to the implicated chromosomal region). Two-point LOD scores and single-locus sib-pair results gave some support for suggestive linkage, but this was not substantiated by multilocus analysis, and the results were further tempered by multiple test effects. We conclude that there is no compelling evidence for linkage between BP and chromosome 18 pericentromeric markers in this sample.	New York State Psychiat Inst, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, New York, NY 10032 USA; Columbia Genome Ctr, New York, NY USA; Rockefeller Univ, Lab Stat Genet, New York, NY 10021 USA; Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Psychiat, Jerusalem, Israel	New York State Psychiatry Institute; Columbia University; Columbia University; Rockefeller University; Hebrew University of Jerusalem; Hadassah University Medical Center	Baron, M (corresponding author), New York State Psychiat Inst, 722 W 168th St,Unit 58, New York, NY 10032 USA.	mb17@columbia.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH044292, R37MH044292, R01MH043979, R01MH042535] Funding Source: NIH RePORTER; NIMH NIH HHS [MH43979, MH42535, MH44292] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ADAMS P, 1994, GENET EPIDEMIOL, V11, P87, DOI 10.1002/gepi.1370110109; ANDREASEN NC, 1977, ARCH GEN PSYCHIAT, V34, P1229; Baron M, 1997, MOL PSYCHIATR, V2, P200, DOI 10.1038/sj.mp.4000211; BARON M, 1994, PSYCHIATR GENET, V4, P43, DOI 10.1097/00041444-199421000-00007; Berrettini W, 1996, MOL PSYCHIATR, V1, P172; Berrettini WH, 1997, ARCH GEN PSYCHIAT, V54, P27; BERRETTINI WH, 1994, P NATL ACAD SCI USA, V91, P5918, DOI 10.1073/pnas.91.13.5918; Coon H, 1996, BIOL PSYCHIAT, V39, P689, DOI 10.1016/0006-3223(95)00292-8; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Davis S, 1996, AM J HUM GENET, V58, P867; Debruyn A, 1996, BIOL PSYCHIAT, V39, P679, DOI 10.1016/0006-3223(95)00293-6; DeteraWadleigh SD, 1997, AM J MED GENET, V74, P254, DOI 10.1002/(SICI)1096-8628(19970531)74:3<254::AID-AJMG4>3.0.CO;2-Q; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; Ewald H, 1997, PSYCHIATR GENET, V7, P1, DOI 10.1097/00041444-199700710-00001; Freimer NB, 1996, NAT GENET, V12, P436, DOI 10.1038/ng0496-436; Gershon ES, 1996, AM J MED GENET, V67, P202, DOI 10.1002/(SICI)1096-8628(19960409)67:2<202::AID-AJMG11>3.0.CO;2-N; Kalsi G, 1997, HUM HERED, V47, P268, DOI 10.1159/000154423; Kato T, 1996, AM J MED GENET, V67, P546, DOI 10.1002/(SICI)1096-8628(19961122)67:6<546::AID-AJMG6>3.0.CO;2-F; KNOWLES JA, 1992, AM J HUM GENET, V51, P905; KNOWLES JA, 1998, IN PRESS AM J MED GE; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; Kuokkanen S, 1996, NAT GENET, V13, P477, DOI 10.1038/ng0896-477; LaBuda MC, 1996, AM J HUM GENET, V59, P1343; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Maier W, 1995, PSYCHIAT RES, V59, P7, DOI 10.1016/0165-1781(95)02799-8; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; MynettJohnson LA, 1997, BIOL PSYCHIAT, V42, P486, DOI 10.1016/S0006-3223(96)00427-1; Ott J., 1991, ANAL HUMAN GENETIC L; PAULS DL, 1995, AM J HUM GENET, V57, P636; Pauls DL, 1996, AM J HUM GENET, V58, P1384; RISCH N, 1992, HUM HERED, V42, P77, DOI 10.1159/000154047; Risch N, 1996, NAT GENET, V12, P351, DOI 10.1038/ng0496-351; Satsangi J, 1996, NAT GENET, V14, P199, DOI 10.1038/ng1096-199; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SPITZER RL, 1978, ARCH GEN PSYCHIAT, V35, P773, DOI 10.1001/archpsyc.1978.01770300115013; STINE OC, 1995, AM J HUM GENET, V57, P1384; STRAUB RE, 1993, GENOMICS, V15, P48, DOI 10.1006/geno.1993.1008; STRAUB RE, 1994, NAT GENET, V8, P291, DOI 10.1038/ng1194-291; SUAREZ BK, 1994, GENETIC APPROACHES M, P23; Terwedow H., 1996, American Journal of Human Genetics, V59, pA238; TERWEDOW H, 1996, AM J HUM GENET S, V59, P1372; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; TERWILLIGER JD, 1994, 4 WORKSH NORD GEN IN; TRAN LD, 1991, SIBPAL SIBPAIR LINKA; Tsiouris SJ, 1996, AM J MED GENET, V67, P491, DOI 10.1002/(SICI)1096-8628(19960920)67:5<491::AID-AJMG11>3.0.CO;2-I; Turecki G, 1996, PSYCHIAT RES, V63, P17, DOI 10.1016/0165-1781(96)02864-8; Turecki G, 1996, ACTA PSYCHIAT SCAND, V93, P317, DOI 10.1111/j.1600-0447.1996.tb10655.x; WEEKS DE, 1992, AM J HUM GENET, V50, P859	50	36	37	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1998	62	4					916	924		10.1086/301785	http://dx.doi.org/10.1086/301785			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZM197	9529343	Green Published, Bronze			2022-12-18	WOS:000073514400023
J	Ligon, AH; Beaudet, AL; Shaffer, LG				Ligon, AH; Beaudet, AL; Shaffer, LG			Simultaneous, multilocus FISH analysis for detection of microdeletions in the diagnostic evaluation of developmental delay and mental retardation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FLUORESCENCE INSITU HYBRIDIZATION; IN-SITU HYBRIDIZATION; SUBMICROSCOPIC DELETIONS; CRYPTIC TRANSLOCATIONS; MOLECULAR ANALYSIS; ANGELMAN SYNDROME; DIGEORGE-SYNDROME; WILLIAMS-SYNDROME; REGION; GENE	Many microdeletion and contiguous gene-deletion syndromes include mental retardation as a clinical feature. We have developed MultiFISH, a FISH assay using several probes to simultaneously screen for multiple microdeletion syndromes in patients who present with unexplained developmental delay and/or mental retardation. This screening tool can be used to determine whether a particular microdeletion syndrome is involved in the etiology of these clinical phenotypes. In this pilot study we combined probes for the commonly deleted regions of Prader-Willi, Angelman, Williams, Smith-Magenis, and DiGeorge/velocardiofacial syndromes in a single hybridization. The probes were differentially labeled, allowing multicolor detection, and 200 individual samples were screened in a blinded fashion. For all patients found by MultiFISH to have deletions, the deletions were originally identified and/or later confirmed by use of single-probe FISH analysis in our diagnostic cytogenetics laboratory. One patient, who was referred for developmental delay and was shown to have a normal G-banded karyotype, was identified by MultiFISH as having a microdeletion at the DiGeorge/velocardiofacial commonly deleted region. Forty-six of the 200 total samples were tested for microdeletions by use of single FISH probes in the diagnostic laboratory. Ten of these cases were found to have deletions, and all deletions were subsequently detected by use of a MultiFISH screen performed in a blinded fashion. Additionally, for all 200 patients tested by use of MultiFISH, no false-positive deletion results were observed. We demonstrate the ability of this technique to scan for and to identify microdeletions in a proportion of patients whose routine karyotype appears normal yet who are mentally retarded and/or developmentally delayed.	BAYLOR COLL MED,DEPT MOL & HUMAN GENET,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT CELL BIOL,HOUSTON,TX 77030; BAYLOR COLL MED,HOWARD HUGHES MED INST,HOUSTON,TX 77030	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute								*AM SOC HUM GEN AM, 1996, AM J HUM GENET, V58, P1085; BREUNING MH, 1993, AM J HUM GENET, V52, P249; CHEN KS, 1995, AM J HUM GENET, V56, P175; DELACH JA, 1994, AM J MED GENET, V52, P85, DOI 10.1002/ajmg.1320520117; DESMAZE C, 1993, HUM GENET, V90, P663, DOI 10.1007/BF00202489; DRISCOLL DA, 1992, AM J MED GENET, V44, P261, DOI 10.1002/ajmg.1320440237; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; Frangiskakis JM, 1996, CELL, V86, P59, DOI 10.1016/S0092-8674(00)80077-X; GREENBERG F, 1991, AM J HUM GENET, V49, P1207; Greenberg F, 1996, AM J MED GENET, V62, P247, DOI 10.1002/(SICI)1096-8628(19960329)62:3<247::AID-AJMG9>3.3.CO;2-9; KEPPLERNOREUIL KM, 1995, J MED GENET, V32, P619, DOI 10.1136/jmg.32.8.619; KLINGER K, 1992, AM J HUM GENET, V51, P55; KUWANO A, 1991, AM J HUM GENET, V49, P707; Kuwano Akira, 1992, Human Molecular Genetics, V1, P417, DOI 10.1093/hmg/1.6.417; Leaverton P.E., 1991, REV BIOSTATISTICS PR; LeBeau MM, 1996, NAT GENET, V12, P341, DOI 10.1038/ng0496-341; LEDBETTER DH, 1992, AM J HUM GENET, V51, P451; LINDSAY EA, 1995, AM J MED GENET, V56, P191, DOI 10.1002/ajmg.1320560216; LINDSAY EA, 1993, GENOMICS, V17, P403, DOI 10.1006/geno.1993.1339; NAKAO M, 1994, HUM MOL GENET, V3, P309, DOI 10.1093/hmg/3.2.309; NICKERSON E, 1995, AM J HUM GENET, V56, P1156; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Ried Thomas, 1992, Human Molecular Genetics, V1, P307, DOI 10.1093/hmg/1.5.307; SHAFFER LG, 1995, CURRENT PROTOCOLS HU; SHAPIRA SK, 1997, IN PRESS AM J HUM GE, V61; Speicher MR, 1996, NAT GENET, V12, P368, DOI 10.1038/ng0496-368; Tassabehji M, 1996, NAT GENET, V13, P272, DOI 10.1038/ng0796-272; WILKIE AOM, 1990, AM J HUM GENET, V46, P1112	28	36	36	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1997	61	1					51	59		10.1086/513904	http://dx.doi.org/10.1086/513904			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM728	9245984	Green Published, Bronze			2022-12-18	WOS:A1997XM72800011
J	Lauteala, T; Sistonen, P; Savontaus, ML; Mykkanen, J; Simell, J; Lukkarinen, M; Simell, O; Aula, P				Lauteala, T; Sistonen, P; Savontaus, ML; Mykkanen, J; Simell, J; Lukkarinen, M; Simell, O; Aula, P			Lysinuric protein intolerance (LPI) gene maps to the long arm of chromosome 14	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEURONAL CEROID-LIPOFUSCINOSIS; MULTILOCUS LINKAGE ANALYSIS; DIASTROPHIC DYSPLASIA; MISSENSE MUTATION; DISEQUILIBRIUM; RECEPTOR; IDENTIFICATION; FINLAND; LOCALIZATION; TRANSPORTER	Lysinuric protein intolerance (LPI) is an autosomal recessive disease characterized by defective transport of cationic amino acids and by hyperammonemia. Linkage analysis in 20 Finnish LPI families assigned the LPI gene locus to the proximal long arm of chromosome 14. Recombinations placed the locus between framework markers D14S72 and MYH7, a 10-cM interval in which the markers D14S742, D14S50, D14S283, and TCRA showed no recombinations with the phenotype. The phenotype was in highly significant linkage disequilibrium with markers D14S50, D14S283, and TCRA. The strongest allelic association obtained with marker TCRA, resulting in a P-excess value of .98, suggests that the LPI gene locus lies in close proximity to this marker, probably within a distance of <100 kb.	UNIV TURKU,DEPT PEDIAT,SF-20520 TURKU,FINLAND; FINNISH RED CROSS & BLOOD TRANSFUS SERV,SF-00310 HELSINKI,FINLAND	University of Turku	Lauteala, T (corresponding author), UNIV TURKU,DEPT MED GENET,KIINAMYLLYNKATU 10,SF-20520 TURKU,FINLAND.		Mykkänen, Juha/Q-1663-2015	Mykkänen, Juha/0000-0001-9898-2660				AITTOMAKI K, 1995, CELL, V82, P959, DOI 10.1016/0092-8674(95)90275-9; CLOSS EI, 1993, J BIOL CHEM, V268, P20796; CLOSS EI, 1993, J BIOL CHEM, V268, P7538; Collins A, 1996, GENOMICS, V36, P157, DOI 10.1006/geno.1996.0436; CROSS NCP, 1988, CELL, V53, P881, DOI 10.1016/S0092-8674(88)90349-2; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; DESJEUX JF, 1980, J CLIN INVEST, V65, P1382, DOI 10.1172/JCI109802; DIB C, 1996, NATURE, V380, P15; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HELLSTEN E, 1993, GENOMICS, V16, P720, DOI 10.1006/geno.1993.1253; HELLSTEN E, 1995, THESIS NATL PUBLIC H; HEUSEL JW, 1991, J BIOL CHEM, V266, P6152; Hoglund P, 1996, NAT GENET, V14, P316, DOI 10.1038/ng1196-316; IKONEN E, 1991, EMBO J, V10, P51, DOI 10.1002/j.1460-2075.1991.tb07920.x; INCERTI B, 1993, AM J HUM GENET, V53, P908; KATO T, 1984, PEDIATRICS, V73, P489; KOOP BF, 1994, GENOMICS, V19, P478, DOI 10.1006/geno.1994.1097; KURE S, 1992, J CLIN INVEST, V90, P160, DOI 10.1172/JCI115831; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LAUTEALA T, IN PRESS HUM GENET; LEHESJOKI AE, 1993, HUM MOL GENET, V2, P1229, DOI 10.1093/hmg/2.8.1229; MITCHELL A, 1991, GENOMICS, V11, P1063, DOI 10.1016/0888-7543(91)90033-B; MITCHELL GA, 1989, P NATL ACAD SCI USA, V86, P197, DOI 10.1073/pnas.86.1.197; MORTON NE, 1992, ANN HUM GENET, V56, P223, DOI 10.1111/j.1469-1809.1992.tb01147.x; NAGATA M, 1987, EUR J PEDIATR, V146, P427, DOI 10.1007/BF00444955; NORIO R, 1973, ANN CLIN RES, V5, P109; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; PARTO K, 1993, CHEST, V104, P1176, DOI 10.1378/chest.104.4.1176; PARTO K, 1994, HUM PATHOL, V25, P400, DOI 10.1016/0046-8177(94)90150-3; Pennacchio LA, 1996, SCIENCE, V271, P1731, DOI 10.1126/science.271.5256.1731; PERHEENT.J, 1965, LANCET, V2, P813, DOI 10.1016/S0140-6736(65)92446-3; RAJANTIE J, 1981, J CLIN INVEST, V67, P1078, DOI 10.1172/JCI110120; RAJANTIE J, 1980, LANCET, V7, P1219; SANKILA EM, 1992, NAT GENET, V1, P109, DOI 10.1038/ng0592-109; Simell O, 1995, METAB MOL BASES INHE, V1, P3603; VESA J, 1995, NATURE, V376, P584, DOI 10.1038/376584a0; YOSHIMOTO T, 1991, VIROLOGY, V185, P10, DOI 10.1016/0042-6822(91)90748-Z	40	36	37	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1997	60	6					1479	1486		10.1086/515457	http://dx.doi.org/10.1086/515457			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XE294	9199570	Green Published, Bronze			2022-12-18	WOS:A1997XE29400027
J	Rao, VS; Cupples, LA; vanDuijn, CM; Kurz, A; Green, RC; Chui, H; Duara, R; Auerbach, SA; Volicer, L; Wells, J; Van Broeckhoven, C; Growdon, JH; Haines, JL; Farrer, LA				Rao, VS; Cupples, LA; vanDuijn, CM; Kurz, A; Green, RC; Chui, H; Duara, R; Auerbach, SA; Volicer, L; Wells, J; Van Broeckhoven, C; Growdon, JH; Haines, JL; Farrer, LA			Evidence for major gene inheritance of Alzheimer disease in families of patients with and without apolipoprotein E epsilon 4	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CORONARY-ARTERY DISEASE; EARLY-ONSET; SEGREGATION ANALYSIS; E POLYMORPHISM; RISK FACTOR; E GENOTYPE; 1ST-DEGREE RELATIVES; COMPLEX SEGREGATION; TYPE-4 ALLELE; POPULATION	Apolipoprotein E (APOE) genotype is the single most important determinant to the common form of Alzheimer disease (AD) yet identified, Several studies show that family history of AD is not entirely accounted for by APOE genotype, Also, there is evidence for an interaction between APOE genotype and gender, We carried out a complex segregation analysis in 636 nuclear families of consecutively ascertained and rigorously diagnosed probands in the Multi-Institutional Research in Alzheimer Genetic Epidemiology study in order to derive models of disease transmission which account for the influences of APOE genotype of the proband and gender, In the total group of families, models postulating sporadic occurrence, no major gene effect, random environmental transmission, and Mendelian inheritance were rejected, Transmission of AD in families of probands with at least one epsilon 4 allele best fit a dominant model, Moreover, single gene inheritance best explained clustering of the disorder in families of probands lacking epsilon 4, but a more complex genetic model or multiple genetic models may ultimately account for risk in this group of families, Our results also suggest that susceptibility to AD differs between men and women regardless of the proband's APOE status, Assuming a dominant model, AD appears to be completely penetrant in women, whereas only 62%-65% of men with predisposing genotypes develop AD. However, parameter estimates from the arbitrary major gene model suggests that AD is expressed dominantly in women and additively in men, These observations, taken together with epidemiologic data, are consistent with the hypothesis of an interaction between genes and other biological factors affecting disease susceptibility.	BOSTON UNIV, SCH MED, DEPT NEUROL, BOSTON, MA 02118 USA; BOSTON UNIV, SCH MED, DEPT BIOSTAT & EPIDEMIOL, BOSTON, MA 02118 USA; HARVARD UNIV, SCH MED, DEPT NEUROL, BOSTON, MA 02115 USA; MASSACHUSETTS GEN HOSP, MOL NEUROGENET UNIT, BOSTON, MA 02114 USA; ERASMUS UNIV ROTTERDAM, DEPT EPIDEMIOL & BIOSTAT, NL-3000 DR ROTTERDAM, NETHERLANDS; TECH UNIV MUNICH, PSYCHIAT KLIN, D-8000 MUNICH, GERMANY; EMORY UNIV, DEPT NEUROL, NEUROBEHAV PROGRAM, ATLANTA, GA 30322 USA; UNIV SO CALIF, LOS ANGELES, CA USA; UNIV MIAMI, SCH MED, MIAMI, FL USA; EDITH NOURSE ROGERS MEM VET ADM HOSP, CTR GERIATR RES EDUC & CLIN, BEDFORD, MA 01730 USA; UNIV ANTWERP VIB, DEPT BIOCHEM,BORN BUNGE FDN, NEUROGENET LAB, B-2020 ANTWERP, BELGIUM	Boston University; Boston University; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Erasmus University Rotterdam; Technical University of Munich; Emory University; University of Southern California; University of Miami; Geriatric Research Education & Clinical Center; Flanders Institute for Biotechnology (VIB); University of Antwerp			Farrer, Lindsay/AAS-1035-2020; Van Broeckhoven, Christine/G-8362-2017; Van Broeckhoven, Christine/M-7853-2019; Volicer, Ladislav/K-7576-2019; Haines, Jonathan/C-3374-2012	Van Broeckhoven, Christine/0000-0003-0183-7665; Van Broeckhoven, Christine/0000-0003-0183-7665; Volicer, Ladislav/0000-0002-6939-7531; Haines, Jonathan/0000-0002-4351-4728; Cupples, L. Adrienne/0000-0003-0273-7965; Farrer, Lindsay/0000-0001-5533-4225	NATIONAL INSTITUTE ON AGING [R01AG011503, P30AG010130, R01AG009029] Funding Source: NIH RePORTER; NIA NIH HHS [P30-AG10130, R01-AG11503, R01-AG09029] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AMOUYEL P, 1993, LANCET, V342, P1309; ATWOOD LD, 1992, COMMUN STAT SIMULAT, V21, P769, DOI 10.1080/03610919208813049; BAILEYWILSON JE, 1987, STAT ANAL GENETIC EP; BONNEY GE, 1986, BIOMETRICS, V42, P611, DOI 10.2307/2531211; BONNEY GE, 1984, AM J MED GENET, V18, P731, DOI 10.1002/ajmg.1320180420; BORGAONKAR DS, 1993, LANCET, V342, P625, DOI 10.1016/0140-6736(93)91458-X; BREITNER JCS, 1988, NEUROLOGY, V38, P207; BROUSSEAU T, 1994, NEUROLOGY, V44, P342, DOI 10.1212/WNL.44.2.342; CHARTIERHARLIN MC, 1994, HUM MOL GENET, V3, P569, DOI 10.1093/hmg/3.4.569; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; CUMMING AM, 1984, CLIN GENET, V25, P310; CUPPLES LA, 1991, AM J HUM GENET, V49, P76; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; DUARA R, IN PRESS NEUROLOGY; FARRER LA, 1995, JAMA-J AM MED ASSOC, V274, P1627, DOI 10.1001/jama.1995.03530200063039; FARRER LA, 1995, ANN NEUROL, V38, P797, DOI 10.1002/ana.410380515; FARRER LA, 1994, AM J HUM GENET, V54, P374; FARRER LA, 1994, NEUROLOGY, V44, P652, DOI 10.1212/WNL.44.4.652; FARRER LA, 1991, AM J HUM GENET, V48, P1026; FARRER LA, 1989, ANN NEUROL, V25, P485, DOI 10.1002/ana.410250511; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Haines JL, 1996, GENOMICS, V33, P53, DOI 10.1006/geno.1996.0158; HARDY J, 1993, LANCET, V342, P737; HIRST C, 1994, GENET EPIDEMIOL, V11, P365, DOI 10.1002/gepi.1370110406; HUFF FJ, 1988, NEUROLOGY, V38, P786, DOI 10.1212/WNL.38.5.786; JARVIK GP, 1995, NEUROLOGY, V45, P1092, DOI 10.1212/WNL.45.6.1092; JARVIK GP, 1994, NAT GENET, V8, P115, DOI 10.1038/ng1094-115a; Jarvik GP, 1996, AM J HUM GENET, V58, P191; JOACHIM CL, 1988, ANN NEUROL, V24, P50, DOI 10.1002/ana.410240110; KAMBOH MI, 1995, NAT GENET, V10, P486, DOI 10.1038/ng0895-486; KHACHATURIAN ZS, 1985, ARCH NEUROL-CHICAGO, V42, P1097, DOI 10.1001/archneur.1985.04060100083029; KOKMEN E, 1988, NEUROLOGY, V38, P975, DOI 10.1212/WNL.38.6.975; KUUSI T, 1989, ARTERIOSCLEROSIS, V9, P237, DOI 10.1161/01.ATV.9.2.237; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; Lautenschlager NT, 1996, NEUROLOGY, V46, P641, DOI 10.1212/WNL.46.3.641; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; LIDDELL M, 1994, J MED GENET, V31, P197, DOI 10.1136/jmg.31.3.197; MAESTRE G, 1995, ANN NEUROL, V37, P254, DOI 10.1002/ana.410370217; MAHIEUX F, 1994, ANN NEUROL, V35, P506, DOI 10.1002/ana.410350424; MARTIN RL, 1988, ARCH GEN PSYCHIAT, V45, P894; MAYEUX R, 1995, AM J PUBLIC HEALTH, V85, P1280, DOI 10.2105/AJPH.85.9.1280; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; MAYEUX R, 1991, ARCH NEUROL-CHICAGO, V48, P269, DOI 10.1001/archneur.1991.00530150037014; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MENZEL HJ, 1983, ARTERIOSCLEROSIS, V3, P310, DOI 10.1161/01.ATV.3.4.310; MORTON NE, 1974, AM J HUM GENET, V26, P489; Myers RH, 1996, NEUROLOGY, V46, P673, DOI 10.1212/WNL.46.3.673; NALBANTOGLU J, 1994, ANN NEUROL, V36, P889, DOI 10.1002/ana.410360614; OKUIZUMI K, 1995, NAT GENET, V11, P207, DOI 10.1038/ng1095-207; ORDOVAS JM, 1987, J LIPID RES, V28, P371; PAGANINIHILL A, 1994, AM J EPIDEMIOL, V140, P256, DOI 10.1093/oxfordjournals.aje.a117244; PAYAMI H, 1994, JAMA-J AM MED ASSOC, V271, P1316, DOI 10.1001/jama.271.17.1316; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; RAO VS, 1994, AM J HUM GENET, V55, P991; ROSES AD, 1994, J NEUROPATH EXP NEUR, V53, P429, DOI 10.1097/00005072-199409000-00002; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SCHOENBERG BS, 1987, ANN NEUROL, V22, P724, DOI 10.1002/ana.410220608; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; SILVERMAN JM, 1986, AM J PSYCHIAT, V143, P1279; SILVERMAN JM, 1994, ARCH GEN PSYCHIAT, V51, P577; SORBI S, 1994, NEUROSCI LETT, V177, P100, DOI 10.1016/0304-3940(94)90054-X; STCLAIR D, 1995, J MED GENET, V32, P57, DOI 10.1136/jmg.32.1.57; STGEORGEHYSLOP P, 1994, SCIENCE, V263, P537, DOI 10.1126/science.8290965; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; TALBOT C, 1994, LANCET, V343, P1432, DOI 10.1016/S0140-6736(94)92557-7; TSAI MS, 1994, AM J HUM GENET, V54, P643; VANBOCKXMEER FM, 1992, LANCET, V340, P879, DOI 10.1016/0140-6736(92)93288-X; VANDUIJN CM, 1994, GENET EPIDEMIOL, V11, P539, DOI 10.1002/gepi.1370110609; VANDUIJN CM, 1995, BMJ-BRIT MED J, V310, P627, DOI 10.1136/bmj.310.6980.627; VANDUIJN CM, 1993, J MED GENET, V30, P640, DOI 10.1136/jmg.30.8.640; VANDUIJN CM, 1995, ANN NEUROL, V37, P605, DOI 10.1002/ana.410370510; VANDUIJN CM, 1994, NAT GENET, V7, P74, DOI 10.1038/ng0594-74; VANGOOL WA, 1994, LANCET, V344, P275, DOI 10.1016/S0140-6736(94)93044-9; WENHAM PR, 1991, LANCET, V337, P1158, DOI 10.1016/0140-6736(91)92823-K; Wragg M, 1996, LANCET, V347, P509, DOI 10.1016/S0140-6736(96)91140-X	76	36	38	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1996	59	3					664	675						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN625	8751868				2022-12-18	WOS:A1996VN62500021
J	Migeon, BR; Jeppesen, P; Torchia, BS; Fu, SD; Dunn, MA; Axelman, J; Schmeckpeper, BJ; Fantes, J; Zori, RT; Driscoll, DJ				Migeon, BR; Jeppesen, P; Torchia, BS; Fu, SD; Dunn, MA; Axelman, J; Schmeckpeper, BJ; Fantes, J; Zori, RT; Driscoll, DJ			Lack of X inactivation associated with maternal X isodisomy: Evidence for a counting mechanism prior to X inactivation during human embryogenesis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMOSOME INACTIVATION; HISTONE-H4 ACETYLATION; MOUSE EMBRYOS; GENE; CELL; EXPRESSION; REGION; SEQUENCES; ORIGIN; LOCUS	We have previously reported functional disomy for X-linked genes in females with tiny ring X chromosomes and a phenotype significantly more abnormal than Turner syndrome. In such cases the disomy results from failure of these X chromosomes to inactivate because they lack DNA sequences essential for cis X inactivation. Here we describe a novel molecular mechanism for functional X disomy that is associated with maternal isodisomy. In this case, the severe mental retardation and multiple congenital abnormalities in a female with a mosaic 45,X/ 46,X,del(X) (q21.3-qter)/ 46X,r(X) karyotype are associated with overexpression of the genes within Xpter to Xq21.31 in many of her cells. Her normal X, ring X, and deleted linear X chromosomes originate from the same maternal X chromosome, and all are transcriptionally active. None expresses X inactive specific transcript (XIST), although the locus and region of the putative X inactivation center (XIC) are present on both normal and linear deleted X chromosomes. To our knowledge, this is the first report of a functional maternal X isodisomy, and the largest X chromosome to escape inactivation. In addition, these results (1) show that cis inactivation does not invariably occur in human females with two X chromosomes, even when the XIC region is present on both of them; (2) provide evidence for a critical time prior to the visible onset of X inactivation in the embryo when decisions about X inactivation are made; and (3) support the hypothesis that the X chromosome counting mechanism involves chromosomal imprinting, occurs prior to the onset of random inactivation, and is required for subsequent inactivation of the chromosome.	JOHNS HOPKINS UNIV,SCH MED,CTR MED GENET,BALTIMORE,MD 21205; WESTERN GEN HOSP,MRC,HUMAN GENET UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND; UNIV FLORIDA,DIV PEDIAT GENET,RC PHILIPS UNIT,GAINESVILLE,FL; UNIV FLORIDA,CTR MAMMALIAN GENET,GAINESVILLE,FL	Johns Hopkins University; University of Edinburgh; State University System of Florida; University of Florida; State University System of Florida; University of Florida					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029044] Funding Source: NIH RePORTER; NICHD NIH HHS [HD05465, HD29044] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BARKER DF, 1993, GENOMICS, V18, P712, DOI 10.1016/S0888-7543(05)80381-7; BOGGS BA, 1994, P NATL ACAD SCI USA, V91, P6083, DOI 10.1073/pnas.91.13.6083; BROWN CJ, 1989, AM J HUM GENET, V45, P592; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; COLLINS C, 1991, GENOMICS, V11, P997, DOI 10.1016/0888-7543(91)90025-A; FANTES JA, 1992, AM J HUM GENET, V51, P1286; HSU SH, 1976, SCIENCE, V191, P392, DOI 10.1126/science.1246620; JACOBS PA, 1980, NATURE, V286, P714, DOI 10.1038/286714a0; JACOBS PA, 1988, ANN HUM GENET, V52, P93, DOI 10.1111/j.1469-1809.1988.tb01084.x; JACOBS PA, 1990, ANN HUM GENET, V54, P209, DOI 10.1111/j.1469-1809.1990.tb00379.x; JANI MM, 1995, GENOMICS, V27, P182, DOI 10.1006/geno.1995.1022; JEPPESEN P, 1993, CELL, V74, P281, DOI 10.1016/0092-8674(93)90419-Q; KAUFMAN MH, 1978, NATURE, V271, P547, DOI 10.1038/271547a0; KAY GF, 1993, CELL, V72, P171, DOI 10.1016/0092-8674(93)90658-D; KAY GF, 1994, CELL, V77, P639, DOI 10.1016/0092-8674(94)90049-3; KORNREICH R, 1992, GENOMICS, V13, P70, DOI 10.1016/0888-7543(92)90203-5; LAFRENIERE RG, 1993, GENOMICS, V17, P502, DOI 10.1006/geno.1993.1356; LAFRENIERE RG, 1993, HUM MOL GENET, V2, P1105, DOI 10.1093/hmg/2.8.1105; LATT SA, 1976, CHROMOSOMA, V57, P135, DOI 10.1007/BF00292912; LEHRACH H., 1990, GENOME ANAL, P39; LEPPIG KA, 1993, HUM MOL GENET, V2, P883, DOI 10.1093/hmg/2.7.883; LORDASANCHEZ I, 1992, HUM GENET, V89, P524; LYON MF, 1991, TRENDS GENET, V7, P69, DOI 10.1016/0168-9525(91)90271-Q; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; MIGEON BR, 1982, CELL, V29, P595, DOI 10.1016/0092-8674(82)90175-1; MIGEON BR, 1979, CELL, V18, P637, DOI 10.1016/0092-8674(79)90118-1; MIGEON BR, 1993, P NATL ACAD SCI USA, V90, P12025, DOI 10.1073/pnas.90.24.12025; MIGEON BR, 1985, P NATL ACAD SCI USA, V82, P3390, DOI 10.1073/pnas.82.10.3390; MIGEON BR, 1994, AM J HUM GENET, V55, P497; MIGEON BR, 1995, AM J HUM GENET, V56, P647; MIGEON BR, 1995, SOMAT CELL MOLEC GEN, V21, P113, DOI 10.1007/BF02255786; MITCHELL A, 1992, CHROMOSOMA, V101, P333, DOI 10.1007/BF00346012; PERRY P, 1974, NATURE, V251, P156, DOI 10.1038/251156a0; RASTAN S, 1983, J EMBRYOL EXP MORPH, V78, P1; ROBINSON WP, 1995, AM J HUM GENET, V56, P444; SCHINZEL AA, 1993, HUM GENET, V92, P175; SUGAWARA O, 1985, CYTOGENET CELL GENET, V39, P210, DOI 10.1159/000132137; TAN SS, 1993, NAT GENET, V3, P170, DOI 10.1038/ng0293-170; TURNER BM, 1989, EUR J BIOCHEM, V179, P131, DOI 10.1111/j.1432-1033.1989.tb14530.x; WOLFF DJ, 1994, AM J HUM GENET, V55, P87	41	36	37	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1996	58	1					161	170						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TL697	8554052				2022-12-18	WOS:A1996TL69700020
J	THOMSON, G				THOMSON, G			ANALYSIS OF COMPLEX HUMAN GENETIC-TRAITS - AN ORDERED-NOTATION METHOD AND NEW TESTS FOR MODE OF INHERITANCE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEPENDENT DIABETES-MELLITUS; HLA-ASSOCIATED DISEASES; AFFECTED RELATIVE PAIRS; AFFECTED SIB METHOD; LINKAGE STRATEGIES; RHEUMATOID-ARTHRITIS; SUSCEPTIBILITY; LOCUS; HETEROGENEITY; ALLELES	A novel ordered notation is introduced that allows description and calculation of the probability of any nuclear-pedigree configuration of disease status and marker-allele information. Algorithms are given that allow for complex models of disease predisposition, a highly polymorphic or less polymorphic marker locus, gametic disequilibrium between the marker and disease loci (marker association with disease), recombination between the marker and disease loci, and different ascertainment schemes. The theoretical foundation is presented for a series of new tests to identify modes of inheritance and genetic heterogeneity. These use marker-locus data in nuclear families from four ascertainment schemes: simplex (S), multiplex parent-child (MPC), multiplex sibs (MS), and multiplex parent-sibs (MPS). The tests are (1) extension of the antigen-genetype-frequencies-among-patients method to MPC, MS, and MPS pedigrees; (2) determination of the expected rates of transmission, or not, of marker alleles from parents to an affected child, for all pedigree types; (3) determination of expected identity by descent (IBD) values for affected sib pairs when a parent is affected (MPS pedigrees); and (4) determination of the expected marker-allele frequencies in affected-sib-pair IBD categories (MS and MPS pedigrees). A sampling strategy that includes the four pedigree types S, MPC, MS, and MPS is recommended for complex diseases once linkage and/or association of a marker with disease has been established. The full array of new and old tests that can be applied to these pedigrees provides a complementary suite of methods that can facilitate the mapping and characterization of complex human genetic traits.			THOMSON, G (corresponding author), UNIV CALIF BERKELEY,DEPT INTEGRAT BIOL,3060 VALLEY LIFE SCI BLDG,BERKELEY,CA 94720, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD012731] Funding Source: NIH RePORTER; NICHD NIH HHS [HD12731] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BERBERICH FR, 1983, HUM IMMUNOL, V6, P207, DOI 10.1016/0198-8859(83)90094-0; BISHOP DT, 1990, AM J HUM GENET, V46, P254; BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; CLERGETDARPOUX F, 1991, AM J HUM GENET, V49, P42; CLERGETDARPOUX F, 1989, GENET EPIDEMIOL, V6, P59, DOI 10.1002/gepi.1370060112; CLERGETDARPOUX F, 1988, ANN HUM GENET, V52, P248; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; DORMAN JS, 1991, BAILLIERE CLIN ENDOC, V5, P229, DOI 10.1016/S0950-351X(05)80125-9; EWENS WJ, 1986, THEOR POPUL BIOL, V30, P388, DOI 10.1016/0040-5809(86)90042-0; FIELD LL, 1991, BAILLIERE CLIN ENDOC, V5, P413, DOI 10.1016/S0950-351X(05)80139-9; FIELD LL, 1994, NAT GENET, V8, P189, DOI 10.1038/ng1094-189; FIELD LL, 1989, GENET EPIDEMIOL, V6, P101, DOI 10.1002/gepi.1370060119; FIELD LL, 1986, GENET EPIDEMIOL S, V1, P323; HASHIMOTO L, 1994, NATURE, V371, P161, DOI 10.1038/371161a0; HODGE SE, 1980, ANN HUM GENET, V43, P399, DOI 10.1111/j.1469-1809.1980.tb01573.x; JORDE LB, 1994, AM J HUM GENET, V54, P884; KLITZ W, 1992, EVOL BIOL, V26, P35; LOUIS EJ, 1983, ANN HUM GENET, V47, P225, DOI 10.1111/j.1469-1809.1983.tb00991.x; LOUIS EJ, 1986, DIABETES, V35, P958, DOI 10.2337/diabetes.35.9.958; MACDONALD MJ, 1986, P NATL ACAD SCI USA, V83, P7049, DOI 10.1073/pnas.83.18.7049; MIJOVIC CH, 1991, BAILLIERE CLIN ENDOC, V5, P321, DOI 10.1016/S0950-351X(05)80130-2; MOTRO U, 1991, GENET EPIDEMIOL, V8, P317, DOI 10.1002/gepi.1370080504; MOTRO U, 1985, GENETICS, V110, P525; PAYAMI H, 1989, AM J HUM GENET, V45, P541; PAYAMI H, 1987, AM J HUM GENET, V41, P331; RIGBY AS, 1991, GENET EPIDEMIOL, V8, P153, DOI 10.1002/gepi.1370080303; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P242; RISCH N, 1990, AM J HUM GENET, V46, P222; RISCH N, 1987, AM J HUM GENET, V40, P1; ROBINSON WP, 1993, GENET EPIDEMIOL, V10, P273, DOI 10.1002/gepi.1370100502; ROTTER JI, 1984, CLIN GENET, V26, P529; SERJEANTSON SW, 1991, BAILLIERE CLIN ENDOC, V5, P299, DOI 10.1016/S0950-351X(05)80129-6; THOMSON G, 1993, GENET EPIDEMIOL, V10, P289, DOI 10.1002/gepi.1370100503; THOMSON G, 1994, GENET EPIDEMIOL, V11, P353, DOI 10.1002/gepi.1370110405; THOMSON G, 1983, TISSUE ANTIGENS, V21, P81; THOMSON G, 1995, CRIT REV CL LAB SCI, V32, P183, DOI 10.3109/10408369509084684; THOMSON G, 1988, AM J HUM GENET, V43, P799; THOMSON G, 1988, ANNU REV GENET, V22, P31; THOMSON G, 1984, AM J HUM GENET, V36, P1309; THOMSON G, 1980, ANN HUM GENET, V43, P383, DOI 10.1111/j.1469-1809.1980.tb01572.x; THOMSON G, 1991, IMMUNOGENETICS AUTOI, V1, P188; THOMSON G, 1977, MEASURING SELECTION, P545; THOMSON G, 1995, AM J HUM GENET, V57; TIWARI JL, 1985, HLA DISEASE ASS; VANEERDEWEGH P, 1989, MULTIPOINT MAPPING L, P153; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WORDSWORTH P, 1992, AM J HUM GENET, V51, P585; [No title captured]	49	36	36	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1995	57	2					474	486						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RL771	7668274				2022-12-18	WOS:A1995RL77100031
J	HAN, JY; CHOO, KHA; SHAFFER, LG				HAN, JY; CHOO, KHA; SHAFFER, LG			MOLECULAR CYTOGENETIC CHARACTERIZATION OF 17-ROB(13Q14Q) ROBERTSONIAN TRANSLOCATIONS BY FISH, NARROWING THE REGION CONTAINING THE BREAKPOINTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN ACROCENTRIC CHROMOSOMES; SATELLITE-III DNA; FLUORESCENCE INSITU HYBRIDIZATION; RIBOSOMAL-RNA GENES; RECIPROCAL TRANSLOCATIONS; SEQUENCES; SUBFAMILY; ORGANIZATION	We have characterized 17 rob(13q14q) Robertsonian translocations, using six molecular probes that hybridize to the repetitive sequences of the centromeric and short-arm regions of the five acrocentric chromosomes by FISH. The rearrangements include six de novo rearrangements and the chromosomally normal parents, five maternally and three paternally inherited translocations, and three translocations of unknown origin. The D21Z1/D13Z1 and D14Z1/D22Z1 centromeric alpha-satellite DNA probes showed all rob(13q14q) chromosomes to be dicentric. The rDNA probes did not show hybridization on any of the 17 cases studied. The pTRS-47 satellite III DNA probe specific for chromosomes 14 and 22 was retained around the breakpoints in all cases. However, the pTRS-63 satellite III DNA probe specific for chromosome 14 did not show any signals on the translocation chromosomes examined. In 16 of 17 translocations studied, strong hybridization signals on the translocations were detected with the pTRI-6 satellite I DNA probe specific for chromosome 13. All parents of the six de novo rob(13q14q), including one whose pTRI-6 sequence was lost, showed strong positive hybridization signals on each pair of chromosomes 14 and 13, with pTRS-47, pTRS-63, and pTR1-6. Therefore, the translocation breakpoints in the majority of rob(13q14q) are between the pTRS-47 and pTRS-63 sequences in the pll region of chromosome 14 and between the pTRI-6 and rDNA sequences within the pll region of chromosome 13.	BAYLOR COLL MED,DEPT MOLEC & HUMAN GENET,HOUSTON,TX 77030; DONG A UNIV,COLL MED,DEPT CLIN PATHOL,PUSAN,SOUTH KOREA; ROYAL CHILDRENS HOSP,MURDOCH INST RES BIRTH DEFECTS,MELBOURNE,VIC,AUSTRALIA	Baylor College of Medicine; Dong A University; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne								BONTHRON DT, 1993, AM J HUM GENET, V53, P629; CHEUNG SW, 1990, CYTOGENET CELL GENET, V54, P97, DOI 10.1159/000132970; CHOO KH, 1988, NUCLEIC ACIDS RES, V16, P1273, DOI 10.1093/nar/16.4.1273; CHOO KH, 1991, NUCLEIC ACIDS RES, V19, P1179, DOI 10.1093/nar/19.6.1179; CHOO KH, 1990, MOL BIOL MED, V7, P437; CHOO KH, 1990, NUCLEIC ACIDS RES, V18, P5641, DOI 10.1093/nar/18.19.5641; CHOO KH, 1989, GENOMICS, V5, P332, DOI 10.1016/0888-7543(89)90066-9; CHOO KHA, 1992, AM J HUM GENET, V50, P706; DONNAI D, 1993, AM J MED GENET, V46, P681, DOI 10.1002/ajmg.1320460615; EARLE E, 1992, AM J HUM GENET, V50, P717; EVANS JA, 1978, CYTOGENET CELL GENET, V20, P96, DOI 10.1159/000130843; GARDNER RJM, 1989, CHROMOSOME ABNORMALI, P54; GOSDEN JR, 1981, AM J HUM GENET, V33, P243; GOSDEN JR, 1979, CLIN GENET, V15, P518; GRAVHOLT CH, 1992, GENOMICS, V14, P924, DOI 10.1016/S0888-7543(05)80113-2; KALITSIS P, 1993, GENOMICS, V16, P104, DOI 10.1006/geno.1993.1147; KURNIT DM, 1986, CYTOGENET CELL GENET, V43, P109, DOI 10.1159/000132305; MATTEI MG, 1979, HUM GENET, V50, P33, DOI 10.1007/BF00295586; MOYZIS RK, 1989, GENOMICS, V4, P273, DOI 10.1016/0888-7543(89)90331-5; NIELSEN J, 1976, CLIN GENET, V10, P161; NIELSEN J, 1991, HUM GENET, V87, P81, DOI 10.1007/BF01213097; OHNO S, 1961, LANCET, V2, P123; SHAFFER LG, 1994, AM J HUM GENET, V55, P968; SYLVESTER JE, 1986, HUM GENET, V73, P193, DOI 10.1007/BF00401226; THERMAN E, 1989, ANN HUM GENET, V53, P49, DOI 10.1111/j.1469-1809.1989.tb01121.x; WAYE JS, 1989, P NATL ACAD SCI USA, V86, P6250, DOI 10.1073/pnas.86.16.6250; WILSON GN, 1978, P NATL ACAD SCI USA, V75, P5367, DOI 10.1073/pnas.75.11.5367; WOLFF DJ, 1992, AM J HUM GENET, V50, P174; WORTON RG, 1988, SCIENCE, V239, P64, DOI 10.1126/science.3336775; 1989, ANN GENET, V32, P5	30	36	46	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1994	55	5					960	967						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB682	7977359				2022-12-18	WOS:A1994QB68200016
J	OBERMAIERKUSSER, B; LORENZ, B; SCHUBRING, S; PAPROTTA, A; ZERRES, K; MEITINGER, T; MEIRE, F; COCHAUX, P; BLANKENAGEL, A; KOMMERELL, G; JAKSCH, M; GERBITZ, KD				OBERMAIERKUSSER, B; LORENZ, B; SCHUBRING, S; PAPROTTA, A; ZERRES, K; MEITINGER, T; MEIRE, F; COCHAUX, P; BLANKENAGEL, A; KOMMERELL, G; JAKSCH, M; GERBITZ, KD			FEATURES OF MTDNA MUTATION PATTERNS IN EUROPEAN PEDIGREES AND SPORADIC CASES WITH LEBER HEREDITARY OPTIC NEUROPATHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							NEURORETINOPATHY; GENE; LINKAGE		ACAD HOSP SCHWABING,DIABET RES INST,MUNICH,GERMANY; UNIV MUNICH,DEPT PEDIAT GENET,MUNICH,GERMANY; UNIV REGENSBURG,DEPT OPHTHALMOL,REGENSBURG,GERMANY; UNIV BONN,INST HUMAN GENET,W-5300 BONN,GERMANY; STATE UNIV GHENT,DEPT OPHTHALMOL,B-9000 GHENT,BELGIUM; FREE UNIV BRUSSELS,INST HUMAN GENET,BRUSSELS,BELGIUM; UNIV HEIDELBERG,DEPT OPHTHALMOL,HEIDELBERG,GERMANY; UNIV FREIBURG,DEPT OPHTHALMOL,FREIBURG,GERMANY	University of Munich; University of Regensburg; University of Bonn; Ghent University; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Ruprecht Karls University Heidelberg; University of Freiburg	OBERMAIERKUSSER, B (corresponding author), ACAD HOSP SCHWABING,INST CLIN CHEM,MUNICH,GERMANY.			Meitinger, Thomas/0000-0002-8838-8403				BROWN MD, 1992, FASEB J, V6, P2791, DOI 10.1096/fasebj.6.10.1634041; CARVALHO MRS, 1992, HUM HERED, V42, P316, DOI 10.1159/000154089; GERBITZ KD, 1993, FEBS LETT, V314, P251; HOLT IJ, 1989, J MED GENET, V26, P739, DOI 10.1136/jmg.26.12.739; HOWELL N, 1991, AM J HUM GENET, V48, P935; HOWELL N, 1993, GENETICS, V133, P133; JOHNS DR, 1993, BIOCHEM BIOPH RES CO, V196, P810, DOI 10.1006/bbrc.1993.2321; JOHNS DR, 1992, BIOCHEM BIOPH RES CO, V187, P1551, DOI 10.1016/0006-291X(92)90479-5; JOHNS DR, 1991, BIOCHEM BIOPH RES CO, V174, P1324, DOI 10.1016/0006-291X(91)91567-V; JOHNS DR, 1993, ARCH OPHTHALMOL-CHIC, V111, P495, DOI 10.1001/archopht.1993.01090040087038; JUVONEN V, 1993, AM J HUM GENET, V53, P289; LEBER T, 1971, A VONGRAEFES ARCH OP, V14, P249; LOTT MT, 1990, AM J OPHTHALMOL, V109, P625, DOI 10.1016/S0002-9394(14)72429-8; MACKEY D, 1992, AM J HUM GENET, V51, P1218; NAKAMURA M, 1993, HUM GENET, V91, P339; NEWMAN NJ, 1993, ARCH NEUROL-CHICAGO, V50, P540, DOI 10.1001/archneur.1993.00540050082021; NIKOSKELAINEN EK, 1987, ARCH OPHTHALMOL-CHIC, V105, P665, DOI 10.1001/archopht.1987.01060050083043; SEEDORFF T, 1970, ACTA OPHTHALMOL, V163, P133; VAN SENUS A. H. C., 1963, DOC OPHTHALMOL, V17, P1; WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231	21	36	37	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1994	55	5					1063	1066						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB682	7977345				2022-12-18	WOS:A1994QB68200028
J	BROWN, DL; GORIN, MB; WEEKS, DE				BROWN, DL; GORIN, MB; WEEKS, DE			EFFICIENT STRATEGIES FOR GENOMIC SEARCHING USING THE AFFECTED-PEDIGREE-MEMBER METHOD OF LINKAGE ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								The affected-pedigree-member (APM) method of linkage analysis is a nonparametric statistic that tests for nonrandom cosegregation of a disease and marker loci. The APM statistic is based on the observation that if a marker locus is near a disease-susceptibility locus, then affected individuals within a family should be more similar at the marker locus than is expected by chance. The APM statistic measures marker similarity in terms of identity by state (IBS) of marker alleles; that is, two alleles are IBS if they are the same, regardless of their ancestral origin. Since the APM statistic measures increased marker similarity, it makes no assumptions concerning how the disease is inherited; this can be an advantage when dealing with complex diseases for which the mode of inheritance is difficult to determine. We investigate here the power of the APM statistic to detect linkage in the context of a genomewide search. In such a search, the APM statistic is evaluated at a grid of markers. Then regions with high APM statistics are investigated more thoroughly by typing more markers in the region. Using simulated data, we investigate various search strategies and recommend an optimal search strategy that maximizes the power to detect linkage while minimizing the false-positive rate and number of markers. We determine an optimal series of three increasing cut-points and an independent criterion for significance.	UNIV PITTSBURGH,DEPT HUMAN GENET,PITTSBURGH,PA 15261; UNIV PITTSBURGH,DEPT OPHTHALMOL,PITTSBURGH,PA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh			Weeks, Daniel E/B-2995-2012	Weeks, Daniel E/0000-0001-9410-7228	NATIONAL EYE INSTITUTE [R01EY009859] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R29HG000719] Funding Source: NIH RePORTER; NEI NIH HHS [EY09859] Funding Source: Medline; NHGRI NIH HHS [HG00719] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BOEHNKE M, 1988, AM J HUM GENET, V43, P336; ELSTON RC, 1992, 16TH P INT BIOM C HA, P39; FEINGOLD E, 1993, AM J HUM GENET, V53, P234; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; LANDER ES, 1989, GENETICS, V121, P185; MORTON NE, 1955, AM J HUM GENET, V7, P277; PRESS WH, 1986, NUMERICAL RECIPES AR; RISCH N, 1991, AM J HUM GENET, V48, P1058; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WEEKS DE, 1992, AM J HUM GENET, V50, P859; WEEKS DE, 1992, INSERM ATELIER, V44; WEEKS DE, 1993, MAR BIOM SOC SPRING; WEEKS DE, 1991, 23RD P S INT SEATTL, P386; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	14	36	36	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1994	54	3					544	552						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ158	8116624				2022-12-18	WOS:A1994MZ15800018
J	ASHKENAZI, IE; REINBERG, A; BICAKOVAROCHER, A; TICHER, A				ASHKENAZI, IE; REINBERG, A; BICAKOVAROCHER, A; TICHER, A			THE GENETIC BACKGROUND OF INDIVIDUAL VARIATIONS OF CIRCADIAN-RHYTHM PERIODS IN HEALTHY-HUMAN ADULTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SHIFT WORKERS; TEMPERATURE	As a group phenomenon, human variables exhibit a rhythm with a period (tau) equal to 24 h. However, healthy human adults may differ from one another with regard to the persistence of the 24-h periods of a set of variables' rhythms within a given individual. Such an internal desynchronization (or individual circadian dyschronism) was documented during isolation experiments without time cues, both in the present study involving 78 male shift workers and in 20 males and 19 females living in a natural setting. Circadian rhythms of sleep-wake cycles, oral temperature, grip strength of both hands, and heart rate were recorded, and power-spectra analyses of individual time series of about 15 days were used to quantify the rhythm period of each variable. The period of the sleep-wake cycle seldom differed from 24 h, while rhythm periods of the other variables exhibited a trimodal distribution (tau = 24 h, tau > 24 h, tau < 24 h). Among the temperature rhythm periods which were either <24 h or >24 h, none was detected between 23.2 and 24 h or between 24 and 24.8 h. Furthermore, the deviations from the 24-h period were predominantly grouped in multiples of +/-0.8 h. Similar results were obtained when the rhythm periods of hand grip strength were analyzed (for each hand separately). In addition, the distribution of grip strength rhythm periods of the left hand exhibited a gender-related difference. These results suggested the presence of genetically controlled variability. Consequently, the distribution pattern of the periods was analyzed to elucidate its compatibility with a genetic control consisting of either a two-allele system, a multiple-allele system, or a polygenic system. The analysis resulted in structuring a model which integrates the function of a constitutive (essential) gene which produces the exact 24-h period (the Dian domain) with a set of (inducible) polygenes, the alleles of which, contribute identical time entities to the period. The time entities which affected the rhythm periods of the variables examined were in the magnitude of +/-0.8 h. Such an assembly of genes may create periods ranging from 20 to 28 h (the Circadian domain). The model was termed by us ''The Dian-Circadian Model.'' This model can also be used to explain the beat phenomena in biological rhythms, the presence of 7-d and 30-d periods, and interindividual differences in sensitivity of rhythm characteristics (phase shifts, synchronization, etc.) to external (and environmental) factors.	FDN ADOLPHE DE ROTHSCHILD,CHRONOBIOL UNIT,F-75019 PARIS,FRANCE		ASHKENAZI, IE (corresponding author), TEL AVIV UNIV,SACKLER SCH MED,DEPT HUMAN GENET,CHRONOBIOL UNIT,IL-69978 TEL AVIV,ISRAEL.							ASCHOFF J, 1974, PFLUG ARCH EUR J PHY, V346, P215, DOI 10.1007/BF00595708; ASCHOFF J, 1975, CHRONOBIOLOGIA, V2, P23; Aschoff J., 1981, BIOL RHYTHMS, P311; BARCAL R, 1968, NATURE, V200, P1128; BARGIELLO TA, 1984, P NATL ACAD SCI-BIOL, V81, P2142, DOI 10.1073/pnas.81.7.2142; BICAKOVAROCHER A, 1984, ANN REV CHRONOPHARMA, V1, P169; BICAKOVAROCHER A, 1988, ANN REV CHRONOPHARMA, V5, P119; De Prins J., 1986, ANN REV CHRONOPHARMA, V2, P27, DOI 10.1016/B978-0-08-034135-4.50006-X; FELDMAN JF, 1982, ANNU REV PLANT PHYS, V33, P583, DOI 10.1146/annurev.pp.33.060182.003055; HALBERG F, 1967, J PHYSIOLOGY PARIS, V59, P117; HANSON B R, 1984, Cardiologia (Rome), V29, P267; Hardy GH, 1908, SCIENCE, V28, P49, DOI 10.1126/science.28.706.49; Haus E., 1992, BIOL RHYTHMS CLIN LA, P6; KERKHOF GA, 1985, BIOL PSYCHOL, V20, P83, DOI 10.1016/0301-0511(85)90019-5; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Moore-Ede MC., 1982, CLOCKS TIME US; MOTOHASHI Y, 1987, ERGONOMICS, V30, P1235, DOI 10.1080/00140138708966019; MOTOHASHI Y, 1990, CHRONOBIOLOGY CLIN M, P57; NELSON W, 1979, CHRONOBIOLOGIA, V6, P305; REINBERG A, 1984, NATURE, V308, P272, DOI 10.1038/308272a0; REINBERG A, 1984, CR ACAD SCI III-VIE, V299, P633; REINBERG A, 1985, J ENDOCRINOL, V105, P247, DOI 10.1677/joe.0.1050247; REINBERG A, 1985, Chronobiology International, V2, P195, DOI 10.3109/07420528509055559; REINBERG A, 1984, Chronobiology International, V1, P127, DOI 10.3109/07420528409059130; REINBERG A, 1983, PHARMACOL THERAPEUT, V22, P425, DOI 10.1016/0163-7258(83)90011-6; REINBERG A, 1979, DIABETES METAB, V5, P33; REINBERG A, 1988, EUR J APPL PHYSIOL O, V57, P15, DOI 10.1007/BF00691232; Reinberg A, 1983, BIOL RHYTHMS MED; Stern Curt, 1943, SCIENCE, V97, P137, DOI 10.1126/science.97.2510.137; Wever RA., 1979, CIRCADIAN SYSTEM MAN, DOI 10.1007/978-1-4612-6142-1	31	36	36	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1993	52	6					1250	1259						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LG133	8503453				2022-12-18	WOS:A1993LG13300026
J	PRENGER, VL; BEATY, TH; KWITEROVICH, PO				PRENGER, VL; BEATY, TH; KWITEROVICH, PO			GENETIC DETERMINATION OF HIGH-DENSITY LIPOPROTEIN-CHOLESTEROL AND APOLIPOPROTEIN A-I PLASMA-LEVELS IN A FAMILY STUDY OF CARDIAC-CATHETERIZATION PATIENTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CLINICS PROGRAM FAMILY; REGRESSIVE MODELS; MAJOR GENE; DISEASE; PEDIGREES; TRAITS	Plasma levels of two lipoprotein risk factors, high-density lipoprotein-cholesterol (HDL-C) and apolipoprotein A-1 (apo A-1), have been shown to be negatively associated with the risk of developing coronary artery disease, and several reports have examined familial factors in HDL-C and apo A-1 levels. A number of studies suggest that shared genes influence familial resemblance of these lipoprotein levels far more than do shared environments. Possible mechanisms for the inheritance of these two risk factors (HDL-C and apo A-1 plasma levels) are explored using data from 390 individuals in 69 families ascertained through probands undergoing diagnostic cardiac catheterization. Segregation analysis was used to test a series of specific models of inheritance. Evidence for single-locus control of apo A-1 levels, with Mendelian transmission of a dominant allele leading to elevated apo A-1 levels, was seen in these families, although there was additional correlation among sibs present. This locus accounted for 48.6% and 37.2% of the total variation in apo A-1 levels in males and females, respectively. Similar evidence of segregation at a single locus controlling HDL-C levels was not seen in these families.	JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT EPIDEMIOL,BALTIMORE,MD 21218; JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,LIPID RES ATHEROSCLEROSIS UNIT,BALTIMORE,MD 21218; JOHNS HOPKINS UNIV,SCH MED,DEPT MED,LIPID RES ATHEROSCLEROSIS UNIT,BALTIMORE,MD 21218	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University					NHLBI NIH HHS [HL07024-16, 1-P50-HL47212-01, HL31497] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031497, P50HL047212] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; AMOS CI, 1987, GENET EPIDEMIOL, V4, P115, DOI 10.1002/gepi.1370040206; ARON L, 1978, J BIOL CHEM, V253, P7220; Bachorik PS, 1991, TECHNIQUES DIAGNOSTI, P425; BEATY TH, 1983, AM J MED GENET, V16, P117, DOI 10.1002/ajmg.1320160118; BONNEY GE, 1984, AM J MED GENET, V18, P731, DOI 10.1002/ajmg.1320180420; BORECKI IB, 1986, AM J HUM GENET, V38, P373; BUCHER KD, 1987, AM J HUM GENET, V40, P489; DEMENAIS FM, 1989, GENET EPIDEMIOL, V6, P597, DOI 10.1002/gepi.1370060505; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; ELSTON RC, 1986, 7TH INT C HUM GEN BE; HASSTEDT SJ, 1984, ATHEROSCLEROSIS, V51, P21, DOI 10.1016/0021-9150(84)90141-2; JACOBS DR, 1990, AM J EPIDEMIOL, V131, P32, DOI 10.1093/oxfordjournals.aje.a115483; JIANG XR, 1986, CLIN CHEM, V32, P930; KULLER LH, 1976, AM J EPIDEMIOL, V104, P425, DOI 10.1093/oxfordjournals.aje.a112315; MACIEJKO JJ, 1983, NEW ENGL J MED, V309, P385, DOI 10.1056/NEJM198308183090701; MOLL PP, 1986, AM J HUM GENET, V38, P361; MOLL PP, 1989, AM J HUM GENET, V44, P124; NAMBOODIRI K K, 1985, Genetic Epidemiology, V2, P227, DOI 10.1002/gepi.1370020302; NAMBOODIRI KK, 1983, ARTERIOSCLEROSIS, V3, P616, DOI 10.1161/01.ATV.3.6.616; POMETTA D, 1979, ATHEROSCLEROSIS, V34, P419, DOI 10.1016/0021-9150(79)90066-2; Sokal R.R., 1981, BIOMETRY, V2nd ed.; STEIN O, 1979, BIOCHIM BIOPHYS ACTA, V574, P495, DOI 10.1016/0005-2760(79)90246-7; WILLIAMS RR, 1990, ARCH INTERN MED, V150, P582, DOI 10.1001/archinte.150.3.582; 1982, NIH75628 US DEP HLTH; 1991, 1991 HEART STROKE FA; 1989, CLIN IMPLICATIONS HD	27	36	37	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1992	51	5					1047	1057						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JU840	1415250				2022-12-18	WOS:A1992JU84000014
J	MILLS, KA; BUETOW, KH; XU, Y; RITTY, TM; MATHEWS, KD; BODRUG, SE; WIJMENGA, C; BALAZS, I; MURRAY, JC				MILLS, KA; BUETOW, KH; XU, Y; RITTY, TM; MATHEWS, KD; BODRUG, SE; WIJMENGA, C; BALAZS, I; MURRAY, JC			GENETIC AND PHYSICAL MAPPING ON CHROMOSOME-4 NARROWS THE LOCALIZATION OF THE GENE FOR FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY (FSHD)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISM; MULTILOCUS LINKAGE ANALYSIS; HUNTINGTONS-DISEASE GENE; HUMAN GENOME; LONG ARM; LOCUS; IDENTIFICATION; ASSOCIATION; COMMITTEE; REGION	We have used a combination of classical RFLPs and PCR-based polymorphisms including CA repeats and single-strand conformation polymorphisms to generate a fine-structure genetic map of the distal long arm of chromosome 4q. This map is now genetically linked to the pre-existing anchor map of 4pter-4q31 and generates, for the first time, a complete linkage map of this chromosome. The map consists of 32 anchor loci placed with odds of greater than 1,000:1. The high-resolution map in the cytogenetic region surrounding 4q35 provides the order 4cen-D4S171-F11-D4S187-D4S163-D4S139-4qter. When we used somatic cell hybrids from a t(X;4)(p21;q35) translocation, these five markers fell into three groups consistent with the genetic map-D4S171 and F11 in 4pter-4q35, D4S163 and D4S139 in 4q35-4qter, and D4S187 as a junction fragment between these two regions. These markers are in tight linkage to the gene for facioscapulohumeral muscular dystrophy (FSHD) mapped to this region by several collaborating investigators and provide a framework for further detailed analysis of this region.	UNIV IOWA HOSP & CLIN, DEPT PEDIAT, IOWA CITY, IA 52242 USA; FOX CHASE CANC INST, DIV CLIN RES, PHILADELPHIA, PA 19111 USA; UNIV TORONTO, DEPT MOLEC & MED GENET, TORONTO M5S 1A1, ONTARIO, CANADA; HOSP SICK CHILDREN, TORONTO M5G 1X8, ONTARIO, CANADA; LEIDEN UNIV, DEPT NEUROL, 2300 RA LEIDEN, NETHERLANDS; LIFECODES CORP, VALHALLA, NY USA	University of Iowa; Fox Chase Cancer Center; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Leiden University; Leiden University - Excl LUMC			Wijmenga, Cisca/D-2173-2009; Wijmenga, Cisca/AAE-7719-2019	Wijmenga, Cisca/0000-0002-5635-1614; mathews, katherine/0000-0003-4160-0435	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000355, P50HG000206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE009170] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00355, HG00206] Funding Source: Medline; NIDCR NIH HHS [DE09170] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ALTHERR MR, 1991, NUCLEIC ACIDS RES, V19, P1168, DOI 10.1093/nar/19.5.1168; BODRUG SE, 1990, J MED GENET, V27, P426, DOI 10.1136/jmg.27.7.426; BODRUG SE, 1991, EMBO J, V10, P3931, DOI 10.1002/j.1460-2075.1991.tb04963.x; BUETOW KH, 1990, GENOMICS, V8, P13, DOI 10.1016/0888-7543(90)90220-O; BUETOW KH, 1991, AM J HUM GENET, V48, P911; COX DR, 1989, CYTOGENET CELL GENET, V51, P121, DOI 10.1159/000132788; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; EDWARDS JH, 1976, CYTOGENET CELL GENET, V16, P289, DOI 10.1159/000130612; GOLDGAR DE, 1989, AM J HUM GENET, V44, P6; KATO A, 1989, CYTOGENET CELL GENET, V52, P77, DOI 10.1159/000132844; KEATS B, 1989, CYTOGENET CELL GENET, V51, P459, DOI 10.1159/000132805; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1986, GENET EPIDEMIOL, V3, P39, DOI 10.1002/gepi.1370030105; MACDONALD ME, 1989, NEURON, V3, P183, DOI 10.1016/0896-6273(89)90031-7; MATHEWS KD, 1992, AM J HUM GENET, V51, P428; MILLS KA, IN PRESS GENOMICS; MILNER ECB, 1989, NUCLEIC ACIDS RES, V17, P4002, DOI 10.1093/nar/17.10.4002; MONACO AP, 1988, ADV HUM GENET, V17, P61; MORTON NE, 1955, AM J HUM GENET, V7, P277; MURRAY JC, 1988, AM J HUM GENET, V42, P490; MURRAY JC, 1987, HUM GENET, V76, P274; NAKAMURA Y, 1988, AM J HUM GENET, V43, P638; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; NEUWEILER J, 1990, NUCLEIC ACIDS RES, V18, P691, DOI 10.1093/nar/18.3.691; NING Y, 1991, P NATL ACAD SCI USA, V88, P5635, DOI 10.1073/pnas.88.13.5635; ORITA M, 1990, GENOMICS, V8, P271, DOI 10.1016/0888-7543(90)90282-Y; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; SARFARAZI M, 1992, AM J HUM GENET, V51, P396; SNELL RG, 1989, J MED GENET, V26, P673, DOI 10.1136/jmg.26.11.673; THEILMANN J, 1989, J MED GENET, V26, P676, DOI 10.1136/jmg.26.11.676; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4636, DOI 10.1093/nar/18.15.4636-a; WEBER JL, 1989, AM J HUM GENET, V44, P388; Wijmenga C, 1990, LANCET, V336, P651, DOI 10.1016/0140-6736(90)92148-B; [No title captured]	35	36	36	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1992	51	2					432	439						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JF776	1642243				2022-12-18	WOS:A1992JF77600026
J	GRAY, MR				GRAY, MR			DETECTION OF DNA-SEQUENCE POLYMORPHISMS IN HUMAN GENOMIC DNA BY USING DENATURING GRADIENT GEL BLOTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN INSULIN-RECEPTOR; FACTOR-VIII GENE; STEROID 21-HYDROXYLASE GENES; POLYMERASE CHAIN-REACTION; SINGLE-BASE CHANGES; COLLAGEN GENE; LINKAGE MAP; BETA-2-ADRENERGIC RECEPTOR; MOLECULAR-GENETICS; HEMOPHILIA-A	Denaturing gradient gel electrophoresis can detect sequence differences outside restriction-enzyme recognition sites. DNA sequence polymorphisms can be detected as restriction-fragment melting polymorphisms (RFMPs) in genomic DNA by using blots made from denaturing gradient gels. In contrast to the use of Southern blots to find sequence differences, denaturing gradient gel blots can detect differences almost anywhere, not just at 4-6-bp restriction-enzyme recognition sites. Human genomic DNA was digested with one of several randomly selected 4-bp recognition-site restriction enzymes, electrophoresed in denaturing gradient gels, and transferred to nylon membranes. The blots were hybridized with radioactive probes prepared from the factor VIII, type II collagen, insulin receptor, beta(2)-adrenergic receptor, and 21-hydroxylase genes; in unrelated individuals, several RFMPs were found in fragments from every locus tested. No restriction map or sequence information was used to detect RFMPs. RFMPs can be used as genetic markers, because their alleles segregate in a Mendelian manner. Unlike most other methods for detecting DNA sequence polymorphisms, a genomic DNA blot made from one gel can be hybridized consecutively with many (30 or more) different probes.	TUFTS UNIV,SCH MED,DEPT ANAT & CELLULAR BIOL,BOSTON,MA 02111	Tufts University	GRAY, MR (corresponding author), TUFTS UNIV,SCH MED,DEPT OBSTET & GYNECOL,DIV REPROD ENDOCRINOL,STEARNS 215,136 HARRISON AVE,BOSTON,MA 02111, USA.				NHGRI NIH HHS [HG00126] Funding Source: Medline; NHLBI NIH HHS [HL43203] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043203] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABRAMS ES, 1990, GENOMICS, V7, P463, DOI 10.1016/0888-7543(90)90188-Z; ALAKOKKO L, 1990, GENOMICS, V8, P454, DOI 10.1016/0888-7543(90)90031-O; ANTONARAKIS SE, 1987, MOL BIOL MED, V4, P81; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BERNATZKY R, 1986, GENETICS, V112, P887; CHEAH KSE, 1985, P NATL ACAD SCI USA, V82, P2555, DOI 10.1073/pnas.82.9.2555; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COTTON RGH, 1988, P NATL ACAD SCI USA, V85, P4397, DOI 10.1073/pnas.85.12.4397; COX NJ, 1988, NUCLEIC ACIDS RES, V16, P8204, DOI 10.1093/nar/16.16.8204; DENTE L, 1983, NUCLEIC ACIDS RES, V11, P1645, DOI 10.1093/nar/11.6.1645; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; DRAYNA D, 1985, SCIENCE, V230, P753, DOI 10.1126/science.4059909; ELBEIN SC, 1986, P NATL ACAD SCI USA, V83, P5223, DOI 10.1073/pnas.83.14.5223; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Fischer S G, 1979, Methods Enzymol, V68, P183; FISCHER SG, 1983, P NATL ACAD SCI-BIOL, V80, P1579, DOI 10.1073/pnas.80.6.1579; GITSCHIER J, 1985, NATURE, V314, P738, DOI 10.1038/314738a0; GITSCHIER J, 1984, NATURE, V312, P326, DOI 10.1038/312326a0; GRAY M, 1991, GENETICS, V127, P139; HODGSON CP, 1987, NUCLEIC ACIDS RES, V15, P6295, DOI 10.1093/nar/15.15.6295; HOFKER MH, 1986, AM J HUM GENET, V39, P438; KOBILKA BK, 1987, J BIOL CHEM, V262, P7321; KOBILKA BK, 1987, P NATL ACAD SCI USA, V84, P46, DOI 10.1073/pnas.84.1.46; KROLEWSKI AS, IN PRESS GENOMICS; LERMAN LS, 1986, COLD SPRING HARB SYM, V51, P285, DOI 10.1101/SQB.1986.051.01.034; LEWIN B, 1979, GENE EXPRESSION, V2, P5; MANIATIS T, 1975, BIOCHEMISTRY-US, V14, P3787, DOI 10.1021/bi00688a010; MILLER WL, 1989, ANNU REV GENET, V23, P371, DOI 10.1146/annurev.ge.23.120189.002103; MYERS RM, 1985, NUCLEIC ACIDS RES, V13, P3111, DOI 10.1093/nar/13.9.3111; MYERS RM, 1988, HUMAN GENETIC DISEAS; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; RAMIREZ F, 1989, COLLAGEN MOL BIOL, V4, P21; REINDOLLAR R, IN PRESS AM J OBSTET; SANGIORGI FO, 1985, NUCLEIC ACIDS RES, V13, P2207, DOI 10.1093/nar/13.7.2207; SEINO S, 1989, P NATL ACAD SCI USA, V86, P114, DOI 10.1073/pnas.86.1.114; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STROM CM, 1988, NUCLEIC ACIDS RES, V16, P9077, DOI 10.1093/nar/16.18.9077; SYKES B, 1985, J MED GENET, V22, P187, DOI 10.1136/jmg.22.3.187; SYKES B, 1983, DIS MARKERS, V1, P141; TRAYSTMAN MD, 1990, GENOMICS, V6, P293, DOI 10.1016/0888-7543(90)90569-G; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; URABE K, 1990, AM J HUM GENET, V46, P1178; WEBER JL, 1989, AM J HUM GENET, V44, P388; WHITE PC, 1986, P NATL ACAD SCI USA, V83, P5111, DOI 10.1073/pnas.83.14.5111; WHITE PC, 1987, NEW ENGL J MED, V316, P1519, DOI 10.1056/NEJM198706113162406; WOOD WI, 1984, NATURE, V312, P330, DOI 10.1038/312330a0	48	36	37	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1992	50	2					331	346						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HD001	1310376				2022-12-18	WOS:A1992HD00100009
J	STAPLES, AJ; ROBERTSON, EF; RANIERI, E; RYALL, RG; HAAN, EA				STAPLES, AJ; ROBERTSON, EF; RANIERI, E; RYALL, RG; HAAN, EA			A MATERNAL SERUM SCREEN FOR TRISOMY-18 - AN EXTENSION OF MATERNAL SERUM SCREENING FOR DOWN-SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALPHA-FETOPROTEIN; DOWNS-SYNDROME; UNCONJUGATED ESTRIOL; PREGNANCIES; ABNORMALITIES	The feasibility of extending second-trimester maternal blood screening for Down syndrome so as to include screening for trisomy 18 was examined using stored maternal serum samples collected for neural tube-defect screening. There were 12 samples from trisomy 18 pregnancies and 390 controls. The median maternal serum concentration of alpha-fetoprotein, free alpha-subunit human chorionic gonadotrophin, free beta-subunit human chorionic gonadotrophin, intact human chorionic gonadotrophin, total estriol, unconjugated estriol, estradiol, human placental lactogen, and progesterone were lowered in those pregnancies affected by trisomy 18 when compared with unaffected pregnancies matched for racial origin, maternal age, gestational age, and sample-storage duration. At an estimated odds risk of 1:400, 83.3% of affected pregnancies were detected using an algorithm which combines the maternal age-related risk with the maternal serum concentrations of unconjugated estriol, free alpha-subunit human chorionic gonadotrophin, free beta-subunit human chorionic gonadotrophin, estradiol, and human placental lactogen. The associated false-positive rate was 2.6%. At high risk odds of 1:10, the detection rate was 58.3%, with an associated false-positive rate of 0.3%. Beta-subunit human chorionic gonadotrophin and unconjugated estriol were the most powerful discriminators. It is possible to incorporate into existing Down syndrome screening programs an algorithm for detecting trisomy 18 with high sensitivity and specificity.	ADELAIDE CHILDRENS HOSP INC,DEPT CHEM PATHOL,ADELAIDE,SA 5006,AUSTRALIA		STAPLES, AJ (corresponding author), ADELAIDE CHILDRENS HOSP INC,DEPT MED GENET & EPIDEMIOL,ADELAIDE,SA 5006,AUSTRALIA.							BARTELS I, 1988, HUM GENET, V80, P496; BAUMGARTEN A, 1985, LANCET, V1, P1280; BOGART MH, 1987, PRENATAL DIAG, V7, P623, DOI 10.1002/pd.1970070904; CANICK JA, 1988, BRIT J OBSTET GYNAEC, V95, P330, DOI 10.1111/j.1471-0528.1988.tb06601.x; CANICK JA, 1989, PRENAT DIAGN, V10, P546; CUCKLE HS, 1984, LANCET, V2, P413; DARNULE A, 1990, AM J HUM GENET S, V47, pA272; DIMAIO MS, 1987, NEW ENGL J MED, V317, P342, DOI 10.1056/NEJM198708063170603; FUHRMANN W, 1985, LANCET, V1, P751; HOOK EB, 1983, JAMA-J AM MED ASSOC, V249, P2034, DOI 10.1001/jama.249.15.2034; KNIGHT GJ, 1988, CLIN OBSTET GYNECOL, V31, P306, DOI 10.1097/00003081-198806000-00009; MERKATZ IR, 1984, AM J OBSTET GYNECOL, V148, P886, DOI 10.1016/0002-9378(84)90530-1; NEBIOLO L, 1990, PRENATAL DIAG, V10, P575, DOI 10.1002/pd.1970100905; PALOMAKI GE, 1986, LANCET, V2, P1460; PETROCIK E, 1990, AM J MED GENET, V37, P114, DOI 10.1002/ajmg.1320370127; WALD NJ, 1988, BRIT J OBSTET GYNAEC, V95, P334, DOI 10.1111/j.1471-0528.1988.tb06602.x; WALD NJ, 1988, BRIT MED J, V297, P883, DOI 10.1136/bmj.297.6653.883	17	36	36	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1991	49	5					1025	1033						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GM873	1833973				2022-12-18	WOS:A1991GM87300013
J	DEMENAIS, FM				DEMENAIS, FM			REGRESSIVE LOGISTIC-MODELS FOR FAMILIAL DISEASES - A FORMULATION ASSUMING AN UNDERLYING LIABILITY MODEL	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEX SEGREGATION ANALYSIS; GENETIC-ANALYSIS; QUANTITATIVE TRAITS	Statistical models have been developed to delineate the major-gene and non-major-gene factors accounting for the familial aggregation of complex diseases. The mixed model assumes an underlying liability to the disease, to which a major gene, a multifactorial component, and random environment contribute independently. Affection is defined by a threshold on the liability scale. The regressive logistic models assume that the logarithm of the odds of being affected is a linear function of major genotype, phenotypes of antecedents and other covariates. An equivalence between these two approaches cannot be derived analytically. I propose a formulation of the regressive logistic models on the supposition of an underlying liability model of disease. Relatives are assumed to have correlated liabilities to the disease; affected persons have liabilities exceeding an estimable threshold. Under the assumption that the correlation structure of the relatives' liabilities follows a regressive model, the regression coefficients on antecedents are expressed in terms of the relevant familial correlations. A parsimonious parameterization is a consequence of the assumed liability model, and a one-to-one correspondence with the parameters of the mixed model can be established. The logits, derived under the class A regressive model and under the class D regressive model, can be extended to include a large variety of patterns of family dependence, as well as gene-environment interactions.			DEMENAIS, FM (corresponding author), HOWARD UNIV,CTR CANC,DIV BIOSTAT & EPIDEMIOL,2041 GEORGIA AVE,WASHINGTON,DC 20059, USA.		Demenais, Florence/G-3298-2013	Demenais, Florence/0000-0001-8361-0936	NIGMS NIH HHS [GM41885] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041885] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABEL L, 1990, GENET EPIDEMIOL, V7, P391, DOI 10.1002/gepi.1370070602; AITKEN, 1934, P EDINB MATH SOC B, V4, P106; BONNEY GE, 1987, BIOMETRICS, V43, P951, DOI 10.2307/2531548; BONNEY GE, 1986, BIOMETRICS, V42, P611, DOI 10.2307/2531211; BONNEY GE, 1984, AM J MED GENET, V18, P731, DOI 10.1002/ajmg.1320180420; BONNEY GE, IN PRESS HUM HERED; DEMENAIS FM, 1989, GENET EPIDEMIOL, V6, P597, DOI 10.1002/gepi.1370060505; DEMENAIS FM, 1990, GENET EPIDEMIOL, V7, P319, DOI 10.1002/gepi.1370070503; DEMENIAS FM, 1990, AM J HUM GENET, V47, pA132; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; JOHNSON NL, 1970, DISTRIBUTIONS STATIS, V2; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; MENDELL N, 1971, BIOMETRICS, V27, P483; MENDELL NR, 1974, BIOMETRICS, V30, P41, DOI 10.2307/2529616; MORTON NE, 1974, AM J HUM GENET, V26, P489; Pearson K, 1903, PHILOS T R SOC LOND, V200, P1, DOI 10.1098/rsta.1903.0001; REICH T, 1972, ANN HUM GENET, V36, P163, DOI 10.1111/j.1469-1809.1972.tb00767.x	19	36	36	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1991	49	4					773	785						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GG665	1897524				2022-12-18	WOS:A1991GG66500009
J	PRESSMAN, S; ROTTER, JI				PRESSMAN, S; ROTTER, JI			EPSTEIN-BARR-VIRUS TRANSFORMATION OF CRYOPRESERVED LYMPHOCYTES - PROLONGED EXPERIENCE WITH TECHNIQUE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter											PRESSMAN, S (corresponding author), CEDARS SINAI MED CTR,CTR MED GENET BIRTH DEFECTS,LOS ANGELES,CA 90048, USA.							ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; LOUIE LG, 1991, AM J HUM GENET, V48, P637; MILLER G, 1973, P NATL ACAD SCI USA, V70, P190, DOI 10.1073/pnas.70.1.190	3	36	36	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1991	49	2					467	467						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GA866	1651051				2022-12-18	WOS:A1991GA86600032
J	LOUIE, LG; KING, MC				LOUIE, LG; KING, MC			A NOVEL-APPROACH TO ESTABLISHING PERMANENT LYMPHOBLASTOID CELL-LINES - EPSTEIN-BARR-VIRUS TRANSFORMATION OF CRYOPRESERVED LYMPHOCYTES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter											LOUIE, LG (corresponding author), UNIV CALIF BERKELEY,SCH SOCIAL WORK,BERKELEY,CA 94720, USA.			King, Mary-Claire/0000-0001-9426-1743				ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856	1	36	37	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1991	48	3					637	638						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK470	1847792				2022-12-18	WOS:A1991FK47000028
J	STAMBOLIAN, D; LEWIS, RA; BUETOW, K; BOND, A; NUSSBAUM, R				STAMBOLIAN, D; LEWIS, RA; BUETOW, K; BOND, A; NUSSBAUM, R			NANCE-HORAN SYNDROME - LOCALIZATION WITHIN THE REGION XP21.I-XP22.3 BY LINKAGE ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV PENN,SCH MED,DEPT HUMAN GENET,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,HOWARD HUGHES MED INST,PHILADELPHIA,PA 19104; FOX CHASE CANC INST,DIV POPULAT SCI,PHILADELPHIA,PA 19111; BAYLOR UNIV,DEPT OPHTHALMOL,HOUSTON,TX 77030; BAYLOR UNIV,INST MOLEC GENET,HOUSTON,TX 77030; UNIV PENN,SCH MED,DEPT OPHTHALMOL,PHILADELPHIA,PA 19104	University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania; Fox Chase Cancer Center; Baylor University; Baylor College of Medicine; Baylor University; University of Pennsylvania					NATIONAL EYE INSTITUTE [K11EY000268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE009164] Funding Source: NIH RePORTER; NEI NIH HHS [5K11EY00268] Funding Source: Medline; NIDCR NIH HHS [P50DE09164] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; BIXLER D, 1984, CLIN GENET, V26, P30; BUCKLE VJ, 1984, CLIN GENET, V26, P1, DOI 10.1111/j.1399-0004.1984.tb00780.x; BUCKLE VJ, 1985, CYTOGENET CELL GENET, V40, P594; CHELLY J, 1988, HUM GENET, V78, P222, DOI 10.1007/BF00291665; CLARKE A, 1986, J MED GENET, V23, P501, DOI 10.1136/jmg.23.6.501; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; COOK PJL, 1974, ANN HUM GENET, V37, P261, DOI 10.1111/j.1469-1809.1974.tb01834.x; DEMARTINVILLE B, 1985, AM J HUM GENET, V37, P235; DRAYNA D, 1985, SCIENCE, V230, P753, DOI 10.1126/science.4059909; EMANUEL BS, 1988, AM J HUM GENET, V43, P575; FAVOR J, 1987, MOUSE NEWS LETT, V77, P139; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRACCARO M, 1967, ANN HUM GENET, V31, P45, DOI 10.1111/j.1469-1809.1967.tb02019.x; FRANCKE U, 1985, AM J HUM GENET, V37, P250; FRANCKE U, 1984, CYTOGENET CELL GENET, V38, P298, DOI 10.1159/000132078; GREENBERG CR, 1987, AM J HUM GENET, V41, P128; HARTLEY DA, 1984, NUCLEIC ACIDS RES, V12, P5277, DOI 10.1093/nar/12.13.5277; HOFKER MH, 1986, HUM GENET, V74, P270, DOI 10.1007/BF00282547; HORAN MB, 1974, AUST PAEDIATR J, V10, P98; KRILL AE, 1969, AM J OPHTHALMOL, V68, P867, DOI 10.1016/0002-9394(69)94582-6; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MACHLER M, 1986, HUM GENET, V73, P271, DOI 10.1007/BF00401243; MANDEL JL, 1989, CYTOGENET CELL GENET, V51, P384, DOI 10.1159/000132801; MARLHENS F, 1987, HUM GENET, V77, P379, DOI 10.1007/BF00291430; MIDDLESWORTH W, 1985, NUCLEIC ACIDS RES, V13, P57; NANCE W E, 1974, Birth Defects Original Article Series, V10, P285; READ AP, 1986, HUM GENET, V73, P267, DOI 10.1007/BF00401242; SCHMICKEL RD, 1986, J PEDIATR-US, V109, P231, DOI 10.1016/S0022-3476(86)80377-8; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; THAKKER RV, 1987, J MED GENET, V24, P756, DOI 10.1136/jmg.24.12.756; VANDORP DB, 1979, J PEDIAT OPHTH STRAB, V16, P166; Walsh FB, 1937, B JOHNS HOPKINS HOSP, V61, P125; WIEACKER P, 1984, AM J HUM GENET, V36, P265; WILSON JM, 1982, J CLIN INVEST, V69, P706, DOI 10.1172/JCI110499	35	36	36	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1990	47	1					13	19						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DK482	1971992				2022-12-18	WOS:A1990DK48200003
J	LAIRD, CD; LAMB, MM; THORNE, JL				LAIRD, CD; LAMB, MM; THORNE, JL			2 PROGENITOR CELLS FOR HUMAN OOGONIA INFERRED FROM PEDIGREE DATA AND THE X-INACTIVATION IMPRINTING MODEL OF THE FRAGILE-X SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV WASHINGTON,CTR CHILD DEV & MENTAL RETARDAT,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT GENET,SEATTLE,WA 98195	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	LAIRD, CD (corresponding author), UNIV WASHINGTON,DEPT ZOOL,NJ-15,SEATTLE,WA 98195, USA.							ARVEILER B, 1988, AM J HUM GENET, V42, P380; BAKKER E, 1987, NATURE, V329, P554, DOI 10.1038/329554a0; BROWN WT, 1986, AM J MED GENET, V23, P643, DOI 10.1002/ajmg.1320230158; BROWN WT, 1985, HUM GENET, V71, P11, DOI 10.1007/BF00295659; BROWN WT, 1987, HUM GENET, V75, P311, DOI 10.1007/BF00284100; BUCHANAN JA, 1987, HUM GENET, V76, P165, DOI 10.1007/BF00284915; CAMERINO G, 1983, NATURE, V306, P701, DOI 10.1038/306701a0; CHANDRA HS, 1975, NATURE, V253, P165, DOI 10.1038/253165a0; CROUSE HV, 1960, GENETICS, V45, P1429; DARRAS BT, 1987, NATURE, V329, P556, DOI 10.1038/329556a0; DAVID TJ, 1972, J MED GENET, V9, P316, DOI 10.1136/jmg.9.3.316; DAVIES KE, 1985, HUM GENET, V70, P249; FIALKOW PJ, 1973, ANN HUM GENET, V37, P39, DOI 10.1111/j.1469-1809.1973.tb01813.x; FRYNS JP, 1983, CLIN GENET, V24, P156; GANDINI E, 1968, P NATL ACAD SCI USA, V61, P945, DOI 10.1073/pnas.61.3.945; Gartler S M, 1972, Cell Differ, V1, P215, DOI 10.1016/0045-6039(72)90039-5; GARTLER SM, 1975, EXP CELL RES, V91, P454, DOI 10.1016/0014-4827(75)90127-5; GITSCHIER J, 1986, American Journal of Human Genetics, V39, pA200; GOONEWARDENA P, 1986, CLIN GENET, V30, P249; HALL BD, 1985, AM J MED GENET, V22, P417, DOI 10.1002/ajmg.1320220228; HALL JG, 1988, AM J HUM GENET, V43, P355; HARTL DL, 1971, AM J HUM GENET, V23, P124; ISRAEL M H, 1987, American Journal of Medical Genetics, V26, P19, DOI 10.1002/ajmg.1320260106; JOHNSON TE, 1976, DEV BIOL, V54, P23, DOI 10.1016/0012-1606(76)90283-9; LAIRD C, 1987, TRENDS GENET, V3, P274, DOI 10.1016/0168-9525(87)90268-X; LAIRD CD, 1989, AM ZOOL, V29, P569; LAIRD CD, 1987, GENETICS, V117, P587; LAIRD CD, UNPUB AM J MED GENET; LANMAN JT, 1987, AM J HUM GENET, V41, P138; LUBS HA, 1969, AM J HUM GENET, V21, P231; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Martin JP, 1943, J NEUROL PSYCHIATRY, V6, P154, DOI 10.1136/jnnp.6.3-4.154; MCKUSICK VA, 1988, MENDELIAN INHERITANC; MCMAHON A, 1983, J EMBRYOL EXP MORPH, V74, P207; MIGEON BR, 1977, NATURE, V269, P242, DOI 10.1038/269242a0; MINTZ B, 1974, ANNU REV GENET, V8, P411, DOI 10.1146/annurev.ge.08.120174.002211; MOOD AM, 1974, INTRO THEORY STATIST; NESBITT MN, 1971, DEV BIOL, V26, P252, DOI 10.1016/0012-1606(71)90125-4; NUSSBAUM RL, 1986, ANNU REV GENET, V20, P109; OBERLE I, 1987, HUM GENET, V77, P60; OBERLE I, 1986, P NATL ACAD SCI USA, V83, P1016, DOI 10.1073/pnas.83.4.1016; OPITZ JM, 1986, AM J MED GENET, V23, P1, DOI 10.1002/ajmg.1320230102; PEMBREY ME, 1985, AM J MED GENET, V21, P709, DOI 10.1002/ajmg.1320210413; REED TE, 1955, AM J HUM GENET, V7, P28; REIK W, 1987, NATURE, V328, P248, DOI 10.1038/328248a0; Russell L.B., 1964, ROLE CHROMOSOMES DEV, P153; SAPIENZA C, 1987, NATURE, V328, P251, DOI 10.1038/328251a0; Searle A. G., 1978, Genetic mosaics and chimeras in mammals., P209; SHAPIRO LR, 1986, AM J MED GENET, V23, P325, DOI 10.1002/ajmg.1320230125; SHERMAN SL, 1985, HUM GENET, V71, P184; SHERMAN SL, 1985, HUM GENET, V69, P289, DOI 10.1007/BF00291644; SHERMAN SL, 1984, ANN HUM GENET, V48, P21, DOI 10.1111/j.1469-1809.1984.tb00830.x; SORIANO P, 1986, CELL, V46, P19, DOI 10.1016/0092-8674(86)90856-1; STEINBACH P, 1986, HUM GENET, V72, P248, DOI 10.1007/BF00291888; Sutherland G, 1985, FRAGILE SITES HUMAN; SUTHERLAND GR, 1985, TRENDS GENET, V1, P108, DOI 10.1016/0168-9525(85)90042-3; SVED JA, 1990, AM J HUM GENET, V46, P443; SVED JA, 1988, BRAIN DYSFUNCT, V1, P245; SWAIN JL, 1987, CELL, V50, P719, DOI 10.1016/0092-8674(87)90330-8; THIBODEAU SN, 1988, HUM GENET, V79, P219, DOI 10.1007/BF00366240; Van Wagenen G, 1965, EMBRYOLOGY OVARY TES; VEENEMA H, 1987, J MED GENET, V24, P23, DOI 10.1136/jmg.24.1.23; VEENEMA H, 1987, J MED GENET, V24, P413, DOI 10.1136/jmg.24.7.413; VOGEL F, 1986, HUMAN GENETICS; Weismann A, 1893, GERM PLASM THEORY HE; Wilson E. B, 1937, CELL DEV HEREDITY	66	36	37	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1990	46	4					696	719						24	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CW549	1969225				2022-12-18	WOS:A1990CW54900008
J	MATSUNAGA, E; SHIOKAWA, S; NAKAMURA, H; MARUYAMA, T; TSUDA, K; FUKUMAKI, Y				MATSUNAGA, E; SHIOKAWA, S; NAKAMURA, H; MARUYAMA, T; TSUDA, K; FUKUMAKI, Y			MOLECULAR ANALYSIS OF THE GENE OF THE ALPHA-ANTITRYPSIN DEFICIENCY VARIANT, MNICHINAN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									KYUSHU UNIV,GENET INFORMAT RES LAB,FUKUOKA 812,JAPAN; KYUSHU UNIV,DEPT BIOCHEM,FUKUOKA 812,JAPAN; MIYAZAKI MED COLL,DEPT INTERNAL MED 2,MIYAZAKI 88916,JAPAN	Kyushu University; Kyushu University; University of Miyazaki								ADAMS JG, 1981, P NATL ACAD SCI-BIOL, V78, P469, DOI 10.1073/pnas.78.1.469; BAO J-J, 1988, Genomics, V2, P165, DOI 10.1016/0888-7543(88)90099-7; BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; BRANTLY M, 1988, AM J MED, V84, P13; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; CARISON JA, 1989, J CLIN INVEST, V83, P1183; CARRELL RW, 1982, NATURE, V298, P329, DOI 10.1038/298329a0; CASEY R, 1978, BRIT J HAEMATOL, V38, P195, DOI 10.1111/j.1365-2141.1978.tb01036.x; COOPER DN, 1985, HUM GENET, V69, P201, DOI 10.1007/BF00293024; DEJONG WWW, 1968, NATURE, V220, P788, DOI 10.1038/220788a0; DESIMONE V, 1987, EMBO J, V6, P2759, DOI 10.1002/j.1460-2075.1987.tb02570.x; DYCAICO MJ, 1988, SCIENCE, V242, P1409, DOI 10.1126/science.3264419; FUCHAROEN S, 1989, J BIOL CHEM, V264, P7780; HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3; HOFKER MH, 1989, HUM GENET, V81, P264, DOI 10.1007/BF00279001; JOHNSON CS, 1983, HEMOGLOBIN, V7, P125, DOI 10.3109/03630268309048642; JONES RT, 1966, SCIENCE, V154, P1024, DOI 10.1126/science.154.3752.1024; LOEBERMANN H, 1984, J MOL BIOL, V177, P531, DOI 10.1016/0022-2836(84)90298-5; LONG GL, 1984, BIOCHEMISTRY-US, V23, P4828, DOI 10.1021/bi00316a003; NAKAMURA H, 1980, J JPN SOC INTERN MED, V69, P47; NAKAMURA T, 1987, BLOOD, V70, P809; NUKIWA T, 1986, J BIOL CHEM, V261, P5989; NUKIWA T, 1987, BIOCHEMISTRY-US, V26, P5259, DOI 10.1021/bi00391a008; PERLINO E, 1987, EMBO J, V6, P2767, DOI 10.1002/j.1460-2075.1987.tb02571.x; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; SUZUKI K, 1987, J BIOL CHEM, V262, P611; TAKAHASHI H, 1988, J BIOL CHEM, V263, P15528; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; WAJCMAN H, 1973, BIOCHIM BIOPHYS ACTA, V295, P495, DOI 10.1016/0005-2795(73)90045-7; YOSHIDA A, 1976, P NATL ACAD SCI USA, V73, P1324, DOI 10.1073/pnas.73.4.1324	31	36	38	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1990	46	3					602	612						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CT668	2309708				2022-12-18	WOS:A1990CT66800025
J	WALLACE, MR; CONNEALLY, PM; BENSON, MD				WALLACE, MR; CONNEALLY, PM; BENSON, MD			A DNA TEST FOR INDIANA SWISS HEREDITARY AMYLOIDOSIS (FAP-II)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									RICHARD L ROUDEBUSH VET ADM MED CTR,A772,1481 W 10TH ST,INDIANAPOLIS,IN 46202; INDIANA UNIV,SCH MED,DEPT MED GENET,INDIANAPOLIS,IN 46202; INDIANA UNIV,SCH MED,DEPT MED,INDIANAPOLIS,IN 46202	US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis					NCRR NIH HHS [RR-00750] Funding Source: Medline; NIADDK NIH HHS [AM 7448, AM 20582] Funding Source: Medline; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [P60AM020582] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000750] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ANDERSSON R, 1970, ACTA MED SCAND, V188, P85; ANDRADE C, 1952, BRAIN, V75, P408, DOI 10.1093/brain/75.3.408; ANDRADE C, 1970, ARTHRITIS RHEUM, V13, P902, DOI 10.1002/art.1780130622; ARAKI S, 1968, ARCH NEUROL-CHICAGO, V18, P593, DOI 10.1001/archneur.1968.00470360015001; BENSON MD, 1983, ARTHRITIS RHEUM, V26, P1493, DOI 10.1002/art.1780261211; BENSON MD, 1987, ARTHRITIS RHEUM, V30, P195, DOI 10.1002/art.1780300210; BENSON MD, 1977, ANN INTERN MED, V86, P419, DOI 10.7326/0003-4819-86-4-419; BLAKE CCF, 1978, J MOL BIOL, V121, P339, DOI 10.1016/0022-2836(78)90368-6; COHEN AS, 1987, J PATHOL, V151, P1, DOI 10.1002/path.1711510102; DWULET FE, 1983, BIOCHEM BIOPH RES CO, V114, P657, DOI 10.1016/0006-291X(83)90831-8; DWULET FE, 1986, J CLIN INVEST, V78, P880, DOI 10.1172/JCI112675; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FREDERIKSEN T, 1962, AM J MED, V33, P328, DOI 10.1016/0002-9343(62)90230-9; GAFNI J, 1985, Q J MED, V55, P33; HELVIE J, 1986, CLIN RES, V34, pA704; HUSBY G, 1986, SCAND J IMMUNOL, V23, P253, DOI 10.1111/j.1365-3083.1986.tb01966.x; JACOBSON DR, 1987, CLIN RES, V35, pA594; JULIEN J, 1983, REV NEUROL-FRANCE, V139, P259; KINCAID JC, 1984, CLIN RES, V32, pA821; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; MADISEN L, 1987, AM J MED GENET, V27, P379, DOI 10.1002/ajmg.1320270216; MAHLOUDJI M, 1969, MEDICINE, V48, P1; MERETOJA J, 1973, CLIN GENET, V4, P173; NAKAZATO M, 1984, BIOCHEM BIOPH RES CO, V123, P921, DOI 10.1016/S0006-291X(84)80222-3; ORKIN SH, 1983, J CLIN INVEST, V71, P775, DOI 10.1172/JCI110826; Robbins J, 1978, Recent Prog Horm Res, V34, P477; RUKAVINA JG, 1956, MEDICINE, V35, P239, DOI 10.1097/00005792-195609000-00003; SARAIVA MJM, 1986, J LAB CLIN MED, V108, P17; SASAKI H, 1985, GENE, V37, P191; SASAKI H, 1984, BIOCHEM BIOPH RES CO, V125, P636, DOI 10.1016/0006-291X(84)90586-2; SHIMADA K, 1986, BIOESSAYS, V4, P208, DOI 10.1002/bies.950040506; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPARKES RS, 1987, HUM GENET, V75, P151, DOI 10.1007/BF00591077; VANALLEN MW, 1969, NEUROLOGY, V19, P10, DOI 10.1212/WNL.19.1.10; WALLACE MR, 1985, BIOCHEM BIOPH RES CO, V129, P753, DOI 10.1016/0006-291X(85)91956-4; WALLACE MR, 1986, J CLIN INVEST, V78, P6, DOI 10.1172/JCI112573; WALLACE MR, 1987, CLIN RES, V35, pA419; WALLACE MR, 1988, J CLIN INVEST, V81, P189, DOI 10.1172/JCI113293	38	36	37	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1988	43	2					182	187						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	P6084	2840822				2022-12-18	WOS:A1988P608400012
J	SMOLIN, LA; CLARK, KF; SCHNEIDER, JA				SMOLIN, LA; CLARK, KF; SCHNEIDER, JA			AN IMPROVED METHOD FOR HETEROZYGOTE DETECTION OF CYSTINOSIS, USING POLYMORPHONUCLEAR LEUKOCYTES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF SAN DIEGO, SCH MED, DEPT PEDIAT, M-009-F, LA JOLLA, CA 92093 USA	University of California System; University of California San Diego					NCRR NIH HHS [RR 00827] Funding Source: Medline; NIDDK NIH HHS [DK 18434] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018434] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARRETT AJ, 1972, LYSOSOMES LABORATORY, P46; GAHL WA, 1982, J BIOL CHEM, V257, P9570; GAHL WA, 1984, AM J HUM GENET, V36, P277; GAHL WA, 1982, SCIENCE, V217, P1263, DOI 10.1126/science.7112129; GREENE AA, 1985, PEDIATR RES, V19, P1170, DOI 10.1203/00006450-198511000-00011; JONAS AJ, 1983, J BIOL CHEM, V258, P1727; JONAS AJ, 1982, J BIOL CHEM, V257, P13185; JONAS AJ, 1982, P NATL ACAD SCI-BIOL, V79, P4442, DOI 10.1073/pnas.79.14.4442; LOWRY OH, 1951, J BIOL CHEM, V193, P265; OSHIMA RG, 1974, J BIOL CHEM, V249, P6033; SCHNEIDER JA, 1967, BIOCHEM BIOPH RES CO, V29, P527, DOI 10.1016/0006-291X(67)90516-5; SCHNEIDER JA, 1967, SCIENCE, V157, P1321, DOI 10.1126/science.157.3794.1321; SCHNEIDER JA, 1983, METABOLIC BASIS INHE, P1844; SCHULMAN JD, 1970, ARCH INTERN MED, V125, P660, DOI 10.1001/archinte.125.4.660; STEINHERZ R, 1982, NEW ENGL J MED, V306, P1468, DOI 10.1056/NEJM198206173062407	15	36	38	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1987	41	2					266	275						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	J7575	3618595				2022-12-18	WOS:A1987J757500015
J	MOLL, PP; SING, CF; WILLIAMS, RR; MAO, SJT; KOTTKE, BA				MOLL, PP; SING, CF; WILLIAMS, RR; MAO, SJT; KOTTKE, BA			THE GENETIC DETERMINATION OF PLASMA APOLIPOPROTEIN A-I LEVELS MEASURED BY RADIOIMMUNOASSAY - A STUDY OF HIGH-RISK PEDIGREES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MICHIGAN,DEPT HUMAN GENET,ANN ARBOR,MI 48109; UNIV UTAH,DEPT MED,SALT LAKE CITY,UT 84112; MAYO CLIN & MAYO FDN,ROCHESTER,MN 55905	University of Michigan System; University of Michigan; Utah System of Higher Education; University of Utah; Mayo Clinic	MOLL, PP (corresponding author), UNIV MICHIGAN,DEPT ENDOCRINOL,ANN ARBOR,MI 48109, USA.			Sing, Charles/0000-0001-5872-7956	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL021088, R01HL024489] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL24489, HL21088] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALBERS JJ, 1976, METABOLISM, V25, P633, DOI 10.1016/0026-0495(76)90060-3; ALBERS JJ, 1984, ARTERIOSCLEROSIS, V4, pA555; Berg K, 1981, Prog Clin Biol Res, V69 Pt C, P117; BERG K, 1982, HUMAN GENETICS B, P111; BOERWINKLE E, 1985, THESIS U MICHIGAN; BRESLOW JL, 1982, P NATL ACAD SCI-BIOL, V79, P6861, DOI 10.1073/pnas.79.22.6861; BREWER HB, 1978, BIOCHEM BIOPH RES CO, V80, P623, DOI 10.1016/0006-291X(78)91614-5; BRUNS GAP, 1984, ARTERIOSCLEROSIS, V4, P97, DOI 10.1161/01.ATV.4.2.97; BRUNZELL JD, 1984, ARTERIOSCLEROSIS, V4, P79, DOI 10.1161/01.ATV.4.2.79; BURNS TL, 1984, AM J HUM GENET, V36, P1060; CANNINGS C, 1978, ADV APPL PROBAB, V10, P26, DOI 10.2307/1426718; CHEUNG MC, 1977, J CLIN INVEST, V60, P43, DOI 10.1172/JCI108767; CHEUNG P, 1984, P NATL ACAD SCI-BIOL, V81, P508, DOI 10.1073/pnas.81.2.508; DADONE MM, 1984, AM J MED GENET, V17, P565, DOI 10.1002/ajmg.1320170304; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; FRANCESCHINI G, 1980, J CLIN INVEST, V66, P892, DOI 10.1172/JCI109956; GLOMSET JA, 1983, METABOLIC BASIS INHE, P643; HASSTEDT SJ, 1982, COMPUT BIOMED RES, V15, P295, DOI 10.1016/0010-4809(82)90064-7; HASSTEDT SJ, 1984, ATHEROSCLEROSIS, V51, P21, DOI 10.1016/0021-9150(84)90141-2; HASSTEDT SJ, 1979, AM J HUM GENET, V31, pA135; HASSTEDT SJ, 1986, AM J MED GENET; Hasstedt SJ, 1981, 13 U UT DEP MED BIOP; IZZO C, 1981, CLIN CHEM, V27, P371; KARATHANASIS SK, 1983, NATURE, V301, P718, DOI 10.1038/301718a0; KARATHANASIS SK, 1984, ARTERIOSCLEROSIS, V4, pA562; KARATHANASIS SK, 1983, P NATL ACAD SCI-BIOL, V80, P6147, DOI 10.1073/pnas.80.20.6147; KARATHANASIS SK, 1983, NATURE, V304, P371, DOI 10.1038/304371a0; KAY LL, 1982, P NATL ACAD SCI-BIOL, V79, P2485, DOI 10.1073/pnas.79.8.2485; KOTTKE BA, 1985, CIRCULATION, V71, pA415; KUKITA H, 1984, ATHEROSCLEROSIS, V51, P261, DOI 10.1016/0021-9150(84)90173-4; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; LALOUEL JM, 1979, 14 U UT DEP MED BIOP; MACIEJKO JJ, 1983, NEW ENGL J MED, V309, P385, DOI 10.1056/NEJM198308183090701; MACIEJKO JJ, 1982, CLIN CHEM, V28, P199; MENZEL HJ, 1982, J LIPID RES, V23, P915; MENZEL HJ, 1984, J BIOL CHEM, V259, P3070; MILLER NE, 1983, ATHEROSCLEROSIS MECH, P125; MOLL PP, 1984, AM J HUM GENET, V36, P197; MORTON NE, 1974, AM J HUM GENET, V26, P489; NEEL JV, 1984, AM J HUM GENET, V36, P1135; NIKKILA EA, 1983, METABOLIC BASIS INHE, P622; NORUM RA, 1982, NEW ENGL J MED, V306, P1513, DOI 10.1056/NEJM198206243062503; POWNALL HJ, 1983, ATHEROSCLEROSIS MECH, P125; RALL SC, 1983, ARTERIOSCLEROSIS, V3, pA515; SCHAEFER EJ, 1984, ARTERIOSCLEROSIS, V4, P303, DOI 10.1161/01.ATV.4.4.303; SCHONFELD G, 1974, J CLIN INVEST, V53, P1458, DOI 10.1172/JCI107694; SHOULDERS CC, 1982, NUCLEIC ACIDS RES, V10, P4873, DOI 10.1093/nar/10.16.4873; SING CF, 1985, AM J HUM GENET, V37, P268; SISTONEN P, 1980, AM J HUM GENET, V32, P1; THIRD JLHC, 1984, METABOLISM, V33, P136, DOI 10.1016/0026-0495(84)90126-4; THOMPSON EA, 1979, GENETIC ANAL COMMON, P363; UTERMANN G, 1982, HUM GENET, V61, P329; WALLACE RB, 1980, CIRCULATION, V62, P77; WEISGRABER KH, 1983, J BIOL CHEM, V258, P2508; WILLIAMS RR, 1984, GENETIC EPIDEMIOLOGY, P419; WILLIAMS RR, 1986, J AM MED ASS; ZANNIS IV, 1984, ADV HUMAN GENETICS, V14, P125; ZANNIS VI, 1981, BIOCHEMISTRY-US, V20, P7089, DOI 10.1021/bi00528a006	58	36	36	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1986	38	3					361	372						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	A5781	3082191				2022-12-18	WOS:A1986A578100010
J	BOUTIN, B; FENG, SH; ARNAUD, P				BOUTIN, B; FENG, SH; ARNAUD, P			THE GENETIC-POLYMORPHISM OF ALPHA2-HS GLYCOPROTEIN - STUDY BY ULTRATHIN-LAYER ISOELECTRIC-FOCUSING AND IMMUNOBLOT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MED UNIV S CAROLINA,DEPT BASIC & CLIN IMMUNOL & MICROBIOL,CHARLESTON,SC 29425	Medical University of South Carolina					NCI NIH HHS [CA-25746] Funding Source: Medline; PHS HHS [G-275] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ANDERSON NL, 1979, BIOCHEM BIOPH RES CO, V88, P258, DOI 10.1016/0006-291X(79)91724-8; ARNAUD P, 1983, BIOCHIM BIOPHYS ACTA, V749, P270, DOI 10.1016/0167-4838(83)90235-2; AWDEH ZL, 1980, P NATL ACAD SCI-BIOL, V77, P3576, DOI 10.1073/pnas.77.6.3576; CLEVE H, 1979, HUM GENET, V47, P193, DOI 10.1007/BF00273201; CONFAVREUX C, 1982, ELECTROPHORESIS, V3, P206, DOI 10.1002/elps.1150030405; COX DW, 1983, ELECTROPHORESIS 82, P243; GEJYO F, 1983, J BIOL CHEM, V258, P4966; GEJYO F, 1981, BIOCHIM BIOPHYS ACTA, V671, P78, DOI 10.1016/0005-2795(81)90096-9; GLYNN P, 1982, J IMMUNOL METHODS, V51, P251, DOI 10.1016/0022-1759(82)90264-2; GORG A, 1978, ANAL BIOCHEM, V89, P60, DOI 10.1016/0003-2697(78)90726-1; HEREMANS JF, 1960, GLOBULINES SERIQUES, P103; JEPPSSON JO, 1978, EUR J BIOCHEM, V83, P143, DOI 10.1111/j.1432-1033.1978.tb12078.x; LEBRETON JP, 1979, J CLIN INVEST, V64, P1118, DOI 10.1172/JCI109551; LEBRETON JP, 1977, FEBS LETT, V80, P351, DOI 10.1016/0014-5793(77)80474-2; LEWIS JG, 1982, FEBS LETT, V138, P37, DOI 10.1016/0014-5793(82)80389-X; LEWIS JG, 1981, IMMUNOLOGY, V42, P481; LEWIS JG, 1978, FEBS LETT, V92, P211, DOI 10.1016/0014-5793(78)80756-X; LEWIS JG, 1983, FEBS LETT, V161, P306, DOI 10.1016/0014-5793(83)81030-8; LEWIS JG, 1983, THESIS U OTAGO DUNED, P1; MATSUSHIMA K, 1982, BIOCHIM BIOPHYS ACTA, V701, P200, DOI 10.1016/0167-4838(82)90114-5; Putnam FW., 1984, PLASMA PROTEINS, VIV, P1; SARAVIS CA, 1984, ELECTROPHORESIS, V5, P54, DOI 10.1002/elps.1150050110; SCHMID K, 1961, BIOCHIM BIOPHYS ACTA, V47, P440, DOI 10.1016/0006-3002(61)90539-X; SCHULTZE HE, 1962, NATURWISSENSCHAFTEN, V49, P15, DOI 10.1007/BF00632835; SCHWICK HG, 1984, PLASMA PROTEINS, V4, P167; TRIFFITT JT, 1976, NATURE, V262, P226, DOI 10.1038/262226a0; UMETSU K, 1984, HUM GENET, V67, P70, DOI 10.1007/BF00270561; VANOSS CJ, 1975, J TRAUMA, V15, P451, DOI 10.1097/00005373-197505000-00013; VANOSS CJ, 1974, PREP BIOCHEM, V4, P127, DOI 10.1080/00327487408068768; VANOSS CJ, 1974, IMMUNOL COMMUN, V3, P329, DOI 10.3109/08820137409061113; VAUGHAN L, 1982, BIOCHIM BIOPHYS ACTA, V701, P339, DOI 10.1016/0167-4838(82)90237-0; WEIDINGER S, 1984, ELECTROPHORESIS 84, P487	32	36	36	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1985	37	6					1098	1105						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AXE36	4083279				2022-12-18	WOS:A1985AXE3600005
J	HASSOLD, T; KUMLIN, E; TAKAESU, N; LEPPERT, M				HASSOLD, T; KUMLIN, E; TAKAESU, N; LEPPERT, M			DETERMINATION OF THE PARENTAL ORIGIN OF SEX-CHROMOSOME MONOSOMY USING RESTRICTION FRAGMENT LENGTH POLYMORPHISMS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV UTAH,MED CTR,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84132	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	HASSOLD, T (corresponding author), UNIV HAWAII,JOHN A BURNS SCH MED,DEPT ANAT & REPROD BIOL,HONOLULU,HI 96822, USA.				NICHD NIH HHS [HD-07879] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; BRANDRIFF B, 1984, HUM GENET, V66, P193, DOI 10.1007/BF00286600; DRAYNA D, 1984, P NATL ACAD SCI-BIOL, V81, P2836, DOI 10.1073/pnas.81.9.2836; FORD CE, 1981, TRISOMY, V21, P103; HASSOLD T, 1980, ANN HUM GENET, V44, P151, DOI 10.1111/j.1469-1809.1980.tb00955.x; HASSOLD T, 1984, ANN HUM GENET, V48, P129, DOI 10.1111/j.1469-1809.1984.tb01008.x; HOOK EB, 1983, HUM GENET, V64, P24, DOI 10.1007/BF00289473; JACOBS PA, 1982, ANN HUM GENET, V46, P223, DOI 10.1111/j.1469-1809.1982.tb00714.x; JACOBS PA, 1975, ROLE NATURAL SELECTI, P337; KULIER AM, 1977, HUM GENET, V38, P127; Maniatis T., 1982, MOL CLONING; MARTIN RH, 1983, HUM GENET, V63, P305, DOI 10.1007/BF00274750; OHAMA K, 1972, HUMANGENETIK, V16, P267, DOI 10.1007/BF00273474; PAGE DC, 1984, AM J HUM GENET, V36, P565; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; RUSSELL LB, 1974, MUTAT RES, V25, P367, DOI 10.1016/0165-1218(74)90013-5; SANGER R, 1977, J MED GENET, V14, P210, DOI 10.1136/jmg.14.3.210; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TAKAHARA H, 1977, HIROSHIMA J MED SCI, V26, P291; WARBURTON D, 1980, LANCET, V1, P167	20	36	36	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1985	37	5					965	972						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ASD55	2996336				2022-12-18	WOS:A1985ASD5500014
J	ROSENBLUM, BB; NEEL, JV; HANASH, SM; JOSEPH, JL; YEW, N				ROSENBLUM, BB; NEEL, JV; HANASH, SM; JOSEPH, JL; YEW, N			IDENTIFICATION OF GENETIC-VARIANTS IN ERYTHROCYTE LYSATE BY TWO-DIMENSIONAL GEL-ELECTROPHORESIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MICHIGAN,SCH MED,DEPT PEDIAT,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan	ROSENBLUM, BB (corresponding author), UNIV MICHIGAN,SCH MED,DEPT HUMAN GENET,ANN ARBOR,MI 48109, USA.				NCI NIH HHS [CA-26803] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA026803] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSON NL, 1979, BIOCHEM BIOPH RES CO, V88, P258, DOI 10.1016/0006-291X(79)91724-8; COMINGS DE, 1982, CLIN CHEM, V28, P798; EDWARDS JJ, 1979, BLOOD, V53, P1121; FISHER RA, 1977, ANN HUM GENET, V40, P371; GOLDMAN D, 1983, AM J HUM GENET, V35, P827; HAMAGUCHI H, 1982, HUM GENET, V62, P142; HAMAGUCHI H, 1981, HUM GENET, V59, P215; HAMAGUCHI H, 1982, HUM GENET, V60, P176, DOI 10.1007/BF00569708; HAMAGUCHI H, 1982, HUM GENET, V62, P148; HARRIS H, 1980, PRINCIPLES HUMAN BIO, pR15; LEAVITT J, 1982, CLIN CHEM, V28, P850; MCCONKEY EH, 1979, P NATL ACAD SCI USA, V76, P6500, DOI 10.1073/pnas.76.12.6500; MCLELLAN T, 1983, GENETICS, V104, P381; NAZ RK, 1983, BIOL REPROD, V28, P249, DOI 10.1095/biolreprod28.1.249; NAZ RK, 1984, P NATL ACAD SCI US; NEEL JV, 1984, METHODS APPLICATIONS; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; ROSENBLUM BB, 1982, CLIN CHEM, V28, P925; ROSENBLUM BB, 1983, P NATL ACAD SCI-BIOL, V80, P5002, DOI 10.1073/pnas.80.16.5002; ROSENBLUM BB, 1983, BIOL PROSPECTIVE, V1, P85; SAMMONS DW, 1981, ELECTROPHORESIS, V2, P135, DOI 10.1002/elps.1150020303; SMITH SC, 1980, GENETICS, V96, P967; WALTON KE, 1979, J BIOL CHEM, V254, P7951; WANNER LA, 1982, AM J HUM GENET, V34, P209; WILSON JM, 1983, P NATL ACAD SCI-BIOL, V80, P870, DOI 10.1073/pnas.80.3.870; WILSON JM, 1981, J BIOL CHEM, V256	26	36	36	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	3					601	612						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	SY119	6203403				2022-12-18	WOS:A1984SY11900009
J	SCHONBERG, S; NIERMEIJER, MF; BOOTSMA, D; HENDERSON, E; GERMAN, J				SCHONBERG, S; NIERMEIJER, MF; BOOTSMA, D; HENDERSON, E; GERMAN, J			WERNERS SYNDROME - PROLIFERATION INVITRO OF CLONES OF CELLS BEARING CHROMOSOME TRANSLOCATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NEW YORK BLOOD CTR,310 E 67TH ST,NEW YORK,NY 10021; ERASMUS UNIV,DEPT CELL BIOL & GENET,3000 DR ROTTERDAM,NETHERLANDS; TEMPLE UNIV,HLTH SCI CTR,SCH MED,DEPT MICROBIOL,PHILADELPHIA,PA 19140	New York Blood Center; Erasmus University Rotterdam; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD004134] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-04134] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BROWN WT, 1983, CHROMOSOME MUTATION, P85; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; EPSTEIN CJ, 1966, MEDICINE, V45, P177, DOI 10.1097/00005792-196605000-00001; FUJIWARA Y, 1977, J CELL PHYSIOL, V92, P365, DOI 10.1002/jcp.1040920305; German J., 1983, CHROMOSOME MUTATION, P97; HAND R, 1975, P NATL ACAD SCI USA, V72, P758, DOI 10.1073/pnas.72.2.758; HENDERSON E, 1977, VIROLOGY, V76, P152, DOI 10.1016/0042-6822(77)90292-6; HOEHN H, 1975, CYTOGENET CELL GENET, V15, P282, DOI 10.1159/000130526; HOLLIDAY R, 1974, NATURE, V248, P762, DOI 10.1038/248762a0; MARTIN GM, 1970, LAB INVEST, V23, P86; NORDENSON I, 1977, HEREDITAS, V87, P151; NORWOOD TH, 1979, J INVEST DERMATOL, V73, P92, DOI 10.1111/1523-1747.ep12532778; RAY JH, 1983, CHROMOSOME MUTATION, P135; SALK D, 1981, CYTOGENET CELL GENET, V30, P108, DOI 10.1159/000131597; SALK D, 1981, CYTOGENET CELL GENET, V30, P92, DOI 10.1159/000131596; SALK D, 1982, HUM GENET, V62, P1, DOI 10.1007/BF00295598; SALK D, 1981, HUM GENET, V58, P310, DOI 10.1007/BF00294930; SCAPPATICCI S, 1982, HUM GENET, V62, P16, DOI 10.1007/BF00295599; SCHONBERG SA, 1981, AM J HUM GENET, V33, pA120; STEEL CM, 1977, NATURE, V270, P349, DOI 10.1038/270349a0; SUTHERLAND GR, 1977, SCIENCE, V197, P265, DOI 10.1126/science.877551	21	36	37	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	2					387	397						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	SM324	6324581				2022-12-18	WOS:A1984SM32400013
J	INUI, K; GREBNER, EE; JACKSON, LG; WENGER, DA				INUI, K; GREBNER, EE; JACKSON, LG; WENGER, DA			JUVENILE GM2 GANGLIOSIDOSIS (AMB VARIANT) - INABILITY TO ACTIVATE HEXOSAMINIDASE-A BY ACTIVATOR PROTEIN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV COLORADO,SCH MED,DEPT PEDIAT,DENVER,CO 80262; THOMAS JEFFERSON UNIV,DEPT MED GENET,PHILADELPHIA,PA 19107	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Jefferson University					NICHD NIH HHS [HD-08315] Funding Source: Medline; NINDS NIH HHS [NS-10698] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BRETT EM, 1973, ARCH DIS CHILD, V48, P775, DOI 10.1136/adc.48.10.775; CHESTER MA, 1979, HUM HERED, V29, P124, DOI 10.1159/000153028; CONZELMANN E, 1978, P NATL ACAD SCI USA, V75, P3979, DOI 10.1073/pnas.75.8.3979; CONZELMANN E, 1978, EUR J BIOCHEM, V84, P27, DOI 10.1111/j.1432-1033.1978.tb12137.x; DUBOIS G, 1980, ANAL BIOCHEM, V102, P313, DOI 10.1016/0003-2697(80)90159-1; ERZBERGER A, 1980, CLIN CHIM ACTA, V108, P361, DOI 10.1016/0009-8981(80)90342-3; GOLDIE WD, 1977, ANN NEUROL, V2, P156, DOI 10.1002/ana.410020212; GOLDMAN JE, 1980, ACTA NEUROPATHOL, V52, P189, DOI 10.1007/BF00705807; GREBNER EE, 1979, AM J OBSTET GYNECOL, V134, P547, DOI 10.1016/0002-9378(79)90838-X; HECHTMAN P, 1982, PEDIATR RES, V16, P217, DOI 10.1203/00006450-198203000-00011; JOHNSON WG, 1977, NEUROLOGY, V27, P1012, DOI 10.1212/WNL.27.11.1012; KUDOH T, 1981, J LAB CLIN MED, V98, P704; LI SC, 1981, BIOCHEM BIOPH RES CO, V101, P479, DOI 10.1016/0006-291X(81)91285-7; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MENKES JH, 1971, ARCH NEUROL-CHICAGO, V25, P14, DOI 10.1001/archneur.1971.00490010024003; OBRIEN JS, 1977, CLIN GENET, V11, P171; OBRIEN JS, 1978, METABOLIC BASIS INHE, P841; OKADA S, 1970, J PEDIATR-US, V77, P1063, DOI 10.1016/S0022-3476(70)80096-8; OKADA S, 1969, SCIENCE, V165, P698, DOI 10.1126/science.165.3894.698; OONK JGW, 1979, NEUROLOGY, V29, P380, DOI 10.1212/WNL.29.3.380; RADIN NS, 1969, BRAIN RES, V14, P497, DOI 10.1016/0006-8993(69)90124-3; RAPIN I, 1976, ARCH NEUROL-CHICAGO, V33, P120, DOI 10.1001/archneur.1976.00500020048008; SANDHOFF K, 1979, HUM GENET, V50, P107, DOI 10.1007/BF00390234; SANDHOFF K, 1969, FEBS LETT, V4, P351, DOI 10.1016/0014-5793(69)80274-7; SUZUKI K, 1970, NEUROLOGY, V20, P190, DOI 10.1212/WNL.20.2.190; SUZUKI Y, 1972, J LIPID RES, V13, P687; SUZUKI Y, 1970, NEUROLOGY, V20, P848, DOI 10.1212/WNL.20.9.848; SVENNERHOLM L, 1957, BIOCHIM BIOPHYS ACTA, V24, P604, DOI 10.1016/0006-3002(57)90254-8; WARNER TG, 1979, BIOCHEMISTRY-US, V18, P2783, DOI 10.1021/bi00580a014; WENGER DA, 1976, LIFE SCI, V19, P413, DOI 10.1016/0024-3205(76)90047-3; WILLNER JP, 1981, NEUROLOGY, V31, P787, DOI 10.1212/WNL.31.7.787	31	36	36	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	4					551	564						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RG731	6224417				2022-12-18	WOS:A1983RG73100001
J	WANNER, LA; NEEL, JV; MEISLER, MH				WANNER, LA; NEEL, JV; MEISLER, MH			SEPARATION OF ALLELIC VARIANTS BY TWO-DIMENSIONAL ELECTROPHORESIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											WANNER, LA (corresponding author), UNIV MICHIGAN,DEPT HUMAN GENET,ANN ARBOR,MI 48109, USA.							AYALA FJ, 1974, GENETICS, V77, P343; BERRY RJ, 1977, PROC R SOC SER B-BIO, V197, P485, DOI 10.1098/rspb.1977.0082; BLOOR JH, 1981, J BIOL CHEM, V256, P373; BROWN AJL, 1979, P NATL ACAD SCI USA, V76, P2381, DOI 10.1073/pnas.76.5.2381; EDWARDS Y, 1980, NATURE, V284, P511, DOI 10.1038/284511a0; ELLIOTT RW, 1979, GENETICS, V91, P295; HARRIS H, 1977, P NATL ACAD SCI USA, V74, P698, DOI 10.1073/pnas.74.2.698; HJORTH JP, 1980, BIOCHEM GENET, V18, P281, DOI 10.1007/BF00484242; JONES RT, 1975, ABNORMAL HEMOGLOBINS; KRAMER JM, 1981, THESIS U MICHIGAN AN; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE CY, 1980, BIOCHEM GENET, V18, P1003, DOI 10.1007/BF00500131; MCCONKEY EH, 1979, P NATL ACAD SCI USA, V76, P6500, DOI 10.1073/pnas.76.12.6500; NEEL JV, 1980, P NATL ACAD SCI-BIOL, V77, P6037, DOI 10.1073/pnas.77.10.6037; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; RACINE RR, 1980, NATURE, V283, P855, DOI 10.1038/283855a0; RAMSHAW JAM, 1979, GENETICS, V93, P1019; RAMSHAW JAM, 1978, NATURE, V275, P68, DOI 10.1038/275068a0; SELANDER RK, 1969, GENETICS, V63, P653; TANIS R, 1974, ANN HUM GENET, V38, P179, DOI 10.1111/j.1469-1809.1974.tb01949.x; TANIS RJ, 1973, AM J HUM GENET, V25, P655; TASHIAN RE, 1980, HEMOGLOBIN, V4, P635, DOI 10.3109/03630268008997733; WALTON KE, 1979, J BIOL CHEM, V254, P7951	23	36	36	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1982	34	2					209	215						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NH732	6176122				2022-12-18	WOS:A1982NH73200004
J	PEARSON, G; MANN, JD; BENSEN, J; BULL, RW				PEARSON, G; MANN, JD; BENSEN, J; BULL, RW			INVERSION DUPLICATION OF CHROMOSOME-6 WITH TRISOMIC CO-DOMINANT EXPRESSION OF HLA ANTIGENS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MICHIGAN STATE UNIV,DEPT MED,E LANSING,MI 48824	Michigan State University	PEARSON, G (corresponding author), BUTTERWORTH HOSP,DEPT CLIN LABS,GRAND RAPIDS,MI 49503, USA.							CHIYO H, 1975, HUMANGENETIK, V30, P63, DOI 10.1007/BF00273632; De Grouchy J, 1977, CLIN ATLAS HUMAN CHR; de la Chapelle A, 1976, Blood, V47, P815; McKusick V. A, 1975, MENDELIAN INHERITANC; RETHORE MO, 1975, ANN GENET-PARIS, V18, P81; RETHORE MO, 1976, ANN GENET-PARIS, V19, P140; SINET PM, 1976, EXP CELL RES, V97, P47, DOI 10.1016/0014-4827(76)90653-4; THERKELSEN AJ, 1971, ANN GENET-PARIS, V14, P13; TRUNCA C, 1977, AM J MED GENET, V1, P217, DOI 10.1002/ajmg.1320010208; TURPEN R, 1969, HUMAN AFFLICTIONS CH, P69	10	36	36	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1979	31	1					29	34						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GR115	433922				2022-12-18	WOS:A1979GR11500003
J	FLUHARTY, AL; STEVENS, RL; DAVIS, LL; SHAPIRO, LJ; KIHARA, H				FLUHARTY, AL; STEVENS, RL; DAVIS, LL; SHAPIRO, LJ; KIHARA, H			PRESENCE OF ARYLSULFATASE-A (ARS-A) IN MULTIPLE SULFATASE DEFICIENCY DISORDER FIBROBLASTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HARBOR GEN HOSP,DEPT PEDIAT,DIV MED GENET,TORRANCE,CA 90509; PACIFIC STATE HOSP,INST NEUROPSYCHIAT,RES GRP,POMONA,CA 91766	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	FLUHARTY, AL (corresponding author), UNIV CALIF LOS ANGELES,SCH MED,LOS ANGELES,CA 90024, USA.							BAUM H, 1959, CLIN CHIM ACTA, V4, P453, DOI 10.1016/0009-8981(59)90119-6; ETO Y, 1974, ARCH NEUROL-CHICAGO, V30, P153, DOI 10.1001/archneur.1974.00490320041005; FLUHARTY AL, 1975, BIOCHEM BIOPH RES CO, V64, P955, DOI 10.1016/0006-291X(75)90140-0; FLUHARTY AL, 1974, LIPIDS, V9, P865, DOI 10.1007/BF02532611; FLUHARTY AL, 1974, BIOCHEM BIOPH RES CO, V59, P455, DOI 10.1016/S0006-291X(74)80001-X; LIE SO, 1972, P NATL ACAD SCI USA, V69, P2361, DOI 10.1073/pnas.69.9.2361; LIEBAERS I, 1977, J PEDIATR-US, V90, P423, DOI 10.1016/S0022-3476(77)80707-5; LIM TW, 1974, CARBOHYD RES, V37, P103, DOI 10.1016/S0008-6215(00)87067-6; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Moser HW., 1972, METABOLIC BASIS INHE, P688; NEUFELD EF, 1976, CURRENT TRENDS SPHIN, P253; PORTER MT, 1972, BIOCHIM BIOPHYS ACTA, V258, P769, DOI 10.1016/0005-2744(72)90178-7; PORTER MT, 1969, P NATL ACAD SCI USA, V62, P887, DOI 10.1073/pnas.62.3.887; SHAPIRA E, 1975, J PEDIATR-US, V86, P881, DOI 10.1016/S0022-3476(75)80218-6; SHAPIRO LJ, 1977, PEDIATR RES, V11, P894, DOI 10.1203/00006450-197708000-00008; STEVENS RL, 1975, J BIOL CHEM, V250, P2495; STEVENS RL, 1974, BIOCHIM BIOPHYS ACTA, V370, P249, DOI 10.1016/0005-2744(74)90049-7	17	36	36	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1978	30	3					249	255						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FE044	27985				2022-12-18	WOS:A1978FE04400002
J	OBRIEN, JS; TENNANT, L; VEATH, ML; SCOTT, CR; BUCKNALL, WE				OBRIEN, JS; TENNANT, L; VEATH, ML; SCOTT, CR; BUCKNALL, WE			CHARACTERIZATION OF UNUSUAL HEXOSAMINIDASE-A (HEX-A) DEFICIENT HUMAN MUTANTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV WASHINGTON,SCH MED,DEPT PEDIAT,SEATTLE,WA 98195; BAYLOR UNIV,COLL MED,TEXAS MED CTR,DEPT OBSTET & GYNECOL,HOUSTON,TX 77030	University of Washington; University of Washington Seattle; Baylor College of Medicine; Baylor University; University of Texas System; University of Texas Health Science Center Houston	OBRIEN, JS (corresponding author), UNIV CALIF SAN DIEGO,SCH MED,DEPT NEUROSCI,LA JOLLA,CA 92093, USA.							BACH G, 1975, J BIOL CHEM, V250, P1328; DANCE N, 1970, BIOCHIM BIOPHYS ACTA, V222, P662, DOI 10.1016/0304-4165(70)90193-5; DREYFUS JC, 1975, NEW ENGL J MED, V292, P61, DOI 10.1056/NEJM197501092920201; GEIGER B, 1976, BIOCHEMISTRY-US, V15, P3484, DOI 10.1021/bi00661a014; KELLY TE, 1976, CLIN GENET, V9, P540; LEROY JG, 1972, PEDIATR RES, V6, P752, DOI 10.1203/00006450-197210000-00002; LI YT, 1973, J BIOL CHEM, V248, P7512; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; LOWRY OH, 1951, J BIOL CHEM, V193, P265; NAVON R, 1973, AM J HUM GENET, V25, P287; OBRIEN JS, 1975, CLIN GENET, V8, P303; OBRIEN JS, 1970, NEW ENGL J MED, V283, P15, DOI 10.1056/NEJM197007022830104; OBRIEN JS, 1978, AM J HUM GENET, V30, P672; OBRIEN JS, 1977, CLIN GENET, V11, P171; OKADA S, 1969, SCIENCE, V165, P698, DOI 10.1126/science.165.3894.698; SANDHOFF K, 1971, J NEUROCHEM, V18, P2469, DOI 10.1111/j.1471-4159.1971.tb00204.x; SANDHOFF K, 1971, H-S Z PHYSIOL CHEM, V352, P1119, DOI 10.1515/bchm2.1971.352.2.1119; SEYAMA Y, 1974, J BIOCHEM-TOKYO, V75, P495, DOI 10.1093/oxfordjournals.jbchem.a130418; TALLMAN JF, 1974, NATURE, V252, P254, DOI 10.1038/252254a0; THOMPSON JN, 1973, SCIENCE, V181, P866, DOI 10.1126/science.181.4102.866; TOMASI LG, 1974, NEUROLOGY, V24, P1158, DOI 10.1212/WNL.24.12.1158; VIDGOFF J, 1973, AM J HUM GENET, V25, P372; WENGER DA, 1972, ARCH BIOCHEM BIOPHYS, V153, P116, DOI 10.1016/0003-9861(72)90427-4	23	36	36	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1978	30	6					602	608						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GK656	747188				2022-12-18	WOS:A1978GK65600004
J	REED, T; UCHIDA, IA; NORTON, JA; CHRISTIAN, JC				REED, T; UCHIDA, IA; NORTON, JA; CHRISTIAN, JC			COMPARISONS OF DERMATOGLYPHIC PATTERNS IN MONOCHORIONIC AND DICHORIONIC MONOZYGOTIC TWINS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									INDIANA UNIV,SCH MED,DEPT PSYCHIAT,INDIANAPOLIS,IN 46202; MCMASTER UNIV,MED CTR,DEPT PEDIAT,HAMILTON L8S 4J9,ONTARIO,CANADA	Indiana University System; Indiana University-Purdue University Indianapolis; McMaster University	REED, T (corresponding author), INDIANA UNIV,SCH MED,DEPT MED GENET,INDIANAPOLIS,IN 46202, USA.							ADAMS MS, 1967, GENET RES, V10, P313, DOI 10.1017/S0016672300011071; ALLEN G, 1968, ACTA GENET MED GEMEL, V17, P359, DOI 10.1017/S1120962300012762; BRYON E, 1974, ARCH DIS CHILD, V49, P908; Bulmer M. G., 1970, BIOL TWINNING MAN; CHRISTIAN JC, 1976, ACTA GENET MED GEMEL, V25, P145, DOI 10.1017/S000156600001401X; CHRISTIAN JC, 1974, AM J HUM GENET, V26, P154; CHRISTIAN JC, 1977, ACTA GENET MED GEMEL, V26, P49, DOI 10.1017/S0001566000010187; CHRISTIAN JC, 1976, AM J HUM GENET, V28, P174; CHRISTIAN JC, 1975, MAR JOINT M EAST N A; CHRISTIAN JC, 1976, EXCERPTA MEDICA  397, P28; COREY LA, 1975, AM J HUM GENET, V27, pA28; COREY LA, 1976, AM J HUM GENET, V28, P433; COREY LA, 1976, EXCERPTA MEDICA  397, P178; Cummins H, 1961, FINGERPRINTS PALMS S; HOLT SB, 1968, GENETICS DERMAL RIDG; MELNICK M, 1977, 2ND INT C TWIN STUD; PENROSE L S, 1968, Birth Defects Original Article Series, V4, P1; PENROSE LS, 1954, ANN HUM GENET, V19, P10, DOI 10.1111/j.1469-1809.1954.tb01260.x; PENROSE LS, 1969, HUM BIOL, V41, P427; PENROSE LS, 1970, J MENT DEFIC RES, V14, P111; REED T, 1977, ACTA GENET MED GEMEL, V26, P83, DOI 10.1017/S0001566000010230; REED T, 1975, HUM HERED, V25, P263, DOI 10.1159/000152734; REED T, 1976, EXCERPTA MEDICA  397, P207; Strong S.J, 1967, PLACENTA TWIN PREGNA; WALKER NF, 1958, PEDIATR CLIN N AM, V5, P531; WOOLF CM, 1976, AM J HUM GENET, V28, P400; WOOLF CM, 1977, AM J HUM GENET, V29, P503	27	36	36	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1978	30	4					383	391						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FP353	568879				2022-12-18	WOS:A1978FP35300007
J	NEUFELD, EF; LIEBAERS, I; EPSTEIN, CJ; YATZIV, S; MILUNSKY, A; MIGEON, BR				NEUFELD, EF; LIEBAERS, I; EPSTEIN, CJ; YATZIV, S; MILUNSKY, A; MIGEON, BR			HUNTER SYNDROME IN FEMALES - THERE AN AUTOSOMAL RECESSIVE FORM OF IDURONATE SULFATASE DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NIAMDD,HUMAN BIOL CHEM & GENET SECT,BETHESDA,MD 20014; UNIV CALIF SAN FRANCISCO,DEPT PEDIAT,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143; JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205; EUNICE KENNEDY SHRIVER CTR MENTAL RETARDAT,WALTHAM,MA 02154	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Johns Hopkins University				Milunsky, Aubrey/0000-0003-2114-4823				BACH G, 1973, P NATL ACAD SCI USA, V70, P2134, DOI 10.1073/pnas.70.7.2134; BOOTH CW, 1974, PEDIATRICS, V53, P396; CANTZ M, 1972, J BIOL CHEM, V247, P5456; Cantz M, 1972, METHOD ENZYMOL, V28, P884; CHASE GA, 1973, HUM HERED, V23, P19, DOI 10.1159/000152548; DONNELLY PV, 1975, PEDIATRICS, V56, P429; FRATANTONI JC, 1968, SCIENCE, V162, P570, DOI 10.1126/science.162.3853.570; LIEBAERS I, 1976, PEDIATR RES, V10, P733, DOI 10.1203/00006450-197610080-00007; LIEBAERS I, 1977, J PEDIATR-US, V90, P423, DOI 10.1016/S0022-3476(77)80707-5; LOWRY RB, 1971, NEW ENGL J MED, V284, P221; MCKUSICK VA, 1972, HERITABLE DISORDERS, P521; MIGEON BR, 1977, AM J HUM GENET, V29, P448; MIGEON BR, 1977, GENETIC MECHANISM SE; MILUNSKY A, 1973, NEW ENGL J MED, V288, P106; NEUFELD EF, 1975, ANNU REV BIOCHEM, V44, P357, DOI 10.1146/annurev.bi.44.070175.002041; PUNNETT HH, 1973, NEW ENGL J MED, V288, P856	16	36	36	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1977	29	5					455	461						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DV673	409284				2022-12-18	WOS:A1977DV67300004
J	DUNNETTE, J; WEINSHILBOUM, R				DUNNETTE, J; WEINSHILBOUM, R			HUMAN-SERUM DOPAMINE BETA-HYDROXYLASE - CORRELATION OF ENZYMATIC-ACTIVITY WITH IMMUNOREACTIVE PROTEIN IN GENETICALLY DEFINED SAMPLES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MAYO FDN,DEPT PHARMACOL,ROCHESTER,MN 55901; MAYO FDN,DEPT INTERN MED,ROCHESTER,MN 55901	Mayo Clinic; Mayo Clinic								BLACK IB, 1974, BRAIN RES, V75, P133, DOI 10.1016/0006-8993(74)90775-6; CIARANELLO RD, 1974, PHARMACOLOGY BASEL, V12, P272; COLEMAN M, 1974, CLIN GENET, V5, P312; DEPOTTER WP, 1969, J PHYSIOL-LONDON, V204, pP102; EBSTEIN RP, 1974, NEUROLOGY, V24, P684, DOI 10.1212/WNL.24.7.684; EBSTEIN RP, 1973, LIFE SCI, V13, P769, DOI 10.1016/0024-3205(73)90067-2; GEFFEN LB, 1969, J PHYSIOL-LONDON, V204, pP58; GEFFEN LB, 1969, J PHYSIOL-LONDON, V204, P593, DOI 10.1113/jphysiol.1969.sp008934; KAUFMAN S, 1965, PHARMACOL REV, V17, P71; MOLINOFF PB, 1971, J PHARMACOL EXP THER, V178, P425; OKA M., 1967, LIFE SCI, V6, P461, DOI 10.1016/0024-3205(67)90048-3; RABINOWITZ D, 1973, NATURE-NEW BIOL, V245, P245, DOI 10.1038/newbio245245a0; ROSS SB, 1973, LIFE SCI, V12, P529, DOI 10.1016/0024-3205(73)90056-8; RUSH RA, 1972, CIRC RES, V31, P444, DOI 10.1161/01.RES.31.3.444; RUSH RA, 1974, P NATL ACAD SCI USA, V71, P872, DOI 10.1073/pnas.71.3.872; SMITH A D, 1970, Tissue and Cell, V2, P547, DOI 10.1016/S0040-8166(70)80030-1; SMITH AD, 1967, BIOCHEM J, V103, P480, DOI 10.1042/bj1030480; Snedecor G. W., 1967, STATISTICAL METHODS, P135; STJARNE L, 1967, BIOCHEM PHARMACOL, V16, P1719, DOI 10.1016/0006-2952(67)90247-X; STRAUSS AJL, 1964, J IMMUNOL, V93, P24; SUTTON HE, 1972, AM J HUM GENET, V24, P343; VIVEROS OH, 1968, LIFE SCI PT 1 PHYSI, V7, P609, DOI 10.1016/0024-3205(68)90186-0; WEINSHILBOUM R, 1971, CIRC RES, V28, P307, DOI 10.1161/01.RES.28.3.307; WEINSHILBOUM RM, 1975, AM J HUM GENET, V27, P573; WEINSHILBOUM RM, 1971, SCIENCE, V174, P1349, DOI 10.1126/science.174.4016.1349; WEINSHILBOUM RM, 1973, SCIENCE, V181, P943, DOI 10.1126/science.181.4103.943; WEINSHILBOUM RM, 1971, NEW ENGL J MED, V285, P938, DOI 10.1056/NEJM197110212851703	27	36	37	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1976	28	2					155	166						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	BJ476	57719				2022-12-18	WOS:A1976BJ47600005
J	JOHNSON, AM; CLEVE, H; ALPER, C				JOHNSON, AM; CLEVE, H; ALPER, C			VARIANTS OF GROUP-SPECIFIC COMPONENT SYSTEM AS DEMONSTRATED BY IMMUNOFIXATION ELECTROPHORESIS - REPORT OF A NEW VARIANT, GC-BOSTON (GC-B)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV N CAROLINA, SCH MED, DEPT PEDIAT, CHAPEL HILL, NC 27514 USA; CTR BLOOD RES, BOSTON, MA 02115 USA; UNIV MUNICH, INST ANTHROPOL & HUMAN GENET, MUNICH, FED REP GER	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); University of Munich								ALPER CA, 1969, VOX SANG, V17, P445, DOI 10.1111/j.1423-0410.1969.tb00414.x; AZEN EA, 1969, BIOCHEM GENET, V3, P215, DOI 10.1007/BF00521138; BEARN AG, 1964, J EXP MED, V120, P83, DOI 10.1084/jem.120.1.83; CLEVE H, 1973, ISRAEL J MED SCI, V9, P1133; CLEVE H, 1963, AM J HUM GENET, V15, P368; CLEVE H, 1970, HUMANGENETIK, V9, P26, DOI 10.1007/BF00696010; DAIGER SP, 1974, AM J HUM GENET, V26, pA24; GANROT PO, 1972, SCAND J CLIN LAB INV, V29, P39, DOI 10.3109/00365517209102749; HENNIG W, 1965, VOX SANG, V10, P214, DOI 10.1111/j.1423-0410.1965.tb04341.x; HIRSCHFELD J, 1962, PROG ALLERGY, V6, P155, DOI 10.1159/000313799; HIRSCHFELD JAN, 1959, ACTA PATHOL ET MICROBIOL SCAND, V47, P160; JOHNSON AM, 1974, J PEDIATR-US, V84, P588; KITCHIN FD, 1966, AM J HUM GENET, V18, P201; LAURELL CB, 1965, ANAL BIOCHEM, V10, P358, DOI 10.1016/0003-2697(65)90278-2; MCDERMID EM, 1972, HUM HERED, V22, P249, DOI 10.1159/000152494; NERSTROM B, 1964, ACTA PATHOL MIC SC, V61, P474, DOI 10.1111/apm.1964.61.3.474; NERSTROM B, 1963, ACTA PATHOL MIC SC, V57, P495; OMOTO K, 1972, JPN J HUM GENET, V17, P1; PARKER WC, 1963, AM J HUM GENET, V15, P353; PERSSON I, 1965, ACTA GENET STAT MED, V15, P51; REINSKOU T, 1965, ACTA GENET STAT MED, V15, P248; RITTNER C, 1969, VOX SANG, V16, P510, DOI 10.1111/j.1423-0410.1969.tb04782.x; RUCKNAGEL DL, 1968, AM J HUM GENET, V20, P478; SPEISER P, 1972, HUMANGENETIK, V17, P81, DOI 10.1007/BF01789606; VAVRUSA B, 1974, VOX SANG, V26, P157, DOI 10.1111/j.1423-0410.1974.tb02681.x	25	36	36	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1975	27	6					728	736						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AX924	1239191				2022-12-18	WOS:A1975AX92400003
J	MARUYAMA, T				MARUYAMA, T			AGE OF A RARE MUTANT GENE IN A LARGE POPULATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TEXAS, CTR DEMOG & POPULATION GENET, HOUSTON, TX 77025 USA	University of Texas System								Feller W., 1951, P 2 BERK S MATH STAT, P227; KIMURA M, 1969, GENETICS, V61, P763; KIMURA M, 1973, GENETICS, V75, P199; LAMPERTI J, 1967, B AM MATH SOC, V73, P382, DOI 10.1090/S0002-9904-1967-11762-2; LI WH, 1972, AM J HUM GENET, V24, P667; MARUYAMA T, IN PRESS; NEI M, 1971, Theoretical Population Biology, V2, P419, DOI 10.1016/0040-5809(71)90030-X; Tamura A, 1964, Jinrui Idengaku Zasshi, V9, P183	8	36	36	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1974	26	6					669	673						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	V0911	4440678				2022-12-18	WOS:A1974V091100001
J	ROTHHAMMER, F; NEEL, JV; ROCHA, FD; SUNDLING, GY				ROTHHAMMER, F; NEEL, JV; ROCHA, FD; SUNDLING, GY			GENETIC STRUCTURE OF A TRIBAL POPULATION, YANOMAMA INDIANS .8. DERMATOGLYPHIC DIFFERENCES AMONG VILLAGES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CHILE, DEPT GENET, SANTIAGO, CHILE; UNIV MICHIGAN, MED SCH, DEPT HUMAN GENET, ANN ARBOR, MI 48104 USA; UNIV FED RIO GRANDE SUL, INS BIOCIENCIAS, DEPT GENET, PORTO ALEGRE, BRAZIL	Universidad de Chile; University of Michigan System; University of Michigan; Universidade Federal do Rio Grande do Sul								BECHER D, 1960, SURARA PAKIDAI ZWEI, V26; Chagnon Napoleon, 1968, YANOMAMO FIERCE PEOP; Coope E., 1971, ONGOING EVOLUTION LA, P405; Cummins H, 1961, FINGER PRINTS PALMS; GERSHOWITZ H, 1972, ANN HUM GENET, V35, P261, DOI 10.1111/j.1469-1809.1957.tb01400.x; HOLT SB, 1968, GENETICS DERMAL RIDG; JANTZ R L, 1969, American Journal of Physical Anthropology, V30, P355, DOI 10.1002/ajpa.1330300305; LAYRISSE M, 1962, SOUTHWEST J ANTHROP, V18, P78, DOI 10.1086/soutjanth.18.1.3629125; LOESCH D, 1971, ANN HUM GENET, V34, P277, DOI 10.1111/j.1469-1809.1971.tb00240.x; MAVALWALA J, 1963, ANN HUM GENET, V26, P305, DOI 10.1111/j.1469-1809.1963.tb01326.x; MAVALWALA JD, 1962, ANN HUM GENET, V26, P137, DOI 10.1111/j.1469-1809.1962.tb01319.x; MIGLIAZZA E, 1972, THESIS U INDIANA; NEEL J, 1971, 4 P INT C HUM GEN; NEEL J V, 1970, Proceedings of the National Academy of Sciences of the United States of America, V65, P323, DOI 10.1073/pnas.65.2.323; NEEL JV, 1972, ANN HUM GENET, V35, P255, DOI 10.1111/j.1469-1809.1957.tb01399.x; NEEL JV, 1964, AM J HUM GENET, V16, P52; NEEL JV, 1972, AM J HUM GENET; NEEL JV, IN PRESS; NISWANDER JD, 1967, AM J HUM GENET, V19, P490; Penrose L S, 1971, Ann Hum Genet, V34, P291, DOI 10.1111/j.1469-1809.1971.tb00241.x; PENROSE LS, 1954, ANN HUM GENET, V19, P10, DOI 10.1111/j.1469-1809.1954.tb01260.x; PENROSE LS, 1970, J MENT DEFIC RES, V14, P111; PONS J, 1959, AM J HUM GENET, V11, P252; RIFE DC, 1953, AM J HUM GENET, V5, P389; ROBERTS DF, 1971, MAN, V6, P61, DOI 10.2307/2798428; ROTHHAMM.F, 1969, HUM BIOL, V41, P151; ROTHHAMMER F, 1971, HUM HERED, V21, P198, DOI 10.1159/000152402; Rothhammer F, 1969, Z Morphol Anthropol, V61, P217; Scheffe H., 1999, ANAL VARIANCE, V72; Sokal Robert R., 1969, BIOMETRY; SPIELMAN RS, 1972, AM J PHYS ANTHROPOL, V37, P345, DOI 10.1002/ajpa.1330370304; Steward Julian, 1959, NATIVE PEOPLES S AM; SUNDERLAND E, 1968, AM J PHYS ANTHROPOL, V28, P339, DOI 10.1002/ajpa.1330280320; VIEIRAFILHO JPB, 1970, CIENCIA CULTURA SAO, V22, P327; VIEIRAFILHO JPB, 1970, CIENCIA CULT, V22, P182; WARD RH, 1972, ANN HUM GENET, V36, P21, DOI 10.1111/j.1469-1809.1972.tb00579.x; WEITKAMP LR, 1972, ANN HUM GENET, V35, P433, DOI 10.1111/j.1469-1809.1957.tb01868.x; WEITKAMP LR, 1972, ANN HUM GENET, V35, P271, DOI 10.1111/j.1469-1809.1957.tb01401.x; ZERRIES O, 1964, ERGEBNISSE FROBENIUS, V1	39	36	36	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1973	25	2					152	166						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	P0622	4689037				2022-12-18	WOS:A1973P062200004
J	SINGER, HS; SCHAFER, IA				SINGER, HS; SCHAFER, IA			CLINICAL AND ENZYMATIC VARIATIONS IN GM1 GENERALIZED GANGLIOSIDOSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		CALLAHAN JW, 1970, BIOCHIM BIOPHYS ACTA, V215, P527, DOI 10.1016/0304-4165(70)90104-2; DERRY DM, 1968, NEUROLOGY, V18, P340, DOI 10.1212/WNL.18.4.340; GATT S, 1966, BIOCHIM BIOPHYS ACTA, V113, P567, DOI 10.1016/S0926-6593(66)80014-0; HO MW, 1971, CLIN CHIM ACTA, V32, P443; HO MW, 1969, SCIENCE, V165, P611, DOI 10.1126/science.165.3893.611; JUNGALWALA FB, 1968, J BIOL CHEM, V243, P4258; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACBRINN M, 1969, NEW ENGL J MED, V281, P338, DOI 10.1056/NEJM196908142810702; MACBRINN MC, 1969, SCIENCE, V163, P946, DOI 10.1126/science.163.3870.946; OBRIEN J, 1969, J PEDIATR, V75, P167, DOI 10.1016/S0022-3476(69)80387-2; OBRIEN JS, 1969, LANCET, V2, P805; OBRIEN JS, 1970, GANGLIOSIDE STORAGE, P225; OCKERMAN PA, 1968, J CLIN LAB INVEST, V22, P199; OKADA S, 1968, SCIENCE, V160, P1002, DOI 10.1126/science.160.3831.1002; PATTON VM, 1971, ARCH NEUROL-CHICAGO, V24, P529, DOI 10.1001/archneur.1971.00480360063008; PINSKY L, 1970, NATURE, V228, P1093, DOI 10.1038/2281093b0; ROBINSON D, 1967, BIOCHEM J, V102, P525, DOI 10.1042/bj1020525; SMITHIES O, 1959, BIOCHEM J, V71, P585, DOI 10.1042/bj0710585; SUZUKI K, 1969, J NEUROPATH EXP NEUR, V28, P25, DOI 10.1097/00005072-196901000-00003; SUZUKI Y, 1971, ARCH NEUROL-CHICAGO, V24, P58, DOI 10.1001/archneur.1971.00480310086008; TAPPEL AL, 1968, COMPR BIOCHEM, V23, P77; VANHOOF F, 1968, EUR J BIOCHEM, V7, P34	22	36	36	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1972	24	4					454	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M8063	5031983				2022-12-18	WOS:A1972M806300007
J	FELDMAN, MW; NABHOLZ, M; BODMER, WF				FELDMAN, MW; NABHOLZ, M; BODMER, WF			EVOLUTION OF RH POLYMORPHISM - A MODEL FOR INTERACTION OF INCOMPATIBILITY REPRODUCTIVE COMPENSATION AND HETEROZYGOTE ADVANTAGE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article														Bodmer, Walter/0000-0001-6244-9792				BODMER WF, 1965, GENETICS, V51, P411; BODMER WF, 1967, GENETICS, V57, P237; BODMER WF, 1966, 7 P INT TRANSPL C NY, V129, P473; CAVALLISFORZA LL, IN PRESS; CEPPELLINI R, 1967, HISTOCOMPATIBILITY T; CURTONI ES, 1967, HISTOCOMPATIBILIT ED; EDWARDS AWF, 1961, 2 P INT C HUM GEN RO, P222; FISHER R A, 1947, Am Sci, V35, P95; Fisher R. A., 1947, AM SCI, V35, P113; Fisher RA, 1944, NATURE, V153, P106, DOI 10.1038/153106b0; GLASS B, 1950, AMER J OBSTET GYNEC, V57, P323; Haldane JBS, 1944, NATURE, V153, P106, DOI 10.1038/153106a0; Haldane JBS, 1942, ANN EUGEN, V11, P333; HOGBEN L, 1943, NATURE, V153, P721; KARLIN S, 1968, GENETICS, V59, P117; LEVENE HOWARD, 1961, PROGR MED GENET, V1, P120; LEVIN BR, 1967, AM J HUM GENET, V19, P288; LI CC, 1953, AM NAT, V87, P257, DOI 10.1086/281782; MOHR J, 1956, Acta Genet Stat Med, V6, P24; MOLLISON P, 1967, BLOOD TRANSFUSION CL; Mourant A., 1954, DISTRIBUTION HUMAN B; RACE RR, 1964, BLOOD GROUPS MAN; VOGEL F., 1960, ACTA GENET ET STATIST MED, V10, P247; VOGEL F, 1954, AM J HUM GENET, V6, P279; WIENER AS, 1964, AM J HUM GENET, V16, P246; Wiener AS, 1942, SCIENCE, V96, P407, DOI 10.1126/science.96.2496.407	26	36	36	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1969	21	2					171	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	D3696	4976959				2022-12-18	WOS:A1969D369600007
J	DEKABAN, AS				DEKABAN, AS			TRANSMISSION OF A D/D RECIPROCAL TRANSLOCATION IN A FAMILY WITH HIGH INCIDENCE OF MENTAL RETARDATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BUHLER EM, 1963, ACTA PAEDIATR, V52, P177, DOI 10.1111/j.1651-2227.1963.tb03762.x; COOPER HL, 1961, MAMMALIAN CHROMOSOME, V4, P12; DEGROUCHY J, 1963, CR HEBD ACAD SCI, V256, P1614; ENGEL E, 1965, CYTOGENETICS, V4, P157, DOI 10.1159/000129852; GERMAN J, 1964, J CELL BIOL, V20, P37, DOI 10.1083/jcb.20.1.37; HAMERTON J. L., 1963, CYTOGENETICS [BASEL], V2, P194, DOI 10.1159/000129779; JAGIELLO GM, 1963, NEW ENGL J MED, V269, P66, DOI 10.1056/NEJM196307112690202; KJESSLER B, 1964, LANCET, V1, P1421; LEJEUNE J, 1960, CR HEBD ACAD SCI, V250, P2468; MOORHEAD PS, 1960, EXP CELL RES, V20, P613, DOI 10.1016/0014-4827(60)90138-5; SCHMID W., 1963, CYTOGENETICS [BASEL], V2, P175, DOI 10.1159/000129778; WALKER S, 1962, ANN HUM GENET, V26, P151, DOI 10.1111/j.1469-1809.1962.tb01322.x; YUNIS JJ, 1964, NEW ENGL J MED, V271, P1133, DOI 10.1056/NEJM196411262712203; ZERGOLLERN LJILJANA, 1964, CYTOGENETICS, V3, P148, DOI 10.1159/000129806	14	36	36	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1966	18	3					288	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	77584	5944421				2022-12-18	WOS:A19667758400006
J	COOPER, AJ; MCDONOUGH, JR; BLUMBERG, BS; WORKMAN, PL				COOPER, AJ; MCDONOUGH, JR; BLUMBERG, BS; WORKMAN, PL			BIOCHEMICAL POLYMORPHIC TRAITS IN A U S WHITE AND NEGRO POPULATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALLISON AC, 1960, NATURE, V186, P531, DOI 10.1038/186531a0; BLUMBERG BS, 1961, BIOCHIM BIOPHYS ACTA, V50, P90, DOI 10.1016/0006-3002(61)91064-2; BLUMBERG BS, 1961, NATURE, V189, P897, DOI 10.1038/189897a0; BLUMBERG BS, 1961, C GENETIC POLYMORRPH; GERALD PS, 1961, HUM GENET, P76; GLASS B, 1953, AM J HUM GENET, V5, P1; HARRIS H, 1950, ANN EUGENIC, V15, P24, DOI 10.1111/j.1469-1809.1949.tb02419.x; MCDONOUGH JR, 1963, CIRCULATION; MCGUIRE C, 1955, 3 RES PAP HUM DEV; MOTULSKY AG, 1961, C GENETIC POLYMORPHI; POULIK MD, 1957, NATURE, V180, P1477, DOI 10.1038/1801477a0; Race Robert Russell, 1958, BLOOD GROUPS MAN; ROBINSON AR, 1957, J LAB CLIN MED, V50, P745; ROBINSON JC, 1963, J LAB CLIN MED; ROSENFIELD RE, 1962, TRANSFUSION, V2, P287, DOI 10.1111/j.1537-2995.1962.tb00244.x; SINGER K, 1951, BLOOD, V6, P413, DOI 10.1182/blood.V6.5.413.413; SMITHIES O, 1959, BIOCHEM J, V72, P121, DOI 10.1042/bj0720121; SMITHIES O, 1955, BIOCHEM J, V61, P629, DOI 10.1042/bj0610629; WORKMAN PL, 1963, AM J HUM GENET, V15, P429	19	36	36	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1963	15	4					420	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2968A	14097236				2022-12-18	WOS:A19632968A00003
J	FIRSCHEIN, I				FIRSCHEIN, I			POPULATION DYNAMICS OF SICKLE-CELL TRAIT IN BLACK CARIBS OF BRITISH HONDURAS, CENTRAL AMERICA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ADAMS J, 1901, STDTVA; ALLISON A. C., 1957, EXPTL PARASITOL, V6, P418, DOI 10.1016/0014-4894(57)90032-2; ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; ALLISON AC, 1954, ANN HUM GENET, V19, P39, DOI 10.1111/j.1469-1809.1954.tb01261.x; ALLISON AC, 1956, CLIN SCI, V15, P497; ALLISON AC, 1956, ANN HUM GENET, V21, P67, DOI 10.1111/j.1469-1809.1971.tb00266.x; ALLISON AC, 1954, T ROY SOC TROP MED H, V48, P312, DOI 10.1016/0035-9203(54)90101-7; BLACKLOCK D. B., 1925, Annals of Tropical Medicine and Parasitology, V19, P327; BLACKLOCK DB, 1925, ANN TROP MED PARASIT, V19, P37; BRUCECHWATT LJ, 1952, ANN TROP MED PARASIT, V46, P173, DOI 10.1080/00034983.1952.11685522; CEPPELLINI R, 1955, ANN HUM GENET, V20, P97; CHRISTOPHERS S. R., 1924, Indian Journal of Medical Research, V12, P273; Clark H. C., 1949, MALARIOLOGY, V2, P874; COELHO R, 1955, THESIS; COLBOURNE M J, 1954, J Trop Med Hyg, V57, P203; Conzemius E, 1928, AM ANTHROPOL, V30, P183, DOI 10.1525/aa.1928.30.2.02a00010; Covell Sir G., 1950, Tropical Diseases Bulletin, V47, P1147; DAVIES J. N. P., 1948, East African Medical Journal, V25, P228; DELBROUCK J, 1958, Ann Soc Belg Med Trop (1920), V38, P103; DUREN A N, 1951, Ann Soc Belg Med Trop (1920), V31, P129; EDINGTON G M, 1955, Trans R Soc Trop Med Hyg, V49, P253, DOI 10.1016/0035-9203(55)90068-7; EDWARDS B, 1906, HCCBCWI; FIELD JW, 1949, T ROY SOC TROP MED H, V43, P33, DOI 10.1016/0035-9203(49)90022-X; GABALDON A, 1949, MALARIOLOGY, P764; GARNHAM PCC, 1949, ANN TROP MED PARASIT, V43, P47, DOI 10.1080/00034983.1949.11685394; GERSHOWITZ H, 1959, AM J PHYS ANTHROPOL, V17, P195, DOI 10.1002/ajpa.1330170305; GIGLIOLI G, 1948, MALARIA FILARIASIS Y; HACKETT LW, 1941, SHM, P148; HIERNAUX J, 1952, ANN MUS CONG BEL SER, V2; JELLIFFE DB, 1952, T ROY SOC TROP MED H, V46, P13, DOI 10.1016/0035-9203(52)90002-3; Kitchen S. F., 1949, MALARIOLOGY, V2, P966; Komp W H, 1940, Science, V91, P522, DOI 10.1126/science.91.2370.522; KUMM HENRY W., 1941, AMER JOUR TROP MED, V21, P559; KUNKEL HG, 1957, J CLIN INVEST, V36, P1615, DOI 10.1172/JCI103561; LABAT JB, 1942, NVIA; LAYRISSE M, 1958, AM J PHYS ANTHROPOL, V16, P173, DOI 10.1002/ajpa.1330160203; LAYRISSE M, 1957, NATURE, V179, P478, DOI 10.1038/179478b0; LEHMANN H, 1956, BRIT MED J, V2, P333, DOI 10.1136/bmj.2.4988.333; LIVINGSTONE FB, 1957, BRIT MED J, V1, P762, DOI 10.1136/bmj.1.5021.762-b; LIVINGSTONE FB, 1958, AM ANTHROPOL, V60, P533, DOI 10.1525/aa.1958.60.3.02a00110; MACDONALD G, 1951, BRIT MED BULL, V8, P33, DOI 10.1093/oxfordjournals.bmb.a074051; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Mackey J. P., 1953, East African Medical Journal, V30, P13; Miller M. J., 1956, Transactions of the Royal Society of Tropical Medicine and Hygiene, V50, P294, DOI 10.1016/0035-9203(56)90037-2; NEEL JV, 1957, NEW ENGL J MED, V256, P161, DOI 10.1056/NEJM195701242560405; NEEL JV, 1953, AM J HUM GENET, V5, P154; NEEL JV, 1956, ANN HUM GENET, V21, P1, DOI 10.1111/j.1469-1809.1971.tb00262.x; PLATEL G., 1940, Annales de la Societe Belge de Medecine Tropicale, V20, P297; SHEPHARD C, 1931, HAISV; Shortt H. E., 1951, British Medical Journal London ii, VA51, P1103; Smith E. C., 1943, TRANS ROY SOC TROP MED AND HYG, V36, P287, DOI 10.1016/S0035-9203(43)90054-9; SWELLENGREBEL NH, 1950, ANN TROP MED PARASIT, V44, P84, DOI 10.1080/00034983.1950.11685430; TAYLOR DM, 1951, VIKING FUND PUB ANTH, V17, P1; WALTON GA, 1947, ANN TROP MED PARASIT, V41, P380, DOI 10.1080/00034983.1947.11685341; WHITBOURNE MB, 1930, WEST AFR MED J, V4, P3; Wilson D. B., 1950, Tropical Diseases Bulletin, V47, P677; YOUNG W, 1895, ABCISV	57	36	36	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1961	13	2					233	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2960A	13699768				2022-12-18	WOS:A19612960A00001
J	STEINBERG, AG; MORTON, NE				STEINBERG, AG; MORTON, NE			SEQUENTIAL TEST FOR LINKAGE BETWEEN CYSTIC FIBROSIS OF THE PANCREAS AND THE MNS LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BAILEY NTJ, 1951, ANN EUGENIC, V16, P223, DOI 10.1111/j.1469-1809.1951.tb02474.x; Berkson J, 1938, J AM STAT ASSOC, V33, P526, DOI 10.2307/2279690; MORTON NE, 1956, AM J HUM GENET, V8, P80; MORTON NE, 1955, AM J HUM GENET, V7, P277; SMITH CAB, 1954, ANN EUGENIC, V18, P278; STEINBERG AG, 1956, AM J HUM GENET, V8, P162	6	36	39	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1956	8	3					177	189						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF070	13362225				2022-12-18	WOS:A1956WF07000006
J	Sacoto, MJG; Tchasovnikarova, IA; Torti, E; Forster, C; Andrew, EH; Anselm, I; Baranano, KW; Briere, LC; Cohen, JS; Craigen, WJ; Cytrynbaum, C; Ekhilevitch, N; Elrick, MJ; Fatemi, A; Fraser, JL; Gallagher, RC; Guerin, A; Haynes, D; High, FA; Inglese, CN; Kiss, C; Koenig, MK; Krier, J; Lindstrom, K; Marble, M; Meddaugh, H; Moran, ES; Morel, CF; Mu, WY; Muller, EA; Nance, J; Natowicz, MR; Numis, AL; Ostrem, B; Pappas, J; Stafstrom, CE; Streff, H; Sweetser, DA; Szybowska, M; Walker, MA; Wang, W; Weiss, K; Weksberg, R; Wheeler, PG; Yoon, G; Kingston, RE; Juusola, J				Sacoto, Maria J. Guillen; Tchasovnikarova, Iva A.; Torti, Erin; Forster, Cara; Andrew, E. Hallie; Anselm, Irina; Baranano, Kristin W.; Briere, Lauren C.; Cohen, Julie S.; Craigen, William J.; Cytrynbaum, Cheryl; Ekhilevitch, Nina; Elrick, Matthew J.; Fatemi, Ali; Fraser, Jamie L.; Gallagher, Renata C.; Guerin, Andrea; Haynes, Devon; High, Frances A.; Inglese, Cara N.; Kiss, Courtney; Koenig, Mary Kay; Krier, Joel; Lindstrom, Kristin; Marble, Michael; Meddaugh, Hannah; Moran, Ellen S.; Morel, Chantal F.; Mu, Weiyi; Muller, Eric A., II; Nance, Jessica; Natowicz, Marvin R.; Numis, Adam L.; Ostrem, Bridget; Pappas, John; Stafstrom, Carl E.; Streff, Haley; Sweetser, David A.; Szybowska, Marta; Walker, Melissa A.; Wang, Wei; Weiss, Karin; Weksberg, Rosanna; Wheeler, Patricia G.; Yoon, Grace; Kingston, Robert E.; Juusola, Jane		Undiagnosed Dis Network	De Novo Variants in the ATPase Module of MORC2 Cause a Neurodevelopmental Disorder with Growth Retardation and Variable Craniofacial Dysmorphism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MARIE-TOOTH DISEASE; MUTATIONS	MORC2 encodes an ATPase that plays a role in chromatin remodeling, DNA repair, and transcriptional regulation. Heterozygous variants in MORC2 have been reported in individuals with autosomal-dominant Charcot-Marie-Tooth disease type 2Z and spinal muscular atrophy, and the onset of symptoms ranges from infancy to the second decade of life. Here, we present a cohort of 20 individuals referred for exome sequencing who harbor pathogenic variants in the ATPase module of MORC2. Individuals presented with a similar phenotype consisting of developmental delay, intellectual disability, growth retardation, microcephaly, and variable craniofacial dysmorphism. Weakness, hyporeflexia, and electrophysiologic abnormalities suggestive of neuropathy were frequently observed but were not the predominant feature. Five of 18 individuals for whom brain imaging was available had lesions reminiscent of those observed in Leigh syndrome, and five of six individuals who had dilated eye exams had retinal pigmentary abnormalities. Functional assays revealed that these MORC2 variants result in hyperactivation of epigenetic silencing by the HUSH complex, supporting their pathogenicity. The described set of morphological, growth, developmental, and neurological findings and medical concerns expands the spectrum of genetic disorders resulting from pathogenic variants in MORC2.	[Sacoto, Maria J. Guillen; Torti, Erin; Forster, Cara; Wang, Wei; Juusola, Jane] GeneDx Inc, Gaithersburg, MD 20877 USA; [Tchasovnikarova, Iva A.; Kingston, Robert E.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Tchasovnikarova, Iva A.; Kingston, Robert E.] Harvard Med Sch, Dept Genet, Boston, MA 02114 USA; [Andrew, E. Hallie; Fraser, Jamie L.] Childrens Natl Hosp, Rare Dis Inst, Myelin Disorders Program, Washington, DC 20010 USA; [Anselm, Irina] Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Baranano, Kristin W.; Cohen, Julie S.; Elrick, Matthew J.; Fatemi, Ali; Nance, Jessica; Stafstrom, Carl E.] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21287 USA; [Briere, Lauren C.; High, Frances A.; Sweetser, David A.] Massachusetts Gen Hosp, Dept Med Genet & Metab, Boston, MA 02114 USA; [Cohen, Julie S.; Fatemi, Ali] Kennedy Krieger Inst, Dept Neurol & Dev Med, Div Neurogenet, Baltimore, MD 21205 USA; [Cohen, Julie S.; Nance, Jessica] Kennedy Krieger Inst, Ctr Genet Muscle Disorders, Baltimore, MD 21205 USA; [Craigen, William J.; Streff, Haley] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Cytrynbaum, Cheryl; Weksberg, Rosanna] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada; [Cytrynbaum, Cheryl; Inglese, Cara N.; Weksberg, Rosanna; Yoon, Grace] Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; [Ekhilevitch, Nina; Weiss, Karin] Genet Inst Inc, Rambam Hlth Care Campus, IL-3109601 Haifa, Israel; [Fatemi, Ali] Johns Hopkins Univ, Dept Pediat, Sch Med, Baltimore, MD 21287 USA; [Gallagher, Renata C.] Univ Calif San Francisco, Dept Pediat, Div Med Genet, San Francisco, CA 94158 USA; [Guerin, Andrea; Kiss, Courtney] Queens Univ, Dept Pediat, Div Med Genet, Kingston, ON K7L 2V7, Canada; [Haynes, Devon; Wheeler, Patricia G.] Arnold Palmer Hosp Children, Div Genet, Orlando Hlth, Orlando, FL 32806 USA; [Koenig, Mary Kay] Univ Texas Houston, Dept Pediat, McGovern Med Sch, Houston, TX 77030 USA; [Krier, Joel] Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA; [Lindstrom, Kristin] Phoenix Childrens Hosp, Div Genet & Metab, Phoenix, AZ 85016 USA; [Marble, Michael] LSU Hlth Sci Ctr, Dept Pediat, Div Clin Genet & Metab, New Orleans, LA 70112 USA; [Marble, Michael] Childrens Hosp, New Orleans, LA 70112 USA; [Meddaugh, Hannah] Childrens Hosp New Orleans, Dept Clin Genet & Metab, New Orleans, LA 70118 USA; [Moran, Ellen S.] NYU, Langone Orthoped Hosp, Hassenfeld Childrens Hosp, New York Univ Langone, New York, NY 10003 USA; [Morel, Chantal F.; Szybowska, Marta] Univ Hlth Network, Fred A Litwin Family Ctr Genet Med, Toronto, ON M5T 3L9, Canada; [Morel, Chantal F.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; [Mu, Weiyi] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Sch Med, Baltimore, MD 21287 USA; [Muller, Eric A., II] Stanford Childrens Hlth, Clin Genet, San Francisco, CA 94109 USA; [Natowicz, Marvin R.] Cleveland Clin, Inst Pathol & Lab Med, Cleveland, OH 44195 USA; [Natowicz, Marvin R.] Cleveland Clin, Inst Genom Med, Cleveland, OH 44195 USA; [Numis, Adam L.] Univ Calif San Francisco, Dept Neurol & Pediat, San Francisco, CA 94158 USA; [Ostrem, Bridget] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Pappas, John] NYU, Clin Genet Serv, Pediat, Grossman Sch Med, New York, NY 10016 USA; [Walker, Melissa A.] Massachusetts Gen Hosp, Dept Neurol, Div Neurogenet, Boston, MA 02114 USA; [Weksberg, Rosanna] Univ Toronto, Dept Pediat, Toronto, ON M5G 1X8, Canada; [Weksberg, Rosanna] Univ Toronto, Inst Med Sci, Toronto, ON M5G 1X8, Canada	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Children's National Health System; Harvard University; Boston Children's Hospital; Johns Hopkins University; Johns Hopkins Medicine; Harvard University; Massachusetts General Hospital; Kennedy Krieger Institute; Kennedy Krieger Institute; Baylor College of Medicine; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Rambam Health Care Campus; Johns Hopkins University; University of California System; University of California San Francisco; Queens University - Canada; University of Texas System; University of Texas Health Science Center Houston; Harvard University; Brigham & Women's Hospital; Phoenix Children's Hospital; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Children's Hospital of New Orleans; Children's Hospital of New Orleans; New York University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Johns Hopkins University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; New York University; Harvard University; Massachusetts General Hospital; University of Toronto; University of Toronto	Sacoto, MJG (corresponding author), GeneDx Inc, Gaithersburg, MD 20877 USA.	mguillen@genedx.com	Sweetser, David/ABB-9347-2021; Numis, Adam Lawrence/AAI-5395-2021; Pappas, John/K-6530-2012	Sweetser, David/0000-0002-1621-3284; Fraser, Jamie/0000-0002-7794-8903; Tchasovnikarova, Iva/0000-0002-0477-0956; Pappas, John/0000-0001-5625-2598; Elrick, Matthew/0000-0001-7608-7593; Guerin, Andrea/0000-0003-2941-7603	NIH Common Fund through the Office of Strategic Coordination, Office of the NIH Director [U01HG007690]	NIH Common Fund through the Office of Strategic Coordination, Office of the NIH Director	I.A.T. is a postdoctoral fellow of the Damon Runyon Cancer Research Foundation. Research reported in this manuscript was supported by the NIH Common Fund through the Office of Strategic Coordination, Office of the NIH Director under award number U01HG007690. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albulym OM, 2016, ANN NEUROL, V79, P419, DOI 10.1002/ana.24575; Ando M, 2017, EUR J NEUROL, V24, P1274, DOI 10.1111/ene.13360; Douse CH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03045-x; Hyun YS, 2016, BRAIN, V139, DOI 10.1093/brain/aww082; Lassuthova P, 2016, BRAIN, V139, DOI 10.1093/brain/awv411; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li DQ, 2012, CELL REP, V2, P1657, DOI 10.1016/j.celrep.2012.11.018; Mcrae JF, 2017, NATURE, V542, P433, DOI 10.1038/nature21062; Moissiard G, 2012, SCIENCE, V336, P1448, DOI 10.1126/science.1221472; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Retterer K, 2016, GENET MED, V18, P696, DOI 10.1038/gim.2015.148; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Sanchez-Solana B, 2014, BBA-MOL CELL RES, V1843, P316, DOI 10.1016/j.bbamcr.2013.11.012; Sancho P, 2019, HUM MOL GENET, V28, P1629, DOI 10.1093/hmg/ddz006; Schottmann G, 2016, BRAIN, V139, DOI 10.1093/brain/aww252; Semplicini C, 2017, BRAIN, V140, DOI 10.1093/brain/awx019; Sevilla T, 2016, BRAIN, V139, P62, DOI 10.1093/brain/awv311; Shy ME, 2006, J NEUROL SCI, V242, P55, DOI 10.1016/j.jns.2005.11.015; Tchasovnikarova IA, 2017, NAT GENET, V49, P1035, DOI 10.1038/ng.3878; Verma P, 2010, CHANNELS, V4, P319, DOI 10.4161/chan.4.4.12905; Zanni G, 2017, BRAIN, V140, DOI 10.1093/brain/awx083	21	35	35	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 6	2020	107	2					352	363		10.1016/j.ajhg.2020.06.013	http://dx.doi.org/10.1016/j.ajhg.2020.06.013			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MY5YF	32693025	Bronze, Green Published			2022-12-18	WOS:000558491800015
J	Radenkovic, S; Bird, MJ; Emmerzaal, TL; Wong, SY; Felgueira, C; Stiers, KM; Sabbagh, L; Himmelreich, N; Poschet, G; Windmolders, P; Verheijen, J; Witters, P; Altassan, R; Honzik, T; Eminoglu, TF; James, PM; Edmondson, AC; Hertecant, J; Kozicz, T; Thiel, C; Vermeersch, P; Cassiman, D; Beamer, L; Morava, E; Ghesquiere, B				Radenkovic, Silvia; Bird, Matthew J.; Emmerzaal, Tim L.; Wong, Sunnie Y.; Felgueira, Catarina; Stiers, Kyle M.; Sabbagh, Leila; Himmelreich, Nastassja; Poschet, Gernot; Windmolders, Petra; Verheijen, Jan; Witters, Peter; Altassan, Ruqaiah; Honzik, Tomas; Eminoglu, Tuba F.; James, Phillip M.; Edmondson, Andrew C.; Hertecant, Jozef; Kozicz, Tamas; Thiel, Christian; Vermeersch, Pieter; Cassiman, David; Beamer, Lesa; Morava, Eva; Ghesquiere, Bart			The Metabolic Map into the Pathomechanism and Treatment of PGM1-CDG	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL DISORDERS; GALACTOSE SUPPLEMENTATION; IDENTIFICATION; DEFICIENCY; PHENOTYPE; CELLS	Phosphoglucomutase 1 (PGM1) encodes the metabolic enzyme that interconverts glucose-6-P and glucose-1-P. Mutations in PGM1 cause impairment in glycogen metabolism and glycosylation, the latter manifesting as a congenital disorder of glycosylation (CDG). This unique metabolic defect leads to abnormal N-glycan synthesis in the endoplasmic reticulum (ER) and the Golgi apparatus (GA). On the basis of the decreased galactosylation in glycan chains, galactose was administered to individuals with PGM1-CDG and was shown to markedly reverse most disease-related laboratory abnormalities. The disease and treatment mechanisms, however, have remained largely elusive. Here, we confirm the clinical benefit of galactose supplementation in PGM1-CDG-affected individuals and obtain significant insights into the functional and biochemical regulation of glycosylation. We report here that, by using tracer-based metabolomics, we found that galactose treatment of PGM1-CDG fibroblasts metabolically re-wires their sugar metabolism, and as such replenishes the depleted levels of galactose-1-P, as well as the levels of UDP-glucose and UDP-galactose, the nucleotide sugars that are required for ER- and GA-linked glycosylation, respectively. To this end, we further show that the galactose in UDP-galactose is incorporated into mature, de novo glycans. Our results also allude to the potential of monosaccharide therapy for several other CDG.	[Radenkovic, Silvia; Bird, Matthew J.; Ghesquiere, Bart] VIB Ctr Canc Biol, Metabol Expertise Ctr, Ctr Canc Biol, B-3000 Leuven, Belgium; [Radenkovic, Silvia; Bird, Matthew J.; Felgueira, Catarina; Windmolders, Petra; Cassiman, David] Katholieke Univ Leuven, Dept Chron Dis Metab & Aging, Lab Hepatol, B-3000 Leuven, Belgium; [Radenkovic, Silvia; Bird, Matthew J.; Ghesquiere, Bart] Katholieke Univ Leuven, Dept Oncol, Metabol Expertise Ctr, B-3000 Leuven, Belgium; [Bird, Matthew J.; Vermeersch, Pieter] Univ Hosp Leuven, Clin Dept Lab Med, B-3000 Leuven, Belgium; [Emmerzaal, Tim L.; Kozicz, Tamas] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Anat, NL-6535 HR Nijmegen, Netherlands; [Wong, Sunnie Y.; Sabbagh, Leila; Kozicz, Tamas] Tulane Univ, Sch Med, Hayward Genet Ctr, New Orleans, LA 70112 USA; [Stiers, Kyle M.; Beamer, Lesa] Univ Missouri, Biochem Dept, Columbia, MO 65211 USA; [Himmelreich, Nastassja; Thiel, Christian] Heidelberg Univ, Dept 1, Ctr Child & Adolescent Med, D-69120 Heidelberg, Germany; [Poschet, Gernot] Heidelberg Univ, Ctr Organismal Studies, D-69120 Heidelberg, Germany; [Verheijen, Jan; Kozicz, Tamas; Morava, Eva] Mayo Clin, Dept Clin Genom, Ctr Individualized Med, Rochester, MN 55905 USA; [Witters, Peter; Altassan, Ruqaiah; Cassiman, David; Morava, Eva] Univ Hosp Leuven, Metab Ctr, B-3000 Leuven, Belgium; [Altassan, Ruqaiah] McGill Univ, Montreal Childrens Hosp, Med Genet Dept, Montreal, PQ H4A 3J1, Canada; [Honzik, Tomas] Charles Univ Prague, Fac Med 1, Dept Pediat & Adolescent Med, Prague 12108, Czech Republic; [Honzik, Tomas] Univ Hosp Prague, Prague 12108, Czech Republic; [Eminoglu, Tuba F.] Ankara Univ, Sch Med, Dept Pediat Metab & Nutr, TR-06560 Ankara, Turkey; [James, Phillip M.] Phoenix Childrens Hosp, Phoenix Childrens Med Grp, Genet & Metab, Phoenix, AZ 85016 USA; [Edmondson, Andrew C.] Childrens Hosp Philadelphia, Dept Pediat, Div Human Genet, Philadelphia, PA 19104 USA; [Hertecant, Jozef] United Arab Emirates Univ, Dept Pediat, Al Ain, U Arab Emirates; [Vermeersch, Pieter] Katholieke Univ Leuven, Dept Cardiovasc Sci, B-3000 Leuven, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; KU Leuven; University Hospital Leuven; Radboud University Nijmegen; Tulane University; University of Missouri System; University of Missouri Columbia; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Mayo Clinic; KU Leuven; University Hospital Leuven; McGill University; Charles University Prague; General University Hospital Prague; Ankara University; Phoenix Children's Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; United Arab Emirates University; KU Leuven	Ghesquiere, B (corresponding author), VIB Ctr Canc Biol, Metabol Expertise Ctr, Ctr Canc Biol, B-3000 Leuven, Belgium.; Ghesquiere, B (corresponding author), Katholieke Univ Leuven, Dept Oncol, Metabol Expertise Ctr, B-3000 Leuven, Belgium.; Morava, E (corresponding author), Mayo Clin, Dept Clin Genom, Ctr Individualized Med, Rochester, MN 55905 USA.; Morava, E (corresponding author), Univ Hosp Leuven, Metab Ctr, B-3000 Leuven, Belgium.	morava-kozicz.eva@mayo.edu; bart.ghesquiere@kuleuven.vib.be	Ghesquiere, Bart/HGU-8736-2022; Radenkovic, Silvia/GNM-6207-2022; Vermeersch, Pieter/M-8352-2016; Eminoglu, Fatma Tuba/AAF-8522-2019; Emmerzaal, Tim/E-1754-2016; Cassiman, David/H-6813-2014	Ghesquiere, Bart/0000-0003-1547-1705; Vermeersch, Pieter/0000-0001-7076-061X; Emmerzaal, Tim/0000-0002-5066-0221; Cassiman, David/0000-0002-6154-0970; Thiel, Christian/0000-0001-6419-8747; Bird, Matthew/0000-0003-3185-0780; Himmelreich, Nastassja/0000-0002-1895-625X; Verheijen, Jan/0000-0003-0481-9649; Radenkovic, Silvia/0000-0001-8190-7736; Poschet, Gernot/0000-0002-5344-0865; Edmondson, Andrew/0000-0003-0313-0743	KU Leuven internal C1 funding grant [EFF-D2860-C14/17/110]; Nutricia Metabolic Research Fund; General University Hospital in Prague in the Czech Republic [RVO-VFN 64165]; Ministry of Health of the Czech Republic [MZ CR AZV 16-31932A]; Shire Research Chair; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008638] Funding Source: NIH RePORTER	KU Leuven internal C1 funding grant; Nutricia Metabolic Research Fund(Danone Nutricia); General University Hospital in Prague in the Czech Republic; Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Shire Research Chair; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	B.G., D.C., and P.V. were generously supported by a KU Leuven internal C1 funding grant (EFF-D2860-C14/17/110), B.G. by the Nutricia Metabolic Research Fund, T.H. by the General University Hospital in Prague in the Czech Republic (RVO-VFN 64165) and the Ministry of Health of the Czech Republic (MZ CR AZV 16-31932A). D.C. acknowledges generous support from the Shire Research Chair. We also thank Dr. Gert Matthijs (UZ Leuven) and Dr. Kucukcongar A. (Gazi University Medical School) for kindly providing us with PGM1-CDG fibroblast cultures. Finally, we are very grateful for the help related to the GC-MS analyses of hexose-P sugars by Dr. Frank David (Research Institute Chromatography, Kortrijk, Belgium).	Beamer L, 2015, J INHERIT METAB DIS, V38, P243, DOI 10.1007/s10545-014-9757-9; Buescher JM, 2015, CURR OPIN BIOTECH, V34, P189, DOI 10.1016/j.copbio.2015.02.003; Campeau PM, 2008, MOL GENET METAB, V95, P11, DOI 10.1016/j.ymgme.2008.07.001; Chen J, 2002, CLIN CHEM, V48, P604; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; Gaude E, 2018, MOL CELL, V69, P581, DOI 10.1016/j.molcel.2018.01.034; He P, 2012, J BIOL CHEM, V287, P18210, DOI 10.1074/jbc.M112.355677; Hu YM, 2017, ANALYST, V142, P2748, DOI 10.1039/c7an00396j; JAEKEN J, 1984, CLIN CHIM ACTA, V144, P245, DOI 10.1016/0009-8981(84)90059-7; Jaeken J, 2017, J INHERIT METAB DIS, V40, P569, DOI 10.1007/s10545-017-0050-6; Morava E, 2014, MOL GENET METAB, V112, P275, DOI 10.1016/j.ymgme.2014.06.002; Nowak-Sliwinska P, 2018, ANGIOGENESIS, V21, P425, DOI 10.1007/s10456-018-9613-x; Ondruskova N, 2014, NEUROENDOCRINOL LETT, V35, P137; Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0; Regni C, 2004, STRUCTURE, V12, P55, DOI 10.1016/j.str.2003.11.015; Reijngoud DJ, 2018, J INHERIT METAB DIS, V41, P309, DOI 10.1007/s10545-017-0124-5; ROBINSON BH, 1992, BIOCHEM MED METAB B, V48, P122, DOI 10.1016/0885-4505(92)90056-5; Roth Ziv, 2012, International Journal of Carbohydrate Chemistry, DOI 10.1155/2012/640923; Stojkovic T, 2009, NEW ENGL J MED, V361, P425, DOI 10.1056/NEJMc0901158; Tegtmeyer LC, 2014, NEW ENGL J MED, V370, P533, DOI 10.1056/NEJMoa1206605; Timal S, 2012, HUM MOL GENET, V21, P4151, DOI 10.1093/hmg/dds123; Voermans NC, 2017, NEUROMUSCULAR DISORD, V27, P370, DOI 10.1016/j.nmd.2017.01.014; Witters P, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111222; Wong SYW, 2017, GENET MED, V19, P1226, DOI 10.1038/gim.2017.41; Wong SYW, 2016, J PEDIATR-US, V175, P130, DOI 10.1016/j.jpeds.2016.04.021; 2008, J BIOL CHEM, V283, P2694, DOI DOI 10.1074/JBC.M800408200	26	35	37	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 2	2019	104	5					835	846		10.1016/j.ajhg.2019.03.003	http://dx.doi.org/10.1016/j.ajhg.2019.03.003			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HW3QV	30982613	Green Accepted, Bronze, Green Submitted, Green Published			2022-12-18	WOS:000466608700005
J	Whitworth, J; Smith, PS; Martin, JE; West, H; Luchetti, A; Rodger, F; Clark, G; Carss, K; Stephens, J; Stirrups, K; Penkett, C; Mapeta, R; Ashford, S; Megy, K; Shakeel, H; Ahmed, M; Adlard, J; Barwell, J; Brewer, C; Casey, RT; Armstrong, R; Cole, T; Evans, DG; Fostira, F; Greenhalgh, L; Hanson, H; Henderson, A; Hoffman, J; Izatt, L; Kumar, A; Kwong, A; Lalloo, F; Ong, KR; Paterson, J; Park, SM; Chen-Shtoyerman, R; Searle, C; Side, L; Skytte, AB; Snape, K; Woodward, ER; Tischkowitz, MD; Maher, ER				Whitworth, James; Smith, Philip S.; Martin, Jose-Ezequiel; West, Hannah; Luchetti, Andrea; Rodger, Faye; Clark, Graeme; Carss, Keren; Stephens, Jonathan; Stirrups, Kathleen; Penkett, Chris; Mapeta, Rutendo; Ashford, Sofie; Megy, Karyn; Shakeel, Hassan; Ahmed, Munaza; Adlard, Julian; Barwell, Julian; Brewer, Carole; Casey, Ruth T.; Armstrong, Ruth; Cole, Trevor; Evans, Dafydd Gareth; Fostira, Florentia; Greenhalgh, Lynn; Hanson, Helen; Henderson, Alex; Hoffman, Jonathan; Izatt, Louise; Kumar, Ajith; Kwong, Ava; Lalloo, Fiona; Ong, Kai Ren; Paterson, Joan; Park, Soo-Mi; Chen-Shtoyerman, Rakefet; Searle, Claire; Side, Lucy; Skytte, Anne-Bine; Snape, Katie; Woodward, Emma R.; Tischkowitz, Marc D.; Maher, Eamonn R.		NIHR BioResource Rare Dis Consorti	Comprehensive Cancer-Predisposition Gene Testing in an Adult Multiple Primary Tumor Series Shows a Broad Range of Deleterious Variants and Atypical Tumor Phenotypes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GERMLINE MUTATIONS; BREAST-CANCER; FRAMEWORK; FAMILIES; RISK	Multiple primary tumors (MPTs) affect a substantial proportion of cancer survivors and can result from various causes, including inherited predisposition. Currently, germline genetic testing of MPT-affected individuals for variants in cancer-predisposition genes (CPGs) is mostly targeted by tumor type. We ascertained pre-assessed MPT individuals (with at least two primary tumors by age 60 years or at least three by 70 years) from genetics centers and performed whole-genome sequencing (WGS) on 460 individuals from 440 families. Despite previous negative genetic assessment and molecular investigations, pathogenic variants in moderate- and high-risk CPGs were detected in 67/440 (15.2%) probands. WGS detected variants that would not be (or were not) detected by targeted resequencing strategies, including low-frequency structural variants (6/440 [1.4%] probands). In most individuals with a germline variant assessed as pathogenic or likely pathogenic (P/LP), at least one of their tumor types was characteristic of variants in the relevant CPG. However, in 29 probands (42.2% of those with a P/LP variant), the tumor phenotype appeared discordant. The frequency of individuals with truncating or splice-site CPG variants and at least one discordant tumor type was significantly higher than in a control population (chi(2) - 43.642; p <= 0.0001). 2/67 (3%) probands with P/LP variants had evidence of multiple inherited neoplasia allele syndrome (MINAS) with deleterious variants in two CPGs. Together with variant detection rates from a previous series of similarly ascertained MPT-affected individuals, the present results suggest that first-line comprehensive CPG analysis in an MPT cohort referred to clinical genetics services would detect a deleterious variant in about a third of individuals.	[Whitworth, James; Smith, Philip S.; Martin, Jose-Ezequiel; West, Hannah; Luchetti, Andrea; Rodger, Faye; Clark, Graeme; Shakeel, Hassan; Casey, Ruth T.; Armstrong, Ruth; Park, Soo-Mi; Tischkowitz, Marc D.; Maher, Eamonn R.] Univ Cambridge, Dept Med Genet, NIHR Cambridge Biomed Res Ctr, Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [Whitworth, James; Smith, Philip S.; Martin, Jose-Ezequiel; West, Hannah; Luchetti, Andrea; Rodger, Faye; Clark, Graeme; Shakeel, Hassan; Casey, Ruth T.; Armstrong, Ruth; Park, Soo-Mi; Tischkowitz, Marc D.; Maher, Eamonn R.] Canc Res UK Cambridge Ctr, Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [Carss, Keren; Stephens, Jonathan; Stirrups, Kathleen; Penkett, Chris; Mapeta, Rutendo; Ashford, Sofie; Megy, Karyn; Armstrong, Ruth; Park, Soo-Mi; Tischkowitz, Marc D.; Maher, Eamonn R.; NIHR BioResource Rare Dis Consorti] Cambridge Univ Hosp, NIHR BioResource, Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [Carss, Keren; Stephens, Jonathan; Stirrups, Kathleen; Penkett, Chris; Mapeta, Rutendo; Megy, Karyn] Univ Cambridge, NHS Blood & Transplant Ctr, Dept Haematol, Cambridge Biomed Campus, Cambridge CB2 0PT, England; [Ahmed, Munaza; Side, Lucy] Princess Anne Hosp, Dept Clin Genet, Southampton S016 5YA, Hants, England; [Ahmed, Munaza; Kumar, Ajith; Side, Lucy] Great Ormond St Hosp Sick Children, North East Thames Reg Genet Serv, London WC1N 3JH, England; [Adlard, Julian] Chapel Allerton Hosp, Yorkshire Reg Genet Serv, Leeds LS7 4SA, W Yorkshire, England; [Adlard, Julian] Leicester Royal Infirm, Univ Hosp Leicester, Dept Clin Genet, Leicester LE1 5WW, Leics, England; [Brewer, Carole] Royal Devon & Exeter Hosp, Peninsula Clin Genet, Exeter EX1 2ED, Devon, England; [Armstrong, Ruth; Paterson, Joan; Park, Soo-Mi] East Anglian Med Genet Serv, Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [Cole, Trevor; Hoffman, Jonathan; Ong, Kai Ren] Birmingham Womens & Childrens Hosp NHS Fdn Trust, West Midlands Reg Genet Serv, Birmingham B15 2TG, W Midlands, England; [Cole, Trevor; Hoffman, Jonathan; Ong, Kai Ren] Birmingham Womens & Childrens Hosp NHS Fdn Trust, Birmingham Hlth Partners, Birmingham B15 2TG, W Midlands, England; [Evans, Dafydd Gareth; Lalloo, Fiona; Woodward, Emma R.] Univ Manchester, Manchester Ctr Acad Hlth Sci, St Marys Hosp, Manchester Ctr Genom Med,Div Evolut & Genom Sci, Manchester M13 9WL, Lancs, England; [Fostira, Florentia] Natl Ctr Sci Res Demokritos, Mol Diagnost Lab, Athens, Greece; [Greenhalgh, Lynn] Liverpool Womens Hosp, Dept Clin Genet, Liverpool L8 7SS, Merseyside, England; [Hanson, Helen; Snape, Katie] St George Hosp, Dept Clin Genet, London SW17 0QT, England; [Henderson, Alex] Newcastle Upon Tyne Hosp, Int Ctr Life, Northern Genet Serv, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Izatt, Louise] Guys & St Thomas Hosp, Dept Clin Genet, London SE1 9RT, England; [Kwong, Ava] Univ Hong Kong, Div Breast Surg, Pokfulam, Hong Kong, Peoples R China; [Kwong, Ava] Hong Kong Hereditary Breast Canc Family Registry, Shau Kei Wan, Hong Kong, Peoples R China; [Kwong, Ava] Hong Kong Sanat & Hosp, Happy Valley, Hong Kong, Peoples R China; [Chen-Shtoyerman, Rakefet] Kaplan Med Ctr, Clin Genet Inst, IL-76100 Rehovot, Israel; [Chen-Shtoyerman, Rakefet] Hebrew Univ Jerusalem, Jerusalem, Israel; [Chen-Shtoyerman, Rakefet] Hadassah Med Ctr, Jerusalem, Israel; [Searle, Claire] City Hosp, Nottingham Univ Hosp, Dept Clin Genet, Nottingham NG5 1PB, England; [Skytte, Anne-Bine] Aarhus Univ Hosp, Dept Clin Genet, DK-8200 Aarhus, Denmark	University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Chapel Allerton Hospital; University Hospitals of Leicester NHS Trust; University of Leicester; University of Exeter; Birmingham Women's Hospital; Birmingham Women's Hospital; University of Manchester; National Centre of Scientific Research "Demokritos"; University of Liverpool; St Georges University London; Newcastle University - UK; Guy's & St Thomas' NHS Foundation Trust; University of Hong Kong; Hebrew University of Jerusalem; Kaplan Medical Center; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center; Nottingham University Hospital NHS Trust; University of Nottingham; Aarhus University	Maher, ER (corresponding author), Univ Cambridge, Dept Med Genet, NIHR Cambridge Biomed Res Ctr, Cambridge Biomed Campus, Cambridge CB2 0QQ, England.; Maher, ER (corresponding author), Canc Res UK Cambridge Ctr, Cambridge Biomed Campus, Cambridge CB2 0QQ, England.; Maher, ER (corresponding author), Cambridge Univ Hosp, NIHR BioResource, Cambridge Biomed Campus, Cambridge CB2 0QQ, England.	erm1000@medschl.cam.ac.uk	Southgate, Laura/H-7924-2019; Woodward, Emma/U-1282-2019; CHEN-SHTOYERMAN, RAKEFET/ABC-2491-2021; Snape, Katie/AAA-8101-2022; Lawrie, Allan/A-2708-2012; Fostira, Florentia/Z-5730-2019; Allsup, David/H-2195-2017; Gale, Daniel/D-5594-2013; Savic, Sinisa/Q-6217-2019; Evans, D Gareth/AAB-4308-2022; MAHER, EAMONN R/A-9507-2008; Brown, Matthew A/E-5749-2010; Tischkowitz, Marc/O-4452-2018; Ponsford, Mark J/ABA-3891-2020; Booth, Claire/I-3667-2016; Martin, Jose Ezequiel/F-4869-2012; Sargur, Ravishankar/C-2270-2009; Kwong, Ava/D-8005-2013	Southgate, Laura/0000-0002-2090-1450; Woodward, Emma/0000-0002-6297-2855; CHEN-SHTOYERMAN, RAKEFET/0000-0002-5055-5907; Lawrie, Allan/0000-0003-4192-9505; Allsup, David/0000-0001-6159-6109; Gale, Daniel/0000-0002-9170-1579; Savic, Sinisa/0000-0001-7910-0554; Evans, D Gareth/0000-0002-8482-5784; MAHER, EAMONN R/0000-0002-6226-6918; Brown, Matthew A/0000-0003-0538-8211; Tischkowitz, Marc/0000-0002-7880-0628; Ponsford, Mark J/0000-0002-0236-1059; Chinnery, Patrick/0000-0002-7065-6617; Gissen, Paul/0000-0002-9712-6122; james, roger/0000-0002-0058-1357; Michaelides, Michel/0000-0002-1552-7046; Stephens, Jonathan/0000-0003-2020-9330; Smith, Philip/0000-0002-9306-1747; Carss, Keren/0000-0003-4939-156X; Megy, Karyn/0000-0002-2826-3879; Aitman, Timothy/0000-0002-7875-4502; Booth, Claire/0000-0002-2626-5037; Martin, Jose Ezequiel/0000-0002-0051-8868; vonk noordegraaf, anton/0000-0002-4057-758X; Meacham, Stuart/0000-0002-3667-6059; , Jesmeen/0000-0003-4169-8209; Deevi, Sri Vishnu Vardhan/0000-0002-0405-4335; mumford, andrew/0000-0002-5523-511X; freson, kathleen/0000-0002-4381-2442; Matser, Vera/0000-0002-2010-6844; Erber, Wendy/0000-0002-1028-9376; MacLaren, Robert/0000-0002-3096-4682; Sargur, Ravishankar/0000-0002-8535-630X; Skytte, Anne-Bine/0000-0002-0067-9557; Bradley, John/0000-0002-7774-8805; Thompson, Dorothy/0000-0001-5491-3911; Smith, Kenneth/0000-0003-3829-4326; Kingston, Nathalie/0000-0002-9190-2231; Burns, Siobhan/0000-0002-3356-9506; QASIM, WASEEM/0000-0001-8353-4494; Kwong, Ava/0000-0002-6968-9489; /0000-0003-2885-4692; Machado, Rajiv David/0000-0001-9247-0744; Lango Allen, Hana/0000-0002-7803-8688; Grozeva, Detelina/0000-0003-3239-8415; Toshner, Mark/0000-0002-3969-6143	Cancer Research UK Cambridge Cancer Centre; NIHR [RG65966]; European Research Council; NIHR; Medical Research Council; National Health Service (NHS) in the East of England through the Clinical Academic Reserve; NIHR Manchester Biomedical Research Centre; MRC [G0800671] Funding Source: UKRI	Cancer Research UK Cambridge Cancer Centre; NIHR(National Institute for Health Research (NIHR)); European Research Council(European Research Council (ERC)European Commission); NIHR(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Health Service (NHS) in the East of England through the Clinical Academic Reserve; NIHR Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	J.W. is supported by a Clinical Research Training Fellowship from the Cancer Research UK Cambridge Cancer Centre. Funding for the National Institute for Health Research (NIHR) BioResource Rare Diseases project was provided by the NIHR (grant number RG65966). E.R.M. acknowledges support from the European Research Council (Advanced Researcher Award), the NIHR (Senior Investigator Award and Cambridge NIHR Biomedical Research Centre), the Cancer Research UK Cambridge Cancer Centre, and the Medical Research Council (Infrastructure Award). The University of Cambridge has received salary support for E.R.M. from the National Health Service (NHS) in the East of England through the Clinical Academic Reserve. The views expressed herein are those of the authors and not necessarily those of the NHS or the Department of Health. D.G.E. is an NIHR Senior Investigator and is supported by the NIHR Manchester Biomedical Research Centre.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Antoniou AC, 2014, NEW ENGL J MED, V371, P497, DOI [10.1056/NEJMoa1400382, 10.1056/NEJMc1410673]; Aoude LG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100683; Belkadi A, 2015, P NATL ACAD SCI USA, V112, P5473, DOI 10.1073/pnas.1418631112; Carss KJ, 2017, AM J HUM GENET, V100, P75, DOI 10.1016/j.ajhg.2016.12.003; Casey RT, 2017, J CLIN ENDOCR METAB, V102, P4013, DOI 10.1210/jc.2017-00562; Castro-Vega LJ, 2014, HUM MOL GENET, V23, P2440, DOI 10.1093/hmg/ddt639; Chen XY, 2016, BIOINFORMATICS, V32, P1220, DOI 10.1093/bioinformatics/btv710; Clark GR, 2014, J CLIN ENDOCR METAB, V99, pE2046, DOI 10.1210/jc.2014-1659; Comino-Mendez I, 2011, NAT GENET, V43, P663, DOI 10.1038/ng.861; Coughlin EM, 1998, MOL GENET METAB, V63, P254, DOI 10.1006/mgme.1998.2684; Cybulski C, 2004, AM J HUM GENET, V75, P1131, DOI 10.1086/426403; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Feero WG, 2014, JAMA-J AM MED ASSOC, V311, P1017, DOI 10.1001/jama.2014.1718; Gonzalez KD, 2009, J CLIN ONCOL, V27, P1250, DOI 10.1200/JCO.2008.16.6959; International Agency for Research on Cancer, 2004, INT RUL MULT PRIM CA; Ipe J, 2017, CTS-CLIN TRANSL SCI, V10, P67, DOI 10.1111/cts.12440; Jafri M, 2015, CANCER DISCOV, V5, P723, DOI 10.1158/2159-8290.CD-14-1096; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Lalloo F, 2003, LANCET, V361, P1101, DOI 10.1016/S0140-6736(03)12856-5; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mandelker D., 2017, JAMA-J AM MED ASSOC, V318, P823; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Metcalfe KA, 2005, GYNECOL ONCOL, V96, P222, DOI 10.1016/j.ygyno.2004.09.039; Mody RJ, 2015, JAMA-J AM MED ASSOC, V314, P913, DOI 10.1001/jama.2015.10080; National Human Genome Research Institute, 2016, COST SEQ HUM GEN; Parsons DW, 2016, JAMA ONCOL, V2, P616, DOI 10.1001/jamaoncol.2015.5699; Pearlman R, 2017, JAMA ONCOL, V3, P464, DOI 10.1001/jamaoncol.2016.5194; R Core Team, 2017, R LANG ENV STAT COMP; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Rahman N, 2014, NATURE, V505, P302, DOI 10.1038/nature12981; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Roller E, 2016, BIOINFORMATICS, V32, P2375, DOI 10.1093/bioinformatics/btw163; Schrader KA, 2016, JAMA ONCOL, V2, P104, DOI 10.1001/jamaoncol.2015.5208; Smedley D, 2015, NUCLEIC ACIDS RES, V43, pW589, DOI 10.1093/nar/gkv350; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Suzuki T, 2014, J HUM GENET, V59, P649, DOI 10.1038/jhg.2014.88; SWIFT M, 1991, NEW ENGL J MED, V325, P1831, DOI 10.1056/NEJM199112263252602; Tattini L, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00092; Thompson D, 2005, JNCI-J NATL CANCER I, V97, P813, DOI 10.1093/jnci/dji141; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Travis LB, 2006, CANCER EPIDEM BIOMAR, V15, P2020, DOI 10.1158/1055-9965.EPI-06-0414; University Medical Center Groningen, FACD ONL FAM CANC DA; Weischer M, 2007, J CLIN ONCOL, V25, P57, DOI 10.1200/JCO.2005.05.5160; Weren RDA, 2015, NAT GENET, V47, P668, DOI 10.1038/ng.3287; Whitworth J, 2016, JAMA ONCOL, V2, P373, DOI 10.1001/jamaoncol.2015.4771; Whitworth J, 2015, EUR J HUM GENET, V23, P581, DOI 10.1038/ejhg.2014.157; Zarrei M, 2015, NAT REV GENET, V16, P172, DOI 10.1038/nrg3871; Zhang JH, 2015, NEW ENGL J MED, V373, P2336, DOI 10.1056/NEJMoa1508054	54	35	35	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 5	2018	103	1					3	18		10.1016/j.ajhg.2018.04.013	http://dx.doi.org/10.1016/j.ajhg.2018.04.013			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GM5IG	29909963	Green Published, Green Accepted, hybrid			2022-12-18	WOS:000438168800001
J	Piekutowska-Abramczuk, D; Assouline, Z; Matakovic, L; Feichtinger, RG; Konarikova, E; Jurkiewicz, E; Stawinski, P; Gusic, M; Koller, A; Pollak, A; Gasperowicz, P; Trubicka, J; Ciara, E; Iwanicka-Pronicka, K; Rokicki, D; Hanein, S; Wortmann, SB; Sperl, W; Rotig, A; Prokisch, H; Pronicka, E; Ploski, R; Barcia, G; Mayr, JA				Piekutowska-Abramczuk, Dorota; Assouline, Zahra; Matakovic, Lavinija; Feichtinger, Rene G.; Konarikova, Eliska; Jurkiewicz, Elzbieta; Stawinski, Piotr; Gusic, Mirjana; Koller, Andreas; Pollak, Agnieszka; Gasperowicz, Piotr; Trubicka, Joanna; Ciara, Elzbieta; Iwanicka-Pronicka, Katarzyna; Rokicki, Dariusz; Hanein, Sylvain; Wortmann, Saskia B.; Sperl, Wolfgang; Rotig, Agnes; Prokisch, Holger; Pronicka, Ewa; Ploski, Rafa; Barcia, Giulia; Mayr, Johannes A.			NDUFB8 Mutations Cause Mitochondrial Complex I Deficiency in Individuals with Leigh-like Encephalomyopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RESPIRATORY-CHAIN DEFICIENCY; ACAD9 MUTATIONS; DISEASE; ARCHITECTURE; DIAGNOSIS; FEATURES	Respiratory chain complex I deficiency is the most frequently identified biochemical defect in childhood mitochondrial diseases. Clinical symptoms range from fatal infantile lactic acidosis to Leigh syndrome and other encephalomyopathies or cardiomyopathies. To date, disease-causing variants in genes coding for 27 complex I subunits, including 7 mitochondrial DNA genes, and in 11 genes encoding complex I assembly factors have been reported. Here, we describe rare biallelic variants in NDUFB8 encoding a complex I accessory subunit revealed by whole-exome sequencing in two individuals from two families. Both presented with a progressive course of disease with encephalo(cardio) myopathic features including muscular hypotonia, cardiac hypertrophy, respiratory failure, failure to thrive, and developmental delay. Blood lactate was elevated. Neuroimaging disclosed progressive changes in the basal ganglia and either brain stem or internal capsule. Biochemical analyses showed an isolated decrease in complex I enzymatic activity in muscle and fibroblasts. Complementation studies by expression of wild-type NDUFB8 in cells from affected individuals restored mitochondrial function, confirming NDUFB8 variants as the cause of complex I deficiency. Hereby we establish NDUFB8 as a relevant gene in childhood-onset mitochondrial disease.	[Piekutowska-Abramczuk, Dorota; Trubicka, Joanna; Ciara, Elzbieta; Pronicka, Ewa] Childrens Mem Hlth Inst, Dept Med Genet, PL-04730 Warsaw, Poland; [Assouline, Zahra; Barcia, Giulia] Hop Necker Enfants Malad, Dept Genet, F-75015 Paris, France; [Matakovic, Lavinija; Feichtinger, Rene G.; Koller, Andreas; Wortmann, Saskia B.; Sperl, Wolfgang; Mayr, Johannes A.] Salzburger Landeskliniken, Dept Pediat, A-5020 Salzburg, Austria; [Matakovic, Lavinija; Feichtinger, Rene G.; Koller, Andreas; Wortmann, Saskia B.; Sperl, Wolfgang; Mayr, Johannes A.] Paracelsus Med Univ Salzburg, A-5020 Salzburg, Austria; [Konarikova, Eliska; Gusic, Mirjana; Wortmann, Saskia B.; Prokisch, Holger] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Konarikova, Eliska; Gusic, Mirjana; Wortmann, Saskia B.; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Jurkiewicz, Elzbieta] Childrens Mem Hlth Inst, Dept Diagnost Imaging, PL-04730 Warsaw, Poland; [Stawinski, Piotr; Gasperowicz, Piotr; Ploski, Rafa] Med Univ Warsaw, Dept Med Genet, PL-02106 Warsaw, Poland; [Stawinski, Piotr; Pollak, Agnieszka] Inst Physiol & Pathol Hearing, Dept Genet, PL-05830 Warsaw, Poland; [Iwanicka-Pronicka, Katarzyna] Childrens Mem Hlth Inst, Dept Audiol & Phoniatr, PL-04730 Warsaw, Poland; [Rokicki, Dariusz; Pronicka, Ewa] Childrens Mem Hlth Inst, Dept Paediat Nutr & Metab Dis, PL-04730 Warsaw, Poland; [Hanein, Sylvain; Rotig, Agnes] Univ Paris 05, Sorbonne Paris Cite,Inst Imagine, INSERM, U1163, F-75015 Paris, France	Children's Memorial Health Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Paracelsus Private Medical University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Children's Memorial Health Institute; Medical University of Warsaw; Institute of Physiology & Hearing Pathology; Children's Memorial Health Institute; Children's Memorial Health Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Mayr, JA (corresponding author), Salzburger Landeskliniken, Dept Pediat, A-5020 Salzburg, Austria.; Mayr, JA (corresponding author), Paracelsus Med Univ Salzburg, A-5020 Salzburg, Austria.; Ploski, R (corresponding author), Med Univ Warsaw, Dept Med Genet, PL-02106 Warsaw, Poland.	rploski@wp.pl; h.mayr@salk.at	Koňaříková, Eliška/AAG-4073-2021; hanein, sylvain/AAG-4933-2019; Trubicka, Joanna/R-1215-2018; ROTIG, AGNES/G-9592-2017	Koňaříková, Eliška/0000-0001-7365-5006; hanein, sylvain/0000-0001-5817-6330; Trubicka, Joanna/0000-0002-9848-3674; Ploski, Rafal/0000-0001-6286-5526; Jurkiewicz, Elzbieta/0000-0003-4505-8815; Iwanicka-Pronicka, Katarzyna/0000-0003-2164-6663; Rokicki, Dariusz/0000-0002-9736-2838; Piekutowska-Abramczuk, Dorota/0000-0002-9786-3704; Gasperowicz, Piotr/0000-0002-1037-7974; Ciara, Elzbieta/0000-0002-1065-7968; Pronicka, Ewa/0000-0002-5705-4814; Prokisch, Holger/0000-0003-2379-6286; Gusic, Mirjana/0000-0002-9350-291X; ROTIG, AGNES/0000-0003-0589-0703; Koller, Andreas/0000-0001-6108-8411; Pollak, Agnieszka/0000-0002-2847-1782	NSC [2012/05/B/NZ2/01627]; CMHI [S136/13, S145/16]; E-Rare project GENOMIT [01GM1603, 01GM1207, O1GML 1207]; E-Rare project GENOMIT (Austrian Science Fonds [FWF]) [I 2741-B26]; PMU-FFF [R-16/03/082-FEK]; EC PEOPLE-ITN (MEET) [317433]	NSC(Ministry of Science and Technology, Taiwan); CMHI; E-Rare project GENOMIT; E-Rare project GENOMIT (Austrian Science Fonds [FWF]); PMU-FFF; EC PEOPLE-ITN (MEET)	The study was partly supported by NSC 2012/05/B/NZ2/01627 to D.P.-A., CMHI S136/13 and S145/16 to E.P., E-Rare project GENOMIT (01GM1603 and 01GM1207 to H.P., O1GML 1207 to A.R, Austrian Science Fonds [FWF]: I 2741-B26 to J.A.M.), PMU-FFF R-16/03/082-FEK (to R.G.F. and A.K.), and EC FP7-PEOPLE-ITN (GA #317433, MEET) projects.	Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Bricout M, 2014, J MED GENET, V51, P429, DOI 10.1136/jmedgenet-2013-102256; Collet M, 2016, EUR J HUM GENET, V24, P1112, DOI 10.1038/ejhg.2015.264; Fassone E, 2012, J MED GENET, V49, P578, DOI 10.1136/jmedgenet-2012-101159; Gu JK, 2016, NATURE, V537, P639, DOI 10.1038/nature19359; Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846; Haack TB, 2010, NAT GENET, V42, P1131, DOI 10.1038/ng.706; Herzer M, 2010, NEUROPEDIATRICS, V41, P30, DOI 10.1055/s-0030-1255062; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501; Kremer LS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15824; Kremer LS, 2017, METHODS MOL BIOL, V1567, P391, DOI 10.1007/978-1-4939-6824-4_24; Lazarou M, 2009, BBA-MOL CELL RES, V1793, P78, DOI 10.1016/j.bbamcr.2008.04.015; Letts JA, 2016, NATURE, V537, P644, DOI 10.1038/nature19774; Mayr JA, 2015, J INHERIT METAB DIS, V38, P629, DOI 10.1007/s10545-015-9831-y; Metodiev MD, 2014, J MED GENET, V51, P834, DOI 10.1136/jmedgenet-2014-102532; Olsen RKJ, 2016, AM J HUM GENET, V98, P1130, DOI 10.1016/j.ajhg.2016.04.006; Pronicka E, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0930-9; Rodenburg RJ, 2016, BBA-BIOENERGETICS, V1857, P938, DOI 10.1016/j.bbabio.2016.02.012; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686; Wu M, 2016, CELL, V167, P1598, DOI 10.1016/j.cell.2016.11.012; Zhu JP, 2016, NATURE, V536, P354, DOI 10.1038/nature19095; Zickermann V, 2015, SCIENCE, V347, P44, DOI 10.1126/science.1259859	24	35	36	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 1	2018	102	3					460	467		10.1016/j.ajhg.2018.01.008	http://dx.doi.org/10.1016/j.ajhg.2018.01.008			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FX9ZL	29429571	Bronze, Green Published			2022-12-18	WOS:000426469600016
J	Sferra, A; Baillat, G; Rizza, T; Barresi, S; Flex, E; Tasca, G; D'Amico, A; Bellacchio, E; Ciolfi, A; Caputo, V; Cecchetti, S; Torella, A; Zanni, G; Diodato, D; Piermarini, E; Niceta, M; Coppola, A; Tedeschi, E; Martinelli, D; Dionisi-Vici, C; Nigro, V; Dallapiccola, B; Compagnucci, C; Tartaglia, M; Haase, G; Bertini, E				Sferra, Antonella; Baillat, Gilbert; Rizza, Teresa; Barresi, Sabina; Flex, Elisabetta; Tasca, Giorgio; D'Amico, Adele; Bellacchio, Emanuele; Ciolfi, Andrea; Caputo, Viviana; Cecchetti, Serena; Torella, Annalaura; Zanni, Ginevra; Diodato, Daria; Piermarini, Emanuela; Niceta, Marcello; Coppola, Antonietta; Tedeschi, Enrico; Martinelli, Diego; Dionisi-Vici, Carlo; Nigro, Vincenzo; Dallapiccola, Bruno; Compagnucci, Claudia; Tartaglia, Marco; Haase, Georg; Bertini, Enrico			TBCE Mutations Cause Early-Onset Progressive Encephalopathy with Distal Spinal Muscular Atrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM; MOTOR-NEURONOPATHY; GOLGI-APPARATUS; MISSENSE MUTATION; MOUSE MUTANT; TUBULIN; MICE; FRAGMENTATION; FRAMEWORK; NEURONS	Tubulinopathies constitute a family of neurodevelopmental/neurodegenerative disorders caused by mutations in several genes encoding tubulin isoforms. Loss-of-function mutations in TBCE, encoding one of the five tubulin-specific chaperones involved in tubulin folding and polymerization, cause two rare neurodevelopmental syndromes, hypoparathyroidism-retardation-dysmorphism and Kenny-Caffey syndrome. Although a missense mutation in Tbce has been associated with progressive distal motor neuronopathy in the pmn/pmn mice, no similar degenerative phenotype has been recognized in humans. We report on the identification of an early-onset and progressive neurodegenerative encephalopathy with distal spinal muscular atrophy resembling the phenotype of pmn/pmn mice and caused by biallelic TBCE mutations, with the c.464T>A (p.Ile155Asn) change occurring at the heterozygous/homozygous state in six affected subjects from four unrelated families originated from the same geographical area in Southern Italy. Western blot analysis of patient fibroblasts documented a reduced amount of TBCE, suggestive of rapid degradation of the mutant protein, similarly to what was observed in pmn/pmn fibroblasts. The impact of TBCE mutations on microtubule polymerization was determined using biochemical fractionation and analyzing the nucleation and growth of microtubules at the centrosome and extracentrosomal sites after treatment with nocodazole. Primary fibroblasts obtained from affected subjects displayed a reduced level of polymerized a-tubulin, similarly to tail fibroblasts of pmn/pmn mice. Moreover, markedly delayed microtubule re-polymerization and abnormal mitotic spindles with disorganized microtubule arrangement were also documented. Although loss of function of TBCE has been documented to impact multiple developmental processes, the present findings provide evidence that hypomorphic TBCE mutations primarily drive neurodegeneration.	[Sferra, Antonella; Rizza, Teresa; Barresi, Sabina; Tasca, Giorgio; D'Amico, Adele; Bellacchio, Emanuele; Ciolfi, Andrea; Torella, Annalaura; Zanni, Ginevra; Diodato, Daria; Piermarini, Emanuela; Niceta, Marcello; Martinelli, Diego; Dionisi-Vici, Carlo; Dallapiccola, Bruno; Compagnucci, Claudia; Tartaglia, Marco; Bertini, Enrico] Osped Pediat Bambino Gesu, Genet & Rare Dis Res Div, I-00146 Rome, Italy; [Baillat, Gilbert; Haase, Georg] Aix Marseille Univ, CNRS, UMR 7289, Inst Neurosci Timone, F-13005 Marseille, France; [Flex, Elisabetta] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [Ciolfi, Andrea] CREA, Ctr Ric Alimenti & Nutr, I-00178 Rome, Italy; [Caputo, Viviana] Univ Roma La Sapienza, Dept Expt Med, I-00161 Rome, Italy; [Cecchetti, Serena] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Torella, Annalaura; Nigro, Vincenzo] Univ Naples 2, Dept Biochem Biophys & Gen Pathol, I-80138 Naples, Italy; [Torella, Annalaura; Nigro, Vincenzo] Telethon Inst Genet & Med, I-80078 Pozzuoli, Italy; [Coppola, Antonietta] Univ Naples Federico II, Dept Neurosci Reprod & Odontostomatol Sci, I-80131 Naples, Italy; [Tedeschi, Enrico] Univ Naples Federico II, Dept Adv Biomed Sci, I-80131 Naples, Italy	IRCCS Bambino Gesu; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Istituto Superiore di Sanita (ISS); Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Sapienza University Rome; Istituto Superiore di Sanita (ISS); Universita della Campania Vanvitelli; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Naples Federico II; University of Naples Federico II	Tartaglia, M; Bertini, E (corresponding author), Osped Pediat Bambino Gesu, Genet & Rare Dis Res Div, I-00146 Rome, Italy.	marco.tartaglia@opbg.net; bertini@opbg.net	Flex, Elisabetta/A-5958-2017; Bellacchio, Emanuele/AAH-9255-2019; Dionisi-Vici, Carlo/K-2045-2018; /AAB-8553-2019; Tedeschi, Enrico/AAN-7112-2020; Bertini, Enrico/ABG-1278-2020; Rizza, Teresa/AAA-6260-2020; Nigro, Vincenzo/AAB-2274-2022; Niceta, Marcello/V-1557-2019; Tasca, Giorgio/J-5153-2018; Tartaglia, Marco/K-2955-2018; Ciolfi, Andrea/J-4954-2018; Cecchetti, Serena/N-1061-2015; Bertini, Enrico/A-2284-2014; Dallapiccola, Bruno/K-8692-2016; Diodato, Daria/K-2639-2016; Sferra, Antonella/J-2774-2018; Zanni, Ginevra/L-2869-2015	Flex, Elisabetta/0000-0002-6802-1356; Dionisi-Vici, Carlo/0000-0002-0007-3379; Tedeschi, Enrico/0000-0002-0511-0132; Niceta, Marcello/0000-0003-4766-7753; Tasca, Giorgio/0000-0003-0849-9144; Tartaglia, Marco/0000-0001-7736-9672; Ciolfi, Andrea/0000-0002-6191-0978; Cecchetti, Serena/0000-0002-3601-176X; Bertini, Enrico/0000-0001-9276-4590; Dallapiccola, Bruno/0000-0002-5031-1013; Torella, Annalaura/0000-0003-2479-6018; Bellacchio, Emanuele/0000-0002-2757-849X; Nigro, Vincenzo/0000-0002-3378-5006; Diodato, Daria/0000-0003-3607-8523; Sferra, Antonella/0000-0001-8701-3696; BARRESI, SABINA/0000-0002-7307-388X; Zanni, Ginevra/0000-0002-6367-1843	Fondazione Bambino Gesu (Vite Coraggiose); Bulgari (GeneRare); Ministero della Salute [RC2015, RC2016]; Agence Nationale de la Recherche	Fondazione Bambino Gesu (Vite Coraggiose); Bulgari (GeneRare); Ministero della Salute(Ministry of Health, Italy); Agence Nationale de la Recherche(French National Research Agency (ANR))	We are grateful to the participating families. This work was supported in part by grants from Fondazione Bambino Gesu (Vite Coraggiose to M.T.), Bulgari (GeneRare to B.D.), Ministero della Salute (RC2015 and RC2016 to M.N., M.T., and E. Bertini), and Agence Nationale de la Recherche (to G.H.).	Arber CE, 2016, NEUROPATH APPL NEURO, V42, P220, DOI 10.1111/nan.12242; Bahi-Buisson N, 2014, BRAIN, V137, P1676, DOI 10.1093/brain/awu082; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Bellouze S, 2014, HUM MOL GENET, V23, P5961, DOI 10.1093/hmg/ddu320; Bommel H, 2002, J CELL BIOL, V159, P563, DOI 10.1083/jcb.200208001; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cordeddu V, 2014, NAT GENET, V46, P815, DOI 10.1038/ng.3035; Courtens W, 2006, AM J MED GENET A, V140A, P611, DOI 10.1002/ajmg.a.31122; Dong CL, 2015, HUM MOL GENET, V24, P2125, DOI 10.1093/hmg/ddu733; GONATAS NK, 1992, AM J PATHOL, V140, P731; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Kapitein LC, 2015, NEURON, V87, P492, DOI 10.1016/j.neuron.2015.05.046; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kortum F, 2015, NAT GENET, V47, P661, DOI 10.1038/ng.3282; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; Martin N, 2002, NAT GENET, V32, P443, DOI 10.1038/ng1016; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; MINOTTI AM, 1991, J BIOL CHEM, V266, P3987; Mourelatos Z, 1996, P NATL ACAD SCI USA, V93, P5472, DOI 10.1073/pnas.93.11.5472; Niceta M, 2015, AM J HUM GENET, V96, P816, DOI 10.1016/j.ajhg.2015.03.001; Parvari R, 2002, NAT GENET, V32, P448, DOI 10.1038/ng1012; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanders AAWM, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00431; Schaefer MKE, 2007, J NEUROSCI, V27, P8779, DOI 10.1523/JNEUROSCI.1599-07.2007; SCHMALBRUCH H, 1991, J NEUROPATH EXP NEUR, V50, P192, DOI 10.1097/00005072-199105000-00002; Serna M, 2015, J CELL SCI, V128, P1824, DOI 10.1242/jcs.167387; Simons C, 2013, AM J HUM GENET, V92, P767, DOI 10.1016/j.ajhg.2013.03.018; Smith BN, 2014, NEURON, V84, P324, DOI 10.1016/j.neuron.2014.09.027; Tian GL, 2006, P NATL ACAD SCI USA, V103, P13491, DOI 10.1073/pnas.0602798103; Voloshin O, 2010, CELL MOL LIFE SCI, V67, P2025, DOI 10.1007/s00018-010-0308-8	30	35	37	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 6	2016	99	4					974	983		10.1016/j.ajhg.2016.08.006	http://dx.doi.org/10.1016/j.ajhg.2016.08.006			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DY7UB	27666369	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000385333700018
J	Lodder, EM; De Nittis, P; Koopman, CD; Wiszniewski, W; de Souza, CFM; Lahrouchi, N; Guex, N; Napolioni, V; Tessadori, F; Beekman, L; Nannenberg, EA; Boualla, L; Blom, NA; de Graaff, W; Kamermans, M; Cocciadiferro, D; Malerba, N; Mandriani, B; Akdemir, ZHC; Fish, RJ; Eldomery, MK; Ratbi, I; Wilde, AAM; de Boer, T; Simonds, WF; Neerman-Arbez, M; Sutton, VR; Kok, F; Lupski, JR; Reymond, A; Bezzina, CR; Bakkers, J; Merla, G				Lodder, Elisabeth M.; De Nittis, Pasquelena; Koopman, Charlotte D.; Wiszniewski, Wojciech; Moura de Souza, Carolina Fischinger; Lahrouchi, Najim; Guex, Nicolas; Napolioni, Valerio; Tessadori, Federico; Beekman, Leander; Nannenberg, Eline A.; Boualla, Lamiae; Blom, Nico A.; de Graaff, Wim; Kamermans, Maarten; Cocciadiferro, Dario; Malerba, Natascia; Mandriani, Barbara; Akdemir, Zeynep Hande Coban; Fish, Richard J.; Eldomery, Mohammad K.; Ratbi, Ilham; Wilde, Arthur A. M.; de Boer, Teun; Simonds, William F.; Neerman-Arbez, Marguerite; Sutton, V. Reid; Kok, Fernando; Lupski, James R.; Reymond, Alexandre; Bezzina, Connie R.; Bakkers, Jeroen; Merla, Giuseppe			GNBS Mutations Cause an Autosomal-Recessive Multisystem Syndrome with Sinus Bradycardia and Cognitive Disability	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEART-RATE; BETA-SUBUNIT; COMPLEX; GENE; POLYMORPHISM; ACTIVATION; G-BETA-5; BRAIN; LIGHT; MICE	GNB5 encodes the G protein beta subunit 5 and is involved in inhibitory G protein signaling. Here, we report mutations in GNB5 that are associated with heart-rate disturbance, eye disease, intellectual disability, gastric problems, hypotonia, and seizures in nine individuals from six families. We observed an association between the nature of the variants and clinical severity; individuals with loss-of-function alleles had more severe symptoms, including substantial developmental delay, speech defects, severe hypotonia, pathological gastro-esophageal re flux, retinal disease, and sinus-node dysfunction, whereas related heterozygotes harboring missense variants presented with a clinically milder phenotype. Zebrafish gnb5 knockouts recapitulated the phenotypic spectrum of affected individuals, including cardiac, neurological, and ophthalmological abnormalities, supporting a direct role of GNB5 in the control of heart rate, hypotonia, and vision.	[Lodder, Elisabeth M.; Lahrouchi, Najim; Beekman, Leander; Wilde, Arthur A. M.; Bezzina, Connie R.] Univ Amsterdam, Acad Med Ctr, Ctr Heart, Dept Clin & Expt Cardiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [De Nittis, Pasquelena; Guex, Nicolas; Reymond, Alexandre] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [De Nittis, Pasquelena; Cocciadiferro, Dario; Malerba, Natascia; Mandriani, Barbara; Merla, Giuseppe] IRCCS Casa Sollievo Sofferenza, Med Genet Unit, Viale Cappuccini, I-71013 Foggia, Italy; [Koopman, Charlotte D.; de Boer, Teun; Bakkers, Jeroen] Univ Med Ctr Utrecht, Dept Med Physiol, Div Heart & Lungs, NL-3584 CT Utrecht, Netherlands; [Koopman, Charlotte D.; Tessadori, Federico; Bakkers, Jeroen] Univ Med Ctr Utrecht, Royal Netherlands Acad Arts & Sci KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Wiszniewski, Wojciech; Akdemir, Zeynep Hande Coban; Eldomery, Mohammad K.; Sutton, V. Reid; Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Moura de Souza, Carolina Fischinger] Hosp Clin Porto Alegre, Med Genet Serv, BR-2350 Porto Alegre, RS, Brazil; [Guex, Nicolas] SSwiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Napolioni, Valerio] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Palo Alto, CA 94304 USA; [Nannenberg, Eline A.] Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Boualla, Lamiae; Ratbi, Ilham] Mohammed V Univ Rabat, Fac Med & Pharm, Ctr Genom Humaine, Rabat 8007, Morocco; [Blom, Nico A.] Acad Med Ctr, Dept Pediat Cardiol, Emma Childrens Hosp, NL-1105 AZ Amsterdam, Netherlands; [de Graaff, Wim; Kamermans, Maarten] Netherlands Inst Neurosci, Rebinal Signal Proc Lab, NL-1105 BA Amsterdam, Netherlands; [Kamermans, Maarten] Univ Amsterdam, Acad Med Ctr, Dept Genome Anal, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Cocciadiferro, Dario; Malerba, Natascia] Univ Foggia, PhD Program Expt & Regenerat Med, Fac Med, I-71121 Foggia, Italy; [Mandriani, Barbara] Univ Brescia, Dept Mol & Translat Med, PhD Program Mol Genet Appl Med Sci, I-25121 Brescia, Italy; [Fish, Richard J.; Neerman-Arbez, Marguerite] Univ Med Ctr CMU, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Simonds, William F.] Natl Inst Diabet & Digest & Kidney Dis, Metab Dis Branch, NIH, Bethesda, MD 20892 USA; [Sutton, V. Reid; Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA; [Kok, Fernando] Univ Sao Paulo, Sch Med, Dept Neurol, Child Neurol Div, BR-01246903 Sao Paulo, Brazil; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	University of Amsterdam; Academic Medical Center Amsterdam; University of Lausanne; IRCCS Casa Sollievo Della Sofferenza; Utrecht University; Utrecht University Medical Center; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Baylor College of Medicine; Swiss Institute of Bioinformatics; Stanford University; University of Amsterdam; Mohammed First University of Oujda; Mohammed V University in Rabat; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam; University of Foggia; University of Brescia; University of Geneva; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Baylor College of Medicine; Universidade de Sao Paulo; Baylor College of Medicine	Merla, G (corresponding author), IRCCS Casa Sollievo Sofferenza, Med Genet Unit, Viale Cappuccini, I-71013 Foggia, Italy.; Bakkers, J (corresponding author), Univ Med Ctr Utrecht, Dept Med Physiol, Div Heart & Lungs, NL-3584 CT Utrecht, Netherlands.; Bakkers, J (corresponding author), Univ Med Ctr Utrecht, Royal Netherlands Acad Arts & Sci KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands.	j.bakkers@hubrecht.eu; g.merla@operapadrepio.it	Lodder, Elisabeth/X-5385-2019; Malerba, Natascia/K-6110-2016; De Nittis, Pasquelena/AAL-8306-2020; merla, giuseppe/K-4627-2012; , WaNgtJ/AAR-7045-2020; Cocciadiferro, Dario/AAH-9606-2019; Bakkers, Jeroen/H-5551-2011; de Souza, Carolina Fischinger Moura/V-9921-2019; Napolioni, Valerio/GNH-5123-2022	Lodder, Elisabeth/0000-0001-6017-3796; Malerba, Natascia/0000-0003-0714-3314; merla, giuseppe/0000-0001-5078-928X; Cocciadiferro, Dario/0000-0002-8583-3866; Bakkers, Jeroen/0000-0002-9418-0422; Mandriani, Barbara/0000-0002-4139-0602; Neerman-Arbez, Marguerite/0000-0002-9351-4195; de Boer, Teun/0000-0002-0561-6491; De Nittis, Pasquelena/0000-0001-7144-8425; Reymond, Alexandre/0000-0003-1030-8327; Tessadori, Federico/0000-0001-9975-0546; GUEX, Nicolas/0000-0001-6023-0519; Bezzina, Connie/0000-0002-0633-3514	Regeneron Pharmaceuticals; Takeda Pharmaceutical Company; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS078056] Funding Source: NIH RePORTER	Regeneron Pharmaceuticals(Regeneron); Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	J.R.L. has stock ownership in 23andMe, is a paid consultant for Regeneron Pharmaceuticals, has stock options in Lasergen, is a member of the Scientific Advisory Board of Baylor Miraca Genetics Laboratories, and is a co-inventor on multiple United States and European patents related to molecular diagnostics for inherited neuropathies, eye diseases, and bacterial genomic fingerprinting. Baylor College of Medicine (BCM) and Miraca Holdings have formed a joint venture with shared ownership and governance of the Baylor Miraca Genetics Laboratories (BMGL), which performs clinical exome sequencing. The Department of Molecular and Human Genetics at BCM derives revenue from the chromosomal microarray analysis and clinical exome sequencing offered in the BMGL (http://www.bmgl.com/BMGL/Default.aspx/website). G.M. is a paid consultant for Takeda Pharmaceutical Company.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alfaiz AA, 2014, HUM MUTAT, V35, P447, DOI 10.1002/humu.22529; Arno G., 2016, J AM MED ASS OPHTHAL; Borck G, 2015, GENOME RES, V25, P155, DOI 10.1101/gr.176925.114; Cheever ML, 2008, NAT STRUCT MOL BIOL, V15, P155, DOI 10.1038/nsmb.1377; Daly AF, 2016, ENDOCR-RELAT CANCER, V23, P221, DOI 10.1530/ERC-16-0082; Daly AF, 2016, ENDOCR-RELAT CANCER, V23, P161, DOI 10.1530/ERC-15-0478; den Hoed M, 2013, NAT GENET, V45, P621, DOI 10.1038/ng.2610; Gautam N, 1998, CELL SIGNAL, V10, P447, DOI 10.1016/S0898-6568(98)00006-0; Krishnan A, 2015, MOL PHYLOGENET EVOL, V91, P27, DOI 10.1016/j.ympev.2015.05.009; Krispel CM, 2003, J GEN PHYSIOL, V122, P703, DOI 10.1085/jgp.200308938; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Nakao R, 2012, PEDIATR INT, V54, P829, DOI 10.1111/j.1442-200X.2012.03707.x; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Nikonov SS, 2013, J NEUROSCI, V33, P5182, DOI 10.1523/JNEUROSCI.5204-12.2013; Petrovski S., 2016, AM J HUMAN GENETICS; Posokhova E, 2010, CIRC RES, V107, P1350, DOI 10.1161/CIRCRESAHA.110.224212; Rao A, 2007, J NEUROSCI, V27, P14199, DOI 10.1523/JNEUROSCI.4934-07.2007; Salgado D, 2016, HUM MUTAT, V37, P439, DOI 10.1002/humu.22965; Smolock EM, 2012, PHYSIOL GENOMICS, V44, P689, DOI 10.1152/physiolgenomics.00041.2012; Trivellin G, 2014, NEW ENGL J MED, V371, P2363, DOI 10.1056/NEJMoa1408028; Tummala H, 2006, INVEST OPHTH VIS SCI, V47, P4714, DOI 10.1167/iovs.06-0292; Vincent A., 2016, AM J HUMAN GENETICS; WATSON AJ, 1994, J BIOL CHEM, V269, P22150; Witherow DS, 2003, RECEPTOR CHANNEL, V9, P205, DOI 10.1080/10606820390203848; Xie KQ, 2010, NAT NEUROSCI, V13, P661, DOI 10.1038/nn.2549; Yang JQ, 2010, CIRC RES, V107, P1345, DOI 10.1161/CIRCRESAHA.110.224220; Ye YC, 2014, CELL SIGNAL, V26, P2514, DOI 10.1016/j.cellsig.2014.07.030; Yuan B, 2015, J CLIN INVEST, V125, P636, DOI 10.1172/JCI77435; Zhang JH, 2011, J NEUROCHEM, V119, P544, DOI 10.1111/j.1471-4159.2011.07457.x; Zhang L, 2005, J HUM HYPERTENS, V19, P709, DOI 10.1038/sj.jhh.1001883	32	35	36	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 1	2016	99	3					704	710		10.1016/j.ajhg.2016.06.025	http://dx.doi.org/10.1016/j.ajhg.2016.06.025			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DV7KM	27523599	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000383114800015
J	Tajuddin, SM; Schick, UM; Eicher, JD; Chami, N; Giri, A; Brody, JA; Hill, WD; Kacprowski, T; Li, J; Lyytikainen, LP; Manichaikul, A; Mihailov, E; O'Donoghue, ML; Pankratz, N; Pazoki, R; Polfus, LM; Smith, AV; Schurmann, C; Vacchi-Suzzi, C; Waterworth, DM; Evangelou, E; Yanek, LR; Burt, A; Chen, MH; van Rooij, FJA; Floyd, JS; Greinacher, A; Harris, TB; Highland, HM; Lange, LA; Liu, Y; Magi, R; Nalls, MA; Mathias, RA; Nickerson, DA; Nikus, K; Starr, JM; Tardif, JC; Tzoulaki, I; Edwards, DRV; Wallentin, L; Bartz, TM; Becker, LC; Denny, JC; Raffield, LM; Rioux, JD; Friedrich, N; Fornage, M; Gao, H; Hirschhorn, JN; Liewald, DCM; Rich, SS; Uitterlinden, A; Bastarache, L; Becker, DM; Boerwinkle, E; de Denus, S; Bottinger, EP; Hayward, C; Hofman, A; Homuth, G; Lange, E; Launer, LJ; Lehtimaki, T; Lu, YC; Metspalu, A; O'Donnell, CJ; Quarells, RC; Richard, M; Torstenson, ES; Taylor, KD; Vergnaud, AC; Zonderman, AB; Crosslin, DR; Deary, IJ; Dorr, M; Elliott, P; Evans, MK; Gudnason, V; Kahonen, M; Psaty, BM; Rotter, JI; Slater, AJ; Dehghan, A; White, HD; Ganesh, SK; Loos, RJF; Esko, T; Faraday, N; Wilson, JG; Cushman, M; Johnson, AD; Edwards, TL; Zakai, NA; Lettre, G; Reiner, AP; Auer, PL				Tajuddin, Salman M.; Schick, Ursula M.; Eicher, John D.; Chami, Nathalie; Giri, Ayush; Brody, Jennifer A.; Hill, W. David; Kacprowski, Tim; Li, Jin; Lyytikainen, Leo-Pekka; Manichaikul, Ani; Mihailov, Evelin; O'Donoghue, Michelle L.; Pankratz, Nathan; Pazoki, Raha; Polfus, Linda M.; Smith, Albert Vernon; Schurmann, Claudia; Vacchi-Suzzi, Caterina; Waterworth, Dawn M.; Evangelou, Evangelos; Yanek, Lisa R.; Burt, Amber; Chen, Ming-Huei; van Rooij, Frank J. A.; Floyd, James S.; Greinacher, Andreas; Harris, Tamara B.; Highland, Heather M.; Lange, Leslie A.; Liu, Yongmei; Magi, Reedik; Nalls, Mike A.; Mathias, Rasika A.; Nickerson, Deborah A.; Nikus, Kjell; Starr, John M.; Tardif, Jean-Claude; Tzoulaki, Ioanna; Edwards, Digna R. Velez; Wallentin, Lars; Bartz, Traci M.; Becker, Lewis C.; Denny, Joshua C.; Raffield, Laura M.; Rioux, John D.; Friedrich, Nele; Fornage, Myriam; Gao, He; Hirschhorn, Joel N.; Liewald, David C. M.; Rich, Stephen S.; Uitterlinden, Andre; Bastarache, Lisa; Becker, Diane M.; Boerwinkle, Eric; de Denus, Simon; Bottinger, Erwin P.; Hayward, Caroline; Hofman, Albert; Homuth, Georg; Lange, Ethan; Launer, Lenore J.; Lehtimaki, Terho; Lu, Yingchang; Metspalu, Andres; O'Donnell, Chris J.; Quarells, Rakale C.; Richard, Melissa; Torstenson, Eric S.; Taylor, Kent D.; Vergnaud, Anne-Claire; Zonderman, Alan B.; Crosslin, David R.; Deary, Ian J.; Dorr, Marcus; Elliott, Paul; Evans, Michele K.; Gudnason, Vilmundur; Kahonen, Mika; Psaty, Bruce M.; Rotter, Jerome I.; Slater, Andrew J.; Dehghan, Abbas; White, Harvey D.; Ganesh, Santhi K.; Loos, Ruth J. F.; Esko, Tonu; Faraday, Nauder; Wilson, James G.; Cushman, Mary; Johnson, Andrew D.; Edwards, Todd L.; Zakai, Neil A.; Lettre, Guillaume; Reiner, Alex P.; Auer, Paul L.			Large-Scale Exome-wide Association Analysis Identifies Loci for White Blood Cell Traits and Pleiotropy with Immune-Mediated Diseases	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACUTE MYELOID-LEUKEMIA; UROKINASE RECEPTOR; GENETIC-VARIANTS; LYMPHOBLASTIC-LEUKEMIA; TRANSCRIPTION FACTORS; SUSCEPTIBILITY LOCI; LYMPHOID ORGANS; EMERGE NETWORK; RISK LOCI; EXPRESSION	White blood cells play diverse roles in innate and adaptive immunity. Genetic association analyses of phenotypic variation in circulating white blood cell (WBC) counts from large samples of otherwise healthy individuals can provide insights into genes and biologic pathways involved in production, differentiation, or clearance of particular WBC lineages (myeloid, lymphoid) and also potentially inform the genetic basis of autoimmune, allergic, and blood diseases. We performed an exome array-based meta-analysis of total WBC and subtype counts (neutrophils, monocytes, lymphocytes, basophils, and eosinophils) in a multi-ancestry discovery and replication sample of similar to 157,622 individuals from 25 studies. We identified 16 common variants (8 of which were coding variants) associated with one or more WBC traits, the majority of which are pleiotropically associated with autoimmune diseases. Based on functional annotation, these loci included genes encoding surface markers of myeloid, lymphoid, or hematopoietic stem cell differentiation (CD69, CD33, CD87), transcription factors regulating lineage specification during hematopoiesis (ASXL1, IRF8, IKZF1, JMJD1C, ETS2-PSMG1), and molecules involved in neutrophil clearance/apoptosis (C10orf54, LTA), adhesion (TNXB), or centrosome and microtubule structure/function (KIF9, TUBD1). Together with recent reports of somatic ASXL1 mutations among individuals with idiopathic cytopenias or clonal hematopoiesis of undetermined significance, the identification of a common regulatory 3 ' UTR variant of ASXL1 suggests that both germline and somatic ASXL1 mutations contribute to lower blood counts in otherwise asymptomatic individuals. These association results shed light on genetic mechanisms that regulate circulating WBC counts and suggest a prominent shared genetic architecture with inflammatory and autoimmune diseases.	[Tajuddin, Salman M.; Zonderman, Alan B.; Evans, Michele K.] NIA, Lab Epidemiol & Populat Sci, NIH, Baltimore, MD 21224 USA; [Schick, Ursula M.; Schurmann, Claudia; Bottinger, Erwin P.; Lu, Yingchang; Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Schick, Ursula M.; Schurmann, Claudia; Lu, Yingchang; Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Genet Obes & Related Metab Traits Program, New York, NY 10029 USA; [Eicher, John D.; Chen, Ming-Huei; Johnson, Andrew D.] NHLBI, Populat Sci Branch, Framingham Heart Study, Framingham, MA 01702 USA; [Chami, Nathalie; Tardif, Jean-Claude; Rioux, John D.; Lettre, Guillaume] Univ Montreal, Dept Med, Montreal, PQ H3T 1J4, Canada; [Chami, Nathalie; Tardif, Jean-Claude; Rioux, John D.; de Denus, Simon; Lettre, Guillaume] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Giri, Ayush; Torstenson, Eric S.] Vanderbilt Univ, Div Epidemiol, Inst Med & Publ Hlth, Nashville, TN 37235 USA; [Brody, Jennifer A.; Floyd, James S.] Univ Washington, Dept Med, Seattle, WA 98101 USA; [Hill, W. David; Starr, John M.; Liewald, David C. M.; Deary, Ian J.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh EH8 9JZ, Midlothian, Scotland; [Hill, W. David; Liewald, David C. M.; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh EH8 9JZ, Midlothian, Scotland; [Kacprowski, Tim; Homuth, Georg] Univ Med Greifswald, Interfac Inst Genet & Funct Genom, Dept Funct Genom, D-17475 Greifswald, Germany; [Kacprowski, Tim; Homuth, Georg] Ernst Moritz Arndt Univ Greifswald, D-17475 Greifswald, Germany; [Kacprowski, Tim; Friedrich, Nele; Dorr, Marcus] DZHK German Ctr Cardiovasc Res, Greifswald, Germany; [Li, Jin] Stanford Univ, Sch Med, Dept Med, Div Cardiovasc Med, Palo Alto, CA 94305 USA; [Lyytikainen, Leo-Pekka; Lehtimaki, Terho] Fimlab Labs, Dept Clin Chem, Tampere 33520, Finland; [Lyytikainen, Leo-Pekka; Lehtimaki, Terho] Univ Tampere, Sch Med, Dept Clin Chem, Tampere 33014, Finland; [Manichaikul, Ani; Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA; [Mihailov, Evelin; Magi, Reedik; Metspalu, Andres; Esko, Tonu] Univ Tartu, Estonian Genome Ctr, EE-51010 Tartu, Estonia; [O'Donoghue, Michelle L.] Brigham & Womens Hosp, Div Cardiovasc, TIMI Study Grp, Boston, MA 02115 USA; [Pankratz, Nathan] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55454 USA; [Pazoki, Raha; van Rooij, Frank J. A.; Uitterlinden, Andre; Hofman, Albert; Dehghan, Abbas] Erasmus Univ, Med Ctr, Dept Epidemiol, NL-3000 DR Rotterdam, Netherlands; [Polfus, Linda M.; Highland, Heather M.; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Ctr Human Genet, Houston, TX 77030 USA; [Smith, Albert Vernon; Gudnason, Vilmundur] Iceland Heart Assoc, IS-201 Kopavogur, Iceland; [Smith, Albert Vernon; Gudnason, Vilmundur] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland; [Vacchi-Suzzi, Caterina] SUNY Stony Brook, Dept Family Populat & Prevent Med, Stony Brook, NY 11794 USA; [Waterworth, Dawn M.] GlaxoSmithKline, Target Sci, Genet, King Of Prussia, PA 19406 USA; [Evangelou, Evangelos; Tzoulaki, Ioanna; Gao, He; Vergnaud, Anne-Claire; Elliott, Paul] Imperial Coll London, Sch Publ Hlth, MRC PHE Ctr Environm & Hlth, Dept Epidemiol & Biostat, London W2 1PG, England; [Evangelou, Evangelos; Tzoulaki, Ioanna] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Yanek, Lisa R.; Becker, Diane M.] Johns Hopkins Univ, Sch Med, Dept Med, Div Gen Internal Med, Baltimore, MD 21205 USA; [Burt, Amber] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Greinacher, Andreas] Univ Med Greifswald, Inst Immunol & Transfus Med, D-17475 Greifswald, Germany; [Harris, Tamara B.; Launer, Lenore J.] NIA, Lab Epidemiol Demog & Biometry, Intramural Res Program, NIH, Bethesda, MD 20892 USA; [Highland, Heather M.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27514 USA; [Lange, Leslie A.; Raffield, Laura M.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27514 USA; [Liu, Yongmei] Wake Forest Sch Med, Div Publ Hlth Sci, Ctr Human Genet, Winston Salem, NC 27157 USA; [Nalls, Mike A.] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Mathias, Rasika A.] Johns Hopkins Univ, Sch Med, Dept Med, Div Allergy & Clin Immunol, Baltimore, MD 21205 USA; [Mathias, Rasika A.; Becker, Lewis C.] Johns Hopkins Univ, Sch Med, Dept Med, Div Gen Internal Med, Baltimore, MD 21205 USA; [Nickerson, Deborah A.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98105 USA; [Nikus, Kjell] Tampere Univ Hosp, Dept Cardiol, Ctr Heart, Tampere 33521, Finland; [Nikus, Kjell] Univ Tampere, Sch Med, Tampere 33014, Finland; [Starr, John M.] Alzheimer Scotland Dementia Res Ctr, Edinburgh EH8 9JZ, Midlothian, Scotland; [Edwards, Digna R. Velez] Vanderbilt Univ, Vanderbilt Genet Inst, Inst Med & Publ Hlth, Vanderbilt Epidemiol Ctr,Dept Obstet & Gynecol, Nashville, TN 37203 USA; [Wallentin, Lars] Uppsala Univ, Cardiol, Dept Med Sci, S-75185 Uppsala, Sweden; [Wallentin, Lars] Uppsala Univ, Uppsala Clin Res Ctr, S-75185 Uppsala, Sweden; [Bartz, Traci M.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Becker, Lewis C.] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA; [Denny, Joshua C.; Bastarache, Lisa] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37203 USA; [Friedrich, Nele] Univ Med Greifswald, Inst Clin Chem & Lab Med, D-13347 Greifswald, Germany; [Fornage, Myriam; Richard, Melissa] Univ Texas Hlth Sci Ctr Houston, Inst Mol Med, Houston, TX 77030 USA; [Hirschhorn, Joel N.; Esko, Tonu] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Hirschhorn, Joel N.] Boston Childrens Hosp, Dept Endocrinol, Boston, MA 02115 USA; [Uitterlinden, Andre] Erasmus Univ, Med Ctr, Dept Internal Med, NL-3000 DR Rotterdam, Netherlands; [Uitterlinden, Andre] NCHA, NL-3015 GD Rotterdam, Netherlands; [Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [de Denus, Simon] Univ Montreal, Fac Pharm, Montreal, PQ H3T 1J4, Canada; [Hayward, Caroline] Univ Edinburgh, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Hofman, Albert] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Lange, Ethan] Univ N Carolina, Dept Genet & Biostat, Chapel Hill, NC 27599 USA; [O'Donnell, Chris J.] NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; [O'Donnell, Chris J.] Boston Vet Adm Healthcare, Cardiol Sect, Boston, MA 02118 USA; [O'Donnell, Chris J.] Boston Vet Adm Healthcare, Ctr Populat Genom, Boston, MA 02118 USA; [Quarells, Rakale C.] Morehouse Sch Med, Social Epidemiol Res Ctr, Cardiovasc Res Inst, Atlanta, GA 30310 USA; [Taylor, Kent D.; Rotter, Jerome I.] Los Angeles Biomed Res Inst, Inst Translat Genom & Populat Sci, Torrance, CA 90502 USA; [Taylor, Kent D.; Rotter, Jerome I.] Harbor UCLA Med Ctr, Dept Pediat, Torrance, CA 90502 USA; [Crosslin, David R.] Univ Washington, Dept Biomed Informat & Med Educ, Seattle, WA 98195 USA; [Dorr, Marcus] Univ Med Greifswald, Dept Cardiol, D-17475 Greifswald, Germany; [Kahonen, Mika] Tampere Univ Hosp, Dept Clin Physiol, Tampere 33521, Finland; [Kahonen, Mika] Univ Tampere, Sch Med, Dept Clin Physiol, Tampere 33014, Finland; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Epidemiol, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Hlth Serv, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98101 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA 98101 USA; [Slater, Andrew J.] OmicSoft Corp, Cary, NC 27513 USA; [Slater, Andrew J.] GlaxoSmithKline, Genet Target Sci, Res Triangle Pk, NC 27709 USA; [White, Harvey D.] Auckland City Hosp, Green Lane Cardiovasc Serv, Auckland 1142, New Zealand; [White, Harvey D.] Univ Auckland, Auckland 1142, New Zealand; [Ganesh, Santhi K.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48108 USA; [Ganesh, Santhi K.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48108 USA; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA; [Faraday, Nauder] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA; [Cushman, Mary; Zakai, Neil A.] Univ Vermont, Dept Med, Div Hematol Oncol, Colchester, VT 05446 USA; [Edwards, Todd L.] Vanderbilt Univ, Vanderbilt Genet Inst, Inst Med & Publ Hlth, Div Epidemiol,Dept Med, Nashville, TN 37203 USA; [Reiner, Alex P.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Reiner, Alex P.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; [Auer, Paul L.] Univ Wisconsin Milwaukee, Zilber Sch Publ Hlth, Milwaukee, WI 53205 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Universite de Montreal; Universite de Montreal; Vanderbilt University; University of Washington; University of Washington Seattle; University of Edinburgh; University of Edinburgh; Greifswald Medical School; Ernst Moritz Arndt Universitat Greifswald; German Centre for Cardiovascular Research; Stanford University; Tampere University; University of Virginia; University of Tartu; Harvard University; Brigham & Women's Hospital; University of Minnesota System; University of Minnesota Twin Cities; Erasmus University Rotterdam; Erasmus MC; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Icelandic Heart Association; University of Iceland; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; GlaxoSmithKline; Imperial College London; University of Ioannina; Johns Hopkins University; University of Washington; University of Washington Seattle; Greifswald Medical School; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Wake Forest University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University; Johns Hopkins University; University of Washington; University of Washington Seattle; Tampere University; Tampere University Hospital; Tampere University; Vanderbilt University; Uppsala University; Uppsala University; University of Washington; University of Washington Seattle; Johns Hopkins University; Vanderbilt University; Greifswald Medical School; University of Texas System; University of Texas Health Science Center Houston; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Baylor College of Medicine; Universite de Montreal; University of Edinburgh; Harvard University; Harvard T.H. Chan School of Public Health; University of North Carolina; University of North Carolina Chapel Hill; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Morehouse School of Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Washington; University of Washington Seattle; Greifswald Medical School; Tampere University; Tampere University Hospital; Tampere University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; GlaxoSmithKline; Auckland City Hospital; University of Auckland; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Icahn School of Medicine at Mount Sinai; Johns Hopkins University; University of Mississippi; University of Mississippi Medical Center; University of Vermont; Vanderbilt University; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Wisconsin System; University of Wisconsin Milwaukee	Reiner, AP (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.; Reiner, AP (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA.; Auer, PL (corresponding author), Univ Wisconsin Milwaukee, Zilber Sch Publ Hlth, Milwaukee, WI 53205 USA.	apreiner@u.washington.edu; pauer@uwm.edu	Tzoulaki, Ioanna/ABE-6269-2020; Kacprowski, Tim/K-8650-2013; Loos, Ruth/GON-5877-2022; Evans, Michele Kim/AAE-4776-2019; Rioux, John D/A-9599-2015; Denny, Josh/AAL-3359-2021; Nikus, Kjell/K-7813-2019; Floyd, James/G-7563-2015; Cushman, Mary/K-1157-2019; Rotter, Jerome/AAY-6598-2021; Dehghan, Abbas/ABE-7377-2020; Kacprowski, Tim/N-9692-2019; Dörr, Marcus/F-1919-2010; Johnson, Andrew D/G-6520-2013; Gudnason, Vilmundur/AAE-7126-2019; Auer, Paul/AAC-5060-2019; Schurmann, Claudia/L-1204-2016; Evangelou, Evangelos/C-3033-2013; Lehtimäki, Terho/AAD-1094-2022; Deary, Ian J/C-6297-2009; Loos, Ruth J F/Q-2862-2016; Mägi, Reedik/AAJ-9679-2021; Smith, Albert Vernon/K-5150-2015; Dehghan, Abbas/B-9896-2008	Tzoulaki, Ioanna/0000-0002-4275-9328; Kacprowski, Tim/0000-0002-5393-2413; Rioux, John D/0000-0001-7560-8326; Denny, Josh/0000-0002-3049-7332; Cushman, Mary/0000-0002-7871-6143; Kacprowski, Tim/0000-0002-5393-2413; Dörr, Marcus/0000-0001-7471-475X; Johnson, Andrew D/0000-0001-6369-5178; Gudnason, Vilmundur/0000-0001-5696-0084; Schurmann, Claudia/0000-0003-4158-9192; Evangelou, Evangelos/0000-0002-5488-2999; Lehtimäki, Terho/0000-0002-2555-4427; Deary, Ian J/0000-0002-1733-263X; Loos, Ruth J F/0000-0002-8532-5087; Pazoki, Raha/0000-0002-5142-2348; Chami, Nathalie/0000-0002-8547-6424; Pankratz, Nathan/0000-0001-5958-693X; Rich, Stephen/0000-0003-3872-7793; Smith, Albert Vernon/0000-0003-1942-5845; Magi, Reedik/0000-0002-2964-6011; Chen, Ming-Huei/0000-0003-3551-8726; Kahonen, Mika/0000-0002-4510-7341; Manichaikul, Ani/0000-0002-5998-795X; Gueranger, Anne-Claire/0000-0003-0728-9313; Tajuddin, Salman M./0000-0002-7919-8528; Elliott, Paul/0000-0002-7511-5684; Evans, Michele/0000-0002-8546-2831; Slater, Andrew/0000-0002-2467-0231; Raffield, Laura/0000-0002-7892-193X; Zonderman, Alan B/0000-0002-6523-4778; Dehghan, Abbas/0000-0001-6403-016X; Nikus, Kjell/0000-0002-9345-9851	NHLBI [R21 HL121422-02, R01 HL086694]; Canada Research Chair program; Canadian Institute of Health Research MOP [123382]; National Institute on Aging, NIH Intramural Research Program; a component of the NIH Roadmap for Medical Research [UL1RR025005]; MRC [MR/L01341X/1, MC_PC_U127561128] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD074711] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007055, R21HL121422, R01HL105756, R01HL086694, ZIAHL006170, R21HL121429, R01HL112064, R01HL122684, R01HL120393] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG008657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR059469] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000513] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018522] Funding Source: NIH RePORTER; Medical Research Council [MR/L01341X/1, MR/K026992/1, MC_PC_U127561128] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10136] Funding Source: researchfish	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Canada Research Chair program(Canada Research Chairs); Canadian Institute of Health Research MOP; National Institute on Aging, NIH Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); a component of the NIH Roadmap for Medical Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank all participants and study coordinating centers of the participating studies and cohorts. P.L.A. was supported by NHLBI R21 HL121422-02. G.L. was supported by the Canada Research Chair program and the Canadian Institute of Health Research MOP#123382. This work was supported in part by the National Institute on Aging, NIH Intramural Research Program. Data analyses utilized the computational resources of the NIH HPC Biowulf cluster at the NIH. The Framingham Heart Study (FHS) acknowledges the Shared Computing Cluster at Boston University. Infrastructure and data analysis for the ARIC study was partly supported by Grant Number UL1RR025005, a component of the NIH Roadmap for Medical Research, and grant R01 HL086694 from the NHLBI. Airwave study thanks Louisa Cavaliero who assisted in data collection and management, Peter McFarlane and the Glasgow CARE, Patricia Munroe at Queen Mary University of London, and Joanna Sarnecka and Ania Zawodniak at Northwick Park for their contributions to the study. SOLID-TIMI-52 and STABILITY thank Liling Warren for contributions to the genetic analysis of the study datasets. Estonian Genome Center, University of Tartu (EGCUT) thanks Mr. V. Soo, Mr. S. Smith, and Dr. L. Milani for their contribution. The Rotterdam Study (RS) thanks Ms. Mila Jhamai, Ms. Sarah Higgins, and Mr. Marijn Verkerk for their help in creating the Exomechip database, and Ms. Carolina MedinaGomez, Mr. Lennard Karsten, and Dr. Linda Broer. Additional acknowledgments and funding information are provided in the Supplemental Data.	Abdel-Wahab O, 2013, J EXP MED, V210, P2641, DOI 10.1084/jem.20131141; Auer PL, 2016, EUR J HUM GENET, V24, P1188, DOI 10.1038/ejhg.2015.270; Auer PL, 2014, NAT GENET, V46, P629, DOI 10.1038/ng.2962; Auer PL, 2012, AM J HUM GENET, V91, P794, DOI 10.1016/j.ajhg.2012.08.031; Bentham J, 2015, NAT GENET, V47, P1457, DOI 10.1038/ng.3434; Bradfield JP, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002293; Cargo CA, 2015, BLOOD, V126, P2362, DOI 10.1182/blood-2015-08-663237; Chami N, 2016, AM J HUM GENET, V99, P8, DOI 10.1016/j.ajhg.2016.05.007; Chen L, 2014, SCIENCE, V345, P1580, DOI 10.1126/science.1251033; Chen M, 2015, GENE DEV, V29, P2123, DOI 10.1101/gad.267278.115; Chiquet-Ehrismann R, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004960; Conduit PT, 2015, NAT REV MOL CELL BIO, V16, P611, DOI 10.1038/nrm4062; Cordell HJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9019; Crosslin DR, 2013, HUM MOL GENET, V22, P2119, DOI 10.1093/hmg/ddt010; Crosslin DR, 2012, HUM GENET, V131, P639, DOI 10.1007/s00439-011-1103-9; Cserti CM, 2007, BLOOD, V110, P2250, DOI 10.1182/blood-2007-03-077602; de Paulis A, 2004, J IMMUNOL, V173, P5739, DOI 10.4049/jimmunol.173.9.5739; Dehghan A, 2011, CIRCULATION, V123, P731, DOI 10.1161/CIRCULATIONAHA.110.948570; Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; Dowell JA, 2001, J CLIN PHARMACOL, V41, P1206, DOI 10.1177/00912700122012751; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Dupuis A, 2013, LEUKEMIA, V27, P503, DOI 10.1038/leu.2012.204; Eicher JD, 2016, AM J HUM GENET, V99, P40, DOI 10.1016/j.ajhg.2016.05.005; Elghetany MT, 2003, CYTOM PART B-CLIN CY, V51B, P9, DOI 10.1002/cyto.b.10008; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Forde S, 2007, BLOOD, V109, P1825, DOI 10.1182/blood-2006-05-023028; Fotiadis D, 2013, MOL ASPECTS MED, V34, P139, DOI 10.1016/j.mam.2012.10.007; Francis Olivia L, 2011, World J Biol Chem, V2, P119, DOI 10.4331/wjbc.v2.i6.119; Gasteiger G, 2014, NAT REV IMMUNOL, V14, P631, DOI 10.1038/nri3726; Ge Y, 2008, LEUKEMIA, V22, P521, DOI 10.1038/sj.leu.2405066; Gelsi-Boyer V, 2009, BRIT J HAEMATOL, V145, P788, DOI 10.1111/j.1365-2141.2009.07697.x; Grove ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068095; Halene S, 2010, EXP HEMATOL, V38, P90, DOI 10.1016/j.exphem.2009.11.004; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Hancock AM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001375; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Hu XL, 2011, AM J HUM GENET, V89, P496, DOI 10.1016/j.ajhg.2011.09.002; Johnson AD, 2010, NAT GENET, V42, P608, DOI 10.1038/ng.604; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Keller MF, 2014, HUM MOL GENET, V23, P6944, DOI 10.1093/hmg/ddu401; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kong M, 2013, INT J IMMUNOGENET, V40, P120, DOI 10.1111/j.1744-313X.2012.01141.x; Kwok B, 2015, BLOOD, V126, P2355, DOI 10.1182/blood-2015-08-667063; Leslie R, 2014, BIOINFORMATICS, V30, P185, DOI 10.1093/bioinformatics/btu273; Li J, 2013, HUM MOL GENET, V22, P1457, DOI 10.1093/hmg/dds534; Liu DJJ, 2014, NAT GENET, V46, P200, DOI 10.1038/ng.2852; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Malik M, 2015, HUM MOL GENET, V24, P3557, DOI 10.1093/hmg/ddv092; Malik M, 2013, J NEUROSCI, V33, P13320, DOI 10.1523/JNEUROSCI.1224-13.2013; Migliorini G, 2013, BLOOD, V122, P3298, DOI 10.1182/blood-2013-03-491316; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Nalls MA, 2008, AM J HUM GENET, V82, P81, DOI 10.1016/j.ajhg.2007.09.003; Nalls MA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002113; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; NYKJAER A, 1994, J IMMUNOL, V152, P505; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Orru V, 2013, CELL, V155, P242, DOI 10.1016/j.cell.2013.08.041; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Park YJ, 2009, BLOOD, V114, P860, DOI 10.1182/blood-2008-12-193524; Pistis G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069206; Pulley J, 2010, CTS-CLIN TRANSL SCI, V3, P42, DOI 10.1111/j.1752-8062.2010.00175.x; Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547; Ramasamy A, 2014, NAT NEUROSCI, V17, P1418, DOI 10.1038/nn.3801; Reiner AP, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002108; Rijneveld AW, 2002, J IMMUNOL, V168, P3507, DOI 10.4049/jimmunol.168.7.3507; Sancho D, 2003, J CLIN INVEST, V112, P872, DOI 10.1172/JCI200319112; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Selleri C, 2005, BLOOD, V105, P2198, DOI 10.1182/blood-2004-06-2424; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Sroczynska P, 2014, BLOOD, V123, P1870, DOI 10.1182/blood-2013-08-522094; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Ulyanova T, 1999, EUR J IMMUNOL, V29, P3440, DOI 10.1002/(SICI)1521-4141(199911)29:11<3440::AID-IMMU3440>3.3.CO;2-3; Utsugi M, 2009, J IMMUNOL, V182, P5225, DOI 10.4049/jimmunol.0801352; van der Harst P, 2012, NATURE, V492, P369, DOI 10.1038/nature11677; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang L, 2014, P NATL ACAD SCI USA, V111, P14846, DOI 10.1073/pnas.1407447111; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Watanabe S, 2013, NAT STRUCT MOL BIOL, V20, P1425, DOI 10.1038/nsmb.2702; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Winkler TW, 2014, NAT PROTOC, V9, P1192, DOI 10.1038/nprot.2014.071; Yamamoto M, 2011, J EXP MED, V208, P1533, DOI 10.1084/jem.20101660; Yamanaka R, 1997, P NATL ACAD SCI USA, V94, P13187, DOI 10.1073/pnas.94.24.13187; Yanaba K, 2008, IMMUNOL REV, V223, P284, DOI 10.1111/j.1600-065X.2008.00646.x; Yanez A, 2015, BLOOD, V125, P1452, DOI 10.1182/blood-2014-09-600833; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yoon KW, 2015, SCIENCE, V349, DOI 10.1126/science.1261669; Yoshida H, 2001, MOL CELL BIOL, V21, P1239, DOI 10.1128/MCB.21.4.1239-1248.2001; Zannettino ACW, 1998, BLOOD, V92, P2613, DOI 10.1182/blood.V92.8.2613.420k15_2613_2628; Zhang Q, 2015, BIOCHEM BIOPH RES CO, V465, P64, DOI 10.1016/j.bbrc.2015.07.130; Zhang XL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-532	96	35	37	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 7	2016	99	1					22	39		10.1016/j.ajhg.2016.05.003	http://dx.doi.org/10.1016/j.ajhg.2016.05.003			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT6TI	27346689	Green Submitted, Bronze, Green Published, Green Accepted			2022-12-18	WOS:000381616600003
J	Davis, JR; Fresard, L; Knowles, DA; Pala, M; Bustamante, CD; Battle, A; Montgomery, SB				Davis, Joe R.; Fresard, Laure; Knowles, David A.; Pala, Mauro; Bustamante, Carlos D.; Battle, Alexis; Montgomery, Stephen B.			An Efficient Multiple-Testing Adjustment for eQTL Studies that Accounts for Linkage Disequilibrium between Variants	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ASSOCIATION; TRANSCRIPTOME	Methods for multiple-testing correction in local expression quantitative trait locus (cis-eQTL) studies are a trade-off between statistical power and computational efficiency. Bonferroni correction, though computationally trivial, is overly conservative and fails to account for linkage disequilibrium between variants. Permutation-based methods are more powerful, though computationally far more intensive. We present an alternative correction method called eigenMT, which runs over 500 times faster than permutations and has adjusted p values that closely approximate empirical ones. To achieve this speed while also maintaining the accuracy of permutation-based methods, we estimate the effective number of independent variants tested for association with a particular gene, termed M-eff by using the eigenvalue decomposition of the genotype correlation matrix. We employ a regularized estimator of the correlation matrix to ensure M-eff is robust and yields adjusted p values that closely approximate p values from permutations. Finally, using a common genotype matrix, we show that eigenMT can be applied with even greater efficiency to studies across tissues or conditions. Our method provides a simpler, more efficient approach to multiple-testing correction than existing methods and fits within existing pipelines for eQTL discovery.	[Davis, Joe R.; Bustamante, Carlos D.; Montgomery, Stephen B.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Fresard, Laure; Montgomery, Stephen B.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Knowles, David A.] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Pala, Mauro] CNR, Ist Ric Genet & Biomed, I-09042 Monserrato, Italy; [Battle, Alexis] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA	Stanford University; Stanford University; Stanford University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); Johns Hopkins University	Montgomery, SB (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	smontgom@stanford.edu	Pala, Mauro/AAY-4774-2020	Fresard, Laure/0000-0001-8154-6328; Montgomery, Stephen/0000-0002-5200-3903; Pala, Mauro/0000-0002-3165-5291; Bustamante, Carlos D./0000-0002-4187-7920	Stanford Graduate Fellowship; Stanford Genome Training Program; Stanford Center for Computational, Evolutionary, and Human Genomics Fellowship; NIH [R01MH101814]; Edward Mallinckrodt Jr. Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101814] Funding Source: NIH RePORTER	Stanford Graduate Fellowship(Stanford University); Stanford Genome Training Program; Stanford Center for Computational, Evolutionary, and Human Genomics Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward Mallinckrodt Jr. Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the GTEx Consortium and, in particular, Eleazar Eskin, Manolis Dermitzakis, Olivier Delaneau, and Halit Ongen for fruitful discussion. We thank Emily Tsang for valuable comments on the main text and figures. J.D. is supported by the Stanford Graduate Fellowship and the Stanford Genome Training Program. L.F. is supported by the Stanford Center for Computational, Evolutionary, and Human Genomics Fellowship. C.D.B., A.B. and S.B.M. are supported by the NIH (grant no. R01MH101814). S.B.M. is supported by the Edward Mallinckrodt Jr. Foundation.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Battle A, 2014, GENOME RES, V24, P14, DOI 10.1101/gr.155192.113; Browning BL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-309; Cheverud JM, 2001, HEREDITY, V87, P52, DOI 10.1046/j.1365-2540.2001.00901.x; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Gao XY, 2010, GENET EPIDEMIOL, V34, P100, DOI 10.1002/gepi.20430; Johnson RC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-724; Kuhn RM, 2013, BRIEF BIOINFORM, V14, P144, DOI 10.1093/bib/bbs038; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Ledoit O, 2004, J MULTIVARIATE ANAL, V88, P365, DOI 10.1016/S0047-259X(03)00096-4; Lee D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080540; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Ongen H., 2015, BIORXIV; Peterson C., 2015, BIORXIV; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Salyakina D, 2005, HUM HERED, V60, P19, DOI 10.1159/000087540; Sanchez-Mazas A, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/971818; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Stegle O, 2012, NAT PROTOC, V7, P500, DOI 10.1038/nprot.2011.457; Sul JH, 2015, AM J HUM GENET, V96, P857, DOI 10.1016/j.ajhg.2015.04.012	26	35	35	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 7	2016	98	1					216	224		10.1016/j.ajhg.2015.11.021	http://dx.doi.org/10.1016/j.ajhg.2015.11.021			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DA8JL	26749306	Green Published, Bronze			2022-12-18	WOS:000368050800016
J	Stray-Pedersen, A; Cobben, JM; Prescott, TE; Lees, S; Cang, CL; Aranda, K; Ahmed, S; Alders, M; Gerstner, T; Aslaksen, K; Tetreault, M; Qin, W; Hartley, T; Jhangiani, SN; Muzny, DM; Tarailo-Graovac, M; van Karnebeek, CDM; Lupski, JR; Ren, DJ; Yoon, G				Stray-Pedersen, Asbjorg; Cobben, Jan-Maarten; Prescott, Trine E.; Lee, Sora; Cang, Chunlei; Aranda, Kimberly; Ahmed, Sohnee; Alders, Marielle; Gerstner, Thorsten; Aslaksen, Kathinka; Tetreault, Martine; Qin, Wen; Hartley, Taila; Jhangiani, Shalini N.; Muzny, Donna M.; Tarailo-Graovac, Maja; van Karnebeek, Clara D. M.; Lupski, James R.; Ren, Dejian; Yoon, Grace		Care4Rare Canada Consortium; Baylor-Hopkins Ctr Mendelian	Biallelic Mutations in UNC80 Cause Persistent Hypotonia, Encephalopathy, Growth Retardation, and Severe Intellectual Disability	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CATION CHANNEL; NEURONAL EXCITABILITY; SEQUENCING DATA; NALCN CAUSE; CHANNELOPATHIES; COMPLEX; DELAY	Ion channel proteins are required for both the establishment of resting membrane potentials and the generation of action potentials. Hundreds of mutations in genes encoding voltage-gated ion channels responsible for action potential generation have been found to cause severe neurological diseases. In contrast, the roles of voltage-independent "leak" channels, important for the establishment and maintenance of resting membrane potentials upon which action potentials are generated, are not well established in human disease. UNC80 is a large component of the NALCN sodium-leak channel complex that regulates the basal excitability of the nervous system. Loss-of-function mutations of NALCN cause infantile hypotonia with psychomotor retardation and characteristic fades (IHPRF). We report four individuals from three unrelated families who have homozygous missense or compound heterozygous truncating mutations in UNC80 and persistent hypotonia, encephalopathy, growth failure, and severe intellectual disability. Compared to control cells, HEK293T cells transfected with an expression plasmid containing the c.5098C>T (p.Pro1700Ser) UNC80 mutation found in one individual showed markedly decreased NALCN channel currents. Our findings demonstrate the fundamental significance of UNC80 and basal ionic conductance to human health.	[Stray-Pedersen, Asbjorg; Jhangiani, Shalini N.; Muzny, Donna M.; Lupski, James R.] Baylor Coll Med, Dept Human Mol Genet, Houston, TX 77030 USA; [Stray-Pedersen, Asbjorg; Jhangiani, Shalini N.; Muzny, Donna M.; Lupski, James R.] Baylor Hopkins Ctr Mendelian Genom, Houston, TX 77030 USA; [Stray-Pedersen, Asbjorg] Oslo Univ Hosp, Norwegian Natl Newborn Screening Program, N-0424 Oslo, Norway; [Cobben, Jan-Maarten] Univ Hosp, Acad Med Ctr, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands; [Prescott, Trine E.] Oslo Univ Hosp, Dept Med Genet, N-0424 Oslo, Norway; [Lee, Sora; Cang, Chunlei; Aranda, Kimberly; Ren, Dejian] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Ahmed, Sohnee; Yoon, Grace] Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; [Ahmed, Sohnee; Yoon, Grace] Univ Toronto, Toronto, ON M5G 1X8, Canada; [Alders, Marielle] AMC Univ Hosp, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands; [Gerstner, Thorsten] Sorlandet Hosp, Dept Pediat, N-4838 Arendal, Norway; [Aslaksen, Kathinka] Sorlandet Hosp, Dept Pediat, N-4615 Kristiansand, Norway; [Tetreault, Martine] McGill Univ, Dept Human Genet, Montreal, PQ H3A 0G4, Canada; [Tetreault, Martine] Genome Quebec Innovat Ctr, Montreal, PQ H3A 0G4, Canada; [Qin, Wen; Hartley, Taila] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada; [Tarailo-Graovac, Maja] Univ British Columbia, Ctr Mol Med & Therapeut, Dept Med Genet, Vancouver, BC V5Z 4H4, Canada; [van Karnebeek, Clara D. M.] Univ British Columbia, Dept Paediat, Vancouver, BC V5Z 4H4, Canada; [van Karnebeek, Clara D. M.] Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA; [Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Jhangiani, Shalini N.; Muzny, Donna M.; Lupski, James R.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Yoon, Grace] Univ Toronto, Hosp Sick Children, Div Neurol, Toronto, ON M5G 1X8, Canada	Baylor College of Medicine; University of Oslo; University of Amsterdam; Academic Medical Center Amsterdam; University of Oslo; University of Pennsylvania; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Amsterdam; Academic Medical Center Amsterdam; McGill University; University of Ottawa; Children's Hospital of Eastern Ontario; University of British Columbia; University of British Columbia; University of British Columbia; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Ren, DJ (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	dren@sas.upenn.edu; grace.yoon@utoronto.ca	Cang, Chunlei/D-9185-2019	Stray-Pedersen, Asbjorg/0000-0002-9168-0878; Ahmed, Sohnee/0000-0002-3938-2304; Tarailo-Graovac, Maja/0000-0002-4472-8584; Cang, Chunlei/0000-0002-3302-0927	Regeneron Pharmaceuticals; NIH [NS055293, NS074257]; Genome Canada; Canadian Institutes of Health Research; Ontario Genomics Institute; Ontario Research Fund; Genome Quebec; Children's Hospital of Eastern Ontario Foundation; Hospital for Sick Children; National Human Genome Research Institute; National Heart Lung and Blood Institute [U54HG006542]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055293, R01NS074257] Funding Source: NIH RePORTER	Regeneron Pharmaceuticals(Regeneron); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genome Canada(Genome Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Genomics Institute; Ontario Research Fund; Genome Quebec; Children's Hospital of Eastern Ontario Foundation; Hospital for Sick Children; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank the participants and families for their contribution to this study. This work was selected for study by the Care4Rare Canada (Enhanced Care for Rare Genetic Diseases in Canada) Consortium Gene Discovery Steering Committee: Kym Boycott (lead; University of Ottawa), Alex MacKenzie (co-lead; University of Ottawa), J.M. (McGill University), Michael Brudno (University of Toronto), Dennis Bulman (University of Ottawa), and David Dyment (University of Ottawa). We also thank Hanne S. Sorte and Man Ann Kulseth (Department of Medical Genetics, Oslo University Hospital) for excellent technical assistance. J.R.L. has stock ownership in 23andMe, is a paid consultant for Regeneron Pharmaceuticals, has stock options in Lasergen, is a member of the Scientific Advisory Board of Baylor Miraca Genetics Laboratories, and is a co-inventor on multiple US and European patents related to molecular diagnostics for inherited neuropathies, eye diseases, and bacterial genomic fingerprinting. The Department of Molecular and Human Genetics at Baylor College of Medicine (J.R.L.) derives revenue from the chromosomal microarray analysis and clinical exome sequencing offered in the Baylor Miraca Genetics Laboratory (http://www.bmgl.com). This work was supported, in part, by funding from the NIH to D.R. (NS055293 and NS074257). Funding was also received from Genome Canada, the Canadian Institutes of Health Research, the Ontario Genomics Institute, Ontario Research Fund, Genome Quebec, Children's Hospital of Eastern Ontario Foundation, and The Hospital for Sick Children. The Baylor-Hopkins Center for Mendelian Genomics is supported by the National Human Genome Research Institute and the National Heart Lung and Blood Institute (U54HG006542).	Al-Sayed MD, 2013, AM J HUM GENET, V93, P721, DOI 10.1016/j.ajhg.2013.08.001; Bainbridge MN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002243; Catterall WA, 2008, J NEUROSCI, V28, P11768, DOI 10.1523/JNEUROSCI.3901-08.2008; Challis D, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-8; Chong JX, 2015, AM J HUM GENET, V96, P462, DOI 10.1016/j.ajhg.2015.01.003; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Flourakis M, 2015, CELL, V162, P836, DOI 10.1016/j.cell.2015.07.036; Humphrey JA, 2007, CURR BIOL, V17, P624, DOI 10.1016/j.cub.2007.02.037; Jospin M, 2007, CURR BIOL, V17, P1595, DOI 10.1016/j.cub.2007.08.036; Jurkat-Rott K, 2010, ADV EXP MED BIOL, V686, P305, DOI 10.1007/978-90-481-9485-8_18; Koroglu C, 2013, J MED GENET, V50, P515, DOI 10.1136/jmedgenet-2013-101634; Kullmann DM, 2010, J PHYSIOL-LONDON, V588, P1823, DOI 10.1113/jphysiol.2010.190652; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lu BX, 2007, CELL, V129, P371, DOI 10.1016/j.cell.2007.02.041; Lu BX, 2010, NEURON, V68, P488, DOI 10.1016/j.neuron.2010.09.014; Lu BX, 2009, NATURE, V457, P741, DOI 10.1038/nature07579; Nash HA, 2002, CURR BIOL, V12, P2152, DOI 10.1016/S0960-9822(02)01358-1; Pierce-Shimomura JT, 2008, P NATL ACAD SCI USA, V105, P20982, DOI 10.1073/pnas.0810359105; Reid JG, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-30; Ren DJ, 2011, NEURON, V72, P899, DOI 10.1016/j.neuron.2011.12.007; Tetreault M, 2015, HUM GENET, V134, P981, DOI 10.1007/s00439-015-1577-y; Wang H, 2009, CHANNELS, V3, P161, DOI 10.4161/chan.3.3.8853; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Yeh E, 2008, PLOS BIOL, V6, P552, DOI 10.1371/journal.pbio.0060055	26	35	38	2	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 7	2016	98	1					202	209		10.1016/j.ajhg.2015.11.004	http://dx.doi.org/10.1016/j.ajhg.2015.11.004			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DA8JL	26708751	Green Published, Bronze			2022-12-18	WOS:000368050800014
J	Schmidt, WM; Rutledge, SL; Schule, R; Mayerhofer, B; Zuchner, S; Boltshauser, E; Bittner, RE				Schmidt, Wolfgang M.; Rutledge, S. Lane; Schuele, Rebecca; Mayerhofer, Benjamin; Zuechner, Stephan; Boltshauser, Eugen; Bittner, Reginald E.			Disruptive SCYL1 Mutations Underlie a Syndrome Characterized by Recurrent Episodes of Liver Failure, Peripheral Neuropathy, Cerebellar Atrophy, and Ataxia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SPINOCEREBELLAR NEURODEGENERATION; ALPHA-DYSTROGLYCAN; RECESSIVE FORM; GLYCOSYLATION; PROTEIN; DOMAIN; MOUSE	Hereditary ataxias comprise a group of genetically heterogeneous disorders characterized by clinically variable cerebellar dysfunction and accompanied by involvement of other organ systems. The molecular underpinnings for many of these diseases are widely unknown. Previously, we discovered the disruption of Scyl1 as the molecular basis of the mouse mutant mdf, which is affected by neurogenic muscular atrophy, progressive gait ataxia with tremor, cerebellar vermis atrophy, and optic-nerve thinning. Here, we report on three human individuals, from two unrelated families, who presented with recurrent episodes of acute liver failure in early infancy and are affected by cerebellar vermis atrophy, ataxia, and peripheral neuropathy. By whole-exome sequencing, compound-heterozygous mutations within SCYL1 were identified in all affected individuals. We further show that in SCYL1-deficient human fibroblasts, the Golgi apparatus is massively enlarged, which is in line with the concept that SCYL1 regulates Golgi integrity. Thus, our findings define SCYL1 mutations as the genetic cause of a human hepatocerebellar neuropathy syndrome.	[Schmidt, Wolfgang M.; Mayerhofer, Benjamin; Bittner, Reginald E.] Med Univ Vienna, Ctr Anat & Cell Biol, Dept Neuromuscular Res, A-1090 Vienna, Austria; [Rutledge, S. Lane] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [Schuele, Rebecca] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat Dis, D-72076 Tubingen, Germany; [Schuele, Rebecca] Univ Tubingen, German Res Ctr Neurodegenerat Dis, D-72076 Tubingen, Germany; [Schuele, Rebecca; Zuechner, Stephan] Univ Miami, Miller Sch Med, Dr John T Macdonald Dept Human Genet, Miami, FL 33136 USA; [Schuele, Rebecca; Zuechner, Stephan] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA; [Boltshauser, Eugen] Univ Childrens Hosp, Div Pediat Neurol, CH-8032 Zurich, Switzerland	Medical University of Vienna; University of Alabama System; University of Alabama Birmingham; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Miami; University of Miami; University Children's Hospital Zurich	Bittner, RE (corresponding author), Med Univ Vienna, Ctr Anat & Cell Biol, Dept Neuromuscular Res, A-1090 Vienna, Austria.	reginald.bittner@meduniwien.ac.at	Schüle, Rebecca/B-5763-2019	Schüle, Rebecca/0000-0002-7781-2766; Schmidt, Wolfgang/0000-0002-6944-2443	Interdisciplinary Center for Clinical Research Tubingen [1970-0-0]; European Union [PIOF-GA-2012-326681]; German Ministry for Education and Research [01GM1408B]; NIH [5R01NS072248, 1R01NS075764, 5R01NS054132]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054132, U54NS065712, R01NS072248, R01NS075764] Funding Source: NIH RePORTER	Interdisciplinary Center for Clinical Research Tubingen; European Union(European Commission); German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors are grateful for the participation of the affected individuals and their parents in this study. The authors thank David R. Kelly, M.D. (Pathologist-in-Chief and Medical Director of Laboratories, Children's of Alabama, Birmingham, AL and Clinical Professor of Pathology, University of Alabama at Birmingham) for pathological expertise, Lisa Abreu, Feifei Tao, and Cima Saghira (Hussman Institute for Human Genomics, University of Miami) for coordination of clinical data collection and assistance in molecular genetic analysis, and Jennifer Reichbauer (Hertie Institute for Clinical Brain Research, University of Tubingen) for RNA analysis in family 2. The authors thank Ludger Schols, M.D. (Hertie-Institute for Clinical Brain Research and German Research Center for Neurodegenerative Diseases) for establishing the research cooperation that finally led to identification of the third individual with SCYL1 mutations. This study was supported by the Interdisciplinary Center for Clinical Research Tubingen (grant 1970-0-0 to R.S.), the European Union (grant PIOF-GA-2012-326681 "HSP/CMT genetics" to R.S.), E-RARE grants of the German Ministry for Education and Research to the NEUROLIPID project (01GM1408B to R.S.), and the NIH (grants 5R01NS072248, 1R01NS075764, and 5R01NS054132 to S.Z.).	Anheim M, 2012, NEW ENGL J MED, V366, P636, DOI 10.1056/NEJMra1006610; BLOT S, 1995, J NEUROPATH EXP NEUR, V54, P812; Burman JL, 2008, J BIOL CHEM, V283, P22774, DOI 10.1074/jbc.M801869200; Burman JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009537; Casey JP, 2012, MOL GENET METAB, V106, P351, DOI 10.1016/j.ymgme.2012.04.017; Chafe SC, 2010, MOL BIOL CELL, V21, P2483, DOI 10.1091/mbc.E10-03-0176; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Corbett MA, 2011, AM J HUM GENET, V88, P657, DOI 10.1016/j.ajhg.2011.04.011; Di Gregorio E, 2014, AM J HUM GENET, V95, P209, DOI 10.1016/j.ajhg.2014.07.001; Garcia Segarra N., 2015, AM J MED GENET A; Gonzalez M, 2015, HUM MUTAT, V36, P950, DOI 10.1002/humu.22836; Grewal PK, 2001, NAT GENET, V28, P151, DOI 10.1038/88865; Haack TB, 2015, AM J HUM GENET, V97, P163, DOI 10.1016/j.ajhg.2015.05.009; Hamlin JNR, 2014, J CELL SCI, V127, P1454, DOI 10.1242/jcs.136481; Jayadev S, 2013, GENET MED, V15, P673, DOI 10.1038/gim.2013.28; Lenhart PD, 2014, AM J OPHTHALMOL, V158, P1164, DOI 10.1016/j.ajo.2014.08.013; Liu SCH, 2000, BBA-GENE STRUCT EXPR, V1517, P148, DOI 10.1016/S0167-4781(00)00234-7; Longman C, 2003, HUM MOL GENET, V12, P2853, DOI 10.1093/hmg/ddg307; Mancuso M, 2014, J NEUROL, V261, pS528, DOI 10.1007/s00415-014-7387-7; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Pyle A, 2015, BRAIN, V138, P276, DOI 10.1093/brain/awu348; Schmidt WM, 2007, EMBO REP, V8, P691, DOI 10.1038/sj.embor.7401001; Senderek J, 2005, NAT GENET, V37, P1312, DOI 10.1038/ng1678; Storey E, 2014, SEMIN NEUROL, V34, P280, DOI 10.1055/s-0034-1386766; van Meel E, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-106	25	35	37	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2015	97	6					855	861		10.1016/j.ajhg.2015.10.011	http://dx.doi.org/10.1016/j.ajhg.2015.10.011			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DB3UM	26581903	Green Published, Bronze			2022-12-18	WOS:000368437900007
J	Hammer, C; Begemann, M; McLaren, PJ; Bartha, I; Michel, A; Klose, B; Schmitt, C; Waterboer, T; Pawlita, M; Schulz, TF; Ehrenreich, H; Fellay, J				Hammer, Christian; Begemann, Martin; McLaren, Paul J.; Bartha, Istvan; Michel, Angelika; Klose, Beate; Schmitt, Corinna; Waterboer, Tim; Pawlita, Michael; Schulz, Thomas F.; Ehrenreich, Hannelore; Fellay, Jacques			Amino Acid Variation in HLA Class II Proteins Is a Major Determinant of Humoral Response to Common Viruses	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ASSOCIATION; COMPLEX; NARCOLEPSY; CATAPLEXY; ALLELES; DISEASE; LOCUS; RISK	The magnitude of the human antibody response to viral antigens is highly variable. To explore the human genetic contribution to this variability, we performed genome-wide association studies of the immunoglobulin G response to 14 pathogenic viruses in 2,363 immunocompetent adults. Significant associations were observed in the major histocompatibility complex region on chromosome 6 for influenza A virus, Epstein-Barr virus, JC polyomavirus, and Merkel cell polyomavirus. Using local imputation and fine mapping, we identified specific amino acid residues in human leucocyte antigen (HLA) class II proteins as the most probable causal variants underlying these association signals. Common HLA-DR beta 1 haplotypes showed virus-specific patterns of humoral-response regulation. We observed an overlap between variants affecting the humoral response to influenza A and EBV and variants previously associated with autoimmune diseases related to these viruses. The results of this study emphasize the central and pathogen-specific role of HLA class II variation in the modulation of humoral immune response to viral antigens in humans.	[Hammer, Christian; McLaren, Paul J.; Bartha, Istvan; Fellay, Jacques] Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Hammer, Christian; McLaren, Paul J.; Bartha, Istvan; Fellay, Jacques] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Hammer, Christian; Begemann, Martin; Ehrenreich, Hannelore] Max Planck Inst Expt Med, Clin Neurosci, D-37075 Gottingen, Germany; [Michel, Angelika; Waterboer, Tim; Pawlita, Michael] German Canc Res Ctr, Infect & Canc Program, Div Mol Diagnost Oncogen Infect, D-69120 Heidelberg, Germany; [Klose, Beate; Schmitt, Corinna; Schulz, Thomas F.] Hannover Med Sch, Inst Virol, D-30625 Hannover, Germany; [Ehrenreich, Hannelore] DFG Res Ctr Nanoscale Microscopy & Mol Physiol Br, D-37075 Gottingen, Germany	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics; Helmholtz Association; German Cancer Research Center (DKFZ); Hannover Medical School	Hammer, C (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland.	christian.hammer@epfl.ch	Waterboer, Tim/G-1252-2010; Schulz, Thomas/AAA-1634-2019; Hammer, Christian/C-5827-2014; Fellay, Jacques/A-6681-2009	Hammer, Christian/0000-0003-4548-7548; Fellay, Jacques/0000-0002-8240-939X; McLaren, Paul/0000-0001-6019-7018; Ehrenreich, Hannelore/0000-0001-8371-5711; Bartha, Istvan/0000-0003-3360-1999; Schulz, Thomas/0000-0001-8792-5345	Max Planck Society; Max Planck Forderstiftung; DFG Research Center for Nanoscale Microscopy and Molecular Physiology of the Brain; Niedersachsen-Research Network on Neuroinfectiology of the Ministry of Science and Culture of Lower Saxony; Brain & Behavior Research Foundation; Daimler and Benz Foundation; Swiss National Science Foundation [PP00P3_133703]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Max Planck Forderstiftung(Max Planck Society); DFG Research Center for Nanoscale Microscopy and Molecular Physiology of the Brain(German Research Foundation (DFG)); Niedersachsen-Research Network on Neuroinfectiology of the Ministry of Science and Culture of Lower Saxony; Brain & Behavior Research Foundation(NARSAD); Daimler and Benz Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank the study participants for their important contributions to this study. This work was supported by the Max Planck Society, the Max Planck Forderstiftung, and the DFG Research Center for Nanoscale Microscopy and Molecular Physiology of the Brain, as well as by the Niedersachsen-Research Network on Neuroinfectiology of the Ministry of Science and Culture of Lower Saxony. The computations were performed at the Vital-IT (http://www.vital-it.ch) center for high-performance computing of the SIB Swiss Institute of Bioinformatics. This work was also supported by a Young Investigator Grant from the Brain & Behavior Research Foundation, as well as a postdoctoral scholarship from the Daimler and Benz Foundation, both awarded to C.H. J.F. is supported by a professorship grant from the Swiss National Science Foundation (PP00P3_133703).	Begemann M, 2010, ARCH GEN PSYCHIAT, V67, P879, DOI 10.1001/archgenpsychiatry.2010.107; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; DONG RP, 1993, TISSUE ANTIGENS, V41, P20, DOI 10.1111/j.1399-0039.1993.tb01972.x; Draborg AH, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/535738; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; GRUNDBACHER FJ, 1974, AM J HUM GENET, V26, P1; Hammer C, 2014, MOL PSYCHIATR, V19, P1143, DOI 10.1038/mp.2013.110; Han B, 2014, AM J HUM GENET, V94, P522, DOI 10.1016/j.ajhg.2014.02.013; HONG GH, 1994, J RHEUMATOL, V21, P442; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Jia X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057858; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Mignot E, 2001, AM J HUM GENET, V68, P686, DOI 10.1086/318799; Narwaney KJ, 2013, VACCINE, V31, P1123, DOI 10.1016/j.vaccine.2012.12.026; Partinen M, 2014, LANCET NEUROL, V13, P1072, DOI 10.1016/S1474-4422(14)70168-1; Patsopoulos NA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003926; Pender MP, 2014, CLIN TRANSL IMMUNOL, V3, DOI 10.1038/cti.2014.25; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phelps RG, 1999, KIDNEY INT, V56, P1638, DOI 10.1046/j.1523-1755.1999.00720.x; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Ribbe K, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-91; Rubicz R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003147; Rubicz R, 2011, HUM HERED, V72, P133, DOI 10.1159/000331220; Scally SW, 2013, J EXP MED, V210, P2569, DOI 10.1084/jem.20131241; Singh AK, 2013, J AUTOIMMUN, V43, P26, DOI 10.1016/j.jaut.2013.02.003; Sundqvist E, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004084; Tafti M, 2014, SLEEP, V37, P19, DOI 10.5665/sleep.3300; Tsang JS, 2014, CELL, V157, P499, DOI 10.1016/j.cell.2014.03.031; Waterboer T, 2005, CLIN CHEM, V51, P1845, DOI 10.1373/clinchem.2005.052381; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011	31	35	38	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 5	2015	97	5					738	743		10.1016/j.ajhg.2015.09.008	http://dx.doi.org/10.1016/j.ajhg.2015.09.008			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CW2ED	26456283	Green Published, hybrid			2022-12-18	WOS:000364803000009
J	Perrault, I; Hamdan, FF; Rio, M; Capo-Chichi, JM; Boddaert, N; Decarie, JC; Maranda, B; Nabbout, R; Sylvain, M; Lortie, A; Roux, PP; Rossigno, E; Gerard, X; Barcia, G; Berquin, P; Munnich, A; Rouleau, GA; Kaplan, J; Rozet, JM; Michaud, JL				Perrault, Isabelle; Hamdan, Fadi F.; Rio, Marlene; Capo-Chichi, Jose-Mario; Boddaert, Nathalie; Decarie, Jean-Claude; Maranda, Bruno; Nabbout, Rima; Sylvain, Michel; Lortie, Anne; Roux, Philippe P.; Rossigno, Elsa; Gerard, Xavier; Barcia, Giulia; Berquin, Patrick; Munnich, Arnold; Rouleau, Guy A.; Kaplan, Josseline; Rozet, Jean-Michel; Michaud, Jacques L.			Mutations in DOCK7 in Individuals with Epileptic Encephalopathy and Cortical Blindness	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MIGRATION; ERBB4; CELLS; RAC	Epileptic encephalopathies are increasingly thought to be of genetic origin, although the exact etiology remains uncertain in many cases. We describe here three girls from two nonconsanguineous families affected by a clinical entity characterized by dysmorphic features, early-onset intractable epilepsy, intellectual disability, and cortical blindness. In individuals from each family, brain imaging also showed specific changes, including an abnormally marked pontobulbar sulcus and abnormal signals (T2 hyperintensities) and atrophy in the occipital lobe. Exome sequencing performed in the first family did not reveal any gene with rare homozygous variants shared by both affected siblings. It did, however, show one gene, DOCK7, with two rare heterozygous variants (c.2510delA [p.Asp837Alafs*48] and c.3709C>T [p.Arg1237*]) found in both affected sisters. Exome sequencing performed in the proband of the second family also showed the presence of two rare heterozygous variants (c.983C>G [p.Ser328*] and c.6232G>T [p.Glu2078*]) in DOCK7. Sanger sequencing confirmed that all three individuals are compound heterozygotes for these truncating mutations in DOCK7. These mutations have not been observed in public SNP databases and are predicted to abolish domains critical for DOCK7 function. DOCK7 codes for a Rac guanine nucleotide exchange factor that has been implicated in the genesis and polarization of newborn pyramidal neurons and in the morphological differentiation of GABAergic interneurons in the developing cortex. All together, these observations suggest that loss of DOCK7 function causes a syndromic form of epileptic encephalopathy by affecting multiple neuronal processes.	[Perrault, Isabelle; Gerard, Xavier; Kaplan, Josseline; Rozet, Jean-Michel] Inst Natl Sante & Rech Med, UMR 1163, Lab Genet Ophthalmol, F-75015 Paris, France; [Perrault, Isabelle; Rio, Marlene; Gerard, Xavier; Munnich, Arnold; Kaplan, Josseline; Rozet, Jean-Michel] Univ Paris 05, Inst Imagine, Sorbonne Paris Cite, F-75015 Paris, France; [Hamdan, Fadi F.; Capo-Chichi, Jose-Mario; Lortie, Anne; Rossigno, Elsa; Michaud, Jacques L.] Ctr Hosp Univ St Justine, Res Ctr, Montreal, PQ H3T 1C5, Canada; [Rio, Marlene; Munnich, Arnold] Hop Necker Enfants Malad, Dept Genet, F-75015 Paris, France; [Boddaert, Nathalie] Descartes Univ, Hop Necker Enfants Malades, AP HP, Dept Pediat Radiol, F-75015 Paris, France; [Decarie, Jean-Claude] St Justine Hosp, Dept Med Imaging, Montreal, PQ H3T 1C5, Canada; [Maranda, Bruno] CHU Sherbrooke, Div Genet, Sherbrooke, PQ J1H 5N4, Canada; [Nabbout, Rima; Barcia, Giulia] Univ Paris 05, Hop Necker Enfants Malades, AP HP, Dept Pediat Neurol,Ctr Reference Epilepsies Rares, F-75015 Paris, France; [Sylvain, Michel] Ctr Hosp Univ Quebec, Div Neurol, Quebec City, PQ G1V 4G2, Canada; [Roux, Philippe P.] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Berquin, Patrick] Ctr Hosp Univ Amiens, Dept Pediat Neurol, F-80054 Amiens, France; [Rouleau, Guy A.] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; University of Sherbrooke; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Laval University; Universite de Montreal; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; McGill University	Rozet, JM (corresponding author), Inst Natl Sante & Rech Med, UMR 1163, Lab Genet Ophthalmol, F-75015 Paris, France.	jean-michel.rozet@inserm.fr; jacques.michaud@recherche-ste-justine.qc.ca	GERARD, Xavier/H-6039-2017; Barcia, Giulia/H-7907-2017; ROZET, Jean-Michel/E-5737-2016; Roux, Philippe P./J-3996-2012; boddaert, nathalie/GWV-2865-2022; perrault, isabelle/H-3047-2017; KAPLAN, Josseline/I-2622-2017	GERARD, Xavier/0000-0003-0586-4820; Barcia, Giulia/0000-0001-6657-5040; ROZET, Jean-Michel/0000-0001-7951-7886; Roux, Philippe P./0000-0002-5962-0250; Rio, Marlene/0000-0003-2049-5058; perrault, isabelle/0000-0002-8560-1379; Capo-Chichi, Jose-Mario/0000-0002-7440-3633; Rossignol, Elsa/0000-0002-9304-9385; boddaert, nathalie/0000-0003-0991-7774; KAPLAN, Josseline/0000-0002-1849-8658; spiegelman, dan/0000-0003-4971-8868	Fondation Jean-Louis Levesque; Genome Canada; Genome Quebec; INSERM; Association Retina France; Fondation JED	Fondation Jean-Louis Levesque; Genome Canada(Genome Canada); Genome Quebec; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association Retina France; Fondation JED	J.L.M. is a national scientist of the Fonds de Recherche du Quebec-Sante, and J.-M.R. is a national scientist of the Institut National de la Sante et de la Recherche Medicate (INSERM). P.P.R. holds the Canada Research Chair in Signal Transduction and Proteomics. We wish to thank the members of the massively-parallel-sequencing team at McGill University and Genome Quebec Innovation Center for their exome capture and sequencing service of family A. We also thank the members of the bioinformatic-analysis team of Reseau de Medecine Genetique Appliquee du Quebec (Alexandre Dionne-Laporte, Dan Spiegelman, Edouard Henrion, and Ousmane Diallo) for the primary analysis of the exome sequencing data of family A and the members of the Genomic and Bioinformatic Platform of Institut Imagine (Christine Bole, Mohamed Zahrate, Solenn Pruvost, Patrick Nitschke, and Cecile Masson) for exome sequencing and data analysis of family B. We would like to acknowledge the help of Elisabeth Hulier-Ammar, head of clinical research at Institut Imagine. This research was funded by grants from the Fondation Jean-Louis Levesque (J.L.M.), Genome Canada and Genome Quebec (J.L.M. and E.R.), INSERM (J.-M.R.), Association Retina France (J.-M.R.), and Fondation JED (J.-M.R.).	Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Backx L, 2009, EUR J HUM GENET, V17, P378, DOI 10.1038/ejhg.2008.180; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Blasius AL, 2009, P NATL ACAD SCI USA, V106, P2706, DOI 10.1073/pnas.0813208106; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Kasnauskiene J, 2013, AM J MED GENET A, V161A, P1487, DOI 10.1002/ajmg.a.35911; Le Magueresse C, 2013, NEURON, V77, P388, DOI 10.1016/j.neuron.2013.01.011; Tai YL, 2014, CELL REP, V6, P254, DOI 10.1016/j.celrep.2013.12.034; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Watabe-Uchida M, 2006, NEURON, V51, P727, DOI 10.1016/j.neuron.2006.07.020; Yamauchi J, 2008, J CELL BIOL, V181, P351, DOI 10.1083/jcb.200709033; Yang YT, 2012, NAT NEUROSCI, V15, P1201, DOI 10.1038/nn.3171	13	35	38	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 5	2014	94	6					891	897		10.1016/j.ajhg.2014.04.012	http://dx.doi.org/10.1016/j.ajhg.2014.04.012			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AJ0HK	24814191	Bronze, Green Published			2022-12-18	WOS:000337331200009
J	Ordulu, Z; Wong, KE; Currall, BB; Iyanov, AR; Pereira, S; Althari, S; Gusella, JF; Talkowski, ME; Morton, CC				Ordulu, Zehra; Wong, Kristen E.; Currall, Benjamin B.; Iyanov, Andrew R.; Pereira, Shahrin; Althari, Sara; Gusella, James F.; Talkowski, Michael E.; Morton, Cynthia C.			Describing Sequencing Results of Structural Chromosome Rearrangements with a Suggested Next-Generation Cytogenetic Nomenclature	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MICROARRAY ANALYSIS; MEDICAL GENETICS; AMERICAN-COLLEGE; GENOME BROWSER; DATABASE; STANDARDS; ABNORMALITIES; TRANSLOCATION; DISRUPTION; GUIDELINES	With recent rapid advances in genomic technologies, precise delineation of structural chromosome rearrangements at the nucleotide level is becoming increasingly feasible. In this era of "next-generation cytogenetics" (i.e., an integration of traditional cytogenetic techniques and next-generation sequencing), a consensus nomenclature is essential for accurate communication and data sharing. Currently, nomenclature for describing the sequencing data of these aberrations is lacking. Herein, we present a system called Next-Gen Cytogenetic Nomenclature, which is concordant with the International System for Human Cytogenetic Nomenclature (2013). This system starts with the alignment of rearrangement sequences by BLAT or BLAST (alignment tools) and arrives at a concise and detailed description of chromosomal changes. To facilitate usage and implementation of this nomenclature, we are developing a program designated BLA(S)T Output Sequence Tool of Nomenclature (BOSToN), a demonstrative version of which is accessible online. A standardized characterization of structural chromosomal rearrangements is essential both for research analyses and for application in the clinical setting.	[Ordulu, Zehra; Wong, Kristen E.; Currall, Benjamin B.; Iyanov, Andrew R.; Pereira, Shahrin; Morton, Cynthia C.] Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA; [Althari, Sara; Morton, Cynthia C.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Gusella, James F.; Talkowski, Michael E.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Gusella, James F.; Talkowski, Michael E.; Morton, Cynthia C.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Gusella, James F.; Talkowski, Michael E.; Morton, Cynthia C.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Gusella, James F.; Talkowski, Michael E.; Morton, Cynthia C.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Gusella, James F.; Talkowski, Michael E.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Morton, CC (corresponding author), Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA.	cmorton@partners.org	Ordulu, Zehra/ABI-6638-2020	Ordulu, Zehra/0000-0002-3218-1075; Talkowski, Michael/0000-0003-2889-0992; Wong, Kristen/0000-0002-7497-9835	NIH [GM061354, HD060530, HD065286, MH087123, MH095867]; Simons Foundation for Autism Research; Nancy Lurie Marks Family Foundation;  [F32 DC012466];  [T32 GM007748]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060530] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD065286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061354, T32GM007748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH087123, R00MH095867, K99MH095867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC012466] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation for Autism Research; Nancy Lurie Marks Family Foundation; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We are grateful to all participating subjects and families and to the many healthcare professionals who have contributed to the Developmental Genome Anatomy Project. We especially thank Ye Cao, Richard Choy, Cary Scott Gallagher, Anne Giersch, Anita Hawkins, Linda Johnson, Nahid Robertson, and Jun Shen for their contributions during manuscript preparation. This work was supported by NIH grants (GM061354 to C.C.M. and J.F.G., HD060530 to C.C.M., HD065286 to J.F.G., and MH087123 and MH095867 to M.E.T.). B.B.C. is supported by F32 DC012466 and previously by T32 GM007748. M.E.T. and J.F.G. are supported by the Simons Foundation for Autism Research and the Nancy Lurie Marks Family Foundation.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 1978, Cytogenet Cell Genet, V21, P309; [Anonymous], 1972, Cytogenetics, V11, P317; [Anonymous], 1985, BIRTH DEFECTS ORIG A, V21, P1; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; BERNARD O, 1983, EMBO J, V2, P2375, DOI 10.1002/j.1460-2075.1983.tb01749.x; BOOK JA, 1960, ANN HUM GENET, V24, P319; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; CASPERSSON T, 1968, EXP CELL RES, V49, P219, DOI 10.1016/0014-4827(68)90538-7; Caspersson T, 1972, Hereditas, V67, P147; Chen W, 2008, GENOME RES, V18, P1143, DOI 10.1101/gr.076166.108; Chiang C, 2012, NAT GENET, V44, P390, DOI 10.1038/ng.2202; Cooley LD, 2013, GENET MED, V15, P484, DOI 10.1038/gim.2013.49; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HARNDEN DG, 1981, CYTOGENET CELL GENET, V31, P5; Kamalakaran S, 2013, MOL ONCOL, V7, P743, DOI 10.1016/j.molonc.2013.04.008; Kearney HM, 2011, GENET MED, V13, P676, DOI 10.1097/GIM.0b013e31822272ac; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; LGSM Shaffer, 2009, ISCN 2009 INT SYSTEM, DOI DOI 10.1007/S00439-009-0726-6; Lindgren AM, 2013, HUM GENET, V132, P537, DOI 10.1007/s00439-013-1263-x; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; Martinez-Fundichely A, 2014, NUCLEIC ACIDS RES, V42, pD1027, DOI 10.1093/nar/gkt1122; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Mitelman F, 1992, ISCN 1991 GUIDELINES; Mitelman F, 1995, ISCN INT SYSTEM HUMA; Palmer E, 2014, AM J MED GENET A, V164, P377, DOI 10.1002/ajmg.a.36279; Rehm HL, 2013, GENET MED, V15, P733, DOI 10.1038/gim.2013.92; Schluth-Bolard C, 2013, J MED GENET, V50, P144, DOI 10.1136/jmedgenet-2012-101351; SHAFFER LG, 2013, ISCN 2013 INT SYSTEM, P140; Shaffer LG, 2005, ISCN 2005 INT SYSTEM; South ST, 2013, GENET MED, V15, P901, DOI 10.1038/gim.2013.129; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Talkowski ME, 2012, AM J HUM GENET, V91, P1128, DOI 10.1016/j.ajhg.2012.10.016; Talkowski ME, 2012, NEW ENGL J MED, V367, P2226, DOI 10.1056/NEJMoa1208594; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Talkowski ME, 2011, AM J HUM GENET, V88, P469, DOI 10.1016/j.ajhg.2011.03.013; TAUB R, 1984, CELL, V37, P511, DOI 10.1016/0092-8674(84)90381-7; Tjio J. H., 1956, HEREDITAS, V42, P1, DOI [10.1007/978-94-011-6621-8_13, DOI 10.1111/J.1601-5223.1956.TB03010.X]; Vergult S, 2013, EUR J HUM GENET; Xuan JK, 2013, CANCER LETT, V340, P284, DOI 10.1016/j.canlet.2012.11.025	44	35	35	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 1	2014	94	5					695	709		10.1016/j.ajhg.2014.03.020	http://dx.doi.org/10.1016/j.ajhg.2014.03.020			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AG5VB	24746958	Green Published, Bronze			2022-12-18	WOS:000335485700004
J	Liu, PF; Gelowani, V; Zhang, F; Drory, VE; Ben-Shachar, S; Roney, E; Medeiros, AC; Moore, RJ; DiVincenzo, C; Burnette, WB; Higgins, JJ; Li, J; Orr-Urtreger, A; Lupski, JR				Liu, Pengfei; Gelowani, Violet; Zhang, Feng; Drory, Vivian E.; Ben-Shachar, Shay; Roney, Erin; Medeiros, Adam C.; Moore, Rebecca J.; DiVincenzo, Christina; Burnette, William B.; Higgins, Joseph J.; Li, Jun; Orr-Urtreger, Avi; Lupski, James R.			Mechanism, Prevalence, and More Severe Neuropathy Phenotype of the Charcot-Marie-Tooth Type 1A Triplication	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SHORT TANDEM REPEATS; DISEASE TYPE 1A; CROSSING-OVER; GENOMIC REARRANGEMENTS; LOCUS TRIPLICATION; SYNDROME REGION; IA DUPLICATION; BAR LOCUS; DROSOPHILA; GENE	Copy-number variations cause genomic disorders. Triplications, unlike deletions and duplications, are poorly understood because of challenges in molecular identification, the choice of a proper model system for study, and awareness of their phenotypic consequences. We investigated the genomic disorder Charcot-Marie-Tooth disease type 1A (CMT1A), a dominant peripheral neuropathy caused by a 1.4 Mb recurrent duplication occurring by nonallelic homologous recombination. We identified CMT1A triplications in families in which the duplication segregates. The triplications arose de novo from maternally transmitted duplications and caused a more severe distal symmetric polyneuropathy phenotype. The recombination that generated the triplication occurred between sister chromatids on the duplication-bearing chromosome and could accompany gene conversions with the homologous chromosome. Diagnostic testing for CMT1A (n = 20,661 individuals) identified 13% (n = 2,752 individuals) with duplication and 0.024% (n = 5 individuals) with segmental tetrasomy, suggesting that triplications emerge from duplications at a rate as high as similar to 1:550, which is more frequent than the rate of de novo duplication. We propose that individuals with duplications are predisposed to acquiring triplications and that the population prevalence of triplication is underascertained.	[Liu, Pengfei; Gelowani, Violet; Roney, Erin; Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Zhang, Feng] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Zhang, Feng] Fudan Univ, Sch Life Sci, Key Lab Contemporary Anthropol, Minist Educ, Shanghai 200433, Peoples R China; [Drory, Vivian E.] Tel Aviv Sourasky Med Ctr, Dept Neurol, IL-64239 Tel Aviv, Israel; [Drory, Vivian E.; Orr-Urtreger, Avi] Tel Aviv Univ, Sacker Fac Med, IL-6997801 Tel Aviv, Israel; [Ben-Shachar, Shay; Orr-Urtreger, Avi] Tel Aviv Sourasky Med Ctr, Genet Inst, IL-64239 Tel Aviv, Israel; [Medeiros, Adam C.; Moore, Rebecca J.; DiVincenzo, Christina; Higgins, Joseph J.] Quest Diagnost Inc, Athena Diagnost, Worcester, MA 01605 USA; [Burnette, William B.; Li, Jun] Vanderbilt Univ, Ctr Human Genet Res, Dept Neurol, Nashville, TN 37232 USA; [Burnette, William B.] Vanderbilt Univ, Dept Pediat, Nashville, TN 37232 USA; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lupski, James R.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA	Baylor College of Medicine; Fudan University; Fudan University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Vanderbilt University; Vanderbilt University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	jlupski@bcm.edu	Liu, Pengfei/U-9743-2019; Zhang, Feng/C-7735-2009	Liu, Pengfei/0000-0002-4177-709X; Zhang, Feng/0000-0003-4556-8276; Orr-Urtreger, Avi/0000-0001-9305-6203; Burnette, William/0000-0002-7637-5330	National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke [R01NS058529, R01NS066927]; Texas Children's Hospital General Clinical Research Center [M01RR00188]; Intellectual and Developmental Disabilities Research Centers grant [P30HD024064]; Vanderbilt Institute for Clinical and Translational Research fund [VR1687]; Hartwell Foundation; March of Dimes; NIH [NS075397]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS075397, R01NS066927, R01NS058529] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Texas Children's Hospital General Clinical Research Center; Intellectual and Developmental Disabilities Research Centers grant; Vanderbilt Institute for Clinical and Translational Research fund; Hartwell Foundation; March of Dimes(March of Dimes); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Ping Fang and Weihong Jin for technical support and all the participating subjects and families for their time and effort. This work was supported in part by National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke grant R01NS058529 to J.R.L. and grant R01NS066927 to J.L., Texas Children's Hospital General Clinical Research Center grant M01RR00188, Intellectual and Developmental Disabilities Research Centers grant P30HD024064, and Vanderbilt Institute for Clinical and Translational Research fund VR1687. J.R.L. holds stock ownership of 23andMe and Ion Torrent Systems and is a coinventor on multiple United States and European patents for DNA diagnostics. The Department of Molecular and Human Genetics at Baylor College of Medicine receives clinical service revenue for genomic analyses by array comparative genomic hybridization and exome sequencing. J.J.H. holds stock options from Quest Diagnostics and receives research support from the Hartwell Foundation, March of Dimes, and NIH grant NS075397. J.J.H. is a voluntary professor in the Division of Pediatric Neurology at Weill Cornell Medical College. A. C. M., R.J.M., C. D., and J.J.H. are employed by Quest Diagnostics.	Badano JL, 2001, CLIN CHEM, V47, P838; Berg IL, 2010, NAT GENET, V42, P859, DOI 10.1038/ng.658; Beunders G, 2010, J MED GENET, V47, P271, DOI 10.1136/jmg.2009.070490; Bi WM, 2012, J MED GENET, V49, P681, DOI 10.1136/jmedgenet-2012-101002; Bi WM, 2009, NAT GENET, V41, P168, DOI 10.1038/ng.302; Bridges CB, 1936, SCIENCE, V83, P210, DOI 10.1126/science.83.2148.210; Carvalho CMB, 2011, NAT GENET, V43, P1074, DOI 10.1038/ng.944; Chauvin A, 2009, HUM MOL GENET, V18, P3605, DOI 10.1093/hmg/ddp308; Coleman MP, 1998, P NATL ACAD SCI USA, V95, P9985, DOI 10.1073/pnas.95.17.9985; Dittwald P, 2013, GENOME RES, V23, P1395, DOI 10.1101/gr.152454.112; England JD, 2009, NEUROLOGY, V72, P185, DOI 10.1212/01.wnl.0000336370.51010.a1; GARCIA CA, 1995, NEUROLOGY, V45, P2090, DOI 10.1212/WNL.45.11.2090; Giorda R, 2007, HUM MUTAT, V28, P459, DOI 10.1002/humu.20465; HARDING AE, 1980, BRAIN, V103, P259, DOI 10.1093/brain/103.2.259; KAKU DA, 1993, NEUROLOGY, V43, P1806, DOI 10.1212/WNL.43.9.1806; KOJIMA T, 1991, P NATL ACAD SCI USA, V88, P4343, DOI 10.1073/pnas.88.10.4343; Latour P, 2001, CLIN CHEM, V47, P829; Liu PF, 2011, AM J HUM GENET, V89, P580, DOI 10.1016/j.ajhg.2011.09.009; Liu PF, 2011, HUM MOL GENET, V20, P1975, DOI 10.1093/hmg/ddr078; Liu P, 2011, ADV COMMUN TECHNOL, V1, P1, DOI 10.1109/PLASMA.2011.5993125; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Lupski JR, 2013, SCIENCE, V341, P358, DOI 10.1126/science.1239503; Lupski JR, 2011, CELL, V147, P32, DOI 10.1016/j.cell.2011.09.008; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; PENTAO L, 1992, NAT GENET, V2, P292, DOI 10.1038/ng1292-292; Rautenstrauss B, 1998, INT J MOL MED, V1, P333; Ross OA, 2008, ANN NEUROL, V63, P743, DOI 10.1002/ana.21380; SCHINZEL AA, 1994, J MED GENET, V31, P798, DOI 10.1136/jmg.31.10.798; Sereda M, 1996, NEURON, V16, P1049, DOI 10.1016/S0896-6273(00)80128-2; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Sturtevant AH, 1925, GENETICS, V10, P117; Sturtevant AH, 1923, SCIENCE, V57, P746, DOI 10.1126/science.57.1487.746; Sturtevant AH, 1928, GENETICS, V13, P401; Turner DJ, 2008, NAT GENET, V40, P90, DOI 10.1038/ng.2007.40; Wolf NI, 2005, BRAIN, V128, P743, DOI 10.1093/brain/awh409; Yobb TM, 2005, AM J HUM GENET, V76, P865, DOI 10.1086/429841; Zeleny C, 1921, J EXP ZOOL, V34, P202, DOI 10.1002/jez.1400340206; Zhang F, 2010, AM J HUM GENET, V86, P892, DOI 10.1016/j.ajhg.2010.05.001; Zhang F, 2009, NAT GENET, V41, P849, DOI 10.1038/ng.399	39	35	35	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 6	2014	94	3					462	469		10.1016/j.ajhg.2014.01.017	http://dx.doi.org/10.1016/j.ajhg.2014.01.017			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AC6DK	24530202	Green Published, Bronze			2022-12-18	WOS:000332611400019
J	Chen, XL; Shen, YP; Zhang, F; Chiang, C; Pillalamarri, V; Blumenthal, I; Talkowski, M; Wu, BL; Gusella, JF				Chen, Xiaoli; Shen, Yiping; Zhang, Feng; Chiang, Colby; Pillalamarri, Vamsee; Blumenthal, Ian; Talkowski, Michael; Wu, Bai-Lin; Gusella, James F.			Molecular Analysis of a Deletion Hotspot in the NRXN1 Region Reveals the Involvement of Short Inverted Repeats in Deletion CNVs	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COPY-NUMBER VARIATION; STRUCTURAL VARIANTS; GENOMIC REARRANGEMENTS; SEGMENTAL DUPLICATIONS; COMPLEX REARRANGEMENTS; SPECTRUM; PALINDROME; SCHIZOPHRENIA; INSTABILITY; MECHANISM	NRXN1 microdeletions occur at a relatively high frequency and confer increased risk for neurodevelopmental and neurobehavioral abnormalities. The mechanism that makes NRXN1 a deletion hotspot is unknown. Here, we identified deletions of the NRXN1 region in affected cohorts, confirming a strong association with the autism spectrum and other neurodevelopmental disorders. Interestingly, deletions in both affected and control individuals were clustered in the 5' portion of NRXN1 and its immediate upstream region. To explore the mechanism of deletion, we mapped and analyzed the breakpoints of 32 deletions. At the deletion breakpoints, frequent microhomology (68.8%, 2-19 bp) suggested predominant mechanisms of DNA replication error and/or microhomology-mediated end-joining. Long terminal repeat (LTR) elements, unique non-B-DNA structures, and MEME-defined sequence motifs were significantly enriched, but Alu and LINE sequences were not. Importantly, small-size inverted repeats (minus self chains, minus sequence motifs, and partial complementary sequences) were significantly overrepresented in the vicinity of NRXN1 region deletion breakpoints, suggesting that, although they are not interrupted by the deletion process, such inverted repeats can predispose a region to genomic instability by mediating single-strand DNA looping via the annealing of partially reverse complementary strands and the promoting of DNA replication fork stalling and DNA replication error. Our observations highlight the potential importance of inverted repeats of variable sizes in generating a rearrangement hotspot in which individual breakpoints are not recurrent. Mechanisms that involve short inverted repeats in initiating deletion may also apply to other deletion hotspots in the human genome.	[Chen, Xiaoli] Capital Inst Pediat, Beijing 100020, Peoples R China; [Chen, Xiaoli; Shen, Yiping; Chiang, Colby; Pillalamarri, Vamsee; Blumenthal, Ian; Talkowski, Michael; Gusella, James F.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Chen, Xiaoli; Shen, Yiping; Wu, Bai-Lin] Childrens Hosp, Dept Lab Med, Boston, MA 02115 USA; [Shen, Yiping] Shanghai Jiao Tong Univ, Shanghai Childrens Med Ctr, Sch Med, Shanghai 200127, Peoples R China; [Shen, Yiping; Wu, Bai-Lin] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Zhang, Feng] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Zhang, Feng] Fudan Univ, Sch Life Sci, Minist Educ, Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Talkowski, Michael] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Talkowski, Michael; Gusella, James F.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Wu, Bai-Lin] Fudan Univ, Childrens Hosp, Shanghai 200032, Peoples R China; [Wu, Bai-Lin] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Gusella, James F.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Capital Institute of Pediatrics (CIP); Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Shanghai Jiao Tong University; Harvard University; Harvard Medical School; Fudan University; Fudan University; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Fudan University; Fudan University; Harvard University; Harvard Medical School	Wu, BL (corresponding author), Childrens Hosp, Dept Lab Med, 300 Longwood Ave, Boston, MA 02115 USA.	bai-lin.wu@childrens.harvard.edu; gusella@helix.mgh.harvard.edu	Zhang, Feng/C-7735-2009	Zhang, Feng/0000-0003-4556-8276; Chiang, Colby/0000-0002-4113-6065; Talkowski, Michael/0000-0003-2889-0992; Chen, Xiaoli/0000-0003-0536-1553	Natural Science Foundation of China [81100841]; Beijing Science and Technology Fund for Chinese Returned Oversea Scientist; Shanghai Science and Technology Commission [11dz1950300]; National Basic Research Program of China [2011CBA00401, 2012CB944600]; Ministry-of Science and Technology of China for the National 973 Program on Population and Health [2010CB529601]; Nature Science Fund of Shanghai [09JC1402400, 09ZR1404500]; NIH [GM061354, HD065286]; Autism Speaks grant [2042]; National Institute of Mental Health (NIMH) National Research Service Award [MH087123]; Mass General Hospital Executive Committee on Research Fund for Medical Discovery award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD065286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH087123] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Science and Technology Fund for Chinese Returned Oversea Scientist; Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); National Basic Research Program of China(National Basic Research Program of China); Ministry-of Science and Technology of China for the National 973 Program on Population and Health; Nature Science Fund of Shanghai; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Autism Speaks grant; National Institute of Mental Health (NIMH) National Research Service Award; Mass General Hospital Executive Committee on Research Fund for Medical Discovery award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Natural Science Foundation of China (grant 81100841) and the Beijing Science and Technology Fund for Chinese Returned Oversea Scientist (to X.L.C.); a Shanghai Science and Technology Commission major issue grant (11dz1950300) to Y.S.; the National Basic Research Program of China (grants 2011CBA00401 and 2012CB944600 to F.Z.); the Ministry-of Science and Technology of China for the National 973 Program on Population and Health (grant 2010CB529601 to B.L.W.) and the Nature Science Fund of Shanghai (09JC1402400 and 09ZR1404500 to B.L.W.), and NIH grants GM061354 and HD065286 and Autism Speaks grant 2042 to J.F.G. M.T. was supported by a National Institute of Mental Health (NIMH) National Research Service Award (grant MH087123) and a Mass General Hospital Executive Committee on Research Fund for Medical Discovery award.	Akgun E, 1997, MOL CELL BIOL, V17, P5559, DOI 10.1128/MCB.17.9.5559; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bartnik M, 2012, AM J MED GENET B, V159B, P760, DOI 10.1002/ajmg.b.32081; Bradley WEC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009401; Bucan M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000536; Carvalho CMB, 2011, NAT GENET, V43, P1074, DOI 10.1038/ng.944; Carvalho CMB, 2009, HUM MOL GENET, V18, P2188, DOI 10.1093/hmg/ddp151; Chen JM, 2010, SEMIN CANCER BIOL, V20, P222, DOI 10.1016/j.semcancer.2010.05.007; Chen JM, 2005, HUM MUTAT, V26, P125, DOI 10.1002/humu.20202; Ching MSL, 2010, AM J MED GENET B, V153B, P937, DOI 10.1002/ajmg.b.31063; Conrad DF, 2010, NAT GENET, V42, P385, DOI 10.1038/ng.564; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Dittwald P, 2013, HUM MUTAT, V34, P210, DOI 10.1002/humu.22217; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Edelmann L, 1999, AM J HUM GENET, V64, P1076, DOI 10.1086/302343; Edelmann L, 2001, AM J HUM GENET, V68, P1, DOI 10.1086/316952; Feng JN, 2006, NEUROSCI LETT, V409, P10, DOI 10.1016/j.neulet.2006.08.017; Fu WQ, 2010, AM J HUM GENET, V87, P494, DOI 10.1016/j.ajhg.2010.09.006; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; GORDENIN DA, 1993, MOL CELL BIOL, V13, P5315, DOI 10.1128/MCB.13.9.5315; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Gregor A, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-106; Gu Wenli, 2008, Pathogenetics, V1, P4, DOI 10.1186/1755-8417-1-4; Harrison V, 2011, AM J MED GENET A, V155A, P2826, DOI 10.1002/ajmg.a.34255; HENTHORN PS, 1986, P NATL ACAD SCI USA, V83, P5194, DOI 10.1073/pnas.83.14.5194; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Ikeda M, 2010, BIOL PSYCHIAT, V67, P283, DOI 10.1016/j.biopsych.2009.08.034; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kirov G, 2008, HUM MOL GENET, V17, P458, DOI 10.1093/hmg/ddm323; Kirov G, 2009, SCHIZOPHRENIA BULL, V35, P851, DOI 10.1093/schbul/sbp079; Kirov G, 2009, HUM MOL GENET, V18, P1497, DOI 10.1093/hmg/ddp043; Kurahashi H, 2000, AM J HUM GENET, V67, P763, DOI 10.1086/303054; Kurahashi H, 2004, J BIOL CHEM, V279, P35377, DOI 10.1074/jbc.M400354200; Kurahashi H, 2003, AM J HUM GENET, V72, P733, DOI 10.1086/368062; LEACH DRF, 1994, BIOESSAYS, V16, P893, DOI 10.1002/bies.950161207; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Levinson DF, 2011, AM J PSYCHIAT, V168, P302, DOI 10.1176/appi.ajp.2010.10060876; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Magri C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013422; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Muhleisen TW, 2011, SCHIZOPHR RES, V127, P35, DOI 10.1016/j.schres.2011.01.001; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Rujescu D, 2009, HUM MOL GENET, V18, P988, DOI 10.1093/hmg/ddn351; Sahoo T, 2011, GENET MED, V13, P868, DOI 10.1097/GIM.0b013e3182217a06; Schaaf CP, 2012, EUR J HUM GENET, V20, P1240, DOI 10.1038/ejhg.2012.95; Shah AK, 2010, NEUROSCI LETT, V475, P80, DOI 10.1016/j.neulet.2010.03.047; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Sheridan MB, 2010, AM J HUM GENET, V87, P209, DOI 10.1016/j.ajhg.2010.07.002; Soysal Y, 2011, AM J MED GENET A, V155A, P1745, DOI 10.1002/ajmg.a.34101; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Tang S., 2012, J CYST FIBROS; Vissers LELM, 2009, HUM MOL GENET, V18, P3579, DOI 10.1093/hmg/ddp306; Vrijenhoek T, 2008, AM J HUM GENET, V83, P504, DOI 10.1016/j.ajhg.2008.09.011; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang GL, 2009, MOL CARCINOGEN, V48, P286, DOI 10.1002/mc.20508; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Wisniowiecka-Kowalnik B, 2010, AM J MED GENET B, V153B, P983, DOI 10.1002/ajmg.b.31064; Yan J, 2008, NEUROSCI LETT, V438, P368, DOI 10.1016/j.neulet.2008.04.074; Zahir FR, 2008, J MED GENET, V45, P239, DOI 10.1136/jmg.2007.054437; Zhang F, 2010, AM J HUM GENET, V86, P892, DOI 10.1016/j.ajhg.2010.05.001; Zhang F, 2009, NAT GENET, V41, P849, DOI 10.1038/ng.399; Zhao JH, 2010, CELL MOL LIFE SCI, V67, P43, DOI 10.1007/s00018-009-0131-2; Zhu HW, 2011, AM J HUM GENET, V88, P819, DOI 10.1016/j.ajhg.2011.05.004; Zweier C, 2009, AM J HUM GENET, V85, P655, DOI 10.1016/j.ajhg.2009.10.004	78	35	38	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 7	2013	92	3					375	386		10.1016/j.ajhg.2013.02.006	http://dx.doi.org/10.1016/j.ajhg.2013.02.006			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106RF	23472757	Green Published, Bronze			2022-12-18	WOS:000316161700010
J	Zarnegar, BJ; Webster, DE; Lopez-Pajares, V; Hunt, BV; Qu, K; Yan, KJ; Berk, DR; Sen, GL; Khavari, PA				Zarnegar, Brian J.; Webster, Dan E.; Lopez-Pajares, Vanessa; Hunt, Brook Vander Stoep; Qu, Kun; Yan, Karen J.; Berk, David R.; Sen, George L.; Khavari, Paul A.			Genomic Profiling of a Human Organotypic Model of AEC Syndrome Reveals ZNF750 as an Essential Downstream Target of Mutant TP63	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							P53 HOMOLOG; SAM DOMAIN; P63 GENE; FOOT MALFORMATION; DIFFERENTIATION; MUTATIONS; LIMB; PROLIFERATION; CELLS; EEC	The basis for impaired differentiation in TP63 mutant ankyloblepharon-ectodermal dysplasia-clefting (AEC) syndrome is unknown. Human epidermis harboring AEC TP63 mutants recapitulated this impairment, along with downregulation of differentiation activators, including HOPX, GRHL3, KLF4, PROM I, and ZNF750. Gene-set enrichment analysis indicated that disrupted expression of epidermal differentiation programs under the control of ZNF750 and KLF4 accounted for the majority of disrupted epidermal differentiation resulting from AEC mutant TP63. Chromatin immunoprecipitation (ChIP) analysis and ChIP-sequencing of TP63 binding in differentiated keratinocytes revealed ZNF750 as a direct target of wild-type and AEC mutant TP63. Restoring ZNF750 to AEC model tissue rescued activator expression and differentiation, indicating that AEC TP63-mediated ZNF750 inhibition contributes to differentiation defects in AEC. Incorporating disease-causing mutants into regenerated human tissue can thus dissect pathomechanisms and identify targets that reverse disease features.	[Zarnegar, Brian J.; Webster, Dan E.; Lopez-Pajares, Vanessa; Hunt, Brook Vander Stoep; Qu, Kun; Yan, Karen J.; Khavari, Paul A.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; [Berk, David R.] Washington Univ, Sch Med, Div Dermatol, St Louis, MO 63110 USA; [Sen, George L.] Univ Calif San Diego, Dept Cellular & Mol Med, San Diego Sch Med, La Jolla, CA 92093 USA; [Khavari, Paul A.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA	Stanford University; Washington University (WUSTL); University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Khavari, PA (corresponding author), Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA.	khavari@stanford.edu	Qu, Kun/G-3359-2012	Webster, Dan/0000-0001-6874-8451	U.S. Department of Veterans Affairs Office of Research and Development; National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01 AR45192]; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045192] Funding Source: NIH RePORTER	U.S. Department of Veterans Affairs Office of Research and Development(US Department of Veterans Affairs); National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank L. Morcom for expert administrative assistance. This work is supported by the U.S. Department of Veterans Affairs Office of Research and Development and by the National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases R01 AR45192 to P.A.K.	Birnbaum RY, 2006, NAT GENET, V38, P749, DOI 10.1038/ng1813; Bougeard G, 2003, EUR J HUM GENET, V11, P700, DOI 10.1038/sj.ejhg.5201004; Browne G, 2011, J CELL SCI, V124, P2200, DOI 10.1242/jcs.079327; Brunner HG, 2002, J MED GENET, V39, P377, DOI 10.1136/jmg.39.6.377; Celli J, 1999, CELL, V99, P143, DOI 10.1016/S0092-8674(00)81646-3; Chi SW, 1999, EMBO J, V18, P4438, DOI 10.1093/emboj/18.16.4438; Crackower MA, 1996, HUM MOL GENET, V5, P571, DOI 10.1093/hmg/5.5.571; Duijf PHG, 2002, HUM MOL GENET, V11, P799, DOI 10.1093/hmg/11.7.799; Ferone G, 2012, EMBO MOL MED, V4, P192, DOI 10.1002/emmm.201100199; Ianakiev P, 2000, AM J HUM GENET, V67, P59, DOI 10.1086/302972; Ingraham CR, 2006, NAT GENET, V38, P1335, DOI 10.1038/ng1903; Julapalli MR, 2009, AM J MED GENET A, V149A, P1900, DOI 10.1002/ajmg.a.32797; Kantaputra PN, 2003, J DENT RES, V82, P433, DOI 10.1177/154405910308200606; Koster MI, 2009, AM J MED GENET A, V149A, P1942, DOI 10.1002/ajmg.a.32794; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Lo Iacono N, 2008, DEVELOPMENT, V135, P1377, DOI 10.1242/dev.011759; Lopez RG, 2009, NAT CELL BIOL, V11, P1181, DOI 10.1038/ncb1960; Mangiulli M, 2009, NUCLEIC ACIDS RES, V37, P6092, DOI 10.1093/nar/gkp674; MARINONI JC, 1995, CLIN GENET, V47, P90; McGrath JA, 2001, HUM MOL GENET, V10, P221, DOI 10.1093/hmg/10.3.221; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Ridky TW, 2010, NAT MED, V16, P1450, DOI 10.1038/nm.2265; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Sen GL, 2008, GENE DEV, V22, P1865, DOI 10.1101/gad.1673508; Sen GL, 2012, DEV CELL, V22, P669, DOI 10.1016/j.devcel.2011.12.001; Sen GL, 2010, NATURE, V463, P563, DOI 10.1038/nature08683; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Su XH, 2009, EMBO J, V28, P1904, DOI 10.1038/emboj.2009.151; Su XH, 2009, CELL STEM CELL, V5, P64, DOI 10.1016/j.stem.2009.04.003; Ting SB, 2005, SCIENCE, V308, P411, DOI 10.1126/science.1107511; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Wells J, 2002, METHODS, V26, P48, DOI 10.1016/S1046-2023(02)00007-5; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yang A, 2006, MOL CELL, V24, P593, DOI 10.1016/j.molcel.2006.10.018; Yang CF, 2008, J INVEST DERMATOL, V128, P1662, DOI 10.1038/jid.2008.1; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	38	35	35	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 7	2012	91	3					435	443		10.1016/j.ajhg.2012.07.007	http://dx.doi.org/10.1016/j.ajhg.2012.07.007			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	004LL	22922031	Bronze, Green Published			2022-12-18	WOS:000308683100004
J	Hor, H; Bartesaghi, L; Kutalik, Z; Vicario, JL; de Andres, C; Pfister, C; Lammers, GJ; Guex, N; Chrast, R; Tafti, M; Peraita-Adrados, R				Hor, Hyun; Bartesaghi, Luca; Kutalik, Zoltan; Vicario, Jose L.; de Andres, Clara; Pfister, Corinne; Lammers, Gert J.; Guex, Nicolas; Chrast, Roman; Tafti, Mehdi; Peraita-Adrados, Rosa			A Missense Mutation in Myelin Oligodendrocyte Glycoprotein as a Cause of Familial Narcolepsy with Cataplexy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEMYELINATING DISEASES; MULTIPLE-SCLEROSIS; TAIEP RAT; ANTIBODIES; PROTEIN; REGION; ASSOCIATION; PEPTIDES; GENOME; LOCUS	Narcolepsy is a rare sleep disorder characterized by excessive daytime sleepiness and cataplexy. Familial narcolepsy accounts for less than 100% of all narcolepsy cases. However, documented multiplex families are very rare and causative mutations have not been identified to date. To identify a causative mutation in familial narcolepsy, we performed linkage analysis in the largest ever reported family, which has 12 affected members, and sequenced coding regions of the genome (exome sequencing) of three affected members with narcolepsy and cataplexy.	[Kutalik, Zoltan; Guex, Nicolas] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Bartesaghi, Luca; Kutalik, Zoltan; Chrast, Roman] Univ Lausanne, Dept Med Genet, CH-1005 Lausanne, Switzerland; [Vicario, Jose L.] Blood Ctr Community Madrid, Madrid 28032, Spain; [de Andres, Clara; Peraita-Adrados, Rosa] Gregorio Maranon Univ Hosp, Dept Clin Neurophysiol, Sleep & Epilepsy Unit, Madrid 28007, Spain; [Lammers, Gert J.] Leiden Univ, Med Ctr, Dept Neurol, NL-2300 Leiden, Netherlands; [Tafti, Mehdi] CHU Vaudois, CIRS, CH-1011 Lausanne, Switzerland; [Hor, Hyun; Pfister, Corinne; Tafti, Mehdi] Univ Lausanne, CIG, CH-1015 Lausanne, Switzerland	Swiss Institute of Bioinformatics; University of Lausanne; General University Gregorio Maranon Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne	Tafti, M (corresponding author), Univ Lausanne, CIG, CH-1015 Lausanne, Switzerland.	mehdi.tafti@unil.ch; mperaita.hgugm@salud.madrid.org	Tafti, Mehdi/A-8887-2017; Bartesaghi, Luca/AAK-7242-2021	Tafti, Mehdi/0000-0002-6997-3914; Bartesaghi, Luca/0000-0001-8218-4648; Chrast, Roman/0000-0003-4189-3514; Peraita-Adrados, Rosa/0000-0002-4172-4000; Lammers, Gert Jan/0000-0003-4755-7060; GUEX, Nicolas/0000-0001-6023-0519	University of Lausanne, Swiss National Science Foundation [PP00P3_124833]; European Narcolepsy Network (EU-NN); UCB Pharma (Belgium)	University of Lausanne, Swiss National Science Foundation(Swiss National Science Foundation (SNSF)); European Narcolepsy Network (EU-NN); UCB Pharma (Belgium)(UCB Pharma SA)	Supported by the University of Lausanne, Swiss National Science Foundation (grant PP00P3_124833 to R.C.), the European Narcolepsy Network (EU-NN), and an unrestricted research grant from UCB Pharma (Belgium). Thanks to Markus Reindl for providing the MOG plasmids, Petra Zavadakova for assistance in linkage analysis, the Genomic Technologies Facility of the University of Lausanne for exome sequencing, Maria-Jose Dominguez, Antonia Garcia, and Nunci Pereda for sleep studies at the Sleep Unit of Gregorio Maranon University Hospital in Madrid, and Ioannis Xenarios from Vital-It- Swiss Institute of Bioinformatics for protein modeling analysis. We thank especially Dr. Michel Billiard for advice and suggestions and all the individuals and family members who participated in this research. MT and GJL received honorarium as invited speakers and members of the narcolepsy advisory board and unrestricted research grants from UCB Pharma (Belgium).	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; Breithaupt C, 2003, P NATL ACAD SCI USA, V100, P9446, DOI 10.1073/pnas.1133443100; Breithaupt C, 2008, J IMMUNOL, V181, P1255, DOI 10.4049/jimmunol.181.2.1255; Clements CS, 2003, P NATL ACAD SCI USA, V100, P11059, DOI 10.1073/pnas.1833158100; Cvetkovic-Lopes V, 2010, J CLIN INVEST, V120, P713, DOI 10.1172/JCI41366; Dauvilliers Y, 2004, ANN NEUROL, V56, P382, DOI 10.1002/ana.20208; Dauvilliers Y, 2007, LANCET, V369, P499, DOI 10.1016/S0140-6736(07)60237-2; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Deuquet J, 2011, EMBO MOL MED, V3, P208, DOI 10.1002/emmm.201100124; Di Pauli F, 2011, CLIN IMMUNOL, V138, P247, DOI 10.1016/j.clim.2010.11.013; DYER CA, 1994, J NEUROCHEM, V62, P777; Eguibar JR, 2010, NEUROSCI LETT, V483, P189, DOI 10.1016/j.neulet.2010.07.086; Francks C, 2004, AM J HUM GENET, V75, P1046, DOI 10.1086/426404; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hallmayer J, 2009, NAT GENET, V41, P708, DOI 10.1038/ng.372; Hor H, 2010, NAT GENET, V42, P786, DOI 10.1038/ng.647; Konradi C, 2012, NEUROBIOL DIS, V45, P37, DOI 10.1016/j.nbd.2011.01.025; Kornum BR, 2011, NAT GENET, V43, P66, DOI 10.1038/ng.734; Lalive PH, 2011, MULT SCLER J, V17, P297, DOI 10.1177/1352458510389220; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Linares D, 2003, J AUTOIMMUN, V21, P339, DOI 10.1016/j.jaut.2003.09.001; LININGTON C, 1988, AM J PATHOL, V130, P443; Mignot E, 1998, NEUROLOGY, V50, pS16, DOI 10.1212/WNL.50.2_Suppl_1.S16; Mignot E, 2001, AM J HUM GENET, V68, P686, DOI 10.1086/318799; Nakayama J, 2000, GENOMICS, V65, P84, DOI 10.1006/geno.2000.6143; Nishino S, 2000, LANCET, V355, P39, DOI 10.1016/S0140-6736(99)05582-8; Peyron C, 1998, J NEUROSCI, V18, P9996; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Reindl M, 1999, BRAIN, V122, P2047, DOI 10.1093/brain/122.11.2047; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Song J, 1999, J NEUROCYTOL, V28, P671, DOI 10.1023/A:1007060832459; Takahashi N, 2011, PROG NEUROBIOL, V93, P13, DOI 10.1016/j.pneurobio.2010.09.004; Winterstein C, 2008, J CELL SCI, V121, P834, DOI 10.1242/jcs.022731; SEATTLESEQ ANNOTATIO	36	35	36	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 9	2011	89	3					474	479		10.1016/j.ajhg.2011.08.007	http://dx.doi.org/10.1016/j.ajhg.2011.08.007			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	820XQ	21907016	Green Published, Bronze			2022-12-18	WOS:000294939800014
J	Biffi, A; Anderson, CD; Nalls, MA; Rahman, R; Sonni, A; Cortellini, L; Rost, NS; Matarin, M; Hernandez, DG; Plourde, A; de Bakker, PIW; Ross, OA; Greenberg, SM; Furie, KL; Meschia, JF; Singleton, AB; Saxena, R; Rosand, J				Biffi, Alessandro; Anderson, Christopher D.; Nalls, Michael A.; Rahman, Rosanna; Sonni, Akshata; Cortellini, Lynelle; Rost, Natalia S.; Matarin, Mar; Hernandez, Dena G.; Plourde, Anna; de Bakker, Paul I. W.; Ross, Owen A.; Greenberg, Steven M.; Furie, Karen L.; Meschia, James F.; Singleton, Andrew B.; Saxena, Richa; Rosand, Jonathan			Principal-Component Analysis for Assessment of Population Stratification in Mitochondrial Medical Genetics	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA; ASSOCIATION; RISK	Although inherited mitochondrial genetic variation can cause human disease, no validated methods exist for control of confounding due to mitochondrial population stratification (PS). We sought to identify a reliable method for PS assessment in mitochondrial medical genetics. We analyzed mitochondria' SNP data from 1513 European American individuals concomitantly genotyped with the use of a previously validated panel of 144 mitochondrial markers as well as the Affymetrix 6.0 (n = 432), Illumina 610-Quad (n = 458), or Illumina 660 (n = 623) platforms. Additional analyses were performed in 938 participants in the Human Genome Diversity Panel (HGDP) (Illumina 650). We compared the following methods for controlling for PS: haplogroup-stratified analyses, mitochondrial principal-component analysis (PCA), and combined autosomal-mitochondrial PCA. We computed mitochondria' genomic inflation factors (mtGIFs) and test statistics for simulated case-control and continuous phenotypes (10,000 simulations each) with varying degrees of correlation with mitochondria' ancestry. Results were then compared across adjustment methods. We also calculated power for discovery of true associations under each method, using a simulation approach. Mitochondria! PCA recapitulated haplogroup information, but haplogroup-stratified analyses were inferior to mitochondria' PCA in controlling for PS. Correlation between nuclear and mitochondria' principal components (PCs) was very limited. Adjustment for nuclear PCs had no effect on mitochondria' analysis of simulated phenotypes. Mitochondria! PCA performed with the use of data from commercially available genome-wide arrays correlated strongly with PCA performed with the use of an exhaustive mitochondria' marker panel. Finally, we demonstrate, through simulation, no loss in power for detection of true associations with the use of mitochondria' PCA.	[Biffi, Alessandro; Anderson, Christopher D.; Rahman, Rosanna; Sonni, Akshata; Cortellini, Lynelle; Rost, Natalia S.; Plourde, Anna; Saxena, Richa; Rosand, Jonathan] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Biffi, Alessandro; Anderson, Christopher D.; Rahman, Rosanna; Sonni, Akshata; Cortellini, Lynelle; Rost, Natalia S.; Plourde, Anna; Greenberg, Steven M.; Furie, Karen L.; Rosand, Jonathan] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Biffi, Alessandro; Anderson, Christopher D.; Rahman, Rosanna; Sonni, Akshata; Cortellini, Lynelle; Rost, Natalia S.; Plourde, Anna; de Bakker, Paul I. W.; Saxena, Richa; Rosand, Jonathan] 7 Cambridge Ctr, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02139 USA; [Nalls, Michael A.; Matarin, Mar; Hernandez, Dena G.; Singleton, Andrew B.] NIA, Neurogenet Lab, Intramural Res Program, Bethesda, MD 20892 USA; [Matarin, Mar] UCL Inst Neurol, Dept Clin & Expt Epilepsy, London WC1N 3BG, England; [Hernandez, Dena G.] UCL, Inst Neurol, Dept Mol Neurosci, London WC1E 6BT, England; [Hernandez, Dena G.] UCL, Inst Neurol, Reta Lila Weston Labs, London WC1E 6BT, England; [de Bakker, Paul I. W.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Genet, Boston, MA 02115 USA; [Ross, Owen A.; Meschia, James F.] Mayo Clin Jacksonville, Dept Neurol, Jacksonville, FL 32224 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of London; University College London; University of London; University College London; University of London; University College London; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Mayo Clinic	Rosand, J (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.	jrosand@partners.org	de Bakker, Paul IW/B-8730-2009; Demchuk, Andrew M/E-1103-2012; Ross, Owen/D-7573-2013; Singleton, Andrew B/C-3010-2009; Matarin, Mar/F-1771-2016; Saxena, Richa/AAG-7279-2020; Meschia, James/GPP-1636-2022	de Bakker, Paul IW/0000-0001-7735-7858; Demchuk, Andrew M/0000-0002-4930-7789; Matarin, Mar/0000-0002-4717-5735; Meschia, James/0000-0002-4475-8142; Ross, Owen/0000-0003-4813-756X; Anderson, Christopher/0000-0002-0053-2002; Saxena, Richa/0000-0003-2233-1065	American Heart Association / Bugher Foundation Centers for Stroke Prevention Research [0775010N]; Deane Institute for Integrative Study of Atrial Fibrillation and Stroke; Myron and Jane Hanley Award in Stroke Research; Marriott Disease Risk and Regenerative Medicine Initiative Award in Individualized Medicine; National Institute for Neurologic Disorders and Stroke [R01NS052585, R01NS059727, 5K23NS042720, 5P50NS051343]; Fulbright Foundation; American Association of University Women; National Center for Research Resources [U54 RR020278]; NIH National Institute on Aging [Z01 AG000954-06]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052585, K23NS042720, P50NS051343, K23NS064052, R01NS059727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000954] Funding Source: NIH RePORTER	American Heart Association / Bugher Foundation Centers for Stroke Prevention Research(American Heart Association); Deane Institute for Integrative Study of Atrial Fibrillation and Stroke; Myron and Jane Hanley Award in Stroke Research; Marriott Disease Risk and Regenerative Medicine Initiative Award in Individualized Medicine; National Institute for Neurologic Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Fulbright Foundation; American Association of University Women; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by the American Heart Association / Bugher Foundation Centers for Stroke Prevention Research (0775010N), the Deane Institute for Integrative Study of Atrial Fibrillation and Stroke, the Myron and Jane Hanley Award in Stroke Research, the Marriott Disease Risk and Regenerative Medicine Initiative Award in Individualized Medicine, the National Institute for Neurologic Disorders and Stroke (R01NS052585, R01NS059727, 5K23NS042720, 5P50NS051343), the Fulbright Foundation, the American Association of University Women, and the National Center for Research Resources (U54 RR020278). This research was supported in part by the Intramural Research Program of the NIH National Institute on Aging (Z01 AG000954-06).	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Cann HM, 2002, SCIENCE, V296, P261; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Ghezzi D, 2005, EUR J HUM GENET, V13, P748, DOI 10.1038/sj.ejhg.5201425; Hudson G, 2008, BRAIN, V131, DOI 10.1093/brain/awm224; Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394; Ioannidis JPA, 2008, J EVAL CLIN PRACT, V14, P951, DOI 10.1111/j.1365-2753.2008.00986.x; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Kelly PJ, 2003, STROKE, V34, pE51, DOI 10.1161/01.STR.0000071109.23410.AB; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; McRae AF, 2008, GENOME RES, V18, P911, DOI 10.1101/gr.074872.107; Meschia James F, 2003, BMC Neurol, V3, P4, DOI 10.1186/1471-2377-3-4; Meschia James F, 2002, BMC Med Genet, V3, P1, DOI 10.1186/1471-2350-3-1; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Pakendorf B, 2005, ANNU REV GENOM HUM G, V6, P165, DOI 10.1146/annurev.genom.6.080604.162249; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Poyton RO, 2009, TRENDS ENDOCRIN MET, V20, P332, DOI 10.1016/j.tem.2009.04.001; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Price AL, 2008, AM J HUM GENET, V83, P132, DOI 10.1016/j.ajhg.2008.06.005; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raule N, 2007, MITOCHONDRION, V7, P29, DOI 10.1016/j.mito.2006.11.013; Rosand J, 2004, ARCH INTERN MED, V164, P880, DOI 10.1001/archinte.164.8.880; Saxena R, 2006, AM J HUM GENET, V79, P54, DOI 10.1086/504926; Tiwari HK, 2008, HUM HERED, V66, P67, DOI 10.1159/000119107; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Webb E, 2008, BRIT J CANCER, V99, P2088, DOI 10.1038/sj.bjc.6604805; Yu XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001530; Ziegler A, 2008, BIOMETRICAL J, V50, P8, DOI 10.1002/bimj.200710398	29	35	36	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 11	2010	86	6					904	917		10.1016/j.ajhg.2010.05.005	http://dx.doi.org/10.1016/j.ajhg.2010.05.005			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	613AT	20537299	Green Published, Bronze			2022-12-18	WOS:000278948900008
J	Odeh, H; Hunker, KL; Belyantseva, IA; Azaiez, H; Avenarius, MR; Zheng, LL; Peters, LM; Gagnon, LH; Hagiwara, N; Skynner, MJ; Brilliant, MH; Allen, ND; Riazuddin, S; Johnson, KR; Raphael, Y; Najmabadi, H; Friedman, TB; Bartles, JR; Smith, RJH; Kohrman, DC				Odeh, Hana; Hunker, Kristina L.; Belyantseva, Inna A.; Azaiez, Hela; Avenarius, Matthew R.; Zheng, Lili; Peters, Linda M.; Gagnon, Leona H.; Hagiwara, Nobuko; Skynner, Michael J.; Brilliant, Murray H.; Allen, Nicholas D.; Riazuddin, Saima; Johnson, Kenneth R.; Raphael, Yehoash; Najmabadi, Hossein; Friedman, Thomas B.; Bartles, James R.; Smith, Richard J. H.; Kohrman, David C.			Mutations in Grxcr1 Are The Basis for Inner Ear Dysfunction in the Pirouette Mouse	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PARALLEL ACTIN BUNDLES; HAIR-CELLS; UNCONVENTIONAL MYOSIN; RECESSIVE DEAFNESS; CRYSTAL-STRUCTURE; BIRD COCHLEA; HEARING-LOSS; STEREOCILIA; GENE; ESPIN	Recessive mutations at the mouse pirouette (pi) locus result in hearing loss and vestibular dysfunction due to neuroepithelial defects in the inner ear. Using a positional cloning strategy, we have identified mutations in the gene Grxcr1 (glutaredoxin cysteine-rich 1) in five independent allelic strains of pirouette mice. We also provide sequence data of GRXCR1 from humans with profound hearing loss suggesting that pirouette is a model for studying the mechanism of nonsyndromic deafness DFNB25. Grxcr1 encodes a 290 amino acid protein that contains a region of similarity to glutaredoxin proteins and a cysteine-rich region at its C terminus. Grxcr1 is expressed in sensory epithelia of the inner ear, and its encoded protein is localized along the length of stereocilia, the actin-filament-rich mechanosensory structures at the apical Surface of auditory and vestibular hair cells. The precise architecture of hair cell stereocilia is essential for normal hearing. Loss of function of Grxcr1 in homozygous pirouette mice results in abnormally thin and slightly shortened stereocilia. When overexpressed in transfected cells, GRXCR1 localizes along the length of actin-filament-rich structures at the dorsal-apical surface and induces structures with greater actin filament content and/or increased lengths in a subset of cells. Our results suggest that deafness in pirouette mutants is associated with loss of GRXCR1 function in modulating actin cytoskeletal architecture in the developing stereocilia of sensory hair cells.	[Odeh, Hana; Hunker, Kristina L.; Avenarius, Matthew R.; Raphael, Yehoash; Kohrman, David C.] Univ Michigan, Sch Med, Kresge Hearing Res Inst, Dept Otolaryngol, Ann Arbor, MI 48109 USA; [Odeh, Hana] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Avenarius, Matthew R.; Kohrman, David C.] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; [Belyantseva, Inna A.; Peters, Linda M.; Riazuddin, Saima; Friedman, Thomas B.] Natl Inst Deafness & Other Commun Disorders, Sect Human Genet, Mol Genet Lab, NIH, Rockville, MD 20850 USA; [Azaiez, Hela; Smith, Richard J. H.] Univ Iowa, Dept Otolaryngol, Iowa City, IA 52242 USA; [Azaiez, Hela; Smith, Richard J. H.] Univ Iowa, Interdept PhD Genet Program, Iowa City, IA 52242 USA; [Zheng, Lili; Bartles, James R.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Gagnon, Leona H.; Johnson, Kenneth R.] Jackson Lab, Bar Harbor, ME 04609 USA; [Hagiwara, Nobuko; Brilliant, Murray H.] Univ Arizona, Coll Med, Steele Mem Childrens Res Ctr, Dept Pediat, Tucson, AZ 85724 USA; [Skynner, Michael J.; Allen, Nicholas D.] Babraham Inst, Neurobiol Programme, Cambridge CB2 4AT, England; [Najmabadi, Hossein] Univ Social Welf & Rehabil Sci, Genet Res Ctr, Tehran, Iran	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); University of Iowa; University of Iowa; Northwestern University; Feinberg School of Medicine; Jackson Laboratory; University of Arizona; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Kohrman, DC (corresponding author), Univ Michigan, Sch Med, Kresge Hearing Res Inst, Dept Otolaryngol, Ann Arbor, MI 48109 USA.	dkohrman@umich.edu	allen, nick d/A-4336-2010; Najmabadi, Hossein/P-8182-2017; Azaiez, Hela/AAQ-7011-2020; Peters, Linda/P-5370-2018	Azaiez, Hela/0000-0002-2863-6970; Bartles, James/0000-0002-7056-3875; Allen, Nicholas/0000-0003-4009-186X; Smith, Richard/0000-0003-1201-6731; Najmabadi, Hossein/0000-0002-6084-7778; Peters, Linda/0000-0002-9961-4293; Avenarius, Matthew/0000-0001-9516-5163	Deafness Research Foundation; NIH-NIDCD [R29-DC03049, R01-DC003049, R01-DC004314, R01-DC002842, T32-DC000011, P30-DC05188, DC62108, Z01-DC000048]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000048, R29DC003049, T32DC000011, R01DC003049, R01DC002842, P30DC005188, ZIADC000039, N01DC062108, R01DC004314, R01DC004301] Funding Source: NIH RePORTER	Deafness Research Foundation; NIH-NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Margaret Lomax and Sally Camper for critical reading of the manuscript, and we thank Ursula Jakob, Jochen Schacht, Suhua Sha, andjohn Moran for helpful discussions. We acknowledge Alyce LaDeau and Kate Donnell for identification of the pi<SUP>2J</SUP> and pi<SUP>3J</SUP> mutants, Sandra Gray for help with mouse husbandry at The Jackson Laboratory, Tzy-Wen Gong for tissue panel RNA and inner ear dissection expertise, Robert J. Morell for in situ hybridization advice, and Bruce Donohoe and Chris Edwards for assistance with confocal microscopy analysis. We thank Sarah Davis, Joe Schacht, Junghan Kim, and Sue Lee for excellent technical assistance. We also appreciate the genomic sequencing of several BAC clones by the NIH Mouse Genome Sequencing Network, including the group headed by Bruce Birren and Ken Dewar at MIT. This work was Supported by a grant from the Deafness Research Foundation (D.C.K.), by NIH-NIDCD grants R29-DC03049 (D.C.K.), R01-DC003049 (D.C.K.), R01-DC004314 (J.R.B.), R01-DC002842 (R.J.H.S.), T32-DC000011 (H.O.), and P30-DC05188 (D.C.K. and Y.R.), by NIH-NIDCD contract DC62108 (K.R.J.), and by NIH-NIDCD intramural funds Z01-DC000048 (T.B.F.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bartles JR, 2000, CURR OPIN CELL BIOL, V12, P72, DOI 10.1016/S0955-0674(99)00059-9; Bartles JR, 1996, J CELL SCI, V109, P1229; Belli G, 2002, J BIOL CHEM, V277, P37590, DOI 10.1074/jbc.M201688200; Belyantseva IA, 2005, NAT CELL BIOL, V7, P148, DOI 10.1038/ncb1219; Belyantseva IA, 2003, P NATL ACAD SCI USA, V100, P13958, DOI 10.1073/pnas.2334417100; Beyer LA, 2000, J NEUROCYTOL, V29, P227, DOI 10.1023/A:1026515619443; Bixby KA, 1999, NAT STRUCT BIOL, V6, P38; Board PG, 2000, J BIOL CHEM, V275, P24798, DOI 10.1074/jbc.M001706200; Brown SDM, 2008, NAT REV GENET, V9, P277, DOI 10.1038/nrg2309; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Daudet N, 2002, CELL MOTIL CYTOSKEL, V53, P326, DOI 10.1002/cm.10092; DICKIE MM, 1946, J HERED, V37, P335, DOI 10.1093/oxfordjournals.jhered.a105550; Erven A, 2002, EUR J NEUROSCI, V16, P1433, DOI 10.1046/j.1460-9568.2002.02213.x; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; Finkel T, 2001, IUBMB LIFE, V52, P3, DOI 10.1080/15216540252774694; FLOCK A, 1977, J CELL BIOL, V75, P339, DOI 10.1083/jcb.75.2.339; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Gillespie PG, 2009, CELL, V139, P33, DOI 10.1016/j.cell.2009.09.010; Goodyear RJ, 2005, J COMP NEUROL, V485, P75, DOI 10.1002/cne.20513; Hagiwara N, 2003, DEV BIOL, V254, P93, DOI 10.1016/S0012-1606(02)00030-1; Halleck MS, 1998, GENOME RES, V8, P354, DOI 10.1101/gr.8.4.354; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Holmgren A, 2000, ANTIOXID REDOX SIGN, V2, P811, DOI 10.1089/ars.2000.2.4-811; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Jeong D, 2008, CIRC RES, V102, P711, DOI 10.1161/CIRCRESAHA.107.165985; KALTENBACH JA, 1994, J COMP NEUROL, V350, P187, DOI 10.1002/cne.903500204; Karolyi IJ, 2003, HUM MOL GENET, V12, P2797, DOI 10.1093/hmg/ddg308; KATTI SK, 1995, PROTEIN SCI, V4, P1998, DOI 10.1002/pro.5560041005; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kurima K, 2002, NAT GENET, V30, P277, DOI 10.1038/ng842; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LANE PW, 1967, J HERED, V58, P21, DOI 10.1093/oxfordjournals.jhered.a107531; LIM DJ, 1985, ACTA OTO-LARYNGOL, P1; Loomis PA, 2003, J CELL BIOL, V163, P1045, DOI 10.1083/jcb.200309093; Manor U, 2008, SEMIN CELL DEV BIOL, V19, P502, DOI 10.1016/j.semcdb.2008.07.006; Marchler-Bauer A, 2003, NUCLEIC ACIDS RES, V31, P383, DOI 10.1093/nar/gkg087; Matthews JM, 2002, IUBMB LIFE, V54, P351, DOI 10.1080/15216540216035; Mitchem KL, 2002, HUM MOL GENET, V11, P1887, DOI 10.1093/hmg/11.16.1887; Naz S, 2004, J MED GENET, V41, P591, DOI 10.1136/jmg.2004.018523; Odeh H, 2004, AUDIOL NEURO-OTOL, V9, P303, DOI 10.1159/000080701; Petit C, 2009, NAT NEUROSCI, V12, P703, DOI 10.1038/nn.2330; Probst FJ, 1998, SCIENCE, V280, P1444, DOI 10.1126/science.280.5368.1444; Revenu C, 2004, NAT REV MOL CELL BIO, V5, P635, DOI 10.1038/nrm1437; Rhee SG, 2003, J AM SOC NEPHROL, V14, pS211, DOI 10.1097/01.ASN.0000077404.45564.7E; Rhee SG, 1999, EXP MOL MED, V31, P53, DOI 10.1038/emm.1999.9; Rzadzinska A, 2005, CELL MOTIL CYTOSKEL, V62, P157, DOI 10.1002/cm.20094; Salles FT, 2009, NAT CELL BIOL, V11, P443, DOI 10.1038/ncb1851; Schneider ME, 2002, NATURE, V418, P837, DOI 10.1038/418837a; Schraders M, 2010, AM J HUM GENET, V86, P138, DOI 10.1016/j.ajhg.2009.12.017; Skynner MJ, 1999, INT J DEV BIOL, V43, P85; Tang BL, 2001, J BIOL CHEM, V276, P40008, DOI 10.1074/jbc.M106189200; TILNEY LG, 1986, DEV BIOL, V116, P100, DOI 10.1016/0012-1606(86)90047-3; TILNEY LG, 1986, DEV BIOL, V116, P119, DOI 10.1016/0012-1606(86)90048-5; Wang AH, 1998, SCIENCE, V280, P1447, DOI 10.1126/science.280.5368.1447; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; WOOLLEY GW, 1945, J HERED, V36, P281, DOI 10.1093/oxfordjournals.jhered.a105523; Zheng LL, 2000, CELL, V102, P377, DOI 10.1016/S0092-8674(00)00042-8; Zine A, 1996, BRAIN RES, V721, P49, DOI 10.1016/0006-8993(96)00147-3	60	35	38	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 12	2010	86	2					148	160		10.1016/j.ajhg.2010.01.016	http://dx.doi.org/10.1016/j.ajhg.2010.01.016			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	556ZS	20137774	Green Published, Bronze			2022-12-18	WOS:000274637200005
J	Baruch, S; Hudson, K				Baruch, Susannah; Hudson, Kathy			Civilian and Military Genetics: Nondiscrimination Policy in a Post-GINA World	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							POSTTRAUMATIC-STRESS-DISORDER; COLORECTAL-CANCER; PUBLIC-HEALTH; DISCRIMINATION; PRIVACY; PERSPECTIVES; INFORMATION; WORKPLACE; INSURANCE; RISK	Evidence is emerging of a growing societal consensus about appropriate and inappropriate uses of genetic information. The Genetic Information Nondiscrimination Act of 2008 provides new legal protections to Americans by prohibiting the discriminatory use of genetic information by health insurers and employers. Additionally, the United States military recently created new policies for fair use of genetic information in the determination of benefits for servicemen and servicewomen leaving military service. Although critical issues remain, such as the potential for genetic information to be used to deny people other forms of insurance, and how the military will use genetic medicine overall, significant progress has been made.	[Baruch, Susannah; Hudson, Kathy] Genet & Publ Policy Ctr, Washington, DC 20036 USA		Baruch, S (corresponding author), Genet & Publ Policy Ctr, 1717 Massachusetts Ave NW,Suite 530, Washington, DC 20036 USA.	sbaruch2@jhu.edu						ALPER JS, 1994, J PUBLIC HLTH POLICY, V3, P345; [Anonymous], 2007, ECONOMIST; Apse KA, 2004, GENET MED, V6, P510, DOI 10.1097/01.GIM.0000144013.96456.6C; BARUCH S, 2007, US PUBLIC OPINION US; BILLINGS PR, 1992, AM J HUM GENET, V50, P476; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Bombard Y, 2007, CLIN GENET, V71, P220, DOI 10.1111/j.1399-0004.2007.00770.x; Bombard Y, 2008, EUR J HUM GENET, V16, P279, DOI 10.1038/sj.ejhg.5201937; Catz DS, 2005, COMMUNITY GENET, V8, P161, DOI 10.1159/000086759; CHESTER JG, 2008, MED PRIVACY STILL IS; COLLINS FS, 1997, HLTH INSURANCE AGE G; Dolgin J L, 2000, Brooklyn Law Rev, V66, P755; Fulda KG, 2006, J MED ETHICS, V32, P143, DOI 10.1136/jme.2004.010272; Fuller BP, 1999, SCIENCE, V285, P1359, DOI 10.1126/science.285.5432.1359; Geller Lisa N, 1996, Sci Eng Ethics, V2, P71, DOI 10.1007/BF02639319; *GEN ALL, 2004, FAC DISCR GEN DISCR; Gostin L O, 1999, Jurimetrics, P21; GOSTIN LO, 2001, GENETICS POLICY LAW; GOSTIN LO, 1999, JAMA-J AM MED ASSOC, V8, P745; Hadley DW, 2003, ARCH INTERN MED, V163, P573, DOI 10.1001/archinte.163.5.573; Hall MA, 2005, GENET MED, V7, P311, DOI 10.1097/01.GIM.0000162874.58370.C0; Hall MA, 2007, J FAM PRACTICE, V56, P829; HAM PA, 2003, ARMY LAWYER      JUL, P1; HARMON A, 2008, NY TIMES        0224; Hellman D, 2003, AM J LAW MED, V29, P77; Hoop JG, 2008, GENET TEST, V12, P245, DOI 10.1089/gte.2007.0097; HUDSON K, 2004, STATEMENT GENETICS P; Hudson KL, 2008, NEW ENGL J MED, V358, P2661, DOI 10.1056/NEJMp0803964; Hudson KL, 2007, NEW ENGL J MED, V356, P2021, DOI 10.1056/NEJMp078033; HUDSON KL, 1995, SCIENCE, V270, P391, DOI 10.1126/science.270.5235.391; Hustead JL, 2002, AM J LAW MED, V28, P285; JACOBI JV, 2003, FLA STATE U LAW REV, V2, P363; Kass NE, 2007, AM J MED GENET A, V143A, P707, DOI 10.1002/ajmg.a.31576; Kass NE, 2004, AM J MED GENET A, V128A, P261, DOI 10.1002/ajmg.a.30057; KAUFMANN MB, 1999, LOYOLA U CHICAGO LAW, V3, P393; Kim PT, 2002, NORTHWEST U LAW REV, V96, P1497; Koenen KC, 2008, J AFFECT DISORDERS, V105, P109, DOI 10.1016/j.jad.2007.04.021; Laegsgaard MM, 2008, AM J MED GENET B, V147B, P375, DOI 10.1002/ajmg.b.30609; LANMAN RB, 2005, ANAL ADEQUACY CURREN; Lapham EV, 1996, SCIENCE, V274, P621, DOI 10.1126/science.274.5287.621; Lewis MJ, 2007, COMMUNITY GENET, V10, P72, DOI 10.1159/000099084; Matloff ET, 2000, J CLIN ONCOL, V18, P2484, DOI 10.1200/JCO.2000.18.12.2484; *MICH DEP COMM HLT, 2006, STAT MICH INF CONS G; MILLER PS, 2000, J HLTH CARE LAW POLI, V2, P225; *MYR GEN LAB INC, 2007, MYR INF CONS HER CAN; *NAT CANC I NAT I, 2006, GEN TEST BREAST OV C; NUNES M, 2006, PUBLIC REMARKS GENET; Penziner E, 2008, AM J MED GENET B, V147B, P320, DOI 10.1002/ajmg.b.30600; Peterson MR, 1996, AM J PUBLIC HEALTH, V86, P592, DOI 10.2105/AJPH.86.4.592; PFEFFER NL, 2003, J GENET COUNS, V5, P419; PLATT J, 2006, PUBLIC REMARKS GENET; POLLITZ K, 2007, INQUIRY, V3, P350; *PS INC, 2008, PSYN INF CONS GEN TE; Rogausch A, 2006, PHARMACOGENOMICS, V7, P49, DOI 10.2217/14622416.7.1.49; Rothenberg K, 1997, SCIENCE, V275, P1755, DOI 10.1126/science.275.5307.1755; Rothstein MA, 1997, GENETIC SECRETS PROT; Rothstein MA, 2008, SCI AM, V299, P64, DOI 10.1038/scientificamerican0908-64; Rothstein MA, 2007, J LAW MED ETHICS, V35, P59, DOI 10.1111/j.1748-720X.2007.00154.x; SCHOEN C, 2001, SECURITY MATTERS INS; Silvers A, 2003, J LAW MED ETHICS, V31, P377, DOI 10.1111/j.1748-720X.2003.tb00101.x; Silvers A, 2002, VANDERBILT LAW REV, V55, P1341; Slaughter Louise McIntosh, 2006, Stanford Law Pol Rev, V17, P67; *US CONGR RES SERV, 2005, GEN INF LEG ISS REL; WERTZ DC, 1998, HLTH LAW REV, V3, P9; Wolf SM, 1995, J LAW MED ETHICS, V23, P345, DOI 10.1111/j.1748-720X.1995.tb01376.x; 2000, FED REG, V65, P6877; 2007, GENETIC INFORM NONDI	67	35	37	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 10	2008	83	4					435	444		10.1016/j.ajhg.2008.09.003	http://dx.doi.org/10.1016/j.ajhg.2008.09.003			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	363AV	18940308	Green Published, Bronze			2022-12-18	WOS:000260239200001
J	Franke, L; de Kovel, CGE; Aulchenko, YS; Trynka, G; Zhernakova, A; Hunt, KA; Blauw, HM; van den Berg, LH; Ophoff, R; Deloukas, P; van Heel, DA; Wijmenga, C				Franke, Lude; de Kovel, Carolien G. E.; Aulchenko, Yurii S.; Trynka, Gosia; Zhernakova, Alexandra; Hunt, Karen A.; Blauw, Hylke M.; van den Berg, Leonard H.; Ophoff, Roel; Deloukas, Panagiotis; van Heel, David A.; Wijmenga, Cisca			Detection, imputation, and association analysis of small deletions and null alleles on oligonucleotide arrays	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COPY-NUMBER VARIATION; GENOME-WIDE ASSOCIATION; SNP GENOTYPING DATA; AMYOTROPHIC-LATERAL-SCLEROSIS; HIDDEN-MARKOV MODEL; CELIAC-DISEASE; LINKAGE DISEQUILIBRIUM; SEGMENTAL DUPLICATIONS; GAMETIC DISEQUILIBRIUM; INTERACTION NETWORK	Copy-number variation (CNV) is a major contributor to human genetic variation. Recently, CNV associations with human disease have been reported. Many genome-wide association (GWA) studies in complex diseases have been performed with sets of biallelic single-nucleotide polymorphisms (SNPs), but the available CNV methods are still limited. We present a new method (TriTyper) that can infer genotypes in case-control data sets for deletion CNVs, or SNPs with an extra, untyped allele at a high-resolution single SNP level. By accounting for linkage disequilibrium (LD), as well as intensity data, calling accuracy is improved. Analysis of 3102 unrelated individuals with European descent, genotyped with Illumina Infinium BeadChips, resulted in the identification of 1880 SNPs with a common untyped allele, and these SNPs are in strong LD with neighboring biallelic SNPs. Simulations indicate our method has superior power to detect associations compared to biallelic SNPs that are in LD with these SNPs, yet without increasing type I errors, as shown in a GWA analysis in celiac disease. Genotypes for 1204 triallelic SNPs could be fully imputed, with only biallelic-genotype calls, permitting association analysis of these SNPs in many published data sets. We estimate that 682 of the 1655 unique loci reflect deletions; this is on average 99 deletions per individual, four times greater than those detected by other methods. Whereas the identified loci are strongly enriched for known deletions, 61% have not been reported before. Genes overlapping with these loci more often have paralogs (p = 0.006) and biologically interact with fewer genes than expected (p = 0.004).	[Franke, Lude; de Kovel, Carolien G. E.; Zhernakova, Alexandra; Ophoff, Roel; Wijmenga, Cisca] Univ Med Ctr Utrecht, DBG Dept Med Genet, Complex Genet Sect, NL-3584 CG Utrecht, Netherlands; [Aulchenko, Yurii S.] Erasmus MC, Dept Epidemiol & Biostat, NL-3000 CA Rotterdam, Netherlands; [Franke, Lude; Trynka, Gosia; Wijmenga, Cisca] Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Franke, Lude; Trynka, Gosia; Wijmenga, Cisca] Univ Groningen, NL-9700 RB Groningen, Netherlands; [Hunt, Karen A.; van Heel, David A.] Barts & London Queen Marys Sch Med & Dent, Inst Cell & Mol Sci, London E1 2AT, England; [Blauw, Hylke M.; van den Berg, Leonard H.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol, NL-3584 CX Utrecht, Netherlands; [Ophoff, Roel] Univ Calif Los Angeles, David Geffen Sch Med, Ctr Neurobehav Genet, Los Angeles, CA 90095 USA; [Deloukas, Panagiotis] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; University of Groningen; University of Groningen; University of London; Queen Mary University London; Utrecht University; Utrecht University Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Wellcome Trust Sanger Institute	Wijmenga, C (corresponding author), Univ Med Ctr Utrecht, DBG Dept Med Genet, Complex Genet Sect, NL-3584 CG Utrecht, Netherlands.	c.wijmenga@umcutrecht.nl	Aulchenko, Yurii/M-8270-2013; Zhernakova, Alexandra/ABA-9372-2020; Deloukas, Panos/B-2922-2013; Wijmenga, Cisca/AAE-7719-2019; Franke, Lude/P-7036-2016; de Kovel, Carolien/AAI-3531-2021; Wijmenga, Cisca/D-2173-2009	Aulchenko, Yurii/0000-0002-7899-1575; Deloukas, Panos/0000-0001-9251-070X; Wijmenga, Cisca/0000-0002-5635-1614; Franke, Lude/0000-0002-5159-8802; de Kovel, Carolien/0000-0002-7818-1396; Zhernakova, Alexandra/0000-0002-4574-0841; Trynka, Gosia/0000-0002-6955-9529; van Heel, David/0000-0002-0637-2265	Medical Research Council [G0000934] Funding Source: Medline; Wellcome Trust [GR068094MA, 068545/Z/02] Funding Source: Medline; MRC [G0000934] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Alfarano C, 2005, NUCLEIC ACIDS RES, V33, pD418, DOI 10.1093/nar/gki051; Babron MC, 2003, EUR J HUM GENET, V11, P828, DOI 10.1038/sj.ejhg.5201051; Carlson CS, 2006, HUM MOL GENET, V15, P1931, DOI 10.1093/hmg/ddl115; Carter NP, 2007, NAT GENET, V39, pS16, DOI 10.1038/ng2028; CEPPELLINI R, 1955, ANN HUM GENET, V20, P97; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; de Smith AJ, 2007, HUM MOL GENET, V16, P2783, DOI 10.1093/hmg/ddm208; Estivill X, 2007, PLOS GENET, V3, P1787, DOI 10.1371/journal.pgen.0030190; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fung HC, 2006, LANCET NEUROL, V5, P911, DOI 10.1016/S1474-4422(06)70578-6; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Greco L, 1998, AM J HUM GENET, V62, P669, DOI 10.1086/301754; Greco L, 2001, ANN HUM GENET, V65, P35, DOI 10.1046/j.1469-1809.2001.6510035.x; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; HEDRICK PW, 1987, GENETICS, V117, P331; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; HUNT KA, 2008, NAT GENET IN PRESS; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Karell K, 2003, HUM IMMUNOL, V64, P469, DOI 10.1016/S0198-8859(03)00027-2; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Kohler JR, 2007, AM J HUM GENET, V81, P684, DOI 10.1086/520823; Komura D, 2006, GENOME RES, V16, P1575, DOI 10.1101/gr.5629106; Kosta K, 2007, AM J HUM GENET, V81, P808, DOI 10.1086/520096; Leykin I, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-7; Liu JJ, 2002, AM J HUM GENET, V70, P51, DOI 10.1086/338453; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Monsuur AJ, 2005, NAT GENET, V37, P1341, DOI 10.1038/ng1680; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Pinto D, 2007, HUM MOL GENET, V16, pR168, DOI 10.1093/hmg/ddm241; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Riccioni R, 2003, LEUKEMIA, V17, P98, DOI 10.1038/sj.leu.2402812; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schymick JC, 2007, LANCET NEUROL, V6, P322, DOI 10.1016/S1474-4422(07)70037-6; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Simon-Sanchez J, 2007, HUM MOL GENET, V16, P1, DOI 10.1093/hmg/ddl436; Slatkin M, 1996, HEREDITY, V76, P377, DOI 10.1038/hdy.1996.55; Sollid LM, 2000, ANNU REV IMMUNOL, V18, P53, DOI 10.1146/annurev.immunol.18.1.53; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Stephenson AG, 2002, R NEWS, V2, P31; van Es MA, 2008, NAT GENET, V40, P29, DOI 10.1038/ng.2007.52; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; Yu ZX, 2007, HUM GENET, V122, P495, DOI 10.1007/s00439-007-0427-y; Zapata C, 2000, EVOLUTION, V54, P1809, DOI 10.1111/j.0014-3820.2000.tb00711.x; Zapata-Velandia Adriana, 2004, J Immune Based Ther Vaccines, V2, P6, DOI 10.1186/1476-8518-2-6; Zhang J, 2006, CYTOGENET GENOME RES, V115, P205, DOI 10.1159/000095916	62	35	40	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2008	82	6					1316	1333		10.1016/j.ajhg.2008.05.008	http://dx.doi.org/10.1016/j.ajhg.2008.05.008			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	312CP	18519066	Green Published, Bronze			2022-12-18	WOS:000256647000009
J	Everett, KV; Chioza, BA; Georgoula, C; Reece, A; Capon, F; Parker, KA; Cord-Udy, C; McKeigue, P; Mitton, S; Pierro, A; Puri, P; Mitchison, HM; Chung, EMK; Gardiner, RM				Everett, Kate V.; Chioza, Barry A.; Georgoula, Christina; Reece, Ashley; Capon, Francesca; Parker, Keith A.; Cord-Udy, Cathy; McKeigue, Paul; Mitton, Sally; Pierro, Agostino; Puri, Prern; Mitchison, Hannah M.; Chung, Eddie M. K.; Gardiner, R. Mark			Genome-wide high-density SNP-based linkage analysis of infantile hypertrophic pyloric stenosis identifies loci on chromosomes 11ql4-q22 and xq23	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NITRIC-OXIDE SYNTHASE; RECEPTOR POTENTIAL SUPERFAMILY; SMOOTH-MUSCLE-CELLS; CATION CHANNEL; COMPLEX TRAITS; ERYTHROMYCIN; GENE; EPIDEMIOLOGY; TRPC6; ACTIVATION	Infantile hypertrophic pyloric stenosis (IHPS) has an incidence of 1-8 per 1000 live births and is inherited as a complex sex-modified multifactorial trait with a striking male preponderance. Syndromic and monogenic forms exist, and two loci have been identified. Infants present with vomiting due to gastric-outlet obstruction caused by hypertrophy of the smooth muscle of the pylorus. A genome-wide SNP-based high-density linkage scan was carried out on 81 IHPS pedigrees. Nonparametric and parametric linkage analysis identified loci on chromosomes 11q14-q22 (Z(max) = 3.9, p < 0.0001; HLOD(max) = 3.4, alpha = 0.34) and Xq23 (Z(max) = 4.3, p < 0.00001; HLOD(max) = 4.8, alpha = 0.56). The two linked chromosomal regions each harbor functional candidate genes that are members of the canonical transient receptor potential (TRPC) family of ion channels and have a potential role in smooth-muscle control and hypertrophy.	[Everett, Kate V.; Chioza, Barry A.; Georgoula, Christina; Reece, Ashley; Capon, Francesca; Parker, Keith A.; McKeigue, Paul; Pierro, Agostino; Mitchison, Hannah M.; Chung, Eddie M. K.; Gardiner, R. Mark] UCL, Inst Child Hlth, London WC1N 1EH, England; [Cord-Udy, Cathy] Barts & London NHS Trust, London E1 1BB, England; [Mitton, Sally] St Georges Heatlthcare NHS Trust, London SW17 0QT, England; [Puri, Prern] Our Ladys Childrens Hosp, Dublin 12, Ireland	University of London; University College London; Barts Health NHS Trust; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin	Everett, KV (corresponding author), UCL, Inst Child Hlth, London WC1N 1EH, England.	kate.everett@ucl.ac.uk	Mitchison, Hannah M./C-1891-2008; Chioza, Barry/C-1586-2008; Everett, Kate/C-1566-2008; Capon, Francesca/F-4763-2011	Chioza, Barry/0000-0002-3546-1726; Capon, Francesca/0000-0003-2432-5793; Everett, Kate/0000-0001-6700-1698; Mitchison, Hannah/0000-0002-3163-6293				Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; APPLEGATE MS, 1995, ARCH PEDIAT ADOL MED, V149, P1123, DOI 10.1001/archpedi.1995.02170230077011; Bush EW, 2006, J BIOL CHEM, V281, P33487, DOI 10.1074/jbc.M605536200; Capon F, 2006, AM J HUM GENET, V79, P378, DOI 10.1086/505952; CARTER C O, 1954, Lancet, V266, P746; CARTER CO, 1961, BRIT MED BULL, V17, P251, DOI 10.1093/oxfordjournals.bmb.a069918; Chung E, 1996, AM J HUM GENET, V58, P363; Cooper WO, 2002, ARCH PEDIAT ADOL MED, V156, P647, DOI 10.1001/archpedi.156.7.647; Coulie B, 1998, GUT, V43, P395, DOI 10.1136/gut.43.3.395; Cui W, 2005, BIRTH DEFECTS RES A, V73, P876, DOI 10.1002/bdra.20196; Dietrich A, 2005, MOL CELL BIOL, V25, P6980, DOI 10.1128/MCB.25.16.6980-6989.2005; Dietrich A, 2006, PHARMACOL THERAPEUT, V112, P744, DOI 10.1016/j.pharmthera.2006.05.013; DILORENZO C, 1994, DIGEST DIS SCI, V39, P1399; Evans DM, 2004, AM J HUM GENET, V75, P687, DOI 10.1086/424696; Feighner SD, 1999, SCIENCE, V284, P2184, DOI 10.1126/science.284.5423.2184; FINSEN VR, 1979, ARCH DIS CHILD, V54, P720, DOI 10.1136/adc.54.9.720; FRIED K, 1981, CLIN GENET, V20, P328; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; HABBICK BF, 1989, CAN MED ASSOC J, V140, P395; Heller A, 2000, J MED GENET, V37, P529, DOI 10.1136/jmg.37.7.529; Hodgson SV, 1995, CLIN GENET, V48, P328; Honein MA, 1999, LANCET, V354, P2101, DOI 10.1016/S0140-6736(99)10073-4; Huang CL, 2004, J AM SOC NEPHROL, V15, P1690, DOI 10.1097/01.ASN.0000129115.69395.65; HUANG PL, 1993, CELL, V75, P1273, DOI 10.1016/0092-8674(93)90615-W; Inoue R, 2001, CIRC RES, V88, P325, DOI 10.1161/01.RES.88.3.325; JACKSON L, 1993, AM J MED GENET, V47, P940, DOI 10.1002/ajmg.1320470703; John S, 2004, AM J HUM GENET, V75, P54, DOI 10.1086/422195; Jung S, 2002, AM J PHYSIOL-CELL PH, V282, pC347, DOI 10.1152/ajpcell.00283.2001; LAMMER EJ, 1987, J MED GENET, V24, P482, DOI 10.1136/jmg.24.8.482; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lee YM, 2003, AM J PHYSIOL-GASTR L, V284, pG604, DOI 10.1152/ajpgi.00069.2002; Mahon BE, 2001, J PEDIATR-US, V139, P380, DOI 10.1067/mpd.2001.117577; MITCHELL LE, 1993, AM J DIS CHILD, V147, P1203, DOI 10.1001/archpedi.1993.02160350077012; MURTAGH K, 1992, DIGEST DIS, V10, P190, DOI 10.1159/000171357; Persson S, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.4.e70; RASMUSSEN L, 1989, INT J EPIDEMIOL, V18, P413, DOI 10.1093/ije/18.2.413; SANFILIPPO JA, 1976, J PEDIATR SURG, V11, P177; Saur D, 2004, P NATL ACAD SCI USA, V101, P1662, DOI 10.1073/pnas.0305473101; Sawcer S, 1997, GENET EPIDEMIOL, V14, P223, DOI 10.1002/(SICI)1098-2272(1997)14:3<223::AID-GEPI1>3.0.CO;2-6; Schechter R, 1997, PAEDIATR PERINAT EP, V11, P407, DOI 10.1046/j.1365-3016.1997.d01-32.x; SMITH DW, 1964, J PEDIATR-US, V64, P210, DOI 10.1016/S0022-3476(64)80264-X; Soderhall C, 1998, CLIN GENET, V53, P421; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P16586, DOI 10.1073/pnas.0606894103; WALPOLE IR, 1981, AM J MED GENET, V23, P7; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821; Yu Y, 2004, P NATL ACAD SCI USA, V101, P13861, DOI 10.1073/pnas.0405908101; Zhao LP, 1999, AM J HUM GENET, V64, P1739, DOI 10.1086/512072	49	35	37	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2008	82	3					756	762		10.1016/j.ajhg.2007.12.023	http://dx.doi.org/10.1016/j.ajhg.2007.12.023			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	275JN	18308288	Green Published, Bronze, Green Accepted			2022-12-18	WOS:000254067800020
J	Wallace, C; Chapman, JM; Clayton, DG				Wallace, C; Chapman, JM; Clayton, DG			Improved power offered by a score test for linkage disequilibrium mapping of quantitative-trait loci by selective genotyping	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC ASSOCIATION; SAMPLE; MODELS	Selective genotyping is used to increase efficiency in genetic association studies of quantitative traits by genotyping only those individuals who deviate from the population mean. However, selection distorts the conditional distribution of the trait given genotype, and such data sets are usually analyzed using case-control methods, quantitative analysis within selected groups, or a combination of both. We show that Hotelling's T-2 test, recently proposed for association studies of one or several tagging single-nucleotide polymorphisms in a prospective (i.e., trait given genotype) design, can also be applied to the retrospective (i.e., genotype given trait) selective-genotyping design, and we use simulation to demonstrate its improved power over existing methods.	Queen Mary Univ London, Barts & London Sch Med & Dent, Dept Clin Pharmacol, London, England; London Sch Hyg & Trop Med, London, England; Univ Cambridge, Diabet & Inflammat Lab, Cambridge Inst Med Res, Cambridge, England	University of London; Queen Mary University London; University of London; London School of Hygiene & Tropical Medicine; University of Cambridge	Wallace, C (corresponding author), Bart & London Sch Med & Dent, William Harvey Res Inst, Charterhouse Sq, London EC1M 6BQ, England.	c.wallace@qmul.ac.uk		Wallace, Chris/0000-0001-9755-1703	Medical Research Council [G0601942] Funding Source: Medline; Wellcome Trust [EPNCBC49] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; CHAPMAN JM, 2005, THESIS U CAMBRIDGE C; Chen ZH, 2005, AM J HUM GENET, V77, P661, DOI 10.1086/491658; Clayton D, 2004, GENET EPIDEMIOL, V27, P415, DOI 10.1002/gepi.20032; Cornish KM, 2005, MOL PSYCHIATR, V10, P686, DOI 10.1038/sj.mp.4001641; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; LANDER ES, 1989, GENETICS, V121, P185; PRENTICE RL, 1979, BIOMETRIKA, V66, P403, DOI 10.1093/biomet/66.3.403; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; RAO CR, 1962, J ROY STAT SOC B, V24, P152; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Slatkin M, 1999, AM J HUM GENET, V64, P1765, DOI 10.1086/302413; STUART A, 1999, KENDALLS ADV THEOR A, V2, P486; Van Gestel S, 2000, BEHAV GENET, V30, P141, DOI 10.1023/A:1001907321955; Xiong MM, 2002, AM J HUM GENET, V70, P1257, DOI 10.1086/340392; Xiong MM, 2002, HUM HERED, V53, P158, DOI 10.1159/000064978	16	35	36	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2006	78	3					498	504		10.1086/500562	http://dx.doi.org/10.1086/500562			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	032AY	16465623	Green Published, Bronze			2022-12-18	WOS:000236747500016
J	Hill-Harfe, KL; Kaplan, L; Stalker, HJ; Zori, RT; Pop, R; Scherer, G; Wallace, MR				Hill-Harfe, KL; Kaplan, L; Stalker, HJ; Zori, RT; Pop, R; Scherer, G; Wallace, MR			Fine mapping of chromosome 17 translocation breakpoints >= 900 Kb upstream of SOX9 in acampomelic campomelic dysplasia and a mild, familial skeletal dysplasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTOSOMAL SEX REVERSAL; CHONDROCYTE-SPECIFIC ENHANCER; SRY-RELATED GENE; RECIPROCAL TRANSLOCATION; CAMPTOMELIC SYNDROME; TRANSCRIPTION FACTOR; 5-GENERATION FAMILY; VARIABLE EXPRESSION; COLLAGEN GENE; II COLLAGEN	Previously, our group reported a five-generation family in which a balanced t(13; 17) translocation is associated with a spectrum of skeletal abnormalities, including Robin sequence, hypoplastic scapulae, and a missing pair of ribs. Using polymerase chain reaction (PCR) with chromosome-specific markers to analyze DNA from somatic cell hybrids containing the derivative translocation chromosomes, we narrowed the breakpoint on each chromosome. Subsequent sequencing of PCR products spanning the breakpoints identified the breaks precisely. The chromosome 17 breakpoint maps similar to 932 kb upstream of the sex-determining region Y (SRY) -related high-mobility group box gene (SOX9) within a noncoding transcript represented by two IMAGE cDNA clones. A growing number of reports have implicated chromosome 17 breakpoints at a distance of up to 1 Mb from SOX9 in some cases of campomelic dysplasia ( CD). Although this multigeneration family has a disorder that shares some features with CD, their phenotype is significantly milder than any reported cases of (nonmosaic) CD. Therefore, this case may represent an etiologically distinct skeletal dysplasia or may be an extremely mild familial example of CD, caused by the most proximal translocation breakpoint from SOX9 reported to date. In addition, we have refined the breakpoint in an acampomelic CD case described elsewhere and have found that it lies similar to 900 kb upstream of SOX9.	Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; Univ Florida, Coll Med, Dept Pediat, Div Genet, Gainesville, FL 32610 USA; Univ Freiburg, Inst Human Genet & Anthropol, Freiburg, Germany	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Freiburg	Wallace, MR (corresponding author), Univ Florida, Coll Med, Dept Mol Genet & Microbiol, 1600 SW Archer Rd,POB 100266, Gainesville, FL 32610 USA.	peggyw@ufl.edu						Bagheri-Fam S, 2001, GENOMICS, V78, P73, DOI 10.1006/geno.2001.6648; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Bernard P, 2003, HUM MOL GENET, V12, P1755, DOI 10.1093/hmg/ddg182; BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; Bishop CE, 2000, NAT GENET, V26, P490, DOI 10.1038/82652; Bridgewater LC, 1998, J BIOL CHEM, V273, P14998, DOI 10.1074/jbc.273.24.14998; Cameron FJ, 1996, HUM MOL GENET, V5, P1625, DOI 10.1093/hmg/5.10.1625; deKok YJM, 1996, HUM MOL GENET, V5, P1229, DOI 10.1093/hmg/5.9.1229; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; HOUSTON CS, 1983, AM J MED GENET, V15, P3, DOI 10.1002/ajmg.1320150103; Huang B, 1999, AM J MED GENET, V87, P349, DOI 10.1002/(SICI)1096-8628(19991203)87:4<349::AID-AJMG13>3.0.CO;2-N; JAGER RJ, 1990, NATURE, V348, P452, DOI 10.1038/348452a0; Jamieson RV, 2002, HUM MOL GENET, V11, P33, DOI 10.1093/hmg/11.1.33; Knower KC, 2003, CYTOGENET GENOME RES, V101, P185, DOI 10.1159/000074336; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KWOK C, 1995, AM J HUM GENET, V57, P1028; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; LYNCH SA, 1993, J MED GENET, V30, P683, DOI 10.1136/jmg.30.8.683; Mansour S, 2002, J MED GENET, V39, P597, DOI 10.1136/jmg.39.8.597; MANSOUR S, 1995, J MED GENET, V32, P415, DOI 10.1136/jmg.32.6.415; MARAIA R, 1991, CLIN GENET, V39, P401; McDowall S, 1999, J BIOL CHEM, V274, P24023, DOI 10.1074/jbc.274.34.24023; MELLOWS HJ, 1980, CLIN GENET, V18, P137; Meyer J, 1997, HUM MOL GENET, V6, P91, DOI 10.1093/hmg/6.1.91; Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487; Ninomiya S, 1996, HUM MOL GENET, V5, P69, DOI 10.1093/hmg/5.1.69; NINOMIYA S, 1995, AM J MED GENET, V56, P31, DOI 10.1002/ajmg.1320560109; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Olney PN, 1999, AM J MED GENET, V84, P20, DOI 10.1002/(SICI)1096-8628(19990507)84:1<20::AID-AJMG5>3.3.CO;2-E; Pfeifer D, 1999, AM J HUM GENET, V65, P111, DOI 10.1086/302455; Pop R, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013185; Qin YJ, 2004, HUM MOL GENET, V13, P1213, DOI 10.1093/hmg/ddh141; Savarirayan R, 1998, J MED GENET, V35, P597, DOI 10.1136/jmg.35.7.597; Savarirayan R, 2003, PEDIATR PATHOL MOL M, V22, P37, DOI 10.1080/15227950307695; Scherer G, 1999, AM J HUM GENET, V65, pA342; SHAFAI T, 1976, J PEDIATR-US, V89, P512, DOI 10.1016/S0022-3476(76)80568-9; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Sock E, 2003, HUM MOL GENET, V12, P1439, DOI 10.1093/hmg/ddg158; Stalker H, 2005, AM J MED GENET A, V132A, P114, DOI 10.1002/ajmg.a.30452; Stalker HJ, 1997, AM J MED GENET, V73, P247; Stalker HJ, 2001, AM J MED GENET, V103, P339, DOI 10.1002/ajmg.1559; THURMON TF, 1973, J PEDIATR-US, V83, P841, DOI 10.1016/S0022-3476(73)80384-1; Unger S, 2005, AM J MED GENET A, V132A, P113, DOI 10.1002/ajmg.a.30451; Velagaleti GVN, 2005, AM J HUM GENET, V76, P652, DOI 10.1086/429252; Vidal VPI, 2001, NAT GENET, V28, P216, DOI 10.1038/90046; Wagner T, 1997, CYTOGENET CELL GENET, V76, P172, DOI 10.1159/000134538; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; WINTER R, 1985, PRENATAL DIAG, V5, P1, DOI 10.1002/pd.1970050102; Wirth J, 1996, HUM GENET, V97, P186, DOI 10.1007/BF02265263; Wunderle VM, 1998, P NATL ACAD SCI USA, V95, P10649, DOI 10.1073/pnas.95.18.10649; Xie WF, 1999, J BONE MINER RES, V14, P757, DOI 10.1359/jbmr.1999.14.5.757; YOUNG ID, 1992, J MED GENET, V29, P251, DOI 10.1136/jmg.29.4.251	54	35	37	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2005	76	4					663	671		10.1086/429254	http://dx.doi.org/10.1086/429254			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	904RS	15717285	Bronze, Green Published			2022-12-18	WOS:000227516000012
J	Maier, LM; Chapman, J; Howson, JMM; Clayton, DG; Pask, R; Strachan, DP; McArdle, WL; Twells, RCJ; Todd, JA				Maier, LM; Chapman, J; Howson, JMM; Clayton, DG; Pask, R; Strachan, DP; McArdle, WL; Twells, RCJ; Todd, JA			No evidence of association or interaction between the IL4RA, IL4, and IL13 genes in type 1 diabetes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMMON VARIANTS; HUMAN-DISEASES; SUSCEPTIBILITY; EPISTASIS; GENOTYPE; LINKAGE; MODELS	Attempts to identify susceptibility loci that, on their own, have marginal main effects by use of gene-gene interaction tests have increased in popularity. The results obtained from analyses of epistasis are, however, difficult to interpret. Gene-gene interaction, albeit only marginally significant, has recently been reported for the interleukin-4 and interleukin-13 genes (IL4 and IL13) with the interleukin-4 receptor A gene (IL4RA), contributing to the susceptibility of type 1 diabetes (T1D). We aimed to replicate these findings by genotyping both large family and case-control data sets and by using previously published data. Gene-gene interaction tests were performed using linear regression models in cases only. We did not find any single-locus associations with T1D and did not obtain evidence of gene-gene interaction. Additional support from independent samples will be even more important in the study of gene-gene interactions and other subgroup analyses.	Addenbrookes Hosp, JDRF WT Diabet & Inflammat Lab, Cambridge Inst Med Res, Cambridge CB2 2XY, England; Univ Bristol, Avon Longitudinal Study Parents & Children, Bristol, Avon, England; St George Hosp, Sch Med, Dept Community Hlth Sci, London, England; Univ Cambridge, Cambridge Inst Med Res, Juvenile Diabet Res Fdn, Wellcome Trust Diabet & Inflammat Lab, Cambridge, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Bristol; St Georges University London; University of Cambridge	Maier, LM (corresponding author), Addenbrookes Hosp, JDRF WT Diabet & Inflammat Lab, Cambridge Inst Med Res, Hills Rd, Cambridge CB2 2XY, England.	lisa.maier@cimr.cam.ac.uk	Todd, John A/A-3542-2010	Todd, John A/0000-0003-2740-8148; Howson, Joanna/0000-0001-7618-0050	MRC [G0000934] Funding Source: UKRI; Medical Research Council [G0000934] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Altmuller J, 2001, AM J HUM GENET, V69, P936, DOI 10.1086/324069; BAIN SC, 1990, AUTOIMMUNITY, V7, P83, DOI 10.3109/08916939008993380; Bugawan TL, 2003, AM J HUM GENET, V72, P1505, DOI 10.1086/375655; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Clayton D, 2004, GENET EPIDEMIOL, V27, P415, DOI 10.1002/gepi.20032; Clayton D, 2001, LANCET, V358, P1356, DOI 10.1016/S0140-6736(01)06418-2; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; Culverhouse R, 2002, AM J HUM GENET, V70, P461, DOI 10.1086/338759; Dahlman I, 2002, NAT GENET, V30, P149, DOI 10.1038/ng825; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Hoh J, 2004, CURR OPIN GENET DEV, V14, P229, DOI 10.1016/j.gde.2004.04.006; Ioannidis JPA, 2003, LANCET, V361, P567, DOI 10.1016/S0140-6736(03)12516-0; LERNMARK A, 1991, DIABETOLOGIA, V34, P61, DOI 10.1007/BF00404029; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Maier LM, 2003, GENES IMMUN, V4, P469, DOI 10.1038/sj.gene.6364007; Mirel DB, 2002, DIABETES, V51, P3336, DOI 10.2337/diabetes.51.11.3336; Moore JH, 2003, HUM HERED, V56, P73, DOI 10.1159/000073735; PIEGORSCH WW, 1994, STAT MED, V13, P153, DOI 10.1002/sim.4780130206; Thomas DC, 2004, JNCI-J NATL CANCER I, V96, P421, DOI 10.1093/jnci/djh094; Umbach DM, 1997, STAT MED, V16, P1731, DOI 10.1002/(SICI)1097-0258(19970815)16:15<1731::AID-SIM595>3.0.CO;2-S; Vella A, 2004, DIABETES, V53, P1158, DOI 10.2337/diabetes.53.4.1158; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522	23	35	38	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2005	76	3					517	521		10.1086/428387	http://dx.doi.org/10.1086/428387			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	895HO	15660293	Bronze, Green Published			2022-12-18	WOS:000226851900014
J	de Beur, SJ; Ding, CL; Germain-Lee, E; Cho, J; Maret, A; Levine, MA				de Beur, SJ; Ding, CL; Germain-Lee, E; Cho, J; Maret, A; Levine, MA			Discordance between genetic and epigenetic defects in pseudohypoparathyroidism type 1b revealed by inconsistent loss of maternal imprinting at GNAS1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYCLASE COUPLING PROTEIN; DEFICIENT ACTIVITY; ALPHA-SUBUNIT; PSEUDO-HYPOPARATHYROIDISM; REGULATORY PROTEIN; ADENYLATE-CYCLASE; METHYLATION; MUTATIONS; IB; TRANSCRIPTION	Although the molecular basis of pseudohypoparathyroidism type 1b (PHP type 1b) remains unknown, a defect in imprinting at the GNAS1 locus has been suggested by the consistent finding of paternal-specific patterns of DNA methylation on maternally inherited GNAS1 alleles. To characterize the relationship between the genetic and epigenetic defects in PHP type 1b, we analyzed allelic expression and methylation of CpG islands within exon 1A of GNAS1 in patients with sporadic PHP type 1b and in affected and unaffected individuals from five multigenerational kindreds with PHP type 1b. All subjects with resistance to parathyroid hormone (PTH) showed loss of methylation of the exon 1A region on the maternal GNAS1 allele and/or biallelic expression of exon 1A containing transcripts, consistent with an imprinting defect. Paternal transmission of the disease-associated haplotype was associated with normal patterns of GNAS1 methylation and PTH responsiveness. We found that affected and unaffected siblings in one kindred had inherited the same GNAS1 allele from their affected mother, evidence for dissociation between the genetic and epigenetic GNAS1 defects. The absence of the epigenetic defect in subjects who have inherited a defective maternal GNAS1 allele suggests that the genetic mutation may be incompletely penetrant, and it indicates that the epigenetic defect, not the genetic mutation, leads to renal resistance to PTH in PHP type 1b.	Johns Hopkins Univ, Sch Med, Dept Med, Div Endocrinol & Metab, Baltimore, MD 21224 USA; Johns Hopkins Univ, Sch Med, Ilyssa Ctr Mol & Cellular Endocrinol, Baltimore, MD 21224 USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Div Pediat Endocrinol, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	de Beur, SJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Endocrinol & Metab, 4940 Eastern Ave,B114, Baltimore, MD 21224 USA.	sjandebe@jhmi.edu		Levine, Michael/0000-0003-0036-7809; Germain-Lee, Emily/0000-0002-5727-610X	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046720, R01DK034281, T32DK007751] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR000052, M01 RR00052] Funding Source: Medline; NIDDK NIH HHS [T32 DK007751, DK34281, R01-DK46720, T32-DK07751] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albright F, 1942, ENDOCRINOLOGY, V30, P922; Bastepe M, 2001, HUM MOL GENET, V10, P1231, DOI 10.1093/hmg/10.12.1231; Bastepe M, 2001, AM J HUM GENET, V68, P1283, DOI 10.1086/320117; Buiting K, 2000, CLIN GENET, V58, P284, DOI 10.1034/j.1399-0004.2000.580406.x; Buiting K, 1998, AM J HUM GENET, V63, P170, DOI 10.1086/301935; CAMPBELL R, 1994, J MED GENET, V31, P607, DOI 10.1136/jmg.31.8.607; DOWNS RW, 1983, J CLIN INVEST, V71, P231, DOI 10.1172/JCI110763; DUHL DMJ, 1994, NAT GENET, V8, P59, DOI 10.1038/ng0994-59; FARFEL Z, 1980, NEW ENGL J MED, V303, P237, DOI 10.1056/NEJM198007313030501; FARFEL Z, 1982, J CLIN ENDOCR METAB, V55, P113, DOI 10.1210/jcem-55-1-113; FARFEL Z, 1980, J CLIN ENDOCR METAB, V51, P1202, DOI 10.1210/jcem-51-5-1202; Freson K, 2002, HUM MOL GENET, V11, P2741, DOI 10.1093/hmg/11.22.2741; Germain-Lee EL, 2002, BIOCHEM BIOPH RES CO, V296, P67, DOI 10.1016/S0006-291X(02)00833-1; Glenn CC, 2000, PRENATAL DIAG, V20, P300, DOI 10.1002/(SICI)1097-0223(200004)20:4<300::AID-PD803>3.0.CO;2-A; Hayward BE, 2000, HUM MOL GENET, V9, P835, DOI 10.1093/hmg/9.5.835; Hayward BE, 1998, P NATL ACAD SCI USA, V95, P15475, DOI 10.1073/pnas.95.26.15475; Hayward BE, 2001, J CLIN INVEST, V107, pR31, DOI 10.1172/JCI11887; Hayward BE, 1998, P NATL ACAD SCI USA, V95, P10038, DOI 10.1073/pnas.95.17.10038; Horsthemke B, 1997, HUM MUTAT, V10, P329, DOI 10.1002/(SICI)1098-1004(1997)10:5<329::AID-HUMU1>3.3.CO;2-Y; Jan De Beur Suzanne M, 2003, J Bone Miner Res, V18, P424, DOI 10.1359/jbmr.2003.18.3.424; JANDEBEUR SM, 1998, 80 ANN M END SOC NEW, P62; Juppner H, 1998, P NATL ACAD SCI USA, V95, P11798, DOI 10.1073/pnas.95.20.11798; KAARTINEN JM, 1994, PEDIATR RES, V35, P594, DOI 10.1203/00006450-199405000-00011; Kearns M, 2000, NUCLEIC ACIDS RES, V28, P3301, DOI 10.1093/nar/28.17.3301; Lee MP, 1999, P NATL ACAD SCI USA, V96, P5203, DOI 10.1073/pnas.96.9.5203; Levine LM., 2001, PARATHYROIDS BASIC C, P807; LEVINE MA, 1986, J CLIN ENDOCR METAB, V62, P497, DOI 10.1210/jcem-62-3-497; LEVINE MA, 1983, J CLIN INVEST, V72, P316, DOI 10.1172/JCI110971; LEVINE MA, 1980, BIOCHEM BIOPH RES CO, V94, P1319, DOI 10.1016/0006-291X(80)90563-X; LEVINE MA, 1983, AM J MED, V74, P545, DOI 10.1016/0002-9343(83)91008-2; Liu J, 2000, MOL CELL BIOL, V20, P5808, DOI 10.1128/MCB.20.16.5808-5817.2000; Liu J, 2000, J CLIN INVEST, V106, P1167, DOI 10.1172/JCI10431; Mantovani G, 2002, J CLIN ENDOCR METAB, V87, P4736, DOI 10.1210/jc.2002-020183; Nagane Y, 2000, BRAIN RES PROTOC, V5, P167, DOI 10.1016/S1385-299X(00)00008-8; Namnoum AB, 1998, J CLIN ENDOCR METAB, V83, P824, DOI 10.1210/jc.83.3.824; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; SCHWINDINGER WF, 1998, 80 ANN M END SOC NEW, P480; SWAROOP A, 1991, NUCLEIC ACIDS RES, V19, P4725, DOI 10.1093/nar/19.17.4725; Weinstein LS, 2001, ENDOCR REV, V22, P675, DOI 10.1210/er.22.5.675; Weinstein LS, 2000, AM J PHYSIOL-RENAL, V278, pF507, DOI 10.1152/ajprenal.2000.278.4.F507; WOLFF GL, 1978, GENETICS, V88, P529; Yu SH, 1998, P NATL ACAD SCI USA, V95, P8715, DOI 10.1073/pnas.95.15.8715; Zheng H, 2001, J CLIN ENDOCR METAB, V86, P4627, DOI 10.1210/jc.86.10.4627	44	35	39	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2003	73	2					314	322		10.1086/377136	http://dx.doi.org/10.1086/377136			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	702KW	12858292	Bronze, Green Published			2022-12-18	WOS:000184223900008
J	Lupski, JR				Lupski, JR			2002 Curt Stern Award Address - Genomic disorders: Recombination-based disease resulting from genome architecture	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							MARIE-TOOTH DISEASE; HOMOLOGOUS RECOMBINATION; DNA REARRANGEMENTS; COX10 GENE; DUPLICATION; REPEAT; MECHANISM; CMT1A-REP; DELETION; HYBRIDIZATION		Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Texas Childrens Hosp, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza,Room 604B, Houston, TX 77030 USA.							Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bi WM, 2002, GENOME RES, V12, P713, DOI 10.1101/gr.73702; Boerkoel CF, 1999, ANN NY ACAD SCI, V883, P22, DOI 10.1111/j.1749-6632.1999.tb08563.x; Cann HM, 2002, SCIENCE, V296, P261; CHANG FY, 1994, IEEE T COMPON PACK B, V17, P3, DOI 10.1109/96.296425; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; Emanuel BS, 2001, NAT REV GENET, V2, P791, DOI 10.1038/35093500; Estivill X, 2002, HUM MOL GENET, V11, P1987, DOI 10.1093/hmg/11.17.1987; GREENBERG F, 1991, AM J HUM GENET, V49, P1207; Inoue K, 2002, ANNU REV GENOM HUM G, V3, P199, DOI 10.1146/annurev.genom.3.032802.120023; Inoue K, 2001, GENOME RES, V11, P1018, DOI 10.1101/gr.180401; Keller MP, 1999, MOL BIOL EVOL, V16, P1019, DOI 10.1093/oxfordjournals.molbev.a026191; Kiyosawa H, 1996, HUM MOL GENET, V5, P745, DOI 10.1093/hmg/5.6.745; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Murakami T, 1997, GENOMICS, V42, P161, DOI 10.1006/geno.1997.4711; Park SS, 2002, GENOME RES, V12, P729, DOI 10.1101/gr.82802; PATEL PI, 1994, TRENDS GENET, V10, P128, DOI 10.1016/0168-9525(94)90214-3; PENTAO L, 1992, NAT GENET, V2, P292, DOI 10.1038/ng1292-292; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; PINKEL D, 1988, P NATL ACAD SCI USA, V85, P9138, DOI 10.1073/pnas.85.23.9138; Potocki L, 1999, AM J HUM GENET, V64, P471, DOI 10.1086/302240; Potocki L, 2000, NAT GENET, V24, P84, DOI 10.1038/71743; Reiter LT, 1996, NAT GENET, V12, P288, DOI 10.1038/ng0396-288; Reiter LT, 1997, HUM MOL GENET, V6, P1595, DOI 10.1093/hmg/6.9.1595; Samonte RV, 2002, NAT REV GENET, V3, P65, DOI 10.1038/nrg705; SCHWARTZ DC, 1984, CELL, V37, P67, DOI 10.1016/0092-8674(84)90301-5; Stankiewicz P, 2002, CURR OPIN GENET DEV, V12, P312, DOI 10.1016/S0959-437X(02)00304-0; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Stankiewicz P, 2001, GENOME RES, V11, P1205, DOI 10.1101/gr.181101	30	35	36	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2003	72	2					246	252		10.1086/346217	http://dx.doi.org/10.1086/346217			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	640GK	12596790	Bronze, Green Published			2022-12-18	WOS:000180680000007
J	Dermaut, B; Theuns, J; Sleegers, K; Hasegawa, H; Van den Broeck, M; Vennekens, K; Corsmit, E; St George-Hyslop, P; Cruts, M; van Duijn, CM; Van Broeckhoven, C				Dermaut, B; Theuns, J; Sleegers, K; Hasegawa, H; Van den Broeck, M; Vennekens, K; Corsmit, E; St George-Hyslop, P; Cruts, M; van Duijn, CM; Van Broeckhoven, C			The gene encoding nicastrin, a major gamma-secretase component, modifies risk for familial early-onset Alzheimer disease in a Dutch population-based sample	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VARIABLE EXPRESSION; REGULATORY REGION; PRESENILIN-1; ASSOCIATION; MUTATIONS; ROTTERDAM; LINKAGE	Nicastrin regulates gamma-secretase cleavage of the amyloid precursor protein by forming complexes with presenilins, in which most mutations causing familial early-onset Alzheimer disease (EOAD) have been found. The gene encoding nicastrin (NCSTN) maps to 1q23, a region that has been linked and associated with late-onset Alzheimer disease (LOAD) in various genome screens. In 78 familial EOAD cases, we found 14 NCSTN single-nucleotide polymorphisms (SNPs): 10 intronic SNPs, 3 silent mutations, and 1 missense mutation (N417Y). N417Y is unlikely to be pathogenic, since it did not alter amyloid beta secretion in an in vitro assay and its frequency was similar in case and control subjects. However, SNP haplotype estimation in two population-based series of Dutch patients with EOAD (n = 116) and LOAD (n = 240) indicated that the frequency of one SNP haplotype (HapB) was higher in the group with familial EOAD (7%), compared with the LOAD group (3%) and control group (3%). In patients with familial EOAD without the APOE epsilon4 allele, the HapB frequency further increased, to 14%, resulting in a fourfold increased risk (odds ratio = 4.1; 95% confidence interval 1.2-13.3; P = .01). These results are compatible with an important role of gamma-secretase dysfunction in the etiology of familial EOAD.	Univ Instelling Antwerp VIB, Dept Mol Genet, B-2610 Antwerp, Belgium; Erasmus Med Ctr, Dept Epidemiol & Biostat, Rotherham, S Yorkshire, England; Univ Toronto, Ctr Res Neurodegenerat Dis, Toronto, ON, Canada; Univ Toronto, Dept Med, Toronto, ON, Canada; Univ Toronto, Toronto Western Hosp, Dept Med Neurol, Toronto, ON M5T 2S8, Canada	Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Van Broeckhoven, C (corresponding author), Univ Instelling Antwerp VIB, Dept Mol Genet, Univ Plein 1, B-2610 Antwerp, Belgium.	christine.vanbroeckhoven@ua.ac.be	Van Broeckhoven, Christine/G-8362-2017; Cruts, Marc/J-6161-2013; Dermaut, Bart/AAM-2483-2020; Van Broeckhoven, Christine/M-7853-2019	Van Broeckhoven, Christine/0000-0003-0183-7665; Cruts, Marc/0000-0002-1338-992X; Van Broeckhoven, Christine/0000-0003-0183-7665; Theuns, Jessie/0000-0001-5087-7650; Van Duijn, Cornelia/0000-0002-2374-9204				Alderborn A, 2000, GENOME RES, V10, P1249, DOI 10.1101/gr.10.8.1249; Chen FS, 2001, NAT CELL BIOL, V3, P751, DOI 10.1038/35087069; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; Cruts M, 1998, HUM MOL GENET, V7, P43, DOI 10.1093/hmg/7.1.43; Dermaut B, 2001, J NEUROL, V248, P935, DOI 10.1007/s004150170044; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Hiltunen M, 2001, NEUROLOGY, V57, P1663, DOI 10.1212/WNL.57.9.1663; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; Kehoe P, 1999, HUM MOL GENET, V8, P237, DOI 10.1093/hmg/8.2.237; Lambert JC, 2001, J MED GENET, V38, P353, DOI 10.1136/jmg.38.6.353; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; OTT A, 1995, BRIT MED J, V310, P970, DOI 10.1136/bmj.310.6985.970; SHAM PC, 1995, ANN HUM GENET, V59, P97, DOI 10.1111/j.1469-1809.1995.tb01608.x; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Theuns J, 2000, HUM MOL GENET, V9, P325, DOI 10.1093/hmg/9.3.325; Theuns J, 2001, HUM GENET, V108, P552, DOI 10.1007/s004390100508; van Duijn CM, 1999, EUR J HUM GENET, V7, P801, DOI 10.1038/sj.ejhg.5200373; VANDUIJN CM, 1994, NAT GENET, V7, P74, DOI 10.1038/ng0594-74; VANDUIJN CM, 1994, AM J HUM GENET, V55, P714; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009	21	35	39	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2002	70	6					1568	1574		10.1086/340732	http://dx.doi.org/10.1086/340732			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	549LP	11992262	Green Published, Bronze			2022-12-18	WOS:000175445700018
J	Ferdinandusse, S; van Grunsven, EG; Oostheim, W; Denis, S; Hogenhout, EM; Ijlst, L; van Roermund, CWT; Waterham, HR; Goldfischer, S; Wanders, RJA				Ferdinandusse, S; van Grunsven, EG; Oostheim, W; Denis, S; Hogenhout, EM; Ijlst, L; van Roermund, CWT; Waterham, HR; Goldfischer, S; Wanders, RJA			Reinvestigation of peroxisomal 3-ketoacyl-CoA thiolase deficiency: Identification of the true defect at the level of D-bifunctional protein	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BETA-OXIDATION; D-3-HYDROXYACYL-COA DEHYDRATASE; ZELLWEGER SYNDROME; ALPHA-OXIDATION; MOLECULAR-BASIS; GENE; RESOLUTION; DISORDER	In this report, we reinvestigate the only patient ever reported with a deficiency of peroxisomal 3-ketoacyl-CoA thiolase (THIO). At the time when they were described, the abnormalities in this patient, which included accumulation of very-long-chain fatty acids and the bile-acid intermediate trihydroxycholestanoic acid, were believed to be the logical consequence of a deficiency of the peroxisomal beta-oxidation enzyme THIO. In light of the current knowledge of the peroxisomal beta-oxidation system, however, the reported biochemical aberrations can no longer be explained by a deficiency of this thiolase. In this study, we show that the true defect in this patient is at the level of D-bifunctional protein (DBP). Immunoblot analysis revealed the absence of DBP in postmortem brain of the patient, whereas THIO was normally present. In addition, we found that the patient had a homozygous deletion of part of exon 3 and intron 3 of the DBP gene, resulting in skipping of exon 3 at the cDNA level. Our findings imply that the group of single-peroxisomal beta-oxidation-enzyme deficiencies is limited to straight-chain acyl-CoA oxidase, DBP, and alpha-methylacyl-CoA racemase deficiency and that there is no longer evidence for the existence of THIO deficiency as a distinct clinical entity.	Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, Lab Genet Metab Dis F0 224, NL-1100 DE Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, Emma Childrens Hosp, Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Pediat, Emma Childrens Hosp, Amsterdam, Netherlands; Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA	University of Amsterdam; Academic Medical Center Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Yeshiva University; Albert Einstein College of Medicine	Wanders, RJA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, Lab Genet Metab Dis F0 224, POB 22700, NL-1100 DE Amsterdam, Netherlands.			Ferdinandusse, Sacha/0000-0002-7738-5709				BOUT A, 1991, BIOCHIM BIOPHYS ACTA, V1090, P43, DOI 10.1016/0167-4781(91)90035-K; CLAYTON PT, 1990, J CLIN INVEST, V85, P1267, DOI 10.1172/JCI114563; Ferdinandusse S, 2000, NAT GENET, V24, P188, DOI 10.1038/72861; GOLDFISCHER S, 1986, J PEDIATR-US, V108, P25, DOI 10.1016/S0022-3476(86)80764-8; Jiang LL, 1996, J BIOCHEM, V120, P633; Leenders F, 1998, MAMM GENOME, V9, P1036, DOI 10.1007/s003359900921; Ossendorp BC, 1996, ARCH BIOCHEM BIOPHYS, V334, P251, DOI 10.1006/abbi.1996.0453; POLLTHE BT, 1988, AM J HUM GENET, V42, P422; SCHRAM AW, 1987, P NATL ACAD SCI USA, V84, P2494, DOI 10.1073/pnas.84.8.2494; Suzuki Y, 1997, AM J HUM GENET, V61, P1153, DOI 10.1086/301599; TAGER JM, 1985, BIOCHEM BIOPH RES CO, V126, P1269, DOI 10.1016/0006-291X(85)90322-5; van Grunsven EG, 1999, HUM MOL GENET, V8, P1509, DOI 10.1093/hmg/8.8.1509; van Grunsven EG, 1998, P NATL ACAD SCI USA, V95, P2128, DOI 10.1073/pnas.95.5.2128; van Grunsven EG, 1999, AM J HUM GENET, V64, P99, DOI 10.1086/302180; Van Veldhoven PP, 2001, BIOCHEM SOC T, V29, P292, DOI 10.1042/BST0290292; Wanders R.J., 2001, METABOLIC MOL BASES, P3219; Wanders RJA, 2001, BIOCHEM SOC T, V29, P250, DOI 10.1042/0300-5127:0290250	17	35	35	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2002	70	6					1589	1593		10.1086/340970	http://dx.doi.org/10.1086/340970			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	549LP	11992265	Bronze, Green Published			2022-12-18	WOS:000175445700021
J	Martin, CL; Wong, A; Gross, A; Chung, J; Fantes, JA; Ledbetter, DH				Martin, CL; Wong, A; Gross, A; Chung, J; Fantes, JA; Ledbetter, DH			The evolutionary origin of human subtelomeric homologies - or where the ends begin	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA-SEQUENCE; TELOMERE; REGION; CHROMOSOMES; GENES; POLYMORPHISM; DUPLICATION; INTEGRATION; DUPLICONS; 22Q	The subtelomeric regions of human chromosomes are comprised of sequence homologies shared between distinct subsets of chromosomes. In the course of developing a set of unique human telomere clones, we identified many clones containing such shared homologies, characterized by the presence of cross-hybridization signals on one or more telomeres in a fluorescence in situ hybridization (FISH) assay. We studied the evolutionary origin of seven subtelomeric clones by performing comparative FISH analysis on a primate panel that included great apes and Old World monkeys. All clones tested showed a single hybridization site in Old World monkeys that corresponded to one of the orthologous human sites, thus indicating the ancestral origin. The timing of the duplication events varied among the subtelomeric regions, from similar to5 to similar to25 million years ago. To examine the origin of and mechanism for one of these subtelomeric duplications, we compared the sequence derived from human 2q13-an ancestral fusion site of two great ape telomeric regions-with its paralogous subtelomeric sequences at 9p and 22q. These paralogous regions share large continuous homologies and contain three genes: RABL2B, forkhead box D4, and COBW-like. Our results provide further evidence for subtelomeric-mediated genomic duplication and demonstrate that these segmental duplications are most likely the result of ancestral unbalanced translocations that have been fixed in the genome during recent primate evolution.	Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Edinburgh, Dept Med Sci, Med Genet Sect, Edinburgh, Midlothian, Scotland	University of Chicago; University of Edinburgh	Ledbetter, DH (corresponding author), Univ Chicago, Dept Human Genet, 920 E 58th St, Chicago, IL 60637 USA.	dhl@genetics.uchicago.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036715] Funding Source: NIH RePORTER; NICHD NIH HHS [5R01 HD 36715-03] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bailey JA, 2002, AM J HUM GENET, V70, P83, DOI 10.1086/338458; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; BALDINI A, 1993, HUM GENET, V90, P577; BROWN WRA, 1990, CELL, V63, P119, DOI 10.1016/0092-8674(90)90293-N; Cheung VG, 2001, NATURE, V409, P953, DOI 10.1038/35057192; Christian SL, 1999, HUM MOL GENET, V8, P1025, DOI 10.1093/hmg/8.6.1025; Courseaux A, 2001, SCIENCE, V291, P1293, DOI 10.1126/science.1057284; deSouza SJ, 1996, GENES CELLS, V1, P493, DOI 10.1046/j.1365-2443.1996.d01-264.x; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; EDWARDS YH, 1995, GENOMICS, V30, P350, DOI 10.1006/geno.1995.9866; Eichler EE, 2001, TRENDS GENET, V17, P661, DOI 10.1016/S0168-9525(01)02492-1; Flint J, 1997, HUM MOL GENET, V6, P1305, DOI 10.1093/hmg/6.8.1305; Horvath JE, 2000, HUM MOL GENET, V9, P113, DOI 10.1093/hmg/9.1.113; IJDO JW, 1991, P NATL ACAD SCI USA, V88, P9051, DOI 10.1073/pnas.88.20.9051; Inoue K, 2001, GENOME RES, V11, P1018, DOI 10.1101/gr.180401; Ji YG, 2000, GENOME RES, V10, P597, DOI 10.1101/gr.10.5.597; Kasai F, 2000, CHROMOSOME RES, V8, P727, DOI 10.1023/A:1026745505264; Keller MP, 1999, MOL BIOL EVOL, V16, P1019, DOI 10.1093/oxfordjournals.molbev.a026191; Kiyosawa H, 1996, HUM MOL GENET, V5, P745, DOI 10.1093/hmg/5.6.745; Knight SJL, 2000, AM J HUM GENET, V67, P320, DOI 10.1086/302998; Knight SJL, 1999, LANCET, V354, P1676, DOI 10.1016/S0140-6736(99)03070-6; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Larsson C, 1995, GENOMICS, V30, P464, DOI 10.1006/geno.1995.1266; Lese CM, 1999, GENOME RES, V9, P888, DOI 10.1101/gr.9.9.888; Linardopoulou E, 2001, HUM MOL GENET, V10, P2373, DOI 10.1093/hmg/10.21.2373; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Ning Y, 1996, HUM GENET, V97, P765; OVERVELD P, 2000, HUM MOL GENET, V9, P2879; Pryde FE, 1997, CURR OPIN GENET DEV, V7, P822, DOI 10.1016/S0959-437X(97)80046-9; Reiter LT, 1996, NAT GENET, V12, P288, DOI 10.1038/ng0396-288; Riethman HC, 2001, NATURE, V409, P948, DOI 10.1038/35057180; Scherthan H, 1996, J CELL BIOL, V134, P1109, DOI 10.1083/jcb.134.5.1109; Scherthan H, 2000, MOL BIOL CELL, V11, P4189, DOI 10.1091/mbc.11.12.4189; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; vanDeutekom JCT, 1996, HUM MOL GENET, V5, P1997, DOI 10.1093/hmg/5.12.1997; Viale A, 1998, MOL BIOL EVOL, V15, P196, DOI 10.1093/oxfordjournals.molbev.a025915; Wienberg J, 1994, CHROMOSOME RES, V2, P405, DOI 10.1007/BF01552800; WIENBERG J, 1992, CHROMOSOMA, V101, P265, DOI 10.1007/BF00346004; WILKIE AOM, 1991, CELL, V64, P595, DOI 10.1016/0092-8674(91)90243-R; Wong ACC, 1997, AM J HUM GENET, V60, P113; Wong ACC, 1999, GENOMICS, V59, P326, DOI 10.1006/geno.1999.5889; YUNIS JJ, 1982, SCIENCE, V215, P1525, DOI 10.1126/science.7063861	42	35	35	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2002	70	4					972	984		10.1086/339768	http://dx.doi.org/10.1086/339768			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	528PL	11875757	Bronze, Green Published			2022-12-18	WOS:000174252100014
J	Sambuughin, N; McWilliams, S; de Bantel, A; Sivakumar, K; Nelson, TE				Sambuughin, N; McWilliams, S; de Bantel, A; Sivakumar, K; Nelson, TE			Single-amino-acid deletion in the RYR1 gene, associated with malignant hyperthermia susceptibility and unusual contraction phenotype	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RYANODINE RECEPTOR MUTATIONS; CENTRAL CORE DISEASE; CAFFEINE; IDENTIFICATION; SENSITIVITY	Malignant hyperthermia (MH) is an anesthetic-drug-induced, life-threatening hypermetabolic syndrome caused by abnormal calcium regulation in skeletal muscle. Often inherited as an autosomal dominant trait, MH has linkage to 30 different mutations in the RYR1 gene, which encodes a calcium-release-channel protein found in the sarcoplasmic reticulum membrane in skeletal muscle. All published RYR1 mutations exclusively represent single-nucleotide changes. The present report documents, in exon 44 of RYR1 in two unrelated, MH-susceptible families, a 3-bp deletion that results in deletion of a conserved glutamic acid at position 2347. This is the first deletion, in RYR1, found to be associated with MH susceptibility. MH susceptibility was confirmed among some family members by in vitro diagnostic pharmacological contracture testing of biopsied skeletal muscle. Although a single-amino-acid deletion appears to be a subtle change in the protein, the deletion of Glu2347 from RYR1 produces an unusually large electrically evoked contraction tension in MH-positive individuals, suggesting that this deletion produces an alteration in skeletal-muscle calcium regulation, even in the absence of pharmacological agents.	Wake Forest Univ, Bowman Gray Sch Med, Dept Anesthesiol, Winston Salem, NC 27157 USA; Barrow Neurol Inst, Phoenix, AZ 85013 USA	Wake Forest University; Wake Forest Baptist Medical Center; Barrow Neurological Institute	Nelson, TE (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Anesthesiol, Med Ctr Blvd, Winston Salem, NC 27157 USA.							Allen GC, 1998, ANESTHESIOLOGY, V88, P579, DOI 10.1097/00000542-199803000-00006; ALLEN PD, 1986, MUSCLE NERVE, V5, P474; Brown RL, 2000, HUM MOL GENET, V9, P1515, DOI 10.1093/hmg/9.10.1515; Chamley D, 2000, BRIT J ANAESTH, V84, P500, DOI 10.1093/oxfordjournals.bja.a013478; ETCHRIVI TS, 1998, ARCH PHYSIOL BIOCHEM, V106, P1; FUJII J, 1991, SCIENCE, V253, P448, DOI 10.1126/science.1862346; Jurkat-Rott K, 2000, MUSCLE NERVE, V23, P4, DOI 10.1002/(SICI)1097-4598(200001)23:1<4::AID-MUS3>3.0.CO;2-D; LARACH MG, 1989, ANESTH ANALG, V69, P511; McCarthy TV, 2000, HUM MUTAT, V15, P410, DOI 10.1002/(SICI)1098-1004(200005)15:5<410::AID-HUMU2>3.0.CO;2-D; Monnier N, 2000, HUM MOL GENET, V9, P2599, DOI 10.1093/hmg/9.18.2599; NELSON TE, 1983, NEW ENGL J MED, V309, P416, DOI 10.1056/NEJM198308183090706; ROBERTS MC, IN PRESS ANESTHESIOL; SAMBUUGHIN N, IN PRESS ANESTHESIOL; SAMBUUGHIN N, IN PRESS NEUROMUSCUL; Tong JF, 1997, J BIOL CHEM, V272, P26332, DOI 10.1074/jbc.272.42.26332	15	35	37	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2001	69	1					204	208		10.1086/321270	http://dx.doi.org/10.1086/321270			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XM	11389482	Bronze, Green Published			2022-12-18	WOS:000170108100020
J	Hodes, ME; Woodward, K; Spinner, NB; Emanuel, BS; Enrico-Simon, A; Kamholz, J; Stambolian, D; Zackai, EH; Pratt, VM; Thomas, IT; Crandall, K; Dlouhy, SR; Malcolm, S				Hodes, ME; Woodward, K; Spinner, NB; Emanuel, BS; Enrico-Simon, A; Kamholz, J; Stambolian, D; Zackai, EH; Pratt, VM; Thomas, IT; Crandall, K; Dlouhy, SR; Malcolm, S			Additional copies of the proteolipid protein gene causing Pelizaeus-Merzbacher disease arise by separate integration into the X chromosome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PLP GENE; DUPLICATION; CHARCOT; MARIE; TOOTH; CMT1A; POLYMORPHISM; NEUROPATHY; HNPP; RECOMBINATION	The proteolipid protein gene (PLP) is normally present at chromosome Xq22. Mutations and duplications of this gene are associated with Pelizaeus-Merzbacher disease (PMD). Here we describe two new families in which males affected with PMD were found to have a copy of PLP on the short arm of the X chromosome, in addition to a normal copy on Xq22. In the first family, the extra copy was first detected by the presence of heterozygosity of the AhaII dimorphism within the PLP gene. The results of FISH analysis showed an additional copy of PLP in Xp22.1, although no chromosomal rearrangements could be detected by standard karyotype analysis. Another three affected males from the family had similar findings. In a second unrelated family with signs of PMD, cytogenetic analysis showed a pericentric inversion of the X chromosome. In the inv(X) carried by several affected family members, FISH showed PLP signals at Xp11.4 and Xq22. A third family has previously been reported, in which affected members had an extra copy of the PLP gene detected at Xq26 in a chromosome with an otherwise normal banding pattern. The identification of three separate families in which PLP is duplicated at a noncontiguous site suggests that such duplications could be a relatively common but previously undetected cause of genetic disorders.	Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; Inst Child Hlth, Clin & Mol Genet Unit, London, England; Childrens Hosp Philadelphia, Div Human Genet & Mol Biol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Ophthalmol, Philadelphia, PA 19104 USA; Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA; N Carolina Dept Environm Hlth & Nat Resources, Div Maternal & Child Hlth, Black Mt, NC USA	Indiana University System; Indiana University-Purdue University Indianapolis; University of London; University College London; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Wake Forest University; Wake Forest Baptist Medical Center	Hodes, ME (corresponding author), Indiana Univ, Sch Med, Dept Med & Mol Genet, 975 W Walnut St,IB130, Indianapolis, IN 46202 USA.		Crandall, Keith A./H-2789-2019	Crandall, Keith A./0000-0002-0836-3389	NICHD NIH HHS [HD26979, P30 HD026979] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD026979] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		CHANDA S, 1992, COMP PHYSIOL ECOL, V17, P1; CREMERS FPM, 1987, HUM GENET, V77, P23, DOI 10.1007/BF00284707; ELLIS D, 1994, NAT GENET, V6, P333, DOI 10.1038/ng0494-333; HARDING AE, 1995, BRAIN, V118, P809, DOI 10.1093/brain/118.3.809; HARDING B, 1995, NEUROPATH APPL NEURO, V21, P111, DOI 10.1111/j.1365-2990.1995.tb01036.x; HODES ME, 1993, DEV NEUROSCI-BASEL, V15, P383, DOI 10.1159/000111361; HODES ME, 1998, NEUROBASE; HUDSON LD, 1989, P NATL ACAD SCI USA, V86, P8128, DOI 10.1073/pnas.86.20.8128; Inoue K, 1999, ANN NEUROL, V45, P624, DOI 10.1002/1531-8249(199905)45:5<624::AID-ANA11>3.3.CO;2-T; Inoue K, 1996, AM J HUM GENET, V59, P32; Kazazian HH, 1998, CURR OPIN GENET DEV, V8, P343, DOI 10.1016/S0959-437X(98)80092-0; KIYOSAWA H, 1995, HUM MOL GENET, V4, P2327, DOI 10.1093/hmg/4.12.2327; Kleinjan DJ, 1998, HUM MOL GENET, V7, P1611, DOI 10.1093/hmg/7.10.1611; Lopes J, 1998, HUM MOL GENET, V7, P141, DOI 10.1093/hmg/7.1.141; MATTEI MG, 1986, HUM GENET, V72, P352, DOI 10.1007/BF00290964; MIMAULT C, 1995, HUM GENET, V96, P236, DOI 10.1007/BF00207388; Nave KA, 1996, NEUROSCIENTIST, V2, P33, DOI 10.1177/107385849600200111; NICHOLSON GA, 1992, AM J MED GENET, V44, P455, DOI 10.1002/ajmg.1320440414; Oldridge M, 1999, AM J HUM GENET, V64, P446, DOI 10.1086/302245; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; OSAKA H, 1995, HUM GENET, V95, P461; Pellegrino JE, 1996, AM J MED GENET, V61, P377, DOI 10.1002/(SICI)1096-8628(19960202)61:4<377::AID-AJMG13>3.0.CO;2-P; RAEYMAEKERS P, 1992, J MED GENET, V29, P5, DOI 10.1136/jmg.29.1.5; RASKIND WH, 1991, AM J HUM GENET, V49, P1355; Reiter LT, 1998, AM J HUM GENET, V62, P1023, DOI 10.1086/301827; Sambrook J., 1989, MOL CLONING; Sistermans EA, 1998, NEUROLOGY, V50, P1749, DOI 10.1212/WNL.50.6.1749; TROFATTER JA, 1991, NUCLEIC ACIDS RES, V19, P6057, DOI 10.1093/nar/19.21.6057-a; TROFATTER JA, 1989, P NATL ACAD SCI USA, V86, P9427, DOI 10.1073/pnas.86.23.9427; UPADHYAYA M, 1993, HUM GENET, V91, P392; WILLARD HF, 1985, SCIENCE, V230, P940, DOI 10.1126/science.3840606; Woodward K, 1998, AM J HUM GENET, V63, P207, DOI 10.1086/301933	32	35	36	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2000	67	1					14	22		10.1086/302965	http://dx.doi.org/10.1086/302965			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	347JY	10827108	Bronze, Green Published			2022-12-18	WOS:000088926900005
J	Forrest, WF; Feingold, E				Forrest, WF; Feingold, E			Composite statistics for QTL mapping with moderately discordant sibling pairs	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							QUANTITATIVE TRAIT LOCI; SIB PAIRS; LINKAGE ANALYSIS; MAXIMUM-LIKELIHOOD; OLIGOGENIC DISEASE; SHARING STATISTICS; GENETIC-LINKAGE; SCORE TEST; COMPONENTS; CONCORDANT	Extreme discordant sibling-pair (EDSP) designs have been shown in theory to be very powerful for mapping quantitative-trait loci (QTLs) in humans. However, their practical applicability has been somewhat limited by the need to phenotype very large populations to find enough pairs that are extremely discordant. In this paper, we demonstrate that there is also substantial power in pairs that are only moderately discordant, and that designs using moderately discordant pairs can yield a more practical balance between phenotyping and genotyping efforts. The power we demonstrate for moderately discordant pairs stems from a new statistical result. Statistical analysis in discordant-pair studies is generally done by testing for reduced identity by descent (IBD) sharing in the pairs. By contrast, the most commonly-used statistical methods for more standard QTL mapping are Haseman-Elston regression and variance-components analysis. Both of these use statistics that are functions of the trait values given IBD information for the pedigree. We show that IBD sharing statistics and "trait value given IBD" statistics contribute complementary rather than redundant information, and thus that statistics of the two types can be combined to form more powerful tests of linkage. We propose a simple composite statistic, and test it with simulation studies. The simulation results show that our composite statistic increases power only minimally for extremely discordant pairs. However, it boosts the power of moderately discordant pairs substantially and makes them a very practical alternative. Our composite statistic is straightforward to calculate with existing software; we give a practical example of its use by applying it to a Genetic Analysis Workshop (GAW) data set.	Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Forrest, WF (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, A300 Crabtree Hall, Pittsburgh, PA 15261 USA.			Feingold, Eleanor/0000-0003-2898-6484	NHGRI NIH HHS [R01HG00848] Funding Source: Medline; NIA NIH HHS [R01AG16989-01] Funding Source: Medline; NIGMS NIH HHS [GM31575] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016989] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alcais A, 1999, GENET EPIDEMIOL, V17, P102, DOI 10.1002/(SICI)1098-2272(1999)17:2<102::AID-GEPI2>3.0.CO;2-6; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; AMOS CI, 1994, AM J HUM GENET, V54, P535; Amos CI, 1997, GENET EPIDEMIOL, V14, P743, DOI 10.1002/(SICI)1098-2272(1997)14:6<743::AID-GEPI30>3.0.CO;2-O; BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; COMMENGES D, 1994, GENET EPIDEMIOL, V11, P201, DOI 10.1002/gepi.1370110209; COMMENGES D, 1994, GENET EPIDEMIOL, V11, P189, DOI 10.1002/gepi.1370110208; de Andrade M, 1997, GENET EPIDEMIOL, V14, P773, DOI 10.1002/(SICI)1098-2272(1997)14:6<773::AID-GEPI35>3.0.CO;2-L; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; DONNELLY KP, 1983, THEOR POPUL BIOL, V23, P34, DOI 10.1016/0040-5809(83)90004-7; Drigalenko E, 1998, AM J HUM GENET, V63, P1242; Dudoit S, 2000, Biostatistics, V1, P1, DOI 10.1093/biostatistics/1.1.1; Dudoit S, 1999, ANN STAT, V27, P943; Duggirala R, 1999, AM J HUM GENET, V64, P1127, DOI 10.1086/302316; ELSTON RC, IN PRESS GENET EPIDE; Fisher SE, 1999, AM J HUM GENET, V64, P146, DOI 10.1086/302190; Fulker DW, 1996, BEHAV GENET, V26, P527, DOI 10.1007/BF02359758; Ghosh S, 1999, P NATL ACAD SCI USA, V96, P2198, DOI 10.1073/pnas.96.5.2198; Gu C, 1997, GENET EPIDEMIOL, V14, P791, DOI 10.1002/(SICI)1098-2272(1997)14:6<791::AID-GEPI38>3.0.CO;2-J; Gu C, 1996, GENET EPIDEMIOL, V13, P513, DOI 10.1002/(SICI)1098-2272(1996)13:6<513::AID-GEPI1>3.0.CO;2-1; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Knapp M, 1998, ANN HUM GENET, V62, P75, DOI 10.1017/S0003480098006617; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; Kruse R, 1997, GENET EPIDEMIOL, V14, P833, DOI 10.1002/(SICI)1098-2272(1997)14:6<833::AID-GEPI45>3.3.CO;2-L; MacCluer JW, 1997, GENET EPIDEMIOL, V14, P737, DOI 10.1002/(SICI)1098-2272(1997)14:6<737::AID-GEPI29>3.0.CO;2-Q; McPeek MS, 1999, GENET EPIDEMIOL, V16, P225, DOI 10.1002/(SICI)1098-2272(1999)16:3<225::AID-GEPI1>3.0.CO;2-#; Nicolaou M, 1999, GENET EPIDEMIOL, V17, pS679; Pugh EW, 1997, GENET EPIDEMIOL, V14, P867, DOI 10.1002/(SICI)1098-2272(1997)14:6<867::AID-GEPI51>3.0.CO;2-K; RISCH N, 1995, SCIENCE, V268, P1584, DOI 10.1126/science.7777857; Risch NJ, 1996, AM J HUM GENET, V58, P836; Rochberg DR, 1997, GENET EPIDEMIOL, V14, P873; Rogus JJ, 1997, GENET EPIDEMIOL, V14, P879, DOI 10.1002/(SICI)1098-2272(1997)14:6<879::AID-GEPI53>3.0.CO;2-J; Sobel E, 1996, AM J HUM GENET, V58, P1323; Wright FA, 1997, AM J HUM GENET, V60, P740; Xu XP, 1999, AM J HUM GENET, V64, P1694, DOI 10.1086/302405; Zinn-Justin A, 1999, GENET EPIDEMIOL, V17, P35, DOI 10.1002/(SICI)1098-2272(1999)17:1<35::AID-GEPI3>3.0.CO;2-#	37	35	35	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2000	66	5					1642	1660		10.1086/302897	http://dx.doi.org/10.1086/302897			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QT	10762549	Green Published, Bronze			2022-12-18	WOS:000088373700018
J	Hinson, DD; Ross, RM; Krisans, S; Shaw, JL; Kozich, V; Rolland, MO; Divry, P; Mancini, J; Hoffmann, GF; Gibson, KM				Hinson, DD; Ross, RM; Krisans, S; Shaw, JL; Kozich, V; Rolland, MO; Divry, P; Mancini, J; Hoffmann, GF; Gibson, KM			Identification of a mutation cluster in mevalonate kinase deficiency, including a new mutation in a patient of Mennonite ancestry	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MOLECULAR-CLONING; ACIDURIA; FIBROBLASTS; CHOLESTEROL; RAT	Mevalonate kinase (MKase) deficiency (MKD) is a rare autosomal recessive disorder in the pathway of cholesterol and nonsterol isoprenoid biosynthesis. Thus far, two disease-causing missense alleles have been identified, N301T and A334T. We report four additional mutations associated with MKD: L264F, T243I, L265P and 1268T, the last found in a patient of Mennonite ancestry. Electrophoretic analysis of bacterially expressed wildtype and mutant MKase indicated that I268T and T243I mutants produced normal or somewhat reduced amounts of MKase protein; conversely, L264F and L265P mutations resulted in considerably decreased, or absent, MKase protein. Immunoblot analysis of MKase from all patients suggested that the MKase polypeptide was grossly intact and produced in amounts comparable to control levels. Three mutations resulted in significantly diminished MKase enzyme activity (<2%), whereas the I268T allele yielded similar to 20% residual enzyme activity. Our results should allow more-accurate identification of carriers and indicate a mutation "cluster" within amino acids 240-270 of the mature MKase polypeptide.	Oregon Hlth Sci Univ, Biochem Genet Lab, Dept Mol & Med Genet, Portland, OR 97201 USA; Baylor Univ, Med Ctr, Inst Metab Dis, Dallas, TX USA; San Diego State Univ, Coll Sci, Dept Biol, San Diego, CA 92182 USA; San Diego State Univ, Coll Sci, Inst Mol Biol, San Diego, CA 92182 USA; Fac Med 1, Inst Inherited Metab Dis, Prague, Czech Republic; Hop Debrousse, Serv Biochem, Lyon, France; Childrens Hosp, Dept Pediat Neurol, Marseille, France; Univ Marburg, Dept Neuropediat & Metab Dis, Marburg, Germany	Oregon Health & Science University; Baylor University; Baylor University Medical Center; California State University System; San Diego State University; California State University System; San Diego State University; Charles University Prague; CHU Lyon; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Philipps University Marburg	Gibson, KM (corresponding author), Oregon Hlth Sci Univ, Biochem Genet Lab, Dept Mol & Med Genet, Baird Hall Room 2029,Mail Code L-473,3181 SW Sam, Portland, OR 97201 USA.		Kozich, Viktor/A-7672-2008	Kozich, Viktor/0000-0001-5820-5277				BIARDI L, 1994, J BIOL CHEM, V269, P1197; CHAMBLISS KL, 1995, J BIOL CHEM, V270, P461, DOI 10.1074/jbc.270.1.461; Chambliss KL, 1996, J BIOL CHEM, V271, P17330, DOI 10.1074/jbc.271.29.17330; GIBSON KM, 1989, ENZYME, V41, P47, DOI 10.1159/000469050; GIBSON KM, 1990, J LIPID RES, V31, P515; Gibson M, 1996, J INHERIT METAB DIS, V19, P739, DOI 10.1007/BF01799165; GOEBELSCHREINER B, 1995, J INHERIT METAB DIS, V18, P197, DOI 10.1007/BF00711765; Hinson DD, 1997, J BIOL CHEM, V272, P26756, DOI 10.1074/jbc.272.42.26756; Hinson DD, 1997, J LIPID RES, V38, P2216; HOFFMAN G, 1986, NEW ENGL J MED, V314, P1610, DOI 10.1056/NEJM198606193142504; HOFFMANN GF, 1993, PEDIATRICS, V91, P915; Houten S. M., 1998, Journal of Inherited Metabolic Disease, V21, P51; KOZICH V, 1991, J INHERIT METAB DIS, V14, P265, DOI 10.1007/BF01800602; MANCINI J, 1993, PEDIATR NEUROL, V9, P243, DOI 10.1016/0887-8994(93)90095-T; Potter D, 1997, J BIOL CHEM, V272, P5741, DOI 10.1074/jbc.272.9.5741; Potter D, 1997, J BIOL CHEM, V272, P25449, DOI 10.1074/jbc.272.41.25449; SCHAFER BL, 1992, J BIOL CHEM, V267, P13229; TANAKA RD, 1990, P NATL ACAD SCI USA, V87, P2872, DOI 10.1073/pnas.87.8.2872	18	35	37	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1999	65	2					327	335		10.1086/302489	http://dx.doi.org/10.1086/302489			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	223JA	10417275	Bronze, Green Published			2022-12-18	WOS:000081836900008
J	Whittemore, AS; Lin, IG; Oakley-Girvan, I; Gallagher, RP; Halpern, J; Kolonel, LN; Wu, AH; Hsieh, CL				Whittemore, AS; Lin, IG; Oakley-Girvan, I; Gallagher, RP; Halpern, J; Kolonel, LN; Wu, AH; Hsieh, CL			No evidence of linkage for chromosome 1q42.2-43 in prostate cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							SUSCEPTIBILITY LOCUS; 1Q; FAMILIES; GENOME; GENE		Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; Univ So Calif, Los Angeles, CA 90089 USA; Univ Hawaii Manoa, Honolulu, HI 96822 USA	Stanford University; University of Southern California; University of Hawaii System; University of Hawaii Manoa	Whittemore, AS (corresponding author), Stanford Univ, Sch Med, Dept Hlth Res & Policy, Redwood Bldg,Room T204, Stanford, CA 94305 USA.				NCI NIH HHS [CA67044] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U01CA067044, R01CA067044] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Berthon P, 1998, AM J HUM GENET, V62, P1416, DOI 10.1086/301879; CARTER BS, 1992, P NATL ACAD SCI USA, V89, P3367, DOI 10.1073/pnas.89.8.3367; Cooney KA, 1997, J NATL CANCER I, V89, P955, DOI 10.1093/jnci/89.13.955; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Eeles RA, 1998, AM J HUM GENET, V62, P653, DOI 10.1086/301745; Hsieh CL, 1997, J NATL CANCER I, V89, P1893, DOI 10.1093/jnci/89.24.1893; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; McIndoe RA, 1997, AM J HUM GENET, V61, P347, DOI 10.1086/514853; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; Yuan B, 1997, AM J HUM GENET, V60, P459	12	35	35	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1999	65	1					254	256		10.1086/302457	http://dx.doi.org/10.1086/302457			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	212NZ	10364541	Green Published, Bronze			2022-12-18	WOS:000081224300033
J	Ikegawa, S; Nishimura, G; Nagai, T; Hasegawa, T; Ohashi, H; Nakamura, Y				Ikegawa, S; Nishimura, G; Nagai, T; Hasegawa, T; Ohashi, H; Nakamura, Y			Mutation of the type X collagen gene (COL10A1) causes spondylometaphyseal dysplasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SCHMID METAPHYSEAL CHONDRODYSPLASIA; FIBRILLAR COLLAGENS; CARTILAGE; LOCALIZATION; SPECTRUM; DOMAIN; CHAIN; BONE	Spondylometaphyseal dysplasia (SMD) comprises a heterogeneous group of heritable skeletal dysplasias characterized by modifications of the vertebral bodies of the spine and metaphyses of the tubular bones. The genetic etiology of SMD is currently unknown; however, the type X collagen gene (COL10A1) is considered an excellent candidate, for two reasons: first, Schmid metaphyseal chondrodysplasia, a condition known to result from COL10A1 mutations, shows a significant phenotypic overlap with SMD; and, second, transgenic mice carrying deletions in type X collagen show SMD phenotypes. Hence, we examined the entire coding region of COL10A1 by direct sequencing of DNA from five unrelated patients with SMD and found a heterozygous missense mutation (Gly595Glu) cosegregating with the disease phenotype in one SMD family. This initial documented identification of a mutation in SMD expands our knowledge concerning the range of the pathological phenotypes that can be produced by aberrations of type X collagen (type X collagenopathy).	Univ Tokyo, Inst Med Sci, Lab Genome Med, Ctr Human Genome,Minato Ku, Tokyo 108, Japan; Keio Univ, Sch Med, Dept Pediat, Tokyo, Japan; Dokkyo Univ, Sch Med, Dept Radiol, Tochigi, Japan; Dokkyo Univ, Koshigaya Hosp, Dept Pediat, Sch Med, Saitama, Japan; Saitama Childrens Med Ctr, Div Med Genet, Saitama, Japan	University of Tokyo; Keio University; Dokkyo Medical University; Dokkyo Medical University; Saitama Children's Medical Center	Ikegawa, S (corresponding author), Univ Tokyo, Inst Med Sci, Lab Genome Med, Ctr Human Genome,Minato Ku, 4-6-1 Shirokanedai, Tokyo 108, Japan.	sikegawa@ims.u-tokyo.ac.jp	Hasegawa, Tomonobu/L-3331-2013					Bonaventure J, 1996, AM J MED GENET, V63, P148, DOI 10.1002/(SICI)1096-8628(19960503)63:1<148::AID-AJMG26>3.0.CO;2-N; BRASS A, 1992, FEBS LETT, V303, P126, DOI 10.1016/0014-5793(92)80503-9; HASEGAWA T, 1994, PEDIATR RADIOL, V24, P194, DOI 10.1007/BF02012189; Ikegawa S, 1997, HUM MUTAT, V9, P131, DOI 10.1002/(SICI)1098-1004(1997)9:2<131::AID-HUMU5>3.0.CO;2-C; JACENKO O, 1993, NATURE, V365, P56, DOI 10.1038/365056a0; KIRSCH T, 1991, EUR J BIOCHEM, V196, P575, DOI 10.1111/j.1432-1033.1991.tb15852.x; KOZLOWSKI K, 1967, Presse Medicale, V75, P2769; Kuivaniemi H, 1997, HUM MUTAT, V9, P300, DOI 10.1002/(SICI)1098-1004(1997)9:4<300::AID-HUMU2>3.0.CO;2-9; LACHMAN RS, 1988, PEDIATR RADIOL, V18, P93, DOI 10.1007/BF02387549; MAROTEAUX P, 1991, PEDIATR RADIOL, V21, P293, DOI 10.1007/BF02018629; SCHMID TM, 1985, J CELL BIOL, V100, P598, DOI 10.1083/jcb.100.2.598; SPRANGER J, 1994, EUR J PEDIATR, V153, P56, DOI 10.1007/BF01959208; TAYBI H, 1996, RADIOLOGY SYNDROMES, P928; THOMAS JT, 1991, BIOCHEM J, V280, P617, DOI 10.1042/bj2800617; Wallis GA, 1996, J MED GENET, V33, P450, DOI 10.1136/jmg.33.6.450; WARMAN ML, 1993, NAT GENET, V5, P79, DOI 10.1038/ng0993-79	16	35	38	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1998	63	6					1659	1662		10.1086/302158	http://dx.doi.org/10.1086/302158			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EL	9837818	Green Published, Bronze			2022-12-18	WOS:000077707700011
J	Tsujikawa, M; Kurahashi, H; Tanaka, T; Okada, M; Yamamoto, S; Maeda, N; Watanabe, H; Inoue, Y; Kiridoshi, A; Matsumoto, K; Ohashi, Y; Kinoshita, S; Shimomura, Y; Nakamura, Y; Tano, Y				Tsujikawa, M; Kurahashi, H; Tanaka, T; Okada, M; Yamamoto, S; Maeda, N; Watanabe, H; Inoue, Y; Kiridoshi, A; Matsumoto, K; Ohashi, Y; Kinoshita, S; Shimomura, Y; Nakamura, Y; Tano, Y			Homozygosity mapping of a gene responsible for gelatinous drop-like corneal dystrophy to chromosome 1p	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CDNA CLONING; LINKAGE MAP	Gelatinous drop-like corneal dystrophy (GDLD) is a rare autosomal recessive disorder characterized clinically by grayish corneal deposits of amyloid and by severely impaired visual acuity. Most patients require corneal transplantation. To localize a gene responsible for GDLD, we performed linkage analysis of 10 consanguineous Japanese families with a total of 13 affected members. Homozygosity mapping provided a maximum LOD score of 9.80 at the D1S2741 marker locus on the short arm of chromosome 1. Haplotype analysis further defined the disease locus within a region of similar to 2.6 cM between D1S2890 and D1S2801.	Osaka Univ, Sch Med, Dept Med Genet, Div Clin Genet,Biomed Res Ctr, Suita, Osaka 5650871, Japan; Osaka Univ, Sch Med, Dept Ophthalmol, Suita, Osaka 5650871, Japan; Univ Tokyo, Inst Med Sci, Mol Med Lab, Ctr Human Genome, Tokyo, Japan; Kumamoto Univ, Sch Med, Dept Ophthalmol, Kumamoto 860, Japan; Ehime Univ, Sch Med, Dept Ophthalmol, Matsuyama, Ehime 790, Japan; Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan	Osaka University; Osaka University; University of Tokyo; Kumamoto University; Ehime University; Kyoto Prefectural University of Medicine	Nakamura, Y (corresponding author), Osaka Univ, Sch Med, Dept Med Genet, Div Clin Genet,Biomed Res Ctr, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.		Tanaka, Toshihiro/J-9310-2014	Tanaka, Toshihiro/0000-0001-6201-9784				BERI RK, 1994, FEBS LETT, V356, P117, DOI 10.1016/0014-5793(94)01247-4; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; GRIMBERG J, 1989, NUCLEIC ACIDS RES, V17, P8390, DOI 10.1093/nar/17.20.8390; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HANES J, 1994, J MOL BIOL, V244, P665, DOI 10.1006/jmbi.1994.1763; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MONDINO BJ, 1981, AM J OPHTHALMOL, V92, P732, DOI 10.1016/S0002-9394(14)74671-9; Munier FL, 1997, NAT GENET, V15, P247, DOI 10.1038/ng0397-247; NAKAIZUMI Y, 1914, ACTA SOC OPHTHALMOL, V18, P949; RAMSEY MS, 1972, AM J OPHTHALMOL, V73, P560, DOI 10.1016/0002-9394(72)90008-6; SKONIER J, 1992, DNA CELL BIOL, V11, P511, DOI 10.1089/dna.1992.11.511; SMOLIN G, 1994, CORNEA, P499; Vance JM, 1996, AM J HUM GENET, V58, P757; WEBER FL, 1980, ARCH OPHTHALMOL-CHIC, V98, P144, DOI 10.1001/archopht.1980.01020030146017; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WHITEHEAD AS, 1988, IMMUNOGENETICS, V28, P388, DOI 10.1007/BF00364241	16	35	37	0	2	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1998	63	4					1073	1077		10.1086/302071	http://dx.doi.org/10.1086/302071			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	131LP	9758629	Bronze, Green Published			2022-12-18	WOS:000076577800020
J	Badner, JA; Gershon, ES; Goldin, LR				Badner, JA; Gershon, ES; Goldin, LR			Optimal ascertainment strategies to detect linkage to common disease alleles	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETICALLY COMPLEX TRAITS; MODELS	Traditionally, extended pedigrees with many affected individuals have been studied for the purpose of detection of linkage. For traits caused by a rare susceptibility allele, this is a productive strategy. However, this sampling strategy may not work well for traits determined by multiple loci in which one or more have common susceptibility alleles. We simulated three single-additive-locus models of inheritance and two-locus models with additive or multiplicative interactions, all with rare or common susceptibility alleles. A trait locus was linked, with no recombination, to a marker locus with four equally frequent alleles. Family structure varied, but the total number of affected individuals was held constant. Two generations of individuals were genotyped. We used three nonparametric affected-sib-pair programs and two nonparametric pedigree-analysis programs to perform linkage analysis. For single-locus, additive, and multiplicative models, we found that, when the susceptibility allele was rare, (frequency .0025), extended pedigrees with first or second cousins had the most power for detection of linkage. However, when the susceptibility allele was common in the single-locus, additive, and multiplicative two-locus models (frequency .25), extended pedigrees were no more powerful than nuclear families. There was also a decrease in power when the pedigrees had a greater number of affected individuals, more so for the single-locus and multiplicative models than for the additive model. We conclude that for single-locus, additive, and multiplicative models of qualitative traits with common alleles, there is no benefit to the collection of extended pedigrees, and there may be a loss of power in the collection of pedigrees with many affected individuals.	NIMH, Intramural Res Program, Clin Neurogenet Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Badner, JA (corresponding author), NIMH, Intramural Res Program, Clin Neurogenet Branch, Bldg 10,Room 3N218,10 Ctr Dr,MSC 1274, Bethesda, MD 20892 USA.				NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NCRR NIH HHS [1 P41 RR03655] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BARON M, 1994, PSYCHIATR GENET, V4, P43, DOI 10.1097/00041444-199421000-00007; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Davis S, 1997, AM J HUM GENET, V61, P1431, DOI 10.1086/301635; EGELAND JA, 1987, NATURE, V325, P783, DOI 10.1038/325783a0; GREENBERG DA, 1989, GENET EPIDEMIOL, V6, P259, DOI 10.1002/gepi.1370060145; HASSTEDT SJ, 1994, PEDIGREE ANAL PACKAG; Hauser ER, 1996, GENET EPIDEMIOL, V13, P117, DOI 10.1002/(SICI)1098-2272(1996)13:2<117::AID-GEPI1>3.0.CO;2-5; HOLMANS P, 1993, AM J HUM GENET, V52, P362; JAMES JW, 1971, ANN HUM GENET, V35, P47, DOI 10.1111/j.1469-1809.1956.tb01377.x; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; NEUMAN RJ, 1992, GENET EPIDEMIOL, V9, P347, DOI 10.1002/gepi.1370090506; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P222; RISCH N, 1987, AM J HUM GENET, V40, P1; SAGE, 1994, STAT AN GEN EP VERS; Weeks DE., 1990, AM J HUM GENET, V47, pA203; Wijsman EM, 1997, GENET EPIDEMIOL, V14, P719, DOI 10.1002/(SICI)1098-2272(1997)14:6<719::AID-GEPI28>3.0.CO;2-S	20	35	35	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1998	63	3					880	888		10.1086/302007	http://dx.doi.org/10.1086/302007			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	119VN	9718337	Green Published, Bronze			2022-12-18	WOS:000075919000027
J	Clementi, M; Angi, M; Forabosco, P; Di Gianantonio, E; Tenconi, R				Clementi, M; Angi, M; Forabosco, P; Di Gianantonio, E; Tenconi, R			Inheritance of astigmatism: Evidence for a major autosomal dominant locus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHILDREN	Although astigmatism is a frequent refractive error, its mode of inheritance remains uncertain. Complex segregation analysis was performed, by the POINTER and COMDS programs, with data from a geographically well-defined sample of 125 nuclear families of individuals affected by astigmatism. POINTER could not distinguish between alternative genetic models, and only the hypothesis of no familial transmission could be rejected. After inclusion of the severity parameter, COMDS results defined a genetic model for corneal astigmatism and provided evidence for single-major-locus inheritance. These results suggest that genetic linkage studies could be implemented and that they should be limited to multiplex families with severely affected individuals.	Univ Padua, Dipartimento Pediat, Serv Genet Clin & Epidemiol, I-35128 Padua, Italy; Univ Padua, Clin Oculist, I-35128 Padua, Italy; Univ Modena, Dipartimento Sci Morfol & Medicolegali, I-41100 Modena, Italy	University of Padua; University of Padua; Universita di Modena e Reggio Emilia	Clementi, M (corresponding author), Univ Padua, Dipartimento Pediat, Serv Genet Clin & Epidemiol, I-35128 Padua, Italy.		Forabosco, Paola/AAM-5540-2021	FORABOSCO, PAOLA/0000-0002-2006-2693				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ANGI MR, 1992, BEHAV BRAIN RES, V49, P91, DOI 10.1016/S0166-4328(05)80198-6; Bennet AG, 1962, EYE, V4, P145; FRANCOIS J, 1958, HEREDITE OPHTALMOLOG, P214; GROSVENOR T, 1978, AM J OPTOM PHYS OPT, V55, P214; HOWLAND HC, 1985, VISION RES, V25, P73, DOI 10.1016/0042-6989(85)90082-3; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; MASH AJ, 1975, INVEST OPHTH VISUAL, V14, P826; MORTON NE, 1991, ANN HUM GENET, V55, P301, DOI 10.1111/j.1469-1809.1991.tb00857.x; MORTON NE, 1974, AM J HUM GENET, V26, P318; POWELL S, 1948, OPTICIAN, V116, P286; SAUNDERS KJ, 1995, SURV OPHTHALMOL, V40, P207, DOI 10.1016/S0039-6257(95)80027-1; SPENGLER E, 1904, KLIN MONATSBL AUGENH, V42, P164; TEIKARI JM, 1989, CORNEA, V8, P263; WAARDENBURG PJ, 1963, GENETICS OPHTHALMOLO	15	35	36	0	2	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1998	63	3					825	830		10.1086/302014	http://dx.doi.org/10.1086/302014			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	119VN	9718344	Green Published, Bronze			2022-12-18	WOS:000075919000021
J	Mao, X				Mao, X			Chinese geneticists' views of ethical issues in genetic testing and screening: Evidence for eugenics in China	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ATTITUDES; LAW	To identify Chinese geneticists' views of ethical issues in genetic testing and screening, a national survey was conducted. Of 402 Chinese geneticists asked to participate, 255 (63%) returned by mail anonymous questionnaires. The majority of respondents thought that genetic testing should be offered in the workplace for cr-antitrypsin deficiency (95%) and the predisposition of executives to heart disease, cancer, and diabetes (94%); that genetic testing should be included in preemployment physical examinations (86%); that governments should require premarital carrier tests (86%), newborn screening for sickle cell (77%), and Duchenne muscular dystrophy (71%); and that children should be tested for genes for late-onset disorders such as Huntington disease (85%), susceptibility to cancers (85%), familial hypercholesterolemia (84%), alcoholism (69%), and Alzheimer disease (61%). Most believed that partners should know each other's genetic status before marriage (92%), that carriers of the same defective gene should not mate with each other (91%), and that women should have a prenatal diagnosis if medically indicated (91%). The majority said that in China decisions about family planning were shared by the couple (82%). More than half had views that, in China, there were no laws to prohibit disability discrimination (64%), particularly to protect people with adult polycystic kidney disease (57%), cystic fibrosis (56%), or genetic predisposition to other diseases (50%). To some extent, these results might provide a basis for a discussion of eugenics in China, particularly about China's Maternal and Infant Health Care Law (1994).	W China Univ Med Sci, Dept Psychiat, Div Genet, Chengdu 610041, Peoples R China	Sichuan University	Mao, X (corresponding author), Inst Canc Res, Haddow Labs, Sect Mol Carcinogenesis, 15 Cotswold Rd, Sutton SM2 5NG, Surrey, England.	xin@ictac.uk	Sandall, Jane/D-4146-2009	Sandall, Jane/0000-0003-2000-743X	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000540] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01-HG00540-02] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Beardsley T, 1997, SCI AM, V276, P33, DOI 10.1038/scientificamerican0397-33; CHEN JH, 1993, CHILD CARE HLTH DEV, V19, P71, DOI 10.1111/j.1365-2214.1993.tb00715.x; Fu JL, 1995, ANNU REV GENET, V29, P1; Galjaard H, 1997, PATHOL BIOL, V45, P250; GARVER KL, 1994, AM J HUM GENET, V54, P148; HARPER PS, 1986, J MED GENET, V23, P385, DOI 10.1136/jmg.23.5.385; Harper PS, 1997, GENETICS SOC CLIN PR; Heredero L, 1992, Birth Defects Orig Artic Ser, V28, P52; Larson Edward, 1995, SEX RACE SCI EUGENIC; LI YQ, 1994, NATURE, V365, P200; LIU SR, 1986, CHINESE MED J-PEKING, V99, P113; LUO HY, 1988, J MED GENET, V25, P253, DOI 10.1136/jmg.25.4.253; MADDOX J, 1995, NATURE, V378, P549; Mao X, 1997, CLIN GENET, V52, P100; Mao X, 1997, NAT GENET, V17, P20, DOI 10.1038/ng0997-20; Mao X, 1996, NATURE, V384, P404, DOI 10.1038/384404b0; MCCAFFREY MC, 1989, AM J HUM GENET, V44, P608; Ming G, 1993, Int J Rehabil Res, V16, P299, DOI 10.1097/00004356-199312000-00005; Morton NE, 1998, NAT GENET, V18, P18, DOI 10.1038/ng0198-18; OBrien C, 1996, NATURE, V383, P204, DOI 10.1038/383204a0; Paul D.B., 1995, CONTROLLING HUMAN HE; PAUL DB, 1992, SOC RES, V59, P663; Qiu R Z, 1993, Camb Q Healthc Ethics, V2, P69; SMITH RA, 1990, BRIT MED J, V300, P1112, DOI 10.1136/bmj.300.6732.1112; TAKEBE H, 1997, UNESCO AS BIOETH C K; Wertz D, 1995, GUIDELINES ETHICAL I; Wertz D C, 1997, J Contemp Health Law Policy, V13, P299; WERTZ DC, 1993, CLIN GENET, V43, P104, DOI 10.1111/j.1399-0004.1993.tb04460.x; WERTZ DC, 1995, EUR SOC HUM GEN BERL; *WHO, 1998, WHO M ETH ISS MED GE; Wilson JMG, 1968, PRINCIPLES PRACTICES; Wu J, 1994, Verh K Acad Geneeskd Belg, V56, P383; ZHANG LZ, 1988, CHINESE MED J-PEKING, V101, P303; ZHANG SZ, 1991, CLIN GENET, V39, P81; ZHOU ZL, 1995, CHINESE MED J-PEKING, V108, P387; 1995, LANCET, V346, P131; 1997, NAT GENET, V15, P1; 1994, PEOPLES DAILY   1027; 1994, NATURE, V367, P1; 1998, NATURE, V392, P109	40	35	35	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1998	63	3					688	695		10.1086/302020	http://dx.doi.org/10.1086/302020			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	119VN	9718350	Bronze, Green Published			2022-12-18	WOS:000075919000005
J	Hasstedt, SJ; Bovill, EG; Callas, PW; Long, GL				Hasstedt, SJ; Bovill, EG; Callas, PW; Long, GL			An unknown genetic defect increases venous thrombosis risk, through interaction with protein C deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FACTOR-V-LEIDEN; S DEFICIENCY; QUANTITATIVE TRAITS; COMPLEX SEGREGATION; PURPURA FULMINANS; NEWBORN-INFANT; R506Q MUTATION; FAMILIES; RESISTANCE; DISEASE	We used two-locus segregation analysis to test whether an unknown genetic defect interacts with protein C deficiency to increase susceptibility to venous thromboembolic disease in a single large pedigree. Sixty-seven pedigree members carry a His107Pro mutation In the protein C gene, which reduces protein C levels to a mean of 46% of normal. Twenty-one carriers of the mutation and five other pedigree members had verified thromboembolic disease. We inferred the presence in this pedigree of a thrombosis-susceptibility gene interacting with protein C deficiency, by rejecting the hypothesis that the cases of thromboembolic disease resulted from protein C deficiency alone and by not rejecting Mendelian transmission of the interacting gene. When coinherited with protein C deficiency, the interacting gene conferred a probability of a thrombotic episode of similar to 79% for men and similar to 99% for women, before age 60 years.	Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; Univ Vermont, Dept Pathol, Burlington, VT 05405 USA; Univ Vermont, Dept Biometry, Burlington, VT 05405 USA; Univ Vermont, Dept Biochem, Burlington, VT 05405 USA	Utah System of Higher Education; University of Utah; University of Vermont; University of Vermont; University of Vermont	Hasstedt, SJ (corresponding author), Univ Utah, Dept Human Genet, 15 N 2030 E,Room 2100, Salt Lake City, UT 84112 USA.				NHLBI NIH HHS [HL46703] Funding Source: Medline; NICHD NIH HHS [HD17463] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R23HD017463, R01HD017463] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL046703] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; Beauchamp NJ, 1996, BLOOD, V88, P1700; BECKMANN RJ, 1985, NUCLEIC ACIDS RES, V13, P5233, DOI 10.1093/nar/13.14.5233; BERRUYER M, 1994, AM J HEMATOL, V46, P214, DOI 10.1002/ajh.2830460310; BOVILL EG, 1989, BLOOD, V73, P712; BOYLE CR, 1979, BIOMETRICS, V35, P55, DOI 10.2307/2529936; BRANSON HE, 1983, LANCET, V2, P1165; Brenner B, 1996, BLOOD, V88, P877; BROEKMANS AW, 1983, NEW ENGL J MED, V309, P340, DOI 10.1056/NEJM198308113090604; DAHLBACK B, 1993, P NATL ACAD SCI USA, V90, P1004, DOI 10.1073/pnas.90.3.1004; DAHLBACK B, 1994, HAEMOSTASIS, V24, P139; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; ESMON CT, 1993, THROMB HAEMOSTASIS, V70, P29; ESTELLES A, 1984, THROMB HAEMOSTASIS, V52, P53; Florell SR, 1997, AM J HEMATOL, V54, P53, DOI 10.1002/(SICI)1096-8652(199701)54:1<53::AID-AJH8>3.3.CO;2-#; FOSTER DC, 1985, P NATL ACAD SCI USA, V82, P4673, DOI 10.1073/pnas.82.14.4673; GANDRILLE S, 1988, BRIT J HAEMATOL, V68, P329, DOI 10.1111/j.1365-2141.1988.tb04210.x; GANDRILLE S, 1995, BLOOD, V86, P219, DOI 10.1182/blood.V86.1.219.bloodjournal861219; GILL PE, 1986, 862 STANF U DEP OP R; GLADSON CL, 1988, THROMB HAEMOSTASIS, V59, P18; GRIFFIN JH, 1981, J CLIN INVEST, V68, P1370, DOI 10.1172/JCI110385; HASSTEDT SJ, 1993, GENET EPIDEMIOL, V10, P145, DOI 10.1002/gepi.1370100302; HASSTEDT SJ, 1994, PAP PEDIGREE ANAL PA; HORELLOU MH, 1984, BRIT MED J, V289, P1285, DOI 10.1136/bmj.289.6454.1285; Kato Y., 1988, OSA P SHORT WAVELENG, V2, P47; KOELEMAN BPC, 1995, THROMB HAEMOSTASIS, V74, P580; KOELEMAN BPC, 1994, BLOOD, V84, P1031; KOSTER T, 1995, BLOOD, V85, P2756, DOI 10.1182/blood.V85.10.2756.bloodjournal85102756; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; Lane DA, 1997, THROMB HAEMOSTASIS, V77, P197; Mann K., 1995, WILLIAMS HEMATOLOGY, P1206; MARCINIAK E, 1985, BLOOD, V65, P15; MARLAR RA, 1989, THROMB HAEMOSTASIS, V61, P529; McColl M, 1996, BLOOD COAGUL FIBRIN, V7, P689, DOI 10.1097/00001721-199610000-00005; MILETICH J, 1987, NEW ENGL J MED, V317, P991, DOI 10.1056/NEJM198710153171604; MILETICH JP, 1993, CELL, V72, P477, DOI 10.1016/0092-8674(93)90063-V; MORTON NE, 1974, AM J HUM GENET, V26, P489; Pabinger I, 1996, ARTERIOSCL THROM VAS, V16, P742, DOI 10.1161/01.ATV.16.6.742; PLUTZKY J, 1986, P NATL ACAD SCI USA, V83, P546, DOI 10.1073/pnas.83.3.546; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; REINER AP, 1995, METABOLIC MOL BASES, V3, P3181; Reitsma PH, 1996, NUCLEIC ACIDS RES, V24, P157, DOI 10.1093/nar/24.1.157; RISCH N, 1993, AM J HUM GENET, V53, P702; Seligsohn U, 1997, THROMB HAEMOSTASIS, V78, P297; SELIGSOHN U, 1984, NEW ENGL J MED, V310, P559, DOI 10.1056/NEJM198403013100904; Simmonds RE, 1996, BLOOD, V88, P4195; TAIT RC, 1995, THROMB HAEMOSTASIS, V73, P87; TOMCZAK JA, 1994, THROMB RES, V74, P243, DOI 10.1016/0049-3848(94)90112-0; TRAUSCHTVANHORN JJ, 1992, AM J OBSTET GYNECOL, V167, P968, DOI 10.1016/S0002-9378(12)80021-4; vanBoven HH, 1996, THROMB HAEMOSTASIS, V75, P417; ZOLLER B, 1995, THROMB HAEMOSTASIS, V73, P743; ZOLLER B, 1995, BLOOD, V85, P3518, DOI 10.1182/blood.V85.12.3518.bloodjournal85123518; Zuger M, 1996, THROMB HAEMOSTASIS, V76, P475	53	35	35	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1998	63	2					569	576		10.1086/301947	http://dx.doi.org/10.1086/301947			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110CB	9683579	Green Published, Bronze			2022-12-18	WOS:000075360800033
J	Jackson, SNJ; Pinkney, J; Bargiotta, A; Veal, CD; Howlett, TA; McNally, PG; Corral, R; Johnson, A; Trembath, RC				Jackson, SNJ; Pinkney, J; Bargiotta, A; Veal, CD; Howlett, TA; McNally, PG; Corral, R; Johnson, A; Trembath, RC			A defect in the regional deposition of adipose tissue (partial lipodystrophy) is encoded by a gene at chromosome 1q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL PARTIAL LIPODYSTROPHY; MULTILOCUS LINKAGE ANALYSIS; INSULIN; EXTREMITIES; OBESITY; DISEASE; HUMANS	Partial lipodystrophy (PLD), also known as "Dunnigan-Kobboerling syndrome," is transmitted as a highly penetrant autosomal dominant disorder that is characterized by a dramatic absence of adipose tissue in the limbs and trunk, more evident in females than in males. En contrast, fat is retained on the face, in retro-orbital space, and at periserous sites. Associated metabolic abnormalities, including insulin resistance, hyperinsulinemia, and dyslipidemia, are referred to as "metabolic syndrome X" (Reaven 1988). Despite the intense interest in the genetic determinants underlying fat deposition, the genes involved in the lipodystrophic syndromes have not been identified. We ascertained two multigeneration families, with a combined total of 18 individuals with PLD, and performed a genomewide search, We obtained conclusive evidence for linkage of the PLD locus to microsatellite markers on chromosome 1q21 (D1S498, maximum LOD score 6.89 at recombination fraction .00), with no evidence of heterogeneity. Haplotype and multipoint analysis support the location of the FED locus within a 21.2-cM chromosomal region that is flanked by the markers D1S2881 and D1S484, These data represent an important step in the effort to isolate and characterize the PLD gene. The identification of the gene will have important implications for the understanding of both developmental sand metabolic aspects of the adipocyte and may prove useful as a single-gene model for the common metabolic disorder known as "syndrome X."	Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; Univ Leicester, Dept Med & Therapeut, Leicester LE1 7RH, Leics, England; Leicester Royal Infirm NHS Trust, Dept Endocrinol & Diabet, Leicester LE1 5WW, Leics, England; Southmead Hosp Natl Hlth Serv Trust, Dept Endocrinol & Diabet, Bristol, Avon, England; Bristol Royal Infirm Natl Hlth Serv Trust, Dept Endocrinol & Diabet, Bristol, Avon, England	University of Leicester; University of Leicester; Bristol Royal Infirmary	Trembath, RC (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.			Veal, Colin/0000-0002-9840-2512; Trembath, Richard/0000-0003-0550-3400				Bjorntorp P, 1996, INT J OBESITY, V20, P291; BURN J, 1986, J MED GENET, V23, P128, DOI 10.1136/jmg.23.2.128; COLEMAN DL, 1979, SCIENCE, V203, P663, DOI 10.1126/science.760211; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; CRAIG JM, 1994, NAT GENET, V7, P376, DOI 10.1038/ng0794-376; Dani C, 1997, J CELL SCI, V110, P1279; DAVIDSON MB, 1975, DIABETOLOGIA, V11, P561, DOI 10.1007/BF01222107; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DUNNIGAN MG, 1974, Q J MED, V43, P33; ELDER JT, 1992, HUM GENET, V89, P487; Harris Robert A., 1997, P525; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Jackson SNJ, 1997, QJM-INT J MED, V90, P27; KAHN SE, 1995, J CLIN ENDOCR METAB, V80, P1399, DOI 10.1210/jc.80.4.1399; KOBBERLING J, 1975, HUMANGENETIK, V29, P111, DOI 10.1007/BF00430347; KOBBERLING J, 1986, J MED GENET, V23, P120, DOI 10.1136/jmg.23.2.120; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Peters JM, 1998, NAT GENET, V18, P292, DOI 10.1038/ng0398-292; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Schwarz EJ, 1997, MOL CELL BIOL, V17, P1552, DOI 10.1128/MCB.17.3.1552; Trembath RC, 1997, HUM MOL GENET, V6, P813, DOI 10.1093/hmg/6.5.813	23	35	35	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1998	63	2					534	540		10.1086/301971	http://dx.doi.org/10.1086/301971			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110CB	9683602	Green Published, Bronze			2022-12-18	WOS:000075360800029
J	Berube, NG; Smith, JR; Pereira-Smith, OM				Berube, NG; Smith, JR; Pereira-Smith, OM			The genetics of cellular senescence	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN-DIPLOID CELLS; IN-VIVO; CHROMOSOME-7; FIBROBLASTS; SUPPRESSION; PHENOTYPE; CULTURE; LINES; P53		Baylor Coll Med, Huffington Ctr Aging, Div Mol Virol, Houston, TX 77030 USA; Baylor Coll Med, Dept Cell Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Berube, NG (corresponding author), Baylor Coll Med, Huffington Ctr Aging, Div Mol Virol, 1 Baylor Plaza, Houston, TX 77030 USA.	nberybe@bcm.tmc.edu	Berube, Nathalie G/E-3885-2015		NIA NIH HHS [R37AG05333, P01AG13663] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R37AG005333, P01AG013663] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ATADJA P, 1995, P NATL ACAD SCI USA, V92, P8348, DOI 10.1073/pnas.92.18.8348; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; BOND JA, 1995, CANCER RES, V55, P2404; Bryan TM, 1997, EUR J CANCER, V33, P767, DOI 10.1016/S0959-8049(97)00065-8; Campisi J, 1997, EUR J CANCER, V33, P703, DOI 10.1016/S0959-8049(96)00058-5; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Effros RB, 1998, AM J HUM GENET, V62, P1003, DOI 10.1086/301845; Garkavtsev I, 1997, MOL CELL BIOL, V17, P2014, DOI 10.1128/MCB.17.4.2014; Garkavtsev I, 1997, CYTOGENET CELL GENET, V76, P176, DOI 10.1159/000134539; Garkavtsev I, 1996, NAT GENET, V14, P415, DOI 10.1038/ng1296-415; GREIDER CW, 1990, BIOESSAYS, V12, P363, DOI 10.1002/bies.950120803; HARLEY CB, 1995, CURR OPIN GENET DEV, V5, P249, DOI 10.1016/0959-437X(95)80016-6; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Holt SE, 1997, EUR J CANCER, V33, P761, DOI 10.1016/S0959-8049(97)00066-X; Karlsson C, 1996, CANCER RES, V56, P241; LEVY MZ, 1992, J MOL BIOL, V225, P951, DOI 10.1016/0022-2836(92)90096-3; MATSUMURA T, 1979, J GERONTOL, V34, P328, DOI 10.1093/geronj/34.3.328; Morin GB, 1997, EUR J CANCER, V33, P750, DOI 10.1016/S0959-8049(97)00061-0; NORWOOD TH, 1979, J INVEST DERMATOL, V73, P92, DOI 10.1111/1523-1747.ep12532778; OGATA T, 1993, MOL CELL BIOL, V13, P6036, DOI 10.1128/MCB.13.10.6036; OGATA T, 1995, JPN J CANCER RES, V86, P35, DOI 10.1111/j.1349-7006.1995.tb02985.x; Oshimura M, 1997, EUR J CANCER, V33, P710, DOI 10.1016/S0959-8049(97)00090-7; PEREIRASMITH OM, 1990, J CELL PHYSIOL, V144, P546, DOI 10.1002/jcp.1041440324; SANDHU AK, 1994, P NATL ACAD SCI USA, V91, P5498, DOI 10.1073/pnas.91.12.5498; Schachter F, 1998, AM J HUM GENET, V62, P1008, DOI 10.1086/301849; SHAY JW, 1991, BIOCHIM BIOPHYS ACTA, V1072, P1, DOI 10.1016/0304-419X(91)90003-4; Smith JR, 1996, SCIENCE, V273, P63, DOI 10.1126/science.273.5271.63; Vojta PJ, 1996, GENE CHROMOSOME CANC, V16, P55; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	30	35	36	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1998	62	5					1015	1019		10.1086/301848	http://dx.doi.org/10.1086/301848			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZL922	9545418	Green Published, Bronze			2022-12-18	WOS:000073487000003
J	Ezekowitz, RAB				Ezekowitz, RAB			Genetic heterogeneity of mannose-binding proteins: The Jekyll and Hyde of innate immunity?	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMORPHISM; ASSOCIATION; COMPLEMENT; FREQUENCY; HOMOLOGY; CHILDREN; PATHWAY; DOMAIN; DEFECT; LECTIN		Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Pediat,Lab Dev Immunol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Ezekowitz, RAB (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Pediat,Lab Dev Immunol, 15 Parkman St,WAC 731, Boston, MA 02114 USA.	Ezekowitz.alan@mgh.harvard.edu						DRICKAMER K, 1986, J BIOL CHEM, V261, P6878; Dushay MS, 1998, AM J HUM GENET, V62, P10, DOI 10.1086/301694; Epstein J, 1996, CURR OPIN IMMUNOL, V8, P29, DOI 10.1016/S0952-7915(96)80101-4; EZEKOWITZ R A B, 1991, Current Biology, V1, P60; EZEKOWITZ RAB, 1988, J EXP MED, V167, P1034, DOI 10.1084/jem.167.3.1034; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; GARRED P, 1992, CLIN EXP IMMUNOL, V90, P517; GARRED P, 1993, CLIN EXP IMMUNOL, V94, P99; GARRED P, 1994, EUR J IMMUNOGENET, V21, P125, DOI 10.1111/j.1744-313X.1994.tb00183.x; GARRED P, 1995, LANCET, V346, P941, DOI 10.1016/S0140-6736(95)91559-1; GARRED P, 1992, EUR J IMMUNOGENET, V19, P403, DOI 10.1111/j.1744-313X.1992.tb00083.x; HOLMSKOV U, 1993, GLYCOBIOLOGY, V3, P147, DOI 10.1093/glycob/3.2.147; HOPPE HJ, 1994, FEBS LETT, V344, P191, DOI 10.1016/0014-5793(94)00383-1; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Lipscombe R. J., 1992, Human Molecular Genetics, V1, P709, DOI 10.1093/hmg/1.9.709; LU J, 1990, J IMMUNOL, V144, P2287; MADSEN HO, 1995, J IMMUNOL, V155, P3013; MADSEN HO, 1994, IMMUNOGENETICS, V40, P37, DOI 10.1007/BF00163962; MATSUSHITA M, 1992, J EXP MED, V176, P1497, DOI 10.1084/jem.176.6.1497; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; MOLHOTRA R, 1994, IMMUNOLOGY, V82, P439; SHERIFF S, 1994, NAT STRUCT BIOL, V1, P789, DOI 10.1038/nsb1194-789; SUMIYA M, 1991, LANCET, V337, P1569, DOI 10.1016/0140-6736(91)93263-9; SUPER M, 1989, LANCET, V2, P1236; Thiel S, 1997, NATURE, V386, P506, DOI 10.1038/386506a0; Turner M W, 1993, Immunodeficiency, V4, P285; Turner MW, 1996, IMMUNOL TODAY, V17, P532, DOI 10.1016/0167-5699(96)10062-1; WEIS WI, 1991, SCIENCE, V254, P1608, DOI 10.1126/science.1721241; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; WEIS WI, 1994, STRUCTURE, V2, P1227, DOI 10.1016/S0969-2126(94)00124-3	30	35	37	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1998	62	1					6	9		10.1086/301696	http://dx.doi.org/10.1086/301696			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YY246	9443889	Green Published, Bronze			2022-12-18	WOS:000072127900002
J	Kenneson, A; Cramer, DW; Warren, ST				Kenneson, A; Cramer, DW; Warren, ST			Fragile X premutations are not a major cause of early menopause	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PREMATURE OVARIAN FAILURE; TISSUE-SPECIFIC EXPRESSION; CGG REPEAT; PRENATAL-DIAGNOSIS; CARRIER FEMALES; FMRI GENE; POPULATION; ALLELES; SITE; PREVALENCE	Fragile X syndrome is an X-linked mental retardation condition that usually is due to a trinucleotide-repeat expansion in the FMR1 gene. Whereas full-mutation alleles (>230 repeats) lead to fragile X syndrome, premutation alleles (similar to 60-200 repeats) are apparently non-penetrant. However, previous studies have suggested that female premutation carriers may have an increased incidence of premature menopause. To test this possible association, we screened for premutation alleles among 216 women with early menopause (at age <47 years), 33 of whom had premature menopause (at age <40 years), as well as among 107 control women, all of whom were ascertained solely on the basis of age at menopause. No full-mutation alleles were found; and only one premutation allele was found, but, it was in a member of the control group. These results are consistent with what would be expected on the basis of chance only. Our sample size was sufficient to rule out a greater than or equal to 3-fold increased risk of early menopause and a greater than or equal to 9-fold increased risk of premature menopause due to an FMR1 premutation, under a model considering the risk of both sporadic and familial early menopause. Likewise, our results rule out a greater than or equal to 4-fold increased risk of familial early menopause and a greater than or equal to 26-fold increased risk of familial premature menopause, under a less probable model in which only familial early menopause is considered. These results indicate that the fragile X premutation is not a major risk factor for early menopause and suggest that the risk of premature menopause to fragile X-premutation carriers may not be as great as that reported elsewhere.	Emory Univ, Sch Med, Howard Hughes Med Inst, Rollins Res Ctr, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Genet, Atlanta, GA 30322 USA; Brigham & Womens Hosp, Dept Obstet & Gynecol, Obstet & Gynecol Epidemiol Ctr, Boston, MA 02115 USA	Emory University; Howard Hughes Medical Institute; Emory University; Emory University; Emory University; Harvard University; Brigham & Women's Hospital	Warren, ST (corresponding author), Emory Univ, Sch Med, Howard Hughes Med Inst, Rollins Res Ctr, Room 4035,1510 Clifton Rd, Atlanta, GA 30322 USA.	swarren@bimcore.emory.edu	Warren, Stephen T/A-2498-2012		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD020521, P01HD035576, R01HD023661] Funding Source: NIH RePORTER; NICHD NIH HHS [R37 HD20521, R01 HD23661, P01 HD35576] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALPER MM, 1986, J REPROD MED, V31, P699; BACHNER D, 1993, HUM MOL GENET, V2, P2043, DOI 10.1093/hmg/2.12.2043; Black S. H., 1995, American Journal of Human Genetics, V57, pA31; Brown WT, 1996, AM J MED GENET, V64, P191, DOI 10.1002/(SICI)1096-8628(19960712)64:1<191::AID-AJMG34>3.3.CO;2-G; BROWN WT, 1993, JAMA-J AM MED ASSOC, V270, P1569, DOI 10.1001/jama.270.13.1569; CONWAY GS, 1995, LANCET, V346, P309, DOI 10.1016/S0140-6736(95)92194-X; COULAM CB, 1986, OBSTET GYNECOL, V67, P604; CRAMER DW, 1995, FERTIL STERIL, V64, P740, DOI 10.1016/S0015-0282(16)57849-2; CRAMER DW, 1995, AM J OBSTET GYNECOL, V172, P568, DOI 10.1016/0002-9378(95)90574-X; CRONISTER A, 1991, AM J MED GENET, V38, P269, DOI 10.1002/ajmg.1320380221; DEGRAAFF E, 1995, HUM MOL GENET, V4, P45; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; Eichler EE, 1996, HUM MOL GENET, V5, P319, DOI 10.1093/hmg/5.3.319; FENG Y, 1995, SCIENCE, V268, P731, DOI 10.1126/science.7732383; FENG Y, 1995, AM J HUM GENET, V56, P106; FRYNS JP, 1986, AM J MED GENET, V23, P157, DOI 10.1002/ajmg.1320230110; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; HERGERSBERG M, 1995, HUM MOL GENET, V4, P359, DOI 10.1093/hmg/4.3.359; HINDS HL, 1993, NAT GENET, V3, P36, DOI 10.1038/ng0193-36; Kunst CB, 1996, AM J HUM GENET, V58, P513; KUNST CB, 1994, CELL, V77, P853, DOI 10.1016/0092-8674(94)90134-1; Malter HE, 1997, NAT GENET, V15, P165, DOI 10.1038/ng0297-165; Martin NG, 1997, AM J MED GENET, V69, P114, DOI 10.1002/(SICI)1096-8628(19970303)69:1<114::AID-AJMG23>3.0.CO;2-R; Meadows KL, 1996, AM J MED GENET, V64, P428, DOI 10.1002/(SICI)1096-8628(19960809)64:2<428::AID-AJMG39>3.3.CO;2-7; Partington MW, 1996, AM J MED GENET, V64, P370, DOI 10.1002/(SICI)1096-8628(19960809)64:2<370::AID-AJMG27>3.0.CO;2-B; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; RICHARDS RI, 1991, J MED GENET, V28, P818, DOI 10.1136/jmg.28.12.818; RIGGINS GJ, 1992, AM J MED GENET, V43, P237, DOI 10.1002/ajmg.1320430138; ROUSSEAU F, 1995, AM J HUM GENET, V57, P1006; ROUSSEAU F, 1991, NEW ENGL J MED, V325, P1673, DOI 10.1056/NEJM199112123252401; SCHWARTZ CE, 1994, AM J MED GENET, V51, P400, DOI 10.1002/ajmg.1320510419; Sherman SL, 1996, AM J MED GENET, V64, P256, DOI 10.1002/(SICI)1096-8628(19960809)64:2<256::AID-AJMG4>3.0.CO;2-S; SHERMAN SL, 1995, AM J HUM GENET, V57, P991; SHERMAN SL, 1988, AM J MED GENET, V30, P625, DOI 10.1002/ajmg.1320300163; SNOW K, 1993, AM J HUM GENET, V53, P1217; Spence WC, 1996, AM J MED GENET, V64, P181, DOI 10.1002/(SICI)1096-8628(19960712)64:1<181::AID-AJMG31>3.3.CO;2-Q; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; TIZZANO EF, 1992, J MED GENET, V29, P59; TURNER G, 1994, LANCET, V344, P1500, DOI 10.1016/S0140-6736(94)90313-1; ViannaMorgante AM, 1996, AM J MED GENET, V64, P373, DOI 10.1002/(SICI)1096-8628(19960809)64:2<373::AID-AJMG28>3.0.CO;2-B; WARREN ST, 1995, ANNU REV NEUROSCI, V18, P77, DOI 10.1146/annurev.neuro.18.1.77; WARREN ST, 1994, JAMA-J AM MED ASSOC, V271, P536, DOI 10.1001/jama.271.7.536; ZHONG N, 1993, NAT GENET, V5, P248, DOI 10.1038/ng1193-248	43	35	36	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1997	61	6					1362	1369		10.1086/301647	http://dx.doi.org/10.1086/301647			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YT019	9399905	Bronze, Green Published			2022-12-18	WOS:000071555900020
J	Boehmer, ALM; Brinkmann, AO; Niermeijer, MF; Bakker, L; Halley, DJJ; Drop, SLS				Boehmer, ALM; Brinkmann, AO; Niermeijer, MF; Bakker, L; Halley, DJJ; Drop, SLS			Germ-line and somatic mosaicism in the androgen insensitivity syndrome: Implications for genetic counseling	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							STRAND CONFORMATION POLYMORPHISM; LETHAL OSTEOGENESIS IMPERFECTA; RECEPTOR GENE; PRENATAL-DIAGNOSIS; REPEAT POLYMORPHISM; I COLLAGEN; MUTATIONS; PHENOTYPES; AR		CNRS,IBSM,EP 91 STRUCT & GENET INFORMAT,MARSEILLE,FRANCE; INST J PAOLI I CALMETTES,INSERM U119,F-13009 MARSEILLE,FRANCE; INSERM U372,UNITE PATHOGENIE INFECT LENTIVIRUS,MARSEILLE,FRANCE; CHU HENRI MONDOR,SERV BIOCHIM,MOL GENET LAB,F-94010 CRETEIL,FRANCE; CHU HENRI MONDOR,INSERM U91,F-94010 CRETEIL,FRANCE; HEBREW UNIV JERUSALEM,DEPT EVOLUT SYSTEMAT & ECOL,JERUSALEM,ISRAEL; UNIV LYON 1,CTR GENET MOL & CELLULAIRE,CNRS UMR 106,F-69622 VILLEURBANNE,FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut Paoli-Calmette (IPC); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Hebrew University of Jerusalem; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1								Ausubel F.M., 1994, CURRENT PROTOCOLS MO, V1; BAKKER E, 1987, NATURE, V329, P554, DOI 10.1038/329554a0; Bevan CL, 1996, HUM MOL GENET, V5, P265, DOI 10.1093/hmg/5.2.265; BROWN CJ, 1989, AM J HUM GENET, V44, P264; BYERS PH, 1988, AM J HUM GENET, V42, P237; COHN DH, 1990, AM J HUM GENET, V46, P591; DARRAS BT, 1987, NATURE, V329, P556, DOI 10.1038/329556a0; DAVIES HR, 1995, CLIN ENDOCRINOL, V43, P69; FABER PW, 1989, MOL CELL ENDOCRINOL, V61, P257, DOI 10.1016/0303-7207(89)90137-8; HIORT O, 1993, J CLIN ENDOCR METAB, V77, P262, DOI 10.1210/jc.77.1.262; HOLTERHUS PM, 1996, HORM RES S, V46, P458; HUGHES IA, 1994, CLIN ENDOCRINOL, V40, P295; LAZARO C, 1994, NEW ENGL J MED, V331, P1403, DOI 10.1056/NEJM199411243312102; LEVINSON B, 1990, AM J HUM GENET, V46, P53; LOBACCARO JM, 1994, CLIN ENDOCRINOL, V40, P297; LOBACCARO JM, 1993, J STEROID BIOCHEM, V44, P211, DOI 10.1016/0960-0760(93)90081-7; LOBACCARO JM, 1992, J STEROID BIOCHEM, V43, P659, DOI 10.1016/0960-0760(92)90291-P; LUMBROSO S, 1994, EUR J ENDOCRINOL, V130, P327, DOI 10.1530/eje.0.1300327; MOREL Y, 1994, EUR J ENDOCRINOL, V130, P325, DOI 10.1530/eje.0.1300352; PRIOR L, 1992, AM J HUM GENET, V51, P143; RISSTALPERS C, 1994, PEDIATR RES, V36, P227, DOI 10.1203/00006450-199408000-00015; SLEDDENS HFBM, 1993, HUM MOL GENET, V2, P493, DOI 10.1093/hmg/2.4.493; SLEDDENS HFBM, 1992, NUCLEIC ACIDS RES, V20, P1427; VERHOEF S, 1995, LANCET, V345, P202, DOI 10.1016/S0140-6736(95)90213-9	24	35	38	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1997	60	4					1003	1006						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WT614	9106550				2022-12-18	WOS:A1997WT61400034
J	Bryndorf, T; Christensen, B; Vad, M; Parner, J; Carelli, MP; Ward, BE; Klinger, KW; Bang, J; Philip, J				Bryndorf, T; Christensen, B; Vad, M; Parner, J; Carelli, MP; Ward, BE; Klinger, KW; Bang, J; Philip, J			Prenatal detection of chromosome aneuploidies in uncultured chorionic villus samples by FISH	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FLUORESCENCE INSITU HYBRIDIZATION; RAPID DETECTION; DNA PROBES; DIAGNOSIS; INTERPHASE; CELLS; ABERRATIONS; CULTURE	We developed a 1-d FISH assay for detection of numerical chromosome abnormalities in uncultured chorionic villus samples (CVS). Probes specific for chromosomes 13, 18, 21, X, and Y were used to determine ploidy by analysis of signal number in hybridized nuclei. Aneuploidy detection using this assay was directly compared with the results obtained by conventional cytogenetic analysis in a consecutive, clinical study of 2,709 CVS and placental samples. The FISH assay yielded discrete differences in the signal profiles between cytogenetically normal and abnormal samples. On the basis of these results, we generated FISH-assay cutoff values that discriminated between karyotypically normal and aneuploid samples. Samples with mosaicism and a single sample with possible heritable small chromosome X probe target were exceptions and showed poor agreement between FISH results and conventional cytogenetics. We conclude that the FISH assay may act as a more accurate and less labor-demanding alternative to ''direct'' CVS analysis.	RIGSHOSP,JULIANE MARIE CTR,ULTRASOUND LAB,DK-2100 COPENHAGEN O,DENMARK; INTEGRATED GENET INC,FRAMINGHAM,MA 01701; UNIV COPENHAGEN,FAC MED,DEPT BIOSTAT,COPENHAGEN,DENMARK	Rigshospitalet; University of Copenhagen	Bryndorf, T (corresponding author), RIGSHOSP,CHROMOSOME LAB,SECT 4051,JULIANE MARIE CTR,SECT CLIN GENET,DK-2100 COPENHAGEN O,DENMARK.							BARTSCH O, 1991, CLIN GENET, V40, P47; BRYNDORF T, 1994, PRENATAL DIAG, V14, P87, DOI 10.1002/pd.1970140203; BRYNDORF T, 1993, PRENATAL DIAG, V13, P815, DOI 10.1002/pd.1970130905; EVANS MI, 1992, AM J OBSTET GYNECOL, V167, P1522, DOI 10.1016/0002-9378(92)91731-O; KLINGER K, 1992, AM J HUM GENET, V51, P55; LEBO RV, 1992, AM J MED GENET, V43, P848, DOI 10.1002/ajmg.1320430519; LICHTER P, 1988, P NATL ACAD SCI USA, V85, P9664, DOI 10.1073/pnas.85.24.9664; MIZUNOE T, 1992, PRENATAL DIAG, V12, P549, DOI 10.1002/pd.1970120615; PELLESTOR F, 1994, HUM GENET, V94, P346; RAO PN, 1993, PRENATAL DIAG, V13, P233, DOI 10.1002/pd.1970130402; SANTAMARIA AS, 1993, LANCET, V341, P1544; SCHWARTZ S, 1993, AM J HUM GENET, V52, P851; SIMONI G, 1983, HUM GENET, V63, P349, DOI 10.1007/BF00274761; SIMONI G, 1994, PRENATAL DIAG, V14, P1185, DOI 10.1002/pd.1970141304; SMIDTJENSEN S, 1989, PRENATAL DIAG, V9, P309, DOI 10.1002/pd.1970090503; Strovel J. W., 1992, American Journal of Human Genetics, V51, pA12; VERLINSKY Y, 1995, PRENATAL DIAG, V15, P831, DOI 10.1002/pd.1970150907; VERMA RS, 1992, GENOMICS, V14, P113, DOI 10.1016/S0888-7543(05)80291-5; Wald NJ, 1995, PRENATAL DIAG, V15, P1227, DOI 10.1002/pd.1970151305; WARD BE, 1993, AM J HUM GENET, V52, P854; WEIER HUG, 1992, ANAL CELL PATHOL, V4, P81; WOLFE J, 1985, J MOL BIOL, V182, P477, DOI 10.1016/0022-2836(85)90234-7; 1993, AM J HUM GENET, V53, P526	23	35	37	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1996	59	4					918	926						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL283	8808609				2022-12-18	WOS:A1996VL28300023
J	Vieland, VJ; Hodge, SE				Vieland, VJ; Hodge, SE			The problem of ascertainment for linkage analysis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SAMPLING PROBLEM; PEDIGREE DATA; X-LINKAGE; PARAMETERS; RESOLUTION; MODELS	It is generally believed that ascertainment corrections are unnecessary in linkage analysis, provided individuals are selected for study solely on the basis of trait phenotype and not on the basis of marker genotype. The theoretical rationale for this is that standard linkage analytic methods involve conditioning likelihoods on all the trait data, which may be viewed as an application of the ascertainment assumption-free (AAF) method of Ewens and Shute. In this paper, we show that when the observed pedigree structure depends on which relatives within a pedigree happen to have been the probands (proband-dependent, or PD, sampling) conditioning on all the trait data is not a valid application of the AAF method and will result in asymptotically biased estimates of genetic parameters (except under single ascertainment). Furthermore, this result holds even if the recombination fraction R is the only parameter of interest. Since the fod score is proportional to the likelihood of the marker data conditional. on all the trait data, this means that when data are obtained under PD sampling the fod score will yield asymptotically biased estimates of R, and that so-called mod scores (i.e., lod scores maximized over both R and parameters theta of the trait distribution) will yield asymptotically biased estimates of R and theta. Furthermore, the problem appears to be intractable, in the sense that it is not possible to formulate the correct likelihood conditional on observed pedigree structure. In this paper we do not investigate the numerical magnitude of the bias, which may be small in many situations. On the other hand, virtually all linkage data sets are collected under PD sampling. Thus, the existence of this bias will be the rule rather than the exception in the usual applications.	UNIV IOWA,COLL MED,DEPT PSYCHIAT,IOWA CITY,IA 52242; COLUMBIA UNIV COLL PHYS & SURG,NEW YORK STATE PSYCHIAT INST,DEPT PSYCHIAT,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,NEW YORK STATE PSYCHIAT INST,DIV BIOSTAT,NEW YORK,NY 10032	University of Iowa; Columbia University; New York State Psychiatry Institute; Columbia University; New York State Psychiatry Institute	Vieland, VJ (corresponding author), UNIV IOWA,COLL MED,DEPT PREVENT MED & ENVIRONM HLTH,2800 STEINDLER BLDG,IOWA CITY,IA 52242, USA.				NIDDK NIH HHS [DK-31813] Funding Source: Medline; NIMH NIH HHS [MH-52841, MH-48858] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R55DK031813, R01DK031813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052841, R55MH052841, R01MH048858] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		CANNINGS C, 1977, CLIN GENET, V12, P208; *CAS W RES U DEP E, 1992, SAGE STAT AN GEN EP; CLERGETDARPOUX F, 1992, ANN HUM GENET, V56, P145, DOI 10.1111/j.1469-1809.1992.tb01140.x; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; CURTIS D, 1995, AM J HUM GENET, V57, P703; EDWARDS JH, 1971, ANN HUM GENET, V34, P229, DOI 10.1111/j.1469-1809.1971.tb00237.x; ELSTON RC, 1995, AM J HUM GENET, V56, P15; ELSTON RC, 1989, AM J MED GENET, V34, P487, DOI 10.1002/ajmg.1320340407; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; ELSTON RC, 1979, AM J HUM GENET, V31, P62; EWENS WJ, 1986, THEOR POPUL BIOL, V30, P388, DOI 10.1016/0040-5809(86)90042-0; Fisher R. A., 1935, ANN EUGEN, V6, P187; Fisher RA, 1935, ANN EUGENIC, V6, P339, DOI 10.1111/j.1469-1809.1935.tb02116.x; GERSHON ES, 1977, J PSYCHIAT RES, V13, P161, DOI 10.1016/0022-3956(77)90005-X; GREENBERG DA, 1989, AM J MED GENET, V34, P480, DOI 10.1002/ajmg.1320340406; HODGE SE, 1994, GENET EPIDEMIOL, V11, P329, DOI 10.1002/gepi.1370110403; HODGE SE, 1988, AM J HUM GENET, V43, P364; HODGE SE, 1995, AM J HUM GENET, V57, P937; KALBFLEI.JD, 1970, J ROY STAT SOC B, V32, P175; MORTON NE, 1959, AM J HUM GENET, V11, P1; MORTON NE, 1955, AM J HUM GENET, V7, P277; Ott J., 1991, ANAL HUMAN GENETIC L; RISCH N, 1984, AM J HUM GENET, V36, P363; SHUTE NCE, 1988, AM J HUM GENET, V43, P387; VIELAND VJ, 1995, AM J HUM GENET, V56, P33	25	35	35	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1996	58	5					1072	1084						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UH192	8651268				2022-12-18	WOS:A1996UH19200020
J	GILBERTDUSSARDIER, B; BONNEAU, D; GIGAREL, N; LEMERRER, M; BONNET, D; PHILIP, N; SERVILLE, F; VERLOES, A; ROSSI, A; AYME, S; WEISSENBACH, J; MATTEI, MG; LYONNET, S; MUNNICH, A				GILBERTDUSSARDIER, B; BONNEAU, D; GIGAREL, N; LEMERRER, M; BONNET, D; PHILIP, N; SERVILLE, F; VERLOES, A; ROSSI, A; AYME, S; WEISSENBACH, J; MATTEI, MG; LYONNET, S; MUNNICH, A			A NOVEL MICROSATELLITE DNA MARKER AT LOCUS D7S1870 DETECTS HEMIZYGOSITY IN 75-PERCENT OF PATIENTS WITH WILLIAMS-SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									HOP NECKER ENFANTS MALAD,INSERM,U393,UNITE RECH HANDICAPS GENET ENFANT,F-75743 PARIS,FRANCE; HOP DUPUYTREN,SERV PEDIAT 1,LIMOGES,FRANCE; HOP JEAN BERNARD,UNITE GENET MED,POITIERS,FRANCE; HOP ENFANTS LA TIMONE,CTR GENET MED,F-13385 MARSEILLE,FRANCE; HOP PELLEGRIN ENFANTS,SERV GENET,BORDEAUX,FRANCE; UNIV LIEGE,CTR GENET HUMAINE,LIEGE,BELGIUM; CTR TRANSFUS SANGUINE & GENET HUMAINE,BOIS GUILLAUME,FRANCE; HOP PAUL BROUSSE,INSERM,SC11,VILLEJUIF,FRANCE; GENETHON,EVRY,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Limoges; CHU Poitiers; Universite de Poitiers; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Bordeaux; University of Liege; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	GILBERTDUSSARDIER, B (corresponding author), HOP NECKER ENFANTS MALAD,INSERM,U393,SERV GENET,149 RUE SEVRES,F-75743 PARIS,FRANCE.		Philip, Nicole/I-2881-2016; Bonneau, Dominique/K-6110-2015; Ayme, Segolene/ABE-2545-2020; VERLOES, Alain/E-7287-2014	VERLOES, Alain/0000-0003-4819-0264; GILBERT-DUSSARDIER, Brigitte/0000-0001-7182-9914				BEUREN AJ, 1962, CIRCULATION, V26, P1235, DOI 10.1161/01.CIR.26.6.1235; BUETOW KH, 1994, NAT GENET, V6, P391, DOI 10.1038/ng0494-391; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; FAZIO MJ, 1991, AM J HUM GENET, V48, P696; GREEN JE, 1990, AIDS RES HUM RETROV, V6, P85; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; JONES KL, 1975, J PEDIATR-US, V86, P718, DOI 10.1016/S0022-3476(75)80356-8; MORRIS CA, 1993, AM J MED GENET, V47, P478, DOI 10.1002/ajmg.1320470409; MORRIS CA, 1988, J PEDIATR-US, V113, P318, DOI 10.1016/S0022-3476(88)80272-5; WILLIAMS JC, 1961, CIRCULATION, V24, P1311, DOI 10.1161/01.CIR.24.6.1311	10	35	36	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1995	56	2					542	544						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QF423	7847392				2022-12-18	WOS:A1995QF42300025
J	HELLER, DA; PEDERSEN, NL; DEFAIRE, U; MCCLEARN, GE				HELLER, DA; PEDERSEN, NL; DEFAIRE, U; MCCLEARN, GE			GENETIC AND ENVIRONMENTAL CORRELATIONS AMONG SERUM-LIPIDS AND APOLIPOPROTEINS IN ELDERLY TWINS REARED TOGETHER AND APART	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CORONARY HEART-DISEASE; CARDIOVASCULAR-DISEASE; PLASMA-LIPIDS; CHOLESTEROL; RISK; LIPOPROTEINS; FAMILY; AGE	Genetic and environmental correlations among five serum-lipid measures were examined in the Swedish Adoption/Twin Study of Aging. The sample included 302 twin pairs; 146 of these twin pairs were separated at an early age and were reared apart, The lipid measures examined include total cholesterol, HDL-cholesterol, triglycerides, and apolipoproteins A-I and B. Genetic and environmental correlations were evaluated for two different age groups, formed by dividing the sample at the median. The younger group included individuals 41.8-65.4 years of age at the midpoint of testing, although only 24 individuals were <50 years of age. The older group included all those >65.4 years of age, up to age 87 years of age. Substantial genetic correlations were found within each age group, although there is no evidence for a single genetic factor common to al five lipids. The comparison of twins reared together with twins reared apart allowed estimation of the effects of shared rearing environment; however, shared rearing environment only appears to be a significant mediator of the phenotypic correlation between apolipoprotein B and cholesterol in the older group. Examination of the genetic and environmental covariances suggests that the relative contributions of genetic factors are lower in the older group. Nonshared environmental factors are relatively more important mediators of phenotypic correlations among the serum lipids in individuals >65.4 years of age than they are for the younger group, Sex differences in the mediation of these serum lipids were not as clear.	PENN STATE UNIV,COLL HLTH & HUMAN DEV,PROGRAM BEHAV HLTH,UNIVERSITY PK,PA 16802; KAROLINSKA INST,INST ENVIRONM MED,DEPT EPIDEMIOL,S-10401 STOCKHOLM,SWEDEN; KAROLINSKA HOSP,DEPT MED,DIV CARDIOVASC MED,S-10401 STOCKHOLM,SWEDEN	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	HELLER, DA (corresponding author), PENN STATE UNIV,COLL HLTH & HUMAN DEV,CTR DEV & HLTH GENET,AMY GARDNER HOUSE,UNIVERSITY PK,PA 16802, USA.				NIA NIH HHS [AG 04563] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG004563] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BERG K, 1989, CLIN GENET, V36, P299; BIERMAN EL, 1985, HDB BIOL AGING, P721; BOEHNKE M, 1986, AM J MED GENET, V23, P775, DOI 10.1002/ajmg.1320230306; CAREY G, 1988, BEHAV GENET, V18, P329, DOI 10.1007/BF01260933; CASTELLI WP, 1989, AM J CARDIOL, V63, pH12; CEDERLOF R, 1978, TWIN RES C, P189; COLLETTO GMDD, 1981, HUM HERED, V31, P232, DOI 10.1159/000153214; CONNOR SL, 1982, CIRCULATION, V65, P1290, DOI 10.1161/01.CIR.65.7.1290; Edwards A.L., 1976, INTRO LINEAR REGRESS; Falconer D. S., 1981, INTRO QUANTITATIVE G; FEINLEIB M, 1977, AM J EPIDEMIOL, V106, P284, DOI 10.1093/oxfordjournals.aje.a112464; HELLER DA, 1993, NEW ENGL J MED, V328, P1150, DOI 10.1056/NEJM199304223281603; HOPKINS PN, 1989, ANNU REV NUTR, V9, P303; Joreskog K. G., 1989, LISREL 7 GUIDE PROGR; KANNEL WB, 1978, B NEW YORK ACAD MED, V54, P573; KREISBERG RA, 1987, AM J MED, V82, P54, DOI 10.1016/0002-9343(87)90272-5; MCGUE M, 1983, GENET RES, V42, P117, DOI 10.1017/S0016672300021595; Neale M.C.C.L., 2013, METHODOLOGY GENETIC, V67, DOI DOI 10.1007/978-94-015-8018-2; NEALE MC, 1989, BEHAV GENET, V19, P63, DOI 10.1007/BF01065884; NESTEL PJ, 1981, LIPOPROTEINS ATHEROS, P3; NIKKILA EA, 1978, METABOLISM, V27, P1661, DOI 10.1016/0026-0495(78)90288-3; PEDERSEN NL, 1984, ACTA GENET MED GEMEL, V33, P243, DOI 10.1017/S0001566000007285; PEDERSEN NL, 1991, ACTA GENET MED GEMEL, V40, P7, DOI 10.1017/S0001566000006681; RAO DC, 1983, AM J PHYS ANTHROPOL, V62, P33, DOI 10.1002/ajpa.1330620107; RIFAI N, 1988, ANN CLIN LAB SCI, V18, P429; SING CF, 1989, INT J EPIDEMIOL, V18, pS183; STAMLER J, 1973, MED CLIN N AM, V57, P5, DOI 10.1016/S0025-7125(16)32300-8; VOGLER GP, 1987, AM J EPIDEMIOL, V125, P706, DOI 10.1093/oxfordjournals.aje.a114583; WHITFIELD JB, 1983, ATHEROSCLEROSIS, V48, P265, DOI 10.1016/0021-9150(83)90044-8	29	35	35	1	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1994	55	6					1255	1267						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB684	7977387				2022-12-18	WOS:A1994QB68400024
J	RAO, VS; VANDUIJN, CM; CONNORLACKE, L; CUPPLES, LA; GROWDON, JH; FARRER, LA				RAO, VS; VANDUIJN, CM; CONNORLACKE, L; CUPPLES, LA; GROWDON, JH; FARRER, LA			MULTIPLE ETIOLOGIES FOR ALZHEIMER-DISEASE ARE REVEALED BY SEGREGATION ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							APOLIPOPROTEIN-E TYPE-4; GENETIC-LINKAGE; EARLY-ONSET; 1ST-DEGREE RELATIVES; REGRESSIVE MODELS; MAJOR GENE; TRAITS; RISK; POPULATION; FAMILIES	We have evaluated several transmission models for Alzheimer disease (AD), using the logistic regressive approach in 401 nuclear families of consecutively ascertained and rigorously diagnosed probands. Models postulating no major gene effect, random environmental transmission, recessive inheritance, and sporadic occurrence were rejected under varied assumptions regarding the associations among sex, age, and major gene susceptibility. Transmission of the disorder was not fully explained by a single Mendelian model for all families. Stratification of families as early- and late-onset by using the median of family mean onset ages showed that, regardless of the model studied, two groups of families fit better than a single group. AD in early-onset families is transmitted as an autosomal dominant trait with full penetrance in both sexes and has a gene frequency of 1.5%. Dominant inheritance also gave the best fit of the data in late-onset families, but this hypothesis was rejected, suggesting the presence of heterogeneity within this subset. Our study also revealed that genetically nonsusceptible males and females develop AD, indicating the presence of phenocopies within early-onset and late-onset groups. Moreover, our results suggest that the higher risk to females is not solely due to their increased longevity.	BOSTON UNIV,SCH MED,DEPT NEUROL,NEUROGENET LAB,BOSTON,MA 02118; BOSTON UNIV,SCH PUBL HLTH,DEPT BIOSTAT & EPIDEMIOL,BOSTON,MA; HARVARD UNIV,SCH MED,DEPT NEUROL,BOSTON,MA 02115; ERASMUS UNIV ROTTERDAM,DEPT EPIDEMIOL & BIOSTAT,3000 DR ROTTERDAM,NETHERLANDS	Boston University; Boston University; Harvard University; Harvard Medical School; Erasmus University Rotterdam			Farrer, Lindsay/AAS-1035-2020	Cupples, L. Adrienne/0000-0003-0273-7965; Farrer, Lindsay/0000-0001-5533-4225	NCRR NIH HHS [RR03655] Funding Source: Medline; NIA NIH HHS [P50-AG05134, R01-AG09029] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005134, R01AG009029] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ATWOOD LD, 1992, COMMUN STAT SIMULAT, V21, P769, DOI 10.1080/03610919208813049; BAILEYWILSON JE, 1987, STATISTICAL ANAL GEN; BONNEY GE, 1986, BIOMETRICS, V42, P611, DOI 10.2307/2531211; BONNEY GE, 1984, AM J MED GENET, V18, P731, DOI 10.1002/ajmg.1320180420; BORGAONKAR DS, 1993, LANCET, V342, P625, DOI 10.1016/0140-6736(93)91458-X; BREITNER JCS, 1988, NEUROLOGY, V38, P207; BRETELER MMB, 1992, EPIDEMIOL REV, V14, P59, DOI 10.1093/oxfordjournals.epirev.a036092; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DEMENAIS FM, 1992, GENET EPIDEMIOL, V9, P419, DOI 10.1002/gepi.1370090605; ELANDTJOHNSON RC, 1970, AM J HUM GENET, V22, P129; ELSTON RC, 1979, AM J HUM GENET, V31, P62; EVANS DA, 1989, JAMA-J AM MED ASSOC, V262, P2551, DOI 10.1001/jama.262.18.2551; FARRER LA, 1994, AM J HUM GENET, V54, P374; FARRER LA, 1994, NEUROLOGY, V44, P652, DOI 10.1212/WNL.44.4.652; FARRER LA, 1991, ARCH NEUROL-CHICAGO, V48, P599, DOI 10.1001/archneur.1991.00530180051017; FARRER LA, 1991, AM J HUM GENET, V48, P1026; FARRER LA, 1990, NEUROLOGY, V40, P395, DOI 10.1212/WNL.40.3_Part_1.395; FARRER LA, 1989, ANN NEUROL, V25, P485, DOI 10.1002/ana.410250511; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; HESTON LL, 1981, ARCH GEN PSYCHIAT, V31, P1085; JOACHIM CL, 1988, ANN NEUROL, V24, P50, DOI 10.1002/ana.410240110; KAY DWK, 1964, BRIT J PSYCHIAT, V110, P146, DOI 10.1192/bjp.110.465.146; KHACHATURIAN ZS, 1985, ARCH NEUROL-CHICAGO, V22, P1097; KOKMEN E, 1988, NEUROLOGY, V38, P975, DOI 10.1212/WNL.38.6.975; MAYEUX R, 1993, ANN NEUROL, V33, P494, DOI 10.1002/ana.410330513; MCGUFFIN P, 1991, ETHICAL ISSUES MOL G, P42; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MORTON NE, 1974, AM J HUM GENET, V26, P489; MULLAN M, 1992, NAT GENET, V2, P340, DOI 10.1038/ng1292-340; NEE LE, 1987, NEUROLOGY, V37, P359, DOI 10.1212/WNL.37.3.359; NOGUCHI S, 1993, LANCET, V342, P737, DOI 10.1016/0140-6736(93)91728-5; PAYAMI H, 1993, LANCET, V342, P738; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; PERICAKVANCE MA, 1988, EXP NEUROL, V102, P271, DOI 10.1016/0014-4886(88)90220-8; POIRIER J, 1993, LANCET, V342, P697, DOI 10.1016/0140-6736(93)91705-Q; ROCCA WA, 1991, ANN NEUROL, V30, P381, DOI 10.1002/ana.410300310; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; SCHOENBERG BS, 1987, ANN NEUROL, V22, P724, DOI 10.1002/ana.410220608; STGEORGEHYSLOP P, 1992, NAT GENET, V2, P330, DOI 10.1038/ng1292-330; STGEORGEHYSLOP PH, 1989, NEUROBIOL AGING, V10, P417, DOI 10.1016/0197-4580(89)90082-1; STGEORGEHYSLOP PH, 1990, NATURE, V347, P194, DOI 10.1038/347194a0; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; TANZI RE, 1992, AM J HUM GENET, V51, P273; TREVES T, 1986, ARCH NEUROL-CHICAGO, V43, P26, DOI 10.1001/archneur.1986.00520010022014; VAN BROECKHOVEN C, 1992, NAT GENET, V2, P335, DOI 10.1038/ng1292-335; VANDUIJN CM, 1991, BRIT MED J, V302, P1491, DOI 10.1136/bmj.302.6791.1491; VANDUIJN CM, 1993, J MED GENET, V30, P640, DOI 10.1136/jmg.30.8.640; VANDUIJN CM, 1994, NAT GENET, V7, P74, DOI 10.1038/ng0594-74	50	35	35	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1994	55	5					991	1000						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB682	7977363				2022-12-18	WOS:A1994QB68200020
J	DIANZANI, I; GIANNATTASIO, S; DESANCTIS, L; MARRA, E; PONZONE, A; CAMASCHELLA, C; PIAZZA, A				DIANZANI, I; GIANNATTASIO, S; DESANCTIS, L; MARRA, E; PONZONE, A; CAMASCHELLA, C; PIAZZA, A			GENETIC HISTORY OF PHENYLKETONURIA MUTATIONS IN ITALY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							PHENYLALANINE-HYDROXYLASE GENE; POPULATIONS; DIAGNOSIS; SPECTRUM; ALLELES; EUROPE; LOCUS		UNIV TURIN,DIPARTIMENTO SCI BIOMED & ONCOL UMANA,TURIN,ITALY; UNIV TURIN,DIPARTIMENTO GENET BIOL & CHIM MED,TURIN,ITALY; CNR,CII,CIOS,TURIN,ITALY; CNR,CTR STUDIO MITOCONDRI & METAB ENERGET,I-70126 BARI,ITALY	University of Turin; University of Turin; Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR)	DIANZANI, I (corresponding author), UNIV TURIN,IST CLIN PEDIAT,TURIN,ITALY.		Camaschella, Clara/A-3289-2015	Giannattasio, Sergio/0000-0001-5559-5556; Piazza, Alberto/0000-0002-2355-4183				CAVALLISFORZA LL, 1993, SCIENCE, V259, P639, DOI 10.1126/science.8430313; DIANZANI I, 1991, AM J HUM GENET, V48, P631; Dianzani I., 1992, American Journal of Human Genetics, V51, pA349; EIKEN HG, 1991, NUCLEIC ACIDS RES, V19, P1427, DOI 10.1093/nar/19.7.1427; EISENSMITH RC, 1992, AM J HUM GENET, V51, P1355; GULDBERG P, 1993, HUM MOL GENET, V2, P1703, DOI 10.1093/hmg/2.10.1703; KONECKI DS, 1991, HUM GENET, V87, P377; OZGUC M, 1993, 2ND INT WORKSH PHEN; PIAZZA A, 1988, ANN HUM GENET, V52, P203, DOI 10.1111/j.1469-1809.1988.tb01098.x; PIAZZA A, 1993, SCIENCE, V260, P1767, DOI 10.1126/science.8511584; Romano Valentino, 1993, Developmental Brain Dysfunction, V6, P83; Scriver Charles R., 1993, Developmental Brain Dysfunction, V6, P11; TSUI LC, 1992, TRENDS GENET, V8, P392, DOI 10.1016/0168-9525(92)90301-J	13	35	35	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1994	55	4					851	853						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PJ027	7942862				2022-12-18	WOS:A1994PJ02700028
J	KHOURY, MJ				KHOURY, MJ			CASE-PARENTAL CONTROL METHOD IN THE SEARCH FOR DISEASE-SUSCEPTIBILITY GENES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							FACTOR-ALPHA-GENE; CLEFT-LIP; CIGARETTE-SMOKING; ASSOCIATION; PALATE				KHOURY, MJ (corresponding author), CTR DIS CONTROL & PREVENT,NATL CTR ENVIRONM HLTH,DIV BIRTH DEFECTS & DEV DISABIL,ATLANTA,GA 30341, USA.							ARDINGER HH, 1989, AM J HUM GENET, V45, P348; ERICSON A, 1979, AM J OBSTET GYNECOL, V135, P348, DOI 10.1016/0002-9378(79)90703-8; KAHN HA, 1989, STATISTICAL METHODS; KHOURY MJ, 1989, AM J DIS CHILD, V143, P333, DOI 10.1001/archpedi.1989.02150150091023; KNAPP M, 1993, AM J HUM GENET, V52, P1085; MORTON NE, 1984, GENETIC EPIDEMIOLOGY, P245; Rothman K, 1986, MODERN EPIDEMIOLOGY; SCHAID DJ, 1993, AM J HUM GENET, V53, P1114; SHIANG R, 1993, AM J HUM GENET, V53, P836; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1029, DOI 10.1093/oxfordjournals.aje.a116397	10	35	41	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1994	55	2					414	415						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NZ336	8080552				2022-12-18	WOS:A1994NZ33600029
J	GRAVEL, RA; AKERMAN, BR; LAMHONWAH, AM; LOYER, M; LEONDELRIO, A; ITALIANO, I				GRAVEL, RA; AKERMAN, BR; LAMHONWAH, AM; LOYER, M; LEONDELRIO, A; ITALIANO, I			MUTATIONS PARTICIPATING IN INTERALLELIC COMPLEMENTATION IN PROPIONIC ACIDEMIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MUT METHYLMALONIC ACIDURIA; COA CARBOXYLASE DEFICIENCY; DEFECTIVE PROTON-ATPASE; BETA-SUBUNIT; ASPARTATE TRANSCARBAMOYLASE; GENETIC-CHARACTERIZATION; HUMAN-FIBROBLASTS; ESCHERICHIA-COLI; ALPHA-CHAIN; PCCB GENE	Deficiency of propionyl-CoA carboxylase (PCC; alpha(4) beta(4)) results in the rare, autosomal recessive disease propionic acidemia. Cell fusion experiments have revealed two complementation groups, pccA and pccB, corresponding to defects of the PCCA (alpha-subunit) and PCCB (beta-subunit) genes, respectively. The pccBCC group includes subgroups, pccB and pccC, which are thought to reflect interallelic complementation between certain mutations of the PCCB gene. In this study, we have identified the mutations in two pccB, one pccC, and two pccBC eel: lines and have deduced those alleles participating in interallelic complementation. One pccB line was a compound heterozygote of Pro228Leu and Asn536Asp. The latter mutation was also detected in a noncomplementing pccBC line. This leaves Pro228Leu responsible for complementation in the pccB cells. The second pccB line contained an insertional duplication, dupKICK140-143, and a splice mutation IVS +1 G-->T, located after Lys466. We suggest that the dupKICK mutation is the complementing allele, since the second allele is incompatible with normal splicing. The pccC line studied was homozygous for Arg410Trp, which is necessarily the complementing allele in that line. For a second pccC line, we previously had proposed that Delta Ile408 was the complementing allele. We now show that its second allele, ''Ins.Del,'' a 14-bp deletion replaced by a 12-bp insertion beginning at codon 407, fails to complement in homozygous form. We conclude that the interallelic complementation results from mutations in domains that can interact between beta-subunits in the PCC heteromer to restore enzymatic function. On the basis of sequence homology with the Propionibacterium shermanii transcarboxylase 12S subunit, we suggest that the pccC domain, defined by Ile408 and Arg410, may involve the propionyl-CoA binding site.	MCGILL UNIV, DEPT BIOL, MONTREAL, PQ, CANADA	McGill University	GRAVEL, RA (corresponding author), MCGILL UNIV, MONTREAL CHILDRENS HOSP, RES INST, 2300 TUPPER ST, MONTREAL H3H 1P3, PQ, CANADA.		Leon-Del-Rio, Alfonso/L-5932-2019					CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CRANE AM, 1992, J CLIN INVEST, V89, P385, DOI 10.1172/JCI115597; GRAVEL RA, 1977, AM J HUM GENET, V29, P378; GRAVEL RA, 1980, ARCH BIOCHEM BIOPHYS, V201, P669, DOI 10.1016/0003-9861(80)90557-3; JENNESS DD, 1983, J BIOL CHEM, V258, P3266; KALOUSEK F, 1980, J BIOL CHEM, V255, P60; KENNERKNECHT I, 1990, HUM GENET, V86, P238; KRANTZ LJR, 1990, GENOMICS, V124, P213; KRAUS JP, 1986, P NATL ACAD SCI USA, V83, P2047, DOI 10.1073/pnas.83.7.2047; LAMHONWAH AM, 1994, GENOMICS, V19, P500, DOI 10.1006/geno.1994.1099; LAMHONWAH AM, 1990, GENOMICS, V8, P249, DOI 10.1016/0888-7543(90)90279-4; LAMHONWAH AM, 1989, NUCLEIC ACIDS RES, V17, P4396, DOI 10.1093/nar/17.11.4396; LAMHONWAH AM, 1987, AM J HUM GENET, V41, P1124; LEE SY, 1987, J BACTERIOL, V169, P3938, DOI 10.1128/jb.169.9.3938-3944.1987; MAGGIO MB, 1987, J BIOL CHEM, V262, P8981; MCINNES RR, 1984, P NATL ACAD SCI-BIOL, V81, P4480, DOI 10.1073/pnas.81.14.4480; OHURA T, 1989, AM J HUM GENET, V45, P33; OHURA T, 1993, HUM GENET, V92, P397, DOI 10.1007/BF01247343; OHUTA T, 1993, J INHERIT METAB DIS, V16, P863; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PARSONAGE D, 1987, J BIOL CHEM, V262, P6301; POTO EM, 1977, J BIOL CHEM, V253, P2979; RAFF ML, 1991, J CLIN INVEST, V87, P203, DOI 10.1172/JCI114972; ROSENBERG LE, 1989, METABOLIC BASIS INHE, P821; SAUNDERS M, 1979, J CLIN INVEST, V64, P1695, DOI 10.1172/JCI109632; SCHACHMAN HK, 1984, P NATL ACAD SCI-BIOL, V81, P115, DOI 10.1073/pnas.81.1.115; SENAPATHY P, 1990, METHOD ENZYMOL, V183, P252; SHAPIRO NI, 1985, SOMAT CELL MOLEC GEN, V11, P135, DOI 10.1007/BF01534702; STANKOVICS J, 1993, AM J HUM GENET, V52, P144; TAHARA T, 1993, J INHERIT METAB DIS, V16, P353, DOI 10.1007/BF00710282; TAHARA T, 1990, P NATL ACAD SCI USA, V87, P1372, DOI 10.1073/pnas.87.4.1372; TRIGGSRAINE BL, 1991, AM J HUM GENET, V49, P1041; WAH AML, 1983, AM J HUM GENET, V35, P389; WINSHIP PR, 1989, NUCLEIC ACIDS RES, V17, P1266, DOI 10.1093/nar/17.3.1266; WOLF B, 1980, AM J HUM GENET, V32, P16; WOLF B, 1979, J PEDIATR-US, V95, P563, DOI 10.1016/S0022-3476(79)80768-4; ZABIN I, 1975, ANNU REV BIOCHEM, V44, P295, DOI 10.1146/annurev.bi.44.070175.001455	37	35	35	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1994	55	1					51	58						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NW461	8023851				2022-12-18	WOS:A1994NW46100008
J	SUAREZ, BK; HAMPE, CL				SUAREZ, BK; HAMPE, CL			LINKAGE AND ASSOCIATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									WASHINGTON UNIV, SCH MED, DEPT GENET, ST LOUIS, MO 63110 USA	Washington University (WUSTL)	SUAREZ, BK (corresponding author), WASHINGTON UNIV, SCH MED, DEPT PSYCHIAT, ST LOUIS, MO 63110 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL041035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH031302, P50MH031302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA008028] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL41035] Funding Source: Medline; NIAAA NIH HHS [AA08028] Funding Source: Medline; NIMH NIH HHS [MH31302] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AIRD I, 1954, BRIT MED J, V1, P153, DOI 10.1136/bmj.1.4854.153; AIRD I, 1953, BRIT MED J, V1, P799, DOI 10.1136/bmj.1.4814.799; Buchanan JA, 1921, BRIT J EXP PATHOL, V2, P247; CLARKE C. A., 1961, PROGR MED GENET, V1, P81; DODGSON CL, 1946, ALICE IN WONDERLAND; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; HALDANE JBS, 1964, PERSPECT BIOL MED, V7, P343; HODGE SE, 1993, AM J HUM GENET, V53, P367; LI CC, 1961, HUMAN GENETICS; PARSIAN A, 1991, ARCH GEN PSYCHIAT, V48, P655; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506	12	35	36	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1994	54	3					554	559						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ158	8116626				2022-12-18	WOS:A1994MZ15800021
J	KWIATKOWSKI, TJ; ORR, HT; BANFI, S; MCCALL, AE; JODICE, C; PERSICHETTI, F; NOVELLETTO, A; LEBORGNEDEMARQUOY, F; DUVICK, LA; FRONTALI, M; SUBRAMONY, SH; BEAUDET, AL; TERRENATO, L; ZOGHBI, HY; RANUM, LPW				KWIATKOWSKI, TJ; ORR, HT; BANFI, S; MCCALL, AE; JODICE, C; PERSICHETTI, F; NOVELLETTO, A; LEBORGNEDEMARQUOY, F; DUVICK, LA; FRONTALI, M; SUBRAMONY, SH; BEAUDET, AL; TERRENATO, L; ZOGHBI, HY; RANUM, LPW			THE GENE FOR AUTOSOMAL-DOMINANT SPINOCEREBELLAR ATAXIA (SCA1) MAPS CENTROMERIC TO D6S89 AND SHOWS NO RECOMBINATION, IN 9 LARGE KINDREDS, WITH A DINUCLEOTIDE REPEAT AT THE AM10 LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS LINKAGE ANALYSIS; HEREDITARY ATAXIA; SHORT ARM; HLA; POLYMORPHISMS; CHROMOSOME-6; REGION; ONSET; DNA; AGE	Spinocerebellar ataxia type 1 (SCA1) is an autosomal dominant disorder which is genetically linked to the short arm of chromosome 6, telomeric to the human major histocompatibility complex (HLA) and very close to D6S89. Previous multipoint linkage analysis using HLA, D6S89, and SCA1 suggested that SCA1 maps centromeric to D6S89. Data from this study using nine large kindreds indicate a maximum lod score between SCA1 and D6S89 of 67.58 at a maximum recombination fraction of .004. To localize SCA1 more precisely, we identified five dinucleotide polymorphisms near D6S89. Genotypic analyses at these polymorphic loci were carried out in nine multigeneration SCA1 kindreds and in the Centre d'Etude du Polymorphisme Humain reference families. A new marker, AM10GA, demonstrates no recombination with SCA1. The maximum lod score for AM10GA linkage to SCA1 is 42.14 at a recombination fraction of 0. Linkage analysis and analysis of recombination events confirm that SCA1 maps centromeric to D6S89 and establish the following order: CEN-D6S109-AM10GA/SCA1-D6S89-LR40-D6S202-TEL.	TOR VERGATA UNIV,DIPARTIMENTO BIOL,ROME,ITALY; CNR,IST MED SPERIMENTALE,ROME,ITALY; UNIV MISSISSIPPI,MED CTR,SCH MED,DEPT NEUROL,JACKSON,MS 39216; BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030; UNIV MINNESOTA,DEPT LAB MED & PATHOL,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,DEPT HUMAN GENET,MINNEAPOLIS,MN 55455	University of Rome Tor Vergata; Consiglio Nazionale delle Ricerche (CNR); University of Mississippi; University of Mississippi Medical Center; Baylor College of Medicine; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	KWIATKOWSKI, TJ (corresponding author), BAYLOR COLL MED,INST MOLEC GENET,1 BAYLOR PLAZA,HOUSTON,TX 77030, USA.		Banfi, Sandro/K-3963-2018	Banfi, Sandro/0000-0002-6541-8833; Zoghbi, Huda/0000-0002-0700-3349; Orr, Harry/0000-0001-6118-741X; Persichetti, Francesca/0000-0002-9804-644X; iodice, carla/0000-0002-1549-5005; Novelletto, Andrea/0000-0002-1146-7680	NICHD NIH HHS [5P30HD024064] Funding Source: Medline; NINDS NIH HHS [R01 NS27699, NS22920] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022920, R37NS022920, R01NS027699] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BREUKEL C, 1990, NUCLEIC ACIDS RES, V18, P3097, DOI 10.1093/nar/18.10.3097; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; FEENER CA, 1991, AM J HUM GENET, V48, P621; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; HAINES JL, 1984, NEUROLOGY, V34, P1542, DOI 10.1212/WNL.34.12.1542; HEERY DM, 1990, TRENDS GENET, V6, P173; JACKSON JF, 1977, NEW ENGL J MED, V296, P1138, DOI 10.1056/NEJM197705192962003; KEATS BJB, 1991, AM J HUM GENET, V49, P972; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEBORGNEDEMARQUOY F, 1991, NUCLEIC ACIDS RES, V19, P6060; MARCHUK D, 1991, NUCLEIC ACIDS RES, V19, P1154, DOI 10.1093/nar/19.5.1154; NINO HE, 1980, NEUROLOGY, V30, P12, DOI 10.1212/WNL.30.1.12; RANUM LPW, 1991, NUCLEIC ACIDS RES, V19, P1171, DOI 10.1093/nar/19.5.1171-a; RANUM LPW, 1991, AM J HUM GENET, V49, P31; SPADARO M, 1992, ACTA NEUROL SCAND, V85, P257; YAKURA H, 1974, NEW ENGL J MED, V291, P154; ZOGHBI HY, 1989, AM J HUM GENET, V44, P255; ZOGHBI HY, 1988, ANN NEUROL, V23, P580, DOI 10.1002/ana.410230609; ZOGHBI HY, 1991, AM J HUM GENET, V49, P23; 1992, SCIENCE, V256, P67	20	35	36	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1993	53	2					391	400						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LN820	8101039				2022-12-18	WOS:A1993LN82000011
J	MATSUMURA, K; NONAKA, I; TOME, FMS; ARAHATA, K; COLLIN, H; LETURCQ, F; RECAN, D; KAPLAN, JC; FARDEAU, M; CAMPBELL, KP				MATSUMURA, K; NONAKA, I; TOME, FMS; ARAHATA, K; COLLIN, H; LETURCQ, F; RECAN, D; KAPLAN, JC; FARDEAU, M; CAMPBELL, KP			MILD DEFICIENCY OF DYSTROPHIN-ASSOCIATED PROTEINS IN BECKER MUSCULAR-DYSTROPHY PATIENTS HAVING IN-FRAME DELETIONS IN THE ROD DOMAIN OF DYSTROPHIN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SKELETAL-MUSCLE; GLYCOPROTEIN COMPLEX; TERMINAL DOMAIN; MOLECULAR-BASIS; DUCHENNE; MEMBRANE; BINDING; GENE; EXPRESSION; ACTIN	The dystrophin-glycoprotein complex spans the sarcolemma to provide a linkage between the subsarcolemmal cytoskeleton and the extracellular matrix in skeletal muscle. In Duchenne muscular dystrophy (DMD), the absence of dystrophin leads to a drastic reduction in all of the dystrophin-associated proteins in the sarcolemma, thus causing the disruption of the dystrophin-glycoprotein complex and the loss of the linkage to the extracellular matrix. The resulting sarcolemmal instability is presumed to render muscle fibers susceptible to necrosis. In the present study, we investigated the status of the dystrophin-associated proteins in the skeletal muscle from patients with Becker muscular dystrophy (BMD), a milder allelic form of DMD. BMD patients having in-frame deletions in the rod domain of dystrophin showed a mild to moderate reduction in all of the dystrophin-associated proteins in the sarcolemma, but this reduction was not as severe as that in DMD patients. The reduction of the immunostaining for the dystrophin-associated proteins showed a good correlation with that for dystrophin in both intensity and distribution. Our results indicate that (1) the abnormality of the sarcolemmal glycoprotein complex, which is similar to but milder than that in DMD patients, also exists in these BMD patients and (2) the rod domain of dystrophin is not crucial for the interaction with the dystrophin-associated proteins.	UNIV IOWA,COLL MED,HOWARD HUGHES MED INST,400 EMBRB,IOWA CITY,IA 52242; NATL INST NEUROSCI,TOKYO,JAPAN; INST COCHIN GENET MOLEC,INSERM,U129,PARIS,FRANCE; INSERM,U153,F-75005 PARIS,FRANCE; UNIV IOWA,COLL MED,DEPT PHYSIOL & BIOPHYS,IOWA CITY,IA 52242	Howard Hughes Medical Institute; University of Iowa; National Center for Neurology & Psychiatry - Japan; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Iowa				Campbell, Kevin/0000-0003-2066-5889				ARAHATA K, 1989, P NATL ACAD SCI USA, V86, P7154, DOI 10.1073/pnas.86.18.7154; ARAHATA K, 1991, J NEUROL SCI, V101, P148, DOI 10.1016/0022-510X(91)90039-A; ARAHATA K, 1988, NATURE, V333, P861, DOI 10.1038/333861a0; BAUMBACH LL, 1989, NEUROLOGY, V39, P465, DOI 10.1212/WNL.39.4.465; BEGGS AH, 1991, AM J HUM GENET, V49, P54; BULMAN DE, 1991, AM J HUM GENET, V48, P295; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; ENGLAND SB, 1990, NATURE, V343, P180, DOI 10.1038/343180a0; ERVASTI JM, 1991, J BIOL CHEM, V266, P9161; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; GANGOPADHYAY SB, 1992, AM J HUM GENET, V51, P562; GILLARD EF, 1989, AM J HUM GENET, V45, P507; GOSPE SM, 1989, NEUROLOGY, V39, P1277, DOI 10.1212/WNL.39.10.1277; HEMMINGS L, 1992, J CELL BIOL, V116, P1369, DOI 10.1083/jcb.116.6.1369; HOFFMAN EP, 1989, NEUROLOGY, V39, P1011, DOI 10.1212/WNL.39.8.1011; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HOFFMAN EP, 1988, NEW ENGL J MED, V318, P1363, DOI 10.1056/NEJM198805263182104; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; IKEYA K, 1992, AM J MED GENET, V43, P580, DOI 10.1002/ajmg.1320430315; KOENIG M, 1989, AM J HUM GENET, V45, P498; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; LEVINE BA, 1992, FEBS LETT, V298, P44, DOI 10.1016/0014-5793(92)80019-D; LOVE DR, 1991, J MED GENET, V28, P860, DOI 10.1136/jmg.28.12.860; MALHOTRA SB, 1988, SCIENCE, V242, P755, DOI 10.1126/science.3055295; MATSUMURA K, 1993, LANCET, V341, P521, DOI 10.1016/0140-6736(93)90279-P; MATSUMURA K, 1992, NATURE, V359, P320, DOI 10.1038/359320a0; MATSUMURA K, 1992, NATURE, V360, P588, DOI 10.1038/360588a0; MATSUMURA K, IN PRESS NEUROMUSCUL; MATSUMURA K, IN PRESS J CLIN INVE; MATSUMURA K, 1991, CLIN NEUROL TOKYO, V31, P286; MATSUMURA K, IN PRESS NEUROLOGY; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; NICHOLSON LVB, 1990, ACTA NEUROPATHOL, V80, P239, DOI 10.1007/BF00294640; OHLENDIECK K, 1991, FEBS LETT, V283, P230, DOI 10.1016/0014-5793(91)80595-T; OHLENDIECK K, 1991, NEURON, V7, P499, DOI 10.1016/0896-6273(91)90301-F; OHLENDIECK K, 1991, J CELL BIOL, V112, P135, DOI 10.1083/jcb.112.1.135; OHLENDIECK K, 1993, NEUROLOGY, V43, P795, DOI 10.1212/WNL.43.4.795; OHLENDIECK K, 1991, J CELL BIOL, V115, P1685, DOI 10.1083/jcb.115.6.1685; SLATER CR, 1991, J NEUROL SCI, V101, P187, DOI 10.1016/0022-510X(91)90044-8; SUZUKI A, 1992, FEBS LETT, V308, P154, DOI 10.1016/0014-5793(92)81265-N; TACHI N, 1992, J NEUROL SCI, V110, P165, DOI 10.1016/0022-510X(92)90024-F; TINSLEY JM, 1992, NATURE, V360, P591, DOI 10.1038/360591a0; VAINZOF M, 1993, HUM MOL GENET, V2, P39, DOI 10.1093/hmg/2.1.39; WAY M, 1992, FEBS LETT, V301, P243, DOI 10.1016/0014-5793(92)80249-G; YOSHIDA M, 1990, J BIOCHEM-TOKYO, V108, P748, DOI 10.1093/oxfordjournals.jbchem.a123276	46	35	35	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1993	53	2					409	416						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LN820	8328458				2022-12-18	WOS:A1993LN82000013
J	RICCARDI, VM				RICCARDI, VM			GENOTYPE, MALLEOTYPE, PHENOTYPE, AND RANDOMNESS - LESSONS FROM NEUROFIBROMATOSIS-1 (NF-1)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							TYPE-1 NEUROFIBROMATOSIS; GENE				RICCARDI, VM (corresponding author), NEUROFIBROMATOSIS INST,LA CRESCENTA,CA, USA.							ALLANSON JE, 1991, J MED GENET, V28, P752, DOI 10.1136/jmg.28.11.752; [Anonymous], 1988, Neurofibromatosis, V1, P172; BARLOW DP, 1993, SCIENCE, V260, P309, DOI 10.1126/science.8469984; CASKEY CT, 1992, SCIENCE, V256, P784, DOI 10.1126/science.1589758; CHAO LY, 1993, NAT GENET, V3, P127, DOI 10.1038/ng0293-127; EASTON DF, 1993, AM J HUM GENET, V53, P305; EDWARDS JH, 1989, ANN HUM GENET, V53, P33, DOI 10.1111/j.1469-1809.1989.tb01120.x; KAYES LM, 1992, J MED GENET, V29, P686, DOI 10.1136/jmg.29.10.686; REY JA, 1993, CANCER GENET CYTOGEN, V66, P1, DOI 10.1016/0165-4608(93)90140-H; RICCARDI V M, 1982, Current Problems in Cancer, V7, P1, DOI 10.1016/S0147-0272(82)80016-0; Riccardi V. M., 1992, NEUROFIBROMATOSIS PH; RICCARDI VM, 1988, AM J HUM GENET, V42, P284; RICCARDI VM, 1990, TUBEROUS SCLEROSIS N, P167; SMITS A, 1992, AM J MED GENET, V43, P261, DOI 10.1002/ajmg.1320430141; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734	16	35	36	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1993	53	2					301	304						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LN820	8328448				2022-12-18	WOS:A1993LN82000001
J	ABELIOVICH, D; LERER, I; PASHUTLAVON, I; SHMUELI, E; RAASROTHSCHILD, A; FRYDMAN, M				ABELIOVICH, D; LERER, I; PASHUTLAVON, I; SHMUELI, E; RAASROTHSCHILD, A; FRYDMAN, M			NEGATIVE EXPANSION OF THE MYOTONIC-DYSTROPHY UNSTABLE SEQUENCE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CLONE; RFLP	We have analyzed the unstable fragment of the myotonic dystrophy (DM) gene in a pregnancy at 50% risk for DM. The affected father in this family had a 3.0-kb expansion of the DM unstable region. The fetus inherited the mutated gene, but with an expansion of 0.5 kb. This case represented a counseling problem in light of the absence of data concerning ''negative expansion.'' Analysis of the DM gene in 17 families with 72 affected individuals revealed four more cases of negative expansions, all of them in paternal transmissions. The possible significance of this finding is discussed.	CHAIM SHEBA MED CTR,INST GENET,IL-52621 TEL HASHOMER,ISRAEL	Chaim Sheba Medical Center	ABELIOVICH, D (corresponding author), HADASSAH UNIV HOSP,DEPT HUMAN GENET,EIN KEREM,IL-91120 JERUSALEM,ISRAEL.							ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; BROOK JD, 1990, NUCLEIC ACIDS RES, V18, P4962, DOI 10.1093/nar/18.16.4962; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; FROSSARD P, 1985, American Journal of Human Genetics, V37, pA153; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; HARLEY HG, 1992, LANCET, V339, P1125, DOI 10.1016/0140-6736(92)90729-M; Harper P.S., 1989, MYOTONIC DYSTROPHY; HARPER PS, 1992, AM J HUM GENET, V51, P10; HUNTER A, 1992, J MED GENET, V29, P774, DOI 10.1136/jmg.29.11.774; KOCH MC, 1991, AM J HUM GENET, V48, P1084; KORNELUK RG, 1989, GENOMICS, V4, P146, DOI 10.1016/0888-7543(89)90293-0; KORNELUK RG, 1987, NUCLEIC ACIDS RES, V15, P6769, DOI 10.1093/nar/15.16.6769; LAVEDAN C, 1993, LANCET, V341, P237, DOI 10.1016/0140-6736(93)90097-Z; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MULLEY JC, 1993, LANCET, V341, P236, DOI 10.1016/0140-6736(93)90096-Y; PERRYMAN MB, 1988, NUCLEIC ACIDS RES, V16, P8744, DOI 10.1093/nar/16.17.8744; SHELBOURNE P, 1992, HUM MOL GENET, V1, P467, DOI 10.1093/hmg/1.7.467; SUTHERS GK, 1992, J MED GENET, V29, P761, DOI 10.1136/jmg.29.11.761; TSILFIDIS C, 1992, NAT GENET, V1, P192, DOI 10.1038/ng0692-192	21	35	35	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1993	52	6					1175	1181						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LG133	8503449				2022-12-18	WOS:A1993LG13300019
J	RICHARD, CW; BOEHNKE, M; BERG, DJ; LICHY, JH; MEEKER, TC; HAUSER, E; MYERS, RM; COX, DR				RICHARD, CW; BOEHNKE, M; BERG, DJ; LICHY, JH; MEEKER, TC; HAUSER, E; MYERS, RM; COX, DR			A RADIATION HYBRID MAP OF THE DISTAL SHORT ARM OF HUMAN CHROMOSOME-11, CONTAINING THE BECKWITH-WEIDEMANN AND ASSOCIATED EMBRYONAL TUMOR DISEASE LOCI	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SOMATIC-CELL HYBRIDS; WIEDEMANN SYNDROME; WILMS TUMOR; ADRENOCORTICAL CARCINOMA; INSITU HYBRIDIZATION; TRISOMY 11P15; REGION; GENE; PCR; HETEROZYGOSITY	We describe a high-resolution radiation hybrid (RH) map of the distal short arm of human chromosome 11 containing the Beckwith-Weidemann gene and the associated embryonal tumor disease loci. Thirteen human 11p15 genes and 17 new anonymous probes were mapped by a statistical analysis of the cosegregation of markers in 102 rodent-human radiation hybrids retaining fragments of human chromosome 11. The 17 anonymous probes were generated from lambda phage containing human 11p15.5 inserts, by using ALU-PCR. A comprehensive map of all 30 loci and a framework map of nine clusters of loci ordered at odds of 1,000:1 were constructed by a multipoint maximum-likelihood approach by using the computer program RHMAP. This RH map localizes one new gene to chromosome 11p15 (WEE1), provides more precise order information for several 11p15 genes (CTSD, H19, HPX, ST5, RNH, and SMPD1), confirms previous map orders for other 11p15 genes (CALCA, PTH, HBBC, TH, HRAS, and DRD4), and maps 17 new anonymous probes within the 11p15.5 region. This RH map should prove useful in better defining the positions of the Beckwith-Weidemann and associated embryonal tumor disease-gene loci.	UNIV MICHIGAN,SCH PUBL HLTH,DEPT BIOSTAT,ANN ARBOR,MI 48109; NCI,TUMOR VIRUS BIOL LAB,BETHESDA,MD 20892; UNIV CALIF SAN FRANCISCO,DEPT PSYCHIAT,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143	University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco				Berg, Daniel/0000-0002-9181-8902; Hauser, Elizabeth/0000-0003-0367-9189	NHGRI NIH HHS [HG00206] Funding Source: Medline; NICHD NIH HHS [HD24610] Funding Source: Medline; NIMH NIH HHS [MH00802] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD024610] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG000206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K11MH000802] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BOEHNKE M, 1991, AM J HUM GENET, V49, P1174; BREUKEL C, 1990, NUCLEIC ACIDS RES, V18, P3097, DOI 10.1093/nar/18.10.3097; BROWN KW, 1992, CANCER GENET CYTOGEN, V58, P66, DOI 10.1016/0165-4608(92)90136-V; COX DR, 1990, SCIENCE, V250, P245, DOI 10.1126/science.2218528; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GELERNTER J, 1992, GENOMICS, V13, P108; GERHARD DS, 1987, SOMAT CELL MOLEC GEN, V13, P293, DOI 10.1007/BF01534923; GLASER T, 1989, SOMAT CELL MOLEC GEN, V15, P477, DOI 10.1007/BF01534910; GLASER T, 1990, GENOMICS, V6, P48, DOI 10.1016/0888-7543(90)90447-3; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HARRISONLAVOIE KJ, 1989, GENOMICS, V5, P501, DOI 10.1016/0888-7543(89)90016-5; HENRY I, 1989, P NATL ACAD SCI USA, V86, P3247, DOI 10.1073/pnas.86.9.3247; HENRY I, 1989, CYTOGENET CELL GENET, V50, P155, DOI 10.1159/000132748; HENRY I, 1989, HUM GENET, V81, P273, DOI 10.1007/BF00279003; HENRY I, 1991, NATURE, V351, P665, DOI 10.1038/351665a0; IGARASHI M, 1991, NATURE, V353, P80, DOI 10.1038/353080a0; JOURNEL H, 1985, ANN GENET-PARIS, V28, P97; JUNIEN C, 1991, CYTOGENET CELL GENET, V58, P459, DOI 10.1159/000133171; KOUFOS A, 1989, AM J HUM GENET, V44, P711; LAW M L, 1988, Genomics, V3, P48, DOI 10.1016/0888-7543(88)90158-9; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; LICHY JH, 1992, CELL GROWTH DIFFER, V3, P541; MANNENS M, 1990, CANCER RES, V50, P3279; MANNENS M, 1991, CYTOGENET CELL GENET, V58, P1967; MANNENS M, 1991, AM J HUM GENET S, V49, pA148; NELSON DL, 1989, P NATL ACAD SCI USA, V86, P6686, DOI 10.1073/pnas.86.17.6686; OKANO Y, 1986, JPN J HUM GENET, V31, P365, DOI 10.1007/BF01907937; OMALLEY KL, 1988, NUCLEIC ACIDS RES, V16, P4437; PEREIRA LD, 1991, GENOMICS, V9, P229, DOI 10.1016/0888-7543(91)90246-B; PING AJ, 1989, AM J HUM GENET, V44, P720; PRITCHARD C, 1990, P NATL ACAD SCI USA, V87, P7309, DOI 10.1073/pnas.87.18.7309; REEVE AE, 1989, MOL CELL BIOL, V9, P1799, DOI 10.1128/MCB.9.4.1799; RICHARD CW, 1991, AM J HUM GENET, V49, P1189; TANIGAMI A, 1992, AM J HUM GENET, V50, P56; THEUNE S, 1991, GENOMICS, V9, P511, DOI 10.1016/0888-7543(91)90418-E; TURLEAU C, 1984, HUM GENET, V67, P219, DOI 10.1007/BF00273006; WAZIRI M, 1983, J PEDIATR-US, V102, P873, DOI 10.1016/S0022-3476(83)80014-6; WEKSBERG R, 1990, GENOMICS, V8, P693, DOI 10.1016/0888-7543(90)90256-T; WEREMOWICZ S, 1990, GENOMICS, V8, P717, DOI 10.1016/0888-7543(90)90260-2; ZEMEL S, 1992, NAT GENET, V2, P61, DOI 10.1038/ng0992-61; ZHANG YH, 1992, NAT GENET, V1, P40, DOI 10.1038/ng0492-40	41	35	35	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1993	52	5					915	921						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LB889	8387721				2022-12-18	WOS:A1993LB88900008
J	EVETT, IW; SCRANAGE, J; PINCHIN, R				EVETT, IW; SCRANAGE, J; PINCHIN, R			AN ILLUSTRATION OF THE ADVANTAGES OF EFFICIENT STATISTICAL-METHODS FOR RFLP ANALYSIS IN FORENSIC-SCIENCE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE LOCUS PROFILES; VNTR LOCI	The debate about the statistics of DNA profiling in forensic science casework has been carried out mainly from the perspective which is generally known as ''match/binning.'' This approach has an initial appeal because of its apparent conceptual simplicity. However, the simplicity is illusory because it encourages misconceptions which obscure the essential forensic issues. This is exemplified in a recent report of the National Research Council, which places great emphasis on the need for conservative estimation of relative frequencies while missing the point that the power of RFLP technology cannot be realized if the matching stage is inefficient. Our approach to the problem is a one-stage rather than a two-stage process, by means of one function-the likelihood ratio-which determines the evidential strength. This paper describes experiments which have been carried out to assess the power of the method in forensic science and compares it with match/binning methodology. Tests for gauging the effects of between-probe dependence are included, with the results complementing those of Risch and Devlin.			EVETT, IW (corresponding author), FORENS SCI SERV INC,CENT RES & SUPPORT ESTAB,READING RG7 4PN,BERKS,ENGLAND.							[Anonymous], 1992, DNA TECHNOLOGY FOREN; Berry DA, 1992, APPL STAT, V41, P499, DOI 10.1111/j.1467-9876.1992/tb02418.x; Berry DA, 1991, STAT SCI, V6, P175; BUDOWLE B, 1991, AM J HUM GENET, V48, P841; BUFFERY C, 1991, FORENSIC SCI INT, V52, P53, DOI 10.1016/0379-0738(91)90096-2; DEVLIN B, 1991, AM J HUM GENET, V48, P662; EVETT IW, 1991, J FORENSIC SCI SOC, V31, P41, DOI 10.1016/S0015-7368(91)73116-2; EVETT IW, 1992, J FORENSIC SCI SOC, V32, P307, DOI 10.1016/S0015-7368(92)73088-6; EVETT IW, 1991, INT J LEGAL MED, V104, P267, DOI 10.1007/BF01369583; EVETT IW, 1992, JUSTICE PEACE, V156, P583; GJERTSON DW, 1988, AM J HUM GENET, V43, P860; LINDLEY DV, 1977, BIOMETRIKA, V64, P207, DOI 10.1093/biomet/64.2.207; RISCH NJ, 1992, SCIENCE, V255, P717, DOI 10.1126/science.1738844	13	35	35	0	17	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1993	52	3					498	505						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KR720	8095367				2022-12-18	WOS:A1993KR72000007
J	LYN, D; CHERNEY, BW; LALANDE, M; BERENSON, JR; LICHTENSTEIN, A; LUPOLD, S; BHATIA, KG; SMULSON, M				LYN, D; CHERNEY, BW; LALANDE, M; BERENSON, JR; LICHTENSTEIN, A; LUPOLD, S; BHATIA, KG; SMULSON, M			A DUPLICATED REGION IS RESPONSIBLE FOR THE POLY(ADP-RIBOSE) POLYMERASE POLYMORPHISM, ON CHROMOSOME-13, ASSOCIATED WITH A PREDISPOSITION TO CANCER	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA-SEQUENCES; GENE; FLOW	The poly(ADP-ribose) polymerase (PADPRP) gene (13q33-qter) depicts a two-allele (A/B) polymorphism. In the noncancer population, the frequency of the B allele is higher among blacks than among whites. Since the incidence of multiple myeloma and prostate and lung cancer is higher in the U.S. black population, we have analyzed the B-allele frequency in germ-line DNA to determine whether the PADPRP gene correlates with a polymorphic susceptibility to these diseases. For multiple myeloma and prostate cancer, an increased frequency of the B allele appeared to be striking only in black patients. In contrast, the distribution of the B allele in germ-line DNA did not differ among white patients with these diseases, when compared with the control group. An elevated B-allele frequency was also found in germ-line DNA in blacks with colon cancer. These observations suggest that the PADPRP polymorphism may provide a valid marker for a predisposition to these cancers in black individuals. To determine the genomic structure of the polymorphic PADPRP sequences, a 2.68-kb HindIII clone was isolated and sequenced from a chromosome 13-enriched library. Sequence analysis of this clone (A allele) revealed a dose sequence similarity (91.8%) to PADPRP cDNA (1q42) and an absence of introns, suggesting that the gene on 13q exists as a processed pseudogene. A 193-bp conserved duplicated region within the A allele was identified as the source of the polymorphism. The nucleotide differences between the PADPRP gene on chromosome 13 and related PADPRP genes were exploited to develop oligonucleotides that can detect the difference between the A/B genotypes, in a PCR. This PCR assay offers the opportunity for analyzing additional black cancer patients, to determine how the PADPRP processed pseudogene or an unidentified gene that cosegregates with the PADPRP gene might be involved with the development of malignancy.	GEORGETOWN UNIV,SCH MED,DEPT BIOCHEM & MOLEC BIOL,3900 RESEVOIR RD NW,WASHINGTON,DC 20057	Georgetown University					NATIONAL CANCER INSTITUTE [R01CA013195] Funding Source: NIH RePORTER; NCI NIH HHS [CA 13195] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AUER B, 1989, DNA-J MOLEC CELL BIO, V8, P575, DOI 10.1089/dna.1989.8.575; BHATIA KG, 1990, CANCER RES, V50, P5406; CHAKRABORTY R, 1992, AM J HUM GENET, V50, P145; CHERNEY BW, 1987, P NATL ACAD SCI USA, V84, P8370, DOI 10.1073/pnas.84.23.8370; COOPER DN, 1985, HUM GENET, V69, P201, DOI 10.1007/BF00293024; COWELL JK, 1989, CYTOGENET CELL GENET, V52, P1, DOI 10.1159/000132827; LALANDE M, 1984, CANCER GENET CYTOGEN, V13, P283, DOI 10.1016/0165-4608(84)90073-6; MAEDA N, 1983, P NATL ACAD SCI-BIOL, V80, P5012, DOI 10.1073/pnas.80.16.5012; MIYAMOTO MM, 1988, P NATL ACAD SCI USA, V85, P7627, DOI 10.1073/pnas.85.20.7627; POTTERN LM, 1992, CANCER EPIDEM BIOMAR, V1, P177; RIEDEL DA, 1991, NEOPLASTIC DISEASES, P347; RIES GLA, 1990, CANCER STATISTICS RE; Sambrook J., 1989, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; UEDA K, 1985, ANNU REV BIOCHEM, V54, P73, DOI 10.1146/annurev.bi.54.070185.000445; WEINER AM, 1986, ANNU REV BIOCHEM, V55, P631, DOI 10.1146/annurev.bi.55.070186.003215	16	35	36	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1993	52	1					124	134						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KK908	8434580				2022-12-18	WOS:A1993KK90800015
J	DEVLIN, B; RISCH, N				DEVLIN, B; RISCH, N			A NOTE ON HARDY-WEINBERG EQUILIBRIUM OF VNTR DATA BY USING THE FEDERAL BUREAU OF INVESTIGATIONS FIXED-BIN METHOD	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LOCI	To fully utilize the information of VNTR data for forensic inference, the probability of observing the matching suspect and evidentiary profile in a reference population is estimated, usually by assuming independence of alleles within and between loci. This assumption has been challenged on the basis of the observation that there is frequently an excess of single-band phenotypes (SBP) in forensic data bases, which could indicate lack of independence. Nevertheless, another explanation is that the excess SBP are artifacts of laboratory methods. In this report we examine the excess of SBP for three VNTR loci studied by the FBI (D17S79 and D2S44, for blacks, and D14S13, for Caucasians). The FBI claims that the excess is due to the effect of null alleles; the null alleles are suspected to be too small to be detected. We estimate the frequency of null alleles for two loci (D17S79 and D14S13) by comparing, for these loci, the data from the FBI data base and the data from the Lifecodes data base. These comparisons yield information on small fragments because Lifecodes uses the restriction enzyme PstI, which yields larger fragments than does HaeIII, which the FBI uses. For D17S79 in blacks, we estimate a null allele frequency of 4.4%, and, for D14S13 in Caucasians, we estimate a frequency of 3.0%. The null-allele frequency for D2S44 in blacks is derived similarly, again being based on analyses of DNA cut with HaeIII and PstI; our estimate of the null-allele frequency for this locus is 1.5%. Using these null-allele frequency estimates and a goodness-of-fit test, we show that there is no evidence for deviations from Hardy-Weinberg expectations of genotype probabilities at these loci.	YALE UNIV,DEPT HUMAN GENET,NEW HAVEN,CT 06520	Yale University	DEVLIN, B (corresponding author), YALE UNIV,SCH MED,DEPT EPIDEMIOL & PUBL HLTH,60 COLL ST,POB 3333,NEW HAVEN,CT 06510, USA.				NCI NIH HHS [CA45052] Funding Source: Medline; NHGRI NIH HHS [HG00648] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA045052] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000648] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BALAZS I, 1989, AM J HUM GENET, V44, P182; BUDOWLE B, 1991, AM J HUM GENET, V48, P841; CHAKRABORTY R, 1992, HUM GENET, V88, P267, DOI 10.1007/BF00197257; COHEN JE, 1990, AM J HUM GENET, V46, P358; COHEN JE, 1991, SCIENCE, V243, P1037; DEVLIN B, 1990, SCIENCE, V249, P1416, DOI 10.1126/science.2205919; DEVLIN B, 1992, AM J HUM GENET, V51, P534; DEVLIN B, 1992, J AM STAT ASSOC, V87, P337; DEVLIN B, 1991, AM J HUM GENET, V48, P662; DEVLIN B, 1991, SCIENCE, V243, P1039; EFRON B, 1991, SCIENCE, V253, P390, DOI 10.1126/science.253.5018.390; GREEN P, 1991, SCIENCE, V243, P1038; LANDER ES, 1991, AM J HUM GENET, V48, P819; LANDER ES, 1989, NATURE, V339, P501, DOI 10.1038/339501a0; LANDER ES, 1991, AM J HUM GENET, V49, P899; RICE JA, 1988, MATH STATISTICS DATA; RISCH NJ, 1992, SCIENCE, V255, P717, DOI 10.1126/science.1738844; Wahlund S, 1928, HEREDITAS, V11, P65, DOI 10.1111/j.1601-5223.1928.tb02483.x; WEIR B, 1992, IN PRESS AM J HUM GE, V51; WEIR BS, 1992, GENETICS, V130, P873	20	35	35	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1992	51	3					549	553						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JJ828	1496986				2022-12-18	WOS:A1992JJ82800011
J	WILLIAMS, RC; KNOWLER, WC; PETTITT, DJ; LONG, JC; ROKALA, DA; POLESKY, HF; HACKENBERG, RA; STEINBERG, AG; BENNETT, PH				WILLIAMS, RC; KNOWLER, WC; PETTITT, DJ; LONG, JC; ROKALA, DA; POLESKY, HF; HACKENBERG, RA; STEINBERG, AG; BENNETT, PH			THE MAGNITUDE AND ORIGIN OF EUROPEAN-AMERICAN ADMIXTURE IN THE GILA RIVER INDIAN COMMUNITY OF ARIZONA - A UNION OF GENETICS AND DEMOGRAPHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DIABETES-MELLITUS; PIMA-INDIANS	Complementary genetic and demographic analyses estimate the total proportion of European-American admixture in the Gila River Indian Community and trace its mode of entry. Among the 9,616 residents in the sample, 2,015 persons claim only partial Native American heritage. A procedure employing 23 alleles or haplotypes at eight loci was used to estimate the proportion of European-American admixture, m(a), for the entire sample and within six categories of Caucasian admixture calculated from demographic data, m(d). The genetic analysis gave an estimate of total European-American admixture in the community of 0.054 (95% confidence interval [CI] .044-.063), while an estimate from demographic records was similar, .059. Regression of m(a) on m(d) yielded a fitted line m(a) = .922m(d), r = .959 (P = .0001). When total European-American admixture is partitioned between the contributing populations, Mexican-Americans have provided .671, European-Americans .305, and African-Americans .023. These results are discussed within the context of the ethnic composition of the Gila River Indian Community, the assumptions underlying the methods, and the potential that demographic data have for enriching genetic measurements of human admixture. It is concluded that, despite the severe assumptions of the mathematical methods, accurate, reliable estimates of genetic admixture are possible from allele and haplotype frequencies, even when there is little demographic information for the population.	BLOOD SYST INC,HISTOCOMPATIBIL LAB,SCOTTSDALE,AZ; NIDDKD,DIABET & ARTHRIT EPEDIMIOL SECT,PHOENIX,AZ; UNIV NEW MEXICO,DEPT ANTHROPOL,ALBUQUERQUE,NM 87131; UNIV MANITOBA,DEPT ANTHROPOL,WINNIPEG R3T 2N2,MANITOBA,CANADA; MEM BLOOD CTR MINNEAPOLIS,MINNEAPOLIS,MN; UNIV COLORADO,DEPT ANTHROPOL,BOULDER,CO 80309; CASE WESTERN RESERVE UNIV,DEPT BIOL,CLEVELAND,OH 44106	Vitalant; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of New Mexico; University of Manitoba; University of Colorado System; University of Colorado Boulder; Case Western Reserve University	WILLIAMS, RC (corresponding author), ARIZONA STATE UNIV,DEPT ANTHROPOL,TEMPE,AZ 85287, USA.		Bennett, Peter/AAH-9605-2021					Bahr Donald M., 1983, HDB N AM INDIANS, V10, P193; BENNETT PH, 1971, LANCET, V2, P125; BERNSTEIN F, 1931, COMITATO ITALIONA ST; Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; CHAKRABORTY R, 1986, YEARB PHYS ANTHROPOL, V29, P1; CORLE E, 1951, GILA RIVER SW; Ezell PH, 1983, HDB N AM INDIANS, V10, P149; Fontana Bernard L., 1983, HDB N AM INDIANS, V10, P137; Giblett ER., 1969, GENETIC MARKERS HUMA; Hackenberg R. A., 1983, HDB N AM INDIANS, V10, P161; HACKENBERG RA, 1973, HDB SOCIAL CULTURAL, P289; KNOWLER WC, 1990, DIABETES METAB REV, V6, P1, DOI 10.1002/dmr.5610060101; KNOWLER WC, 1988, AM J HUM GENET, V43, P520; KNOWLER WC, 1978, AM J EPIDEMIOL, V108, P497, DOI 10.1093/oxfordjournals.aje.a112648; LI CC, 1976, 1ST COURSE POPULATIO; LONG JC, 1983, AM J PHYS ANTHROPOL, V61, P411, DOI 10.1002/ajpa.1330610403; LONG JC, 1991, GENETICS, V127, P417; LONG JC, 1991, AM J PHYS ANTHROPOL, V84, P141, DOI 10.1002/ajpa.1330840204; MATSON GA, 1968, AM J PHYS ANTHROPOL, V29, P311, DOI 10.1002/ajpa.1330290308; Race R. R, 1968, BLOOD GROUPS MAN; SILVER H, 1982, PROBABILITY INCLUSIO; Steinberg A.G., 1981, DISTRIBUTION HUMAN I; STEINBERG ARTHUR G., 1962, PROGR MED GENET, V2, P1; SZATHMARY EJ, 1972, HUM BIOL, V44, P655; SZATHMARY EJE, 1978, AM J PHYS ANTHROPOL, V48, P29, DOI 10.1002/ajpa.1330480106; WILLIAMS RC, 1986, AM J HUM GENET, V39, P409; WILLIAMS RC, 1985, AM J PHYS ANTHROPOL, V66, P1, DOI 10.1002/ajpa.1330660102; WILLIAMS RC, 1992, HUM IMMUNOL, V33, P29, DOI 10.1016/0198-8859(92)90049-S; WILLIAMS RC, 1992, HUM IMMUNOL, V33, P39, DOI 10.1016/0198-8859(92)90050-W	29	35	37	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1992	51	1					101	110						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JA467	1609790				2022-12-18	WOS:A1992JA46700011
J	OOSTERWIJK, JC; NELEN, M; VANZANDVOORT, PM; VANOSCH, LDM; ORANJE, AP; WITTEBOPOST, D; VANOOST, BA				OOSTERWIJK, JC; NELEN, M; VANZANDVOORT, PM; VANOSCH, LDM; ORANJE, AP; WITTEBOPOST, D; VANOOST, BA			LINKAGE ANALYSIS OF KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, AND REGIONAL ASSIGNMENT TO HUMAN-CHROMOSOME XP21.2-P22.2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							X-CHROMOSOME; DNA; COMMITTEE	Keratosis follicularis spinulosa decalvans (KFSD) is a rare X-chromosomal disorder. It consists of follicular hyperkeratosis of the skin, scarring alopecia of the scalp, absence of the eyebrows, and corneal degeneration. There is photophobia in childhood, but the symptoms tend to diminish after puberty, and prognosis for vision is good. Some heterozygotes do show clinical symptoms. In a large Dutch pedigree we performed DNA analysis in order to localize the KFSD gene. In 54 individuals, including 21 affected males, RFLP analysis was done using DNA probes covering the X chromosome. Two-point linkage analyses with 19 informative DNA markers revealed significant linkage to DNA probes on Xp21.1-p22.3. The highest lod scores of 5.70 and 4.38 were obtained with DXS41 and DXS16 at a recombination fraction of zero and 4 cM, respectively. Multipoint linkage data place KFSD between DXS16 and DXS269. Our data confirm X linkage of KFSD in this family and tentatively map the gene on Xp22.2-p21.2. Combined with clinical investigation, RFLP analysis may become an important tool in carrier detection.	STATE UNIV UTRECHT HOSP,DEPT OPHTHALMOL,3501 CA UTRECHT,NETHERLANDS; UNIV HOSP NIJMEGEN,DEPT HUMAN GENET,DNA DIAGNOST LAB,NIJMEGEN,NETHERLANDS	Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen	OOSTERWIJK, JC (corresponding author), STATE UNIV UTRECHT HOSP,CTR CLIN GENET,POB 18009,3501 CA UTRECHT,NETHERLANDS.		Oosterwijk, Jan C./G-5770-2011; Nelen, Marcel R./L-4542-2015					ALITALO T, 1991, GENOMICS, V9, P505, DOI 10.1016/0888-7543(91)90417-D; ALITALO T, 1991, HUM GENET, V86, P599, DOI 10.1007/BF00201548; BROWN CJ, 1988, HUM GENET, V80, P296, DOI 10.1007/BF01790101; DAVIES KE, 1990, CYTOGENET CELL GENET, V55, P254, DOI 10.1159/000133019; DELMASTRO RG, 1990, HUM GENET, V86, P228, DOI 10.1007/BF00197710; FRANCESCHETTI A, 1957, Ophthalmologica, V133, P259; GUILLET G, 1987, PEDIATRIE, V42, P437; HAPPLE R, 1982, HAUTARZT, V33, P73; HAZELL M, 1984, BRIT J DERMATOL, V111, P101, DOI 10.1111/j.1365-2133.1984.tb04023.x; HOLTHUIS P, 1943, OPHTHALMOLOGICA, V106, P325; JONKERS GH, 1950, OPHTHALMOLOGICA, V120, P365; KEATS B, 1989, CYTOGENET CELL GENET, V51, P459, DOI 10.1159/000132805; KIDD KK, 1989, CYTOGENET CELL GENET, V51, P622, DOI 10.1159/000132810; KOHLER U, 1981, KLIN MONATSBL AUGENH, V179, P123, DOI 10.1055/s-2008-1057277; KUOKKANEN K, 1971, ACTA DERM-VENEREOL, V51, P146; LAMERIS HJ, 1905, NED TIJDSCHR GENEES, V41, P1524; LATHROP GM, 1984, AM J HUM GENET, V36, P460; McKusick VA, 1990, MENDELIAN INHERITANC; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MUSARELLA MA, 1990, GENOMICS, V8, P286, DOI 10.1016/0888-7543(90)90284-2; RAND R, 1983, ARCH DERMATOL, V119, P22, DOI 10.1001/archderm.119.1.22; ROCHAT GF, 1906, NED T GENEESK, V42, P515; SIEMENS HW, 1925, ARCH RASSEN GES BIOL, V17, P47; VANOOST BA, 1991, AM J MED GENET, V38, P328, DOI 10.1002/ajmg.1320380232; VANOSCH LDM, IN PRESS J MED GENET; Waardenburg P.J., 1961, GENETICS OPHTHALMOLO, V1; WILLEMS PJ, 1991, GENOMICS, V9, P565, DOI 10.1016/0888-7543(91)90347-H; WILLIAMSON R, 1990, CYTOGENET CELL GENET, V55, P685; ZHU D, 1990, HUM GENET, V86, P54	29	35	35	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1992	50	4					801	807						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HL848	1550124				2022-12-18	WOS:A1992HL84800016
J	KEATS, BJB; POLLACK, MS; MCCALL, A; WILENSKY, MA; WARD, LJ; LU, M; ZOGHBI, HY				KEATS, BJB; POLLACK, MS; MCCALL, A; WILENSKY, MA; WARD, LJ; LU, M; ZOGHBI, HY			TIGHT LINKAGE OF THE GENE FOR SPINOCEREBELLAR ATAXIA TO D6S89 ON THE SHORT ARM OF CHROMOSOME-6 IN A KINDRED FOR WHICH CLOSE LINKAGE TO BOTH HLA AND F13A1 IS EXCLUDED	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY ATAXIA; HUMAN-COMPLEMENT; LOCUS; ONSET; POLYMORPHISM; ANTIGEN; FAMILY; AGE	A locus for an autosomal dominant form of spinocerebellar ataxia (SCA1) has been assigned to the short arm of chromosome 6 on the basis of linkage to the major histocompatibility system (HLA). In this study of a five-generation American black family, close linkage between the disease locus and both HLA and the coagulation factor XIIIA (F13A1) locus was excluded, and lod scores for all locations of the disease locus between HLA and F13A1 were less than -1.4. These results suggest that the locus causing spinocerebellar ataxia in this family is not in this region. However, the disease locus was found to be closely linked to a microsatellite polymorphism, D6S89, which is between HLA and F13A1. The maximum lod score for SCA1 and D6S89 is 4.90 at a recombination fraction of 0, both in males and in females. These data show that exclusion of close linkage to the HLA complex and F13A1 in a kindred with spinocerebellar ataxia does not rule out the possibility that the disease locus in that family is on 6p. Accordingly, all families segregating a dominantly inherited ataxia should be evaluated for linkage to D6S89, to determine whether the locus causing the disease is SCA1.	TULANE UNIV,MED CTR,NEW ORLEANS,LA 70118; BAYLOR COLL MED,INST MOLEC GENET,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT MICROBIOL,HOUSTON,TX 77030	Tulane University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	KEATS, BJB (corresponding author), LOUISIANA STATE UNIV,MED CTR,DEPT BIOMETRY & GENET,1901 PERDIDO ST,NEW ORLEANS,LA 70112, USA.			Zoghbi, Huda/0000-0002-0700-3349	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R37HG000345, R01HG000345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028356, R37GM028356] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG 00345] Funding Source: Medline; NIAID NIH HHS [AI 28036] Funding Source: Medline; NIGMS NIH HHS [GM 28356] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AUBURGER G, 1990, AM J HUM GENET, V46, P1163; AWDEH ZL, 1980, P NATL ACAD SCI-BIOL, V77, P3576, DOI 10.1073/pnas.77.6.3576; BUDOWLE B, 1983, Biotechniques, V1, P176; CURRIER RD, 1984, OLIVOPONTOCEREBELLAR, P1; Danilovs J., 1980, HISTOCOMPATIBILITY T, P287; GRAHAM JB, 1984, HUM GENET, V67, P132, DOI 10.1007/BF00272987; HAINES JL, 1984, NEUROLOGY, V34, P1542, DOI 10.1212/WNL.34.12.1542; HARDING AE, 1982, BRAIN, V105, P1, DOI 10.1093/brain/105.1.1; JACKSON JF, 1977, NEW ENGL J MED, V296, P1138, DOI 10.1056/NEJM197705192962003; KEATS B, 1989, CYTOGENET CELL GENET, V51, P459, DOI 10.1159/000132805; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LITT M, 1990, NUCLEIC ACIDS RES, V18, P4301, DOI 10.1093/nar/18.14.4301; MORTON NE, 1989, ANN HUM GENET, V53, P263, DOI 10.1111/j.1469-1809.1989.tb01793.x; MORTON NE, 1980, AM J MED GENET, V6, P251, DOI 10.1002/ajmg.1320060309; NINO HE, 1980, NEUROLOGY, V30, P12, DOI 10.1212/WNL.30.1.12; PLOUGHMAN LM, 1989, AM J HUM GENET, V44, P543; RANUM LPW, 1991, AM J HUM GENET, V44, P31; RAO DC, 1977, HUM HERED, V27, P99, DOI 10.1159/000152856; RICH SS, 1987, AM J HUM GENET, V41, P524; SIM E, 1986, BIOCHEM J, V239, P763, DOI 10.1042/bj2390763; WRAXALL BGD, 1986, J FORENSIC SCI, V31, P1439; YAKURA H, 1974, NEW ENGL J MED, V291, P154; ZOGHBI HY, 1989, AM J HUM GENET, V44, P255; ZOGHBI HY, 1988, ANN NEUROL, V23, P580, DOI 10.1002/ana.410230609; ZOGHBI HY, 1991, AM J HUM GENET, V49, P23	25	35	36	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1991	49	5					972	977						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GM873	1928103				2022-12-18	WOS:A1991GM87300008
J	LORDASANCHEZ, I; BINKERT, F; MAECHLER, M; SCHINZEL, A				LORDASANCHEZ, I; BINKERT, F; MAECHLER, M; SCHINZEL, A			A MOLECULAR STUDY OF X-ISOCHROMOSOMES - PARENTAL ORIGIN, CENTROMERIC STRUCTURE, AND MECHANISMS OF FORMATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TURNERS SYNDROME; DNA; POLYMORPHISMS; ABNORMALITIES; CHROMOSOME; FAMILIES; NUMBER; RFLPS	Fourteen individuals with an i(Xq) or idic(Xq) were studied using RFLP analysis in order to determine both parental origin and extent of heterozygosity of the isochromosome and to search for the presence of short-arm material. In five cases the isochromosome was paternally derived, while nine patients had a maternal i(Xq). The analysis of heterozygosity of the nine maternally derived isochromosomes by using Xq markers showed heterozygosity in two cases, suggesting an origin from two homologous X chromosomes. Homozygosity was found at all informative loci in seven cases, which therefore are probably the product of either centromere misdivision or sister-chromatid exchange. Presence of Xp markers was seen both in the three i(Xq) chromosomes which appeared dicentric by cytogenetic analysis and in three additional cytogenetically monocentric cases. Mean parental ages were greater for the maternally derived cases as compared with the paternally derived cases.	UNIV ZURICH,INST MED GENET,RAMISTR 74,CH-8001 ZURICH,SWITZERLAND	University of Zurich								ANTONARAKIS SE, 1990, AM J HUM GENET, V47, P968; CALLEN DF, 1987, HUM GENET, V77, P236, DOI 10.1007/BF00284476; CAROTHERS AD, 1989, CLIN GENET, V36, P53; CONNOR JM, 1989, ACTA PAEDIATR SC   S, V356, P77; DENG HX, 1990, JPN J HUM GENET, V35, P245, DOI 10.1007/BF01876853; FRASER NJ, 1989, GENOMICS, V5, P144, DOI 10.1016/0888-7543(89)90099-2; HARBISON M, 1988, CYTOGENET CELL GENET, V47, P217, DOI 10.1159/000132553; HEILIG R, 1988, AM J MED GENET, V30, P543, DOI 10.1002/ajmg.1320300156; HSU LYF, 1978, J MED GENET, V15, P222, DOI 10.1136/jmg.15.3.222; JACOBS PA, 1990, ANN HUM GENET, V54, P209, DOI 10.1111/j.1469-1809.1990.tb00379.x; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; MANDEL JL, 1989, CYTOGENET CELL GENET, V51, P384, DOI 10.1159/000132801; OTTO PA, 1981, HUM GENET, V59, P308, DOI 10.1007/BF00295462; SANGER R, 1971, J MED GENET, V8, P417, DOI 10.1136/jmg.8.4.417; SCHMID W, 1974, HUMANGENETIK, V24, P93; SHAFFER LG, 1991, HUM GENET, V86, P375; SHARP CB, 1990, HUM GENET, V85, P330; Van Dyke D., 1988, CYTOGENETICS MAMMALI, P635; VILLAMAR M, 1990, ANN GENET-PARIS, V33, P29; WENNSTROM JD, 1966, HEREDITAS, V54, P260	20	35	39	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1991	49	5					1034	1040						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GM873	1681727				2022-12-18	WOS:A1991GM87300014
J	FISHER, CR; FISHER, CW; CHUANG, DT; COX, RP				FISHER, CR; FISHER, CW; CHUANG, DT; COX, RP			OCCURRENCE OF A TYR393-]ASN (Y393N) MUTATION IN THE EL-ALPHA-GENE OF THE BRANCHED-CHAIN ALPHA-KETO ACID DEHYDROGENASE COMPLEX IN MAPLE SYRUP URINE DISEASE PATIENTS FROM A MENNONITE POPULATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							E1-ALPHA SUBUNIT; MESSENGER-RNA; CELL-LINES; CDNA; SEQUENCE; DNA	Maple syrup urine disease (MSUD) is caused by a deficiency in the mitochondrial branched-chain a-keto acid dehydrogenase complex. The incidence of MSUD in the Philadelphia Mennonites is 1/176 births resulting from consanguinity. In this study, we amplified cDNAs for the decarboxylase E1-alpha subunit of the branched-chain alpha-keto acid dehydrogenase complex from a classical MSUD patient and from an obligatory heterozygote of a Mennonite family by the PCR. Sequencing of the amplified cDNAs disclosed at codon 393 of the mature E1-alpha polypeptide a base substitution changing a tyrosine (encoded by TAC) to an asparagine residue (encoded by AAC), which is designated Y393N. A segment of the E1-alpha gene containing the 5' portion of exon 9 was amplified. Probing of the amplified genomic DNA with allele-specific oligonucleotide probes showed that the mutation in the E1-alpha gene was homozygous in six Mennonites affected with classical MSUD and was present in heterozygous carriers. The identification of the MSUD mutation in the Philadelphia Mennonites will facilitate diagnosis and carrier detection for this population.	UNIV TEXAS, SW MED CTR, DEPT BIOCHEM, DALLAS, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	COX, RP (corresponding author), UNIV TEXAS, SW MED CTR, DEPT INTERNAL MED, DALLAS, TX 75235 USA.				NIDDK NIH HHS [DK-26758, DK-37373] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026758, R01DK037373] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AUERBACH VH, 1973, INBORN ERRORS METABO, P337; CHASE A, 1977, PROGR CLIN BIOL RES, V18, P107; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHUANG DT, 1988, METHOD ENZYMOL, V166, P135; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; DANNER DJ, 1989, METABOLIC BASIS INHE, V1, P671; DARIUSH N, IN PRESS FEBS LETT; FISHER CW, 1989, J BIOL CHEM, V264, P3448; HARTL FU, 1989, BIOCHIM BIOPHYS ACTA, V988, P1, DOI 10.1016/0304-4157(89)90002-6; HU CWC, 1988, J BIOL CHEM, V263, P9007; INDO Y, 1987, J CLIN INVEST, V80, P63, DOI 10.1172/JCI113064; MARSHALL L, 1981, AM J HUM GENET, V33, pA139; MATSUDA I, 1990, BIOCHEM BIOPH RES CO, V172, P646, DOI 10.1016/0006-291X(90)90723-Z; MITCHELL GA, 1989, P NATL ACAD SCI USA, V86, P197, DOI 10.1073/pnas.86.1.197; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; YEAMAN SJ, 1989, BIOCHEM J, V257, P625, DOI 10.1042/bj2570625; ZHANG B, 1988, GENE, V69, P159, DOI 10.1016/0378-1119(88)90390-3; ZHANG B, 1987, J BIOL CHEM, V262, P15220; ZHANG B, 1989, J CLIN INVEST, V83, P1425, DOI 10.1172/JCI114033	20	35	36	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1991	49	2					429	434						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GA866	1867199				2022-12-18	WOS:A1991GA86600021
J	LIN, LI; LIN, KS; LIN, KH; CHANG, HC				LIN, LI; LIN, KS; LIN, KH; CHANG, HC			THE SPECTRUM OF BETA-THALASSEMIA MUTATIONS IN TAIWAN - IDENTIFICATION OF A NOVEL FRAMESHIFT MUTATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SOUTH CHINA; DNA	Seventy-four beta-thalassemia genes from 37 unrelated beta-thalassemia-major patients were systematically characterized by using PCR, dot-blot hybridization, and direct sequencing of amplified genomic DNA. We found that six mutations - namely, II-654, 41/42, - 28, 17-beta, - 29, and 27/28 - were prevalent, accounting, respectively, for 45.9%, 28.4%, 10.8%, 10.8%, 1.4%, and 2.7% of studied patients. The 27/28 mutation has at codon 27-28 a cytosine insertion which has never been reported before. These results indicate that four oligo-probes (II-654, 41/42, - 28, and 17-beta) allow allele-mutant determination by oligonucleotide analysis in 95.9% of this group of patients, and direct sequencing can be carried out for other samples. These data will facilitate the prenatal diagnosis of this disease by DNA analysis in Taiwan.	NATL TAIWAN UNIV HOSP,COLL MED,DEPT CLIN PATHOL,TAIPEI 100,TAIWAN; NATL TAIWAN UNIV HOSP,COLL MED,SCH MED TECHNOL,TAIPEI 100,TAIWAN; NATL TAIWAN UNIV HOSP,COLL MED,DEPT PEDIAT,TAIPEI 100,TAIWAN	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital			Lin, Liang-In/K-4600-2019; Lin, Kuosui/F-7945-2011	Lin, Kuosui/0000-0003-2917-5261; LIN, LIANG-IN/0000-0002-3561-1093; LIN, KAI-HSIN/0000-0002-5833-7066				Bunn HF, 1986, HEMOGLOBIN MOL GENET; CAI SP, 1988, BLOOD, V71, P1357; CHAN V, 1987, AM J HUM GENET, V41, P678; Goossens M, 1981, Methods Enzymol, V76, P805; HUANG SZ, 1986, HUM GENET, V74, P162, DOI 10.1007/BF00282081; HUANG SZ, 1990, HUM GENET, V84, P129; KAZAZIAN HH, 1986, BLOOD, V68, P964; Ko T. M., 1989, Journal of the Formosan Medical Association, V88, P678; KUTLAR A, 1989, HEMOGLOBIN, V13, P775; WONG C, 1987, NATURE, V330, P384, DOI 10.1038/330384a0; ZHANG JZ, 1988, HUM GENET, V78, P37, DOI 10.1007/BF00291231	11	35	44	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1991	48	4					809	812						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK478	2014803				2022-12-18	WOS:A1991FK47800021
J	SPRITZ, RA; STRUNK, KM; HSIEH, CL; SEKHON, GS; FRANCKE, U				SPRITZ, RA; STRUNK, KM; HSIEH, CL; SEKHON, GS; FRANCKE, U			HOMOZYGOUS TYROSINASE GENE MUTATION IN AN AMERICAN BLACK WITH TYROSINASE-NEGATIVE (TYPE-IA) OCULOCUTANEOUS ALBINISM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA; HYBRIDIZATION; LOCUS; CDNA	We have identified a tyrosinase gene mutation in an American black with classic, tyrosinase-negative oculocutaneous albinism. This mutation results in an amino acid substitution (Cys --> Arg) at codon 89 of the tyrosinase polypeptide. The proband is homozygous for the substitution, suggesting that this mutation may be frequently associated with tyrosinase-negative oculocutaneous albinism in blacks.	UNIV WISCONSIN,DEPT PEDIAT,MADISON,WI 53706; STANFORD UNIV,MED CTR,DEPT GENET,STANFORD,CA 94305; STANFORD UNIV,MED CTR,HOWARD HUGHES MED INST,STANFORD,CA 94305	University of Wisconsin System; University of Wisconsin Madison; Stanford University; Howard Hughes Medical Institute; Stanford University	SPRITZ, RA (corresponding author), UNIV WISCONSIN,DEPT MED GENET,309 GENET LAB,445 HENRY MALL,MADISON,WI 53706, USA.				NIGMS NIH HHS [GM26105] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026105] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARTON D E, 1988, Genomics, V3, P17, DOI 10.1016/0888-7543(88)90153-X; GIEBEL LB, 1990, NUCLEIC ACIDS RES, V18, P3103, DOI 10.1093/nar/18.10.3103-a; GIEBEL LB, 1990, P NATL ACAD SCI USA, V87, P3255, DOI 10.1073/pnas.87.9.3255; GIEBEL LB, IN PRESS GENOMICS; GIEBEL LB, IN PRESS J CLIN INVE; KIKUCHI H, 1990, HUM GENET, V85, P123; KING RA, 1988, DERMATOL CLIN, V6, P217, DOI 10.1016/S0733-8635(18)30668-5; KOGAN SC, 1990, PCR PROTOCOLS, P288; KUGELMAN TP, 1961, J INVEST DERMATOL, V37, P73, DOI 10.1038/jid.1961.84; KWON BS, 1987, P NATL ACAD SCI USA, V84, P7473, DOI 10.1073/pnas.84.21.7473; LERNER AB, 1950, PHYSIOL REV, V30, P91, DOI 10.1152/physrev.1950.30.1.91; LICHTER P, 1988, HUM GENET, V80, P224, DOI 10.1007/BF01790090; LITT M, 1990, NUCLEIC ACIDS RES, V18, P5921, DOI 10.1093/nar/18.19.5921-a; Maslen CL, 1988, GENOMICS, V2, P66, DOI 10.1016/0888-7543(88)90110-3; MULLER G, 1988, EMBO J, V7, P2723, DOI 10.1002/j.1460-2075.1988.tb03126.x; ORKIN SH, 1984, ANNU REV GENET, V18, P131; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHIBAHARA S, 1990, EUR J BIOCHEM, V189, P455, DOI 10.1111/j.1432-1033.1990.tb15510.x; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPRITZ R, 1988, NUCLEIC ACIDS RES, V16, P9890, DOI 10.1093/nar/16.20.9890; SPRITZ RA, 1990, NUCLEIC ACIDS RES, V18, P3672, DOI 10.1093/nar/18.12.3672-a; SPRITZ RA, 1990, NEW ENGL J MED, V322, P1724, DOI 10.1056/NEJM199006143222407; SPRITZ RA, 1990, GENOMICS, V8, P371, DOI 10.1016/0888-7543(90)90295-6; SPRITZ RA, 1990, AM J HUM GENET S, V47, pA117; TOMITA Y, 1989, BIOCHEM BIOPH RES CO, V164, P990, DOI 10.1016/0006-291X(89)91767-1; YAMAMOTO H, 1987, JPN J GENET, V62, P271, DOI 10.1266/jjg.62.271; [No title captured]	29	35	36	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1991	48	2					318	324						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EV744	1899321				2022-12-18	WOS:A1991EV74400016
J	CONCANNON, P; WRIGHT, JA; WRIGHT, LG; SYLVESTER, DR; SPIELMAN, RS				CONCANNON, P; WRIGHT, JA; WRIGHT, LG; SYLVESTER, DR; SPIELMAN, RS			T-CELL RECEPTOR GENES AND INSULIN-DEPENDENT DIABETES-MELLITUS (IDDM) - NO EVIDENCE FOR LINKAGE FROM AFFECTED SIB PAIRS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV PENN,SCH MED,PHILADELPHIA,PA 19104	University of Pennsylvania	CONCANNON, P (corresponding author), VIRGINIA MASON RES CTR,DIV IMMUNOL,1000 SENECA ST,SEATTLE,WA 98101, USA.			Concannon, Patrick/0000-0002-5801-1859	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035047, P30DK019525] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-240] Funding Source: Medline; NIDDK NIH HHS [DK-35047, DK-19525] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BEALL SS, 1989, J NEUROIMMUNOL, V21, P59, DOI 10.1016/0165-5728(89)90159-8; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; BENOIST C, 1989, CELL, V58, P1027, DOI 10.1016/0092-8674(89)90501-1; BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; BOITARD C, 1985, P NATL ACAD SCI USA, V82, P6627, DOI 10.1073/pnas.82.19.6627; BOTTAZZO GF, 1985, NEW ENGL J MED, V313, P353, DOI 10.1056/NEJM198508083130604; CHARMLEY P, IN PRESS TISSUE ANTI; CONCANNON P, 1987, J EXP MED, V165, P1130, DOI 10.1084/jem.165.4.1130; COX NJ, 1989, AM J HUM GENET, V42, P167; CUDWORTH AG, 1975, BRIT MED J, V3, P133, DOI 10.1136/bmj.3.5976.133; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FIELD L L, 1988, American Journal of Human Genetics, V43, pA214; FIELD LL, 1989, GENET EPIDEMIOL, V6, P101, DOI 10.1002/gepi.1370060119; GATTI R A, 1984, Biotechniques, V2, P148; HOOVER ML, 1986, COLD SPRING HARB SYM, V51, P803, DOI 10.1101/SQB.1986.051.01.093; HOOVER ML, 1989, IMMUNOBIOLOGY HLA, V2, P411; ITO M, 1988, DIABETES, V37, P1633, DOI 10.2337/diabetes.37.12.1633; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; MILLWARD BA, 1987, CLIN EXP IMMUNOL, V70, P152; OKSENBERG JR, 1988, HUM IMMUNOL, V22, P111, DOI 10.1016/0198-8859(88)90041-9; OWERBACH D, 1982, DIABETES, V31, P275, DOI 10.2337/diabetes.31.3.275; PERL A, 1989, IMMUNOLOGY, V67, P135; REICH EP, 1989, NATURE, V341, P326, DOI 10.1038/341326a0; RICH SS, 1986, DIABETES, V35, P927, DOI 10.2337/diabetes.35.8.927; ROBINSON MA, 1985, P NATL ACAD SCI USA, V82, P3804, DOI 10.1073/pnas.82.11.3804; SEBOUN E, 1989, CELL, V57, P1095, DOI 10.1016/0092-8674(89)90046-9; SHEEHY MJ, 1989, HUM IMMUNOL, V26, P261, DOI 10.1016/0198-8859(89)90004-9; SHIZURU JA, 1988, SCIENCE, V240, P659, DOI 10.1126/science.2966437; SO A, 1987, IMMUNOGENETICS, V25, P141, DOI 10.1007/BF00344026; SPEILMAN RS, 1980, ANN HUM GENET, V44, P135; SPIELMAN R S, 1987, American Journal of Human Genetics, V41, pA186; SUAREZ BK, 1979, CLIN GENET, V15, P126; SVEJGAARD A, 1983, IMMUNOL REV, V70, P193, DOI 10.1111/j.1600-065X.1983.tb00715.x; SVEJGAARD A, 1989, GENET EPIDEMIOL, V6, P1, DOI 10.1002/gepi.1370060104; THOMSON G, 1989, GENET EPIDEMIOL, V6, P155, DOI 10.1002/gepi.1370060129; Thomson G, 1977, HLA DISEASE, P84; WILSON RK, 1988, IMMUNOL REV, V101, P149, DOI 10.1111/j.1600-065X.1988.tb00736.x	37	35	35	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1990	47	1					45	52						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DK482	1971998				2022-12-18	WOS:A1990DK48200007
J	BORIGHT, AP; SCRIVER, CR; LANCASTER, GA; CHOY, F				BORIGHT, AP; SCRIVER, CR; LANCASTER, GA; CHOY, F			PROLIDASE DEFICIENCY - BIOCHEMICAL CLASSIFICATION OF ALLELES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MCGILL UNIV, MONTREAL CHILDRENS HOSP,RES INST, DEBELLE LAB BIOCHEM GENET,A-707,2300 TUPPER ST, MONTREAL H3H 1P3, QUEBEC, CANADA; MCGILL UNIV, DEPT BIOL, MONTREAL H3A 2T5, QUEBEC, CANADA; MCGILL UNIV, CTR HUMAN GENET, MONTREAL H3A 2T5, QUEBEC, CANADA	McGill University; McGill University; McGill University								BAKSI K, 1974, INDIAN J BIOCHEM BIO, V2, P7; Bergmann M, 1937, J BIOL CHEM, V117, P189; BORIGHT A P, 1988, American Journal of Human Genetics, V43, pA3; BORIGHT AP, 1988, THESIS MCGILL U; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROOK J D, 1987, Genomics, V1, P320, DOI 10.1016/0888-7543(87)90031-0; BUTTERWORTH J, 1984, J INHERIT METAB DIS, V7, P32, DOI 10.1007/BF01805618; BUTTERWORTH J, 1985, J INHERIT METAB DIS, V8, P193, DOI 10.1007/BF01805434; CHINARD FP, 1952, J BIOL CHEM, V199, P91; ENDO F, 1987, PEDIATR RES, V22, P627, DOI 10.1203/00006450-198712000-00002; FAULL KF, 1976, CLIN CHIM ACTA, V70, P313, DOI 10.1016/0009-8981(76)90433-2; GRAY RGF, 1983, J INHERIT METAB DIS, V6, P143; HARRIS H, 1980, HUMAN BIOCH GENETICS; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; JACKSON SH, 1975, CAN MED ASSOC J, V113, P759; KALOUSTIAN VMD, 1982, DERMATOLOGICA, V164, P293, DOI 10.1159/000250106; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAURELL CB, 1966, ANAL BIOCHEM, V15, P45, DOI 10.1016/0003-2697(66)90246-6; LEMIEUX B, 1984, J INHERIT METAB DIS, V7, P145; LEWIS WHP, 1969, ANN HUM GENET, V32, P317, DOI 10.1111/j.1469-1809.1969.tb00081.x; LEWIS WHP, 1967, NATURE, V215, P351, DOI 10.1038/215351a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MANAO G, 1972, PHYSIOL CHEM PHYS M, V4, P75; MYARA I, 1985, CLIN CHIM ACTA, V150, P1, DOI 10.1016/0009-8981(85)90305-5; MYARA I, 1982, CLIN CHIM ACTA, V125, P193, DOI 10.1016/0009-8981(82)90196-6; MYARA I, 1987, CLIN CHIM ACTA, V170, P263, DOI 10.1016/0009-8981(87)90136-7; MYARA I, 1984, LIFE SCI, V34, P1985, DOI 10.1016/0024-3205(84)90363-1; OHHASHI T, 1988, J INHERIT METAB DIS, V11, P166, DOI 10.1007/BF01799867; PHANG JM, METABOLCI BASIS INHE, P577; PRIESTMAN DA, 1984, CLIN CHIM ACTA, V142, P263, DOI 10.1016/0009-8981(84)90385-1; PROIA RL, 1984, J BIOL CHEM, V259, P3350; RICHTER AM, IN PRESS BIOCH CELL; ROYCE PM, 1982, J INHERIT METAB DIS, V5, P111, DOI 10.1007/BF01800003; SAMBUY Y, 1984, MECH AGEING DEV, V26, P13, DOI 10.1016/0047-6374(84)90161-1; SHEFFIELD LJ, 1977, J PEDIATR-US, V91, P578, DOI 10.1016/S0022-3476(77)80506-4; SJOSTROM H, 1973, BIOCHIM BIOPHYS ACTA, V327, P457, DOI 10.1016/0005-2744(73)90429-4	36	35	36	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1989	44	5					731	740						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	U3338	2705457				2022-12-18	WOS:A1989U333800015
J	SAXON, PJ; SCHULTZ, RA; STANBRIDGE, EJ; FRIEDBERG, EC				SAXON, PJ; SCHULTZ, RA; STANBRIDGE, EJ; FRIEDBERG, EC			HUMAN CHROMOSOME-15 CONFERS PARTIAL COMPLEMENTATION OF PHENOTYPES TO XERODERMA PIGMENTOSUM GROUP F-CELLS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									STANFORD UNIV,MED CTR,SCH MED,DEPT PATHOL,300 PASTEUR DR,STANFORD,CA 94305; UNIV CALIF IRVINE,DEPT MICROBIOL & MOLEC GENET,IRVINE,CA 92717	Stanford University; University of California System; University of California Irvine					NCI NIH HHS [CA-44247, CA-09151, CA-19401] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009151, R01CA044247, R37CA019401, R01CA019401] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		CLEAVER JE, 1968, NATURE, V218, P652, DOI 10.1038/218652a0; CLEAVER JE, 1981, DNA REPAIR LABORATOR, P277; Clever JE., 1983, METABOLIC BASIS INHE, P1227; COLBEREGARAPIN F, 1986, GENE, V50, P279, DOI 10.1016/0378-1119(86)90332-X; FRIEDBERG EC, 1987, MUTAT RES, V184, P67, DOI 10.1016/0167-8817(87)90063-0; FRIEDBERG EC, 1985, DNA REPAIR, P505; FRIEND KK, 1976, SOMAT CELL GENET, V2, P183, DOI 10.1007/BF01542631; GIANNELLI F, 1974, J CELL SCI, V15, P163; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HOEIJMAKERS JHJ, 1987, EXP CELL RES, V169, P111, DOI 10.1016/0014-4827(87)90230-8; HOEIJMAKERS JHJ, 1987, J CELL SCI S, V6, P111; Kraemer K H, 1987, Curr Probl Dermatol, V17, P166; KRAEMER KH, 1984, CLIN DERMATOL, V2, P33; LAMBERT C, 1988, EMBO J, V7, P3245, DOI 10.1002/j.1460-2075.1988.tb03191.x; LAMBERT WC, 1985, MUTAT RES, V145, P227, DOI 10.1016/0167-8817(85)90031-8; LEHMANN AR, 1985, MUTAT RES, V150, P61, DOI 10.1016/0027-5107(85)90101-0; LOHRER H, 1988, MOL GEN GENET, V212, P474, DOI 10.1007/BF00330852; MAYNE LV, 1988, GENE, V66, P65, DOI 10.1016/0378-1119(88)90225-9; ROYERPOKORA B, 1984, NATURE, V311, P390, DOI 10.1038/311390a0; SAXON PJ, 1985, MOL CELL BIOL, V5, P140, DOI 10.1128/MCB.5.1.140; SCHULTZ RA, 1985, SOMAT CELL MOLEC GEN, V11, P617, DOI 10.1007/BF01534726; SCHULTZ RA, 1987, P NATL ACAD SCI USA, V84, P4176, DOI 10.1073/pnas.84.12.4176; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SQUIRES S, 1988, MUTAT RES, V193, P181, DOI 10.1016/0167-8817(88)90048-X; STEFANINI M, 1985, EXP CELL RES, V161, P373, DOI 10.1016/0014-4827(85)90094-1; THOMPSON LH, 1985, MUTAT RES, V150, P423, DOI 10.1016/0027-5107(85)90139-3; THOMPSON LH, 1988, SOMAT CELL MOLEC GEN, V14, P605, DOI 10.1007/BF01535314; VANDUIN M, 1986, CELL, V44, P913, DOI 10.1016/0092-8674(86)90014-0; WEBER CA, 1988, MOL CELL BIOL, V8, P1137, DOI 10.1128/MCB.8.3.1137; WOOD RD, 1988, CELL, V53, P97, DOI 10.1016/0092-8674(88)90491-6; Worton R G, 1979, Methods Enzymol, V58, P322; YAGI T, 1983, MUTAT RES, V112, P59, DOI 10.1016/0167-8817(83)90024-X	33	35	35	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1989	44	4					474	485						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	T8109	2929593				2022-12-18	WOS:A1989T810900006
J	HOOK, EB; CROSS, PK				HOOK, EB; CROSS, PK			MATERNAL CIGARETTE-SMOKING, DOWN SYNDROME IN LIVE BIRTHS, AND INFANT RACE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NEW YORK STATE DEPT HLTH,BUR ENVIRONM EPIDEMIOL & OCCUPAT HLTH,ALBANY,NY 12201; UNION UNIV ALBANY MED COLL,DEPT PEDIAT,ALBANY,NY 12208	State University of New York (SUNY) System; Albany Medical College								CREASY MR, 1974, LANCET, V1, P473; HARDY JB, 1979, 1ST YEAR LIFE COLLAB; Heinonen OP, 1977, BIRTH DEFECTS DRUGS; HOOK EB, 1982, AM J EPIDEMIOL, V116, P743, DOI 10.1093/oxfordjournals.aje.a113463; HOOK EB, 1985, AM J HUM GENET, V37, P1216; HOOK EB, IN PRESS HUM GENET; HOOK EB, 1982, DOWN SYNDROME ADV BI, P11; KLINE J, 1983, AM J HUM GENET, V35, P421; KLINE J, 1981, FRONTIERS KNOWLEDGE, V2, P131; LAMSON SH, 1980, AM J HUM GENET, V32, P743; LANDESMANDWYER S, 1979, TERATOLOGY, V19, P119, DOI 10.1002/tera.1420190116; MYRIANTHOPOULOS N C, 1974, Birth Defects Original Article Series, V10, P1; Myrianthopoulos NC; Collaborative Perinatal Project (U.S.), 1985, MALFORMATIONS CHILDR; Niswander K.R., 1972, WOMEN THEIR PREGNANC; Porter IH, 1976, BIRTH DEFECTS RISKS, P173; SEVER LE, 1983, NINCDS COLLABORATIVE, V1; SHIONO PH, 1986, TERATOLOGY, V34, P65, DOI 10.1002/tera.1420340109; VANDENBROUCKE JP, 1987, AM J EPIDEMIOL, V126, P10, DOI 10.1093/oxfordjournals.aje.a114640	18	35	35	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1988	42	3					482	489						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M6206	2964776				2022-12-18	WOS:A1988M620600011
J	ANAGNOU, NP; ANTONARAKIS, SE; OBRIEN, SJ; MODI, WS; NIENHUIS, AW				ANAGNOU, NP; ANTONARAKIS, SE; OBRIEN, SJ; MODI, WS; NIENHUIS, AW			CHROMOSOMAL LOCALIZATION AND RACIAL DISTRIBUTION OF THE POLYMORPHIC HUMAN DIHYDROFOLATE-REDUCTASE PSEUDOGENE (DHFRPI)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NHLBI,CLIN HEMATOL BRANCH,BETHESDA,MD 20205; JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205; NCI,VIRAL CARCINOGENESIS LAB,FREDERICK,MD 21701	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)			OBRIEN, STEPHEN/ABD-1346-2020; Anagnou, Nicholas/GLR-3609-2022; Antonarakis, Stylianos/N-8866-2014	Antonarakis, Stylianos/0000-0001-8907-5823; OBRIEN, STEPHEN/0000-0001-7857-0757				ANAGNOU NP, 1984, P NATL ACAD SCI-BIOL, V81, P5170, DOI 10.1073/pnas.81.16.5170; ANAGNOU NP, 1985, BLOOD, V65, P1245; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; CHAKRAVARTI A, 1984, P NATL ACAD SCI-BIOL, V81, P6085, DOI 10.1073/pnas.81.19.6085; CHEN MJ, 1982, P NATL ACAD SCI-BIOL, V79, P7435, DOI 10.1073/pnas.79.23.7435; FUNANAGE VL, 1984, MOL CELL BIOL, V4, P2010, DOI 10.1128/MCB.4.10.2010; Goodbourn S E, 1984, Mol Biol Med, V2, P223; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; KAN YW, 1980, SCIENCE, V209, P388, DOI 10.1126/science.7384810; MASTERS J, 1982, J MOL BIOL, V167, P2; MAURER BJ, 1985, SOMAT CELL MOLEC GEN, V11, P79, DOI 10.1007/BF01534737; MAURER BJ, 1984, P NATL ACAD SCI-BIOL, V81, P1484, DOI 10.1073/pnas.81.5.1484; MURRAY JC, 1984, P NATL ACAD SCI-BIOL, V81, P3486, DOI 10.1073/pnas.81.11.3486; NIENHUIS AW, 1985, CELL, V42, P421, DOI 10.1016/0092-8674(85)90099-6; NUSSBAUM RL, 1985, AM J HUM GENET, V37, P1192; OBRIEN SJ, 1983, NATURE, V302, P839, DOI 10.1038/302839a0; OBRIEN SJ, 1982, TECHNIQUES SOMATIC C, P342; REED TE, 1969, SCIENCE, V165, P762, DOI 10.1126/science.165.3895.762; SHIMADA T, 1984, GENE, V31, P1, DOI 10.1016/0378-1119(84)90188-4	19	35	35	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1988	42	2					345	352						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M3133	3341383				2022-12-18	WOS:A1988M313300017
J	JULIER, C; LATHROP, GM; REGHIS, A; SZAJNERT, MF; LALOUEL, JM; KAPLAN, JC				JULIER, C; LATHROP, GM; REGHIS, A; SZAJNERT, MF; LALOUEL, JM; KAPLAN, JC			A LINKAGE AND PHYSICAL MAP OF CHROMOSOME-22, AND SOME APPLICATIONS TO GENE-MAPPING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									INSERM, U129, INST PATHOL MOLEC, F-75005 PARIS, FRANCE; UNIV UTAH, MED CTR, HOWARD HUGHES MED INST, SALT LAKE CITY, UT 84112 USA; CHU MUSTAPHA, CTR NATL TRANSFUS SANGUINE, ALGER, ALGERIA	Institut National de la Sante et de la Recherche Medicale (Inserm); Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah			JULIER, Cécile/M-9824-2017	JULIER, Cécile/0000-0002-1538-0240				Alwine J C, 1979, Methods Enzymol, V68, P220; ANDERSON MLM, 1984, NUCLEIC ACIDS RES, V12, P6647, DOI 10.1093/nar/12.17.6647; BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; CHIU IM, 1984, CELL, V37, P123; COOK PJL, 1978, CYTOGENET CELL GENET, V22, P518, DOI 10.1159/000131013; DALLAFAVERA R, 1982, SCIENCE, V218, P686, DOI 10.1126/science.6291150; DRAYNA D, 1984, P NATL ACAD SCI-BIOL, V81, P2836, DOI 10.1073/pnas.81.9.2836; EIBERG H, 1986, CLIN GENET, V29, P354; EMANUAL BS, 1984, CYTOGENET CELL GENET, V38, P127, DOI 10.1159/000132044; FELLOUS M, 1971, CR ACAD SCI D NAT, V272, P3356; FISHER RA, 1977, ANN HUM GENET, V41, P151, DOI 10.1111/j.1469-1809.1977.tb01909.x; FRANCKE U, 1982, CYTOGENET CELL GENET, V32, P276; GRUNEBAUM L, 1984, J CLIN INVEST, V73, P1491, DOI 10.1172/JCI111354; HOLLIS GF, 1984, NATURE, V307, P752, DOI 10.1038/307752a0; HORSCAYLA MC, 1981, HUM GENET, V58, P140, DOI 10.1007/BF00278698; JEFFREYS AJ, 1984, NUCLEIC ACIDS RES, V12, P3235, DOI 10.1093/nar/12.7.3235; JOHNSSON A, 1984, EMBO J, V3, P921, DOI 10.1002/j.1460-2075.1984.tb01908.x; JOSEPHS SF, 1984, SCIENCE, V223, P487, DOI 10.1126/science.6318322; JULIER C, 1985, CYTOGENET CELL GENET, V40, P665; JULIER C, 1985, CYTOGENET CELL GENET, V40, P663; JULIER C, 1984, THESIS U PARIS 7; JUNIEN C, 1978, HUM GENET, V42, P233, DOI 10.1007/BF00291301; KAPLAN JC, 1987, J MED GENET, V24, P65, DOI 10.1136/jmg.24.2.65; KAPLAN JC, 1979, CR SOC BIOL, V173, P368; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEPPERT M, 1986, AM J HUM GENET, V39, P425; LEROUX A, 1975, NATURE, V258, P619, DOI 10.1038/258619a0; MCALPINE PJ, 1978, CYTOGENET CELL GENET, V22, P629, DOI 10.1159/000131040; MENDELSOHN ML, 1973, SCIENCE, V179, P1126, DOI 10.1126/science.179.4078.1126; NAIKI M, 1975, BIOCHEMISTRY-US, V14, P4837, DOI 10.1021/bi00693a010; NAYLOR SL, 1984, P NATL ACAD SCI-BIOL, V81, P2447, DOI 10.1073/pnas.81.8.2447; NIELSEN LS, 1984, CYTOGENET CELL GENET, V37, P555; OTT J, 1978, ANN HUM GENET, V42, P255, DOI 10.1111/j.1469-1809.1978.tb00657.x; REGHIS A, 1983, HUM GENET, V64, P173, DOI 10.1007/BF00327119; REGHIS A, 1981, HUM GENET, V59, P148, DOI 10.1007/BF00293065; REGHIS A, 1981, THESIS FM ALGER; ROBBINS KC, 1981, P NATL ACAD SCI-BIOL, V78, P2918, DOI 10.1073/pnas.78.5.2918; SCOTT EM, 1969, AM J HUM GENET, V21, P194; TAUB RA, 1983, NATURE, V304, P172, DOI 10.1038/304172a0; TIPPETT P, 1985, CYTOGENET CELL GENET, V40, P268, DOI 10.1159/000132177; WELLER P, 1984, EMBO J, V3, P439, DOI 10.1002/j.1460-2075.1984.tb01825.x; WHITE R, 1985, NATURE, V313, P101, DOI 10.1038/313101a0	43	35	35	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1988	42	2					297	308						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M3133	2893546				2022-12-18	WOS:A1988M313300012
J	CHEN, YT; HE, JK; DING, JH; BROWN, BI				CHEN, YT; HE, JK; DING, JH; BROWN, BI			GLYCOGEN DEBRANCHING ENZYME - PURIFICATION, ANTIBODY CHARACTERIZATION, AND IMMUNOBLOT ANALYSES OF TYPE-III GLYCOGEN-STORAGE-DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									WASHINGTON UNIV,SCH MED,DEPT BIOL CHEM,ST LOUIS,MO 63110	Washington University (WUSTL)	CHEN, YT (corresponding author), DUKE UNIV,MED CTR,DEPT PEDIAT,BOX 3028,DURHAM,NC 27710, USA.				NCRR NIH HHS [RR30] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BATES EJ, 1975, FEBS LETT, V58, P181, DOI 10.1016/0014-5793(75)80254-7; BECKER JU, 1977, BIOCHEMISTRY-US, V16, P291, DOI 10.1021/bi00621a021; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown B. I., 1968, CARBOHYD METABOL, V2, P123; Brown D.H., 1966, METHOD ENZYMOL, P515, DOI 10.1016/0076-6879(66)08093-5; DING J H, 1986, American Journal of Human Genetics, V39, pA7; DREYFUS JC, 1971, BIOCHEM BIOPH RES CO, V44, P1364, DOI 10.1016/S0006-291X(71)80236-X; GILLARD BK, 1977, BIOCHEMISTRY-US, V16, P3978, DOI 10.1021/bi00637a007; GORDON RB, 1972, BIOCHIM BIOPHYS ACTA, V289, P97, DOI 10.1016/0005-2744(72)90112-X; HOWELL RR, 1983, METABOLIC BASIS INHE, P141; ILLINGWORTH B, 1962, P NATL ACAD SCI USA, V48, P1619, DOI 10.1073/pnas.48.9.1619; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE EYC, 1970, BIOCHEMISTRY-US, V9, P2347, DOI 10.1021/bi00813a019; SHALTIEL S, 1973, P NATL ACAD SCI USA, V70, P778, DOI 10.1073/pnas.70.3.778; TAYLOR C, 1975, EUR J BIOCHEM, V51, P105, DOI 10.1111/j.1432-1033.1975.tb03911.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANHOOF F, 1967, EUR J BIOCHEM, V2, P265; WHITE RC, 1974, BIOCHIM BIOPHYS ACTA, V365, P274, DOI 10.1016/0005-2795(74)90271-2; WHITE RC, 1981, ANAL BIOCHEM, V115, P388, DOI 10.1016/0003-2697(81)90022-1	19	35	37	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1987	41	6					1002	1015						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	L2984	2961257				2022-12-18	WOS:A1987L298400004
J	MILLER, YE; DANIELS, GL; JONES, C; PALMER, DK				MILLER, YE; DANIELS, GL; JONES, C; PALMER, DK			IDENTIFICATION OF A CELL-SURFACE ANTIGEN PRODUCED BY A GENE ON HUMAN CHROMOSOME-3 (CEN-Q22) AND NOT EXPRESSED BY RHNULL CELLS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									ELEANOR ROOSEVELT INST CANC RES,DENVER,CO; UNIV COLORADO,HLTH SCI CTR,DEPT BIOCHEM BIOPHYS & GENET,DENVER,CO 80262; UNIV LONDON UNIV COLL,MRC,BLOOD GRP UNIT,LONDON WC1E 6BT,ENGLAND	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of London; University College London	MILLER, YE (corresponding author), VET ADM MED CTR,DEPT MED,DIV PULM SCI,RES 151,1055 CLERMONT ST,DENVER,CO 80220, USA.				NATIONAL CANCER INSTITUTE [R01CA018734, R23CA034831] Funding Source: NIH RePORTER; NCI NIH HHS [CA34831, CA18734] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADVANI H, 1982, BRIT J HAEMATOL, V51, P107, DOI 10.1111/j.1365-2141.1982.tb07295.x; ALHADEFF B, 1977, CYTOGENET CELL GENET, V19, P236, DOI 10.1159/000130814; ANSTEE DJ, 1982, EUR J IMMUNOL, V12, P228, DOI 10.1002/eji.1830120311; ANSTEE DJ, 1984, BIOCHEM J, V221, P97, DOI 10.1042/bj2210097; BIES R, 1984, CLIN RES, V32, pA29; BOBROW M, 1974, NATURE, V251, P77, DOI 10.1038/251077a0; EDWARDS P A W, 1980, Biochemical Society Transactions, V8, P334; ENNS CA, 1982, P NATL ACAD SCI-BIOL, V79, P3241, DOI 10.1073/pnas.79.10.3241; GOODFELLOW PN, 1982, SOMAT CELL GENET, V8, P197, DOI 10.1007/BF01538677; JONES C, 1980, CYTOGENET CELL GENET, V28, P181, DOI 10.1159/000131529; JONES PP, 1980, SELECTED METHODS CEL, P398; KLOPPEL TM, 1984, J CELL BIOCHEM, V24, P307, DOI 10.1002/jcb.240240402; KUYPERS F, 1984, BIOCHEM J, V221, P931, DOI 10.1042/bj2210931; MILLER YE, 1983, AM J HUM GENET, V35, P573; PARKKINEN E, 1984, HEREDITAS, V101, P217, DOI 10.1111/j.1601-5223.1984.tb00918.x; PLOWMAN GD, 1983, NATURE, V303, P70, DOI 10.1038/303070a0; RABIN M, 1985, AM J HUM GENET, V37, P1112; Race RR., 1975, BLOOD GROUPS MAN; RETTIG WJ, 1984, P NATL ACAD SCI-BIOL, V81, P6437, DOI 10.1073/pnas.81.20.6437; RIDGWELL K, 1983, BIOCHEM J, V213, P267, DOI 10.1042/bj2130267; SEABRIGH.M, 1971, LANCET, V2, P971; SELIGMAN PA, 1986, AM J HUM GENET, V38, P540; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VOS GH, 1961, LANCET, V1, P14; VOSS R, 1980, ANN HUM GENET, V44, P1, DOI 10.1111/j.1469-1809.1980.tb00940.x	25	35	35	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1987	41	6					1061	1070						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	L2984	3120581				2022-12-18	WOS:A1987L298400009
J	WRIGHT, AF; BHATTACHARYA, SS; CLAYTON, JF; DEMPSTER, M; TIPPETT, P; MCKEOWN, CME; JAY, M; JAY, B; BIRD, AC				WRIGHT, AF; BHATTACHARYA, SS; CLAYTON, JF; DEMPSTER, M; TIPPETT, P; MCKEOWN, CME; JAY, M; JAY, B; BIRD, AC			LINKAGE RELATIONSHIPS BETWEEN X-LINKED RETINITIS-PIGMENTOSA AND 9 SHORT-ARM MARKERS - EXCLUSION OF THE DISEASE LOCUS FROM XP21 AND LOCALIZATION TO BETWEEN DXS7 AND DXS14	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV EDINBURGH,WESTERN GEN HOSP,DEPT MED,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND; UNIV LONDON UNIV COLL,MRC,BLOOD GRP UNIT,LONDON WC1E 6BT,ENGLAND; UNIV LONDON,DEPT CLIN OPHTHALMOL,LONDON,ENGLAND; MOORFIELDS EYE HOSP,LONDON WC1V 7AN,ENGLAND; BIRMINGHAM MATERN HOSP,DEPT CLIN GENET,BIRMINGHAM B15 2TG,W MIDLANDS,ENGLAND	University of Edinburgh; University of London; University College London; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	WRIGHT, AF (corresponding author), UNIV EDINBURGH,WESTERN GEN HOSP,MRC,CLIN & POPULAT CYTOGENET UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND.		Bhattacharya, Shom/N-2926-2016	Bhattacharya, Shom/0000-0002-1601-6344				ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; ARDEN GB, 1983, BRIT J OPHTHALMOL, V67, P419, DOI 10.1136/bjo.67.7.419; BERSON EL, 1979, AM J OPHTHALMOL, V87, P460, DOI 10.1016/0002-9394(79)90231-9; BHATTACHARYA SS, 1984, NATURE, V309, P253, DOI 10.1038/309253a0; BHATTACHARYA SS, 1985, BRIT J OPHTHALMOL, V69, P340, DOI 10.1136/bjo.69.5.340; BIRD AC, 1975, BRIT J OPHTHALMOL, V59, P177, DOI 10.1136/bjo.59.4.177; BOUGHMAN JA, 1980, AM J HUM GENET, V32, P223; BRUNS G, 1984, CYTOGENET CELL GENET, V37, P428; CLAYTON J, 1986, HUM GENET, V73, P68, DOI 10.1007/BF00292667; CLAYTON JF, 1986, HUM GENET, V74, P168, DOI 10.1007/BF00282083; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRANCKE U, 1985, AM J HUM GENET, V37, P250; FRIEDRICH U, 1985, HUM GENET, V71, P93; GOODFELLOW PN, 1985, CYTOGENET CELL GENET, V40, P296, DOI 10.1159/000132178; HECKENLIVELY J, 1983, PRINCIPLES PRACTICE, V1, P522; HOFKER MH, 1985, HUM GENET, V70, P148, DOI 10.1007/BF00273073; JAY M, 1982, BRIT J OPHTHALMOL, V66, P405, DOI 10.1136/bjo.66.7.405; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; KUNKEL LM, 1982, NUCLEIC ACIDS RES, V10, P1557, DOI 10.1093/nar/10.5.1557; MANN JD, 1962, LANCET, V1, P8; MARTYN LJ, 1972, AM J OPHTHALMOL, V73, P403, DOI 10.1016/0002-9394(72)90070-0; MUKAI S, 1985, AM J OPHTHALMOL, V100, P225, DOI 10.1016/0002-9394(85)90786-X; NUSSBAUM RL, 1985, HUM GENET, V70, P45, DOI 10.1007/BF00389458; NUSSBAUM RL, 1986, AM J HUM GENET, V38, P149; PAGE D, 1982, P NATL ACAD SCI-BIOL, V79, P5352, DOI 10.1073/pnas.79.17.5352; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; WIEACKER P, 1984, AM J HUM GENET, V36, P265; WRIGHT AF, 1983, T OPHTHAL SOC UK, V103, P467	29	35	35	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1987	41	4					635	644						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	K4621	3477957				2022-12-18	WOS:A1987K462100012
J	HILL, AVS; GENTILE, B; BONNARDOT, JM; ROUX, J; WEATHERALL, DJ; CLEGG, JB				HILL, AVS; GENTILE, B; BONNARDOT, JM; ROUX, J; WEATHERALL, DJ; CLEGG, JB			POLYNESIAN ORIGINS AND AFFINITIES - GLOBIN GENE VARIANTS IN EASTERN POLYNESIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALPHA-THALASSEMIA; REARRANGEMENTS; RECOMBINATION; POLYMORPHISM; PACIFIC; LOCI		UNIV OXFORD, JOHN RADCLIFFE HOSP,NUFFIELD DEPT CLIN MED,MRC, HAEMATOL UNIT, OXFORD OX3 9DU, ENGLAND; INST RECH MED LOUIS MALARDE, TAHITI, FRANCE; CTR HOSP TERR TAHITI, TAHITI, FRANCE	University of Oxford			HILL, Adrian V>S>/C-1306-2008					ANTONARAKIS SE, 1985, HUM GENET, V69, P1, DOI 10.1007/BF00295521; Bellwood P., 1978, MANS CONQUEST PACIFI; BROCKWAY RW, 1983, J HUM EVOL, V12, P501, DOI 10.1016/S0047-2484(83)80028-1; CRAIB JL, 1983, SCIENCE, V219, P922, DOI 10.1126/science.219.4587.922; EMBURY SH, 1980, J CLIN INVEST, V66, P1319, DOI 10.1172/JCI109984; FLINT J, 1986, NATURE, V321, P744, DOI 10.1038/321744a0; Goodbourn S E, 1984, Mol Biol Med, V2, P223; GOODBOURN SEY, 1983, P NATL ACAD SCI-BIOL, V80, P5022, DOI 10.1073/pnas.80.16.5022; GOOSSENS M, 1980, P NATL ACAD SCI-BIOL, V77, P518, DOI 10.1073/pnas.77.1.518; HEYERDAHL T., 1952, AM INDIANS PACIFIC; Higgs D R, 1983, Curr Top Hematol, V4, P37; HIGGS DR, 1986, P NATL ACAD SCI USA, V83, P5165, DOI 10.1073/pnas.83.14.5165; HIGGS DR, 1980, NATURE, V284, P632, DOI 10.1038/284632a0; HIGGS DR, 1984, NUCLEIC ACIDS RES, V12, P6965, DOI 10.1093/nar/12.18.6965; HILL AVS, 1985, AM J HUM GENET, V37, P571; HILL AVS, 1985, CELL, V42, P809, DOI 10.1016/0092-8674(85)90277-6; HILL AVS, 1986, BLOOD, V67, P1611; Howells, 1973, PACIFIC ISLANDERS; KIRK RL, 1980, POPULATION STRUCTURE, P113; LIEINJO LE, 1985, HUM GENET, V70, P116, DOI 10.1007/BF00273068; Old JM., 1983, METHODS HEMATOLOGY T, V6, P74; SERJEANTSON SW, 1984, J PAC HIST, V19, P160, DOI 10.1080/00223348408572491; Simmons R. T, 1966, ARCHAEOL PHYS ANTHRO, V1, P155; SIMMONS RT, 1962, OCEANIA, V32, P198, DOI 10.1002/j.1834-4461.1962.tb01763.x; SUKUMARAN PK, 1983, NUCLEIC ACIDS RES, V11, P4635; TRENT RJ, 1986, AM J HUM GENET, V39, P350; TRENT RJ, 1981, NUCLEIC ACIDS RES, V9, P6723, DOI 10.1093/nar/9.24.6723; TRENT RJ, 1985, AM J HEMATOL, V18, P431, DOI 10.1002/ajh.2830180414; WAINSCOAT JS, 1986, NATURE, V319, P491, DOI 10.1038/319491a0; WINICHAGOON P, 1982, NUCLEIC ACIDS RES, V10, P5853, DOI 10.1093/nar/10.19.5853	30	35	35	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1987	40	5					453	463						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	H5759	2883894				2022-12-18	WOS:A1987H575900007
J	MUNROE, DG; CHANG, PL				MUNROE, DG; CHANG, PL			TISSUE-SPECIFIC EXPRESSION OF HUMAN ARYLSULFATASE-C ISOZYMES AND STEROID SULFATASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MCMASTER UNIV,MED CTR,DEPT PEDIAT,HUMAN GENET PROGRAM,3N18,1200 MAIN ST W,HAMILTON L8N 3Z5,ONTARIO,CANADA	McMaster University								BADEN HP, 1980, PEDIATR RES, V14, P1347, DOI 10.1203/00006450-198012000-00015; BEDIN M, 1981, HUM GENET, V59, P256; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURNS GRJ, 1983, BIOCHIM BIOPHYS ACTA, V759, P199, DOI 10.1016/0304-4165(83)90313-6; CHANCE PF, 1983, AM J HUM GENET, V35, P234; CHANG P L, 1984, American Journal of Human Genetics, V36, p8S; CHANG PL, 1985, ANAL BIOCHEM, V144, P362, DOI 10.1016/0003-2697(85)90129-0; CHANG PL, IN PRESS J BIOL CHEM; DANCIS J, 1980, PEDIATR RES, V14, P521; DANCIS J, 1983, J INHERIT METAB DIS, V6, P173, DOI 10.1007/BF02310876; DOLLY JO, 1972, BIOCHEM J, V128, P337, DOI 10.1042/bj1280337; EPSTEIN EH, 1981, J CLIN INVEST, V67, P1257, DOI 10.1172/JCI110153; ETO Y, 1974, ARCH NEUROL-CHICAGO, V30, P153, DOI 10.1001/archneur.1974.00490320041005; FLUHARTY AL, 1975, BIOCHEM BIOPH RES CO, V64, P955, DOI 10.1016/0006-291X(75)90140-0; FRANCE JT, 1969, J CLIN ENDOCR METAB, V29, P138, DOI 10.1210/jcem-29-1-138; GAUTHIER R, 1978, STEROIDS, V31, P783, DOI 10.1016/S0039-128X(78)80043-9; IWAMORI M, 1976, ARCH BIOCHEM BIOPHYS, V174, P199, DOI 10.1016/0003-9861(76)90339-8; JOBSIS AC, 1980, AM J PATHOL, V99, P279; JOBSIS AC, 1983, BRIT J DERMATOL, V108, P567, DOI 10.1111/j.1365-2133.1983.tb01058.x; LIPMAN EL, 1982, AM J HUM GENET, V34, pA172; LYKKESFELDT G, 1981, LANCET, V2, P255; LYKKESFELDT G, 1984, HUM GENET, V65, P355, DOI 10.1007/BF00291559; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; MEHL E, 1968, BIOCHIM BIOPHYS ACTA, V151, P619, DOI 10.1016/0005-2744(68)90008-9; MEYER JC, 1979, HUM GENET, V53, P115, DOI 10.1007/BF00289462; MIGEON BR, 1982, NATURE, V299, P838, DOI 10.1038/299838a0; MOHANDAS T, 1980, P NATL ACAD SCI-BIOL, V77, P6759, DOI 10.1073/pnas.77.11.6759; MOHANDAS T, 1979, P NATL ACAD SCI USA, V76, P5779, DOI 10.1073/pnas.76.11.5779; MULLER CR, 1980, HUM GENET, V54, P197, DOI 10.1007/BF00278971; NOEL H, 1983, J STEROID BIOCHEM, V19, P1591, DOI 10.1016/0022-4731(83)90375-8; Race RR., 1975, BLOOD GROUPS MAN; ROPERS HH, 1981, HUM GENET, V57, P354, DOI 10.1007/BF00281683; ROSE FA, 1982, J INHERIT METAB DIS, V5, P145, DOI 10.1007/BF01800170; SCHEMPP W, 1983, HUM GENET, V63, P171, DOI 10.1007/BF00291539; SHAPIRO LJ, 1979, SCIENCE, V204, P1224, DOI 10.1126/science.156396; SHAPIRO LJ, 1978, LANCET, V1, P70; SHAPIRO LJ, 1978, LANCET, V2, P756; SIMARD JPS, 1985, BIOCHEM BIOPH RES CO, V128, P1388, DOI 10.1016/0006-291X(85)91094-0; VOGEL W, 1984, HUM GENET, V66, P367, DOI 10.1007/BF00287644	39	35	36	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1987	40	2					102	114						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	G7740	3471087				2022-12-18	WOS:A1987G774000003
J	THOMSON, G				THOMSON, G			DETERMINING THE MODE OF INHERITANCE OF RFLP-ASSOCIATED DISEASES USING THE AFFECTED SIB-PAIR METHOD	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											THOMSON, G (corresponding author), UNIV CALIF BERKELEY,DEPT GENET,MULFORD HALL,BERKELEY,CA 94720, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD012731] Funding Source: NIH RePORTER; NICHD NIH HHS [HD12731] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; CHRISTIANSEN FT, 1984, HISTOCOMPATIBILITY T, P378; DAY NE, 1976, TISSUE ANTIGENS, V8, P109; EDWARDS AWF, 1971, BIOMETRICS, V27, P873, DOI 10.2307/2528824; FISHMAN PM, 1978, AM J HUM GENET, V30, P308; GREEN JR, 1977, TISSUE ANTIGENS, V9, P31; LANGE K, 1986, AM J HUM GENET, V39, P148; LOUIS EJ, 1983, ANN HUM GENET, V47, P225, DOI 10.1111/j.1469-1809.1983.tb00991.x; LOUIS EJ, UNPUB AFFECTED SIB M, V6; MOTRO U, 1985, GENETICS, V110, P525; PAYAMI H, 1984, AM J HUM GENET, V36, P352; PAYAMI H, 1986, TISSUE ANTIGENS, V27, P57; RISCH N, 1982, AM J HUM GENET, V34, P191; SPIELMAN RS, 1980, ANN HUM GENET, V44, P135, DOI 10.1111/j.1469-1809.1980.tb00954.x; STEWART GJ, 1981, HUM IMMUNOL, V3, P13, DOI 10.1016/0198-8859(81)90040-9; SUAREZ B, 1979, DIABETES, V28, P527, DOI 10.2337/diabetes.28.6.527; SUAREZ BK, 1978, ANN HUM GENET, V42, P87, DOI 10.1111/j.1469-1809.1978.tb00933.x; SUAREZ BK, 1978, TISSUE ANTIGENS, V12, P87, DOI 10.1111/j.1399-0039.1978.tb01303.x; SUAREZ BK, 1982, TISSUE ANTIGENS, V20, P193; THOMSON G, 1983, TISSUE ANTIGENS, V21, P81; THOMSON G, 1981, THEOR POPUL BIOL, V20, P168, DOI 10.1016/0040-5809(81)90009-5; THOMSON G, 1984, AM J HUM GENET, V36, P466; THOMSON G, 1980, ANN HUM GENET, V43, P383, DOI 10.1111/j.1469-1809.1980.tb01572.x; Thomson G, 1977, HLA DISEASE, P84; THOMSON G, 1977, MEASURING SELECTION, P545; THOMSON G, UNPUB HLA IDDM PREDI; WALKER A, 1980, DIABETES, V29, P1036, DOI 10.2337/diabetes.29.12.1036	27	35	35	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1986	39	2					207	221						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	E1459	3019132				2022-12-18	WOS:A1986E145900007
J	KOBAYASHI, K; SAHEKI, T; IMAMURA, Y; NODA, T; INOUE, I; MATUO, S; HAGIHARA, S; NOMIYAMA, H; JINNO, Y; SHIMADA, K				KOBAYASHI, K; SAHEKI, T; IMAMURA, Y; NODA, T; INOUE, I; MATUO, S; HAGIHARA, S; NOMIYAMA, H; JINNO, Y; SHIMADA, K			MESSENGER-RNA CODING FOR ARGININOSUCCINATE SYNTHETASE IN CITRULLINEMIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									KUMAMOTO UNIV, SCH MED, DEPT BIOCHEM, KUMAMOTO 860, JAPAN	Kumamoto University	KOBAYASHI, K (corresponding author), KAGOSHIMA UNIV, SCH MED, DEPT BIOCHEM, USUKI CHO 1208-1, KAGOSHIMA 890, JAPAN.		Nomiyama, Hisayuki/F-2840-2013	Nomiyama, Hisayuki/0000-0002-2716-4043				AKABOSHI I, 1983, J INHERIT METAB DIS, V6, P36, DOI 10.1007/BF02391191; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BOCK HGO, 1983, NUCLEIC ACIDS RES, V11, P6505, DOI 10.1093/nar/11.18.6505; BRIAND P, 1983, BIOCHIM BIOPHYS ACTA, V760, P389, DOI 10.1016/0304-4165(83)90379-3; CARRITT B, 1977, EXP CELL RES, V106, P71, DOI 10.1016/0014-4827(77)90242-7; CARRITT B, 1979, CYTOGENET CELL GENET, V23, P171, DOI 10.1159/000131323; CARRITT B, 1977, CYTOGENET CELL GENET, V19, P44, DOI 10.1159/000130793; CRKVENJAKOV R, 1982, BIOCHEM BIOPH RES CO, V105, P1524, DOI 10.1016/0006-291X(82)90961-5; ESUMI H, 1983, P NATL ACAD SCI-BIOL, V80, P95, DOI 10.1073/pnas.80.1.95; FORGET BG, 1983, BANBURY REPORT, V14, P3; FREYTAG SO, 1984, J BIOL CHEM, V259, P3160; FREYTAG SO, 1984, MOL CELL BIOL, V4, P1978, DOI 10.1128/MCB.4.10.1978; GLYNIAS MJ, 1984, BIOCHEMISTRY-US, V23, P3454, DOI 10.1021/bi00310a011; GRACY RW, 1970, ARCH BIOCHEM BIOPHYS, V136, P480, DOI 10.1016/0003-9861(70)90219-5; HARDING JD, 1978, J BIOL CHEM, V253, P7531; JINNO Y, 1984, J INHERIT METAB DIS, V7, P133, DOI 10.1007/BF01801773; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MANIATIS T, 1980, ANNU REV GENET, V14, P145, DOI 10.1146/annurev.ge.14.120180.001045; McKusick V.A., 1983, MENDELIAN INHERITANC; MCMURRAY WC, 1962, LANCET, V1, P138; MIZUNO T, 1984, P NATL ACAD SCI-BIOL, V81, P1966, DOI 10.1073/pnas.81.7.1966; MORI M, 1979, P NATL ACAD SCI USA, V76, P3179, DOI 10.1073/pnas.76.7.3179; MORI M, 1981, J BIOL CHEM, V256, P4127; MUECKLER MM, 1981, J CELL BIOL, V90, P495, DOI 10.1083/jcb.90.2.495; MUECKLER MM, 1983, J BIOL CHEM, V258, P6109; ORKIN SH, 1983, BANBURY REPORT, V14, P19; PELHAM HRB, 1976, EUR J BIOCHEM, V67, P247, DOI 10.1111/j.1432-1033.1976.tb10656.x; PESTKA S, 1984, P NATL ACAD SCI-BIOL, V81, P7525, DOI 10.1073/pnas.81.23.7525; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; ROSENBERG LE, 1983, SCIENCE, V222, P426, DOI 10.1126/science.6623083; SAHEKI T, 1982, CLIN CHIM ACTA, V118, P93; SAHEKI T, 1984, J INHERIT METAB DIS, V7, P2, DOI 10.1007/BF01805609; SAHEKI T, 1981, CLIN CHIM ACTA, V109, P325, DOI 10.1016/0009-8981(81)90318-1; SAHEKI T, 1985, J INHERIT METAB DIS, V8, P155, DOI 10.1007/BF01819306; SAHEKI T, 1983, J BIOCHEM, V93, P1531, DOI 10.1093/oxfordjournals.jbchem.a134291; SAHEKI T, 1983, UREA CYCLE DISEASES, P63; SARGENT T D, 1983, Science (Washington D C), V222, P135, DOI 10.1126/science.6688681; SASE M, 1985, HUM GENET, V69, P130, DOI 10.1007/BF00293282; SHIH VE, 1976, UREA CYCLE, P367; SIMONS RW, 1983, CELL, V34, P683, DOI 10.1016/0092-8674(83)90401-4; SU TS, 1981, J BIOL CHEM, V256, P1826; SU TS, 1983, NATURE, V301, P533, DOI 10.1038/301533a0; SU TS, 1982, J CLIN INVEST, V70, P1334, DOI 10.1172/JCI110736; SUL HS, 1984, J BIOL CHEM, V259, P555; TAKADA S, 1979, J BIOCHEM, V86, P1353, DOI 10.1093/oxfordjournals.jbchem.a132652; THOMAS PS, 1983, METHOD ENZYMOL, V100, P255; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; WIGINTON DA, 1983, P NATL ACAD SCI-BIOL, V80, P7481, DOI 10.1073/pnas.80.24.7481; YENOFSKY R, 1982, BIOCHEMISTRY-US, V21, P3909, DOI 10.1021/bi00260a001; YOSHITAKE S, 1982, ANAL LETT PT B, V15, P147, DOI 10.1080/00032718208064372	50	35	35	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1986	38	5					667	680						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	C9730	3459354				2022-12-18	WOS:A1986C973000005
J	FEDER, J; GURLING, HMD; DARBY, J; CAVALLISFORZA, LL				FEDER, J; GURLING, HMD; DARBY, J; CAVALLISFORZA, LL			DNA RESTRICTION FRAGMENT ANALYSIS OF THE PROOPIOMELANOCORTIN GENE IN SCHIZOPHRENIA AND BIPOLAR DISORDERS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV LONDON, INST PSYCHIAT, DEPT PSYCHIAT, GENET SECT, LONDON SE5 8AF, ENGLAND	University of London; King's College London	FEDER, J (corresponding author), STANFORD UNIV, DEPT GENET, STANFORD, CA 94305 USA.		Gurling, Hugh M/A-5029-2010		NIH HHS [NH-07004-01] Funding Source: Medline; PHS HHS [28428, 20467] Funding Source: Medline	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		CHANG ACY, 1980, P NATL ACAD SCI-BIOL, V77, P4890, DOI 10.1073/pnas.77.8.4890; CHANG JC, 1981, LANCET, V2, P1127; COCHET M, 1982, NATURE, V297, P335, DOI 10.1038/297335a0; FEDER J, 1983, AM J HUM GENET, V35, P1090; FEIGHNER JP, 1972, ARCH GEN PSYCHIAT, V26, P57, DOI 10.1001/archpsyc.1972.01750190059011; GERSHON ES, 1983, GENETICS NEUROLOGICA, P121; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; HORNYKIEWICZ O, 1982, NATURE, V299, P484, DOI 10.1038/299484a0; JACQUET YF, 1982, SCIENCE, V218, P175, DOI 10.1126/science.6289433; JACQUET YF, 1976, SCIENCE, V194, P632, DOI 10.1126/science.185695; KALIN NH, 1982, PSYCHIAT RES, V7, P87, DOI 10.1016/0165-1781(82)90056-7; KARATHANASIS SK, 1983, NATURE, V305, P823, DOI 10.1038/305823a0; KETY SS, 1976, PSYCHIAT ANN, V6, P11; KIDD KK, 1973, SOC BIOL, V20, P254, DOI 10.1080/19485565.1973.9988051; KIDD KK, 1978, ARCH GEN PSYCHIAT, V35, P925; KIDD VJ, 1983, NATURE, V304, P230, DOI 10.1038/304230a0; KWOK SCM, 1981, BIOCHEM BIOPH RES CO, V98, P844; MEARS JG, 1978, P NATL ACAD SCI USA, V75, P1222, DOI 10.1073/pnas.75.3.1222; OROURKE DH, 1982, AM J HUM GENET, V34, P630; PHILLIPS JA, 1981, P NATL ACAD SCI-BIOL, V78, P6372, DOI 10.1073/pnas.78.10.6372; REUS VI, 1982, NEW ENGL J MED, V306, P238; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; RISCH SC, 1982, BIOL PSYCHIAT, V17, P1071; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Spitzer Robert, 1978, CRITICAL ISSUES PSYC; SPRITZ RA, 1983, AM J HUM GENET, V35, P333; STEFFEN D, 1978, CELL, V15, P1003, DOI 10.1016/0092-8674(78)90284-2; WAIKAN Y, 1978, P NATL ACAD SCI USA, V75, P5631, DOI 10.1073/pnas.75.11.5631; WEATHERALL DJ, 1982, CELL, V29, P7, DOI 10.1016/0092-8674(82)90084-8; WETTERBERG L, 1982, BRAIN PEPTIDES HORMO, P257; WHITFELD PL, 1982, DNA-J MOLEC CELL BIO, V1, P133, DOI 10.1089/dna.1.1982.1.133; WIJSMAN E, UNPUB OPTIMIZING SEL; WILCOCK J, 1969, PSYCHOL BULL, V72, P1, DOI 10.1037/h0027517; WYMAN AR, 1980, P NATL ACAD SCI-BIOL, V77, P6754, DOI 10.1073/pnas.77.11.6754	34	35	36	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1985	37	2					286	294						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AGY59	2984925				2022-12-18	WOS:A1985AGY5900004
J	HOOK, EB; REGAL, RR				HOOK, EB; REGAL, RR			A SEARCH FOR A PATERNAL-AGE EFFECT UPON CASES OF 47, + 21 IN WHICH THE EXTRA CHROMOSOME IS OF PATERNAL ORIGIN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNION UNIV ALBANY MED COLL,DEPT PEDIAT,ALBANY,NY 12208; UNIV MINNESOTA,DEPT MATH SCI,DULUTH,MN 55812	Albany Medical College; University of Minnesota System; University of Minnesota Duluth	HOOK, EB (corresponding author), NEW YORK STATE DEPT HLTH,BUR MATERNAL & CHILD HLTH,ALBANY,NY 12237, USA.							CAROTHERS AD, 1978, ANN HUM GENET, V41, P277, DOI 10.1111/j.1469-1809.1978.tb01895.x; DELMAZO J, 1982, HUM GENET, V62, P316, DOI 10.1007/BF00304546; HOOK EB, 1982, HUM GENET, V62, P167; MAGENIS RE, 1981, TRISOMY 21 RES PERSP, P77; MANNING CH, 1981, HUM GENET, V59, P101, DOI 10.1007/BF00293054; MATTEI JF, 1980, J MED GENET, V17, P368, DOI 10.1136/jmg.17.5.368; MIKKELSEN M, 1980, ANN HUM GENET, V44, P17, DOI 10.1111/j.1469-1809.1980.tb00942.x; WAGENBICHLER P, 1976, HUM GENET, V32, P13, DOI 10.1007/BF00569971	8	35	35	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	2					413	421						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	SM324	6231859				2022-12-18	WOS:A1984SM32400016
J	LIDKSY, AS; ROBSON, KJH; THIRUMALACHARY, C; BARKER, PE; RUDDLE, FH; WOO, SLC				LIDKSY, AS; ROBSON, KJH; THIRUMALACHARY, C; BARKER, PE; RUDDLE, FH; WOO, SLC			THE PKU LOCUS IN MAN IS ON CHROMOSOME-12	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									YALE UNIV,DEPT BIOL,NEW HAVEN,CT 06511	Yale University	LIDKSY, AS (corresponding author), BAYLOR COLL MED,HOWARD HUGHES MED INST,DEPT CELL BIOL,HOUSTON,TX 77030, USA.				NICHD NIH HHS [HD-17711] Funding Source: Medline; NIGMS NIH HHS [GM9966] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD017711, R01HD017711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM009966, R37GM009966] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERG K, 1974, CLIN GENET, V6, P147; HSIA DYY, 1960, AM J HUM GENET, V12, P277; KAMARYT J, 1978, HUM GENET, V43, P205, DOI 10.1007/BF00293596; MANIATIS T, 1975, P NATL ACAD SCI USA, V72, P1184, DOI 10.1073/pnas.72.3.1184; PAUL TD, 1979, CLIN GENET, V16, P217; PENROSE LS, 1951, ANN EUGENIC, V16, P241, DOI 10.1111/j.1469-1809.1951.tb02477.x; RYAN J, 1983, P NATL ACAD SCI-BIOL, V80, P4460, DOI 10.1073/pnas.80.14.4460; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; WAHL GM, 1979, P NATL ACAD SCI USA, V76, P3683, DOI 10.1073/pnas.76.8.3683; WOO SLC, 1983, NATURE, V306, P151, DOI 10.1038/306151a0	10	35	35	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	3					527	533						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	SY119	6547271				2022-12-18	WOS:A1984SY11900003
J	NANCE, WE; KRAMER, AA; COREY, LA; WINTER, PM; EAVES, LJ				NANCE, WE; KRAMER, AA; COREY, LA; WINTER, PM; EAVES, LJ			A CAUSAL-ANALYSIS OF BIRTH-WEIGHT IN THE OFFSPRING OF MONOZYGOTIC TWINS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											NANCE, WE (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT HUMAN GENET,RICHMOND,VA 23298, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD015838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007492] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-15838] Funding Source: Medline; NIGMS NIH HHS [T32-GM-07492, GM-21045] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBERMAN E, 1980, BRIT J OBSTET GYNAEC, V87, P275, DOI 10.1111/j.1471-0528.1980.tb04539.x; BILLEWICZ WZ, 1972, J BIOSOC SCI, V4, P455, DOI 10.1017/S0021932000008786; COREY LA, 1979, ACTA GENET MED GEMEL, V28, P41, DOI 10.1017/S0001566000009326; DONALD H. P., 1939, PROC ROY SOC EDINBURGH, V59, P91; KARN MN, 1951, ANN EUGENIC, V15, P306; LUBCHENCO LO, 1966, PEDIATRICS, V37, P403; MAURER HM, 1983, PEDIATRICS, P53; MODANLOU HD, 1980, OBSTET GYNECOL, V55, P420; MORTON NE, 1955, ANN HUM GENET, V20, P125; NANCE WE, 1976, GENETICS, V83, P811; NANCE WE, 1978, GENETIC EPIDEMIOLOGY, P87; NANCE WE, 1976, ACTA GENET MED GEMEL, V25, P96; OUNSTED M, 1968, NATURE, V220, P599, DOI 10.1038/220599a0; PENROSE LS, 1951, ANN EUGEN, V16, P378; Penrose LS, 1954, CARYOLOGIA S, V6, P521; PHELAN MC, 1982, NEW ENGL J MED, V307, P99, DOI 10.1056/NEJM198207083070206; ROBERTS DF, 1981, BRIT MED BULL, V37, P239, DOI 10.1093/oxfordjournals.bmb.a071709; Robson E., 1978, HUMAN GROWTH, V1, P285; ROBSON EB, 1955, ANN HUM GENET, V19, P262, DOI 10.1111/j.1469-1809.1955.tb01352.x; STEVENSON DK, 1982, J PEDIATR-US, V100, P515, DOI 10.1016/S0022-3476(82)80745-2	20	35	35	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	6					1211	1223						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	RU705	6685976				2022-12-18	WOS:A1983RU70500015
J	ROECKER, GO; HUETHER, CA				ROECKER, GO; HUETHER, CA			AN ANALYSIS FOR PATERNAL-AGE EFFECT IN OHIOS DOWN SYNDROME BIRTHS, 1970-1980	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											ROECKER, GO (corresponding author), UNIV CINCINNATI,DEPT BIOL SCI,CINCINNATI,OH 45221, USA.							CROSS PK, 1982, AM J HUM GENET, V34, pA121; ERICKSON JD, 1979, AM J HUM GENET, V31, P489; ERICKSON JD, 1981, J MED GENET, V18, P22, DOI 10.1136/jmg.18.1.22; ERICKSON JD, 1978, ANN HUM GENET, V41, P289, DOI 10.1111/j.1469-1809.1978.tb01896.x; HOOK EB, 1981, AM J HUM GENET, V33, P123; HOOK EB, 1982, CLIN GENETICS PROBLE; HUETHER CA, 1981, AM J PUBLIC HEALTH, V71, P1367, DOI 10.2105/AJPH.71.12.1367; HUETHER CA, 1982, AM J EPIDEMIOL, V115, P846, DOI 10.1093/oxfordjournals.aje.a113372; LAMSON SH, 1980, HUM GENET, V55, P49, DOI 10.1007/BF00329126; MATSUNAGA E, 1978, HUM GENET, V40, P259, DOI 10.1007/BF00272186; MIKKELSEN M, 1980, ANN HUM GENET, V44, P17, DOI 10.1111/j.1469-1809.1980.tb00942.x; REGAL RR, 1980, AM J EPIDEMIOL, V112, P650, DOI 10.1093/oxfordjournals.aje.a113037; ROBERTS DF, 1980, J MED GENET, V17, P363, DOI 10.1136/jmg.17.5.363; Snedecor G.W., 1980, STAT METHODS, V7; STENE J, 1981, HUM GENET, V59, P119, DOI 10.1007/BF00293059; STENE J, 1977, ANN HUM GENET, V40, P299, DOI 10.1111/j.1469-1809.1977.tb00194.x; STENE J, 1978, ANN HUM GENET, V41, P465, DOI 10.1111/j.1469-1809.1978.tb00917.x	17	35	35	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	6					1297	1306						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RU705	6228138				2022-12-18	WOS:A1983RU70500024
J	HARRIS, DJ; BEGLEITER, ML; CHAMBERLIN, J; HANKINS, L; MAGENIS, RE				HARRIS, DJ; BEGLEITER, ML; CHAMBERLIN, J; HANKINS, L; MAGENIS, RE			PARENTAL TRISOMY 21 MOSAICISM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV OREGON, HLTH SCI CTR, DIV MED GENET, PORTLAND, OR 97201 USA; UNIV OREGON, HLTH SCI CTR, DIV CRIPPLED CHILDREN, PORTLAND, OR 97201 USA	University of Oregon; University of Oregon	HARRIS, DJ (corresponding author), CHILDRENS MERCY HOSP, CTR GENET COUNSELING, KANSAS CITY, MO 64108 USA.				NICHD NIH HHS [HD07997] Funding Source: Medline; CIT NIH HHS [MCT-000920-11-1] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); CIT NIH HHS		AARSKOG D, 1969, ACTA PAEDIATR SCAND, V58, P609, DOI 10.1111/j.1651-2227.1969.tb04769.x; ALFI OS, 1980, AM J HUM GENET, V32, P477; BLANK CE, 1962, BRIT MED J, P378, DOI 10.1136/bmj.2.5301.378; CASPERSSON T, 1971, HEREDITAS-GENETISK A, V67, P89; CAVALLISTORZA LL, 1971, GENETICS HUMAN POPUL, P856; DHADIAL R, 1972, J GENET HUM, V20, P297; EDWARDS JH, 1963, LANCET, V2, P902; FERGUSONSMITH MA, 1976, LANCET, V2, P252; FERRIER S, 1964, J GENET HUM, V13, P315; FROHLICH GS, 1979, NEW YORK STATE J MED, V79, P929; GIANNELL.F, 1965, CYTOGENETICS, V4, P186, DOI 10.1159/000129854; GOLBUS MS, 1979, NEW ENGL J MED, V300, P157, DOI 10.1056/NEJM197901253000402; HARTL DL, 1971, AM J HUM GENET, V23, P124; HOOK EB, 1977, AM J HUM GENET, V29, P94; HSU LYF, 1971, AM J HUM GENET, V23, P592; KAFFE S, 1974, J MED GENET, V11, P378, DOI 10.1136/jmg.11.4.378; KRMPOTIC E, 1971, AM J OBSTET GYNECOL, V110, P589, DOI 10.1016/0002-9378(71)90705-8; MAGENIS RE, 1970, SCIENCE, V170, P85, DOI 10.1126/science.170.3953.85; MAGENIS RE, 1977, HUM GENET, V37, P7, DOI 10.1007/BF00293766; MEHES K, 1973, HUMANGENETIK, V17, P297; MIKKELSEN M, 1970, ANN NY ACAD SCI, V171, P370, DOI 10.1111/j.1749-6632.1970.tb39345.x; MILUNSKY A, 1973, PRENATAL DIAGNOSIS H; NUZZO F, 1975, ANN GENET-PARIS, V18, P111; Oster J., 1953, MONGOLISM; OSUNA A, 1977, J MED GENET, V14, P286, DOI 10.1136/jmg.14.4.286; OVERTON KM, 1976, AM J HUM GENET, V28, P417; PAPP Z, 1974, CLIN GENET, V6, P192; PENROSE L S, 1956, Acta Genet Stat Med, V6, P35; Penrose L.S., 1966, DOWNS ANOMALY; PRIEST J H, 1970, Journal of Medical Genetics, V7, P142, DOI 10.1136/jmg.7.2.142; PRIEST JH, 1973, J MED GENET, V10, P328, DOI 10.1136/jmg.10.4.328; RICHARDS BW, 1974, J MENT DEFIC RES, V18, P199; RUSSELL LB, 1979, GENETICS, V91, P141; SEABRIGH.M, 1971, LANCET, V2, P971; SMITH DW, 1962, AM J DIS CHILD, V104, P534; STENE J, 1970, HUM HERED, V20, P112, DOI 10.1159/000152301; TIMSON J, 1971, LANCET, V1, P549; UCHIDA IA, 1970, ANN NY ACAD SCI, V171, P361, DOI 10.1111/j.1749-6632.1970.tb39344.x; VERRESEN H, 1964, LANCET, V1, P526; WEINSTEIN ED, 1963, J PEDIATR-US, V63, P599, DOI 10.1016/S0022-3476(63)80370-4	40	35	35	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1982	34	1					125	133						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ585	6211090				2022-12-18	WOS:A1982MZ58500010
J	VALENTIN, J				VALENTIN, J			EXCLUSIONS AND ATTRIBUTIONS OF PATERNITY - PRACTICAL EXPERIENCES OF FORENSIC GENETICS AND STATISTICS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									STATE INST BLOOD GRP SEROL,STATENS RATTSKEMISKA LAB,LINKOPING,SWEDEN					Valentin, Jack/0000-0003-3364-3355				CHAKRABO.R, 1974, AM J HUM GENET, V26, P477; CHAKRABORTY R, 1976, AM J HUM GENET, V28, P615; Essen-Moller E., 1938, MITT ANTHR GES, V68, P9; FISHER RA, 1954, STATISTICAL METHODS; Giblett ER., 1969, GENETIC MARKERS HUMA; GURTLER H, 1956, Acta Med Leg Soc (Liege), V9, P83; HENNINGSEN K, 1974, 34TH P C INT LANG FR; HUMMEL K, 1969, DEUT Z GES GERIC MED, V66, P97, DOI 10.1007/BF02319171; HUMMEL K, 1977, ARZTL LAB, V23, P285; HUMMEL K, 1977, 7TH P INT TAG GES FO, P511; Hummel K., 1971, BIOSTATISTICAL OPINI; HUMMEL K, 1961, MEDIZINISCHE VATERSC; JOHANNSEN KH, 1977, VATERSCHAFTSFESTSTEL; KATAJA M, 1975, THESIS HELSINKI U TE; KRUGER J, 1975, ARZTL LAB, V21, P429; LANGANEY A, 1975, AM J HUM GENET, V27, P558; LIE H, 1973, RUNDSKRIV G4173 DET, P1; MIALE JB, 1976, FAMILY LAW Q, V10, P247; NERSTROM B, 1965, THESIS U COPENHAGEN; PROKOP O, 1969, HUMAN BLOOD SERUM GR; Race RR., 1975, BLOOD GROUPS MAN; RASMUSON M, 1979, HEREDITAS, V91, P279; SALMON D, 1974, NOUV REV FR HEMATOL, V14, P477; SALMON D, 1971, MED LEG DOMMAGE CORPOR, V4, P348; SALMON D, 1976, AM J HUM GENET, V28, P622; SCHULTEMONTING J, 1969, Z IMMUNITATSFORSCH, V138, P295; SCHULTEMONTING J, 1972, BUNDESGESUNDHEITSBLA, V15, P257; Stern Curt, 1973, PRINCIPLES HUMAN GEN; VALENTIN J, 1976, Hereditas (Lund), V84, P253; VALENTIN J, 1976, AM J HUM GENET, V28, P620; VALENTIN J, 1977, 7TH P INT TAG GESF B, P591; WALTER E, 1971, METRIKA, V17, P146, DOI 10.1007/BF02613819; 1962, SV JURISTTIDN, V47, P41	33	35	36	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1980	32	3					420	431						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	JX059	6930157				2022-12-18	WOS:A1980JX05900012
J	BONNETAMIR, B; KARLIN, S; KENETT, R				BONNETAMIR, B; KARLIN, S; KENETT, R			ANALYSIS OF GENETIC DATA ON JEWISH POPULATIONS .1. HISTORICAL BACKGROUND, DEMOGRAPHIC FEATURES, AND GENETIC-MARKERS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									WEIZMANN INST SCI,DEPT MATH,REHOVOT 76100,ISRAEL; STANFORD UNIV,DEPT MATH,STANFORD,CA 94305	Weizmann Institute of Science; Stanford University	BONNETAMIR, B (corresponding author), TEL AVIV UNIV,SACKLER SCH MED,DEPT HUMAN GENET,RAMAT AVIV,ISRAEL.		Kenett, Ron/I-7246-2019	Kenett, Ron/0000-0003-2315-0477				ADAM A, 1973, ISRAEL J MED SCI, V9, P1383; ALBERT ED, 1972, HISTOCOMPATIBILITY T, P147; BAKI R, 1974, ENCYCLOPEDIA HEBRAIC, V26, P983; Ben Zvi I., 1957, EXILED REDEEMED; BODMER J, 1972, HISTOCOMPATIBILITY T, P117; BODMER J, 1972, HISTOCOMPATIBILITY T, P125; BODMER JG, 1970, AM J HUM GENET, V22, P396; BODMER WF, 1975, TRANSFUSION IMMUNOL, P35; BONNE B, 1963, HUM BIOL, V35, P61; BONNETAMIR B, 1977, HUM GENET, V37, P319, DOI 10.1007/BF00393615; BONNETAMIR B, 1978, TISSUE ANTIGENS, V11, P206, DOI 10.1111/j.1399-0039.1978.tb01249.x; BONNETAMIR B, 1978, TISSUE ANTIGENS, V11, P230, DOI 10.1111/j.1399-0039.1978.tb01254.x; BONNETAMIR B, 1978, TISSUE ANTIGENS, V11, P235, DOI 10.1111/j.1399-0039.1978.tb01255.x; BONNETAMIR B, 1978, TISSUE ANTIGENS, V11, P221, DOI 10.1111/j.1399-0039.1978.tb01252.x; BONNETAMIR B, AM J PHYS ANTHR; BONNETAMIR B, 1979, GENETIC DISEASES ASH; BRAUTBAR C, 1978, TISSUE ANTIGENS, V11, P201, DOI 10.1111/j.1399-0039.1978.tb01248.x; BRAUTBAR C, 1975, HISTOCOMPATIBILITY T, P205; CARMELLI D, HUM BIOL; CEPPELLINI R, 1955, ANN HUM GENET, V20, P97; COHEN T, 1971, ISRAEL J MED SCI, V7, P1509; COON CS, 1942, JEWS GENTILE WORLD, P30; DUBNOV S, 1948, DIVREY YEMEY AM OLAM, V7; EGOROV IK, 1975, HISTOCOMPATIBILITY T, P186; Fishberg Maurice., 1911, JEWS; FRAIKOR AL, 1977, SOC BIOL, V24, P117, DOI 10.1080/19485565.1977.9988272; GAZIT E, 1978, TISSUE ANTIGENS, V11, P226, DOI 10.1111/j.1399-0039.1978.tb01253.x; GAZIT E, 1978, TISSUE ANTIGENS, V11, P195, DOI 10.1111/j.1399-0039.1978.tb01247.x; GAZIT E, 1978, TISSUE ANTIGENS, V11, P217, DOI 10.1111/j.1399-0039.1978.tb01251.x; Goitein Shelomo Dov, 1955, JEWS ARABS THEIR CON; GOLDBERG H, 1971, INT J MIDDLE E STUD, V2, P245, DOI 10.1017/S0020743800001124; GOLDSCHMIDT E, 1961, AM J GENET, V24, P191; Goldschmidt E., 1963, GENETICS MIGRANT ISO; GOODMAN R, 1975, MODERN TRENDS HUMAN; GUREVITCH J, 1956, ANN HUM GENET, V21, P135, DOI 10.1111/j.1469-1809.1971.tb00273.x; HACOHEN D, 1969, ONE PEOPLE STORY EAS; Harris, 1976, HDB ENZYME ELECTROPH; HIRSCHBERG HZ, 1960, N AFRICAN JEWRY; HIRSCHBERG HZ, 1946, ISRAEL IN ARABIA; KARLIN S, 1979, AM J HUM GENET, V31, P341; KOLODNY EH, 1979, GENETIC DISEASES ASH; Lewontin R.C., 1972, J EVOLUTION BIOL, V14, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; MACZYNSKARUSINI.B, 1974, ACTA HAEMATOL POL, V4, P111; MOURANT AE, 1959, JEWISH J SOCIOL, V1, P155; Mourant AE, 1976, DISTRIBUTION HUMAN B; PADEH B, 1973, ISR J MED SCI, V9, P1331; Patai Raphael., 1975, MYTH JEWISH RACE; RAMOT B, 1974, GENETIC POLYMORPHISM; ROBERTS DF, 1973, SOC BIOL, V20, P64, DOI 10.1080/19485565.1973.9988023; RUPPIN A, 1930, SOCIAL STRUCTURE JEW, V1; SHEBA C, 1962, AM J PUBLIC HEALTH N, V52, P1101, DOI 10.2105/AJPH.52.7.1101; SHEBA C, 1968, MADAH, V13, P94; SZEINBERG A, 1958, BLOOD, V13, P1043, DOI 10.1182/blood.V13.11.1043.1043; SZEINBERG A, 1979, GENETIC DISEASES ASH; SZEINBERG A, 1971, P INT S PHENYLKETONU; ZAMIR R, 1978, TISSUE ANTIGENS, V11, P213, DOI 10.1111/j.1399-0039.1978.tb01250.x; ZOLLSCHAN I, 1920, RASSEN PROBLEM; 1971, ENCYCLOPEDIA JUDAICA; 1965, ENCYCLOPEDIA HEBRAIC, V11; 1974, ISRAEL GOVERNMENT YB, P458	60	35	35	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1979	31	3					324	340						17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	HE538	380329				2022-12-18	WOS:A1979HE53800008
J	CHAGANTI, RSK; GERMAN, J				CHAGANTI, RSK; GERMAN, J			HUMAN MALE-INFERTILITY, PROBABLY GENETICALLY-DETERMINED, DUE TO DEFECTIVE MEIOSIS AND SPERMATOGENIC ARREST	AMERICAN JOURNAL OF HUMAN GENETICS			English	Note									NEW YORK BLOOD CTR, NEW YORK, NY 10021 USA	New York Blood Center								ARLETT CF, 1978, ANNU REV GENET, V12, P95, DOI 10.1146/annurev.ge.12.120178.000523; BAKER BS, 1976, ANNU REV GENET, V10, P53, DOI 10.1146/annurev.ge.10.120176.000413; BAKER BS, 1978, GENETICS, V90, P531; BEAMER WG, 1978, S GENETIC MOSAICS CH, P29; CHAGANTI RSK, 1965, CYTOGENETIC STUDIES; CHANDLEY AC, 1977, CHROMOSOMA, V62, P243, DOI 10.1007/BF00286046; CUTLER SJ, 1975, 3RD NATIONAL CANCER; Darlington C. D., 1937, RECENT ADV CYTOLOGY; DARLINGTON CD, 1966, HANDLING CHROMOSOMES; DAY RS, 1974, CANCER RES, V34, P1965; EVANS EP, 1964, CYTOGENETICS, V3, P289, DOI 10.1159/000129818; HOTTA Y, 1977, CHROMOSOMA, V62, P255, DOI 10.1007/BF00286047; HULTEN M, 1974, HEREDITAS, V78, P105; HULTEN M, 1974, HEREDITAS, V78, P117; HULTEN M, 1973, ADV HUM GENET, P327; Nicoletti B, 1968, ATTI ASSOC GENET IT, V13, P1; PEARSON PL, 1970, CYTOGENETICS, V9, P460, DOI 10.1159/000130115; PHILLIPS RJ, 1973, GENET RES, V22, P91, DOI 10.1017/S0016672300012866; PURNELL DJ, 1973, CYTOGENET CELL GENET, V12, P327, DOI 10.1159/000130471; REES H, 1961, BOT REV, V27, P288, DOI 10.1007/BF02860084; SASAKI MS, 1977, JPN J GENET, V52, P472; STERN H, 1973, ANNU REV GENET, V7, P37, DOI 10.1146/annurev.ge.07.120173.000345	22	35	36	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1979	31	5					634	641						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HS030	574357				2022-12-18	WOS:A1979HS03000013
J	PAIGEN, B; WARD, E; STEENLAND, K; HOUTEN, L; GURTOO, HL; MINOWADA, J				PAIGEN, B; WARD, E; STEENLAND, K; HOUTEN, L; GURTOO, HL; MINOWADA, J			ARYL-HYDROCARBON HYDROXYLASE IN CULTURED LYMPHOCYTES OF TWINS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NEW YORK STATE DEPT HLTH, ROSWELL PK MEM INST, DEPT EXPTL THERAPEUT, BUFFALO, NY 14263 USA; NEW YORK STATE DEPT HLTH, ROSWELL PK MEM INST, DEPT BIOSTAT, BUFFALO, NY 14263 USA; NEW YORK STATE DEPT HLTH, ROSWELL PK MEM INST, DEPT IMMUNOL, BUFFALO, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute	PAIGEN, B (corresponding author), NEW YORK STATE DEPT HLTH, ROSWELL PK MEM INST, DEPT MOLEC BIOL, BUFFALO, NY 14263 USA.							ATLAS SA, 1976, CANCER RES, V36, P4619; BASTJUN RC, 1974, NATURE, V250, P664, DOI 10.1038/250664a0; CONNEY AH, 1967, PHARMACOL REV, V19, P317; CROUT JE, 1975, NEW ENGL J MED, V292, P221, DOI 10.1056/NEJM197501302920501; FELDMAN MW, 1975, SCIENCE, V190, P1163, DOI 10.1126/science.1198102; GURTOO HL, 1977, J NATL CANCER I, V59, P787, DOI 10.1093/jnci/59.3.787; GURTOO HL, 1975, CANCER RES, V35, P1235; HAUGEN DA, 1976, J BIOL CHEM, V251, P7929; HUANG MT, 1976, J BIOL CHEM, V251, P4659; HUBERMAN E, 1976, P NATL ACAD SCI USA, V73, P607, DOI 10.1073/pnas.73.2.607; KAPITULNIK J, 1977, CLIN PHARMACOL THER, V21, P166; KELLERMA.G, 1973, AM J HUM GENET, V25, P327; KELLERMANN G, 1975, DRUG METAB DISPOS, V3, P47; KELLERMANN G, 1973, NEW ENGL J MED, V289, P934, DOI 10.1056/NEJM197311012891802; LEVIN W, 1976, P NATL ACAD SCI USA, V73, P3867, DOI 10.1073/pnas.73.11.3867; NEBERT DW, 1969, CANCER RES, V29, P1763; NEBERT DW, 1968, J BIOL CHEM, V243, P6242; OKUDA T, 1977, CANCER RES, V37, P3904; PAIGEN B, 1977, NEW ENGL J MED, V297, P346, DOI 10.1056/NEJM197708182970702; PAIGEN B, 1977, CANCER RES, V37, P1829; PAIGEN B, 1978, 3RD P INT S MICR DRU; PAIGEN B, 1978, POLYCYCLIC HYDROCARB; SMITH SM, 1961, MATH TABLES RES WORK; THOMAS PE, 1976, MOL PHARMACOL, V12, P746; TOKUHATA GK, 1964, AM J PUBLIC HEALTH N, V54, P24, DOI 10.2105/AJPH.54.1.24; WANG IY, 1977, LIFE SCI, V20, P1265, DOI 10.1016/0024-3205(77)90501-X; WHITE SC, 1975, SCIENCE, V188, P71, DOI 10.1126/science.1078732; WIEBEL FJ, 1975, P NATL ACAD SCI USA, V72, P3917, DOI 10.1073/pnas.72.10.3917; YANG SK, 1977, BIOCHEM BIOPH RES CO, V77, P1176, DOI 10.1016/S0006-291X(77)80103-4	29	35	35	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1978	30	5					561	571						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GA288	569973				2022-12-18	WOS:A1978GA28800010
J	WAGENER, D; CAVALLISFORZA, LL; BARAKAT, R				WAGENER, D; CAVALLISFORZA, LL; BARAKAT, R			ETHNIC VARIATION OF GENETIC-DISEASE - ROLES OF DRIFT FOR RECESSIVE LETHAL GENES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									STANFORD UNIV,DEPT GENET,STANFORD,CA 94305; HARVARD UNIV,DIV ENGN & APPL PHYS,CAMBRIDGE,MA 02138	Stanford University; Harvard University								ABRAMOWITZ M., 1965, HDB MATH FUNCTIONS; ARONSON SM, 1964, TAYSACHS DISEASE, P118; CARMELLI D, UNPUBLISHED; CHASE GA, 1972, AM J HUM GENET, V24, P339; Clark J. G. D., 1972, STAR CARR CASE STUDY; CONNEALLY PM, 1973, TEX REP BIOL MED, V31, P639; FINE M, 1973, AM JEWISH YB 1972; FRAIKOR AL, 1977, SOC BIOL, V24, P117, DOI 10.1080/19485565.1977.9988272; FRAIKOR AL, 1973, THESIS U COLORADO; GOLDSCHMIDT E, 1956, 25TH ANN M GEN SOC A; KOZINN PJ, 1957, J PEDIATR-US, V51, P58, DOI 10.1016/S0022-3476(57)80282-0; McKusick V A, 1966, Ala J Med Sci, V3, P408; MCKUSICK VA, 1973, ISRAEL J MED SCI, V9, P1375; MCKUSICK VA, 1967, J CHRON DIS, V20, P115, DOI 10.1016/0021-9681(67)90045-8; MCKUSICK VA, 1971, MENDELIAN INHERITANC; MYRIANTHOPOULOS NC, 1970, NATURE, V227, P609, DOI 10.1038/227609a0; MYRIANTHOPOULOS NC, 1966, AM J HUM GENET, V18, P313; MYRIANTHOPOULOS NC, 1962, CEREBRAL SPHINGOLIPI, P359; MYRIANTHOPOULOS NC, 1972, 4TH P INT S SPHING, P561; RAO DC, 1973, AM J HUM GENET, V25, P594; SHAW RF, 1969, NATURE, V224, P1214, DOI 10.1038/2241214b0; WAGENER DK, 1975, AM J HUM GENET, V27, P348; Wright S, 1937, P NATL ACAD SCI USA, V23, P307, DOI 10.1073/pnas.23.6.307; Wright S, 1969, THEORY GENE FREQUENC, V2; WRIGHT SW, 1968, AM J HUM GENET, V20, P157	25	35	35	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1978	30	3					262	270						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FE044	677123				2022-12-18	WOS:A1978FE04400004
J	GEIGER, B; ARNON, R; SANDHOFF, K				GEIGER, B; ARNON, R; SANDHOFF, K			IMMUNOCHEMICAL AND BIOCHEMICAL INVESTIGATION OF HEXOSAMINIDASE-S	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									WEIZMANN INST SCI,DEPT CHEM IMMUNOL,REHOVOT,ISRAEL; MAX PLANCK INST PSYCHIAT,D-8000 MUNICH 40,FED REP GER	Weizmann Institute of Science; Max Planck Society								BEUTLER E, 1975, NATURE, V258, P262, DOI 10.1038/258262a0; BEUTLER E, 1975, AM J HUM GENET, V27, P628; BRAIDMAN I, 1974, FEBS LETT, V41, P181, DOI 10.1016/0014-5793(74)81206-8; DESNICK RJ, 1972, SPHINGOLIPIDS SPHING, P351; GALJAARD H, 1974, EXP CELL RES, V87, P444, DOI 10.1016/0014-4827(74)90515-1; GEIGER B, 1974, FEBS LETT, V45, P276, DOI 10.1016/0014-5793(74)80861-6; GEIGER B, 1976, BIOCHEMISTRY-US, V15, P3484, DOI 10.1021/bi00661a014; GEIGER B, 1975, EUR J BIOCHEM, V56, P311, DOI 10.1111/j.1432-1033.1975.tb02235.x; IKONNE JU, 1975, AM J HUM GENET, V27, P639; KOLODNY H, 1972, SPHINGOLIPIDS SPHING, P321; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; POENARU L, 1973, CLIN CHIM ACTA, V43, P439; POENARU L, 1973, BIOMED EXPRESS, V19, P538; PRICE RG, 1972, BIOCHIM BIOPHYS ACTA, V271, P145, DOI 10.1016/0005-2795(72)90142-0; RATTAZZI MC, 1974, AM J HUM GENET, V20, pA71; ROBINSON D, 1968, BIOCHEM J, V107, P321, DOI 10.1042/bj1070321; SANDHOFF K, 1971, J NEUROCHEM, V18, P2469, DOI 10.1111/j.1471-4159.1971.tb00204.x; SANDHOFF K, 1968, H-S Z PHYSIOL CHEM, V349, P1095, DOI 10.1515/bchm2.1968.349.2.1095; SANDHOFF K, 1971, H-S Z PHYSIOL CHEM, V352, P1119, DOI 10.1515/bchm2.1971.352.2.1119; SANDHOFF K, 1969, FEBS LETT, V4, P351, DOI 10.1016/0014-5793(69)80274-7; SRIVASTAVA SK, 1973, NATURE, V241, P463, DOI 10.1038/241463a0; STIRLING JL, 1971, BIOCHEM J, V123, pP11; STIRLING JL, 1972, BIOCHIM BIOPHYS ACTA, V271, P154, DOI 10.1016/0005-2795(72)90143-2; THOMAS GH, 1974, NATURE, V250, P580, DOI 10.1038/250580a0	24	35	36	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1977	29	5					508	522						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DV673	409285				2022-12-18	WOS:A1977DV67300010
J	BAER, A; LIEINJO, LE; WELCH, QB; LEWIS, AN				BAER, A; LIEINJO, LE; WELCH, QB; LEWIS, AN			GENETIC FACTORS AND MALARIA IN TEMUAN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									SAN DIEGO STATE UNIV,DEPT BIOL,SAN DIEGO,CA 92115; UNIV CALIF,SCH MED,DEPT INT HLTH,SAN FRANCISCO,CA 94143; INST MED RES,KUALA LUMPUR,MALAYSIA	California State University System; San Diego State University; University of California System; University of California San Francisco; Kementerian Kesihatan Malaysia								BAER A, IN PRESS; BOLTON J M, 1969, Medical Journal of Malaya, V24, P36; CAREY I, 1961, TENGLEQ KUI SEROK; Denton R.K., 1968, SEMAI NONVIOLENT PEO; Field JWSA, 1963, MICROSCOPICAL DIAGNO; ISHIHARA S, 1969, TESTS COLORBLINDNESS; KALMUS H, 1964, GENETICS, P229; KIRK RL, 1960, NATURE, V185, P185, DOI 10.1038/185185a0; LIE-INJO L E, 1972, Human Heredity, V22, P118; LIE-INJO L E, 1972, Human Heredity, V22, P338; LIE-INJO LUAN ENG, 1964, NATURE, V204, P291; LIEINJO LE, 1972, ACTA HAEMATOL-BASEL, V47, P210, DOI 10.1159/000208526; LIEINJO LE, 1973, HUM HERED, V23, P487, DOI 10.1159/000152614; LIEINJO LE, 1967, NATURE, V215, P777, DOI 10.1038/215777a0; LIEINJO LE, 1973, AM J HUM GENET, V25, P382; LIEINJO LE, 1971, SE ASIAN J TROP MED, V2, P133; LIEINJO LE, 1964, T ROY SOC TROP MED H, V58, P500; LIEINJO LE, 1965, NATURE, V208, P1329; LIVINGSTONE FB, 1971, ANNU REV GENET, V5, P33, DOI 10.1146/annurev.ge.05.120171.000341; MILLER LH, 1975, SCIENCE, V189, P561, DOI 10.1126/science.1145213; NEEL JV, 1972, EVOL BIOL, V6, P363; PETRAKIS NL, 1971, AM J PHYS ANTHROPOL, V35, P141, DOI 10.1002/ajpa.1330350117; VELLA F, 1962, OCEANIA, V32, P219, DOI 10.1002/j.1834-4461.1962.tb01765.x; WELCH QB, 1972, HUM HERED, V22, P28, DOI 10.1159/000152464; WELCH QB, 1971, HUMANGENETIK, V14, P61, DOI 10.1007/BF00273033	25	35	36	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1976	28	2					179	188						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	BJ476	817597				2022-12-18	WOS:A1976BJ47600009
J	LI, WH				LI, WH			FIRST ARRIVAL TIME AND MEAN AGE OF A DELETERIOUS MUTANT GENE IN A FINITE POPULATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TEXAS, CTR DEMOG & POPULATION GENET, HOUSTON, TX 77025 USA	University of Texas System				Li, Wen-Hsiung/0000-0003-1086-1456	NIGMS NIH HHS [GM 20293] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLISON AC, 1954, ANN HUM GENET, V19, P39, DOI 10.1111/j.1469-1809.1954.tb01261.x; ALLISON AC, 1961, ANN NY ACAD SCI, V91, P710, DOI 10.1111/j.1749-6632.1961.tb31102.x; ALLISON AC, 1954, T ROY SOC TROP MED H, V48, P312, DOI 10.1016/0035-9203(54)90101-7; BIRDSELL JB, 1972, SOC BIOL, V19, P136, DOI 10.1080/19485565.1972.9987979; CHASE GA, 1972, AM J HUM GENET, V24, P339; KIMURA M, 1969, GENETICS, V63, P701; KIMURA M, 1969, GENETICS, V61, P763; KIMURA M, 1957, ANN MATH STAT, V28, P882, DOI 10.1214/aoms/1177706791; KIMURA M, 1962, GENETICS, V47, P713; KIMURA M, 1973, GENETICS, V75, P199; LEHMANN H, 1949, NATURE, V164, P494, DOI 10.1038/164494a0; LI WH, 1973, AM J HUM GENET, V25, P598; LI WH, 1972, AM J HUM GENET, V24, P667; LIVINGSTONE FB, 1958, AM ANTHROPOL, V60, P533, DOI 10.1525/aa.1958.60.3.02a00110; Livingstone FB, 1967, ABNORMAL HEMOGLOBINS; MARUYAMA T, 1974, GENET RES, V23, P137, DOI 10.1017/S0016672300014750; MARUYAMA T, 1974, GENETICS, V76, P367; MARUYAMA T, 1974, EVOLUTION, V28, P161, DOI 10.2307/2407248; MARUYAMA T, 1971, JPN J GENET, V46, P407, DOI 10.1266/jjg.46.407; MYRIANTHOPOULOS NC, 1972, AM J HUM GENET, V24, P341; NEI M, 1971, Theoretical Population Biology, V2, P426, DOI 10.1016/0040-5809(71)90031-1; NEI M, 1971, Theoretical Population Biology, V2, P419, DOI 10.1016/0040-5809(71)90030-X; RUCKNAGEL DONALD L., 1961, PROGR MED GENET, V1, P158; WIESENFELD SL, 1967, SCIENCE, V157, P1134, DOI 10.1126/science.157.3793.1134	24	35	35	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1975	27	3					274	286						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AD236	803010				2022-12-18	WOS:A1975AD23600003
J	SWIFT, M; COHEN, J; PINKHAM, R				SWIFT, M; COHEN, J; PINKHAM, R			MAXIMUM-LIKELIHOOD METHOD FOR ESTIMATING DISEASE PREDISPOSITION OF HETEROZYGOTES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV N CAROLINA,DEPT MED,GENET CURRICULUM,CHAPEL HILL,NC 27514; NYU,MED CTR,NEW YORK,NY 10016; STEVENS INST TECHNOL,DEPT MATH,HOBOKEN,NJ 07030; UNIV N CAROLINA,BIOL SCI RES CTR,CHAPEL HILL,NC 27514	University of North Carolina; University of North Carolina Chapel Hill; New York University; Stevens Institute of Technology; University of North Carolina; University of North Carolina Chapel Hill								CLARKE CA, 1956, BRIT MED J, V2, P725, DOI 10.1136/bmj.2.4995.725; CRAMER H, 1951, MATHEMATICAL METHODS; Fisher R. A., 1956, STATISTICAL METHODS; FISHER RA, 1958, STATISTICAL METHODS; HALLETT WY, 1965, AM REV RESPIR DIS, V92, P714; JABLON S, 1966, 19 NATL CANC I MON, P445; KENDALL MG, 1961, ADV THEORY STATISTIC; LYNCH HT, 1967, HEREDITARY FACTORS C; MCKUSICK VA, 1971, MENDELIAN INHERITANC; OLSON FE, 1962, J CHRON DIS, V15, P157, DOI 10.1016/0021-9681(62)90065-6; OSULLIVAN JB, 1967, J CHRON DIS, V20, P535, DOI 10.1016/0021-9681(67)90084-7; PENROSE LS, 1948, BRIT J CANCER, V2, P168, DOI 10.1038/bjc.1948.25; Penrose LS, 1935, LANCET, V2, P192; PERRY TL, 1966, J PSYCHIAT RES, V4, P51, DOI 10.1016/0022-3956(66)90014-8; Rimoin DL, 1971, GENETIC DISORDERS EN; SIMPSON NE, 1968, CAN MED ASSOC J, V98, P427; SWIFT M, 1972, SCIENCE, V178, P308, DOI 10.1126/science.178.4058.308; SWIFT M, 1971, NATURE, V230, P370, DOI 10.1038/230370a0; 1967, 1000 PUBL HEALTH  10; 1962, MORTALITY STATISTICS, V2; 1955, VITAL STATISTICS U S; 1968, US LIFE TABLES CAUSE	22	35	35	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1974	26	3					304	317						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	T0991	4827364				2022-12-18	WOS:A1974T099100002
J	WEBER, WW; BRENNER, W				WEBER, WW; BRENNER, W			FILTER PAPER METHOD FOR DETERMINING ISONIAZID ACETYLATOR PHENOTYPE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NYU,SCH MED,DEPT PHARMACOL,GUTTMAN LAB HUMAN PHARMACOL & PHARMACOGENET,550 FIRST AVE,NEW YORK,NY 10016	New York University								Bratton AC, 1939, J BIOL CHEM, V128, P537; EIDUS L, 1973, INT J CLIN PHARM TH, V7, P82; EIDUS L, 1973, ANTIMICROB AGENTS CH, V3, P130, DOI 10.1128/AAC.3.1.130; EIDUS L, 1971, ARZNEI-FORSCHUNG, V21, P1696; ELLARD G A, 1973, Tubercle, V54, P57, DOI 10.1016/0041-3879(73)90015-9; EVANS D A P, 1969, Journal of Medical Genetics, V6, P405, DOI 10.1136/jmg.6.4.405; EVANS DAP, 1960, BRIT MED J, V2, P485, DOI 10.1136/bmj.2.5197.485; EZE LC, 1972, J MED GENET, V7, P57; GUTHRIE R, 1971, PHENYLKETONURIA SOME; HEARSE DJ, 1973, BIOCHEM J, V132, P519, DOI 10.1042/bj1320519; JEANES CWL, 1972, CAN MED ASSOC J, V106, P331; JENNE JW, 1960, AM REV RESPIR DIS, V81, P1; MATTILA MJ, 1967, ANN MED EXP BIOL FEN, V45, P423; PARKER JM, 1969, HUM HERED, V19, P402, DOI 10.1159/000152245; RAO KVN, 1970, BMJ-BRIT MED J, V3, P495, DOI 10.1136/bmj.3.5721.495; SCHRODER H, 1972, BRIT MED J, V3, P506, DOI 10.1136/bmj.3.5825.506; SCHRODER H, 1972, J MED GENET, V9, P168, DOI 10.1136/jmg.9.2.168; SCOTT EM, 1969, J CLIN INVEST, V48, P1173, DOI 10.1172/JCI106081; WEBER WW, 1973, METABOLIC CONJUGATIO, V3; WEBER WW, 1973, 3 P PHARM TOX S WASH, P4	20	35	35	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1974	26	4					467	473						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	T5051	4841635				2022-12-18	WOS:A1974T505100004
J	CHOWN, B; LEWIS, M; LOWEN, B; KAITA, H				CHOWN, B; LEWIS, M; LOWEN, B; KAITA, H			UNLINKED MODIFIER OF RH BLOOD-GROUPS - EFFECTS WHEN HETEROZYGOUS AND WHEN HOMOZYGOUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALLEN FH, 1969, RH HR BLOOD SYSTEM B; BOETTCHER B, 1971, VOX SANG, V21, P200, DOI 10.1111/j.1423-0410.1971.tb00577.x; CHOWN B, 1971, VOX SANG, V21, P126, DOI 10.1111/j.1423-0410.1971.tb00569.x; CHOWN B, 1971, VOX SANG, V21, P385, DOI 10.1111/j.1423-0410.1971.tb04794.x; CHOWN B, 1971, LANCET, V1, P396; HABER GV, 1967, TRANSFUSION, V7, P389; HASEKURA H, 1970, P JPN ACAD, V46, P733, DOI 10.2183/pjab1945.46.733; HASKURA H, 1971, P JAP ACAD, V47, P579; HUESTIS DW, 1962, TRANSFUSION, V2, P419, DOI 10.1111/j.1537-2995.1962.tb00267.x; ISHIMORI T, 1967, TRANSFUSION, V7, P84, DOI 10.1111/j.1537-2995.1967.tb04845.x; ISHIMORI T, 1966, P JPN ACAD, V42, P658, DOI 10.2183/pjab1945.42.658; LEVINE P, 1961, AM J HUM GENET, V13, P299; LEVINE P, 1964, NATURE, V204, P892, DOI 10.1038/204892b0; LEVINE P, 1965, TRANSFUSION, V5, P492, DOI 10.1111/j.1537-2995.1965.tb01193.x; LEVINE P, 1964, 10 P C INT SOC BLOOD, P350; NAGEL V, IN PRESS; POLESKY HF, 1971, 24 ANN M AM ASS BLOO; Race R. R, 1968, BLOOD GROUPS MAN; ROSENFIELD RE, 1960, AM J HUM GENET, V12, P147; ROSENFIELD RE, 1962, TRANSFUSION, V2, P287, DOI 10.1111/j.1537-2995.1962.tb00244.x; SCHMIDT PJ, 1969, 12 C INT SOC BLOOD T; SENHAUSER DA, 1970, TRANSFUSION, V10, P89, DOI 10.1111/j.1537-2995.1970.tb00711.x; SHAPIRO MAURICE, 1964, J FORENSIC MED, V11, P52; STOUT TD, 1963, VOX SANG, V8, P262, DOI 10.1111/j.1423-0410.1963.tb05235.x; STURGEON P, 1970, BLOOD-J HEMATOL, V36, P310, DOI 10.1182/blood.V36.3.310.310; TIPPETT PA, 1961, VOX SANG, V6, P21, DOI 10.1111/j.1423-0410.1961.tb03133.x; VOS GH, 1961, LANCET, V1, P14	27	35	35	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1972	24	6					623	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	O0504	4628355				2022-12-18	WOS:A1972O050400002
J	EPSTEIN, CJ; SCHNEIDER, EL; CONTE, FA; FRIEDMAN, S				EPSTEIN, CJ; SCHNEIDER, EL; CONTE, FA; FRIEDMAN, S			PRENATAL DETECTION OF GENETIC DISORDERS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Boyden S.V., 1970, IMPACT CIVILIZATION; COURTBROWN WM, 1966, CHROMOSOME STUDIES A; EPSTEIN CJ, 1971, AM J HUM GENET, V23, P533; FUCHS F, 1956, NATURE, V177, P330, DOI 10.1038/177330a0; JACOBSON CB, 1967, AM J OBSTET GYNECOL, V99, P796, DOI 10.1016/0002-9378(67)90395-X; Macintyre M N, 1971, Birth Defects Orig Artic Ser, V7, P10; MIKKELSEN M, 1970, HUM HERED, V20, P457, DOI 10.1159/000152346; MILUNSKY A, 1970, NEW ENGL J MED, V283, P1498, DOI 10.1056/NEJM197012312832705; MILUNSKY A, 1970, NEW ENGL J MED, V283, P1370, DOI 10.1056/NEJM197012172832505; MILUNSKY A, 1970, NEW ENGL J MED, V283, P1441, DOI 10.1056/NEJM197012242832605; Nadler H L, 1971, Birth Defects Orig Artic Ser, V7, P5; NADLER HL, 1968, PEDIATRICS, V42, P912; REDDING A, 1968, BIRTH DEFECTS OAS, V4, P7; STEELE MW, 1966, LANCET, V1, P383; TURNER G, 1971, DEV MED CHILD NEUROL, V13, P71; Vetchinnikova, IN PRESS	16	35	35	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1972	24	2					214	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M2541	5016512				2022-12-18	WOS:A1972M254100009
J	WALZER, S; GERALD, PS				WALZER, S; GERALD, PS			CHROMOSOME ABNORMALITIES IN 11,154 NEWBORN INFANTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Meeting Abstract																			0	35	35	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1972	24	6					A38	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	O0504					2022-12-18	WOS:A1972O050400099
J	WOOLF, CM				WOOLF, CM			MISSING MAXILLARY LATERAL INCISORS - GENETIC STUDY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		GORLIN RJ, 1964, SYNDROMES HEAD NECK; Grahnen H., 1956, ODONT REV, V7, P1; GRAHNEN H, 1962, GENETICS DENTAL HEAL, P194; GRUNEBERG H, 1951, PROC R SOC SER B-BIO, V138, P437, DOI 10.1098/rspb.1951.0034; JOHR ALBERT C., 1934, ARCH JULIUS KLAUS STIFT, V9, P73; Keeler CE, 1934, J HERED, V25, P391, DOI 10.1093/oxfordjournals.jhered.a103846; MANDEVILLE LC, 1950, ANN EUGENIC, V15, P1; MESKIN LAWRENCE H., 1963, JOUR DENT RES, V42, P1476, DOI 10.1177/00220345630420062501; WOOLF C M, 1965, Plast Reconstr Surg, V35, P543, DOI 10.1097/00006534-196505000-00011	9	35	36	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1971	23	3					289	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	J3602	5089845				2022-12-18	WOS:A1971J360200005
J	HECHT, F; NIEVAARD, JE; DUNCANSON, N; MILLER, JR; HIGGINS, JV; KIMBERLING, WJ; WALKER, FA; SMITH, GS; THULINE, HC; TISCHLER, B				HECHT, F; NIEVAARD, JE; DUNCANSON, N; MILLER, JR; HIGGINS, JV; KIMBERLING, WJ; WALKER, FA; SMITH, GS; THULINE, HC; TISCHLER, B			DOUBLE ANEUPLOIDY - FREQUENCY OF XXY IN MALES WITH DOWNS SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BARR ML, 1960, J MENT DEFIC RES, V4, P89; BARR ML, 1966, PERSONAL COMMUNICATI; FERGUSON-SMITH MALCOLM A., 1966, P277; FERGUSONSMITH MA, 1962, ACTA CYTOL, V6, P73; FORD CE, 1959, LANCET, V1, P709; HAMERTON JL, 1962, BRIT MED J, P220, DOI 10.1136/bmj.1.5273.220; HARNDEN DG, 1960, ANN HUM GENET, V24, P165; JACOBS PA, 1959, NATURE, V183, P302, DOI 10.1038/183302a0; KLINGER HP, 1957, STAIN TECHNOL, V32, P235, DOI 10.3109/10520295709111629; LEJEUNE J, 1959, CR HEBD ACAD SCI, V248, P1721; LEJEUNE J, 1963, PEDIATRICS, V32, P326; MIKKELSEN M, 1964, INT COPENHAGEN C SCI, P162; MOORE KL, 1959, LANCET, V1, P217; MOORE KL, 1966, SEX CHROMATIN     ED, P277; MOSIER HD, 1960, PEDIATRICS, V25, P291; OSTER J, 1964, INT COPENHAGEN C  ED, P162; Penrose L.S., 1966, DOWNS ANOMALY; SCHMID W., 1963, CYTOGENETICS [BASEL], V2, P175, DOI 10.1159/000129778; SHAPIRO A, 1960, J MENT DEFIC RES, V4, P48; SHAPIRO A, 1962, PERSONAL COMMUNICATI; TAYLOR A I, 1968, Journal of Medical Genetics, V5, P227, DOI 10.1136/jmg.5.3.227; TAYLOR ANGELA I., 1967, J MED GENET, V4, P258, DOI 10.1136/jmg.4.4.258	22	35	35	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1969	21	4					352	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	D7993	4240108				2022-12-18	WOS:A1969D799300003
J	WEITKAMP, LR; SING, CF; SHREFFLER, DC; GUTTORMSEN, SA				WEITKAMP, LR; SING, CF; SHREFFLER, DC; GUTTORMSEN, SA			GENETIC LINKAGE RELATIONS OF ADENYLATE KINASE -FURTHER DATA ON ABO-AK LINKAGE GROUP	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article														Sing, Charles/0000-0001-5872-7956				BOWMAN JE, 1967, NATURE, V214, P1156, DOI 10.1038/2141156a0; FILDES RA, 1966, NATURE, V209, P261, DOI 10.1038/209261a0; MORTON NE, 1955, AM J HUM GENET, V7, P277; Race R. R, 1968, BLOOD GROUPS MAN; RAPLEY S, 1968, ANN HUM GENET, V31, P237, DOI 10.1111/j.1469-1809.1968.tb00554.x; ROBSON EB, 1966, ANN HUM GENET, V29, P325, DOI 10.1111/j.1469-1809.1966.tb00528.x; SHREFFLER D, IN PRESS; SMITH CAB, 1959, AM J HUM GENET, V11, P289; WEITKAMP LR, IN PRESS	9	35	35	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1969	21	6					600	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	F0121	5365762				2022-12-18	WOS:A1969F012100008
J	BIAS, WB; MIGEON, BR				BIAS, WB; MIGEON, BR			HAPTOGLOBIN - A LOCUS ON D1 CHROMOSOME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BLOOM GE, 1966, 36 ANN M SOC PED RES; DEGROUCHY J, 1966, ANN GENET-PARIS, V9, pG80; GERALD PS, 1964, J CLIN INVEST, V43, P1297; HIRSCHFELD JAN, 1959, ACTA PATHOL ET MICROBIOL SCAND, V47, P160; HUSTINX TWJ, 1965, NATURE, V207, P327, DOI 10.1038/207327b0; KITCHIN FD, 1965, P SOC EXP BIOL MED, V119, P1153; MIGEON BR, 1965, B JOHNS HOPKINS HOSP, V116, P396; PEACOCK AC, 1965, SCIENCE, V147, P1451, DOI 10.1126/science.147.3664.1451; SMITHIES O, 1955, BIOCHEM J, V61, P629, DOI 10.1042/bj0610629; STEINBERG AG, 1963, AM J HUM GENET, V15, P96; YUNIS JJ, 1964, LANCET, V2, P935	11	35	35	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1967	19	3P2					393	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	96074	6026932				2022-12-18	WOS:A19679607400004
J	LONG, WK; WILSON, SW; FRENKEL, EP				LONG, WK; WILSON, SW; FRENKEL, EP			ASSOCIATIONS BETWEEN RED CELL GLUCOSE-6-PHOSPHATE DEHYDROGENASE VERIANTS AND VASCULAR DISEASES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ADAMS RD, 1962, DISEASES MUSCLE STUD, P220; BIRKMAN HN, 1964, COLD SPRING HARB SYM, V29, P391, DOI 10.1101/SQB.1964.029.01.041; BOYER SH, 1962, P NATL ACAD SCI USA, V48, P1868, DOI 10.1073/pnas.48.10.1868; BREWER GJ, 1962, JAMA-J AM MED ASSOC, V180, P386, DOI 10.1001/jama.1962.03050180032008; BRINK A. J., 1965, S AFRICAN MED J, V39, P108; BRODIE BB, 1956, J PHARM PHARMACOL, V8, P1, DOI 10.1111/j.2042-7158.1956.tb12123.x; BRODY S, 1965, GENETICS, V52, P430; CARSON PE, 1966, AM J MED, V41, P744, DOI 10.1016/0002-9343(66)90035-0; CARSON PE, 1963, 9 P C EUR SOC HAEM L, P655; COOPER AJ, 1963, AM J HUM GENET, V15, P420; DAVIDSON RG, 1963, P NATL ACAD SCI USA, V50, P481, DOI 10.1073/pnas.50.3.481; DAWSON DM, 1964, ARCH NEUROL-CHICAGO, V11, P369, DOI 10.1001/archneur.1964.00460220031004; DEWAN ML, 1965, AM J PATHOL, V46, P215; GITTELSOHN AM, 1965, GENETICS EPIDEMIOLOG, P305; HARRISON TR, 1958, PRINCIPLES INTERN ED, P691; KALLNER GERTRUDE, 1962, ISRAEL MED JOUR, V21, P1; KIRK JE, 1964, CLIN CHEM, V10, P184; KIRKMAN HN, 1963, AM J HUM GENET, V15, P241; LINDER D, 1965, AM J HUM GENET, V17, P212; LOFLAND HB, 1965, ARCH PATHOL, V80, P291; LONG WK, 1965, J LAB CLIN MED, V65, P81; MCDONOUGH JR, 1965, J CHRON DIS, V18, P443, DOI 10.1016/0021-9681(65)90027-5; MOSES C, 1963, ATHEROSCLEROSIS MECH, P101; NEEL JV, 1965, GENETICS EPIDEMIO ED, P305; OJO GO, 1966, LANCET, V1, P854; PARRY EHO, 1965, BRIT MED J, V1, P921, DOI 10.1136/bmj.1.5439.921; PHILLIPS JH, 1960, MEDICINE, V39, P241, DOI 10.1097/00005792-196005000-00003; PINTO PVC, 1966, J CLIN INVEST, V45, P823, DOI 10.1172/JCI105398; REEF H, 1962, CIRCULATION, V25, P66, DOI 10.1161/01.CIR.25.1.66; REIFENSTEIN EC, 1958, PRINCIPLES INTERNAL, P691; SALVIDIO E, 1963, NATURE, V200, P372, DOI 10.1038/200372a0; SCHRIER SL, 1958, P SOC EXP BIOL MED, V99, P354, DOI 10.3181/00379727-99-24348; SHAPIRO RN, 1958, AM J SURG, V96, P396, DOI 10.1016/0002-9610(58)90932-2; SIPERSTEIN MD, 1959, AM J MED, V26, P685, DOI 10.1016/0002-9343(59)90228-1; SIPERSTEIN MD, 1951, SCIENCE, V113, P747, DOI 10.1126/science.113.2948.747; TARLOV AR, 1962, ARCH INTERN MED, V109, P209, DOI 10.1001/archinte.1962.03620140081013; TOOR M, 1960, CIRCULATION, V22, P265, DOI 10.1161/01.CIR.22.2.265; WINTROBE MM, 1961, CLINICAL HEMATOLOGY, P669; WINTROBE MM, 1961, CLINICAL HEMATOLOGY, P690	39	35	35	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1967	19	1					35	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	88552	4960001				2022-12-18	WOS:A19678855200004
J	PIKKARAINEN, J; TAKKUNEN, J; KULONEN, E				PIKKARAINEN, J; TAKKUNEN, J; KULONEN, E			SERUM CHOLESTEROL IN FINNISH TWINS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ADLERSBERG D, 1957, CIRCULATION, V16, P487; BIALKIN G, 1962, PEDIATRICS, V29, P566; BONNIER G, 1962, BIOLOGISK VARIATIONS; CLARK PJ, 1956, AM J HUM GENET, V8, P49; CROXTON FE, 1953, ELEMENTARY STATISTIC; DIEM K, 1960, WISSENSCHAFTLICHE TA, P588; EPSTEIN FH, 1959, AM J MED, V26, P39, DOI 10.1016/0002-9343(59)90325-0; FISHER RA, 1950, STATISTICAL METHODS, P229; FRIEDMAN M, 1958, CIRCULATION, V17, P852, DOI 10.1161/01.CIR.17.5.852; GEDDA L, 1960, Acta Genet Med Gemellol (Roma), V9, P135; GERTLER MM, 1954, CORONARY DISEASES YO; KEMPTHORNE O, 1961, AM J HUM GENET, V13, P320; KEYS A, 1958, LANCET, V2, P175; KINSELL LW, 1952, J CLIN ENDOCR METAB, V12, P909, DOI 10.1210/jcem-12-1-50; LEPPANEN V, 1956, SCAND J CLIN LAB INV, V8, P201, DOI 10.3109/00365515609049272; MCDONOUGH JR, 1962, CIRCULATION, V25, P962, DOI 10.1161/01.CIR.25.6.962; MEYER K, 1962, ACTA MED SCAND, V172, P401; NATELSON BS, 1957, MICROTECHNIQUES CLIN, P430; OSBORNE RH, 1959, AM J MED, V26, P54, DOI 10.1016/0002-9343(59)90326-2; OSBORNE RH, 1958, SCIENCE, V128, P727, DOI 10.1126/science.128.3326.727; OSBORNE RH, 1958, SCIENCE, V127, P1294, DOI 10.1126/science.127.3309.1294; Osborne RH, 1959, GENETIC BASIS MORPHO; PAGE IH, 1957, CIRCULATION, V16, P163, DOI 10.1161/01.CIR.16.2.163; PALOHEIMO J, 1961, ANN MED EXP FENN  S8, V39; PIKKARAINEN J, 1964, ANN MED EXP BIOL FEN, V42, P117; PIKKARAINEN J, 1964, CLIN CHIM ACTA, V10, P496, DOI 10.1016/0009-8981(64)90186-X; RUSSEK HI, 1958, AM J MED SCI, V235, P266, DOI 10.1097/00000441-195803000-00003; SAMMALISTO L, 1961, ACTA GENET STAT MED, V11, P251; THOMAS CB, 1961, ANN INTERN MED, V54, P413, DOI 10.7326/0003-4819-54-3-413; THOMAS CB, 1955, ANN INTERN MED, V42, P90, DOI 10.7326/0003-4819-42-1-90	30	35	35	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1966	18	2					115	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	74253	5948307				2022-12-18	WOS:A19667425300001
J	RENWICK, JH; SCHULZE, J				RENWICK, JH; SCHULZE, J			ANALYSIS OF SOME DATA ON LINKAGE BETWEEN XG + COLORBLINDNESS IN MAN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ADAM A, 1963, ANN HUM GENET, V26, P187, DOI 10.1111/j.1469-1809.1963.tb01974.x; ALTMAN PL, 1962, GROWTH REPRODUCTION, P80; ALTMAN PL, 1962, GROWTH REPRODUCTION, P97; ALTMAN PL, 1962, GROWTH INCLUDING REP, P73; BAILEY NTJ, 1961, INTRODUCTION MATHEMA; Bridges PN, 1942, J HERED, V33, P403, DOI 10.1093/oxfordjournals.jhered.a105104; CARTER TC, 1951, J GENET, V50, P307, DOI 10.1007/BF02996226; CARTER TC, 1954, Z INDUKT ABSTAMM VER, V86, P210, DOI 10.1007/BF00444789; COOK PL, IN PRESS; DAVIES SH, 1963, AM J HUM GENET, V15, P481; ELLIOTT CG, 1953, DISSERTATION CAMBRID; FERGUSON-SMITH M. A., 1962, CYTO GENETICS [BASEL], V1, P325, DOI 10.1159/000129743; FORD CE, 1956, NATURE, V178, P1020, DOI 10.1038/1781020a0; FRASER GR, 1964, ANN HUM GENET, V27, P395; GREEN MC, 1962, GROWTH INCLUDING REP, P73; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; HALDANE JBS, 1947, ANN EUGENIC, V14, P10, DOI 10.1111/j.1469-1809.1947.tb02374.x; JACKSON CE, 1964, AM J HUM GENET, V16, P403; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Longely AE, 1939, J AGRIC RES, V59, P0475; MCCLINTOCK B, 1929, SCIENCE, V29, P629; MORTON NE, 1956, AM J HUM GENET, V8, P80; MORTON NE, 1955, AM J HUM GENET, V7, P277; Neyman, 1936, STATISTICAL RES MEMO, V1, P1; PORTER IH, 1962, ANN HUM GENET, V26, P107, DOI 10.1111/j.1469-1809.1962.tb01316.x; RENWICK JH, 1961, 2 P INT C HUM GEN AM, pE145; RENWICK JH, 1963, 11 P INT C GEN, V1, P279; RENWICK JH, IN PRESS; RHOADES MM, 1962, GROWTH REPRODUCTION, P97; SLIZYNSKI BM, 1960, GENET RES, V1, P477, DOI 10.1017/S0016672300000446; SMITH CAB, 1959, AM J HUM GENET, V11, P289; WARREN KB, 1962, GROWTH REPRODUCTION, P80; [No title captured]	33	35	35	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1964	16	4					410	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2974A	14250422				2022-12-18	WOS:A19642974A00007
J	WIENER, AS; GORDON, EB; MOORJANKOWSKI, J				WIENER, AS; GORDON, EB; MOORJANKOWSKI, J			BLOOD GROUPS OF APES + MONKEYS .4. RH-HR BLOOD TYPES OF ANTHROPOID APES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BUTTS CA, 1953, AMER J PHYS ANTHROP, V11, P215; EYQUEM A, 1962, ANN NY ACAD SCI, V97, P320, DOI 10.1111/j.1749-6632.1962.tb34646.x; MOORJANKOWSKI J, 1964, TRANSFUSION, V4, P92, DOI 10.1111/j.1537-2995.1964.tb02837.x; MOORJANKOWSKI J, IN PRESS; MOURANT AE, 1946, SCIENCE, V104, P277, DOI 10.1126/science.104.2699.277; Wiener Alexander S., 1943, PROC SOC EXP BIOL AND MED, V54, P316; Wiener AS, 1952, AM J PHYS ANTHROP-NE, V10, P372, DOI 10.1002/ajpa.1330100323; Wiener AS, 1953, AM J PHYS ANTHROP-NE, V11, P39, DOI 10.1002/ajpa.1330110113; WIENER AS, 1961, AM J PHYS ANTHROPOL, V19, P35, DOI 10.1002/ajpa.1330190104; WIENER AS, 1952, AM J HUM GENET, V4, P363; WIENER AS, 1945, SCIENCE, V102, P177, DOI 10.1126/science.102.2642.177; WIENER AS, 1963, EXP MED SURG, V21, P159; WIENER AS, 1963, SCIENCE, V142, P67, DOI 10.1126/science.142.3588.67; WIENER AS, IN PRESS; WIENER AS, 1963, RHHR SYLLABUS; WIENER AS, 1950, BLOOD, V5, P693; WIENER AS, 1958, HEREDITY BLOOD GROUP	17	35	35	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1964	16	2					246	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2972A	14174804				2022-12-18	WOS:A19642972A00012
J	GOODMAN, HO; LUKE, JE; ROSEN, S; HACKEL, E				GOODMAN, HO; LUKE, JE; ROSEN, S; HACKEL, E			HERITABILITY IN DENTAL CARIES, CERTAIN ORAL MICROFLORA AND SALIVARY COMPONENTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Bibby B. G., 1942, JOUR DENTAL RES, V21, P61, DOI 10.1177/00220345420210011001; BODECKER C. F., 1939, Journal of the American Dental Association, V26, P1453; Book JAaG H., 1953, ODONTOL REVY, V4, P1; CLARK PJ, 1956, AM J HUM GENET, V8, P49; COX GJ, 1952, NAT ACAD SC NAT RES, V225, P243; CURBY WA, 1953, J LAB CLIN MED, V41, P493; HATTON M E, 1955, J Dent Res, V34, P397; HOROWITZ SL, 1958, SCIENCE, V128, P300, DOI 10.1126/science.128.3319.300; Jay P, 1936, J PEDIATR-US, V8, P725, DOI 10.1016/S0022-3476(36)80125-5; KNUTSON JOHN W., 1938, U S PUBL HEALTH REPTS, V53, P1021; Myers VC, 1944, J BIOL CHEM, V154, P39; NEEL JV, 1955, HUMAN HEREDITY; PERMAR D, 1946, J DENT RES, V25, P475, DOI 10.1177/00220345460250060801; RICHARDS A. G., 1958, JOUR AMER DENTAL ASSOC, V56, P351; RICHARDSON ROBERT L., 1958, JOUR DENTAL RES, V37, P697, DOI 10.1177/00220345580370041701; SULLIVAN JH, 1950, J DENT RES, V29, P165, DOI 10.1177/00220345500290020901; TURNER NC, 1953, J HERED, V44, P86, DOI 10.1093/oxfordjournals.jhered.a106360; WITKOP CJ, 1958, EUGEN QUART, V5, P15, DOI 10.1080/19485565.1958.9987342	18	35	37	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1959	11	3					263	273						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF075	13851069				2022-12-18	WOS:A1959WF07500005
J	ZEMAN, W; KAELBLING, R; PASAMANICK, B				ZEMAN, W; KAELBLING, R; PASAMANICK, B			IDIOPATHIC DYSTONIA MUSCULORUM DEFORMANS .1. THE HEREDITARY PATTERN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ABRAHAMSON I, 1922, J NERV MENT DIS, V51, P451; BEDER W, 1926, CITED INDIRECTLY; BEILIN JA, 1934, Z GES NEUROL PSYCHIA, V152, P126; Benedek L, 1940, J NERV MENT DIS, V91, P608, DOI 10.1097/00005053-194005000-00006; BERNSTEIN S, 1912, WIEN KLIN WCHNSCHR, V25, P1567; DAWIDENKOW SN, 1921, MITT STAATL U BAKU, V1, P151; DZERSCHINSKY, CITED INDIRECTLY; FOSSEY H, 1922, NY J MED, V116, P329; GOWERS WR, 1893, MANUAL DISEASES NERV; HAENISCH, 1914, NEUR CBL, V33, P69; HALLERVORDEN J, 1957, HANDBUCH SPEZIELLEN, V13, P925; Herz E, 1944, ARCH NEURO PSYCHIATR, V51, P319, DOI 10.1001/archneurpsyc.1944.02290280017002; JAKOB A, 1924, CITED INDIRECTLY; JANKOWSKA H, 1934, ZBL GES NEUROL, V74, P359; KEHRER F, 1936, HDB NEUROLOGIE BUNCK, V16, P222; Mankowsky BN, 1929, MON PSYCHIATR NEUROL, V72, P165; MENDEL K, 1936, HDB NEUROLOGIE BERLI, V16, P848; Mendel K, 1919, MON PSYCHIATR NEUROL, V46, P309; Munch-Petersen CJ, 1930, ACTA PSYCH NEUROL, V5, P493, DOI 10.1111/j.1600-0447.1930.tb08233.x; OPPENHEIM H, 1923, LEHRBUCH NERVENKRANK, V7; Oppenheim H., 1911, NEUROL CENTRALBL, V30, P1090; PRICE GE, 1921, ARCH NEUROL PSYCHIAT, V5, P768; QUANDT J, 1956, Z NERVENHEILK, V175, P100; Regensburg J, 1930, MON PSYCHIATR NEUROL, V75, P323; ROSE A, 1937, CITED INDIRECTLY; SANTANGELO G, 1934, G PSYCHIAT NEUROPAT, V62, P52; Schwalbe W., 1908, THESIS; SPILLER WG, 1913, J NERV MENT DIS, V40, P529; SVEJCAR J, 1924, CASOPIS LEK CES, V63, P97; SVEJCAR J, 1924, ZBL NEUR, V37, P40; Taylor EW, 1920, ARCH NEURO PSYCHIATR, V4, P417, DOI 10.1001/archneurpsyc.1920.02180220066005; VANBOGAERT L, 1946, J NEUROL NEUROSUR PS, V9, P125; VANBOGAERT L, 1940, MONATSSCHR NEUROL PS, V103, P321; VANBOGAERT L, 1948, ACTA NEUR PSYCHIATR, V48, P3; VOGT C, 1942, CITED INDIRECTLY; VON KEYSERLINGK H, 1956, Nervenarzt, V27, P34; Wechsler IS, 1922, ARCH NEURO PSYCHIATR, V8, P538, DOI 10.1001/archneurpsyc.1922.02190170085005	37	35	36	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1959	11	2					188	202						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF073	13661153				2022-12-18	WOS:A1959WF07300006
J	GARTLER, SM				GARTLER, SM			A FAMILY STUDY OF URINARY BETA-AMINOISOBUTYRIC ACID EXCRETION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Berry HK, 1953, AM J PHYS ANTHROP-NE, V11, P559, DOI 10.1002/ajpa.1330110405; BERRY HK, 1955, AM J HUM GENET, V7, P93; BONSNES RW, 1945, J BIOL CHEM, V158, P581; CALCHINOVATI C, 1954, ANN EUGENIC, V18, P335; FINK K, 1951, P SOC EXP BIOL MED, V78, P135; FISHER RA, 1939, ANN EUGEN, V9, P150; HARRIS H, 1953, ANN EUGENIC, V18, P43; PARE CMB, 1954, LANCET, V266, P702; Sutton HE, 1955, AM J PHYS ANTHROP-NE, V13, P53, DOI 10.1002/ajpa.1330130106	9	35	36	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1956	8	2					120	126						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF069	13313522				2022-12-18	WOS:A1956WF06900006
J	MATSUNAGA, E				MATSUNAGA, E			INTRA-UTERINE SELECTION BY THE ABO INCOMPATIBILITY OF MOTHER AND FOETUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Haldane JBS, 1942, ANN EUGEN, V11, P333; HIRSZFELD L., 1926, KLIN WOCHENSCHR, V5, P741, DOI 10.1007/BF01724752; KOBAYASHI T, 1940, HANZAIGAKU ZASSHI, V14, P727; Levine P, 1943, J HERED, V34, P71, DOI 10.1093/oxfordjournals.jhered.a105249; MATSUNAGA E., 1953, PROC JAPANESE AC AD, V29, P529; MATSUNAGA E, 1953, P JAPAN ACAD, V29, P399; Waterhouse JAH, 1947, BR J SOC MED, V1, P1; Wiener AS, 1942, SCIENCE, V96, P407, DOI 10.1126/science.96.2496.407	8	35	35	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1955	7	1					66	71						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA210	14361395				2022-12-18	WOS:A1955WA21000008
J	MULLER, HJ				MULLER, HJ			PROGRESS AND PROSPECTS IN HUMAN GENETICS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material																		Altenburg E, 1920, GENETICS, V5, P1; ALTENBURG E, 1946, GENETICS, P452; CREW FAE, 1947, GENETICS RELATION CL, P111; Muller HJ, 1925, J HERED, V16, P433, DOI 10.1093/oxfordjournals.jhered.a102537; ROBERTS JAF, 1940, INTRO MED GENETICS, P266; SCHULTZ JACK, 1949, JOUR HEREDITY, V40, P31; Sinnott E.W., 1939, PRINCIPLES GENETICS, P408; SNYDER LH, 1946, PRINCIPLES HEREDITY, P450	8	35	35	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1949	1	1					1	18						18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XU075	17948379				2022-12-18	WOS:A1949XU07500001
J	Glastonbury, CA; Alves, AC; Moustafa, JSE; Small, KS				Glastonbury, Craig A.; Alves, Alexessander Couto; Moustafa, Julia S. El-Sayed; Small, Kerrin S.			Cell-Type Heterogeneity in Adipose Tissue Is Associated with Complex Traits and Reveals Disease-Relevant Cell-Specific eQTLs	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; HUMAN IMMUNE-SYSTEM; GENE-EXPRESSION; SUSCEPTIBILITY LOCI; DNA METHYLATION; INFLAMMATION; MACROPHAGES; DIFFERENTIATION; DECONVOLUTION; ARCHITECTURE	Adipose tissue is an important endocrine organ with a role in many cardiometabolic diseases. It is comprised of a heterogeneous collection of cell types that can differentially impact disease phenotypes. Cellular heterogeneity can also confound -omic analyses but is rarely taken into account in analysis of solid-tissue transcriptomes. Here, we investigate cell-type heterogeneity in two population-level subcutaneous adipose-tissue RNA-seq datasets (TwinsUK, n = 766 and the Genotype-Tissue Expression project [GTEx], n = 326) by estimating the relative proportions of four distinct cell types (adipocytes, macrophages, CD4+ T cells, and micro-vascular endothelial cells). We find significant cellular heterogeneity within and between the TwinsUK and GTEx adipose datasets. We find that adipose cell-type composition is heritable and confirm the positive association between adipose-resident macrophage proportion and obesity (high BMI), but we find a stronger BMI-independent association with dual-energy X-ray absorptiometry (DXA) derived body-fat distribution traits. We benchmark the impact of adipose-tissue cell composition on a range of standard analyses, including phenotype-gene expression association, co-expression networks, and cis-eQTL discovery. Our results indicate that it is critical to account for cell-type composition when combining adipose transcriptome datasets in co-expression analysis and in differential expression analysis with obesity-related traits. We applied gene expression by cell-type proportion interaction models (G x Cell) to identify 26 cell-type-specific expression quantitative trait loci (eQTLs) in 20 genes, including four autoimmune disease genome-wide association study (GWAS) loci. These results identify cell-specific eQTLs and demonstrate the potential of in silico deconvolution of bulk tissue to identify cell-type-restricted regulatory variants.	[Glastonbury, Craig A.; Alves, Alexessander Couto; Moustafa, Julia S. El-Sayed; Small, Kerrin S.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Glastonbury, Craig A.] BenevolentAI, London, England	University of London; King's College London	Glastonbury, CA; Small, KS (corresponding author), Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England.; Glastonbury, CA (corresponding author), BenevolentAI, London, England.	craig.glastonbury@benevolent.ai; kerrin.small@kcl.ac.uk		Small, Kerrin/0000-0003-4566-0005; El-Sayed Moustafa, Julia Sarah/0000-0001-6963-6654; Glastonbury, Craig/0000-0001-5542-2225	MRC Project [MR/L01999X/1]; MRC Programme grant [MR/M004422/1]; Wellcome Trust; European Community; National Institute for Health Research (NIHR); King's College London; Medical Research Council [MR/L016311/1]; MRC [MR/M004422/1, MR/L016311/1, MR/L01999X/1] Funding Source: UKRI	MRC Project(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Programme grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); European Community(European Commission); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); King's College London(General Electric); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank Aaron Newman, the author of CIBERSORT, for significant and useful discussions. This study was supported by an MRC Project grant (MR/L01999X/1) to K.S.S and an MRC Programme grant (MR/M004422/1) to K.S.S. The TwinsUK study was funded by the Wellcome Trust and the European Community's Seventh Framework Programme (FP7/2007-2013). The TwinsUK study also receives support from the National Institute for Health Research (NIHR)-funded BioResource, Clinical Research Facility, and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London. This project was enabled through access to the MRC eMedLab Medical Bioinformatics infrastructure, supported by the Medical Research Council (grant number MR/L016311/1).	Boker S, 2011, PSYCHOMETRIKA, V76, P306, DOI 10.1007/s11336-010-9200-6; Boutens L, 2016, DIABETOLOGIA, V59, P879, DOI 10.1007/s00125-016-3904-9; BRIGGS RC, 1994, J CELL BIOCHEM, V56, P559, DOI 10.1002/jcb.240560417; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Buil A, 2015, NAT GENET, V47, P88, DOI 10.1038/ng.3162; Cancello R, 2005, DIABETES, V54, P2277, DOI 10.2337/diabetes.54.8.2277; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Civelek M, 2017, AM J HUM GENET, V100, P428, DOI 10.1016/j.ajhg.2017.01.027; Dahl A, 2019, GENETICS, V211, P1179, DOI 10.1534/genetics.118.301768; Davis JR, 2016, AM J HUM GENET, V98, P216, DOI 10.1016/j.ajhg.2015.11.021; Delaneau O, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15452; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Rafols ME, 2014, ENDOCRINOL NUTR, V61, P100, DOI 10.1016/j.endonu.2013.03.011; Fairfax BP, 2014, SCIENCE, V343, P1118, DOI 10.1126/science.1246949; Glastonbury CA, 2016, AM J HUM GENET, V99, P567, DOI 10.1016/j.ajhg.2016.07.001; Gong T, 2013, BIOINFORMATICS, V29, P1083, DOI 10.1093/bioinformatics/btt090; Greenawalt DM, 2011, GENOME RES, V21, P1008, DOI 10.1101/gr.112821.110; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Heilbronn LK, 2008, CURR PHARM DESIGN, V14, P1225, DOI 10.2174/138161208784246153; Jaffe AE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r31; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kirino Y, 2013, NAT GENET, V45, P202, DOI 10.1038/ng.2520; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lappalainen T, 2017, NAT REV GENET, V18, P441, DOI 10.1038/nrg.2017.32; Lara-Castro C, 2007, CURR OPIN LIPIDOL, V18, P263, DOI 10.1097/MOL.0b013e32814a645f; Lee DJ, 2007, J IMMUNOL, V179, P8128, DOI 10.4049/jimmunol.179.12.8128; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; McCall MN, 2016, AM J HUM GENET, V99, P624, DOI 10.1016/j.ajhg.2016.07.007; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Nilsson E, 2014, DIABETES, V63, P2962, DOI 10.2337/db13-1459; Ren SC, 2013, CELL RES, V23, P732, DOI 10.1038/cr.2013.61; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Roederer M, 2015, CELL, V161, P387, DOI 10.1016/j.cell.2015.02.046; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Stegle O, 2012, NAT PROTOC, V7, P500, DOI 10.1038/nprot.2011.457; Titus AJ, 2017, HUM MOL GENET, V26, pR216, DOI 10.1093/hmg/ddx275; Travers RL, 2015, INT J OBESITY, V39, P762, DOI 10.1038/ijo.2014.195; van Harmelen V, 2003, INT J OBESITY, V27, P889, DOI 10.1038/sj.ijo.0802314; Vinuela A, 2018, HUM MOL GENET, V27, P732, DOI 10.1093/hmg/ddx424; Westra HJ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005223; Wheeler HE, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006423; Yengo L, 2018, HUM MOL GENET, V27, P3641, DOI 10.1093/hmg/ddy271	46	34	35	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 6	2019	104	6					1013	1024		10.1016/j.ajhg.2019.03.025	http://dx.doi.org/10.1016/j.ajhg.2019.03.025			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IB4KJ	31130283	Green Published, Green Submitted, hybrid			2022-12-18	WOS:000470240000001
J	Suzuki, Y; Chitayat, D; Sawada, H; Deardorff, MA; McLaughlin, HM; Begtrup, A; Millar, K; Harrington, J; Chong, KR; Roifman, M; Grand, K; Tominaga, M; Takada, F; Shuster, S; Obara, M; Mutoh, H; Kushima, R; Nishimura, G				Suzuki, Yoshiro; Chitayat, David; Sawada, Hirotake; Deardorff, Matthew A.; McLaughlin, Heather M.; Begtrup, Amber; Millar, Kathryn; Harrington, Jennifer; Chong, Karen; Roifman, Maian; Grand, Katheryn; Tominaga, Makoto; Takada, Fumio; Shuster, Shirley; Obara, Megumi; Mutoh, Hiroshi; Kushima, Reiko; Nishimura, Gen			TRPV6 Variants Interfere with Maternal-Fetal Calcium Transport through the Placenta and Cause Transient Neonatal Hyperparathyroidism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHANNEL TRPV6; PROSTATE-CANCER; CAT-LIKE; EXPRESSION; MUTATIONS; PREGNANCY; METABOLISM; ECAC1; INACTIVATION; CALMODULIN	Transient neonatal hyperparathyroidism (TNHP) is etiologically a heterogeneous condition. One of the etiologies is an insufficient maternal-fetal calcium transport through the placenta. We report six subjects with homozygous and/or compound-heterozygous mutations in the gene encoding the transient receptor potential cation channel, subfamily V, member 6 (TRPV6), an epithelial Ca2+-selective channel associated with this condition. Exome sequencing on two neonates with skeletal findings consistent with neonatal hyperparathyroidism identified homozygous frameshift mutations before the first transmembrane domain in a subject born to first-cousins parents of Pakistani descent as well as compound-heterozygous mutations (a combination of a frameshift mutation and an intronic mutation that alters mRNA splicing) in an individual born to a non-consanguineous couple of African descent. Subsequently, targeted mutation analysis of TRPV6 performed on four other individuals (born to non-consanguineous Japanese parents) with similar X-rays findings identified compound-heterozygous mutations. The skeletal findings improved or resolved in most subjects during the first few months of life. We identified three missense variants (at the outer edges of the second and third transmembrane domains) that alter the localization of the TRPV6: one recurrent variant at the S2-S3 loop and two recurrent variants (in the fourth ankyrin repeat domain) that impair TRPV6 stability. Compound heterozygous loss-of-function mutations for the pathogenic frameshift allele and the allele with an intronic c.607thorn5G>A mutation resulted in the most severe phenotype. These results suggest that TNHP is an autosomal-recessive disease caused by TRPV6 mutations that affect maternal-fetal calcium transport.	[Suzuki, Yoshiro; Tominaga, Makoto] Natl Inst Nat Sci, Natl Inst Physiol Sci, Okazaki Inst Integrat Biosci, Div Cell Signaling, Okazaki, Aichi 4448787, Japan; [Suzuki, Yoshiro; Tominaga, Makoto] SOKENDAI, Dept Physiol Sci, Okazaki, Aichi 4448787, Japan; [Chitayat, David; Millar, Kathryn; Chong, Karen; Roifman, Maian; Shuster, Shirley] Univ Toronto, Mt Sinai Hosp, Dept Obstet & Gynecol, Prenatal Diag & Med Genet Program, Toronto, ON M5G 1Z5, Canada; [Chitayat, David] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Clin Genet & Metab, Toronto, ON M5G 1X8, Canada; [Sawada, Hirotake; Obara, Megumi] Univ Miyazaki, Fac Med, Dept Dev & Urol Reprod Med, Div Pediat, Miyazaki 8891692, Japan; [Deardorff, Matthew A.; Grand, Katheryn] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [McLaughlin, Heather M.; Begtrup, Amber] GeneDx, Gaithersburg, MD 20877 USA; [Harrington, Jennifer] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Endocrinol & Metab, Toronto, ON M5G 1X8, Canada; [Takada, Fumio] Kitasato Univ, Grad Sch Med Sci, Dept Med Genet & Genom, Sagamihara, Kanagawa 2520375, Japan; [Takada, Fumio] Kitasato Univ Hosp, Ctr Clin Genet & Genom, Div Genet & Genom, Sagamihara, Kanagawa 2520374, Japan; [Mutoh, Hiroshi] Tokyo Metropolitan Childrens Med Ctr, Dept Neonatol, Tokyo 1838561, Japan; [Kushima, Reiko] Tokyo Metropolitan Bokutoh Hosp, Dept Neonatol, Tokyo 1308575, Japan; [Nishimura, Gen] Saitama Med Univ Hosp, Intractable Dis Ctr, Saitama 3501298, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB); Graduate University for Advanced Studies - Japan; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Miyazaki; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Kitasato University; Kitasato University; Tokyo Metropolitan Children's Medical Center; Saitama Medical University	Chitayat, D (corresponding author), Univ Toronto, Mt Sinai Hosp, Dept Obstet & Gynecol, Prenatal Diag & Med Genet Program, Toronto, ON M5G 1Z5, Canada.; Chitayat, D (corresponding author), Univ Toronto, Hosp Sick Children, Dept Pediat, Div Clin Genet & Metab, Toronto, ON M5G 1X8, Canada.	david.chitayat@sinaihealthsystem.ca		SUZUKI, YOSHIRO/0000-0003-0010-1867; Harrington, Jennifer/0000-0001-6484-4403	Ministry of Education, Culture, Sports, Science, and Technology in Japan [15K08199]	Ministry of Education, Culture, Sports, Science, and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank Matthias A. Hediger (University of Bern, Switzerland) for human TRPV6 cDNA, and we thank Claire T. Saito and Takaaki Sokabe (Okazaki Institute for Integrative Bioscience) for technical assistance and discussion. We also thank the Functional Genomics Facility of the NIBB Core Research Facility for the gel imaging system. This work was supported by a grant-in-aid for scientific research provided to Y.S. and M.T. by the Ministry of Education, Culture, Sports, Science, and Technology (grant number 15K08199) in Japan.	Belkacemi L, 2004, CELL TISSUE RES, V315, P107, DOI 10.1007/s00441-003-0811-4; Bianco SDC, 2007, J BONE MINER RES, V22, P274, DOI 10.1359/JBMR.061110; Bodding M, 2002, J BIOL CHEM, V277, P36656, DOI 10.1074/jbc.M202822200; Bosch B, 2016, EUR J PEDIATR, V175, P1, DOI 10.1007/s00431-015-2664-8; Egbuna OI, 2008, BEST PRACT RES CL RH, V22, P129, DOI 10.1016/j.berh.2007.11.006; Fecher-Trost C, 2017, CELL CALCIUM, V67, P116, DOI 10.1016/j.ceca.2017.04.006; Fecher-Trost C, 2013, J BIOL CHEM, V288, P16629, DOI 10.1074/jbc.M113.469726; GLASS EJ, 1981, ARCH DIS CHILD, V56, P565, DOI 10.1136/adc.56.7.565; Hacker AN, 2012, NUTR REV, V70, P397, DOI 10.1111/j.1753-4887.2012.00491.x; Hoenderop JGJ, 2001, J PHYSIOL-LONDON, V537, P747; Hughes DA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001686; Lambers TT, 2004, J BIOL CHEM, V279, P28855, DOI 10.1074/jbc.M313637200; Lee BM, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-49; Li D, 2016, J CLIN ENDOCR METAB, V101, P2196, DOI 10.1210/jc.2016-1211; Lietman SA, 2009, J CLIN ENDOCR METAB, V94, P4372, DOI 10.1210/jc.2008-2484; Nesbit MA, 2013, NEW ENGL J MED, V368, P2476, DOI 10.1056/NEJMoa1300253; Nesbit MA, 2013, NAT GENET, V45, P93, DOI 10.1038/ng.2492; Niemeyer BA, 2001, P NATL ACAD SCI USA, V98, P3600, DOI 10.1073/pnas.051511398; Nilius B, 2000, J PHYSIOL-LONDON, V527, P239, DOI 10.1111/j.1469-7793.2000.00239.x; Nilius B, 2003, PFLUG ARCH EUR J PHY, V445, P584, DOI 10.1007/s00424-002-0923-9; Nilius B, 2002, J BIOL CHEM, V277, P30852, DOI 10.1074/jbc.M202418200; Parkes I, 2013, GYNECOL ENDOCRINOL, V29, P515, DOI 10.3109/09513590.2012.754880; Peng JB, 2000, BIOCHEM BIOPH RES CO, V278, P326, DOI 10.1006/bbrc.2000.3716; Peng JB, 2001, GENOMICS, V76, P99, DOI 10.1006/geno.2001.6606; Peng JB, 2001, BIOCHEM BIOPH RES CO, V282, P729, DOI 10.1006/bbrc.2001.4638; Phelps CB, 2008, BIOCHEMISTRY-US, V47, P2476, DOI 10.1021/bi702109w; PITKIN RM, 1985, AM J OBSTET GYNECOL, V151, P99, DOI 10.1016/0002-9378(85)90434-X; Salles JP, 2016, ANN ENDOCRINOL-PARIS, V77, P163, DOI 10.1016/j.ando.2016.04.004; Saotome K, 2016, NATURE, V534, P506, DOI 10.1038/nature17975; Suzuki Y, 2008, J BONE MINER RES, V23, P1249, DOI [10.1359/jbmr.080314, 10.1359/JBMR.080314]; Tanaka AJ, 2015, AM J HUM GENET, V97, P457, DOI 10.1016/j.ajhg.2015.07.014; Unger S, 2005, EUR J PEDIATR, V164, P236, DOI 10.1007/s00431-004-1591-x; Wagener BM, 2009, TRAFFIC, V10, P1286, DOI 10.1111/j.1600-0854.2009.00957.x; Weissgerber P, 2011, SCI SIGNAL, V4, P6, DOI 10.1126/scisignal.2001791; Wissenbach U, 2001, J BIOL CHEM, V276, P19461, DOI 10.1074/jbc.M009895200; Woudenberg-Vrenken TE, 2012, AM J PHYSIOL-GASTR L, V303, pG879, DOI 10.1152/ajpgi.00089.2012; Zhou YM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3399	37	34	34	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 7	2018	102	6					1104	1114		10.1016/j.ajhg.2018.04.006	http://dx.doi.org/10.1016/j.ajhg.2018.04.006			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GJ0LP	29861107	Bronze, Green Published			2022-12-18	WOS:000434946200008
J	Sivley, RM; Dou, XY; Meiler, J; Bush, WS; Capra, JA				Sivley, R. Michael; Dou, Xiaoyi; Meiler, Jens; Bush, William S.; Capra, John A.			Comprehensive Analysis of Constraint on the Spatial Distribution of Missense Variants in Human Protein Structures	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MUTATIONS; REGIONS; CHALLENGES; DISCOVERY; SELECTION; RESIDUES; DOMINANT; SEQUENCE; PTPN11	The spatial distribution of genetic variation within proteins is shaped by evolutionary constraint and provides insight into the functional importance of protein regions and the potential pathogenicity of protein alterations. Here, we comprehensively evaluate the 3D spatial patterns of human germline and somatic variation in 6,604 experimentally derived protein structures and 33,144 computationally derived homology models covering 77% of all human proteins. Using a systematic approach, we quantify differences in the spatial distributions of neutral germline variants, disease-causing germline variants, and recurrent somatic variants. Neutral missense variants exhibit a general trend toward spatial dispersion, which is driven by constraint on core residues. In contrast, germline disease-causing variants are generally clustered in protein structures and form clusters more frequently than recurrent somatic variants identified from tumor sequencing. In total, we identify 215 proteins with significant spatial constraints on the distribution of disease-causing missense variants in experimentally derived protein structures, only 65 (30%) of which have been previously reported. This analysis identifies many clusters not detectable from sequence information alone; only 12% of proteins with significant clustering in 3D were identified from similar analyses of linear protein sequence. Furthermore, spatial analyses of mutations in homology-based structural models are highly correlated with those from experimentally derived structures, supporting the use of computationally derived models. Our approach highlights significant differences in the spatial constraints on different classes of mutations in protein structure and identifies regions of potential function within individual proteins.	[Sivley, R. Michael; Meiler, Jens; Capra, John A.] Vanderbilt Univ, Dept Biomed Informat, Nashville, TN 37232 USA; [Dou, Xiaoyi; Capra, John A.] Vanderbilt Univ, Dept Comp Sci, Nashville, TN 37212 USA; [Meiler, Jens] Vanderbilt Univ, Dept Chem, Nashville, TN 37212 USA; [Meiler, Jens; Capra, John A.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37212 USA; [Bush, William S.] Case Western Reserve Univ, Dept Populat & Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Bush, William S.] Case Western Reserve Univ, Inst Computat Biol, Cleveland, OH 44106 USA; [Capra, John A.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA; [Capra, John A.] Vanderbilt Univ, Vanderbilt Genet Inst, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Case Western Reserve University; Case Western Reserve University; Vanderbilt University; Vanderbilt University	Capra, JA (corresponding author), Vanderbilt Univ, Dept Biomed Informat, Nashville, TN 37232 USA.; Capra, JA (corresponding author), Vanderbilt Univ, Dept Comp Sci, Nashville, TN 37212 USA.; Capra, JA (corresponding author), Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37212 USA.; Bush, WS (corresponding author), Case Western Reserve Univ, Dept Populat & Quantitat Hlth Sci, Cleveland, OH 44106 USA.; Bush, WS (corresponding author), Case Western Reserve Univ, Inst Computat Biol, Cleveland, OH 44106 USA.; Capra, JA (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA.; Capra, JA (corresponding author), Vanderbilt Univ, Vanderbilt Genet Inst, Nashville, TN 37232 USA.	wsb36@case.edu; tony.capra@vanderbilt.edu	Bush, William/N-1369-2019	Bush, William/0000-0002-9729-6519	NIH [T32 EY021453, R01 GM080403, R01 GM099842, R01 HL122010, U54 AG052427, UF01 AG07133]; SPORE grant from the Vanderbilt-Ingram Cancer Center; Vanderbilt Ambassadors Discovery Grant in Cancer Research; NATIONAL EYE INSTITUTE [T32EY021453] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099842, R01GM080403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U54AG052427] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SPORE grant from the Vanderbilt-Ingram Cancer Center; Vanderbilt Ambassadors Discovery Grant in Cancer Research; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	R.M.S. was supported by the NIH (T32 EY021453) and a SPORE grant from the Vanderbilt-Ingram Cancer Center. J.M. was supported by the NIH (R01 GM080403, R01 GM099842, R01 HL122010). W.S.B. was supported by the NIH (U54 AG052427, UF01 AG07133). J.A.C. was supported by institutional funds and a Vanderbilt Ambassadors Discovery Grant in Cancer Research. This work was conducted in part using the resources of the Advanced Computing Center for Research and Education at Vanderbilt University, Nashville, TN. These funding bodies had no part in the design of the study or collection, analysis, and interpretation of data or in writing the manuscript. We thank Jonathan Sheehan and Greg Sliwoski for helpful discussions. The authors would like to thank the Genome Aggregation Database (gnomAD) and the groups that provided exome and genome variant data to this resource. A full list of contributing groups can be found at http://gnomad.broadinstitute.org/about.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Araya CL, 2016, NAT GENET, V48, P117, DOI 10.1038/ng.3471; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270; Capra JA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002567; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Carpenter EP, 2008, CURR OPIN STRUC BIOL, V18, P581, DOI 10.1016/j.sbi.2008.07.001; Chakravarty Debyani, 2017, JCO Precis Oncol, V2017, DOI 10.1200/PO.17.00011; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; de Beer TAP, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003382; DIGGLE PJ, 1991, BIOMETRICS, V47, P1155, DOI 10.2307/2532668; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gaines KF, 2000, WATERBIRDS, V23, P64; Gong S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009186; Guo Y, 2013, AM J HUM GENET, V93, P78, DOI 10.1016/j.ajhg.2013.05.022; Hunt RC, 2014, TRENDS GENET, V30, P308, DOI 10.1016/j.tig.2014.04.006; Kamburov A, 2015, P NATL ACAD SCI USA, V112, pE5486, DOI 10.1073/pnas.1516373112; Kontaridis MI, 2006, J BIOL CHEM, V281, P6785, DOI 10.1074/jbc.M513068200; Lahiry P, 2010, NAT REV GENET, V11, P60, DOI 10.1038/nrg2707; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Madabushi S, 2002, J MOL BIOL, V316, P139, DOI 10.1006/jmbi.2001.5327; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Meyer MJ, 2016, HUM MUTAT, V37, P447, DOI 10.1002/humu.22963; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nehrt NL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S4-S9; Nishi H, 2016, PROTEIN SCI, V25, P316, DOI 10.1002/pro.2845; Niu BF, 2016, NAT GENET, V48, P827, DOI 10.1038/ng.3586; Oldfield CJ, 2014, ANNU REV BIOCHEM, V83, P553, DOI 10.1146/annurev-biochem-072711-164947; Peterson TA, 2012, J AM MED INFORM ASSN, V19, P275, DOI 10.1136/amiajnl-2011-000655; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Pieper U, 2011, NUCLEIC ACIDS RES, V39, pD465, DOI 10.1093/nar/gkq1091; Piovesan D, 2018, NUCLEIC ACIDS RES, V46, pD471, DOI 10.1093/nar/gkx1071; Porta-Pardo E, 2017, NAT METHODS, V14, P782, DOI [10.1038/NMETH.4364, 10.1038/nmeth.4364]; Reimand J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004919; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Sawyer GM, 2009, J MOL BIOL, V390, P1030, DOI 10.1016/j.jmb.2009.06.009; Schueler-Furman O, 2003, PROTEINS, V52, P225, DOI 10.1002/prot.10365; Stehr H, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-54; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Tokheim C, 2016, CANCER RES, V76, P3719, DOI 10.1158/0008-5472.CAN-15-3190; Turner TN, 2015, HUM MOL GENET, V24, P5995, DOI 10.1093/hmg/ddv309; Velankar S, 2013, NUCLEIC ACIDS RES, V41, pD483, DOI 10.1093/nar/gks1258	57	34	34	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 1	2018	102	3					415	426		10.1016/j.ajhg.2018.01.017	http://dx.doi.org/10.1016/j.ajhg.2018.01.017			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FX9ZL	29455857	Green Submitted, Bronze, Green Published			2022-12-18	WOS:000426469600013
J	Wiessner, M; Roos, A; Munn, CJ; Viswanathan, R; Whyte, T; Cox, D; Schoser, B; Sewry, C; Roper, H; Phadke, R; Bettolo, CM; Barresi, R; Charlton, R; Bonnemann, CG; Neto, OA; Reed, UC; Zanoteli, E; Moreno, CAM; Ertl-Wagner, B; Stucka, R; De Goede, C; da Silva, TB; Hathazi, D; Dell'Aica, M; Zahedi, RP; Thiele, S; Muller, J; Kingston, H; Muller, S; Curtis, E; Walter, MC; Strom, TM; Straub, V; Bushby, K; Muntoni, F; Swan, LE; Lochmuller, H; Senderek, J				Wiessner, Manuela; Roos, Andreas; Munn, Christopher J.; Viswanathan, Ranjith; Whyte, Tamieka; Cox, Dan; Schoser, Benedikt; Sewry, Caroline; Roper, Helen; Phadke, Rahul; Bettolo, Chiara Marini; Barresi, Rita; Charlton, Richard; Bonnemann, Carsten G.; Neto, Osorio Abath; Reed, Umbertina C.; Zanoteli, Edmar; Moreno, Cristiane Araujo Martins; Ertl-Wagner, Birgit; Stucka, Rolf; De Goede, Christian; da Silva, Tamiris Borges; Hathazi, Denisa; Dell'Aica, Margherita; Zahedi, Rene P.; Thiele, Simone; Muller, Juliane; Kingston, Helen; Mueller, Susanna; Curtis, Elizabeth; Walter, Maggie C.; Strom, Tim M.; Straub, Volker; Bushby, Kate; Muntoni, Francesco; Swan, Laura E.; Lochmuller, Hanns; Senderek, Jan			Mutations in INPPSK, Encoding a Phosphoinositide 5-Phosphatase, Cause Congenital Muscular Dystrophy with Cataracts and Mild Cognitive Impairment	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MARINESCO-SJOGREN-SYNDROME; POLYPHOSPHATE PHOSPHATASE SKIP; UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM; MEMBRANE TRAFFICKING; SIGNAL-TRANSDUCTION; SKELETAL-MUSCLE; MYOPATHY; GENE; DISEASE	Phosphoinositides are small phospholipids that control diverse cellular downstream signaling events. Their spatial and temporal availability is tightly regulated by a set of specific lipid kinases and phosphatases. Congenital muscular dystrophies are hereditary disorders characterized by hypotonia and weakness from birth with variable eye and central nervous system involvement. In individuals exhibiting congenital muscular dystrophy, early-onset cataracts, and mild intellectual disability but normal cranial magnetic resonance imaging, we identified bi-allelic mutations in INPP5K, encoding inositol polyphosphate-5-phosphatase K. Mutations impaired phosphatase activity toward the phosphoinositide phosphatidylinositol (4,5)-bisphosphate or altered the subcellular localization of INPP5K. Down regulation of INPP5K orthologs in zebrafish embryos disrupted muscle fiber morphology and resulted in abnormal eye development. These data link congenital muscular dystrophies to defective phosphoinositide 5-phosphatase activity that is becoming increasingly recognized for its role in mediating pivotal cellular mechanisms contributing to disease.	[Wiessner, Manuela; Viswanathan, Ranjith; Schoser, Benedikt; Stucka, Rolf; Thiele, Simone; Walter, Maggie C.; Senderek, Jan] Ludwig Maximilians Univ Munchen, Dept Neurol, Friedrich Baur Inst, D-80336 Munich, Germany; [Roos, Andreas; Cox, Dan; Bettolo, Chiara Marini; Barresi, Rita; Charlton, Richard; Muller, Juliane; Straub, Volker; Bushby, Kate; Lochmuller, Hanns] Newcastle Univ, Inst Med Genet, MRC Ctr Neuromuscular Dis, John Walton Muscular Dystrophy Res Ctr, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Roos, Andreas; Hathazi, Denisa; Dell'Aica, Margherita; Zahedi, Rene P.] Leibniz Inst Analyt Wissensch ISAS, D-44227 Dortmund, Germany; [Munn, Christopher J.; da Silva, Tamiris Borges; Swan, Laura E.] Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Crown St, Liverpool L69 3BX, Merseyside, England; [Whyte, Tamieka; Sewry, Caroline; Phadke, Rahul; Muntoni, Francesco] UCL Great Ormond St Inst Child Hlth, London WC1N 1EH, England; [Whyte, Tamieka; Sewry, Caroline; Phadke, Rahul; Muntoni, Francesco] Great Ormond St Hosp Sick Children, London WC1N 1EH, England; [Whyte, Tamieka; Muntoni, Francesco] UCL Inst Neurol, MRC Ctr Neuromuscular Dis, London WC1N 3BG, England; [Sewry, Caroline] RJAH Orthopaed Hosp, Wolfson Ctr Inherited Neuromuscular Disorders, Oswestry SY10 7AG, Shrops, England; [Roper, Helen] Heart England NHS Fdn Trust, Birmingham Heartlands Hosp, Birmingham B9 5SS, W Midlands, England; [Barresi, Rita; Charlton, Richard] Newcastle Upon Tyne Hosp NHS Fdn Trust, Rare Dis Advisory Grp, Serv Neuromuscular Dis, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Bonnemann, Carsten G.; Neto, Osorio Abath] NINDS, Neuromuscular & Neurogenet Disorders Childhood Se, Neurogenet Branch, NIH, Bethesda, MD 20814 USA; [Reed, Umbertina C.; Zanoteli, Edmar; Moreno, Cristiane Araujo Martins] Univ Sao Paulo, Fac Med, Dept Neurol, BR-01246903 Sao Paulo, Brazil; [Ertl-Wagner, Birgit] Ludwig Maximilians Univ Munchen, Inst Clin Radiol, D-81377 Munich, Germany; [De Goede, Christian] Lancashire Teaching Hosp NHS Fdn Trust, Royal Preston Hosp, Dept Paediat Neurol, Preston PR2 9HT, Lancs, England; [De Goede, Christian] Univ Lancaster, Fac Hlth & Med, Lancaster LA1 4YG, England; [Kingston, Helen] Cent Manchester Univ Hosp NHS Fdn Trust, St Marys Hosp, Manchester Ctr Genom Med, Oxford Rd, Manchester M13 9WL, Lancs, England; [Mueller, Susanna] Ludwig Maximilians Univ Munchen, Inst Pathol, D-80337 Munich, Germany; [Curtis, Elizabeth] Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp Birmingham, Dept Cellular Pathol, Birmingham B15 2TH, W Midlands, England; [Strom, Tim M.] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Strom, Tim M.] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Viswanathan, Ranjith] EMBL Heidelberg, Dev Biol Unit, D-69117 Heidelberg, Germany	University of Munich; Newcastle University - UK; Dortmund University of Technology; Leibniz Institut fur Analytische Wissenschaften (ISAS); University of Liverpool; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Keele University; Heart of England NHS Foundation Trust; University of Birmingham; Newcastle Upon Tyne Hospitals NHS Foundation Trust; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Universidade de Sao Paulo; University of Munich; Royal Preston Hospital; Lancaster University; University of Manchester; University of Munich; University of Birmingham; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; European Molecular Biology Laboratory (EMBL)	Senderek, J (corresponding author), Ludwig Maximilians Univ Munchen, Dept Neurol, Friedrich Baur Inst, D-80336 Munich, Germany.	jan.senderek@med.uni-muenchen.de	Barresi, Rita/AAB-9569-2022; Ertl-Wagner, Birgit/AAD-5708-2020; Zahedi, René/A-9148-2012; Abath Neto, Osorio/H-1420-2017; Senderek, Jan/F-8405-2015; Phadke, Rahul/U-6960-2019; Zahedi, Rene/HGU-5710-2022; Schoser, Benedikt/AAH-6286-2020	Barresi, Rita/0000-0001-7351-959X; Zahedi, René/0000-0002-4960-5460; Abath Neto, Osorio/0000-0003-2787-5483; Senderek, Jan/0000-0002-8263-1783; Cox, Daniel/0000-0002-5405-6267; Hathazi, Denisa/0000-0002-0683-7552; Schoser, Benedikt/0000-0002-2757-8131; Viswanathan, Ranjith/0000-0002-3223-8078; Swan, Laura/0000-0002-6312-6263; de Araujo Martins Moreno, Cristiane/0000-0002-5867-6359; Ertl-Wagner, Birgit/0000-0002-7896-7049; Straub, Volker/0000-0001-9046-3540	Friedrich-Baur-Stiftung; Wellcome Trust Institutional Strategic Support Fund [105616/Z/14/Z]; Medical Research Council [MRC/N010035/1]; National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London; European Union Seventh Framework Programme [305444, 305121]; Muscular Dystrophy UK [512315]; Medical Research Council; Nationally Commissioned Highly Specialised Service (HSS) for Neuromuscular Diseases (NHS England); Sanofi Genzyme; Trophos; GlaxoSmithKline; AVI BioPharma; PTC; Sarepta Therapeutics; Medical Research Council [MR/N010035/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0515-10022] Funding Source: researchfish; Rosetrees Trust [M145] Funding Source: researchfish; Muscular Dystrophy UK [RA4/924, RA4/0924] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003129] Funding Source: NIH RePORTER; MRC [MR/N010035/1] Funding Source: UKRI	Friedrich-Baur-Stiftung; Wellcome Trust Institutional Strategic Support Fund(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London; European Union Seventh Framework Programme(European Commission); Muscular Dystrophy UK; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Nationally Commissioned Highly Specialised Service (HSS) for Neuromuscular Diseases (NHS England); Sanofi Genzyme(Sanofi-AventisGenzyme Corporation); Trophos; GlaxoSmithKline(GlaxoSmithKline); AVI BioPharma; PTC; Sarepta Therapeutics; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Rosetrees Trust(Rosetrees Trust); Muscular Dystrophy UK; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We wish to thank the families and study individuals for their contribution. We are grateful to Professor Heinrich Leonhardt and Dr. Joel Ryan for critical reading of the manuscript and their valuable comments. This work was supported by the Friedrich-Baur-Stiftung (to J.S.), the Wellcome Trust Institutional Strategic Support Fund (105616/Z/14/Z to L.E.S.), the Medical Research Council (MRC/N010035/1 to L.E.S.), the National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London (to EM.), and the European Union Seventh Framework Programme (grant agreements 305444 [RD-Connect] and 305121 [NeurOmics] to H.L., EM., and V.S.). The support of the Muscular Dystrophy UK to the Dubowitz Neuromuscular Centre (grant 512315 and centre grant) and of the Medical Research Council to the Neuromuscular Centres in London (UCL) and Newcastle for the Biobank is also gratefully acknowledged. Diagnostic facilities in Newcastle and London are supported by the Nationally Commissioned Highly Specialised Service (HSS) for Neuromuscular Diseases (NHS England).; B.S. has served on scientific advisory boards for Sanofi Genzyme, BioMarin, Amicus Therapeutics, and Audentes Therapeutics and receives research support from Sanofi Genzyme. C.S. is a member of the scientific advisory board of Audentes Therapeutics. F.M. has served on scientific advisory boards for Acceleron Pharma, Sanofi Genzyme, AVI BioPharma, Debiopharma Group, GlaxoSmithKline, Prosensa, Servier, Summit, and Santhera Pharmaceutical, receives research support from Trophos and GlaxoSmithKline, and has received funding for clinical trials from AVI BioPharma, PTC, and Sarepta Therapeutics.	Anttonen AK, 2005, NAT GENET, V37, P1309, DOI 10.1038/ng1677; ATTREE O, 1992, NATURE, V358, P239, DOI 10.1038/358239a0; Azzedine H, 2003, AM J HUM GENET, V72, P1141, DOI 10.1086/375034; Balla T, 2009, CELL CALCIUM, V45, P527, DOI 10.1016/j.ceca.2009.03.013; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; Bolino A, 2000, NAT GENET, V25, P17, DOI 10.1038/75542; Chow CY, 2007, NATURE, V448, P68, DOI 10.1038/nature05876; Chung KT, 2002, J BIOL CHEM, V277, P47557, DOI 10.1074/jbc.M208377200; Cullup T, 2013, NAT GENET, V45, P83, DOI 10.1038/ng.2497; De Leo MG, 2016, NAT CELL BIOL, V18, P839, DOI 10.1038/ncb3386; De Matteis MA, 2004, NAT CELL BIOL, V6, P487, DOI 10.1038/ncb0604-487; De Palma C, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.312; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dyson Jennifer M, 2012, Subcell Biochem, V58, P215, DOI 10.1007/978-94-007-3012-0_7; Gibbs EM, 2013, FEBS J, V280, P4187, DOI 10.1111/febs.12412; Grinstein S, 2010, AM J PHYSIOL-CELL PH, V299, pC876, DOI 10.1152/ajpcell.00342.2010; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; Gurung R, 2003, J BIOL CHEM, V278, P11376, DOI 10.1074/jbc.M209991200; Hendershot LM, 2004, MT SINAI J MED, V71, P289; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Ijuin T, 2000, J BIOL CHEM, V275, P10870, DOI 10.1074/jbc.275.15.10870; Ijuin T, 2003, MOL CELL BIOL, V23, P1209, DOI 10.1128/MCB.23.4.1209-1220.2003; Ijuin T, 2008, MOL CELL BIOL, V28, P5184, DOI 10.1128/MCB.01990-06; Ijuin T, 2016, GENES CELLS, V21, P457, DOI 10.1111/gtc.12353; Ijuin T, 2012, J BIOL CHEM, V287, P31330, DOI 10.1074/jbc.M112.388785; Ijuin T, 2012, J BIOL CHEM, V287, P6991, DOI 10.1074/jbc.M111.335539; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kim S, 2006, FASEB J, V20, P2399, DOI 10.1096/fj.05-4621fje; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Krieger M, 2013, BRAIN, V136, P3634, DOI 10.1093/brain/awt283; Laporte J, 1996, NAT GENET, V13, P175, DOI 10.1038/ng0696-175; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Ma YJ, 2001, CELL, V107, P827, DOI 10.1016/S0092-8674(01)00623-7; Martin TFJ, 1998, ANNU REV CELL DEV BI, V14, P231, DOI 10.1146/annurev.cellbio.14.1.231; Martin TFJ, 2001, CURR OPIN CELL BIOL, V13, P493, DOI 10.1016/S0955-0674(00)00241-6; McCrea HJ, 2009, PHYSIOLOGY, V24, P8, DOI 10.1152/physiol.00035.2008; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Mercuri E, 2012, ANN NEUROL, V72, P9, DOI 10.1002/ana.23548; Moreau K, 2012, J CELL BIOL, V196, P483, DOI 10.1083/jcb.201110114; Narkis G, 2007, AM J HUM GENET, V81, P530, DOI 10.1086/520771; Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604; North KN, 2014, NEUROMUSCULAR DISORD, V24, P97, DOI 10.1016/j.nmd.2013.11.003; O'Grady GL, 2016, ANN NEUROL, V80, P101, DOI 10.1002/ana.24687; Odorizzi G, 2000, TRENDS BIOCHEM SCI, V25, P229, DOI 10.1016/S0968-0004(00)01543-7; Ramachandran N, 2013, ACTA NEUROPATHOL, V125, P439, DOI 10.1007/s00401-012-1073-6; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Reed UC, 1999, BRAIN DEV-JPN, V21, P274, DOI 10.1016/S0387-7604(98)00100-4; Roos A, 2014, ACTA NEUROPATHOL, V127, P761, DOI 10.1007/s00401-013-1224-4; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; Schmid AC, 2004, FEBS LETT, V576, P9, DOI 10.1016/j.febslet.2004.08.052; Senderek J, 2005, NAT GENET, V37, P1312, DOI 10.1038/ng1678; Senderek J, 2003, HUM MOL GENET, V12, P349, DOI 10.1093/hmg/ddg030; SEWRY CA, 1988, ANN NEUROL, V24, P576, DOI 10.1002/ana.410240416; Simonsen A, 2001, CURR OPIN CELL BIOL, V13, P485, DOI 10.1016/S0955-0674(00)00240-4; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Topaloglu H, 1997, Eur J Paediatr Neurol, V1, P127, DOI 10.1016/S1090-3798(97)80045-1; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Wang CH, 2010, J CHILD NEUROL, V25, P1559, DOI 10.1177/0883073810381924; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; Zhao LH, 2010, HUM MOL GENET, V19, P25, DOI 10.1093/hmg/ddp464; Zirin J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005006; Zurek N, 2011, TRAFFIC, V12, P28, DOI 10.1111/j.1600-0854.2010.01134.x	64	34	39	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 2	2017	100	3					523	536		10.1016/j.ajhg.2017.01.024	http://dx.doi.org/10.1016/j.ajhg.2017.01.024			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EN2PH	28190456	Green Published, hybrid			2022-12-18	WOS:000395851900016
J	Guo, DC; Duan, XY; Regalado, ES; Mellor-Crummey, L; Kwartler, CS; Kim, D; Lieberman, K; de Vries, BBA; Pfundt, R; Schinzel, A; Kotzot, D; Shen, XT; Yang, ML; Bamshad, MJ; Nickerson, DA; Gornik, HL; Ganesh, SK; Braverman, AC; Grange, DK; Milewicz, DM				Guo, Dong-chuan; Duan, Xue-Yan; Regalado, Ellen S.; Mellor-Crummey, Lauren; Kwartler, Callie S.; Kim, Dong; Lieberman, Kenneth; de Vries, Bert B. A.; Pfundt, Rolph; Schinzel, Albert; Kotzot, Dieter; Shen, Xuetong; Yang, Min-Lee; Bamshad, Michael J.; Nickerson, Deborah A.; Gornik, Heather L.; Ganesh, Santhi K.; Braverman, Alan C.; Grange, Dorothy K.; Milewicz, Dianna M.		Univ Washington Ctr Mendelian	Loss-of-Function Mutations in YY1AP1 Lead to Grange Syndrome and a Fibromuscular Dysplasia-Like Vascular Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							THORACIC AORTIC-ANEURYSMS; ASSOCIATION; IMMORTALIZATION; TRANSCRIPTION; DISSECTIONS; COMPLEX; ACTIN; INO80; MICE	Fibromuscular dysplasia (FMD) is a heterogeneous group of non-atherosclerotic and non-inflammatory arterial diseases that primarily involves the renal and cerebrovascular arteries. Grange syndrome is an autosomal-recessive condition characterized by severe and early-onset vascular disease similar to FMD and variable penetrance of brachydactyly, syndactyly, bone fragility, and learning disabilities. Exome-sequencing analysis of DNA from three affected siblings with Grange syndrome identified compound heterozygous nonsense variants in YY1AP1, and homozygous nonsense or frameshift YY1AP1 variants were subsequently identified in additional unrelated pro bands with Grange syndrome. YY1AP1 encodes yin yang 1 (YY1)-associated protein 1 and is an activator of the YY1 transcription factor. We determined that YY1AP1 localizes to the nucleus and is a component of the INO80 chromatin remodeling complex, which is responsible for transcriptional regulation, DNA repair, and replication. Molecular studies revealed that loss of YY1AP1 in vascular smooth muscle cells leads to cell cycle arrest with decreased proliferation and increased levels of the cell cycle regulator p21/WAF/CDKN1A and disrupts TGF-beta-driven differentiation of smooth muscle cells. Identification of YY1AP1 mutations as a cause of FMD indicates that this condition can result from underlying genetic variants that significantly alter the phenotype of vascular smooth muscle cells.	[Guo, Dong-chuan; Duan, Xue-Yan; Regalado, Ellen S.; Mellor-Crummey, Lauren; Kwartler, Callie S.; Milewicz, Dianna M.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Internal Med, Houston, TX 77030 USA; [Kim, Dong] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Neurosurg, Houston, TX 77030 USA; [Lieberman, Kenneth] Joseph M Sanzari Childrens Hosp, Pediat Nephrol, Hackensack, NJ 07601 USA; [de Vries, Bert B. A.; Pfundt, Rolph] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 Nijmegen, Netherlands; [Schinzel, Albert] Univ Zurich, Inst Med Genet, CH-8006 Zurich, Switzerland; [Kotzot, Dieter] Med Univ Innsbruck, Dept Med Genet Mol & Clin Pharmacol, A-6020 Innsbruck, Austria; [Shen, Xuetong] Univ Texas Hlth Sci Ctr Houston, Dept Epigenet & Mol Carcinogenesis, Houston, TX 77030 USA; [Yang, Min-Lee; Ganesh, Santhi K.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Bamshad, Michael J.; Nickerson, Deborah A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Gornik, Heather L.] Cleveland Clin, Inst Heart & Vasc, Dept Cardiovasc Med, Cleveland, OH 44195 USA; [Braverman, Alan C.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Grange, Dorothy K.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Radboud University Nijmegen; University of Zurich; Medical University of Innsbruck; University of Texas System; University of Texas Health Science Center Houston; University of Michigan System; University of Michigan; University of Washington; University of Washington Seattle; Cleveland Clinic Foundation; Washington University (WUSTL); Washington University (WUSTL)	Milewicz, DM (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Internal Med, Houston, TX 77030 USA.	dianna.m.milewicz@uth.tmc.edu	Pfundt, Rolph/L-4576-2015; Kwartler, Callie/AGB-4204-2022	Kwartler, Callie/0000-0002-3722-9939; Regalado, Ellen/0000-0002-5859-218X; Yang, Min-Lee/0000-0003-2823-8320; Blue, Elizabeth/0000-0002-0633-0305; Kim, Dong/0000-0002-1523-6396; Shen, Xuetong/0000-0002-4267-5298	National Heart, Lung and Blood Institute [RO1 HL109942, P01HL110869]; Vivian L. Smith Foundation; Henrietta B. and Frederick H. Bugher Foundation; National Human Genome Research Institute [1U54HG006493]; National Heart, Lung and Blood Institute Resequencing and Genotyping Service; NIH, National Center for Research Resources [CTSA 1UL1RR024989]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439, UL1TR000371] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL110869, R01HL109942] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006493, U54HG006493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093104] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Vivian L. Smith Foundation; Henrietta B. and Frederick H. Bugher Foundation; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung and Blood Institute Resequencing and Genotyping Service; NIH, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Heart, Lung and Blood Institute (RO1 HL109942 and P01HL110869), the Vivian L. Smith Foundation, and the Henrietta B. and Frederick H. Bugher Foundation to D.M.M., National Human Genome Research Institute (1U54HG006493 to D.A.N. and M.J.B.), and the National Heart, Lung and Blood Institute Resequencing and Genotyping Service. The collection of clinical data and samples from individuals with FMD by H.L.G. were supported by NIH, National Center for Research Resources (CTSA 1UL1RR024989).	Boileau C, 2012, NAT GENET, V44, P916, DOI 10.1038/ng.2348; Cai Y, 2007, NAT STRUCT MOL BIOL, V14, P872, DOI 10.1038/nsmb1276; Cao JM, 2010, HUM MOL GENET, V19, P1908, DOI 10.1093/hmg/ddq066; Cao LL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137411; Conaway RC, 2009, TRENDS BIOCHEM SCI, V34, P71, DOI 10.1016/j.tibs.2008.10.010; Grange DK, 1998, AM J MED GENET, V75, P469, DOI 10.1002/(SICI)1096-8628(19980217)75:5<469::AID-AJMG4>3.0.CO;2-I; Gudjonsson T, 2002, GENE DEV, V16, P693, DOI 10.1101/gad.952602; Guo DC, 2013, AM J HUM GENET, V93, P398, DOI 10.1016/j.ajhg.2013.06.019; Guo DC, 2009, AM J HUM GENET, V84, P617, DOI 10.1016/j.ajhg.2009.04.007; Kapoor P, 2014, TRENDS CELL BIOL, V24, P238, DOI 10.1016/j.tcb.2013.10.007; Kawai-Kowase K, 2007, AM J PHYSIOL-CELL PH, V292, pC59, DOI 10.1152/ajpcell.00394.2006; Kiando SR, 2015, J HYPERTENS, V33, P1802, DOI 10.1097/HJH.0000000000000625; MCCORMAC.LJ, 1966, AM HEART J, V72, P188, DOI 10.1016/0002-8703(66)90442-X; Milewicz DM, 2010, AM J MED GENET A, V152A, P2437, DOI 10.1002/ajmg.a.33657; Olin JW, 2014, CIRCULATION, V129, P1048, DOI 10.1161/01.cir.0000442577.96802.8c; Olin JW, 2012, CIRCULATION, V126, P2925, DOI 10.1161/CIRCULATIONAHA.112.149500; Pannier-Moreau I, 1997, J HYPERTENS, V15, P1797, DOI 10.1097/00004872-199715120-00092; Papke CL, 2013, HUM MOL GENET, V22, P3123, DOI 10.1093/hmg/ddt167; Robanus-Maandag E, 1998, GENE DEV, V12, P1599, DOI 10.1101/gad.12.11.1599; Rzucidlo EM, 2007, J VASC SURG, V45, p25A, DOI 10.1016/j.jvs.2007.03.001; Savard S, 2012, CIRCULATION, V126, P3062, DOI 10.1161/CIRCULATIONAHA.112.117499; Shameer K, 2014, CIRC-CARDIOVASC GENE, V7, P607, DOI 10.1161/CIRCGENETICS.113.000233; STANLEY JC, 1975, ARCH SURG-CHICAGO, V110, P561; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Volonghi I, 2012, AM J MED GENET A, V158A, P2894, DOI 10.1002/ajmg.a.35593; Wallerstein R, 2006, AM J MED GENET A, V140A, P1316, DOI 10.1002/ajmg.a.31125; Wang CY, 2004, J BIOL CHEM, V279, P17750, DOI 10.1074/jbc.M310532200; WAZER DE, 1995, P NATL ACAD SCI USA, V92, P3687, DOI 10.1073/pnas.92.9.3687; Weymann S, 2001, AM J MED GENET, V99, P190, DOI 10.1002/1096-8628(2001)9999:9999<::AID-AJMG1138>3.0.CO;2-R; Xu J, 2007, CIRCULATION, V116, P2148, DOI 10.1161/CIRCULATIONAHA.107.707752; Zhao X, 2015, ONCOGENE, V34, P5095, DOI 10.1038/onc.2014.438	31	34	34	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 5	2017	100	1					21	30		10.1016/j.ajhg.2016.11.008	http://dx.doi.org/10.1016/j.ajhg.2016.11.008			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EH6UX	27939641	Bronze, Green Published			2022-12-18	WOS:000391910500002
J	Maluenda, J; Manso, C; Quevarec, L; Vivanti, A; Marguet, F; Gonzales, M; Guimiot, F; Petit, F; Toutain, A; Whalen, S; Grigorescu, R; Coeslier, AD; Gut, M; Gut, I; Laquerriere, A; Devaux, J; Melki, J				Maluenda, Jerome; Manso, Constance; Quevarec, Loic; Vivanti, Alexandre; Marguet, Florent; Gonzales, Marie; Guimiot, Fabien; Petit, Florence; Toutain, Annick; Whalen, Sandra; Grigorescu, Romulus; Coeslier, Anne Dieux; Gut, Marta; Gut, Ivo; Laquerriere, Annie; Devaux, Jerome; Melki, Judith			Mutations in GLDN, Encoding Gliomedin, a Critical Component of the Nodes of Ranvier, Are Responsible for Lethal Arthrogryposis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOMAINS	Arthrogryposis multiplex congenita (AMC) is a developmental condition characterized by multiple joint contractures resulting from reduced or absent fetal movements. Through linkage analysis, homozygosity mapping, and exome sequencing in four unrelated families affected by lethal AMC, we identified biallelic mutations in GLDN in the affected individuals. GLDN encodes gliomedin, a secreted cell adhesion molecule involved in the formation of the nodes of Ranvier. Transmission electron microscopy of the sciatic nerve from one of the affected individuals showed a marked lengthening defect of the nodes. The GLDN mutations found in the affected individuals abolish the cell surface localization of gliomedin and its interaction with its axonal partner, neurofascin-186 (NF186), in a cell-based assay. The axoglial contact between gliomedin and NF186 is essential for the initial clustering of Na+ channels at developing nodes. These results indicate a major role of gliomedin in node formation and the development of the peripheral nervous system in humans. These data indicate that mutations of GLDN or CNTNAP1 (MIM: 616286), encoding essential components of the nodes of Ranvier and paranodes, respectively, lead to inherited nodopathies, a distinct disease entity among peripheral neuropathies.	[Maluenda, Jerome; Quevarec, Loic; Vivanti, Alexandre; Melki, Judith] Univ Paris Saclay, INSERM, UMR 1169, F-94276 Le Kremlin Bicetre, France; [Manso, Constance; Devaux, Jerome] Aix Marseille Univ, CNRS, UMR 7286, Ctr Rech Neurobiol & Neurophysiol Marseille, F-13444 Marseille, France; [Marguet, Florent; Laquerriere, Annie] Rouen Univ Hosp, Pathol Lab, F-76000 Rouen, France; [Marguet, Florent; Laquerriere, Annie] Univ Rouen, INSERM, NeoVasc Lab, F-76000 Rouen, France; [Gonzales, Marie; Whalen, Sandra; Grigorescu, Romulus] Hop Trousseau, Dept Genet Med, F-75571 Paris, France; [Gonzales, Marie; Whalen, Sandra; Grigorescu, Romulus] Univ Paris 06, F-75571 Paris, France; [Guimiot, Fabien] Hop Robert Debre, INSERM, U1141, Serv Biol Dev, F-75019 Paris, France; [Petit, Florence; Coeslier, Anne Dieux] Ctr Hosp Reg Univ, Hop Jeanne de Flandre, Clin Genet Guy Fontaine, F-59037 Lille, France; [Toutain, Annick] Ctr Hosp Univ Tours, Hop Bretonneau, Serv Genet, F-37044 Tours, France; [Gut, Marta; Gut, Ivo] Univ Pompeu Fabra, Barcelona Inst Sci & Technol, CNAG CRG, Baldiri i Reixac 4, Barcelona 08028, Spain	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; CHU Tours; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Melki, J (corresponding author), Univ Paris Saclay, INSERM, UMR 1169, F-94276 Le Kremlin Bicetre, France.	judith.melki@inserm.fr	Gut, Ivo/ABF-3188-2020; Devaux, jerome/X-8581-2019; Vivanti, Alexandre/AAN-1693-2020	Gut, Ivo/0000-0001-7219-632X; Devaux, jerome/0000-0001-6383-4334; Vivanti, Alexandre/0000-0002-4921-0047; Toutain, Annick/0000-0002-5999-5300; MANSO, Constance/0000-0002-8136-074X; Quevarec, Loic/0000-0001-8431-432X; Maluenda, Jerome/0000-0002-6653-1336	French Ministry of Health (PHRC) [AOM10181]; Association Francaise contre les Myopathies [DAJ1891, MNM1 2012-14580]; University Paris Saclay [ERM2013]; INSERM; Agence Nationale pour la Recherche [E-Rare-2]; ERA-Net for Research on Rare Diseases	French Ministry of Health (PHRC); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); University Paris Saclay; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale pour la Recherche(French National Research Agency (ANR)); ERA-Net for Research on Rare Diseases	This work was supported by grants from the French Ministry of Health (PHRC 2010, AOM10181), the Association Francaise contre les Myopathies (DAJ1891), the University Paris Saclay (ERM2013), and INSERM to J. Melki. This work was supported by the Agence Nationale pour la Recherche under the frame of E-Rare-2, the ERA-Net for Research on Rare Diseases, and the Association Francaise contre les Myopathies (MNM1 2012-14580) to J.D. The authors would like to thank Damien Gentil for technical assistance, the Clinical Research Unit of Bicetre Hospital, and the Direction of Clinical Research and Development (AP-HP).	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Eshed Y, 2005, NEURON, V47, P215, DOI 10.1016/j.neuron.2005.06.026; Eshed Y, 2007, J CELL BIOL, V177, P551, DOI 10.1083/jcb.200612139; FAHY M J, 1990, Genetic Counseling, V1, P3; Feinberg K, 2010, NEURON, V65, P490, DOI 10.1016/j.neuron.2010.02.004; HALL JG, 1985, CLIN ORTHOP RELAT R, P44; Hall JG, 2014, EUR J MED GENET, V57, P464, DOI 10.1016/j.ejmg.2014.03.008; Labasque M, 2011, J BIOL CHEM, V286, P42426, DOI 10.1074/jbc.M111.266353; Laquerriere A, 2014, HUM MOL GENET, V23, P2279, DOI 10.1093/hmg/ddt618; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Maertens B, 2007, J BIOL CHEM, V282, P10647, DOI 10.1074/jbc.M611339200; Peles E, 1997, EMBO J, V16, P978, DOI 10.1093/emboj/16.5.978; Rios JC, 2000, J NEUROSCI, V20, P8354, DOI 10.1523/JNEUROSCI.20-22-08354.2000; Ruschendorf F, 2005, BIOINFORMATICS, V21, P2123, DOI 10.1093/bioinformatics/bti264; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Zhou J, 2012, AM J HUM GENET, V91, P5, DOI 10.1016/j.ajhg.2012.05.001	19	34	35	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 6	2016	99	4					928	933		10.1016/j.ajhg.2016.07.021	http://dx.doi.org/10.1016/j.ajhg.2016.07.021			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DY7UB	27616481	Bronze, Green Published			2022-12-18	WOS:000385333700013
J	Sanchez-Caballero, L; Ruzzenente, B; Bianchi, L; Assouline, Z; Barcia, G; Metodiev, MD; Rio, M; Funalot, B; van den Brand, MAM; Guerrero-Castillo, S; Molenaar, JP; Koolen, D; Brandt, U; Rodenburg, RJ; Nijtmans, LG; Rotig, A				Sanchez-Caballero, Laura; Ruzzenente, Benedetta; Bianchi, Lucas; Assouline, Zahra; Barcia, Giulia; Metodiev, Metodi D.; Rio, Marlene; Funalot, Benoit; van den Brand, Mariel A. M.; Guerrero-Castillo, Sergio; Molenaar, Joery P.; Koolen, David; Brandt, Ulrich; Rodenburg, Richard J.; Nijtmans, Leo G.; Rotig, Agnes			Mutations in Complex I Assembly Factor TMEM126B Result in Muscle Weakness and Isolated Complex I Deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BOVINE HEART-MITOCHONDRIA; NUBPL MUTATIONS; MOLECULAR CHAPERONE; CRYSTAL-STRUCTURE; DISEASE; PROTEIN; ENCEPHALOPATHY; NDUFAF1; CIA30; NADH	Mitochondrial complex I deficiency results in a plethora of often severe clinical phenotypes manifesting in early childhood. Here, we report on three complex-I-deficient adult subjects with relatively mild clinical symptoms, including isolated, progressive exercise-induced myalgia and exercise intolerance but with normal later development. Exome sequencing and targeted exome sequencing revealed compound-heterozygous mutations in TMEM126B, encoding a complex I assembly factor. Further biochemical analysis of subject fibroblasts revealed a severe complex I deficiency caused by defective assembly. Lentiviral complementation with the wild-type cDNA restored the complex I deficiency, demonstrating the pathogenic nature of these mutations. Further complexome analysis of one subject indicated that the complex I assembly defect occurred during assembly of its membrane module. Our results show that TMEM126B defects can lead to complex I deficiencies and, interestingly, that symptoms can occur only after exercise.	[Sanchez-Caballero, Laura; van den Brand, Mariel A. M.; Guerrero-Castillo, Sergio; Brandt, Ulrich; Rodenburg, Richard J.; Nijtmans, Leo G.] Radboud Univ Nijmegen, Med Ctr, Dept Pediat, Radboud Ctr Mitochondrial Med, Geert Grootepl Zuid 10, NL-6525 GA Nijmegen, Netherlands; [Ruzzenente, Benedetta; Bianchi, Lucas; Metodiev, Metodi D.; Rotig, Agnes] Univ Paris 05, Sorbonne Paris Cite, INSERM U1163, Inst Imagine, F-75015 Paris, France; [Assouline, Zahra; Barcia, Giulia; Rio, Marlene] Hop Necker Enfants Malad, Dept Pediat & Genet, F-75015 Paris, France; [Funalot, Benoit] Hop Henri Mondor, Dept Genet, F-94010 Creteil, France; [Molenaar, Joery P.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, Geert Grootepl Zuid 10, NL-6525 GA Nijmegen, Netherlands; [Koolen, David] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Radboud University Nijmegen; Radboud University Nijmegen	Nijtmans, LG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Pediat, Radboud Ctr Mitochondrial Med, Geert Grootepl Zuid 10, NL-6525 GA Nijmegen, Netherlands.; Rotig, A (corresponding author), Univ Paris 05, Sorbonne Paris Cite, INSERM U1163, Inst Imagine, F-75015 Paris, France.	leo.nijtmans@radboudumc.nl; agnes.rotig@inserm.fr	van den Brand, Mariel/S-1215-2017; Brandt, Ulrich/GLV-1242-2022; Guerrero-Castillo, Sergio/E-2285-2016; Guerrero-Castillo, Sergio/T-1515-2019; Rötig, Agnès/G-9592-2017; Ruzzenente, Benedetta/H-4793-2017; Nijtmans, L.G.J./L-4549-2015; Metodiev, Metodi/C-4780-2015; Barcia, Giulia/H-7907-2017; Rodenburg, Richard/N-3579-2014; Brandt, Ulrich/C-4406-2008; Koolen, D.A./L-4448-2015	van den Brand, Mariel/0000-0001-9924-6083; Brandt, Ulrich/0000-0003-1869-6811; Guerrero-Castillo, Sergio/0000-0002-6630-0562; Guerrero-Castillo, Sergio/0000-0002-6630-0562; Rötig, Agnès/0000-0003-0589-0703; Ruzzenente, Benedetta/0000-0001-7366-114X; Metodiev, Metodi/0000-0002-9596-2434; Barcia, Giulia/0000-0001-6657-5040; Rodenburg, Richard/0000-0001-5227-3527; Brandt, Ulrich/0000-0003-1869-6811; Funalot, Benoit/0000-0001-6352-6518; Rio, Marlene/0000-0003-2049-5058	European Commission [FP7-PEOPLE-ITN. GA. 317433]; Association Francaise contre les Myopathies (MNM) [15740]; E-Rare project GENOMIT [01GM1207]	European Commission(European CommissionEuropean Commission Joint Research Centre); Association Francaise contre les Myopathies (MNM); E-Rare project GENOMIT	We would like to acknowledge the Genome Technology Center at the Radboud UMC and BGI Copenhagen for providing the exome sequencing service. This work was partially funded by the European Commission (FP7-PEOPLE-ITN. GA. 317433), by the Association Francaise contre les Myopathies (MNM 2012 no. 15740), and by the E-Rare project GENOMIT (01GM1207).	Andrews B, 2013, P NATL ACAD SCI USA, V110, P18934, DOI 10.1073/pnas.1319247110; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Carilla-Latorre S, 2010, J CELL SCI, V123, P1674, DOI 10.1242/jcs.066076; Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200; Dunning CJR, 2007, EMBO J, V26, P3227, DOI 10.1038/sj.emboj.7601748; Fassone E, 2012, J MED GENET, V49, P578, DOI 10.1136/jmedgenet-2012-101159; Fassone E, 2011, J MED GENET, V48, P691, DOI 10.1136/jmedgenet-2011-100340; Fassone E, 2010, HUM MOL GENET, V19, P4837, DOI 10.1093/hmg/ddq414; Gerards M, 2010, J MED GENET, V47, P507, DOI 10.1136/jmg.2009.067553; Guarani V, 2014, MOL CELL BIOL, V34, P847, DOI 10.1128/MCB.01551-13; Hanein S, 2009, AM J HUM GENET, V84, P493, DOI 10.1016/j.ajhg.2009.03.003; Heide H, 2012, CELL METAB, V16, P538, DOI 10.1016/j.cmet.2012.08.009; Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; Janssen R, 2002, HUM GENET, V110, P264, DOI 10.1007/s00439-001-0673-3; Kevelam SH, 2013, NEUROLOGY, V80, P1577, DOI 10.1212/WNL.0b013e31828f1914; Koene S, 2012, J INHERIT METAB DIS, V35, P737, DOI 10.1007/s10545-012-9492-z; Nouws J, 2012, BRAIN, V135, P12, DOI 10.1093/brain/awr261; Nouws J, 2010, CELL METAB, V12, P283, DOI 10.1016/j.cmet.2010.08.002; Ogilvie I, 2005, J CLIN INVEST, V115, P2784, DOI 10.1172/JCI26020; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Saada A, 2008, AM J HUM GENET, V82, P32, DOI 10.1016/j.ajhg.2007.08.003; Saada A, 2009, AM J HUM GENET, V84, P718, DOI 10.1016/j.ajhg.2009.04.020; Sugiana C, 2008, AM J HUM GENET, V83, P468, DOI 10.1016/j.ajhg.2008.09.009; Tenisch EV, 2012, NEUROLOGY, V79, P391, DOI 10.1212/WNL.0b013e3182611232; Tucker EJ, 2012, HUM MUTAT, V33, P411, DOI 10.1002/humu.21654; Ugalde C, 2004, HUM MOL GENET, V13, P2461, DOI 10.1093/hmg/ddh262; Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686; Vogel R, 2004, CURR OPIN NEUROL, V17, P179, DOI 10.1097/00019052-200404000-00016; Vogel RO, 2007, GENE DEV, V21, P615, DOI 10.1101/gad.408407; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; Wessels HJCT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068340; Wessels HJCT, 2009, PROTEOMICS, V9, P4221, DOI 10.1002/pmic.200900157; Zickermann V, 2015, SCIENCE, V347, P44, DOI 10.1126/science.1259859	35	34	35	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 7	2016	99	1					208	216		10.1016/j.ajhg.2016.05.022	http://dx.doi.org/10.1016/j.ajhg.2016.05.022			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT6TI	27374773	Bronze, Green Published			2022-12-18	WOS:000381616600018
J	Vincent, A; Audo, I; Tavares, E; Maynes, JT; Tumber, A; Wright, T; Li, SN; Michiels, C; Condroyer, C; MacDonald, H; Verdet, R; Sahel, JA; Hamel, CP; Zeitz, C; Heon, E				Vincent, Ajoy; Audo, Isabelle; Tavares, Erika; Maynes, Jason T.; Tumber, Anupreet; Wright, Thomas; Li, Shuning; Michiels, Christelle; Condroyer, Christel; MacDonald, Heather; Verdet, Robert; Sahel, Jose-Alain; Hamel, Christian P.; Zeitz, Christina; Heon, Elise		GNB3 Consortium	Biallelic Mutations in GNB3 Cause a Unique Form of Autosomal-Recessive Congenital Stationary Night Blindness	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ON-BIPOLAR CELLS; PROTEIN BETA-SUBUNIT; CONE PHOTORECEPTORS; LIGHT RESPONSE; MISSENSE MUTATION; CRYSTAL-STRUCTURE; GAMMA-SUBUNIT; B-WAVE; GENE; ELECTRORETINOGRAM	Congenital stationary night blindness (CSNB) is a heterogeneous group of non-progressive inherited retinal disorders with characteristic electroretinogram (ERG) abnormalities. Riggs and Schubert-Bornschein are subtypes of CSNB and demonstrate distinct ERG features. Riggs CSNB demonstrates selective rod photoreceptor dysfunction and occurs due to mutations in genes encoding proteins involved in rod phototransduction cascade; night blindness is the only symptom and eye examination is otherwise normal. Schubert-Bornschein CSNB is a consequence of impaired signal transmission between the photoreceptors and bipolar cells. Schubert-Bornschein CSNB is subdivided into complete CSNB with an ON bipolar signaling defect and incomplete CSNB with both ON and OFF pathway involvement. Both subtypes are associated with variable degrees of night blindness or photophobia, reduced visual acuity, high myopia, and nystagmus. Whole-exome sequencing of a family screened negative for mutations in genes associated with CSNB identified biallelic mutations in the guanine nucleotide-binding protein subunit beta-3 gene (GNB3). Two siblings were compound heterozygous for a deletion (c.170_172delAGA [p.Lys57del]) and a nonsense mutation (c.1017G>A [p.Trp339*]). The maternal aunt was homozygous for the nonsense mutation (c.1017G>A [p.Trp339*]). Mutational analysis of GNB3 in a cohort of 58 subjects with CSNB identified a sporadic case individual with a homozygous GNB3 mutation (c.200C>T [p.Ser67Phe]). GNB3 encodes the beta subunit of G protein heterotrimer (G alpha beta gamma) and is known to modulate ON bipolar cell signaling and cone transducin function in mice. Affected human subjects showed an unusual CSNB phenotype with variable degrees of ON bipolar dysfunction and reduced cone sensitivity. This unique retinal disorder with dual anomaly in visual processing expands our knowledge about retinal signaling.	[Vincent, Ajoy; Tumber, Anupreet; Wright, Thomas; MacDonald, Heather; Heon, Elise] Hosp Sick Children, Dept Ophthalmol, Toronto, ON M5G 1X8, Canada; [Vincent, Ajoy; Tavares, Erika; Li, Shuning; Heon, Elise] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 0A4, Canada; [Vincent, Ajoy; Heon, Elise] Univ Toronto, Dept Ophthalmol, 340 Coll St, Toronto, ON M5T 3A9, Canada; [Audo, Isabelle; Michiels, Christelle; Condroyer, Christel; Sahel, Jose-Alain; Zeitz, Christina] Univ Paris 06, Sorbonne Univ, Inst Vis, INSERM,CNRS, 17 Rue Moreau, F-75012 Paris, France; [Audo, Isabelle; Sahel, Jose-Alain] Ctr Hosp Natl Ophtalmol CHNO Quinze Vingts, DHU Sight Restore, INSERM DHOS CIC1423, 28 Rue Charenton, F-75012 Paris, France; [Audo, Isabelle; Sahel, Jose-Alain] UCL, Inst Ophthalmol, London EC1V 9EL, England; [Maynes, Jason T.] Hosp Sick Children, Dept Anesthesia & Pain Med, Toronto, ON M5G 1X8, Canada; [Maynes, Jason T.] Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 0A4, Canada; [MacDonald, Heather] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [MacDonald, Heather] Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; [Verdet, Robert] Ctr Eye, 3 Rue Rigoberta Menchu, F-84000 Avignon, France; [Sahel, Jose-Alain] Fdn Ophtalmol Adolphe Rothschild, F-75019 Paris, France; [Sahel, Jose-Alain] Inst France, Acad Sci, F-75006 Paris, France; [Hamel, Christian P.] Hop St Eloi, Inst Neurosci Montpellier, INSERM, U1051, F-34295 Montpellier 05, France; [Hamel, Christian P.] CHU Montpellier, Affect Sensorielles Genet, 191 Ave Doyen Gaston Giraud, F-34295 Montpellier, France; [Hamel, Christian P.] Univ Montpellier, 163 Ave Auguste Broussonnet, F-34090 Montpellier, France	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; CHNO des Quinze-Vingts; UDICE-French Research Universities; Sorbonne Universite; University of London; University College London; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Fondation Adolphe de Rothschild; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier	Heon, E (corresponding author), Hosp Sick Children, Dept Ophthalmol, Toronto, ON M5G 1X8, Canada.; Heon, E (corresponding author), Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 0A4, Canada.; Heon, E (corresponding author), Univ Toronto, Dept Ophthalmol, 340 Coll St, Toronto, ON M5T 3A9, Canada.	elise.heon@sickkids.ca	De Baere, Elfride/E-7405-2017; Zeitz, Christina/F-2757-2017; Vincent, Ajoy/D-1149-2018; Maynes, Jason/AAE-4344-2020; Sahel, Jose-Alain/F-3172-2017; wright, thomas/AAF-8599-2020; Tavares, Erika/ABB-9701-2020	De Baere, Elfride/0000-0002-5609-6895; Zeitz, Christina/0000-0002-3510-1712; Vincent, Ajoy/0000-0001-6446-3846; Sahel, Jose-Alain/0000-0002-4831-1153; wright, thomas/0000-0001-5071-9978; Audo, Isabelle/0000-0003-0698-5309	Mira Godard Research fund; Ophthalmology Research Fund (The Hospital for Sick Children); University of Toronto McLaughlin Centre; Fondation Voir et Entendre; Prix Dalloz for "La recherche en ophtalmologie"; LABEX LIFESENSES [ANR-10-LABX-65, ANR-11-IDEX-0004-0]; Foundation Fighting Blindness [C-CMM-0907-0428-INSERM04]; Prix de la Fondation de l'CEil	Mira Godard Research fund; Ophthalmology Research Fund (The Hospital for Sick Children); University of Toronto McLaughlin Centre; Fondation Voir et Entendre; Prix Dalloz for "La recherche en ophtalmologie"; LABEX LIFESENSES; Foundation Fighting Blindness(European Commission); Prix de la Fondation de l'CEil	This work was supported by the Mira Godard Research fund (E.H.) and the Ophthalmology Research Fund (The Hospital for Sick Children). Funding for whole-exome sequencing was provided by the University of Toronto McLaughlin Centre. The authors acknowledge the contribution of the high-throughput sequencing platform of The Centre for Applied Genomics, Toronto, Canada. Some of the DNA samples included in this study originate from the NeuroSensCol DNA bank, part of the BioCollections network for research in neuroscience (principal investigator J.A. Sahel, co-principal investigator I. Audo, partner with Centre Hospitalier National d'Ophtalmologie [CHNO] des Quinze-Vingts, INSERM, and CNRS). The study was supported by the Fondation Voir et Entendre (C.Z.), Prix Dalloz for "La recherche en ophtalmologie" (C.Z.), LABEX LIFESENSES (reference ANR-10-LABX-65) supported by French state funds managed by the Agence Nationale de la Recherche within the Investissements d'Avenir program (ANR-11-IDEX-0004-0), a Foundation Fighting Blindness center grant (C-CMM-0907-0428-INSERM04), and Prix de la Fondation de l'CEil (I.A.). The authors acknowledge the families for their active participation in the study.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; AnsariLari MA, 1996, GENOME RES, V6, P314, DOI 10.1101/gr.6.4.314; Audo I, 2012, AM J HUM GENET, V90, P321, DOI 10.1016/j.ajhg.2011.12.007; Audo I, 2009, AM J HUM GENET, V85, P720, DOI 10.1016/j.ajhg.2009.10.013; Bech-Hansen NT, 2000, NAT GENET, V26, P319, DOI 10.1038/81619; Bech-Hansen NT, 1998, NAT GENET, V19, P264, DOI 10.1038/947; Bellone RR, 2008, GENETICS, V179, P1861, DOI 10.1534/genetics.108.088807; Bijveld MMC, 2013, OPHTHALMOLOGY, V120, P2072, DOI 10.1016/j.ophtha.2013.03.002; Bullido MJ, 2004, NEUROBIOL AGING, V25, P853, DOI 10.1016/j.neurobiolaging.2003.10.006; Bush RA, 1996, J OPT SOC AM A, V13, P557, DOI 10.1364/JOSAA.13.000557; BUSH RA, 1994, INVEST OPHTH VIS SCI, V35, P635; Cheever ML, 2008, NAT STRUCT MOL BIOL, V15, P155, DOI 10.1038/nsmb.1377; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Dhingra A, 2002, J NEUROSCI, V22, P4878, DOI 10.1523/JNEUROSCI.22-12-04878.2002; Dhingra A, 2000, J NEUROSCI, V20, P9053; Dhingra A, 2012, J NEUROSCI, V32, P11343, DOI 10.1523/JNEUROSCI.1436-12.2012; Dragas R, 2014, DOC OPHTHALMOL, V129, P97, DOI 10.1007/s10633-014-9453-y; Dryja TP, 2005, P NATL ACAD SCI USA, V102, P4884, DOI 10.1073/pnas.0501233102; DRYJA TP, 1993, NAT GENET, V4, P280, DOI 10.1038/ng0793-280; Dryja TP, 1996, NAT GENET, V13, P358, DOI 10.1038/ng0796-358; Euler T, 2014, NAT REV NEUROSCI, V15, P507, DOI 10.1038/nrn3783; Frishman L. J., 2006, PRINCIPLES PRACTICE, P139; GAL A, 1994, NAT GENET, V7, P551, DOI 10.1038/ng0894-551c; Gao Y Q, 1998, Mol Vis, V4, P16; GarciaHiguera I, 1996, BIOCHEMISTRY-US, V35, P13985, DOI 10.1021/bi9612879; Goldlust IS, 2013, P NATL ACAD SCI USA, V110, P14990, DOI 10.1073/pnas.1305999110; Hood DC, 1996, J OPT SOC AM A, V13, P623, DOI 10.1364/JOSAA.13.000623; Huang LQ, 2003, J COMP NEUROL, V455, P1, DOI 10.1002/cne.10396; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Koike C, 2010, CELL CALCIUM, V48, P95, DOI 10.1016/j.ceca.2010.08.004; Koike C, 2010, P NATL ACAD SCI USA, V107, P332, DOI 10.1073/pnas.0912730107; Koyasu T, 2008, CURR EYE RES, V33, P91, DOI 10.1080/02713680701823232; Larhammar D, 2009, PHILOS T R SOC B, V364, P2867, DOI 10.1098/rstb.2009.0077; LEE RH, 1992, J BIOL CHEM, V267, P24776; LEREA CL, 1986, SCIENCE, V234, P77, DOI 10.1126/science.3529395; Li Z, 2009, AM J HUM GENET, V85, P711, DOI 10.1016/j.ajhg.2009.10.003; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; MASU M, 1995, CELL, V80, P757, DOI 10.1016/0092-8674(95)90354-2; McCulloch DL, 2015, DOC OPHTHALMOL, V130, P1, DOI 10.1007/s10633-014-9473-7; MIYAKE Y, 1986, ARCH OPHTHALMOL-CHIC, V104, P1013, DOI 10.1001/archopht.1986.01050190071042; Morgans CW, 2010, BIOESSAYS, V32, P609, DOI 10.1002/bies.200900198; Morgans CW, 2009, P NATL ACAD SCI USA, V106, P19174, DOI 10.1073/pnas.0908711106; Naeem MA, 2012, INVEST OPHTH VIS SCI, V53, P1353, DOI 10.1167/iovs.11-8026; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Neuille M., 2016, CLIN GENET; Nikonov SS, 2013, J NEUROSCI, V33, P5182, DOI 10.1523/JNEUROSCI.5204-12.2013; Okawa H, 2010, J GEN PHYSIOL, V136, P443, DOI 10.1085/jgp.201010477; ONG OC, 1995, J BIOL CHEM, V270, P8495, DOI 10.1074/jbc.270.15.8495; Peachey NS, 2012, AM J HUM GENET, V90, P331, DOI 10.1016/j.ajhg.2011.12.006; PENG YW, 1992, P NATL ACAD SCI USA, V89, P10882, DOI 10.1073/pnas.89.22.10882; Pusch CM, 2000, NAT GENET, V26, P324, DOI 10.1038/81627; Riazuddin SA, 2010, AM J HUM GENET, V87, P523, DOI 10.1016/j.ajhg.2010.08.013; RIGGS LA, 1954, AM J OPHTHALMOL, V38, P70, DOI 10.1016/0002-9394(54)90011-2; Ritchey ER, 2010, NEUROSCIENCE, V169, P1376, DOI 10.1016/j.neuroscience.2010.05.081; Schneider FM, 2015, EUR J CELL BIOL, V94, P420, DOI 10.1016/j.ejcb.2015.06.005; SCHUBERT G, 1952, OPHTHALMOLOGICA, V123, P396, DOI 10.1159/000301211; Shen Y, 2009, J NEUROSCI, V29, P6088, DOI 10.1523/JNEUROSCI.0132-09.2009; SIEVING PA, 1994, VISUAL NEUROSCI, V11, P519, DOI 10.1017/S0952523800002431; Siffert W, 1999, J AM SOC NEPHROL, V10, P1921; Siffert W, 1998, NAT GENET, V18, P45, DOI 10.1038/ng0198-45; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; Tummala H, 2006, INVEST OPHTH VIS SCI, V47, P4714, DOI 10.1167/iovs.06-0292; van Genderen MM, 2009, AM J HUM GENET, V85, P730, DOI 10.1016/j.ajhg.2009.10.012; Vincent A, 2014, J MED GENET, V51, P797, DOI 10.1136/jmedgenet-2014-102620; Weinstein LS, 2006, TRENDS PHARMACOL SCI, V27, P260, DOI 10.1016/j.tips.2006.03.005; Wycisk KA, 2006, AM J HUM GENET, V79, P973, DOI 10.1086/508944; Zeitz C, 2006, AM J HUM GENET, V79, P657, DOI 10.1086/508067; Zeitz C, 2015, PROG RETIN EYE RES, V45, P58, DOI 10.1016/j.preteyeres.2014.09.001; Zeitz C, 2013, AM J HUM GENET, V92, P67, DOI 10.1016/j.ajhg.2012.10.023; Zill P, 2000, NEUROREPORT, V11, P1893, DOI 10.1097/00001756-200006260-00018	72	34	34	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 5	2016	98	5					1011	1019		10.1016/j.ajhg.2016.03.021	http://dx.doi.org/10.1016/j.ajhg.2016.03.021			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DL8DF	27063057	Bronze, Green Published			2022-12-18	WOS:000375869300018
J	Bhoj, EJ; Li, D; Harr, M; Edvardson, S; Elpeleg, O; Chisholm, E; Juusola, J; Douglas, G; Sacoto, MJG; Siquier-Pernet, K; Saadi, A; Bole-Feysot, C; Nitschke, P; Narravula, A; Walke, M; Horner, MB; Day-Salvatore, DL; Jayakar, P; Vergano, SAS; Tarnopolsky, MA; Hegde, M; Colleaux, L; Crino, P; Hakonarson, H				Bhoj, Elizabeth J.; Li, Dong; Harr, Margaret; Edvardson, Shimon; Elpeleg, Orly; Chisholm, Elizabeth; Juusola, Jane; Douglas, Ganka; Sacoto, Maria J. Guillen; Siquier-Pernet, Karine; Saadi, Abdelkrim; Bole-Feysot, Christine; Nitschke, Patrick; Narravula, Alekhya; Walke, Maria; Horner, Michele B.; Day-Salvatore, Debra-Lynn; Jayakar, Parul; Vergano, Samantha A. Schrier; Tarnopolsky, Mark A.; Hegde, Madhuri; Colleaux, Laurence; Crino, Peter; Hakonarson, Hakon			Mutations in TBCK, Encoding TBC1-Domain-Containing Kinase, Lead to a Recognizable Syndrome of Intellectual Disability and Hypotonia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LEUCINE; MTOR; GLUCOSE; PATHWAY	Through an international multi-center collaboration, 13 individuals from nine unrelated families and affected by likely pathogenic biallelic variants in TBC1-domain-containing kinase (TBCK) were identified through whole-exome sequencing. All affected individuals were found to share a core phenotype of intellectual disability and hypotonia, and many had seizures and showed brain atrophy and white-matter change's on neuroimaging. Minor non-specific facial dysmorphism was also noted in some individuals, including multiple older children who developed coarse features similar to those of storage disorders. TBCK has been shown to regulate the mammalian target of rapamycin (mTOR) signaling pathway, which is also stimulated by exogenous leucine supplementation. TBCK was absent in cells from affected individuals, and decreased phosphorylation of phospho-ribosomal protein S6 was also observed, a finding suggestive of downregulation of mTOR signaling. Lastly, we demonstrated that activation of the mTOR pathway in response to L-leucine supplementation was retained, suggesting a possible avenue for directed therapies for this condition.	[Bhoj, Elizabeth J.; Li, Dong; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Bhoj, Elizabeth J.; Harr, Margaret] Childrens Hosp Philadelphia, Dept Genet, Philadelphia, PA 19104 USA; [Edvardson, Shimon] Hadassah Univ Hosp, Pediat Neurol Unit, IL-91120 Jerusalem, Israel; [Edvardson, Shimon; Elpeleg, Orly] Hadassah Hebrew Univ, Med Ctr, Monique & Jacques Roboh Dept Genet Res, IL-91120 Jerusalem, Israel; [Chisholm, Elizabeth; Vergano, Samantha A. Schrier] Childrens Hosp Kings Daughters, Div Med Genet & Metab, Norfolk, VA 23507 USA; [Juusola, Jane; Douglas, Ganka; Sacoto, Maria J. Guillen] GeneDx, Gaithersburg, MD 20877 USA; [Siquier-Pernet, Karine; Colleaux, Laurence] Univ Paris 05, Sorbonne Paris Cite, Necker Enfants Malad Hosp,INSERM,UMR 1163, Lab Mol & Pathophysiol Bases Cognit Disorders,Ins, F-75015 Paris, France; [Saadi, Abdelkrim] Etab Hosp Specialise Benaknoun, Dept Neurol, Algiers, Algeria; [Bole-Feysot, Christine] Univ Paris 05, Sorbonne Paris Cite, INSERM,UMR 1163, Genom Platform,Inst Imagine, F-75015 Paris, France; [Nitschke, Patrick] Univ Paris 05, Sorbonne Paris Cite, Inst Imagine, Plateforme Bioinformat, F-75015 Paris, France; [Narravula, Alekhya; Hegde, Madhuri] Emory Univ, Emory Genet Lab, Decatur, GA 30033 USA; [Walke, Maria; Jayakar, Parul] Nicklaus Childrens Hosp, Miami, FL 33155 USA; [Horner, Michele B.; Day-Salvatore, Debra-Lynn] St Peters Univ Hosp, Dept Med Genet & Genom Med, New Brunswick, NJ 08901 USA; [Tarnopolsky, Mark A.] McMaster Univ, Med Ctr, Dept Pediat, Hamilton, ON L8N 3Z5, Canada; [Crino, Peter] Temple Univ, Dept Neurol, Philadelphia, PA 19122 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Emory University; Saint Peter's University Hospital; McMaster University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Bhoj, EJ (corresponding author), Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA.; Bhoj, EJ (corresponding author), Childrens Hosp Philadelphia, Dept Genet, Philadelphia, PA 19104 USA.	bhoje@email.chop.edu	COLLEAUX, LAURENCE/AAA-8144-2022; COLLEAUX, Laurence/H-6455-2017	COLLEAUX, LAURENCE/0000-0002-0987-7648; SIQUIER-PERNET, KARINE/0000-0001-7854-0267	National Research Agency [ANR-10-IAHU-01]; Fondation pour la Recherche Medicale [DEQ20120323702]; Institute for Translational Medicine and Therapeutics of the University of Pennsylvania; NIH National Center for Advancing Translational Sciences [UL1TR000003]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD086984] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000003] Funding Source: NIH RePORTER	National Research Agency(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Institute for Translational Medicine and Therapeutics of the University of Pennsylvania; NIH National Center for Advancing Translational Sciences; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We thank the families in this study for their enthusiastic participation. The contributions of Mais Hashem, Niema Ibrahim, and Fowzan S. Alkuraya of the King Faisal Specialist Hospital and Research Center included providing cells from family 1 and were invaluable to the development of this project. We would also like to acknowledge the very helpful assistance of GeneMatcher and Megan Cho of GeneDx in the identification of additional affected individuals. It was supported in part by grants from the National Research Agency (ANR-10-IAHU-01) and the Fondation pour la Recherche Medicale (DEQ20120323702) to L.C. This work was supported in part by the Institute for Translational Medicine and Therapeutics of the University of Pennsylvania and by the NIH National Center for Advancing Translational Sciences under award number UL1TR000003. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Abdulwahab F, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0693-2; Alazami AM, 2015, CELL REP, V10, P148, DOI 10.1016/j.celrep.2014.12.015; Chen XG, 2010, MOL CARCINOGEN, V49, P603, DOI 10.1002/mc.20628; Combaret L, 2005, J PHYSIOL-LONDON, V569, P489, DOI 10.1113/jphysiol.2005.098004; Crino PB, 2011, TRENDS MOL MED, V17, P734, DOI 10.1016/j.molmed.2011.07.008; Harris J.C., 2005, INTELLECTUAL DISABIL, P448; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Kalogeropoulo D, 2008, METABOLISM, V57, P1747, DOI 10.1016/j.metabol.2008.09.001; Komurov K, 2010, J BIOL CHEM, V285, P21134, DOI 10.1074/jbc.M110.137828; Liu YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071349; Lynch CJ, 2001, J NUTR, V131, p861S, DOI 10.1093/jn/131.3.861S; Pedroso JAB, 2015, NUTRIENTS, V7, P3914, DOI 10.3390/nu7053914; Takei N, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00028; van Karnebeek CDM, 2012, MOL GENET METAB, V105, P368, DOI 10.1016/j.ymgme.2011.11.191	14	34	35	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 7	2016	98	4					782	788		10.1016/j.ajhg.2016.03.016	http://dx.doi.org/10.1016/j.ajhg.2016.03.016			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DJ4UO	27040691	Green Published, Bronze			2022-12-18	WOS:000374203800016
J	Gallego, CJ; Burt, A; Sundaresan, AS; Ye, Z; Shaw, C; Crosslin, DR; Crane, PK; Fullerton, SM; Hansen, K; Carrell, D; Kuivaniemi, H; Derr, K; de Andrade, M; McCarty, CA; Kitchner, TE; Ragon, BK; Stallings, SC; Papa, G; Bochenek, J; Smith, ME; Aufox, SA; Pacheco, JA; Pate, V; Friesema, EM; Erwin, AL; Gottesman, O; Gerhard, GS; Ritchie, M; Motulsky, AG; Kullo, IJ; Larson, EB; Tromp, G; Brilliant, MH; Bottinger, E; Denny, JC; Roden, DM; Williams, MS; Jarvik, GP				Gallego, Carlos J.; Burt, Amber; Sundaresan, Agnes S.; Ye, Zi; Shaw, Christopher; Crosslin, David R.; Crane, Paul K.; Fullerton, S. Malia; Hansen, Kris; Carrell, David; Kuivaniemi, Helena; Derr, Kimberly; de Andrade, Mariza; McCarty, Catherine A.; Kitchner, Terrie E.; Ragon, Brittany K.; Stallings, Sarah C.; Papa, Gabriella; Bochenek, Joseph; Smith, Maureen E.; Aufox, Sharon A.; Pacheco, Jennifer A.; Pate, Vaibhav; Friesema, Elisha M.; Erwin, Angelika Ludtke; Gottesman, Omri; Gerhard, Glenn S.; Ritchie, Marylyn; Motulsky, Arno G.; Kullo, Iftikhar J.; Larson, Eric B.; Tromp, Gerard; Brilliant, Murray H.; Bottinger, Erwin; Denny, Joshua C.; Roden, Dan M.; Williams, Marc S.; Jarvik, Gail P.			Penetrance of Hemochromatosis in HFE Genotypes Resulting in p.Cys282Tyr and p.[Cys282Tyr];[His63Asp] in the eMERGE Network	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ELECTRONIC MEDICAL-RECORDS; HEREDITARY HEMOCHROMATOSIS; INCIDENTAL FINDINGS; GENE; POPULATION; DIAGNOSIS; MANAGEMENT; MUTATIONS; DISEASES; C282Y	Hereditary hemochromatosis (HH) is a common autosomal-recessive disorder associated with pathogenic HFE variants, most commonly those resulting in p.Cys282Tyr and p.His63Asp. Recommendations on returning incidental findings of HFE variants in individuals undergoing genome-scale sequencing should be informed by penetrance estimates of HH in unselected samples. We used the eMERGE Network, a multicenter cohort with genotype data linked to electronic medical records, to estimate the diagnostic rate and clinical penetrance of HH in 98 individuals homozygous for the variant coding for HFE p.Cys282Tyr and 397 compound heterozygotes with variants resulting in p.[His63Asp];[Cys282Tyr]. The diagnostic rate of HH in males was 24.4% for p.Cys282Tyr homozygotes and 3.5% for compound heterozygotes (p < 0.001); in females, it was 14.0% for p.Cys282Tyr homozygotes and 2.3% for compound heterozygotes (p < 0.001). Only males showed differences across genotypes in transferrin saturation levels (100% of homozygotes versus 37.5% of compound heterozygotes with transferrin saturation > 50%; p = 0.003), serum ferritin levels (77.8% versus 33.3% with serum ferritin > 300 ng/ml; p = 0.006), and diabetes (44.7% versus 28.0%; p = 0.03). No differences were found in the prevalence of heart disease, arthritis, or liver disease, except for the rate of liver biopsy (10.9% versus 1.8% [p = 0.013] in males; 9.1% versus 2% [p = 0.035] in females). Given the higher rate of HH diagnosis than in prior studies, the high penetrance of iron overload, and the frequency of at-risk genotypes, in addition to other suggested actionable adult-onset genetic conditions, opportunistic screening should be considered for p.[Cys282Tyr];[Cys282Tyr] individuals with existing genomic data.	[Gallego, Carlos J.; Burt, Amber; Shaw, Christopher; Crosslin, David R.; Jarvik, Gail P.] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Gallego, Carlos J.] Univ Washington, Dept Pharm, Pharmaceut Outcomes Res & Policy Program, Seattle, WA 98195 USA; [Sundaresan, Agnes S.] Geisinger Hlth Syst, Ctr Hlth Res, Danville, PA 17822 USA; [Ye, Zi; Kullo, Iftikhar J.] Mayo Clin, Dept Internal Med, Div Cardiovasc Dis, Rochester, MN 55905 USA; [Crane, Paul K.] Univ Washington, Dept Med, Div Gen Internal Med, Seattle, WA 98104 USA; [Fullerton, S. Malia] Univ Washington, Dept Bioeth & Humanities, Seattle, WA 98195 USA; [Hansen, Kris; Carrell, David; Larson, Eric B.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA 98101 USA; [Derr, Kimberly; Tromp, Gerard] Geisinger Hlth Syst, Siegfried & Janet Weis Ctr Res, Danville, PA 17822 USA; [de Andrade, Mariza] Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN 55905 USA; [McCarty, Catherine A.] Essentia Inst Rural Hlth, Div Res, Duluth, MN 55805 USA; [Kitchner, Terrie E.; Brilliant, Murray H.] Marshfield Med Res Fdn, Ctr Human Genet, Marshfield, WI 54449 USA; [Ragon, Brittany K.] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA; [Stallings, Sarah C.; Papa, Gabriella] Vanderbilt Univ, Sch Med, Vanderbilt Inst Clin & Translat Res, Nashville, TN 37203 USA; [Bochenek, Joseph; Denny, Joshua C.] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37232 USA; [Smith, Maureen E.; Aufox, Sharon A.; Pacheco, Jennifer A.; Pate, Vaibhav] Northwestern Univ, Feinberg Sch Med, Ctr Genet Med, Chicago, IL 60611 USA; [Friesema, Elisha M.] Northwestern Univ, Feinberg Sch Med, Div Gen Internal Med & Geriatr, Chicago, IL 60611 USA; [Erwin, Angelika Ludtke; Gottesman, Omri; Bottinger, Erwin] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Gerhard, Glenn S.] Temple Univ, Sch Med, Dept Med Genet & Mol Biochem, Philadelphia, PA 19140 USA; [Ritchie, Marylyn] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Denny, Joshua C.; Roden, Dan M.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; [Roden, Dan M.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA; [Williams, Marc S.] Geisinger Hlth Syst, Genom Med Inst, Danville, PA 17822 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Geisinger Health System; Mayo Clinic; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; Geisinger Health System; Mayo Clinic; University of Texas System; UTMD Anderson Cancer Center; Vanderbilt University; Vanderbilt University; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Icahn School of Medicine at Mount Sinai; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Vanderbilt University; Vanderbilt University; Geisinger Health System	Gallego, CJ (corresponding author), Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA.	cgallego@med.umich.edu; gjarvik@medicine.washington.edu	Fullerton, Stephanie Malia/H-8696-2019; Tromp, Gerard/B-2677-2017; Denny, Josh/AAL-3359-2021; Kuivaniemi, Helena/Q-8178-2019; Roden, Dan/ABD-5412-2021; Zi, Ye/GWM-3932-2022	Fullerton, Stephanie Malia/0000-0002-0938-6048; Tromp, Gerard/0000-0002-7761-0806; Denny, Josh/0000-0002-3049-7332; Kuivaniemi, Helena/0000-0001-5753-8766; McCarty, Catherine/0000-0003-1089-0142; Pacheco, Jennifer/0000-0001-8021-5818; Shaw, Christopher/0000-0002-3461-4305	National Human Genome Research Institute (NHGRI) [U01HG006828, U01HG006830, U01HG006389, U01HG006382, U01HG006375, U01HG006379, U01HG006380, U01HG006388, U01HG006378, U01HG006385]; National Institute of General Medical Sciences [5T32GM007454]; NHGRI [U01HG0006507, U01HG007307]; National Cancer Institute; Patient-Centered Outcomes Research Career Development Program of the Agency for Healthcare Research and Quality [K12 HS021686]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K12HS021686] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009666] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427, UL1TR001422] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006380, U01HG006507, U01HG006379, U01HG006388, U01HG006382, U01HG007307, U01HG006375, U01HG006828, U01HG008657, U01HG006385, U01HG006389, U01HG006830, U01HG008701, U01HG006378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007454] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Patient-Centered Outcomes Research Career Development Program of the Agency for Healthcare Research and Quality; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The eMERGE Network was initiated and funded by the National Human Genome Research Institute (NHGRI) through the following grants: U01HG006828 (Cincinnati Children's Hospital Medical Center and Boston Children's Hospital), U01HG006830 (Children's Hospital of Philadelphia), U01HG006389 (Essentia Institute of Rural Health, Marshfield Clinic Research Foundation, and Pennsylvania State University), U01HG006382 (Geisinger Clinic), U01HG006375 (Group Health Cooperative and the University of Washington), U01HG006379 (Mayo Clinic), U01HG006380 (Icahn School of Medicine at Mount Sinai), U01HG006388 (Northwestern University), U01HG006378 (Vanderbilt University Medical Center), and U01HG006385 (Vanderbilt University Medical Center serving as the coordinating center). G.P.J. was supported by grant 5T32GM007454 from the National Institute of General Medical Sciences and grants U01HG0006507 and U01HG007307 from the NHGRI and National Cancer Institute. C.J.G. was supported by grant K12 HS021686 from the Patient-Centered Outcomes Research Career Development Program of the Agency for Healthcare Research and Quality.	Adams PC, 2005, NEW ENGL J MED, V352, P1769, DOI 10.1056/NEJMoa041534; Aharon-Peretz J, 2004, NEW ENGL J MED, V351, P1972, DOI 10.1056/NEJMoa033277; Allen KJ, 2008, NEW ENGL J MED, V358, P221, DOI 10.1056/NEJMoa073286; Amendola LM, 2015, GENOME RES, V25, P305, DOI 10.1101/gr.183483.114; Andersen RV, 2004, BLOOD, V103, P2914, DOI 10.1182/blood-2003-10-3564; Asberg A, 2007, SCAND J GASTROENTERO, V42, P1073, DOI 10.1080/00365520701245488; Bacon BR, 2011, HEPATOLOGY, V54, P328, DOI 10.1002/hep.24330; Banks MJ, 1998, INT J QUAL HEALTH C, V10, P163, DOI 10.1093/intqhc/10.2.163; Bardou-Jacquet E, 2014, CLIN RES HEPATOL GAS, V38, P143, DOI 10.1016/j.clinre.2013.11.003; Beutler E, 2002, LANCET, V359, P211, DOI 10.1016/S0140-6736(02)07447-0; Cadet E, 2005, J MED GENET, V42, P390, DOI 10.1136/jmg.2004.027284; Delatycki MB, 2005, LANCET, V366, P314, DOI 10.1016/S0140-6736(05)63012-7; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Gottesman O, 2013, GENET MED, V15, P761, DOI 10.1038/gim.2013.72; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; McCarty CA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-13; Niederau C, 1996, GASTROENTEROLOGY, V110, P1107, DOI 10.1053/gast.1996.v110.pm8613000; Olynyk JK, 1999, NEW ENGL J MED, V341, P718, DOI 10.1056/NEJM199909023411002; Pedersen P, 2009, ANN HEMATOL, V88, P775, DOI 10.1007/s00277-008-0679-1; Pietrangelo A, 2010, GASTROENTEROLOGY, V139, P393, DOI 10.1053/j.gastro.2010.06.013; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; Rossi Enrico, 2004, Clin Biochem Rev, V25, P183; Turner Stephen, 2011, Curr Protoc Hum Genet, VChapter 1, DOI 10.1002/0471142905.hg0119s68; van Bokhoven MA, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7251; Verma SS, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00370; Waalen J, 2002, BLOOD CELL MOL DIS, V29, P418, DOI 10.1006/bcmd.2002.0596; Whitlock EP, 2006, ANN INTERN MED, V145, P209, DOI 10.7326/0003-4819-145-3-200608010-00009	28	34	35	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 1	2015	97	4					512	520		10.1016/j.ajhg.2015.08.008	http://dx.doi.org/10.1016/j.ajhg.2015.08.008			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CT2FL	26365338	Green Published, hybrid			2022-12-18	WOS:000362617300002
J	Migliavacca, E; Golzio, C; Mannik, K; Blumenthal, I; Oh, EC; Harewood, L; Kosmicki, JA; Loviglio, MN; Giannuzzi, G; Hippolyte, L; Maillard, AM; Alfaiz, AA; van Haelst, MM; Andrieux, J; Gusella, JF; Daly, MJ; Beckmann, JS; Jacquemont, S; Talkowski, ME; Katsanis, N; Reymond, A				Migliavacca, Eugenia; Golzio, Christelle; Maennik, Katrin; Blumenthal, Ian; Oh, Edwin C.; Harewood, Louise; Kosmicki, Jack A.; Loviglio, Maria Nicla; Giannuzzi, Giuliana; Hippolyte, Loyse; Maillard, Anne M.; Alfaiz, Ali Abdullah; van Haelst, Mieke M.; Andrieux, Joris; Gusella, James F.; Daly, Mark J.; Beckmann, Jacques S.; Jacquemont, Sebastien; Talkowski, Michael E.; Katsanis, Nicholas; Reymond, Alexandre		16p11 2 European Consortium	A Potential Contributory Role for Ciliary Dysfunction in the 16p11.2 600 kb BP4-BP5 Pathology	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COPY NUMBER VARIATION; SPATIAL WORKING-MEMORY; DE-NOVO MUTATIONS; CENTROSOMAL PROTEIN; JOUBERT-SYNDROME; PRIMARY CILIUM; AUTISM; DELETION; CEP290; SCHIZOPHRENIA	The 16p11.2 600 kb copy-number variants (CNVs) are associated with mirror phenotypes on BMI, head circumference, and brain volume and represent frequent genetic lesions in autism spectrum disorders (ASDs) and schizophrenia. Here we interrogated the transcriptome of individuals carrying reciprocal 16p11.2 CNVs. Transcript perturbations correlated with clinical endophenotypes and were enriched for genes associated with ASDs, abnormalities of head size, and ciliopathies. Ciliary gene expression was also perturbed in orthologous mouse models, raising the possibility that ciliary dysfunction contributes to 16p11.2 pathologies. In support of this hypothesis, we found structural ciliary defects in the CA1 hippocampal region of 16p11.2 duplication mice. Moreover, by using an established zebrafish model, we show genetic interaction between KCTD13, a key driver of the mirrored neuroanatomical phenotypes of the 16p11.2 CNV, and ciliopathy-associated genes. Overexpression of BBS7 rescues head size and neuroanatomical defects of kctd13 morphants, whereas suppression or overexpression of CEP290 rescues phenotypes induced by KCTD13 under-or overexpression, respectively. Our data suggest that dysregulation of ciliopathy genes contributes to the clinical phenotypes of these CNVs.	[Migliavacca, Eugenia; Maennik, Katrin; Harewood, Louise; Loviglio, Maria Nicla; Giannuzzi, Giuliana; Alfaiz, Ali Abdullah; Reymond, Alexandre] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Migliavacca, Eugenia; Alfaiz, Ali Abdullah; Beckmann, Jacques S.] SIB, CH-1015 Lausanne, Switzerland; [Golzio, Christelle; Oh, Edwin C.; Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Durham, NC 27710 USA; [Golzio, Christelle; Oh, Edwin C.; Katsanis, Nicholas] Duke Univ, Dept Cell Biol, Durham, NC 27710 USA; [Maennik, Katrin] Univ Tartu, Estonian Genome Ctr, EE-51010 Tartu, Estonia; [Blumenthal, Ian; Gusella, James F.; Talkowski, Michael E.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Kosmicki, Jack A.; Daly, Mark J.] Massachusetts Gen Hosp, Dept Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Kosmicki, Jack A.; Daly, Mark J.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Kosmicki, Jack A.; Daly, Mark J.] Broad Inst Harvard & MIT, Cambridge Ctr 7, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Kosmicki, Jack A.; Daly, Mark J.] Broad Inst Harvard & MIT, Cambridge Ctr 7, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Hippolyte, Loyse; Maillard, Anne M.; Beckmann, Jacques S.; Jacquemont, Sebastien] Lausanne Univ Hosp CHUV, Serv Med Genet, CH-1011 Lausanne, Switzerland; [van Haelst, Mieke M.] Univ Med Ctr Utrecht, Dept Med Genet, NL-3508 AB Utrecht, Netherlands; [Andrieux, Joris] CHRU Lille, Inst Genet Med, Hop Jeanne de Flandre, F-59037 Lille, France; [Gusella, James F.; Talkowski, Michael E.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; [Gusella, James F.; Talkowski, Michael E.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02114 USA; [Beckmann, Jacques S.] Univ Lausanne, Dept Med Genet, CH-1011 Lausanne, Switzerland	University of Lausanne; Swiss Institute of Bioinformatics; Duke University; Duke University; University of Tartu; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Utrecht University; Utrecht University Medical Center; Universite de Lille - ISITE; CHU Lille; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Lausanne	Katsanis, N (corresponding author), Duke Univ, Ctr Human Dis Modeling, Durham, NC 27710 USA.	katsanis@cellbio.duke.edu; alexandre.reymond@unil.ch	Kooy, Frank/F-5276-2014; AT, Vulto-van Silfhout/H-4199-2015; Rauch, Anita/C-5568-2014; Daly, Mark J/B-2453-2017; Maillard, Anne/N-4779-2017; Jacquemont, Sebastien/AAS-5060-2021; Le Caignec, Cedric/K-8467-2015; Isidor, Bertrand/L-2435-2015; Ounap, Katrin/Q-1103-2016; Beckmann, Jacques S/A-9772-2008; Giannuzzi, Giuliana/N-7117-2017; Nordgren, Ann/AAQ-9142-2021; Nordgren, Ann C/N-4057-2013; Mucciolo, Mafalda/AAB-8222-2019; Renieri, Alessandra/K-5950-2016	Kooy, Frank/0000-0003-2024-0485; Rauch, Anita/0000-0003-2930-3163; Daly, Mark J/0000-0002-0949-8752; Maillard, Anne/0000-0002-4811-0693; Jacquemont, Sebastien/0000-0001-6838-8767; Le Caignec, Cedric/0000-0002-0598-653X; Isidor, Bertrand/0000-0001-6480-126X; Ounap, Katrin/0000-0002-4594-6364; Beckmann, Jacques S/0000-0002-9741-1900; Nordgren, Ann/0000-0003-3285-4281; Nordgren, Ann C/0000-0003-3285-4281; Mucciolo, Mafalda/0000-0003-2228-8271; Golzio, Christelle/0000-0002-4420-3921; Peeters, Hilde/0000-0002-7295-3375; Talkowski, Michael/0000-0003-2889-0992; Harewood, Louise/0000-0002-6398-6714; Renieri, Alessandra/0000-0002-0846-9220; GILBERT-DUSSARDIER, Brigitte/0000-0001-7182-9914; Rooryck, Caroline/0000-0002-9789-3591; Reymond, Alexandre/0000-0003-1030-8327; Giannuzzi, Giuliana/0000-0002-4030-0601; Rajcan-Separovic, Evica/0000-0002-4528-7135; Siffredi, Vanessa/0000-0002-9137-0730	Swiss Scientific Exchange NMS Program; Swiss National Science Foundation (SNSF); Brain and Behavior Research Foundation; Saudi Arabian National Guard Health Affairs; Simons Foundation [SFARI274424, SFARI239983, SFARI238504, SFARI240021]; Swiss National Science Foundation [31003A_160203]; SNSF [CRIS FN CRSII33-133044]; Leenaards Foundation Prize; NIH [P50MH094260, MH095867]; Nancy Lurie Marks Family Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072301, R01DK075972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH095867, R00MH095867, P50MH094268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS093200] Funding Source: NIH RePORTER	Swiss Scientific Exchange NMS Program; Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Brain and Behavior Research Foundation; Saudi Arabian National Guard Health Affairs; Simons Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SNSF(Swiss National Science Foundation (SNSF)); Leenaards Foundation Prize; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nancy Lurie Marks Family Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the members of the Lausanne Genomic Technologies Facility, Patrick Meylan, and Alexandre Thiery for technical help. We are grateful to all the families participating to the Simons Variation in Individuals Project (Simons VIP), as well as to the Simons VIP working group. K.M. was awarded a scholarship from the Swiss Scientific Exchange NMS Program, S.J. is recipient of a Bursary Professor fellowship of the Swiss National Science Foundation (SNSF), and C.G., E.C.O., and M.E.T. are grantees of NARSAD Young Investigator Grants from the Brain and Behavior Research Foundation. A. A. A. was awarded a scholarship from the Saudi Arabian National Guard Health Affairs. This work is supported by the Simons Foundation (grants SFARI274424 to A.R., SFARI239983 to N.K., SFARI238504 to M.E.T., and SFARI240021 to J.F.G.), the Swiss National Science Foundation (grant 31003A_160203 to A.R.), a specific SNSF Sinergia grant (CRIS FN CRSII33-133044 to A.R.), the Leenaards Foundation Prize (S.J. and A.R.), by NIH P50MH094260 (N.K.) and MH095867 (M.E.T.), and the Nancy Lurie Marks Family Foundation (J.F.G. and M.E.T.). N.K. is a Distinguished Brumley Professor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann B, 2013, HUM MOL GENET, V22, P1328, DOI 10.1093/hmg/dds540; Acs P., 2014, BRAIN STRUCT FUNCT; Agassandian K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093484; Baker K, 2011, AM J MED GENET A, V155A, P1, DOI 10.1002/ajmg.a.33773; Beunders G, 2013, AM J HUM GENET, V92, P210, DOI 10.1016/j.ajhg.2012.12.011; Blaker-Lee A, 2012, DIS MODEL MECH, V5, P834, DOI 10.1242/dmm.009944; Blumenthal I, 2014, AM J HUM GENET, V94, P870, DOI 10.1016/j.ajhg.2014.05.004; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; Brancati F, 2007, AM J HUM GENET, V81, P104, DOI 10.1086/519026; Breunig JJ, 2008, P NATL ACAD SCI USA, V105, P13127, DOI 10.1073/pnas.0804558105; Brinckman DD, 2013, AM J MED GENET A, V161, P2964, DOI 10.1002/ajmg.a.36245; Chaignat E, 2011, GENOME RES, V21, P106, DOI 10.1101/gr.112748.110; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen YZ, 2009, MOL CELL, V35, P841, DOI 10.1016/j.molcel.2009.09.004; Cheung C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012233; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Courchesne E, 2011, JAMA-J AM MED ASSOC, V306, P2001, DOI 10.1001/jama.2011.1638; Crepel A, 2011, AM J MED GENET B, V156B, P243, DOI 10.1002/ajmg.b.31163; Cukier HN, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-1; de Anda FC, 2012, NAT NEUROSCI, V15, P1022, DOI 10.1038/nn.3141; DeLuca DS, 2012, BIOINFORMATICS, V28, P1530, DOI 10.1093/bioinformatics/bts196; Ezratty EJ, 2011, CELL, V145, P1129, DOI 10.1016/j.cell.2011.05.030; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Girard SL, 2011, NAT GENET, V43, P860, DOI 10.1038/ng.886; Glahn DC, 2003, BIOL PSYCHIAT, V53, P624, DOI 10.1016/S0006-3223(02)01641-4; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Golzio C, 2012, NATURE, V485, P363, DOI 10.1038/nature11091; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Henrichsen CN, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001054; Henrichsen CN, 2009, NAT GENET, V41, P424, DOI 10.1038/ng.345; Hitti FL, 2014, NATURE, V508, P88, DOI 10.1038/nature13028; Horev G, 2011, P NATL ACAD SCI USA, V108, P17076, DOI 10.1073/pnas.1114042108; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jacquemont S, 2011, NATURE, V478, P97, DOI 10.1038/nature10406; Janssen S, 2011, HUM GENET, V129, P79, DOI 10.1007/s00439-010-0902-8; Klinger M, 2014, MOL BIOL CELL, V25, P495, DOI 10.1091/mbc.E13-09-0526; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Larkins CE, 2011, MOL BIOL CELL, V22, P4694, DOI 10.1091/mbc.E10-12-0994; Liu YP, 2014, J CLIN INVEST, V124, P2059, DOI 10.1172/JCI71898; Lund SP, 2012, STAT APPL GENET MOL, V11, DOI 10.1515/1544-6115.1826; Luo R, 2012, AM J HUM GENET, V91, P38, DOI 10.1016/j.ajhg.2012.05.011; Maillard AM, 2015, MOL PSYCHIATR, V20, P140, DOI 10.1038/mp.2014.145; Marley A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046647; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Merla G, 2006, AM J HUM GENET, V79, P332, DOI 10.1086/506371; Nik-Zainal S, 2011, J MED GENET, V48, P197, DOI 10.1136/jmg.2010.082412; Nurmi EL, 2001, GENOMICS, V77, P105, DOI 10.1006/geno.2001.6617; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Oh EC, 2012, DEVELOPMENT, V139, P443, DOI 10.1242/dev.050054; Oprea GE, 2008, SCIENCE, V320, P524, DOI 10.1126/science.1155085; Otto EA, 2010, NAT GENET, V42, P840, DOI 10.1038/ng.662; Piskulic D, 2007, PSYCHIAT RES, V150, P111, DOI 10.1016/j.psychres.2006.03.018; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Qureshi AY, 2014, J NEUROSCI, V34, P11199, DOI 10.1523/JNEUROSCI.1366-14.2014; Rachel RA, 2012, J CLIN INVEST, V122, P1233, DOI 10.1172/JCI60981; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Reinthaler EM, 2014, HUM MOL GENET, V23, P6069, DOI 10.1093/hmg/ddu306; Reymond A, 2007, CURR OPIN GENET DEV, V17, P381, DOI 10.1016/j.gde.2007.08.009; Ricard G, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000543; Sampson MG, 2010, AM J MED GENET A, V152A, P2618, DOI 10.1002/ajmg.a.33628; Sandbacka M, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-125; Sanna-Cherchi S, 2012, AM J HUM GENET, V91, P987, DOI 10.1016/j.ajhg.2012.10.007; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Shalata A, 2013, AM J HUM GENET, V93, P1061, DOI 10.1016/j.ajhg.2013.10.025; Shinawi M, 2010, J MED GENET, V47, P332, DOI 10.1136/jmg.2009.073015; Smith SEP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002627; Smyth G. K., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027/MACHINEREADABLECITATION/RIS]; Soneson C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-91; Sparrow DB, 2013, HUM MOL GENET, V22, P1625, DOI 10.1093/hmg/ddt012; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stratigopoulos G, 2014, CELL METAB, V19, P767, DOI 10.1016/j.cmet.2014.04.009; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; van Dam Teunis Jp, 2013, Cilia, V2, P7, DOI 10.1186/2046-2530-2-7; Vimaleswaran KS, 2012, HUM MOL GENET, V21, P4537, DOI 10.1093/hmg/dds283; Walters RG, 2010, NATURE, V463, P671, DOI 10.1038/nature08727; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE; Wood Heather, 2012, Nat Rev Neurol, V8, P657, DOI 10.1038/nrneurol.2012.240; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446; Xu B, 2011, NAT GENET, V43, P864, DOI 10.1038/ng.902; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zufferey F, 2012, J MED GENET, V49, P660, DOI 10.1136/jmedgenet-2012-101203	86	34	35	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 7	2015	96	5					784	796		10.1016/j.ajhg.2015.04.002	http://dx.doi.org/10.1016/j.ajhg.2015.04.002			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CH7AZ	25937446	Green Published, Green Accepted, Bronze			2022-12-18	WOS:000354189300009
J	Wiszniewski, W; Hunter, JV; Hanchard, NA; Willer, JR; Shaw, C; Tian, Q; Illner, A; Wang, XQ; Cheung, SW; Patel, A; Campbell, IM; Gelowani, V; Hixson, P; Ester, AR; Azamian, MS; Potocki, L; Zapata, G; Hernandez, PP; Ramocki, MB; Santos-Cortez, RLP; Wang, G; York, MK; Justice, MJ; Chu, ZLD; Bader, PI; Omo-Griffith, L; Madduri, NS; Scharer, G; Crawford, HP; Yanatatsaneejit, P; Eifert, A; Kerr, J; Bacino, CA; Franklin, AIA; Goin-Kochel, RP; Simpson, G; Immken, L; Haque, ME; Stosic, M; Williams, MD; Morgan, TM; Pruthi, S; Omary, R; Boyadjiev, SA; Win, KK; Thida, A; Hurles, M; Hibberd, ML; Khor, CC; Chau, NVV; Gallagher, TE; Mutirangura, A; Stankiewicz, P; Beaudet, AL; Maletic-Savatic, M; Rosenfeld, JA; Shaffer, LG; Davis, EE; Belmont, JW; Dunstan, S; Simmons, CP; Bonnen, PE; Leal, SM; Katsanis, N; Lupski, JR; Lalani, SR				Wiszniewski, Wojciech; Hunter, Jill V.; Hanchard, Neil A.; Willer, Jason R.; Shaw, Chad; Tian, Qi; Illner, Anna; Wang, Xueqing; Cheung, Sau W.; Patel, Ankita; Campbell, Ian M.; Gelowani, Violet; Hixson, Patricia; Ester, Audrey R.; Azamian, Mahshid S.; Potocki, Lorraine; Zapata, Gladys; Hernandez, Patricia P.; Ramocki, Melissa B.; Santos-Cortez, Regie L. P.; Wang, Gao; York, Michele K.; Justice, Monica J.; Chu, Zili D.; Bader, Patricia I.; Omo-Griffith, Lisa; Madduri, Nirupama S.; Scharer, Gunter; Crawford, Heather P.; Yanatatsaneejit, Pattamawadee; Eifert, Anna; Kerr, Jeffery; Bacino, Carlos A.; Franklin, Adiaha I. A.; Goin-Kochel, Robin P.; Simpson, Gayle; Immken, Ladonna; Haque, Muhammad E.; Stosic, Marija; Williams, Misti D.; Morgan, Thomas M.; Pruthi, Sumit; Omary, Reed; Boyadjiev, Simeon A.; Win, Kay K.; Thida, Aye; Hurles, Matthew; Hibberd, Martin Lloyd; Khor, Chiea Chuen; Chau, Nguyen Van Vinh; Gallagher, Thomas E.; Mutirangura, Apiwat; Stankiewicz, Pawel; Beaudet, Arthur L.; Maletic-Savatic, Mirjana; Rosenfeld, Jill A.; Shaffer, Lisa G.; Davis, Erica E.; Belmont, John W.; Dunstan, Sarah; Simmons, Cameron P.; Bonnen, Penelope E.; Leal, Suzanne M.; Katsanis, Nicholas; Lupski, James R.; Lalani, Seema R.			TM4SF20 Ancestral Deletion and Susceptibility to a Pediatric Disorder of Early Language Delay and Cerebral White Matter Hyperintensities	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INCIDENTAL FINDINGS; DEVELOPMENTAL DELAY; MR-IMAGES; BRAIN; CHILDREN; POPULATION; PREVALENCE; SPEECH	White matter hyperintensities (WMHs) of the brain are important markers of aging and small-vessel disease. WMHs are rare in healthy children and, when observed, often occur with comorbid neuroinflammatory or vasculitic processes. Here, we describe a complex 4 kb deletion in 2q36.3 that segregates with early childhood communication disorders and WMH in 15 unrelated families predominantly from Southeast Asia. The premature brain aging phenotype with punctate and multifocal WMHs was observed in similar to 70% of young carrier parents who underwent brain MRI. The complex deletion removes the penultimate exon 3 of TM4SF20, a gene encoding a transmembrane protein of unknown function. Minigene analysis showed that the resultant net loss of an exon introduces a premature stop codon, which, in turn, leads to the generation of a stable protein that fails to target to the plasma membrane and accumulates in the cytoplasm. Finally, we report this deletion to be enriched in individuals of Vietnamese Kinh descent, with an allele frequency of about 1%, embedded in an ancestral haplotype. Our data point to a constellation of early language delay and WMH phenotypes, driven by a likely toxic mechanism of TM4SF20 truncation, and highlight the importance of understanding and managing population-specific low-frequency pathogenic alleles.	[Wiszniewski, Wojciech; Hanchard, Neil A.; Shaw, Chad; Tian, Qi; Wang, Xueqing; Cheung, Sau W.; Patel, Ankita; Campbell, Ian M.; Gelowani, Violet; Hixson, Patricia; Ester, Audrey R.; Azamian, Mahshid S.; Potocki, Lorraine; Zapata, Gladys; Hernandez, Patricia P.; Santos-Cortez, Regie L. P.; Wang, Gao; Justice, Monica J.; Crawford, Heather P.; Bacino, Carlos A.; Stankiewicz, Pawel; Beaudet, Arthur L.; Belmont, John W.; Bonnen, Penelope E.; Leal, Suzanne M.; Lupski, James R.; Lalani, Seema R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Hunter, Jill V.; Illner, Anna; Chu, Zili D.] Texas Childrens Hosp, Dept Pediat Radiol, Houston, TX 77030 USA; [Hanchard, Neil A.; Lupski, James R.] Texas Childrens Hosp, Dept Pediat, Houston, TX 77030 USA; [Hanchard, Neil A.; Davis, Erica E.; Belmont, John W.; Lalani, Seema R.] Baylor Coll Med, Childrens Nutr Res Ctr, Dept Pediat, Houston, TX 77030 USA; [Willer, Jason R.; Katsanis, Nicholas] Duke Univ, Med Ctr, Ctr Human Dis Modeling, Durham, NC 27710 USA; [Ramocki, Melissa B.; Stosic, Marija; Maletic-Savatic, Mirjana] Texas Childrens Hosp, Baylor Coll Med, Jan & Dan Duncan Neurol Res Inst, Dept Pediat & Neurosci, Houston, TX 77030 USA; [York, Michele K.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Bader, Patricia I.; Omo-Griffith, Lisa] Northeast Indiana Genet Counseling Ctr, Ft Wayne, IN 46845 USA; [Madduri, Nirupama S.] Vanderbilt Univ, Div Dev Med, Nashville, TN 37232 USA; [Scharer, Gunter] Childrens Hosp, Dept Pediat, Aurora, CO 80045 USA; [Yanatatsaneejit, Pattamawadee; Mutirangura, Apiwat] Chulalongkorn Univ, Ctr Excellence Mol Genet Canc & Human Dis, Bangkok 10330, Thailand; [Eifert, Anna] Texas Childrens Hosp, Dept Speech & Language, Houston, TX 77030 USA; [Kerr, Jeffery] Dells Childrens Med Ctr, Dept Neurol, Austin, TX 78723 USA; [Franklin, Adiaha I. A.] Texas Childrens Hosp, Dept Dev Pediat, Houston, TX 77030 USA; [Goin-Kochel, Robin P.] Baylor Coll Med, Dept Pediat, Psychol Sect, Houston, TX 77030 USA; [Goin-Kochel, Robin P.] Texas Childrens Hosp, Houston, TX 77030 USA; [Simpson, Gayle; Immken, Ladonna] Specially Children Dells Childrens Med Ctr, Austin, TX 78723 USA; [Williams, Misti D.; Morgan, Thomas M.] Vanderbilt Univ, Div Med Genet & Genom Med, Nashville, TN 37232 USA; [Pruthi, Sumit; Omary, Reed] Vanderbilt Univ, Nashville, TN 37232 USA; [Boyadjiev, Simeon A.] Univ Calif Davis, Dept Pediat, Genet Sect, Davis, CA 95817 USA; [Win, Kay K.] Harlem Hosp Med Ctr, Dept Med, New York, NY 10037 USA; [Thida, Aye] Allcare Pediat, Missouri City, TX 77459 USA; [Hurles, Matthew] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Hibberd, Martin Lloyd; Khor, Chiea Chuen] Genome Inst Singapore, Singapore 138672, Singapore; [Chau, Nguyen Van Vinh] Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Gallagher, Thomas E.] Tripler Army Med Ctr, Honolulu, HI 96859 USA; [Rosenfeld, Jill A.] PerkinElmer Inc, Signature Genom Labs, Spokane, WA 99207 USA; [Shaffer, Lisa G.] Genet Vet Sci Inc, Paw Print Genet, Spokane, WA 99202 USA; [Simmons, Cameron P.] Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam; [Bonnen, Penelope E.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Duke University; Baylor College of Medicine; Baylor College of Medicine; Vanderbilt University; Children's Hospital Colorado; Chulalongkorn University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Vanderbilt University; Vanderbilt University; University of California System; University of California Davis; Wellcome Trust Sanger Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); United States Department of Defense; United States Army; University of Oxford; Baylor College of Medicine	Lalani, SR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	seemal@bcm.tmc.edu	Dunstan, Sarah/AAO-9597-2020; Simmons, Cameron P/ABA-3896-2021; Stankiewicz, Paweł/AAP-7906-2021; Lalani, Seema/AAI-5090-2020; Hanchard, Neil/AAY-9075-2021; Belmont, John W/AAI-2494-2019; Belmont, John/AAH-6084-2021	Simmons, Cameron P/0000-0002-9039-7392; Stankiewicz, Paweł/0000-0002-6456-7490; Hanchard, Neil/0000-0003-1925-2665; Belmont, John W/0000-0001-7409-3578; Azamian, Mahshid/0000-0002-8543-8284; Hixson, Patricia/0000-0001-8287-6791; Davis, Erica/0000-0002-2412-8397; Hibberd, Martin/0000-0001-8587-1849; Shaw, Chad/0000-0001-7267-5398; Khor, Chiea Chuen/0000-0002-1128-4729; Willer, Jason/0000-0002-5869-3992; Kochel, Robin/0000-0001-6666-4369; Katsanis, Nicholas/0000-0002-2480-0171; Dunstan, Sarah/0000-0001-7873-933X; Campbell, Ian/0000-0002-3749-2884; Maletic-Savatic, Mirjana/0000-0002-6548-4662	Doris Duke Charitable Foundation (DDCF); Gillson Longenbaugh Foundation; National Institutes of Health [RO1-HL091771]; NINDS [RO1-NS058529-03, K23NS078056]; NHGRI [5U54HG006542]; NIMH [P50-MH094268]; Simons Foundation (SFARI) [239983]; Molecular Medicine Scholars Program at BCM [HL-66991]; NIH/NINDS [5K08NS062711]; McKnight Endowment for Science; Dana Foundation; NIH Intellectual and the Developmental Disabilities Research Grant [P30HD024064]; Children's Miracle Network endowed chair in pediatric genetics; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091771, T32HL066991] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273, U54HG006542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS062711, R01NS058529, K23NS078056] Funding Source: NIH RePORTER	Doris Duke Charitable Foundation (DDCF)(Doris Duke Charitable Foundation (DDCF)); Gillson Longenbaugh Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Simons Foundation (SFARI); Molecular Medicine Scholars Program at BCM; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); McKnight Endowment for Science; Dana Foundation; NIH Intellectual and the Developmental Disabilities Research Grant; Children's Miracle Network endowed chair in pediatric genetics; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are indebted to the families who participated in this research study. Support for this work was provided by the Doris Duke Charitable Foundation (DDCF) and Gillson Longenbaugh Foundation to S.R.L., National Institutes of Health (RO1-HL091771) to J.W.B. and S.R.L., NINDS (RO1-NS058529-03) and NHGRI (5U54HG006542) to J.R.L.; and NIMH (P50-MH094268) and a grant from the Simons Foundation (SFARI # 239983) to N.K. W.W. is supported by a Career Development Award K23NS078056 grant from the NINDS and Molecular Medicine Scholars Program at BCM (HL-66991). M.B.R. is grateful for the support of grant 5K08NS062711 from the NIH/NINDS. M.M.-S. was supported by the McKnight Endowment for Science, Dana Foundation, and the NIH Intellectual and the Developmental Disabilities Research Grant (P30HD024064). S.A.B. is partially funded by a Children's Miracle Network endowed chair in pediatric genetics. N.K. is a Distinguished Jean and George W. Brumley Professor. We thank Emily Hall and Jillian Pearring for technical support. The Department of Molecular and Human Genetics at Baylor College of Medicine offers extensive genetic laboratory testing, including chromosomal microarray analysis, and derives revenue from this activity. J.A.R. is an employee of Signature Genomic Laboratories, a subsidiary of PerkinElmer, Inc.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Back SA, 2006, MENT RETARD DEV D R, V12, P129, DOI 10.1002/mrdd.20107; Berditchevski F, 2001, J CELL SCI, V114, P4143; Boone PM, 2010, HUM MUTAT, V31, P1326, DOI 10.1002/humu.21360; Choi S, 2009, BLOOD, V113, P1845, DOI 10.1182/blood-2008-05-160671; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; Decobert F, 2005, PEDIATR RADIOL, V35, P587, DOI 10.1007/s00247-005-1406-x; El-Hattab AW, 2009, HUM GENET, V126, P589, DOI 10.1007/s00439-009-0706-x; Gupta SN, 2008, J NEUROL SCI, V264, P34, DOI 10.1016/j.jns.2007.06.055; Hopkins RO, 2006, J NEUROIMAGING, V16, P243, DOI 10.1111/j.1552-6569.2006.00047.x; Kalnin AJ, 2008, PEDIATR NEUROL, V39, P404, DOI 10.1016/j.pediatrneurol.2008.08.008; Kang CS, 2011, ANNU REV GENOM HUM G, V12, P145, DOI 10.1146/annurev-genom-090810-183119; Katzman GL, 1999, JAMA-J AM MED ASSOC, V282, P36, DOI 10.1001/jama.282.1.36; Khor CC, 2011, NAT GENET, V43, P1139, DOI 10.1038/ng.960; Kieslich M, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.2.e21; Kim BS, 2002, AM J NEURORADIOL, V23, P1674; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Muscal E, 2010, J RHEUMATOL, V37, P1768, DOI 10.3899/jrheum.090983; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Prathanee Benjamas, 2009, Journal of the Medical Association of Thailand, V92, P930; RANDALL D, 1974, BRIT J DISORD COMMUN, V9, P3; Rescorla L, 1997, J SPEECH LANG HEAR R, V40, P556, DOI 10.1044/jslhr.4003.556; Shih SC, 2009, CANCER RES, V69, P3272, DOI 10.1158/0008-5472.CAN-08-4886; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Tomblin JB, 1997, J SPEECH LANG HEAR R, V40, P1245, DOI 10.1044/jslhr.4006.1245; Verbruggen KT, 2009, EUR J PAEDIATR NEURO, V13, P181, DOI 10.1016/j.ejpn.2008.04.014; Widjaja E, 2008, ACTA RADIOL, V49, P589, DOI 10.1080/02841850801950087; YLIKOSKI A, 1995, STROKE, V26, P1171, DOI 10.1161/01.STR.26.7.1171	29	34	35	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 8	2013	93	2					197	210		10.1016/j.ajhg.2013.05.027	http://dx.doi.org/10.1016/j.ajhg.2013.05.027			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	202AP	23810381	Green Published, Bronze			2022-12-18	WOS:000323186200001
J	Biesecker, LG				Biesecker, Leslie G.			Incidental Variants Are Critical for Genomics	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INFORMED-CONSENT; PERSPECTIVES; RETURN; DISCLOSURE; RESEARCHER	The topic of incidental variants detected through exome and genome sequencing is controversial, both in clinical practice and in research. The arguments for and against the deliberate analysis and return of incidental variants focus on issues of clinical validity, clinical utility, autonomy, clinical and research infrastructure and costs, and, in the research arena, therapeutic misconception. These topics are briefly reviewed and an argument is made that these variants are the future of genomic medicine. As a field, we should take full advantage of all opportunities to study these variants by searching them out, returning them to patients and research participants, and studying their utility for predictive medicine.	NHGRI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Biesecker, LG (corresponding author), NHGRI, NIH, Bethesda, MD 20892 USA.	leslieb@helix.nih.gov			National Human Genome Research Institute of the National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200359, ZIAHG200387] Funding Source: NIH RePORTER	National Human Genome Research Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The author is grateful to Barbara Biesecker for reviewing a presubmission draft of this manuscript and to the anonymous reviewers for their helpful suggestions. The author is supported by the intramural research program of the National Human Genome Research Institute of the National Institutes of Health. The opinions expressed here are those of the author and do not necessarily reflect the views of the institutions to which he is affiliated. The author is an uncompensated consultant to the Illumina Corporation and receives honoraria from Wiley-Blackwell for editing.	Abdul-Karim R, 2013, PEDIATRICS, V131, P564, DOI 10.1542/peds.2012-0084; Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Berg JS, 2013, GENET MED, V15, P36, DOI 10.1038/gim.2012.112; Christenhusz GM, 2013, EUR J HUM GENET, V21, P248, DOI 10.1038/ejhg.2012.130; Clayton EW, 2008, J LAW MED ETHICS, V36, P286, DOI 10.1111/j.1748-720X.2008.00271.x; Clayton EW, 2012, GENET MED, V14, P473, DOI 10.1038/gim.2012.10; Downing NR, 2013, PATIENT EDUC COUNS, V90, P133, DOI 10.1016/j.pec.2012.09.010; Evans JP, 2012, GENET MED, V14, P358, DOI 10.1038/gim.2012.8; Fabsitz RR, 2010, CIRC-CARDIOVASC GENE, V3, P574, DOI 10.1161/CIRCGENETICS.110.958827; Facio FM, 2011, EUR J HUM GENET, V19, P1213, DOI 10.1038/ejhg.2011.123; Fernandez CV, 2013, GENET MED, V15, P558, DOI 10.1038/gim.2012.183; Fisher R, 2012, GENET MED, V14, P458, DOI 10.1038/gim.2012.6; Fullerton SM, 2012, GENET MED, V14, P424, DOI 10.1038/gim.2012.15; Gliwa C, 2013, AM J BIOETHICS, V13, P32, DOI 10.1080/15265161.2012.754062; Green ED, 2011, NATURE, V470, P204, DOI 10.1038/nature09764; Green R., GENET MED; Green RC, 2012, GENET MED, V14, P405, DOI 10.1038/gim.2012.21; Haga SB, 2012, GENET TEST MOL BIOMA, V16, P193, DOI 10.1089/gtmb.2011.0118; Haga SB, 2012, GENET TEST MOL BIOMA, V16, P21, DOI 10.1089/gtmb.2011.0045; Johnson G, 2012, GENET MED, V14, P444, DOI 10.1038/gim.2012.20; Johnston JJ, 2012, AM J HUM GENET, V91, P97, DOI 10.1016/j.ajhg.2012.05.021; Kohane IS, 2006, JAMA-J AM MED ASSOC, V296, P212, DOI 10.1001/jama.296.2.212; Kohane IS, 2012, GENET MED, V14, P399, DOI 10.1038/gim.2011.68; Kohane IS, 2012, NAT REV DRUG DISCOV, V11, P89, DOI 10.1038/nrd3659; Kruer M, 2006, JAMA-J AM MED ASSOC, V296, P2801, DOI 10.1001/jama.296.23.2801-a; Lawrenz F, 2008, J LAW MED ETHICS, V36, P249, DOI 10.1111/j.1748-720X.2008.00267.x; Lemke AA, 2013, CLIN GENET, V84, P230, DOI 10.1111/cge.12060; Meacham MC, 2010, J EMPIR RES HUM RES, V5, P31, DOI 10.1525/jer.2010.5.3.31; Murphy J, 2009, AM J PUBLIC HEALTH, V99, P2128, DOI 10.2105/AJPH.2008.157099; Nobile H, 2013, EXPERT REV MOL DIAGN, V13, P35, DOI [10.1586/erm.12.116, 10.1586/ERM.12.116]; Ossorio P, 2012, GENET MED, V14, P461, DOI 10.1038/gim.2012.5; Simon C, 2012, J MED ETHICS, V38, P417, DOI 10.1136/medethics-2011-100273; Simon CM, 2011, J EMPIR RES HUM RES, V6, P53, DOI 10.1525/jer.2011.6.4.53; Townsend A, 2012, AM J MED GENET A, V158A, P2519, DOI 10.1002/ajmg.a.35554; Williams JK, 2012, GENET TEST MOL BIOMA, V16, P508, DOI 10.1089/gtmb.2011.0248; Wolf SM, 2012, GENET MED, V14, P355, DOI 10.1038/gim.2012.26; Zawati MH, 2012, GENET MED, V14, P484, DOI 10.1038/gim.2012.13	37	34	34	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 2	2013	92	5					648	651		10.1016/j.ajhg.2013.04.001	http://dx.doi.org/10.1016/j.ajhg.2013.04.001			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	139KY	23643378	Bronze, Green Published			2022-12-18	WOS:000318582800002
J	Machado, LR; Hardwick, RJ; Bowdrey, J; Bogle, H; Knowles, TJ; Sironi, M; Hollox, EJ				Machado, Lee R.; Hardwick, Robert J.; Bowdrey, Jennifer; Bogle, Helen; Knowles, Timothy J.; Sironi, Manuela; Hollox, Edward J.			Evolutionary History of Copy-Number-Variable Locus for the Low-Affinity Fc gamma Receptor: Mutation Rate, Autoimmune Disease, and the Legacy of Helminth Infection	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HYGIENE HYPOTHESIS; GENETIC-VARIATION; NK CELLS; DIVERSITY; POLYMORPHISM; ASSOCIATION; FCGR3B; SUSCEPTIBILITY; EXPRESSION; RECOMBINATION	Both sequence variation and copy-number variation (CNV) of the genes encoding receptors for immunoglobulin G (Fc gamma receptors) have been genetically and functionally associated with a number of autoimmune diseases. However, the molecular nature and evolutionary context of this variation is unknown. Here, we describe the structure of the CNV, estimate its mutation rate and diversity, and place it in the context of the known functional alloantigen variation of these genes. Deletion of Fc gamma receptor IIIB, associated with systemic lupus erythematosus, is a result of independent nonallelic homologous recombination events with a frequency of approximately 0.1%. We also show that pathogen diversity, in particular helminth diversity, has played a critical role in shaping the functional variation at these genes both between mammalian species and between human populations. Positively selected amino acids are involved in the interaction with IgG and include some amino acids that are known polymorphic alloantigens in humans. This supports a genetic contribution to the hygiene hypothesis, which states that past evolution in the context of helminth diversity has left humans with an array of susceptibility alleles for autoimmune disease in the context of a helminth-free environment. This approach shows the link between pathogens and autoimmune disease at the genetic level and provides a strategy for interrogating the genetic variation underlying autoimmune-disease risk and infectious-disease susceptibility.	[Machado, Lee R.; Hardwick, Robert J.; Bowdrey, Jennifer; Bogle, Helen; Hollox, Edward J.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Knowles, Timothy J.] Univ Birmingham, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England; [Sironi, Manuela] Sci Inst IRCCS Eugenio Medea, Bioinformat Lab, I-23852 Bosisio Parini, Italy	University of Leicester; University of Birmingham; IRCCS Eugenio Medea	Hollox, EJ (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.	ejh33@le.ac.uk	Sironi, manuela/K-5633-2016	Sironi, manuela/0000-0002-2267-5266; Hollox, Edward/0000-0002-0115-2298; Machado, Lee/0000-0001-7974-2178	Wellcome Trust [087663]	Wellcome Trust(Wellcome TrustEuropean Commission)	We would like to thank Mark Jobling for access to a capillary-electrophoresis machine and Rita Neumann for helpful discussions. This work was supported by Wellcome Trust grant 087663 to E.J.H.	Abu Bakar S, 2009, P NATL ACAD SCI USA, V106, P853, DOI 10.1073/pnas.0809073106; Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Amigo J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-428; Armour JAL, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1089; Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; BASKAR P, 1990, J IMMUNOL, V144, P2321; Breunis WB, 2009, HUM MUTAT, V30, pE640, DOI 10.1002/humu.20997; Breunis WB, 2008, BLOOD, V111, P1029, DOI 10.1182/blood-2007-03-079913; Bux J, 2008, VOX SANG, V94, P277, DOI 10.1111/j.1423-0410.2007.01031.x; Bux J, 1997, BLOOD, V89, P1027, DOI 10.1182/blood.V89.3.1027; Cann HM, 2002, SCIENCE, V296, P261; deAndres B, 1997, BLOOD, V89, P3826, DOI 10.1182/blood.V89.10.3826.3826_3826_3836; Dunne DW, 2005, NAT REV IMMUNOL, V5, P420, DOI 10.1038/nri1601; Espeli M, 2010, CURR OPIN IMMUNOL, V22, P715, DOI 10.1016/j.coi.2010.10.003; Fanciulli M, 2008, CYTOGENET GENOME RES, V123, P161, DOI 10.1159/000184704; Felsenstein J, 2005, PHYLIP PHYLOGENY INF; Floto RA, 2005, NAT MED, V11, P1056, DOI 10.1038/nm1288; Fu WQ, 2010, AM J HUM GENET, V87, P494, DOI 10.1016/j.ajhg.2010.09.006; Fumagalli M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-264; Fumagalli M, 2009, J EXP MED, V206, P1395, DOI 10.1084/jem.20082779; GARCIAPENARRUBIA P, 1989, J EXP MED, V169, P99, DOI 10.1084/jem.169.1.99; Gaunt TR, 2010, HUM MUTAT, V31, P414, DOI 10.1002/humu.21199; Handley LJL, 2007, TRENDS GENET, V23, P432, DOI 10.1016/j.tig.2007.07.002; Hollox EJ, 2009, HUM MUTAT, V30, P477, DOI 10.1002/humu.20911; HUDSON RR, 1985, GENETICS, V111, P147; Jackson JA, 2009, IMMUNOLOGY, V126, P18, DOI 10.1111/j.1365-2567.2008.03010.x; JEFFREYS AJ, 1990, CELL, V60, P473, DOI 10.1016/0092-8674(90)90598-9; KHALIFE J, 1989, J IMMUNOL, V142, P4422; Khor CC, 2011, NAT GENET, V43, P1241, DOI 10.1038/ng.981; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lindsay SJ, 2006, AM J HUM GENET, V79, P890, DOI 10.1086/508709; McKinney C, 2012, HUM MOL GENET, V21, P2370, DOI 10.1093/hmg/dds039; McKinney C, 2010, ANN RHEUM DIS, V69, P1711, DOI 10.1136/ard.2009.123588; Metes D, 1998, BLOOD, V91, P2369, DOI 10.1182/blood.V91.7.2369.2369_2369_2380; Morris DL, 2010, EUR J HUM GENET, V18, P1027, DOI 10.1038/ejhg.2010.56; Niederer HA, 2010, HUM MOL GENET, V19, P3282, DOI 10.1093/hmg/ddq216; Niederer HA, 2010, ANN NY ACAD SCI, V1183, P69, DOI 10.1111/j.1749-6632.2009.05132.x; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; POULIN R, 1995, ECOL MONOGR, V65, P283, DOI 10.2307/2937061; Pozzoli U, 2010, TRENDS GENET, V26, P95, DOI 10.1016/j.tig.2009.12.010; QIU WQ, 1990, SCIENCE, V248, P732, DOI 10.1126/science.2139735; RAVETCH JV, 1989, J EXP MED, V170, P481, DOI 10.1084/jem.170.2.481; REILLY AF, 1994, IMMUNOGENETICS, V40, P456; Robinson JI, 2012, HUM MUTAT, V33, P741, DOI 10.1002/humu.22031; Rosenberg NA, 2006, ANN HUM GENET, V70, P841, DOI 10.1111/j.1469-1809.2006.00285.x; Sironi M, 2010, MICROBES INFECT, V12, P421, DOI 10.1016/j.micinf.2010.02.002; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stewart-Akers AM, 2004, GENES IMMUN, V5, P521, DOI 10.1038/sj.gene.6364121; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Tenesa A, 2007, GENOME RES, V17, P520, DOI 10.1101/gr.6023607; Willcocks LC, 2010, P NATL ACAD SCI USA, V107, P7881, DOI 10.1073/pnas.0915133107; Wilson IJ, 2003, J R STAT SOC A STAT, V166, P155, DOI 10.1111/1467-985X.00264; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	54	34	35	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 8	2012	90	6					973	985		10.1016/j.ajhg.2012.04.018	http://dx.doi.org/10.1016/j.ajhg.2012.04.018			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	958TC	22608500	Bronze, Green Published			2022-12-18	WOS:000305262600004
J	Christoforou, A; Dondrup, M; Mattingsdal, M; Mattheisen, M; Giddaluru, S; Nothen, MM; Rietschel, M; Cichon, S; Djurovic, S; Andreassen, OA; Jonassen, I; Steen, VM; Puntervoll, P; Le Hellard, S				Christoforou, Andrea; Dondrup, Michael; Mattingsdal, Morten; Mattheisen, Manuel; Giddaluru, Sudheer; Noethen, Markus M.; Rietschel, Marcella; Cichon, Sven; Djurovic, Srdjan; Andreassen, Ole A.; Jonassen, Inge; Steen, Vidar M.; Puntervoll, Pal; Le Hellard, Stephanie			Linkage-Disequilibrium-Based Binning Affects the Interpretation of GWASs	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; HERITABILITY; PATHWAYS; GENETICS; SNPS; SET	Genome-wide association studies (GWASs) are critically dependent on detailed knowledge of the pattern of linkage disequilibrium (LD) in the human genome. GWASs generate lists of variants, usually SNPs, ranked according to the significance of their association to a trait. Downstream analyses generally focus on the gene or genes that are physically closest to these SNPs and ignore their LD profile with other SNPs. We have developed a flexible R package (LDsnpR) that efficiently assigns SNPs to genes on the basis of both their physical position and their pairwise LD with other SNPs. We used the positional-binning and LD-based-binning approaches to investigate whether including these "LD-based" SNPs would affect the interpretation of three published GWASs on bipolar affective disorder (BP) and of the imputed versions of two of these GWASs. We show how including LE) can be important for interpreting and comparing GWASs. In the published, unimputed GWASs, LD-based binning effectively "recovered" 6.1%-8.3% of Ensembl-defined genes. It altered the ranks of the genes and resulted in nonnegligible differences between the lists of the top 2,000 genes emerging from the two binning approaches. It also improved the overall gene-based concordance between independent BP studies. In the imputed datasets, although the increases in coverage (>0.4%) and rank changes were more modest, even greater concordance between the studies was observed, attesting to the potential of LD-based binning on imputed data as well. Thus, ignoring LD can result in the misinterpretation of the GWAS findings and have an impact on subsequent genetic and functional studies.	[Christoforou, Andrea; Giddaluru, Sudheer; Cichon, Sven; Steen, Vidar M.; Le Hellard, Stephanie] Univ Bergen, Dept Clin Med, Dr Einar Martens Res Grp Biol Psychiat, N-5021 Bergen, Norway; [Christoforou, Andrea; Giddaluru, Sudheer; Steen, Vidar M.; Le Hellard, Stephanie] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Dondrup, Michael; Jonassen, Inge; Puntervoll, Pal] Uni Res, Uni Comp, Computat Biol Unit, N-5008 Bergen, Norway; [Mattingsdal, Morten; Djurovic, Srdjan; Andreassen, Ole A.] Univ Oslo, Inst Clin Med, N-0318 Oslo, Norway; [Mattingsdal, Morten] Sorlandet Hosp HF, Res Unit, N-4604 Kristiansand, Norway; [Mattheisen, Manuel; Noethen, Markus M.; Cichon, Sven] Univ Bonn, Life & Brain Ctr, Dept Genom, D-53127 Bonn, Germany; [Mattheisen, Manuel; Noethen, Markus M.; Cichon, Sven] Univ Bonn, Inst Human Genet, D-53127 Bonn, Germany; [Mattheisen, Manuel] Univ Bonn, Inst Genom Math, D-53127 Bonn, Germany; [Mattheisen, Manuel] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Noethen, Markus M.] German Ctr Neurodegenerat Disorders, D-53175 Bonn, Germany; [Rietschel, Marcella] Univ Mannheim, Cent Inst Mental Hlth, Dept Genet Epidemiol Psychiat, D-68159 Mannheim, Germany; [Cichon, Sven] Forschungszentrum Julich, Inst Neurosci & Med, D-52425 Julich, Germany; [Djurovic, Srdjan] Oslo Univ Hosp, Dept Med Genet, N-0424 Oslo, Norway; [Djurovic, Srdjan; Andreassen, Ole A.] Oslo Univ Hosp, Div Mental Hlth & Addict, N-0424 Oslo, Norway; [Jonassen, Inge] Univ Bergen, Dept Informat, N-5008 Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Oslo; University of Bonn; University of Bonn; University of Bonn; Harvard University; Harvard T.H. Chan School of Public Health; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Central Institute of Mental Health; University of Mannheim; Helmholtz Association; Research Center Julich; University of Oslo; University of Oslo; University of Bergen	Christoforou, A (corresponding author), Univ Bergen, Dept Clin Med, Dr Einar Martens Res Grp Biol Psychiat, N-5021 Bergen, Norway.	andrea.christoforou@med.uib.no	Mattingsdal, Morten/Q-9367-2016; Cichon, Sven/H-8803-2013; Cichon, Sven/B-9618-2014; Mattheisen, Manuel/B-4949-2012; mattingsdal, morten/H-6133-2019; Andreassen, Ole A./AAY-7531-2020; Jonassen, Inge/AAC-7035-2020; Mattheisen, Manuel/S-3725-2019	Mattingsdal, Morten/0000-0003-4440-0324; Cichon, Sven/0000-0002-9475-086X; Cichon, Sven/0000-0002-9475-086X; Mattheisen, Manuel/0000-0002-8442-493X; Mattheisen, Manuel/0000-0002-8442-493X; Djurovic, Srdjan/0000-0002-8140-8061; Jonassen, Inge/0000-0003-4110-0748; Dondrup, Michael/0000-0002-2371-5928; Andreassen, Ole A./0000-0002-4461-3568; Le Hellard, Stephanie/0000-0002-8085-051X; Nothen, Markus/0000-0002-8770-2464	Bergen Research Foundation; University of Bergen; Research Council of Norway (FUGE, Psyksik Helse); Research Council of Norway (eVita); UNI Computing; Western Norway Regional Health Authority (Helse Vest); Dr. Einar Martens Fund; South-Eastern Norway Regional Health Authority (Helse Sor-Ost); National Institutes of Health; National Heart, Lung, and Blood Institute [U01 HL089856, RO1 MH087590, R01 MH081862]; German Federal Ministry of Education and Research [01GS08144]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL089856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087590, R01MH081862] Funding Source: NIH RePORTER	Bergen Research Foundation; University of Bergen; Research Council of Norway (FUGE, Psyksik Helse)(Research Council of Norway); Research Council of Norway (eVita)(Research Council of Norway); UNI Computing; Western Norway Regional Health Authority (Helse Vest); Dr. Einar Martens Fund; South-Eastern Norway Regional Health Authority (Helse Sor-Ost); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We acknowledge Isabel Hanson Scientific Writing for critical help with the manuscript preparation. This work was supported by grants from the Bergen Research Foundation, the University of Bergen, the Research Council of Norway (FUGE, Psyksik Helse, and eVita), UNI Computing, Western Norway Regional Health Authority (Helse Vest), the Dr. Einar Martens Fund, South-Eastern Norway Regional Health Authority (Helse Sor-Ost), the National Institutes of Health and the National Heart, Lung, and Blood Institute (U01 HL089856, RO1 MH087590 and R01 MH081862), and the German Federal Ministry of Education and Research (National Genome Research Network 2, the National Genome Research Network plus, and the Integrated Genome Research Network MooDS [grant 01GS08144 to S.C.]). LDsnpR was developed within the eSysbio project. We acknowledge Hakon Sagehaug for contributing Java code and members of the BioStar QA community for their help and interesting discussions.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bergen SE, 2011, PSYCHIAT GENET, V21, P136, DOI 10.1097/YPG.0b013e3283469aa9; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Bondy B, 2011, WORLD J BIOL PSYCHIA, V12, P81, DOI 10.3109/15622975.2010.546428; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cantor RM, 2010, AM J HUM GENET, V86, P6, DOI 10.1016/j.ajhg.2009.11.017; Cichon S, 2011, AM J HUM GENET, V88, P372, DOI [10.1016/j.ajhg.2011.01.017, 10.1016/j.ajhg.2011.03.001]; Davies G, 2011, MOL PSYCHIATR, V16, P996, DOI 10.1038/mp.2011.85; Djurovic S, 2010, J AFFECT DISORDERS, V126, P312, DOI 10.1016/j.jad.2010.04.007; Gershon ES, 2011, AM J PSYCHIAT, V168, P253, DOI 10.1176/appi.ajp.2010.10091340; Gibson G, 2010, NAT GENET, V42, P558, DOI 10.1038/ng0710-558; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Hong MG, 2009, HUM GENET, V126, P289, DOI 10.1007/s00439-009-0676-z; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Ioannidis JPA, 2009, NAT REV GENET, V10, P318, DOI 10.1038/nrg2544; Lawrence R, 2005, GENOME RES, V15, P1503, DOI 10.1101/gr.4217605; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Lehne B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020133; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Neale BM, 2008, AM J MED GENET B, V147B, P1288, DOI 10.1002/ajmg.b.30747; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Santos PSC, 2011, EUR J HUM GENET, V19, P733, DOI 10.1038/ejhg.2010.228; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; So HC, 2011, GENET EPIDEMIOL, V35, P310, DOI 10.1002/gepi.20579; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Stranger BE, 2011, GENETICS, V187, P367, DOI 10.1534/genetics.110.120907; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vandiedonck C, 2011, GENOME RES, V21, P1042, DOI 10.1101/gr.116681.110; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wray NR, 2005, TWIN RES HUM GENET, V8, P87; Zhang KL, 2011, NUCLEIC ACIDS RES, V39, pW437, DOI 10.1093/nar/gkr391	39	34	34	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 6	2012	90	4					727	733		10.1016/j.ajhg.2012.02.025	http://dx.doi.org/10.1016/j.ajhg.2012.02.025			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	926LV	22444669	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000302833400017
J	Ionita-Laza, I; Makarov, V; Yoon, S; Raby, B; Buxbaum, J; Nicolae, DL; Lin, XH				Ionita-Laza, Iuliana; Makarov, Vlad; Yoon, Seungtai; Raby, Benjamin; Buxbaum, Joseph; Nicolae, Dan L.; Lin, Xihong			Finding Disease Variants in Mendelian Disorders By Using Sequence Data: Methods and Applications	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILY-BASED ASSOCIATION; RARE VARIANTS; HUMAN GENOME; COMMON; MUTATIONS; NUMBER; GENES	Many sequencing studies are now underway to identify the genetic causes for both Mendelian and complex traits. Via exome-sequencing, genes harboring variants implicated in several Mendelian traits have already been identified. The underlying methodology in these studies is a multistep algorithm based on filtering variants identified in a small number of affected individuals and depends on whether they are novel (not yet seen in public resources such as dbSNP), shared among affected individuals, and other external functional information on the variants. Although intuitive, these filter-based methods are nonoptimal and do not provide any measure of statistical uncertainty. We describe here a formal statistical approach that has several distinct advantages: (1) it provides fast computation of approximate p values for individual genes, (2) it adjusts for the background variation in each gene, (3) it allows for incorporation of functional or linkage-based information, and (4) it accommodates designs based on both affected relative pairs and unrelated affected individuals. We show via simulations that the proposed approach can be used in conjunction with the existing filter-based methods to achieve a substantially better ranking of a gene relevant for disease when compared to currently used filter-based approaches, this is especially so in the presence of disease locus heterogeneity. We revisit recent studies on three Mendelian diseases and show that the proposed approach results in the implicated gene being ranked first in all studies, and approximate p values of 10(-6) for the Miller Syndrome gene, 1.0 x 10(-4) for the Freeman-Sheldon Syndrome gene, and 3.5 x 10(-5) for the Kabuki Syndrome gene.	[Ionita-Laza, Iuliana] Columbia Univ, Dept Biostat, New York, NY 10032 USA; [Makarov, Vlad; Yoon, Seungtai; Buxbaum, Joseph] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; [Raby, Benjamin] Harvard Univ, Brigham & Womens Hosp, Channing Lab, Sch Med, Boston, MA 02115 USA; [Nicolae, Dan L.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Nicolae, Dan L.] Univ Chicago, Dept Stat, Chicago, IL 60637 USA; [Lin, Xihong] Harvard Univ, Dept Biostat, Boston, MA 02115 USA	Columbia University; Icahn School of Medicine at Mount Sinai; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Chicago; University of Chicago; Harvard University	Ionita-Laza, I (corresponding author), Columbia Univ, Dept Biostat, New York, NY 10032 USA.	ii2135@columbia.edu	Buxbaum, Joseph D/G-6001-2010; Raby, Benjamin/AAK-3866-2021	Nicolae, Dan/0000-0002-0918-4630; Buxbaum, Joseph/0000-0001-8898-8313	National Science Foundation [DMS-1100279]; National Institutes of Health [1R03HG005908]; National Cancer Institute [R37-CA076404, P01-CA134294]; ARRA [MH089025]; NATIONAL CANCER INSTITUTE [P01CA134294, R37CA076404] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R03HG005908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH089025] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1100279] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ARRA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The research was partially supported by National Science Foundation grant DMS-1100279 and National Institutes of Health grant 1R03HG005908 (to I.I.-L.), and grants R37-CA076404 and P01-CA134294 from the National Cancer Institute (to XL.). Control exomes were sequenced as part of an ongoing ARRA-funded autism exome-sequencing grant (MH089025, Mark Daly, communicating principal investigator, Joseph Buxbaum, Bernie Devlin, Richard Gibbs, Gerard Schellenberg, James Sutcliffe, collaborating principal investigators). The authors gratefully acknowledge two referees for their valuable comments that substantially improved the paper.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bhatia G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000954; Chakravarti A, 2011, GENOME RES, V21, P643, DOI 10.1101/gr.123554.111; EFRON B, 1976, BIOMETRIKA, V63, P435, DOI 10.2307/2335721; Fay MP, 1997, STAT MED, V16, P791; Han F, 2010, HUM HERED, V70, P42, DOI 10.1159/000288704; Ionita-Laza I, 2007, AM J HUM GENET, V81, P607, DOI 10.1086/519748; Ionita-Laza I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001289; Ionita-Laza I, 2009, P NATL ACAD SCI USA, V106, P5008, DOI 10.1073/pnas.0807815106; IONITALAZA I, 2011, GENETICS IN PRESS, DOI DOI 10.1534/GENETICS.111.131813; King CR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001202; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; LANGE K, 1974, THEOR POPUL BIOL, V6, P92, DOI 10.1016/0040-5809(74)90033-1; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Rakovski CS, 2007, GENET EPIDEMIOL, V31, P9, DOI 10.1002/gepi.20186; Roeder K, 2006, AM J HUM GENET, V78, P243, DOI 10.1086/500026; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029	27	34	35	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC 9	2011	89	6					701	712		10.1016/j.ajhg.2011.11.003	http://dx.doi.org/10.1016/j.ajhg.2011.11.003			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	864AF	22137099	Green Published, Bronze			2022-12-18	WOS:000298208700002
J	Nousbeck, J; Burger, B; Fuchs-Telem, D; Pavlovsky, M; Fenig, S; Sarig, O; Itin, P; Sprecher, E				Nousbeck, Janna; Burger, Bettina; Fuchs-Telem, Dana; Pavlovsky, Mor; Fenig, Shlomit; Sarig, Ofer; Itin, Peter; Sprecher, Eli			A Mutation in a Skin-Specific Isoform of SMARCAD1 Causes Autosomal-Dominant Adermatoglyphia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DERMAL RIDGE-PATTERNS; EPIDERMAL RIDGES; ABSENCE; FINGERPRINTS; FAMILY; DYSPLASIAS	Monogenic disorders offer unique opportunities for researchers to shed light upon fundamental physiological processes in humans. We investigated a large family affected with autosomal-dominant adermatoglyphia (absence of fingerprints) also known as the "immigration delay disease." Using linkage and haplotype analyses, we mapped the disease phenotype to 4q22. One of the genes located in this interval is SMARCAD1, a member of the SNF subfamily of the helicase protein superfamily. We demonstrated the existence of a short isoform of SMARCAD1 exclusively expressed in the skin. Sequencing of all SMARCAD1 coding and noncoding exons revealed a heterozygous transversion predicted to disrupt a conserved donor splice site adjacent to the 3' end of a noncoding exon uniquely present in the skin-specific short isoform of the gene. This mutation segregated with the disease phenotype throughout the entire family. Using a minigene system, we found that this mutation causes aberrant splicing, resulting in decreased stability of the short RNA isoform as predicted by computational analysis and shown by RT-PCR. Taken together, the present findings implicate a skin-specific isoform of SMARCAD1 in the regulation of dermatoglyph development.	[Nousbeck, Janna; Fuchs-Telem, Dana; Pavlovsky, Mor; Fenig, Shlomit; Sarig, Ofer; Sprecher, Eli] Tel Aviv Sourasky Med Ctr, Dept Dermatol, IL-64239 Tel Aviv, Israel; [Burger, Bettina; Itin, Peter] Univ Basel Hosp, Dept Biomed, CH-4051 Basel, Switzerland; [Itin, Peter] Univ Basel Hosp, Dept Dermatol, CH-4051 Basel, Switzerland; [Fuchs-Telem, Dana; Sprecher, Eli] Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, IL-61390 Ramat Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; University of Basel; University of Basel; Tel Aviv University; Sackler Faculty of Medicine	Sprecher, E (corresponding author), Tel Aviv Sourasky Med Ctr, Dept Dermatol, IL-64239 Tel Aviv, Israel.	elisp@tasmc.health.gov.il		Burger, Bettina/0000-0002-7686-0176				Adra CN, 2000, GENOMICS, V69, P162, DOI 10.1006/geno.2000.6281; Atasu M, 1999, CLIN DYSMORPHOL, V8, P101; Babler W J, 1991, Birth Defects Orig Artic Ser, V27, P95; BAIRD HW, 1968, LANCET, V2, P1250; Basan M, 1965, Arch Klin Exp Dermatol, V222, P546, DOI 10.1007/BF00514755; Bokhari A, 2002, TERATOLOGY, V66, P19, DOI 10.1002/tera.10044; Burger B, 2011, J AM ACAD DERMATOL, V64, P974, DOI 10.1016/j.jaad.2009.11.013; Day DA, 1998, J ENDOCRINOL, V157, P361, DOI 10.1677/joe.0.1570361; Fishelson M., 2002, BIOINFORMATICS, V18, pS189, DOI [10.1093/bioinformatics/18.suppl_1.S189, DOI 10.1093/BIOINFORMATICS/18.SUPPL_1.S189]; LIMOVA M, 1993, J AM ACAD DERMATOL, V29, P355, DOI 10.1016/0190-9622(93)70195-Y; Lugassy J, 2006, AM J HUM GENET, V79, P724, DOI 10.1086/507792; Okazaki N, 2008, J MOL BIOL, V382, P257, DOI 10.1016/j.jmb.2008.07.031; REED T, 1983, AM J MED GENET, V16, P81, DOI 10.1002/ajmg.1320160113; Reed T, 2006, AM J MED GENET A, V140A, P263, DOI 10.1002/ajmg.a.31086; Roca X, 2003, NUCLEIC ACIDS RES, V31, P6321, DOI 10.1093/nar/gkg830; Scheibert J, 2009, SCIENCE, V323, P1503, DOI 10.1126/science.1166467; Schoor M, 1999, MECH DEVELOP, V85, P73, DOI 10.1016/S0925-4773(99)00090-8; Schwartz DC, 1999, MOL CELL BIOL, V19, P5247; Singh G, 2006, BIOTECHNIQUES, V41, P177, DOI 10.2144/000112208; SIRINAVIN C, 1975, J MED GENET, V12, P339, DOI 10.1136/jmg.12.4.339; VERBOV J, 1970, J INVEST DERMATOL, V54, P261, DOI 10.1111/1523-1747.ep12258550; Warman PH, 2009, J EXP BIOL, V212, P2015, DOI 10.1242/jeb.028977	22	34	36	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG 12	2011	89	2					302	307		10.1016/j.ajhg.2011.07.004	http://dx.doi.org/10.1016/j.ajhg.2011.07.004			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	810TA	21820097	Green Published, Bronze			2022-12-18	WOS:000294148800010
J	Abou Jamra, R; Fuerst, R; Kaneva, R; Diaz, GO; Rivas, F; Mayoral, F; Gay, E; Sans, S; Gonzalez, MJ; Gil, S; Cabaleiro, F; del Rio, F; Perez, F; Haro, J; Auburger, G; Milanova, V; Kostov, C; Chorbov, V; Stoyanova, V; Nikolova-Hill, A; Onchev, G; Kremensky, I; Jablensky, A; Schulze, TG; Propping, P; Rietschel, M; Nothen, MM; Cichon, S; Wienker, TF; Schumacher, J				Abou Jamra, Rami; Fuerst, Robert; Kaneva, Radka; Diaz, Guillermo Orozco; Rivas, Fabio; Mayoral, Fermin; Gay, Eudoxia; Sans, Sebastian; Gonzalez, Maria Jose; Gil, Susana; Cabaleiro, Francisco; del Rio, Francisco; Perez, Fermin; Haro, Jesus; Auburger, Georg; Milanova, Vihra; Kostov, Christian; Chorbov, Vesselin; Stoyanova, Vessela; Nikolova-Hill, Amelia; Onchev, George; Kremensky, Ivo; Jablensky, Assen; Schulze, Thomas G.; Propping, Peter; Rietschel, Marcella; Noethen, Markus M.; Cichon, Sven; Wienker, Thomas F.; Schumacher, Johannes			The first genomewide interaction and locus-heterogeneity linkage scan in bipolar affective disorder: Strong evidence of epistatic effects between loci on chromosomes 2q and 6q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NF-KAPPA-B; SUSCEPTIBILITY LOCUS; DYSBINDIN GENE; WIDE SCAN; NATIONAL-INSTITUTE; INCREASE SUSCEPTIBILITY; PUTATIVE LOCI; SCHIZOPHRENIA; SUGGESTS; POLYMORPHISMS	We present the first genomewide interaction and locus-heterogeneity linkage scan in bipolar affective disorder (BPAD), using a large linkage data set (52 families of European descent; 448 participants and 259 affected individuals). Our results provide the strongest interaction evidence between BPAD genes on chromosomes 2q22-q24 and 6q23-q24, which was observed symmetrically in both directions (nonparametric LOD [NPL] scores of 7.55 on 2q and 7.63 on 6q; P < .0001 and P = .0001, respectively, after a genomewide permutation procedure). The second-best BPAD interaction evidence was observed between chromosomes 2q22-q24 and 15q26. Here, we also observed a symmetrical interaction (NPL scores of 6.26 on 2q and 4.59 on 15q; and P = .0057 and .0022, respectively). We covered the implicated regions by genotyping additional marker sets and performed a detailed interaction linkage analysis, which narrowed the susceptibility intervals. Although the heterogeneity analysis produced less impressive results (highest NPL score of 3.32) and a less consistent picture, we achieved evidence of locus heterogeneity at chromosomes 2q, 6p, 11p, 13q, and 22q, which was supported by adjacent markers within each region and by previously reported BPAD linkage findings. Our results provide systematic insights in the framework of BPAD epistasis and locus heterogeneity, which should facilitate gene identification by the use of more-comprehensive cloning strategies.	NIMH, Unit Genet Basis Mood & Anxiety Disorders, Natl Inst Hlth, Bethesda, MD 20892 USA; Cent Inst Mental Hlth, Div Genet Epidemiol Psychiat, D-6800 Mannheim, Germany; Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA 6009, Australia; Community Adolescent Team, Hunter New England Hlth, New Lambton, Australia; Pfalzklinikum, Klin Psychiat & Psychotherapie, Rockenhausen, Germany; Goethe Univ Frankfurt, Neurol Clin, D-6000 Frankfurt, Germany; Mental Hlth Care Ctr Algeciras Cadiz, Cadiz, Spain; Puerto Santamaria Cadiz, La Unidad Rehabil Area, Cadiz, Spain; Mental Hlth Care Ctr San Dionisio Jerez Frontera, Cadiz, Spain; Prov Hosp, Jaen, Spain; Mental Hlth Care Ctr Montoro, Cordoba, Spain; Mental Hlth Care Ctr Lucena, Cordoba, Spain; Univ Hosp Reina Sofia, Cordoba, Spain; Civil Hosp Carlos Haya, Malaga, Spain; Med Univ Sofia, Dept Psychiat, Sofia, Bulgaria; Med Univ Sofia, Natl Genet Lab, Sofia, Bulgaria; Med Univ Sofia, Mol Med Ctr, Sofia, Bulgaria; Univ Cologne, Cologne Ctr Genom, Cologne, Germany; Univ Bonn, Life & Brain Ctr, Dept Genom, D-5300 Bonn, Germany; Univ Bonn, Inst Med Biometry Informat & Epidemiol, D-5300 Bonn, Germany; Univ Bonn, Inst Human Genet, D-5300 Bonn, Germany	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Central Institute of Mental Health; University of Western Australia; Goethe University Frankfurt; Hospital Universitario Reina Sofia - Cordoba; Medical University Sofia; Medical University Sofia; Medical University Sofia; University of Cologne; University of Bonn; University of Bonn; University of Bonn	Schumacher, J (corresponding author), NIMH, Unit Genet Basis Mood & Anxiety Disorders, Natl Inst Hlth, 35 Convent Dr,1A-202, Bethesda, MD 20892 USA.	schumacherj@mail.nih.gov	Cichon, Sven/H-8803-2013; Cichon, Sven/B-9618-2014; Jablensky, Assen/H-5116-2014; Kaneva, Radka P/V-6535-2017; Schulze, Thomas G/H-2157-2013; mayoral, fermin/C-2652-2013; Kaneva, Radka P/AGS-5076-2022; Nöthen, Markus/B-2027-2009; Abou Jamra, Rami/AAC-8192-2019; Kaneva, Radka/AAT-5322-2021; Jamra, Rami Abou/I-2350-2012; Schumacher, Johannes/F-4970-2015; Jamra, Rami Abou/I-4805-2015	Cichon, Sven/0000-0002-9475-086X; Cichon, Sven/0000-0002-9475-086X; Jablensky, Assen/0000-0003-0602-6810; Kaneva, Radka P/0000-0002-1437-1393; Kaneva, Radka P/0000-0002-1437-1393; Nöthen, Markus/0000-0002-8770-2464; Abou Jamra, Rami/0000-0002-1542-1399; Jamra, Rami Abou/0000-0002-1542-1399; Schumacher, Johannes/0000-0001-9217-6457; Jamra, Rami Abou/0000-0002-1542-1399; Onchev, Georgi/0000-0002-5139-5917; Mayoral-Cleries, Fermin/0000-0002-9710-9672				American Psychiatric Association DSM-IV, 1994, DSM 4 DIAGN STAT MAN; Badner JA, 2002, MOL PSYCHIATR, V7, P405, DOI 10.1038/sj.mp.4001012; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bjornsson A, 2003, AM J HUM GENET, V73, P986, DOI 10.1086/378417; Bournat JC, 2000, J NEUROSCI RES, V61, P21, DOI 10.1002/1097-4547(20000701)61:1<21::AID-JNR3>3.0.CO;2-7; Breen G, 2006, AM J PSYCHIAT, V163, P1636, DOI 10.1176/appi.ajp.163.9.1636; Carlson CS, 2004, NATURE, V429, P446, DOI 10.1038/nature02623; Cheng R, 2006, MOL PSYCHIATR, V11, P252, DOI 10.1038/sj.mp.4001778; Cichon S, 2001, HUM MOL GENET, V10, P2933, DOI 10.1093/hmg/10.25.2933; Cox NJ, 1999, NAT GENET, V21, P213, DOI 10.1038/6002; Craddock N, 1999, J MED GENET, V36, P585, DOI 10.1136/jmg.36.8.585; Craddock N, 2006, EUR J HUM GENET, V14, P660, DOI 10.1038/sj.ejhg.5201549; Detera-Wadleigh SD, 1999, P NATL ACAD SCI USA, V96, P5604, DOI 10.1073/pnas.96.10.5604; Ewald H, 2002, MOL PSYCHIATR, V7, P734, DOI 10.1038/sj.mp.4001074; Ewald H, 2003, AM J MED GENET B, V120B, P63, DOI 10.1002/ajmg.b.20039; Fallin MD, 2004, AM J HUM GENET, V75, P204, DOI 10.1086/422474; Frankel WN, 1996, NAT GENET, V14, P371, DOI 10.1038/ng1296-371; Gudbjartsson DF, 2005, NAT GENET, V37, P1015, DOI 10.1038/ng1005-1015; Holmans P, 2004, AM J HUM GENET, V74, P1154, DOI 10.1086/421333; Holmans P, 2007, AM J PSYCHIAT, V164, P248, DOI 10.1176/appi.ajp.164.2.248; Joo EJ, 2007, NEUROSCI LETT, V418, P272, DOI 10.1016/j.neulet.2007.03.037; Kaufman KR, 2005, INT CLIN PSYCHOPHARM, V20, P239, DOI 10.1097/00004850-200507000-00008; Kelsoe JR, 2001, P NATL ACAD SCI USA, V98, P585, DOI 10.1073/pnas.011358498; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Lee YA, 2000, AM J HUM GENET, V67, P1020, DOI 10.1086/303075; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; Liu HC, 2004, J NEUROIMMUNOL, V150, P116, DOI 10.1016/j.jneuroim.2004.01.006; Maes M, 1999, PSYCHOPHARMACOLOGY, V143, P401, DOI 10.1007/s002130050965; Maziade M, 2005, MOL PSYCHIATR, V10, P486, DOI 10.1038/sj.mp.4001594; McInnis MG, 2003, BIOL PSYCHIAT, V54, P1265, DOI 10.1016/j.biopsych.2003.08.001; McQueen MB, 2005, AM J HUM GENET, V77, P582, DOI 10.1086/491603; Middleton FA, 2004, AM J HUM GENET, V74, P886, DOI 10.1086/420775; Nemeth ZH, 2002, J BIOL CHEM, V277, P7713, DOI 10.1074/jbc.M109711200; O'Brien SM, 2006, J AFFECT DISORDERS, V90, P263, DOI 10.1016/j.jad.2005.11.015; Ophoff RA, 2002, AM J HUM GENET, V71, P565, DOI 10.1086/342291; Pae CU, 2007, AM J MED GENET B, V144B, P701, DOI 10.1002/ajmg.b.30439; Park N, 2004, MOL PSYCHIATR, V9, P1091, DOI 10.1038/sj.mp.4001541; Raybould R, 2005, BIOL PSYCHIAT, V57, P696, DOI 10.1016/j.biopsych.2005.01.018; Rice JP, 1997, AM J MED GENET, V74, P247, DOI 10.1002/(SICI)1096-8628(19970531)74:3<247::AID-AJMG3>3.0.CO;2-N; Schulze TG, 2004, BIOL PSYCHIAT, V56, P18, DOI 10.1016/j.biopsych.2004.04.004; Schumacher J, 2005, AM J HUM GENET, V77, P1102, DOI 10.1086/498619; Segurado R, 2003, AM J HUM GENET, V73, P49, DOI 10.1086/376547; Shaw SH, 2003, MOL PSYCHIATR, V8, P558, DOI 10.1038/sj.mp.4001267; Vazza G, 2007, MOL PSYCHIATR, V12, P87, DOI 10.1038/sj.mp.4001895; Venken T, 2005, AM J HUM GENET, V76, P237, DOI 10.1086/427836	45	34	34	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2007	81	5					974	986		10.1086/521690	http://dx.doi.org/10.1086/521690			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	224XE	17924339	Green Published, Bronze			2022-12-18	WOS:000250480900009
J	Jiang, R; Yang, H; Zhou, LQ; Kuo, CCJ; Sun, FZ; Chen, T				Jiang, Rui; Yang, Hua; Zhou, Linqi; Kuo, C.-C. Jay; Sun, Fengzhu; Chen, Ting			Sequence-based prioritization of nonsynonymous single-nucleotide polymorphisms for the study of disease mutations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FUNCTIONAL CONSEQUENCES; LAC REPRESSOR; GENE; HEMOGLOBIN; PREDICTION; RECEPTOR; DATABASE; SEATTLE; VARIANT; FAMILY	The increasing demand for the identification of genetic variation responsible for common diseases has translated into a need for sophisticated methods for effectively prioritizing mutations occurring in disease-associated genetic regions. In this article, we prioritize candidate nonsynonymous single-nucleotide polymorphisms (nsSNPs) through a bioinformatics approach that takes advantages of a set of improved numeric features derived from protein-sequence information and a new statistical learning model called "multiple selection rule voting" (MSRV). The sequence-based features can maximize the scope of applications of our approach, and the MSRV model can capture subtle characteristics of individual mutations. Systematic validation of the approach demonstrates that this approach is capable of prioritizing causal mutations for both simple monogenic diseases and complex polygenic diseases. Further studies of familial Alzheimer diseases and diabetes show that the approach can enrich mutations underlying these polygenic diseases among the top of candidate mutations. Application of this approach to unclassified mutations suggests that there are 10 suspicious mutations likely to cause diseases, and there is strong support for this in the literature.	Univ So Calif, Dept Elect Engn, Signal & Image Proc Inst, Los Angeles, CA 90089 USA; Univ So Calif, Dept Elect Engn, Mol & Computat Biol Program, Los Angeles, CA 90089 USA; Tsinghua Univ, Dept Automat, Beijing 100084, Peoples R China; Tsinghua Univ, Tsinghua Natl Lab Informat Sci & Technol, Bioinformat Div, Beijing 100084, Peoples R China	University of Southern California; University of Southern California; Tsinghua University; Tsinghua University	Chen, T (corresponding author), MCB 201,1050 Childs Way, Los Angeles, CA 90089 USA.	tingchen@usc.edu	Kuo, C.-C. Jay/A-7110-2011; Sun, Fengzhu/G-4373-2010; Jiang, Rui/B-1345-2012	Kuo, C.-C. Jay/0000-0001-9474-5035; Sun, Fengzhu/0000-0002-8552-043X; Jiang, Rui/0000-0002-7533-3753	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002790] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM008991] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Aerts S, 2006, NAT BIOTECHNOL, V24, P719, DOI 10.1038/nbt0606-719d; Agarwal AK, 2002, J CLIN ENDOCR METAB, V87, P408, DOI 10.1210/jc.87.1.408; Agostini M, 2006, CELL METAB, V4, P303, DOI 10.1016/j.cmet.2006.09.003; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929; Balasubramanian S, 2005, NUCLEIC ACIDS RES, V33, P1710, DOI 10.1093/nar/gki311; Bao L, 2005, BIOINFORMATICS, V21, P2185, DOI 10.1093/bioinformatics/bti365; Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; Berg JM., 2002, BIOCHEMISTRY; Birney E, 2006, NUCLEIC ACIDS RES, V34, pD556, DOI 10.1093/nar/gkj133; Blazej RG, 2006, P NATL ACAD SCI USA, V103, P7240, DOI 10.1073/pnas.0602476103; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 2017, CLASSIFICATION REGRE; Chasman D, 2001, J MOL BIOL, V307, P683, DOI 10.1006/jmbi.2001.4510; CHOW EY, 1994, HEMOGLOBIN, V18, P231, DOI 10.3109/03630269409043624; Durbin R, 1998, BIOL SEQUENCE ANAL P; Fan RE, 2005, J MACH LEARN RES, V6, P1889; Ferrer-Costa C, 2004, PROTEINS, V57, P811, DOI 10.1002/prot.20252; Ferrer-Costa C, 2002, J MOL BIOL, V315, P771, DOI 10.1006/jmbi.2001.5255; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Gelhaus A, 2001, HUM MUTAT, V18, P444, DOI 10.1002/humu.1215; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; Hatta Y, 1999, IMMUNOGENETICS, V49, P280, DOI 10.1007/s002510050494; Hegele RA, 2002, DIABETES, V51, P3586, DOI 10.2337/diabetes.51.12.3586; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; HUEHNS ER, 1970, BLOOD-J HEMATOL, V36, P209, DOI 10.1182/blood.V36.2.209.209; Jiang R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-417; Krishnan VG, 2003, BIOINFORMATICS, V19, P2199, DOI 10.1093/bioinformatics/btg297; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Lau AY, 2004, P NATL ACAD SCI USA, V101, P6576, DOI 10.1073/pnas.0305043101; LEVITT M, 1978, BIOCHEMISTRY-US, V17, P4277, DOI 10.1021/bi00613a026; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MARKIEWICZ P, 1994, J MOL BIOL, V240, P421, DOI 10.1006/jmbi.1994.1458; MERAULT G, 1986, HEMOGLOBIN, V10, P593, DOI 10.3109/03630268609036564; Mitchell M. T., 1997, MACHINE LEARNING; MOOPENN WF, 1981, AM J HEMATOL, V11, P137, DOI 10.1002/ajh.2830110204; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; OHBA Y, 1983, HEMOGLOBIN, V7, P47, DOI 10.3109/03630268309038400; POLLAK MR, 1994, NAT GENET, V8, P303, DOI 10.1038/ng1194-303; Quinlan JR, 1993, C4 5 PROGRAMS MACHIN; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; RENNELL D, 1991, J MOL BIOL, V222, P67, DOI 10.1016/0022-2836(91)90738-R; Saunders CT, 2002, J MOL BIOL, V322, P891, DOI 10.1016/S0022-2836(02)00813-6; Stamatoyannopoulos G, 1969, N Engl J Med, V281, P916; Suckow J, 1996, J MOL BIOL, V261, P509, DOI 10.1006/jmbi.1996.0479; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Thomas PD, 2004, P NATL ACAD SCI USA, V101, P15398, DOI 10.1073/pnas.0404380101; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Uckun-Kitapci A, 2005, AM J MED GENET A, V132A, P125, DOI 10.1002/ajmg.a.30403; Verzilli CJ, 2005, J R STAT SOC C-APPL, V54, P191, DOI 10.1111/j.1467-9876.2005.00478.x; Yue P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-166	57	34	37	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2007	81	2					346	360		10.1086/519747	http://dx.doi.org/10.1086/519747			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	197FQ	17668383	Green Published, Bronze			2022-12-18	WOS:000248540400013
J	Leach, NT; Sun, Y; Michaud, S; Zheng, Y; Ligon, KL; Ligon, AH; Sander, T; Korf, BR; Lu, WN; Harris, DJ; Gusella, JF; Maas, RL; Quade, BJ; Cole, AJ; Kelz, MB; Morton, CC				Leach, Natalia T.; Sun, Yi; Michaud, Sebastien; Zheng, Yi; Ligon, Keith L.; Ligon, Azra H.; Sander, Thomas; Korf, Bruce R.; Lu, Weining; Harris, David J.; Gusella, James F.; Maas, Richard L.; Quade, Bradley J.; Cole, Andrew J.; Kelz, Max B.; Morton, Cynthia C.			Disruption of diacylglycerol kinase delta (DGKD) associated with seizures in humans and mice	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FUNCTIONAL-CHARACTERIZATION; PARTIAL EPILEPSY; MUTATIONS; SUSCEPTIBILITY; RECEPTOR; FEBRILE; GENE; STIMULATION; DELETION; CHANNEL	We report a female patient with a de novo balanced translocation, 46, X, t(X;2)(p11.2;q37)dn, who exhibits seizures, capillary abnormality, developmental delay, infantile hypotonia, and obesity. The 2q37 breakpoint observed in association with the seizure phenotype is of particular interest, because it lies near loci implicated in epilepsy in humans and mice. Fluorescence in situ hybridization mapping of the translocation breakpoints showed that no known genes are disrupted at Xp11.2, whereas diacylglycerol kinase delta (DGKD) is disrupted at 2q37. Expression studies in Drosophila and mouse suggest that DGKD is involved in central nervous system development and function. Electroencephalographic assessment of Dgkd mutant mice revealed abnormal epileptic discharges and electrographic seizures in three of six homozygotes. These findings implicate DGKD disruption by the t( X; 2)( p11.2; q37) dn in the observed phenotype and support a more general role for DGKD in the etiology of seizures.	Brigham & Womens Hosp, Dept Obstet, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Gynecol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Reprod Biol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Cambridge, MA 02138 USA; Massachusetts Gen Hosp, Epilepsy Serv, Boston, MA 02114 USA; Massachusetts Gen Hosp, Epilepsy Res Lab, Boston, MA 02114 USA; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; Boston Univ, Ctr Med, Dept Med, Boston, MA 02215 USA; Childrens Hosp, Div Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; CRCHUL, Unite Rech Pediat, Quebec City, PQ, Canada; Max Delbruck Ctr, GMC, Berlin, Germany; Univ Alabama, Dept Genet, Tuscaloosa, AL 35487 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Boston University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Pennsylvania; Laval University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Alabama System; University of Alabama Tuscaloosa	Morton, CC (corresponding author), Brigham & Womens Hosp, Dept Obstet, 77 Ave Louis Pasteur,NRB160, Boston, MA 02115 USA.	cmorton@partners.org	Kelz, Max/E-4054-2010; Korf, Bruce R/H-4882-2012	Kelz, Max/0000-0002-2803-6078; Ligon, Keith/0000-0002-7733-600X; Lu, Weining/0000-0002-6570-3044	NCI NIH HHS [P30 CA06516, P30 CA006516] Funding Source: Medline; NICHD NIH HHS [F32 HD043627, F32 HD43627] Funding Source: Medline; NIGMS NIH HHS [K08 GM077357, P01 GM061354] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD043627] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA006516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061354, K08GM077357] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Baldanzi G, 2004, ONCOGENE, V23, P4828, DOI 10.1038/sj.onc.1207633; Bertrand D, 2002, EPILEPSIA, V43, P112, DOI 10.1046/j.1528-1157.43.s.5.16.x; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; Bijlsma EK, 1999, J MED GENET, V36, P604; Bordi F, 1999, PROG NEUROBIOL, V59, P55, DOI 10.1016/S0301-0082(98)00095-1; Carmeliet P, 2003, NAT REV GENET, V4, P710, DOI 10.1038/nrg1158; CONRAD B, 1995, CLIN GENET, V48, P134; Crotty T, 2006, P NATL ACAD SCI USA, V103, P15485, DOI 10.1073/pnas.0604104103; de Turco EBR, 2001, P NATL ACAD SCI USA, V98, P4740, DOI 10.1073/pnas.081536298; Dietrich A, 2005, PFLUG ARCH EUR J PHY, V451, P72, DOI 10.1007/s00424-005-1460-0; Eerola I, 2003, AM J HUM GENET, V73, P1240, DOI 10.1086/379793; Escayg A, 2001, AM J HUM GENET, V68, P866, DOI 10.1086/319524; Ferraro TN, 1999, J NEUROSCI, V19, P6733, DOI 10.1523/JNEUROSCI.19-16-06733.1999; FISHER AM, 1994, AM J MED GENET, V53, P366, DOI 10.1002/ajmg.1320530412; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; Hirose S, 2005, EPILEPSIA, V46, P38, DOI 10.1111/j.0013-9580.2005.461011.x; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Jallon P, 2005, EPILEPSIA, V46, P10, DOI 10.1111/j.1528-1167.2005.00309.x; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Kalachikov S, 2002, NAT GENET, V30, P335, DOI 10.1038/ng832; Kranenburg O, 2004, BBA-REV CANCER, V1654, P23, DOI 10.1016/j.bbcan.2003.09.004; Nakayama J, 2002, ANN NEUROL, V52, P654, DOI 10.1002/ana.10347; Okada T, 1999, J BIOL CHEM, V274, P27359, DOI 10.1074/jbc.274.39.27359; Pacheco MA, 1996, PROG NEUROBIOL, V50, P255, DOI 10.1016/S0301-0082(96)00035-4; PAVLIDIS P, 1994, CELL, V79, P23, DOI 10.1016/0092-8674(94)90397-2; Sakane F, 2002, J BIOL CHEM, V277, P43519, DOI 10.1074/jbc.M206895200; Sander T, 2000, HUM MOL GENET, V9, P1465, DOI 10.1093/hmg/9.10.1465; Scheffer IE, 1998, ANN NEUROL, V44, P890, DOI 10.1002/ana.410440607; Stromme P, 2002, NAT GENET, V30, P441, DOI 10.1038/ng862; Suzuki T, 2004, NAT GENET, V36, P842, DOI 10.1038/ng1393; van Blitterswijk WJ, 2000, CELL SIGNAL, V12, P595, DOI 10.1016/S0898-6568(00)00113-3; Wallace RH, 2001, NAT GENET, V28, P49, DOI 10.1038/88259; WALLEN B, 1998, ACOM, V1, P1; Wenger SL, 1997, CLIN GENET, V51, P290; YOUNG RS, 1983, J MED GENET, V20, P199, DOI 10.1136/jmg.20.3.199	36	34	36	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2007	80	4					792	799		10.1086/513019	http://dx.doi.org/10.1086/513019			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	153VV	17357084	Bronze, Green Published			2022-12-18	WOS:000245465200019
J	Mirault, ME; Boucher, P; Tremblay, A				Mirault, Marc-Edouard; Boucher, Patrick; Tremblay, Alain			Nucleotide-resolution mapping of topoisomerase-mediated and apoptotic DNA strand scissions at or near an MLL translocation hotspot	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BREAKPOINT CLUSTER REGION; ACUTE MYELOID-LEUKEMIA; II CLEAVAGE; CHROMOSOME TRANSLOCATIONS; GENOMIC BREAKPOINTS; GENE; SITES; RECOMBINATION; COMPLEXES; ETOPOSIDE	The emergence of therapy-related acute myeloid leukemia (t-AML) has been associated with DNA topoisomerase II (TOP2)-targeted drug treatments and chromosomal translocations frequently involving the MLL, or ALL-1, gene. Two distinct mechanisms have been implicated as potential triggers of t-AML translocations: TOP2-mediated DNA cleavage and apoptotic higher-order chromatin fragmentation. Assessment of the role of TOP2 in this process has been hampered by a lack of techniques allowing in vivo mapping of TOP2-mediated DNA cleavage at nucleotide resolution in single-copy genes. A novel method, extension ligation-mediated polymerase chain reaction (ELMPCR), was used here for mapping topoisomerase-mediated DNA strand breaks and apoptotic DNA cleavage across a translocation-prone region of MLL in human cells. We report the first genomic map integrating translocation breakpoints and topoisomerase I, TOP2, and apoptotic DNA cleavage sites at nucleotide resolution across an MLL region harboring a t-AML translocation hotspot. This hotspot is flanked by a TOP2 cleavage site and is localized at one extremity of a minor apoptotic cleavage region, where multiple single- and double-strand breaks were induced by caspase-activated apoptotic nucleases. This cleavage pattern was in sharp contrast to that observed similar to 200 bp downstream in the exon 12 region, which displayed much stronger apoptotic cleavage but where no double-strand breaks were detected and no t-AML-associated breakpoints were reported. The localization and remarkable clustering of the t-AML breakpoints cannot be explained simply by the DNA cleavage patterns but might result from potential interactions between TOP2 poisoning, apoptotic DNA cleavage, and DNA repair attempts at specific sites of higher-order chromatin structure in apoptosis-evading cells. ELMPCR provides a new tool for investigating the role of DNA topoisomerases in fundamental genetic processes and translocations associated with cancer treatments involving topoisomerase-targeted drugs.	CHU Laval, Unite Sante & Environm, Ctr Rech, CHU Quebec, Quebec City, PQ G1V 4G2, Canada; Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University	Mirault, ME (corresponding author), CHU Laval, Unite Sante & Environm, Ctr Rech, CHU Quebec, Local 9700,2705 Blvd Laurier, Quebec City, PQ G1V 4G2, Canada.	memirault@crchul.ulaval.ca						Angers M, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.16.e83; Aplan PD, 1996, BLOOD, V87, P2649, DOI 10.1182/blood.V87.7.2649.bloodjournal8772649; Betti CJ, 2003, CANCER RES, V63, P1377; Betti CJ, 2001, CANCER RES, V61, P4550; Borgnetto ME, 1999, J MOL BIOL, V285, P545, DOI 10.1006/jmbi.1998.2330; Broeker PLS, 1996, BLOOD, V87, P1912, DOI 10.1182/blood.V87.5.1912.bloodjournal8751912; Bromberg KD, 2003, J BIOL CHEM, V278, P7406, DOI 10.1074/jbc.M212056200; Bromberg KD, 2001, BIOCHEMISTRY-US, V40, P8410, DOI 10.1021/bi010681q; BUGG BY, 1991, P NATL ACAD SCI USA, V88, P7654, DOI 10.1073/pnas.88.17.7654; CAPRANICO G, 1990, NUCLEIC ACIDS RES, V18, P4553, DOI 10.1093/nar/18.15.4553; Corral J, 1996, CELL, V85, P853, DOI 10.1016/S0092-8674(00)81269-6; DANKS MK, 1988, BIOCHEMISTRY-US, V27, P8861, DOI 10.1021/bi00424a026; Drouin R, 2000, METH MOL B, V148, P175; Durrieu F, 2000, CURR BIOL, V10, P923, DOI 10.1016/S0960-9822(00)00620-5; Felix CA, 1998, BBA-GENE STRUCT EXPR, V1400, P233, DOI 10.1016/S0167-4781(98)00139-0; Furuta T, 2003, J BIOL CHEM, V278, P20303, DOI 10.1074/jbc.M300198200; Gillert E, 1999, ONCOGENE, V18, P4663, DOI 10.1038/sj.onc.1202842; GRIMALDI KA, 1994, NUCLEIC ACIDS RES, V22, P2311, DOI 10.1093/nar/22.12.2311; GU Y, 1994, CANCER RES, V54, P2327; HSIANG YH, 1989, CANCER RES, V49, P5077; Joel SP, 1996, J CLIN ONCOL, V14, P257, DOI 10.1200/JCO.1996.14.1.257; KAS E, 1992, EMBO J, V11, P705, DOI 10.1002/j.1460-2075.1992.tb05103.x; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Komura J, 1998, NUCLEIC ACIDS RES, V26, P1807, DOI 10.1093/nar/26.7.1807; Langer T, 2003, GENE CHROMOSOME CANC, V36, P393, DOI 10.1002/gcc.10167; LIU LF, 1989, ANNU REV BIOCHEM, V58, P351, DOI 10.1146/annurev.bi.58.070189.002031; LONG BH, 1985, CANCER RES, V45, P3106; Lovett BD, 2001, P NATL ACAD SCI USA, V98, P9802, DOI 10.1073/pnas.171309898; Meyer C, 2005, P NATL ACAD SCI USA, V102, P449, DOI 10.1073/pnas.0406994102; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Nilson I, 1996, BRIT J HAEMATOL, V93, P966, DOI 10.1046/j.1365-2141.1996.d01-1748.x; OSHEROFF N, 1989, BIOCHEMISTRY-US, V28, P6157, DOI 10.1021/bi00441a005; Patenaude A, 2004, J BIOL CHEM, V279, P27302, DOI 10.1074/jbc.M402496200; PEDERSENBJERGAARD J, 1994, BLOOD, V83, P2780, DOI 10.1182/blood.V83.10.2780.2780; Pfeifer GP, 1996, MOL BIOTECHNOL, V5, P281, DOI 10.1007/BF02900367; Pourquier P, 1997, J BIOL CHEM, V272, P26441, DOI 10.1074/jbc.272.42.26441; Pui CH, 2000, BRIT J HAEMATOL, V109, P13, DOI 10.1046/j.1365-2141.2000.01843.x; Raffini LJ, 2002, P NATL ACAD SCI USA, V99, P4568, DOI 10.1073/pnas.062066799; Reichel M, 2001, ONCOGENE, V20, P2900, DOI 10.1038/sj.onc.1204401; Rowley JD, 2001, NAT REV CANCER, V1, P245, DOI 10.1038/35106108; Rowley JD, 2002, GENE CHROMOSOME CANC, V33, P331, DOI 10.1002/gcc.10040; Rowley JD, 1998, ANNU REV GENET, V32, P495, DOI 10.1146/annurev.genet.32.1.495; Sordet O, 2004, J BIOL CHEM, V279, P50499, DOI 10.1074/jbc.M410277200; Sordet O, 2004, J BIOL CHEM, V279, P33968, DOI 10.1074/jbc.M404620200; Sordet Olivier, 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P271, DOI 10.2174/1568011033482378; Stanulla M, 1997, MOL CELL BIOL, V17, P4070, DOI 10.1128/MCB.17.7.4070; Strissel PL, 2000, HUM MOL GENET, V9, P1671, DOI 10.1093/hmg/9.11.1671; Strissel PL, 1998, BLOOD, V92, P3793, DOI 10.1182/blood.V92.10.3793.422a24_3793_3803; UDVARDY A, 1991, MOL CELL BIOL, V11, P4973, DOI 10.1128/MCB.11.10.4973; Vaughan ATM, 2002, APOPTOSIS, V7, P173, DOI 10.1023/A:1014374717773; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; Whitmarsh RJ, 2003, ONCOGENE, V22, P8448, DOI 10.1038/sj.onc.1207052; Zhang YM, 2004, GENE CHROMOSOME CANC, V41, P257, DOI 10.1002/gcc.20077	53	34	34	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2006	79	5					779	791		10.1086/507791	http://dx.doi.org/10.1086/507791			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	100KJ	17033956	Green Published, Bronze			2022-12-18	WOS:000241667400001
J	Miyake, N; Kurotaki, N; Sugawara, H; Shimokawa, O; Harada, N; Kondoh, T; Tsukahara, M; Ishikiriyama, S; Sonoda, T; Miyoshi, Y; Sakazume, S; Fukushima, Y; Ohashi, H; Nagai, T; Kawame, H; Kurosawa, K; Touyama, M; Shiihara, T; Okamoto, N; Nishimoto, J; Yoshiura, K; Ohta, T; Kishino, T; Niikawa, N; Matsumoto, N				Miyake, N; Kurotaki, N; Sugawara, H; Shimokawa, O; Harada, N; Kondoh, T; Tsukahara, M; Ishikiriyama, S; Sonoda, T; Miyoshi, Y; Sakazume, S; Fukushima, Y; Ohashi, H; Nagai, T; Kawame, H; Kurosawa, K; Touyama, M; Shiihara, T; Okamoto, N; Nishimoto, J; Yoshiura, K; Ohta, T; Kishino, T; Niikawa, N; Matsumoto, N			Preferential paternal origin of microdeletions caused by prezygotic chromosome or chromatid rearrangements in Sotos syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WOLF-HIRSCHHORN-SYNDROME; UNEQUAL MEIOTIC CROSSOVERS; SPINAL MUSCULAR-ATROPHY; DISEASE TYPE 1A; PARENTAL ORIGIN; 7Q11.23 DELETIONS; WILLIAMS-SYNDROME; ELASTIN GENE; DUPLICATION; MECHANISMS	Sotos syndrome (SoS) is characterized by pre- and postnatal overgrowth with advanced bone age; a dysmorphic face with macrocephaly and pointed chin; large hands and feet; mental retardation; and possible susceptibility to tumors. It has been shown that the major cause of SoS is haploinsufficiency of the NSD1 gene at 5q35, because the majority of patients had either a common microdeletion including NSD1 or a truncated type of point mutation in NSD1. In the present study, we traced the parental origin of the microdeletions in 26 patients with SoS by the use of 16 microsatellite markers at or flanking the commonly deleted region. Deletions in 18 of the 20 informative cases occurred in the paternally derived chromosome 5, whereas those in the maternally derived chromosome were found in only two cases. Haplotyping analysis of the marker loci revealed that the paternal deletion in five of seven informative cases and the maternal deletion in one case arose through an intrachromosomal rearrangement, and two other cases of the paternal deletion involved an interchromosomal event, suggesting that the common microdeletion observed in SoS did not occur through a uniform mechanism but preferentially arose prezygotically.	Nagasaki Univ, Sch Med, Dept Human Genet, Nagasaki 8528523, Japan; Nagasaki Univ, Sch Med, Dept Pediat, Nagasaki 8528523, Japan; Nagasaki Univ, Ctr Gene Res, Nagasaki 8528523, Japan; Kyushu Med Sci Nagasaki Lab, Nagasaki, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi, Japan; Yamagata Univ, Sch Med, Dept Orthoped, Yamagata 99023, Japan; Yamagata Univ, Sch Med, Dept Pediat, Yamagata 99023, Japan; Yamaguchi Univ, Sch Med, Fac Hlth Sci, Ube, Yamaguchi 755, Japan; Chiba Childrens Hosp, Div Med Genet, Chiba, Japan; Miyazaki Med Coll, Dept Pediat, Miyazaki 88916, Japan; Osaka Univ, Grad Sch Med, Dept Dev Med Pediat, Suita, Osaka, Japan; Shinshu Univ, Sch Med, Dept Hyg & Med Genet, Matsumoto, Nagano 390, Japan; Saitama Childrens Med Ctr, Div Med Genet, Saitama, Japan; Dokkyo Univ, Sch Med, Koshigaya Hosp, Dept Pediat, Koshigaya, Japan; Nagano Children Hosp, Div Med Genet, Nagano, Japan; Kanagawa Childrens Med Ctr, Div Med Genet, Yokohama, Kanagawa, Japan; Okinawa Child Dev Ctr, Okinawa, Japan; Osaka Med Ctr, Dept Planning & Res, Osaka, Japan; Res Inst Maternal & Child Hlth, Osaka, Japan; Mutual Aid Assoc Publ Sch Teachers, Kinki Cent Hosp, Dept Pediat, Itami, Hyogo, Japan	Nagasaki University; Nagasaki University; Nagasaki University; Japan Science & Technology Agency (JST); Yamagata University; Yamagata University; Yamaguchi University; Chiba Children's Hospital; University of Miyazaki; Osaka University; Shinshu University; Saitama Children's Medical Center; Dokkyo Medical University; Osaka Medical Center for Cancer & Cardiovascular Diseases	Matsumoto, N (corresponding author), Nagasaki Univ, Sch Med, Dept Human Genet, Sakamoto 1-12-4, Nagasaki 8528523, Japan.		Kurosawa, Kenji/B-6561-2016	Kurosawa, Kenji/0000-0002-6817-7748; Shiihara, Takashi/0000-0002-0852-7451				Baumer A, 1998, HUM MOL GENET, V7, P887, DOI 10.1093/hmg/7.5.887; Bort S, 1997, AM J HUM GENET, V60, P230; BRZUSTOWICZ LM, 1994, AM J HUM GENET, V54, P482; Carrozzo R, 1997, AM J HUM GENET, V61, P228, DOI 10.1086/513907; CHANDLEY AC, 1991, J MED GENET, V28, P217, DOI 10.1136/jmg.28.4.217; COLE TRP, 1994, J MED GENET, V31, P20, DOI 10.1136/jmg.31.1.20; Correa CL, 2000, AM J HUM GENET, V66, P1969, DOI 10.1086/302920; Douglas J, 2003, AM J HUM GENET, V72, P132, DOI 10.1086/345647; Dutly F, 1996, HUM MOL GENET, V5, P1893, DOI 10.1093/hmg/5.12.1893; Kurotaki N, 2002, NAT GENET, V30, P365, DOI 10.1038/ng863; Lazaro C, 1996, HUM GENET, V98, P696, DOI 10.1007/s004390050287; LEDBETTER DH, 1995, HUM MOL GENET, V4, P1757, DOI 10.1093/hmg/4.suppl_1.1757; Lopes J, 1997, NAT GENET, V17, P136, DOI 10.1038/ng1097-136; Mainardi PC, 2001, J MED GENET, V38, P151, DOI 10.1136/jmg.38.3.151; Moloney DM, 1996, NAT GENET, V13, P48, DOI 10.1038/ng0596-48; Morison IM, 1998, HUM MOL GENET, V7, P1599, DOI 10.1093/hmg/7.10.1599; Nagai T, 2003, J MED GENET, V40, P285, DOI 10.1136/jmg.40.4.285; NICKERSON E, 1995, AM J HUM GENET, V56, P1156; PALAU F, 1993, HUM MOL GENET, V2, P2031, DOI 10.1093/hmg/2.12.2031; Potocki L, 2000, NAT GENET, V24, P84, DOI 10.1038/71743; QUARRELL OWJ, 1991, J MED GENET, V28, P256, DOI 10.1136/jmg.28.4.256; Robinson WP, 1998, J MED GENET, V35, P130, DOI 10.1136/jmg.35.2.130; Shaffer LG, 2000, ANNU REV GENET, V34, P297, DOI 10.1146/annurev.genet.34.1.297; Shaw CJ, 2002, AM J HUM GENET, V71, P1072, DOI 10.1086/344346; TUPLER R, 1992, J MED GENET, V29, P53, DOI 10.1136/jmg.29.1.53; Urban Z, 1996, AM J HUM GENET, V59, P958; Wieczorek D, 2000, EUR J HUM GENET, V8, P519, DOI 10.1038/sj.ejhg.5200498; Wirth B, 1997, AM J HUM GENET, V61, P1102, DOI 10.1086/301608; Wu YQ, 1999, HUM MOL GENET, V8, P313, DOI 10.1093/hmg/8.2.313	29	34	35	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2003	72	5					1331	1337		10.1086/375166	http://dx.doi.org/10.1086/375166			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671PZ	12687502	Bronze, Green Published			2022-12-18	WOS:000182474400027
J	Griseri, P; Pesce, B; Patrone, G; Osinga, J; Puppo, F; Sancandi, M; Hofstra, R; Romeo, G; Ravazzolo, R; Devoto, M; Ceccherini, I				Griseri, P; Pesce, B; Patrone, G; Osinga, J; Puppo, F; Sancandi, M; Hofstra, R; Romeo, G; Ravazzolo, R; Devoto, M; Ceccherini, I			A rare haplotype of the RET proto-oncogene is a risk-modifying allele in Hirschsprung disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							3'-SPLICING VARIANTS; MISSENSE MUTATION; TYROSINE KINASE; PROTOONCOGENE; ISOFORMS; EXPRESSION	Hirschsprung disease (HSCR) is a common genetic disorder characterized by intestinal obstruction secondary to enteric aganglionosis. HSCR demonstrates a complex pattern of inheritance, with the RET proto-oncogene acting as a major gene and with several additional susceptibility loci related to the Ret-signaling pathway or to other developmental programs of neural crest cells. To test how the HSCR phenotype may be affected by the presence of genetic variants, we investigated the role of a single-nucleotide polymorphism (SNP), 2508C-->T (S836S), in exon 14 of the RET gene, characterized by low frequency among patients with HSCR and overrepresentation in individuals affected by sporadic medullary thyroid carcinoma. Typing of several different markers across the RET gene demonstrated that a whole conserved haplotype displayed anomalous distribution and nonrandom segregation in families with HSCR. We provide genetic evidence about a protective role of this low-penetrant haplotype in the pathogenesis of HSCR and demonstrate a possible functional effect linked to RET messenger RNA expression.	Ist Giannina Gaslini, Genet Mol Lab, I-16148 Genoa, Italy; Univ Genoa, Dipartimento Oncol Biol & Genet, Genoa, Italy; Univ Bologna, Cattedra Genet Med, Bologna, Italy; Univ Groningen, Dept Med Genet, NL-9700 AB Groningen, Netherlands; Nemours Childrens Clin, Dept Res, Wilmington, DE USA	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; University of Bologna; University of Groningen	Ceccherini, I (corresponding author), Ist Giannina Gaslini, Genet Mol Lab, Lgo G Gaslini 5, I-16148 Genoa, Italy.		griseri, paola/AAJ-4823-2020; Ceccherini, Isabella/P-8195-2014; Devoto, Marcella/AAP-7595-2021	Ceccherini, Isabella/0000-0001-8732-1955; DEVOTO, MARCELLA/0000-0002-4431-5114; Hofstra, Robert/0000-0001-7498-3829; Puppo, Francesca/0000-0002-9823-0810	Telethon [E.0791] Funding Source: Medline	Telethon(Fondazione Telethon)		Alberti L, 1998, ONCOGENE, V17, P1079, DOI 10.1038/sj.onc.1202046; ATTIE T, 1995, HUM MOL GENET, V4, P1381, DOI 10.1093/hmg/4.8.1381; Auricchio A, 1999, AM J HUM GENET, V64, P1216, DOI 10.1086/302329; BADNER JA, 1990, AM J HUM GENET, V46, P568; Borrego S, 2000, J MED GENET, V37, P572, DOI 10.1136/jmg.37.8.572; CECCHERINI I, 1994, ONCOGENE, V9, P3025; de Graaff E, 2001, GENE DEV, V15, P2433, DOI 10.1101/gad.205001; Fitze G, 2002, LANCET, V359, P1200, DOI 10.1016/S0140-6736(02)08218-1; Gabriel SB, 2002, NAT GENET, V31, P89, DOI 10.1038/ng868; Griseri P, 2000, EUR J HUM GENET, V8, P721, DOI 10.1038/sj.ejhg.5200521; GRISERI P, 2000, GENE FUNCT DIS, V1, P184; Ivanchuk SM, 1998, ONCOGENE, V16, P991, DOI 10.1038/sj.onc.1201622; Le Hir H, 2000, ONCOLOGY-BASEL, V58, P311, DOI 10.1159/000012118; MYERS SM, 1995, ONCOGENE, V11, P2039; Parisi MA, 2000, CURR OPIN PEDIATR, V12, P610, DOI 10.1097/00008480-200012000-00017; Patrone G, 2000, BIOTECHNIQUES, V29, P1012, DOI 10.2144/00295st02; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; Puppo F, 2002, FEBS LETT, V523, P123, DOI 10.1016/S0014-5793(02)02957-5; Zhao JH, 2000, HUM HERED, V50, P133, DOI 10.1159/000022901	19	34	36	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2002	71	4					969	974		10.1086/342774	http://dx.doi.org/10.1086/342774			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	604HT	12214285	Green Published, Bronze			2022-12-18	WOS:000178613800025
J	Howe, JR; Shellnut, J; Wagner, B; Ringold, JC; Sayed, MG; Ahmed, AF; Lynch, PM; Amos, CI; Sistonen, P; Aaltonen, LA				Howe, JR; Shellnut, J; Wagner, B; Ringold, JC; Sayed, MG; Ahmed, AF; Lynch, PM; Amos, CI; Sistonen, P; Aaltonen, LA			Common deletion of SMAD4 in juvenile polyposis is a mutational hotspot	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN GENETIC-DISEASE; FAMILIAL JUVENILE; GASTROINTESTINAL CARCINOMA; BRCA2 MUTATIONS; CANCER; ORIGIN; DNA; HAPLOTYPE; SEQUENCE; PATTERNS	Juvenile polyposis (JP) is an autosomal dominant syndrome in which affected patients develop upper- and/or lower-gastrointestinal (GI) polyps. A subset of families with JP have germline mutations in the SMAD4 (MADH4) gene and are at increased risk of GI cancers. To date, six families with JP have been described as having the same SMAD4 deletion (1244-1247delAGAC). The objective of the present study is to determine whether this deletion is a common ancestral mutation or a mutational hotspot. DNA from members of four families with JP, from Iowa, Mississippi, Texas, and Finland, that had this 4-bp deletion was used to genotype 15 simple tandem repeat polymorphism (STRP) markers flanking the SMAD4 gene, including 2 new STRPs within 6.3 and 70.9 kb of the deletion. Haplotypes cosegregating with JP in each family were constructed, and the distances of the closest markers were determined from the draft sequence of the human genome. No common haplotype was observed in these four families with JP. A 14-bp region containing the deletion had four direct repeats and one inverted repeat. Because no common ancestor was suggested by haplotype analysis and the sequence flanking the deletion contains repeats frequently associated with microdeletions, this common SMAD4 deletion in JP most likely represents a mutational hotspot.	Univ Iowa, Coll Med, Dept Surg, Iowa City, IA 52242 USA; Univ Texas, MD Anderson Canc Ctr, Dept Gastrointestinal Med & Nutr, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; Univ Helsinki, Dept Med Genet, Haartman Inst, Helsinki, Finland; Univ Helsinki, Finnish Red Cross Blood Transfus Serv, Helsinki, Finland	University of Iowa; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Helsinki; University of Helsinki	Howe, JR (corresponding author), Univ Iowa Hosp & Clin, Dept Surg, 200 Hawkins Dr, Iowa City, IA 52242 USA.	james-howe@uiowa.edu	Aaltonen, Lauri/A-5375-2010	Aaltonen, Lauri/0000-0001-6839-4286; Howe, James/0000-0001-5312-5972	NATIONAL CANCER INSTITUTE [P50CA062924] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA062924, CA62924] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; COOPER DN, 1990, HUM GENET, V85, P55; Eppert K, 1996, CELL, V86, P543, DOI 10.1016/S0092-8674(00)80128-2; GARDNER E, 1994, HUM MOL GENET, V3, P1771, DOI 10.1093/hmg/3.10.1771; GRODEN J, 1993, AM J HUM GENET, V52, P263; Hahn SA, 1996, CANCER RES, V56, P490; HOFTING I, 1993, Z GASTROENTEROL, V31, P480; HORRILLENO EG, 1957, CANCER, V10, P1210, DOI 10.1002/1097-0142(195711/12)10:6<1210::AID-CNCR2820100619>3.0.CO;2-2; Howe JR, 1998, SCIENCE, V280, P1086, DOI 10.1126/science.280.5366.1086; Howe JR, 1998, ANN SURG ONCOL, V5, P751, DOI 10.1007/BF02303487; Howes LG, 1998, DRUG SAFETY, V18, P1, DOI 10.2165/00002018-199818010-00001; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; KRAWCZAK M, 1991, HUM GENET, V86, P425; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; MCCOLL I, 1964, P ROY SOC MED, V57, P896; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Moisio AL, 1996, AM J HUM GENET, V59, P1243; MORRAL N, 1994, NAT GENET, V7, P169, DOI 10.1038/ng0694-169; Neuhausen SL, 1998, AM J HUM GENET, V62, P1381, DOI 10.1086/301885; Roth S, 1999, GENE CHROMOSOME CANC, V26, P54, DOI 10.1002/(SICI)1098-2264(199909)26:1<54::AID-GCC8>3.0.CO;2-D; SACHATELLO CR, 1974, SURGERY, V75, P107; Sajantila A, 1999, EUR J HUM GENET, V7, P263, DOI 10.1038/sj.ejhg.5200257; SCOTTCONNER CE, 1995, J AM COLL SURGEONS, V181, P407; SHAM P, 1997, STAT HUMAN GENETICS, P146; STEMPER TJ, 1975, ANN INTERN MED, V83, P639, DOI 10.7326/0003-4819-83-5-639; SUBRAMONY C, 1994, AM J CLIN PATHOL, V102, P91, DOI 10.1093/ajcp/102.1.91; Tonin PN, 1998, AM J HUM GENET, V63, P1341, DOI 10.1086/302099; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	28	34	38	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2002	70	5					1357	1362		10.1086/340258	http://dx.doi.org/10.1086/340258			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	541XT	11920286	Bronze, Green Published			2022-12-18	WOS:000175012400026
J	Meistrich, ML; Byrne, J				Meistrich, ML; Byrne, J			Genetic disease in offspring of long-term survivors of childhood and adolescent cancer treated with potentially mutagenic therapies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									Univ Texas, MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; Childrens Natl Med Ctr, Washington, DC 20010 USA	University of Texas System; UTMD Anderson Cancer Center; Children's National Health System	Meistrich, ML (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Box 66,1515 Holcombe Blvd, Houston, TX 77030 USA.							Byrne J, 1998, AM J HUM GENET, V62, P45, DOI 10.1086/301677; FLEISS JL, 1991, STAT METHODS RATES P, P38; HAWKINS MM, 1991, J NATL CANCER I, V83, P1643, DOI 10.1093/jnci/83.22.1643; Nicholson HS, 1996, CANCER, V78, P887; Witt KL, 1996, MUTAT RES-FUND MOL M, V355, P209, DOI 10.1016/0027-5107(96)00029-2	5	34	38	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2002	70	4					1069	1071		10.1086/339466	http://dx.doi.org/10.1086/339466			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	528PL	11885031	Bronze, Green Published			2022-12-18	WOS:000174252100029
J	Morle, L; Bozon, M; Zech, JC; Alloisio, N; Raas-Rothschild, A; Philippe, C; Lambert, JC; Godet, J; Plauchu, H; Edery, P				Morle, L; Bozon, M; Zech, JC; Alloisio, N; Raas-Rothschild, A; Philippe, C; Lambert, JC; Godet, J; Plauchu, H; Edery, P			A locus for autosomal dominant colobomatous microphthalmia maps to chromosome 15q12-q15	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INTERSTITIAL DELETION; EYE DEVELOPMENT; EXPRESSION; MUTATIONS; 14Q32; GENES	Congenital microphthalmia is a common developmental ocular disorder characterized by shortened axial length. Isolated microphthalmia is clinically and genetically heterogeneous and may be inherited in an autosomal dominant, autosomal recessive, or X-linked manner. Here, we studied a five-generation family of Sephardic Jewish origin that included 38 members, of whom 7 have either unilateral or bilateral microphthalmia of variable severity inherited as an autosomal dominant trait with incomplete penetrance. After exclusion of several candidate loci, we performed a genome-scan study and demonstrated linkage to chromosome 15q12-q15. Positive LOD scores were obtained with a maximum at the D15S1007 locus (maximum LOD score 3.77, at recombination fraction 0.00). Haplotype analyses supported the location of the disease-causing gene in a 13.8-cM interval between loci D15S1002 and D15S1040.	Univ Lyon 1, CNRS UMR 5534, Ctr Genet Mol & Cellulaire, F-69622 Villeurbanne, France; Hospices Civils Lyon, Hop Edouard Herriot, Serv Ophtalmol, Lyon, France; Hospices Civils Lyon, Hop Hotel Dieu, Serv Genet, Lyon, France; CHU Nice, Unite Genet Med & Foetopathol, Nice, France; Hadassah Univ Hosp, Dept Human Genet, IL-91120 Jerusalem, Israel	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; CHU Lyon; CHU Nice; Hebrew University of Jerusalem	Edery, P (corresponding author), Univ Lyon 1, CNRS UMR 5534, Ctr Genet Mol & Cellulaire, 43 Blvd 11 Novembre 1918, F-69622 Villeurbanne, France.		Edery, Patrick/B-6407-2012	PHILIPPE, Christophe/0000-0001-7098-6520				Amos-Landgraf JM, 1999, AM J HUM GENET, V65, P370, DOI 10.1086/302510; AUTIO S, 1988, CLIN GENET, V34, P293; BARROSNUNEZ P, 1995, CLIN GENET, V48, P160; Bateman J B, 1984, Int Ophthalmol Clin, V24, P87, DOI 10.1097/00004397-198402410-00008; Bermejo E, 1998, AM J MED GENET, V75, P497, DOI 10.1002/(SICI)1096-8628(19980217)75:5<497::AID-AJMG8>3.0.CO;2-K; Bessant DAR, 1999, BRIT J OPHTHALMOL, V83, P919, DOI 10.1136/bjo.83.8.919; Bessant DAR, 1998, AM J HUM GENET, V62, P1113, DOI 10.1086/301843; Busby A, 1998, ARCH DIS CHILD-FETAL, V79, pF168, DOI 10.1136/fn.79.3.F168; Christian SL, 1999, HUM MOL GENET, V8, P1025, DOI 10.1093/hmg/8.6.1025; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Eccles MR, 1999, CLIN GENET, V56, P1, DOI 10.1034/j.1399-0004.1999.560101.x; Freund C, 1996, HUM MOL GENET, V5, P1471, DOI 10.1093/hmg/5.Supplement_1.1471; FRYNS JP, 1995, J MED GENET, V32, P326, DOI 10.1136/jmg.32.4.326; GHOSE S, 1991, OPHTHALMIC PAED GEN, V12, P177, DOI 10.3109/13816819109025814; Graw J, 1996, DEV GENET, V18, P181, DOI 10.1002/(SICI)1520-6408(1996)18:3<181::AID-DVG1>3.0.CO;2-5; HOEFNAGEL D, 1963, ARCH OPHTHALMOL-CHIC, V69, P760; Jean D, 1998, MECH DEVELOP, V76, P3, DOI 10.1016/S0925-4773(98)00117-8; KOHN G, 1988, CLIN GENET, V33, P321; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Liu YL, 1996, GENOMICS, V31, P58, DOI 10.1006/geno.1996.0009; MARTHA AD, 1993, HUM MOL GENET, V2, P1982, DOI 10.1093/hmg/2.11.1982-a; MARTIN F, 1990, J MED GENET, V27, P637, DOI 10.1136/jmg.27.10.637; Othman MI, 1998, AM J HUM GENET, V63, P1411, DOI 10.1086/302113; PEARCE WG, 1986, CAN J OPHTHALMOL, V21, P291; Percin EF, 2000, NAT GENET, V25, P397, DOI 10.1038/78071; Prosser J, 1998, HUM MUTAT, V11, P93, DOI 10.1002/(SICI)1098-1004(1998)11:2<93::AID-HUMU1>3.0.CO;2-M; RICHARD I, 1994, GENOMICS, V23, P619, DOI 10.1006/geno.1994.1550; Sanyanusin P, 1996, GENOMICS, V35, P258, DOI 10.1006/geno.1996.0350; Smith S A, 1994, Clin Dysmorphol, V3, P287; Tomita K, 1996, NEURON, V16, P723, DOI 10.1016/S0896-6273(00)80093-8; TONK V, 1995, CLIN GENET, V48, P151; van Heyningen V, 1998, CLIN GENET, V54, P272, DOI 10.1034/j.1399-0004.1998.5440403.x; Vignal Alain, 1993, V1, P211; VINGOLO EM, 1994, J MED GENET, V31, P721, DOI 10.1136/jmg.31.9.721; VORONINA VA, 2000, ARVO ANN M FORT LAUD; WARBURG M, 1993, J MED GENET, V30, P664, DOI 10.1136/jmg.30.8.664; ZLOTOGORA J, 1994, AM J MED GENET, V49, P261, DOI 10.1002/ajmg.1320490302	37	34	40	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2000	67	6					1592	1597		10.1086/316894	http://dx.doi.org/10.1086/316894			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	378WE	11035633	Green Published, Bronze			2022-12-18	WOS:000165607600026
J	de Vries, BBA; Arts, WFM; Breedveld, GJ; Hoogeboom, JJM; Niermeijer, MF; Heutink, P				de Vries, BBA; Arts, WFM; Breedveld, GJ; Hoogeboom, JJM; Niermeijer, MF; Heutink, P			Benign hereditary chorea of early onset maps to chromosome 14q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MATURATION FACTOR-BETA; HUNTINGTONS-DISEASE; GENE; FAMILY; GLIA; EXPRESSION; PROTEIN; CELLS; LOCUS; IT15	Benign hereditary chorea (BHC) is an autosomal dominant disorder characterized by an early-onset nonprogressive chorea. The early onset and the benign course distinguishes BHC from the more common Huntington disease (HD). Previous studies on families with BHC have shown that BHC and HD are not allelic. We studied a large Dutch kindred with BHC and obtained strong evidence for linkage between the disorder and markers on chromosome 14q (maximum LOD score 6.32 at recombination fraction 0). The BHC locus in this family was located between markers D14S49 and D14S1064, a region spanning similar to 20.6 cM that contains several interesting candidate genes involved in the development and/or maintenance of the CNS: glia maturation factor-beta, GTP cyclohydrolase 1 and the survival of motor neurons (SMN)-interacting protein 1. The mapping of the BHC locus to 14q is a first step toward identification of the gene involved, which might, subsequently, shed light on the pathogenesis of this and other choreatic disorders.	Erasmus Univ, Univ Hosp Dijkzigt, Dept Clin Genet, NL-3000 DR Rotterdam, Netherlands; Erasmus Univ, Univ Hosp Dijkzigt, Dept Pediat Neurol, NL-3000 DR Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	de Vries, BBA (corresponding author), Erasmus Univ, Dept Clin Genet, POB 1738, NL-3000 DR Rotterdam, Netherlands.			Heutink, Peter/0000-0001-5218-1737				BRUYN GW, 1986, EXTRAPYRAMIDAL DISOR, V49, P335; CHUN RWM, 1973, JAMA-J AM MED ASSOC, V225, P1603, DOI 10.1001/jama.225.13.1603; DAMASIO H, 1977, ANN NEUROL, V1, P602, DOI 10.1002/ana.410010619; Gellera C, 1996, AM J HUM GENET, V59, P475; HAERER AF, 1967, NEW ENGL J MED, V276, P1220, DOI 10.1056/NEJM196706012762202; HAERER AF, 1966, NEUROLOGY, V16, P307; Hageman G, 1996, CLIN NEUROL NEUROSUR, V98, P165, DOI 10.1016/0303-8467(96)00015-7; HARPER PS, 1978, CLIN GENET, V13, P85; ICHINOSE H, 1994, NAT GENET, V8, P236, DOI 10.1038/ng1194-236; KAPLAN R, 1991, J NEUROCHEM, V57, P483, DOI 10.1111/j.1471-4159.1991.tb03777.x; KREMER B, 1994, NEW ENGL J MED, V330, P1401, DOI 10.1056/NEJM199405193302001; LELI DA, 1984, J NEUROL NEUROSUR PS, V47, P471, DOI 10.1136/jnnp.47.5.471; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MACMILLAN JC, 1993, J MED GENET, V30, P1012, DOI 10.1136/jmg.30.12.1012; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; PINCUS JH, 1967, J PEDIATR-US, V70, P724, DOI 10.1016/S0022-3476(67)80322-6; QUARRELL OWJ, 1988, J MED GENET, V25, P191, DOI 10.1136/jmg.25.3.191; SCHADY W, 1988, J NEUROL NEUROSUR PS, V51, P295, DOI 10.1136/jnnp.51.2.295; SEGAWA M, 1986, HDB CLIN NEUROLOGY, P529; VANCAMP G, 1997, TRENDS GENET, V13, P82; WANG BR, 1992, BRAIN RES, V591, P1, DOI 10.1016/0006-8993(92)90971-B; WHEELER PG, 1993, PEDIATR NEUROL, V9, P337, DOI 10.1016/0887-8994(93)90101-H; YAPIJAKIS C, 1995, CLIN GENET, V47, P133; ZAHEER A, 1993, J NEUROCHEM, V60, P914, DOI 10.1111/j.1471-4159.1993.tb03237.x	25	34	34	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2000	66	1					136	142		10.1086/302725	http://dx.doi.org/10.1086/302725			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279FK	10631144	Green Published, Bronze			2022-12-18	WOS:000085033600015
J	Hendrickx, J; Lee, P; Keating, JP; Carton, D; Sardharwalla, EB; Tuchman, M; Baussan, C; Willems, PJ				Hendrickx, J; Lee, P; Keating, JP; Carton, D; Sardharwalla, EB; Tuchman, M; Baussan, C; Willems, PJ			Complete genomic structure and mutational spectrum of PHKA2 in patients with X-linked liver glycogenosis type I and II	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PHOSPHORYLASE-KINASE-DEFICIENCY; NORMAL ENZYME-ACTIVITY; ALPHA-SUBUNIT; SKELETAL-MUSCLE; STORAGE DISEASE; CDNA CLONING; HUMAN CALMODULIN; BETA-SUBUNIT; GENE; ISOFORM	X-linked liver glycogenosis (XLG) is probably the most frequent glycogen-storage disease. XLG can be divided into two subtypes: XLG I, with a deficiency in phosphorylase kinase (PHK) activity in peripheral blood cells and liver; and XLG II, with normal in vitro PHK activity in peripheral blood cells and with variable activity in liver. Both types of XLG are caused by mutations in the same gene, PHKA2, that encodes the regulatory alpha subunit of PHK. To facilitate mutation analysis in PHKA2, we determined its genomic structure. The gene consists of 33 exons, spanning greater than or equal to 65 kb. By SSCP analysis of the different PHKA2 exons, we identified five new XLG I mutations, one new XLG II mutation, and one mutation present in both a patient with XLG I and a patient with XLG IT, bringing the total to 19 XLG I and 12 XLG II mutations. Most XLG I mutations probably lead to truncation or disruption of the PHKA2 protein. In contrast, all XLG II mutations are missense mutations or small in-frame deletions and insertions. These results suggest that the biochemical differences between XLG I and XLG TT might be due to the different nature of the disease-causing mutations in PHKA2. XLG I mutations may lead to absence of the alpha subunit, which causes an unstable PHK holoenzyme and deficient enzyme activity, whereas XLG II mutations may lead to in vivo deregulation of PHK, which might be difficult to demonstrate in vitro.	Univ Antwerp, Dept Med Genet, B-2020 Antwerp, Belgium; Great Ormond St Hosp, Inst Child Hlth, London, England; St Louis Childrens Hosp, Dept Pediat, Paris, France; Washington Univ, Sch Med, St Louis, MO 63130 USA; State Univ Ghent Hosp, Kinderklin Hooft, B-9000 Ghent, Belgium; Royal Manchester Childrens Hosp, Willink Biochem Genet Unit, Manchester, Lancs, England; Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; Ctr Hosp Bicetre, Dept Biochim 1, Bicetre, France	University of Antwerp; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; UDICE-French Research Universities; Universite Paris Cite; Washington University (WUSTL); Ghent University; Ghent University Hospital; Royal Manchester Children's Hospital; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP	Hendrickx, J (corresponding author), Univ Antwerp, RUCA, Dept Physiol, Groenenborgerlaan 171, B-2020 Antwerp, Belgium.							BAKKER HD, 1991, J INHERIT METAB DIS, V14, P269, DOI 10.1007/BF01800604; BLONDEN LAJ, 1989, NUCLEIC ACIDS RES, V17, P5611, DOI 10.1093/nar/17.14.5611; Burwinkel B, 1998, HUM GENET, V102, P423, DOI 10.1007/s004390050715; Burwinkel B, 1996, HUM MOL GENET, V5, P653, DOI 10.1093/hmg/5.5.653; COHEN PTW, 1976, EUR J BIOCHEM, V66, P347, DOI 10.1111/j.1432-1033.1976.tb10524.x; DAVIDSON JJ, 1992, P NATL ACAD SCI USA, V89, P2096, DOI 10.1073/pnas.89.6.2096; FISCHER R, 1988, J BIOL CHEM, V263, P17055; GITZELMANN R, 1957, Helv Paediatr Acta, V12, P425; HANKS SK, 1989, MOL ENDOCRINOL, V3, P110, DOI 10.1210/mend-3-1-110; Hendrickx J, 1998, EUR J PEDIATR, V157, P919, DOI 10.1007/s004310050967; HENDRICKX J, 1995, HUM MOL GENET, V4, P77, DOI 10.1093/hmg/4.1.77; Hendrickx J, 1996, HUM MOL GENET, V5, P649, DOI 10.1093/hmg/5.5.649; Hendrickx J, 1996, HUM GENET, V97, P551; HENDRICKX J, 1993, HUM MOL GENET, V2, P583, DOI 10.1093/hmg/2.5.583; HENDRY JH, 1994, EXP HEMATOL, V22, P2; Hirono H, 1995, BIOCHEM MOL BIOL INT, V36, P505; HUIJING F, 1969, AM J HUM GENET, V21, P275; KEATING JP, 1985, AM J DIS CHILD, V139, P609, DOI 10.1001/archpedi.1985.02140080079037; KILIMANN MW, 1988, P NATL ACAD SCI USA, V85, P9381, DOI 10.1073/pnas.85.24.9381; LEDERER B, 1975, BIOCHEM J, V147, P23, DOI 10.1042/bj1470023; LOZANO MJ, 1994, J INHERIT METAB DIS, V17, P116, DOI 10.1007/BF00735410; MAIRE I, 1991, CLIN BIOCHEM, V24, P169, DOI 10.1016/0009-9120(91)90511-C; PICTON C, 1983, METHOD ENZYMOL, V102, P219; SCHIMKE RN, 1973, J PEDIATR-US, V83, P1031, DOI 10.1016/S0022-3476(73)80544-X; SCHNEIDER A, 1993, NAT GENET, V5, P381, DOI 10.1038/ng1293-381; SENGUPTA B, 1987, J BIOL CHEM, V262, P16663; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SULSTON J, 1992, NATURE, V356, P37, DOI 10.1038/356037a0; TUCHMAN M, 1986, METABOLISM, V35, P627, DOI 10.1016/0026-0495(86)90169-1; VANDENBERG IET, 1995, AM J HUM GENET, V56, P381; WAWRZYNCZAK EJ, 1984, BIOCHEM INT, V9, P177; WEHNER M, 1995, HUM GENET, V96, P616; WILLEMS PJ, 1990, EUR J PEDIATR, V149, P268, DOI 10.1007/BF02106291; WULLRICH A, 1993, J BIOL CHEM, V268, P23208; WullrichSchmoll A, 1996, EUR J BIOCHEM, V238, P374, DOI 10.1111/j.1432-1033.1996.0374z.x; ZANDER NF, 1988, P NATL ACAD SCI USA, V85, P2929, DOI 10.1073/pnas.85.9.2929	36	34	38	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1999	64	6					1541	1549		10.1086/302399	http://dx.doi.org/10.1086/302399			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	203FA	10330341	Green Published, Bronze			2022-12-18	WOS:000080696200006
J	Bird, TD				Bird, TD			Outrageous fortune: The risk of suicide in genetic testing for Huntington disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									Univ Washington, Dept Neurol, Seattle, WA 98108 USA; Univ Washington, Dept Med, Seattle, WA 98108 USA; Univ Washington, Dept Psychiat, Seattle, WA 98108 USA; VA Puget Sound Med Ctr, Ctr Geriatr Res Educ & Clin, Seattle, WA 98108 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Geriatric Research Education & Clinical Center	Bird, TD (corresponding author), Univ Washington, Dept Neurol, Seattle, WA 98108 USA.							Almqvist EW, 1999, AM J HUM GENET, V64, P1293, DOI 10.1086/302374; BARETTE J, 1979, PSYCHOL MED, V9, P327, DOI 10.1017/S0033291700030841; BENNETT RL, 1996, TESTING HUNTINGTON D, P1; CONWELL Y, 1991, NEW ENGL J MED, V325, P1100, DOI 10.1056/NEJM199110103251511; COTE TR, 1992, JAMA-J AM MED ASSOC, V268, P2066, DOI 10.1001/jama.268.15.2066; FARRER LA, 1986, AM J MED GENET, V24, P305, DOI 10.1002/ajmg.1320240211; HANS MB, 1980, J NERV MENT DIS, V168, P209, DOI 10.1097/00005053-198004000-00003; HARPER PS, 1996, HUNTINGTONS DIS, P85; Huntington G., 1872, MED SURG REP, V26, P320; KELLERMANN AL, 1992, NEW ENGL J MED, V327, P467, DOI 10.1056/NEJM199208133270705; LIPE H, 1993, AM J MED GENET, V48, P231, DOI 10.1002/ajmg.1320480412; ROHDE K, 1995, J AM GERIATR SOC, V43, P187, DOI 10.1111/j.1532-5415.1995.tb06388.x; ROY A, 1995, COMPREHENSIVE TXB PS, V2, P1739; STENAGER EN, 1992, J NEUROL NEUROSUR PS, V55, P542, DOI 10.1136/jnnp.55.7.542; STENAGER EN, 1992, ARCH NEUROL-CHICAGO, V49, P1296, DOI 10.1001/archneur.1992.00530360098025; STORM HH, 1992, CANCER, V69, P1507; WEISSMAN MM, 1989, NEW ENGL J MED, V321, P1209, DOI 10.1056/NEJM198911023211801; WESTERMEYER JF, 1991, J NERV MENT DIS, V179, P259, DOI 10.1097/00005053-199105000-00003; Wexler N S, 1985, Prog Med Genet, V6, P277	19	34	34	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1999	64	5					1289	1292		10.1086/302388	http://dx.doi.org/10.1086/302388			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	192RP	10205259	Green Published, Bronze			2022-12-18	WOS:000080093000006
J	Knight, SAB; Kim, R; Pain, D; Dancis, A				Knight, SAB; Kim, R; Pain, D; Dancis, A			Insights from model systems - The yeast connection to Friedreich ataxia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRIPLET-REPEAT EXPANSION; IRON ACCUMULATION; MITOCHONDRIAL-DNA; HOMOLOG; PROTEIN; DEFICIENCY; FRATAXIN; HSP70; LACKING; FAMILY		Univ Penn, Dept Med, Div Hematol Oncol, Stellar Chance Labs 1013, Philadelphia, PA 19104 USA; Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Dancis, A (corresponding author), Univ Penn, Dept Med, Div Hematol Oncol, Stellar Chance Labs 1013, 422 Curie Blvd, Philadelphia, PA 19104 USA.			Knight, Simon/0000-0001-7407-3390	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053953, R37DK053953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057067] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK53953-01] Funding Source: Medline; NIGMS NIH HHS [GM57067-01] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLIKMETS R, 1998, AM J HUM GENET S, V63, pA26; Askwith C, 1998, TRENDS BIOCHEM SCI, V23, P135, DOI 10.1016/S0968-0004(98)01192-X; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Bidichandani SI, 1998, AM J HUM GENET, V62, P111, DOI 10.1086/301680; Bidichandani SI, 1997, AM J HUM GENET, V60, P1251; Briones P, 1997, J INHERIT METAB DIS, V20, P569, DOI 10.1023/A:1005303008439; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Chomyn A, 1998, AM J HUM GENET, V62, P745, DOI 10.1086/301813; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; ENGMAN DM, 1989, MOL CELL BIOL, V9, P5163, DOI 10.1128/MCB.9.11.5163; Foury F, 1997, FEBS LETT, V411, P373, DOI 10.1016/S0014-5793(97)00734-5; Horst M, 1997, EMBO J, V16, P1842, DOI 10.1093/emboj/16.8.1842; KANG PJ, 1990, NATURE, V348, P137, DOI 10.1038/348137a0; Kispal G, 1997, FEBS LETT, V418, P346, DOI 10.1016/S0014-5793(97)01414-2; Knight SAB, 1998, J BIOL CHEM, V273, P18389, DOI 10.1074/jbc.273.29.18389; Koutnikova H, 1997, NAT GENET, V16, P345, DOI 10.1038/ng0897-345; LAMARCHE JB, 1980, CAN J NEUROL SCI, V7, P389, DOI 10.1017/S0317167100022927; Li LT, 1996, J BIOL CHEM, V271, P16927, DOI 10.1074/jbc.271.28.16927; Martin J, 1997, J BIOENERG BIOMEMBR, V29, P35, DOI 10.1023/A:1022407705182; OUAHCHI K, 1995, NAT GENET, V9, P141, DOI 10.1038/ng0295-141; PALAU F, 1995, ANN NEUROL, V37, P359, DOI 10.1002/ana.410370312; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Schilke B, 1996, J CELL BIOL, V134, P603, DOI 10.1083/jcb.134.3.603; Shimada Y, 1998, J HUM GENET, V43, P115, DOI 10.1007/s100380050051; Smeyers P, 1996, HUM GENET, V97, P824; Strain J, 1998, J BIOL CHEM, V273, P31138, DOI 10.1074/jbc.273.47.31138; SZANTO J, 1966, ARCH NEUROL-CHICAGO, V14, P438, DOI 10.1001/archneur.1966.00470100094012; Wilson RB, 1998, ANN NEUROL, V44, P132, DOI 10.1002/ana.410440121; Wilson RB, 1997, NAT GENET, V16, P352, DOI 10.1038/ng0897-352	29	34	35	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1999	64	2					365	371		10.1086/302270	http://dx.doi.org/10.1086/302270			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	169HA	9973274	Green Published, Bronze			2022-12-18	WOS:000078740600006
J	Field, LL; Tobias, R; Robinson, WP; Paisey, R; Bain, S				Field, LL; Tobias, R; Robinson, WP; Paisey, R; Bain, S			Maternal uniparental disomy of chromosome 1 with no apparent phenotypic effects	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							DEPENDENT DIABETES-MELLITUS; HUMAN SPERM; MULTICOLOR FISH; ANEUPLOIDY; MOSAICISM; NONDISJUNCTION; LOCUS; CVS; SUSCEPTIBILITY; RECOMBINATION		Univ Calgary, Hlth Sci Ctr, Dept Med Genet, Calgary, AB T2N 4N1, Canada; Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; Torbay Hosp, Torquay, England; Univ Birmingham, Dept Med, Birmingham, W Midlands, England	University of Calgary; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of British Columbia; University of Birmingham	Field, LL (corresponding author), Univ Calgary, Hlth Sci Ctr, Dept Med Genet, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.		Robinson, Wendy/AAB-6420-2020; Robinson, Wendy P/I-9590-2014	Robinson, Wendy/0000-0002-2010-6174; Robinson, Wendy P/0000-0002-2010-6174				BAIN SC, 1990, AUTOIMMUNITY, V7, P83, DOI 10.3109/08916939008993380; ENGEL E, 1993, AM J MED GENET, V46, P670, DOI 10.1002/ajmg.1320460613; Field LL, 1997, CLIN INVEST MED, V20, P41; FIELD LL, 1994, NAT GENET, V8, P189, DOI 10.1038/ng1094-189; Field LL, 1996, GENOMICS, V33, P1, DOI 10.1006/geno.1996.0153; Gelb BD, 1998, AM J HUM GENET, V62, P848, DOI 10.1086/301795; Hahnemann JM, 1997, AM J MED GENET, V70, P179, DOI 10.1002/(SICI)1096-8628(19970516)70:2<179::AID-AJMG15>3.0.CO;2-G; HALL JG, 1990, AM J HUM GENET, V46, P857; Hanna JS, 1997, AM J MED GENET, V68, P98, DOI 10.1002/(SICI)1096-8628(19970110)68:1<98::AID-AJMG20>3.3.CO;2-I; Hassold T, 1996, ENVIRON MOL MUTAGEN, V28, P167; Howard PJ, 1995, CLIN GENET, V48, P313; JONES C, 1995, PRENATAL DIAG, V15, P843, DOI 10.1002/pd.1970150909; Koehler KE, 1996, HUM MOL GENET, V5, P1495, DOI 10.1093/hmg/5.Supplement_1.1495; LEDBETTER DH, 1995, HUM MOL GENET, V4, P1757, DOI 10.1093/hmg/4.suppl_1.1757; LEDBETTER DH, 1992, PRENATAL DIAG, V12, P317, DOI 10.1002/pd.1970120503; MARTIN RH, 1991, AM J MED GENET, V39, P321, DOI 10.1002/ajmg.1320390315; MARTIN RH, 1995, AM J HUM GENET, V57, P1395; NEU RL, 1988, CLIN GENET, V33, P73; Pulkkinen L, 1997, AM J HUM GENET, V61, P611, DOI 10.1086/515524; ROBINSON WP, 1993, AM J HUM GENET, V53, P740; Spriggs EL, 1996, AM J HUM GENET, V58, P356; TESHIMA IE, 1992, PRENATAL DIAG, V12, P443, DOI 10.1002/pd.1970120514	22	34	34	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1998	63	4					1216	1220		10.1086/302050	http://dx.doi.org/10.1086/302050			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	131LP	9758608	Green Published, Bronze			2022-12-18	WOS:000076577800035
J	Carbone, MA; MacKay, N; Ling, MF; Cole, DEC; Douglas, C; Rigat, B; Feigenbaum, A; Clarke, JTR; Haworth, JC; Greenberg, CR; Seargeant, L; Robinson, BH				Carbone, MA; MacKay, N; Ling, MF; Cole, DEC; Douglas, C; Rigat, B; Feigenbaum, A; Clarke, JTR; Haworth, JC; Greenberg, CR; Seargeant, L; Robinson, BH			Amerindian pyruvate carboxylase deficiency is associated with two distinct missense mutations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AMINO-ACID-SEQUENCE; BIOTIN ENZYMES; DOMAIN-STRUCTURE; COA CARBOXYLASE; CDNA; PROTEINS; CLONING; DNA	We characterized the pyruvate carboxylase (PC) gene by PCR amplification, subcloning, and sequencing. The coding region has 19 exons and 18 introns spanning similar to 16 kb of genomic DNA. Screening both the cDNA and the gene of individuals with the simple A form of PC deficiency revealed an 1828G-->A missense mutation in 11 Ojibwa and 2 Cree patients and 2229G-->T transversion mutation in 2 brothers of Micmac origin. Carrier frequency may be as high as 1/10 in some groupings. The two point mutations are located in a region of homology conserved among yeast, rat, and human PC, in the vicinity of the carboxylation domain of the enzyme. These data provide the first characterization of the human PC gene structure, the identification of common pathogenic mutations, and the demonstration of a founder effect in the Ojibwa and Cree patients.	Hosp Sick Children, Dept Genet, Res Inst, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Biochem, Toronto, ON, Canada; Banting & Best Inst, Toronto, ON, Canada; Univ Manitoba, Dept Pediat Child Hlth & Human Genet, Sect Genet & Metab, Winnipeg, MB R3T 2N2, Canada; Childrens Hosp, Winnipeg, MB R3A 1S1, Canada; Hlth Sci Ctr, Dept Clin Chem, Winnipeg, MB, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba	Robinson, BH (corresponding author), Hosp Sick Children, Dept Genet, Res Inst, 555 Univ Ave,Room 9107, Toronto, ON M5G 1X8, Canada.	bhr@sickkids.on.ca						BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; CRABTREE B, 1972, BIOCHEM J, V130, P391, DOI 10.1042/bj1300391; FREYTAG SO, 1984, J BIOL CHEM, V259, P2831; Jitrapakdee S, 1996, BIOCHEM BIOPH RES CO, V223, P695, DOI 10.1006/bbrc.1996.0958; Jitrapakdee S, 1997, J BIOL CHEM, V272, P20522, DOI 10.1074/jbc.272.33.20522; KEECH B, 1967, J BIOL CHEM, V242, P1983; KEECH DB, 1963, J BIOL CHEM, V238, P2609; KUMAR GK, 1982, J BIOL CHEM, V257, P13828; LAMHONWAH AM, 1987, ARCH BIOCHEM BIOPHYS, V254, P631, DOI 10.1016/0003-9861(87)90146-9; LEE SH, 1979, J BIOL CHEM, V254, P420; LI SJ, 1992, J BIOL CHEM, V267, P16841; LIM F, 1988, J BIOL CHEM, V263, P11493; MACKAY N, 1994, BIOCHEM BIOPH RES CO, V202, P1009, DOI 10.1006/bbrc.1994.2029; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; OBERMAYER M, 1976, TRENDS BIOCHEM SCI, V1, P169, DOI 10.1016/0968-0004(76)90198-5; Robinson B.H., 1995, METABOLIC MOL BASES, P1479; ROBINSON BH, 1983, J BIOL CHEM, V258, P6660; ROBINSON BH, 1987, AM J HUM GENET, V40, P50; ROBINSON BH, 1984, AM J HUM GENET, V36, P283; ROBINSON BH, 1989, ADV HUM GENET, V18, P151; ROBINSON BH, 1985, J PRENAT DIAGN, V5, P67; SAMOLS D, 1988, J BIOL CHEM, V263, P6461; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHANK RP, 1985, BRAIN RES, V329, P364, DOI 10.1016/0006-8993(85)90552-9; TOH H, 1993, EUR J BIOCHEM, V215, P687, DOI 10.1111/j.1432-1033.1993.tb18080.x; UTTER MF, 1975, ADV ENZYMOL RAMB, V42, P1; UTTER MF, 1963, J BIOL CHEM, V238, P2603; VANCOSTER RN, 1991, PEDIATR RES, V30, P1; WALTER P, 1973, FEBS LETT, V37, P170, DOI 10.1016/0014-5793(73)80451-X; WEXLER ID, 1994, BBA-MOL BASIS DIS, V1227, P46, DOI 10.1016/0925-4439(94)90105-8; WOOD HG, 1977, ANNU REV BIOCHEM, V46, P385, DOI 10.1146/annurev.bi.46.070177.002125; ZHANG J, 1993, P NATL ACAD SCI USA, V90, P1766, DOI 10.1073/pnas.90.5.1766	32	34	35	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1998	62	6					1312	1319		10.1086/301884	http://dx.doi.org/10.1086/301884			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZU224	9585612	Green Published, Bronze			2022-12-18	WOS:000074174700007
J	Groenewald, JZ; Liebenberg, J; Groenewald, IM; Warnich, L				Groenewald, JZ; Liebenberg, J; Groenewald, IM; Warnich, L			Linkage disequilibrium analysis in a recently founded population: Evaluation of the variegate porphyria founder in South African Afrikaners	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							PROTOPORPHYRINOGEN OXIDASE GENE; MUTATIONS; FAMILIES		Univ Stellenbosch, Dept Genet, ZA-7600 Stellenbosch, South Africa	Stellenbosch University	Groenewald, JZ (corresponding author), Univ Stellenbosch, Dept Genet, Private Bag X1, ZA-7600 Stellenbosch, South Africa.		Groenewald, Johannes Z/F-4667-2011	Groenewald, Johannes Z/0000-0002-9474-6246; Warnich, Louise/0000-0002-9331-998X				DAWSONSAUNDERS B, 1990, BASIC CLIN BIOSTATIS; Dean G, 1971, PORPHYRIAS STORY INH; deJager T, 1996, J MED GENET, V33, P567, DOI 10.1136/jmg.33.7.567; Deybach JC, 1996, HUM MOL GENET, V5, P407, DOI 10.1093/hmg/5.3.407; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HOUWEN RHJ, 1994, NAT GENET, V8, P380, DOI 10.1038/ng1294-380; JENKINS T, 1990, J MED GENET, V27, P760, DOI 10.1136/jmg.27.12.760; Labuda M, 1996, AM J HUM GENET, V59, P633; Lam HM, 1997, HUM GENET, V99, P126; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Meissner PN, 1996, NAT GENET, V13, P95, DOI 10.1038/ng0596-95; PUFFENBERGER EG, 1994, HUM MOL GENET, V3, P1217; ROBERTS AG, 1995, HUM MOL GENET, V4, P2387, DOI 10.1093/hmg/4.12.2387; Starfield M, 1997, AM J HUM GENET, V61, P370, DOI 10.1086/514848; TAKETANI S, 1995, GENOMICS, V29, P698, DOI 10.1006/geno.1995.9949; Warnich L, 1996, HUM GENET, V97, P690; Warnich L, 1996, HUM MOL GENET, V5, P981, DOI 10.1093/hmg/5.7.981; WARNICH L, 1996, BRAZ J GENET S, V19, P235	18	34	34	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1998	62	5					1254	1258		10.1086/301833	http://dx.doi.org/10.1086/301833			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZL922	9545403	Green Published, Bronze			2022-12-18	WOS:000073487000031
J	Hockertz, MK; Paty, DW; Beall, SS				Hockertz, MK; Paty, DW; Beall, SS			Susceptibility to relapsing-progressive multiple sclerosis is associated with inheritance of genes linked to the variable region of the TcR beta locus: Use of affected family-based controls	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article; Proceedings Paper	31st Meeting of the Canadian-Congress-of-Neurological-Sciences	JUN 25-29, 1996	ONTARIO, CANADA	Canadian Congress Neurol Sci			T-CELL RECEPTOR; DEPENDENT DIABETES-MELLITUS; CHAIN GENES; GERMLINE REPERTOIRE; RELATIVE RISKS; 2 MODELS; HLA; DISEASE; POLYMORPHISM; COMPLEX	We tested the hypothesis that susceptibility to relapsing-progressive (RP) (but not to relapsing-remitting [RR]) multiple sclerosis (MS) is associated with a gene linked to the TcR beta-chain variable region delimited by the V beta 8-BamHI and V beta 11-BamHI RFLP alleles in DRw15(+) MS patients, using a contingency-table test of patient data and affected family-based controls. Control alleles and haplotypes were composed of parental marker alleles and haplotypes not transmitted to the affected child, in 90 simplex and 31 multiplex families from British Columbia. A total of 6,164 alleles at 11 loci were segregated through families of probands with RP MS or RR MS. The V beta 8-V beta 11 subhaplotype frequencies in the DRw15(+) RP MS (but not RR MS) patients differed from control frequencies, because of an increase of the 2-1 subhaplotype (P = .02). V beta 8-BamHI and V beta 11-BamHI allele frequencies (P = .05 and .009, respectively) in the DRw15(+) RP MS (but not RR MS) patients differed from control frequencies. The V beta 1-V beta 8 subhaplotype frequencies in the DRw15(-) RP MS (but not RR MS) patients differed from control frequencies (P = .03), with a significantly increased frequency of the 1-1 subhaplotype (P = .01; RR = 7.1) in RP MS versus RR MS patients. Susceptibility to RP MS is associated both with a recessive inheritance of a gene linked to the 3' (V beta 11) end of the 2-1 subhaplotype defined by the V beta 8-BamHI and V beta 11-BamHI alleles in DRw15(+) patients and with a gene, located on the 1-1 subhaplotype, defined by the V beta 1-TaqI and V beta 8-MspI alleles of the TcR beta-chain complex in DRw15(-) patients.	Univ British Columbia, Dept Med, Div Neurol, Vancouver, BC V6T 2B5, Canada	University of British Columbia	Beall, SS (corresponding author), Univ British Columbia, Dept Med, Div Neurol, Koerner Pavil,Room S159,2211 Wesbrook Mall, Vancouver, BC V6T 2B5, Canada.	beall@msmri.med.ubc.ca						BEALL S, 47 ANN M AM AC NEUR; BEALL S, 1996, 31 ANN M CAN C NEUR, P25; BEALL SS, 1987, J IMMUNOL, V139, P1320; BEALL SS, 1993, J NEUROIMMUNOL, V45, P53, DOI 10.1016/0165-5728(93)90163-S; BEALL SS, 1989, J NEUROIMMUNOL, V21, P59, DOI 10.1016/0165-5728(89)90159-8; BEALL SS, 1993, 43 ANN M AM SOC HUM; BEALL SS, 1987, 16 ANN M UCLA S MOL; Bell JI, 1996, NAT GENET, V13, P377, DOI 10.1038/ng0896-377; BIDWELL JL, 1987, MOL IMMUNOL, V24, P513, DOI 10.1016/0161-5890(87)90026-5; CHARMLEY P, 1993, IMMUNOGENETICS, V38, P92; CHARMLEY P, 1991, J NEUROIMMUNOL, V32, P231, DOI 10.1016/0165-5728(91)90193-B; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; CONCANNON P, 1987, J EXP MED, V165, P1130, DOI 10.1084/jem.165.4.1130; COX NJ, 1988, AM J HUM GENET, V43, P954; CROW JF, 1986, BASIC CONCEPTS POPUL, P1; DALCANTO MC, 1995, MICROSC RES TECHNIQ, V32, P215, DOI 10.1002/jemt.1070320305; Droogan AG, 1996, NEUROLOGY, V47, P1049, DOI 10.1212/WNL.47.4.1049; EBERS G, 1994, ANN NEUROL S1, V1, pS12; EBERS GC, 1986, NEW ENGL J MED, V315, P1638, DOI 10.1056/NEJM198612253152603; Ebers GC, 1996, NAT GENET, V13, P472, DOI 10.1038/ng0896-472; EBERS GC, 1994, J NEUROIMMUNOL, V53, P117, DOI 10.1016/0165-5728(94)90021-3; Epplen C, 1997, ANN NEUROL, V41, P341, DOI 10.1002/ana.410410309; FALCONER DS, 1989, INTRO QUANTITATIVE G, P300; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; FIELD LL, 1991, AM J HUM GENET, V49, P627; FUGGER L, 1990, IMMUNOGENETICS, V31, P278; GOVERMAN J, 1993, CELL, V72, P551, DOI 10.1016/0092-8674(93)90074-Z; HAEGERT DG, 1994, ANN NEUROL, V36, pS204, DOI 10.1002/ana.410360807; Haines JL, 1996, NAT GENET, V13, P469, DOI 10.1038/ng0896-469; HAUSER SL, 1995, ANN NY ACAD SCI, V756, P233, DOI 10.1111/j.1749-6632.1995.tb44521.x; HILLERT J, 1994, ANN NEUROL, V36, pS15, DOI 10.1002/ana.410360706; HILLERT J, 1991, J NEUROIMMUNOL, V31, P141; HOCKERTZ M, 1996, 31 ANN M CAN C NEUR; HODGE SE, 1993, AM J HUM GENET, V53, P367; HORNE C, 1993, TISSUE ANTIGENS, V41, P243, DOI 10.1111/j.1399-0039.1993.tb02013.x; INGELFINGER JA, 1983, BIOSTATISTICS CLIN M, P160; KELLARWOOD HF, 1995, J NEUROIMMUNOL, V58, P183, DOI 10.1016/0165-5728(95)00015-T; KHOURY MJ, 1994, AM J HUM GENET, V55, P414; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LYNCH SG, 1991, ANN NEUROL, V30, P402, DOI 10.1002/ana.410300313; Mahtani MM, 1996, NAT GENET, V14, P90, DOI 10.1038/ng0996-90; MARTINEZNAVES E, 1993, J NEUROIMMUNOL, V47, P9, DOI 10.1016/0165-5728(93)90279-8; MELVOLD RW, 1987, J IMMUNOL, V138, P1429; OLERUP O, 1991, TISSUE ANTIGENS, V38, P1, DOI 10.1111/j.1399-0039.1991.tb02029.x; PATY D, 1994, ANN NEUROL, V36, pS134, DOI 10.1002/ana.410360732; PAYAMI H, 1989, AM J HUM GENET, V45, P541; PERL A, 1989, IMMUNOLOGY, V67, P135; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; REDEKOP WK, 1995, THESIS U BRIT COLUMB; RISCH N, 1987, AM J HUM GENET, V40, P1; RISCH N, 1997, SCIENCE, V275, P1327; ROBINSON MA, 1985, P NATL ACAD SCI USA, V82, P3804, DOI 10.1073/pnas.82.11.3804; RODRIGUEZ M, 1992, J IMMUNOL, V148, P921; RODRIGUEZ M, 1994, AUTOIMMUNITY, V19, P221, DOI 10.3109/08916939409071347; Rowen L, 1996, SCIENCE, V272, P1755, DOI 10.1126/science.272.5269.1755; SADOVNICK AD, 1993, ANN NEUROL, V33, P281, DOI 10.1002/ana.410330309; SADOVNICK AD, 1994, ANN NEUROL, V36, pS18, DOI 10.1002/ana.410360707; Sawcer S, 1996, NAT GENET, V13, P464, DOI 10.1038/ng0896-464; SCHAID DJ, 1993, AM J HUM GENET, V53, P1114; SEBOUN E, 1989, CELL, V57, P1095, DOI 10.1016/0092-8674(89)90046-9; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; SUAREZ BK, 1994, AM J HUM GENET, V54, P554; THOMSON G, 1989, GENET EPIDEMIOL, V6, P155, DOI 10.1002/gepi.1370060129; THOMSON G, 1988, ANNU REV GENET, V22, P31; THOMSON G, 1995, AM J HUM GENET, V57, P487; THOMSON G, 1991, IMMUNOGENETICS AUTOI, P195; Tiwari JL, 1985, HLA DIS ASS, P152; VANDEVYVER C, 1994, J NEUROIMMUNOL, V52, P25, DOI 10.1016/0165-5728(94)90158-9; WEI S, 1995, AM J HUM GENET, V56, P963; WEINSHENKER BG, 1989, BRAIN, V112, P133, DOI 10.1093/brain/112.1.133; WOOD NW, 1995, NEUROLOGY, V45, P1859, DOI 10.1212/WNL.45.10.1859	71	34	34	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1998	62	2					373	385		10.1086/301700	http://dx.doi.org/10.1086/301700			13	Genetics & Heredity	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA927	9463308	Bronze, Green Published			2022-12-18	WOS:000072416000021
J	Poland, GA				Poland, GA			Variability in immune response to pathogens: Using measles vaccine to probe immunogenetic determinants of response	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CLASS-II REGION; RESTRICTED PRESENTATION; ANTIGEN PRESENTATION; VIRAL-ANTIGEN; TAP GENES; T-CELLS; HLA; TRANSPORTERS; PEPTIDE; ALLELES		Mayo Clin & Mayo Fdn, Clin Pharmacol Unit, Mayo Vaccine Res Grp, Rochester, MN 55905 USA	Mayo Clinic	Poland, GA (corresponding author), Mayo Clin & Mayo Fdn, Clin Pharmacol Unit, Mayo Vaccine Res Grp, 611B Guggenheim Bldg,200 1st St SW, Rochester, MN 55905 USA.	poland.gregory@mayo.edu			NIAID NIH HHS [R01-2AI-33144, N01-AI-45240] Funding Source: Medline; FDA HHS [HHS FD-5-000-886] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033144, N01AI045240] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FDA HHS; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDROLEWICZ MJ, 1993, P NATL ACAD SCI USA, V90, P9130, DOI 10.1073/pnas.90.19.9130; AOKI Y, 1993, IMMUNOGENETICS, V38, P382; BARRON KS, 1995, ARTHRITIS RHEUM, V38, P684, DOI 10.1002/art.1780380517; BLACK FL, 1981, AM J HUM GENET, V33, P894; BLACK FL, 1977, HLTH DISEASE TRIBAL, P115; Bodmer J, 1996, CIBA F SYMP, V197, P233; CHEN RT, 1990, J INFECT DIS, V162, P1036, DOI 10.1093/infdis/162.5.1036; DESEDATOUS J, 1978, AM J DIS CHILD, V132, P287, DOI 10.1001/archpedi.1978.02120280071015; Detels R, 1996, IMMUNOL LETT, V51, P29, DOI 10.1016/0165-2478(96)02551-5; DEVERSON EV, 1990, NATURE, V348, P738, DOI 10.1038/348738a0; DIMANLIG P, 1994, COLD SPRING HARB LAB; ELLIS RW, 1993, HEPATITIS B VACCINES; Haldane J. B. S., 1949, Ricerca Scientifica Suppl, P68; HAYNEY MS, 1995, MAYO CLIN PROC, V70, P951, DOI 10.4065/70.10.951; Hayney MS, 1997, VACCINE, V15, P3, DOI 10.1016/S0264-410X(96)00133-8; Hayney MS, 1996, J INVEST MED, V44, P261; HAYNEY MS, 1994, 34 INT C ANT AG CHEM; HAYNEY MS, IN PRESS INT J INFEC; HEDRICK PW, 1990, HUM HERED, V40, P213, DOI 10.1159/000153933; HEEMELS MT, 1994, IMMUNITY, V1, P775, DOI 10.1016/S1074-7613(94)80019-7; HILL A, 1995, P NATL ACAD SCI USA, V92, P341, DOI 10.1073/pnas.92.2.341; Jacobson S, 1988, Ann N Y Acad Sci, V540, P352, DOI 10.1111/j.1749-6632.1988.tb27096.x; JACOBSON S, 1989, J VIROL, V63, P1756, DOI 10.1128/JVI.63.4.1756-1762.1989; JACOBSON S, 1984, J IMMUNOL, V133, P754; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; LEOPARDI R, 1993, CELL IMMUNOL, V147, P388, DOI 10.1006/cimm.1993.1078; LONG EO, 1989, IMMUNOL TODAY, V10, P45, DOI 10.1016/0167-5699(89)90303-4; MALNATI MS, 1992, NATURE, V357, P702, DOI 10.1038/357702a0; MATHIAS RG, 1989, AM J PUBLIC HEALTH, V79, P475, DOI 10.2105/AJPH.79.4.475; MOMBURG F, 1994, NATURE, V367, P648, DOI 10.1038/367648a0; NEEFJES J, 1995, EUR J IMMUNOL, V25, P1133, DOI 10.1002/eji.1830250444; NEEFJES JJ, 1993, SCIENCE, V261, P769, DOI 10.1126/science.8342042; NUCHTERN JG, 1990, NATURE, V343, P4; PANUM PL, 1939, MED CLASSICS, V3, P829; POLAND GA, 1995, FASEB J, V9, pA240; POLAND GA, IN PRESS VACCINE; POWIS SH, 1993, IMMUNOGENETICS, V37, P373, DOI 10.1007/BF00216802; QUADRI SA, 1995, TRANSPLANT P, V27, P680; SAVAGE DN, 1905, TISSUE ANTIGENS, V46, P213; SHEPHERD JC, 1993, CELL, V74, P577, DOI 10.1016/0092-8674(93)80058-M; Singh N, 1997, EMERG INFECT DIS, V3, P41; SPIES T, 1990, NATURE, V348, P744, DOI 10.1038/348744a0; SZAFER F, 1994, IMMUNOGENETICS, V39, P374; Townsend A, 1993, Semin Cell Biol, V4, P53, DOI 10.1006/scel.1993.1007; TROWSDALE J, 1990, NATURE, V348, P741, DOI 10.1038/348741a0; WEISS S, 1991, CELL, V64, P767, DOI 10.1016/0092-8674(91)90506-T	46	34	35	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1998	62	2					215	220		10.1086/301736	http://dx.doi.org/10.1086/301736			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA927	9463343	Bronze, Green Published			2022-12-18	WOS:000072416000002
J	Roelfsema, JH; Spruit, L; Saris, JJ; Chang, P; Pirson, Y; vanOmmen, GJB; Peters, DJM; Breuning, MH				Roelfsema, JH; Spruit, L; Saris, JJ; Chang, P; Pirson, Y; vanOmmen, GJB; Peters, DJM; Breuning, MH			Mutation detection in the repeated part of the PKD1 gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYCYSTIC KIDNEY-DISEASE; POLYCYSTIC-KIDNEY-DISEASE-1 PKD1; NONSENSE MUTATION; LINKAGE DISEQUILIBRIUM; GEL-ELECTROPHORESIS; HUMAN GENOME; MAP; PROTEIN; FAMILY; REGION	The principle cause of one of the most prevalent genetic disorders, autosomal dominant polycystic kidney disease, involves mutations in the PKD1 gene. However, since its identification in 1994, only 27 mutations have been published. Detection of mutations has been complicated because the greater part of the gene lies within a genomic region that is reiterated several times at another locus on chromosome 16. Amplification of DNA fragments in the repeated part of the PKD1 gene will lead to coamplification of highly homologous fragments derived from this other locus. These additional fragments severely hamper point-mutation detection. None of the point mutations published to date are located in the repeated part of the PKD1 gene. However, we have reduced the problems posed by the strong homology, by using the protein-truncation test, and we have identified eight novel mutations, seven of which are located in the repeated part of the PKD1 gene.	LEIDEN STATE UNIV, SYLVIUS LAB, DEPT HUMAN GENET, NL-2333 AL LEIDEN, NETHERLANDS; LEIDEN UNIV HOSP, DEPT NEPHROL, NL-2333 AA LEIDEN, NETHERLANDS; UNIV LOUVAIN, SCH MED, NEPHROL UNIT, LOUVAIN, BELGIUM	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC)			Breuning, Martijn H/E-3429-2010; Peters, Dorien/AFH-8507-2022	Peters, Dorien/0000-0001-6974-7143				BARNES WM, 1994, P NATL ACAD SCI USA, V91, P2216, DOI 10.1073/pnas.91.6.2216; BREUNING MH, 1990, J MED GENET, V27, P603, DOI 10.1136/jmg.27.10.603; BROOKCARTER PT, 1994, NAT GENET, V8, P328, DOI 10.1038/ng1294-328; BURN TC, 1995, HUM MOL GENET, V4, P575, DOI 10.1093/hmg/4.4.575; CECCHERINI I, 1989, CYTOGENET CELL GENET, V51, P975; CHAPMAN AB, 1992, NEW ENGL J MED, V327, P916, DOI 10.1056/NEJM199209243271303; COTTON RGH, 1988, P NATL ACAD SCI USA, V85, P4397, DOI 10.1073/pnas.85.12.4397; DALGAARD O Z, 1957, Acta Med Scand Suppl, V328, P1; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; EULDERINK F, 1978, ARCH PATHOL LAB MED, V102, P592; FOUGEROUSSE F, 1992, NUCLEIC ACIDS RES, V20, P1165, DOI 10.1093/nar/20.5.1165-a; GABOW PA, 1984, ANN INTERN MED, V101, P238, DOI 10.7326/0003-4819-101-2-238; GABOW PA, 1990, HEPATOLOGY, V11, P1033, DOI 10.1002/hep.1840110619; GERMINO GG, 1992, GENOMICS, V13, P144, DOI 10.1016/0888-7543(92)90214-D; GLUCKSMANNKUIS MA, 1995, CELL, V81, P289; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HOSSACK KF, 1988, NEW ENGL J MED, V319, P907, DOI 10.1056/NEJM198810063191404; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; LEIER CV, 1984, ANN INTERN MED, V100, P683, DOI 10.7326/0003-4819-100-5-683; MILUTINOVIC J, 1980, AM J MED, V68, P741, DOI 10.1016/0002-9343(80)90266-1; MILUTINOVIC J, 1989, AM J KIDNEY DIS, V13, P340, DOI 10.1016/S0272-6386(89)80043-5; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Moy GW, 1996, J CELL BIOL, V133, P809, DOI 10.1083/jcb.133.4.809; MYERS RM, 1987, METHOD ENZYMOL, V155, P501; NAYLOR J, 1993, HUM MOL GENET, V2, P1773, DOI 10.1093/hmg/2.11.1773; Neophytou P, 1996, HUM GENET, V98, P437, DOI 10.1007/s004390050235; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; Peral B, 1996, HUM MOL GENET, V5, P539, DOI 10.1093/hmg/5.4.539; Peral B, 1996, AM J HUM GENET, V58, P86; Peral B, 1997, AM J HUM GENET, V60, P1399, DOI 10.1086/515467; PERAL B, 1995, HUM MOL GENET, V4, P569, DOI 10.1093/hmg/4.4.569; PERAL B, 1994, AM J HUM GENET, V54, P899; PETERS DJM, 1992, CONTRIB NEPHROL, V97, P128; Qian F, 1996, CELL, V87, P979, DOI 10.1016/S0092-8674(00)81793-6; REEDERS ST, 1992, NAT GENET, V1, P235, DOI 10.1038/ng0792-235; Roelfsema J H, 1996, Adv Nephrol Necker Hosp, V25, P131; Roelfsema JH, 1996, NEPHROL DIAL TRANSPL, V11, P5; ROEST PAM, 1993, HUM MOL GENET, V2, P1719, DOI 10.1093/hmg/2.10.1719; Rossetti S, 1996, AM J MED GENET, V65, P155, DOI 10.1002/(SICI)1096-8628(19961016)65:2<155::AID-AJMG15>3.0.CO;2-P; SCHEFF RT, 1980, ANN INTERN MED, V92, P202, DOI 10.7326/0003-4819-92-2-202; SNAREY A, 1994, AM J HUM GENET, V55, P365; TURCO AE, 1995, HUM MOL GENET, V4, P1331, DOI 10.1093/hmg/4.8.1331; WARD CJ, 1994, CELL, V77, P881; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WHITE MB, 1992, GENOMICS, V12, P301, DOI 10.1016/0888-7543(92)90377-5; ZERRES K, 1993, J MED GENET, V30, P583, DOI 10.1136/jmg.30.7.583	47	34	39	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1997	61	5					1044	1052		10.1086/301600	http://dx.doi.org/10.1086/301600			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YH017	9345095	Bronze, Green Published			2022-12-18	WOS:A1997YH01700008
J	Horwitz, M; Benson, KF; Li, FQ; Wolff, J; Leppert, MF; Hobson, L; Mangelsdorf, M; Yu, S; Hewett, D; Richards, RK; Raskind, WH				Horwitz, M; Benson, KF; Li, FQ; Wolff, J; Leppert, MF; Hobson, L; Mangelsdorf, M; Yu, S; Hewett, D; Richards, RK; Raskind, WH			Genetic heterogeneity in familial acute myelogenous leukemia: Evidence for a second locus at chromosome 16q21-23.2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSCRIPTION FACTOR FAMILY; TRINUCLEOTIDE REPEAT; PLATELET DISORDER; MYELOID-LEUKEMIA; LINKAGE ANALYSIS; HUMAN GENOME; LOCALIZATION; HUMAN-CHROMOSOME-16; HEMATOPOIESIS; MONOSOMY-7	The identification of genes responsible for the rare cases of familial leukemia may afford insight into the mechanism underlying the more common sporadic occurrences. Here we test a single family with 11 relevant meioses transmitting autosomal dominant acute myelogenous leukemia (AML) and myelodysplasia for linkage to three potential candidate loci. In a different family with inherited AML, linkage to chromosome 21q22.1-22.2 was recently reported; we exclude linkage to 21q22.1-22.2, demonstrating that familial AML is a heterogeneous disease. After reviewing familial leukemia and observing anticipation in the form of a declining age of onset with each generation, we had proposed 9p21-22 and 16q22 as additional candidate loci. Whereas linkage to 9p21-22 can be excluded, the finding of a maximum two-point LOD score of 2.82 with the microsatellite marker D16S522 at a recombination fraction theta = 0 provides evidence supporting linkage to 16q22. Haplotype analysis reveals a 23.5-cM (17.9-Mb) commonly inherited region among all affected family members extending from D16S451 to D1GS289, In order to extract maximum linkage information with missing individuals, incomplete informativeness with individual markers in this interval, and possible deviance from strict autosomal dominant inheritance, we performed nonparametric linkage analysis (NPL) and found a maximum NPL statistic corresponding to a P-value of .00098, close to the maximum conditional probability of linkage expected for a pedigree with this structure. Mutational analysis in this region specifically excludes expansion of the AT-rich minisatellite repeat FRA16B fragile site and the CAG trinucleotide repeat in the E2F-4 transcription factor. The ''repeat expansion detection'' method, capable of detecting dynamic mutation associated with anticipation, more generally excludes large CAG repeat expansion as a cause of leukemia in this family.	UNIV WASHINGTON,DEPT MED,DIV GEN INTERNAL MED,SEATTLE,WA 98195; UNIV WASHINGTON,SCH MED,DEPT MED,MARKEY MOL MED CTR,SEATTLE,WA 98195; UNIV UTAH,ECCLES INST HUMAN GENET,SALT LAKE CITY,UT; UNIV ADELAIDE,WOMENS & CHILDRENS HOSP,DEPT CYTOGENET,ADELAIDE,SA,AUSTRALIA; UNIV ADELAIDE,DEPT GENET,ADELAIDE,SA,AUSTRALIA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Utah System of Higher Education; University of Utah; University of Adelaide; Womens & Childrens Hospital Australia; University of Adelaide	Horwitz, M (corresponding author), UNIV WASHINGTON,DEPT MED,DIV MED GENET,BOX 357720,SEATTLE,WA 98195, USA.		Mangelsdorf, Marie E/A-2318-2013	Mangelsdorf, Marie E/0000-0002-7855-7701; Richards, Robert Ian/0000-0002-5978-6453; Horwitz, Marshall/0000-0002-1683-1680	NCI NIH HHS [R37 CA16448] Funding Source: Medline; NHLBI NIH HHS [T32 HL07312] Funding Source: Medline; NICHD NIH HHS [HD0108-03] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA016448] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007312] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BLATTNER WA, 1978, ANN INTERN MED, V89, P173, DOI 10.7326/0003-4819-89-2-173; BLEYL S, 1995, AM J HUM GENET, V56, P408; BOEHNKE M, 1991, AM J HUM GENET, V48, P22; Buard J, 1997, NAT GENET, V15, P327, DOI 10.1038/ng0497-327; BUSQUE L, 1993, BLOOD, V82, P337; Castilla LH, 1996, CELL, V87, P687, DOI 10.1016/S0092-8674(00)81388-4; DOGGETT NA, 1995, NATURE, V377, pS335; DOWTON SB, 1985, BLOOD, V65, P557; EPSTEIN CJ, 1988, ANNU REV GENET, V22, P51, DOI 10.1146/annurev.ge.22.120188.000411; Epstein CJ, 1995, METABOLIC MOL BASES, VI, P749; Fasman KH, 1996, NUCLEIC ACIDS RES, V24, P57, DOI 10.1093/nar/24.1.57; FERRO MT, 1994, CANCER GENET CYTOGEN, V78, P160, DOI 10.1016/0165-4608(94)90084-1; FIALKOW PJ, 1991, BLOOD, V77, P1415; FITZGERALD PH, 1969, LANCET, V2, P752; Flanigan K, 1996, AM J HUM GENET, V59, P392; Francastel C, 1997, LEUKEMIA, V11, P273, DOI 10.1038/sj.leu.2400552; GINSBERG D, 1994, GENE DEV, V8, P2665, DOI 10.1101/gad.8.22.2665; GUNZ FW, 1978, J NATL CANCER I, V60, P1243, DOI 10.1093/jnci/60.6.1243; Ho CY, 1996, BLOOD, V87, P5218, DOI 10.1182/blood.V87.12.5218.bloodjournal87125218; Horwitz M, 1996, AM J HEMATOL, V52, P295, DOI 10.1002/(SICI)1096-8652(199608)52:4<295::AID-AJH9>3.0.CO;2-N; Horwitz M, 1997, LEUKEMIA, V11, P1347, DOI 10.1038/sj.leu.2400707; Horwitz M, 1996, AM J HUM GENET, V59, P990; IGARASHI K, 1995, P NATL ACAD SCI USA, V92, P7445, DOI 10.1073/pnas.92.16.7445; KATO S, 1983, AM J DIS CHILD, V137, P641, DOI 10.1001/archpedi.1983.02140330025007; KNUDSON AG, 1993, P NATL ACAD SCI USA, V90, P10914, DOI 10.1073/pnas.90.23.10914; KOZMAN HM, 1995, GENOMICS, V25, P44, DOI 10.1016/0888-7543(95)80108-X; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LASPADA AR, 1994, ANN NEUROL, V36, P814, DOI 10.1002/ana.410360604; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEBEAU MM, 1984, NATURE, V308, P607, DOI 10.1038/308607a0; Legare RD, 1995, BLOOD, V86, P3056; LEVANON D, 1994, GENOMICS, V23, P425, DOI 10.1006/geno.1994.1519; LI FP, 1981, CANCER GENET CYTOGEN, V4, P189, DOI 10.1016/0165-4608(81)90013-3; NAKAMURA T, 1993, P NATL ACAD SCI USA, V90, P4631, DOI 10.1073/pnas.90.10.4631; NISHIZAWA M, 1989, P NATL ACAD SCI USA, V86, P7711, DOI 10.1073/pnas.86.20.7711; Olopade OI, 1996, LEUKEMIA, V10, P669; PAUL B, 1987, BRIT J HAEMATOL, V65, P321, DOI 10.1111/j.1365-2141.1987.tb06860.x; RICHARDS RI, 1996, TODAY LIFE SCI, V8, P14; Sachs L, 1996, P NATL ACAD SCI USA, V93, P4742, DOI 10.1073/pnas.93.10.4742; SCHALLING M, 1993, NAT GENET, V4, P135, DOI 10.1038/ng0693-135; SCHWEITZER M, 1973, SCAND J HAEMATOL, V11, P97; SHEN Y, 1994, GENOMICS, V22, P68, DOI 10.1006/geno.1994.1346; Speck NA, 1995, CRIT REV EUKAR GENE, V5, P337, DOI 10.1615/CritRevEukarGeneExpr.v5.i3-4.60; SUTHERLAND GR, 1995, P NATL ACAD SCI USA, V92, P3636, DOI 10.1073/pnas.92.9.3636; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; WALKER GJ, 1994, GENOMICS, V20, P490, DOI 10.1006/geno.1994.1206; Wang Q, 1996, CELL, V87, P697, DOI 10.1016/S0092-8674(00)81389-6; WIJMENGA C, 1995, GENOMICS, V26, P611, DOI 10.1016/0888-7543(95)80185-O; YOSHIDA MC, 1991, CYTOGENET CELL GENET, V58, P2003; Yu S, 1997, CELL, V88, P367, DOI 10.1016/S0092-8674(00)81875-9; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	51	34	35	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1997	61	4					873	881		10.1086/514894	http://dx.doi.org/10.1086/514894			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YA591	9382098	Green Published, Bronze			2022-12-18	WOS:A1997YA59100014
J	Hasstedt, SJ; Hoffman, M; Leppert, MF; Elbein, SC				Hasstedt, SJ; Hoffman, M; Leppert, MF; Elbein, SC			Recessive inheritance of obesity in familial non-insulin-dependent diabetes mellitus, and lack of linkage to nine candidate genes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LIPOPROTEIN-LIPASE GENE; GLYCOGEN-SYNTHASE GENE; HUMAN OB GENE; BODY-MASS INDEX; BETA(3)-ADRENERGIC RECEPTOR GENE; NECROSIS-FACTOR-ALPHA; MAJOR GENE; QUANTITATIVE TRAITS; DNA POLYMORPHISMS; JAPANESE SUBJECTS	Segregation analysis of body-mass index (BMI) supported recessive inheritance of obesity, in pedigrees ascertained through siblings with non-insulin dependent diabetes mellitus (NIDDM), BMI was estimated as 39 kg/m(2) for those subjects homozygous at the inferred locus. Two-locus segregation analysis provided weak support for a second recessive locus, with BMI estimated as 32 kg/m(2) for homozygotes. NIDDM prevalence was increased among those subjects presumed to be homozygous at either locus, Using both parametric and nonparametric methods, we found no evidence of linkage of obesity to any of nine candidate genes/regions, including the Prader-Willi chromosomal region (PWS), the human homologue of the mouse agouti gene (ASP), and the genes for leptin (OB), the leptin receptor (OBR/DB), the beta(3)-adrenergic receptor (ADRB3), lipoprotein lipase (LPL), hepatic lipase (LIPC), glycogen synthase (GYS), and tumor necrosis factor alpha (TNFA).	UNIV UTAH,DIV ENDOCRINOL,DEPT MED,SALT LAKE CITY,UT 84112; VET AFFAIRS MED CTR,DIV ENDOCRINOL DIABET & METAB,SALT LAKE CITY,UT 84148	Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Hasstedt, SJ (corresponding author), UNIV UTAH,DEPT HUMAN GENET,15 N 2030E ROOM 2100,SALT LAKE CITY,UT 84112, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R23HD017463, R01HD017463] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK039311, R01DK039311] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR00064] Funding Source: Medline; NICHD NIH HHS [HD17463] Funding Source: Medline; NIDDK NIH HHS [DK39311] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHN YI, 1993, J LIPID RES, V34, P421; BJORBAEK C, 1994, DIABETES, V43, P976, DOI 10.2337/diabetes.43.8.976; BORECKI IB, 1993, AM J HUM GENET, V53, P676; BOUCHARD C, 1995, INT J OBESITY, V19, pS10; BOYLE CR, 1979, BIOMETRICS, V35, P55, DOI 10.2307/2529936; Brunzell J.D., 1995, METABOLIC MOL BASES, P1913; Bruskiewich R, 1996, CYTOGENET CELL GENET, V73, P331, DOI 10.1159/000134369; Candelore MR, 1996, ENDOCRINOLOGY, V137, P2638, DOI 10.1210/en.137.6.2638; CLEMENT K, 1995, NEW ENGL J MED, V333, P352, DOI 10.1056/NEJM199508103330605; Clement K, 1996, DIABETES, V45, P687, DOI 10.2337/diabetes.45.5.687; COMUZZIE AG, 1995, GENET EPIDEMIOL, V12, P475, DOI 10.1002/gepi.1370120505; Considine RV, 1996, DIABETES, V45, P992, DOI 10.2337/diabetes.45.7.992; Considine RV, 1996, BIOCHEM BIOPH RES CO, V220, P735, DOI 10.1006/bbrc.1996.0473; CURTIS D, 1993, HUM HERED, V43, P173, DOI 10.1159/000154174; DONALDSON MDC, 1994, ARCH DIS CHILD, V70, P58, DOI 10.1136/adc.70.1.58; Duggirala R, 1996, AM J HUM GENET, V59, P694; ECKEL RH, 1989, NEW ENGL J MED, V320, P1060; ELBEIN SC, 1995, DIABETES, V44, P1259, DOI 10.2337/diabetes.44.11.1259; ELBEIN SC, 1994, DIABETES, V43, P1061, DOI 10.2337/diabetes.43.8.1061; Elbein SC, 1996, J CLIN ENDOCR METAB, V81, P4422, DOI 10.1210/jc.81.12.4422; ELBEIN SC, 1994, J CLIN ENDOCR METAB, V79, P1450, DOI 10.1210/jc.79.5.1450; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; EMORINE L, 1994, TRENDS PHARMACOL SCI, V15, P3, DOI 10.1016/0165-6147(94)90118-X; FELBER JP, 1993, DIABETOLOGIA, V36, P1221, DOI 10.1007/BF00400798; FERRANNINI E, 1995, METABOLISM, V44, P15, DOI 10.1016/0026-0495(95)90313-5; Fujisawa T, 1996, DIABETOLOGIA, V39, P349, DOI 10.1007/s001250050452; GASSER T, 1995, ANN HUM BIOL, V22, P217, DOI 10.1080/03014469500003882; GILL PE, 1986, 862 SOL STANF U DEP; GROOP LC, 1993, NEW ENGL J MED, V328, P10, DOI 10.1056/NEJM199301073280102; HAMADA Y, 1995, DIABETOLOGIA, V38, P1249; HAMANN A, 1995, BIOCHEM BIOPH RES CO, V211, P833, DOI 10.1006/bbrc.1995.1887; HANSEN BC, 1995, DIABETES CARE, V18, pA2; HASSTEDT SJ, 1989, GENET EPIDEMIOL, V6, P319, DOI 10.1002/gepi.1370060203; HASSTEDT SJ, 1993, GENET EPIDEMIOL, V10, P145, DOI 10.1002/gepi.1370100302; HASSTEDT SJ, 1994, PAP PEDIGREE ANAL PA; HEGELE RA, 1993, ARTERIOSCLER THROMB, V13, P720, DOI 10.1161/01.ATV.13.5.720; HOTAMISLIGIL GS, 1994, DIABETES, V43, P1271, DOI 10.2337/diabetes.43.11.1271; JEMAA R, 1995, INT J OBESITY, V19, P270; KADOWAKI H, 1995, BIOCHEM BIOPH RES CO, V215, P555, DOI 10.1006/bbrc.1995.2500; KADOWAKI T, 1993, NEW ENGL J MED, V328, P1568; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; KUROYAMA H, 1994, DIABETOLOGIA, V37, P536, DOI 10.1007/s001250050144; KURSBAYASHI T, 1996, DIABETES, V45, P1358; KWON HY, 1994, P NATL ACAD SCI USA, V91, P9760, DOI 10.1073/pnas.91.21.9760; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; LEHTO M, 1993, GENOMICS, V15, P461; Li LS, 1996, DIABETOLOGIA, V39, P857, DOI 10.1007/s001250050521; Maffei M, 1996, DIABETES, V45, P679, DOI 10.2337/diabetes.45.5.679; MAGENIS RE, 1990, AM J MED GENET, V35, P333, DOI 10.1002/ajmg.1320350307; MIESENBOCK G, 1993, J CLIN INVEST, V91, P448, DOI 10.1172/JCI116222; MOLL PP, 1991, AM J HUM GENET, V49, P1243; MORTON NE, 1974, AM J HUM GENET, V26, P489; NEDWIN GE, 1985, NUCLEIC ACIDS RES, V13, P6361, DOI 10.1093/nar/13.17.6361; NESS R, 1991, HUM BIOL, V63, P39; Niki T, 1996, DIABETES, V45, P675, DOI 10.2337/diabetes.45.5.675; Norman RA, 1996, DIABETES, V45, P1229, DOI 10.2337/diabetes.45.9.1229; NORMAN RA, 1995, J CLIN INVEST, V96, P158, DOI 10.1172/JCI118016; OTT J, 1983, ANN HUM GENET, V47, P311, DOI 10.1111/j.1469-1809.1983.tb01001.x; PRICE RA, 1994, HUM BIOL, V66, P251; PRICE RA, 1990, HUM BIOL, V62, P747; Reed DR, 1996, DIABETES, V45, P691, DOI 10.2337/diabetes.45.5.691; REED DR, 1995, INT J OBESITY, V19, P599; SchalinJantti C, 1996, HYPERTENSION, V27, P67, DOI 10.1161/01.HYP.27.1.67; SCHUMACHER MC, 1992, DIABETES, V41, P416, DOI 10.2337/diabetes.41.4.416; SHIMOKAWA K, 1994, BIOCHEM BIOPH RES CO, V202, P463, DOI 10.1006/bbrc.1994.1951; SMITH CAB, 1961, 2ND P INT C HUM GEN, V1, P212; SPARKES R S, 1987, Genomics, V1, P138, DOI 10.1016/0888-7543(87)90005-X; Stern MP, 1996, DIABETES, V45, P563, DOI 10.2337/diabetes.45.5.563; STIRLING B, 1995, DIABETES, V44, P999, DOI 10.2337/diabetes.44.8.999; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; TENKANEN H, 1994, J LIPID RES, V35, P220; TIRET L, 1992, GENET EPIDEMIOL, V9, P398; UKKOLA O, 1995, ATHEROSCLEROSIS, V115, P99, DOI 10.1016/0021-9150(94)05504-C; WALSTON J, 1995, NEW ENGL J MED, V333, P343, DOI 10.1056/NEJM199508103330603; Wang XL, 1996, CIRCULATION, V93, P1339, DOI 10.1161/01.CIR.93.7.1339; WIDEN E, 1995, NEW ENGL J MED, V333, P348, DOI 10.1056/NEJM199508103330604; WILSON DE, 1990, J CLIN INVEST, V86, P735, DOI 10.1172/JCI114770; Xu W, 1995, Obes Res, V3, P559; YEN TT, 1994, FASEB J, V8, P479, DOI 10.1096/fasebj.8.8.8181666; YOUNG MR, 1988, AM J HUM GENET, V43, P705; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; ZOUALI H, 1993, NEW ENGL J MED, V328, P1568	83	34	37	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1997	61	3					668	677		10.1086/515509	http://dx.doi.org/10.1086/515509			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XY523	9326333	Green Published, Bronze			2022-12-18	WOS:A1997XY52300025
J	Richards, M; Macaulay, V; Sykes, B; Pettitt, P; Hedges, R; Forster, P; Bandelt, HJ				Richards, M; Macaulay, V; Sykes, B; Pettitt, P; Hedges, R; Forster, P; Bandelt, HJ			Paleolithic and neolithic lineages in the European mitochondrial gene pool - Reply	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							DNA; POPULATIONS; TRANSITION		UNIV OXFORD,INST MOL MED,DEPT CELLULAR SCI,OXFORD,ENGLAND; UNIV OXFORD,RES LAB ARCHAEOL,OXFORD,ENGLAND; UNIV HAMBURG,HEINRICH PETTE INST EXPT VIROL & IMMUNOL,D-2000 HAMBURG,GERMANY; UNIV HAMBURG,MATH SEMINAR,D-2000 HAMBURG,GERMANY	University of Oxford; University of Oxford; Heinrich Pette Institute; University of Hamburg; University of Hamburg			Pettitt, Paul/R-3539-2019					Ammerman A.J., 1984, NEOLITHIC TRANSITION; AMMERMAN AJ, 1989, ANTIQUITY, V63, P162, DOI 10.1017/S0003598X00075694; ArisBrosou S, 1996, MOL BIOL EVOL, V13, P494, DOI 10.1093/oxfordjournals.molbev.a025610; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; BANDELT HJ, 1995, GENETICS, V141, P743; BARTOLOMEI G, 1992, PREISTORIA ALPINA, V28, P131; Bendall KE, 1996, AM J HUM GENET, V59, P1276; BERTRANPETIT J, 1995, ANN HUM GENET, V59, P63, DOI 10.1111/j.1469-1809.1995.tb01606.x; BISCHOFF JL, 1989, J ARCHAEOL SCI, V16, P563, DOI 10.1016/0305-4403(89)90022-8; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; DJINDJIAN F, 1991, AURIGNACIEN EUROPE P, P136; Forster P, 1996, AM J HUM GENET, V59, P935; HAESAERTS P, 1990, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V60, P203; Hahn J., 1993, ORIGEN HOMBRE MODERN, P61; Harding RM, 1997, AM J HUM GENET, V60, P772; Howell N, 1996, AM J HUM GENET, V59, P501; Kozlowski JK., 1992, P PREHIST SOC, V58, P1; MELLARS PA, 1992, PHILOS T ROY SOC B, V337, P225, DOI 10.1098/rstb.1992.0100; MENOZZI P, 1978, SCIENCE, V201, P86; OTTE M, 1990, EMERGENCE MODERN HUM; Parsons TJ, 1997, NAT GENET, V15, P363, DOI 10.1038/ng0497-363; PULT I, 1994, BIOL CHEM H-S, V375, P837; Richards M, 1996, AM J HUM GENET, V59, P185; Semino O, 1996, AM J HUM GENET, V59, P964; STRAUS LG, 1994, EVOL ANTHOL, V3, P194; TEMPLETON AR, 1995, GENETICS, V140, P767; Thomas J., 1996, ORIGINS SPREAD AGR P, P310; Torroni A, 1996, GENETICS, V144, P1835; WARD RH, 1996, VARIATION HUMAN GENO; Whittle AWR., 1996, EUROPE NEOLITHIC CRE; Willis K. J., 1994, HOLOCENE, V4, P326, DOI DOI 10.1177/095968369400400313; ZVELEBIL M, 1989, ANTIQUITY, V63, P379, DOI 10.1017/S0003598X00076110	33	34	34	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1997	61	1					251	254						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM728					2022-12-18	WOS:A1997XM72800040
J	Bergen, AAB; Pinckers, AJLG				Bergen, AAB; Pinckers, AJLG			Localization of a novel X-linked progressive cone dystrophy gene to Xq27: Evidence for genetic heterogeneity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; DEGENERATION; CARRIERS; LOCUS	Clinical reexamination and DNA linkage analysis were carried out in an X-linked progressive cone dystrophy (XLPCD) family, previously described by Pinckers and Timmerman in 1981. In a large pedigree segregating XLPCD, by use of greater than or equal to 27 markers spanning the entire X chromosome, a novel locus for XLPCD was identified in Xq27. All other regions on the chromosome could be excluded. Since this novel locus is distinct from previously identified genes or regions involved in XLPCD, we further establish genetic heterogeneity underlying this disease entity.	UNIV NIJMEGEN,DEPT OPHTHALMOL,NIJMEGEN,NETHERLANDS	Radboud University Nijmegen	Bergen, AAB (corresponding author), NETHERLANDS OPHTHALM RES INST,POB 12141,NL-1100 AC AMSTERDAM,NETHERLANDS.		Bergen, Arthur/J-3637-2013	Bergen, Arthur/0000-0002-6333-9576				BARTLEY J, 1989, CYTOGENET CELL GENET, V51, P959; BERGEN AAB, 1993, GENOMICS, V18, P463, DOI 10.1006/geno.1993.1504; BERGEN AAB, 1991, HUM GENET, V88, P162, DOI 10.1007/BF00206065; BERGEN AAB, 1993, CYTOGENET CELL GENET, V624, P231; FLEISCHMAN JA, 1981, ARCH OPHTHALMOL-CHIC, V99, P468, DOI 10.1001/archopht.1981.03930010470016; HECKENLIVELY JR, 1986, ARCH OPHTHALMOL-CHIC, V104, P324; HONG HK, 1994, AM J HUM GENET, V55, P1173; HONG HK, 1991, AM J HUM GENET, V49, P138; JACOBSON DM, 1989, OPHTHALMOLOGY, V96, P885; KEUNEN JEE, 1990, ARCH OPHTHALMOL-CHIC, V108, P1713, DOI 10.1001/archopht.1990.01070140067031; MEIRE FM, 1994, BRIT J OPHTHALMOL, V78, P103, DOI 10.1136/bjo.78.2.103; NATHANS J, 1989, SCIENCE, V245, P831, DOI 10.1126/science.2788922; PINCKERS A, 1992, INT OPHTHALMOL, V16, P185, DOI 10.1007/BF00916439; PINCKERS A, 1987, INT OPHTHALMOL, V10, P241, DOI 10.1007/BF00155631; PINCKERS A, 1981, OPHTHALMIC PAED GEN, V1, P17, DOI 10.3109/13816818109036022; PINCKERS A, 1981, OPHTHALMIC PAED GEN, V1, P25, DOI 10.3109/13816818109036023; REICHEL E, 1989, AM J OPHTHALMOL, V108, P540, DOI 10.1016/0002-9394(89)90431-5; VANEVERDINGEN JAM, 1992, J MED GENET, V29, P291, DOI 10.1136/jmg.29.5.291; VERDOORN C, 1988, DOC OPHTHALMOL, V70, P195, DOI 10.1007/BF00154453	19	34	35	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1997	60	6					1468	1473		10.1086/515458	http://dx.doi.org/10.1086/515458			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XE294	9199568	Green Published, Bronze, Green Submitted			2022-12-18	WOS:A1997XE29400025
J	Pokorski, RJ				Pokorski, RJ			Insurance underwriting in the genetic era	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TERM-CARE INSURANCE; ALZHEIMERS-DISEASE; DEMENTIA	Genetic technology is assuming a greater role in the practice of medicine. Insurers have a vested interest because individually underwritten insurance cannot be sold without risk classification, and much of the medical information needed to classify risks will have a genetic component. This paper reviews recent genetic advances and their potential impact on life, disability income, long-term care, and critical illness insurance. Alzheimer disease is chosen to illustrate the effect of an organized effort to withhold medical information from insurance companies. Consumers will not support a private insurance mechanism with extensive cross-subsidization among policyholders and where medical information becomes inviolate simply because it is genetic. A framework for deliberations with the medical community is proposed.			Pokorski, RJ (corresponding author), SWISS RE,60 KATONA DR,SUITE 19,FAIRFIELD,CT 06430, USA.							Abati A, 1996, CANCER, V78, P1; *AD HOC COMM GEN T, 1995, AM J HUM GENET, V56, P327; ADELSBERGER B, 1996, AIR FORCE TIMES 0212; *ALL GEN SUPP GROU, 1994, INF CONS PART GEN RE; *AM AC ACT, 1980, J AM ACAD ACTUARIES, V6, P132; *AM COUNC LIF INS, 1995, 1995 LIF INS FACT BO; *AM COUNC LIF INS, 1994, 1994 LIF INS FACT BO; [Anonymous], 1995, JAMA, V274, P1627; BARINAGA M, 1995, SCIENCE, V268, P1845, DOI 10.1126/science.7604254; BEAM BT, 1994, MCGILLS LIFE INSURAN, P687; BEARDSLEY T, 1996, SCI AM           MAR, P100; BECKER DN, 1984, BESTS REV        SEP, P154; BECKER DN, 1984, BESTS REV        SEP, P155; BECKER DN, 1984, BESTS REV        SEP, P26; BECKER DN, 1984, BESTS REV        SEP, P28; *BERKSH LIF, 1993, AFIELD           MAY, P9; Bernstein T, 1994, RADON RENTAL HOUSING; Blass JP, 1996, J AM GERIATR SOC, V44, P209, DOI 10.1111/j.1532-5415.1996.tb02443.x; *BOARD TRUST FED O, 1995, 1995 ANN REP; CORONEL S, 1995, LONG TERM CARE INSUR; COTTON P, 1995, JAMA-J AM MED ASSOC, V273, P93, DOI 10.1001/jama.273.2.93; DIXON M, 1995, MONITORING ATTITUDES; EARLEY CL, 1995, AM J HUM GENET, V57, P727; *FIN SERV PUBL, 1995, YOUR 1995 FIN PLANN; Geller Lisa N, 1996, Sci Eng Ethics, V2, P71, DOI 10.1007/BF02639319; Ghossein RA, 1996, CANCER-AM CANCER SOC, V78, P10, DOI 10.1002/(SICI)1097-0142(19960701)78:1<10::AID-CNCR3>3.3.CO;2-T; GILBERT S, 1995, NY TIMES        1213, pC13; GROSS JD, 1995, SCIENCE, V270, P1282; *HOM OFF REF LAB, 1994, INSIGHT, V8, P10; HUBER P, 1992, FORBES          0928, P146; HYMAN BT, 1995, NEW ENGL J MED, V333, P1283, DOI 10.1056/NEJM199511093331910; JOST BC, 1995, J AM GERIATR SOC, V43, P1248, DOI 10.1111/j.1532-5415.1995.tb07401.x; KING RA, 1992, GENETIC BASIS COMMON; KOCO L, 1996, NATL UNDERWRITE 0429, P21; Lerman C, 1996, Oncology (Williston Park), V10, P191; LEVINE AJ, 1995, JAMA-J AM MED ASSOC, V273, P592, DOI 10.1001/jama.273.7.592; MACLEAN JB, 1939, LIFE INSURANCE; Masood E, 1996, NATURE, V379, P389, DOI 10.1038/379389a0; MCGILL DM, 1994, MCGILLS LIFE INSURAN, P19; Mehlman MJ, 1996, AM J HUM GENET, V58, P393; MURTAUGH CM, 1995, INQUIRY-J HEALTH CAR, V32, P271; MYERS RJ, 1996, SUMMARY PROVISIONS O; *NAT CTR HUM GEN R, 1993, NIH PUBL; Nelson NJ, 1996, J NATL CANCER I, V88, P70, DOI 10.1093/jnci/88.2.70-a; NORTON EC, 1994, JAMA-J AM MED ASSOC, V271, P1520, DOI 10.1001/jama.271.19.1520; OSTRER H, 1993, AM J HUM GENET, V52, P565; Parnetti L, 1996, J AM GERIATR SOC, V44, P133, DOI 10.1111/j.1532-5415.1996.tb02428.x; Perera FP, 1996, JNCI-J NATL CANCER I, V88, P496, DOI 10.1093/jnci/88.8.496; PESHKIN BN, 1996, ONCOLOGY, V10, P176; PILGRIM JW, 1990, 1990 ANN M SOC ACT O; POKORSKI RJ, 1995, NATURE, V376, P13, DOI 10.1038/376013a0; POLVIKOSKI T, 1995, NEW ENGL J MED, V333, P1242, DOI 10.1056/NEJM199511093331902; POST SG, 1994, CLIN GERIATR MED, V10, P379, DOI 10.1016/S0749-0690(18)30352-5; QUINT M, 1994, NY TIMES        1128, pD1; RAND TG, 1993, ACP OBSERVER     APR, P12; ROSS PE, 1995, FORBES          1009, P118; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Skolnick AA, 1996, JAMA-J AM MED ASSOC, V275, P581; SMITH CC, 1979, TRANSACTIONS, V5, P863; *SOC ACT, 1982, 1975 80 15 YEAR SEL, P55; *SOC ACT, 1989, ACT STAND PRACT 12 C, P1; Stephenson J, 1996, JAMA-J AM MED ASSOC, V275, P503, DOI 10.1001/jama.275.7.503; *SWISS REINS, 1994, LIF UND SWISS RE MOR; TROWBRIDGE CL, 1989, FUNDEMENTAL CONCEPTS, P53; *US DEP LAB, 1995, EMPL BEN MED LARG PR; VOELKER R, 1996, JAMA-J AM MED ASSOC, V275, P584; ZOLER ML, 1991, MED WORLD NEWS   JAN, P32; 1991, NATURE, V352, P11; 1996, NATURE, V379, P379; 1996, LANCET, V347, P133	70	34	34	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1997	60	1					205	216						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	WA818	8981964				2022-12-18	WOS:A1997WA81800027
J	Robinson, WP				Robinson, WP			The extent, mechanism, and consequences of genetic variation, for recombination rate	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							MAJOR HISTOCOMPATIBILITY COMPLEX; HYPERVARIABLE MINISATELLITE REGIONS; MEIOTIC RECOMBINATION; CAENORHABDITIS-ELEGANS; DROSOPHILA-MELANOGASTER; PERICENTRIC-INVERSION; CROSSING-OVER; HOT-SPOT; SACCHAROMYCES-CEREVISIAE; LINKAGE DISEQUILIBRIUM				Robinson, WP (corresponding author), BRITISH COLUMBIA CHILDRENS HOSP, DEPT MED GENET, C234-4500 OAK ST, VANCOUVER, BC Y6H 3N1, CANADA.		Robinson, Wendy P/I-9590-2014; Robinson, Wendy/AAB-6420-2020	Robinson, Wendy P/0000-0002-2010-6174; Robinson, Wendy/0000-0002-2010-6174				[Anonymous], 1992, Science, V258, P67; ASHLEY T, 1993, CHROMOSOMA, V102, P112, DOI 10.1007/BF00356028; ASHLEY T, 1994, HUM GENET, V94, P587, DOI 10.1007/BF00206950; BAKER BS, 1976, ANNU REV GENET, V10, P53, DOI 10.1146/annurev.ge.10.120176.000413; BARNES TM, 1995, GENETICS, V141, P159; Bridges CB, 1915, J EXP ZOOL, V19, P1, DOI 10.1002/jez.1400190102; BROOKS LD, 1986, GENETICS, V114, P525; Brooks LD., 1988, EVOLUTION SEX, P87; BUETOW KH, 1991, AM J HUM GENET, V48, P911; CHANDLEY AC, 1988, CYTOGENET CELL GENET, V48, P152, DOI 10.1159/000132613; CHANDLEY AC, 1987, J MED GENET, V24, P325, DOI 10.1136/jmg.24.6.325; Charlesworth B, 1996, GENET RES, V67, P27, DOI 10.1017/S0016672300033450; CHENG N, 1996, KEYST S MOL CELL BIO, P15; CHINNICI JP, 1971, GENETICS, V69, P71; CHURCH K, 1969, CAN J GENET CYTOL, V11, P209, DOI 10.1139/g69-025; COYNE JA, 1993, GENETICS, V134, P487; de Boer P, 1977, Heredity (Edinb), V39, P335, DOI 10.1038/hdy.1977.74; DEBRAEKELEER M, 1991, HUM REPROD, V6, P245, DOI 10.1093/oxfordjournals.humrep.a137315; Detlefsen JA, 1921, J EXP ZOOL, V32, P333, DOI 10.1002/jez.1400320206; EGEL R, 1995, TRENDS GENET, V11, P206, DOI 10.1016/S0168-9525(00)89046-0; ESPOSITO MS, 1994, CURR GENET, V25, P1, DOI 10.1007/BF00712959; Fisher R., 1930, GENETICAL THEORY NAT; FISHERLINDAHL K, 1991, TRENDS GENET, V7, P273; GABRIELROBEZ O, 1988, CYTOGENET CELL GENET, V48, P84, DOI 10.1159/000132595; GERMAN J, 1974, CHROMOSOMES CANCER, P601; GRELL RF, 1966, GENETICS, V54, P411; GRIFFIN DK, 1995, HUM MOL GENET, V4, P2227, DOI 10.1093/hmg/4.12.2227; HANDEL MA, 1992, BIOESSAYS, V14, P817, DOI 10.1002/bies.950141205; HARI KL, 1995, CELL, V82, P815, DOI 10.1016/0092-8674(95)90478-6; HAWLEY RS, 1980, GENETICS, V94, P625; HAWLEY RS, 1993, CELL, V72, P301, DOI 10.1016/0092-8674(93)90108-3; HAWLEY RS, 1993, ANNU REV GENET, V27, P281; HAWLEY RS, 1994, HUM MOL GENET, V3, P1521, DOI 10.1093/hmg/3.9.1521; HAYDEN MS, 1992, DEV GENET, V13, P498, DOI 10.1002/dvg.1020130611; HEINE D, 1994, GENOMICS, V23, P168, DOI 10.1006/geno.1994.1474; HIMMELBAUER H, 1993, GENOMICS, V17, P110, DOI 10.1006/geno.1993.1291; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; KIDWELL MG, 1972, GENETICS, V70, P419; KLITZ W, 1995, AM J HUM GENET, V57, P1436; KLITZ W, 1987, GENETICS, V116, P633; Koehler KE, 1996, HUM MOL GENET, V5, P1495, DOI 10.1093/hmg/5.Supplement_1.1495; LAURIE DA, 1985, ANN HUM GENET, V49, P203, DOI 10.1111/j.1469-1809.1985.tb01694.x; LAURIE DA, 1981, HEREDITY, V47, P409, DOI 10.1038/hdy.1981.102; LAURIE DA, 1981, CYTOGENET CELL GENET, V31, P153, DOI 10.1159/000131641; LEDBETTER DH, 1995, HUM MOL GENET, V4, P1757, DOI 10.1093/hmg/4.suppl_1.1757; Levo A, 1996, IMMUNOGENETICS, V43, P136; LISKAY RM, 1987, GENETICS, V115, P161; MAGUIRE MP, 1968, GENETICS, V60, P353; MARTIN RH, 1987, HUM GENET, V77, P108, DOI 10.1007/BF00272374; MARTIN RH, 1983, HUM GENET, V63, P305, DOI 10.1007/BF00274750; MARTIN RH, 1995, AM J HUM GENET, V57, P1395; McKee BD, 1996, BIOESSAYS, V18, P411, DOI 10.1002/bies.950180511; MCNELLYINGLE CA, 1966, GENET RES, V7, P169, DOI 10.1017/S0016672300009599; METZENBERG AB, 1991, GENETICS, V128, P143; MICIC M, 1982, CLIN GENET, V22, P266; Munne S, 1996, CYTOGENET CELL GENET, V72, P43, DOI 10.1159/000134158; PALDI A, 1995, CURR BIOL, V5, P1030, DOI 10.1016/S0960-9822(95)00207-7; PETERSON AC, 1995, HUM MOL GENET, V4, P887, DOI 10.1093/hmg/4.5.887; Petes T. D., 1991, MOL CELLULAR BIOL YE, P407; Plough HH, 1917, J EXP ZOOL, V24, P147, DOI 10.1002/jez.1400240202; REEVES RH, 1990, GENOMICS, V8, P141, DOI 10.1016/0888-7543(90)90236-N; REEVES RH, 1991, MAMM GENOME, V1, P158, DOI 10.1007/BF00351062; ROBINSON WP, 1995, HUM MOL GENET, V4, P801, DOI 10.1093/hmg/4.5.801; ROBINSON WP, 1991, GENETICS, V129, P931; ROSE AM, 1979, GENETICS, V92, P409; ROSSI JM, 1994, GENOMICS, V23, P178, DOI 10.1006/geno.1994.1475; SANTANGELO DB, 1992, GENOMICS, V13, P1334, DOI 10.1016/0888-7543(92)90061-V; SCHULTZ J, 1951, COLD SPRING HARB SYM, V16, P175, DOI 10.1101/SQB.1951.016.01.015; Shashi V, 1996, AM J HUM GENET, V58, P1231; SHENKAR R, 1991, MOL CELL BIOL, V11, P1813, DOI 10.1128/MCB.11.4.1813; SHIROISHI T, 1993, GENETICA, V88, P187, DOI 10.1007/BF02424475; SIMCHEN G, 1969, NATURE, V222, P329, DOI 10.1038/222329a0; SKAKKEBAEK NE, 1973, J REPROD FERTIL, V35, P23; SQUITIERI F, 1994, HUM MOL GENET, V3, P2103, DOI 10.1093/hmg/3.12.2103; SUNG P, 1993, NATURE, V365, P852, DOI 10.1038/365852a0; TANZI RE, 1992, AM J HUM GENET, V50, P551; THOMSEN M, 1994, EUR J IMMUNOGENET, V21, P33, DOI 10.1111/j.1744-313X.1994.tb00174.x; THOMSON G, 1991, HLA 1991, P485; VILLENEUVE AM, 1994, GENETICS, V136, P887; WAHLS WP, 1990, CELL, V60, P95, DOI 10.1016/0092-8674(90)90719-U; WILLIAMSON JH, 1970, MUTAT RES, V9, P287, DOI 10.1016/0027-5107(70)90130-2; WU TC, 1995, GENETICS, V140, P55; WU TC, 1994, SCIENCE, V263, P515, DOI 10.1126/science.8290959; Xu Y., 1994, American Journal of Human Genetics, V55, pA136; YAMAMOTO M, 1979, GENETICS, V93, P437; YOSHINO M, 1995, GENOMICS, V27, P298, DOI 10.1006/geno.1995.1046; YOSHINO M, 1994, IMMUNOGENETICS, V39, P381, DOI 10.1007/BF00176154; Yu J, 1996, AM J HUM GENET, V59, P1186; ZETKA M, 1995, TRENDS GENET, V11, P27, DOI 10.1016/S0168-9525(00)88983-0; ZETKA MC, 1995, GENETICS, V141, P1339; ZETKA MC, 1992, GENETICS, V131, P321	91	34	35	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1996	59	6					1175	1183						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV315	8940261				2022-12-18	WOS:A1996VV31500002
J	White, LM; Rogan, PK; Nicholls, RD; Wu, BL; Korf, B; Knoll, JHM				White, LM; Rogan, PK; Nicholls, RD; Wu, BL; Korf, B; Knoll, JHM			Allele-specific replication of 15q11-q13 loci: A diagnostic test for detection of uniparental disomy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRADER-WILLI-SYNDROME; ANGELMAN SYNDROME; DNA METHYLATION; INSITU HYBRIDIZATION; CHROMOSOME-15 DELETION; MOLECULAR DIAGNOSIS; FAMILIAL ANGELMAN; PARENTAL ORIGIN; SYNDROME REGION; EXPRESSED GENE	Allele-specific replication differences have been observed in imprinted chromosomal regions, We have exploited this characteristic of an imprinted region by using FISH at D15S9 and SNRPN (small nuclear ribonucleo protein N) on interphase nuclei to distinguish between Angelman and Prader-Willi syndrome patient samples with uniparental disomy of chromosome 15q11-q13 (n = 11) from those with biparental inheritance (n = 13), The familial recurrence risks are low when the child has de novo uniparental disomy and may be as high as 50% when the child has biparental inheritance, The frequency of interphase cells with asynchronous replication was significantly lower in patients with uniparental disomy than in patients with biparental inheritance, Within the sample population of patients with biparental inheritance, those with altered methylation and presumably imprinting center mutations could nor be distinguished from those with no currently detectable mutation, This test is cost effective because it is performed on interphase cells from the same hybridized cytological preparation in which a deletion is excluded, and additional specimens are nor required to determine the parental origin of chromosome 15.	CHILDRENS HOSP,DIV GENET,BOSTON,MA 02115; HARVARD UNIV,BETH ISRAEL HOSP,SCH MED,DEPT PATHOL,BOSTON,MA; PENN STATE UNIV,COLL MED,DEPT PEDIAT,DIV GENET,HERSHEY,PA; CASE WESTERN RESERVE UNIV,DEPT GENET,CLEVELAND,OH 44106; CASE WESTERN RESERVE UNIV,CTR HUMAN GENET,CLEVELAND,OH 44106	Harvard University; Boston Children's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Case Western Reserve University; Case Western Reserve University			Korf, Bruce R/H-4882-2012; Rogan, Peter/B-9845-2017	Rogan, Peter/0000-0003-2070-5254; Knoll, Joan/0000-0001-6691-1710	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R55HD029098, P01HD018658] Funding Source: NIH RePORTER; NICHD NIH HHS [HD29098-01, HD18658] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BUITING K, 1994, HUM MOL GENET, V3, P893, DOI 10.1093/hmg/3.6.893; BUITING K, 1995, NAT GENET, V9, P396; BUTLER MG, 1983, LANCET, V1, P1285; BUTLER MG, 1986, AM J MED GENET, V23, P793, DOI 10.1002/ajmg.1320230307; CLAYTONSMITH J, 1993, AM J MED GENET, V47, P683, DOI 10.1002/ajmg.1320470519; CREMER T, 1988, HUM GENET, V80, P235, DOI 10.1007/BF01790091; DITTRICH B, 1992, HUM GENET, V90, P313; DONLON TA, 1986, P NATL ACAD SCI USA, V83, P6964; DONLON TA, 1986, P NATL ACAD SCI USA, V83, P4408, DOI 10.1073/pnas.83.12.4408; DRISCOLL DJ, 1992, GENOMICS, V13, P917, DOI 10.1016/0888-7543(92)90001-9; GLENN CC, 1993, HUM MOL GENET, V2, P2001, DOI 10.1093/hmg/2.12.2001; GLENN CC, 1993, HUM MOL GENET, V2, P1377, DOI 10.1093/hmg/2.9.1377; Glenn CC, 1996, AM J HUM GENET, V58, P335; HANSEN RS, 1995, HUM MOL GENET, V4, P813; KAPLAN LC, 1987, AM J MED GENET, V28, P45, DOI 10.1002/ajmg.1320280107; KITSBERG D, 1993, NATURE, V364, P459, DOI 10.1038/364459a0; KNOLL JHM, 1991, AM J HUM GENET, V48, P16; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; KNOLL JHM, 1993, HUM MOL GENET, V2, P183, DOI 10.1093/hmg/2.2.183; KNOLL JHM, 1994, NAT GENET, V6, P41, DOI 10.1038/ng0194-41; KNOLL JHM, 1994, CURRENT PROTOCOLS HU, V1; Kuwano Akira, 1992, Human Molecular Genetics, V1, P417, DOI 10.1093/hmg/1.6.417; LASALLE JM, 1995, NAT GENET, V9, P386, DOI 10.1038/ng0495-386; LEDBETTER DH, 1981, NEW ENGL J MED, V304, P325, DOI 10.1056/NEJM198102053040604; MAGENIS ER, 1989, AM J MED GENET, V35, P333; MALCOLM S, 1991, LANCET, V337, P694, DOI 10.1016/0140-6736(91)90278-W; MALCOLM S, 1994, CYTOGENET CELL GENET, V67, P1, DOI 10.1159/000133717; MASCARI MJ, 1992, NEW ENGL J MED, V326, P1599, DOI 10.1056/NEJM199206113262404; MEIJERSHEIJBOER EJ, 1992, J MED GENET, V29, P853, DOI 10.1136/jmg.29.12.853; MUTIRANGURA A, 1993, GENOMICS, V18, P546, DOI 10.1016/S0888-7543(11)80011-X; NAKAO M, 1994, HUM MOL GENET, V3, P309, DOI 10.1093/hmg/3.2.309; NICHOLLS RD, 1989, AM J MED GENET, V33, P66, DOI 10.1002/ajmg.1320330109; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; OZCELIK T, 1992, NAT GENET, V2, P265, DOI 10.1038/ng1292-265; REED ML, 1994, NAT GENET, V6, P163, DOI 10.1038/ng0294-163; REIS A, 1994, AM J HUM GENET, V54, P741; Ried Thomas, 1992, Human Molecular Genetics, V1, P307, DOI 10.1093/hmg/1.5.307; SAITOH S, IN PRESS P NATL ACAD; SURCLIFFE JS, 1994, NAT GENET, V8, P52; TKACHUK DC, 1990, SCIENCE, V250, P559, DOI 10.1126/science.2237408; WAGSTAFF J, 1992, NAT GENET, V1, P291, DOI 10.1038/ng0792-291; WEBB T, 1995, J MED GENET, V32, P181, DOI 10.1136/jmg.32.3.181; WEVRICK R, 1994, HUM MOL GENET, V3, P1877, DOI 10.1093/hmg/3.10.1877; WILLIAMS CA, 1990, AM J MED GENET, V35, P350, DOI 10.1002/ajmg.1320350308; WILLIAMS CA, 1995, AM J MED GENET, V56, P237, DOI 10.1002/ajmg.1320560224; WOODAGE T, 1994, AM J MED GENET, V54, P219, DOI 10.1002/ajmg.1320540308	46	34	37	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1996	59	2					423	430						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VM288	8755930				2022-12-18	WOS:A1996VM28800019
J	NOTHEN, MM; EGGERMANN, K; ALBUS, M; BORRMANN, M; RIETSCHEL, M; KORNER, J; MAIER, W; MINGES, J; LICHTERMANN, D; FRANZEK, E; WEIGELT, B; KNAPP, M; PROPPING, P				NOTHEN, MM; EGGERMANN, K; ALBUS, M; BORRMANN, M; RIETSCHEL, M; KORNER, J; MAIER, W; MINGES, J; LICHTERMANN, D; FRANZEK, E; WEIGELT, B; KNAPP, M; PROPPING, P			ASSOCIATION ANALYSIS OF THE MONOAMINE-OXIDASE-A GENE IN BIPOLAR AFFECTIVE-DISORDER BY USING FAMILY-BASED INTERNAL CONTROLS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							HAPLOTYPE		UNIV BONN,DEPT PSYCHIAT,D-53111 BONN,GERMANY; UNIV BONN,INST MED STAT,D-53111 BONN,GERMANY; STATE MENTAL HOSP,HAAR,GERMANY; UNIV MAINZ,DEPT PSYCHIAT,W-6500 MAINZ,GERMANY; UNIV WURZBURG,DEPT PSYCHIAT,W-8700 WURZBURG,GERMANY; UNIV DRESDEN,DEPT PSYCHIAT,DRESDEN,GERMANY	University of Bonn; University of Bonn; Johannes Gutenberg University of Mainz; University of Wurzburg; Technische Universitat Dresden	NOTHEN, MM (corresponding author), UNIV BONN,INST HUMANGENET,WILHELMSTR 31,D-53111 BONN,GERMANY.		Nöthen, Markus/B-2027-2009	Nöthen, Markus/0000-0002-8770-2464; Gill, Michael/0000-0003-0206-5337				ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; KAWADA Y, 1995, AM J HUM GENET, V56, P335; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LIM LCC, 1994, AM J HUM GENET, V54, P1122; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; 1987, DIAGNOSTIC STATISTIC	7	34	36	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1995	57	4					975	977						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RV793	7573065				2022-12-18	WOS:A1995RV79300035
J	BLOUIN, JL; CHRISTIE, DH; GOS, A; LYNN, A; MORRIS, MA; LEDBETTER, DH; CHAKRAVARTI, A; ANTONARAKIS, SE				BLOUIN, JL; CHRISTIE, DH; GOS, A; LYNN, A; MORRIS, MA; LEDBETTER, DH; CHAKRAVARTI, A; ANTONARAKIS, SE			A NEW DINUCLEOTIDE REPEAT POLYMORPHISM AT THE TELOMERE OF CHROMOSOME 21Q REVEALS A SIGNIFICANT DIFFERENCE BETWEEN MALE AND FEMALE RATES OF RECOMBINATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA POLYMORPHISMS; HUMAN GENOME; REDUCED RECOMBINATION; PARENTAL ORIGIN; TRISOMY-21; SEQUENCE; NONDISJUNCTION; METAPHASE; LINKAGE; MARKERS	We have used a half-YAC containing the human chromosome 21 long-arm telomere to clone, map, and characterize a new dinucleotide repeat polymorphism (D21S1575) close to 21qter. This marker is <120 kb from the telomeric (TTAGGG)(n) sequences and is the most distal highly polymorphic marker on chromosome 21q. This marker has a heterozygosity of 71% because of a variable (TA), repeat embedded within a long interspersed element (LINE) element. Genotyping of the CEPH families and linkage analysis provided a more accurate determination of the full length of the chromosome 21 genetic map. A highly significant difference was detected between male and female recombination rates in the telomeric region: in the most telomeric 2.3 Mb of chromosome 21q, recombination was only observed in male meioses.	CANTONAL HOSP,DIV MED GENET,GENEVA,SWITZERLAND; UNIV GENEVA,SCH MED,DEPT GENET & MICROBIOL,GENES R US LAB HUMAN MOLEC GENET,GENEVA,SWITZERLAND; CASE WESTERN RESERVE UNIV,DEPT GENET,CLEVELAND,OH; UNIV HOSP CLEVELAND,CLEVELAND,OH; NIH,NATL CTR HUMAN GENOME RES,BETHESDA,MD	University of Geneva; University of Geneva; Case Western Reserve University; University Hospitals of Cleveland; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)			Christie, Derek/AAU-2930-2020; Antonarakis, Stylianos E/N-8866-2014; Christie, Derek PTH/A-3273-2016	Christie, Derek/0000-0001-7642-0245; Antonarakis, Stylianos E/0000-0001-8907-5823; Christie, Derek PTH/0000-0001-7642-0245				[Anonymous], 1994, CELL, V77, P881; ANTONARAKIS SE, 1993, NAT GENET, V3, P146, DOI 10.1038/ng0293-146; ANTONARAKIS SE, 1991, NEW ENGL J MED, V324, P872, DOI 10.1056/NEJM199103283241302; ANTONARAKIS SE, 1992, AM J HUM GENET, V50, P544; ASHLEY T, 1993, CYTOGENET CELL GENET, V62, P169, DOI 10.1159/000133464; ASHLEY T, 1994, HUM GENET, V94, P587, DOI 10.1007/BF00206950; ASHLEY T, 1994, CHROMOSOME, V102, P112; BROWN WRA, 1989, NATURE, V338, P774, DOI 10.1038/338774a0; CHEN HM, 1994, HUM MUTAT, V4, P208, DOI 10.1002/humu.1380040306; DOMBROSKI BA, 1991, SCIENCE, V254, P1805, DOI 10.1126/science.1662412; ECONOMOU EP, 1990, P NATL ACAD SCI USA, V87, P2951, DOI 10.1073/pnas.87.8.2951; European Chromosome 16 Tuberous Sclerosis C., 1993, CELL, V75, P1305; FLINT J, 1995, NAT GENET, V9, P132, DOI 10.1038/ng0295-132; HAMER DH, 1993, SCIENCE, V261, P321, DOI 10.1126/science.8332896; HING AV, 1993, AM J HUM GENET, V53, P509; HULTEN M, 1974, HEREDITAS, V76, P55; LICHTER P, 1988, HUM GENET, V80, P224, DOI 10.1007/BF01790090; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; MCINNIS MG, 1993, GENOMICS, V16, P562, DOI 10.1006/geno.1993.1231; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; PATTERSON D, 1993, PROGR CLIN BIOL RES, V304, P33; PETERSEN MB, 1991, AM J HUM GENET, V48, P65; RESTON JT, 1995, GENOMICS, V26, P31, DOI 10.1016/0888-7543(95)80079-2; ROGNER UC, 1994, HUM MOL GENET, V3, P2137, DOI 10.1093/hmg/3.12.2137; ROUYER F, 1990, EMBO J, V9, P505, DOI 10.1002/j.1460-2075.1990.tb08137.x; SACCONE S, 1992, P NATL ACAD SCI USA, V89, P4913, DOI 10.1073/pnas.89.11.4913; SACCONE S, 1993, P NATL ACAD SCI USA, V90, P11929, DOI 10.1073/pnas.90.24.11929; SHERMAN SL, 1991, AM J HUM GENET, V49, P608; SHERMAN SL, 1994, HUM MOL GENET, V3, P1529, DOI 10.1093/hmg/3.9.1529; SHIMIZU N, IN PRESS CYTOCGENET; SOEDA E, 1995, GENOMICS, V25, P73, DOI 10.1016/0888-7543(95)80111-X; WARREN AC, 1987, SCIENCE, V237, P652, DOI 10.1126/science.2955519; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; WILKIE AOM, 1990, AM J HUM GENET, V46, P1112; 1993, CELL, V72, P971	35	34	35	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1995	57	2					388	394						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RL771	7668265				2022-12-18	WOS:A1995RL77100022
J	COX, DW				COX, DW			GENES OF THE COPPER PATHWAY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							WILSON DISEASE GENE; MENKES DISEASE; CANDIDATE GENE; TRANSPORTING ATPASE; ESTERASE-D; CERULOPLASMIN; METABOLISM; RESISTANCE; DEFICIENCY; TOXICOSIS		UNIV TORONTO,DEPT MOLEC & MED GENET,TORONTO,ON,CANADA; UNIV TORONTO,DEPT PAEDIAT,TORONTO,ON M5S 1A1,CANADA	University of Toronto; University of Toronto	COX, DW (corresponding author), HOSP SICK CHILDREN,RES INST,DEPT GENET,555 UNIV AVE,TORONTO,ON M5G 1X8,CANADA.							ASKWITH C, 1994, CELL, V76, P403, DOI 10.1016/0092-8674(94)90346-8; BOWCOCK AM, 1988, AM J HUM GENET, V43, P664; BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; BULLPC, 1994, TRENDS GENET, V10, P246; CALLAHAN HL, 1991, J BIOL CHEM, V266, P18427; CHELLY J, 1993, NAT GENET, V3, P14, DOI 10.1038/ng0193-14; COUSINS RJ, 1985, PHYSIOL REV, V65, P238, DOI 10.1152/physrev.1985.65.2.238; COX DW, 1972, AM J HUM GENET, V24, P646; CZAJA MJ, 1987, J CLIN INVEST, V80, P1200, DOI 10.1172/JCI113180; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; Danks DM, 1989, METABOLIC BASIS INHE, P1411; DAS S, 1994, AM J HUM GENET, V55, P883; DAS S, 1995, AM J HUM GENET, V56, P570; EPSTEIN O, 1981, J CLIN PATHOL, V34, P1071, DOI 10.1136/jcp.34.10.1071; FRYDMAN M, 1985, P NATL ACAD SCI USA, V82, P1819, DOI 10.1073/pnas.82.6.1819; HALLIWELL B, 1994, NUTR REV, V52, P253; IAZWINSKA EC, 1993, AM J HUM GENET, V53, P347; KALER SG, 1994, NAT GENET, V8, P195, DOI 10.1038/ng1094-195; LEVINSON B, 1994, NAT GENET, V6, P369, DOI 10.1038/ng0494-369; LOGAN JI, 1994, Q J MED, V87, P663; MERCER JFB, 1994, NAT GENET, V6, P374, DOI 10.1038/ng0494-374; MERCER JFB, 1993, NAT GENET, V3, P20, DOI 10.1038/ng0193-20; MERTZ W, 1981, SCIENCE, V213, P1332, DOI 10.1126/science.7022654; MIYAJIMA H, 1987, NEUROLOGY, V37, P761, DOI 10.1212/WNL.37.5.761; MOSTAFA WZ, 1990, INT J DERMATOL, V29, P134, DOI 10.1111/j.1365-4362.1990.tb04086.x; ODERMATT A, 1993, J BIOL CHEM, V268, P12775; ONO T, 1991, JPN J CANCER RES, V82, P486, DOI 10.1111/j.1349-7006.1991.tb01875.x; OSAKI S, 1969, J BIOL CHEM, V244, P5757; PETRUKHIN K, 1994, HUM MOL GENET, V3, P1647, DOI 10.1093/hmg/3.9.1647; RAD MR, 1994, YEAST, V10, P1217, DOI 10.1002/yea.320100910; RAUCH H, 1983, J HERED, V74, P141, DOI 10.1093/oxfordjournals.jhered.a109751; REED V, 1994, NAT GENET, V8, P11, DOI 10.1038/ng0994-11; REILLY M, 1993, J NEUROL NEUROSUR PS, V56, P298, DOI 10.1136/jnnp.56.3.298; ROESER HP, 1970, J CLIN INVEST, V49, P2408, DOI 10.1172/JCI106460; SARKAR B, 1993, J PEDIATR-US, V123, P828, DOI 10.1016/S0022-3476(05)80870-4; SASAKI N, 1994, BIOCHEM BIOPH RES CO, V202, P512, DOI 10.1006/bbrc.1994.1958; SILVER S, 1989, TRENDS BIOCHEM SCI, V14, P76, DOI 10.1016/0968-0004(89)90048-0; STERNLIEB I, 1990, HEPATOLOGY, V12, P1234, DOI 10.1002/hep.1840120526; TANNER MS, 1986, RECENT ADV PAEDIATRI, V8, P103; TANZI RE, 1993, NAT GENET, V5, P344, DOI 10.1038/ng1293-344; THOMAS GR, 1995, NAT GENET, V9, P210, DOI 10.1038/ng0295-210; TWEDT DC, 1979, J AM VET MED ASSOC, V175, P269; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; WALSHE JM, 1956, AM J MED, V21, P487, DOI 10.1016/0002-9343(56)90066-3; WIRTH PL, 1985, J NATL CANCER I, V75, P277; WU JS, 1994, NAT GENET, V7, P541, DOI 10.1038/ng0894-541; YANG F, 1986, P NATL ACAD SCI USA, V83, P3257, DOI 10.1073/pnas.83.10.3257; YUZBASIYANGURKAN V, 1993, GENOMICS, V15, P86, DOI 10.1006/geno.1993.1013	48	34	34	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1995	56	4					828	834						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QP663	7717393				2022-12-18	WOS:A1995QP66300003
J	FELDMAN, GJ; ROBIN, NH; BRUETON, LA; ROBERTSON, E; THOMPSON, EM; SIEGELBARTELT, J; GASSER, DL; BAILEY, LC; ZACKAI, EH; MUENKE, M				FELDMAN, GJ; ROBIN, NH; BRUETON, LA; ROBERTSON, E; THOMPSON, EM; SIEGELBARTELT, J; GASSER, DL; BAILEY, LC; ZACKAI, EH; MUENKE, M			A GENE FOR CLEIDOCRANIAL DYSPLASIA MAPS TO THE SHORT ARM OF CHROMOSOME-6	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CLEIDO-CRANIAL DYSOSTOSIS; ABNORMALITIES; TRISOMY; FAMILY; AGE	Cleidocranial dysplasia (CCD) is an autosomal dominant generalized bone dysplasia characterized by mild-to-moderate short stature, clavicular aplasia or hypoplasia, supernumerary and ectopic teeth, delayed eruption of secondary teeth, a characteristic craniofacial appearance, and a variety of other skeletal anomalies. We have performed linkage studies in five families with CCD, with 24 affected and 20 unaffected individuals, using microsatellite markers spanning two candidate regions on chromosomes 8q and 6. The strongest support for linkage was with chromosome 6p microsatellite marker D6S282 with a two-point lod score of 4.84 (theta =.03). Furthermore, the multipoint led score was 5.70 in the interval between D6S282 and D6S291. These data show that the gene for autosomal dominant CCD is located within a 19-cM interval on the short arm of chromosome 6, between D6S282 and D6S291.	CHILDRENS HOSP PHILADELPHIA,DIV HUMAN GENET & MOLEC BIOL,PHILADELPHIA,PA 19104; UNIV PENN,DEPT PEDIAT,PHILADELPHIA,PA 19104; UNIV PENN,DEPT GENET,PHILADELPHIA,PA 19104; NORTHWICK PK HOSP & CLIN RES CTR,KENNEDY GALTON CTR,HARROW HA1 3UJ,MIDDX,ENGLAND; HOSP SICK CHILDREN,DEPT GENET,TORONTO,ON M5G 1X8,CANADA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Imperial College London; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)				Muenke, Maximilian/0000-0002-7719-6545	NICHD NIH HHS [5T32HD07107, R29HD28732] Funding Source: Medline; NIDCR NIH HHS [DE-09164] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007107, R29HD028732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE009164] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		BRUETON LA, 1992, AM J MED GENET, V43, P612, DOI 10.1002/ajmg.1320430322; CHITAYAT D, 1992, AM J MED GENET, V42, P298, DOI 10.1002/ajmg.1320420307; COPELAND NG, 1993, SCIENCE, V262, P57, DOI 10.1126/science.8211130; Fitchet SM, 1929, J BONE JOINT SURG, V11, P838; Francke U, 1977, Birth Defects Orig Artic Ser, V13, P167; GOODMAN RM, 1975, CLIN GENET, V8, P20; HAHN GV, 1992, GENOMICS, V14, P759, DOI 10.1016/S0888-7543(05)80181-8; HITCHIN AD, 1974, BRIT J ORAL SURG, V12, P46, DOI 10.1016/0007-117X(74)90060-2; JARVIS JL, 1974, AM J ROENTGENOL, V121, P5, DOI 10.2214/ajr.121.1.5; JENSEN BL, 1993, J CRAN GENET DEV BIO, V13, P89; JENSEN BL, 1990, J ORAL PATHOL MED, V19, P89, DOI 10.1111/j.1600-0714.1990.tb00803.x; JENSEN BL, 1994, J CRAN GENET DEV BIO, V14, P163; JENSEN BL, 1993, J CRAN GENET DEV BIO, V13, P98; KREIBORG S, 1981, AM J ORTHOD DENTOFAC, V79, P549, DOI 10.1016/S0002-9416(81)90465-6; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LYONS KM, 1991, TRENDS GENET, V7, P408, DOI 10.1016/0168-9525(91)90265-R; MARTINEZFRIAS ML, 1988, AM J MED GENET, V31, P845, DOI 10.1002/ajmg.1320310418; MIGLIORISI JA, 1980, BRIT J ORAL SURG, V18, P212, DOI 10.1016/0007-117X(80)90065-7; NAKAI H, 1979, HUM GENET, V51, P349; NIENHAUS H, 1993, AM J MED GENET, V46, P630, DOI 10.1002/ajmg.1320460605; ROSEN V, 1992, TRENDS GENET, V8, P97, DOI 10.1016/0168-9525(92)90063-A; SCHINZEL A, 1980, HUM GENET, V53, P169; SCOTT CI, 1993, HUMAN MALFORMATIONS, V2, P655; SOULE AB, 1946, J BONE JOINT SURG, V28, P81; ZACKAI EH, 1994, 15TH DW SMITH WORKSH	25	34	34	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1995	56	4					938	943						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QP663	7717404				2022-12-18	WOS:A1995QP66300015
J	CAMPEAU, E; WATKINS, D; ROULEAU, GA; BABUL, R; BUCHANAN, JA; MESCHINO, W; DERKALOUSTIAN, VM				CAMPEAU, E; WATKINS, D; ROULEAU, GA; BABUL, R; BUCHANAN, JA; MESCHINO, W; DERKALOUSTIAN, VM			LINKAGE ANALYSIS OF THE NAIL-PATELLA SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							REPEAT POLYMORPHISM; LOCUS; MAP; RECOMBINATION; CHROMOSOME-9; REGION; GENE	Nail-patella syndrome (NPS) is an autosomal dominant disorder characterized by dysplasia of nails and patella, decreased mobility of the elbow, iliac horns, and, in some cases, nephropathy. The disorder has been mapped to the long arm of chromosome 9, but the precise localization and identity of the NPS gene are unknown. Linkage analysis in three NPS families, using highly informative dinucleotide repeat polymorphisms on 9q33-q34, confirmed linkage of NPS to this chromosome. Recombinations were detected, by two-point linkage analysis, between NPS and the centromeric markers D9S60 and the gelsolin gene and the telomeric markers D9S64 and D9S66, in one of the families. Haplotype analysis suggested an additional recombination between NPS and the argininosuccinate synthetase (ASS) gene. These results localize the NPS gene to an interval on 9q34.1, distal to D9S60 and proximal to ASS, comprising a genetic distance of similar to 9 cM. This represents a significant refinement in the localization of the NPS gene.	MONTREAL GEN HOSP,RES INST,DEPT MED,DIV MED GENET,MONTREAL,PQ H3G 1A4,CANADA; MONTREAL CHILDRENS HOSP,DEPT PEDIAT,DIV MED GENET,MONTREAL,PQ H3H 1P3,CANADA; MCGILL UNIV,DEPT HUMAN GENET,MONTREAL,PQ H3H 1P3,CANADA; N YORK GEN HOSP,GENET MOLEC LAB,N YORK,ON,CANADA	McGill University; McGill University; McGill University; University of Toronto; University Toronto Affiliates; North York General Hospital								CARIDI G, 1992, HUM GENET, V90, P174; CARSON WJ, 1992, GENOMICS, V13, P852, DOI 10.1016/0888-7543(92)90168-R; CLARKE CA, 1961, ANN HUM GENET, V25, P25, DOI 10.1111/j.1469-1809.1961.tb01493.x; GOODALL CM, 1963, ANN HUM GENET, V26, P243, DOI 10.1111/j.1469-1809.1963.tb01981.x; GREENSPAN DS, 1992, GENOMICS, V12, P836, DOI 10.1016/0888-7543(92)90320-R; HARRIS RM, 1993, GENOMICS, V15, P265, DOI 10.1006/geno.1993.1056; JAMESON RJ, 1956, ANN HUM GENET, V20, P348; KWIATKOWSKI DJ, 1993, AM J HUM GENET, V53, P1279; KWIATKOWSKI DJ, 1991, NUCLEIC ACIDS RES, V19, P967, DOI 10.1093/nar/19.4.967; KWIATKOWSKI DJ, 1992, GENOMICS, V12, P229, DOI 10.1016/0888-7543(92)90370-8; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEVERSHA MA, 1992, ANN HUM GENET, V56, P201; OTT J, 1974, AM J HUM GENET, V26, P588; OZELIUS LJ, 1992, GENOMICS, V14, P715, DOI 10.1016/S0888-7543(05)80173-9; PILLAY VK, 1965, ANN HUM GENET, V28, P301; PUFFENBERGER EG, 1990, AMJ HUM GENET S, V47, pA915; RENWICK JH, 1955, ANN HUM GENET, V19, P312, DOI 10.1111/j.1469-1809.1955.tb01356.x; RENWICK JH, 1965, ANN HUM GENET, V28, P379, DOI 10.1111/j.1469-1809.1965.tb00493.x; RENWICK JH, 1965, ANN HUM GENET, V28, P369, DOI 10.1111/j.1469-1809.1965.tb00492.x; RIZZO R, 1993, CLIN GENET, V44, P1; SCHLEUTERMANN DA, 1969, AM J HUM GENET, V21, P606; SHARMA JC, 1966, ANN HUM GENET, V30, P193, DOI 10.1111/j.1469-1809.1966.tb00018.x; SOBEL RS, 1971, AM J HUM GENET, V23, P146; YUILLE MAR, 1990, NUCLEIC ACIDS RES, V18, P7472, DOI 10.1093/nar/18.24.7472	24	34	34	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1995	56	1					243	247						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QC101	7825584				2022-12-18	WOS:A1995QC10100031
J	SANMILLAN, JL; VIRIBAY, M; PERAL, B; MARTINEZ, I; WEISSENBACH, J; MORENO, F				SANMILLAN, JL; VIRIBAY, M; PERAL, B; MARTINEZ, I; WEISSENBACH, J; MORENO, F			REFINING THE LOCALIZATION OF THE PKD2 LOCUS ON CHROMOSOME 4Q BY LINKAGE ANALYSIS IN SPANISH FAMILIES WITH AUTOSOMAL-DOMINANT POLYCYSTIC KIDNEY-DISEASE TYPE-2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HETEROGENEITY; MARKER; GENE	Autosomal dominant polycystic kidney disease (ADPKD) is a genetically heterogeneous disorder. At least two distinct forms of ADPKD are now well defined. In similar to 86% of affected European families, a gene defect localized to 16p13.3 was responsible for ADPKD, while a second locus has been recently localized to 4q13-q23 as candidate for the disease in the remaining families. We present confirmation of linkage to microsatellite markers on chromosome 4q in eight Spanish families with ADPKD, in which the disease was not linked to 16p13.3. By linkage analysis with marker D4S423, a maximum lod score of 9.03 at a recombination fraction of .00 was obtained. Multipoint linkage analysis, as well as a study of recombinant haplotypes, placed the PKD2 locus between D4S1542 and D4S1563, thereby defining a genetic interval of similar to 1 cM. The refined map will serve as a genetic framework for additional genetic and physical mapping of the region and will improve the accuracy of presymptomatic diagnosis of PKD2.	HOSP GALDACANO, SERV NEFROL, GALDACANO, SPAIN; GENETHON, EVRY, FRANCE	Galdakao Hospital	SANMILLAN, JL (corresponding author), HOSP RAMON Y CAJAL, MOLEC GENET UNIT, CRTRA COLMENAR KM 91, E-28034 MADRID, SPAIN.		San-Millán, José L./F-9944-2015; Peral, Belén/F-4562-2015	Peral, Belén/0000-0003-4984-4020				BEAR JC, 1984, AM J MED GENET, V18, P45, DOI 10.1002/ajmg.1320180108; BEAR JC, 1992, AM J MED GENET, V43, P548, DOI 10.1002/ajmg.1320430309; BREUNING MH, 1990, J MED GENET, V27, P603, DOI 10.1136/jmg.27.10.603; BRISSENDEN JE, 1991, J AM SOC NEPHROL, V2, P913; DALGAARD O Z, 1957, Acta Med Scand Suppl, V328, P1; FENTON I, 1992, CONTRIB NEPHROL, V97, P118; FOSSDAL R, 1993, HUM GENET, V91, P609; GABOW PA, 1992, KIDNEY INT, V41, P1311, DOI 10.1038/ki.1992.195; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HARRIS PC, 1991, LANCET, V338, P1484, DOI 10.1016/0140-6736(91)92300-Q; KIMBERLING WJ, 1993, GENOMICS, V18, P467, DOI 10.1016/S0888-7543(11)80001-7; KIMBERLING WJ, 1988, NEW ENGL J MED, V319, P913, DOI 10.1056/NEJM198810063191405; LATHROP GM, 1984, AM J HUM GENET, V36, P460; MILLS KA, 1992, GENOMICS, V14, P209, DOI 10.1016/S0888-7543(05)80208-3; Ott J., 1991, ANAL HUMAN GENETIC L; PARFREY PS, 1990, NEW ENGL J MED, V323, P1085, DOI 10.1056/NEJM199010183231601; PERAL B, 1993, J MED GENET, V30, P910, DOI 10.1136/jmg.30.11.910; PERAL B, 1994, AM J HUM GENET, V54, P899; PETERS DJM, 1993, NAT GENET, V5, P359, DOI 10.1038/ng1293-359; PETERS DJM, 1992, CONTRIB NEPHROL, V97, P128; RAVINE D, 1992, LANCET, V340, P1330, DOI 10.1016/0140-6736(92)92503-8; REEDERS ST, 1985, NATURE, V317, P542, DOI 10.1038/317542a0; ROMEO G, 1988, LANCET, V2, P8; VALLES M, 1989, NEFROLOGIA S, V9, P1; WARD CJ, 1994, CELL, V77, P881	25	34	36	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1995	56	1					248	253						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QC101	7825585				2022-12-18	WOS:A1995QC10100032
J	VANDUIJN, CM; HENDRIKS, L; FARRER, LA; BACKHOVENS, H; CRUTS, M; WEHNERT, A; HOFMAN, A; Van Broeckhoven, C				VANDUIJN, CM; HENDRIKS, L; FARRER, LA; BACKHOVENS, H; CRUTS, M; WEHNERT, A; HOFMAN, A; Van Broeckhoven, C			A POPULATION-BASED STUDY OF FAMILIAL ALZHEIMER-DISEASE - LINKAGE TO CHROMOSOME-14, CHROMOSOME-19, AND CHROMOSOME-21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRECURSOR PROTEIN GENE; DINUCLEOTIDE REPEAT POLYMORPHISM; APOLIPOPROTEIN-E; APP GENE; CEREBRAL-HEMORRHAGE; TYPE-4 ALLELE; LOCUS; MUTATION; DNA; PCR	Linkage of Alzheimer disease (AD) to DNA markers on chromosomes 14, 19, and 21 was studied in 10 families in which the disease was apparently inherited as an autosomal dominant trait. Families were derived from a Dutch population-based epidemiologic study of early-onset AD, Although in all probands the onset of AD was at or before age 65 years, the mean age at onset was after age 65 years in four families (referred to as ''LOAD''). Among the six families with early-onset AD (referred to as ''EOAD,'' i.e., mean age of onset of AD of relatives was at or before age 65 years), conclusive linkage to 14q24.3 was found in one family with a very early onset (around 47 years), while linkage to the same region was excluded in two other families. For the LOAD families, predominantly negative lod scores were obtained, and the overall lod score excluded linkage to chromosome 14. The results with markers on chromosome 19 and chromosome 21 were not conclusive for EOAD and LOAD. The findings of our study confirm genetic heterogeneity within familial EOAD.	UNIV ANTWERP, BORN BUNGE FDN, DEPT BIOCHEM, NEUROGENET LAB, B-2610 ANTWERP, BELGIUM; ERASMUS UNIV ROTTERDAM, SCH MED, DEPT EPIDEMIOL & BIOSTAT, 3000 DR ROTTERDAM, NETHERLANDS; BOSTON UNIV, DEPT NEUROL, BOSTON, MA 02215 USA; INNOGENET, GHENT, BELGIUM	University of Antwerp; Erasmus University Rotterdam; Boston University; Innogenetics NV			Farrer, Lindsay/AAS-1035-2020; Cruts, Marc/J-6161-2013; Van Broeckhoven, Christine/M-7853-2019	Cruts, Marc/0000-0002-1338-992X; Van Broeckhoven, Christine/0000-0003-0183-7665; Farrer, Lindsay/0000-0001-5533-4225	NIA NIH HHS [AG09029] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG009029] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ADROER R, 1992, NEUROSCI LETT, V141, P69, DOI 10.1016/0304-3940(92)90336-6; BAKKER E, 1991, AM J HUM GENET, V49, P518; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; CRUTS M, 1992, NUCLEIC ACIDS RES, V20, P1159; FARRER LA, 1991, AM J HUM GENET, V48, P1026; FARRER LA, 1990, NEUROLOGY, V40, P395, DOI 10.1212/WNL.40.3_Part_1.395; FARRER LA, 1993, GENET EPIDEMIOL, V10, P425, DOI 10.1002/gepi.1370100616; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; Hodge SE, 1979, AM J HUM GENET, V31, P761; HOFMAN A, 1989, NEUROLOGY, V39, P1589, DOI 10.1212/WNL.39.12.1589; HUDSON TJ, 1992, GENOMICS, V13, P622, DOI 10.1016/0888-7543(92)90133-D; KAMINO K, 1992, AM J HUM GENET, V51, P998; KAZANTSEV A, 1992, NUCLEIC ACIDS RES, V20, P1164, DOI 10.1093/nar/20.5.1164-a; LANNFELT L, 1993, NAT GENET, V4, P218, DOI 10.1038/ng0793-218; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MULLAN M, 1992, NAT GENET, V2, P340, DOI 10.1038/ng1292-340; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; OTT J, 1992, AM J HUM GENET, V51, P283; OTT J, 1976, AM J HUM GENET, V28, P528; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; POIRIER J, 1993, LANCET, V342, P697, DOI 10.1016/0140-6736(93)91705-Q; RISCH N, 1988, AM J HUM GENET, V42, P353; Sambrook J., 1989, MOL CLONING LAB MANU; SAUNDERS AM, 1993, LANCET, V342, P710, DOI 10.1016/0140-6736(93)91709-U; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; SHARMA V, 1991, NUCLEIC ACIDS RES, V19, P1722, DOI 10.1093/nar/19.7.1722; SHAW DJ, 1989, HUM GENET, V83, P71, DOI 10.1007/BF00274152; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; STGEORGEHYSLOP P, 1992, NAT GENET, V2, P330, DOI 10.1038/ng1292-330; STINISSEN P, 1990, NUCLEIC ACIDS RES, V18, P3672, DOI 10.1093/nar/18.12.3672; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; TANZI RE, 1992, AM J HUM GENET, V50, P551; TANZI RE, 1992, AM J HUM GENET, V51, P273; VAN BROECKHOVEN C, 1992, NAT GENET, V2, P335, DOI 10.1038/ng1292-335; VANDUIJN CM, 1993, J MED GENET, V30, P640, DOI 10.1136/jmg.30.8.640; VANDUIJN CM, 1994, NAT GENET, V7, P74, DOI 10.1038/ng0594-74; VANDUIJN CM, 1991, INT J EPIDEMIOL, V20, pS13, DOI 10.1093/ije/20.Supplement_2.S13; VANDUIJN CM, 1991, LANCET, V337, P978, DOI 10.1016/0140-6736(91)91611-W; WANG Z, 1992, GENOMICS, V13, P535; WARREN AC, 1993, HUM GENET, V91, P87; WILLIAMSON R, 1991, CYTOGENET CELL GENET, V58, P1190, DOI 10.1159/000133727; ZHANG W, 1991, NUCLEIC ACIDS RES, V19, P6649, DOI 10.1093/nar/19.23.6649	50	34	34	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1994	55	4					714	727						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PJ027	7942850				2022-12-18	WOS:A1994PJ02700015
J	HAATAJA, L; SCHLEUTKER, J; LAINE, AP; RENLUND, M; SAVONTAUS, ML; DIB, C; WEISSENBACH, J; PELTONEN, L; AULA, P				HAATAJA, L; SCHLEUTKER, J; LAINE, AP; RENLUND, M; SAVONTAUS, ML; DIB, C; WEISSENBACH, J; PELTONEN, L; AULA, P			THE GENETIC-LOCUS FOR FREE SIALIC-ACID STORAGE DISEASE MAPS TO THE LONG ARM OF CHROMOSOME-6	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SALLA DISEASE; LINKAGE DISEQUILIBRIUM; PRENATAL-DIAGNOSIS; INFANTILE FORM; EXCLUSION; DISORDER; DNA; MONOSACCHARIDES; CONFIRMATION; METABOLISM	Salla disease (SD), or adult-type free sialic acid storage disease, is an autosomal recessive lysosomal storage disorder characterized by impaired transport of free sialic acid across the lysosomal membrane and severe psychomotor retardation. Random linkage analysis of a sample of 27 Finnish families allowed us to localize the SD locus to the long arm of chromosome 6. The highest lod score of 8.95 was obtained with a microsatellite marker of locus D6S286 at theta =.00. Evidence for linkage disequilibrium was observed between the SD locus and the alleles of three closely linked markers, suggesting that the length of the critical region for the SD locus is in the order of 190 kb.	NATL PUBL HLTH INST,DEPT HUMAN MOLEC GENET,SF-00300 HELSINKI,FINLAND; UNIV TURKU,DEPT MED GENET,TURKU,FINLAND; UNIV HELSINKI,DEPT OBSTET,HELSINKI,FINLAND	Finland National Institute for Health & Welfare; University of Turku; University of Helsinki			Haataja, Leena/GPG-3986-2022; Haataja, Leena/G-1160-2016	Haataja, Leena/0000-0002-8057-6194; Schleutker, Johanna/0000-0002-1863-0305				AULA P, 1979, ARCH NEUROL-CHICAGO, V36, P88, DOI 10.1001/archneur.1979.00500380058006; CHEN M, 1992, SCIENCE, V258, P67; DAZZO A, 1982, P NATL ACAD SCI-BIOL, V79, P4535, DOI 10.1073/pnas.79.15.4535; EDWARDS JH, 1987, J MED GENET, V24, P539, DOI 10.1136/jmg.24.9.539; FONTAINE G, 1968, HELV PAEDIATR AC S17, V123, P1; GAHL WA, 1989, METABOLIC BASIS INHE, P2619; HAATAJA L, 1992, HUM GENET, V88, P298; Haldane JBS, 1919, J GENET, V8, P299; HANCOCK LW, 1982, J NEUROCHEM, V38, P803, DOI 10.1111/j.1471-4159.1982.tb08701.x; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HASTBACKA J, 1993, J MED GENET, V30, P265, DOI 10.1136/jmg.30.4.265; HELLSTEN E, 1993, GENOMICS, V16, P720, DOI 10.1006/geno.1993.1253; JARVELA I, 1991, GENOMICS, V10, P333, DOI 10.1016/0888-7543(91)90316-7; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Luria SE, 1943, GENETICS, V28, P491; MANCINI GMS, 1992, P NATL ACAD SCI USA, V89, P6609, DOI 10.1073/pnas.89.14.6609; MANCINI GMS, 1989, J BIOL CHEM, V264, P15247; MANCINI GMS, 1991, DEV NEUROSCI-BASEL, V13, P327, DOI 10.1159/000112181; MANCINI GMS, 1991, J CLIN INVEST, V87, P1329, DOI 10.1172/JCI115136; OBRIEN JS, 1977, BIOCHEM BIOPH RES CO, V79, P1136, DOI 10.1016/0006-291X(77)91124-X; RENLUND M, 1984, J PEDIATR-US, V104, P232, DOI 10.1016/S0022-3476(84)80998-1; RENLUND M, 1986, SCIENCE, V232, P759, DOI 10.1126/science.3961501; RENLUND M, 1983, NEUROLOGY, V33, P57, DOI 10.1212/WNL.33.1.57; RENLUND M, 1987, AM J MED GENET, V28, P377, DOI 10.1002/ajmg.1320280216; SCHLEUTKER J, 1991, HUM GENET, V88, P95, DOI 10.1007/BF00204936; SEPPALA R, 1991, J BIOL CHEM, V266, P7456; SULISALO T, 1993, NAT GENET, V3, P338, DOI 10.1038/ng0493-338; TONDEUR M, 1982, EUR J PEDIATR, V139, P142, DOI 10.1007/BF00441499; VAMOS E, 1986, PRENATAL DIAG, V6, P437, DOI 10.1002/pd.1970060607; VANDENPLAS S, 1984, J MED GENET, V21, P164, DOI 10.1136/jmg.21.3.164; Vesa J., 1993, European Journal of Human Genetics, V1, P125; VILKKI J, 1988, HUM GENET, V80, P317, DOI 10.1007/BF00273643; WARMAN ML, 1993, GENOMICS, V17, P694, DOI 10.1006/geno.1993.1391; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WILKIE PJ, 1993, GENOMICS, V15, P225, DOI 10.1006/geno.1993.1042	35	34	36	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1994	54	6					1042	1049						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NP053	8198127				2022-12-18	WOS:A1994NP05300013
J	BOUSTANY, RM; QIAN, WH; SUZUKI, K				BOUSTANY, RM; QIAN, WH; SUZUKI, K			MUTATIONS IN ACID BETA-GALACTOSIDASE CAUSE GM(1)-GANGLIOSIDOSIS IN AMERICAN PATIENTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE-MUTATIONS; GM1-GANGLIOSIDOSIS	We describe four new mutations in the beta-galactosidase gene. These are the first mutations causing infantile and juvenile GM1-gangliosidosis to be described in American patients. Cell lines from two patients with juvenile and from six patients with infantile GM1-gangliosidosis were analyzed. Northern blot analysis showed the acid beta-galactosidase message to be of normal size and quantity in two juvenile and four infantile cases and of normal size but reduced quantity in two infantile cases. The mutations are distinct from the Japanese mutations. All are point mutations leading to amino acid substitutions: Lys577 --> Arg, Arg590 --> His, and Glu632 --> Gly. The fourth mutation, Arg208 --> Cys, accounts for 10 of 16 possible alleles. Two infantile cases from Puerto Rico of Spanish ancestry are homozygous for this mutation, suggesting that this allele may have come to South America and North America via Puerto Rico. That these mutations cause clinical disease was confirmed by marked reduction in catalytic activity of the mutant proteins in the Cos-1 cell expression system.	DUKE UNIV,MED CTR,DEPT PEDIAT,DURHAM,NC 27710; UNIV N CAROLINA,BRAIN & DEV RES CTR,CHAPEL HILL,NC 27514	Duke University; University of North Carolina; University of North Carolina Chapel Hill	BOUSTANY, RM (corresponding author), DUKE UNIV,MED CTR,DEPT PEDIAT NEUROL,BOX 3533,DURHAM,NC 27710, USA.				NICHD NIH HHS [HD24061] Funding Source: Medline; NINDS NIH HHS [NS 25289] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025289, R55NS025289] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CHAKRABORTY S, 1991, AM J HUM GENET S, V49, pA451; MORREAU H, 1989, J BIOL CHEM, V264, P20655; NANBA E, 1991, BIOCHEM BIOPH RES CO, V178, P158, DOI 10.1016/0006-291X(91)91793-C; NANBA E, 1990, BIOCHEM BIOPH RES CO, V773, P141; NISHIMOTO J, 1991, AM J HUM GENET, V49, P566; O'Brien JS, 1989, METABOLIC BASIS INHE, P1797; OSHIMA A, 1991, AM J HUM GENET, V49, P1091; OSHIMA A, 1992, CLIN GENET, V41, P235; OSHIMA A, 1988, BIOCHEM BIOPH RES CO, V157, P238, DOI 10.1016/S0006-291X(88)80038-X; SUZUKI K, 1987, METHOD ENZYMOL, V138, P727; WRAY S, 1989, DUANES CLIN OPTHALMO, V3, P1; YOSHIDA K, 1991, AM J HUM GENET, V49, P435	12	34	35	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1993	53	4					881	888						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LY627	8213816				2022-12-18	WOS:A1993LY62700012
J	MACLEAN, CJ; SHAM, PC; KENDLER, KS				MACLEAN, CJ; SHAM, PC; KENDLER, KS			JOINT LINKAGE OF MULTIPLE LOCI FOR A COMPLEX DISORDER	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INFERRING MODE; LOD SCORES; HETEROGENEITY; STRATEGIES; TRAITS; INHERITANCE; PENETRANCE; 2-LOCUS	Many investigators who have been searching for linkage to complex diseases have by now accumulated a drawer full of negative results. If disease is actually caused by genes at several loci, these data might contain multiple-locus system (MLS) information that the investigator does not realize. Trying to obtain this information formally, through the MLS likelihood, leads to severe computational and statistical difficulties. Therefore, we propose a scheme of inference based on single-locus (SL) statistics, considered jointly. By simulation, we find that the MLS lod score is closely approximated by the sum of SL lod scores. However, we also find that for moderately large systems, say three or four loci, both MLS and SL lod scores are likely to be inconclusive. Nonetheless, MLS can often be detected through the correlation of individual pedigree SL lod scores. Significant correlation is itself evidence of an MLS, because, in the absence of linkage, false-positive lod scores arc necessarily random. Under epistasis SL lod scores tend to be positively correlated among pedigrees, while under independent action SL lod scores from high-density samples tend to be negatively correlated.	VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT HUMAN GENET,RICHMOND,VA 23298	Virginia Commonwealth University	MACLEAN, CJ (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PSYCHIAT,BOX 710,RICHMOND,VA 23298, USA.		Kendler, Kenneth/AAF-2876-2019		NIMH NIH HHS [NIMH MH41953, NIMH MH45390] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH045390, R01MH041953] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		CLERGETDARPOUX F, 1992, ANN HUM GENET, V56, P145, DOI 10.1111/j.1469-1809.1992.tb01140.x; DIEHL SR, 1989, SCHIZOPHRENIA BULL, V15, P403, DOI 10.1093/schbul/15.3.403; DURNER M, 1992, AM J MED GENET, V42, P271, DOI 10.1002/ajmg.1320420302; EDWARDS JH, 1976, CYTOGENET CELL GENET, V3, P289; Elston R C, 1981, Adv Hum Genet, V11, P63; GOLDIN LR, 1992, GENET EPIDEMIOL, V9, P61, DOI 10.1002/gepi.1370090107; GREENBERG DA, 1989, GENET EPIDEMIOL, V6, P259, DOI 10.1002/gepi.1370060145; GREENBERG DA, 1989, AM J MED GENET, V34, P480, DOI 10.1002/ajmg.1320340406; GREENBERG DA, 1990, GENET EPIDEMIOL, V7, P467, DOI 10.1002/gepi.1370070608; HODGE SE, 1983, AM J HUM GENET, V35, P1139; KENDALL MG, 1961, ADV THEORY STATISTIC, V2; LANDER ES, 1986, P NATL ACAD SCI USA, V83, P7353, DOI 10.1073/pnas.83.19.7353; Lathrop G. M., 1990, AM J HUM GENET S, V47, pA188; MACLEAN CJ, 1992, AM J HUM GENET, V50, P1259; MARTINEZ M, 1990, GENET EPIDEMIOL, V7, P219, DOI 10.1002/gepi.1370070306; MARTINEZ MM, 1989, AM J HUM GENET, V44, P552; Mather K, 1971, BIOMETRICAL GENETICS; Ott J., 1991, ANAL HUMAN GENETIC L; Rieger R., 1976, GLOSSARY GENETICS CY; RISCH N, 1990, AM J HUM GENET, V46, P222; Scheffe H., 1959, ANAL VARIANCE; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; SUAREZ BK, IN PRESS NEW GENETIC; VIELAND VJ, 1992, GENET EPIDEMIOL, V9, P45, DOI 10.1002/gepi.1370090106	24	34	34	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1993	53	2					353	366						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LN820	8328454				2022-12-18	WOS:A1993LN82000008
J	VANDENMAAGDENBERG, AMJM; WEI, W; DEBRUIJN, IH; DEKNIJFF, P; FUNKE, H; SMELT, AHM; LEUVEN, JAG; VANTHOOFT, FM; ASSMANN, G; HOFKER, MH; HAVEKES, LM; FRANTS, RR				VANDENMAAGDENBERG, AMJM; WEI, W; DEBRUIJN, IH; DEKNIJFF, P; FUNKE, H; SMELT, AHM; LEUVEN, JAG; VANTHOOFT, FM; ASSMANN, G; HOFKER, MH; HAVEKES, LM; FRANTS, RR			CHARACTERIZATION OF 5 NEW MUTANTS IN THE CARBOXYL-TERMINAL DOMAIN OF HUMAN APOLIPOPROTEIN-E - NO COSEGREGATION WITH SEVERE HYPERLIPIDEMIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GRADIENT GEL-ELECTROPHORESIS; POLYMERASE CHAIN-REACTION; RECEPTOR-BINDING ACTIVITY; SINGLE-BASE CHANGES; III HYPERLIPOPROTEINEMIA; FAMILIAL DYSBETALIPOPROTEINEMIA; PLASMA-LIPOPROTEINS; E POLYMORPHISM; VARIANT; DNA	Assessment of the apolipoprotein E (apoE) phenotype by isoelectric focusing of both hyperlipidemic and normolipidemic individuals identified five new variants. All mutations were confined to the downstream part of the APOE gene by using denaturing gradient gel electrophoresis (DGGE). Sequence analysis revealed five new mutations causing unique amino acid substitutions in the carboxyl-terminal part of the protein containing the putative lipid-binding domain. Three hyperlipoproteinemic probands were carriers of the APOE*2(Val236-->Glu) allele, the APOE*3(Cys112-->Arg; Arg251-->Gly) allele, or the APOE*1(Arg158-->Cys; Leu252-->Glu) allele. DGGE of the region encoding the receptor-binding domain was useful for haplotyping the mutations at codons 112 and 158. Family studies failed to demonstrate cosegregation between the new mutations and severe hyperlipoproteinemia, although a number of carriers for the APOE*3(Cys112-->Arg; Arg251-->Gly) allele and the APOE*1(Arg158-->Cys; Leu252-->Glu) allele expressed hypertriglyceridemia and/or hypercholesterolemia. Two other mutant alleles, APOE*4- (Cys112-->Arg; Arg274-->His) and APOE*4+(Ser296-->Arg), were found in normolipidemic probands. The lack of cosegregation of these new mutations with severe hyperlipoproteinemia suggests that these mutations do not exert a dominant effect on the functioning of apoE.	LEIDEN UNIV,CTR MED GENET,DEPT HUMAN GENET,POB 9503,2312 AV LEIDEN,NETHERLANDS; TNO,IVVO,GAUBIUS LAB,2313 AD LEIDEN,NETHERLANDS; LEIDEN UNIV HOSP,DEPT CARDIOL & GEN INTERNAL MED,2333 AA LEIDEN,NETHERLANDS; UNIV MUNSTER,ZENT LAB,INST KLIN CHEM & LAB MED,W-4400 MUNSTER,GERMANY	Leiden University; Leiden University - Excl LUMC; Netherlands Organization Applied Science Research; Leiden University; Leiden University Medical Center (LUMC); University of Munster			van den Maagdenberg, Arn M.J.M./AAE-9052-2019; de Knijff, Peter/Y-2519-2018	de Knijff, Peter/0000-0002-0899-771X				BEAUMONT JL, 1970, B WORLD HEALTH ORGAN, V43, P891; BOGUSKI MS, 1985, P NATL ACAD SCI USA, V82, P992, DOI 10.1073/pnas.82.4.992; CAI SP, 1990, J CLIN INVEST, V85, P550, DOI 10.1172/JCI114471; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; DEKNIJFF P, 1991, J CLIN INVEST, V88, P643, DOI 10.1172/JCI115349; FISCHER SG, 1979, CELL, V16, P191, DOI 10.1016/0092-8674(79)90200-9; GIANTURCO SH, 1983, J BIOL CHEM, V258, P4526; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; HAVEKES L, 1986, HUM GENET, V73, P157, DOI 10.1007/BF00291607; HAVEKES LM, 1987, J LIPID RES, V28, P455; HIXON JE, 1990, J LIPID RES, V31, P545; KOGAN S, 1990, P NATL ACAD SCI USA, V87, P2092, DOI 10.1073/pnas.87.6.2092; LALAZAR A, 1988, J BIOL CHEM, V263, P3542; LERMAN LS, 1987, METHOD ENZYMOL, V155, P482; LI WH, 1988, J LIPID RES, V29, P245; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MAHLEY RW, 1984, J LIPID RES, V25, P1277; MANN WA, 1989, BIOCHIM BIOPHYS ACTA, V1005, P239, DOI 10.1016/0005-2760(89)90043-X; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Myers R. M., 1988, Genome analysis: a practical approach., P95; MYERS RM, 1987, METHOD ENZYMOL, V155, P501; PAIK YK, 1985, P NATL ACAD SCI USA, V82, P3445, DOI 10.1073/pnas.82.10.3445; RALL SC, 1989, J CLIN INVEST, V83, P1095, DOI 10.1172/JCI113988; RALL SC, 1982, P NATL ACAD SCI-BIOL, V79, P4696, DOI 10.1073/pnas.79.15.4696; RALL SC, 1983, J CLIN INVEST, V72, P1288, DOI 10.1172/JCI111085; RALL SC, 1982, J BIOL CHEM, V257, P4171; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; SMIT M, 1990, J LIPID RES, V31, P45; SMIT M, 1988, HUM GENET, V80, P287, DOI 10.1007/BF01790099; SMIT M, 1988, HUM HERED, V38, P277, DOI 10.1159/000153799; TAJIMA S, 1989, J BIOCHEM-TOKYO, V105, P249, DOI 10.1093/oxfordjournals.jbchem.a122648; UTERMANN G, 1980, AM J HUM GENET, V32, P339; UTERMANN G, 1985, DIABETES OBESITY HYP, V3, P1; WARDELL MR, 1987, J CLIN INVEST, V80, P483, DOI 10.1172/JCI113096; WARDELL MR, 1990, J LIPID RES, V31, P535; WARDELL MR, 1989, J BIOL CHEM, V264, P21205; WEINSTEIN LS, 1990, P NATL ACAD SCI USA, V87, P8287, DOI 10.1073/pnas.87.21.8287; WEISGRABER KH, 1990, J LIPID RES, V31, P1503; WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194; YAMAMURA T, 1984, J CLIN INVEST, V74, P1229, DOI 10.1172/JCI111532; ZANNIS VI, 1981, BIOCHEMISTRY-US, V20, P1033, DOI 10.1021/bi00507a059	41	34	34	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1993	52	5					937	946						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LB889	8488843				2022-12-18	WOS:A1993LB88900011
J	BROWN, MD; TORRONI, A; SHOFFNER, JM; WALLACE, DC				BROWN, MD; TORRONI, A; SHOFFNER, JM; WALLACE, DC			MITOCHONDRIAL TRANSFER RNATHR MUTATIONS AND LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							DISEASE				BROWN, MD (corresponding author), EMORY UNIV,SCH MED,DEPT GENET & MOLEC MED,ATLANTA,GA 30322, USA.		Torroni, Antonio/E-1557-2011	Torroni, Antonio/0000-0002-4163-4478	NINDS NIH HHS [NS09042, NS01336, NS21468] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001336] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		MORAES CT, 1991, AM J HUM GENET, V48, P492; SEIBEL P, 1990, BIOCHEM BIOPH RES CO, V173, P561, DOI 10.1016/S0006-291X(05)80071-3; TANAKA M, 1990, LANCET, V336, P1452, DOI 10.1016/0140-6736(90)93162-I; WALLACE DC, 1991, CYTOGENET CELL GENET, V58, P1103, DOI 10.1159/000133724; YOON KL, 1991, BIOCHEM BIOPH RES CO, V176, P1112, DOI 10.1016/0006-291X(91)90399-R; ZHENG X, 1989, NEUROLOGY, V39, P1203, DOI 10.1212/WNL.39.9.1203	6	34	34	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1992	51	2					446	447						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JF776	1379415				2022-12-18	WOS:A1992JF77600030
J	XIE, B; WANG, W; MAHURAN, DJ				XIE, B; WANG, W; MAHURAN, DJ			A CYS138-TO-ARG SUBSTITUTION IN THE GM2 ACTIVATOR PROTEIN IS ASSOCIATED WITH THE AB VARIANT FORM OF GM2 GANGLIOSIDOSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GM2-ACTIVATOR PROTEIN; ENDOPLASMIC-RETICULUM; ASSAY	The AB-variant form of G(M2) gangliosidosis is an inherited lysosomal storage disease. Biochemical data have linked its cause to the lack of a functional G(M2) activator protein (activator). In the present study we identify a mutation in the gene encoding the activator protein of an AB-variant patient. These data represent direct evidence that the disease in the patient described here is a result of mutations at the Activator gene locus. A T412 --> C transition was found in the homozygous form in cDNA and genomic DNA from the patient. This nucleotide change would result in the substitution of Cys138 by an Arg residue in the activator protein. Whereas the patient's fibroblasts produce apparently normal levels of activator mRNA, they lack a functional activator protein. Transfection of either a construct containing the normal activator cDNA, pAct1, or a cDNA construct containing the T --> C transition caused COS-1 cells to transcribe high levels of activator mRNA. Lysates from cells transfected with pAct1 produced an elevated level of both pro- and mature forms of the activator protein, with an accompanying 11-fold enhancement in the ability of purified hexosaminidase A to hydrolyze G(M2) ganglioside. However, lysates from cells transfected with the mutant cDNA construct contained only low levels of the pro-activator protein, which failed to enhance hexosaminidase A activity significantly above the endogenous level of mock transfected COS cells. We conclude that the T412 --> C transition in the G(M2) Activator gene of the patient is responsible for the disease phenotype.	HOSP SICK CHILDREN,RES INST,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA; UNIV TORONTO,DEPT CLIN BIOCHEM,TORONTO M5S 1A1,ONTARIO,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto								ALBER T, 1989, ANNU REV BIOCHEM, V58, P765, DOI 10.1146/annurev.biochem.58.1.765; BANERJEE A, 1984, H-S Z PHYSIOL CHEM, V365, P347, DOI 10.1515/bchm2.1984.365.1.347; BROWN CA, 1989, J BIOL CHEM, V264, P21705; BURG J, 1985, BIOL CHEM H-S, V366, P887, DOI 10.1515/bchm3.1985.366.2.887; KLIMA H, 1991, FEBS LETT, V289, P260, DOI 10.1016/0014-5793(91)81084-L; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LODISH HF, 1988, J BIOL CHEM, V263, P2107; MAHURAN DJ, 1991, BIOCHIM BIOPHYS ACTA, V1096, P87, DOI 10.1016/0925-4439(91)90044-A; MEIER EM, 1991, J BIOL CHEM, V266, P1879; NEUFELD EF, 1991, ANNU REV BIOCHEM, V60, P257, DOI 10.1146/annurev.biochem.60.1.257; NEUMANN JR, 1987, BIOTECHNIQUES, V5, P444; PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245; Sambrook J., 1989, MOL CLONING LAB MANU; Sandhoff KCE, 1989, METABOLIC BASIS INHE, V2, P1807; SCHRODER M, 1991, FEBS LETT, V290, P1, DOI 10.1016/0014-5793(91)81211-P; SMITH DB, 1990, CURRENT PROTOCOLS MO; WILLARD HF, 1983, NUCLEIC ACIDS RES, V11, P2017, DOI 10.1093/nar/11.7.2017; XIE B, 1991, BIOCHEM BIOPH RES CO, V177, P1217, DOI 10.1016/0006-291X(91)90671-S	18	34	34	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1992	50	5					1046	1052						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HR473	1570834				2022-12-18	WOS:A1992HR47300021
J	KESSLING, A; OUELLETTE, S; BOUFFARD, O; CHAMBERLAND, A; BETARD, C; SELINGER, E; XHIGNESSE, M; LUSSIERCACAN, S; DAVIGNON, J				KESSLING, A; OUELLETTE, S; BOUFFARD, O; CHAMBERLAND, A; BETARD, C; SELINGER, E; XHIGNESSE, M; LUSSIERCACAN, S; DAVIGNON, J			PATTERNS OF ASSOCIATION BETWEEN GENETIC-VARIABILITY IN APOLIPOPROTEIN (APO)-B, APO AI-CIII-AIV, AND CHOLESTEROL ESTER TRANSFER PROTEIN GENE REGIONS AND QUANTITATIVE VARIATION IN LIPID AND LIPOPROTEIN TRAITS - INFLUENCE OF GENDER AND EXOGENOUS HORMONES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CORONARY HEART-DISEASE; B-GENE; DNA POLYMORPHISMS; SERUM-CHOLESTEROL; I GENE; PVUII; ATHEROSCLEROSIS; INDIVIDUALS; POPULATION; FREQUENCY	Patterns of RFLP association were studied, to identify gene regions influencing quantitative variation in lipid and lipoprotein traits (coronary artery disease [CAD] risk factors or metabolically related traits). Subjects (118 female and 229 male; age 20-59 years) were selected for health. Multiple RFLPs were used to sample variability in regions around genes for apolipoprotein (apo) B (restriction enzymes HincII, PvuII, EcoRI, and XbaI), apo AI-CIII-AIV (BamHI, XmnI, TaqI, PstI, SstI, and PvuII) and cholesterol ester transfer protein (TaqI). Separate analyses were done by gender. The sample was truncated at mean +/- 4 SD, to remove extreme outliers. There was no significant gender difference in RFLP genotype frequency distribution. After trait-level adjustment to maximize removal of concomitant variability, analysis of variance was used to estimate the percentage trait phenotypic variance explained by measured variability in the gene regions studied. Fewer gene regions were involved in m en, with less influence on quantitative trait variation than in women, in whom hormone use affected association patterns. Gender differences imply that pooling genders or adjusting data for gender effects removes genetic information and should be avoided. The association patterns show that variability around the candidate genes modulates trait levels: the genes are contributors to the genetics of CAD risk variables in a healthy sample.	INST RECH CLIN MONTREAL, HYPERLIPIDEMIA & ATHEROSCLEROSIS RES GRP, MONTREAL H2W 1R7, QUEBEC, CANADA	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal								ASSMANN G, 1989, INT CONGR SER, V817, P341; BAIRD PA, 1990, PERSPECT BIOL MED, V33, P203; Bunn HF, 1986, HEMOGLOBIN MOL GENET; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COHEN T, 1986, NUCLEIC ACIDS RES, V14, P1924, DOI 10.1093/nar/14.4.1924; CROUSE JR, 1984, CLIN CHEM, V30, P1125; DAC NV, 1989, J LIPID RES, V30, P1437; DARNFORS C, 1986, NUCLEIC ACIDS RES, V14, P7135, DOI 10.1093/nar/14.17.7135; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; DAVIGNON J, 1983, HYPERTENSION PHYSIOP, P672; DRAYNA D, 1987, NUCLEIC ACIDS RES, V15, P4698, DOI 10.1093/nar/15.11.4698; FROSSARD PM, 1986, NUCLEIC ACIDS RES, V14, P4373, DOI 10.1093/nar/14.10.4373; FRUCHART JC, 1982, CLIN CHEM, V28, P59; GRUNDY SM, 1986, JAMA-J AM MED ASSOC, V256, P2849, DOI 10.1001/jama.256.20.2849; HAVILAND MB, 1991, AM J HUM GENET, V49, P350; HOBBS HH, 1987, NEW ENGL J MED, V317, P734, DOI 10.1056/NEJM198709173171204; HUANG LS, 1990, J LIPID RES, V31, P71; HUMPHRIES SE, 1988, ATHEROSCLEROSIS, V72, P89, DOI 10.1016/0021-9150(88)90069-X; JEENAH M, 1990, MOL BIOL MED, V7, P233; KARATHANASIS SK, 1985, J LIPID RES, V26, P451; KESSLING AM, 1988, ATHEROSCLEROSIS, V70, P13, DOI 10.1016/0021-9150(88)90095-0; KESSLING AM, 1988, AM J HUM GENET, V42, P458; KESSLING AM, 1988, HUM GENET, V78, P237, DOI 10.1007/BF00291668; KESSLING AM, 1985, CLIN GENET, V28, P296; LABERGE C, 1966, B JOHNS HOPKINS HOSP, V118, P52; LAW A, 1986, LANCET, V1, P1301; LEITERSDORF E, 1990, J CLIN INVEST, V85, P1014, DOI 10.1172/JCI114531; LEVY RI, 1981, ARTERIOSCLEROSIS, V1, P312, DOI 10.1161/01.ATV.1.5.312; LEWIS B, 1974, LANCET, V1, P141; LUSIS AJ, 1988, J LIPID RES, V29, P397; MAILLY F, 1991, J LIPID RES, V32, P613; MORRIS SW, 1985, LANCET, V2, P1127; OETTGEN P, 1986, NUCLEIC ACIDS RES, V14, P5571, DOI 10.1093/nar/14.13.5571; PARRA HJ, 1990, CLIN CHEM, V36, P1431; PROTTER AA, 1986, P NATL ACAD SCI USA, V83, P1467, DOI 10.1073/pnas.83.5.1467; PULLINGER CR, 1989, J LIPID RES, V30, P1065; REES A, 1983, LANCET, V1, P444; SING CF, 1976, AM J HUM GENET, V28, P453; SING CF, 1989, INT J EPIDEMIOL, V18, pS183; SING CF, 1985, AM J HUM GENET, V37, P268; TALMUD PJ, 1985, CYTOGENET CELL GENET, V40, P759; TALMUD PJ, 1987, ATHEROSCLEROSIS, V67, P81, DOI 10.1016/0021-9150(87)90267-X; TALMUD PJ, 1988, J CLIN INVEST, V82, P1803, DOI 10.1172/JCI113795; TEMPLETON AR, 1988, GENETICS, V120, P1145; WILE DB, 1989, ATHEROSCLEROSIS, V78, P9, DOI 10.1016/0021-9150(89)90153-6; XHIGNESSE M, 1991, ARTERIOSCLER THROMB, V11, P1100, DOI 10.1161/01.ATV.11.4.1100; XU CF, 1990, AM J HUM GENET, V47, P429; ZANNIS VI, 1981, BIOCHEMISTRY-US, V20, P1033, DOI 10.1021/bi00507a059; ZERBA KE, IN PRESS GENETICS; 1985, SAS USERS GUIDE	50	34	34	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1992	50	1					92	106						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HA040	1346081				2022-12-18	WOS:A1992HA04000011
J	GRACE, ME; BERG, A; HE, GS; GOLDBERG, L; HOROWITZ, M; GRABOWSKI, GA				GRACE, ME; BERG, A; HE, GS; GOLDBERG, L; HOROWITZ, M; GRABOWSKI, GA			GAUCHER DISEASE - HETEROLOGOUS EXPRESSION OF 2 ALLELES ASSOCIATED WITH NEURONOPATHIC PHENOTYPES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACID BETA-GLUCOSIDASE; HUMAN GLUCOCEREBROSIDASE GENE; MOLECULAR-BIOLOGY; FIBROBLASTS; MUTATIONS; TYPE-1; HETEROGENEITY; ENZYME; DNA; IDENTIFICATION	To investigate the molecular basis for the distinct neuronopathic phenotypes of Gaucher disease, acid beta-glucosidases expressed from mutant DNAs in Gaucher disease type 2 (acute) and type 3 (subacute) patients were characterized in fibroblasts and with the baculovirus expression system in insect cells. Expression of the mutant DNA encoding a proline-for-leucine substitution at amino acid 444 (L444P) resulted in a catalytically defective, unstable acid beta-glucosidase in either fibroblasts from L444P/L444P homozygotes or in insect cells. This mutation was found to be homoallelic in subacute neuronopathic (type 3) Gaucher disease. In comparison, expression of the mutant cDNA encoding an arginine-for-proline substitution at amino acid 415 (P415R) resulted in an inactive and unstable protein in insect cells. This allele was found only in a type 2 patient with the L444P/P415R genotype. The substantial variation in the type 3 phenotype (L444P homozygotes) suggests the complex nature of the molecular basis of phenotypic variation in Gaucher disease. Yet, the association of neuronopathic phenotypes with alleles producing severely compromised (L444P) or functionally null (P415R) enzymes indicates that the effective level of residual activity at the lysosome is likely to be a major determinant of the severity of Gaucher disease.	CUNY MT SINAI SCH MED,DEPT PEDIAT,DIV MED & MOLEC GENET,1 GUSTAVE L LEVY PL,NEW YORK,NY 10029; WEIZMANN INST SCI,IL-76100 REHOVOT,ISRAEL	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Weizmann Institute of Science					NCRR NIH HHS [RR-71] Funding Source: Medline; NIDDK NIH HHS [DK 36729] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036729] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARTON NW, 1990, P NATL ACAD SCI USA, V87, P1913, DOI 10.1073/pnas.87.5.1913; BERGMANN JE, 1989, AM J HUM GENET, V44, P741; BEUTLER E, 1986, P NATL ACAD SCI USA, V83, P7472, DOI 10.1073/pnas.83.19.7472; BEUTLER E, 1990, ANN HUM GENET, V54, P149, DOI 10.1111/j.1469-1809.1990.tb00371.x; BRADY RO, 1965, J BIOL CHEM, V240, P39; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; CHOY FYM, 1986, BIOCHIM BIOPHYS ACTA, V870, P76, DOI 10.1016/0167-4838(86)90010-5; CONZELMANN E, 1984, DEV NEUROSCI-BASEL, V6, P58, DOI 10.1159/000112332; DAHL N, 1990, AM J HUM GENET, V47, P275; DAZZO A, 1984, J BIOL CHEM, V259, P1070; DINUR T, 1986, P NATL ACAD SCI USA, V83, P1660, DOI 10.1073/pnas.83.6.1660; DINUR T, 1984, ANAL BIOCHEM, V136, P223, DOI 10.1016/0003-2697(84)90329-4; DINUR T, 1986, ENZYMES LIPID METABO, V2, P289; DREBORG S, 1980, EUR J PEDIATR, V133, P107, DOI 10.1007/BF00441578; ERICKSON AH, 1985, J BIOL CHEM, V260, P4319; FABBRO D, 1987, AM J HUM GENET, V40, P15; FIRON N, 1990, AM J HUM GENET, V46, P527; GINNS EI, 1982, P NATL ACAD SCI-BIOL, V79, P5607, DOI 10.1073/pnas.79.18.5607; GRABOWSKI GA, 1984, ARCH BIOCHEM BIOPHYS, V231, P144, DOI 10.1016/0003-9861(84)90371-0; GRABOWSKI GA, 1990, CRIT REV BIOCHEM MOL, V25, P385, DOI 10.3109/10409239009090616; GRABOWSKI GA, 1989, ENZYME, V41, P131, DOI 10.1159/000469068; GRABOWSKI GA, 1985, AM J MED GENET, V21, P529, DOI 10.1002/ajmg.1320210316; GRACE ME, 1990, J BIOL CHEM, V265, P6827; GRAVES PN, 1988, DNA-J MOLEC CELL BIO, V7, P521, DOI 10.1089/dna.1.1988.7.521; HONG CM, 1990, DNA CELL BIOL, V9, P233, DOI 10.1089/dna.1990.9.233; HOROWITZ M, 1989, GENOMICS, V4, P87, DOI 10.1016/0888-7543(89)90319-4; Institute of Gaucher Disease, 2020, EP GAUCH DIS; KOLODNY EH, 1990, AM J MED GENET, V36, P467, DOI 10.1002/ajmg.1320360419; LATHAM T, 1990, AM J HUM GENET, V47, P79; LATHAM TE, 1991, DNA CELL BIOL, V10, P15, DOI 10.1089/dna.1991.10.15; LEIBOVITZBENGER.BD, 1982, GAUCHER DISEASE CENT, P481; MARET A, 1983, FEBS LETT, V160, P93, DOI 10.1016/0014-5793(83)80943-0; MARET A, 1989, BIOCHIM BIOPHYS ACTA, V996, P254, DOI 10.1016/0167-4838(89)90255-0; MASUNO M, 1990, HUM GENET, V84, P203; MATTHEWS REF, 1982, CLASSIFICATION NONME; MEYEROWITZ R, 1988, P NATL ACAD SCI USA, V81, P5394; MUELLER OT, 1977, J BIOL CHEM, V252, P825; OHSHI T, 1991, J BIOL CHEM, V266, P3661; OSIECKINEWMAN K, 1987, BIOCHIM BIOPHYS ACTA, V915, P87, DOI 10.1016/0167-4838(87)90128-2; PATTERSON M C, 1991, Neurology, V41, P332; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHIMMEL P, 1990, BIOCHEMISTRY-US, V29, P9495, DOI 10.1021/bi00493a001; Summers M.D., 1987, B TEXAS AGR EXPT STA, V1555; Svennerholm L, 1982, Prog Clin Biol Res, V95, P67; TAGER JM, 1986, ENZYMES LIPID METABO, V2, P735; TAYLOR JW, 1985, NUCLEIC ACIDS RES, V13, P8749, DOI 10.1093/nar/13.24.8749; TAYLOR JW, 1985, NUCLEIC ACIDS RES, V13, P8764; THEOPHILUS B, 1989, AM J HUM GENET, V45, P212; THEOPHILUS BDM, 1989, NUCLEIC ACIDS RES, V17, P7707, DOI 10.1093/nar/17.19.7707; TSUJI S, 1988, P NATL ACAD SCI USA, V85, P2349, DOI 10.1073/pnas.85.7.2349; TSUJI S, 1987, NEW ENGL J MED, V316, P570, DOI 10.1056/NEJM198703053161002; WIGDERSON M, 1989, AM J HUM GENET, V44, P365; WILLEMSEN R, 1987, J NEUROL, V234, P44, DOI 10.1007/BF00314009; WINKELMAN MD, 1983, NEUROLOGY, V33, P994, DOI 10.1212/WNL.33.8.994; YU C, 1990, NEUROLOGY S1, V40, P357; ZIMRAN A, 1989, LANCET, V2, P349; ZIMRAN A, 1990, J CLIN INVEST, V85, P219, DOI 10.1172/JCI114415; ZIMRAN A, 1990, BLOOD, V76, pA199	58	34	34	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1991	49	3					646	655						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GE367	1909090				2022-12-18	WOS:A1991GE36700018
J	GREBNER, EE; TOMCZAK, J				GREBNER, EE; TOMCZAK, J			DISTRIBUTION OF 3 ALPHA-CHAIN BETA-HEXOSAMINIDASE-A MUTATIONS AMONG TAY-SACHS CARRIERS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ASHKENAZI JEWS; DISEASE; DEFECT; GENE	DNA from 176 carriers of the Tay-Sachs gene was tested for the presence of the three mutations most commonly found among Ashkenazi Jews: the so-called insertion, splice junction, and adult mutations. Among 148 Ashkenazi Jews tested, 108 had the insertion mutation, 26 had the splice junction mutation, five had the adult mutation, and nine had none of the three. Among 28 non-Jewish carriers tested, most of whom were obligate carriers, four had the insertion mutation, one had the adult mutation, and the remaining 23 had none of the three.			GREBNER, EE (corresponding author), THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DIV MED GENET,414 MED OFF BLDG,1100 WALNUT ST,PHILADELPHIA,PA 19107, USA.							ARPAIA E, 1988, NATURE, V333, P85, DOI 10.1038/333085a0; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; KABACK MM, 1977, PROGR CLIN BIOL RES, V18, P167; MYEROWITZ R, 1988, J BIOL CHEM, V263, P18587; MYEROWITZ R, 1988, P NATL ACAD SCI USA, V85, P3955, DOI 10.1073/pnas.85.11.3955; NAVON R, 1989, SCIENCE, V243, P1471, DOI 10.1126/science.2522679; OHNO K, 1988, BIOCHEM BIOPH RES CO, V153, P463, DOI 10.1016/S0006-291X(88)81247-6; PAW BH, 1990, AM J HUM GENET, V47, P698; PAW BH, 1989, P NATL ACAD SCI USA, V86, P2413, DOI 10.1073/pnas.86.7.2413; Sandhoff KCE, 1989, METABOLIC BASIS INHE, V2, P1807; SHORE S, 1990, AM J HUM GENET, V47, P169; TRIGGSRAINE BL, 1990, NEW ENGL J MED, V323, P6, DOI 10.1056/NEJM199007053230102	12	34	34	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1991	48	3					604	607						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK470	1825595				2022-12-18	WOS:A1991FK47000020
J	WEREMOWICZ, S; FOX, EA; MORTON, CC; VALLEE, BL				WEREMOWICZ, S; FOX, EA; MORTON, CC; VALLEE, BL			LOCALIZATION OF THE HUMAN ANGIOGENIN GENE TO CHROMOSOME BAND 14Q11, PROXIMAL TO THE T-CELL RECEPTOR ALPHA-SIGMA-LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HARVARD UNIV,SCH MED,CTR BIOCHEM & BIOPHYS SCI & MED,SEELEY G MUDD BLDG,RM 106,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,DEPT PATHOL,BOSTON,MA 02115	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital					NHLBI NIH HHS [HL-07582] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL007582] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ausubel F., 1992, MOL REPROD DEV, DOI DOI 10.1002/MRD.1080010210; BARKER RL, 1989, J IMMUNOL, V143, P952; BICKNELL R, 1989, P NATL ACAD SCI USA, V86, P1573, DOI 10.1073/pnas.86.5.1573; BICKNELL R, 1988, P NATL ACAD SCI USA, V85, P5961, DOI 10.1073/pnas.85.16.5961; BODER E, 1958, PEDIATRICS, V21, P526; BOEHM T, 1988, EMBO J, V7, P385, DOI 10.1002/j.1460-2075.1988.tb02825.x; BOEHM T, 1989, FASEB J, V3, P2344, DOI 10.1096/fasebj.3.12.2676678; BROOK JD, 1985, HUM GENET, V69, P282; BRUNS GAP, 1979, BIOCHEM GENET, V17, P1031, DOI 10.1007/BF00504344; CASPERSSON T, 1970, CHROMOSOMA, V30, P215; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; DURACK DT, 1979, P NATL ACAD SCI USA, V76, P1443, DOI 10.1073/pnas.76.3.1443; EHRMANN RL, 1968, J NATL CANCER I, V41, P1329; ESCH F, 1985, P NATL ACAD SCI USA, V82, P6507, DOI 10.1073/pnas.82.19.6507; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FETT JW, 1985, BIOCHEMISTRY-US, V24, P5480, DOI 10.1021/bi00341a030; GREENBLATT M, 1968, JNCI-J NATL CANCER I, V41, P111; HARNDEN DG, 1985, CYTOGENET CELL GENET; HARPER JW, 1988, P NATL ACAD SCI USA, V85, P1739; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; HEPPELL A, 1988, HUM GENET, V79, P360; KURACHI K, 1985, BIOCHEMISTRY-US, V24, P5494, DOI 10.1021/bi00341a032; LATT SA, 1976, CHROMOSOMA, V57, P135, DOI 10.1007/BF00292912; LEBEAU MM, 1986, P NATL ACAD SCI USA, V83, P9744; LEIBOVICH SJ, 1987, NATURE, V329, P630, DOI 10.1038/329630a0; LOBB RR, 1985, BIOCHEMISTRY-US, V24, P4969, DOI 10.1021/bi00340a001; MAES P, 1988, FEBS LETT, V241, P41, DOI 10.1016/0014-5793(88)81027-5; OLSZEWSKA E, 1988, TRENDS GENET, V4, P92, DOI 10.1016/0168-9525(88)90095-9; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; ROSENBERG HF, 1989, P NATL ACAD SCI USA, V86, P4460, DOI 10.1073/pnas.86.12.4460; RUSSO G, 1988, CELL, V53, P137, DOI 10.1016/0092-8674(88)90495-3; RYBAK SM, 1987, BIOCHEM BIOPH RES CO, V146, P1240, DOI 10.1016/0006-291X(87)90781-9; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCHREIBER AB, 1986, SCIENCE, V232, P1250, DOI 10.1126/science.2422759; SCOTT AF, 1979, P NATL ACAD SCI USA, V76, P4563, DOI 10.1073/pnas.76.9.4563; SHAPIRO R, 1989, BIOCHEMISTRY-US, V28, P7401, DOI 10.1021/bi00444a038; SHAPIRO R, 1989, BIOCHEMISTRY-US, V28, P1726, DOI 10.1021/bi00430a045; SHAPIRO R, 1986, BIOCHEMISTRY-US, V25, P3527, DOI 10.1021/bi00360a008; SHAPIRO R, 1987, BIOCHEMISTRY-US, V26, P5141, DOI 10.1021/bi00390a037; SHAPIRO R, 1987, P NATL ACAD SCI USA, V84, P8783, DOI 10.1073/pnas.84.24.8783; SHAPIRO R, 1987, P NATL ACAD SCI USA, V84, P2238, DOI 10.1073/pnas.84.8.2238; SLIFMAN NR, 1986, J IMMUNOL, V137, P2913; Spector BD, 1982, ATAXIA TELANGIECTASI, P103; STRYDOM DJ, 1985, BIOCHEMISTRY-US, V24, P5486, DOI 10.1021/bi00341a031; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; WEINER HL, 1987, SCIENCE, V237, P280, DOI 10.1126/science.2440105; YUNIS JJ, 1978, CYTOGENET CELL GENET, V22, P679, DOI 10.1159/000131052	47	34	34	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1990	47	6					973	981						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EK400	1978563				2022-12-18	WOS:A1990EK40000014
J	POLGAR, K; ADANY, R; ABEL, G; KAPPELMAYER, J; MUSZBEK, L; PAPP, Z				POLGAR, K; ADANY, R; ABEL, G; KAPPELMAYER, J; MUSZBEK, L; PAPP, Z			CHARACTERIZATION OF RAPIDLY ADHERING AMNIOTIC-FLUID CELLS BY COMBINED IMMUNOFLUORESCENCE AND PHAGOCYTOSIS ASSAYS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									DEBRECEN UNIV MED,SCH MED,DEPT CLIN CHEM,H-4012 DEBRECEN,HUNGARY; DEBRECEN UNIV MED,SCH MED,DEPT PATHOPHYSIOL,H-4012 DEBRECEN,HUNGARY	University of Debrecen; University of Debrecen	POLGAR, K (corresponding author), DEBRECEN UNIV MED,SCH MED,DEPT OBSTET & GYNECOL,POB 37,H-4012 DEBRECEN,HUNGARY.							ABEL G, IN PRESS INT J IMMUN; ALALI SYA, 1984, HISTOCHEM J, V16, P165, DOI 10.1007/BF01003547; AULA P, 1980, BRIT MED J, V281, P1456, DOI 10.1136/bmj.281.6253.1456; BIGNAMI A, 1974, J COMP NEUROL, V153, P27, DOI 10.1002/cne.901530104; BRIERLEY JB, 1982, J COMP NEUROL, V211, P397, DOI 10.1002/cne.902110406; BUNGE RP, 1985, TRENDS NEUROSCI, V8, P424, DOI 10.1016/0166-2236(85)90150-X; CHAPMAN PA, 1982, MED LAB SCI, V39, P215; CHOI BH, 1984, SCIENCE, V223, P407, DOI 10.1126/science.6197755; CREMER M, 1981, HUM GENET, V56, P365, DOI 10.1007/BF00274694; DIMITRIUBONA A, 1983, J IMMUNOL, V130, P145; ESIRI MM, 1984, J CLIN PATHOL, V37, P150, DOI 10.1136/jcp.37.2.150; FRANKLIN WA, 1986, LAB INVEST, V54, P322; GORDON S, 1986, J CELL SCI S, V4, P267; GOSDEN CM, 1977, LANCET, V1, P19; KREIPE H, 1987, J HISTOCHEM CYTOCHEM, V35, P1117, DOI 10.1177/35.10.3476670; MEDINAGOMEZ P, 1986, PRENATAL DIAG, V6, P195, DOI 10.1002/pd.1970060306; MIYAKE T, 1988, BRAIN RES, V451, P133, DOI 10.1016/0006-8993(88)90757-3; MIZEJEWSKI GJ, 1985, ALPHA FETOPROTEIN CO, P157; MUELLER J, 1975, EUR J IMMUNOL, V5, P270, DOI 10.1002/eji.1830050411; MURABE Y, 1983, CELL TISSUE RES, V229, P85; NOSKE W, 1982, EXP CELL RES, V142, P437, DOI 10.1016/0014-4827(82)90385-8; OECHMICHEN M, 1975, MONONUCLEAR PHAGOCYT, P223; OGLE J, 1985, J IMMUNOL METHODS, V47, P47; PAPP Z, 1982, ACTA CYTOL, V26, P751; PAPP Z, 1979, CLIN GENET, V16, P282; POLGAR K, 1988, AM J REPROD IMMUNOL, V18, P81; POLGAR K, 1987, AM J CLIN PATHOL, V87, P37, DOI 10.1093/ajcp/87.1.37; POLGAR K, 1984, NEW ENGL J MED, V310, P1463; POLGAR K, 1988, Acta Paediatrica Hungarica, V29, P63; POLGAR K, 1988, ACTA PHYSIOL HUNG, V71, P551; POLGAR K, 1985, KARYOGRAM, V11, P39; RAFF MC, 1979, BRAIN RES, V174, P283, DOI 10.1016/0006-8993(79)90851-5; SARKAR S, 1980, AM J OBSTET GYNECOL, V136, P67, DOI 10.1016/0002-9378(80)90566-9; SCHELPER RL, 1986, J NEUROPATH EXP NEUR, V45, P1, DOI 10.1097/00005072-198601000-00001; SUTHERLAND GR, 1973, LANCET, V2, P1098; VANFURTH R, 1986, CELL IMMUNOL, P42; VONKOSKULL H, 1981, PRENATAL DIAG, V1, P259, DOI 10.1002/pd.1970010405; WOOD GW, 1979, J NEUROPATH EXP NEUR, V38, P369, DOI 10.1097/00005072-197907000-00002	38	34	38	0	8	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1989	45	5					786	792						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AZ049	2683760				2022-12-18	WOS:A1989AZ04900015
J	TZALL, S; ELLENBOGEN, A; ENG, F; HIRSCHHORN, R				TZALL, S; ELLENBOGEN, A; ENG, F; HIRSCHHORN, R			IDENTIFICATION AND CHARACTERIZATION OF 9 RFLPS AT THE ADENOSINE-DEAMINASE (ADA) LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NYU,SCH MED,DEPT MED,550 1ST AVE,NEW YORK,NY 10016	New York University					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI010343, R01AI010343] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 10343] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AITKEN DA, 1978, CYTOGENET CELL GENET, V22, P514, DOI 10.1159/000131012; BARKER D, 1984, AM J HUM GENET, V36, P1159; BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; BISSBORT S, 1987, HUM GENET, V77, P277, DOI 10.1007/BF00284485; BONTHRON DT, 1985, J CLIN INVEST, V76, P894, DOI 10.1172/JCI112050; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; DADDONA PE, 1984, J BIOL CHEM, V259, P2101; DEMARTINVILLE B, 1984, CYTOGENET CELL GENET, V37, P531; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FRAISSE J, 1979, CYTOGENET CELL GENET, V25, P154; FRISCHAUF AM, 1983, J MOL BIOL, V170, P827, DOI 10.1016/S0022-2836(83)80190-9; GIBLETT ER, 1972, LANCET, V2, P1067; GOODFELLOW PJ, 1987, CYTOGENET CELL GENET, V44, P112, DOI 10.1159/000132354; GOODFELLOW PJ, 1985, CYTOGENET CELL GENET, V40, P645; HIRSCHHORN R, 1986, CLIN IMMUNOL IMMUNOP, V40, P157, DOI 10.1016/0090-1229(86)90081-4; HIRSCHHORN R, 1987, CLIN RES, V36, pA618; HIRSCHHORN R, 1989, J CLIN INVEST, V83, P495; HONIG J, 1984, ANN HUM GENET, V48, P49, DOI 10.1111/j.1469-1809.1984.tb00833.x; KAPLAN JC, 1987, CYTOGENET CELL GENET, V46, P257, DOI 10.1159/000132480; Kredich NM, 1983, METABOLIC BASIS INHE, P1157; LITT M, 1986, AM J HUM GENET, V39, P166; MCLELLAN T, 1984, AM J HUM GENET, V36, P836; MOHANDAS T, 1984, HUM GENET, V66, P292, DOI 10.1007/BF00287630; MOHANDAS T, 1980, CYTOGENET CELL GENET, V26, P28, DOI 10.1159/000131418; ORKIN SH, 1985, MOL CELL BIOL, V5, P762, DOI 10.1128/MCB.5.4.762; ORKIN SH, 1983, J BIOL CHEM, V258, P2753; PETERSEN MB, 1987, J MED GENET, V24, P93, DOI 10.1136/jmg.24.2.93; PHILIP T, 1980, CYTOGENET CELL GENET, V27, P187, DOI 10.1159/000131481; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPENCER N, 1968, ANN HUM GENET, V32, P9, DOI 10.1111/j.1469-1809.1968.tb00044.x; THOMPSON EA, 1988, AM J HUM GENET, V42, P113; TISCHFIELD JA, 1974, HUM HERED, V42, P1; TZALL S, 1987, American Journal of Human Genetics, V41, pA243; VALERIO D, 1985, EMBO J, V4, P437, DOI 10.1002/j.1460-2075.1985.tb03648.x; WIGINTON DA, 1984, NUCLEIC ACIDS RES, V12, P2439, DOI 10.1093/nar/12.5.2439; WIGINTON DA, 1986, BIOCHEMISTRY-US, V25, P8235; WIGLER M, 1978, CELL, V14, P725, DOI 10.1016/0092-8674(78)90254-4; WOOLF CM, 1956, AM J HUM GENET, V8, P236	41	34	35	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1989	44	6					864	875						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	U8549	2567118				2022-12-18	WOS:A1989U854900012
J	WEISS, MJ; RAY, K; FALLON, MD; WHYTE, MP; FEDDE, KN; LAFFERTY, MA; MULIVOR, RA; HARRIS, H				WEISS, MJ; RAY, K; FALLON, MD; WHYTE, MP; FEDDE, KN; LAFFERTY, MA; MULIVOR, RA; HARRIS, H			ANALYSIS OF LIVER BONE KIDNEY ALKALINE-PHOSPHATASE MESSENGER-RNA, DNA, AND ENZYMATIC-ACTIVITY IN CULTURED SKIN FIBROBLASTS FROM 14 UNRELATED PATIENTS WITH SEVERE HYPOPHOSPHATASIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV PENN,SCH MED,DEPT HUMAN GENET,195 JOHN MORGAN BLDG,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT PATHOL & LAB MED,PHILADELPHIA,PA 19104; WASHINGTON UNIV,SCH MED,DIV BONE & MINERAL DIS,ST LOUIS,MO 63110; CORIELL INST MED RES,CAMDEN,NJ	University of Pennsylvania; University of Pennsylvania; Washington University (WUSTL); Coriell Institute for Medical Research			Ray, Kunal/E-6515-2011; Weiss, Mitchell J/A-1245-2013; Weiss, Mitchell J/W-9814-2018	Ray, Kunal/0000-0001-9989-1760; Weiss, Mitchell J/0000-0003-2460-3036	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027018, T32GM007170] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32GM07170, GM27018] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHODIRKER B N, 1987, Genomics, V1, P280, DOI 10.1016/0888-7543(87)90056-5; DANOVITCH SH, 1968, NEW ENGL J MED, V278, P1253, DOI 10.1056/NEJM196806062782303; FALLON MD, 1987, CLIN BIOCH ANAL SERI, V22, P791; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRASER D, 1957, AM J MED, V22, P730, DOI 10.1016/0002-9343(57)90124-9; GREENBERG C R, 1988, Pediatric Research, V23, p329A; HARRIS H, 1959, ANN HUM GENET, V23, P421, DOI 10.1111/j.1469-1809.1959.tb01484.x; HARRIS H, 1981, HARVEY LECT, V76, P95; HENTHORN PS, 1987, P NATL ACAD SCI USA, V84, P1234, DOI 10.1073/pnas.84.5.1234; KAM W, 1985, P NATL ACAD SCI USA, V82, P8715, DOI 10.1073/pnas.82.24.8715; LEE AK, 1987, CLIN BIOCH ANAL SERI, V22, P31; MANIATIS T, 1982, MOL CLONING LABORATO; McComb R.B., 1979, ALKALINE PHOSPHATASE, DOI 10.1007/978-1-4613-2970-1_4; MILLAN JL, 1986, J BIOL CHEM, V261, P3112; MOSS DW, 1985, ENZYME, V34, P212, DOI 10.1159/000469387; MUELLER HD, 1983, J LAB CLIN MED, V102, P24; MULIVOR RA, 1978, AM J HUM GENET, V30, P271; RAY K, 1988, NUCLEIC ACIDS RES, V16, P2361, DOI 10.1093/nar/16.5.2361; Robison R, 1923, BIOCHEM J, V17, P286, DOI 10.1042/bj0170286; RUSSELL RGG, 1965, LANCET, V2, P461; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SMITH M, 1988, Genomics, V2, P139, DOI 10.1016/0888-7543(88)90095-X; SPIEGELMAN BM, 1983, J BIOL CHEM, V258, P83; VANNEUVILLE FJ, 1978, ARCH INT PHYSIOL BIO, V86, P817, DOI 10.3109/13813457809069534; WARSHAW JB, 1971, J CLIN INVEST, V50, P2137, DOI 10.1172/JCI106707; WEISS MJ, 1986, P NATL ACAD SCI USA, V83, P7182, DOI 10.1073/pnas.83.19.7182; WEISS MJ, 1988, J BIOL CHEM, V263, P12002; WEISS MJ, 1988, P NATL ACAD SCI USA, V85, P7666, DOI 10.1073/pnas.85.20.7666; WHYTE MP, 1983, J CLIN ENDOCR METAB, V57, P831, DOI 10.1210/jcem-57-4-831; WHYTE MP, 1987, CALCIFIED TISSUE INT, V40, P244, DOI 10.1007/BF02555256; WHYTE MP, 1987, CALCIFIED TISSUE INT, V40, P1, DOI 10.1007/BF02555720; WHYTE MP, 1985, J CLIN INVEST, V76, P752, DOI 10.1172/JCI112031; WHYTE MP, 1989, METABOLIC BASIS INHE, P2843; Wuthier R.E., 1985, CHEM BIOL MINERALIZE, P113	35	34	34	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1989	44	5					686	694						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	U3338	2705456				2022-12-18	WOS:A1989U333800009
J	BAKER, RT; BOARD, PG				BAKER, RT; BOARD, PG			UNEQUAL CROSSOVER GENERATES VARIATION IN UBIQUITIN CODING UNIT NUMBER AT THE HUMAN UBC POLYUBIQUITIN LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									AUSTRALIAN NATL UNIV,JOHN CURTIN SCH MED RES,DIV CLIN SCI,HUMAN GENET GRP,CANBERRA,ACT 2601,AUSTRALIA	Australian National University; John Curtin School of Medical Research								ARRIBAS C, 1986, BIOCHIM BIOPHYS ACTA, V868, P119, DOI 10.1016/0167-4781(86)90014-X; BAKER RT, 1987, NUCLEIC ACIDS RES, V15, P443, DOI 10.1093/nar/15.2.443; BAKER RT, 1987, NUCLEIC ACIDS RES, V15, P4352, DOI 10.1093/nar/15.10.4352; BAKER RT, 1988, THESIS AUSTR NATIONA; BALL E, 1987, CELL, V51, P221, DOI 10.1016/0092-8674(87)90149-8; BOND U, 1985, MOL CELL BIOL, V5, P949, DOI 10.1128/MCB.5.5.949; BURKE JF, 1984, GENE, V30, P63, DOI 10.1016/0378-1119(84)90105-7; CHEN SH, 1987, SCIENCE, V238, P363, DOI 10.1126/science.3659919; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V161, P156; COWLAND JB, 1988, FEBS LETT, V231, P187, DOI 10.1016/0014-5793(88)80728-2; DWORKINRASTL E, 1984, CELL, V39, P321, DOI 10.1016/0092-8674(84)90010-2; ECKERT RL, 1986, CELL, V46, P583, DOI 10.1016/0092-8674(86)90884-6; EINSPANIER R, 1987, BIOCHEM BIOPH RES CO, V147, P581, DOI 10.1016/0006-291X(87)90970-3; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; FINLEY D, 1985, TRENDS BIOCHEM SCI, V10, P343, DOI 10.1016/0968-0004(85)90108-2; GRUNEBAUM L, 1984, J CLIN INVEST, V73, P1491, DOI 10.1172/JCI111354; HERSHKO A, 1986, PROG NUCLEIC ACID RE, V33, P19, DOI 10.1016/S0079-6603(08)60019-7; HOOK AG, 1988, J BIOL CHEM, V263, P2337; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; LEE HS, 1988, MOL CELL BIOL, V8, P4727, DOI 10.1128/MCB.8.11.4727; LOISEAU P, 1986, IMMUNOGENETICS, V23, P111, DOI 10.1007/BF00377970; LOWE J, 1988, J PATHOL, V155, P9, DOI 10.1002/path.1711550105; LUND PK, 1985, J BIOL CHEM, V260, P7609; MAIRE P, 1987, J MOL BIOL, V197, P425, DOI 10.1016/0022-2836(87)90556-0; Maniatis T., 1982, MOL CLONING; MARDON HJ, 1987, NUCLEIC ACIDS RES, V15, P7725, DOI 10.1093/nar/15.19.7725; MORI H, 1987, SCIENCE, V235, P1641, DOI 10.1126/science.3029875; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; OZKAYNAK E, 1984, NATURE, V312, P663, DOI 10.1038/312663a0; OZKAYNAK E, 1987, EMBO J, V6, P1429, DOI 10.1002/j.1460-2075.1987.tb02384.x; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; RECHSTEINER M, 1987, ANNU REV CELL BIOL, V3, P1, DOI 10.1146/annurev.cb.03.110187.000245; REED KC, 1985, NUCLEIC ACIDS RES, V13, P7207, DOI 10.1093/nar/13.20.7207; Schlesinger M J, 1987, Oxf Surv Eukaryot Genes, V4, P77; SHARP PM, 1987, TRENDS ECOL EVOL, V2, P328, DOI 10.1016/0169-5347(87)90108-X; SIEGELMAN M, 1986, SCIENCE, V231, P823, DOI 10.1126/science.3003913; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SWINDLE J, 1988, EMBO J, V7, P1121, DOI 10.1002/j.1460-2075.1988.tb02921.x; WIBORG O, 1985, EMBO J, V4, P755, DOI 10.1002/j.1460-2075.1985.tb03693.x; YARDEN Y, 1986, NATURE, V323, P226, DOI 10.1038/323226a0	40	34	35	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1989	44	4					534	542						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	T8109	2564731				2022-12-18	WOS:A1989T810900013
J	NUKIWA, T; BRANTLY, ML; OGUSHI, F; FELLS, GA; CRYSTAL, RG				NUKIWA, T; BRANTLY, ML; OGUSHI, F; FELLS, GA; CRYSTAL, RG			CHARACTERIZATION OF THE GENE AND PROTEIN OF THE COMMON ALPHA-L-ANTITRYPSIN NORMAL M2 ALLELE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NHLBI, PULM BRANCH, BLDG 10, ROOM 6D03, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)			Brantly, Mark/AAH-2922-2020					ALLEN RC, 1974, AM J CLIN PATHOL, V62, P732; BEATTY K, 1980, J BIOL CHEM, V255, P3931; BRANTLY M, 1988, AM J MED, V84, P13; BRENNAN SO, 1986, BIOCHIM BIOPHYS ACTA, V873, P13, DOI 10.1016/0167-4838(86)90183-4; CARRELL RW, 1982, NATURE, V298, P329, DOI 10.1038/298329a0; CARRELL RW, 1981, FEBS LETT, V135, P301, DOI 10.1016/0014-5793(81)80805-8; COLAU B, 1984, DNA-J MOLEC CELL BIO, V3, P327, DOI 10.1089/dna.1.1984.3.327; CONSTANS J, 1980, AM J HUM GENET, V33, P119; COURTNEY M, 1984, P NATL ACAD SCI-BIOL, V81, P669, DOI 10.1073/pnas.81.3.669; COURTOIS G, 1987, SCIENCE, V238, P688, DOI 10.1126/science.3499668; COX DW, 1980, HUM GENET, V53, P429, DOI 10.1007/BF00287070; DESIMONE V, 1987, EMBO J, V6, P2759, DOI 10.1002/j.1460-2075.1987.tb02570.x; DYKES DD, 1984, HUM HERED, V34, P308, DOI 10.1159/000153485; Fagerhol M K, 1981, Adv Hum Genet, V11, P1; FRANTS RR, 1978, HUM HERED, V28, P201, DOI 10.1159/000152959; Gadek J., 1982, METABOLIC BASIS INHE, P1450; GENZ T, 1977, HUM GENET, V38, P325, DOI 10.1007/BF00402159; GORG A, 1985, AM J HUM GENET, V37, P922; JOHNSON D, 1978, J BIOL CHEM, V253, P7142; KAMBOH M I, 1983, Disease Markers, V1, P33; KUEPPERS F, 1978, AM J HUM GENET, V30, P359; KURACHI K, 1981, P NATL ACAD SCI-BIOL, V78, P6826, DOI 10.1073/pnas.78.11.6826; LEDER P, 1977, SCIENCE, V196, P175, DOI 10.1126/science.322278; LEICHT M, 1982, NATURE, V297, P655, DOI 10.1038/297655a0; LOEBERMANN H, 1984, J MOL BIOL, V177, P531, DOI 10.1016/0022-2836(84)90298-5; LONG GL, 1984, BIOCHEMISTRY-US, V23, P4828, DOI 10.1021/bi00316a003; NUKIWA T, 1986, J CLIN INVEST, V77, P528, DOI 10.1172/JCI112333; NUKIWA T, 1986, J BIOL CHEM, V261, P5989; NUKIWA T, 1987, BIOCHEMISTRY-US, V26, P5259, DOI 10.1021/bi00391a008; NUKIWA T, 1987, J BIOL CHEM, V262, P11999; OGUSHI F, 1987, J CLIN INVEST, V80, P1366, DOI 10.1172/JCI113214; PERLINO E, 1987, EMBO J, V6, P2767, DOI 10.1002/j.1460-2075.1987.tb02571.x; RABIN M, 1986, SOMAT CELL MOLEC GEN, V12, P209, DOI 10.1007/BF01560668; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; ROGERS J, 1983, BIOCHEM BIOPH RES CO, V116, P375, DOI 10.1016/0006-291X(83)90532-6; ROSENBERG S, 1984, NATURE, V312, P77, DOI 10.1038/312077a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHEN RF, 1987, NUCLEIC ACIDS RES, V15, P8399, DOI 10.1093/nar/15.20.8399; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; WEWERS MD, 1987, NEW ENGL J MED, V316, P1055, DOI 10.1056/NEJM198704233161704; YOSHIDA A, 1979, AM J HUM GENET, V31, P555; YOSHIDA A, 1979, AM J HUM GENET, V31, P564	43	34	37	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1988	43	3					322	330						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	P8841	2901226				2022-12-18	WOS:A1988P884100013
J	WARBURTON, D				WARBURTON, D			UNIPARENTAL DISOMY - A RARE CONSEQUENCE OF THE HIGH-RATE OF ANEUPLOIDY IN HUMAN GAMETES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material									COLUMBIA UNIV,DEPT GENET & DEV,NEW YORK,NY 10027; COLUMBIA UNIV,DEPT PEDIAT,NEW YORK,NY 10027	Columbia University; Columbia University								BRANDRIFF B, 1985, HUM GENET, V70, P18, DOI 10.1007/BF00389451; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; MARTIN RH, 1987, HUM GENET, V77, P108, DOI 10.1007/BF00272374; WRAMSBY H, 1987, NEW ENGL J MED, V316, P121, DOI 10.1056/NEJM198701153160301	4	34	34	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1988	42	2					215	216						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M3133	3341379				2022-12-18	WOS:A1988M313300001
J	ROBINSON, BH; OEI, J; SAUDUBRAY, JM; MARSAC, C; BARTLETT, K; QUAN, F; GRAVEL, R				ROBINSON, BH; OEI, J; SAUDUBRAY, JM; MARSAC, C; BARTLETT, K; QUAN, F; GRAVEL, R			THE FRENCH AND NORTH-AMERICAN PHENOTYPES OF PYRUVATE-CARBOXYLASE DEFICIENCY, CORRELATION WITH BIOTIN CONTAINING PROTEIN BY H-3 BIOTIN INCORPORATION, S-35 STREPTAVIDIN LABELING, AND NORTHERN BLOTTING WITH A CLONED CDNA PROBE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HOP NECKER ENFANTS MALAD,F-75730 PARIS 15,FRANCE; UNIV TORONTO,DEPT PEDIAT & BIOCHEM,TORONTO M5S 1A1,ONTARIO,CANADA; ROYAL VICTORIA HOSP,NEWCASTLE UPON TYNE,ENGLAND	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Toronto	ROBINSON, BH (corresponding author), HOSP SICK CHILDREN,RES INST,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA.		Quan, Fu-Shi/V-1826-2019					ATKIN BM, 1979, PEDIATR RES, V13, P38, DOI 10.1203/00006450-197901000-00009; BARTLETT K, 1984, J INHERITED METAB S1, V1, P74; BURRI BJ, 1981, J CLIN INVEST, V68, P1491, DOI 10.1172/JCI110402; CHARPENTIER C, 1982, J INHERIT METAB DIS, V5, P11, DOI 10.1007/BF01799804; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COUDE FX, 1981, PEDIATRICS, V68, P914; DEVIVO DC, 1977, J CLIN ENDOCR METAB, V45, P1281, DOI 10.1210/jcem-45-6-1281; FREYTAG SO, 1984, J BIOL CHEM, V259, P2831; HAWORTH JC, 1981, J INHERIT METAB DIS, V4, P57, DOI 10.1007/BF02263589; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMHONWAH AM, UNPUB J BIOL CHEM; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; MILLIS AJT, 1973, BIOCHIM BIOPHYS ACTA, V292, P73, DOI 10.1016/0005-2728(73)90251-X; NIKOLAU BJ, 1985, ANAL BIOCHEM, V149, P448, DOI 10.1016/0003-2697(85)90596-2; OIZUMI J, 1983, J INHERIT METAB DIS, V6, P89, DOI 10.1007/BF01800731; PERRY TL, 1985, J INHERIT METAB DIS, V8, P63, DOI 10.1007/BF01801666; ROBINSON BH, 1983, J BIOL CHEM, V258, P6660; ROBINSON BH, 1980, PEDIATR RES, V14, P956, DOI 10.1203/00006450-198008000-00013; ROBINSON BH, 1985, PRENATAL DIAG, V5, P67, DOI 10.1002/pd.1970050112; ROBINSON BH, 1984, AM J HUM GENET, V36, P283; ROBINSON BH, 1985, PEDIATRICS, P111; SAUDUBRAY JM, 1976, ACTA PAEDIATR SCAND, V65, P717, DOI 10.1111/j.1651-2227.1976.tb04960.x; SAUNDERS ME, 1982, AM J HUM GENET, V34, P590; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TSUCHIYAMA A, 1983, J INHERIT METAB DIS, V6, P85, DOI 10.1007/BF01800730; VIDAILHET M, 1981, J INHERIT METAB DIS, V4, P57; WAHL GM, 1979, J BIOL CHEM, V254, P8679; WOLF B, 1983, J PEDIATR-US, V103, P233, DOI 10.1016/S0022-3476(83)80351-5; WOLF B, 1983, CLIN CHIM ACTA, V131, P273, DOI 10.1016/0009-8981(83)90096-7; WOLF B, 1982, AM J HUM GENET, V34, P699	30	34	34	1	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1987	40	1					50	59						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	G0618	3101494				2022-12-18	WOS:A1987G061800005
J	KAMBOH, MI; FERRELL, RE				KAMBOH, MI; FERRELL, RE			GENETIC-STUDIES OF LOW ABUNDANCE HUMAN-PLASMA PROTEINS .2. POPULATION-GENETICS OF COAGULATION FACTOR-XIIIB	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											KAMBOH, MI (corresponding author), UNIV PITTSBURGH,GRAD SCH PUBL HLTH,HUMAN GENET PROGRAM,DEPT BIOSTAT,PITTSBURGH,PA 15261, USA.			Kamboh, M. Ilyas/0000-0002-3453-1438	NCI NIH HHS [CA29614, CA34936] Funding Source: Medline; NCRR NIH HHS [RR05451] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA034936, R01CA029614] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BOARD PG, 1979, AM J HUM GENET, V31, P116; BOARD PG, 1984, ANN HUM GENET, V48, P223, DOI 10.1111/j.1469-1809.1984.tb01018.x; BOARD PG, 1980, AM J HUM GENET, V32, P348; BOARD PG, 1982, FACTOR 13 FRIBONECTI, P69; BOHN H, 1972, ANN NY ACAD SCI, V202, P256, DOI 10.1111/j.1749-6632.1972.tb16339.x; FERRELL RE, 1981, AM J PHYS ANTHROPOL, V55, P351, DOI 10.1002/ajpa.1330550309; GOWER GC, 1972, ASSESSMENT POPULATIO, P1; GRAHAM JB, 1983, ADV HUM GENET, V13, P1; KAMBOH MI, 1986, BIOCHEM GENET, V24, P273, DOI 10.1007/BF00502794; KAMBOH MI, 1985, ELECTROPHORESIS, V6, P185, DOI 10.1002/elps.1150060408; KERA Y, 1981, HUM GENET, V59, P360, DOI 10.1007/BF00295472; KRECKEL P, 1982, BLUT, V45, P337, DOI 10.1007/BF00319528; KRECKEL P, 1982, FACTOR 13 FIBRONECTI, P81; LOWSOWSKY MS, 1977, BR J HAEMATOL, V37, P1; MILLER SA, 1985, ELECTROPHORESIS, V6, P399, DOI 10.1002/elps.1150060809; NAKAMURA S, 1982, ANN HUM GENET, V46, P203, DOI 10.1111/j.1469-1809.1982.tb00712.x; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1982, EVOL BIOL, V14, P1; NISHIGAKI T, 1982, JPN J HUM GENET, V27, P265, DOI 10.1007/BF01901322; SCHWARTZ ML, 1971, J BIOL CHEM, V246, P5851; SCHWARTZ ML, 1973, J BIOL CHEM, V248, P1395; SZATHMARY EJE, 1983, AM J PHYS ANTHROPOL, V62, P249, DOI 10.1002/ajpa.1330620304	22	34	34	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1986	39	6					817	825						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	F5414	3467588				2022-12-18	WOS:A1986F541400016
J	DEWALD, GW; NOONAN, KJ; SPURBECK, JL; JOHNSON, DD				DEWALD, GW; NOONAN, KJ; SPURBECK, JL; JOHNSON, DD			LYMPHOCYTES-T WITH 7-14 TRANSLOCATIONS - FREQUENCY OF OCCURRENCE, BREAKPOINTS, AND CLINICAL AND BIOLOGICAL SIGNIFICANCE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MAYO CLIN & MAYO FDN,DEPT MED GENET,ROCHESTER,MN 55905	Mayo Clinic	DEWALD, GW (corresponding author), MAYO CLIN & MAYO FDN,CYTOGENET LAB,ROCHESTER,MN 55905, USA.							AYME S, 1976, HUM GENET, V31, P161, DOI 10.1007/BF00296144; BEATTYDESANA JW, 1975, NATURE, V255, P242, DOI 10.1038/255242a0; CACCIA N, 1984, CELL, V37, P1091, DOI 10.1016/0092-8674(84)90443-4; CASPERSS.T, 1970, EXP CELL RES, V60, P315, DOI 10.1016/0014-4827(70)90523-9; CHANG HC, 1982, GROWTH CELLS HORMONA, V9, P1187; COHEN MM, 1975, CYTOGENET CELL GENET, V15, P338, DOI 10.1159/000130530; COLLINS MKL, 1985, NATURE, V314, P273, DOI 10.1038/314273a0; COLLINS MKL, 1984, EMBO J, V3, P2347, DOI 10.1002/j.1460-2075.1984.tb02137.x; DEWALD G, 1979, CURRENT METHODS AUTO, P155; DEWALD GW, 1985, CANCER GENET CYTOGEN, V18, P1, DOI 10.1016/0165-4608(85)90032-9; DEWALD GW, 1983, 1983 CLIN LABORATORY, V2, P1; DEWALD GW, 1985, CLIN LABORATORY MOL, P205; GLOVER TW, 1981, AM J HUM GENET, V33, P234; HECHT F, 1981, HOSP PRACT, V16, P81, DOI 10.1080/21548331.1981.11946863; HECHT F, 1975, NATURE, V255, P243, DOI 10.1038/255243a0; HECHT F, 1973, NEW ENGL J MED, V289, P286, DOI 10.1056/NEJM197308092890603; HECHT F, 1984, SCIENCE, V226, P1445, DOI 10.1126/science.6438800; HOWARDPEEBLES PN, 1979, AM J HUM GENET, V31, P214; HUSTINX TWJ, 1979, HUM GENET, V49, P199, DOI 10.1007/BF00277643; JONES C, 1985, SCIENCE, V228, P83, DOI 10.1126/science.3919444; KAISERMCCAW B, 1979, AM J HUM GENET, V31, pA99; KAISERMCCAW B, 1975, P NATL ACAD SCI USA, V72, P2071; KOHN PH, 1982, CANCER GENET CYTOGEN, V6, P289, DOI 10.1016/0165-4608(82)90085-1; LEVITT R, 1978, BLOOD, V52, P1003; MATTEI MG, 1979, CYTOGENET CELL GENET, V23, P95, DOI 10.1159/000131309; NICHOLS WW, 1970, ANN NY ACAD SCI, V171, P478, DOI 10.1111/j.1749-6632.1970.tb39357.x; PEAKMAN DC, 1979, AM J HUM GENET, V31, P149; REDDY KS, 1985, AM J MED GENET, V22, P305, DOI 10.1002/ajmg.1320220213; SAXON A, 1979, NEW ENGL J MED, V300, P700, DOI 10.1056/NEJM197903293001303; SCHERES JMJC, 1980, J PEDIATR-US, V97, P440, DOI 10.1016/S0022-3476(80)80200-9; SEABRIGH.M, 1971, LANCET, V2, P971; SHAHAM M, 1982, J PEDIATR-US, V100, P134, DOI 10.1016/S0022-3476(82)80253-9; SUTHERLAND GR, 1979, AM J HUM GENET, V31, P125; SWIFT M, 1976, CANCER RES, V36, P209; UESHIMA Y, 1984, BLOOD, V63, P1028; UESHIMA Y, 1981, BLOOD, V58, P420; WAKE N, 1982, CANCER GENET CYTOGEN, V6, P345, DOI 10.1016/0165-4608(82)90091-7; WALLACE C, 1984, HUM GENET, V66, P157, DOI 10.1007/BF00286591; WEEMAES CMR, 1981, ACTA PAEDIATR SCAND, V70, P557, DOI 10.1111/j.1651-2227.1981.tb05740.x; WELCH J P, 1975, Nature (London), V255, P241, DOI 10.1038/255241a0; YUNIS JJ, 1977, PROGR CLIN PATHOL, V7, P267; ZECH L, 1978, HEREDITAS, V89, P69; ZECH L, 1984, NATURE, V308, P858, DOI 10.1038/308858a0; 1978, BIRTH DEFECTS ORIG A, V14, P309; 1981, AMNIOTIC FLUID CELL, P1	45	34	36	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1986	38	4					520	532						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	C4893	3486591				2022-12-18	WOS:A1986C489300011
J	BOKLAGE, CE				BOKLAGE, CE			INTERACTIONS BETWEEN OPPOSITE-SEX DIZYGOTIC FETUSES AND THE ASSUMPTIONS OF WEINBERG DIFFERENCE METHOD EPIDEMIOLOGY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											BOKLAGE, CE (corresponding author), E CAROLINA UNIV, SCH MED, BEHAV & DEV GENET LAB, GENET PROGRAM, BRODY 2N78, GREENVILLE, NC 27834 USA.							Allen G, 1981, Prog Clin Biol Res, V69A, P71; Boklage C E, 1981, Prog Clin Biol Res, V69A, P155; BOKLAGE CE, 1984, J CRAN GENET DEV BIO, V4, P151; BOKLAGE CE, 1981, ACTA GENET MED GEMEL, V30, P167, DOI 10.1017/S0001566000007649; BOKLAGE CE, UNPUB HUMAN TWINS ST; BOKLAGE CE, 1984, 17TH MARCH DIM BIRTH; COREY LA, 1979, ACTA GENET MED GEMEL, V28, P41, DOI 10.1017/S0001566000009326; COREY LA, 1978, PROG CLIN BIOL RES, V46, P437; Denenberg V. H., 1984, CEREBRAL DOMINANCE B, P114; DEROM R, 1976, ACTA GENET MED GEMEL, V25, P314, DOI 10.1017/S0001566000014331; DIAMOND MC, 1984, CEREBRAL DOMINANCE B, P134; Elston R C, 1978, Prog Clin Biol Res, V24A, P189; FRASER F C, 1984, American Journal of Human Genetics, V36, p51S; FRASER FC, 1983, AM J HUM GENET, V35, pA89; GALABURDA AM, 1984, CEREBRAL DOMINANCE B, P11; Geschwind N., 1984, CEREBRAL DOMINANCE B, P211; Glick SD, 1984, CEREBRAL DOMINANCE B, P147; GUERRERO R, 1970, INT J FERTIL, V15, P221; GUERRERO R, 1974, NEW ENGL J MED, V291, P1056, DOI 10.1056/NEJM197411142912004; GUERREROV R, 1975, NEW ENGL J MED, V293, P573; HARLAP S, 1979, NEW ENGL J MED, V300, P1445, DOI 10.1056/NEJM197906283002601; HARLAP S, 1980, ACTA GENET MED GEMEL, V29, P40; JAMES WH, 1971, NATURE, V232, P277, DOI 10.1038/232277a0; JAMES WH, 1979, ACTA GENET MED GEMEL, V28, P69, DOI 10.1017/S0001566000009363; JAMES WH, 1975, ANN HUM BIOL, V2, P365, DOI 10.1080/03014467500000981; JAMES WH, 1976, ANN HUM GENET, V40, P197, DOI 10.1111/j.1469-1809.1976.tb00180.x; JAMES WH, 1976, ANN HUM BIOL, V3, P549, DOI 10.1080/03014467600001811; KRAMER AA, 1982, MARCH DIMES BIRTH DE; LAYDE PM, 1980, AM J HUM GENET, V32, P69; LINDLEY M, 1979, SCIENCE, V206, P1428, DOI 10.1126/science.206.4425.1428-b; LOWRY JT, 1979, SCIENCE, V206, P1428, DOI 10.1126/science.505019; MACGILLIVRAY I, 1983, ACTA GENET MED GEMEL, V32, P151, DOI 10.1017/S0001566000006437; MCMILLEN MM, 1979, SCIENCE, V204, P89, DOI 10.1126/science.571144; MYRIANTHOPOULOS N C, 1970, American Journal of Human Genetics, V22, P611; Record RG, 1952, BR J SOC MED, V6, P192; RICHON J, 1978, ANN MED NANCY, V17, P531; WILSON RS, 1970, HUM HERED, V20, P30, DOI 10.1159/000152292; WINDHAM GC, 1984, ACTA GENET MED GEMEL, V33, P87, DOI 10.1017/S0001566000007558	38	34	34	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1985	37	3					591	605						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AKE07	4039888				2022-12-18	WOS:A1985AKE0700015
J	DAIGER, SP; MILLER, M; CHAKRABORTY, R				DAIGER, SP; MILLER, M; CHAKRABORTY, R			HERITABILITY OF QUANTITATIVE VARIATION AT THE GROUP-SPECIFIC COMPONENT (GC) LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV ROCHESTER,SCH MED,DEPT PEDIAT,ROCHESTER,NY 14642	University of Rochester	DAIGER, SP (corresponding author), UNIV TEXAS,HLTH SCI CTR,GRAD SCH BIOMED SCI,CTR DEMOGI & POPULAT GENET,HOUSTON,TX 77025, USA.							BARRAGRY JM, 1977, LANCET, V2, P629; BOUILLON R, 1977, J CLIN ENDOCR METAB, V45, P225, DOI 10.1210/jcem-45-2-225; CAVALLISFORZA LL, 1971, GENETICS HUMAN POPUL, P565; CLEVE H, 1978, HUM GENET, V44, P117, DOI 10.1007/BF00295404; CONSTANS J, 1979, HUM GENET, V48, P143, DOI 10.1007/BF00286897; CONSTANS J, 1977, SCIENCE, V198, P1070, DOI 10.1126/science.73222; COPPENHAVER D, 1981, HUM GENET, V57, P399, DOI 10.1007/BF00281693; DAIGER SP, 1975, P NATL ACAD SCI USA, V72, P2076, DOI 10.1073/pnas.72.6.2076; DAIGER SP, 1978, NEW ENGL J MED, V298, P687; DAIGER SP, 1977, AM J HUM GENET, V29, P593; FALCONER DS, 1960, INTRO QUANTITATIVE G, P114; HADDAD JG, 1976, J CLIN INVEST, V58, P1217, DOI 10.1172/JCI108575; MIHAS AA, 1978, J MED, V9, P109; MILLER ME, 1984, CLIN PHARM THER; MOURANT AE, 1976, DISTRIBUTION HUMAN B, P686; NETER J, 1974, APPL LINEAR STAT MOD, P632; SEARLE SR, 1971, LINEAR MODELS, P477; Snedecor G. W., 1967, STATISTICAL METHODS, P294; SVASTI J, 1978, J BIOL CHEM, V253, P4188; VOGEL F, 1979, HUMAN GENETICS PROBL, P586	20	34	34	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	3					663	676						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	SY119	6203404				2022-12-18	WOS:A1984SY11900016
J	PINSKY, L; KAUFMAN, M; KILLINGER, DW; BURKO, B; SHATZ, D; VOLPE, R				PINSKY, L; KAUFMAN, M; KILLINGER, DW; BURKO, B; SHATZ, D; VOLPE, R			HUMAN MINIMAL ANDROGEN INSENSITIVITY WITH NORMAL DIHYDROTESTOSTERONE-BINDING CAPACITY IN CULTURED GENITAL SKIN FIBROBLASTS - EVIDENCE FOR AN ANDROGEN-SELECTIVE QUALITATIVE ABNORMALITY OF THE RECEPTOR	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MCGILL UNIV, CTR HUMAN GENET, DEPT BIOL, MONTREAL H3A 1B1, QUEBEC, CANADA; UNIV TORONTO, WELLESLEY HOSP, DEPT MED, TORONTO M4Y 1J3, ONTARIO, CANADA	McGill University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	PINSKY, L (corresponding author), SIR MORTIMER B DAVIS JEWISH GEN HOSP, LADY DAVIS INST MED RES, CELL GENET LAB, MONTREAL H3T 1E2, QUEBEC, CANADA.							AIMAN J, 1979, NEW ENGL J MED, V300, P223, DOI 10.1056/NEJM197902013000503; AIMAN J, 1982, J CLIN ENDOCR METAB, V54, P725, DOI 10.1210/jcem-54-4-725; ALBERT A, 1968, J CLIN ENDOCR METAB, V28, P1214, DOI 10.1210/jcem-28-8-1214; AMRHEIN JA, 1976, P NATL ACAD SCI USA, V73, P891, DOI 10.1073/pnas.73.3.891; AMRHEIN JA, 1977, NEW ENGL J MED, V297, P350, DOI 10.1056/NEJM197708182970703; BOWEN P, 1965, ANN INTERN MED, V62, P252, DOI 10.7326/0003-4819-62-2-252; BROWN TR, 1982, J CLIN ENDOCR METAB, V55, P61, DOI 10.1210/jcem-55-1-61; BROWN TR, 1981, J STEROID BIOCHEM, V14, P1013, DOI 10.1016/0022-4731(81)90209-0; EIL C, 1983, J CLIN INVEST, V71, P850, DOI 10.1172/JCI110839; FURUYAMA S, 1970, STEROIDS, V16, P415, DOI 10.1016/S0039-128X(70)80124-6; GRIFFIN JE, 1979, J CLIN INVEST, V64, P1624, DOI 10.1172/JCI109624; GRIFFIN JE, 1980, NEW ENGL J MED, V302, P198, DOI 10.1056/NEJM198001243020404; GRIFFIN JE, 1977, J CLIN ENDOCR METAB, V45, P1137, DOI 10.1210/jcem-45-6-1137; HODGINS MB, 1982, J ENDOCRINOL, V94, P415, DOI 10.1677/joe.0.0940415; IMPERATOMCGINLEY J, 1982, J CLIN ENDOCR METAB, V54, P931, DOI 10.1210/jcem-54-5-931; KAUFMAN M, 1977, SOMAT CELL GENET, V3, P17, DOI 10.1007/BF01550984; KAUFMAN M, 1983, J STEROID BIOCHEM, V18, P383, DOI 10.1016/0022-4731(83)90055-9; KAUFMAN M, 1981, NATURE, V293, P735, DOI 10.1038/293735a0; KAUFMAN M, 1984, AM J MED GENET; KRUSKEMPER HL, 1966, STEROIDS, V8, P13, DOI 10.1016/0039-128X(66)90114-0; LARREA F, 1978, J CLIN ENDOCR METAB, V46, P961, DOI 10.1210/jcem-46-6-961; LINDNER HR, 1972, STEROIDS, V19, P357, DOI 10.1016/0039-128X(72)90076-1; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MIGEON BR, 1981, P NATL ACAD SCI-BIOL, V78, P6339, DOI 10.1073/pnas.78.10.6339; MURAKAMI T, 1979, ENDOCRINOLOGY, V104, P500, DOI 10.1210/endo-104-2-500; PINSKY L, 1981, AM J MED GENET, V10, P91, DOI 10.1002/ajmg.1320100111; PINSKY L, 1983, CAN J BIOCHEM CELL B, V61, P770, DOI 10.1139/o83-097; PINSKY L, 1974, AM J HUM GENET, V26, P563; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SEELEY DH, 1983, MOL CELL ENDOCRINOL, V30, P161, DOI 10.1016/0303-7207(83)90045-X; THORNEYCROFT IH, 1973, STEROIDS, V21, P111, DOI 10.1016/0039-128X(73)90024-X; WALKER AC, 1970, MED J AUSTRALIA, V1, P156, DOI 10.5694/j.1326-5377.1970.tb77782.x; WEICHMAN BM, 1977, J BIOL CHEM, V252, P8856; WEINSTEIN A, 1972, STEROIDS, V20, P789, DOI 10.1016/0039-128X(72)90058-X; WILSON JD, 1975, J BIOL CHEM, V250, P3498; WILSON JD, 1974, NEW ENGL J MED, V290, P1097, DOI 10.1056/NEJM197405162902001; WU C, 1971, STEROIDS, V18, P91, DOI 10.1016/S0039-128X(71)80174-5	37	34	34	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1984	36	5					965	978						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TS302	6333813				2022-12-18	WOS:A1984TS30200004
J	UCHIDA, IA; FREEMAN, VCP; JAMRO, H; PARTINGTON, MW; SOLTAN, HC				UCHIDA, IA; FREEMAN, VCP; JAMRO, H; PARTINGTON, MW; SOLTAN, HC			ADDITIONAL EVIDENCE FOR FRAGILE-X ACTIVITY IN HETEROZYGOUS CARRIERS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV WESTERN ONTARIO,CHILDRENS HOSP,REG MED GENET & BIRTH DEFECTS SERV,LONDON N6B 1B8,ONTARIO,CANADA; MCMASTER UNIV,HLTH SCI CTR,DEPT PATHOL,HAMILTON L8S 4L8,ONTARIO,CANADA; QUEENS UNIV,DEPT PEDIAT,KINGSTON K7L 3N6,ONTARIO,CANADA	Western University (University of Western Ontario); McMaster University; University of Manitoba; Children's Hospital Research Institute of Manitoba; Queens University - Canada	UCHIDA, IA (corresponding author), MCMASTER UNIV,HLTH SCI CTR,DEPT PEDIAT,HAMILTON L8S 4L8,ONTARIO,CANADA.							BROWN BW, 1977, STATISTICS BIOMEDICA; CARPENTER NJ, 1982, AM J DIS CHILD, V136, P392, DOI 10.1001/archpedi.1982.03970410010002; DUNN HG, 1963, AM J MENT DEF, V67, P827; HERBST DS, 1980, AM J MED GENET, V7, P443, DOI 10.1002/ajmg.1320070406; HOWARDPEEBLES PN, 1980, AM J MED GENET, V7, P497, DOI 10.1002/ajmg.1320070410; JACOBS PA, 1980, AM J MED GENET, V7, P471, DOI 10.1002/ajmg.1320070408; PARTINGTON MW, UNPUB FRAGILE X SYND; POPOVICH B, 1982, NEW ENGL J MED, V306, P1551; SUTHERLAND GR, 1977, SCIENCE, V197, P265, DOI 10.1126/science.877551; SUTHERLAND GR, 1979, HUM GENET, V53, P23, DOI 10.1007/BF00289445; TURNER G, 1980, NEW ENGL J MED, V303, P662, DOI 10.1056/NEJM198009183031202; TURNER G, 1980, J PEDIATR-US, V96, P837, DOI 10.1016/S0022-3476(80)80552-X; UCHIDA IA, 1982, AM J HUM GENET, V34, P286	13	34	34	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	5					861	868						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RK604	6614002				2022-12-18	WOS:A1983RK60400006
J	WAINSCOAT, JS; HIGGS, DR; KANAVAKIS, E; CAO, A; GEORGIOU, D; CLEGG, JB; WEATHERALL, DJ				WAINSCOAT, JS; HIGGS, DR; KANAVAKIS, E; CAO, A; GEORGIOU, D; CLEGG, JB; WEATHERALL, DJ			ASSOCIATION OF 2 DNA POLYMORPHISMS IN THE ALPHA-GLOBIN GENE-CLUSTER - IMPLICATIONS FOR GENETIC-ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV OXFORD,JOHN RADCLIFFE HOSP,NUFFIELD DEPT CLIN MED,OXFORD OX3 9DU,ENGLAND; UNIV ATHENS,AGHIA SOPHIA CHILDRENS HOSP,DEPT PAEDIAT 1,ATHENS,GREECE; UNIV CAGLIARI,PAEDIAT CLIN 2,I-09100 CAGLIARI,ITALY; NICOSIA GEN HOSP,THALASSEMIA CTR,NICOSIA,CYPRUS	University of Oxford; National & Kapodistrian University of Athens; The Aghia Sophia Children's Hospital; University of Cagliari	WAINSCOAT, JS (corresponding author), UNIV OXFORD,JOHN RADCLIFFE HOSP,MRC,MOLEC HAEMATOL UNIT,OXFORD OX3 9DU,ENGLAND.							ANTONARAKIS SE, 1982, P NATL ACAD SCI-BIOL, V79, P137, DOI 10.1073/pnas.79.1.137; BELL GI, 1982, NATURE, V295, P31, DOI 10.1038/295031a0; BEUTLER E, 1981, P NATL ACAD SCI-BIOL, V78, P7056, DOI 10.1073/pnas.78.11.7056; GOODBOURN SEY, UNPUB MOL BASIS LENG; HIGGS DR, 1981, NUCLEIC ACIDS RES, V9, P4213, DOI 10.1093/nar/9.17.4213; LAUER J, 1980, CELL, V20, P119, DOI 10.1016/0092-8674(80)90240-8; OLD JM, 1983, GENE ANAL THALASSAEM; PRESSLEY L, 1980, P NATL ACAD SCI-BIOL, V77, P3586, DOI 10.1073/pnas.77.6.3586; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; WILSON JT, 1978, NUCLEIC ACIDS RES, V5, P563, DOI 10.1093/nar/5.2.563	10	34	34	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	6					1086	1089						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RU705	6316779				2022-12-18	WOS:A1983RU70500003
J	COHEN, MM; MARTIN, AO; OBER, C; SIMPSON, SJ				COHEN, MM; MARTIN, AO; OBER, C; SIMPSON, SJ			A FAMILY STUDY OF SPONTANEOUS SISTER CHROMATID EXCHANGE FREQUENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NORTHWESTERN UNIV,SCH MED,DEPT OBSTET & GYNECOL,HUMAN GENET SECT,CHICAGO,IL 60611	Northwestern University	COHEN, MM (corresponding author), CHILDRENS MEM HOSP,DEPT PEDIAT,DIV GENET,CHICAGO,IL 60614, USA.				NICHD NIH HHS [HD-8-2885, HD-11021] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ABE S, 1980, CANCER RES, V40, P1292; ALHADEFF B, 1976, ISRAEL J MED SCI, V12, P1440; ALLEN JW, 1976, CHROMOSOMA, V58, P325, DOI 10.1007/BF00292841; ARDITO G, 1980, MUTAT RES, V78, P209, DOI 10.1016/0165-1218(80)90100-7; BECKER R, 1979, INT J CANCER, V24, P713; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; COHEN MM, 1980, CYTOGENET CELL GENET, V28, P24, DOI 10.1159/000131508; CROSSEN PE, 1977, EXP CELL RES, V104, P453, DOI 10.1016/0014-4827(77)90116-1; CROSSEN PE, 1977, HUM GENET, V35, P345, DOI 10.1007/BF00446625; CROSSEN PE, 1979, MUTAT RES, V62, P125, DOI 10.1016/0027-5107(79)90225-2; CROSSEN PE, 1980, HUM GENET, V53, P425, DOI 10.1007/BF00287068; FONATSCH C, 1979, HUM GENET, V52, P107; GALLOWAY SM, 1975, EXP CELL RES, V94, P454, DOI 10.1016/0014-4827(75)90517-0; HATCHER NH, 1976, AM J HUM GENET, V28, P290; HOLMQUIST GP, 1975, CHROMOSOMA, V52, P245, DOI 10.1007/BF00332114; KATO H, 1976, NATURE, V260, P447, DOI 10.1038/260447a0; KRAM D, 1978, EXP CELL RES, V114, P471, DOI 10.1016/0014-4827(78)90512-8; KURVINK K, 1978, HUM GENET, V44, P137, DOI 10.1007/BF00295406; LAMBERT B, 1976, HEREDITAS, V83, P163; Latt S A, 1980, Adv Hum Genet, V10, P267; LATT SA, 1973, P NATL ACAD SCI USA, V70, P3395, DOI 10.1073/pnas.70.12.3395; LATT SA, 1974, J HISTOCHEM CYTOCHEM, V22, P478, DOI 10.1177/22.7.478; LATT SA, 1975, SOMAT CELL GENET, V1, P293, DOI 10.1007/BF01538452; LEZANA EA, 1977, MUTAT RES, V45, P85, DOI 10.1016/0027-5107(77)90046-X; MILLER RG, 1966, SIMULTANEOUS STATIST; OTTER M, 1979, HUM GENET, V52, P185; PEDERSON C, 1974, HUM GENET, V52, P281; PERRY P, 1974, NATURE, V251, P156, DOI 10.1038/251156a0; PURROTT RJ, 1980, MUTAT RES, V69, P275, DOI 10.1016/0027-5107(80)90092-5; SCHNEIDER EL, 1979, HUM GENET, V46, P57, DOI 10.1007/BF00278902; SCHNEIDER EL, 1978, EXP CELL RES, V115, P269, DOI 10.1016/0014-4827(78)90281-1; Siegel S, 1956, NONPARAMETRIC STATIS; SNEDECOR GW, 1956, STATISTICAL METHODS; SNOPE AJ, 1979, MUTAT RES, V63, P345, DOI 10.1016/0027-5107(79)90065-4; TICE R, 1975, NATURE, V256, P642, DOI 10.1038/256642a0; WOLFF S, 1976, P NATL ACAD SCI USA, V73, P877, DOI 10.1073/pnas.73.3.877; WOLFF S, 1978, CHROMOSOMA, V69, P179, DOI 10.1007/BF00329916; WOLFF S, 1975, EXP CELL RES, V93, P23, DOI 10.1016/0014-4827(75)90418-8	38	34	34	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1982	34	2					294	306						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NH732	7072718				2022-12-18	WOS:A1982NH73200013
J	DARLU, P; RAO, DC; HENROTTE, JG; LALOUEL, JM				DARLU, P; RAO, DC; HENROTTE, JG; LALOUEL, JM			GENETIC-REGULATION OF PLASMA AND RED-BLOOD-CELL MAGNESIUM CONCENTRATIONS IN MAN .1. UNIVARIATE AND BIVARIATE PATH ANALYSES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									WASHINGTON UNIV, SCH MED, DIV BIOSTAT, ST LOUIS, MO 63110 USA; UNIV PARIS 07, ANTHROPOL BIOL LAB, F-75005 PARIS, FRANCE	Washington University (WUSTL); UDICE-French Research Universities; Universite Paris Cite	DARLU, P (corresponding author), FAC PHARM PARIS, RCP MAGNESIUM & OLIGO ELEMENTS, CNRS, 4 AVE OBSERV, F-75270 PARIS 06, FRANCE.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH031302, P50MH031302] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-28719] Funding Source: Medline; NIMH NIH HHS [MH-31302] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Benech A., 1974, Biometrie Humaine, V9, P17; CANTIN M, 1980, 2ND P INT S MAGN MON; DARLU P, 1981, ACTA GENET MED GEMEL, V30, P67, DOI 10.1017/S0001566000006632; Darlu P, 1978, Prog Clin Biol Res, V24 Pt C, P177; DARLU P, 1976, BIOCHEM SYSTEM, V4, P227; DARLU P, 1980, MAGNESIUM HLTH DISEA, P921; DARLU P, 1981, THESIS U PARIS 7, P273; DUNN MJ, 1966, METABOLIS, V15, P884, DOI 10.1016/0026-0495(66)90159-4; DURLACH J, 1973, 1ST INT S MAGN DEF H; Fisher R.A., 1921, METRON, V1, P3, DOI DOI 10.1093/BIOMET/9.1-2.22; GINSBURG S, 1962, BLOOD, V20, P722, DOI 10.1182/blood.V20.6.722.722; Henrotte J. G., 1974, Biometrie Humaine, V9, P23; HENROTTE J G, 1968, Biometrie Humaine, V3, P94; HENROTTE J G, 1969, Biometrie Humaine, V4, P56; Henrotte J. G., 1976, Biometrie Humaine, V11, P15; HENROTTE JG, 1981, MAGNESIUM-B, V3, P237; HENROTTE JG, 1972, ARCH INT PHYSIOL BIO, V80, P941, DOI 10.3109/13813457209070444; HENROTTE JG, 1980, MAGNESIUM HLTH DISEA, P929; HENROTTE JG, 1970, BIOMETRIE HUM, V5, P106; HENROTTE JG, 1973, 1ST INT S MAGN DEF H, P41; HILMY MI, 1968, AM J PHYSIOL, V214, P406, DOI 10.1152/ajplegacy.1968.214.2.406; LEIF RC, 1964, P NATL ACAD SCI USA, V51, P520, DOI 10.1073/pnas.51.3.520; MACLEAN CJ, 1976, BIOMETRICS, V32, P695, DOI 10.2307/2529760; MCGUE M, UNPUB BIVARIATE PATH; MEYER M, 1978, REV FR ENDOCRINOL CL, V19, P101; MORTON NE, 1982, METHODS GENETIC EPID; PARK MH, 1976, J BACTERIOL, V126, P1096, DOI 10.1128/JB.126.3.1096-1103.1976; PASCHEN K, 1971, KLIN WOCHENSCHR, V49, P1314, DOI 10.1007/BF01495517; PAUNIER L, 1968, PEDIATRICS, V41, P385; Paunier L, 1979, Ergeb Inn Med Kinderheilkd, V42, P113; RAO DC, 1979, GENET RES, V33, P175, DOI 10.1017/S0016672300018310; RAO DC, 1982, AM J HUM GENET, V34, P888; ROUSSELET F, 1966, THESIS U PARIS; SALET J, 1970, ARCH FR PEDIATR, V27, P550; Seelig M, 1980, MAGNESIUM DEFICIENCY; SILVER S, 1980, MAGNESIUM HLTH DISEA, P161; SPENCER RW, 1976, ACTA PAEDIATR SCAND, V65, P505, DOI 10.1111/j.1651-2227.1976.tb04921.x; Tufts EV, 1938, J BIOL CHEM, V122, P693; VALBERG LS, 1965, J CLIN INVEST, V44, P379, DOI 10.1172/JCI105151; WALLACH S, 1962, J LAB CLIN MED, V59, P195; Walser M, 1967, Ergeb Physiol, V59, P185; WATSON WS, 1979, METABOLISM, V28, P90, DOI 10.1016/0026-0495(79)90174-4; WATSON WS, 1980, METABOLISM, V29, P397, DOI 10.1016/0026-0495(80)90162-6	43	34	34	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1982	34	6					874	887						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PU211	6891178				2022-12-18	WOS:A1982PU21100006
J	SUTHERLAND, GR				SUTHERLAND, GR			HERITABLE FRAGILE SITES ON HUMAN-CHROMOSOMES .9. POPULATION CYTOGENETICS AND SEGREGATION ANALYSIS OF THE BRDU-REQUIRING FRAGILE SITE AT 10Q25	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											SUTHERLAND, GR (corresponding author), ADELAIDE CHILDRENS HOSP,DEPT HISTOPATHOL,CYTOGENET UNIT,N ADELAIDE,SA 5006,AUSTRALIA.		Sutherland, Grant Robert/D-2606-2012					FORD EB, 1953, ADV GENET, V5, P43, DOI 10.1016/S0065-2660(08)60405-8; SCHERES JMJC, 1980, AM J HUM GENET, V32, P628; SHEPPARD PM, 1958, NATURAL SELECTION HE, P62; SUTHERLAND GR, 1982, AM J HUM GENET, V34, P452; SUTHERLAND GR, 1981, AM J HUM GENET, V33, P946; SUTHERLAND GR, 1980, AM J HUM GENET, V32, P542; VOGEL F, 1979, HUMAN GENETICS PROBL, P373	7	34	34	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1982	34	5					753	756						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PH242	7124730				2022-12-18	WOS:A1982PH24200007
J	ALVESALO, L; VARRELA, J				ALVESALO, L; VARRELA, J			PERMANENT TOOTH SIZES IN 46,XY FEMALES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TURKU,INST DENT,SF-20500 TURKU 50,FINLAND	University of Turku	ALVESALO, L (corresponding author), UNIV KUOPIO,DEPT DENT,SF-70101 KUOPIO 10,FINLAND.							ALVESALO L, 1979, ANN HUM GENET, V43, P97, DOI 10.1111/j.1469-1809.1979.tb02001.x; ALVESALO L, 1975, AM J HUM GENET, V27, P53; ALVESALO L, 1977, AM J HUM GENET, V29, P486; FILIPSSON R, 1965, ACTA ENDOCRINOL-COP, V48, P91, DOI 10.1530/acta.0.0480091; GARN SM, 1962, NATURE, V196, P695, DOI 10.1038/196695a0; GERMAN J, 1973, ANN GENET-PARIS, V16, P225; GORLIN RJ, 1965, J DENT RES, V44, P269, DOI 10.1177/00220345650440012201; Kraus BS, 1965, HUMAN DENTITION BIRT; OHNO S, 1976, NEW ENGL J MED, V295, P1011, DOI 10.1056/NEJM197610282951809; SCOTT JH, 1964, INTRO DENTAL ANATOMY; SHAPIRO BL, 1966, THESIS U MINNESOTA M; SIMPSON J, 1976, DISORDER SEXUAL DIFF; TANNER JM, 1959, LANCET, V2, P141; [No title captured]	14	34	34	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1980	32	5					736	742						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KJ795	7424913				2022-12-18	WOS:A1980KJ79500013
J	ASHTON, GC				ASHTON, GC			MISMATCHES IN GENETIC-MARKERS IN A LARGE FAMILY STUDY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											ASHTON, GC (corresponding author), UNIV HAWAII,JOHN A BURNS SCH MED,DEPT GENET,HONOLULU,HI 96822, USA.							ASHTON GC, 1961, AUST J BIOL SCI, V14, P248, DOI 10.1071/BI9610248; DEFRIES JC, 1976, NATURE, V261, P131, DOI 10.1038/261131a0; Giblett ER., 1969, GENETIC MARKERS HUMA; HILDES RA, 1966, NATURE, V209, P261; HIRSCH J, 1978, RICERCHE PSICOLOGIA, V78, P47; HOPKINSON DA, 1973, ANN HUM GENET, V37, P119, DOI 10.1111/j.1469-1809.1973.tb01820.x; KIM YH, 1969, EXTRAMARITAL RELATIO, P65; MAYKOVICH MK, 1976, J MARRIAGE FAM, V38, P693, DOI 10.2307/350688; PHILIPP EE, 1973, LAW ETHICS AID EMBRY, V17, P66; SCHARFETTER C, 1978, BEHAV GENET, V8, P383, DOI 10.1007/BF01067403; SPENCER N, 1964, NATURE, V204, P742, DOI 10.1038/204742a0; SPENCER N, 1968, ANN HUM GENET, V32, P9, DOI 10.1111/j.1469-1809.1968.tb00044.x	12	34	35	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1980	32	4					601	613						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KB522	6930820				2022-12-18	WOS:A1980KB52200014
J	RUDIGER, HW; BARTRAM, CR; HARDER, W; PASSARGE, E				RUDIGER, HW; BARTRAM, CR; HARDER, W; PASSARGE, E			RATE OF SISTER CHROMATID EXCHANGES IN BLOOM SYNDROME FIBROBLASTS REDUCED BY CO-CULTIVATION WITH NORMAL FIBROBLASTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV ESSEN KLINIKUM,INST HUMANGENET,D-4300 ESSEN 1,FED REP GER	University of Duisburg Essen	RUDIGER, HW (corresponding author), UNIV HAMBURG,KRANKENHAUS EPPENDORF,MED KLIN,D-2000 HAMBURG 20,FED REP GER.							BARTRAM CR, 1979, HUM GENET, V46, P331, DOI 10.1007/BF00273317; BARTRAM CR, 1976, ANN HUM GENET, V40, P79, DOI 10.1111/j.1469-1809.1976.tb00166.x; BOOTSMA D, 1979, MODELS STUDY INBORN, P241; BRYANT EM, 1979, NATURE, V279, P795, DOI 10.1038/279795a0; CHANGANTI RSK, 1974, P NATL ACAD SCI USA, V71, P4508; EVANS HJ, 1978, CYTOGENET CELL GENET, V20, P124, DOI 10.1159/000130844; GERMAN J, 1977, CLIN GENET, V12, P162; GERMAN J, 1977, AM J HUM GENET, V29, P248; GERMAN J, 1979, CLIN GENET, V15, P361; GERMAN J, 1974, CHROMOSOMES CANCER, P601; GIANNELLI F, 1977, NATURE, V265, P466, DOI 10.1038/265466a0; HAND R, 1975, P NATL ACAD SCI USA, V72, P758, DOI 10.1073/pnas.72.2.758; KREPINSKY AB, 1979, HUM GENET, V50, P151, DOI 10.1007/BF00390236; MCKUSICK VA, 1978, METABOLIC BASIS INHE, P1282; SETLOW RB, 1978, NATURE, V271, P713, DOI 10.1038/271713a0; SPERLING K, 1976, HUM GENET, V31, P47, DOI 10.1007/BF00270398; TICE R, 1978, NATURE, V273, P538, DOI 10.1038/273538a0; van Buul P P, 1978, Hum Genet, V44, P187; WILLARD HF, 1978, AM J HUM GENET, V30, P1	19	34	34	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1980	32	2					150	157						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JS405	7386453				2022-12-18	WOS:A1980JS40500002
J	GRAVEL, RA; LOWDEN, JA; CALLAHAN, JW; WOLFE, LS; KIN, NMKNY				GRAVEL, RA; LOWDEN, JA; CALLAHAN, JW; WOLFE, LS; KIN, NMKNY			INFANTILE SIALIDOSIS - PHENOCOPY OF TYPE-1 GM1 GANGLIOSIDOSIS DISTINGUISHED BY GENETIC COMPLEMENTATION AND URINARY OLIGOSACCHARIDES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MONTREAL CHILDRENS HOSP,MONTREAL H3H 1P3,QUEBEC,CANADA	McGill University	GRAVEL, RA (corresponding author), HOSP SICK CHILDREN,RES INST,TORONTO M5G 1X8,ONTARIO,CANADA.							AMINOFF D, 1961, BIOCHEM J, V81, P384, DOI 10.1042/bj0810384; BAUM H, 1959, CLIN CHIM ACTA, V4, P453, DOI 10.1016/0009-8981(59)90119-6; CALLAHAN JW, 1975, BIOCHIM BIOPHYS ACTA, V391, P141, DOI 10.1016/0005-2744(75)90160-6; DERRY DM, 1968, NEUROLOGY, V18, P340, DOI 10.1212/WNL.18.4.340; DULBECCO R, 1954, J EXP MED, V99, P167, DOI 10.1084/jem.99.2.167; DURAND P, 1977, HELV PAEDIATR ACTA, V32, P391; GRAVEL RA, 1977, AM J HUM GENET, V29, P378; JUSTICE RM, 1977, PEDIATR RES, V11, P407; KELLY TE, 1977, AM J MED GENET, V1, P31, DOI 10.1002/ajmg.1320010105; LAKE BD, 1974, HISTOCHEM J, V6, P211, DOI 10.1007/BF01011808; LOWDEN JA, 1979, AM J HUM GENET, V31, P1; LOWDEN JA, 1974, ARCH NEUROL-CHICAGO, V31, P200, DOI 10.1001/archneur.1974.00490390082010; LOWDEN JA, 1973, CLIN CHEM, V19, P1345; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCKUSICK VA, 1978, METABOLIC BASIS INHE, P1282; MIETTINEN T, 1959, ACTA CHEM SCAND, V13, P856, DOI 10.3891/acta.chem.scand.13-0856; NGYINGKIN NMK, 1975, BIOCHEM BIOPH RES CO, V66, P123, DOI 10.1016/S0006-291X(75)80303-2; NORMAN RM, 1959, J PATHOL BACTERIOL, V78, P409, DOI 10.1002/path.1700780208; OBRIEN JS, 1965, AM J DIS CHILD, V109, P338, DOI 10.1001/archpedi.1965.02090020340014; OBRIEN JS, 1978, CLIN GENET, V14, P55; OBRIEN JS, 1978, METABOLIC BASIS INHE, P841; OKADA S, 1968, SCIENCE, V160, P1002, DOI 10.1126/science.160.3831.1002; OKADA S, 1978, CLIN CHIM ACTA, V86, P159, DOI 10.1016/0009-8981(78)90129-8; STANNERS CP, 1971, NATURE-NEW BIOL, V230, P52, DOI 10.1038/newbio230052a0; STRECKER G, 1977, EUR J BIOCHEM, V75, P391, DOI 10.1111/j.1432-1033.1977.tb11540.x; SUZUKI Y, 1977, HUM GENET, V36, P219, DOI 10.1007/BF00273261; WENGER DA, 1978, BIOCHEM BIOPH RES CO, V82, P589, DOI 10.1016/0006-291X(78)90915-4; WOLFE LS, 1974, J BIOL CHEM, V249, P1828; YAMAMOTO A, 1974, ARCH INTERN MED, V134, P627, DOI 10.1001/archinte.134.4.627	29	34	34	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1979	31	6					669	679						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HZ742	117700				2022-12-18	WOS:A1979HZ74200003
J	NWOKORO, N; NEUFELD, EF				NWOKORO, N; NEUFELD, EF			DETECTION OF HUNTER HETEROZYGOTES BY ENZYMATIC ANALYSIS OF HAIR ROOTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NIAMDD,HUMAN BIOCHEM GENET SECT,BETHESDA,MD 20014									BOOTH CW, 1974, PEDIATRICS, V53, P396; CAPOBIANCHI MR, 1976, EXPERIENTIA, V32, P459, DOI 10.1007/BF01920795; DANES BS, 1967, J EXP MED, V126, P509, DOI 10.1084/jem.126.3.509; DONNELLY PV, 1975, PEDIATRICS, V56, P429; FLUHARTY AL, 1977, AM J HUM GENET, V29, pA43; FRANCKE U, 1973, J PEDIATR-US, V82, P472, DOI 10.1016/S0022-3476(73)80123-4; FRANCKE V, 1976, AM J HUM GENET, V28, P123; GARTLER SM, 1971, ANN HUM GENET, V35, P1, DOI 10.1111/j.1469-1809.1956.tb01372.x; GARTLER SM, 1971, SCIENCE, V172, P572, DOI 10.1126/science.172.3983.572; GARTLER SM, 1969, ANN HUM GENET, V33, P171, DOI 10.1111/j.1469-1809.1969.tb01642.x; GRIMM T, 1976, HUM GENET, V32, P329, DOI 10.1007/BF00295824; HALDANE JBS, 1947, ANN EUGENIC, V13, P262; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; Hall C W, 1978, Methods Enzymol, V50, P439; LIEBAERS I, 1976, PEDIATR RES, V10, P733, DOI 10.1203/00006450-197610080-00007; LIEBAERS I, 1977, J PEDIATR-US, V90, P423, DOI 10.1016/S0022-3476(77)80707-5; LYON MF, 1962, AM J HUM GENET, V14, P135; MCKUSICK VA, 1978, METABOLIC BASIS INHE, P1282; MCKUSICK VA, 1972, HERITABLE DISORDERS, P521; MIGEON BR, 1977, AM J HUM GENET, V29, P448; NEUFELD EF, 1975, ANNU REV BIOCHEM, V44, P357, DOI 10.1146/annurev.bi.44.070175.002041; NEUFELD EF, 1977, AM J HUM GENET, V29, P455; NWOKORO N, 1977, AM J HUM GENET, V29, pA82; SILVERS DN, 1972, NEW ENGL J MED, V286, P390, DOI 10.1056/NEJM197202242860802; VOGEL F, 1975, ADV HUM GENET, V5, P223; VOGEL F, 1977, AM J HUM GENET, V29, P312	26	34	34	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1979	31	1					42	49						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GR115	107796				2022-12-18	WOS:A1979GR11500005
J	OBRIEN, JS; NORDEN, AGW				OBRIEN, JS; NORDEN, AGW			NATURE OF MUTATION IN ADULT BETA-GALACTOSIDASE DEFICIENT PATIENTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF SAN DIEGO,SCH MED,DEPT NEUROSCI,LA JOLLA,CA 92093	University of California System; University of California San Diego								DERRY DM, 1968, NEUROLOGY, V18, P340, DOI 10.1212/WNL.18.4.340; GALJAARD H, 1975, NATURE, V257, P60, DOI 10.1038/257060a0; LEROY JG, 1972, PEDIATR RES, V6, P752, DOI 10.1203/00006450-197210000-00002; LOONEN MCB, 1974, LANCET, V2, P785; MEISLER M, 1974, AM J HUM GENET, V26, P683; MELCHERS F, 1973, EUR J BIOCHEM, V35, P380, DOI 10.1111/j.1432-1033.1973.tb02850.x; NORDEN AGW, 1974, BIOCHEM BIOPH RES CO, V56, P193, DOI 10.1016/S0006-291X(74)80333-5; NORDEN AGW, 1974, J BIOL CHEM, V249, P7969; NORDEN AGW, 1975, P NATL ACAD SCI USA, V72, P240, DOI 10.1073/pnas.72.1.240; OBRIEN JS, 1975, CLIN GENET, V8, P303; OBRIEN JS, 1976, CLIN GENET, V9, P495; WENGER DA, 1974, LANCET, V2, P1319; [No title captured]	13	34	34	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1977	29	2					184	190						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DB507	322478				2022-12-18	WOS:A1977DB50700008
J	ZANARDI, P; DELLACQUA, G; MENINI, C; BARRAI, I				ZANARDI, P; DELLACQUA, G; MENINI, C; BARRAI, I			POPULATION-GENETICS IN PROVINCE OF FERRARA .1. GENETIC DISTANCES AND GEOGRAPHIC DISTANCES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV FERRARA,DEPT ZOOL,I-44100 FERRARA,ITALY; GEN HOSP,BLOOD BANK,FERRARA,ITALY	University of Ferrara								BARRAI I, 1971, B WORLD HEALTH ORGAN, V45, P201; BARRAI I, 1973, 4TH P INT C HUM GEN; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; CHUNG CS, 1960, AM J HUM GENET, V13, P9; GANDINI E, 1969, ACTA GENET MED GEMEL, V3, P271; HARPENDING H, 1971, METHODS THEORIES ANT; MORTON NE, 1973, AM J HUM GENET, V25, P422; MORTON NE, 1973, ISRAEL J MED SCI, V9, P1299; Morton NE, 1973, GENETIC STRUCTURE PO; SILVESTRONI E, 1975, AM J HUM GENET, V27, P198; SOKAL PR, 1968, PRINCIPLES NUMERICAL; WORKMAN P, 1973, POPULATION GENETICS, V3, P166	12	34	34	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1977	29	2					169	177						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DB507	403762				2022-12-18	WOS:A1977DB50700006
J	NAKAGOME, Y; CHIYO, H				NAKAGOME, Y; CHIYO, H			NONRANDOM DISTRIBUTION OF EXCHANGE POINTS IN PATIENTS WITH STRUCTURAL REARRANGEMENTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NATL INST GENET, DEPT HUMAN GENET, MISHIMA, SHIZUOKA, JAPAN; KANAGAWA CHILDRENS MED CTR, DIV MED GENET, YOKOHAMA, JAPAN	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan								BETZ A, 1974, ANN GENET-PARIS, V17, P77; BOURGEOIS CA, 1974, CHROMOSOMA, V48, P203; CARPENTIER S, 1972, ANN GENET-PARIS, V15, P283; CASPERSSON T, 1972, EXP CELL RES, V75, P541, DOI 10.1016/0014-4827(72)90469-7; CHANDLEY AC, 1972, CYTOGENETICS, V11, P516, DOI 10.1159/000130218; CHAPELLE AD, 1973, J MED GENET, V10, P384, DOI 10.1136/jmg.10.4.384; COOK PJL, 1974, ANN HUM GENET, V37, P261, DOI 10.1111/j.1469-1809.1974.tb01834.x; CRANDALL BF, 1974, AM J HUM GENET, V26, P385; DALLAPICCOLA B, 1974, ANN GENET-PARIS, V17, P115; DEGROUCHY J, 1974, HUMANGENETIK, V24, P197; DELACHAPELLE A, 1974, AM J HUM GENET, V26, P746; DELACHAPELLE A, 1973, HEREDITAS, V74, P291; DUTRILLAUX B, 1973, CYTOGENET CELL GENET, V12, P245, DOI 10.1159/000130460; FERGUSONSMITH MA, 1973, NATURE-NEW BIOL, V243, P271, DOI 10.1038/newbio243271a0; FORABOSCO A, 1973, ANN GENET-PARIS, V16, P255; FRIEDRICH U, 1974, HUMANGENETIK, V21, P133, DOI 10.1007/BF00281032; FRYNS JP, 1974, HUMANGENETIK, V24, P241; FUJIMOTO A, 1974, J MED GENET, V11, P287, DOI 10.1136/jmg.11.3.287; GIOVANNELLI G, 1974, ANN GENET-PARIS, V17, P119; HIRSCHHO.K, 1973, ANN HUM GENET, V36, P375, DOI 10.1111/j.1469-1809.1973.tb00601.x; HOBOLTH N, 1974, J MED GENET, V11, P299, DOI 10.1136/jmg.11.3.299; HOLMBERG M, 1973, HEREDITAS, V74, P57; JACOBS PA, 1974, J MED GENET, V11, P50, DOI 10.1136/jmg.11.1.50; JACOBSEN P, 1973, HUM HERED, V23, P568, DOI 10.1159/000152624; JONASSON J, 1973, HEREDITAS, V75, P259; KNORRGARTNER H, 1974, HUMANGENETIK, V21, P315; KUROKI Y, 1974, P JPN ACAD, V50, P645, DOI 10.2183/pjab1945.50.645; LATT SA, 1974, SCIENCE, V185, P74, DOI 10.1126/science.185.4145.74; LAURENT C, 1973, ANN GENET-PARIS, V16, P281; LEE CSN, 1974, AM J HUM GENET, V26, P93; LEJEUNE J, 1972, EXP CELL RES, V74, P293, DOI 10.1016/0014-4827(72)90510-1; LUCAS M, 1973, ANN HUM GENET, V37, P9, DOI 10.1111/j.1469-1809.1973.tb01809.x; MACHIN GA, 1974, LANCET, V1, P549; MIKKELSEN M, 1974, HUM HERED, V24, P160, DOI 10.1159/000152648; MIKKELSEN M, 1973, CYTOGENET CELL GENET, V12, P357, DOI 10.1159/000130474; NAKAGOME Y, 1973, CYTOGENET CELL GENET, V12, P35, DOI 10.1159/000130435; NAKAGOME Y, 1973, J MED GENET, V10, P174, DOI 10.1136/jmg.10.2.174; NIEBUHR E, 1973, ANN GENET-PARIS, V16, P199; PFEIFFER RA, 1973, HUMANGENETIK, V20, P187, DOI 10.1007/BF00284860; RETHORE MO, 1973, ANN GENET-PARIS, V16, P271; RETHORE MO, 1974, ANN GENET-PARIS, V17, P109; ROUX C, 1974, ANN GENET-PARIS, V17, P59; RUTHNER U, 1974, HUMANGENETIK, V22, P171; SANCHEZ O, 1974, HUMANGENETIK, V23, P297, DOI 10.1007/BF00272513; SCHINZEL A, 1974, HUMANGENETIK, V22, P287, DOI 10.1007/BF00295488; SCHLEIERMACHER E, 1974, HUMANGENETIK, V23, P163; SCHROTT HG, 1974, J MED GENET, V11, P201, DOI 10.1136/jmg.11.2.201; SCHWANITZ G, 1973, ANN GENET-PARIS, V16, P263; SEABRIGHT M, 1973, CHROMOSOMA, V40, P333, DOI 10.1007/BF00399426; SUBRT I, 1973, HUM HERED, V23, P331, DOI 10.1159/000152593; SUBRT I, 1974, HUMANGENETIK, V23, P219, DOI 10.1007/BF00285108; VOGEL W, 1973, ANN GENET-PARIS, V16, P277; 1972, BIRTH DEFECTS OAS, V8	53	34	34	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1976	28	1					31	41						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	BC888	1247018				2022-12-18	WOS:A1976BC88800005
J	NAMBOODIRI, KK; ELSTON, RC; GLUECK, CJ; FALLAT, R; BUNCHER, CR; TSANG, R				NAMBOODIRI, KK; ELSTON, RC; GLUECK, CJ; FALLAT, R; BUNCHER, CR; TSANG, R			BIVARIATE ANALYSES OF CHOLESTEROL AND TRIGLYCERIDE LEVELS IN FAMILIES IN WHICH PROBANDS HAVE TYPE-2B LIPOPROTEIN PHENOTYPE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV N CAROLINA, DEPT BIOSTATISTICS, CHAPEL HILL, NC 27514 USA; CINCINNATI GEN HOSP, GEN CLIN RES CTR, CINCINNATI, OH 45267 USA; FELS DIV PEDIAT RES, CINCINNATI, OH 45387 USA; UNIV N CAROLINA, GENET CURRICULUM & BIOL SCI RES CTR, CHAPEL HILL, NC 27514 USA; CINCINNATI GEN HOSP, LIPOPROT RES LAB, CINCINNATI, OH 45267 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill								BEUMONT JL, 1970, B WORLD HEALTH ORGAN, V43, P891; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; ELSTON RC, 1973, HUM HERED, V23, P105, DOI 10.1159/000152561; FREDRICKSON DONALD S., 1967, N ENGL J MED, V276, P34, DOI 10.1056/NEJM196701052760107; FREDRICKSON DS, 1968, J CLIN INVEST, V47, P2446, DOI 10.1172/JCI105927; GLUECK CJ, 1973, METABOLISM, V22, P1403, DOI 10.1016/0026-0495(73)90256-4; GOLDSTEIN JL, 1973, P NATL ACAD SCI USA, V70, P2804, DOI 10.1073/pnas.70.10.2804; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; GOLDSTEIN JL, 1973, HOSP PRACT, V8, P53; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; JENSEN J, 1972, AM J MED, V52, P499, DOI 10.1016/0002-9343(72)90041-1; KAPLAN EB, 1972, 823 U N CAR I STAT M; Kessler G., 1966, AUTOMATION ANALYTICA, P341; KHACHADURIAN AK, 1964, AM J MED, V37, P402, DOI 10.1016/0002-9343(64)90196-2; LEES RS, 1965, J CLIN INVEST, V44, P1968, DOI 10.1172/JCI105303; LESTER RH, 1972, AM J HUM GENET, V24, P168; Levy RI, 1972, METABOLIC BASIS INHE, V3, P545; MORTON NE, 1974, AM J HUM GENET, V26, P489; MURPHY EA, 1967, CAN MED ASSOC J, V97, P1181; MURPHY EA, 1967, J CHRON DIS, V20, P79, DOI 10.1016/0021-9681(67)90099-9; NEVIN N. C., 1968, J MED GENET, V5, P9, DOI 10.1136/jmg.5.1.9; NIKKILA EA, 1973, LANCET, V1, P954; Pearson ES, 1958, BIOMETRIKA TABLES ST, V1; ROSE HG, 1973, AM J MED, V54, P148, DOI 10.1016/0002-9343(73)90218-0; SCHROTT HG, 1972, ANN INTERN MED, V76, P711, DOI 10.7326/0003-4819-76-5-711; SMITH CAB, 1969, BIOMATHEMATICS, V2; 1964, AUTOANALYZER MANUAL	27	34	34	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1975	27	4					454	471						18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AM544	168768				2022-12-18	WOS:A1975AM54400002
J	LAYRISSE, Z; LAYRISSE, M; MALAVE, I; TERASAKI, P; WARD, RH; NEEL, JV				LAYRISSE, Z; LAYRISSE, M; MALAVE, I; TERASAKI, P; WARD, RH; NEEL, JV			HISTOCOMPATIBILITY ANTIGENS IN A GENETICALLY ISOLATED AMERICAN INDIAN TRIBE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MICHIGAN,MED SCH,DEPT HUMAN GENET,ANN ARBOR,MI 48104; UNIV CALIF,SCH MED,DEPT SURG,LOS ANGELES,CA 90024; INST CIENT VENEZOLANO,INVEST CIENT,CARACAS,VENEZUELA	University of Michigan System; University of Michigan; University of California System; University of California Los Angeles								Agozzino T, 1970, MAXIMIANUS ELEGIE; ALBERT ED, 1971, TRANSPLANT P, V3, P95; ALLEN F, 1970, HISTOCOMPATIBILITY T; AMOS B, 1970, HISTOCOMPATIBILITY T; BACH FH, 1972, SCIENCE, V176, P1024, DOI 10.1126/science.176.4038.1024; BENACERR.B, 1972, SCIENCE, V175, P273, DOI 10.1126/science.175.4019.273; BODMER JG, 1970, AM J HUM GENET, V22, P396; CHAGNON NA, 1968, YANOMAMA FIERCE PEOP; COLOMBAN.J, 1971, TRANSPLANT P, V3, P121; DAUSSET J, 1972, HUMAN GENETICS ICS25, P331; DAUSSET J, 1967, HISTOCOMPATIBILITY T; GERSHOWITZ H, 1972, ANN HUM GENET, V35, P261, DOI 10.1111/j.1469-1809.1957.tb01400.x; KIMURA M, 1971, NATURE, V229, P467, DOI 10.1038/229467a0; KIMURA M, 1964, GENETICS, V49, P725; KISSMEYERNIELSE.H, 1971, TISSUE ANTIGENS, V1, P74; KLEIN J, 1972, J EXP MED, V135, P924, DOI 10.1084/jem.135.4.924; KLEIN J, 1970, SCIENCE, V168, P1362, DOI 10.1126/science.168.3937.1362; KLEIN J, 1972, CELL IMMUNOL, V4, P442, DOI 10.1016/0008-8749(72)90045-7; LAYRISSE M, 1966, INDIAN SOC VENEZUELA; Mattiuz PL, 1970, HISTOCOMPATIBILITY T; MORRIS P J, 1971, Tissue Antigens, V1, P49; NEEL JV, 1972, ANN HUM GENET, V35, P255, DOI 10.1111/j.1469-1809.1957.tb01399.x; NEEL JV, 1972, GENETICS, V72, P639; NEEL JV, 1968, P NATL ACAD SCI USA, V59, P680, DOI 10.1073/pnas.59.3.680; NEEL JV, 1972, HUM GENET, P96; PAYNE R, 1958, J CLIN INVEST, V37, P1756, DOI 10.1172/JCI103768; REED TE, 1968, AM J HUM GENET, V20, P579; RUBINSTEIN P, 1967, HISTOCOMPATIBILITY T; SINGAL DP, 1969, TRANSPLANTATION, V8, P235, DOI 10.1097/00007890-196909000-00004; TERASAKI PI, 1964, NATURE, V204, P998, DOI 10.1038/204998b0; WARD RH, 1972, ANN HUM GENET, V36, P21, DOI 10.1111/j.1469-1809.1972.tb00579.x; WEITKAMP LR, 1972, ANN HUM GENET, V35, P433, DOI 10.1111/j.1469-1809.1957.tb01868.x; YUNIS EJ, 1971, P NATL ACAD SCI USA, V68, P3031, DOI 10.1073/pnas.68.12.3031; ZERRIES O, 1959, Z MORPHOL ANTHROPOL, V50, P31	34	34	34	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1973	25	5					493	509						17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q7858	4741845				2022-12-18	WOS:A1973Q785800003
J	GAJDUSEK, DC; ALPERS, M				GAJDUSEK, DC; ALPERS, M			GENETIC STUDIES IN RELATION TO KURU .1. CULTURAL, HISTORICAL, AND DEMOGRAPHIC BACKGROUND	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALPERS M, 1965, AM J TROP MED HYG, V14, P852, DOI 10.4269/ajtmh.1965.14.852; ALPERS M, IN PRESS; ALPERS MP, 1965, SLOW LATENT TEMPERAT, P65; ALPERS MP, 1968, CENTRAL NERVOUS SYST, P234; BEE D, 1965, PAPERS NEW GUINEA  A, P39; Bee Darlene, 1962, STUDIES NEW GUINEA L, V6, P111; BENNETT J. H., 1958, AUSTRALASIAN, V7, P269; BENNETT J. H., 1959, MED JOUR AUSTRALIA II, V46, P505; BENNETT JH, 1962, OCEANIA, V33, P24, DOI 10.1002/j.1834-4461.1962.tb00764.x; BENNETT JH, 1962, EUGEN QUART, V9, P59, DOI 10.1080/19485565.1962.9987504; BENNETT JH, 1959, AM J HUM GENET, V11, P169; Berndt CH, 1954, OCEANIA, V24, P289, DOI 10.1002/j.1834-4461.1954.tb00617.x; BERNDT RM, 1965, GODS GHOSTS MEN MELA, P78; BERNDT RM, 1969, ANTHROPOL FORUM, V2, P327; BERNDT RM, 1962, EXCESS RESTRAINT SOC; Berndt RM, 1954, OCEANIA, V25, P140, DOI 10.1002/j.1834-4461.1954.tb00639.x; Berndt RM, 1954, OCEANIA, V25, P23, DOI 10.1002/j.1834-4461.1954.tb00622.x; BROOKFIELD HC, 1962, ANN ASSOC AM GEOGR, V52, P242, DOI 10.1111/j.1467-8306.1962.tb00409.x; BROOKFIELD HC, 1968, ETHNOLOGY, V7, P43, DOI 10.2307/3772807; BROOKFIELD HC, 1963, STRUGGLE LAND AGRICU; BULMER S, 1964, AM ANTHROPOL, V66, P39; CHENOWETH V, 1966, ETHNOMUSICOLOGY, V10, P285, DOI 10.2307/924346; CURTAIN C, IN PRESS; DEIBLER E, 1963, LANGUAGES CHIMBU SUB; DUTOIT BM, 1964, OCEANIA, V35, P85; DUTOIT BM, 1962, J POLYNESIAN SOC, V71, P397; Fortune RF, 1947, MAN, V47, P108, DOI 10.2307/2792437; FRANTZ CI, 1966, PAPERS NEW GUINEA  A, P1; GAJDUSEK D. CARLETON, 1963, TRANS ROY SOC TROP MED AND HYG, V57, P151, DOI 10.1016/0035-9203(63)90057-9; Gajdusek D. Carleton, 1960, SEX AVOIDANCE PEDERA, P137; GAJDUSEK DC, 1961, AM J TROP MED HYG, V10, P80, DOI 10.4269/ajtmh.1961.10.80; GAJDUSEK DC, 1966, NATURE, V209, P794, DOI 10.1038/209794a0; GAJDUSEK DC, 1957, NEW ENGL J MED, V257, P974, DOI 10.1056/NEJM195711142572005; GAJDUSEK DC, 1967, SCIENCE, V155, P212; GAJDUSEK DC, 1961, AM J TROP MED HYG, V10, P599, DOI 10.4269/ajtmh.1961.10.599; GAJDUSEK DC, 1959, AM J MED, V26, P442, DOI 10.1016/0002-9343(59)90251-7; GAJDUSEK DC, 1964, CONGENITAL ABSENCE P, P138; GAJDUSEK DC, SOJOURNS WITH ANGA E; GAJDUSEK DC, 1967, SOUTH PACIFIC EXPEDI; GAJDUSEK DC, IN PRESS; GAJDUSEK DC, 1970, BIBLIOGRAPHY KURU; GAJDUSEK DC, 1972, ANNOTATED ANGA KUKUK; GAJDUSKE DC, 1964, COLD SPRING HARB SYM, V29, P121, DOI 10.1101/SQB.1964.029.01.017; Gibbs Jr. C. J., 1969, INT ARCH ALLERGY   S, V36, P519, DOI 10.1007/978-1-4613-3988-5_24; GLASSE R, 1967, T NEW YORK ACAD SCI, V29, P748, DOI 10.1111/j.2164-0947.1967.tb02298.x; GLASSE RM, 1969, ANTHROPOLOGICAL FORU, V2, P308; GLASSE RM, 1969, PIGS PEARLSHELLS WOM, P16; GLASSE RM, 1962, S FORE SOCIETY PRELI; GLASSE S., 1964, Papua and New Guinea Medical Journal, V7, P36; GLASSE S, 1963, SOCIAL LIFE WOMEN S; Glick L. B., 1964, AM ANTHROPOL, V66, P273; GODELIER M, 1969, LHOMME REV FRANC ANT, V9, P5; KITCHIN FD, 1972, AM J HUM GENET, V24, pS72; LLOYD RC, 1972, LANGUAGES RELATIONSH; LLOYD RC, 1969, PAPERS NEW GUINEA  A, P25; LOVING R, 1966, PAPERS NEW GUINEA  A, P23; MATHEWS JD, 1968, LANCET, V2, P449; MCKAUGHAN H, 1972, ANTHROPOLOGICAL STUD; MCKAUGHAN H, 1964, AM ANTHROPOL, V66, P98; MORTON NE, 1968, AM J PHYS ANTHROPOL, V28, P191, DOI 10.1002/ajpa.1330280216; NICHOLSON R, 1962, STUDIES NEW GUINEA L, P128; Pike Eunice V, 1964, AM ANTHROPOL, V66, P121; PLATO CC, 1972, AM J HUM GENET, V24, pS86; Reay Marie, 1959, KUMA FREEDOM CONFORM; Reid L H, 1969, Acta Trop, V26, P331; RENCK GL, 1967, PAPERS NEW GUINEA  A, P19; SCOTT GK, 1963, OCEANIA, V33, P280, DOI 10.1002/j.1834-4461.1963.tb00810.x; SCOTT GK, 1968, PAPERS NEW GUINEA  A, P45; SIMMONS RT, 1972, AM J HUM GENET, V24, pS39; SIMMONS RT, 1965, OCEANIA, V36, P132, DOI 10.1002/j.1834-4461.1965.tb00282.x; Sorenson E R, 1969, Acta Trop, V26, P281; SORENSON ER, 1966, PEDIATRICS, V37, P149; SORENSON ER, 1971, THESIS STANFORD U; STEINBERG AG, 1972, AM J HUM GENET, V24, pS95; WATSON BJ, 1967, ANTHROP FORUM, V2, P53; WATSON JB, 1967, OCEANIA, V38, P81, DOI 10.1002/j.1834-4461.1967.tb00946.x; WATSON JB, 1968, ETHNOLOGY, V7, P268, DOI 10.2307/3772892; WATSON JB, 1964, ETHNOLOGY, V3, P1, DOI 10.2307/4617552; WATSON JB, 1964, AM ANTHROPOLOGIST  2, V66; WATSON JB, 1963, J POLYNESIAN SOC, V72, P188; Watson V, 1955, SOUTHWEST J ANTHROP, V11, P121, DOI 10.1086/soutjanth.11.2.3628965; WIESENFELD SL, IN PRESS; WIESENFELD SL, TO BE PUBLISHED; WILLIAMS GAIL R., 1964, J GENET HUMAINE, V13, P11; WURM SA, 1964, AM ANTHROPOL, V66, P77; WURM SA, IN PRESS; WURM SA, 1962, LINGUISTIC SURVEY SO, P105	87	34	34	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1972	24	6					S1	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	O0505					2022-12-18	WOS:A1972O050500001
J	MORTON, NE; HARRIS, DE; YEE, S; LEW, R				MORTON, NE; HARRIS, DE; YEE, S; LEW, R			PINGELAP AND MOKIL ATOLLS - MIGRATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BODMER WF, 1968, GENETICS, V59, P565; CROW JF, 1965, EUGEN QUART, V12, P199, DOI 10.1080/19485565.1965.9987630; HARRIS DA, IN PRESS; HARRIS DE, 1969, GENETICS PROGRAM LIB, P41; IMAIZUMI Y, 1970, GENETICS, V66, P569; IMAIZUMI Y, 1970, ARCHAEOLOGY PHYSICAL, V5, P218; LEWONTIN R. C., 1967, ANNU REV GENET, V1, P37, DOI 10.1146/annurev.ge.01.120167.000345; MALECOT G, 1969, CONSEQUENCES STATIST, P651; Malecot G, 1948, MATH HEREDITE; MALECOT G, 1950, ANN U LYON SCIENCE A, V13, P37; MORTON NE, 1962, DEPLACEMENTS HUMAINS, P185; MORTON NE, IN PRESS; RIESENBERG SH, 1965, OCEANIA, V36, P155, DOI 10.1002/j.1834-4461.1965.tb00283.x; Wright S, 1931, GENETICS, V16, P0097; Wright S, 1921, GENETICS, V6, P111; Wright S., 1964, STOCHASTIC MODELS ME, P199	16	34	34	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1971	23	4					339	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	J8113	5097900				2022-12-18	WOS:A1971J811300001
J	TEITELBAUM, MS; MANTEL, N; STARK, CR				TEITELBAUM, MS; MANTEL, N; STARK, CR			LIMITED DEPENDENCE OF HUMAN SEX RATIO ON BIRTH ORDER AND PARENTAL AGES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BERNSTEIN ME, 1953, SCIENCE, V118, P448, DOI 10.1126/science.118.3068.448-a; Ciocco A., 1938, HUM BIOL, V10, P36; EDWARDS AWF, 1962, ADV GENET, V11, P239; Ewart RJ, 1915, J HYG-CAMBRIDGE, V15, P127, DOI 10.1017/S0022172400006161; GOODMAN LA, 1961, ANN HUM GENET, V25, P75, DOI 10.1111/j.1469-1809.1961.tb01500.x; GOODMAN LA, 1966, READINGS MATHEMATICA, P311; KIRBY DRS, 1967, LANCET, V2, P139; LEJEUNE J, 1957, CR HEBD ACAD SCI, V244, P1833; MANTEL N, 1959, J NATL CANCER I, V22, P719; MANTEL N, 1963, J AM STAT ASSOC, V58, P690; MORAN PAP, 1969, ANN HUM GENET, V32, P315, DOI 10.1111/j.1469-1809.1969.tb00080.x; NOVITSKI E, 1958, AM J HUM GENET, V10, P268; NOVITSKI E, 1956, ANN HUM GENET, V21, P123, DOI 10.1111/j.1469-1809.1971.tb00271.x; NOVITSKI E, 1953, SCIENCE, V117, P531, DOI 10.1126/science.117.3046.531; POLLARD GN, 1969, J BIOSOC SCI, V1, P125, DOI 10.1017/S002193200000715X; Russell WT, 1936, J HYG-CAMBRIDGE, V36, P381, DOI 10.1017/S0022172400043722; STARK CR, 1966, J NATL CANCER I, V37, P687; Stevenson A.C., 1967, J MED GENET, V4, P190; Teitelbaum M S, 1970, J Biosoc Sci Suppl, V2, P61; VISARIA PM, 1967, EUGEN QUART, V14, P132, DOI 10.1080/19485565.1967.9987713; WICKSELL SD, 1926, KUNGLIGA FYSIOGRAFIS, V37; WICKSELL SD, 1926, LUNDS U ARSSKRIFT  2, V22	22	34	34	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1971	23	3					271	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	J3602	5089843				2022-12-18	WOS:A1971J360200003
J	TELFER, MA; RICHARDSON, CE; HELMKEN, J; SMITH, GF				TELFER, MA; RICHARDSON, CE; HELMKEN, J; SMITH, GF			DIVERGENT PHENOTYPES AMONG 48,XXXX AND 47,XXX FEMALES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALTER M, 1965, AM J HUM GENET, V17, P473; ARAKAKI D. T., 1963, CYTOGENETICS [BASEL], V2, P57, DOI 10.1159/000129767; CARR DH, 1961, CAN MED ASSOC J, V84, P131; CLEVELAND WW, 1969, J PEDIATR-US, V74, P103, DOI 10.1016/S0022-3476(69)80014-4; DAVIES TS, 1963, BRIT MED J, P1541; DAY RW, 1964, J PEDIATR-US, V64, P24, DOI 10.1016/S0022-3476(64)80313-9; Di Cagno L, 1968, J Ment Defic Res, V12, P226; GROUCHY JD, 1968, ANN GENET, V11, P120; HAMBERT G, 1964, ACTA PSYCHIAT SCAND, V40, P28, DOI 10.1111/j.1600-0447.1964.tb05732.x; JOHNSTON AW, 1961, BRIT MED J, V2, P1046, DOI 10.1136/bmj.2.5259.1046; KEITH CG, 1968, P ROY SOC MED, V61, P251, DOI 10.1177/003591576806100322; KIDD CB, 1963, BRIT J PSYCHIAT, V109, P90, DOI 10.1192/bjp.109.458.90; KOHN G, 1968, J PEDIATR-US, V72, P248, DOI 10.1016/S0022-3476(68)80316-6; KONISHI S, 1968, Congenital Anomalies, V8, P211; LEJEUNE J, 1968, ANN GENET-PARIS, V11, P117; MACLEAN N, 1968, Journal of Medical Genetics, V5, P165, DOI 10.1136/jmg.5.3.165; PENROSE LS, 1967, LANCET, V1, P298; ROBINSON GC, 1964, J PEDIATR-US, V65, P226, DOI 10.1016/S0022-3476(64)80524-2; SANDERSON A, 1961, BRIT MED J, V2, P1065, DOI 10.1136/bmj.2.5259.1065; STEWART JSS, 1960, LANCET, V2, P21; TELPER MA, 1968, J AMER MED ASSOC, V206, P1087, DOI 10.1001/jama.1968.03150050075025	21	34	35	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1970	22	3					326	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	G6436	4392739				2022-12-18	WOS:A1970G643600008
J	BLOOM, GE; GERALD, PS				BLOOM, GE; GERALD, PS			LOCALIZATION OF GENES ON CHROMOSOME 13 - ANALYSIS OF 2 KINDREDS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BIAS WB, 1967, AM J HUM GENET, V19, P393; BLOOM GE, 1967, SCIENCE, V156, P1746, DOI 10.1126/science.156.3783.1746; DEGROUCH.J, 1965, AM J HUM GENET, V17, P501; DEGROUCHY J, 1966, AM J HUM GENET, V18, P467; GERALD PS, 1967, J PEDIATR-US, V70, P172, DOI 10.1016/S0022-3476(67)80411-6; GERALD PS, 1964, BLOOD, V24, P836; GERMAN J, 1964, J CELL BIOL, V20, P37, DOI 10.1083/jcb.20.1.37; GERMAN JL, 1966, CHICAGO C STANDARDIZ, V2, P10; HUEHNS ER, 1964, P NATL ACAD SCI USA, V51, P89, DOI 10.1073/pnas.51.1.89; HUEHNS ER, 1964, LANCET, V1, P589; LEE CSN, 1966, B JOHNS HOPKINS HOSP, V118, P374; Lejeune J, 1965, Ann Genet, V8, P21; MOORHEAD PS, 1960, EXP CELL RES, V20, P613, DOI 10.1016/0014-4827(60)90138-5; PATAU K, 1960, LANCET, V1, P790; POWARS D, 1964, LANCET, V1, P1363; SCHMID W., 1963, CYTOGENETICS [BASEL], V2, P175, DOI 10.1159/000129778; SINGER K, 1951, BLOOD, V6, P413, DOI 10.1182/blood.V6.5.413.413; SMITHIES O, 1965, VOX SANG, V10, P359; WALZER S, 1966, PEDIATRICS, V38, P419; YUNIS JJ, 1964, LANCET, V2, P935; YUNIS JJ, 1966, AM J DIS CHILD, V111, P83, DOI 10.1001/archpedi.1966.02090040119017; 1966, CHICAGO C STANDARDIZ, V2	22	34	34	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1968	20	6					495	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	C8180	5703687				2022-12-18	WOS:A1968C818000001
J	KITCHIN, FD; BEARN, AG				KITCHIN, FD; BEARN, AG			ELECTROPHORETIC PATTERNS OF NORMAL AND VARIANT PHENOTYPES OF GROUP SPECIFIC (GC) COMPONENTS IN HUMAN SERUM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ARFORS KE, 1963, ACTA GENET STAT MED, V13, P231; BEARN AG, 1964, J EXP MED, V120, P83, DOI 10.1084/jem.120.1.83; BOWMAN BH, 1965, P NATL ACAD SCI USA, V53, P722, DOI 10.1073/pnas.53.4.722; CLEVE H, 1963, AM J HUM GENET, V15, P368; CLEVE H, 1965, PROG MED GENET, V4, P202; HENNIG W, 1965, VOX SANG, V10, P214, DOI 10.1111/j.1423-0410.1965.tb04341.x; HIRSCHFELD J, 1962, PROG ALLERGY, V6, P155, DOI 10.1159/000313799; HIRSCHFELD J, 1959, ACTA PATHOL MIC SC, V46, P224; HIRSCHFELD J, 1963, PROTIDES BIOLOGICAL, P130; HIRSCHFELD JAN, 1959, ACTA PATHOL ET MICROBIOL SCAND, V47, P160; KIRK RL, 1963, ACTA GENET STAT MED, V13, P140; KITCHIN FD, 1965, P SOC EXP BIOL MED, V119, P1153; LAURELL CB, 1965, ANAL BIOCHEM, V10, P358, DOI 10.1016/0003-2697(65)90278-2; NERSTROM B, 1964, ACTA PATHOL MIC SC, V61, P474, DOI 10.1111/apm.1964.61.3.474; NERSTROM B, 1963, ACTA PATHOL MIC SC, V57, P495; PARKER WC, 1963, AM J HUM GENET, V15, P353; PEETERS H, 1963, PROTIDES BIOLOGIC ED, P130; PERSSON I, 1965, ACTA GENET STAT MED, V15, P51; RAYMOND S, 1964, ANN NY ACAD SCI, V121, P350, DOI 10.1111/j.1749-6632.1964.tb14208.x; REINSKOU T, 1963, ACTA PATHOL MIC SC, V59, P526; RESSLER N, 1960, CLIN CHIM ACTA, V5, P795, DOI 10.1016/0009-8981(60)90111-X; SCHEIDEGGER JJ, 1955, INT ARCH ALLER A IMM, V7, P103, DOI 10.1159/000228215; SCHULTZE HE, 1963, NATURE, V200, P1103, DOI 10.1038/2001103a0	23	34	34	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1966	18	2					201	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	74253	4159468				2022-12-18	WOS:A19667425300007
J	STERN, C; SARKAR, SS; CENTERWALL, WR				STERN, C; SARKAR, SS; CENTERWALL, WR			NEW DATA ON PROBLEM OF Y-LINKAGE OF HAIRY PINNAE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Cockayne EA, 1933, INHERITED ABNORMALIT; DRONAMRAJU K. R., 1963, SCI AND CULT, V29, P162; DRONAMRAJU KR, 1962, AM J HUM GENET, V14, P102; DRONAMRAJU KR, 1963, J GENET, V58, P324, DOI 10.1007/BF02986303; DRONAMRAJU KR, 1964, NATURE, V201, P424, DOI 10.1038/201424b0; Dronamraju KR, 1960, J GENET, V57, P230; GATES R R, 1957, Acta Genet Med Gemellol (Roma), V6, P103; Gates Reginald Ruggles, 1946, HUMAN GENETICS; GATES RR, 1960, SCIENCE, V132, P145, DOI 10.1126/science.132.3420.145; GATES RR, 1962, LANCET, V2, P357; GATES RR, 1962, AM J HUM GENET, V14, P363; GATES RR, 1961, 1 MANK QUART MANK M; LI CC, 1954, BIOMETRICS, V10, P347, DOI 10.2307/3001590; Li CC., 1955, POPULATION GENETICS; Sarkar S S, 1962, Am J Hum Genet, V14, P434; SARKAR SS, 1961, AM J HUM GENET, V13, P214; SARKAR SS, 1963, LANCET, V1, P1432; SLATIS HM, 1963, AM J HUM GENET, V15, P74; STERN C, 1957, AM J HUM GENET, V9, P147; Trotter M, 1922, AM J PHYS ANTHROPOL, V5, P391, DOI 10.1002/ajpa.1330050412	20	34	34	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1964	16	4					455	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2974A	14250426				2022-12-18	WOS:A19642974A00009
J	SLATIS, HM; APELBAUM, A				SLATIS, HM; APELBAUM, A			HAIRY PINNA OF EAR IN ISRAELI POPULATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		DRONAMRAJU K, 1961, NATURE, V190, P653, DOI 10.1038/190653a0; DRONAMRAJU KR, 1962, AM J HUM GENET, V14, P102; Dronamraju KR, 1960, J GENET, V57, P230; GATES R R, 1957, Acta Genet Med Gemellol (Roma), V6, P103; GATES RR, 1960, SCIENCE, V132, P145, DOI 10.1126/science.132.3420.145; GATES RR, 1961, MANKIND MONOGRAPHS, V1; KALMUS H, 1961, ANN HUM GENET, V25, P51, DOI 10.1111/j.1469-1809.1961.tb01496.x; LI CC, 1954, BIOMETRICS, V10, P347, DOI 10.2307/3001590; Li CC., 1955, POPULATION GENETICS; PENROSE LS, 1958, ANN HUM GENET, V22, P258, DOI 10.1111/j.1469-1809.1958.tb01421.x; SARKAR SS, 1961, AM J HUM GENET, V13, P214; STERN C, 1957, AM J HUM GENET, V9, P147	12	34	34	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1963	15	1					74	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2969A	13989183				2022-12-18	WOS:A19632969A00012
J	NEEL, JV; HIERNAUX, J; LINHARD, J; ROBINSON, A; ZUELZER, WW; LIVINGSTONE, FB				NEEL, JV; HIERNAUX, J; LINHARD, J; ROBINSON, A; ZUELZER, WW; LIVINGSTONE, FB			DATA ON THE OCCURRENCE OF HEMOGLOBIN-C AND OTHER ABNORMAL HEMOGLOBINS IN SOME AFRICAN POPULATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALLISON AC, 1954, T ROY SOC TROP MED H, V48, P312, DOI 10.1016/0035-9203(54)90101-7; BRAIN P, 1955, NATURE, V175, P262, DOI 10.1038/175262b0; DIGGS LW, 1954, BLOOD, V9, P1172, DOI 10.1182/blood.V9.12.1172.1172; DOBSON HL, 1956, CLIN RES P, V4, P26; EDINGTON GM, 1955, BRIT MED J, V2, P1328, DOI 10.1136/bmj.2.4951.1328; EDINGTON GM, 1955, BRIT MED J, V1, P1308, DOI 10.1136/bmj.1.4925.1308; EDINGTON GM, 1954, T ROY SOC TROP MED H, V48, P332, DOI 10.1016/0035-9203(54)90104-2; GLASS B, 1955, AM J HUM GENET, V7, P368; GOSDEN M, 1948, T ROY SOC TROP MED H, V41, P637, DOI 10.1016/S0035-9203(48)90478-7; HERSKOVITS MJ, 1942, MYTH NEGRO PAST, pR14; HIERNAUX J., 1952, Ann. Mus. Roy. Congo Belge, V2; HIERNAUX J, 1954, I ROYAL SCI NATURELL, P111; HIERNAUX J, 1953, I ROYAL COLONIAL BEL, V23, P51; ITANO HA, 1950, P NATL ACAD SCI USA, V36, P613, DOI 10.1073/pnas.36.11.613; ITANO HA, 1953, ARCH BIOCHEM BIOPHYS, V47, P148, DOI 10.1016/0003-9861(53)90444-5; ITANO HA, 1951, P NATL ACAD SCI USA, V37, P775, DOI 10.1073/pnas.37.12.775; JACOB GF, 1955, BRIT MED J, V1, P521, DOI 10.1136/bmj.1.4912.521; JACOB GF, BRIT M J; KAPLAN E, 1953, BLOOD, V8, P735, DOI 10.1182/blood.V8.8.735.735; KAPLAN E, 1951, BLOOD, V6, P1240, DOI 10.1182/blood.V6.12.1240.1240; KEITEL HG, 1956, CLIN RES P, V4, P7; LAMBOTTE-LEGRAND J, 1955, Ann Soc Belg Med Trop (1920), V35, P53; Lehmann H, 1955, MAN, V55, P186, DOI 10.2307/2795332; LEVIN WC, 1953, J LAB CLIN MED, V42, P918; LINHARD J, 1952, REV HEMATOL, V7, P561; MOURANT A. E., 1954; NEEL JV, ANN HUMAN GENET; NEEL JV, 1951, COLD SPRING HARB SYM, V15, P141; PALES L, 1951, SICKLEMIE AOF BIOL C, P42; PORTIER A, 1954, Alger Medicale, V58, P557; RANNEY HM, 1954, J CLIN INVEST, V33, P1634, DOI 10.1172/JCI103044; RANNEY HM, 1953, J CLIN INVEST, V32, P1277, DOI 10.1172/JCI102856; ROBERTS DF, 1955, AM J HUM GENET, V7, P361; ROBERTS DF, 1955, BRIT MED J, V1, P519, DOI 10.1136/bmj.1.4912.519; ROSE J. R., 1955, WEST AFRICAN MED JOUR, V4, P35; SCHNEIDER RG, 1954, J LAB CLIN MED, V44, P133; SCOTT RB, 1955, AMA AM J DIS CHILD, V90, P682, DOI 10.1001/archpedi.1955.04030010684004; SINGER K, 1951, BLOOD, V6, P413, DOI 10.1182/blood.V6.5.413.413; SINGER K, 1951, BLOOD, V6, P429, DOI 10.1182/blood.V6.5.429.429; Singer R, 1953, AM ANTHROPOL, V55, P634, DOI 10.1525/aa.1953.55.5.02a00040; SMITH EW, 1953, B JOHNS HOPKINS HOSP, V93, P94; SPAET TH, 1953, PEDIATRICS, V12, P483; TERRY DW, 1954, NEW ENGL J MED, V251, P365, DOI 10.1056/NEJM195409022511001; VANDEPITTE J, 1954, Ann Soc Belg Med Trop (1920), V34, P501; VANDEPITTE JM, ANN SOC BELGE MED TR; ZARAFONETIS CJD, 1955, CLIN RES P, V3, P29; ZUELZER WW, 1956, PROGR HEMATOLOGY, pR9	47	34	34	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1956	8	3					138	150						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF070					2022-12-18	WOS:A1956WF07000002
J	KALLMANN, FJ; FEINGOLD, L; BONDY, E				KALLMANN, FJ; FEINGOLD, L; BONDY, E			COMPARATIVE ADAPTATIONAL, SOCIAL, AND PSYCHOMETRIC DATA ON THE LIFE HISTORIES OF SENESCENT TWIN PAIRS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Cornell E. L., 1934, PERFORMANCE ABILITY; FEINGOLD L, 1950, THESIS COLUMBIA U; Hogben L., 1933, P ROY SOC EDINB, V53, P105; KALLMANN FJ, 1949, AM J PSYCHIAT, V106, P29, DOI 10.1176/ajp.106.1.29; KALLMANN FJ, 1948, J HERED, V39, P349, DOI 10.1093/oxfordjournals.jhered.a105785; KALLMANN FJ, 1950, 6 C INT PSYCH, P1; KALLMANN FJ, 1949, J INSUR MED, V4, P2; Lauterbach CE, 1925, GENETICS, V10, P525; Merriman C, 1924, PSYCHOL MONOGR, V33, P1; Newman HH., 1937, TWINS STUDY HEREDITY; PRICE BA, 1933, THESIS STANFORD U; Terman Lewis M., 1916, MEASUREMENT INTELLIG, P7; WECHSLER D, 1944, MEASUREMENT ADULT IN; WINGFIELD AH, 1928, TWINS ORPHANS	14	34	34	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1951	3	1					65	73						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XS392	13171374				2022-12-18	WOS:A1951XS39200004
J	KALLMANN, FJ; DEPORTE, J; DEPORTE, E; FEINGOLD, L				KALLMANN, FJ; DEPORTE, J; DEPORTE, E; FEINGOLD, L			SUICIDE IN TWINS AND ONLY CHILDREN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		DUBLIN LI, 1933, BE NOT BE STUDY SUIC, P443; DUBLIN LI, 1936, LENGTH LIFE, P400; KALLMANN FJ, 1947, J NERV MENT DIS, V105, P40, DOI 10.1097/00005053-194701000-00003; Lewis NDC, 1933, PSYCHOANAL REV, V20, P241; Lewis NDC, 1934, PSYCHOANAL REV, V21, P146; Vogt A., 1939, ARCH JULIUS KLAUS STIFT, V14, P475; 1940, 16TH CENS US 1940 PO, P111	7	34	34	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1949	1	2					113	126						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XU076	17948389				2022-12-18	WOS:A1949XU07600001
J	Capalbo, A; Poli, M; Rienzi, L; Girardi, L; Patassini, C; Fabiani, M; Cimadomo, D; Benini, F; Farcomeni, A; Cuzzi, J; Rubio, C; Albani, E; Sacchi, L; Vaiarelli, A; Figliuzzi, M; Findikli, N; Coban, O; Boynukalin, FK; Vogel, I; Hoffmann, E; Livi, C; Levi-Setti, PE; Ubaldi, FM; Simon, C				Capalbo, Antonio; Poli, Maurizio; Rienzi, Laura; Girardi, Laura; Patassini, Cristina; Fabiani, Marco; Cimadomo, Danilo; Benini, Francesca; Farcomeni, Alessio; Cuzzi, Juliana; Rubio, Carmen; Albani, Elena; Sacchi, Laura; Vaiarelli, Alberto; Figliuzzi, Matteo; Findikli, Necati; Coban, Onder; Boynukalin, Fazilet K.; Vogel, Ivan; Hoffmann, Eva; Livi, Claudia; Levi-Setti, Paolo E.; Ubaldi, Filippo M.; Simon, Carlos			Mosaic human preimplantation embryos and their developmental potential in a prospective, non-selection clinical trial	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMOSOMAL MOSAICISM; ANEUPLOIDIES; FERTILITY	Chromosome imbalance (aneuploidy) is the major cause of pregnancy loss and congenital disorders in humans. Analyses of small biopsies from human embryos suggest that aneuploidy commonly originates during early divisions, resulting in mosaicism. However, the developmental potential of mosaic embryos remains unclear. We followed the distribution of aneuploid chromosomes across 73 unselected preimplantation embryos and 365 biopsies, sampled from four multifocal trophectoderm (TE) samples and the inner cell mass (ICM). When mosaicism impacted fewer than 50% of cells in one TE biopsy (low-medium mosaicism), only 1% of aneuploidies affected other portions of the embryo. A double-blinded prospective non-selection trial (NCT03673592) showed equivalent live-birth rates and miscarriage rates across 484 euploid, 282 low-grade mosaic, and 131 medium-grade mosaic embryos. No instances of mosaicism or uniparental disomy were detected in the ensuing pregnancies or newborns, and obstetrical and neonatal outcomes were similar between the study groups. Thus, low-medium mosaicism in the trophectoderm mostly arises after TE and ICM differentiation, and such embryos have equivalent developmental potential as fully euploid ones.	[Capalbo, Antonio; Poli, Maurizio; Girardi, Laura; Patassini, Cristina; Fabiani, Marco; Figliuzzi, Matteo] Igenomix, Reprod Genet, I-36063 Marostica, Italy; [Rienzi, Laura; Cimadomo, Danilo; Vaiarelli, Alberto; Ubaldi, Filippo M.] GeneraLife IVF, Clin Valle Giulia, I-00197 Rome, Italy; [Benini, Francesca; Livi, Claudia] GeneraLife IVF, DEMETRA, I-50141 Florence, Italy; [Farcomeni, Alessio] Univ Roma Tor Vergata, Dept Econ & Finance, I-00133 Rome, Italy; [Cuzzi, Juliana] Igenomix US & Canada, Miami, FL 33126 USA; [Rubio, Carmen; Simon, Carlos] Igenomix, Valencia 46980, Spain; [Rubio, Carmen; Simon, Carlos] Igenomix Fdn, Reprod Genet, Valencia 46980, Spain; [Albani, Elena; Sacchi, Laura; Levi-Setti, Paolo E.] Humanitas Res Hosp, Div Gynecol & Reprod Med, Fertil Ctr, Ist Ricovero & Cura Carattere Sci, I-20089 Milan, Italy; [Findikli, Necati] Bahceci Fulya IVF Ctr, Embryol Lab, TR-34394 Istanbul, Turkey; [Findikli, Necati] Beykent Univ, Dept Biomed Engn, TR-34398 Istanbul, Turkey; [Coban, Onder] British Cyprus IVF Hosp, CY-2681 Nicosia, Cyprus; [Boynukalin, Fazilet K.] Bahceci Fulya IVF Ctr, Infertil Clin, TR-34394 Istanbul, Turkey; [Vogel, Ivan; Hoffmann, Eva] Univ Copenhagen, Fac Hlth & Med Sci, Danish Natl Res Fdn Ctr Chromosome Stabil, Dept Cellular & Mol Med, DK-2200 Copenhagen, Denmark; [Simon, Carlos] Univ Valencia, Valencia, Spain; [Simon, Carlos] INCLIVA, Dept Obstet & Gynecol, Valencia 46010, Spain; [Simon, Carlos] Harvard Univ, Sch Med, Dept Obstet & Gynecol, Boston, MA 02115 USA	University of Rome Tor Vergata; IRCCS Ca Granda Ospedale Maggiore Policlinico; Bahceci Health Group; Beykent University; Bahceci Health Group; University of Copenhagen; University of Valencia; Harvard University; Harvard Medical School	Capalbo, A (corresponding author), Igenomix, Reprod Genet, I-36063 Marostica, Italy.	antonio.capalbo@igenomix.com	Figliuzzi, Matteo/GZM-3449-2022; Fabiani, Marco/AAR-7348-2021; Rubio, Carmen/D-7753-2018; Simon, Carlos/G-2186-2014	Simon, Carlos/0000-0003-0902-9531; Hoffmann, Eva/0000-0002-2588-0652; Capalbo, Antonio/0000-0003-0109-323X	Igenomix; European Research Council [724718-ReCAP]; Novo Nordisk Foundation Young Investigator Award [NNF15OC0016662]; ReproUnion; Danish National Research Foundation [6110-00344B]	Igenomix; European Research Council(European Research Council (ERC)European Commission); Novo Nordisk Foundation Young Investigator Award; ReproUnion; Danish National Research Foundation(Danmarks Grundforskningsfond)	The study was supported by Igenomix. The authors also acknowl-edge the support of a European Research Council consolidator grant (724718-ReCAP) , the Novo Nordisk Foundation Young Investigator Award (NNF15OC0016662) , ReproUnion, and the Danish National Research Foundation (center grant 6110-00344B) . Furthermore, the authors would like to thank all col-leagues and collaborators who have contributed to this study and to acknowledge their work in data collection and treatment monitoring across all the participating sites and institutions. A special acknowledgment is given to the following individuals for their contributions: Carlos Gomez De la Cruz and Emilio de la Fuente Lucena from Igenomix; Cinzia Gentile from Genera Ven-eto, GeneraLife IVF; Erminia Alviggi from Ruesch Clinic, GeneraL-ife IVF; Antonella Smeraldi and Amalia Cesana from Humanitas; and Valentina Zicaro from Demetra.	Besser AG, 2017, REPROD BIOMED ONLINE, V34, P369, DOI 10.1016/j.rbmo.2017.01.003; Bolton H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11165; Capalbo A, 2017, HUM REPROD UPDATE, V23, P706, DOI 10.1093/humupd/dmx026; Capalbo A, 2014, HUM REPROD, V29, P1173, DOI 10.1093/humrep/deu033; Capalbo A, 2013, HUM REPROD, V28, P2298, DOI 10.1093/humrep/det245; Cimadomo D, 2019, HUM REPROD, V34, P1206, DOI 10.1093/humrep/dez078; Coorens THH, 2021, NATURE, V592, P80, DOI 10.1038/s41586-021-03345-1; Cram DS, 2019, REPROD BIOMED ONLINE, V39, pE1, DOI 10.1016/j.rbmo.2019.06.012; Esteki MZ, 2019, NAT MED, V25, P1699, DOI 10.1038/s41591-019-0620-2; Fischer C, 2020, FERTIL STERIL, V114, P6, DOI 10.1016/j.fertnstert.2020.04.056; Garcia-Pascual CM, 2020, GENES-BASEL, V11, DOI 10.3390/genes11070724; Girardi L, 2020, AM J HUM GENET, V106, P525, DOI 10.1016/j.ajhg.2020.03.005; Greco E, 2015, NEW ENGL J MED, V373, P2089, DOI 10.1056/NEJMc1500421; Gruhn JR, 2019, SCIENCE, V365, P1466, DOI 10.1126/science.aav7321; Hsu LYF, 1996, PRENATAL DIAG, V16, P1, DOI 10.1002/(SICI)1097-0223(199601)16:1<1::AID-PD816>3.0.CO;2-W; Huang A, 2009, FERTIL STERIL, V91, P2355, DOI 10.1016/j.fertnstert.2008.03.044; Kahraman S, 2020, HUM REPROD, V35, P727, DOI 10.1093/humrep/dez309; KALOUSEK DK, 1983, SCIENCE, V221, P665, DOI 10.1126/science.6867735; Lensen S, 2019, NEW ENGL J MED, V380, P325, DOI 10.1056/NEJMoa1808737; Mounts EL, 2021, GENET MED, V23, P230, DOI 10.1038/s41436-020-00941-w; Munne S, 2017, FERTIL STERIL, V108, P62, DOI 10.1016/j.fertnstert.2017.05.002; Penzias A, 2020, FERTIL STERIL, V114, P246, DOI 10.1016/j.fertnstert.2020.05.014; Popovic M, 2020, HUM REPROD UPDATE, V26, P313, DOI 10.1093/humupd/dmz050; Shi YH, 2018, NEW ENGL J MED, V378, P126, DOI 10.1056/NEJMoa1705334; Singla S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16796-3; Van den Bogaert K, 2021, GENET MED, V23, P1137, DOI 10.1038/s41436-021-01101-4; van der Meij KRM, 2019, AM J HUM GENET, V105, P1091, DOI 10.1016/j.ajhg.2019.10.005; van Echten-Arends J, 2011, HUM REPROD UPDATE, V17, P620, DOI 10.1093/humupd/dmr014; Viotti M, 2021, FERTIL STERIL, V115, P1212, DOI 10.1016/j.fertnstert.2020.11.041; Weksberg R, 2010, EUR J HUM GENET, V18, P8, DOI 10.1038/ejhg.2009.106; Zegers-Hochschild F, 2017, HUM REPROD, V32, P1786, DOI 10.1093/humrep/dex234	31	33	33	3	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 2	2021	108	12					2238	2247		10.1016/j.ajhg.2021.11.002	http://dx.doi.org/10.1016/j.ajhg.2021.11.002		DEC 2021	10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XK8WT	34798051	hybrid, Green Published			2022-12-18	WOS:000727739200005
J	Barbosa, S; Greville-Heygate, S; Bonnet, M; Godwin, A; Fagotto-Kaufmann, C; Kajava, AV; Laouteouet, D; Mawby, R; Wai, HA; Dingemans, AJM; Hehir-Kwa, J; Willems, M; Capri, Y; Mehta, SG; Cox, H; Goudie, D; Vansenne, F; Turnpenny, P; Vincent, M; Cogne, B; Lesca, G; Hertecant, J; Rodriguez, D; Keren, B; Burglen, L; Gerard, M; Putoux, A; Cantagrel, V; Siquier-Pernet, K; Rio, M; Banka, S; Sarkar, A; Steeves, M; Parker, M; Clement, E; Moutton, S; Mau-Them, FT; Piton, A; de Vries, BBA; Guille, M; Debant, A; Schmidt, S; Baralle, D				Barbosa, Sonia; Greville-Heygate, Stephanie; Bonnet, Maxime; Godwin, Annie; Fagotto-Kaufmann, Christine; Kajava, Andrey, V; Laouteouet, Damien; Mawby, Rebecca; Wai, Htoo Aung; Dingemans, Alexander J. M.; Hehir-Kwa, Jayne; Willems, Marjorlaine; Capri, Yline; Mehta, Sarju G.; Cox, Helen; Goudie, David; Vansenne, Fleur; Turnpenny, Peter; Vincent, Marie; Cogne, Benjamin; Lesca, Gaetan; Hertecant, Jozef; Rodriguez, Diana; Keren, Boris; Burglen, Lydie; Gerard, Marion; Putoux, Audrey; Cantagrel, Vincent; Siquier-Pernet, Karine; Rio, Marlene; Banka, Siddharth; Sarkar, Ajoy; Steeves, Marcie; Parker, Michael; Clement, Emma; Moutton, Sebastien; Mau-Them, Frederic Tran; Piton, Amelie; de Vries, Bert B. A.; Guille, Matthew; Debant, Anne; Schmidt, Susanne; Baralle, Diana		C4RCD Res Grp	Opposite Modulation of RAC1 by Mutations in TRIO Is Associated with Distinct, Domain-Specific Neurodevelopmental Disorders	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INTELLECTUAL DISABILITY; RHO-GTPASES; XENOPUS; GEF; PATHWAY; SPERM	The Rho-guanine nucleotide exchange factor (RhoGEF) TRIO acts as a key regulator of neuronal migration, axonal outgrowth, axon guidance, and synaptogenesis by activating the GTPase RAC1 and modulating actin cytoskeleton remodeling. Pathogenic variants in TRIO are associated with neurodevelopmental diseases, including intellectual disability (ID) and autism spectrum disorders (ASD). Here, we report the largest international cohort of 24 individuals with confirmed pathogenic missense or nonsense variants in TRIO. The nonsense mutations are spread along the TRIO sequence, and affected individuals show variable neurodevelopmental phenotypes. In contrast, missense variants cluster into two mutational hotspots in the TRIO sequence, one in the seventh spectrin repeat and one in the RAC1-activating GEFD1. Although all individuals in this cohort present with developmental delay and a neuro-behavioral phenotype, individuals with a pathogenic variant in the seventh spectrin repeat have a more severe ID associated with macrocephaly than do most individuals with GEFD1 variants, who display milder ID and microcephaly. Functional studies show that the spectrin and GEFD1 variants cause a TRIO-mediated hyper- or hypo-activation of RAC1, respectively, and we observe a striking correlation between RAC1 activation levels and the head size of the affected individuals. In addition, truncations in TRIO GEFD1 in the vertebrate model X. tropicalis induce defects that are concordant with the human phenotype. This work demonstrates distinct clinical and molecular disorders clustering in the GEFD1 and seventh spectrin repeat domains and highlights the importance of tight control of TRIO-RAC1 signaling in neuronal development.	[Barbosa, Sonia; Bonnet, Maxime; Fagotto-Kaufmann, Christine; Kajava, Andrey, V; Laouteouet, Damien; Debant, Anne; Schmidt, Susanne] Univ Montpellier, Ctr Rech Biol Cellulaire Montpellier, CNRS, F-34293 Montpellier, France; [Greville-Heygate, Stephanie; Baralle, Diana] Univ Hosp Southampton Natl Hlth Serv Fdn Trust, Wessex Clin Genet, Southampton SO16 5YA, Hants, England; [Mawby, Rebecca; Wai, Htoo Aung; Baralle, Diana] Univ Southampton, Fac Med, Human Dev & Hlth, Southampton SO16 6YD, Hants, England; [Godwin, Annie; Guille, Matthew] Univ Portsmouth, European Xenopus Resource Ctr, Sch Biol Sci, Portsmouth PO1 2DY, Hants, England; [Dingemans, Alexander J. M.; de Vries, Bert B. A.] Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, NL-6525 GA Nijmegen, Netherlands; [Hehir-Kwa, Jayne] Princess Maxima Ctr Pediat Oncol, NL-3584 CS Utrecht, Netherlands; [Willems, Marjorlaine] Univ Montpellier, Dept Genet Med, Ctr Hosp Reg, F-34295 Montpellier, France; [Capri, Yline] CHU Paris, Dept Genet, F-75019 Paris, France; [Mehta, Sarju G.] Cambridge Univ Hosp Trust, Dept Clin Genet, Cambridge CB2 0QQ, England; [Cox, Helen] Birmingham Womens & Childrens Natl Hlth Serv Fdn, West Midlands Reg Genet Serv, Birmingham B15 2TG, W Midlands, England; [Goudie, David] Ninewells Hosp, Dept Clin Genet, Dundee DD2 1UB, Scotland; [Vansenne, Fleur] Univ Med Ctr Groningen, Dept Clin Genet, NL-9713 GZ Groningen, Netherlands; [Turnpenny, Peter] Royal Devon & Exeter Natl Hlth Serv Fdn Trust, Clin Genet Dept, Exeter EX1 2ED, Devon, England; [Vincent, Marie; Cogne, Benjamin] CHU Nantes, Serv Genet Med, F-44093 Nantes, France; [Lesca, Gaetan] Hosp Civils Lyon, Serv Genet, F-69002 Lyon, France; [Hertecant, Jozef] Tawam Hosp, POB 15258, Al Ain, U Arab Emirates; [Rodriguez, Diana] Sorbonne Univ, Hop Armand Trousseau, AP HP, Serv Neurol Pediat,Ctr Reference Malad Rares Neur, F-75012 Paris, France; [Keren, Boris] Hop La Pitie Salpetriere, Dept Genet Pr Leguern, F-75013 Paris, France; [Burglen, Lydie] Hop Trousseau, Dept Genet & Embryol Med, Ctr Reference Malformat & Malad Congenitales Cerv, F-75012 Paris, France; [Gerard, Marion] CHU Caen, Serv Genet, F-14000 Caen, France; [Putoux, Audrey] Hosp Civils Lyon, Serv Genet, F-69500 Bron, France; [C4RCD Res Grp] Translat Genom Res Inst, TGens Ctr Rare Childhood Disorders, Phoenix, AZ 85012 USA; [Cantagrel, Vincent] Paris Descartes Sorbonne Paris Cite Univ, Imagine Inst, F-75015 Paris, France; [Cantagrel, Vincent; Siquier-Pernet, Karine; Rio, Marlene] INSERM UMR 1163, Dev Brain Disorders Lab, F-75015 Paris, France; [Siquier-Pernet, Karine; Rio, Marlene] Necker Enfants Malad Univ Hosp, AP HP, Serv Genet, F-75015 Paris, France; [Banka, Siddharth] Univ Manchester, Fac Biol, Sch Biol Sci, Div Evolut & Genom Sci, Manchester M13 9WL, Lancs, England; [Banka, Siddharth] Manchester Univ NHS Fdn Trust, St Marys Hosp, Manchester Ctr Genom Med, Hlth Innovat Manchester, Manchester M13 9WL, Lancs, England; [Sarkar, Ajoy] Nottingham Univ Hosp Natl Hlth Serv Trust, Dept Clin Genet, Nottingham NG5 1PB, England; [Steeves, Marcie] Mass Gen Hosp Children, Boston, MA 02114 USA; [Parker, Michael] Sheffield Childrens Natl Hlth Serv Fdn Trust, Clin Genet, Sheffield S10 2TH, S Yorkshire, England; [Clement, Emma] Great Ormond St Hosp Children Natl Hlth Serv Fdn, Clin Genet Dept, London WC1N 3JH, England; [Moutton, Sebastien] Dijon Univ Hosp, Reference Ctr Dev Anomalies, Dept Med Genet, F-21000 Dijon, France; [Mau-Them, Frederic Tran] Burgundy Univ, Serv Genet Anomalies Dev, INSERM U1231, F-21000 Dijon, France; [Piton, Amelie] Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; [Piton, Amelie] Hop Univ Strasbourg, Lab Genet Diagnost, F-67091 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; University of Southampton; University of Portsmouth; Radboud University Nijmegen; Centre Hospitalier Annecy Genevois; Universite de Montpellier; CHU de Montpellier; Assistance Publique Hopitaux Paris (APHP); University of Dundee; University of Groningen; Nantes Universite; CHU de Nantes; CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU Lyon; Translational Genomics Research Institute; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Manchester; University of Manchester; Nottingham University Hospital NHS Trust; Sheffield Children's NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; CHU Dijon Bourgogne; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Schmidt, S (corresponding author), Univ Montpellier, Ctr Rech Biol Cellulaire Montpellier, CNRS, F-34293 Montpellier, France.; Baralle, D (corresponding author), Univ Hosp Southampton Natl Hlth Serv Fdn Trust, Wessex Clin Genet, Southampton SO16 5YA, Hants, England.; Baralle, D (corresponding author), Univ Southampton, Fac Med, Human Dev & Hlth, Southampton SO16 6YD, Hants, England.	susanne.schmidt@crbm.cnrs.fr; d.baralle@soton.ac.uk	Vincent, Cantagrel/H-8698-2017; Kajava, Andrey V/E-1107-2014; Rodriguez, Diana/GVR-7668-2022; Putoux, Audrey/D-7265-2015; Vansenne, Fleur/GRS-5151-2022; Lesca, Gaetan/C-6111-2019; Piton, Amelie/F-1201-2013	Vincent, Cantagrel/0000-0002-5180-4848; Kajava, Andrey V/0000-0002-2342-6886; De Oliveira Barbosa, Sonia/0000-0002-7027-1530; Lesca, Gaetan/0000-0001-7691-9492; Vansenne, Fleur/0000-0002-0156-3417; Wai, Htoo Aung/0000-0002-3560-6980; Piton, Amelie/0000-0003-0408-7468; Tran Mau Them, Frederic/0000-0002-3795-9456; Dingemans, Alexander JM/0000-0002-5648-2155; Guille, Matthew/0000-0001-6865-4519; Greville-Heygate, Stephanie/0000-0003-1516-3016; Clement, Emma/0000-0002-5562-6276; Banka, Siddharth/0000-0002-8527-2210; Hehir-Kwa, Jayne/0000-0003-0837-304X	French National Research Agency ("Investments for the future'') [ANR-10-INBS-04]; Fondation pour la Recherche Medicale (Equipes FRM 2016) [DEQ20160334942]; Ministe re de l'Enseignement Superieur et de la Recherche; Wellcome Trust [212942/Z/18/Z]; Biotechnology and Biological Sciences Research Council [BB/R014841/1]; National Institute for Health Research research professorship [RP-2016-07-011]; Health Education England Genomics Education Programme; Health Innovation Challenge Fund [HICF-1009-003]; National Institute for Health Research; NHS England; Wellcome Trust; Cancer Research UK; Medical Research Council; BBSRC [BB/R014841/1] Funding Source: UKRI	French National Research Agency ("Investments for the future'')(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (Equipes FRM 2016); Ministe re de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute for Health Research research professorship; Health Education England Genomics Education Programme; Health Innovation Challenge Fund; National Institute for Health Research(National Institute for Health Research (NIHR)); NHS England; Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We are grateful to all the patients and their families for their participation in this study. We thank all members of the Debant team for helpful discussions. We acknowledge the imaging facility Montpellier Ressources Imagerie (MRI), a member of the national France-BioImaging infrastructure supported by the French National Research Agency (ANR-10-INBS-04, "Investments for the future''). We thank A. Guille for help with statistical analysis. This work was supported by grants from the Fondation pour la Recherche Medicale (Equipes FRM 2016, DEQ20160334942) to A.D. A PhD fellowship from the Ministe re de l'Enseignement Superieur et de la Recherche supported M.B. The European Xenopus Resource Centre (EXRC) is funded by the Wellcome Trust (212942/Z/18/Z) and the Biotechnology and Biological Sciences Research Council (BB/R014841/1). The Baralle lab is supported by a National Institute for Health Research research professorship to D.B. (RP-2016-07-011). S.G.-H. is funded by a research fellowship from the Health Education England Genomics Education Programme. The DDD study presents independent research commissioned by the Health Innovation Challenge Fund [grant HICF-1009-003]. This research was made possible through access to data and findings generated by the 100,000 Genomes Project, which is managed by Genomics England Limited (a wholly owned company of the Department of Health and Social Care). The 100,000 Genomes Project is funded by the National Institute for Health Research and NHS England. The Wellcome Trust, Cancer Research UK, and the Medical Research Council have also funded research infrastructure. The 100,000 Genomes Project uses data provided by patients and collected by the National Health Service as part of their care and support.	Allen KM, 1998, NAT GENET, V20, P25, DOI 10.1038/1675; Amos B., 2016, CMUCD16188; Ba W, 2016, HUM MOL GENET, V25, P892, DOI 10.1093/hmg/ddv618; Ba W, 2013, EXP CELL RES, V319, P2368, DOI 10.1016/j.yexcr.2013.05.033; Bellanger JM, 1998, ONCOGENE, V16, P147, DOI 10.1038/sj.onc.1201532; Blangy A, 2000, J CELL SCI, V113, P729; Briancon-Marjollet A, 2008, MOL CELL BIOL, V28, P2314, DOI 10.1128/MCB.00998-07; Bucher P, 1996, COMPUT CHEM, V20, P3, DOI 10.1016/S0097-8485(96)80003-9; Cannet A, 2014, MOL BIOL CELL, V25, P4063, DOI 10.1091/mbc.E14-06-1153; Chen L, 2009, DEV BIOL, V325, P162, DOI 10.1016/j.ydbio.2008.10.023; Chen SY, 2011, P NATL ACAD SCI USA, V108, P5861, DOI 10.1073/pnas.1018128108; Chhatriwala MK, 2007, J MOL BIOL, V368, P1307, DOI 10.1016/j.jmb.2007.02.060; Corbetta S, 2009, FASEB J, V23, P1347, DOI 10.1096/fj.08-121574; Davis L, 2009, J BIOL CHEM, V284, P6982, DOI 10.1074/jbc.M809245200; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; DeGeer J, 2013, MOL CELL BIOL, V33, P739, DOI 10.1128/MCB.01264-12; DeLano W. L, 2002, PYMOL MOL GENETICS G; Deniz E, 2018, METHODS MOL BIOL, V1865, P163, DOI 10.1007/978-1-4939-8784-9_12; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Diets IJ, 2019, AM J HUM GENET, V104, P758, DOI 10.1016/j.ajhg.2019.02.023; Dolan BM, 2013, P NATL ACAD SCI USA, V110, P5671, DOI [10.1073/pnas.1219383110, 10.1073/pnas.1219353110]; Estrach S, 2002, CURR BIOL, V12, P307, DOI 10.1016/S0960-9822(02)00658-9; Ferry Q, 2014, ELIFE, V3, DOI 10.7554/eLife.02020; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Guille M., 1999, MOL METHODS DEV BIOL, V27; Harms FL, 2018, AM J HUM GENET, V103, P579, DOI 10.1016/j.ajhg.2018.09.005; Herring BE, 2016, P NATL ACAD SCI USA, V113, P2264, DOI 10.1073/pnas.1600179113; Horn S, 2019, BRAIN, V142, P3351, DOI 10.1093/brain/awz264; Iyer SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033634; Katrancha SM, 2017, HUM MOL GENET, V26, P4728, DOI 10.1093/hmg/ddx355; Katrancha SM, 2019, CELL REP, V26, P2805, DOI 10.1016/j.celrep.2019.02.022; Ladwein M, 2008, FEBS LETT, V582, P2066, DOI 10.1016/j.febslet.2008.04.033; Leone DP, 2010, DEV NEUROBIOL, V70, P659, DOI 10.1002/dneu.20804; Mansour N, 2009, THERIOGENOLOGY, V72, P1221, DOI 10.1016/j.theriogenology.2009.07.013; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Meyer G, 2002, J NEUROCHEM, V83, P490, DOI 10.1046/j.1471-4159.2002.01185.x; Naert Thomas, 2018, Drug Discov Today Technol, V28, P41, DOI 10.1016/j.ddtec.2018.07.001; Naert T, 2016, SCI REP-UK, V6, DOI 10.1038/srep35264; Nakayama T, 2014, METHOD ENZYMOL, V546, P355, DOI 10.1016/B978-0-12-801185-0.00017-9; Neubrand VE, 2010, J CELL SCI, V123, P2110, DOI 10.1242/jcs.064055; O'Brien SP, 2000, P NATL ACAD SCI USA, V97, P12074, DOI 10.1073/pnas.97.22.12074; Pearl E, 2017, THERIOGENOLOGY, V92, P149, DOI 10.1016/j.theriogenology.2017.01.007; Peng YJ, 2010, J BIOL CHEM, V285, P24834, DOI 10.1074/jbc.M109.096537; Pengelly RJ, 2016, J MED GENET, V53, P735, DOI 10.1136/jmedgenet-2016-103942; Pennucci R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024819; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Reijnders MRF, 2017, AM J HUM GENET, V101, P466, DOI 10.1016/j.ajhg.2017.08.007; Sadybekov A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00472-0; Sargent MG, 2005, GENESIS, V41, P41, DOI 10.1002/gene.20092; Schmidt Susanne, 2014, Small GTPases, V5, pe29769, DOI 10.4161/sgtp.29769; Sega AG, 2019, J MED GENET, V56, P113, DOI 10.1136/jmedgenet-2018-105322; Tao T, 2019, J GENET GENOMICS, V46, P87, DOI 10.1016/j.jgg.2019.02.003; Tolias KF, 2011, PROG NEUROBIOL, V94, P133, DOI 10.1016/j.pneurobio.2011.04.011; Vaghi V, 2014, CEREB CORTEX, V24, P1247, DOI 10.1093/cercor/bhs402; van Der Donk R, 2019, GENET MED, V21, P1719, DOI 10.1038/s41436-018-0404-y; van Haren J, 2014, CURR BIOL, V24, P1778, DOI 10.1016/j.cub.2014.06.037; Vouillot L, 2015, G3-GENES GENOM GENET, V5, P407, DOI 10.1534/g3.114.015834; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Zong W, 2015, BRAIN RES, V1608, P82, DOI 10.1016/j.brainres.2015.02.040	62	33	33	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 5	2020	106	3					338	355		10.1016/j.ajhg.2020.01.018	http://dx.doi.org/10.1016/j.ajhg.2020.01.018			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KT6CT	32109419	Green Published, Green Accepted, hybrid			2022-12-18	WOS:000519101800012
J	Dai, P; Huang, LH; Wang, GJ; Gao, X; Qu, CY; Chen, XW; Ma, FR; Zhang, J; Xing, WL; Xi, SY; Ma, BR; Pan, Y; Cheng, XH; Duan, H; Yuan, YY; Zhao, LP; Chang, L; Gao, RZ; Liu, HH; Zhang, W; Huang, SS; Kang, DY; Liang, W; Zhang, K; Jiang, H; Guo, YL; Zhou, Y; Zhang, WX; Lyu, F; Jin, YN; Zhou, Z; Lu, HL; Zhang, X; Liu, P; Ke, J; Hao, JS; Huang, HM; Jiang, D; Ni, X; Long, M; Zhang, L; Qiao, J; Morton, CC; Liu, XZ; Cheng, J; Han, DM				Dai, Pu; Huang, Li-Hui; Wang, Guo-Jian; Gao, Xue; Qu, Chun-Yan; Chen, Xiao-Wei; Ma, Fu-Rong; Zhang, Jie; Xing, Wan-Li; Xi, Shu-Yan; Ma, Bin-Rong; Pan, Ying; Cheng, Xiao-Hua; Duan, Hong; Yuan, Yong-Yi; Zhao, Li-Ping; Chang, Liang; Gao, Ru-Zhen; Liu, Hai-Hong; Zhang, Wei; Huang, Sha-Sha; Kang, Dong-Yang; Liang, Wei; Zhang, Ke; Jiang, Hong; Guo, Yong-Li; Zhou, Yi; Zhang, Wan-Xia; Lyu, Fan; Jin, Ying-Nan; Zhou, Zhen; Lu, Hong-Li; Zhang, Xin; Liu, Ping; Ke, Jia; Hao, Jin-Sheng; Huang, Hai-Meng; Jiang, Di; Ni, Xin; Long, Mo; Zhang, Luo; Qiao, Jie; Morton, Cynthia Casson; Liu, Xue-Zhong; Cheng, Jing; Han, De-Min			Concurrent Hearing and Genetic Screening of 180,469 Neonates with Follow-up in Beijing, China	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COCHLEAR IMPLANT; GJB2; IMPAIRMENT; DEAFNESS; LIMITATIONS; PREVALENCE; MUTATIONS; IDENTIFY	Concurrent hearing and genetic screening of newborns is expected to play important roles not only in early detection and diagnosis of congenital deafness, which triggers intervention, but also in predicting late-onset and progressive hearing loss and identifying individuals who are at risk of drug-induced HL. Concurrent hearing and genetic screening in the whole newborn population in Beijing was launched in January 2012. This study included 180,469 infants born in Beijing between April 2013 and March 2014, with last follow-up on February 24, 2018. Hearing screening was performed using transiently evoked otoacoustic emission (TEOAE) and automated auditory brainstem response (AABR). For genetic testing, dried blood spots were collected and nine variants in four genes, GJB2, SLC26A4, mtDNA 12S rRNA, and GJB3, were screened using a DNA microarray platform. Of the 180,469 infants, 1,915 (1.061%) were referred bilaterally or unilaterally for hearing screening; 8,136 (4.508%) were positive for genetic screening (heterozygote, homozygote, or compound heterozygote and mtDNA homoplasmy or heteroplasmy), among whom 7,896 (4.375%) passed hearing screening. Forty (0.022%) infants carried two variants in GJB2 or SLC26A4 (homozygote or compound heterozygote) and 10 of those infants passed newborn hearing screening. In total, 409 (0.227%) infants carried the mtDNA 12S rRNA variant (m.1555A>G or m.1494C>T), and 405 of them passed newborn hearing screening. In this cohort study, 25% of infants with pathogenic combinations of GJB2 or SLC26A4 variants and 99% of infants with an m.1555A>G or m.1494C>T variant passed routine newborn hearing screening, indicating that concurrent screening provides a more comprehensive approach for management of congenital deafness and prevention of ototoxicity.	[Dai, Pu; Wang, Guo-Jian; Gao, Xue; Duan, Hong; Yuan, Yong-Yi; Huang, Sha-Sha; Kang, Dong-Yang; Zhang, Xin] Chinese Peoples Liberat Army PLA Gen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing 100853, Peoples R China; [Huang, Li-Hui; Cheng, Xiao-Hua; Zhao, Li-Ping; Zhang, Wei; Zhang, Luo; Han, De-Min] Capital Med Univ, Beijing TongRen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing 100730, Peoples R China; [Huang, Li-Hui; Cheng, Xiao-Hua; Zhao, Li-Ping; Zhang, Wei; Zhang, Luo] Beijing Inst Otolaryngol, Beijing 100005, Peoples R China; [Huang, Li-Hui; Cheng, Xiao-Hua; Zhao, Li-Ping; Zhang, Wei; Zhang, Luo; Han, De-Min] Minist Educ, Key Lab Otolaryngol Head & Neck Surg, Beijing 100005, Peoples R China; [Qu, Chun-Yan; Liang, Wei; Long, Mo] China Rehabil Res Ctr Hearing & Speech Impairment, A8, Beijing 100029, Peoples R China; [Chen, Xiao-Wei; Gao, Ru-Zhen; Jiang, Hong] Peking Union Med Coll Hosp, Dept Otorhinolaryngol Head & Neck Surg, Beijing 100730, Peoples R China; [Ma, Fu-Rong; Zhang, Ke] Peking Univ, Dept Otorhinolaryngol Head & Neck Surg, Hosp 3, Beijing 100191, Peoples R China; [Zhang, Jie; Liu, Hai-Hong; Guo, Yong-Li; Zhou, Yi; Hao, Jin-Sheng; Ni, Xin] Capital Med Univ, Beijing Childrens Hosp, Natl Ctr Childrens Hlth, Beijing 100045, Peoples R China; [Xing, Wan-Li; Cheng, Jing] Tsinghua Univ, Dept Biomed Engn, Sch Med, Beijing 100084, Peoples R China; [Xi, Shu-Yan; Lyu, Fan; Jin, Ying-Nan] Beijing Municipal Hlth Commiss, Beijing 100053, Peoples R China; [Ma, Bin-Rong; Zhou, Zhen] Capital Med Univ, Sch Biomed Engn, Beijing 100069, Peoples R China; [Pan, Ying; Zhang, Wan-Xia] Capital Med Univ, Beijing Obstet & Gynecol Hosp, Beijing Maternal & Child Hlth Care Hosp, Dept MCH, Beijing 100026, Peoples R China; [Chang, Liang; Liu, Ping; Qiao, Jie] Peking Univ, Dept Obstet & Gynecol, Ctr Reprod Med, Hosp 3, Beijing 100191, Peoples R China; [Chang, Liang; Liu, Ping; Qiao, Jie] Natl Clin Res Ctr Obstet & Gynecol, Beijing 100191, Peoples R China; [Lu, Hong-Li; Huang, Hai-Meng; Jiang, Di] CapitalBio Corp, Beijing 102206, Peoples R China; [Lu, Hong-Li; Huang, Hai-Meng; Jiang, Di] Natl Engn Res Ctr Beijing Biochip Technol, Beijing 102206, Peoples R China; [Morton, Cynthia Casson] Harvard Med Sch, Dept Obstet & Gynecol & Pathol, Boston, MA 02115 USA; [Morton, Cynthia Casson] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Morton, Cynthia Casson] Univ Manchester, Sch Hlth Sci, Manchester Ctr Audiol & Deafness, Manchester M13 9PL, Lancs, England; [Liu, Xue-Zhong] Univ Miami, Miller Sch Med, Dept Otolaryngol, Miami, FL 33136 USA; [Cheng, Jing] Sichuan Univ, Ctr Precis Med, West China Hosp, Chengdu 610041, Sichuan, Peoples R China	Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Peking University; Capital Medical University; Tsinghua University; Capital Medical University; Capital Medical University; Peking University; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Manchester; University of Miami; Sichuan University	Han, DM (corresponding author), Capital Med Univ, Beijing TongRen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing 100730, Peoples R China.; Han, DM (corresponding author), Minist Educ, Key Lab Otolaryngol Head & Neck Surg, Beijing 100005, Peoples R China.; Cheng, J (corresponding author), Tsinghua Univ, Dept Biomed Engn, Sch Med, Beijing 100084, Peoples R China.; Cheng, J (corresponding author), Sichuan Univ, Ctr Precis Med, West China Hosp, Chengdu 610041, Sichuan, Peoples R China.	jcheng@tsinghua.edu.cn; enthandm@126.com		Yuan, Yongyi/0000-0002-7936-4776; Zhang, Luo/0000-0002-0910-9884	National Key R&D Program, China [2012BAI09B02, 2012AA020101, 2016YFC1000700, 2016YFC1000704, 2018YFC1002200, 2017YFC1001804, 2016YFC1000706, 2018YFC1002100, 2018YFC1003100]; National Natural Science Foundation of China [81870731, 81730029, 61827805, 81873704]; Beijing Natural Science Foundation, China [71922341, 19G10054, 7172052]; China Disabled Persons' Federation [2014zz035]; Capital's Funds for Health Improvement and Research, China [2016-1-5014]; Fostering Funds of Chinese PLA General Hospital for National Distinguished Young Scholar Science Fund [2017-JQPY-001]; National Institute on Deafness and Other Communication Disorders (NIDCD, United States) [R01DC015052]; NIDCD [R01DC005575, R01DC017264, R01DC012115]; University of Manchester National Institute for Health Research Biomedical Research Centre; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC017264, R01DC015052, R01DC005575, R01DC012115] Funding Source: NIH RePORTER	National Key R&D Program, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation, China(Beijing Natural Science Foundation); China Disabled Persons' Federation; Capital's Funds for Health Improvement and Research, China; Fostering Funds of Chinese PLA General Hospital for National Distinguished Young Scholar Science Fund; National Institute on Deafness and Other Communication Disorders (NIDCD, United States); NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); University of Manchester National Institute for Health Research Biomedical Research Centre; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We sincerely thank all subjects and family members for their participation and cooperation in this study. P.D. is supported by National Key R&D Program, China (2016YFC1000700, 2016YFC1000704), National Natural Science Foundation of China (81730029, 61827805), and Beijing Natural Science Foundation, China (19G10054). L.H.H. is supported by National Natural Science Foundation of China (81870730), Beijing Natural Science Foundation, China (7172052), and National Key R&D Program, China (2018YFC1002200). G.J.W. is supported by National Key R&D Program, China (2017YFC1001804). X.G. is supported by National Natural Science Foundation of China (81570929) and Beijing Natural Science Foundation, China (7192234). C.Y.Q. is supported by China Disabled Persons' Federation (2014&zz035). F.R.M. is supported by Capital's Funds for Health Improvement and Research, China (2016-1-5014). Y.Y.Y. is supported by National Key R&D Program, China (2016YFC1000706), National Natural Science Foundation of China (81873704), and Fostering Funds of Chinese PLA General Hospital for National Distinguished Young Scholar Science Fund (2017-JQPY-001). L.C. is supported by National Key R& DProgram, China (2018YFC1003100). S.S.H. is supported by National Natural Science Foundation of China (81870731). P.L. is supported by National Key R&D Program, China (2018YFC1002100). W.L.X. is supported by National Key R&D Program, China(2012BAI09B02, 2012AA020101). C.C.M. is supported by National Institute on Deafness and Other Communication Disorders (NIDCD, United States) grant R01DC015052. X.Z.L. is supported by NIDCD grants R01DC005575, R01DC017264, and R01DC012115. Funding agencies had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication. C. C. M. is supported by National Institute on Deafness and Other Communication Disorders (NIDCD, United States) grant R01DC015052 and by the University of Manchester National Institute for Health Research Biomedical Research Centre.	Barbi M, 2003, PEDIATR INFECT DIS J, V22, P39, DOI 10.1097/00006454-200301000-00012; Chan DK, 2010, GENET MED, V12, P174, DOI 10.1097/GIM.0b013e3181d0d42b; Chu CW, 2015, INT J PEDIATR OTORHI, V79, P584, DOI 10.1016/j.ijporl.2015.01.033; Dai P, 2008, GENET MED, V10, P586, DOI [10.1097/GIM.0b013e31817d2ef1, 10.1097GIM.0b013e31817d2ef1]; Dai P, 2007, GENET MED, V9, P283, DOI 10.1097/GIM.0b013e31804d2371; Dai Pu, 2013, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V48, P973; Dai P, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-26; Dai P, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-74; Fortnum HM, 2001, BRIT MED J, V323, P536, DOI 10.1136/bmj.323.7312.536; Green GE, 2000, JAMA-J AM MED ASSOC, V284, P1245, DOI 10.1001/jama.284.10.1245; Harrison Melody, 2003, Ear and Hearing, V24, P89, DOI 10.1097/01.AUD.0000051749.40991.1F; Huang SS, 2017, INT J PEDIATR OTORHI, V102, P67, DOI 10.1016/j.ijporl.2017.09.001; Kennedy C, 2004, ARCH DIS CHILD-FETAL, V89, pF378, DOI 10.1136/adc.2003.034454; Kim BG, 2013, INT J PEDIATR OTORHI, V77, P833, DOI 10.1016/j.ijporl.2013.02.023; Li CX, 2008, HUM MUTAT, V29, P306, DOI 10.1002/humu.20622; Liu Xin, 2006, Zhonghua Yi Xue Za Zhi, V86, P1318; Minami SB, 2013, GENE, V532, P41, DOI 10.1016/j.gene.2013.08.094; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Nivoloni KDB, 2010, INT J PEDIATR OTORHI, V74, P926, DOI 10.1016/j.ijporl.2010.05.015; Norris VW, 2006, EAR HEARING, V27, P732, DOI 10.1097/01.aud.0000240492.78561.d3; Pagarkar W, 2006, INT J PEDIATR OTORHI, V70, P1119, DOI 10.1016/j.ijporl.2005.10.026; Peng Q, 2016, GENET TEST MOL BIOMA, V20, P603, DOI 10.1089/gtmb.2016.0055; Tsukada K., 2015, ANN OTO RHINOL LARYN, V124, p61S , DOI DOI 10.1177/0003489415575060; Wang GJ, 2008, CHINESE J OTOLOGY, V6, P61; Wang Q, 2019, GENET MED; Wang QJ, 2011, INT J PEDIATR OTORHI, V75, P535, DOI 10.1016/j.ijporl.2011.01.016; Wang S, 2012, J MED MOL BIOL, V10, P10; Wu CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138575; Wu CC, 2017, GENET MED, V19, P6, DOI 10.1038/gim.2016.66; Xia JH, 1998, NAT GENET, V20, P370, DOI 10.1038/3845; Yan YJ, 2013, EUR ARCH OTO-RHINO-L, V270, P2865, DOI 10.1007/s00405-012-2330-y; Yoshida H, 2013, AURIS NASUS LARYNX, V40, P435, DOI 10.1016/j.anl.2013.01.006; Young NM, 2011, ARCH OTOLARYNGOL, V137, P230, DOI 10.1001/archoto.2011.4; Yuan Y, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-79; Zaputovic S, 2005, CROAT MED J, V46, P797; Zhang JQ, 2013, INT J PEDIATR OTORHI, V77, P1929, DOI 10.1016/j.ijporl.2013.08.038	36	33	50	2	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 3	2019	105	4					803	812		10.1016/j.ajhg.2019.09.003	http://dx.doi.org/10.1016/j.ajhg.2019.09.003			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC0EX	31564438	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000488953400010
J	Bosticardo, M; Yamazaki, Y; Cowan, J; Giardino, G; Corsino, C; Scalia, G; Prencipe, R; Ruffner, M; Hill, DA; Sakovich, I; Yemialyanava, I; Tam, JS; Padem, N; Elder, ME; Sleasman, JW; Perez, E; Niebur, H; Seroogy, CM; Sharapova, S; Gebbia, J; Kleiner, GI; Peake, J; Abbott, JK; Gelfand, EW; Crestani, E; Biggs, C; Butte, MJ; Hartog, N; Hayward, A; Chen, K; Heimall, J; Seeborg, F; Bartnikas, LM; Cooper, MA; Pignata, C; Bhandoola, A; Notarangelo, LD				Bosticardo, Marita; Yamazaki, Yasuhiro; Cowan, Jennifer; Giardino, Giuliana; Corsino, Cristina; Scalia, Giulia; Prencipe, Rosaria; Ruffner, Melanie; Hill, David A.; Sakovich, Inga; Yemialyanava, Irma; Tam, Jonathan S.; Padem, Nurcicek; Elder, Melissa E.; Sleasman, John W.; Perez, Elena; Niebur, Hana; Seroogy, Christine M.; Sharapova, Svetlana; Gebbia, Jennifer; Kleiner, Gary Ira; Peake, Jane; Abbott, Jordan K.; Gelfand, Erwin W.; Crestani, Elena; Biggs, Catherine; Butte, Manish J.; Hartog, Nicholas; Hayward, Anthony; Chen, Karin; Heimall, Jennifer; Seeborg, Filiz; Bartnikas, Lisa M.; Cooper, Megan A.; Pignata, Claudio; Bhandoola, Avinash; Notarangelo, Luigi D.			Heterozygous FOXN1 Variants Cause Low TRECs and Severe T Cell Lymphopenia, Revealing a Crucial Role of FOXN1 in Supporting Early Thymopoiesis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							C-KIT; THYMUS; NUDE; MUTATION; IMMUNODEFICIENCY; DEFICIENCY; PHENOTYPE; EXPANSION; ALOPECIA; MOUSE	FOXN1 is the master regulatory gene of thymic epithelium development. FOXN1 deficiency leads to thymic aplasia, alopecia, and nail dystrophy, accounting for the nude/severe combined immunodeficiency (nu/SCID) phenotype in humans and mice. We identified several newborns with low levels of T cell receptor excision circles (TRECs) and T cell lymphopenia at birth, who carried heterozygous loss-of-function FOXN1 variants. Longitudinal analysis showed persistent T cell lymphopenia during infancy, often associated with nail dystrophy. Adult individuals with heterozygous FOXN1 variants had in most cases normal CD4(+) but lower than normal CD8(+) cell counts. We hypothesized a FOXN1 gene dosage effect on the function of thymic epithelial cells (TECs) and thymopoiesis and postulated that these effects would be more prominent early in life. To test this hypothesis, we analyzed TEC subset frequency and phenotype, early thymic progenitor (ETP) cell count, and expression of FOXN1 target genes (Ccl25, Cxcl12, Dll4, Scf, Psmb11, Prss16, and Cd83) in Foxn1(nu/+) (nu/+) mice and age-matched wild-type (+/+) littermate controls. Both the frequency and the absolute count of ETP were significantly reduced in nu/+ mice up to 3 weeks of age. Analysis of the TEC compartment showed reduced expression of FOXN1 target genes and delayed maturation of the medullary TEC compartment in nu/+ mice. These observations establish a FOXN1 gene dosage effect on thymic function and identify FOXN1 haploinsufficiency as an important genetic determinant of T cell lymphopenia at birth.	[Bosticardo, Marita; Yamazaki, Yasuhiro; Corsino, Cristina; Notarangelo, Luigi D.] NIAID, Lab Clin Immunol & Microbiol, IDGS, DIR,NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Cowan, Jennifer; Bhandoola, Avinash] NCI, Lab Genome Integr, CCR, NIH, Bethesda, MD 20892 USA; [Giardino, Giuliana; Prencipe, Rosaria; Pignata, Claudio] Univ Naples Federico II, Dept Translat Med Sci, I-80138 Naples, Italy; [Scalia, Giulia] CEINGE Biotecnol Avanzate, Lab Clin Res & Adv Diagnost, I-80131 Naples, Italy; [Ruffner, Melanie; Hill, David A.; Heimall, Jennifer] Childrens Hosp Philadelphia, Dept Pediat, Div Allergy & Immunol, Philadelphia, PA 19104 USA; [Sakovich, Inga; Yemialyanava, Irma; Sharapova, Svetlana] Belarusian Res Ctr Pediat Oncol Hematol & Immunol, Immunol Lab, Minsk 223053, BELARUS; [Tam, Jonathan S.] Childrens Hosp Los Angeles, Div Clin Immunol & Allergy, Los Angeles, CA 90027 USA; [Padem, Nurcicek] Lurie Childrens Hosp, Div Allergy & Immunol, Chicago, IL 60611 USA; [Elder, Melissa E.] Univ Florida, Dept Pediat, Div Allergy Immunol & Rheumatol, Gainesville, FL 32610 USA; [Sleasman, John W.] Duke Univ, Sch Med, Dept Pediat, Div Allergy Immunol & Pulm Med, Durham, NC 27705 USA; [Perez, Elena] Allergy Associates Palm Beaches, North Palm Beach, FL 33408 USA; [Niebur, Hana] Univ Nebraska, Med Ctr, Div Pediat Allergy & Immunol, 600 S 42nd St, Omaha, NE 68198 USA; [Seroogy, Christine M.] Univ Wisconsin, Sch Med & Publ Hlth, Div Pediat Allergy & Immunol, Madison, WI 53792 USA; [Gebbia, Jennifer; Kleiner, Gary Ira] Univ Miami, Miller Sch Med, Dept Pediat Allergy & Immunol, Miami, FL 33136 USA; [Peake, Jane] Univ Queensland, Sch Med, Lady Cilento Childrens Hosp, Div Paediat Immunol & Allergy, South Brisbane, Qld 4101, Australia; [Abbott, Jordan K.; Gelfand, Erwin W.] Natl Jewish Hlth, Dept Pediat, Immunodeficiency Diag & Treatment Program, Denver, CO 80206 USA; [Crestani, Elena; Biggs, Catherine; Bartnikas, Lisa M.] Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [Biggs, Catherine] Univ British Columbia, British Columbia Childrens Hosp, Dept Pediat, Vancouver, BC V6H 0B3, Canada; [Butte, Manish J.] Univ Calif Los Angeles, Div Allergy Immunol & Rheumatol, Los Angeles, CA 90095 USA; [Hartog, Nicholas] Spectrum Hlth Allergy & Immunol, Grand Rapids, MI 49525 USA; [Hayward, Anthony] Brown Univ, Dept Pediat, Div Allergy & Immunol, Providence, RI 02905 USA; [Hayward, Anthony] Isl Hosp, Providence, RI 02905 USA; [Chen, Karin] Univ Utah, Dept Pediat, Div Allergy & Immunol, Salt Lake City, UT 84112 USA; [Seeborg, Filiz] Texas Childrens Hosp, Dept Pediat, Sect Allergy Immunol & Rheumatol, Houston, TX 77030 USA; [Seeborg, Filiz] Texas Childrens Hosp, Ctr Human Immunobiol, Dept Pediat, Houston, TX 77030 USA; [Cooper, Megan A.] Washington Univ, Div Rheumatol, Dept Pediat, St Louis, MO 63110 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Naples Federico II; CEINGE Biotecnologie Avanzate; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Children's Hospital Los Angeles; Ann & Robert H. Lurie Children's Hospital of Chicago; State University System of Florida; University of Florida; Duke University; University of Nebraska System; University of Nebraska Medical Center; University of Wisconsin System; University of Wisconsin Madison; University of Miami; University of Queensland; National Jewish Health; Harvard University; Boston Children's Hospital; BC Childrens Hospital; University of British Columbia; University of California System; University of California Los Angeles; Brown University; Utah System of Higher Education; University of Utah; Baylor College of Medicine; Baylor College of Medicine; Washington University (WUSTL)	Notarangelo, LD (corresponding author), NIAID, Lab Clin Immunol & Microbiol, IDGS, DIR,NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	luigi.notarangelo@nih.gov	Sharapova, Svetlana/ABF-3330-2020; Abbott, Jordan K/P-2509-2016; Prencipe, Rosaria/AAJ-7535-2020; Butte, Manish/AAM-8604-2020; Butte, Manish/T-8860-2019; Giardino, Giuliana/AAF-9841-2021; Giardino, Giuliana/AAC-2008-2019; Bosticardo, Marita/ABA-2688-2021	Abbott, Jordan K/0000-0001-6334-5266; Butte, Manish/0000-0002-4490-5595; Butte, Manish/0000-0002-4490-5595; Bosticardo, Marita/0000-0002-1771-4523; Biggs, Catherine/0000-0002-4363-2660; Cooper, Megan/0000-0002-5696-172X; Hill, David/0000-0001-9286-4268; Ruffner, Melanie/0000-0002-2943-9944; Peake, Jane/0000-0001-9003-5861	Intramural Research Program of the DIR, NIAID, NIH; Center for Clinical and Translational Research at Brown University [GM115677]; Center for Cancer Research, National Cancer Institute, National Institutes of Health; Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies at St. Louis Children's Hospital; Michael Smith Foundation for Health Research Health Professional-Investigator Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK116668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM115677] Funding Source: NIH RePORTER	Intramural Research Program of the DIR, NIAID, NIH; Center for Clinical and Translational Research at Brown University; Center for Cancer Research, National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies at St. Louis Children's Hospital; Michael Smith Foundation for Health Research Health Professional-Investigator Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Intramural Research Program of the DIR, NIAID, NIH, by Center for Clinical and Translational Research at Brown University (GM115677), the Center for Cancer Research, National Cancer Institute, National Institutes of Health, and by the Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies at St. Louis Children's Hospital. C.B. is supported by a Michael Smith Foundation for Health Research Health Professional-Investigator Award.	Adriani M, 2004, ANN HUM GENET, V68, P265, DOI 10.1046/j.1529-8817.2004.00091.x; Albuquerque AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037042; Auricchio L, 2005, ARCH DERMATOL, V141, P647, DOI 10.1001/archderm.141.5.647; Bajoghli B, 2009, CELL, V138, P186, DOI 10.1016/j.cell.2009.04.017; Bleul CC, 2000, EUR J IMMUNOL, V30, P3371, DOI 10.1002/1521-4141(2000012)30:12<3371::AID-IMMU3371>3.0.CO;2-L; Chen LZ, 2009, BLOOD, V113, P567, DOI 10.1182/blood-2008-05-156265; Cheng LL, 2010, J BIOL CHEM, V285, P5836, DOI 10.1074/jbc.M109.072124; Chou J, 2014, CLIN IMMUNOL, V155, P30, DOI 10.1016/j.clim.2014.08.005; D'Assante R, 2016, INT REV IMMUNOL, V35, P25, DOI 10.3109/08830185.2015.1010724; Devi ARR, 2017, GENE, V627, P222, DOI 10.1016/j.gene.2017.06.033; Farley AM, 2013, DEVELOPMENT, V140, P2015, DOI 10.1242/dev.087320; FLANAGAN SP, 1966, GENET RES, V8, P295, DOI 10.1017/S0016672300010168; Frank J, 1999, NATURE, V398, P473, DOI 10.1038/18997; Gallo V, 2017, J CLIN IMMUNOL, V37, P751, DOI 10.1007/s10875-017-0445-z; Gordon J, 2001, MECH DEVELOP, V103, P141, DOI 10.1016/S0925-4773(01)00333-1; Gray D, 2007, J EXP MED, V204, P2521, DOI 10.1084/jem.20070795; Hozumi K, 2008, J EXP MED, V205, P2507, DOI 10.1084/jem.20080134; Kaufmann E, 1996, MECH DEVELOP, V57, P3, DOI 10.1016/0925-4773(96)00539-4; KOJIMA A, 1984, EXP CELL BIOL, V52, P107; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; Levy E, 2012, ANN DERMATOL VENER, V139, P468, DOI 10.1016/j.annder.2012.03.014; Markert ML, 2011, BLOOD, V117, P688, DOI 10.1182/blood-2010-06-292490; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; Newman JA, 2018, BIORXIV, DOI [10.1101/428011, DOI 10.1101/428011]; Nowell CS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002348; Pignata C, 1996, AM J MED GENET, V65, P167, DOI 10.1002/(SICI)1096-8628(19961016)65:2<167::AID-AJMG17>3.0.CO;2-O; Pignata C, 2001, BLOOD, V97, P880, DOI 10.1182/blood.V97.4.880; RODEWALD HR, 1995, IMMUNITY, V3, P313, DOI 10.1016/1074-7613(95)90116-7; Rodewald HR, 1997, IMMUNITY, V6, P265, DOI 10.1016/S1074-7613(00)80329-5; SCHEIFF JM, 1978, ANAT EMBRYOL, V153, P115, DOI 10.1007/BF00343368; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Tsukamoto N, 2005, CELL IMMUNOL, V234, P77, DOI 10.1016/j.cellimm.2005.06.009; Zampieri M, 2015, MECH AGEING DEV, V151, P60, DOI 10.1016/j.mad.2015.02.002; Zuklys S, 2016, NAT IMMUNOL, V17, P1206, DOI 10.1038/ni.3537	36	33	34	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 5	2019	105	3					549	561		10.1016/j.ajhg.2019.07.014	http://dx.doi.org/10.1016/j.ajhg.2019.07.014			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IV7GX	31447097	Green Published, Bronze			2022-12-18	WOS:000484435700009
J	Nicoli, ER; Weston, MR; Hackbarth, M; Becerril, A; Larson, A; Zein, WM; Baker, PR; Burke, JD; Dorward, H; Davids, M; Huang, Y; Adams, DR; Zerfas, PM; Chen, D; Markello, TC; Toro, C; Wood, T; Elliott, G; Vu, M; Zheng, W; Garrett, LJ; Tifft, CJ; Gahl, WA; Day-Salvatore, DL; Mindell, JA; Malicdan, MCV				Nicoli, Elena-Raluca; Weston, Mary R.; Hackbarth, Mary; Becerril, Alissa; Larson, Austin; Zein, Wadih M.; Baker, Peter R., II; Burke, John Douglas; Dorward, Heidi; Davids, Mariska; Huang, Yan; Adams, David R.; Zerfas, Patricia M.; Chen, Dong; Markello, Thomas C.; Toro, Camilo; Wood, Tim; Elliott, Gene; Vu, Mylinh; Zheng, Wei; Garrett, Lisa J.; Tifft, Cynthia J.; Gahl, William A.; Day-Salvatore, Debra L.; Mindell, Joseph A.; Malicdan, May Christine V.		Undiagnosed Dis Network	Lysosomal Storage and Albinism Due to Effects of a De Novo CLCN7 Variant on Lysosomal Acidification	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHLORIDE CHANNEL; REQUIRES OSTM1; OSTEOPETROSIS; CLC-7; MUTATIONS; DISEASE; LEADS; MEMBRANE; VESICLES; SUBUNIT	Optimal lysosome function requires maintenance of an acidic pH maintained by proton pumps in combination with a counterion transporter such as the Cl-/H+ exchanger, CLCN7 (ClC-7), encoded by CLCN7. The role of ClC-7 in maintaining lysosomal pH has been controversial. In this paper, we performed clinical and genetic evaluations of two children of different ethnicities. Both children had delayed myelination and development, organomegaly, and hypopigmentation, but neither had osteopetrosis. Whole-exome and -genome sequencing revealed a de novo c.2144A>G variant in CLCN7 in both affected children. This p.Tyr715Cys variant, located in the C-terminal domain of ClC-7, resulted in increased outward currents when it was heterologously expressed in Xenopus oocytes. Fibroblasts from probands displayed a lysosomal pH approximately 0.2 units lower than that of control cells, and treatment with chloroquine normalized the pH. Primary fibroblasts from both probands also exhibited markedly enlarged intracellular vacuoles; this finding was recapitulated by the overexpression of human p.Tyr715Cys CLCN7 in control fibroblasts, reflecting the dominant, gain-of-function nature of the variant. A mouse harboring the knock-in Clcn7 variant exhibited hypopigmentation, hepatomegaly resulting from abnormal storage, and enlarged vacuoles in cultured fibroblasts. Our results show that p.Tyr715Cys is a gain-of-function CLCN7 variant associated with developmental delay, organomegaly, and hypopigmentation resulting from lysosomal hyperacidity, abnormal storage, and enlarged intracellular vacuoles. Our data supports the hypothesis that the ClC-7 antiporter plays a critical role in maintaining lysosomal pH.	[Nicoli, Elena-Raluca; Hackbarth, Mary; Davids, Mariska; Huang, Yan; Adams, David R.; Markello, Thomas C.; Toro, Camilo; Tifft, Cynthia J.; Gahl, William A.; Malicdan, May Christine V.] NHGRI, Undiagnosed Dis Program, NIH, Bethesda, MD 20892 USA; [Nicoli, Elena-Raluca; Hackbarth, Mary; Davids, Mariska; Huang, Yan; Adams, David R.; Markello, Thomas C.; Toro, Camilo; Tifft, Cynthia J.; Gahl, William A.; Malicdan, May Christine V.] NIH, Common Fund, Off Director, Bethesda, MD 20892 USA; [Weston, Mary R.; Becerril, Alissa; Mindell, Joseph A.] NINDS, Membrane Transport Biophys Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Larson, Austin; Baker, Peter R., II] Univ Colorado, Sch Med, Dept Pediat, Sect Genet, Aurora, CO 80045 USA; [Zein, Wadih M.] NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA; [Burke, John Douglas; Dorward, Heidi; Gahl, William A.; Malicdan, May Christine V.] NHGRI, Human Biochem Genet Sect, NIH, Bethesda, MD 20892 USA; [Adams, David R.; Markello, Thomas C.; Toro, Camilo; Tifft, Cynthia J.; Gahl, William A.; Malicdan, May Christine V.] NHGRI, Off Clin Director, NIH, Bethesda, MD 20892 USA; [Zerfas, Patricia M.] NIH, Diagnost & Res Serv Branch, Off Res Serv, Bldg 10, Bethesda, MD 20892 USA; [Chen, Dong] Mayo Clin, Dept Lab Med & Pathol, Div Hematopathol, Rochester, MN 55905 USA; [Wood, Tim] Greenwood Genet Ctr, Metab Lab, Greenwood, SC 29646 USA; [Elliott, Gene; Garrett, Lisa J.] NHGRI, Embryon Stem Cell & Transgen Mouse Core, NIH, Bethesda, MD 20892 USA; [Vu, Mylinh; Zheng, Wei] NIH, Natl Ctr Translat Sci, Rockville, MD 20850 USA; [Undiagnosed Dis Network] NIH, Undiagnosed Dis Network, Common Fund, Off Director, Bldg 10, Bethesda, MD 20892 USA; [Day-Salvatore, Debra L.] St Peters Univ Hosp, Dept Med Genet & Genom Med, New Brunswick, NJ 08901 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Colorado System; University of Colorado Anschutz Medical Campus; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; Mayo Clinic; Greenwood Genetic Center; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; Saint Peter's University Hospital	Malicdan, MCV (corresponding author), NHGRI, Undiagnosed Dis Program, NIH, Bethesda, MD 20892 USA.; Malicdan, MCV (corresponding author), NIH, Common Fund, Off Director, Bethesda, MD 20892 USA.; Mindell, JA (corresponding author), NINDS, Membrane Transport Biophys Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.; Malicdan, MCV (corresponding author), NHGRI, Human Biochem Genet Sect, NIH, Bethesda, MD 20892 USA.; Malicdan, MCV (corresponding author), NHGRI, Off Clin Director, NIH, Bethesda, MD 20892 USA.	mindellj@ninds.nih.gov; malicdanm@mail.nih.gov	Zheng, Wei/GOE-5990-2022; Adams, David/ABC-7557-2021; Malicdan, May Christine/AAK-7422-2021; Zheng, Wei/J-8889-2014; Nicoli, Elena-Raluca/F-3968-2011; Larson, Austin/AAN-8673-2021; Larson, Austin/GZG-9853-2022; Zheng, Wei/GQQ-8951-2022; Chen, Dong/V-8825-2019	Zheng, Wei/0000-0003-1034-0757; Nicoli, Elena-Raluca/0000-0002-5545-630X; Larson, Austin/0000-0002-2079-6929; Lanza, Ian/0000-0002-9858-3384; Azamian, Mahshid/0000-0002-8543-8284; Wheeler, Matthew/0000-0001-8721-3022; Hackbarth, Mary/0000-0003-1325-3165; Haendel, Melissa/0000-0001-9114-8737; Stong, Nicholas/0000-0002-0678-637X; Brown, Donna/0000-0002-8805-7225; Bademci, Guney/0000-0002-4052-8833; Oglesbee, Devin/0000-0002-7147-5527; Fisher, Paul/0000-0002-1196-1590; McCauley, Jacob/0000-0002-1805-1733; Douine, Emilie/0000-0002-6048-2887; Urv, Tiina/0000-0002-2040-4972	National Human Genome Research Institute (NHGRI); National Institute of Neurological Disorders and Stroke; National Institutes of Health (NIH) Undiagnosed Diseases Program, part of the Undiagnosed Diseases Network; Common Fund, Office of the Director, NIH; Special Child Health and Early Intervention Services, New Jersey Department of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZICHG200349, ZIAHG200402, ZIAHG000215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003015] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health (NIH) Undiagnosed Diseases Program, part of the Undiagnosed Diseases Network; Common Fund, Office of the Director, NIH; Special Child Health and Early Intervention Services, New Jersey Department of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the probands, their families, and the treating physicians for their cooperation, encouragement, and interest. This work was supported by the Intramural Research Programs of the National Human Genome Research Institute (NHGRI) and the National Institute of Neurological Disorders and Stroke; the National Institutes of Health (NIH) Undiagnosed Diseases Program, part of the Undiagnosed Diseases Network, was supported by the Common Fund, Office of the Director, NIH. St. Peter's University Hospital is a designated regional center for general genetic and newborn screening services in New Jersey and is supported, in part, by Special Child Health and Early Intervention Services, New Jersey Department of Health. We thank Emyr Lloyd-Evans for his insightful comments on this manuscript and both the biochemical genetics laboratory at the Greenwood genetic center and Laura Pollard for their help with the measurement of lysosomal enzymes. The CD63 (H5C6), Lamp1 (H4A3), and Lamp2 (H4B4) antibodies developed by J.T. August and J.E.K. Hildreth (Johns Hopkins University School of Medicine) were obtained from the Developmental Studies Hybridoma Bank, created by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the NIH and maintained at the University of Iowa, Department of Biology. We thank TimWood (Greenwood Genetics) for fibroblasts from proband 2 and Forbes Porter, NICHD, for the NPC25 fibroblast line; Cecilia Rivas and Karen Hazzard (NHGRI, NIH) for their assistance in mouse generation; and Calvin Johnson and Huey Cheung, NIH Center for Information Technology, for developing the software used for lysosomal pH quantification.	Ancans J, 2001, EXP CELL RES, V268, P26, DOI 10.1006/excr.2001.5251; Behringer R., 2014, MANIPULATING MOUSE E, V4; Chalhoub N, 2003, NAT MED, V9, P399, DOI 10.1038/nm842; Cleiren E, 2001, HUM MOL GENET, V10, P2861, DOI 10.1093/hmg/10.25.2861; Devuyst O, 1999, HUM MOL GENET, V8, P247, DOI 10.1093/hmg/8.2.247; Gahl WA, 2016, MOL GENET METAB, V117, P393, DOI 10.1016/j.ymgme.2016.01.007; Gahl WA, 2015, JAMA-J AM MED ASSOC, V314, P1797, DOI 10.1001/jama.2015.12249; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; Hamer I, 2012, CURR DRUG METAB, V13, P1371, DOI 10.2174/138920012803762684; Jentsch TJ, 2007, J PHYSIOL-LONDON, V578, P633, DOI 10.1113/jphysiol.2006.124719; Jentsch TJ, 2005, ANNU REV PHYSIOL, V67, P779, DOI 10.1146/annurev.physiol.67.032003.153245; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; KIEFERLE S, 1994, P NATL ACAD SCI USA, V91, P6943, DOI 10.1073/pnas.91.15.6943; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Kuronita T, 2002, J CELL SCI, V115, P4117, DOI 10.1242/jcs.00075; Lange PF, 2006, NATURE, V440, P220, DOI 10.1038/nature04535; Leisle L, 2011, EMBO J, V30, P2140, DOI 10.1038/emboj.2011.137; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Lu YY, 2014, AUTOPHAGY, V10, P1895, DOI 10.4161/auto.32200; Majumdar A, 2011, MOL BIOL CELL, V22, P1664, DOI 10.1091/mbc.E10-09-0745; Malicdan MCV, 2015, J MED GENET, V52, P830, DOI 10.1136/jmedgenet-2015-103316; Mindell JA, 2012, ANNU REV PHYSIOL, V74, P69, DOI 10.1146/annurev-physiol-012110-142317; Mohammad-Panah R, 2002, J BIOL CHEM, V277, P566, DOI 10.1074/jbc.M106968200; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Poet M, 2006, P NATL ACAD SCI USA, V103, P13854, DOI 10.1073/pnas.0606137103; Sanchez CE, 2012, DEV PSYCHOBIOL, V54, P77, DOI 10.1002/dev.20579; Steinberg BE, 2010, J CELL BIOL, V189, P1171, DOI 10.1083/jcb.200911083; STEINMEYER K, 1991, NATURE, V354, P301, DOI 10.1038/354301a0; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; THIEMANN A, 1992, NATURE, V356, P57, DOI 10.1038/356057a0; TYCKO B, 1983, J CELL BIOL, V97, P1762, DOI 10.1083/jcb.97.6.1762; UCHIDA S, 1994, J BIOL CHEM, V269, P19192; Vilboux T, 2016, J MED GENET, V53, P318, DOI 10.1136/jmedgenet-2015-103416; Weinert S, 2010, SCIENCE, V328, P1401, DOI 10.1126/science.1188072; Xiong J, 2016, SCI CHINA LIFE SCI, V59, P777, DOI 10.1007/s11427-016-5090-x	35	33	33	3	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 6	2019	104	6					1127	1138		10.1016/j.ajhg.2019.04.008	http://dx.doi.org/10.1016/j.ajhg.2019.04.008			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IB4KJ	31155284	Green Published, Bronze			2022-12-18	WOS:000470240000009
J	Cheng, HY; Dharmadhikari, AV; Varland, S; Ma, N; Domingo, D; Kleyner, R; Rope, AF; Yoon, M; Stray-Pedersen, A; Posey, JE; Crews, SR; Eldomery, MK; Akdemir, ZC; Lewis, AM; Sutton, VR; Rosenfeld, JA; Conboy, E; Agre, K; Xia, F; Walkiewicz, M; Longoni, M; High, FA; van Slegtenhorst, MA; Mancini, GMS; Finnila, CR; van Haeringen, A; den Hollander, N; Ruivenkamp, C; Naidu, S; Mahida, S; Palmer, EE; Murray, L; Lim, D; Jayakar, P; Parker, MJ; Giusto, S; Stracuzzi, E; Romano, C; Beighley, JS; Bernier, RA; Kury, S; Nizon, M; Corbett, MA; Shaw, M; Gardner, A; Barnett, C; Armstrong, R; Kassahn, KS; Van Dijck, A; Vandeweyer, G; Kleefstra, T; Schieving, J; Jongmans, MJ; de Vries, BBA; Pfundt, R; Kerr, B; Rojas, SK; Boycott, KM; Person, R; Willaert, R; Eichler, EE; Kooy, RF; Yang, YP; Wu, JC; Lupski, JR; Arnesen, T; Cooper, GM; Chung, WK; Gecz, J; Stessman, HAF; Meng, LY; Lyon, GJ				Cheng, Hanyin; Dharmadhikari, Avinash V.; Varland, Sylvia; Ma, Ning; Domingo, Deepti; Kleyner, Robert; Rope, Alan F.; Yoon, Margaret; Stray-Pedersen, Asbjorg; Posey, Jennifer E.; Crews, Sarah R.; Eldomery, Mohammad K.; Akdemir, Zeynep Coban; Lewis, Andrea M.; Sutton, Vernon R.; Rosenfeld, Jill A.; Conboy, Erin; Agre, Katherine; Xia, Fan; Walkiewicz, Magdalena; Longoni, Mauro; High, Frances A.; van Slegtenhorst, Marjon A.; Mancini, Grazia M. S.; Finnila, Candice R.; van Haeringen, Arie; den Hollander, Nicolette; Ruivenkamp, Claudia; Naidu, Sakkubai; Mahida, Sonal; Palmer, Elizabeth E.; Murray, Lucinda; Lim, Derek; Jayakar, Parul; Parker, Michael J.; Giusto, Stefania; Stracuzzi, Emanuela; Romano, Corrado; Beighley, Jennifer S.; Bernier, Raphael A.; Kury, Sebastien; Nizon, Mathilde; Corbett, Mark A.; Shaw, Marie; Gardner, Alison; Barnett, Christopher; Armstrong, Ruth; Kassahn, Karin S.; Van Dijck, Anke; Vandeweyer, Geert; Kleefstra, Tjitske; Schieving, Jolanda; Jongmans, Marjolijn J.; de Vries, Bert B. A.; Pfundt, Rolph; Kerr, Bronwyn; Rojas, Samantha K.; Boycott, Kym M.; Person, Richard; Willaert, Rebecca; Eichler, Evan E.; Kooy, R. Frank; Yang, Yaping; Wu, Joseph C.; Lupski, James R.; Arnesen, Thomas; Cooper, Gregory M.; Chung, Wendy K.; Gecz, Jozef; Stessman, Holly A. F.; Meng, Linyan; Lyon, Gholson J.			Truncating Variants in NAA15 Are Associated with Variable Levels of Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							N-TERMINAL ACETYLATION; ARF-LIKE GTPASE; ACETYLTRANSFERASE 10 PROTEIN; DE-NOVO MUTATIONS; SACCHAROMYCES-CEREVISIAE; CELLULAR-PROTEINS; HEART-DISEASE; GENES; IDENTIFICATION; MODEL	N-alpha-acetylation is a common co-translational protein modification that is essential for normal cell function in humans. We previously identified the genetic basis of an X-linked infantile lethal Mendelian disorder involving a c.109T>C (p.Ser37Pro) missense variant in NAA10, which encodes the catalytic subunit of the N-terminal acetyltransferase A (NatA) complex. The auxiliary subunit of the NatA complex, NAA15, is the dimeric binding partner for NAA10. Through a genotype-first approach with whole-exome or genome sequencing (WES/WGS) and targeted sequencing analysis, we identified and phenotypically characterized 38 individuals from 33 unrelated families with 25 different de novo or inherited, dominantly acting likely gene disrupting (LGD) variants in NAA15. Clinical features of affected individuals with LGD variants in NAA15 include variable levels of intellectual disability, delayed speech and motor milestones, and autism spectrum disorder. Additionally, mild craniofacial dysmorphology, congenital cardiac anomalies, and seizures are present in some subjects. RNA analysis in cell lines from two individuals showed degradation of the transcripts with LGD variants, probably as a result of nonsense-mediated decay. Functional assays in yeast confirmed a deleterious effect for two of the LGD variants in NAA15. Further supporting a mechanism of haploinsufficiency, individuals with copy-number variant (CNV) deletions involving NAA15 and surrounding genes can present with mild intellectual disability, mild dysmorphic features, motor delays, and decreased growth. We propose that defects in NatA-mediated N-terminal acetylation (NTA) lead to variable levels of neurodevelopmental disorders in humans, supporting the importance of the NatA complex in normal human development.	[Cheng, Hanyin; Dharmadhikari, Avinash V.; Crews, Sarah R.; Xia, Fan; Walkiewicz, Magdalena; Yang, Yaping; Meng, Linyan] Baylor Genet, Houston, TX 77021 USA; [Varland, Sylvia; Arnesen, Thomas] Univ Bergen, Dept Biomed, N-5020 Bergen, Norway; [Ma, Ning; Wu, Joseph C.] Stanford Univ, Sch Med, Stanford Cardiovasc Inst, Stanford, CA 94305 USA; [Ma, Ning; Wu, Joseph C.] Stanford Univ, Sch Med, Dept Med, Div Cardiol, Stanford, CA 94305 USA; [Ma, Ning; Wu, Joseph C.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Domingo, Deepti; Gecz, Jozef] Univ Adelaide, Fac Genes & Evolut, Sch Biol Sci, Adelaide, SA 5000, Australia; [Kleyner, Robert; Yoon, Margaret; Lyon, Gholson J.] Cold Spring Harbor Lab, Stanley Inst Cognit Gen, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA; [Rope, Alan F.] Kaiser Permanente Northwest, Dept Med Genet, Portland, OR 97227 USA; [Stray-Pedersen, Asbjorg; Posey, Jennifer E.; Eldomery, Mohammad K.; Akdemir, Zeynep Coban; Lewis, Andrea M.; Sutton, Vernon R.; Rosenfeld, Jill A.; Xia, Fan; Walkiewicz, Magdalena; Yang, Yaping; Lupski, James R.; Meng, Linyan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Stray-Pedersen, Asbjorg] Oslo Univ Hosp, Div Pediat & Adolescent Med, Norwegian Natl Unit Newborn Screening, N-0424 Oslo, Norway; [Stray-Pedersen, Asbjorg] Univ Oslo, Inst Clin Med, N-0318 Oslo, Norway; [Stessman, Holly A. F.] Creighton Univ, Med Sch, Dept Pharmacol, Omaha, NE 68178 USA; [Lewis, Andrea M.] Texas Childrens Hosp, Dept Pediat, Houston, TX 77030 USA; [Lewis, Andrea M.] Baylor Coll Med, Houston, TX 77030 USA; [Conboy, Erin; Agre, Katherine] Mayo Clin, Dept Clin Genom, Rochester, MN 55905 USA; [Walkiewicz, Magdalena] NIH, NIAID, Bldg 10, Bethesda, MD 20892 USA; [Longoni, Mauro; High, Frances A.] Massachusetts Gen Hosp, Pediat Surg Res Labs, Boston, MA 02114 USA; [Longoni, Mauro] Harvard Med Sch, Dept Surg, Boston, MA 02114 USA; [High, Frances A.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [High, Frances A.] Boston Childrens Hosp, Dept Surg, Boston, MA 02115 USA; [van Slegtenhorst, Marjon A.; Mancini, Grazia M. S.] Erasmus Univ, Med Ctr, Dept Clin Genet, NL-3015 CN Rotterdam, Netherlands; [Finnila, Candice R.; Cooper, Gregory M.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [van Haeringen, Arie; den Hollander, Nicolette; Ruivenkamp, Claudia] Leiden Univ, Med Ctr, Dept Clin Genet, NL-2333 Leiden, Netherlands; [Naidu, Sakkubai; Mahida, Sonal] Kennedy Krieger Inst, 801 North Broadway, Baltimore, MD 21205 USA; [Palmer, Elizabeth E.; Murray, Lucinda] Hunter Genet, Genet Learning Disabil Serv, Waratah, NSW 2298, Australia; [Palmer, Elizabeth E.] Univ New South Wales, Sch Womens & Childrens Hlth, Sydney, NSW 2031, Australia; [Lim, Derek] Birmingham Womens & Childrens NHS Fdn Trust, West Midlands Reg Genet Serv, Mindelsohn Way, Birmingham B15 2TG, W Midlands, England; [Jayakar, Parul] Nicklaus Childrens Hosp, Div Genet & Metab, Miami, FL 33155 USA; [Parker, Michael J.] Sheffield Childrens Hosp, Sheffield Clin Genet Serv, Sheffield S10 2TH, S Yorkshire, England; [Giusto, Stefania; Stracuzzi, Emanuela; Romano, Corrado] Ist Ricovero Cura Carattere Sci, Oasi Res Inst, I-94018 Troina, Italy; [Beighley, Jennifer S.; Bernier, Raphael A.] Univ Washington, Dept Psychiat, Seattle, WA 98195 USA; [Kury, Sebastien; Nizon, Mathilde] CHU Nantes, Dept Med Genet, F-44093 Nantes, France; [Corbett, Mark A.; Shaw, Marie; Gardner, Alison; Gecz, Jozef] Univ Adelaide, Adelaide Med Sch, Adelaide, SA 5000, Australia; [Corbett, Mark A.; Shaw, Marie; Gardner, Alison; Gecz, Jozef] Univ Adelaide, Robinson Res Inst, Adelaide, SA 5000, Australia; [Barnett, Christopher] Womens & Childrens Hosp, SA Pathol, South Australian Clin Genet Serv, Paediat & Reprod Genet, Adelaide, SA 5006, Australia; [Armstrong, Ruth] Addenbrookes Hosp, Addenbrookes Treatment Ctr, Clin Genet, East Anglian Med Genet Serv, Cambridge CB2 0QQ, England; [Kassahn, Karin S.] Womens & Childrens Hosp, Dept Genet & Mol Pathol, SA Pathol, Adelaide, SA 5006, Australia; [Kassahn, Karin S.] Univ Adelaide, Sch Biol Sci, Adelaide, SA 5000, Australia; [Van Dijck, Anke; Vandeweyer, Geert; Kooy, R. Frank] Univ Antwerp, Dept Med Genet, B-2000 Antwerp, Belgium; [Kleefstra, Tjitske; Schieving, Jolanda; Jongmans, Marjolijn J.; de Vries, Bert B. A.; Pfundt, Rolph] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Kerr, Bronwyn] St Marys Hosp, Manchester Univ NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester Ctr Genom Med, Manchester M13 9PL, Lancs, England; [Kerr, Bronwyn] Univ Manchester, Sch Biol Sci, Div Evolut & Genom Sci, Manchester M13 9PL, Lancs, England; [Rojas, Samantha K.; Boycott, Kym M.] Univ Ottawa, Childrens Hosp, Eastern Ontario Res Inst, Ottawa, ON K1H 8L1, Canada; [Person, Richard; Willaert, Rebecca] GeneDx, 207 Perry Pkwy, Gaithersburg, MD 20877 USA; [Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Lupski, James R.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Varland, Sylvia; Arnesen, Thomas] Haukeland Hosp, Dept Surg, N-5021 Bergen, Norway; [Arnesen, Thomas] Univ Bergen, Dept Mol Biol, N-5020 Bergen, Norway; [Chung, Wendy K.] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA; [Chung, Wendy K.] Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA; [Chung, Wendy K.] South Australian Hlth & Med Res Inst, Healthy Mothers Babies & Children, Adelaide, SA 5000, Australia	University of Bergen; Stanford University; Stanford University; Stanford University; University of Adelaide; Cold Spring Harbor Laboratory; Kaiser Permanente; Baylor College of Medicine; University of Oslo; University of Oslo; Creighton University; Baylor College of Medicine; Baylor College of Medicine; Mayo Clinic; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Erasmus University Rotterdam; Erasmus MC; HudsonAlpha Institute for Biotechnology; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Kennedy Krieger Institute; University of New South Wales Sydney; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; University of Washington; University of Washington Seattle; Nantes Universite; CHU de Nantes; University of Adelaide; Robinson Research Institute; University of Adelaide; SA Pathology; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; SA Pathology; University of Adelaide; University of Antwerp; Radboud University Nijmegen; University of Manchester; University of Manchester; University of Ottawa; Children's Hospital of Eastern Ontario; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Baylor College of Medicine; University of Bergen; Haukeland University Hospital; University of Bergen; Columbia University; Columbia University; South Australian Health & Medical Research Institute (SAHMRI)	Meng, LY (corresponding author), Baylor Genet, Houston, TX 77021 USA.; Lyon, GJ (corresponding author), Cold Spring Harbor Lab, Stanley Inst Cognit Gen, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.; Meng, LY (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	lmeng@bcm.edu; gholsonjlyon@gmail.com	Palmer, Emma/AAH-4947-2021; Kooy, Frank/F-5276-2014; Dharmadhikari, Avinash Vijay/AAA-1514-2021; Palmer, Elizabeth Emma/AAD-6956-2019; Arnesen, Thomas/Q-8117-2019; Rojas, Samantha/ABA-2588-2020; Corbett, Mark/A-8063-2010; , WaNgtJ/AAR-7045-2020; Varland, Sylvia/D-8128-2018; Posey, Jennifer E./J-3048-2019; Xia, Fan/GQP-4575-2022; Romano, Corrado/B-9695-2008; Lyon, Gholson/D-2765-2014; KÜRY, Sébastien/G-5971-2015; Stracuzzi, Emanuela/AAB-4983-2020; Kleefstra, Tjitske/G-2619-2012; Gecz, Jozef/X-3469-2019; Cooper, Gregory/D-6914-2011	Kooy, Frank/0000-0003-2024-0485; Dharmadhikari, Avinash Vijay/0000-0003-4182-4543; Palmer, Elizabeth Emma/0000-0003-1844-215X; Arnesen, Thomas/0000-0002-3005-147X; Corbett, Mark/0000-0001-9298-3072; Varland, Sylvia/0000-0002-7303-2391; Posey, Jennifer E./0000-0003-4814-6765; Romano, Corrado/0000-0003-1049-0683; Lyon, Gholson/0000-0002-5869-0716; KÜRY, Sébastien/0000-0001-5497-0465; Stracuzzi, Emanuela/0000-0002-1938-0272; Gecz, Jozef/0000-0002-7884-6861; Domingo, Deepti/0000-0002-7706-872X; Cooper, Gregory/0000-0001-5509-9923; Stessman, Holly/0000-0002-0764-3493; Stray-Pedersen, Asbjorg/0000-0002-9168-0878; Rojas, Samantha/0000-0002-4903-6325; Kassahn, Karin/0000-0002-1662-3355; Lim, Derek/0000-0002-6915-1363; Van Dijck, Anke/0000-0002-6713-2943	US National Human Genome Research Institute (NHGRI)/National Heart Lung and Blood Institute (NHLBI) [UM1HG006542]; Wellcome Trust [HICF-1009-003]; Wellcome Trust Sanger Institute [WT098051]; Nebraska Tobacco Settlement Biomedical Research Development Program [LB692]; NHGRI [K08 HG008986]; Simons Foundation Autism Research Initiative [SFARI 303241, 337701]; National Institutes of Health [R01MH101221]; Clinical Sequencing Evidence-Generating Research (CSER) [NIH/NHGRI 4UM1HG007301-04]; Research Council of Norway [249843]; Norwegian Cancer Society [PR-2009-0222]; Norwegian Health Authorities of Western Norway [912176]; Stanley Institute for Cognitive Genomics at Cold Spring Harbor Laboratory; Department of Health [HICF-1009-003]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD068250] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K08HG008986, U01HG007301, UM1HG006542, UM1HG007301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101221] Funding Source: NIH RePORTER	US National Human Genome Research Institute (NHGRI)/National Heart Lung and Blood Institute (NHLBI); Wellcome Trust(Wellcome Trust); Wellcome Trust Sanger Institute(Wellcome Trust); Nebraska Tobacco Settlement Biomedical Research Development Program; NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Simons Foundation Autism Research Initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical Sequencing Evidence-Generating Research (CSER); Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society); Norwegian Health Authorities of Western Norway; Stanley Institute for Cognitive Genomics at Cold Spring Harbor Laboratory; Department of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	T.A. thanks Nina Glomnes for technical support. We appreciate the study participants and their families, without whom this work would not have been possible. Megan Cho at GeneDx facilitated the collaborations with the clinicians who submitted samples to GeneDx. The Baylor-Hopkins Center for Mendelian Genomics (BHCMG) has been funded by the US National Human Genome Research Institute (NHGRI)/National Heart Lung and Blood Institute (NHLBI) grant number UM1HG006542. The DDD Study presents independent research commissioned by the Health Innovation Challenge Fund (grant HICF-1009-003),a parallel funding partnership between the Wellcome Trust and the Department of Health, and the Wellcome Trust Sanger Institute (grant WT098051). H.A.F.S. is supported by funds from the LB692 Nebraska Tobacco Settlement Biomedical Research Development Program. J.E.P. was supported by NHGRI grant K08 HG008986. This research was further supported in part by the following to E.E.E.: the Simons Foundation Autism Research Initiative (SFARI 303241 and 337701) and National Institutes of Health (R01MH101221). E.E.E. is an investigator of the Howard Hughes Medical Institute. The collection of the proband from HudsonAlpha was supported by Clinical Sequencing Evidence-Generating Research (CSER) study grant number (NIH/NHGRI 4UM1HG007301-04). S.V. and T.A. were funded by the Research Council of Norway (249843), the Norwegian Cancer Society (PR-2009-0222), and the Norwegian Health Authorities of Western Norway (912176). G.J.L. is supported by funds from the Stanley Institute for Cognitive Genomics at Cold Spring Harbor Laboratory. Additional acknowledgments can be found in the Supplemental Data.	Aksnes H, 2015, TRENDS BIOCHEM SCI, V40, P422, DOI 10.1016/j.tibs.2015.05.003; Aksnes H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061012; Arnesen T, 2006, ONCOGENE, V25, P4350, DOI 10.1038/sj.onc.1209469; Arnesen T, 2005, BIOCHEM J, V386, P433, DOI 10.1042/BJ20041071; Arnesen T, 2010, MOL CELL BIOL, V30, P1898, DOI 10.1128/MCB.01199-09; Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Asaumi M, 2005, J BIOCHEM, V137, P147, DOI 10.1093/jb/mvi014; Barrett J. C., 2017, NEW MUTATIONS OLD ST, DOI [10.1101/115964, DOI 10.1101/115964]; Behnia R, 2004, NAT CELL BIOL, V6, P405, DOI 10.1038/ncb1120; Beltran-Alvarez P, 2014, J MOL CELL CARDIOL, V76, P126, DOI 10.1016/j.yjmcc.2014.08.014; Bragin E, 2014, NUCLEIC ACIDS RES, V42, pD993, DOI 10.1093/nar/gkt937; Casey JP, 2015, SCI REP-UK, V5, DOI 10.1038/srep16022; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Dorfel MJ, 2015, GENE, V567, P103, DOI 10.1016/j.gene.2015.04.085; Dorfel MJ, 2017, YEAST, V34, P19, DOI 10.1002/yea.3211; Esmailpour T, 2014, J MED GENET, V51, P185, DOI 10.1136/jmedgenet-2013-101660; Farwell KD, 2015, GENET MED, V17, P578, DOI 10.1038/gim.2014.154; Ferreira JCB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033175; Fluge O, 2002, ONCOGENE, V21, P5056, DOI 10.1038/sj.onc.1205687; Hofmann I, 2006, J CELL SCI, V119, P1494, DOI 10.1242/jcs.02958; Holmes WM, 2014, CRIT REV BIOCHEM MOL, V49, P294, DOI 10.3109/10409238.2014.914151; Holmes WM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5383; Homsy J, 2015, SCIENCE, V350, P1262, DOI 10.1126/science.aac9396; Hua KT, 2011, CANCER CELL, V19, P218, DOI 10.1016/j.ccr.2010.11.010; Hwang CS, 2010, NAT CELL BIOL, V12, P1177, DOI 10.1038/ncb2121; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Jin SC, 2017, NAT GENET, V49, P1593, DOI 10.1038/ng.3970; Kalvik TV, 2013, ONCOGENE, V32, P269, DOI 10.1038/onc.2012.82; Kim HK, 2014, CELL, V156, P158, DOI 10.1016/j.cell.2013.11.031; Lee CC, 2017, MOL CELL, V68, P89, DOI 10.1016/j.molcel.2017.08.025; Lee CF, 2010, J CLIN INVEST, V120, P2920, DOI 10.1172/JCI42275; Lee H, 2014, JAMA-J AM MED ASSOC, V312, P1880, DOI 10.1001/jama.2014.14604; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Liszczak G, 2013, NAT STRUCT MOL BIOL, V20, P1098, DOI 10.1038/nsmb.2636; Lykke-Andersen S, 2015, NAT REV MOL CELL BIO, V16, P665, DOI 10.1038/nrm4063; Marionneau C, 2015, J MOL CELL CARDIOL, V82, P36, DOI 10.1016/j.yjmcc.2015.02.013; Min L, 2013, FEBS LETT, V587, P1630, DOI 10.1016/j.febslet.2013.04.016; MULLEN JR, 1989, EMBO J, V8, P2067, DOI 10.1002/j.1460-2075.1989.tb03615.x; Murthi A, 2005, GENETICS, V170, P1553, DOI 10.1534/genetics.105.043620; Myklebust LM, 2015, HUM MOL GENET, V24, P1956, DOI 10.1093/hmg/ddu611; Park SE, 2015, SCIENCE, V347, P1249, DOI 10.1126/science.aaa3844; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Pezza JA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5384; Popp B, 2015, EUR J HUM GENET, V23, P602, DOI 10.1038/ejhg.2014.150; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Raychaudhuri S, 2008, HUM MOL GENET, V17, P240, DOI 10.1093/hmg/ddm301; Retterer K, 2016, GENET MED, V18, P696, DOI 10.1038/gim.2015.148; RIPLEY LS, 1982, P NATL ACAD SCI-BIOL, V79, P4128, DOI 10.1073/pnas.79.13.4128; Rope AF, 2011, AM J HUM GENET, V89, P28, DOI 10.1016/j.ajhg.2011.05.017; Ruzicka M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182377; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Saunier C, 2016, HUM MUTAT, V37, P755, DOI 10.1002/humu.23001; Scott DC, 2011, SCIENCE, V334, P674, DOI 10.1126/science.1209307; Setty SRG, 2004, NAT CELL BIOL, V6, P414, DOI 10.1038/ncb1121; Shemorry A, 2013, MOL CELL, V50, P540, DOI 10.1016/j.molcel.2013.03.018; Shim JH, 2012, DIGEST DIS, V30, P603, DOI 10.1159/000343090; Sidhu M, 2017, PEDIATR NEUROL, V76, P82, DOI 10.1016/j.pediatrneurol.2017.07.010; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Stessman HAF, 2017, NAT GENET, V49, P515, DOI 10.1038/ng.3792; Sugiura N, 2003, J BIOL CHEM, V278, P40113, DOI 10.1074/jbc.M301218200; Sugiura N, 2001, J BIOL CHEM, V276, P14257, DOI 10.1074/jbc.M100011200; Tarailo-Graovac M, 2017, GENET MED, V19, P1300, DOI 10.1038/gim.2017.50; Van Damme P, 2014, MOL CELL PROTEOMICS, V13, P2031, DOI 10.1074/mcp.M113.035402; Wang ZH, 2011, ASIAN PAC J CANCER P, V12, P1973; Wang ZH, 2012, P NATL ACAD SCI USA, V109, P3053, DOI 10.1073/pnas.1113356109; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Zaidi S, 2013, NATURE, V498, P220, DOI 10.1038/nature12141; Zhao JJ, 2018, AM J MED GENET B, V177, P10, DOI 10.1002/ajmg.b.32574; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	70	33	34	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 3	2018	102	5					985	994		10.1016/j.ajhg.2018.03.004	http://dx.doi.org/10.1016/j.ajhg.2018.03.004			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	GG1IH	29656860	Green Published, Bronze			2022-12-18	WOS:000432440100019
J	Guissart, C; Latypova, X; Rollier, P; Khan, TN; Stamberger, H; McWalter, K; Cho, MT; Kjaergaard, S; Weckhuysen, S; Lesca, G; Besnard, T; Ounap, K; Schema, L; Chiocchetti, AG; McDonald, M; de Bellescize, J; Vincent, M; Van Esch, H; Sattler, S; Forghani, I; Thiffault, I; Freitag, CM; Barbouth, DS; Cadieux-Dion, M; Willaert, R; Sacoto, MJG; Safina, NP; Dubourg, C; Grote, L; Carre, W; Saunders, C; Pajusalu, S; Farrow, E; Boland, A; Karlowicz, DH; Deleuze, JF; Wojcik, MH; Pressman, R; Isidor, B; Vogels, A; Van Paesschen, W; Al-Gazali, L; Al Shamsi, AM; Claustres, M; Pujol, A; Sanders, SJ; Rivier, F; Leboucq, N; Cogne, B; Sasorith, S; Sanlaville, D; Retterer, K; Odent, S; Katsanis, N; Bezieau, S; Koenig, M; Davis, EE; Pasquier, L; Kury, S				Guissart, Claire; Latypova, Xenia; Rollier, Paul; Khan, Tahir N.; Stamberger, Hannah; McWalter, Kirsty; Cho, Megan T.; Kjaergaard, Susanne; Weckhuysen, Sarah; Lesca, Gaetan; Besnard, Thomas; Ounap, Katrin; Schema, Lynn; Chiocchetti, Andreas G.; McDonald, Marie; de Bellescize, Julitta; Vincent, Marie; Van Esch, Hilde; Sattler, Shannon; Forghani, Irman; Thiffault, Isabelle; Freitag, Christine M.; Barbouth, Deborah Sara; Cadieux-Dion, Maxime; Willaert, Rebecca; Sacoto, Maria J. Guillen; Safina, Nicole P.; Dubourg, Christele; Grote, Lauren; Carre, Wilfrid; Saunders, Carol; Pajusalu, Sander; Farrow, Emily; Boland, Anne; Karlowicz, Danielle Hays; Deleuze, Jean-Francois; Wojcik, Monica H.; Pressman, Rena; Isidor, Bertrand; Vogels, Annick; Van Paesschen, Wim; Al-Gazali, Lihadh; Al Shamsi, Aisha Mohamed; Claustres, Mireille; Pujol, Aurora; Sanders, Stephan J.; Rivier, Francois; Leboucq, Nicolas; Cogne, Benjamin; Sasorith, Souphatta; Sanlaville, Damien; Retterer, Kyle; Odent, Sylvie; Katsanis, Nicholas; Bezieau, Stephane; Koenig, Michel; Davis, Erica E.; Pasquier, Laurent; Kury, Sebastien			Dual Molecular Effects of Dominant RORA Mutations Cause Two Variants of Syndromic Intellectual Disability with Either Autism or Cerebellar Ataxia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEURODEVELOPMENTAL DISORDERS; FOUNDER MUTATION; PURKINJE-CELLS; ALPHA GENE; STAGGERER; ZEBRAFISH; MICE; TRANSCRIPTION; DISRUPTION; EXPRESSION	ROR alpha, the RAR-related orphan nuclear receptor alpha, is essential for cerebellar development. The spontaneous mutant mouse staggerer, with an ataxic gait caused by neurodegeneration of cerebellar Purkinje cells, was discovered two decades ago to result from homozygous intragenic Rora deletions. However, RORA mutations were hitherto undocumented in humans. Through a multi-centric collaboration, we identified three copy-number variant deletions (two de novo and one dominantly inherited in three generations), one de novo disrupting duplication, and nine de novo point mutations (three truncating, one canonical splice site, and five missense mutations) involving RORA in 16 individuals from 13 families with variable neurodevelopmental delay and intellectual disability (ID)-associated autistic features, cerebellar ataxia, and epilepsy. Consistent with the human and mouse data, disruption of the D. rerio ortholog, roraa, causes significant reduction in the size of the developing cerebellum. Systematic in vivo complementation studies showed that, whereas wild-type human RORA mRNA could complement the cerebellar pathology, mis sense variants had two distinct pathogenic mechanisms of either haploinsufficiency or a dominant toxic effect according to their localization in the ligand-binding or DNA-binding domains, respectively. This dichotomous direction of effect is likely relevant to the phenotype in humans: individuals with loss-of-function variants leading to haploinsufficiency show ID with autistic features, while individuals with de novo dominant toxic variants present with ID, ataxia, and cerebellar atrophy. Our combined genetic and functional data highlight the complex mutational landscape at the human RORA locus and suggest that dual mutational effects likely determine phenotypic outcome.	[Guissart, Claire; Claustres, Mireille; Sasorith, Souphatta; Koenig, Michel] Inst Univ Rech Clin, EA7402, F-34093 Montpellier, France; [Guissart, Claire; Claustres, Mireille; Sasorith, Souphatta; Koenig, Michel] CHU, Lab Genet Mol, F-34093 Montpellier, France; [Guissart, Claire; Claustres, Mireille; Sasorith, Souphatta; Koenig, Michel] Univ Montpellier, F-34093 Montpellier, France; [Latypova, Xenia; Besnard, Thomas; Vincent, Marie; Isidor, Bertrand; Cogne, Benjamin; Bezieau, Stephane; Kury, Sebastien] CHU Nantes, Serv Genet Med, 9 Quai Moncousu, F-44093 Nantes 1, France; [Latypova, Xenia; Khan, Tahir N.; Katsanis, Nicholas; Davis, Erica E.] Duke Univ, Med Ctr, Ctr Human Dis Modeling, Durham, NC 27701 USA; [Latypova, Xenia; Besnard, Thomas; Vincent, Marie; Isidor, Bertrand; Cogne, Benjamin; Bezieau, Stephane; Kury, Sebastien] Univ Nantes, CNRS, INSERM, Inst Thorax, F-44007 Nantes, France; [Rollier, Paul; Odent, Sylvie; Pasquier, Laurent] CHU Rennes, Ctr Reference Anomalies Dev CLAD Quest, Ctr Reference Deficiences Intellectuelles Causes, Serv Genet Clin, F-35203 Rennes, France; [Stamberger, Hannah; Weckhuysen, Sarah] Univ Hosp Antwerp UZA, Div Neurol, B-2610 Antwerp, Belgium; [Stamberger, Hannah; Weckhuysen, Sarah] VIB, Neurogenet Grp, Ctr Mol Neurol, B-2650 Antwerp, Belgium; [Stamberger, Hannah; Weckhuysen, Sarah] Univ Antwerp, Inst Born Bunge, Lab Neurogenet, B-2650 Antwerp, Belgium; [McWalter, Kirsty; Cho, Megan T.; Willaert, Rebecca; Sacoto, Maria J. Guillen; Retterer, Kyle] GeneDx, 207 Perry Pkwy, Gaithersburg, MD 20877 USA; [Kjaergaard, Susanne] Rigshosp, Copenhagen Univ Hosp, Dept Clin Genet, Chromosome Lab, DK-2100 Copenhagen, Denmark; [Lesca, Gaetan; Sanlaville, Damien] Hosp Civils Lyon, Grp Hosp Est, Serv Genet, Lyon, France; [Lesca, Gaetan; Sanlaville, Damien] Univ Claude Bernard Lyon 1, CNRS, INSERM U1028, Ctr Rech Neurosci Lyon,UMR5292, Lyon, France; [Ounap, Katrin; Pajusalu, Sander] Univ Tartu, Tartu Univ Hosp, United Labs, Dept Clin Genet, 2 L Puusepa St, EE-51014 Tartu, Estonia; [Ounap, Katrin; Pajusalu, Sander] Univ Tartu, Tartu Univ Hosp, Inst Clin Med, 2 L Puusepa St, EE-51014 Tartu, Estonia; [Schema, Lynn] Univ Minnesota Fairview, Minneapolis, MN 55454 USA; [Chiocchetti, Andreas G.; Freitag, Christine M.] JW Goethe Univ Frankfurt, Dept Child & Adolescent Psychiat Psychosomat & Ps, Deutschordenstr 50, D-60528 Frankfurt, Germany; [McDonald, Marie; Karlowicz, Danielle Hays] Duke Univ, Dept Pediat, Div Med Genet, Durham, NC 27710 USA; [de Bellescize, Julitta] Hosp Civils, Epilepsy Sleep & Pediat Neurophysiol Dept, F-69677 Lyon, France; [Van Esch, Hilde; Vogels, Annick] Univ Hosp Leuven, Ctr Human Genet, Herestr 49, B-3000 Leuven, Belgium; [Sattler, Shannon] Carle Physician Grp, Urbana, IL 61801 USA; [Forghani, Irman; Barbouth, Deborah Sara; Pressman, Rena] Univ Miami, Miller Sch Med, Dept Human Genet, Dr John T Macdonald Fdn, 1501 NW 10th Ave,Room 359,M-860, Miami, FL 33136 USA; [Thiffault, Isabelle; Cadieux-Dion, Maxime; Saunders, Carol; Farrow, Emily] Childrens Mercy Hosp, Ctr Pediat Genom Med, Kansas City, MO 64108 USA; [Thiffault, Isabelle; Saunders, Carol; Farrow, Emily] Childrens Mercy Hosp, Dept Pathol & Lab Med, Kansas City, MO 64108 USA; [Thiffault, Isabelle; Safina, Nicole P.; Grote, Lauren; Saunders, Carol; Farrow, Emily] Univ Missouri, Sch Med, Kansas City, MO 64108 USA; [Safina, Nicole P.; Grote, Lauren] Childrens Mercy Hosp, Div Clin Genet, Kansas City, MO 64108 USA; [Safina, Nicole P.; Grote, Lauren] Childrens Mercy Hosp, Dept Pediat, Kansas City, MO 64108 USA; [Dubourg, Christele; Carre, Wilfrid] CHU Rennes, Lab Genet Mol & Genom, F-35033 Rennes, France; [Boland, Anne; Deleuze, Jean-Francois] CEA, DRF, Inst Biol Francois Jacob, CNRGH, Evry, France; [Wojcik, Monica H.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Van Paesschen, Wim] Univ Hosp Leuven, Dept Neurol, Herestr 49, B-3000 Leuven, Belgium; [Al-Gazali, Lihadh] United Arab Emirates Univ, Dept Paediat, Coll Med & Hlth Sci, POB 17666, Al Ain, U Arab Emirates; [Al Shamsi, Aisha Mohamed] Tawam Hosp, Dept Paediatr, POB 15258, Al Ain, U Arab Emirates; [Pujol, Aurora] Hosp Llobregat, IDIBELL, Neurometabol Dis Lab, Gran Via 199, Barcelona 08908, Spain; [Pujol, Aurora] Ctr Biomed Res Rare Dis, CIBERER U759, Barcelona 08908, Spain; [Pujol, Aurora] Catalan Inst Res & Adv Studies ICREA, Barcelona 08010, Spain; [Sanders, Stephan J.] Univ Calif San Francisco, UCSF Weill Inst Neurosci, Dept Psychiat, San Francisco, CA 94158 USA; [Rivier, Francois] Univ Montpellier, CNRS, INSERM,CHU Montpellier,PhyMedExp, Dept Neuropaediatr & CR Malad Neuromusculaires, Montpellier, France; [Leboucq, Nicolas] CHU Montpellier, Neuroradiol, F-34090 Montpellier, France; [Odent, Sylvie] Univ Rennes, CNRS, UMR 6290, 2 Ave Prof Leon Bernard, F-35043 Rennes, France	Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; Nantes Universite; CHU de Nantes; Duke University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; CHU Rennes; University of Antwerp; Flanders Institute for Biotechnology (VIB); University of Antwerp; Rigshospitalet; University of Copenhagen; Assistance Publique Hopitaux Paris (APHP); CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Tartu; University of Tartu; University of Minnesota System; University of Minnesota Twin Cities; Goethe University Frankfurt; Duke University; CHU Lyon; KU Leuven; University Hospital Leuven; University of Miami; Children's Mercy Hospital; Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City; Children's Mercy Hospital; Children's Mercy Hospital; CHU Rennes; CEA; UDICE-French Research Universities; Universite Paris Saclay; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; KU Leuven; University Hospital Leuven; United Arab Emirates University; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; ICREA; University of California System; University of California San Francisco; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes 1	Kury, S (corresponding author), CHU Nantes, Serv Genet Med, 9 Quai Moncousu, F-44093 Nantes 1, France.; Davis, EE (corresponding author), Duke Univ, Med Ctr, Ctr Human Dis Modeling, Durham, NC 27701 USA.; Kury, S (corresponding author), Univ Nantes, CNRS, INSERM, Inst Thorax, F-44007 Nantes, France.	erica.davis@duke.edu; sebastien.kury@chu-nantes.fr	Van Paesschen, Wim/A-4540-2010; Lesca, Gaetan/C-6111-2019; Sanders, Stephan/S-8645-2019; Pasquier, Laurent/AAN-4081-2020; Pujol, Aurora/N-4990-2014; KÜRY, Sébastien/G-5971-2015; Isidor, Bertrand/AAJ-3456-2021; Weckhuysen, Sarah/HGB-9957-2022; Sanlaville, Damien/M-4716-2014; Besnard, Thomas/L-2303-2019; Pajusalu, Sander/U-1739-2019; Pajusalu, Sander/HDO-6793-2022; Van+Esch, Hilde/AAU-5688-2020; Stamberger, Hannah/ABD-1814-2020; Vincent, Marie/K-7342-2018; OUNAP, KATRIN/Q-1103-2016	Van Paesschen, Wim/0000-0002-8535-1699; Pasquier, Laurent/0000-0003-3985-1286; Pujol, Aurora/0000-0002-9606-0600; KÜRY, Sébastien/0000-0001-5497-0465; Isidor, Bertrand/0000-0001-6480-126X; Weckhuysen, Sarah/0000-0003-2878-1147; Sanlaville, Damien/0000-0001-9939-2849; Besnard, Thomas/0000-0003-4804-5147; Pajusalu, Sander/0000-0002-5435-0781; Khan, Tahir/0000-0003-3096-8795; Chiocchetti, Andreas G/0000-0002-7329-9985; Sanders, Stephan/0000-0001-9112-5148; Davis, Erica/0000-0002-2412-8397; Vincent, Marie/0000-0003-1010-5618; Forghani, Irman/0000-0002-5484-5186; Van Esch, Hilde/0000-0002-9604-5726; Freitag, Christine Margarete/0000-0001-9676-4782; OUNAP, KATRIN/0000-0002-4594-6364; Lesca, Gaetan/0000-0001-7691-9492	Agence Nationale pour la Recherche/E-rare Joint-Transnational-Call; National Human Genome Research Institute; National Heart, Lung, and Blood Institute under the Trans-Omics for Precision Medicine (TOPMed); National Eye Institute [UM1 HG008900]; NIH [T32 HD07466]; US NIH [R01 MH106826]; Estonian Research Council [PUT355]; Rescindo Therapeutics, Inc.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007466] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG009141, UM1HG008900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH106826] Funding Source: NIH RePORTER	Agence Nationale pour la Recherche/E-rare Joint-Transnational-Call; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung, and Blood Institute under the Trans-Omics for Precision Medicine (TOPMed); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Estonian Research Council; Rescindo Therapeutics, Inc.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to Dr. R. Hawkes and Dr. C. Armstrong (University of Calgary) for providing the zebrin II antibody. We also thank Mr. Z. Kupchinsky for zebrafish husbandry, Mr. D. Morrow for assisting with reagents for the in vivo modeling study, and members of the Center for Human Disease Modeling for helpful comments. We are also grateful to Ms. J.A. Rosenfeld (Mokry) for her precious help in our search for similar affected individuals and for her review of the manuscript. This work was supported by funds from the Agence Nationale pour la Recherche/E-rare Joint-Transnational-Call 2011 (2011-RARE-004-01 "Euro-SCAR'') to M.K.; from the National Human Genome Research Institute with supplemental funding provided by the National Heart, Lung, and Blood Institute under the Trans-Omics for Precision Medicine (TOPMed) program and the National Eye Institute (to the Broad Center for Mendelian Genomics [UM1 HG008900]); from the NIH grant T32 HD07466 (to M.H.W.); US NIH grant R01 MH106826 to E.E.D.; and from the Estonian Research Council, grant PUT355 (to S.P. and K.O.). We also acknowledge the Deciphering Developmental Disorders (DDD) Study.; K.M., M.T.C., R.W., M.J.G.S., and K.R. are employees of GeneDx, Inc., a wholly owned subsidiary of OPKO Health, Inc. N.K. is a paid consultant for and holds significant stock of Rescindo Therapeutics, Inc.	Akizu N, 2015, NAT GENET, V47, P528, DOI 10.1038/ng.3256; Anttonen AK, 2017, BRAIN, V140, P1267, DOI 10.1093/brain/awx040; BARDONI B, 1994, NAT GENET, V7, P497, DOI 10.1038/ng0894-497; Bertrand S, 2007, PLOS GENET, V3, P2085, DOI 10.1371/journal.pgen.0030188; Borck G, 2015, GENOME RES, V25, P155, DOI 10.1101/gr.176925.114; Boutry-Kryza N, 2012, AM J MED GENET A, V158A, P400, DOI 10.1002/ajmg.a.34222; Cherot E, 2018, CLIN GENET, V93, P567, DOI 10.1111/cge.13102; Doulazmi M, 2001, DEV BRAIN RES, V127, P165, DOI 10.1016/S0165-3806(01)00131-6; Doulazmi M, 2006, J NEUROGENET, V20, P1, DOI 10.1080/01677060600685832; Escriva H, 1998, ANN NY ACAD SCI, V839, P143, DOI 10.1111/j.1749-6632.1998.tb10747.x; Frosk P, 2017, J MED GENET, V54, P490, DOI 10.1136/jmedgenet-2016-104296; GIGUERE V, 1994, GENE DEV, V8, P538, DOI 10.1101/gad.8.5.538; Gold DA, 2007, BRAIN RES, V1140, P19, DOI 10.1016/j.brainres.2005.11.080; Gronborg S, 2015, AM J MED GENET A, V167, P2731, DOI 10.1002/ajmg.a.37227; Hamilton BA, 1996, NATURE, V379, P736, DOI 10.1038/379736a0; Hamling KR, 2015, DEV NEUROBIOL, V75, P1174, DOI 10.1002/dneu.22275; Herrup K, 1996, DEV BRAIN RES, V96, P28, DOI 10.1016/0165-3806(96)00069-7; Hibi M, 2012, DEV NEUROBIOL, V72, P282, DOI 10.1002/dneu.20875; Hu WF, 2014, ANNU REV GENOM HUM G, V15, P195, DOI 10.1146/annurev-genom-090413-025600; Katsuyama Y, 2007, DEV DYNAM, V236, P2694, DOI 10.1002/dvdy.21275; Kury S, 2017, AM J HUM GENET, V100, P352, DOI 10.1016/j.ajhg.2017.01.003; Margolin DH, 2013, NEW ENGL J MED, V368, P1992, DOI 10.1056/NEJMoa1215993; Marin-Valencia I, 2018, J MED GENET, V55, P48, DOI 10.1136/jmedgenet-2017-104627; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; MUSCATELLI F, 1994, NATURE, V372, P672, DOI 10.1038/372672a0; Nguyen A, 2010, FASEB J, V24, P3036, DOI 10.1096/fj.10-154484; Niederriter AR, 2013, JOVE-J VIS EXP, DOI 10.3791/50338; Obholzer N, 2008, J NEUROSCI, V28, P2110, DOI 10.1523/JNEUROSCI.5230-07.2008; Okada S, 2015, SCIENCE, V349, P606, DOI 10.1126/science.aaa4282; Rudolf G, 2016, EUR J HUM GENET, V24, P1761, DOI 10.1038/ejhg.2016.80; Ruff M, 2000, BREAST CANCER RES, V2, P353, DOI 10.1186/bcr80; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sarachana T, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-14; Sayad A, 2017, METAB BRAIN DIS, V32, P1595, DOI 10.1007/s11011-017-0049-6; Schaffer AE, 2014, CELL, V157, P651, DOI 10.1016/j.cell.2014.03.049; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SIDMAN RL, 1962, SCIENCE, V137, P610, DOI 10.1126/science.137.3530.610; Sladek FM, 2011, MOL CELL ENDOCRINOL, V334, P3, DOI 10.1016/j.mce.2010.06.018; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Stankiewicz P, 2017, AM J HUM GENET, V101, P503, DOI 10.1016/j.ajhg.2017.08.014; Ta-Shma A, 2017, AM J HUM GENET, V100, P666, DOI 10.1016/j.ajhg.2017.02.007; Tammimies K, 2015, JAMA-J AM MED ASSOC, V314, P895, DOI 10.1001/jama.2015.10078; Vogel MW, 2000, J NEUROBIOL, V42, P323, DOI 10.1002/(SICI)1097-4695(20000215)42:3<323::AID-NEU4>3.0.CO;2-2; Wang YJ, 2016, ACS CHEM NEUROSCI, V7, P143, DOI 10.1021/acschemneuro.5b00159; Yamamoto T, 2014, EUR J MED GENET, V57, P163, DOI 10.1016/j.ejmg.2014.02.001; YOON CH, 1972, NEUROLOGY, V22, P743, DOI 10.1212/WNL.22.7.743	46	33	35	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 3	2018	102	5					744	759		10.1016/j.ajhg.2018.02.021	http://dx.doi.org/10.1016/j.ajhg.2018.02.021			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	GG1IH	29656859	Green Accepted, Bronze, Green Published, Green Submitted			2022-12-18	WOS:000432440100003
J	Kim, HI; Raffler, J; Lu, WY; Lee, JJ; Abbey, D; Saleheen, D; Rabinowitz, JD; Bennett, MJ; Hand, NJ; Brown, C; Rader, DJ				Kim, Hye In; Raffler, Johannes; Lu, Wenyun; Lee, Jung-Jin; Abbey, Deepti; Saleheen, Danish; Rabinowitz, Joshua D.; Bennett, Michael J.; Hand, Nicholas J.; Brown, Christopher; Rader, Daniel J.			Fine Mapping and Functional Analysis Reveal a Role of SLC22A1 in Acylcarnitine Transport	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHRONIC MYELOID-LEUKEMIA; ORGANIC CATION TRANSPORTER-1; TYPE-2 DIABETES-MELLITUS; CARNITINE METABOLISM; GENETIC-VARIATION; INSULIN-RESISTANCE; DOWN-REGULATION; BETA-OXIDATION; OBESE SUBJECTS; FATTY-ACID	Genome-wide association studies have identified a signal at the SLC22A1 locus for serum acylcarnitines, intermediate metabolites of mitochondrial oxidation whose plasma levels associate with metabolic diseases. Here, we refined the association signal, performed conditional analyses, and examined the linkage structure to find coding variants of SLC22A1 that mediate independent association signals at the locus. We also employed allele-specific expression analysis to find potential regulatory variants of SLC22A1 and demonstrated the effect of one variant on the splicing of SLC22A1. SLC22A1 encodes a hepatic plasma membrane transporter whose role in acylcarnitine physiology has not been described. By targeted metabolomics and isotope tracing experiments in loss-and gain-of-function cell and mouse models of Slc22a1, we uncovered a role of SLC22A1 in the efflux of acylcarnitines from the liver to the circulation. We further validated the impacts of human variants on SLC22A1-mediated acylcarnitine efflux in vitro, explaining their association with serum acylcarnitine levels. Our findings provide the detailed molecular mechanisms of the GWAS association for serum acylcarnitines at the SLC22A1 locus by functionally validating the impact of SLC22A1 and its variants on acylcarnitine transport.	[Kim, Hye In; Abbey, Deepti; Hand, Nicholas J.; Brown, Christopher; Rader, Daniel J.] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Raffler, Johannes] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Bioinformat & Syst Biol, D-85764 Neuherberg, Germany; [Lu, Wenyun; Rabinowitz, Joshua D.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Lee, Jung-Jin; Saleheen, Danish] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Bennett, Michael J.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Bennett, Michael J.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Princeton University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Rader, DJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA.	rader@mail.med.upenn.edu	Hand, Nicholas/Q-4235-2019; Rabinowitz, Joshua/GPP-4019-2022	Hand, Nicholas/0000-0002-8172-1816; Rabinowitz, Joshua/0000-0002-1247-4727; Raffler, Johannes/0000-0003-2495-4020; Brown, Christopher/0000-0002-3785-5008	NIH [RC2HL101864]; Leducq Foundation [10CVD03]; Kwanjeong Educational Foundation; NIH Research Specialist Award [R50CA211437]; NATIONAL CANCER INSTITUTE [R50CA211437] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK019525] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leducq Foundation(Leducq Foundation); Kwanjeong Educational Foundation; NIH Research Specialist Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The present study is supported by the grants from NIH RC2HL101864 (D.J.R.) and the Leducq Foundation 10CVD03 (D.J.R.). We thank Merck for the provision of Slc22a1 conditional knockout mice, Penn Vector Core for the generation of AAVs, Penn CVI histology core for the help in liver histology, and Penn Diabetes Research Center for the use of the Metabolomics Core (P30-DK19525), and members of the Rader lab, especially Dr. Jeffrey T. Billheimer, for helpful discussions. We thank Matthias Arnold (Helmholtz Zentrum Munchen) for his generous help in haplotype analyses. We appreciate Michael D. Gallagher for his kind help and input. We acknowledge Kwanjeong Educational Foundation for their financial support to H.K. and NIH Research Specialist Award (R50CA211437) for W.L.	Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; Aguer C, 2015, FASEB J, V29, P336, DOI 10.1096/fj.14-255901; Ahlin G, 2011, PHARMACOGENOMICS J, V11, P400, DOI 10.1038/tpj.2010.54; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bene J, 2013, ANN NUTR METAB, V62, P80, DOI 10.1159/000345759; Butte NF, 2015, AM J CLIN NUTR, V102, P256, DOI 10.3945/ajcn.115.111872; Christensen MMH, 2011, PHARMACOGENET GENOM, V21, P837, DOI 10.1097/FPC.0b013e32834c0010; Coker M, 2002, J PEDIATR ENDOCR MET, V15, P841; Delaneau O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4934; Denk GU, 2004, HEPATOLOGY, V39, P1382, DOI 10.1002/hep.20176; Dujic T, 2016, DIABETIC MED, V33, P511, DOI 10.1111/dme.13040; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; GENUTH SM, 1981, METABOLISM, V30, P393, DOI 10.1016/0026-0495(81)90121-9; Giannoudis A, 2013, BLOOD, V121, P628, DOI 10.1182/blood-2012-01-405035; Grinfeld J, 2013, BRIT J HAEMATOL, V163, P631, DOI 10.1111/bjh.12591; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Innocenti F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002078; Inokuchi T, 1995, DIABETES RES CLIN PR, V30, P1, DOI 10.1016/0168-8227(95)01140-4; Klen J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/934729; Koren-Michowitz M, 2014, EUR J HAEMATOL, V92, P283, DOI 10.1111/ejh.12235; Lozano E, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/692071; Mai M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082459; McCoin CS, 2015, AM J PHYSIOL-ENDOC M, V308, pE990, DOI 10.1152/ajpendo.00602.2014; McVicker G, 2013, SCIENCE, V342, P747, DOI 10.1126/science.1242429; Mihalik SJ, 2012, DIABETES CARE, V35, P605, DOI [10.2337/dc11-1577, 10.2337/DC11-1577]; Mihalik SJ, 2010, OBESITY, V18, P1695, DOI 10.1038/oby.2009.510; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nies AT, 2014, CLIN CANCER RES, V20, P985, DOI 10.1158/1078-0432.CCR-13-1999; Nies AT, 2009, HEPATOLOGY, V50, P1227, DOI 10.1002/hep.23103; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rutkowsky JM, 2014, AM J PHYSIOL-ENDOC M, V306, pE1378, DOI 10.1152/ajpendo.00656.2013; Sampey BP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038812; Schooneman MG, 2015, AM J PHYSIOL-ENDOC M, V309, pE256, DOI 10.1152/ajpendo.00503.2014; Seiler CY, 2014, NUCLEIC ACIDS RES, V42, pD1253, DOI 10.1093/nar/gkt1060; Seiler SE, 2015, CELL METAB, V22, P65, DOI 10.1016/j.cmet.2015.06.003; Seitz T, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0172-0; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Shu Y, 2008, CLIN PHARMACOL THER, V83, P273, DOI 10.1038/sj.clpt.6100275; Shu Y, 2007, J CLIN INVEST, V117, P1422, DOI 10.1172/JCI30558; Soni MS, 2014, DIABETES, V63, P3805, DOI 10.2337/db13-1677; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; Takahashi N, 2010, J HUM GENET, V55, P731, DOI 10.1038/jhg.2010.98; Tamai I, 1998, J BIOL CHEM, V273, P20378, DOI 10.1074/jbc.273.32.20378; Tarasova L, 2012, PHARMACOGENET GENOM, V22, P659, DOI 10.1097/FPC.0b013e3283561666; Tzvetkov MV, 2009, CLIN PHARMACOL THER, V86, P299, DOI 10.1038/clpt.2009.92; Vaidya S, 2015, EUR J PHARMACOL, V765, P124, DOI 10.1016/j.ejphar.2015.08.034; van de Geijn B, 2015, NAT METHODS, V12, P1061, DOI [10.1038/NMETH.3582, 10.1038/nmeth.3582]; Wang-Sattler R, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.43; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Villarreal-Perez JZ, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-129	55	33	34	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 5	2017	101	4					489	502		10.1016/j.ajhg.2017.08.008	http://dx.doi.org/10.1016/j.ajhg.2017.08.008			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FI8UJ	28942964	Bronze, Green Published			2022-12-18	WOS:000412277300001
J	Paul, A; Drecourt, A; Petit, F; Deguine, DD; Vasnier, C; Oufadem, M; Masson, C; Bonnet, C; Masmoudi, S; Mosnier, I; Mahieu, L; Bouccara, D; Kaplan, J; Challe, G; Domange, C; Mochel, F; Sterkers, O; Gerber, S; Nitschke, P; Bole-Feysot, C; Jonard, L; Gherbi, S; Mercati, O; Ben Aissa, I; Lyonnet, S; Rotig, A; Delahodde, A; Marlin, S				Paul, Antoine; Drecourt, Anthony; Petit, Floriane; Deguine, Delphine Dupin; Vasnier, Christelle; Oufadem, Myriam; Masson, Cecile; Bonnet, Crystel; Masmoudi, Saber; Mosnier, Isabelle; Mahieu, Laurence; Bouccara, Didier; Kaplan, Josseline; Challe, Georges; Domange, Christelle; Mochel, Fanny; Sterkers, Olivier; Gerber, Sylvie; Nitschke, Patrick; Bole-Feysot, Christine; Jonard, Laurence; Gherbi, Souad; Mercati, Oriane; Ben Aissa, Ines; Lyonnet, Stanislas; Rotig, Agnes; Delahodde, Agnes; Marlin, Sandrine			FDXR Mutations Cause Sensorial Neuropathies and Expand the Spectrum of Mitochondrial Fe-S-Synthesis Diseases	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOMINANT OPTIC ATROPHY; AUDITORY NEUROPATHY; ADRENODOXIN REDUCTASE; CLUSTER BIOGENESIS; IRON HOMEOSTASIS; PROTEIN; FERREDOXINS; MECHANISMS; GENE; FRATAXIN	Hearing loss and visual impairment in childhood have mostly genetic origins, some of them being related to sensorial neuronal defects. Here, we report on eight subjects from four independent families affected by auditory neuropathy and optic atrophy. Whole-exome sequencing revealed biallelic mutations in FDXR in affected subjects of each family. FDXR encodes the mitochondrial ferredoxin reductase, the sole human ferredoxin reductase implicated in the biosynthesis of iron-sulfur clusters (ISCs) and in heme formation. ISC proteins are involved in enzymatic catalysis, gene expression, and DNA replication and repair. We observed deregulated iron homeostasis in FDXR mutant fibroblasts and indirect evidence of mitochondrial iron overload. Functional complementation in a yeast strain in which ARH1, the human FDXR ortholog, was deleted established the pathogenicity of these mutations. These data highlight the wide clinical heterogeneity of mitochondrial disorders related to ISC synthesis.	[Paul, Antoine; Drecourt, Anthony; Petit, Floriane; Oufadem, Myriam; Masson, Cecile; Kaplan, Josseline; Gerber, Sylvie; Nitschke, Patrick; Bole-Feysot, Christine; Lyonnet, Stanislas; Rotig, Agnes; Marlin, Sandrine] Univ Paris 05, Sorbonne Paris Cite, Inst IMAGINE, UMR 1163, 24 Blvd Montparnasse, F-75015 Paris, France; [Deguine, Delphine Dupin] Hop Purpan, Serv Genet Med, F-40031 Toulouse, France; [Vasnier, Christelle; Delahodde, Agnes] Univ Paris Saclay, Univ Paris Sud, Inst Integrat Biol Cell, CEA,CNRS, F-91198 Gif Sur Yvette, France; [Bonnet, Crystel] Inst Vis, UMRS 1120, F-75012 Paris, France; [Masmoudi, Saber] Ctr Biotechnol Sfax, Lab Mol & Cellular Screening Proc, Sfax 1177, Tunisia; [Mosnier, Isabelle; Bouccara, Didier; Sterkers, Olivier] Hop La Pitie Salpetriere, AP HP, Serv Otorhinolaryngol, F-75013 Paris, France; [Mahieu, Laurence] Hop Rangueil, Serv Ophtalmol, F-40031 Toulouse, France; [Challe, Georges] Hop La Pitie Salpetriere, AP HP, Serv Ophtalmol, F-75013 Paris, France; [Domange, Christelle] Hop Lariboisiere, Serv Otorhinolaryngol, F-75475 Paris, France; [Mochel, Fanny] Hop La Pitie Salpetriere, AP HP, Dept Genet, F-75013 Paris, France; [Jonard, Laurence] Hop Necker Enfants Malad, AP HP, Serv Genet, Lab Genet Mol, F-75015 Paris, France; [Gherbi, Souad; Mercati, Oriane; Ben Aissa, Ines; Marlin, Sandrine] Hop Necker Enfants Malad, AP HP, Serv Genet, Ctr Reference Surdites, F-75015 Paris, France; [Lyonnet, Stanislas; Marlin, Sandrine] Hop Necker Enfants Malad, AP HP, Serv Genet, F-75015 Paris, France	UDICE-French Research Universities; Universite Paris Cite; CHU de Toulouse; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; Universite de Bordeaux; Centre de Biotechnologie de Sfax; Universite de Sfax; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU de Toulouse; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Marlin, S (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Inst IMAGINE, UMR 1163, 24 Blvd Montparnasse, F-75015 Paris, France.; Marlin, S (corresponding author), Hop Necker Enfants Malad, AP HP, Serv Genet, Ctr Reference Surdites, F-75015 Paris, France.; Marlin, S (corresponding author), Hop Necker Enfants Malad, AP HP, Serv Genet, F-75015 Paris, France.	sandrine.marlin@aphp.fr	Masmoudi, Saber/W-1478-2019; Bonnet, Crystel/AAN-5950-2021; KAPLAN, Josseline/I-2622-2017; ROTIG, AGNES/G-9592-2017	Bonnet, Crystel/0000-0002-1916-9119; Jonard, Laurence/0000-0003-0369-0505; marlin, sandrine/0000-0002-4115-9806; KAPLAN, Josseline/0000-0002-1849-8658; Saber, Masmoudi/0000-0002-1076-5256; ROTIG, AGNES/0000-0003-0589-0703	Institut IMAGINE; association S'entendre; E-Rare project GENOMIT [01GM1207]; Agence Nationale de la Recherche [ANR-10-IAHU-01]; ApoPharma	Institut IMAGINE; association S'entendre; E-Rare project GENOMIT; Agence Nationale de la Recherche(French National Research Agency (ANR)); ApoPharma	We acknowledge the parents, the patients, and the physicians for their participation; Institut IMAGINE and the association S'entendre for their support; and Dr. Patrizia Amati Bonneau for OPA1 and TMEM126A studies. This work was partially funded through the E-Rare project GENOMIT (01GM1207) and the Agence Nationale de la Recherche (ANR-10-IAHU-01). A.D. was supported by a fellowship from ApoPharma.	Adamec J, 2000, AM J HUM GENET, V67, P549, DOI 10.1086/303056; Beilschmidt LK, 2014, BIOCHIMIE, V100, P48, DOI 10.1016/j.biochi.2014.01.009; Bocquet B, 2013, OPHTHAL EPIDEMIOL, V20, P13, DOI 10.3109/09286586.2012.737890; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; BUYS SS, 1991, BLOOD, V78, P3288; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Ewen KM, 2011, BBA-PROTEINS PROTEOM, V1814, P111, DOI 10.1016/j.bbapap.2010.06.003; Jung YS, 1999, J BIOL CHEM, V274, P32402, DOI 10.1074/jbc.274.45.32402; Lane DJR, 2015, BBA-MOL CELL RES, V1853, P1130, DOI 10.1016/j.bbamcr.2015.01.021; Li J, 2001, J BIOL CHEM, V276, P1503, DOI 10.1074/jbc.M007198200; Manzella L, 1998, YEAST, V14, P839, DOI 10.1002/(SICI)1097-0061(19980630)14:9<839::AID-YEA283>3.0.CO;2-A; Meyer E, 2010, MOL VIS, V16, P650; Moser T, 2016, NAT REV NEUROL, V12, P135, DOI 10.1038/nrneurol.2016.10; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Namba K, 2016, OTOL NEUROTOL, V37, P394, DOI 10.1097/MAO.0000000000000978; Nikolopoulos TP, 2014, INT J PEDIATR OTORHI, V78, P171, DOI 10.1016/j.ijporl.2013.12.021; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Schmucker S, 2008, HUM MOL GENET, V17, P3521, DOI 10.1093/hmg/ddn244; Sheftel AD, 2010, P NATL ACAD SCI USA, V107, P11775, DOI 10.1073/pnas.1004250107; Shi YB, 2012, BBA-MOL CELL RES, V1823, P484, DOI 10.1016/j.bbamcr.2011.11.002; Shi YB, 2009, HUM MOL GENET, V18, P3014, DOI 10.1093/hmg/ddp239; Sohn YS, 2012, HAEMATOL-HEMATOL J, V97, P670, DOI 10.3324/haematol.2011.054858; Spiegel R, 2014, EUR J HUM GENET, V22, P902, DOI 10.1038/ejhg.2013.269; Stehling O, 2014, BIOCHIMIE, V100, P61, DOI 10.1016/j.biochi.2014.01.010; von Ameln S, 2012, AM J HUM GENET, V91, P919, DOI 10.1016/j.ajhg.2012.09.002; Webert H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6013	27	33	36	2	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 5	2017	101	4					630	637		10.1016/j.ajhg.2017.09.007	http://dx.doi.org/10.1016/j.ajhg.2017.09.007			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FI8UJ	28965846	Green Published, Bronze			2022-12-18	WOS:000412277300014
J	Habarou, F; Hamel, Y; Haack, TB; Feichtinger, RG; Lebigot, E; Marquardt, I; Busiah, K; Laroche, C; Madrange, M; Grisel, C; Pontoizeau, C; Eisermann, M; Boutron, A; Chretien, D; Chadefaux-Vekemans, B; Barouki, R; Bole-Feysot, C; Nitschke, P; Goudin, N; Boddaert, N; Nemazanyy, I; Delahodde, A; Kolker, S; Rodenburg, RJ; Korenke, GC; Meitinger, T; Strom, TM; Prokisch, H; Rotig, A; Ottolenghi, C; Mayr, JA; de Lonlay, P				Habarou, Florence; Hamel, Yamina; Haack, Tobias B.; Feichtinger, Rene G.; Lebigot, Elise; Marquardt, Iris; Busiah, Kanetee; Laroche, Cecile; Madrange, Marine; Grisel, Coraline; Pontoizeau, Clement; Eisermann, Monika; Boutron, Audrey; Chretien, Dominique; Chadefaux-Vekemans, Bernadette; Barouki, Robert; Bole-Feysot, Christine; Nitschke, Patrick; Goudin, Nicolas; Boddaert, Nathalie; Nemazanyy, Ivan; Delahodde, Agnes; Kolker, Stefan; Rodenburg, Richard J.; Korenke, G. Christoph; Meitinger, Thomas; Strom, Tim M.; Prokisch, Holger; Rotig, Agnes; Ottolenghi, Chris; Mayr, Johannes A.; de Lonlay, Pascale			Biallelic Mutations in LIPT2 Cause a Mitochondrial Lipoylation Defect Associated with Severe Neonatal Encephalopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN LIPOYLTRANSFERASE GENE; MULTIPLE RESPIRATORY-CHAIN; LIPOIC ACID BIOSYNTHESIS; SACCHAROMYCES-CEREVISIAE; CLUSTER BIOGENESIS; HUMAN-DISEASE; DEFICIENCY; DEHYDROGENASE; NFU1; METABOLISM	Lipoate serves as a cofactor for the glycine cleavage system (GCS) and four 2-oxoacid dehydrogenases functioning in energy metabolism (alpha-oxoglutarate dehydrogenase [alpha-KGDHc] and pyruvate dehydrogenase [PDHc]), or amino acid metabolism (branched-chain oxoacid dehydrogenase, 2-oxoadipate dehydrogenase). Mitochondrial lipoate synthesis involves three enzymatic steps catalyzed sequentially by lipoyl(octanoyl) transferase 2 (LIPT2), lipoic acid synthetase (LIAS), and lipoyltransferase 1 (LIPT1). Mutations in LIAS have been associated with nonketotic hyperglycinemia-like early-onset convulsions and encephalopathy combined with a defect in mitochondrial energy metabolism. LIPT1 deficiency spares GCS deficiency and has been associated with a biochemical signature of combined 2-oxoacid dehydrogenase deficiency leading to early death or Leigh-like encephalopathy. We report on the identification of biallelic LIPT2 mutations in three affected individuals from two families with severe neonatal encephalopathy. Brain MRI showed major cortical atrophy with white matter abnormalities and cysts. Plasma glycine was mildly increased. Affected individuals' fibroblasts showed reduced oxygen consumption rates, PDHc, alpha-KGDHc activities, leucine catabolic flux, and decreased protein lipoylation. A normalization of lipoylation was observed after expression of wild-type LIPT2, arguing for LIPT2 requirement in intramitochondrial lipoate synthesis. Lipoic acid supplementation did not improve clinical condition nor activities of PDHc, alpha-KGDHc, or leucine metabolism in fibroblasts and was ineffective in yeast deleted for the orthologous LIP2.	[Habarou, Florence; Hamel, Yamina; Busiah, Kanetee; Madrange, Marine; Grisel, Coraline; Pontoizeau, Clement; Chadefaux-Vekemans, Bernadette; Barouki, Robert; Goudin, Nicolas; Ottolenghi, Chris; de Lonlay, Pascale] Univ Paris 05, Hosp Necker Enfants Malad, AP HP, Reference Ctr Inherited Metab Dis, F-75015 Paris, France; [Habarou, Florence; Pontoizeau, Clement; Chadefaux-Vekemans, Bernadette; Barouki, Robert; Ottolenghi, Chris] Univ Paris 05, Hosp Necker Enfants Malad, Metab Biochem, F-75015 Paris, France; [Hamel, Yamina; Madrange, Marine; Chretien, Dominique; Rotig, Agnes; de Lonlay, Pascale] Univ Paris 05, Sorbonne Paris Cite, UMR1163, Inst IMAGINE, 24 Blvd Montparnasse, F-75015 Paris, France; [Haack, Tobias B.; Meitinger, Thomas; Strom, Tim M.; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Haack, Tobias B.; Meitinger, Thomas; Strom, Tim M.; Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Haack, Tobias B.] Univ Tubingen, Inst Med Genet & Appl Genom, D-72076 Tubingen, Germany; [Feichtinger, Rene G.; Mayr, Johannes A.] Paracelsus Med Univ Salzburg, Dept Pediat, A-5020 Salzburg, Austria; [Lebigot, Elise; Boutron, Audrey] Hop Bicetre, AP HP, Dept Biochem, F-94270 Le Kremlin Bicetre, France; [Marquardt, Iris; Korenke, G. Christoph] Childrens Hosp Klinikum Oldenburg, Dept Neuropediat, D-26133 Oldenburg, Germany; [Laroche, Cecile] Limoges Hosp, Neurol Unit, F-87042 Limoges, France; [Eisermann, Monika; Goudin, Nicolas] Hosp Necker Enfants Malad, AP HP, Neurophysiol Unit, F-75015 Paris, France; [Eisermann, Monika; Goudin, Nicolas] INSERM, U1129, Paris, France; [Eisermann, Monika; Goudin, Nicolas] Paris Descartes Univ, Paris, France; [Eisermann, Monika; Goudin, Nicolas] CEA, Gif Sur Yvette, France; [Bole-Feysot, Christine] Univ Paris 05, Genom Core Facil, Imagine Inst, UMR1163, 24 Blvd Montparnasse, F-75015 Paris, France; [Bole-Feysot, Christine] Hosp Necker Enfants Malad, AP HP, F-75015 Paris, France; [Nitschke, Patrick] Univ Paris 05, Hosp Necker Enfants Malad, Paris Descartes Bioinformat Platform, F-75015 Paris, France; [Boddaert, Nathalie] Univ Paris 05, Hosp Necker Enfants Malad, AP HP,INSERM,Inst Imagine, Dept Pediat Radiol,PRES Sorbonne Paris Cite,U1000, 24 Blvd Montparnasse, F-75015 Paris, France; [Nemazanyy, Ivan] Paris Descartes Univ, Fac Med, F-75015 Paris, France; [Nemazanyy, Ivan] Paris Descartes Univ, INSERM, U1151, Necker Enfants Malad Inst, F-75015 Paris, France; [Delahodde, Agnes] Univ Paris Saclay, Univ Paris Sud, CEA, I2BC,CNRS, F-91198 Gif Sur Yvette, France; [Kolker, Stefan] Univ Childrens Hosp, Dept Gen Pediat, Div Pediat Neurol & Inherited Metab Dis, D-69120 Heidelberg, Germany; [Rodenburg, Richard J.] Radboud UMC, Dept Pediat, Radboud Ctr Mitochondrial Med, Nijmegen, Netherlands	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Eberhard Karls University of Tubingen; Paracelsus Private Medical University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; CHU Limoges; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CEA; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Radboud University Nijmegen	de Lonlay, P (corresponding author), Univ Paris 05, Hosp Necker Enfants Malad, AP HP, Reference Ctr Inherited Metab Dis, F-75015 Paris, France.; de Lonlay, P (corresponding author), Univ Paris 05, Sorbonne Paris Cite, UMR1163, Inst IMAGINE, 24 Blvd Montparnasse, F-75015 Paris, France.; Mayr, JA (corresponding author), Paracelsus Med Univ Salzburg, Dept Pediat, A-5020 Salzburg, Austria.	h.mayr@salk.at; pascale.delonlay@aphp.fr	Ottolenghi, Chris/H-3745-2017; Rodenburg, Richard/N-3579-2014; Kanetee, BUSIAH/AAP-8292-2020; Meitinger, Thomas/O-1318-2015; boddaert, nathalie/GWV-2865-2022; ROTIG, AGNES/G-9592-2017	Ottolenghi, Chris/0000-0002-0734-344X; Rodenburg, Richard/0000-0001-5227-3527; Kanetee, BUSIAH/0000-0002-1059-0791; Mayr, Johannes/0000-0001-6970-336X; ROTIG, AGNES/0000-0003-0589-0703; Prokisch, Holger/0000-0003-2379-6286	Fondation Lejeune; Fondation Bettencourt; AFM [15947]; ANR [ANR-13-BSV1-0020]; Association contre les Maladies Mitochondriales (AMMI); Association Nos Anges; Association Hyperinsulinisme; German Federal Ministry of Education and Research (BMBF) [FKZ 01ZX1405C]; E-Rare project GENOMIT [01GM1207, 01GM1603, O1GML 1207]; Austrian Science Fonds (FWF) [I 2741-B26]	Fondation Lejeune; Fondation Bettencourt; AFM(Association Francaise contre les Myopathies); ANR(French National Research Agency (ANR)); Association contre les Maladies Mitochondriales (AMMI); Association Nos Anges; Association Hyperinsulinisme; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); E-Rare project GENOMIT; Austrian Science Fonds (FWF)(Austrian Science Fund (FWF))	We thank Mohammed Zarhrate for his technical support. This work was supported by Fondation Lejeune (grant 2014), Fondation Bettencourt 2012, AFM 2012-2014 (number 15947), ANR 2013-2016 (ANR-13-BSV1-0020), Association contre les Maladies Mitochondriales (AMMI), Association Nos Anges, and Association Hyperinsulinisme. We are indebted to the Necker Cell Imaging Platform for helpful discussions about cellular analyses. T.B.H. work was supported by the German Federal Ministry of Education and Research (BMBF) within the framework of the e:Med research and funding concept (grant #FKZ 01ZX1405C). Supported by the E-Rare project GENOMIT (01GM1207 and 01GM1603 to H.P., O1GML 1207 to A.R.) and Austrian Science Fonds (FWF) (I 2741-B26 to J.A.M.).	Bolar NA, 2013, HUM MOL GENET, V22, P2590, DOI 10.1093/hmg/ddt107; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Booker SJ, 2004, CHEM BIOL, V11, P10, DOI 10.1016/j.chembiol.2004.01.002; Booker SJ, 2007, CURR OPIN CHEM BIOL, V11, P543, DOI 10.1016/j.cbpa.2007.08.028; Brassier A, 2013, MOL GENET METAB, V109, P28, DOI 10.1016/j.ymgme.2013.01.017; Brivet M, 2003, MOL GENET METAB, V78, P186, DOI 10.1016/S1096-7192(03)00016-7; Cameron JM, 2011, AM J HUM GENET, V89, P486, DOI 10.1016/j.ajhg.2011.08.011; Ferrer-Cortes X, 2016, MITOCHONDRION, V26, P72, DOI 10.1016/j.mito.2015.12.004; FUJIWARA K, 1994, J BIOL CHEM, V269, P16605; Fujiwara K, 1999, EUR J BIOCHEM, V260, P761, DOI 10.1046/j.1432-1327.1999.00204.x; Haack TB, 2013, J INHERIT METAB DIS, V36, P55, DOI 10.1007/s10545-012-9489-7; Hiltunen JK, 2010, BBA-BIOENERGETICS, V1797, P1195, DOI 10.1016/j.bbabio.2010.03.006; Imbard A, 2011, MOL GENET METAB, V104, P507, DOI 10.1016/j.ymgme.2011.08.008; Kishita Y, 2015, AM J HUM GENET, V97, P761, DOI 10.1016/j.ajhg.2015.09.013; Kremer LS, 2016, AM J HUM GENET, V99, P894, DOI 10.1016/j.ajhg.2016.07.018; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lim SC, 2013, HUM MOL GENET, V22, P4460, DOI 10.1093/hmg/ddt295; Marvin ME, 2001, FEMS MICROBIOL LETT, V199, P131, DOI 10.1016/S0378-1097(01)00170-7; Mayr JA, 2014, J INHERIT METAB DIS, V37, P553, DOI 10.1007/s10545-014-9705-8; Mayr JA, 2011, AM J HUM GENET, V89, P792, DOI 10.1016/j.ajhg.2011.11.011; MORRIS TW, 1995, J BACTERIOL, V177, P1; Navarro-Sastre A, 2011, AM J HUM GENET, V89, P656, DOI 10.1016/j.ajhg.2011.10.005; Nizon M, 2014, MITOCHONDRION, V15, P59, DOI 10.1016/j.mito.2014.01.003; Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008; Rouault TA, 2012, DIS MODEL MECH, V5, P155, DOI 10.1242/dmm.009019; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Schonauer MS, 2009, J BIOL CHEM, V284, P23234, DOI 10.1074/jbc.M109.015594; Soreze Y, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-192; SULO P, 1993, J BIOL CHEM, V268, P17634; Tonduti D, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0237-6; Tort F, 2014, HUM MOL GENET, V23, P1907, DOI 10.1093/hmg/ddt585; Vergnes L, 2011, J BIOL CHEM, V286, P380, DOI 10.1074/jbc.M110.184754; YOSHIDA I, 1986, PEDIATR RES, V20, P169, DOI 10.1203/00006450-198602000-00016	34	33	34	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 3	2017	101	2					283	290		10.1016/j.ajhg.2017.07.001	http://dx.doi.org/10.1016/j.ajhg.2017.07.001			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FC5BD	28757203	Bronze, Green Published			2022-12-18	WOS:000406854800012
J	Skraban, CM; Wells, CF; Markose, P; Cho, MT; Nesbitt, AI; Au, PYB; Begtrup, A; Bernat, JA; Bird, LM; Cao, K; de Brouwer, APM; Denenberg, EH; Douglas, G; Gibson, KM; Grand, K; Goldenberg, A; Innes, AM; Juusola, J; Kempers, M; Kinning, E; Markie, DM; Owens, MM; Payne, K; Person, R; Pfundt, R; Stocco, A; Turner, CLS; Verbeek, NE; Walsh, LE; Warner, TC; Wheeler, PG; Wieczorek, D; Wilkens, AB; Zonneveld-Huijssoon, E; Kleefstra, T; Robertson, SP; Santani, A; van Gassen, KLI; Deardorff, MA				Skraban, Cara M.; Wells, Constance F.; Markose, Preetha; Cho, Megan T.; Nesbitt, Addie I.; Au, P. Y. Billie; Begtrup, Amber; Bernat, John A.; Bird, Lynne M.; Cao, Kajia; de Brouwer, Arjan P. M.; Denenberg, Elizabeth H.; Douglas, Ganka; Gibson, Kristin M.; Grand, Katheryn; Goldenberg, Alice; Innes, A. Micheil; Juusola, Jane; Kempers, Marlies; Kinning, Esther; Markie, David M.; Owens, Martina M.; Payne, Katelyn; Person, Richard; Pfundt, Rolph; Stocco, Amber; Turner, Claire L. S.; Verbeek, Nienke E.; Walsh, Laurence E.; Warner, Taylor C.; Wheeler, Patricia G.; Wieczorek, Dagmar; Wilkens, Alisha B.; Zonneveld-Huijssoon, Evelien; Kleefstra, Tjitske; Robertson, Stephen P.; Santani, Avni; van Gassen, Koen L. I.; Deardorff, Matthew A.		Deciphering Developmental	WDR26 Haploinsufficiency Causes a Recognizable Syndrome of Intellectual Disability, Seizures, Abnormal Gait, and Distinctive Facial Features	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							1Q41Q42 MICRODELETION SYNDROME; G-BETA-GAMMA; REPEAT PROTEIN; DIAPHRAGMATIC-HERNIA; GENETIC-VARIATION; MUTATIONS CAUSE; LANGE-SYNDROME; PHENOTYPE; PATHWAY; DISCOVERY	We report 15 individuals with de novo pathogenic variants in WDR26. Eleven of the individuals carry loss-of-function mutations, and four harbor missense substitutions. These 15 individuals comprise ten females and five males, and all have intellectual disability with delayed speech, a history of febrile and/or non-febrile seizures, and a wide-based, spastic, and/or stiff-legged gait. These subjects share a set of common facial features that include a prominent maxilla and upper lip that readily reveal the upper gingiva, widely spaced teeth, and a broad nasal tip. Together, these features comprise a recognizable facial phenotype. We compared these features with those of chromosome 1q41q42 microdeletion syndrome, which typically contains WDR26, and noted that clinical features are consistent between the two subsets, suggesting that haploinsufficiency of WDR26 contributes to the pathology of 1q41q42 microdeletion syndrome. Consistent with this, WDR26 loss-of-function single-nucleotide mutations identified in these subjects lead to nonsense-mediated decay with subsequent reduction of RNA expression and protein levels. We derived a structural model of WDR26 and note that missense variants identified in these individuals localize to highly conserved residues of this WD-40-repeat-containing protein. Given that WDR26 mutations have been identified in similar to 1 in 2,000 of subjects in our clinical cohorts and that WDR26 might be poorly annotated in exome variant-interpretation pipelines, we would anticipate that this disorder could be more common than currently appreciated.	[Skraban, Cara M.; Markose, Preetha; Grand, Katheryn; Wilkens, Alisha B.; Deardorff, Matthew A.] Childrens Hosp Philadelphia, Div Genet, Philadelphia, PA 19104 USA; [Skraban, Cara M.; Deardorff, Matthew A.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Wells, Constance F.; Robertson, Stephen P.] Univ Otago, Dunedin Sch Med, Dept Womens & Childrens Hlth, Clin Genet Grp, Dunedin 9054, New Zealand; [Cho, Megan T.; Begtrup, Amber; Douglas, Ganka; Juusola, Jane; Person, Richard] GeneDx, Gaithersburg, MD 20877 USA; [Nesbitt, Addie I.; Cao, Kajia; Denenberg, Elizabeth H.; Gibson, Kristin M.; Wilkens, Alisha B.; Santani, Avni] Childrens Hosp Philadelphia, Div Genom Diagnost, Philadelphia, PA 19104 USA; [Au, P. Y. Billie; Innes, A. Micheil] Univ Calgary, Cumming Sch Med, Dept Med Genet, Calgary, AB T2N 1N4, Canada; [Au, P. Y. Billie; Innes, A. Micheil] Univ Calgary, Cumming Sch Med, Alberta Childrens Hosp Res Inst, Calgary, AB T2N 1N4, Canada; [Bernat, John A.; Warner, Taylor C.] Univ Iowa, Stead Family Dept Pediat, Div Med Genet, Iowa City, IA 52242 USA; [Bird, Lynne M.] Univ Calif San Diego, Dept Pediat, San Diego, CA 92123 USA; [Bird, Lynne M.] Rady Childrens Hosp, San Diego, CA 92123 USA; [de Brouwer, Arjan P. M.; Kempers, Marlies; Pfundt, Rolph; Kleefstra, Tjitske] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [de Brouwer, Arjan P. M.; Kleefstra, Tjitske] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands; [Goldenberg, Alice] Ctr Hosp Univ Rouen, Ctr Normand Genom Med & Med Personnalisee, Serv Genet, F-76031 Rouen, France; [Kinning, Esther] Queen Elizabeth Hosp, West Scotland Genet Serv, Glasgow G51 4TF, Lanark, Scotland; [Markie, David M.] Univ Otago, Dunedin Sch Med, Dept Pathol, Dunedin 9054, New Zealand; [Owens, Martina M.] Royal Devon & Exeter NHS Fdn Trust, Dept Mol Genet, Barrack Rd, Exeter EX2 5DW, Devon, England; [Payne, Katelyn; Walsh, Laurence E.] Indiana Univ Hlth Phys, Riley Hosp Children, Div Child Neurol, Indianapolis, IN 46202 USA; [Stocco, Amber] INTEGRIS Baptist Child Neurol Clin, Oklahoma City, OK 73112 USA; [Turner, Claire L. S.] Royal Devon & Exeter Hosp, Peninsula Clin Genet Serv, Exeter EX1 2ED, Devon, England; [Verbeek, Nienke E.; Zonneveld-Huijssoon, Evelien; van Gassen, Koen L. I.] Univ Med Ctr Utrecht, Dept Genet, NL-3508 AB Utrecht, Netherlands; [Wheeler, Patricia G.] Arnold Palmer Hosp, Div Genet, Orlando, FL 32806 USA; [Wieczorek, Dagmar] Univ Klinikum Dusseldorf, Inst Humangenet, D-40225 Dusseldorf, Germany; [Deciphering Developmental] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England; [Santani, Avni] Univ Penn, Dept Pathol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Otago; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Calgary; University of Calgary; University of Iowa; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; Radboud University Nijmegen; Radboud University Nijmegen; CHU de Rouen; University of Otago; University of Exeter; James Whitcomb Riley Hospital Children; University of Exeter; Utrecht University; Utrecht University Medical Center; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Wellcome Trust Sanger Institute; University of Pennsylvania; Pennsylvania Medicine	Deardorff, MA (corresponding author), Childrens Hosp Philadelphia, Div Genet, Philadelphia, PA 19104 USA.; Deardorff, MA (corresponding author), Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA.	deardorff@email.chop.edu	Markie, David/I-7893-2019; , WaNgtJ/AAR-7045-2020; Bird, Lynne/AAG-9533-2021; Wieczorek, Dagmar/AAU-6008-2021; Kleefstra, Tjitske/G-2619-2012; de Brouwer, Arjan PM/P-5949-2015; Pfundt, Rolph/L-4576-2015	Wieczorek, Dagmar/0000-0003-2812-6492; Bernat, John/0000-0003-2033-6129; van Gassen, Koen/0000-0001-7934-0662; Bird, Lynne/0000-0003-4833-3747; Innes, Micheil/0000-0001-9881-5467; Markie, David/0000-0001-5452-9194; Walsh, Laurence/0000-0003-4623-1317; Robertson, Stephen/0000-0002-5181-7809	Children's Hospital of Philadelphia Research Institute; CureKids New Zealand; Health Innovation Challenge Fund [HICF-1009-003]; Wellcome Trust; Department of Health; Wellcome Trust Sanger Institute [WT098051]; National Institute for Health Research through the Comprehensive Clinical Research Network	Children's Hospital of Philadelphia Research Institute; CureKids New Zealand; Health Innovation Challenge Fund; Wellcome Trust(Wellcome Trust); Department of Health; Wellcome Trust Sanger Institute(Wellcome Trust); National Institute for Health Research through the Comprehensive Clinical Research Network(National Institute for Health Research (NIHR))	We are exceptionally grateful to the individuals and families who participated in this study; colleagues who contributed samples and clinical information, including Dr. John Tolmie; and Harriet Saunders for technical assistance. This work was supported by institutional funds from the Children's Hospital of Philadelphia Research Institute to C.M.S. and M.A.D. and from CureKids New Zealand to S.P.R. The authors would like to thank the Exome Aggregation Consortium and the groups that provided exome variant data for comparison. We acknowledge the Deciphering Developmental Disorders study, which presents independent research commissioned by the Health Innovation Challenge Fund (grant HICF-1009-003), a parallel funding partnership among the Wellcome Trust, Department of Health, and Wellcome Trust Sanger Institute (grant WT098051). The views expressed in this publication are those of the authors and not necessarily those of the Wellcome Trust or the Department of Health. The research team acknowledges the support of the National Institute for Health Research through the Comprehensive Clinical Research Network.	Au PYB, 2014, AM J MED GENET A, V164, P441, DOI 10.1002/ajmg.a.36320; Ausio J, 2003, CLIN GENET, V64, P83, DOI 10.1034/j.1399-0004.2003.00124.x; Buske OJ, 2015, HUM MUTAT, V36, P931, DOI 10.1002/humu.22851; Cassina M, 2015, AM J MED GENET A, V167, P1418, DOI 10.1002/ajmg.a.37033; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Deardorff MA, 2012, AM J HUM GENET, V90, P1014, DOI 10.1016/j.ajhg.2012.04.019; Dias J, 2014, GENE DEV, V28, P929, DOI 10.1101/gad.240200.114; Farrell CM, 2014, NUCLEIC ACIDS RES, V42, pD865, DOI 10.1093/nar/gkt1059; Feng YS, 2012, FREE RADICAL RES, V46, P777, DOI 10.3109/10715762.2012.678840; Filges I, 2010, AM J MED GENET A, V152A, P987, DOI 10.1002/ajmg.a.33330; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Goto T, 2016, FEBS LETT, V590, P1291, DOI 10.1002/1873-3468.12180; Gussow AB, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0869-4; Izumi K, 2016, MOL SYNDROMOL, V7, P262, DOI 10.1159/000448747; Kaiser FJ, 2014, HUM MOL GENET, V23, P2888, DOI 10.1093/hmg/ddu002; Kantarci S, 2010, AM J MED GENET A, V152A, P2493, DOI 10.1002/ajmg.a.33618; Kervestin S, 2012, NAT REV MOL CELL BIO, V13, P700, DOI 10.1038/nrm3454; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Mazzeu JF, 2007, AM J MED GENET A, V143A, P1790, DOI 10.1002/ajmg.a.31661; Nikkel SM, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-63; Petrovski S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005492; Philippakis AA, 2015, HUM MUTAT, V36, P915, DOI 10.1002/humu.22858; Rice GM, 2006, AM J MED GENET A, V140A, P1637, DOI 10.1002/ajmg.a.31349; Rohatgi S, 2010, AM J MED GENET A, V152A, P1641, DOI 10.1002/ajmg.a.33441; Rosenfeld JA, 2011, EUR J MED GENET, V54, P42, DOI 10.1016/j.ejmg.2010.10.002; Schrier SA, 2012, AM J MED GENET A, V158A, P1865, DOI 10.1002/ajmg.a.35415; Shaffer LG, 2007, GENET MED, V9, P607, DOI 10.1097/GIM.0b013e3181484b49; Slavotinek AM, 2009, CLIN GENET, V75, P429, DOI 10.1111/j.1399-0004.2009.01182.x; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Sun ZZ, 2013, J BIOL CHEM, V288, P16715, DOI 10.1074/jbc.M113.462564; Sun ZZ, 2011, J BIOL CHEM, V286, P43902, DOI 10.1074/jbc.M111.301382; Wat MJ, 2011, J MED GENET, V48, P299, DOI 10.1136/jmg.2011.089680; Wei X, 2010, BIOCHEM BIOPH RES CO, V393, P860, DOI 10.1016/j.bbrc.2010.02.099; Ye YC, 2016, ONCOTARGET, V7, P17854, DOI 10.18632/oncotarget.7439; Yuan B, 2015, J CLIN INVEST, V125, P636, DOI 10.1172/JCI77435; Zhao J, 2009, NEUROSCI LETT, V460, P66, DOI 10.1016/j.neulet.2009.05.024; Zhu Y, 2004, J CELL BIOCHEM, V93, P579, DOI 10.1002/jcb.20175; Zweier C, 2009, AM J HUM GENET, V85, P655, DOI 10.1016/j.ajhg.2009.10.004	39	33	34	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 6	2017	101	1					139	148		10.1016/j.ajhg.2017.06.002	http://dx.doi.org/10.1016/j.ajhg.2017.06.002			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EZ7FK	28686853	Green Published, Bronze			2022-12-18	WOS:000404886800012
J	Jansen, S; Geuer, S; Pfundt, R; Brough, R; Ghongane, P; Herkert, JC; Marco, EJ; Willemsen, MH; Kleefstra, T; Hannibal, M; Shieh, JT; Lynch, SA; Flinter, F; FitzPatrick, DR; Gardham, A; Bernhard, B; Ragge, N; Newbury-Ecob, R; Bernier, R; Kvarnung, M; Magnusson, EAH; Wessels, MW; van Slegtenhorst, MA; Monaghan, KG; de Vries, P; Veltman, JA; Lord, CJ; Vissers, LELM; de Vries, BBA				Jansen, Sandra; Geuer, Sinje; Pfundt, Rolph; Brough, Rachel; Ghongane, Priyanka; Herkert, Johanna C.; Marco, Elysa J.; Willemsen, Marjolein H.; Kleefstra, Tjitske; Hannibal, Mark; Shieh, Joseph T.; Lynch, Sally Ann; Flinter, Frances; FitzPatrick, David R.; Gardham, Alice; Bernhard, Birgitta; Ragge, Nicola; Newbury-Ecob, Ruth; Bernier, Raphael; Kvarnung, Malin; Magnusson, E. A. Helena; Wessels, Marja W.; van Slegtenhorst, Marjon A.; Monaghan, Kristin G.; de Vries, Petra; Veltman, Joris A.; Lord, Christopher J.; Vissers, Lisenka E. L. M.; de Vries, Bert B. A.		Deciphering Dev Disorders Study	De Novo Truncating Mutations in the Last and Penultimate Exons of PPM1D Cause an Intellectual Disability Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOMINANT ROBINOW SYNDROME; SCHIZOPHRENIA; FRAMESHIFT; SPECTRUM; DISEASE; AUTISM; CANCER; BLOOD; GENE; WIP1	Intellectual disability (ID) is a highly heterogeneous disorder involving at least 600 genes, yet a genetic diagnosis remains elusive in similar to 35%-40% of individuals with moderate to severe ID. Recent meta-analyses statistically analyzing de novo mutations in >7,000 individuals with neurodevelopmental disorders highlighted mutations in PPM1D as a possible cause of ID. PPM1D is a type 2C phosphatase that functions as a negative regulator of cellular stress-response pathways by mediating a feedback loop of p38-p53 signaling, thereby contributing to growth inhibition and suppression of stress-induced apoptosis. We identified 14 individuals with mild to severe ID and/or developmental delay and de novo truncating PPM1D mutations. Additionally, deep phenotyping revealed overlapping behavioral problems (ASD, ADHD, and anxiety disorders), hypotonia, broad-based gait, facial dysmorphisms, and periods of fever and vomiting. PPM1D is expressed during fetal brain development and in the adult brain. All mutations were located in the last or penultimate exon, suggesting escape from nonsense-mediated mRNA decay. Both PPM1D expression analysis and cDNA sequencing in EBV LCLs of individuals support the presence of a stable truncated transcript, consistent with this hypothesis. Exposure of cells derived from individuals with PPM1D truncating mutations to ionizing radiation resulted in normal p53 activation, suggesting that p53 signaling is unaffected. However, a cell-growth disadvantage was observed, suggesting a possible effect on the stress-response pathway. Thus, we show that de novo truncating PPM1D mutations in the last and penultimate exons cause syndromic ID, which provides additional insight into the role of cell-cycle checkpoint genes in neurodevelopmental disorders.	[Jansen, Sandra; Geuer, Sinje; Pfundt, Rolph; Willemsen, Marjolein H.; Kleefstra, Tjitske; de Vries, Petra; Veltman, Joris A.; Vissers, Lisenka E. L. M.; de Vries, Bert B. A.] Radboud Univ Nijmegen Med Ctr, Donders Ctr Neurosci, Dept Human Genet, POB 9101, NL-6500 HB Nijmegen, Netherlands; [Brough, Rachel; Ghongane, Priyanka; Lord, Christopher J.] Inst Canc Res, Canc Res UK Gene Funct Lab, London SW3 6JB, England; [Brough, Rachel; Ghongane, Priyanka; Lord, Christopher J.] Inst Canc Res, Breast Canc Now Res Ctr, London SW3 6JB, England; [Herkert, Johanna C.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, POB 30001, NL-9700 RB Groningen, Netherlands; [Marco, Elysa J.] Univ Calif San Francisco, Dept Neurol, 675 Nelson Rising Lane, Suite 405, San Francisco, CA 94143 USA; [Marco, Elysa J.] Univ Calif San Francisco, Dept Pediat, 675 Nelson Rising Lane, Suite 405, San Francisco, CA 94143 USA; [Marco, Elysa J.] Univ Calif San Francisco, Dept Psychiat, 675 Nelson Rising Lane, Suite 405, San Francisco, CA 94143 USA; [Hannibal, Mark] Univ Michigan, Sch Med, Div Pediat Genet Metab & Genom Med, D5257 Med Prof Bldg,1500 East Med Ctr Dr, Ann Arbor, MI 48109 USA; [Shieh, Joseph T.] Univ Calif San Francisco, UCSF Benioff Childrens Hosp, Inst Human Genet, Dept Pediat,Div Med Genet, San Francisco, CA 94143 USA; [Lynch, Sally Ann] Childrens Univ Hosp, Clin Genet, Temple St, Dublin 1, Ireland; [Lynch, Sally Ann] Univ Coll Dublin, Sch Med & Med Sci, Acad Ctr Rare Dis, Dublin 1, Ireland; [Flinter, Frances] Guys & St Thomas NHS Fdn Trust, Dept Clin Genet, Great Maze Pond, London SE1 9RT, England; [FitzPatrick, David R.] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Med Res Council Human Genet Unit, Crewe Rd South, Edinburgh EH4 2XU, Midlothian, Scotland; [Gardham, Alice; Bernhard, Birgitta] North West London Hosp, North West Thames Reg Genet Serv Kennedy Galton C, London HA1 3UJ, England; [Ragge, Nicola] Oxford Brookes Univ, Fac Hlth & Life Sci, Gipsy Lane, Oxford OX3 0BP, England; [Ragge, Nicola] Birmingham Womens Hosp NHS Fdn Trust, West Midlands Reg Clin Genet Serv & Birmingham Hl, Birmingham B15 2TG, W Midlands, England; [Newbury-Ecob, Ruth] St Michaels Hosp, Univ Hosp Bristol NHS Fdn Trust, Dept Clin Genet, Southwell St, Bristol BS2 8EG, Avon, England; [Bernier, Raphael] Univ Washington, Ctr Human Dev & Disabil, POB 357920, Seattle, WA 98195 USA; [Kvarnung, Malin] Karolinska Univ Hosp Solna, Karolinska Inst, Dept Clin Genet, S-17177 Stockholm, Sweden; [Magnusson, E. A. Helena] Habilitat Org, Dept Med & Neurol, Reg Skane 291, S-29189 Kristianstad, Sweden; [Wessels, Marja W.; van Slegtenhorst, Marjon A.] Erasmus MC, Dept Clin Genet, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Monaghan, Kristin G.] GeneDx, Gaithersburg, MD 20877 USA; [Veltman, Joris A.] Maastricht Univ, Med Ctr, Dept Clin Genet, Univ Singel 50, NL-9229 ER Maastricht, Netherlands	Radboud University Nijmegen; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Groningen; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Michigan System; University of Michigan; University of California System; University of California San Francisco; Childrens University Hospital - Temple Street; University College Dublin; Guy's & St Thomas' NHS Foundation Trust; University of Edinburgh; Oxford Brookes University; Birmingham Women's Hospital; University of Bristol; University of Washington; University of Washington Seattle; Karolinska Institutet; Karolinska University Hospital; Erasmus University Rotterdam; Erasmus MC; Maastricht University	de Vries, BBA (corresponding author), Radboud Univ Nijmegen Med Ctr, Donders Ctr Neurosci, Dept Human Genet, POB 9101, NL-6500 HB Nijmegen, Netherlands.	bert.devries@radboudumc.nl	Vissers, Lisenka ELM/A-2598-2015; Kleefstra, Tjitske/G-2619-2012; Veltman, Joris A/F-5128-2010; Willemsen, Marjolein/R-5958-2019; Pfundt, Rolph/L-4576-2015; Lord, Christopher/AAX-7130-2021; Lord, Christopher/B-3295-2012	Vissers, Lisenka ELM/0000-0001-6470-5497; Veltman, Joris A/0000-0002-3218-8250; Hannibal, Mark/0000-0002-9077-3837; Lord, Christopher/0000-0002-3226-0515; Jansen, Sandra/0000-0001-9453-8124; FitzPatrick, David R./0000-0003-4861-969X; Lynch, Sally Ann/0000-0003-3540-1333	Netherlands Organisation for Health Research and Development [917-86-319, 912-12-109, 907-00-365, 918-15-667]; European Research Council [DENOVO 281964]; Medical Research Council University Unit grant; Health Innovation Challenge Fund [HICF-1009-003]; Wellcome Trust; Department of Health; Wellcome Trust Sanger Institute [WT098051]; National Institute for Health Research through Comprehensive Clinical Research Network; MRC [MC_PC_U127561093] Funding Source: UKRI; Medical Research Council [MC_PC_U127561093] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083091] Funding Source: NIH RePORTER	Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); European Research Council(European Research Council (ERC)European Commission); Medical Research Council University Unit grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Health Innovation Challenge Fund; Wellcome Trust(Wellcome Trust); Department of Health; Wellcome Trust Sanger Institute(Wellcome Trust); National Institute for Health Research through Comprehensive Clinical Research Network; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank the individuals and their parents for participating in this study. We thank Caroline Wright for her help in contacting referring clinicians from the Deciphering Developmental Disorders (DDD) study, Megan Cho for her help in contacting referring clinicians from GeneDx, Jessica Radley for clinical support, and Ms. Saskia van der Velde-Visser for culturing cells. This work was financially supported by grants from the Netherlands Organisation for Health Research and Development (917-86-319 to B.B.A.d.V., 912-12-109 to B.B.A.d.V. and J.A.V., 907-00-365 to T.K., and 918-15-667 to J.A.V.) and the European Research Council (starting grant DENOVO 281964 to J.A.V.). D.R.F. is funded by a Medical Research Council University Unit grant to the University of Edinburgh. The DDD study presents independent research commissioned by the Health Innovation Challenge Fund (grant HICF-1009-003), a parallel funding partnership among the Wellcome Trust, Department of Health, and Wellcome Trust Sanger Institute (grant WT098051). The views expressed in this publication are those of the authors and not necessarily those of the Wellcome Trust or the Department of Health. The research team acknowledges the support of the National Institute for Health Research through the Comprehensive Clinical Research Network.	Bunn KJ, 2015, AM J HUM GENET, V96, P623, DOI 10.1016/j.ajhg.2015.02.010; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Ferner RE, 2013, HAND CLINIC, V115, P939, DOI 10.1016/B978-0-444-52902-2.00053-9; Filipponi D, 2013, CANCER CELL, V24, P528, DOI 10.1016/j.ccr.2013.08.022; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Francioli LC, 2014, NAT GENET, V46, P818, DOI 10.1038/ng.3021; Gilissen C, 2014, NATURE, V511, P344, DOI [10.1038/nature13394, 10.3389/fnhum.2013.00444]; Grozeva D, 2015, HUM MUTAT, V36, P1197, DOI 10.1002/humu.22901; Gulsuner S, 2013, CELL, V154, P518, DOI 10.1016/j.cell.2013.06.049; Hamdan FF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004772; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Kleiblova P, 2013, J CELL BIOL, V201, P511, DOI 10.1083/jcb.201210031; Kuechler A, 2015, HUM GENET, V134, P97, DOI 10.1007/s00439-014-1498-1; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lelieveld SH, 2016, NAT NEUROSCI, V19, P1194, DOI 10.1038/nn.4352; Lu XB, 2008, CANCER METAST REV, V27, P123, DOI 10.1007/s10555-008-9127-x; Makishima H, 2013, NAT GENET, V45, P942, DOI 10.1038/ng.2696; McRae J. F., 2016, BIORXIV; Mukhopadhyay A, 2006, INVEST OPHTH VIS SCI, V47, P3565, DOI 10.1167/iovs.06-0141; Nlemeyer CM, 2014, HAEMATOLOGICA, V99, P1653, DOI 10.3324/haematol.2014.114595; Pharoah PDP, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv347; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Ruan CS, 2015, NEUROSCIENCE, V293, P12, DOI 10.1016/j.neuroscience.2015.02.037; Ruark E, 2013, NATURE, V493, P406, DOI 10.1038/nature11725; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Sobreira N, 2015, HUM MUTAT, V36, P425, DOI 10.1002/humu.22769; Swisher EM, 2016, JAMA ONCOL, V2, P370, DOI 10.1001/jamaoncol.2015.6053; Vissers LELM, 2016, NAT REV GENET, V17, P9, DOI 10.1038/nrg3999; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; White J, 2015, AM J HUM GENET, V96, P612, DOI 10.1016/j.ajhg.2015.02.015; White JJ, 2016, AM J HUM GENET, V98, P553, DOI 10.1016/j.ajhg.2016.01.005; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446; Zajkowicz A, 2015, BRIT J CANCER, V112, P1114, DOI 10.1038/bjc.2015.79	37	33	36	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 6	2017	100	4					650	658		10.1016/j.ajhg.2017.02.005	http://dx.doi.org/10.1016/j.ajhg.2017.02.005			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EQ9FK	28343630	Green Published, Bronze, Green Submitted			2022-12-18	WOS:000398389600007
J	Santoni, FA; Stamoulis, G; Garieri, M; Falconnet, E; Ribaux, P; Borel, C; Antonarakis, SE				Santoni, Federico A.; Stamoulis, Georgios; Garieri, Marco; Falconnet, Emilie; Ribaux, Pascale; Borel, Christelle; Antonarakis, Stylianos E.			Detection of Imprinted Genes by Single-Cell Allele-Specific Gene Expression	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MATERNAL UNIPARENTAL DISOMY; WHITE BLOOD-CELLS; REGULATORY VARIATION; PRADER-WILLI; RNA-SEQ; MOUSE; DOMAIN; GENOME; GROWTH; SUGGESTS	Genomic imprinting results in parental-specific gene expression. Imprinted genes are involved in the etiology of rare syndromes and have been associated with common diseases such as diabetes and cancer. Standard RNA bulk cell sequencing applied to whole-tissue samples has been used to detect imprinted genes in human and mouse models. However, lowly expressed genes cannot be detected by using RNA bulk approaches. Here, we report an original and robust method that combines single-cell RNA-seq and whole-genome sequencing into an optimized statistical framework to analyze genomic imprinting in specific cell types and in different individuals. Using samples from the probands of 2 family trios and 3 unrelated individuals, 1,084 individual primary fibroblasts were RNA sequenced and more than 700,000 informative heterozygous single-nucleotide variations (SNVs) were genotyped. The allele-specific coverage per gene of each SNV in each single cell was used to fit a beta-binomial distribution to model the likelihood of a gene being expressed from one and the same allele. Genes presenting a significant aggregate allelic ratio (between 0.9 and 1) were retained to identify of the allelic parent of origin. Our approach allowed us to validate the imprinting status of all of the known imprinted genes expressed in fibroblasts and the discovery of nine putative imprinted genes, thereby demonstrating the advantages of single-cell over bulk RNA-seq to identify imprinted genes. The proposed single-cell methodology is a powerful tool for establishing a cell type-specific map of genomic imprinting.	[Santoni, Federico A.; Stamoulis, Georgios; Garieri, Marco; Falconnet, Emilie; Ribaux, Pascale; Borel, Christelle; Antonarakis, Stylianos E.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Santoni, Federico A.; Antonarakis, Stylianos E.] Univ Hosp Geneva, CH-1211 Geneva, Switzerland; [Antonarakis, Stylianos E.] Inst Genet & Genom Geneva, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva	Santoni, FA; Antonarakis, SE (corresponding author), Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland.; Santoni, FA; Antonarakis, SE (corresponding author), Univ Hosp Geneva, CH-1211 Geneva, Switzerland.; Antonarakis, SE (corresponding author), Inst Genet & Genom Geneva, CH-1211 Geneva, Switzerland.	federico.santoni@unige.ch; stylianos.antonarakis@unige.ch	borel, christelle/AAC-9645-2019; Antonarakis, Stylianos E/N-8866-2014	Antonarakis, Stylianos E/0000-0001-8907-5823; Santoni, Federico/0000-0002-3258-4747	Swiss National Science Foundation [SNF-144082]; European Research Council [ERC-249968]; ChildCare foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); ChildCare foundation	We thank Olivier Delaneau for help with the SHAPEIT software. This work was supported by grants from the Swiss National Science Foundation (SNF-144082), the European Research Council (ERC-249968), and the ChildCare foundation to S.E.A.. The computations were performed at the Vital-IT Center for high-performance computing of the Swiss Institute of Bioinformatics (SIB).	Abu-Amero S, 2008, J MED GENET, V45, P193, DOI 10.1136/jmg.2007.053017; Albert FW, 2015, NAT REV GENET, V16, P197, DOI 10.1038/nrg3891; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Andres AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001157; Babak T, 2015, NAT GENET, V47, P544, DOI 10.1038/ng.3274; Baran Y, 2015, GENOME RES, V25, P927, DOI 10.1101/gr.192278.115; BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; Benetatos L, 2011, INT J CANCER, V129, P773, DOI 10.1002/ijc.26052; Borel C, 2015, AM J HUM GENET, V96, P70, DOI 10.1016/j.ajhg.2014.12.001; Cavaille J, 2002, HUM MOL GENET, V11, P1527, DOI 10.1093/hmg/11.13.1527; Charlier C, 2001, GENOME RES, V11, P850, DOI 10.1101/gr.172701; Chung J, 2012, EPIGENETICS-US, V7, P429, DOI 10.4161/epi.19777; Court F, 2014, GENOME RES, V24, P554, DOI 10.1101/gr.164913.113; Da Rocha ST, 2008, TRENDS GENET, V24, P306, DOI 10.1016/j.tig.2008.03.011; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; Deng XX, 2014, NAT REV GENET, V15, P367, DOI 10.1038/nrg3687; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; DONLON TA, 1988, HUM GENET, V80, P322, DOI 10.1007/BF00273644; EGGERDING FA, 1994, AM J HUM GENET, V55, P253; Gutierrez-Arcelus M, 2013, ELIFE, V2, DOI 10.7554/eLife.00523; Joshi RS, 2016, AM J HUM GENET, V99, P555, DOI 10.1016/j.ajhg.2016.06.032; Kagami M, 2008, NAT GENET, V40, P237, DOI 10.1038/ng.2007.56; Kagami M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000992; Kim JK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9687; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; Kuiper JJW, 2014, HUM MOL GENET, V23, P6081, DOI 10.1093/hmg/ddu307; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Marco-Sola S, 2012, NAT METHODS, V9, P1185, DOI [10.1038/NMETH.2221, 10.1038/nmeth.2221]; Marinov GK, 2014, GENOME RES, V24, P496, DOI 10.1101/gr.161034.113; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; Ogata T, 2008, EPIGENETICS-US, V3, P181, DOI 10.4161/epi.3.4.6550; Pant PVK, 2006, GENOME RES, V16, P331, DOI 10.1101/gr.4559106; Pastinen T, 2010, NAT REV GENET, V11, P533, DOI 10.1038/nrg2815; Plasschaert RN, 2014, DEVELOPMENT, V141, P1805, DOI 10.1242/dev.101428; REIK W, 1995, HUM MOL GENET, V4, P2379, DOI 10.1093/hmg/4.12.2379; Sanchez-Delgado M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006427; SCHINZEL A, 1993, AM J MED GENET, V46, P683, DOI 10.1002/ajmg.1320460616; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817; TEMPLE IK, 1991, J MED GENET, V28, P511, DOI 10.1136/jmg.28.8.511; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Weber MJ, 2006, PLOS GENET, V2, P1984, DOI 10.1371/journal.pgen.0020205; WEKSBERG R, 1993, HUM MOL GENET, V2, P549, DOI 10.1093/hmg/2.5.549; Wylie AA, 2000, GENOME RES, V10, P1711, DOI 10.1101/gr.161600; Ye M, 2013, NAT CELL BIOL, V15, P385, DOI 10.1038/ncb2698; Zheng DY, 2007, GENOME RES, V17, P839, DOI 10.1101/gr.5586307	51	33	33	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 2	2017	100	3					444	453		10.1016/j.ajhg.2017.01.028	http://dx.doi.org/10.1016/j.ajhg.2017.01.028			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EN2PH	28190458	Green Published, Bronze			2022-12-18	WOS:000395851900011
J	Sleven, H; Welsh, SJ; Yu, J; Churchill, MEA; Wright, CF; Henderson, A; Horvath, R; Rankin, J; Vogt, J; Magee, A; McConnell, V; Green, A; King, MD; Cox, H; Armstrong, L; Lehman, A; Nelson, TN; Williams, J; Clouston, P; Hagman, J; Nemeth, AH				Sleven, Hannah; Welsh, Seth J.; Yu, Jing; Churchill, Mair E. A.; Wright, Caroline F.; Henderson, Alex; Horvath, Rita; Rankin, Julia; Vogt, Julie; Magee, Alex; McConnell, Vivienne; Green, Andrew; King, Mary D.; Cox, Helen; Armstrong, Linlea; Lehman, Anna; Nelson, Tanya N.; Williams, Jonathan; Clouston, Penny; Hagman, James; Nemeth, Andrea H.		Deciphering Dev Disorders Study; CAUSES Study	De Novo Mutations in EBF3 Cause a Neurodevelopmental Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							B-CELL FACTOR; TRANSCRIPTION FACTOR; NEURONAL DIFFERENTIATION; GENES; FRAMEWORK; FAMILY; SPECIFICATION; RECOGNITION; ACTIVATION; REGULATOR	Early B cell factor 3 (EBF3) is an atypical transcription factor that is thought to influence the laminar formation of the cerebral cortex. Here, we report that de novo mutations in EBF3 cause a complex neurodevelopmental syndrome. The mutations were identified in two large-scale sequencing projects: the UK Deciphering Developmental Disorders (DDD) study and the Canadian Clinical Assessment of the Utility of Sequencing and Evaluation as a Service (CAUSES) study. The core phenotype includes moderate to severe intellectual disability, and many individuals exhibit cerebellar ataxia, subtle facial dysmorphism, strabismus, and vesicoureteric reflux, suggesting that EBF3 has a widespread developmental role. Pathogenic de novo variants identified in EBF3 include multiple loss-of-function and missense mutations. Structural modeling suggested that the missense mutations affect DNA binding. Functional analysis of mutant proteins with missense substitutions revealed reduced transcriptional activities and abilities to form heterodimers with wild-type EBF3. We conclude that EBF3, a transcription factor previously unknown to be associated with human disease, is important for brain and other organ development and warrants further investigation.	[Sleven, Hannah; Yu, Jing; Nemeth, Andrea H.] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Welsh, Seth J.; Churchill, Mair E. A.; Hagman, James] Univ Colorado, Program Mol Biol, Anschutz Med Campus, Aurora, CO 80045 USA; [Churchill, Mair E. A.] Univ Colorado, Dept Pharmacol, Anschutz Med Campus, Aurora, CO 80045 USA; [Wright, Caroline F.; Deciphering Dev Disorders Study] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SA, England; [Henderson, Alex] Newcastle Upon Tyne Hosp NHS Fdn Trust, Northern Genet Serv, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Horvath, Rita] Newcastle Univ, Inst Med Genet, John Walton Muscular Dystrophy Res Ctr, Cent Pkwy, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Rankin, Julia] Peninsula Clin Genet Serv, Exeter EX1 2ED, Devon, England; [Vogt, Julie; Cox, Helen] Birmingham Womens Hosp, Birmingham Womens NHS Fdn Trust, West Midlands Reg Genet Serv, Birmingham B15 2TG, W Midlands, England; [Magee, Alex; McConnell, Vivienne] Belfast City Hosp, Dept Med Genet, Belfast BT9 7AB, Antrim, North Ireland; [Green, Andrew] Our Ladys Hosp Sick Children, Dept Clin Genet, Dublin D12 N512, Ireland; [Green, Andrew] Univ Coll Dublin, Sch Med & Med Sci, Hlth Sci Ctr, Dublin 4, Ireland; [King, Mary D.] Temple St Childrens Univ Hosp, Dept Paediat Neurol & Clin Neurophysiol, Dublin 1, Ireland; [King, Mary D.] Univ Coll Dublin, Sch Med & Med Sci, Acad Ctr Rare Dis, Dublin 4, Ireland; [Armstrong, Linlea; Lehman, Anna; CAUSES Study] Childrens & Womens Hlth Ctr British Columbia, Dept Med Genet, 4500 Oak St, Vancouver, BC V6H 3N1, Canada; [Nelson, Tanya N.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada; [Nelson, Tanya N.] BC Childrens Hosp, Dept Pathol & Lab Med, Vancouver, BC V6H 3N1, Canada; [Nelson, Tanya N.] BC Womens Hosp, Dept Pathol & Lab Med, Vancouver, BC V6H 3N1, Canada; [Williams, Jonathan; Clouston, Penny] Oxford Univ Hosp NHS Fdn Trust, Churchill Hosp, Oxford Med Genet Labs, Oxford OX3 7LJ, England; [Hagman, James] Natl Jewish Hlth, Dept Biomed Res, Denver, CO 80206 USA; [Nemeth, Andrea H.] Oxford Univ Hosp NHS Fdn Trust, Nuffield Orthopaed Ctr, Oxford Ctr Genom Med, Windmill Rd, Oxford OX3 7HE, England	University of Oxford; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Wellcome Trust Sanger Institute; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; Birmingham Women's Hospital; Belfast City Hospital; Our Ladys Children Hospital Crumlin; University College Dublin; Childrens University Hospital - Temple Street; University College Dublin; BC Women's Hospital & Health Centre; University of British Columbia; BC Childrens Hospital; University of British Columbia; University of British Columbia; Oxford University Hospitals NHS Foundation Trust; University of Oxford; National Jewish Health; Nuffield Orthopaedic Centre; Oxford University Hospitals NHS Foundation Trust	Nemeth, AH (corresponding author), Univ Oxford, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England.; Hagman, J (corresponding author), Univ Colorado, Program Mol Biol, Anschutz Med Campus, Aurora, CO 80045 USA.; Hagman, J (corresponding author), Natl Jewish Hlth, Dept Biomed Res, Denver, CO 80206 USA.; Nemeth, AH (corresponding author), Oxford Univ Hosp NHS Fdn Trust, Nuffield Orthopaed Ctr, Oxford Ctr Genom Med, Windmill Rd, Oxford OX3 7HE, England.	hagmanj@njhealth.org; andrea.nemeth@ndcn.ox.ac.uk	Horvath, Rita/AAY-7042-2020; Green, Andrew/AAJ-7592-2020; Lehman, Anna/R-6706-2017; Hagman, James/R-7013-2019; Churchill, Mair E. A./C-5549-2014	Lehman, Anna/0000-0003-0636-123X; Hagman, James/0000-0002-5436-8455; Churchill, Mair E. A./0000-0003-0862-235X; Wright, Caroline/0000-0003-2958-5076; Yu, Jing/0000-0001-8001-8494; Nelson, Tanya/0000-0001-5344-3516; Green, Andrew/0000-0002-1077-7417; Sleven, Hannah/0000-0001-8804-4777; Williams, Jonathan/0000-0003-2672-2450; Horvath, Rita/0000-0002-9841-170X; Nemeth, Andrea/0000-0002-2941-7657; Armstrong, Linlea/0000-0002-8191-6429	National Jewish Health Flow Cytometry Core; Action Medical Research; Henry Smith Charity; RP Fighting Blindness; Fight for Sight; Wendy Siegel Fund for Leukemia and Cancer Research; Victor W. Bolie and Earleen D. Bolie Graduate Scholarship Fund; Health Innovation Challenge Fund [HICF-1009-003]; Wellcome Trust; Department of Health; Wellcome Trust Sanger Institute [WT098051]; National Institute for Health Research through the Comprehensive Clinical Research Network; Mining for Miracles; British Columbia Children's Hospital Foundation; Genome British Columbia; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI098417] Funding Source: NIH RePORTER; Medical Research Council [G1000848, MR/N027302/1, MC_UP_1502/3, MR/N025431/1] Funding Source: researchfish; Action Medical Research [2063] Funding Source: researchfish; MRC [MC_UP_1502/3, MR/N025431/1, G1000848] Funding Source: UKRI	National Jewish Health Flow Cytometry Core; Action Medical Research; Henry Smith Charity; RP Fighting Blindness; Fight for Sight; Wendy Siegel Fund for Leukemia and Cancer Research; Victor W. Bolie and Earleen D. Bolie Graduate Scholarship Fund; Health Innovation Challenge Fund; Wellcome Trust(Wellcome Trust); Department of Health; Wellcome Trust Sanger Institute(Wellcome Trust); National Institute for Health Research through the Comprehensive Clinical Research Network(National Institute for Health Research (NIHR)); Mining for Miracles; British Columbia Children's Hospital Foundation; Genome British Columbia; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Action Medical Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors would like to thank Gregory Downey and Philippa Marrack for helpful suggestions and support, Desiree Straign for excellent technical assistance, and the National Jewish Health Flow Cytometry Core and Josh Loomis for their support and technical assistance. This work was funded by Action Medical Research and the Henry Smith Charity (A.H.N. and H.S.), RP Fighting Blindness and Fight for Sight (J.Y.), the Wendy Siegel Fund for Leukemia and Cancer Research (J.H.), and the Victor W. Bolie and Earleen D. Bolie Graduate Scholarship Fund (S.J.W.). The DDD study presents independent research commissioned by the Health Innovation Challenge Fund (grant HICF-1009-003), a parallel funding partnership between the Wellcome Trust and the Department of Health, and the Wellcome Trust Sanger Institute (grant WT098051). The views expressed in this publication are those of the author(s) and not necessarily those of the Wellcome Trust or the Department of Health. The research team acknowledges the support of the National Institute for Health Research through the Comprehensive Clinical Research Network. The CAUSES Study is funded by Mining for Miracles, British Columbia Children's Hospital Foundation, and Genome British Columbia.	Belbin O, 2011, HUM GENET, V129, P273, DOI 10.1007/s00439-010-0924-2; Boller S, 2016, IMMUNITY, V44, P527, DOI 10.1016/j.immuni.2016.02.021; Chiara F, 2012, DEV BIOL, V365, P277, DOI 10.1016/j.ydbio.2012.02.034; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Croci L, 2006, DEVELOPMENT, V133, P2719, DOI 10.1242/dev.02437; Dubois L, 1998, CURR BIOL, V8, P199, DOI 10.1016/S0960-9822(98)70084-3; FELDHAUS AL, 1992, MOL CELL BIOL, V12, P1126, DOI 10.1128/MCB.12.3.1126; Fields S, 2008, MOL IMMUNOL, V45, P3786, DOI 10.1016/j.molimm.2008.05.018; Firth HV, 2011, DEV MED CHILD NEUROL, V53, P702, DOI 10.1111/j.1469-8749.2011.04032.x; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Fitzsimmons D, 2001, NUCLEIC ACIDS RES, V29, P4154, DOI 10.1093/nar/29.20.4154; Friocourt G, 2011, FRONT CELL NEUROSCI, V5, DOI [10.3389/fncel.2011.00028, 10.3389/fnbeh.2011.00028]; Fulp CT, 2008, HUM MOL GENET, V17, P3740, DOI 10.1093/hmg/ddn271; Gao H, 2009, P NATL ACAD SCI USA, V106, P11258, DOI 10.1073/pnas.0809485106; Garel S, 1997, DEV DYNAM, V210, P191, DOI 10.1002/(SICI)1097-0177(199711)210:3<191::AID-AJA1>3.0.CO;2-B; HAGMAN J, 1991, EMBO J, V10, P3409, DOI 10.1002/j.1460-2075.1991.tb04905.x; HAGMAN J, 1995, EMBO J, V14, P2907, DOI 10.1002/j.1460-2075.1995.tb07290.x; Harms FL, 2017, AM J HUM GENET, V100, P117, DOI 10.1016/j.ajhg.2016.11.012; Heckl D, 2012, MOL THER, V20, P1187, DOI 10.1038/mt.2012.59; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kitamura K, 2002, NAT GENET, V32, P359, DOI 10.1038/ng1009; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Liao DQ, 2009, MOL CANCER RES, V7, P1893, DOI 10.1158/1541-7786.MCR-09-0229; Lukin K, 2011, EUR J IMMUNOL, V41, P1787, DOI 10.1002/eji.201041137; Lukin K, 2010, P NATL ACAD SCI USA, V107, P7869, DOI 10.1073/pnas.1003525107; Maier H, 2004, NAT IMMUNOL, V5, P1069, DOI 10.1038/ni1119; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McRae J. F., 2016, BIORXIV; Musselman CA, 2012, P NATL ACAD SCI USA, V109, P787, DOI 10.1073/pnas.1113655109; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Pozzoli O, 2001, DEV BIOL, V233, P495, DOI 10.1006/dbio.2001.0230; Prasad MAJ, 2015, BLOOD, V125, P4052, DOI 10.1182/blood-2014-12-617282; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Stromme P, 2002, NAT GENET, V30, P441, DOI 10.1038/ng862; Treiber N, 2010, GENE DEV, V24, P2270, DOI 10.1101/gad.1976610; van de Leemput J, 2014, NEURON, V83, P51, DOI 10.1016/j.neuron.2014.05.013; Wang SS, 1997, J NEUROSCI, V17, P4149; Wang SS, 2004, DEVELOPMENT, V131, P1377, DOI 10.1242/dev.01009; Wright CF, 2015, LANCET, V385, P1305, DOI 10.1016/S0140-6736(14)61705-0; Yamazaki H, 2004, P NATL ACAD SCI USA, V101, P14509, DOI 10.1073/pnas.0406295101	42	33	33	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 5	2017	100	1					138	150		10.1016/j.ajhg.2016.11.020	http://dx.doi.org/10.1016/j.ajhg.2016.11.020			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EH6UX	28017370	Green Published, Bronze			2022-12-18	WOS:000391910500012
J	Santos-Cortez, RLP; Faridi, R; Rehman, AU; Lee, K; Ansar, M; Wang, X; Morell, RJ; Isaacson, R; Belyantseva, IA; Dai, H; Acharya, A; Qaiser, TA; Muhammad, D; Ali, RA; Shams, S; Hassan, MJ; Shahzad, S; Raza, SI; Bashir, ZEH; Smith, JD; Nickerson, DA; Bamshad, MJ; Riazuddin, S; Ahmad, W; Friedman, TB; Leal, SM				Santos-Cortez, Regie Lyn P.; Faridi, Rabia; Rehman, Atteeq U.; Lee, Kwanghyuk; Ansar, Muhammad; Wang, Xin; Morell, Robert J.; Isaacson, Rivka; Belyantseva, Inna A.; Dai, Hang; Acharya, Anushree; Qaiser, Tanveer A.; Muhammad, Dost; Ali, Rana Amjad; Shams, Sulaiman; Hassan, Muhammad Jawad; Shahzad, Shaheen; Raza, Syed Irfan; Bashir, Zil-e-Huma; Smith, Joshua D.; Nickerson, Deborah A.; Bamshad, Michael J.; Riazuddin, Sheikh; Ahmad, Wasim; Friedman, Thomas B.; Leal, Suzanne M.		Univ Washington Ctr Mendelian Geno	Autosomal-Recessive Hearing Impairment Due to Rare Missense Variants within S1PR2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SPHINGOSINE 1-PHOSPHATE RECEPTOR; PROTEIN-COUPLED RECEPTOR; ENDOTHELIAL-CELLS; CRYSTAL-STRUCTURE; HAIR-CELLS; INNER-EAR; SPHINGOSINE-1-PHOSPHATE; S1P(2); ACTIVATION; MUTATIONS	The sphingosine-1-phosphate receptors (S1PRs) are a well-studied class of transmembrane G protein-coupled sphingolipid receptors that mediate multiple cellular processes. However, S1PRs have not been previously reported to be involved in the genetic etiology of human traits. S1PR2 lies within the autosomal-recessive nonsyndromic hearing impairment (ARNSHI) locus DFNB68 on 19p13.2. From exome sequence data we identified two pathogenic S1PR2 variants, c.323G>C (p.Arg108Pro) and c.419A>G (p.Tyr140Cys). Each of these variants co-segregates with congenital profound hearing impairment in consanguineous Pakistani families with maximum LOD scores of 6.4 for family DEM4154 and 3.3 for family PKDF1400. Neither S1PR2 missense variant was reported among similar to 120,000 chromosomes in the Exome Aggregation Consortium database, in 76 unrelated Pakistani exomes, or in 720 Pakistani control chromosomes. Both DNA variants affect highly conserved residues of S1PR2 and are predicted to be damaging by multiple bioinformatics tools. Molecular modeling predicts that these variants affect binding of sphingosine-1-phosphate (p.Arg108Pro) and G protein docking (p.Tyr140Cys). In the previously reported S1pr2(-/-) mice, stria vascularis abnormalities, organ of Corti degeneration, and profound hearing loss were observed. Additionally, hair cell defects were seen in both knockout mice and morphant zebrafish. Family PKDF1400 presents with ARNSHI, which is consistent with the lack of gross malformations in S1pr2(-/-) mice, whereas family DEM4154 has lower limb malformations in addition to hearing loss. Our findings suggest the possibility of developing therapies against hair cell damage (e.g., from ototoxic drugs) through targeted stimulation of S1PR2.	[Santos-Cortez, Regie Lyn P.; Lee, Kwanghyuk; Ansar, Muhammad; Wang, Xin; Dai, Hang; Acharya, Anushree; Leal, Suzanne M.] Baylor Coll Med, Dept Mol & Human Genet, Ctr Stat Genet, Houston, TX 77030 USA; [Faridi, Rabia; Rehman, Atteeq U.; Morell, Robert J.; Belyantseva, Inna A.; Friedman, Thomas B.] NIDCD, Mol Genet Lab, NIH, Bethesda, MD 20892 USA; [Faridi, Rabia; Qaiser, Tanveer A.; Bashir, Zil-e-Huma] Univ Punjab, Ctr Excellence Mol Biol, Lahore 54550, Pakistan; [Ansar, Muhammad; Raza, Syed Irfan; Ahmad, Wasim] Quaid I Azam Univ, Dept Biochem, Fac Biol Sci, Islamabad 45320, Pakistan; [Isaacson, Rivka] Kings Coll London, Dept Chem, Fac Nat & Math Sci, London WC2R 2LS, England; [Muhammad, Dost] Chandka Med Coll, Larkana 77150, Sindh, Pakistan; [Ali, Rana Amjad; Riazuddin, Sheikh] Univ Lahore, Lahore 54550, Pakistan; [Shams, Sulaiman] Abdul Wali Khan Univ, Dept Biochem, Mardan 23200, Khyber Pakhtunk, Pakistan; [Hassan, Muhammad Jawad] Natl Univ Sci & Technol, Dept Healthcare Biotechnol, Atta Ur Rahman Sch Appl Biosci ASAB, Islamabad 44000, Pakistan; [Shahzad, Shaheen] Int Islamic Univ, Dept Biotechnol & Bioinformat, Islamabad 44000, Pakistan; [Smith, Joshua D.; Nickerson, Deborah A.; Bamshad, Michael J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Riazuddin, Sheikh] Allama Iqbal Med Res Ctr, Jinnah Hosp Complex, Lahore 54550, Pakistan; [Riazuddin, Sheikh] Shaheed Zulfiqar Ali Bhutto Med Univ, Islamabad 44000, Pakistan	Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); University of Punjab; Quaid I Azam University; University of London; King's College London; University of Lahore; Abdul Wali Khan University; National University of Sciences & Technology - Pakistan; International Islamic University, Pakistan; University of Washington; University of Washington Seattle	Leal, SM (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Ctr Stat Genet, Houston, TX 77030 USA.	sleal@bcm.edu	Shams, Sulaiman/AEW-4594-2022; Hassan, Muhammad Jawad/CAG-6580-2022; Acharya, Anushree/AAY-2391-2021; Morell, Robert James/Q-2042-2019; Rehman, Atteeq/AAG-8342-2020; Ansar, Muhammad/H-5967-2011; ACHARYA, ANUSHREE/AAU-4739-2021; Ahmad, Wasim/GSD-8904-2022; Faridi, Rabia/GRJ-1495-2022	Shams, Sulaiman/0000-0001-7792-1180; Ansar, Muhammad/0000-0001-5891-7063; Morell, Robert/0000-0003-1537-7356; Faridi, Rabia/0000-0001-7788-8755; Isaacson, Rivka Leah/0000-0002-9978-8904; Lee, Kwanghyuk/0000-0003-1389-1220	NIH intramural funds from the National Institute on Deafness and Other Communication Disorders (NIDCD) [DC000039-18]; Higher Education Commission of Pakistan; NIH-NIDCD [R01 DC011651, R01 DC003594]; NIH [N01-HG-65403]; National Human Genome Research Institute; National Heart, Lung and Blood Institute [U54HG006493]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006493, U54HG006493, N01HG065403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011651, R01DC003594, Z01DC000039, ZIADC000039, ZICDC000086, T32DC000039] Funding Source: NIH RePORTER	NIH intramural funds from the National Institute on Deafness and Other Communication Disorders (NIDCD); Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); NIH-NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We are very grateful to the families that participated in this study. This work was supported by NIH intramural funds from the National Institute on Deafness and Other Communication Disorders (NIDCD) DC000039-18 (to T.B.F.), the Higher Education Commission of Pakistan (to S.R. and W.A.), and NIH-NIDCD grants R01 DC011651 and R01 DC003594 (to S.M.L.). Genome-wide genotyping was performed at the Center for Inherited Disease Research, which is funded through the NIH to The Johns Hopkins University, Contract Number N01-HG-65403 (to S.M.L.). Exome sequencing for family DEM4154 was provided by the University of Washington Center for Mendelian Genomics and was funded by the National Human Genome Research Institute and the National Heart, Lung and Blood Institute grant U54HG006493 to D.A.N., Jay Shendure, and M.J.B. Sequencing work for family PKDF1400 utilized the computational resources of the NIH HPC Biowulf cluster.	Adada M, 2013, FEBS J, V280, P6354, DOI 10.1111/febs.12446; Bens S, 2011, EUR J MED GENET, V54, pE501, DOI 10.1016/j.ejmg.2011.05.004; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Collin RWJ, 2008, AM J HUM GENET, V82, P125, DOI 10.1016/j.ajhg.2007.09.008; Debien E, 2013, EUR J IMMUNOL, V43, P1667, DOI 10.1002/eji.201343312; Favor J, 1996, P NATL ACAD SCI USA, V93, P13870, DOI 10.1073/pnas.93.24.13870; Fishelson M, 2002, Bioinformatics, V18 Suppl 1, pS189; Gandy KAO, 2013, BIOCHEM J, V449, P661, DOI 10.1042/BJ20120213; Golfier S, 2010, FASEB J, V24, P4701, DOI 10.1096/fj.09-141473; Hansen MC, 2013, SCIENCE, V342, P850, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Harada J, 2004, J NEUROCHEM, V88, P1026, DOI 10.1046/j.1471-4159.2003.02219.x; Herr DR, 2007, J NEUROSCI, V27, P1474, DOI 10.1523/JNEUROSCI.4245-06.2007; Hu ZY, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.432; Ishii I, 2001, J BIOL CHEM, V276, P33697, DOI 10.1074/jbc.M104441200; Jo EJ, 2005, CHEM BIOL, V12, P703, DOI 10.1016/j.chembiol.2005.04.019; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Khan SY, 2007, HUM MUTAT, V28, P417, DOI 10.1002/humu.20469; Kitajiri S, 2004, J CELL BIOL, V166, P559, DOI 10.1083/jcb.200402007; Kono M, 2007, J BIOL CHEM, V282, P10690, DOI 10.1074/jbc.M700370200; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Q, 2015, EXP PHYSIOL, V100, P95, DOI 10.1113/expphysiol.2014.082149; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Lorenz JN, 2007, AM J PHYSIOL-REG I, V292, pR440, DOI 10.1152/ajpregu.00085.2006; MacLennan AJ, 2006, HEARING RES, V220, P38, DOI 10.1016/j.heares.2006.06.016; Manzari L, 2010, EUR ARCH OTO-RHINO-L, V267, P1487, DOI 10.1007/s00405-010-1317-9; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mendelson K, 2013, J BIOL CHEM, V288, P2143, DOI 10.1074/jbc.M112.427344; Mitchem KL, 2002, HUM MOL GENET, V11, P1887, DOI 10.1093/hmg/11.16.1887; Nakayama M, 2014, NEUROSCI LETT, V561, P91, DOI 10.1016/j.neulet.2013.12.063; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Parrill AL, 2000, J BIOL CHEM, V275, P39379, DOI 10.1074/jbc.M007680200; Ramsebner R, 2010, LARYNGOSCOPE, V120, P359, DOI 10.1002/lary.20689; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Santos RLP, 2006, HUM GENET, V120, P85, DOI 10.1007/s00439-006-0188-z; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Skoura A, 2009, CARDIOVASC RES, V82, P221, DOI 10.1093/cvr/cvp088; Wang WD, 2001, DEVELOPMENT, V128, P5017; Zhang WL, 2013, PROSTAG OTH LIPID M, V106, P62, DOI 10.1016/j.prostaglandins.2013.06.001; Zhao JW, 2015, CURR ATHEROSCLER REP, V17, DOI 10.1007/s11883-015-0504-y	40	33	36	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 4	2016	98	2					331	338		10.1016/j.ajhg.2015.12.004	http://dx.doi.org/10.1016/j.ajhg.2015.12.004			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DE3BR	26805784	Green Published, Bronze			2022-12-18	WOS:000370502300009
J	Hansen, J; Snow, C; Tuttle, E; Ghoneim, DH; Yang, CS; Spencer, A; Gunter, SA; Smyser, CD; Gurnett, CA; Shinawi, M; Dobyns, WB; Wheless, J; Halterman, MW; Jansen, LA; Paschal, BM; Paciorkowski, AR				Hansen, Jeanne; Snow, Chelsi; Tuttle, Emily; Ghoneim, Dalia H.; Yang, Chun-Song; Spencer, Adam; Gunter, Sonya A.; Smyser, Christopher D.; Gurnett, Christina A.; Shinawi, Marwan; Dobyns, William B.; Wheless, James; Halterman, Marc W.; Jansen, Laura A.; Paschal, Bryce M.; Paciorkowski, Alex R.			De Novo Mutations in SIK1 Cause a Spectrum of Developmental Epilepsies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INFANTILE EPILEPTIC ENCEPHALOPATHY; SALT-INDUCIBLE KINASE; EARLY MYOCLONIC ENCEPHALOPATHY; LENNOX-GASTAUT SYNDROME; OHTAHARA-SYNDROME; WEST-SYNDROME; TRANSCRIPTION FACTOR; GENE-TRANSCRIPTION; MENTAL-RETARDATION; SPASMS	Developmental epilepsies are age-dependent seizure disorders for which genetic causes have been increasingly identified. Here we report six unrelated individuals with mutations in salt-inducible kinase 1 (SIK1) in a series of 101 persons with early myoclonic encephalopathy, Ohtahara syndrome, and infantile spasms. Individuals with SIK1 mutations had short survival in cases with neonatal epilepsy onset, and an autism plus developmental syndrome after infantile spasms in others. All six mutations occurred outside the kinase domain of SIK1 and each of the mutants displayed autophosphorylation and kinase activity toward HDAC5. Three mutations generated truncated forms of SIK1 that were resistant to degradation and also showed changes in sub-cellular localization compared to wild-type SIK1. We also report the human neuropathologic examination of SIK1-related developmental epilepsy, with normal neuronal morphology and lamination but abnormal SIK1 protein cellular localization. Therefore, these results expand the genetic etiologies of developmental epilepsies by demonstrating SIK1 mutations as a cause of severe developmental epilepsy.	[Hansen, Jeanne; Tuttle, Emily; Ghoneim, Dalia H.; Halterman, Marc W.; Paciorkowski, Alex R.] Univ Rochester, Med Ctr, Ctr Neural Dev & Dis, Rochester, NY 14642 USA; [Snow, Chelsi; Yang, Chun-Song; Spencer, Adam; Paschal, Bryce M.] Univ Virginia, Ctr Cell Signaling, Charlottesville, VA 22908 USA; [Gunter, Sonya A.; Jansen, Laura A.] Univ Virginia, Dept Neurol, Charlottesville, VA 22908 USA; [Smyser, Christopher D.; Gurnett, Christina A.] Washington Univ, Dept Neurol, St Louis, MO 63110 USA; [Shinawi, Marwan] Washington Univ, Div Genet & Genom Med, Dept Pediat, St Louis, MO 63110 USA; [Dobyns, William B.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Dobyns, William B.] Univ Washington, Dept Pediat, Div Med Genet, Seattle, WA 98195 USA; [Dobyns, William B.] Seattle Biomed Res Inst, Ctr Integrat Brain Res, Seattle, WA 98105 USA; [Wheless, James] LeBonheur Childrens Hosp, Memphis, TN 38103 USA; [Wheless, James] Univ Tennessee, Memphis, TN 38103 USA; [Halterman, Marc W.; Paciorkowski, Alex R.] Univ Rochester, Dept Neurol, Med Ctr, Rochester, NY 14642 USA; [Paschal, Bryce M.] Univ Virginia, Dept Biochem, Charlottesville, VA 22908 USA; [Paschal, Bryce M.] Univ Virginia, Dept Mol Genet, Charlottesville, VA 22908 USA; [Paciorkowski, Alex R.] Univ Rochester, Med Ctr, Dept Pediat, Rochester, NY 14642 USA; [Paciorkowski, Alex R.] Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA	University of Rochester; University of Virginia; University of Virginia; Washington University (WUSTL); Washington University (WUSTL); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Center for Infectious Disease Research; University of Tennessee System; University of Tennessee Health Science Center; University of Rochester; University of Virginia; University of Virginia; University of Rochester; University of Rochester	Paciorkowski, AR (corresponding author), Univ Rochester, Med Ctr, Ctr Neural Dev & Dis, Rochester, NY 14642 USA.	alex_paciorkowski@urmc.rochester.edu	Dobyns, William Brian/ABC-6525-2021; Dobyns, William/AAI-2768-2020	Dobyns, William/0000-0002-7681-2844; shinawi, Marwan/0000-0003-1329-4100; Gurnett, Christina/0000-0001-9129-315X; Jansen, Laura/0000-0002-7936-3140	NIH, National Institute of Neurologic Disorders and Stroke [K02NS072162, R01NS046616, R01NS076617, K08NS078054]; National Institute on Aging [R01AG040162]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076617, K12NS001690, R01NS046616, K02NS072162, K08NS078054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040162] Funding Source: NIH RePORTER	NIH, National Institute of Neurologic Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors would like to thank the families of our research subjects. Research reported in this work was supported by the NIH, National Institute of Neurologic Disorders and Stroke under award numbers K02NS072162 (to L.A.J.), R01NS046616 (to W.B.D.), R01NS076617 (to M.W.H.), and K08NS078054 (to A.R.P.), and the National Institute on Aging R01AG040162 (to B.M.P.). We would like to acknowledge the University of Rochester Genomics Research Center for sequencing support, and the University of Rochester Center for Integrated Research Computing for providing high-performance computing resources. We wish to thank Dr. Timothy McKinsey (University of Colorado, Denver) for HDAC5 constructs.	Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Bahi-Buisson N, 2008, EPILEPSIA, V49, P1027, DOI 10.1111/j.1528-1167.2007.01520.x; Beaumont TL, 2012, J NEUROSCI, V32, P14389, DOI 10.1523/JNEUROSCI.3408-12.2012; COPPOLA G, 1995, EPILEPSIA, V36, P1017, DOI 10.1111/j.1528-1157.1995.tb00961.x; Dietrich JB, 2012, SYNAPSE, V66, P61, DOI 10.1002/syn.20988; Djukic A, 2006, EPILEPSY RES, V70, pS68, DOI 10.1016/j.eplepsyres.2005.11.022; Dulac O, 2001, EPILEPSIA, V42, P23, DOI 10.1046/j.1528-1157.2001.042suppl.3023.x; DULAC O, 1993, EPILEPSIA, V34, pS7, DOI 10.1111/j.1528-1157.1993.tb04593.x; Finsterwald C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054545; Fulp CT, 2008, HUM MOL GENET, V17, P3740, DOI 10.1093/hmg/ddn271; Guerrini R, 2007, NEUROLOGY, V69, P427, DOI 10.1212/01.wnl.0000266594.16202.c1; Jagannath A, 2013, CELL, V154, P1100, DOI 10.1016/j.cell.2013.08.004; Katoh Y, 2006, FEBS J, V273, P2730, DOI 10.1111/j.1742-4658.2006.05291.x; Le Meur N, 2010, J MED GENET, V47, P22, DOI 10.1136/jmg.2009.069732; Li SA, 2009, J NEUROSCI, V29, P2334, DOI 10.1523/JNEUROSCI.2296-08.2009; Liu Y, 2012, ENDOCRINOLOGY, V153, P223, DOI 10.1210/en.2011-1404; Lux AL, 2004, EPILEPSIA, V45, P1416, DOI 10.1111/j.0013-9580.2004.02404.x; OHTAHARA S, 1987, BRAIN DEV-JPN, V9, P371, DOI 10.1016/S0387-7604(87)80110-9; Ohtahara S, 2006, EPILEPSY RES, V70, pS58, DOI 10.1016/j.eplepsyres.2005.11.021; Otsuka M, 2010, EPILEPSIA, V51, P2449, DOI 10.1111/j.1528-1167.2010.02767.x; Paciorkowski AR, 2013, NEUROGENETICS, V14, P99, DOI 10.1007/s10048-013-0356-y; Partikian A, 2010, J CHILD NEUROL, V25, P423, DOI 10.1177/0883073809341664; Pellock JM, 2010, EPILEPSIA, V51, P2175, DOI 10.1111/j.1528-1167.2010.02657.x; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Saemundsen E, 2008, EPILEPSIA, V49, P1865, DOI 10.1111/j.1528-1167.2008.01688.x; Saitsu H, 2008, NAT GENET, V40, P782, DOI 10.1038/ng.150; Stewart R, 2013, P NATL ACAD SCI USA, V110, P117, DOI 10.1073/pnas.1212676110; Stromme P, 2002, BRAIN DEV-JPN, V24, P266, DOI 10.1016/S0387-7604(02)00079-7; Takemori H, 2003, J STEROID BIOCHEM, V85, P397, DOI 10.1016/S0960-0760(03)00199-7; Takemori H, 2002, J BIOL CHEM, V277, P42334, DOI 10.1074/jbc.M204602200; Takemori H, 2009, ENDOCR J, V56, P121, DOI 10.1507/endocrj.K08E-173; Weaving LS, 2004, AM J HUM GENET, V75, P1079, DOI 10.1086/426462; Yamatogi Y, 2002, BRAIN DEV-JPN, V24, P13, DOI 10.1016/S0387-7604(01)00392-8; You SJ, 2009, PEDIATR NEUROL, V41, P111, DOI 10.1016/j.pediatrneurol.2009.03.006	34	33	36	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 2	2015	96	4					682	690		10.1016/j.ajhg.2015.02.013	http://dx.doi.org/10.1016/j.ajhg.2015.02.013			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CF0DJ	25839329	Green Published, Bronze			2022-12-18	WOS:000352212600016
J	Lachance, J; Tishkoff, SA				Lachance, Joseph; Tishkoff, Sarah A.			Biased Gene Conversion Skews Allele Frequencies in Human Populations, Increasing the Disease Burden of Recessive Alleles	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DETECTING POSITIVE SELECTION; HUMAN GENOME; LINKAGE DISEQUILIBRIUM; REVEALS ADAPTATION; EVOLUTION; RECOMBINATION; POLYMORPHISM; HYPOTHESIS; VARIANTS; FIXATION	Gene conversion results in the nonreciprocal transfer of genetic information between two recombining sequences, and there is evidence that this process is biased toward G and C alleles. However, the strength of GC-biased gene conversion (gBGC) in human populations and its effects on hereditary disease have yet to be assessed on a genomic scale. Using high-coverage whole-genome sequences of African hunter-gatherers, agricultural populations, and primate outgroups, we quantified the effects of GC-biased gene conversion on population genomic data sets. We find that genetic distances (F-ST and population branch statistics) are modified by gBGC. In addition, the site frequency spectrum is left-shifted when ancestral alleles are favored by gBGC and right-shifted when derived alleles are favored by gBGC. Allele frequency shifts due to gBGC mimic the effects of natural selection. As expected, these effects are strongest in high-recombination regions of the human genome. By comparing the relative rates of fixation of unbiased and biased sites, the strength of gene conversion was estimated to be on the order of Nb approximate to 0.05 to 0.09. We also find that derived alleles favored by gBGC are much more likely to be homozygous than derived alleles at unbiased SNPs (+42.2% to 62.8%). This results in a curse of the converted, whereby gBGC causes substantial increases in hereditary disease risks. Taken together, our findings reveal that GC-biased gene conversion has important population genetic and public health implications.	[Lachance, Joseph; Tishkoff, Sarah A.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Lachance, Joseph; Tishkoff, Sarah A.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Lachance, J (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	lachance.joseph@gmail.com; tishkoff@mail.med.upenn.edu		Lachance, Joseph/0000-0002-4650-3741	NIH [DP1 ES022577]; NIH NRSA postdoctoral fellowship [F32HG006648]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG006648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [DP1ES022577] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NRSA postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by an NIH grant (DP1 ES022577) to S.A.T. and an NIH NRSA postdoctoral fellowship (F32HG006648) to J.L. We thank Katie Pollard, Amy Williams, Laurent Duret, Wen-Ya Ko, Matthew Hansen, other members of the S.A.T. lab, and two anonymous reviewers for their helpful comments and suggestions.	Bittles AH, 2010, P NATL ACAD SCI USA, V107, P1779, DOI 10.1073/pnas.0906079106; Boulton A, 1997, P NATL ACAD SCI USA, V94, P8058, DOI 10.1073/pnas.94.15.8058; BROWN TC, 1987, CELL, V50, P945, DOI 10.1016/0092-8674(87)90521-6; BROWN TC, 1989, GENOME, V31, P578, DOI 10.1139/g89-107; Capra JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003684; Casola C, 2012, GENOME RES, V22, P429, DOI 10.1101/gr.127738.111; Charlesworth B., 2010, ELEMENTS EVOLUTIONAR; Chen JM, 2007, NAT REV GENET, V8, P762, DOI 10.1038/nrg2193; Comeron JM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002905; Coop G, 2007, PLOS GENET, V3, P377, DOI 10.1371/journal.pgen.0030035; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; De Maio N, 2013, MOL BIOL EVOL, V30, P2249, DOI 10.1093/molbev/mst131; Di Rienzo A, 2005, TRENDS GENET, V21, P596, DOI 10.1016/j.tig.2005.08.007; Dreszer TR, 2007, GENOME RES, V17, P1420, DOI 10.1101/gr.6395807; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Duret L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000071; Duret L, 2009, ANNU REV GENOM HUM G, V10, P285, DOI 10.1146/annurev-genom-082908-150001; Fay JC, 2000, GENETICS, V155, P1405; Frisse L, 2001, AM J HUM GENET, V69, P831, DOI 10.1086/323612; Gaffney DJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-265; Galtier N, 2007, TRENDS GENET, V23, P273, DOI 10.1016/j.tig.2007.03.011; Galtier N, 2009, TRENDS GENET, V25, P1, DOI 10.1016/j.tig.2008.10.011; Glemin S, 2010, GENETICS, V185, P939, DOI 10.1534/genetics.110.116368; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Haldane JBS, 1927, P CAMB PHILOS SOC, V23, P838, DOI 10.1017/S0305004100015644; Halligan DL, 2009, ANNU REV ECOL EVOL S, V40, P151, DOI 10.1146/annurev.ecolsys.39.110707.173437; Hellenthal G, 2006, CURR OPIN GENET DEV, V16, P565, DOI 10.1016/j.gde.2006.10.001; Katzman S, 2011, GENOME BIOL EVOL, V3, P614, DOI 10.1093/gbe/evr058; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; KIMURA M, 1962, GENETICS, V47, P713; Ko WY, 2011, AM J HUM GENET, V88, P741, DOI 10.1016/j.ajhg.2011.05.005; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Kumar S, 2012, NAT METHODS, V9, P855, DOI 10.1038/nmeth.2147; Lachance J, 2013, BIOESSAYS, V35, P780, DOI 10.1002/bies.201300014; Lachance J, 2012, CELL, V150, P457, DOI 10.1016/j.cell.2012.07.009; Lachance J, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-57; Lam HYK, 2012, NAT BIOTECHNOL, V30, P78, DOI 10.1038/nbt.2065; Lartillot N, 2013, MOL BIOL EVOL, V30, P489, DOI 10.1093/molbev/mss239; Lohmueller KE, 2008, NATURE, V451, P994, DOI 10.1038/nature06611; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; MUKAI T, 1972, GENETICS, V72, P335; NAGYLAKI T, 1983, P NATL ACAD SCI-BIOL, V80, P6278, DOI 10.1073/pnas.80.20.6278; Necsulea A, 2011, HUM MUTAT, V32, P198, DOI 10.1002/humu.21407; Nielsen R, 2004, GENETICS, V168, P2373, DOI 10.1534/genetics.104.031039; Padhukasahasram B., 2013, EUR J HUM GENET; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; R Core Team, 2019, R LANG ENV STAT COMP; Ratnakumar A, 2010, PHILOS T R SOC B, V365, P2571, DOI 10.1098/rstb.2010.0007; SARICH VM, 1973, SCIENCE, V179, P1144, DOI 10.1126/science.179.4078.1144; Schlebusch CM, 2012, SCIENCE, V338, P374, DOI 10.1126/science.1227721; Shriver Mark D, 2004, Hum Genomics, V1, P274; Spencer CCA, 2006, PLOS GENET, V2, P1375, DOI 10.1371/journal.pgen.0020148; TAJIMA F, 1989, GENETICS, V123, P585; Thornton K, 2005, GENETICS, V171, P2143, DOI 10.1534/genetics.105.043786; Torkamani Ali, 2012, Frontiers in Genetics, V3, P211, DOI 10.3389/fgene.2012.00211; Webster MT, 2004, TRENDS GENET, V20, P122, DOI 10.1016/j.tig.2004.01.005; Wegmann D, 2011, NAT GENET, V43, P847, DOI 10.1038/ng.894; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WILKIE AOM, 1994, J MED GENET, V31, P89, DOI 10.1136/jmg.31.2.89; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zeng K, 2006, GENETICS, V174, P1431, DOI 10.1534/genetics.106.061432	62	33	33	2	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 2	2014	95	4					408	420		10.1016/j.ajhg.2014.09.008	http://dx.doi.org/10.1016/j.ajhg.2014.09.008			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AQ2XW	25279983	Green Published, Bronze			2022-12-18	WOS:000342654300006
J	Schulte, EC; Kousi, M; Tan, PL; Tilch, E; Knauf, F; Lichtner, P; Trenkwalder, C; Hogl, B; Frauscher, B; Berger, K; Fietze, I; Hornyak, M; Oertel, WH; Bachmann, CG; Zimprich, A; Peters, A; Gieger, C; Meitinger, T; Muller-Myhsok, B; Katsanis, N; Winkelmann, J				Schulte, Eva C.; Kousi, Maria; Tan, Perciliz L.; Tilch, Erik; Knauf, Franziska; Lichtner, Peter; Trenkwalder, Claudia; Hoegl, Birgit; Frauscher, Birgit; Berger, Klaus; Fietze, Ingo; Hornyak, Magdolna; Oertel, Wolfgang H.; Bachmann, Cornelius G.; Zimprich, Alexander; Peters, Annette; Gieger, Christian; Meitinger, Thomas; Mueller-Myhsok, Bertram; Katsanis, Nicholas; Winkelmann, Juliane			Targeted Resequencing and Systematic In Vivo Functional Testing Identifies Rare Variants in MEIS1 as Significant Contributors to Restless Legs Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; COMMON VARIANTS; CANDIDATE GENES; HIGH-RISK; EXPRESSION; SEQUENCE	Restless legs syndrome (RLS) is a common neurologic condition characterized by nocturnal dysesthesias and an urge to move, affecting the legs. RLS is a complex trait, for which genome-wide association studies (GWASs) have identified common susceptibility alleles of modest (OR 1.2-1.7) risk at six genomic loci. Among these, variants in MEIS1 have emerged as the largest risk factors for RLS, suggesting that perturbations in this transcription factor might be causally related to RLS susceptibility. To establish this causality, direction of effect, and total genetic burden of MEIS1, we interrogated 188 case subjects and 182 control subjects for rare alleles not captured by previous GWASs, followed by genotyping of similar to 3,000 case subjects and 3,000 control subjects, and concluded with systematic functionalization of all discovered variants using a previously established in vivo model of neurogenesis. We observed a significant excess of rare MEIS1 variants in individuals with RLS. Subsequent assessment of all nonsynonymous variants by in vivo complementation revealed an excess of loss-of-function alleles in individuals with RLS. Strikingly, these alleles compromised the function of the canonical MEIS1 splice isoform but were irrelevant to an isoform known to utilize an alternative 3' sequence. Our data link MEIS1 loss of function to the etiopathology of RLS, highlight how combined sequencing and systematic functional annotation of rare variation at GWAS loci can detect risk burden, and offer a plausible explanation for the specificity of phenotypic expressivity of loss-of-function alleles at a locus broadly necessary for neurogenesis and neurodevelopment.	[Schulte, Eva C.; Hornyak, Magdolna; Winkelmann, Juliane] Tech Univ Munich, Klinikum Rechts Isar, Neurol Klin & Poliklin, D-81675 Munich, Germany; [Schulte, Eva C.; Tilch, Erik; Knauf, Franziska; Lichtner, Peter; Meitinger, Thomas; Winkelmann, Juliane] Helmholtz Zentrum Munchen, Inst Humangenet, D-85764 Munich, Germany; [Kousi, Maria; Tan, Perciliz L.; Katsanis, Nicholas] Duke Univ, Dept Cell Biol, Ctr Human Dis Modeling, Durham, NC 27710 USA; [Tilch, Erik; Lichtner, Peter; Meitinger, Thomas; Winkelmann, Juliane] Tech Univ Munich, Inst Humangenet, D-81675 Munich, Germany; [Trenkwalder, Claudia] Paracelsus Elena Klin, D-34128 Kassel, Germany; [Trenkwalder, Claudia] Univ Gottingen, Klin Neurochirurg, D-37075 Gottingen, Germany; [Hoegl, Birgit; Frauscher, Birgit] Med Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria; [Berger, Klaus] Univ Munster, Inst Epidemiol & Sozialmed, D-48149 Munster, Germany; [Fietze, Ingo] Charite, Zentrum Schlafmed, D-10117 Berlin, Germany; [Hornyak, Magdolna] Univ Freiburg, Interdisziplinares Schmerzzentrum, D-79106 Freiburg, Germany; [Hornyak, Magdolna] Diakoniewerk Munchen Maxvorstadt, D-80799 Munich, Germany; [Oertel, Wolfgang H.] Univ Marburg, Klin Neurol, D-35039 Marburg, Germany; [Bachmann, Cornelius G.] Paracelsus Klinikum Osnabruck, Abt Neurol, D-49076 Osnabruck, Germany; [Bachmann, Cornelius G.] Univ Gottingen, Klin Neurophysiol, D-37075 Gottingen, Germany; [Zimprich, Alexander] Med Univ Wien, Dept Neurol, A-1090 Vienna, Austria; [Peters, Annette] Helmholtz Zentrum Munchen, Inst Epidemiol 2, D-85764 Munich, Germany; [Gieger, Christian] Helmholtz Zentrum Munchen, Inst Genet Epidemiol, D-85764 Munich, Germany; [Meitinger, Thomas; Mueller-Myhsok, Bertram; Winkelmann, Juliane] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Mueller-Myhsok, Bertram] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Mueller-Myhsok, Bertram] Univ Liverpool, Inst Translat Med, Liverpool L69 3BX, Merseyside, England; [Winkelmann, Juliane] Stanford Univ, Ctr Sleep Sci & Med, Dept Neurol & Neurosci, Palo Alto, CA 94304 USA	Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Duke University; Technical University of Munich; University of Gottingen; Medical University of Innsbruck; University of Munster; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Freiburg; Philipps University Marburg; University of Gottingen; Medical University of Vienna; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Max Planck Society; University of Liverpool; Stanford University	Winkelmann, J (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Neurol Klin & Poliklin, D-81675 Munich, Germany.	winkelmann@stanford.edu	Trenkwalder, Claudia/ABD-6559-2021; Schulte, Eva C./AAT-2410-2021; Zimprich, Alexander/A-5232-2017; Peters, Annette/A-6117-2011; Trenkwalder, Claudia/AHD-1232-2022; Meitinger, Thomas/O-1318-2015	Zimprich, Alexander/0000-0002-1668-5177; Peters, Annette/0000-0001-6645-0985; Trenkwalder, Claudia/0000-0001-6407-1199; Hogl, Birgit/0000-0003-1894-7641; Winkelmann, Juliane/0000-0003-2667-9691; Schulte, Eva Christina/0000-0003-3105-5672; Katsanis, Nicholas/0000-0002-2480-0171; Fietze, Ingo/0000-0001-5567-5206; Gieger, Christian/0000-0001-6986-9554; Meitinger, Thomas/0000-0002-8838-8403	Technische Universitat Munchen; Helmholtz Zentrum Munchen from the Else Kroner-Fresenius-Stiftung [2013_A124]; Center for Human Disease Modeling, Duke University; Helmholtz Zentrum Munchen [P50 MH094268]; German Bundesministerium fur Bildung und Forschung [03.2007-02.2011 FKZ 01ET0713]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094268] Funding Source: NIH RePORTER	Technische Universitat Munchen; Helmholtz Zentrum Munchen from the Else Kroner-Fresenius-Stiftung; Center for Human Disease Modeling, Duke University; Helmholtz Zentrum Munchen(Helmholtz Association); German Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are gratefully indebted to Katja Junghans, Susanne Lindhof, Jelena Golic, Sybille Frischholz, and Regina Feldmann at the Institut fur Humangenetik, Helmholtz Zentrum Munchen (Munich, Germany) for their expert technical assistance in performing Sequenom genotyping and Light Scanner analyses. Moreover, we thank Rene Rezsohazy at the Universite de Louvain (Louvain, Belgium) for his advice in the construction of the domain-dead construct of MEIS1. This study was funded by in-house institutional funding from Technische Universitat Munchen and Helmholtz Zentrum Munchen, a grant entitled "Functional Analysis of Rare Variants in Restless Legs Syndrome" from the Else Kroner-Fresenius-Stiftung (2013_A124), by seed funding from the Center for Human Disease Modeling, Duke University, and by P50 MH094268 to N.K. Recruitment of case and control cohorts was supported by institutional (Helmholtz Zentrum Munchen) and government funding from the German Bundesministerium fur Bildung und Forschung (03.2007-02.2011 FKZ 01ET0713). W.H.O. is a Senior Research Professor of the Charitable Hertie Foundation, Frankfurt/Main, Germany. N.K. is a Distinguished Brumley Professor.	Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; Barber BA, 2013, ANN ANAT, V195, P431, DOI 10.1016/j.aanat.2013.04.005; Bonnefond A, 2012, NAT GENET, V44, P297, DOI 10.1038/ng.1053; Catoire H, 2011, ANN NEUROL, V70, P170, DOI 10.1002/ana.22435; Cruchaga C, 2014, NATURE, V505, P550, DOI 10.1038/nature12825; Cvejic A, 2011, HAEMATOL-HEMATOL J, V96, P190, DOI 10.3324/haematol.2010.027698; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; Desai AV, 2004, TWIN RES, V7, P589, DOI 10.1375/1369052042663841; Diogo D, 2013, AM J HUM GENET, V92, P15, DOI 10.1016/j.ajhg.2012.11.012; Erickson T, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-22; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kiezun A, 2012, NAT GENET, V44, P623, DOI 10.1038/ng.2303; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mercader N, 1999, NATURE, V402, P425, DOI 10.1038/46580; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Raychaudhuri S, 2011, NAT GENET, V43, P1232, DOI 10.1038/ng.976; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Sarparanta J, 2012, NAT GENET, V44, P450, DOI 10.1038/ng.1103; Schormair B, 2008, NAT GENET, V40, P946, DOI 10.1038/ng.190; Schulte EC, 2011, NEUROLOGY, V76, P1106, DOI 10.1212/WNL.0b013e318211c366; Spieler D, 2014, GENOME RES, V24, P592, DOI 10.1101/gr.166751.113; Stefansson H, 2007, NEW ENGL J MED, V357, P639, DOI 10.1056/NEJMoa072743; Team RC., 2008, R LANG ENV STAT COMP; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Torgerson DG, 2012, AM J HUM GENET, V90, P273, DOI 10.1016/j.ajhg.2012.01.008; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Vilarino-Guell C, 2009, NEUROLOGY, V73, P243, DOI 10.1212/WNL.0b013e3181ae7c79; Waskiewicz AJ, 2001, DEVELOPMENT, V128, P4139; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Winkelmann J, 2007, NAT GENET, V39, P1000, DOI 10.1038/ng2099; Winkelmann J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002171; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Xiong L, 2007, NEUROLOGY, V68, P1631, DOI 10.1212/01.wnl.0000261016.90374.fd; Xiong L, 2009, HUM MOL GENET, V18, P1065, DOI 10.1093/hmg/ddn443; Zaghloul NA, 2010, P NATL ACAD SCI USA, V107, P10602, DOI 10.1073/pnas.1000219107	43	33	33	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 13	2014	95	1					85	95		10.1016/j.ajhg.2014.06.005	http://dx.doi.org/10.1016/j.ajhg.2014.06.005			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AL1RP	24995868	Green Published, hybrid			2022-12-18	WOS:000338904100007
J	Koboldt, DC; Larson, DE; Sullivan, LS; Bowne, SJ; Steinberg, KM; Churchill, JD; Buhr, AC; Nutter, N; Pierce, EA; Blanton, SH; Weinstock, GM; Wilson, RK; Daiger, SP				Koboldt, Daniel C.; Larson, David E.; Sullivan, Lori S.; Bowne, Sara J.; Steinberg, Karyn M.; Churchill, Jennifer D.; Buhr, Aimee C.; Nutter, Nathan; Pierce, Eric A.; Blanton, Susan H.; Weinstock, George M.; Wilson, Richard K.; Daiger, Stephen P.			Exome-Based Mapping and Variant Prioritization for Inherited Mendelian Disorders	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RETINITIS-PIGMENTOSA; MUTATIONS; GENE; SEQUENCE; DISCOVERY; FAMILIES; TOOL	Exome sequencing in families affected by rare genetic disorders has the potential to rapidly identify new disease genes (genes in which mutations cause disease), but the identification of a single causal mutation among thousands of variants remains a significant challenge. We developed a scoring algorithm to prioritize potential causal variants within a family according to segregation with the phenotype, population frequency, predicted effect, and gene expression in the tissue(s) of interest. To narrow the search space in families with multiple affected individuals, we also developed two complementary approaches to exome-based mapping of autosomal-dominant disorders. One approach identifies segments of maximum identity by descent among affected individuals; the other nominates regions on the basis of shared rare variants and the absence of homozygous differences between affected individuals. We showcase our methods by using exome sequence data from families affected by autosomal-dominant retinitis pigmentosa (adRP), a rare disorder characterized by night blindness and progressive vision loss. We performed exome capture and sequencing on 91 samples representing 24 families affected by probable adRP but lacking common disease-causing mutations. Eight of 24 families (33%) were revealed to harbor high-scoring, most likely pathogenic (by clinical assessment) mutations affecting known RP genes. Analysis of the remaining 17 families identified candidate variants in a number of interesting genes, some of which have withstood further segregation testing in extended pedigrees. To empower the search for Mendelian-disease genes in family-based sequencing studies, we implemented them in a cross-platform-compatible software package, MendelScan, which is freely available to the research community.	[Koboldt, Daniel C.; Larson, David E.; Steinberg, Karyn M.; Nutter, Nathan; Weinstock, George M.; Wilson, Richard K.] Washington Univ, Genome Inst, St Louis, MO 63108 USA; [Sullivan, Lori S.; Bowne, Sara J.; Churchill, Jennifer D.; Buhr, Aimee C.; Daiger, Stephen P.] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77025 USA; [Pierce, Eric A.] Harvard Univ, Sch Med, Ocular Genom Inst, Boston, MA 02114 USA; [Blanton, Susan H.] Univ Miami, Hussman Inst Human Genom, Miami, FL 33101 USA	Washington University (WUSTL); University of Texas System; University of Texas Health Science Center Houston; Harvard University; Harvard Medical School; University of Miami	Koboldt, DC (corresponding author), Washington Univ, Genome Inst, St Louis, MO 63108 USA.	dkoboldt@genome.wustl.edu; stephen.p.daiger@uth.tmc.edu	Blanton, Susan Halloran/ABF-1323-2021; Wilson, Richard K./AAF-4139-2019; Weinstock, George M/C-6314-2013	Wilson, Richard K./0000-0002-1992-1358; Weinstock, George M/0000-0002-2997-4592; Larson, David/0000-0001-7934-5906; Meltz Steinberg, Karyn/0000-0002-8676-3337; Churchill Cihlar, Jennifer/0000-0001-9796-193X; Pierce, Eric/0000-0002-2354-4102	Foundation Fighting Blindness; National Eye Institute [EY007142]; National Human Genome Research Institute [HG003079]; NATIONAL EYE INSTITUTE [R01EY007142, R01EY012910] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079] Funding Source: NIH RePORTER	Foundation Fighting Blindness(European Commission); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Elaine Mardis for technology development, Bob Fulton for overseeing data production, Erica Sodergren for project-management support, and Joshua McMichael for graphic design. We are also grateful to contributors to the autosomal-dominant retinitis pigmentosa cohort, including David G. Birch, Dianna H. Wheaton, John R. Heckenlively, Peter Humphries, Marian Humphries, and Kari Branham. This work was supported by the Foundation Fighting Blindness, the National Eye Institute (grant EY007142), and the National Human Genome Research Institute (grant HG003079).	Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Bilguvar K, 2010, NATURE, V467, P207, DOI 10.1038/nature09327; Bolze A, 2010, AM J HUM GENET, V87, P873, DOI 10.1016/j.ajhg.2010.10.028; Bowne SJ, 2013, MOL VIS, V19, P2407; Bowne SJ, 2011, EUR J HUM GENET, V19, P1074, DOI 10.1038/ejhg.2011.86; Churchill JD, 2013, INVEST OPHTH VIS SCI, V54, P1411, DOI 10.1167/iovs.12-11541; Daiger SP, 2013, CLIN GENET, V84, P132, DOI 10.1111/cge.12203; Farkas MH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-486; Gamsiz ED, 2012, GENOMICS, V99, P44, DOI 10.1016/j.ygeno.2011.09.003; Gilissen C, 2010, AM J HUM GENET, V87, P418, DOI 10.1016/j.ajhg.2010.08.004; Hamel C, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-40; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Ionita-Laza I, 2011, AM J HUM GENET, V89, P701, DOI 10.1016/j.ajhg.2011.11.003; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Krawitz PM, 2010, NAT GENET, V42, P827, DOI 10.1038/ng.653; Lalonde E, 2010, HUM MUTAT, V31, P918, DOI 10.1002/humu.21293; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li MX, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003143; Li MX, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1257; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Musunuru K, 2010, NEW ENGL J MED, V363, P2220, DOI 10.1056/NEJMoa1002926; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sincan M, 2012, HUM MUTAT, V33, P593, DOI 10.1002/humu.22034; Sullivan LS, 2006, INVEST OPHTH VIS SCI, V47, P4579, DOI 10.1167/iovs.06-0440; Sullivan LS, 2006, INVEST OPHTH VIS SCI, V47, P3052, DOI 10.1167/iovs.05-1443; Walsh T, 2010, AM J HUM GENET, V87, P90, DOI 10.1016/j.ajhg.2010.05.010; Wang JL, 2010, BRAIN, V133, P3510, DOI 10.1093/brain/awq323; Yandell M, 2011, GENOME RES, V21, P1529, DOI 10.1101/gr.123158.111	33	33	33	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 6	2014	94	3					373	384		10.1016/j.ajhg.2014.01.016	http://dx.doi.org/10.1016/j.ajhg.2014.01.016			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AC6DK	24560519	Bronze, Green Published			2022-12-18	WOS:000332611400011
J	Shamseldin, HE; Rajab, A; Alhashem, A; Shaheen, R; Al-Shidi, T; Alamro, R; Al Harassi, S; Alkuraya, FS				Shamseldin, Hanan E.; Rajab, Anna; Alhashem, Amal; Shaheen, Ranad; Al-Shidi, Tarfa; Alamro, Rana; Al Harassi, Salma; Alkuraya, Fowzan S.			Mutations in DDX59 Implicate RNA Helicase in the Pathogenesis of Orofaciodigital Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEIN; GENE	Orofaciodigital syndrome (OFD) is a recognized clinical entity with core defining features in the mouth, face, and digits, in addition to various other features that have been proposed to define distinct subtypes. The three genes linked to OFD-OFD1, TMEM216, and TCTN3-play a role in ciliary biology, a finding consistent with the clinical overlap between OFD and other ciliopathies. Most autosomal-recessive cases of OFD, however, remain undefined genetically. In two multiplex consanguineous Arab families affected by OFD, we identified a tight linkage interval in chromosomal region 1q32.1. Exome sequencing revealed a different homozygous variant in DDX59 in each of the two families, and at least one of the two variants was accompanied by marked reduction in the level of DDX59. DDX59 encodes a relatively uncharacterized member of the DEAD-box-containing RNA helicase family of proteins, which are known to play a critical role in all aspects of RNA metabolism. We show that Ddx59 is highly enriched in its expression in the developing murine palate and limb buds. At the cellular level, we show that DDX59 is localized dynamically to the nucleus and the cytoplasm. Consistent with the absence of DDX59 representation in ciliome databases and our demonstration of its lack of ciliary localization, ciliogenesis appears to be intact in mutant fibroblasts but ciliary signaling appears to be impaired. Our data strongly implicate this RNA helicase family member in the pathogenesis of OFD, although the causal mechanism remains unclear.	[Shamseldin, Hanan E.; Shaheen, Ranad; Al-Shidi, Tarfa; Alamro, Rana; Alkuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Rajab, Anna; Al Harassi, Salma] Minist Hlth, Genet Serv, Muscat 113, Oman; [Alhashem, Amal] Prince Sultan Mil Med City, Dept Pediat, Riyadh 11159, Saudi Arabia; [Alkuraya, Fowzan S.] Alfaisal Univ, Dept Anat & Cell Biol, Coll Med, Riyadh 11533, Saudi Arabia	King Faisal Specialist Hospital & Research Center; Prince Sultan Military Medical City; Alfaisal University	Alkuraya, FS (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia.	falkuraya@kfshrc.edu.sa		SHAHEEN, RANAD/0000-0002-2590-1759; Alhashem, Amal/0000-0002-9668-7809	King Abdulaziz City for Science and Technology grant [09-MED941-20]; Dubai Harvard Foundation for Medical Research Collaborative Research Grant	King Abdulaziz City for Science and Technology grant; Dubai Harvard Foundation for Medical Research Collaborative Research Grant	We thank the families for their enthusiastic participation. We also thank the Genotyping and Sequencing Core Facilities at King Faisal Specialist Hospital and Research Center for their technical help. This work was supported by King Abdulaziz City for Science and Technology grant 09-MED941-20 (to F.S.A.) and a Dubai Harvard Foundation for Medical Research Collaborative Research Grant (to F.S.A.).	Abdelhaleem M, 2003, GENOMICS, V81, P618, DOI 10.1016/S0888-7543(03)00049-1; Alkuraya FS, 2012, CURR PROTOC HUM GENE, V6, P12, DOI DOI 10.1002/0471142905.HG0612S75; BARAITSER M, 1986, J MED GENET, V23, P116, DOI 10.1136/jmg.23.2.116; Carr IM, 2006, HUM MUTAT, V27, P1041, DOI 10.1002/humu.20383; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; CLAUSSEN O, 1946, NORD MED, V30, P1147; Ferrante MI, 2001, AM J HUM GENET, V68, P569, DOI 10.1086/318802; Gurrieri F, 2007, AM J MED GENET A, V143A, P3314, DOI 10.1002/ajmg.a.32032; JAMIESON DJ, 1991, MOL MICROBIOL, V5, P805, DOI 10.1111/j.1365-2958.1991.tb00753.x; Jankowsky E, 2006, NUCLEIC ACIDS RES, V34, P4181, DOI 10.1093/nar/gkl410; Jankowsky Eckhard, 2008, V488, P343, DOI 10.1007/978-1-60327-475-3_22; Linder P, 2006, NUCLEIC ACIDS RES, V34, P4168, DOI 10.1093/nar/gkl468; Mohr OL, 1941, J CRANIOFAC SURG, V14, P3; Papillon-Leage P.J., 1954, ACTUAL ODONTOSTOMATO, V8, P7; Schmidt U, 2002, FEMS YEAST RES, V2, P267, DOI 10.1016/S1567-1356(02)00109-5; SERAPHIN B, 1989, NATURE, V337, P84, DOI 10.1038/337084a0; Shaheen R, 2012, AM J HUM GENET, V91, P330, DOI 10.1016/j.ajhg.2012.05.025; Thomas S, 2012, AM J HUM GENET, V91, P372, DOI 10.1016/j.ajhg.2012.06.017; Valente EM, 2010, NAT GENET, V42, P619, DOI 10.1038/ng.594	19	33	35	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 5	2013	93	3					555	560		10.1016/j.ajhg.2013.07.012	http://dx.doi.org/10.1016/j.ajhg.2013.07.012			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	297QB	23972372	Bronze, Green Published			2022-12-18	WOS:000330268900015
J	Huber, C; Faqeih, EA; Bartholdi, D; Bole-Feysot, C; Borochowitz, Z; Cavalcanti, DP; Frigo, A; Nitschke, P; Roume, J; Santos, HG; Shalev, SA; Superti-Furga, A; Delezoide, AL; Le Merrer, M; Munnich, A; Cormier-Daire, V				Huber, Celine; Faqeih, Eissa Ali; Bartholdi, Deborah; Bole-Feysot, Christine; Borochowitz, Zvi; Cavalcanti, Denise P.; Frigo, Amandine; Nitschke, Patrick; Roume, Joelle; Santos, Heloisa G.; Shalev, Stavit A.; Superti-Furga, Andrea; Delezoide, Anne-Lise; Le Merrer, Martine; Munnich, Arnold; Cormier-Daire, Valerie			Exome Sequencing Identifies INPPL1 Mutations as a Cause of Opsismodysplasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SHIP2	Opsismodysplasia (OPS) is a severe autosomal-recessive chondrodysplasia characterized by pre- and postnatal micromelia with extremely short hands and feet. The main radiological features are severe platyspondyly, squared metacarpals, delayed skeletal ossification, and metaphyseal cupping. In order to identify mutations causing OPS, a total of 16 cases (7 terminated pregnancies and 9 postnatal cases) from 10 unrelated families were included in this study. We performed exome sequencing in three cases from three unrelated families and only one gene was found to harbor mutations in all three cases: inositol polyphosphate phosphatase-like 1 (INPPL1). Screening INPPL1 in the remaining cases identified a total of 12 distinct INPPL1 mutations in the 10 families, present at the homozygote state in 7 consanguinous families and at the compound heterozygote state in the 3 remaining families. Most mutations (6/12) resulted in premature stop codons, 2/12 were splice site, and 4/12 were missense mutations located in the catalytic domain, 5-phosphatase. INPPL1 belongs to the inosito1-1,4,5-trisphosphate 5-phosphatase family, a family of signal-modulating enzymes that govern a plethora of cellular functions by regulating the levels of specific phosphoinositides. Our finding of INPPL1 mutations in OPS, a severe spondy-lodysplastic dysplasia with major growth plate disorganization, supports a key and specific role of this enzyme in endochondral ossification.	[Huber, Celine; Frigo, Amandine; Le Merrer, Martine; Munnich, Arnold; Cormier-Daire, Valerie] Univ Paris Descartes Sorbonne Paris Cite, INSERM, Unite U781, Hop Necker Enfants Malad,Dept Genet,Fdn Imagine, F-75015 Paris, France; [Faqeih, Eissa Ali] Childrens Hosp, Dept Pediat, King Fahad Med City, Riyadh 11525, Saudi Arabia; [Bartholdi, Deborah] Univ Zurich, Inst Med Genet, CH-8603 Schwerzenbach, Switzerland; [Borochowitz, Zvi] Technion Israel Inst Technol, Simon Winter Inst Human Genet, Bnai Zion Med Ctr, Rappaport Fac Med, IL-31048 Haifa, Israel; [Borochowitz, Zvi] Technion Israel Inst Technol, Res Inst, IL-31048 Haifa, Israel; [Cavalcanti, Denise P.] Univ Estadual Campinas, UNICAMP, Grp Displasias Esquelet, Dpto Genet Med,FCM, BR-13081970 Campinas, SP, Brazil; [Nitschke, Patrick] Univ Paris 05, F-75015 Paris, France; [Santos, Heloisa G.] Hosp Univ S Maria, Serv Genet Med, Dept Med Genet, P-1649035 Lisbon, Portugal; [Shalev, Stavit A.] Technion Israel Inst Technol, HaEmek Med Ctr, IL-31096 Haifa, Israel; [Shalev, Stavit A.] Technion Israel Inst Technol, Rapapport Fac Med, IL-31096 Haifa, Israel; [Superti-Furga, Andrea] Univ Lausanne, CHUV, CH-1011 Lausanne, Switzerland; [Delezoide, Anne-Lise] Univ Paris Diderot, Hop Robert Debre, Serv Biol Dev, F-75019 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Zurich; Bnai Zion Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Universidade Estadual de Campinas; UDICE-French Research Universities; Universite Paris Cite; Universidade de Lisboa; Hospital Santa Maria; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Cormier-Daire, V (corresponding author), Univ Paris Descartes Sorbonne Paris Cite, INSERM, Unite U781, Hop Necker Enfants Malad,Dept Genet,Fdn Imagine, F-75015 Paris, France.	valerie.cormier-daire@inserm.fr	Cavalcanti, Denise/D-3579-2012; superti-furga, andrea/E-9162-2015; cormier-daire, valerie/H-6520-2017	superti-furga, andrea/0000-0002-3543-7531; huber, celine/0000-0002-8601-9655; cormier-daire, valerie/0000-0002-2839-9856	GIS Maladies Rares	GIS Maladies Rares	We thank all families for their contribution to this work. We thank the GIS Maladies Rares for the funding of the exome project.	Boocock GRB, 2003, NAT GENET, V33, P97, DOI 10.1038/ng1062; Byun M, 2010, J EXP MED, V207, P2307, DOI 10.1084/jem.20101597; Cormier-Daire V, 2003, J MED GENET, V40, P195, DOI 10.1136/jmg.40.3.195; Dyson JM, 2005, INT J BIOCHEM CELL B, V37, P2260, DOI 10.1016/j.biocel.2005.05.003; Hiraoka S, 2007, NAT MED, V13, P1363, DOI 10.1038/nm1655; Kagawa S, 2005, J CLIN ENDOCR METAB, V90, P2911, DOI 10.1210/jc.2004-1724; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; MAROTEAUX P, 1984, AM J MED GENET, V19, P171, DOI 10.1002/ajmg.1320190117; Maroteaux P, 1982, Prog Clin Biol Res, V104, P345; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Ooms LM, 2009, BIOCHEM J, V419, P29, DOI 10.1042/BJ20081673; SANTOS HG, 1995, CLIN DYSMORPHOL, V4, P222; Sleeman MW, 2005, NAT MED, V11, P199, DOI 10.1038/nm1178; Smits P, 2010, NEW ENGL J MED, V362, P206, DOI 10.1056/NEJMoa0900158; Warman ML, 2011, AM J MED GENET A, V155A, P943, DOI 10.1002/ajmg.a.33909; Zonana J, 1977, Birth Defects Orig Artic Ser, V13, P155	17	33	38	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN 10	2013	92	1					144	149		10.1016/j.ajhg.2012.11.015	http://dx.doi.org/10.1016/j.ajhg.2012.11.015			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	073RA	23273569	Green Published, Bronze			2022-12-18	WOS:000313759000016
J	Ehret, GB; Lamparter, D; Hoggart, CJ; Whittaker, JC; Beckmann, JS; Kutalik, Z				Ehret, Georg B.; Lamparter, David; Hoggart, Clive J.; Whittaker, John C.; Beckmann, Jacques S.; Kutalik, Zoltan		Genetic Invest Anthropometric Trai	A Multi-SNP Locus-Association Method Reveals a Substantial Fraction of the Missing Heritability	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; ALLELIC HETEROGENEITY; METAANALYSIS; EXPLAIN; GENES	There are many known examples of multiple semi-independent associations at individual loci; such associations might arise either because of true allelic heterogeneity or because of imperfect tagging of an unobserved causal variant. This phenomenon is of great importance in monogenic traits but has not yet been systematically investigated and quantified in complex-trait genome-wide association studies (GWASs). Here, we describe a multi-SNP association method that estimates the effect of loci harboring multiple association signals by using GWAS summary statistics. Applying the method to a large anthropometric GWAS meta-analysis (from the Genetic Investigation of Anthropometric Traits consortium study), we show that for height, body mass index (BMI), and waist-to-hip ratio (WHR), 3%, 2%, and 1%, respectively, of additional phenotypic variance can be explained on top of the previously reported 10% (height), 1.5% (Bryn), and 1% (WHR). The method also permitted a substantial increase (by up to 50%) in the number of loci that replicate in a discovery-validation design. Specifically, we identified 74 loci at which the multi-SNP, a linear combination of SNPs, explains significantly more variance than does the best individual SNP. A detailed analysis of multi-SNPs shows that most of the additional variability explained is derived from SNPs that are not in linkage disequilibrium with the lead SNP, suggesting a major contribution of allelic heterogeneity to the missing heritability.	[Lamparter, David; Beckmann, Jacques S.; Kutalik, Zoltan] Univ Lausanne, Dept Med Genet, CH-1005 Lausanne, Switzerland; [Ehret, Georg B.] Univ Hosp Geneva, Div Cardiol, CH-1211 Geneva, Switzerland; [Ehret, Georg B.] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Lamparter, David; Kutalik, Zoltan] Swiss Inst Bioinformat, CH-1005 Lausanne, Switzerland; [Hoggart, Clive J.] Univ London Imperial Coll Sci Technol & Med, Dept Pediat, London W2 1PG, England; [Whittaker, John C.] GlaxoSmithKline, Quantitat Sci, Stevenage SG1 2NY, Herts, England; [Beckmann, Jacques S.] CHU Vaudois, Serv Med Genet, CH-1011 Lausanne, Switzerland	University of Lausanne; University of Geneva; Johns Hopkins University; Swiss Institute of Bioinformatics; Imperial College London; GlaxoSmithKline; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Kutalik, Z (corresponding author), Univ Lausanne, Dept Med Genet, CH-1005 Lausanne, Switzerland.	zoltan.kutalik@unil.ch	Beckmann, Jacques S/A-9772-2008; EHRET, Georg B/A-9532-2009; Whittaker, John C/B-8609-2012; Colaus, PsyColaus/K-6607-2013	Beckmann, Jacques S/0000-0002-9741-1900; EHRET, Georg B/0000-0002-5730-0675; Whittaker, John C/0000-0002-3529-2379; 	GlaxoSmithKline; Faculty of Biology and Medicine of the University of Lausanne, Switzerland; Swiss National Science Foundation; EU [HEALTH-F4-2007-201550]; National Health and Medical Council of Australia research grant; Agence Nationale de Recherche sur le Sida et les hepatites viral; Swiss National Foundation [FN 33CM30-124087, 5R01HL086694, 310000-112552]	GlaxoSmithKline(GlaxoSmithKline); Faculty of Biology and Medicine of the University of Lausanne, Switzerland; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EU(European Commission); National Health and Medical Council of Australia research grant(National Health and Medical Research Council (NHMRC) of Australia); Agence Nationale de Recherche sur le Sida et les hepatites viral; Swiss National Foundation(Swiss National Science Foundation (SNSF))	We are grateful to the members of the CoLaus study (supported by GlaxoSmithKline and the Faculty of Biology and Medicine of the University of Lausanne, Switzerland); the Swiss Hepatitis C Cohort Study (funded by the Swiss National Science Foundation); the Hypergenes Consortium (Daniele Cusi, funded by an FP7 EU grant [HEALTH-F4-2007-201550]); the International Hepatitis C Genetics Consortium (David Booth and Jacob George, funded by a National Health and Medical Council of Australia research grant); and the French Hepatitis C Cohort (Laurent Abel, Bertrand Nalpas, Thierry Poynard, and Stanislas Pol, funded by the Agence Nationale de Recherche sur le Sida et les hepatites viral) for providing us with the local linkage-disequilibrium structures in their respective cohorts. In particular, we would like to thank Toby Johnson, Sven Bergmann, Vincent Mooser, Peter Vollenweider, and Gerard Waeber for their valuable contribution. We are very grateful for the comments of Peter Visscher and Timothy M. Frayling and two anonymous referees. G.E. is partly supported by FN 33CM30-124087 and 5R01HL086694, J.S.B. received financial contribution from the Swiss National Foundation (310000-112552), and J.C.W. is an employee and shareholder of GlaxoSmithKline. The computations for this paper were performed in part at the Vital-IT Center for high-performance computing of the Swiss Institute of Bioinformatics.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Audrezet M, 2004, HUM MUTAT, V23, P343, DOI 10.1002/humu.20009; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cheney W., 2007, NUMERICAL MATH COMPU, V6th; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Harrel Jr F, 2010, REGRESSION MODELING; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hor H, 2010, NAT GENET, V42, P786, DOI 10.1038/ng.647; Kim JJ, 2012, HUM GENET, V131, P471, DOI 10.1007/s00439-011-1096-4; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Nejentsev S, 2007, NATURE, V450, P887, DOI 10.1038/nature06406; Orozco G, 2009, HUM MOL GENET, V18, P2693, DOI 10.1093/hmg/ddp193; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Theil Henri, 1961, EC FORECASTS POLICY; Tomlinson IPM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002105; Walters RG, 2010, NATURE, V463, P671, DOI 10.1038/nature08727; Wang X, 2012, EUR J HUM GENET, V20, P469, DOI 10.1038/ejhg.2011.219; Wood AR, 2011, HUM MOL GENET, V20, P4082, DOI 10.1093/hmg/ddr328; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	26	33	34	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 2	2012	91	5					863	871		10.1016/j.ajhg.2012.09.013	http://dx.doi.org/10.1016/j.ajhg.2012.09.013			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	036FI	23122585	Bronze, Green Published			2022-12-18	WOS:000311011400008
J	Zhu, Y; Xiong, M				Zhu, Yun; Xiong, Momiao			Family-Based Association Studies for Next-Generation Sequencing	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RARE VARIANTS; ARCHITECTURE; GENOMICS; GENES; RAP80	An individual's disease risk is determined by the compounded action of both common variants, inherited from remote ancestors, that segregated within the population and rare variants, inherited from recent ancestors, that segregated mainly within pedigrees. Next-generation sequencing (NGS) technologies generate high-dimensional data that allow a nearly complete evaluation of genetic variation. Despite their promise, NGS technologies also suffer from remarkable limitations: high error rates, enrichment of rare variants, and a large proportion of missing values, as well as the fact that most current analytical methods are designed for population-based association studies. To meet the analytical challenges raised by NGS, we propose a general framework for sequence-based association studies that can use various types of family and unrelated-individual data sampled from any population structure and a universal procedure that can transform any population-based association test statistic for use in family-based association tests. We develop family-based functional principal-component analysis (FPCA) with or without smoothing, a generalized T-2, combined multivariate and collapsing (CMC) method, and single-marker association test statistics. Through intensive simulations, we demonstrate that the family-based smoothed FPCA (SFPCA) has the correct type I error rates and much more power to detect association of (1) common variants, (2) rare variants, (3) both common and rare variants, and (4) variants with opposite directions of effect from other population-based or family-based association analysis methods. The proposed statistics are applied to two data sets with pedigree structures. The results show that the smoothed FPCA has a much smaller p value than other statistics.	[Zhu, Yun; Xiong, Momiao] Univ Texas Houston, Sch Publ Hlth, Ctr Human Genet, Houston, TX 77030 USA; [Zhu, Yun; Xiong, Momiao] Univ Texas Houston, Sch Publ Hlth, Div Biostat, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Xiong, M (corresponding author), Univ Texas Houston, Sch Publ Hlth, Ctr Human Genet, Houston, TX 77030 USA.	momiao.xiong@uth.tmc.edu	Zhu, Yun/AAD-5474-2020; Zhu, Yun/N-3403-2014	Zhu, Yun/0000-0002-9500-5415; Zhu, Yun/0000-0002-9500-5415	National Institutes of Health [1R01AR057120-01, 1R01HL106034-01, 1U01HG005728-01]; National Heart, Lung, and Blood Institute (NHLBI) [N02-HL-64278]; Boston University [N01-HC-25195]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064278, R01HL106034] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG005728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104411] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Boston University; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The project was supported by grants 1R01AR057120-01, 1R01HL106034-01, and 1U01HG005728-01 from the National Institutes of Health. We thank the anonymous reviewers for their helpful comments.; The Framingham Heart Study is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with Boston University (contract no. N01-HC-25195). This manuscript was not prepared in collaboration with investigators of the Framingham Heart Study and does not necessarily reflect the opinions or views of the Framingham Heart Study, Boston University, or NHLBI. Funding for SNP Health Association Resource (SHARe) genotyping was provided by NHLBI contract N02-HL-64278.	Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; Bourgain C, 2003, AM J HUM GENET, V73, P612, DOI 10.1086/378208; Chaisson MJ, 2009, GENOME RES, V19, P336, DOI 10.1101/gr.079053.108; Chakravarti A, 2011, SCIENCE, V334, P15, DOI 10.1126/science.1214458; Choi Y, 2009, GENET EPIDEMIOL, V33, P668, DOI 10.1002/gepi.20418; Clerget-Darpoux F, 2007, HUM HERED, V64, P91, DOI 10.1159/000101960; Dai HJ, 2011, BREAST CANCER RES TR, V127, P531, DOI 10.1007/s10549-010-1231-2; Eisele L, 2009, EUR J HAEMATOL, V83, P320, DOI 10.1111/j.1600-0609.2009.01287.x; Henderson D, 2006, STOCHASTIC DIFFERENTIAL EQUATIONS IN SCIENCE AND ENGINEERING, P1, DOI 10.1142/9789812774798; Hendrickson SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012862; Johnson PLF, 2008, MOL BIOL EVOL, V25, P199, DOI 10.1093/molbev/msm239; Kaur T, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.63; Lambert BW, 2008, BIOINFORMATICS, V24, P1821, DOI 10.1093/bioinformatics/btn317; Larson MG, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S5; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li Y, 2010, AM J HUM GENET, V87, P728, DOI 10.1016/j.ajhg.2010.10.014; Luo L, 2011, GENOME RES, V21, P1099, DOI 10.1101/gr.115998.110; Lupski JR, 2011, CELL, V147, P32, DOI 10.1016/j.cell.2011.09.008; Lynch M, 2009, GENETICS, V182, P295, DOI 10.1534/genetics.109.100479; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Osorio A, 2009, BREAST CANCER RES TR, V113, P371, DOI 10.1007/s10549-008-9933-4; Ott J, 2011, NAT REV GENET, V12, P465, DOI 10.1038/nrg2989; Pool JE, 2010, GENOME RES, V20, P291, DOI 10.1101/gr.079509.108; Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Talmud PJ, 2009, AM J HUM GENET, V85, P628, DOI 10.1016/j.ajhg.2009.10.014; Thornton T, 2010, AM J HUM GENET, V86, P172, DOI 10.1016/j.ajhg.2010.01.001; Thornton T, 2007, AM J HUM GENET, V81, P321, DOI 10.1086/519497; Xiong MM, 2002, AM J HUM GENET, V70, P1257, DOI 10.1086/340392; Yan J, 2008, CANCER LETT, V271, P179, DOI 10.1016/j.canlet.2008.04.046; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zhang P, 2009, AM J PHYSIOL-HEART C, V296, pH840, DOI 10.1152/ajpheart.00519.2008	34	33	33	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 8	2012	90	6					1028	1045		10.1016/j.ajhg.2012.04.022	http://dx.doi.org/10.1016/j.ajhg.2012.04.022			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	958TC	22682329	Green Published, Bronze			2022-12-18	WOS:000305262600008
J	Ishida, M; Monk, D; Duncan, AJ; Abu-Amero, S; Chong, JH; Ring, SM; Pembrey, ME; Hindmarsh, PC; Whittaker, JC; Stanier, P; Moore, GE				Ishida, Miho; Monk, David; Duncan, Andrew J.; Abu-Amero, Sayeda; Chong, Jiehan; Ring, Susan M.; Pembrey, Marcus E.; Hindmarsh, Peter C.; Whittaker, John C.; Stanier, Philip; Moore, Gudrun E.			Maternal Inheritance of a Promoter Variant in the Imprinted PHLDA2 Gene Significantly Increases Birth Weight	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PLACENTAL EXPRESSION; INTRAUTERINE GROWTH; IPL; H19; ASSOCIATION; HUMANS; ADCY5; MICE	Birth weight is an important indicator of both perinatal and adult health, but little is known about the genetic factors contributing to its variability. Intrauterine growth restriction is a leading cause of perinatal morbidity anti mortality and is also associated with adult disease. A significant correlation has been reported between lower birth weight and increased expression of the maternal PHLDA2 allele in term placenta (the normal imprinting pattern was maintained). However, a mechanism that explains the transcriptional regulation of PHLDA2 on in utero growth has yet to be described. In this study, we sequenced the PHLDA2 promoter region in 263 fetal DNA samples to identity polymorphic variants. We used a luciferase reporter assay to identify in the PHLDA2 promoter a 15 bp repeat sequence (RS1) variant that significantly reduces PHLDA2-promoter efficiency. RS1 genotyping was then performed in three independent white European normal birth cohorts. Meta-analysis of all three (total n = 9,433) showed that maternal inheritance of RS1 resulted in a significant 93 g increase in birth weight (p = 0.01; 95% confidence interval [CI] = 22-163). Moreover, when the mother was homozygous for RS1, the influence on birth weight was 155 g (p = 0.04; 95% CI = 9-300), which is a similar magnitude to the reduction in birth weight caused by maternal smoking.	[Ishida, Miho; Monk, David; Duncan, Andrew J.; Abu-Amero, Sayeda; Chong, Jiehan; Pembrey, Marcus E.; Hindmarsh, Peter C.; Moore, Gudrun E.] UCL, Inst Child Hlth, Clin & Mol Genet Unit, London WC1N 1EH, England; [Ring, Susan M.; Pembrey, Marcus E.] Univ Bristol, Dept Social Med, Bristol BS8 2BN, Avon, England; [Whittaker, John C.] Univ London London Sch Hyg & Trop Med, Noncommunicable Dis Epidemiol Unit, London WC1E 7HT, England; [Stanier, Philip] UCL, Inst Child Hlth, Neural Dev Unit, London WC1N 1EH, England	University of London; University College London; University of Bristol; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Moore, GE (corresponding author), UCL, Inst Child Hlth, Clin & Mol Genet Unit, London WC1N 1EH, England.	gudrun.moore@ucl.ac.uk	Stanier, Philip/C-1593-2008; Whittaker, John C/B-8609-2012; Moore, Gudrun/A-2092-2009	Stanier, Philip/0000-0001-9340-8117; Whittaker, John C/0000-0002-3529-2379; Moore, Gudrun/0000-0002-2099-3420; Chong, Jiehan/0000-0002-5846-7397	Child Health Research Appeal Trust; Medical Research Council; Wellbeing of Women; March of Dimes; PARKS; GOSH Charity; MRC [G1001689, G0801438, G1100226] Funding Source: UKRI; Medical Research Council [G1001689, G0801438, G9815508] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1241] Funding Source: researchfish	Child Health Research Appeal Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellbeing of Women(Wellbeing of Women (WoW)); March of Dimes(March of Dimes); PARKS; GOSH Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Great Ormond Street Hospital Childrens Charity	We would like to thank M. Sweeney for her help at the sequencing facility at the Institute of Neurology and all the members of Professor Moore's Development and Growth research group for valuable suggestions and help. This research was funded by the Child Health Research Appeal Trust (the Institute of Child Health and the Great Ormond Street Hospital for Children [GOSH]), Overseas Research Studentship (M.I.), the Medical Research Council, Wellbeing of Women, March of Dimes, PARKS, and the GOSH Charity. P.S. is supported by the GOSH Charity. We are extremely grateful to all the families who took part in this study, the midwives for their help in recruiting the families, and the whole ALSPAC (Avon Longitudinal Study of Parents and Children) team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists, and nurses. The UK Medical Research Council, the Wellcome Trust, and the University of Bristol provide core support for ALSPAC. We would also like to thank the University College London Fetal Growth Study cohort team for their collaborative work.	Adkins RM, 2010, PEDIATR RES, V68, P429, DOI 10.1203/PDR.0b013e3181f1ca99; Andersson EA, 2010, DIABETOLOGIA, V53, P1908, DOI 10.1007/s00125-010-1790-0; Apostolidou S, 2007, J MOL MED, V85, P379, DOI 10.1007/s00109-006-0131-8; Arya R, 2006, HUM MOL GENET, V15, P1569, DOI 10.1093/hmg/ddl076; Barker DJP, 2004, J AM COLL NUTR, V23, p588S, DOI 10.1080/07315724.2004.10719428; Diplas AI, 2009, EPIGENETICS-US, V4, P235, DOI 10.4161/epi.9019; Fradin D, 2006, J CLIN ENDOCR METAB, V91, P4164, DOI 10.1210/jc.2006-0529; Frank D, 2002, P NATL ACAD SCI USA, V99, P7490, DOI 10.1073/pnas.122039999; Freathy RM, 2010, NAT GENET, V42, P430, DOI 10.1038/ng.567; Gomes MVM, 2005, GROWTH HORM IGF RES, V15, P360, DOI 10.1016/j.ghir.2005.06.016; Hindmarsh PC, 2002, PEDIATR RES, V52, DOI 10.1023/01.PDR.0000020600.45753.78; Jones RW, 2000, EUR J HUM GENET, V8, P653, DOI 10.1038/sj.ejhg.5200502; Kumar N, 2012, PLACENTA, V33, P94, DOI 10.1016/j.placenta.2011.11.018; Lewis RM, 2012, BONE, V50, P337, DOI 10.1016/j.bone.2011.11.003; McIntire DD, 1999, NEW ENGL J MED, V340, P1234, DOI 10.1056/NEJM199904223401603; McMinn J, 2006, PLACENTA, V27, P540, DOI 10.1016/j.placenta.2005.07.004; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Muller S, 2000, HUM MOL GENET, V9, P757, DOI 10.1093/hmg/9.5.757; Petry CJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-22; Petry CJ, 2011, HUM GENET, V130, P663, DOI 10.1007/s00439-011-1005-x; Qian N, 1997, HUM MOL GENET, V6, P2021, DOI 10.1093/hmg/6.12.2021; Saxena A, 2003, PLACENTA, V24, P835, DOI 10.1016/S0143-4004(03)00130-9; Saxena A, 2002, J BIOL CHEM, V277, P49935, DOI 10.1074/jbc.M206497200; Simmons RA, 2009, PEDIATR CLIN N AM, V56, P449, DOI 10.1016/j.pcl.2009.03.004; Tunster SJ, 2010, MOL CELL BIOL, V30, P295, DOI 10.1128/MCB.00662-09	25	33	38	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 6	2012	90	4					715	719		10.1016/j.ajhg.2012.02.021	http://dx.doi.org/10.1016/j.ajhg.2012.02.021			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	926LV	22444668	Green Published, hybrid			2022-12-18	WOS:000302833400015
J	Panicker, V; Wilson, SG; Walsh, JP; Richards, JB; Brown, SJ; Beilby, JP; Bremner, AP; Surdulescu, GL; Qweitin, E; Gillham-Nasenya, I; Soranzo, N; Lim, EM; Fletcher, SJ; Spector, TD				Panicker, Vijay; Wilson, Scott G.; Walsh, John P.; Richards, J. Brent; Brown, Suzanne J.; Beilby, John P.; Bremner, Alexandra P.; Surdulescu, Gabriela L.; Qweitin, Emad; Gillham-Nasenya, Irina; Soranzo, Nicole; Lim, Ee M.; Fletcher, Stephen J.; Spector, Tim D.			A Locus on Chromosome 1p36 Is Associated with Thyrotropin and Thyroid Function as Identified by Genome-wide Association Study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BODY-MASS INDEX; SERUM TSH; ATRIAL-FIBRILLATION; REFERENCE RANGE; FREE-THYROXINE; FREE T4; POPULATION; DISEASE; COHORT; RISK	Thyroid hormones are key regulators of cellular growth, development, and metabolism, and thyroid disorders are a common cause of ill health in the community. Circulating concentrations of thyrotropin (TSH), thyroxine (T4) and triiodothyronine (T3) have a strong heritable component and are thought to be under polygenic control, but the genes responsible are mostly unknown. In order to identify genetic loci associated with these metabolic phenotypes, we performed a genome-wide association study of 2,120,505 SNPs in 2014 female twins from the TwinsUK study and found a significant association between rs10917469 on chromosome 1p36.13 and serum TSH (p = 3.2 x 10(-8)). The association of rs10917469 with serum TSH was replicated (p = 2.0 x 10(-4)) in an independent community-based sample of 1154 participants in the Busselton Health Study. This SNP is located near CAPZB, which might be a regulator of TSH secretion and thus of pituitary-thyroid axis function. Twenty-nine percent of white individuals carry the variant, and the difference in mean TSH concentrations between wild-type individuals and those homozygous for the minor G allele was 0.5 mU/I, which is likely to be clinically relevant. We also provide evidence of suggestive association (p < 5.0 x 10(-8)) of other SNPs with serum TSH, free T4, and free T3 concentrations, and these SNPs might be good targets for further studies. These results advance understanding of the genetic basis of pituitary-thyroid axis function and metabolic regulation.	[Panicker, Vijay; Wilson, Scott G.; Walsh, John P.; Brown, Suzanne J.; Lim, Ee M.] Sir Charles Gairdner Hosp, Dept Endocrinol & Diabet, Nedlands, WA, Australia; [Wilson, Scott G.; Walsh, John P.] Univ Western Australia, Sch Med & Pharmacol, Crawley, WA, Australia; [Wilson, Scott G.; Richards, J. Brent; Surdulescu, Gabriela L.; Qweitin, Emad; Gillham-Nasenya, Irina; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Richards, J. Brent] McGill Univ, Jewish Gen Hosp, Dept Med, Montreal, PQ H3T 1E2, Canada; [Richards, J. Brent] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Beilby, John P.; Lim, Ee M.; Fletcher, Stephen J.] Pathw Lab Med WA, Nedlands, WA, Australia; [Beilby, John P.] Univ Western Australia, Sch Pathol, Nedlands, WA 6009, Australia; [Beilby, John P.] Univ Western Australia, Lab Med, Nedlands, WA 6009, Australia; [Bremner, Alexandra P.] Univ Western Australia, Sch Populat Hlth, Crawley, WA, Australia; [Soranzo, Nicole] Wellcome Trust Sanger Inst, Cambridge, England	University of Western Australia; University of Western Australia; University of London; King's College London; McGill University; Lady Davis Institute; McGill University; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; Wellcome Trust Sanger Institute	Wilson, SG (corresponding author), Sir Charles Gairdner Hosp, Dept Endocrinol & Diabet, Nedlands, WA, Australia.	wilsonsg@cyllene.uwa.edu.au; john.walsh@health.wa.gov.au	Richards, J Brent/AAF-4225-2019	Richards, J Brent/0000-0002-3746-9086; Beilby, John/0000-0002-4915-2254; Walsh, John/0000-0002-1766-2612; BROWN, SUZANNE/0000-0002-8413-561X; Soranzo, Nicole/0000-0003-1095-3852; Wilson, Scott/0000-0002-0357-1373; Panicker, Vijay/0000-0003-1551-8411; Bremner, Alexandra/0000-0002-4068-4860	National Eye Institute/National Institutes of Health; Wellcome Trust; European Community [FP7/2007-2013, HEALTH-F4-2007-201413]; Department of Health via the National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre; King's College London; Canadian Institutes of Health Research; Canadian Foundation for Innovation; Fonds de la Recherche en Sante Quebec; Ministere du Developpement Economique, de l'Innovation et de l'Exportation Quebec; Lady Davis Institute of the Jewish General Hospital; Sir Charles Gairdner Hospital Research Fund	National Eye Institute/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Wellcome Trust(Wellcome TrustEuropean Commission); European Community(European Commission); Department of Health via the National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); King's College London; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Fonds de la Recherche en Sante Quebec(Fonds de la Recherche en Sante du Quebec); Ministere du Developpement Economique, de l'Innovation et de l'Exportation Quebec; Lady Davis Institute of the Jewish General Hospital; Sir Charles Gairdner Hospital Research Fund	We thank the staff from the genotyping facilities at the Wellcome Trust Sanger Institute and the Center for Inherited Disease Research as part of a National Eye Institute/National Institutes of Health project grant. We gratefully acknowledge the contribution of Abbott Diagnostics, North Ryde, Australia, which provided support for the biochemical analysis. This study received funding from the Wellcome Trust, the European Community's Seventh Framework Program grant agreement (FP7/2007-2013), and ENGAGE project grant agreement (HEALTH-F4-2007-201413). The study also received support from the Department of Health via the National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London. Additional funding was provided by the Canadian Institutes of Health Research, Canadian Foundation for Innovation, Fonds de la Recherche en Sante Quebec, Ministere du Developpement Economique, de l'Innovation et de l'Exportation Quebec, the Lady Davis Institute of the Jewish General Hospital (JBR) and the Sir Charles Gairdner Hospital Research Fund (JW, SGW). T.D.S. is an NIHR senior investigator. We are grateful to the volunteer twins who made available their time and the Busselton Population Medical Research Foundation for approving the study.	Andersen S, 2002, J CLIN ENDOCR METAB, V87, P1068, DOI 10.1210/jc.87.3.1068; Arnaud-Lopez L, 2008, AM J HUM GENET, V82, P1270, DOI 10.1016/j.ajhg.2008.04.019; Asvold BO, 2008, ARCH INTERN MED, V168, P855, DOI 10.1001/archinte.168.8.855; Asvold BO, 2007, EUR J ENDOCRINOL, V156, P181, DOI 10.1530/eje.1.02333; Asvold BO, 2007, J CLIN ENDOCR METAB, V92, P841, DOI 10.1210/jc.2006-2208; AULCHENKO Y, 2009, GENABEL GENOMEWIDE S; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Gammage MD, 2007, ARCH INTERN MED, V167, P928, DOI 10.1001/archinte.167.9.928; Hansen PS, 2004, J CLIN ENDOCR METAB, V89, P1181, DOI 10.1210/jc.2003-031641; Heeringa J, 2008, ARCH INTERN MED, V168, P2219, DOI 10.1001/archinte.168.20.2219; Keffer JH, 1996, CLIN CHEM, V42, P125; Knudsen N, 2005, J CLIN ENDOCR METAB, V90, P4019, DOI 10.1210/jc.2004-2225; Makepeace AE, 2008, CLIN ENDOCRINOL, V69, P648, DOI 10.1111/j.1365-2265.2008.03239.x; Nyrnes A, 2006, INT J OBESITY, V30, P100, DOI 10.1038/sj.ijo.0803112; Panicker V, 2008, CLIN ENDOCRINOL, V68, P652, DOI 10.1111/j.1365-2265.2007.03079.x; Panicker V, 2008, J CLIN ENDOCR METAB, V93, P3075, DOI 10.1210/jc.2008-0397; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; R Development Core Team, 2009, R LANG ENV STAT COMP; Samollow PB, 2004, J CLIN ENDOCR METAB, V89, P3276, DOI 10.1210/jc.2003-031706; Shields BM, 2009, J CLIN ENDOCR METAB, V94, P4608, DOI 10.1210/jc.2009-1298; Spector TD, 2006, TWIN RES HUM GENET, V9, P899, DOI 10.1375/twin.9.6.899; Walsh JP, 2010, J CLIN ENDOCR METAB, V95, P1095, DOI 10.1210/jc.2009-1977; Yap AS, 1997, ENDOCRINOLOGY, V138, P2315, DOI 10.1210/en.138.6.2315	25	33	34	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 10	2010	87	3					430	435		10.1016/j.ajhg.2010.08.005	http://dx.doi.org/10.1016/j.ajhg.2010.08.005			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	651JH	20826269	Green Published, Bronze			2022-12-18	WOS:000281923500014
J	Daly, SB; Urquhart, JE; Hilton, E; McKenzie, EA; Kammerer, RA; Lewis, M; Kerr, B; Stuart, H; Donnai, D; Long, DA; Burgu, B; Aydogdu, O; Derbent, M; Garcia-Minaur, S; Reardon, W; Gener, B; Shalev, S; Smith, R; Woolf, AS; Black, GC; Newman, WG				Daly, Sarah B.; Urquhart, Jill E.; Hilton, Emma; McKenzie, Edward A.; Kammerer, Richard A.; Lewis, Malcolm; Kerr, Bronwyn; Stuart, Helen; Donnai, Dian; Long, David A.; Burgu, Berk; Aydogdu, Ozgu; Derbent, Murat; Garcia-Minaur, Sixto; Reardon, Willie; Gener, Blanca; Shalev, Stavit; Smith, Rupert; Woolf, Adrian S.; Black, Graeme C.; Newman, William G.			Mutations in HPSE2 Cause Urofacial Syndrome (vol 86, pg 963, 2010)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Correction													Urquhart, Jill/G-2282-2015; Stuart, Helen/G-3535-2015; Woolf, Adrian S./AAZ-1075-2020; Gener, Blanca/E-4310-2012	Urquhart, Jill/0000-0002-5788-5511; Stuart, Helen/0000-0003-2569-235X; Woolf, Adrian S./0000-0001-5541-1358; Reardon, Willie/0000-0001-7329-9179; Long, David/0000-0001-6580-3435; Hilton, Emma/0000-0002-3750-577X; Newman, William/0000-0002-6382-4678; Burgu, Berk/0000-0003-1546-1179; Kammerer, Richard/0000-0003-4570-5197				Daly SB, 2010, AM J HUM GENET, V86, P963, DOI 10.1016/j.ajhg.2010.05.006	1	33	34	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG 13	2010	87	2					309	309		10.1016/j.ajhg.2010.07.010	http://dx.doi.org/10.1016/j.ajhg.2010.07.010			1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	641EG	20560210	Green Accepted, Bronze, Green Published			2022-12-18	WOS:000281107000018
J	Brkanac, Z; Spencer, D; Shendure, J; Robertson, PD; Matsushita, M; Vu, T; Bird, TD; Olson, MV; Raskind, WH				Brkanac, Zoran; Spencer, David; Shendure, Jay; Robertson, Peggy D.; Matsushita, Mark; Vu, Tiffany; Bird, Thomas D.; Olson, Maynard V.; Raskind, Wendy H.			IFRD1 Is a Candidate Gene for SMNA on Chromosome 7q22-q23	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NERVE GROWTH-FACTOR; PRION PROTEIN GENE; POINT MUTATION; INDUCTION; CELLS; TIS7; PAIN; PC4	We have established strong linkage evidence that supports mapping autosomal-dominant sensory/motor neuropathy with ataxia (SMNA) to chromosome 7q22-q32. SMNA is a rare neurological disorder whose phenotype encompasses both the central and the peripheral nervous system. In order to identify a gene responsible for SMNA, we have undertaken a comprehensive genomic evaluation of the region of linkage, including evaluation for repeat expansion and small deletions or duplications, capillary sequencing of candidate genes, and massively parallel sequencing of all coding exons. We excluded repeat expansion and small deletions or duplications as causative, and through microarray-based hybrid capture and massively parallel short-read sequencing, we identified a nonsynonymous variant in the human interferon-related developmental regulator gene 1 (IFRD1) as a disease-causing candidate. Sequence conservation, animal models, and protein structure evaluation support the involvement of IFRD1 in SMNA. Mutation analysis of IFRD1 in additional patients with similar phenotypes is needed for demonstration of causality and further evaluation of its importance in neurological diseases.	[Brkanac, Zoran; Raskind, Wendy H.] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98104 USA; [Spencer, David; Shendure, Jay; Robertson, Peggy D.; Olson, Maynard V.; Raskind, Wendy H.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98104 USA; [Matsushita, Mark; Vu, Tiffany; Bird, Thomas D.; Raskind, Wendy H.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98104 USA; [Bird, Thomas D.] Univ Washington, Sch Med, Dept Neurol, Seattle, WA 98104 USA; [Bird, Thomas D.; Raskind, Wendy H.] GRECC, Vet Adm Puget Sound Hlth Care Ctr, Seattle, WA 98108 USA; [Bird, Thomas D.; Raskind, Wendy H.] MIRECC, Seattle, WA 98108 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Geriatric Research Education & Clinical Center	Brkanac, Z (corresponding author), Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98104 USA.	zbrkanac@u.washington.edu	Shendure, Jay/AAU-3684-2021	Shendure, Jay/0000-0002-1516-1865	NIH/NHGRI [R21 HG004749]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG004749] Funding Source: NIH RePORTER	NIH/NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We are grateful to the members of the family for their participation in these studies and to Elizabeth Thompson for her intellectual contributions during the early stages of the research. Skillful technical assistance was provided by Ruolan Qiu, Choli Lee, Emily Turner, Sarah Summer, Zarshid Arbibi, Ruben Burbank, Catherine Morgan, Jane Ranchalis, and John Wolf. We thank Chang-En Yu for generous provision of control samples. The research was supported in part by funds and resources from the National Organization for Rare Disorders, the Department of Veterans Affairs, the Mary Gates and the Herschel and Caryl Roman Endowments for Students, and NIH/NHGRI grant R21 HG004749 to J.S.	Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; ARENANDER AT, 1989, J NEUROSCI RES, V23, P257, DOI 10.1002/jnr.490230303; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Bird T., HEREDITARY ATAXIA OV; Brkanac Z, 2002, AM J MED GENET, V114, P450, DOI 10.1002/ajmg.10361; Brkanac Z, 2007, AM J MED GENET B, V144B, P556, DOI 10.1002/ajmg.b.30471; Buanne P, 1998, GENOMICS, V51, P233, DOI 10.1006/geno.1998.5260; Chen DH, 2003, AM J HUM GENET, V72, P839, DOI 10.1086/373883; Dieplinger B, 2007, EUR J NEUROSCI, V26, P3358, DOI 10.1111/j.1460-9568.2007.05951.x; Eckman CB, 1997, HUM MOL GENET, V6, P2087, DOI 10.1093/hmg/6.12.2087; Einarsdottir E, 2004, HUM MOL GENET, V13, P799, DOI 10.1093/hmg/ddh096; GUARDAVACCARO D, 1994, J NEUROSCI RES, V37, P660, DOI 10.1002/jnr.490370514; Indo Y, 1996, NAT GENET, V13, P485, DOI 10.1038/ng0896-485; Jin K, 2004, NEUROLOGY, V62, P502, DOI 10.1212/01.WNL.0000106954.54011.80; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Martinelli S, 2008, HUM MOL GENET, V17, P2018, DOI 10.1093/hmg/ddn099; Minde J, 2009, J NEUROL NEUROSUR PS, V80, P188, DOI 10.1136/jnnp.2007.136051; Mouillet-Richard S, 1999, J NEUROL SCI, V168, P141, DOI 10.1016/S0022-510X(99)00179-3; POCCHIARI M, 1993, ANN NEUROL, V34, P802, DOI 10.1002/ana.410340608; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tartaglia M, 2006, AM J HUM GENET, V78, P279, DOI 10.1086/499925; THOMPSON AJ, 2001, BIOCHIM BIOPHYS ACTA, V44, P242; TIRONE F, 1989, P NATL ACAD SCI USA, V86, P2088, DOI 10.1073/pnas.86.6.2088; Vadivelu SK, 2004, MOL CELL BIOL, V24, P3514, DOI 10.1128/MCB.24.8.3514-3525.2004; VARNUM BC, 1989, ONCOGENE, V4, P1263; Vietor I, 2002, EMBO J, V21, P4621, DOI 10.1093/emboj/cdf461	28	33	34	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 15	2009	84	5					692	697		10.1016/j.ajhg.2009.04.008	http://dx.doi.org/10.1016/j.ajhg.2009.04.008			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	449OB	19409521	Green Published, Bronze			2022-12-18	WOS:000266338800015
J	Kaname, T; Yanagi, K; Chinen, Y; Makita, Y; Okamoto, N; Maehara, H; Owan, I; Kanaya, F; Kubota, Y; Oike, Y; Yamamoto, T; Kurosawa, K; Fukushima, Y; Bohring, A; Opitz, JM; Yoshiura, KI; Niikawa, N; Naritomi, K				Kaname, Tadashi; Yanagi, Kumiko; Chinen, Yasutsugu; Makita, Yoshio; Okamoto, Nobuhiko; Maehara, Hiroki; Owan, Ichiro; Kanaya, Fuminori; Kubota, Yoshiaki; Oike, Yuichi; Yamamoto, Toshiyuki; Kurosawa, Kenji; Fukushima, Yoshimitsu; Bohring, Axel; Opitz, John M.; Yoshiura, Ko-ichiro; Niikawa, Norio; Naritomi, Kenji			Mutations in CD96, a member of the immunoglobulin superfamily, cause a form of the C (Opitz trigonocephaly) syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BOHRING-OPITZ; CLEFT LIP/PALATE; CELL-ADHESION; RECEPTOR; PATIENT; TACTILE; PVRL1; BOY	The C syndrome is characterized by trigonocephaly and associated anomalies, such as unusual facies, psychomotor retardation, redundant skin, joint and limb abnormalities, and visceral anomalies. In an individual with the C syndrome who harbors a balanced chromosomal translocation, t(3; 18)(q13.13; q12.1), we discovered that the TACTILE gene for CD96, a member of the immunoglobulin superfamily, was disrupted at the 3q13.3 breakpoint. In mutation analysis of nine karyotypically normal patients given diagnoses of the C or C-like syndrome, we identified a missense mutation (839C -> T, T280M) in exon 6 of the CD96 gene in one patient with the C-like syndrome. The missense mutation was not found among 420 unaffected Japanese individuals. Cells with mutated CD96 protein (T280M) lost adhesion and growth activities in vitro. These findings indicate that CD96 mutations may cause a form of the C syndrome by interfering with cell adhesion and growth.	Univ Ryukyus, Fac Med, Dept Med Genet, Nishihara, Okinawa 90301, Japan; Univ Ryukyus, Fac Med, Dept Pediat, Nishihara, Okinawa 90301, Japan; Univ Ryukyus, Fac Med, Dept Orthoped, Nishihara, Okinawa 90301, Japan; Asahikawa Med Coll, Dept Pediat, Asahikawa, Hokkaido 078, Japan; Osaka Med Ctr, Dept Dev Med, Izumi, Japan; Res Inst Maternal & Child Hlth, Izumi, Japan; Keio Univ, Sch Med, Dept Cell Differentiat, Tokyo, Japan; Kanagawa Childrens Med Ctr, Div Med Genet, Yokohama, Kanagawa, Japan; Shinshu Univ, Sch Med, Dept Med Genet, Matsumoto, Nagano 390, Japan; Univ Munster, Inst Humangenet, D-4400 Munster, Germany; Univ Utah, Sch Med, Dept Pediat Pathol Obstet & Gynecol & Genet, Salt Lake City, UT USA; Nagasaki Univ, Grad Sch Biomed Sci, Dept Human Genet, Nagasaki 852, Japan; Japan Sci & Technol, SORST, Kawaguchi, Japan	University of the Ryukyus; University of the Ryukyus; University of the Ryukyus; Asahikawa Medical College; Osaka Medical Center for Cancer & Cardiovascular Diseases; Keio University; Shinshu University; University of Munster; Utah System of Higher Education; University of Utah; Nagasaki University; Japan Science & Technology Agency (JST)	Kaname, T (corresponding author), Univ Ryukyus, Fac Med, Dept Med Genet, 207 Uehara, Okinawa 9030215, Japan.	tkaname@med.u-ryukyu.ac.jp	Kubota, Yoshiaki/L-2231-2013; Kurosawa, Kenji/B-6561-2016	Kurosawa, Kenji/0000-0002-6817-7748; MAEHARA, HIROKI/0000-0001-5897-9213				Bohring A, 2006, AM J MED GENET A, V140A, P1257, DOI 10.1002/ajmg.a.31265; Bohring A, 1999, AM J MED GENET, V85, P438, DOI 10.1002/(SICI)1096-8628(19990827)85:5<438::AID-AJMG2>3.0.CO;2-A; Chinen Y, 2006, AM J MED GENET A, V140A, P1655, DOI 10.1002/ajmg.a.31341; Fuchs A, 2004, J IMMUNOL, V172, P3994, DOI 10.4049/jimmunol.172.7.3994; Gorlin RJ, 2001, SYNDROMES HEAD NECK, P1145; Kaname T, 2001, GENE, V266, P147, DOI 10.1016/S0378-1119(01)00375-4; Kolehmainen J, 2004, AM J HUM GENET, V75, P122, DOI 10.1086/422197; Krauss RS, 2005, J CELL SCI, V118, P2355, DOI 10.1242/jcs.02397; McGaughran J, 2000, AM J MED GENET, V94, P311, DOI 10.1002/1096-8628(20001002)94:4<311::AID-AJMG9>3.0.CO;2-U; Mochly-Rosen D, 2001, ADV ENZYME REGUL, V41, P87, DOI 10.1016/S0065-2571(00)00008-X; Nakane T, 2000, AM J MED GENET, V92, P361, DOI 10.1002/1096-8628(20000619)92:5<361::AID-AJMG13>3.0.CO;2-E; OPITZ J M, 1969, Birth Defects Original Article Series, V5, P161; Opitz JM, 2006, FETAL PEDIATR PATHOL, V25, P211, DOI 10.1080/15513810601015753; Osaki M, 2006, AM J MED GENET A, V140A, P897, DOI 10.1002/ajmg.a.31164; PREUS M, 1986, AM J MED GENET, V23, P935, DOI 10.1002/ajmg.1320230409; Sakisaka T, 2004, CURR OPIN CELL BIOL, V16, P513, DOI 10.1016/j.ceb.2004.07.007; SARGENT C, 1985, J MED GENET, V22, P39, DOI 10.1136/jmg.22.1.39; SCHWYZER U, 1988, HELV PAEDIATR ACTA, V42, P309; Sozen MA, 2001, NAT GENET, V29, P141, DOI 10.1038/ng740; Suzuki K, 2000, NAT GENET, V25, P427, DOI 10.1038/78119; WANG PL, 1992, J IMMUNOL, V148, P2600	21	33	34	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2007	81	4					835	841		10.1086/522014	http://dx.doi.org/10.1086/522014			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	208GK	17847009	Bronze, Green Published			2022-12-18	WOS:000249307600025
J	Yan, J; Bi, WM; Lupski, JR				Yan, Jiong; Bi, Weimin; Lupski, James R.			Penetrance of craniofacial anomalies in mouse models of Smith-Magenis syndrome is modified by genomic sequence surrounding Rai1: Not all null alleles are alike	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							17P11.2 DELETIONS; GENETIC-DISEASE; MICE; MUTATIONS; DISRUPTION; DUP(17)(P11.2P11.2); MITOCHONDRIA; PHENOTYPES; PROTEIN; SCORES	Craniofacial abnormality is one of the major clinical manifestations of Smith-Magenis syndrome (SMS). Previous analyses in a mixed genetic background of several SMS mouse models-including Df(11)17/+ and Df(11)17-1/+, which have 2-Mb and 590-kb deletions, respectively, and Rai1(-/+)-revealed that the penetrance of the craniofacial phenotype appears to be influenced by deletion size and genetic background. We generated an additional strain with a 1-Mb deletion intermediate in size between the two described above. Remarkably, the penetrance of its craniofacial anomalies in the mixed background was between those of Df( 11) 17 and Df(11)17-1. We further analyzed the deletion mutations and the Rai1(-/+) allele in a pure C57BL/6 background, to control for nonlinked modifier loci. The penetrance of the craniofacial anomalies was markedly increased for all the strains in comparison with the mixed background. Mice with Df( 11) 17 and Df(11)17-1 deletions had a similar penetrance, suggesting that penetrance may be less influenced by deletion size, whereas that of Rai1(-/+) mice was significantly lower than that of the deletion strains. We hypothesize that potential trans-regulatory sequence(s) or gene( s) that reside within the 590-kb genomic interval surrounding Rai1 are the major modifying genetic element(s) affecting the craniofacial penetrance. Moreover, we confirmed the influence of genetic background and different deletion sizes on the phenotype. The complicated control of the penetrance for one phenotype in SMS mouse models provides tools to elucidate molecular mechanisms for penetrance and clearly shows that a null allele caused by chromosomal deletion can have different phenotypic consequences than one caused by gene inactivation.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Texas Childrens Hosp, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Room 604B,1 Baylor Plaza, Houston, TX 77030 USA.	jlupski@bcm.tmc.edu		Yan, Jiong/0000-0003-0536-8130	PHS HHS [R01 DEO15210] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Allanson JE, 1999, J MED GENET, V36, P394; BI W, IN PRESS INBORN ERRO; Bi W, 2006, AM J MED GENET A, V140A, P2454, DOI 10.1002/ajmg.a.31510; Bi WM, 2005, HUM MOL GENET, V14, P983, DOI 10.1093/hmg/ddi085; Bi WM, 2004, HUM GENET, V115, P515, DOI 10.1007/s00439-004-1187-6; Bi WM, 2002, GENOME RES, V12, P713, DOI 10.1101/gr.73702; Chen K-S, 1996, MENTAL RETARD DEV DI, V2, P122; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; Cheng HYM, 2004, NEURON, V43, P715, DOI 10.1016/j.neuron.2004.08.021; Cooper GM, 2003, CURR OPIN GENET DEV, V13, P604, DOI 10.1016/j.gde.2003.10.001; Duncan IW, 2002, ANNU REV GENET, V36, P521, DOI 10.1146/annurev.genet.36.060402.100441; Franco M, 2006, MOL CELL BIOL, V26, P1932, DOI 10.1128/MCB.26.5.1932-1947.2006; Frazer KA, 2003, GENOME RES, V13, P1, DOI 10.1101/gr.222003; Girirajan S, 2005, J MED GENET, V42, P820, DOI 10.1136/jmg.2005.031211; Girirajan S, 2006, GENET MED, V8, P417, DOI 10.1097/01.gim.0000228215.32110.89; Hammond P, 2005, AM J HUM GENET, V77, P999, DOI 10.1086/498396; Hansen GM, 2000, GENOME RES, V10, P237, DOI 10.1101/gr.10.2.237; IMAL Y, 1995, BRAIN RES MOL BRAIN, V31, P1; Jones KL., 2006, SMITHS RECOGNIZABLE, V6th ed., P268; Katoh Y, 2006, BIOCHEM BIOPH RES CO, V341, P143, DOI 10.1016/j.bbrc.2005.12.156; King DC, 2005, GENOME RES, V15, P1051, DOI 10.1101/gr.3642605; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Kleinjan DJ, 1998, HUM MOL GENET, V7, P1611, DOI 10.1093/hmg/7.10.1611; Kolbe D, 2004, GENOME RES, V14, P700, DOI 10.1101/gr.1976004; Padmanabhan R, 1997, REPROD TOXICOL, V11, P843, DOI 10.1016/S0890-6238(97)00068-3; Potocki L, 2003, GENET MED, V5, P430, DOI 10.1097/01.GIM.0000095625.14160.AB; Rampazzo C, 2000, P NATL ACAD SCI USA, V97, P8239, DOI 10.1073/pnas.97.15.8239; Richtsmeier JT, 2000, DEV DYNAM, V217, P137, DOI 10.1002/(SICI)1097-0177(200002)217:2<137::AID-DVDY1>3.0.CO;2-N; SHAFFER LG, 2001, METABOLIC MOL BASIS, P1291; Shimano H, 1997, J CLIN INVEST, V100, P2115, DOI 10.1172/JCI119746; Slager RE, 2003, NAT GENET, V33, P466, DOI 10.1038/ng1126; Su H, 2000, NAT GENET, V24, P92, DOI 10.1038/71756; Tassabehji M, 2005, SCIENCE, V310, P1184, DOI 10.1126/science.1116142; Tomomori-Sato C, 2004, J BIOL CHEM, V279, P5846, DOI 10.1074/jbc.M312523200; Toulouse A, 2003, GENOMICS, V82, P162, DOI 10.1016/S0888-7543(03)00101-0; Vlangos CN, 2003, MOL GENET METAB, V79, P134, DOI 10.1016/S1096-7192(03)00048-9; Walkey CJ, 1997, P NATL ACAD SCI USA, V94, P12880, DOI 10.1073/pnas.94.24.12880; Walz K, 2003, MOL CELL BIOL, V23, P3646, DOI 10.1128/MCB.23.10.3646-3655.2003; Walz K, 2006, J CLIN INVEST, V116, P3035, DOI 10.1172/JCI28953; Wang ZG, 2001, J BIOL CHEM, V276, P30773, DOI 10.1074/jbc.M104133200; Yan J, 2003, MOL CELL BIOL, V23, P6798, DOI 10.1128/MCB.23.19.6798-6808.2003; Yan J, 2004, HUM MOL GENET, V13, P2613, DOI 10.1093/hmg/ddh288; Zody MC, 2006, NATURE, V440, P1045, DOI 10.1038/nature04689	43	33	34	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2007	80	3					518	525		10.1086/512043	http://dx.doi.org/10.1086/512043			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	139AB	17273973	Green Published, Bronze			2022-12-18	WOS:000244403300013
J	Pe'er, I; Chretien, YR; de Bakker, PIW; Barrett, JC; Daly, MJ; Altshuler, DM				Pe'er, I; Chretien, YR; de Bakker, PIW; Barrett, JC; Daly, MJ; Altshuler, DM			Biases and reconciliation in estimates of linkage disequilibrium in the human genome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; COMMON DISEASE GENES; HAPLOTYPE DIVERSITY; SEQUENCE VARIATION; HUMAN-POPULATIONS; WIDE ASSOCIATION; RECOMBINATION; PATTERNS; BLOCKS; TRAITS	Genetic association studies of common disease often rely on linkage disequilibrium ( LD) along the human genome and in the population under study. Although understanding the characteristics of this correlation has been the focus of many large-scale surveys ( culminating in genomewide haplotype maps), the results of different studies have yielded wide-ranging estimates. Since understanding these differences ( and whether they can be reconciled) has important implications for whole-genome association studies, in this article we dissect biases in these estimations that are due to known aspects of study design and analytic methodology. In particular, we document in the empirical data that the long-known complicating effects of allele frequency, marker density, and sample size largely reconcile all large-scale surveys. Two exceptions are an underappraisal of redundancy among single-nucleotide polymorphisms ( SNPs) when evaluation is limited to short regions ( as in candidate-gene resequencing studies) and an inflation in the extent of LD in HapMap phase I, which is likely due to oversampling of specific haplotypes in the creation of the public SNP map. Understanding these factors can guide the understanding of empirical LD surveys and has implications for genetic association studies.	Massachusetts Gen Hosp, Richard B Simches Res Ctr, Dept Mol Biol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; MIT, Broad Inst, Cambridge, MA 02139 USA; Harvard Univ, MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT)	Daly, MJ (corresponding author), Massachusetts Gen Hosp, Richard B Simches Res Ctr, Dept Mol Biol, 185 Cambridge St, Boston, MA 02114 USA.	mjdaly@chgr.mgh.harvard.edu	Daly, Mark J/B-2453-2017; Altshuler, David M/A-4476-2009; de Bakker, Paul IW/B-8730-2009	Daly, Mark J/0000-0002-0949-8752; Altshuler, David M/0000-0002-7250-4107; de Bakker, Paul IW/0000-0001-7735-7858; Barrett, Jeffrey/0000-0002-1152-370X				Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Carlson CS, 2004, NATURE, V429, P446, DOI 10.1038/nature02623; Clark AG, 2003, AM J HUM GENET, V73, P285, DOI 10.1086/377138; Crawford DC, 2004, AM J HUM GENET, V74, P610, DOI 10.1086/382227; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Evans DM, 2005, AM J HUM GENET, V76, P681, DOI 10.1086/429274; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; HEDRICK PW, 1987, GENETICS, V117, P331; HILL WG, 1994, AM J HUM GENET, V54, P705; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Jorde LB, 2000, GENOME RES, V10, P1435, DOI 10.1101/gr.144500; Ke XY, 2004, HUM MOL GENET, V13, P577, DOI 10.1093/hmg/ddh060; KIMURA M, 1964, GENETICS, V49, P725; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEWONTIN RC, 1964, GENETICS, V50, P757; McKeigue PM, 2000, ANN HUM GENET, V64, P171, DOI 10.1017/S0003480000008022; Morton NE, 2001, P NATL ACAD SCI USA, V98, P5217, DOI 10.1073/pnas.091062198; Nielsen R, 2003, THEOR POPUL BIOL, V63, P245, DOI 10.1016/S0040-5809(03)00005-4; Nothnagel M, 2002, SEMIN NEPHROL, V22, P105, DOI 10.1053/snep.2002.30209; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Phillips MS, 2003, NAT GENET, V33, P382, DOI 10.1038/ng1100; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Reich DE, 2002, NAT GENET, V32, P135, DOI 10.1038/ng947; Reich DE, 2003, NAT GENET, V33, P457, DOI 10.1038/ng1133; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Sabatti C, 2002, GENETICS, V160, P1707; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Teare MD, 2002, ANN HUM GENET, V66, P223, DOI 10.1017/S0003480002001082; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522	43	33	35	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2006	78	4					588	603		10.1086/502803	http://dx.doi.org/10.1086/502803			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	032EE	16532390	Bronze, Green Published			2022-12-18	WOS:000236755900006
J	Cabral, WA; Marini, JC				Cabral, WA; Marini, JC			High proportion of mutant osteoblasts is compatible with normal skeletal function in mosaic carriers of osteogenesis imperfecta	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article; Proceedings Paper	24th Annual Meeting of the American-Society-for-Bone-and-Mineral-Research	SEP 20-24, 2002	SAN ANTONIO, TX	Amer Soc Bone & Mineral Res			MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; COLLAGEN MUTATION DATABASE; I COLLAGEN; SOMATIC MOSAICISM; BONE-MARROW; GENE-THERAPY; NONHEMATOPOIETIC TISSUES; VARIABLE EXPRESSIVITY; PARENTAL MOSAICISM	Individuals with mosaicism for the autosomal dominant bone dysplasia osteogenesis imperfecta (OI) are generally identified by having more than one affected child. The mosaic carriers have both normal and mutant cell populations in somatic and germline tissues but are unaffected or minimally affected by the type I collagen mutation that manifests clinically in their heterozygous offspring. We determined the proportion of mutant osteoblasts in skeletal tissue of two mosaic carriers who each have a COL1A1 mutation in a high proportion of dermal fibroblasts. Both carriers had normal height and bone histology; the first carrier had normal lumbar spine measurements (L1 - L4), as determined by dual-energy x-ray absorptiometry (Z = +1.17). In cultured cells from the first carrier, studied by labeled PCR and single-cell PCR over successive passages, the collagen mutation was present in 85% of fibroblasts and 50% and 75% of osteoblasts from her right iliac crest and left patella, respectively, with minimal selection. The second carrier was studied by PCR amplification of DNA from autopsy paraffin blocks. The proportion of heterozygous cells was 40% in calvarium, 65% in tracheal ring, and 70% in aorta. Thus, in OI, substantially normal skeletal growth, density, and histology are compatible with a 40% - 75% burden of osteoblasts heterozygous for a COL1A1 mutation. These data are encouraging for mesenchymal stem-cell transplantation, since mosaic carriers are a naturally occurring model for cell therapy.	NICHHD, Bone & Extracellular Matrix Branch, Sect Heritable Disorders Bone, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Marini, JC (corresponding author), NICHHD, Bone & Extracellular Matrix Branch, Sect Heritable Disorders Bone, NIH, Bldg 10,Room 9S239,9000 Rockville Pike, Bethesda, MD 20892 USA.	oidoc@helix.nih.gov			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000408] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000408] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Byers P, 2002, CONNECTIVE TISSUE IT, P385, DOI DOI 10.1002/0471221929.CH8; BYERS PH, 1991, J MED GENET, V28, P433, DOI 10.1136/jmg.28.7.433; BYERS PH, 1988, AM J HUM GENET, V42, P237; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CohenSolal L, 1996, MOL CELL PROBE, V10, P219, DOI 10.1006/mcpr.1996.0030; CONSTANTINOU CD, 1989, J CLIN INVEST, V83, P574, DOI 10.1172/JCI113920; Dalgleish R, 1998, NUCLEIC ACIDS RES, V26, P253, DOI 10.1093/nar/26.1.253; Dalgleish R, 1997, NUCLEIC ACIDS RES, V25, P181, DOI 10.1093/nar/25.1.181; Devine SM, 2001, EXP HEMATOL, V29, P244, DOI 10.1016/S0301-472X(00)00635-4; Edwards Matthew J., 1992, Human Mutation, V1, P47, DOI 10.1002/humu.1380010108; Gerson SL, 1999, NAT MED, V5, P262, DOI 10.1038/6470; Gottlieb B, 2001, TRENDS GENET, V17, P79, DOI 10.1016/S0168-9525(00)02178-8; HALL JG, 1988, AM J HUM GENET, V43, P355; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Horwitz EM, 2001, BLOOD, V97, P1227, DOI 10.1182/blood.V97.5.1227; Hou Z, 1999, P NATL ACAD SCI USA, V96, P7294, DOI 10.1073/pnas.96.13.7294; Korkko J, 1998, AM J HUM GENET, V62, P98, DOI 10.1086/301689; LEEFLANG EP, 1995, HUM MOL GENET, V4, P1519; Lund A M, 1999, Hum Mutat, V13, P503, DOI 10.1002/(SICI)1098-1004(1999)13:6<503::AID-HUMU11>3.0.CO;2-L; Lund AM, 1996, EUR J HUM GENET, V4, P39; Lund AM, 1997, ACTA PAEDIATR, V86, P711, DOI 10.1111/j.1651-2227.1997.tb08573.x; Mackenzie TC, 2001, BLOOD CELL MOL DIS, V27, P601, DOI 10.1006/bcmd.2001.0424; Marini JC, 1997, JAMA-J AM MED ASSOC, V277, P746, DOI 10.1001/jama.277.9.746; Marini JC, 1999, NAT MED, V5, P466, DOI 10.1038/8326; MARINI JC, 2001, MANAGEMENT GENETIC S, P281; Niyibizi C, 2002, CRIT REV EUKAR GENE, V12, P163, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i3.10; Oyama M, 1999, GENE THER, V6, P321, DOI 10.1038/sj.gt.3300839; Pereira RF, 1998, P NATL ACAD SCI USA, V95, P1142, DOI 10.1073/pnas.95.3.1142; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; ROBEY PG, 1985, CALCIFIED TISSUE INT, V37, P453, DOI 10.1007/BF02557826; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; WALLIS GA, 1990, AM J HUM GENET, V46, P1034; Wang Q, 1996, J BIOL CHEM, V271, P28617, DOI 10.1074/jbc.271.45.28617; WILLING MC, 1994, AM J HUM GENET, V55, P638; Youssoufian H, 2002, NAT REV GENET, V3, P748, DOI 10.1038/nrg906	36	33	35	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2004	74	4					752	760		10.1086/383252	http://dx.doi.org/10.1086/383252			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Genetics & Heredity	804EA	15024692	Bronze, Green Published			2022-12-18	WOS:000220280800015
J	Atkinson, TP; Schaffer, AA; Grimbacher, B; Schroeder, HW; Woellner, C; Zerbe, CS; Puck, JM				Atkinson, TP; Schaffer, AA; Grimbacher, B; Schroeder, HW; Woellner, C; Zerbe, CS; Puck, JM			An immune defect causing dominant chronic mucocutaneous candidiasis and thyroid disease maps to chromosome 2p in a single family	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRIMARY CONGENITAL GLAUCOMA; HYPER-IGE SYNDROME; LINKAGE ANALYSIS; GRAVES-DISEASE; SUSCEPTIBILITY LOCUS; GENETIC-LINKAGE; AMPHOTERICIN-B; LOD SCORES; HASHIMOTOS-THYROIDITIS; CYTOCHROME P4501B1	We describe a large family in which a combination of chronic mucocutaneous candidiasis (fungal infections of the skin, nails, and mucous membranes) and thyroid disease segregate as an autosomal dominant trait with reduced penetrance. The family includes (a) four members with both candidiasis and thyroid disease, (b) five members, including one pair of phenotype-concordant MZ twins, with candidiasis only, and (c) three members with thyroid disease only. A whole-genome scan using DNA samples from 20 members of the family identified a candidate linkage region on chromosome 2p. By sampling additional individuals and genotyping supplementary markers, we established linkage to a region of similar to 15 cM bounded by D2S367 and D2S2240 and including seven adjacent markers consistent with linkage. With a penetrance estimate of .8, which was based on pedigree and affected status, the peak two-point LOD score was 3.70 with marker D2S2328, and the peak three-point LOD score was 3.82. This is the first linkage assignment of a dominant locus for mucocutaneous candidiasis.	NHGRI, Computat Biol Branch, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20892 USA; NHGRI, Genet & Mol Biol branch, NIH, Bethesda, MD 20892 USA; Univ Alabama, Dept Pediat, Birmingham, AL USA; Univ Alabama, Dept Med, Birmingham, AL USA; Univ Freiburg, Sch Med, Dept Rheumatol & Immunol, Freiburg, Germany	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Freiburg	Puck, JM (corresponding author), NHGRI, Computat Biol Branch, Natl Ctr Biotechnol Informat, NIH, Bldg 49,Room 3A14,49 Convent Dr,MSC 4442, Bethesda, MD 20892 USA.	jpuck@nhgri.nih.gov	Schaffer, Alejandro A/F-2902-2012; Schaffer, Alejandro/N-1222-2019	Schroeder, Harry/0000-0002-3767-6878	NHGRI NIH HHS [N01HG65403] Funding Source: Medline; CENTER FOR INFORMATION TECHNOLOGY [Z01CT000260] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000116, N01HG065403] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [Z01LM000097] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Abreu PC, 1999, AM J HUM GENET, V65, P847, DOI 10.1086/302536; AHONEN P, 1985, CLIN GENET, V27, P535, DOI 10.1111/j.1399-0004.1985.tb02037.x; AHONEN P, 1990, NEW ENGL J MED, V322, P1829, DOI 10.1056/NEJM199006283222601; AHONEN P, 1987, J CLIN ENDOCR METAB, V64, P494, DOI 10.1210/jcem-64-3-494; Barbesino G, 1998, J CLIN ENDOCR METAB, V83, P3290, DOI 10.1210/jc.83.9.3290; Becker A, 1998, HUM HERED, V48, P49, DOI 10.1159/000022781; Bejjani BA, 1998, AM J HUM GENET, V62, P325, DOI 10.1086/301725; Bjorses P, 1998, HUM MOL GENET, V7, P1547, DOI 10.1093/hmg/7.10.1547; BRAGGER C, 1989, EUR J PEDIATR, V149, P168, DOI 10.1007/BF01958272; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; BUTLER RM, 1994, PARALLEL COMPUT, V20, P547, DOI 10.1016/0167-8191(94)90028-0; CALONGE MT, 1994, NAT GENET, V6, P420, DOI 10.1038/ng0494-420; CANALES L, 1969, LANCET, V2, P567; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Donner H, 1997, J CLIN ENDOCR METAB, V82, P4130, DOI 10.1210/jc.82.12.4130; DURANDY A, 1987, J CLIN IMMUNOL, V7, P400, DOI 10.1007/BF00917018; FISCHER A, 1982, CLIN EXP IMMUNOL, V47, P653; FISCHER A, 1978, J CLIN INVEST, V62, P1005, DOI 10.1172/JCI109204; GILL FF, 1989, ANN ALLERGY, V63, P98; Grimbacher B, 1999, AM J HUM GENET, V65, P735, DOI 10.1086/302547; Grimbacher B, 1999, NEW ENGL J MED, V340, P692, DOI 10.1056/NEJM199903043400904; GUPTA SK, 1995, COMPUT BIOMED RES, V28, P116, DOI 10.1006/cbmr.1995.1009; HERMANS PE, 1969, AM J MED, V47, P503, DOI 10.1016/0002-9343(69)90181-8; HERROD HG, 1990, J PEDIATR-US, V116, P377, DOI 10.1016/S0022-3476(05)82824-0; Heward JM, 1999, J CLIN ENDOCR METAB, V84, P2398, DOI 10.1210/jc.84.7.2398; Heward JM, 1998, J CLIN ENDOCR METAB, V83, P3394, DOI 10.1210/jc.83.10.3394; HODGE SE, 1992, AM J HUM GENET, V50, P1053; James SP, 1994, CURRENT PROTOCOLS IM; JORIZZO JL, 1980, ANN INTERN MED, V92, P192, DOI 10.7326/0003-4819-92-2-192; Kirkpatrick CH, 2001, PEDIATR INFECT DIS J, V20, P197, DOI 10.1097/00006454-200102000-00017; KIRKPATRICK CH, 1974, ANN INTERN MED, V80, P310, DOI 10.7326/0003-4819-80-3-310; KROLL JJ, 1973, ARCH DERMATOL, V108, P259, DOI 10.1001/archderm.108.2.259; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Lilic D, 1996, CLIN EXP IMMUNOL, V105, P213, DOI 10.1046/j.1365-2249.1996.d01-765.x; Loeys BL, 1999, EUR J PEDIATR, V158, P650, DOI 10.1007/s004310051169; MONTES LF, 1971, ARCH DERMATOL, V104, P45, DOI 10.1001/archderm.104.1.45; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Ott J, 1999, ANAL HUMAN GENETIC L; PAPAZIAN CE, 1960, NEW ENGL J MED, V262, P16, DOI 10.1056/NEJM196001072620104; Patel SB, 1998, J CLIN INVEST, V102, P1041, DOI 10.1172/JCI3963; PATERSON PY, 1971, CLIN EXP IMMUNOL, V9, P595; Pearce SHS, 1999, AM J HUM GENET, V65, P1462, DOI 10.1086/302610; Sakai K, 2001, HUM MOL GENET, V10, P1379, DOI 10.1093/hmg/10.13.1379; SAMS WM, 1979, AM J MED, V67, P948, DOI 10.1016/0002-9343(79)90635-1; SARFARAZI M, 1995, GENOMICS, V30, P171, DOI 10.1006/geno.1995.9888; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Sobel E, 1996, AM J HUM GENET, V58, P1323; Steensma DP, 2000, MAYO CLIN PROC, V75, P853, DOI 10.4065/75.8.853; STIEHM ER, 1966, PEDIATRICS, V37, P715; Stoilov I, 1997, HUM MOL GENET, V6, P641, DOI 10.1093/hmg/6.4.641; Sutphin A, 1943, J CLIN ENDOCRINOL, V3, P625, DOI 10.1210/jcem-3-12-625; Thorpe E, 1929, AM J DIS CHILD, V38, P228; Tomer Y, 1999, J CLIN ENDOCR METAB, V84, P4656, DOI 10.1210/jc.84.12.4656; Tomer Y, 1998, J CLIN ENDOCR METAB, V83, P4321, DOI 10.1210/jc.83.12.4321; Tomer Y, 1998, AM J HUM GENET, V63, P1749, DOI 10.1086/302146; Vaidya B, 2000, AM J HUM GENET, V66, P1710, DOI 10.1086/302908; Vaidya B, 1999, HUM MOL GENET, V8, P1195, DOI 10.1093/hmg/8.7.1195; VANSCOY RE, 1975, ANN INTERN MED, V82, P766, DOI 10.7326/0003-4819-82-6-766; Wallis G, 1999, TRENDS COGN SCI, V3, P22, DOI 10.1016/S1364-6613(98)01261-3; WELLS RS, 1972, J MED GENET, V9, P302, DOI 10.1136/jmg.9.3.302; WHITAKER J, 1956, J CLIN ENDOCR METAB, V16, P1374, DOI 10.1210/jcem-16-10-1374; Xiao SX, 2000, GENOMICS, V68, P247, DOI 10.1006/geno.2000.6285; ZIMMERMANNBELSING T, 1994, J INTERN MED, V235, P271, DOI 10.1111/j.1365-2796.1994.tb01071.x	66	33	35	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2001	69	4					791	803		10.1086/323611	http://dx.doi.org/10.1086/323611			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	472WP	11517424	Green Published, Bronze			2022-12-18	WOS:000171008200012
J	Whittemore, AS; Halpern, J				Whittemore, AS; Halpern, J			Problems in the definition, interpretation, and evaluation of genetic heterogeneity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS	Suppose that we wish to classify families with multiple cases of disease into one of three categories: those that segregate mutations of a gene of interest, those which segregate mutations of other genes, and those whose disease is due to nonhereditary factors or chance. Among families in the first two categories (the hereditary families), we wish to estimate the proportion, p, of families that segregate mutations of the gene of interest. Although this proportion is a commonly accepted concept, it is well defined only with an unambiguous definition of "family." Even then, extraneous factors such as family sizes and structures can cause p to vary across different populations and, within a population, to be estimated differently by different studies. Restrictive assumptions about the disease are needed, in order to avoid this undesirable variation. The assumptions require that mutations of all disease-causing genes (i) have no effect on family size, (ii) have very low frequencies, and (iii) have penetrances that satisfy certain constraints. Despite the unverifiability of these assumptions, linkage studies often invoke them to estimate p, using the admixture likelihood introduced by Smith and discussed by Ott. We argue against this common practice, because (1) it also requires the stronger assumption of equal penetrances for all etiologically relevant genes; (2) even if all assumptions are met, estimates of p are sensitive to misspecification of the unknown phenocopy rate; (3) even if all the necessary assumptions are met and the phenocopy rate is correctly specified, estimates of p that are obtained by linkage programs such as HOMOG and GENEHUNTER are based on the wrong likelihood and therefore are biased in the presence of phenocopies. We show how to correct these estimates; but, nevertheless, we do not recommend the use of parametric heterogeneity models in linkage analysis, even merely as a tool for increasing the statistical power to detect linkage. This is because the assumptions required by these models cannot be verified, and their violation could actually decrease power. Instead, we suggest that estimation of p be postponed until the relevant genes have been identified. Then their frequencies and penetrances can be estimated on the basis of population-based samples and can be used to obtain more-robust estimates of p for specific populations.	Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA	Stanford University	Whittemore, AS (corresponding author), Stanford Univ, Sch Med, Dept Hlth Res & Policy, Redwood Bldg,Room T204, Stanford, CA 94305 USA.	alicesw@leland.stanford.edu			NCI NIH HHS [R35 CA47448] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R35CA047448] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Janssen B, 1997, HUM HERED, V47, P223, DOI 10.1159/000154416; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; MIETTINE.OS, 1974, AM J EPIDEMIOL, V99, P325, DOI 10.1093/oxfordjournals.aje.a121617; OTT J, 1983, ANN HUM GENET, V47, P311, DOI 10.1111/j.1469-1809.1983.tb01001.x; OTT J, 1996, ANAL HUMAN GENETIC L; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; Thompson EA, 1986, PEDIGREE ANAL HUMAN	7	33	33	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2001	68	2					457	465		10.1086/318186	http://dx.doi.org/10.1086/318186			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	394LD	11170893	Bronze, Green Published			2022-12-18	WOS:000166524800015
J	Sylvius, N; Tesson, F; Gayet, C; Charron, P; Benaiche, A; Mangin, L; Peuchmaurd, M; Duboscq-Bidot, L; Feingold, J; Beckmann, JS; Bouchier, C; Komajda, M				Sylvius, N; Tesson, F; Gayet, C; Charron, P; Benaiche, A; Mangin, L; Peuchmaurd, M; Duboscq-Bidot, L; Feingold, J; Beckmann, JS; Bouchier, C; Komajda, M			A new locus for autosomal dominant dilated cardiomyopathy identified on chromosome 6q12-q14	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONDUCTION-SYSTEM DISEASE; GENE; MUTATIONS; LINKAGE; DEFECT; MAPS	Dilated cardiomyopathy (DCM) is a heart-muscle disease characterized by ventricular dilatation and impaired heart contraction and is heterogeneous both clinically and genetically. To date, 12 candidate disease loci have been described for autosomal dominant DCM. We report the identification of a new locus on chromosome 6q12-16 in a French family with 9 individuals affected by the pure form of autosomal dominant DCM. This locus was found by using a genomewide search after exclusion of all reported disease loci and genes for DCM. The maximum pairwise LOD score was 3.52 at recombination fraction 0.0 for markers D6S1644 and D6S1694. Haplotype construction delineated a region of 16.4 cM between markers D6S1627 and D6S1716. This locus does not overlap with two other disease loci that have been described in nonpure forms of DCM and have been mapped on 6q23-24 and 6q23. The phospholamban, malic enzyme 1-soluble, and laminin-alpha4 genes were excluded as candidate genes, using single-strand conformation polymorphism or linkage analysis.	Univ Paris 11, Assoc Claude Bernard, Lab Genet & Insuffisance Cardiaque, Paris, France; Grp Hosp Pitie Salpetriere, Serv Cardiol, F-75651 Paris 13, France; IFR 14 Coeur Muscles & Vaisseaux, Paris, France; INSERM U393, Unite Rech, Paris, France; Hop Croix Rousse, Serv Cardiol, F-69317 Lyon, France; URA 1922 Genethon, Evry, France	UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon	Bouchier, C (corresponding author), Grp Hosp Pitie Salpetriere, Lab Genet & Insuffisance Cardiaque, Pavillon Rambuteau,47 Blvd Hop, F-75651 Paris 13, France.		Tesson, Frederique/A-3218-2013; Beckmann, Jacques S/A-9772-2008	Beckmann, Jacques S/0000-0002-9741-1900; Sylvius, Nicolas/0000-0002-3470-3711; Charron, Philippe/0000-0002-1782-1118				Bowles KR, 1996, J CLIN INVEST, V98, P1355, DOI 10.1172/JCI118922; Brodsky GL, 2000, CIRCULATION, V101, P473, DOI 10.1161/01.CIR.101.5.473; Charron P, 1997, GENET COUNSEL, V8, P107; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DURAND JB, 1995, CIRCULATION, V92, P3387, DOI 10.1161/01.CIR.92.12.3387; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; Grunig E, 1998, J AM COLL CARDIOL, V31, P186, DOI 10.1016/S0735-1097(97)00434-8; Johnson WG, 1996, AM J MED GENET, V61, P345; Jung M, 1999, AM J HUM GENET, V65, P1068, DOI 10.1086/302580; KASS S, 1994, NAT GENET, V7, P546, DOI 10.1038/ng0894-546; KEELING PJ, 1995, BRIT HEART J, V73, P417; KRAJINOVIC M, 1995, AM J HUM GENET, V57, P846; Li DX, 1999, CIRCULATION, V100, P461, DOI 10.1161/01.CIR.100.5.461; Mangin L, 1999, EUR J HEART FAIL, V1, P353, DOI 10.1016/S1388-9842(99)00047-1; Messina DN, 1997, AM J HUM GENET, V61, P909, DOI 10.1086/514896; Mestroni L, 1999, EUR HEART J, V20, P93, DOI 10.1053/euhj.1998.1145; Mestroni L, 1999, J AM COLL CARDIOL, V34, P181, DOI 10.1016/S0735-1097(99)00172-2; Moolman JA, 2000, CIRCULATION, V101, P1396, DOI 10.1161/01.CIR.101.12.1396; Olson TM, 1996, J CLIN INVEST, V97, P528, DOI 10.1172/JCI118445; Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750; Schonberger J, 2000, CIRCULATION, V101, P1812, DOI 10.1161/01.CIR.101.15.1812; Siu BL, 1999, CIRCULATION, V99, P1022, DOI 10.1161/01.CIR.99.8.1022; Tesson F, 2000, EUR HEART J, V21, P1872, DOI 10.1053/euhj.2000.2245; Tsubata S, 2000, J CLIN INVEST, V106, P655, DOI 10.1172/JCI9224	24	33	35	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2001	68	1					241	246		10.1086/316929	http://dx.doi.org/10.1086/316929			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	392FG	11085912	Bronze, Green Published			2022-12-18	WOS:000166399900025
J	Ravn, K; Chloupkova, M; Christensen, E; Brandt, NJ; Simonsen, H; Kraus, JP; Nielsen, IM; Skovby, F; Schwartz, M				Ravn, K; Chloupkova, M; Christensen, E; Brandt, NJ; Simonsen, H; Kraus, JP; Nielsen, IM; Skovby, F; Schwartz, M			High incidence of propionic acidemia in Greenland is due to a prevalent mutation, 1540insCCC, in the gene for the beta-subunit of propionyl CoA carboxylase	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALPHA-CHAIN; PCCB GENES; LIVER	Propionyl CoA carboxylase (PCC) is a mitochondrial, biotin-dependent enzyme involved in the catabolism of amino acids, odd-chain fatty acids, and other metabolites. PCC consists of two subunits, alpha and beta, encoded by the PCCA and PCCB genes, respectively. Inherited PCC deficiency due to mutations in either gene results in propionic acidemia (PA), an autosomal recessive disease. Surprisingly, PA is highly prevalent among Inuits in Greenland. We have analyzed reverse transcriptase-PCR products of the beta-subunit mRNA, to characterize the responsible mutation(s). A 3-bp insertion, 1540insCCC, was found in homozygous form in three patients and in compound heterozygous form in one patient. The resulting PCC has no measurable activity, and the mutant beta-subunit appears to be very unstable. To test the hypothesis that a common mutation is responsible for PA in the Greenlandic Inuit population, 310 anonymous DNA samples of Inuit origin were screened for 1540insCCC. We found a carrier frequency of 5%, which is very high compared with those of most other autosomal recessive diseases. Analysis of alleles of a very closely linked marker, D3S2453, revealed a high degree of linkage disequilibrium between one specific allele and 1540insCCC, suggesting that this mutation may be a founder mutation.	Univ Hosp, Rigshosp, Juliane Marie Ctr, Dept Clin Genet, Copenhagen, Denmark; State Serum Inst, Dept Clin Biochem, Copenhagen, Denmark; Univ Colorado, Sch Med, Dept Pediat, Denver, CO USA; Naestved Hosp, Dept Paediat, Naestved, Denmark	Rigshospitalet; University of Copenhagen; Statens Serum Institut; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Naestved Hospital	Schwartz, M (corresponding author), Rigshosp 4062, Dept Clin Genet, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.				NICHD NIH HHS [P01 HD008315, P01HD08315] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD008315] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		FENTON WA, 1995, METABOLIC MOL BASES, V1, P1423; Forster P, 1996, AM J HUM GENET, V59, P935; KALOUSEK F, 1980, J BIOL CHEM, V255, P60; Kelson TL, 1996, HUM MOL GENET, V5, P331, DOI 10.1093/hmg/5.3.331; KRAUS JP, 1983, J BIOL CHEM, V258, P7245; KRAUS JP, 1986, P NATL ACAD SCI USA, V83, P8049, DOI 10.1073/pnas.83.21.8049; LAMHONWAH AM, 1986, P NATL ACAD SCI USA, V83, P4864, DOI 10.1073/pnas.83.13.4864; LOWRY OH, 1951, J BIOL CHEM, V193, P265; OHURA T, 1991, HUM GENET, V87, P41, DOI 10.1007/BF01213089; OHURA T, 1989, AM J HUM GENET, V45, P33; Piemontese MR, 1997, EUR J HUM GENET, V5, P171, DOI 10.1159/000484754; Rodriguez-Pombo P, 1998, AM J HUM GENET, V63, P360, DOI 10.1086/301970; Ugarte M, 1999, HUM MUTAT, V14, P275, DOI 10.1002/(SICI)1098-1004(199910)14:4<275::AID-HUMU1>3.0.CO;2-N; WAH AMLH, 1983, AM J HUM GENET, V35, P889	14	33	40	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2000	67	1					203	206		10.1086/302971	http://dx.doi.org/10.1086/302971			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	347JY	10820128	Green Published, Bronze			2022-12-18	WOS:000088926900022
J	Vianna-Morgante, AM; Costa, SS				Vianna-Morgante, AM; Costa, SS			Premature ovarian failure is associated with maternally and paternally inherited premutation in Brazilian families with fragile X	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							FRAXA; POF		Univ Sao Paulo, Inst Biociencias, Dept Biol, BR-05422970 Sao Paulo, Brazil	Universidade de Sao Paulo	Vianna-Morgante, AM (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Biol, CP 11461, BR-05422970 Sao Paulo, Brazil.			Murray, Anna/0000-0002-2351-2522				Allingham-Hawkins SJ, 1999, AM J MED GENET, V83, P322, DOI 10.1002/(SICI)1096-8628(19990402)83:4<322::AID-AJMG17>3.0.CO;2-B; CRONISTER A, 1991, AM J MED GENET, V38, P269, DOI 10.1002/ajmg.1320380221; Hundscheid RDL, 2000, AM J HUM GENET, V66, P413, DOI 10.1086/302774; Murray A, 1998, J MED GENET, V35, P637, DOI 10.1136/jmg.35.8.637; SCHWARTZ CE, 1994, AM J MED GENET, V51, P400, DOI 10.1002/ajmg.1320510419; Uzielli MLG, 1999, AM J MED GENET, V84, P300, DOI 10.1002/(SICI)1096-8628(19990528)84:3<300::AID-AJMG27>3.3.CO;2-X; Vianna-Morgante AM, 1999, GENET MOL BIOL, V22, P471, DOI 10.1590/S1415-47571999000400002; ViannaMorgante AM, 1996, AM J MED GENET, V64, P373, DOI 10.1002/(SICI)1096-8628(19960809)64:2<373::AID-AJMG28>3.0.CO;2-B	8	33	33	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2000	67	1					254	255		10.1086/302976	http://dx.doi.org/10.1086/302976			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	347JY	10848496	Green Published, Bronze			2022-12-18	WOS:000088926900031
J	Betz, RC; Lee, YA; Bygum, A; Brandrup, F; Bernal, AI; Toribio, J; Alvarez, JI; Kukuk, GM; Ibsen, HHW; Rasmussen, HB; Wienker, TF; Reis, A; Propping, P; Kruse, R; Cichon, S; Nothen, MM				Betz, RC; Lee, YA; Bygum, A; Brandrup, F; Bernal, AI; Toribio, J; Alvarez, JI; Kukuk, GM; Ibsen, HHW; Rasmussen, HB; Wienker, TF; Reis, A; Propping, P; Kruse, R; Cichon, S; Nothen, MM			A gene for hypotrichosis simplex of the scalp maps to chromosome 6p21.3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY HYPOTRICHOSIS; INVOLVEMENT; ALOPECIA	Hypotrichosis simplex of the scalp (HSS) is an autosomal dominant form of isolated alopecia causing almost complete loss of scalp hair, with onset in childhood. After exclusion of candidate regions previously associated with hair-loss disorders, we performed a genomewide linkage analysis in two Danish families and localized the gene to chromosome 6p21.3, This was confirmed in a Spanish family, with a total LOD score of 11.97 for marker DGS1701 in all families, The combined haplotype data identify a critical interval of 14.9 cM between markers D6S276 and D6S1607. Localization of the locus for HSS to 6p21.3 is a first step toward identification of the gene. The gene will give important insights into the molecular and cellular basis of hair growth on the scalp.	Univ Bonn, Inst Human Genet, D-53111 Bonn, Germany; Univ Bonn, Inst Med Biometry Informat & Epidemiol, D-53111 Bonn, Germany; Max Delbruck Ctr Mol Med, Gene Mapping Ctr, Berlin, Germany; Humboldt Univ, Dept Pediat Pneumol & Immunol, Berlin, Germany; Humboldt Univ, Inst Human Genet, Berlin, Germany; Odense Univ Hosp, Dept Dermatol, DK-5000 Odense, Denmark; Univ Santiago de Compostela, Dept Dermatol, Santiago De Compostela, Spain; Cruz Roja Valladolid, Valladolid, Spain; Univ Dusseldorf, Dept Dermatol, D-4000 Dusseldorf, Germany	University of Bonn; University of Bonn; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Humboldt University of Berlin; Humboldt University of Berlin; University of Southern Denmark; Odense University Hospital; Universidade de Santiago de Compostela; Heinrich Heine University Dusseldorf	Betz, RC (corresponding author), Univ Bonn, Inst Human Genet, Wilhelmstr 31, D-53111 Bonn, Germany.		Betz, Regina C/E-8591-2011; Cichon, Sven/B-9618-2014; Nöthen, Markus/B-2027-2009; Cichon, Sven/H-8803-2013; Reis, André/D-2309-2009	Betz, Regina C/0000-0001-5024-3623; Cichon, Sven/0000-0002-9475-086X; Nöthen, Markus/0000-0002-8770-2464; Cichon, Sven/0000-0002-9475-086X; Reis, André/0000-0002-6301-6363; Bygum, Anette/0000-0002-3004-0180				Ahmad W, 1998, SCIENCE, V279, P720, DOI 10.1126/science.279.5351.720; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Cichon S, 1998, HUM MOL GENET, V7, P1671, DOI 10.1093/hmg/7.11.1671; Colombe BW, 1999, J INVEST DERM SYMP P, V4, P216, DOI 10.1038/sj.jidsp.5640214; de Andrade M, 1999, J INVEST DERM SYMP P, V4, P220, DOI 10.1038/sj.jidsp.5640215; DIAZ ER, 1995, DERMATOLOGY, V191, P139; Frank J, 1999, NATURE, V398, P473, DOI 10.1038/18997; GRUSS HJ, 1995, BLOOD, V85, P3378, DOI 10.1182/blood.V85.12.3378.bloodjournal85123378; Headon DJ, 1999, NAT GENET, V22, P370, DOI 10.1038/11943; HESS RO, 1991, AM J MED GENET, V39, P125, DOI 10.1002/ajmg.1320390202; IBSEN HHW, 1991, ACTA DERM-VENEREOL, V71, P349; KOHN G, 1987, CLIN GENET, V32, P120; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; PIRACCINI BM, 1993, EUR J DERMATOL, V3, P597; TORIBIO J, 1974, BRIT J DERMATOL, V91, P687, DOI 10.1111/j.1365-2133.1974.tb12455.x; Winter H, 1997, NAT GENET, V16, P372, DOI 10.1038/ng0897-372	17	33	38	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2000	66	6					1979	1983		10.1086/302934	http://dx.doi.org/10.1086/302934			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QU	10793007	Bronze, Green Published			2022-12-18	WOS:000088373800027
J	Martignetti, JA; Heath, KE; Harris, J; Bizzaro, N; Savoia, A; Balduini, CL; Desnick, RJ				Martignetti, JA; Heath, KE; Harris, J; Bizzaro, N; Savoia, A; Balduini, CL; Desnick, RJ			The gene for May-Hegglin anomaly localizes to a < 1-mb region on chromosome 22q12.3-13.1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEBASTIAN-PLATELET-SYNDROME; LEUKOCYTE INCLUSIONS; FECHTNER SYNDROME; VAGINAL DELIVERY; MACROTHROMBOCYTOPENIA; THROMBOCYTOPENIA; PREGNANCY; VARIANT; BODIES; MAPS	The May-Hegglin anomaly (MHA) is an autosomal dominant platelet disorder of unknown etiology. It is characterized by thrombocytopenia, giant platelets, and leukocyte inclusion bodies, and affected heterozygotes are predisposed to bleeding episodes. The MHA gene has recently been localized, by means of linkage analysis, to a 13.6-cM region on chromosome 22, and the complete chromosome 22 sequence has been reported. We recently performed a genome scan for the MHA gene in 29 members of a large, multigenerational Italian family, and we now confirm that the MHA locus is on chromosome 22q12.3-13.1. The maximal two-point LOD score of 4.50 was achieved with the use of marker D22S283, at a recombination fraction of .05. Haplotype analysis narrowed the MHA critical region to 6.6 cM between markers D22S683 and D22S1177. It is of note that the chromosome 22 sequence allowed all markers to be ordered correctly, identified all the candidate genes and predicted genes, and specifically determined the physical size of the MHA region to be 0.7 Mb. These results significantly narrow the region in which the MHA gene is located, and they represent the first use of chromosome 22 data to positionally clone a disease gene.	Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; Osped Civile, Clin Pathol Lab, Venice, Italy; Sofferenza Hosp, IRCCS, Med Genet Serv, Foggia, Italy; Univ Pavia, Policlin San Matteo, IRCCS, Dept Pathol, I-27100 Pavia, Italy	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; IRCCS Casa Sollievo Della Sofferenza; IRCCS Fondazione San Matteo; University of Pavia	Martignetti, JA (corresponding author), Mt Sinai Sch Med, Dept Human Genet, Box 1498,5th Ave,100th St, New York, NY 10029 USA.	jam@msvax.mssm.edu	Heath, Karen Elise/K-7760-2014; Heath, K. E./ABG-4658-2020; Savoia, Anna/B-6463-2014; Savoia, Anna/AIC-4560-2022; Balduini, Carlo L/D-9299-2015	Heath, Karen Elise/0000-0002-5816-7044; Heath, K. E./0000-0002-5816-7044; Savoia, Anna/0000-0002-2407-2696; Savoia, Anna/0000-0002-2407-2696; Balduini, Carlo L/0000-0001-6121-9311	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD028822] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK034045] Funding Source: NIH RePORTER; NCRR NIH HHS [5 MO1 RR00071, M01 RR000071] Funding Source: Medline; NICHD NIH HHS [5 P30 HD28822] Funding Source: Medline; NIDDK NIH HHS [R37 DK034045, 5 R37 DK34045] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADAMS P, 1994, GENET EPIDEMIOL, V11, P87, DOI 10.1002/gepi.1370110109; ANDERSON MA, 1994, IN VITRO, V20, P856; Bizzaro N, 1999, AM J OBSTET GYNECOL, V181, P226, DOI 10.1016/S0002-9378(99)70473-4; BIZZARO N, 1997, MED LAB, V5, P165; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; BUCHANAN JG, 1964, BRIT J HAEMATOL, V10, P508, DOI 10.1111/j.1365-2141.1964.tb00728.x; CABRERA JR, 1981, BRIT J HAEMATOL, V47, P337, DOI 10.1111/j.1365-2141.1981.tb02800.x; CAWLEY JC, 1972, BRIT J HAEMATOL, V22, P491, DOI 10.1111/j.1365-2141.1972.tb05694.x; Dohle H, 1911, ZENTRALBLATT BAKTERI, V61, P63; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; GAUSIS N, 1969, BRIT J HAEMATOL, V16, P619, DOI 10.1111/j.1365-2141.1969.tb00442.x; GERSHONIBARUCH R, 1988, AM J MED GENET, V31, P357, DOI 10.1002/ajmg.1320310213; GREINACHER A, 1990, BLUT, V61, P282, DOI 10.1007/BF01732878; HEGGLIN R, 1945, Helv Med Acta, V12, P439; HEYNEN MJ, 1988, BRIT J HAEMATOL, V70, P441, DOI 10.1111/j.1365-2141.1988.tb02514.x; Ho CJ, 1996, J SYMB COMPUT, V21, P1, DOI 10.1006/jsco.1996.0001; JENIS EH, 1971, AM J CLIN PATHOL, V55, P187; KHALIL SH, 1995, PATHOLOGY, V27, P197, DOI 10.1080/00313029500169872; Kinsella MJ, 1999, MIL MED, V164, P607; Kunishima S, 1999, HUM GENET, V105, P379, DOI 10.1007/s004390051119; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LUSHER JM, 1968, BLOOD, V32, P950, DOI 10.1182/blood.V32.6.950.950; May R, 1909, DTSCH ARCH KLIN MED, V96, P1; Noris P, 1998, AM J MED, V104, P355, DOI 10.1016/S0002-9343(98)00062-X; Ott J, 1994, HDB HUMAN GENETIC LI; Pajor A, 1999, EUR J OBSTET GYN R B, V85, P229, DOI 10.1016/S0301-2115(99)00032-9; PETERSON LC, 1985, BLOOD, V65, P397; ROCCA B, 1993, BRIT J HAEMATOL, V85, P423, DOI 10.1111/j.1365-2141.1993.tb03193.x; Savoia A, 1999, AM J HUM GENET, V65, P1401, DOI 10.1086/302637; Song WJ, 1999, NAT GENET, V23, P166, DOI 10.1038/13793; Toren A, 1999, AM J HUM GENET, V65, P1711, DOI 10.1086/302654; Tsurusawa M, 1999, INT J HEMATOL, V69, P206; Urato AC, 1998, AM J OBSTET GYNECOL, V179, P260, DOI 10.1016/S0002-9378(98)70283-2; WASSMUTH DR, 1963, JAMA-J AM MED ASSOC, V183, P737; Young G, 1999, AM J HEMATOL, V61, P62, DOI 10.1002/(SICI)1096-8652(199905)61:1<62::AID-AJH11>3.3.CO;2-1	35	33	41	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2000	66	4					1449	1454		10.1086/302873	http://dx.doi.org/10.1086/302873			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QP	10739770	Green Published, Bronze			2022-12-18	WOS:000088373400030
J	Yang, XP; She, CW; Guo, LZ; Yu, AC; Lu, YJ; Shi, XL; Feng, GY; He, L				Yang, XP; She, CW; Guo, LZ; Yu, AC; Lu, YJ; Shi, XL; Feng, GY; He, L			A locus for brachydactyly type A-1 maps to chromosome 2q35-q36	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WAARDENBURG SYNDROME; PAIRED DOMAIN; MUTATIONS; GENE; HOXD13	Brachydactyly type A-1 (BDA1) was, in 1903, the first recorded example of a human anomaly with Mendelian autosomal dominant inheritance. Two large families, the affected members of which were radiographed, were recruited in the study we describe here. Two-point linkage analysis for pedigree 1 (maximum LOD score [Z(max)] 6.59 at recombination fraction [theta] 0.00) and for pedigree 2 (Z(max) = 5.53 at theta = 0.00) mapped the locus for BDAI in the two families to chromosome 2q. Haplotype analysis of pedigree 1 confined the locus for family 1 within an interval of <8.1 cM flanked by markers D2S2248 and D2S360, which was mapped to chromosome 2q35-q36 on the cytogenetic map. Haplotype analysis of pedigree 2 confined the locus for family 2 within an interval of <28.8 cM. flanked by markers GATA30E06 and D2S427, which was localized to chromosome 2q35-q37. The two families had no identical haplotype within the defined region, which suggests that the two families mere not related.	Chinese Acad Sci, Shanghai Inst Physiol, Shanghai 200031, Peoples R China; Shanghai Jiao Tong Univ, Shanghai Res Ctr Life Sci, Shanghai 200030, Peoples R China; Shanghai Jiao Tong Univ, Coll Life Sci & Biotechnol, Shanghai 200030, Peoples R China; Huaihua Teachers Coll, Dept Biol, Hunan, Peoples R China; Guiyang Women & Childrens Hosp, Guiyang, Peoples R China; Hong Kong Univ Sci & Technol, Dept Biol, Hong Kong, Hong Kong, Peoples R China; Hunan Med Univ, Affiliated Hosp 2, Changsha, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Hong Kong University of Science & Technology; Central South University	He, L (corresponding author), Chinese Acad Sci, Shanghai Inst Physiol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.		Yang, Xinping/HGA-6104-2022	Shi, Xiaoliu/0000-0002-9759-2254; Yang, Xinping/0000-0003-4086-4180				Asher JH, 1996, HUM MUTAT, V7, P30, DOI 10.1002/(SICI)1098-1004(1996)7:1<30::AID-HUMU4>3.3.CO;2-H; Bell J., 1951, TREASURY HUMAN INHER, VVol 1, P1; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FARABEE W, 1903, THESIS HARVARD U; FITCH N, 1979, J MED GENET, V16, P36, DOI 10.1136/jmg.16.1.36; FromentalRamain C, 1996, DEVELOPMENT, V122, P2997; Goodman FR, 1997, P NATL ACAD SCI USA, V94, P7458, DOI 10.1073/pnas.94.14.7458; Herault Y, 1999, DEV BIOL, V208, P157, DOI 10.1006/dbio.1998.9179; HOTH CF, 1993, AM J HUM GENET, V52, P455; LATHROP GM, 1984, AM J HUM GENET, V36, P460; McKusick V. A, 1975, MENDELIAN INHERITANC; Muragaki Y, 1996, SCIENCE, V272, P548, DOI 10.1126/science.272.5261.548; PIUSSAN C, 1983, J GENET HUM, V31, P107; Polinkovsky A, 1997, NAT GENET, V17, P18, DOI 10.1038/ng0997-18; SHEFFIELD VC, 1995, HUM MOL GENET, V4, P1837, DOI 10.1093/hmg/4.10.1837; Slavotinek A, 1998, CLIN DYSMORPHOL, V7, P21; TASSABEHJI M, 1995, HUM MOL GENET, V4, P2131, DOI 10.1093/hmg/4.11.2131; WEINSTEIN LS, 1990, P NATL ACAD SCI USA, V87, P8287, DOI 10.1073/pnas.87.21.8287	18	33	45	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2000	66	3					892	903		10.1086/302806	http://dx.doi.org/10.1086/302806			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QM	10712204	Green Published, Bronze			2022-12-18	WOS:000088373200012
J	Ciccarese, M; Pacifico, A; Tonolo, G; Pintus, P; Nikoshkov, A; Zuliani, G; Fellin, R; Luthman, H; Maioli, M				Ciccarese, M; Pacifico, A; Tonolo, G; Pintus, P; Nikoshkov, A; Zuliani, G; Fellin, R; Luthman, H; Maioli, M			A new locus for autosomal recessive hypercholesterolemia maps to human chromosome 15q25-q26	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL HYPERCHOLESTEROLEMIA; LDL-RECEPTOR; PLASMA-LIPIDS; LINKAGE; DENSITY; LIPOPROTEINS; CHOLESTEROL; ARP-1	High serum cholesterol is an established risk factor for cardiovascular disease and is the prime target for therapeutic intervention in large groups of patients. The development of modern treatments for this major risk factor was propelled by the early realization that forms of severe hypercholesterolemia could be caused by dominantly inherited defects in the LDL receptor or in the APOB gene. Further understanding of the mechanisms contributing to early atherosclerosis will allow for new targets for therapy. We therefore identified and investigated the genetics of families from Sardinia that have recessive inheritance of precocious hypercholesterolemia. We used five families in an analysis of linkage of the autosomal recessive hypercholesterolemia locus, termed "ARH1," to chromosome 15q25-q26. A genomewide search mapped the disease-causing gene with a LOD score of 3.3 and excluded major contributions to the phenotype of other genes. A candidate gene present in the mapped chromosome region-the ligand-activated liver-transcription-factor gene ARP1 (apolipoprotein regulatory-protein gene)-has been excluded after DNA sequencing. The close-bred nature of the Sardinian population offers unique opportunities for isolation of this hypercholesterolemia-causing gene.	Univ Sassari, Dept Internal Med, Metab Dis Unit, I-07100 Sassari, Italy; Karolinska Inst, Dept Mol Med, Stockholm, Sweden; Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; G Brotzu Hosp, Metab Dis Unit, Cagliari, Italy; Univ Ferrara, Dept Internal Med 2, I-44100 Ferrara, Italy	University of Sassari; Karolinska Institutet; Karolinska Institutet; University of Ferrara	Ciccarese, M (corresponding author), Univ Sassari, Dept Internal Med, Metab Dis Unit, V San Pietro 8, I-07100 Sassari, Italy.		Pintus, Paolo/AAQ-7789-2021	Pintus, Paolo/0000-0002-8666-8399				AUSTIN MA, 1987, AM J EPIDEMIOL, V125, P308, DOI 10.1093/oxfordjournals.aje.a114531; BUCHER KD, 1988, GENET EPIDEMIOL, V5, P17, DOI 10.1002/gepi.1370050103; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DAMMERMAN M, 1995, CIRCULATION, V91, P505, DOI 10.1161/01.CIR.91.2.505; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GOLDSTEIN JL, 1973, P NATL ACAD SCI USA, V70, P2804, DOI 10.1073/pnas.70.10.2804; HARADASHIBA M, 1992, ARTERIOSCLER THROMB, V12, P1071, DOI 10.1161/01.ATV.12.9.1071; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LADIAS JAA, 1991, SCIENCE, V251, P561, DOI 10.1126/science.1899293; MAIOLI M, 1989, ATHEROSCLEROSIS, V75, P245, DOI 10.1016/0021-9150(89)90182-2; MALIK S, 1995, NUCLEIC ACIDS RES, V23, P1536, DOI 10.1093/nar/23.9.1536; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; MYANT NB, 1993, ATHEROSCLEROSIS, V104, P1, DOI 10.1016/0021-9150(93)90171-P; *NAT CHOL ED PROGR, 1994, CIRCULATION, V89, P1333; Ott J., 1991, ANAL HUMAN GENETIC L; PERUSSE L, 1989, ARTERIOSCLEROSIS, V9, P308, DOI 10.1161/01.ATV.9.3.308; QIU Y, 1995, GENOMICS, V29, P240, DOI 10.1006/geno.1995.1237; RICE T, 1991, HUM HERED, V41, P107, DOI 10.1159/000153987; Schmidt HHJ, 1998, J CLIN ENDOCR METAB, V83, P2167, DOI 10.1210/jc.83.6.2167; SIRTORI CR, 1991, EUR HEART J, V12, P818; Thompson GR, 1989, ARTERIOSCLER, V9, P175; Varret M, 1999, AM J HUM GENET, V64, P1378, DOI 10.1086/302370; Varret M, 1998, NUCLEIC ACIDS RES, V26, P248, DOI 10.1093/nar/26.1.248; Zuliani G, 1999, ARTERIOSCL THROM VAS, V19, P802, DOI 10.1161/01.ATV.19.3.802; ZULIANI G, 1995, EUR J CLIN INVEST, V25, P322, DOI 10.1111/j.1365-2362.1995.tb01709.x	25	33	33	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2000	66	2					453	460		10.1086/302753	http://dx.doi.org/10.1086/302753			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QL	10677305	Green Published, Bronze			2022-12-18	WOS:000088373100012
J	Rosenberg, MJ; Vaske, D; Killoran, CE; Ning, Y; Wargowski, D; Hudgins, L; Tifft, CJ; Meck, J; Blancato, JK; Rosenbaum, K; Pauli, RM; Weber, J; Biesecker, LG				Rosenberg, MJ; Vaske, D; Killoran, CE; Ning, Y; Wargowski, D; Hudgins, L; Tifft, CJ; Meck, J; Blancato, JK; Rosenbaum, K; Pauli, RM; Weber, J; Biesecker, LG			Detection of chromosomal aberrations by a whole-genome microsatellite screen	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IDIOPATHIC MENTAL-RETARDATION; FISH; REARRANGEMENTS; TRANSLOCATION; POLYMORPHISMS; MUTATION; STRATEGY; TRISOMY; HUMANS; MAP	Chromosomal aberrations are a common cause of multiple anomaly syndromes that include developmental and growth retardation. Current microscopic techniques are useful for the detection of such aberrations but have a limit of resolution that is above the threshold for phenotypic effect. We hypothesized that a genomewide microsatellite screen could detect chromosomal aberrations that were not detected by standard cytogenetic techniques in a portion of these individuals. To test this hypothesis, we performed a genomewide microsatellite screen of patients, by use of a currently available genetic-marker panel that was originally designed for meiotic mapping of Mendelian traits. We genotyped similar to 400 markers on 17 pairs of parents and their children who had normal karyotypes. By using this approach, we detected and confirmed two cases of segmental aneusomy among 11 children with multiple congenital anomalies. These data demonstrate that a genomewide microsatellite scan can be used to detect chromosomal aberrations that are not detected by microscopic techniques.	Natl Human Genome Res Inst, NIH, Bethesda, MD 20892 USA; Marshfield Med Res Fdn, Marshfield, WI 54449 USA; George Washington Univ, Washington, DC USA; Genecare Genet Ctr, Washington, DC USA; Childrens Natl Med Ctr, Div Med Genet, Washington, DC 20010 USA; Georgetown Univ, Med Ctr, Inst Mol & Human Genet, Washington, DC 20007 USA; Univ Wisconsin, Dept Pediat, Madison, WI USA; Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA; Childrens Hosp & Med Ctr, Div Med Genet, Seattle, WA 98105 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); George Washington University; Children's National Health System; Georgetown University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Seattle Children's Hospital	Biesecker, LG (corresponding author), Natl Human Genome Res Inst, NIH, 49 Convent Dr, Bethesda, MD 20892 USA.		Biesecker, Leslie/AAG-2526-2021; Lindhurst, Marjorie/AHD-3412-2022					BIESECKER LG, 1995, AM J MED GENET, V58, P389, DOI 10.1002/ajmg.1320580426; Borgaonkar DS, 1994, CHROMOSOMAL VARIATIO; Brinkmann B, 1998, AM J HUM GENET, V62, P1408, DOI 10.1086/301869; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; FLINT J, 1995, NAT GENET, V9, P132, DOI 10.1038/ng0295-132; Ghaffari SR, 1998, J MED GENET, V35, P225, DOI 10.1136/jmg.35.3.225; LEDBETTER DH, 1995, HUM MOL GENET, V4, P1757, DOI 10.1093/hmg/4.suppl_1.1757; LEDBETTER DH, 1995, METABOLIC MOL BASES, V1, P811; LIN AE, 1988, AM J MED GENET, V31, P533, DOI 10.1002/ajmg.1320310308; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Mazzarella R, 1998, GENOME RES, V8, P1007, DOI 10.1101/gr.8.10.1007; Sambrook J, 1989, MOL CLONING LAB MANU; SCHINZEL A, 1981, HUM GENET, V56, P263, DOI 10.1007/BF00274676; SCHINZEL A, 1984, CATALOG UNBALANCED C; Schrock E, 1996, SCIENCE, V273, P494, DOI 10.1126/science.273.5274.494; Slavotinek A, 1999, J MED GENET, V36, P405; Speicher MR, 1996, NAT GENET, V12, P368, DOI 10.1038/ng0496-368; Stone D, 1996, HUM GENET, V98, P396, DOI 10.1007/s004390050228; Uhrig S, 1999, AM J HUM GENET, V65, P448, DOI 10.1086/302508; Verma RS., 1995, HUMAN CHROMOSOMES PR, V2; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WILKIE AOM, 1993, AM J HUM GENET, V53, P688	23	33	33	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2000	66	2					419	427		10.1086/302743	http://dx.doi.org/10.1086/302743			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QL	10677301	Green Published, Bronze			2022-12-18	WOS:000088373100008
J	Ozen, RS; Baysal, BE; Devlin, B; Farr, JE; Gorry, M; Ehrlich, GD; Richard, CW				Ozen, RS; Baysal, BE; Devlin, B; Farr, JE; Gorry, M; Ehrlich, GD; Richard, CW			Fine mapping of the split-hand/split-foot locus (SHFM3) at 10q24: Evidence for anticipation and segregation distortion	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MYOTONIC-DYSTROPHY LOCUS; NON-MENDELIAN TRANSMISSION; HOMEOBOX GENE FAMILY; CONE-ROD DYSTROPHY; MEIOTIC DRIVE; DEVELOPMENTAL EXPRESSION; GENOMIC STRUCTURE; LIMB DEVELOPMENT; CTG REPEATS; HAND	Split-hand/split-foot malformation (SHFM, ectrodactyly, or lobster-claw deformity) is a:human limb malformation characterized by aberrant development of central digital rays with absence of fingers and toes, a deep median cleft, and fusion of remaining digits. SHFM is clinically heterogeneous, presenting both in an isolated form and in combination with additional abnormalities affecting the tibia and/or other organ systems, including the genitourinary, craniofacial, and ectodermal structures. Three SHFM disease loci have been genetically. mapped to chromosomes 7q21 (SHFM1), Xq26 (SHFM2), and 10q24 (SHFM3). We mapped data from a large Turkish family with isolated SHFM to chromosome 10q24 and have narrowed the SHFM3 region from 9 cM to an similar to 2-cM critical interval between genetic markers D10S1147 and D10S1240. In several instances we found evidence for a more severe phenotype in offspring of a mildly affected parent, suggesting anticipation. Finally, data from this family, combined with those from six other pedigrees, mapped to 10q24, demonstrate biased transmission of SHFM3 alleles from affected fathers to offspring. The degree of this segregation distortion is obvious in male offspring and is possibly of the same magnitude for female offspring.	Gulhane Mil Med Acad, Dept Med Genet, Ankara, Turkey; Univ Pittsburgh, Med Ctr, Dept Psychiat, Pittsburgh, PA USA; Univ Pittsburgh, Med Ctr, Dept Human Genet, Pittsburgh, PA USA; Univ Pittsburgh, Med Ctr, Dept Pathol, Pittsburgh, PA USA	Gulhane Military Medical Academy; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Richard, CW (corresponding author), Wyeth Ayerst Res, Clin Res & Dev, POB 42528, Philadelphia, PA 19101 USA.			Ehrlich, Garth/0000-0003-1140-6594				Akarsu AN, 1996, HUM MOL GENET, V5, P945, DOI 10.1093/hmg/5.7.945; Baysal BE, 1997, AM J HUM GENET, V60, P121; CAREY N, 1994, NAT GENET, V6, P117, DOI 10.1038/ng0294-117; Chakraborty R, 1996, AM J HUM GENET, V59, P109; Crackower MA, 1996, HUM MOL GENET, V5, P571, DOI 10.1093/hmg/5.5.571; EMERY AEH, 1977, CLIN GENET, V12, P125; EVANS K, 1994, NAT GENET, V6, P210, DOI 10.1038/ng0294-210; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Gemel J, 1996, GENOMICS, V35, P253, DOI 10.1006/geno.1996.0349; GENNARELLI M, 1994, J MED GENET, V31, P980, DOI 10.1136/jmg.31.12.980; Goodman FR, 1997, P NATL ACAD SCI USA, V94, P7458, DOI 10.1073/pnas.94.14.7458; GRAHAM JB, 1955, AM J HUM GENET, V7, P44; Gray IC, 1997, GENOMICS, V43, P85, DOI 10.1006/geno.1997.4809; Gurrieri F, 1996, AM J MED GENET, V62, P427; HAQUE MFU, 1993, HUM GENET, V91, P17; Inglehearn CF, 1997, AM J HUM GENET, V60, P1562; JAGLA K, 1995, MECH DEVELOP, V53, P345, DOI 10.1016/0925-4773(95)00450-5; JARVIK GP, 1994, AM J HUM GENET, V55, P710; JOHNSON KR, 1995, GENOMICS, V29, P457, DOI 10.1006/geno.1995.9981; Johnson RL, 1997, CELL, V90, P979, DOI 10.1016/S0092-8674(00)80364-5; Kengaku M, 1998, SCIENCE, V280, P1274, DOI 10.1126/science.280.5367.1274; Lako M, 1996, GENOMICS, V35, P386, DOI 10.1006/geno.1996.0374; Leeflang EP, 1996, AM J HUM GENET, V59, P896; MACKENZIE HJ, 1951, ANN EUGENIC, V16, P88, DOI 10.1111/j.1469-1809.1951.tb02460.x; Majewski F, 1996, AM J MED GENET, V63, P185; McMullen G, 1913, BIOMETRIKA, V9, P381; MUNIER FL, 1994, HUM GENET, V94, P484; Muragaki Y, 1996, SCIENCE, V272, P548, DOI 10.1126/science.272.5261.548; NUNES ME, 1995, HUM MOL GENET, V4, P2165, DOI 10.1093/hmg/4.11.2165; ORIOLI IM, 1995, AM J HUM GENET, V56, P1207; RaasRothschild A, 1996, J MED GENET, V33, P996, DOI 10.1136/jmg.33.12.996; RAJU K, 1993, MECH DEVELOP, V44, P51, DOI 10.1016/0925-4773(93)90016-Q; RAY AK, 1960, J HERED, V61, P169; Riess O, 1997, HUM GENET, V99, P282, DOI 10.1007/s004390050355; ROBERTS CWM, 1995, AM J PATHOL, V146, P1089; SANYANUSIN P, 1995, NAT GENET, V9, P358, DOI 10.1038/ng0495-358; SCHECHTMAN M, 1994, PHILOS PSYCHOL, V7, P3, DOI 10.1080/09515089408573107; SCHERER SW, 1994, AM J HUM GENET, V55, P12; Scott MP, 1997, NAT GENET, V15, P117, DOI 10.1038/ng0297-117; Semina EV, 1997, HUM MOL GENET, V6, P2109, DOI 10.1093/hmg/6.12.2109; Seto ML, 1997, TERATOLOGY, V56, P262, DOI 10.1002/(SICI)1096-9926(199710)56:4<262::AID-TERA5>3.0.CO;2-0; SHAW AM, 1995, J MED GENET, V32, P145; SHAW RF, 1961, AM J HUM GENET, V13, P89; SMALL KW, 1993, INVEST OPHTH VIS SCI, V34, P1305; SPRANGER M, 1988, EUR J PEDIATR, V147, P202, DOI 10.1007/BF00442225; STADLER HS, 1995, MAMM GENOME, V6, P383, DOI 10.1007/BF00355637; STEVENSON AC, 1960, ANN HUM GENET, V24, P89; Takiyama Y, 1997, HUM MOL GENET, V6, P1063, DOI 10.1093/hmg/6.7.1063; VERMA IC, 1976, CLIN GENET, V9, P8; Wang WD, 1997, CHROMOSOME RES, V5, P501; Yamashita T, 1998, GENOMICS, V48, P87, DOI 10.1006/geno.1997.5163; Zatz M, 1997, J MED GENET, V34, P790, DOI 10.1136/jmg.34.9.790; ZLOTOGORA J, 1994, AM J MED GENET, V53, P29, DOI 10.1002/ajmg.1320530107; ZLOTOGORA J, 1989, J MED GENET, V26, P138, DOI 10.1136/jmg.26.2.138	54	33	35	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1999	64	6					1646	1654		10.1086/302403	http://dx.doi.org/10.1086/302403			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	203FA	10330351	Green Published, Bronze			2022-12-18	WOS:000080696200016
J	Leadon, SA				Leadon, SA			Transcription-coupled repair of DNA damage: Unanticipated players, unexpected complexities	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RNA-POLYMERASE-II; NUCLEOTIDE-EXCISION-REPAIR; PIGMENTOSUM GROUP-G; COCKAYNE-SYNDROME PATIENTS; HUMAN MISMATCH REPAIR; XERODERMA-PIGMENTOSUM; PREFERENTIAL REPAIR; THYMINE GLYCOLS; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI		Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Leadon, SA (corresponding author), Univ N Carolina, Dept Radiat Oncol, CB 7512, Chapel Hill, NC 27599 USA.	saleadon@radonc.unc.edu						Bertrand P, 1998, P NATL ACAD SCI USA, V95, P14278, DOI 10.1073/pnas.95.24.14278; Cooper PK, 1997, SCIENCE, V275, P990, DOI 10.1126/science.275.5302.990; FLEJTER WL, 1992, P NATL ACAD SCI USA, V89, P261, DOI 10.1073/pnas.89.1.261; GOODRICH JA, 1994, CELL, V77, P145, DOI 10.1016/0092-8674(94)90242-9; Gowen LC, 1996, NAT GENET, V12, P191, DOI 10.1038/ng0296-191; Gowen LC, 1998, SCIENCE, V281, P1009, DOI 10.1126/science.281.5379.1009; HENNING KA, 1995, CELL, V82, P555, DOI 10.1016/0092-8674(95)90028-4; LEADON SA, 1991, MUTAT RES, V255, P67, DOI 10.1016/0921-8777(91)90019-L; LEADON SA, 1995, MUTAT RES-DNA REPAIR, V337, P169, DOI 10.1016/0921-8777(95)00021-B; Leadon SA, 1998, MUTAT RES-DNA REPAIR, V407, P177, DOI 10.1016/S0921-8777(98)00007-X; LEADON SA, 1992, J BIOL CHEM, V267, P23175; Leadon SA, 1997, CANCER RES, V57, P3784; LEADON SA, 1993, P NATL ACAD SCI USA, V90, P10499, DOI 10.1073/pnas.90.22.10499; LIN JJ, 1989, BIOCHEMISTRY-US, V28, P7979, DOI 10.1021/bi00446a002; MACINNES MA, 1993, MOL CELL BIOL, V13, P6393, DOI 10.1128/MCB.13.10.6393; MAYNE LV, 1982, CANCER RES, V42, P1473; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; MELLON I, 1989, NATURE, V342, P95, DOI 10.1038/342095a0; Mellon I, 1996, P NATL ACAD SCI USA, V93, P1292, DOI 10.1073/pnas.93.3.1292; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Mu D, 1997, MOL CELL BIOL, V17, P760, DOI 10.1128/MCB.17.2.760; NOUSPIKEL T, 1994, HUM MOL GENET, V3, P963, DOI 10.1093/hmg/3.6.963; Nouspikel T, 1997, P NATL ACAD SCI USA, V94, P3116, DOI 10.1073/pnas.94.7.3116; ODONOVAN A, 1994, NATURE, V371, P432, DOI 10.1038/371432a0; SCHERLY D, 1993, NATURE, V363, P182, DOI 10.1038/363182a0; SCICCHITANO DA, 1989, P NATL ACAD SCI USA, V86, P3050, DOI 10.1073/pnas.86.9.3050; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Scully R, 1997, P NATL ACAD SCI USA, V94, P5605, DOI 10.1073/pnas.94.11.5605; SELBY CP, 1993, J BACTERIOL, V175, P7509, DOI 10.1128/JB.175.23.7509-7514.1993; SELBY CP, 1995, J BIOL CHEM, V270, P4890, DOI 10.1074/jbc.270.9.4890; SMERDON MJ, 1990, NUCLEIC ACIDS RES, V18, P2045, DOI 10.1093/nar/18.8.2045; SWEDER KS, 1992, P NATL ACAD SCI USA, V89, P10696, DOI 10.1073/pnas.89.22.10696; Sweder KS, 1996, GENETICS, V143, P1127; Tantin D, 1998, J BIOL CHEM, V273, P27794, DOI 10.1074/jbc.273.43.27794; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; VANVUUREN AJ, 1994, EMBO J, V13, P1645, DOI 10.1002/j.1460-2075.1994.tb06428.x; VENEMA J, 1990, P NATL ACAD SCI USA, V87, P4707, DOI 10.1073/pnas.87.12.4707; VERMEULEN W, 1993, AM J HUM GENET, V53, P185; WEEDA G, 1990, CELL, V62, P777, DOI 10.1016/0092-8674(90)90122-U	39	33	33	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1999	64	5					1259	1263		10.1086/302390	http://dx.doi.org/10.1086/302390			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	192RP	10205254	Bronze, Green Published			2022-12-18	WOS:000080093000001
J	Waisfisz, Q; Saar, K; Morgan, NV; Altay, C; Leegwater, PA; de Winter, JP; Komatsu, K; Evans, GR; Wegner, RD; Reis, A; Joenje, H; Arwert, F; Mathew, CG; Pronk, JC; Digweed, M				Waisfisz, Q; Saar, K; Morgan, NV; Altay, C; Leegwater, PA; de Winter, JP; Komatsu, K; Evans, GR; Wegner, RD; Reis, A; Joenje, H; Arwert, F; Mathew, CG; Pronk, JC; Digweed, M			The Fanconi anemia group E gene, FANCE, maps to chromosome 6p	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEMENTATION; LOCALIZATION; CLONING	Fanconi anemia (FA) is a genetically heterogeneous autosomal recessive disease with bone marrow failure and predisposition to cancer as major features, often accompanied by developmental anomalies. The cells of patients with FA are hypersensitive to DNA cross-linking agents in terms of cell survival and chromosomal breakage. Of the eight complementation groups (FA-A to FA-H) distinguished thus far by cell fusion studies, the genes for three-FANCA, FANCC, and FANCG-have been identified, and the FANCD gene has been localized to chromosome 3p22-26. We report here the use of homozygosity mapping and genetic linkage analysis to map a fifth distinct genetic locus for FA. DNA from three families was assigned to group FA-E by cell fusion and complementation analysis and was then used to localize the FANCE gene to chromosome 6p21-22 in an 18.2-cM region flanked by markers D6S422 and D6S1610. This study shows that data from even a small number of families can be successfully used to map a gene for a genetically heterogeneous disorder.	Humboldt Univ, Inst Human Genet, D-13353 Berlin, Germany; Free Univ Amsterdam, Dept Human Genet, Amsterdam, Netherlands; Free Univ Amsterdam, Acad Hosp, Dept Clin Chem, Amsterdam, Netherlands; Max Delbruck Ctr Mol Med, Microsatellite Ctr, Berlin, Germany; Guys Hosp, GKT Sch Med, Div Med & Mol Genet, London SE1 9RT, England; St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England; Univ Hacettepe, Dept Paediat, Haematol Unit, TR-06100 Ankara, Turkey; Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Radiat Biol, Hiroshima, Japan	Humboldt University of Berlin; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Manchester; Hacettepe University; Hiroshima University	Digweed, M (corresponding author), Humboldt Univ, Inst Human Genet, Charite Campus Virchow Klinikum,Augustenburger Pl, D-13353 Berlin, Germany.		Mathew, Christopher G/G-3434-2015; Evans, D Gareth/AAB-4308-2022; Morgan, Neil V/A-5475-2009; Reis, André/D-2309-2009	Mathew, Christopher G/0000-0003-4178-1838; Evans, D Gareth/0000-0002-8482-5784; Morgan, Neil V/0000-0001-6433-5692; Reis, André/0000-0002-6301-6363; Saar, Kathrin/0000-0002-4483-1557; Waisfisz, Quinten/0000-0002-7384-9182; Leegwater, Peter/0000-0002-4100-015X				Apostolou S, 1996, NAT GENET, V14, P324, DOI 10.1038/ng1196-324; AUERBACH AD, 1998, GENETIC BASIS HUMAN, P317; de Winter JP, 1998, NAT GENET, V20, P281, DOI 10.1038/3093; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Evans D G, 1994, Clin Dysmorphol, V3, P200; JOENJE H, 1995, BLOOD, V86, P2156, DOI 10.1182/blood.V86.6.2156.bloodjournal8662156; Joenje H, 1997, AM J HUM GENET, V61, P940, DOI 10.1086/514881; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LoTenFoe JR, 1996, NAT GENET, V14, P320, DOI 10.1038/ng1196-320; PRONK JC, 1995, NAT GENET, V11, P338, DOI 10.1038/ng1195-338; Saar K, 1998, EUR J HUM GENET, V6, P501, DOI 10.1038/sj.ejhg.5200241; STRATHDEE CA, 1992, NAT GENET, V1, P196, DOI 10.1038/ng0692-196; STRATHDEE CA, 1992, NATURE, V356, P763, DOI 10.1038/356763a0; WEGNER RD, 1996, CLIN GENET, V30, P479; WHITNEY M, 1995, NAT GENET, V11, P341, DOI 10.1038/ng1195-341	15	33	34	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1999	64	5					1400	1405		10.1086/302385	http://dx.doi.org/10.1086/302385			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	192RP	10205272	Bronze, Green Published			2022-12-18	WOS:000080093000019
J	Nicolao, P; Xiang, FQ; Gunnarsson, LG; Giometto, B; Edstrom, L; Anvret, M; Zhang, ZP				Nicolao, P; Xiang, FQ; Gunnarsson, LG; Giometto, B; Edstrom, L; Anvret, M; Zhang, ZP			Autosomal dominant myopathy with proximal weakness and early respiratory muscle involvement maps to chromosome 2q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECESSIVE NEMALINE MYOPATHY; MUSCULAR-DYSTROPHY LOCUS; LINKAGE; TITIN; GENE; FAILURE; NEBULIN; 2P	Two Swedish families with autosomal dominant myopathy, who also had proximal weakness, early respiratory failure, and characteristic cytoplasmic bodies in the affected muscle biopsies, were screened for linkage by means of the human genome screening set (Cooperative Human Linkage Center Human Screening Set/Weber version 6). Most chromosome regions were completely excluded by linkage analysis (LOD score <-2). Linkage to the chromosomal region 2q24-q31 was established. A maximum combined two-point LOD score of 4.87 at a recombination fraction of 0 was obtained with marker D2S1245. Haplotype analysis indicated that the gene responsible for the disease is likely to be located in the 17-cM region between markers D2S2384 and D2S364. The affected individuals from these two families share an identical haplotype, which suggests a common origin.	Karolinska Hosp, Dept Mol Med, Clin Neurogenet Unit, S-17176 Stockholm, Sweden; Karolinska Hosp, Dept Clin Neurosci, S-17176 Stockholm, Sweden; Univ Padua, Dept Neurol & Psychiat, Neurol Clin 2, Padua, Italy; Orebro Med Ctr Hosp, Dept Neurol & Neurophysiol, S-70185 Orebro, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; University of Padua	Zhang, ZP (corresponding author), Karolinska Hosp, Dept Mol Med, Clin Neurogenet Unit, CMM L8 02 058, S-17176 Stockholm, Sweden.	zhiping.zhang@cmm.ki.se	Giometto, Bruno/AAG-3236-2019	Gunnarsson, Lars-Gunnar/0000-0002-4192-8273; giometto, bruno/0000-0003-2311-9752; Xiang, Fengqing/0000-0003-0892-1536				Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; Bashir R, 1996, GENOMICS, V33, P46, DOI 10.1006/geno.1996.0157; BASHIR R, 1994, HUM MOL GENET, V3, P455, DOI 10.1093/hmg/3.3.455; BEJAOUI K, 1995, NEUROLOGY, V45, P768, DOI 10.1212/WNL.45.4.768; Bejaoui K, 1998, NEUROGENETICS, V1, P189, DOI 10.1007/s100480050028; BUSHBY KMD, 1995, NEUROMUSCULAR DISORD, V5, P71, DOI 10.1016/0960-8966(93)E0006-G; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; EDSTROM L, 1990, J NEUROL SCI, V96, P211, DOI 10.1016/0022-510X(90)90134-9; Fardeau M, 1982, SKELETAL MUSCLE PATH, P161; FURST DO, 1988, J CELL BIOL, V106, P1563, DOI 10.1083/jcb.106.5.1563; Haravuori H, 1998, AM J HUM GENET, V62, P620, DOI 10.1086/301752; LABEIT S, 1995, J MOL BIOL, V248, P308, DOI 10.1016/S0022-2836(95)80052-2; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; NAVE R, 1989, J CELL BIOL, V109, P2177, DOI 10.1083/jcb.109.5.2177; Pelin K, 1997, EUR J HUM GENET, V5, P229, DOI 10.1159/000484768; ROSENOW EC, 1978, AM J MED, V64, P485, DOI 10.1016/0002-9343(78)90235-8; SUZUKI J, 1994, J BIOCHEM-TOKYO, V116, P406, DOI 10.1093/oxfordjournals.jbchem.a124539; Terwilliger J., 1994, HDB HUMAN GENETIC LI; UDD B, 1993, ARCH NEUROL-CHICAGO, V50, P604, DOI 10.1001/archneur.1993.00540060044015; UDD B, 1992, J NEUROL SCI, V113, P214, DOI 10.1016/0022-510X(92)90249-K; WALLGRENPETTERSSON C, 1995, NEUROMUSCULAR DISORD, V5, P441, DOI 10.1016/0960-8966(95)00022-F; [No title captured]	24	33	34	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1999	64	3					788	792		10.1086/302281	http://dx.doi.org/10.1086/302281			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	177HN	10053013	Bronze, Green Published			2022-12-18	WOS:000079204700016
J	Monks, SA; Kaplan, NL; Weir, BS				Monks, SA; Kaplan, NL; Weir, BS			A comparative study of sibship tests of linkage and/or association	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISEQUILIBRIUM; TDT	Population-based tests of association have used data from either case-control studies or studies based on trios (affected child and parents). Case-control studies are more prone to false-positive results caused by inappropriate controls, which can occur if, for example, there is population admixture or stratification. An advantage of family-based tests is that cases and controls are well matched, but parental data may not always be available, especially for late-onset diseases. Three recent family-based tests of association and linkage utilize unaffected siblings as surrogates for untyped parents. Im this paper, we propose an extension of one of these tests. We describe and compare the four tests in the context of a complex disease for both biallelic and multiallelic markers, as well as for sibships of different sizes. We also examine the consequences of having some parental data in the sample.	NIEHS, Biostat Branch, Res Triangle Pk, NC 27709 USA; N Carolina State Univ, Dept Stat, Program Stat Genet, Raleigh, NC 27695 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of North Carolina; North Carolina State University	Monks, SA (corresponding author), NIEHS, Biostat Branch, POB 12233, Res Triangle Pk, NC 27709 USA.				NIGMS NIH HHS [GM45344] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM045344] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Boehnke M, 1998, AM J HUM GENET, V62, P950, DOI 10.1086/301787; Curtis D, 1997, ANN HUM GENET, V61, P319, DOI 10.1017/S000348009700626X; CURTIS D, 1995, AM J HUM GENET, V56, P811; Kaplan NL, 1997, AM J HUM GENET, V60, P691; Martin ER, 1997, AM J HUM GENET, V61, P439, DOI 10.1086/514860; Ott J., 1991, ANAL HUMAN GENETIC L; SHAM PC, 1995, ANN HUM GENET, V59, P323, DOI 10.1111/j.1469-1809.1995.tb00751.x; Spielman RS, 1996, AM J HUM GENET, V59, P983; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714	9	33	40	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1998	63	5					1507	1516		10.1086/302104	http://dx.doi.org/10.1086/302104			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	138QZ	9792878	Green Published, Bronze			2022-12-18	WOS:000076985200027
J	Gotoda, Y; Wakamatsu, N; Kawai, H; Nishida, Y; Matsumoto, T				Gotoda, Y; Wakamatsu, N; Kawai, H; Nishida, Y; Matsumoto, T			Missense and nonsense mutations in the lysosomal alpha-mannosidase gene (MANB) in severe and mild forms of alpha-mannosidosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PURIFICATION; CLONING; CDNA; EXPRESSION; SEQUENCE	alpha-Mannosidosis is an autosomal recessive lysosomal-storage disorder caused by a deficiency of lysosomal alpha-mannosidase activity. This disease shows a wide range of clinical phenotypes, from a severe, infantile form (type I), which is fatal at <3-8 years of age, to a less severe, late-onset form (type II), which ultimately may involve hearing loss, coarse face, mental retardation, and hepatosplenomegaly. To elucidate the molecular mechanism underlying this disease in both types of patients, we have used PCR, followed by either SSCP analysis or direct sequencing, to analyze the 24 exons and intron/ exon boundaries of the alpha-mannosidase gene (MANB) from five patients. Two amino acid substitutions-H72L and R750W, in exons 2 and 18, respectively-and two nonsense mutations-Q639X and R760X, in exons 15 and 19, respectively-were identified in four type II, patients. One amino acid substitution, P356R, was identified in exon 8 from a type I patient. This patient and three of the type II patients were homozygous for their mutations (H72L, P356R, R750W, and R760X) and one type II patient was heterozygous for the Q639X and R750W mutations. Transfection experiments of COS 7 cells, using the alpha-mannosidase cDNA containing one of the missense mutations-H72L, P356R, or R750W-revealed that each of these mutations dramatically reduces the enzymatic activity of alpha-mannosidase. These data demonstrate that widely heterogeneous missense or nonsense mutations of the MANE gene are the molecular basis underlying alpha-mannosidosis.	Univ Tokushima, Sch Med, Dept Internal Med 1, Tokushima 7708503, Japan	Tokushima University	Wakamatsu, N (corresponding author), Univ Tokushima, Sch Med, Dept Internal Med 1, 3 Kuramoto Cho, Tokushima 7708503, Japan.	nobu@clin.med.tokushima-u.ac.jp		Nobuaki, Wakamatsu/0000-0003-1956-8977; Wakamatsu, Nobuaki/0000-0001-5693-2227				AN GH, 1982, MOL CELL BIOL, V2, P1628, DOI 10.1128/MCB.2.12.1628; AUTIO S, 1973, ACTA PAEDIATR SCAND, V62, P555, DOI 10.1111/j.1651-2227.1973.tb17065.x; BENNET JK, 1995, AM J MED GENET, V55, P21, DOI 10.1002/ajmg.1320550108; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHENG SH, 1986, BIOCHEM J, V233, P65, DOI 10.1042/bj2330065; DESNICK RJ, 1976, PEDIATR RES, V10, P985, DOI 10.1203/00006450-197612000-00008; EMILIANI C, 1995, BIOCHEM J, V305, P363, DOI 10.1042/bj3050363; Gotoda Y., 1996, American Journal of Human Genetics, V59, pA260; GRAVEL RA, 1995, METABOLIC MOL BASES, P2839; KAWAI H, 1985, ACTA NEUROPATHOL, V68, P201, DOI 10.1007/BF00690195; Liao YF, 1996, J BIOL CHEM, V271, P28348, DOI 10.1074/jbc.271.45.28348; MITCHELL ML, 1981, CLIN GENET, V20, P191; NEBES VL, 1994, BIOCHEM BIOPH RES CO, V200, P239, DOI 10.1006/bbrc.1994.1440; Nilssen O, 1997, HUM MOL GENET, V6, P717, DOI 10.1093/hmg/6.5.717; NOLL RB, 1989, ARCH NEUROL-CHICAGO, V46, P507, DOI 10.1001/archneur.1989.00520410041020; Riise HMF, 1997, GENOMICS, V42, P200, DOI 10.1006/geno.1997.4668; SCHATZLE J, 1992, J BIOL CHEM, V267, P4000; SPRANGER J, 1976, RADIOLOGY, V119, P401, DOI 10.1148/119.2.401; Thomas GH, 1995, METABOLIC MOL BASES, P2529; TSUJI A, 1987, BIOCHEM INT, V15, P483; Wakamatsu N, 1997, GENE, V198, P351, DOI 10.1016/S0378-1119(97)00337-5; Wang W, 1996, BIOCHEM BIOPH RES CO, V224, P619, DOI 10.1006/bbrc.1996.1075; WIGLER M, 1978, CELL, V14, P725, DOI 10.1016/0092-8674(78)90254-4; WINSHIP PR, 1989, NUCLEIC ACIDS RES, V17, P1266, DOI 10.1093/nar/17.3.1266	24	33	34	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1998	63	4					1015	1024		10.1086/302048	http://dx.doi.org/10.1086/302048			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	131LP	9758606	Bronze, Green Published			2022-12-18	WOS:000076577800014
J	Bestor, TH				Bestor, TH			Cytosine methylation and the unequal developmental potentials of the oocyte and sperm genomes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA METHYLATION; PATERNAL GENOMES; GENE-EXPRESSION; MOUSE; METHYLTRANSFERASE; LOCALIZATION; CELLS		Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA	Columbia University	Bestor, TH (corresponding author), Columbia Univ Coll Phys & Surg, Dept Genet & Dev, 701 W 168th St, New York, NY 10032 USA.				NIAID NIH HHS [AI40041] Funding Source: Medline; NIGMS NIH HHS [GM00616] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARLOW DP, 1993, SCIENCE, V260, P309, DOI 10.1126/science.8469984; BEECHEY C, IN PRESS GENOMIC IMP; BESTOR TH, 1990, PHILOS T ROY SOC B, V326, P179, DOI 10.1098/rstb.1990.0002; Bestor TH, 1996, NAT GENET, V12, P363, DOI 10.1038/ng0496-363; CARLSON LL, 1992, GENE DEV, V6, P2536, DOI 10.1101/gad.6.12b.2536; DRISCOLL DJ, 1990, SOMAT CELL MOLEC GEN, V16, P267, DOI 10.1007/BF01233363; EFSTRATIADIS A, 1994, CURR OPIN GENET DEV, V4, P265, DOI 10.1016/S0959-437X(05)80054-1; Hatada I, 1997, J BIOL CHEM, V272, P9120, DOI 10.1074/jbc.272.14.9120; Hurst LD, 1996, NAT GENET, V12, P234, DOI 10.1038/ng0396-234; Issa JPJ, 1996, P NATL ACAD SCI USA, V93, P11757, DOI 10.1073/pnas.93.21.11757; Jost JP, 1997, NUCLEIC ACIDS RES, V25, P4545, DOI 10.1093/nar/25.22.4545; JUE K, 1995, BIOL REPROD, V53, P561, DOI 10.1095/biolreprod53.3.561; Kass SU, 1997, CURR BIOL, V7, P157, DOI 10.1016/S0960-9822(97)70086-1; Kono T, 1996, NAT GENET, V13, P91, DOI 10.1038/ng0596-91; LaSalle JM, 1996, SCIENCE, V272, P725, DOI 10.1126/science.272.5262.725; Lei H, 1996, DEVELOPMENT, V122, P3195; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; LI E, 1993, COLD SPRING HARB SYM, V58, P297, DOI 10.1101/SQB.1993.058.01.035; Matsuo K, 1998, EMBO J, V17, P1446, DOI 10.1093/emboj/17.5.1446; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; Mertineit C, 1998, DEVELOPMENT, V125, P889; MONK M, 1987, DEVELOPMENT, V99, P371; Mutter GL, 1997, MUTAT RES-FUND MOL M, V396, P141, DOI 10.1016/S0027-5107(97)00180-2; Nabetani A, 1997, MOL CELL BIOL, V17, P789, DOI 10.1128/MCB.17.2.789; NEUMANN B, 1994, NAT GENET, V9, P451; ONO T, 1993, AGE AGEING, V22, pS34, DOI 10.1093/ageing/22.suppl_1.S34; Sgaramella V, 1998, SCIENCE, V279, P635, DOI 10.1126/science.279.5351.635a; SOLTER D, 1988, ANNU REV GENET, V22, P127; Sun FL, 1997, NATURE, V389, P809, DOI 10.1038/39797; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; Tada M, 1997, EMBO J, V16, P6510, DOI 10.1093/emboj/16.21.6510; TATE PH, 1993, CURR OPIN GENET DEV, V3, P226, DOI 10.1016/0959-437X(93)90027-M; TRASLER JM, 1990, MOL CELL BIOL, V10, P1828, DOI 10.1128/MCB.10.4.1828; Tycko B, 1997, MUTAT RES-REV MUTAT, V386, P131, DOI 10.1016/S1383-5742(96)00049-X; TYCKO B, IN PRESS GENOMIC IMP; Weiss A, 1996, CELL, V86, P709, DOI 10.1016/S0092-8674(00)80146-4; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Yoder JA, 1997, J MOL BIOL, V270, P385, DOI 10.1006/jmbi.1997.1125; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	39	33	33	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1998	62	6					1269	1273		10.1086/301891	http://dx.doi.org/10.1086/301891			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZU224	9585619	hybrid, Green Published			2022-12-18	WOS:000074174700001
J	Daniele, A; Parenti, G; d'Addio, M; Andria, G; Ballabio, A; Meroni, G				Daniele, A; Parenti, G; d'Addio, M; Andria, G; Ballabio, A; Meroni, G			Biochemical characterization of arylsulfatase E and functional analysis of mutations found in patients with X-linked chondrodysplasia punctata	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							STEROID SULFATASE CDNA; ENDOPLASMIC-RETICULUM; WARFARIN EMBRYOPATHY; EXPRESSION; CLONING; GENE; DEFICIENCY; XP22.3; CONSERVATION; LOCALIZATION	X-linked chondrodysplasia punctata (CDPX) is a congenital disorder characterized by abnormalities in cartilage and bone development. Mutations leading to amino acid substitutions were identified recently in CDPX patients, in the coding region of the arylsulfatase E (ARSE) gene, a novel member of the sulfatase gene family, Transfection of the ARSE full-length cDNA, in Cos7 cells, allow ed us to establish that its protein product is a 60-kD precursor, which is subject to N-glycosylation, to give a mature 68-kD form that, unique among sulfatases, is localized to the Golgi apparatus. Five missense mutations found in CDPX patients were introduced into wild-tyre ARSE cDNA by site-directed mutagenesis. These mutants were transfected into Cos7 cells, and the arylsulfatase activity and biochemical properties were determined, to study the effect of thee substitutions on the ARSE protein, One of the mutants behaves as the wild-type protein. All four of the other mutations resulted in a complete lack of arylsulfatase activity, although the substitutions do nor appear to affect the stability and subcellular localization of the protein. The loss of activity due to these mutations confirms their involvement in the clinical phenotype and paints to the importance of these residues in the correct folding of a catalytically active ARSE enzyme.	Telethon Inst Genet & Med, I-20132 Milan, Italy; Univ Naples 2, Dept Pediat, Naples, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Universita della Campania Vanvitelli	Meroni, G (corresponding author), Telethon Inst Genet & Med, San Raffaele Biomed Sci Pk,Via Olgettina 58, I-20132 Milan, Italy.		andria, generoso/V-7172-2019; Melis, Daniela/AAD-3623-2019; BALLABIO, Andrea/AAL-2672-2020	Melis, Daniela/0000-0002-9458-3926; BALLABIO, Andrea/0000-0003-1381-4604; Daniele, Aurora/0000-0002-9085-9737; parenti, giancarlo/0000-0002-6287-5748	Telethon [TGM97000, E.0283, TGM06S01] Funding Source: Medline	Telethon(Fondazione Telethon)		BALLABIO A, 1987, P NATL ACAD SCI USA, V84, P4519, DOI 10.1073/pnas.84.13.4519; BALLABIO A, 1995, METABOLIC MOL BASES, P2999; BLOOM GS, 1989, J BIOL CHEM, V264, P16083; Bond CS, 1997, STRUCTURE, V5, P277, DOI 10.1016/S0969-2126(97)00185-8; BORDIER C, 1981, J BIOL CHEM, V256, P1604; CURRY CJR, 1984, NEW ENGL J MED, V311, P1010, DOI 10.1056/NEJM198410183111603; FRANCO B, 1995, CELL, V81, P15, DOI 10.1016/0092-8674(95)90367-4; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; HALL JG, 1980, AM J MED, V68, P122, DOI 10.1016/0002-9343(80)90181-3; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; HOPWOOD JJ, 1990, MOL BIOL MED, V7, P381; Kolodny E.H., 1995, METABOLIC MOL BASES, V7th, P2693; Meroni G, 1996, HUM MOL GENET, V5, P423, DOI 10.1093/hmg/5.4.423; Neufeld EF, 1995, METABOLIC MOL BASES, P2465; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; Parenti G, 1997, CURR OPIN GENET DEV, V7, P386, DOI 10.1016/S0959-437X(97)80153-0; Parenti G, 1997, AM J MED GENET, V73, P139, DOI 10.1002/(SICI)1096-8628(19971212)73:2<139::AID-AJMG7>3.0.CO;2-P; PAULI RM, 1987, AM J HUM GENET, V41, P566; PEPPERKOK R, 1993, CELL, V74, P71, DOI 10.1016/0092-8674(93)90295-2; PETERS C, 1990, J BIOL CHEM, V265, P3374; Puca AA, 1997, GENOMICS, V42, P192, DOI 10.1006/geno.1997.4716; Schiaffino MV, 1996, P NATL ACAD SCI USA, V93, P9055, DOI 10.1073/pnas.93.17.9055; SCHMIDT B, 1995, CELL, V82, P271, DOI 10.1016/0092-8674(95)90314-3; Selmer T, 1996, EUR J BIOCHEM, V238, P341, DOI 10.1111/j.1432-1033.1996.0341z.x; STEIN C, 1989, J BIOL CHEM, V264, P13865; STEIN C, 1989, J BIOL CHEM, V264, P1252; SUPERTIFURGA A, 1994, AM J HUM GENET, V55, P1137; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; TARTAKOFF AM, 1983, J CELL BIOL, V97, P1243, DOI 10.1083/jcb.97.4.1243; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WANG I, 1995, GENOMICS, V26, P229, DOI 10.1016/0888-7543(95)80205-Z; WICKER G, 1991, J BIOL CHEM, V266, P21386; WILLEMSEN R, 1988, HISTOCHEM J, V20, P41, DOI 10.1007/BF01745968; YEN PH, 1987, CELL, V49, P443, DOI 10.1016/0092-8674(87)90447-8	34	33	34	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1998	62	3					562	572		10.1086/301746	http://dx.doi.org/10.1086/301746			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZF407	9497243	Bronze, Green Published			2022-12-18	WOS:000072894400009
J	Mitchell, GA; Ozand, PT; Robert, MF; Ashmarina, L; Roberts, J; Gibson, KM; Wanders, RJ; Wang, SP; Chevalier, I; Plochl, E; Miziorko, H				Mitchell, GA; Ozand, PT; Robert, MF; Ashmarina, L; Roberts, J; Gibson, KM; Wanders, RJ; Wang, SP; Chevalier, I; Plochl, E; Miziorko, H			HMG CoA lyase deficiency: Identification of five causal point mutations in codons 41 and 42, including a frequent Saudi Arabian mutation, R41Q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							3-HYDROXY-3-METHYLGLUTARYL-COA LYASE; CLONING; MOUSE; GENE; HL; EXPRESSION; DIAGNOSIS; THERAPY	The hereditary deficiency of 3-hydroxy-3-methylglutaryl (HMG) CoA lyase (HL; OMIM 246450 [http:// www3.ncbi.nlm.nih.gov:80/htbin-post/Omim/disp mim?246450]) results in episodes of hypoketotic hypoglycemia and coma and is reported to be frequent and clinically severe in Saudi Arabia. We found genetic diversity among nine Saudi HL-deficient probands: six were homozygous for the missense mutation R41Q, and two were homozygous for the frameshift mutation F305fs(-2). In 32 non-Saudi HL-deficient probands, we found three R41Q alleles and also discovered four other deleterious point mutations in codons 41 and 42: R41X, D42E, D42G, and D42H. In purified mutant recombinant HL, all four missense mutations in codons 41 and 42 cause a marked decrease in HL activity. We developed a screening procedure for HL missense mutations that yields residual activity at levels comparable to those obtained using purified HL peptides. Codons 41 and 42 are important for normal HL catalysis and account for a disproportionate 21 (26%) of 82 of mutant alleles in our group of HL-deficient probands.	Hop St Justine, Serv Genet Med, Montreal, PQ H3T 1C5, Canada; King Faisal Specialist Hosp & Res Ctr, Dept Pediat, Riyadh 11211, Saudi Arabia; King Faisal Specialist Hosp & Res Ctr, Dept Biol & Med Res, Riyadh 11211, Saudi Arabia; Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; Baylor Res Inst, Dallas, TX USA; Univ Hosp, Acad Med Ctr, Dept Clin Chem, Amsterdam, Netherlands; Univ Hosp, Acad Med Ctr, Dept Pediat, Amsterdam, Netherlands; Kinderspital, Salzburg, Austria	Universite de Montreal; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; Medical College of Wisconsin; Baylor Scott & White Health; Baylor University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Mitchell, GA (corresponding author), Hop St Justine, Serv Genet Med, 3175 Cote St Catherine, Montreal, PQ H3T 1C5, Canada.	mitchell@ere.umontreal.ca			NIDDK NIH HHS [DK-21491] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK021491, R01DK021491] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON DH, 1989, J BACTERIOL, V171, P6468, DOI 10.1128/jb.171.12.6468-6472.1989; ASHMARINA LI, 1994, J BIOL CHEM, V269, P31929; Baltscheffsky M, 1997, BBA-PROTEIN STRUCT M, V1337, P113, DOI 10.1016/S0167-4838(96)00158-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buesa C, 1996, J LIPID RES, V37, P2420; Cooper DN, 1995, METABOLIC MOL BASES, P259; DASOUKI M, 1987, J INHERIT METAB DIS, V10, P142, DOI 10.1007/BF01800039; GIBSON KM, 1988, EUR J PEDIATR, V148, P180, DOI 10.1007/BF00441397; GIBSON KM, 1988, J INHERIT METAB DIS, V11, P76, DOI 10.1007/BF01800058; Greene CL, 1984, J NEUROGENET, V1, P165, DOI 10.3109/01677068409107082; KRAMER PR, 1980, J BIOL CHEM, V255, P1023; MICHAUD J, 1992, GENOMICS, V13, P389, DOI 10.1016/0888-7543(92)90258-T; MITCHELL GA, 1993, J BIOL CHEM, V268, P4376; MITCHELL GA, 1995, PRENATAL DIAG, V15, P725, DOI 10.1002/pd.1970150807; OZAND PT, 1991, J INHERIT METAB DIS, V14, P174, DOI 10.1007/BF01800590; OZAND PT, 1992, J CHILD NEUROL, V7, pS4, DOI 10.1177/08830738920070010211; PLOCHL E, 1992, CLIN CHEM, V38, P307; PLOCHL E, 1990, KLIN PADIATR, V202, P76, DOI 10.1055/s-2007-1025492; PLOECHL E, 1989, J INHERIT METAB DIS, V12, P343, DOI 10.1007/BF01799236; RASHED MS, 1995, PEDIATR RES, V38, P324, DOI 10.1203/00006450-199509000-00009; Rashed MS, 1997, CLIN CHEM, V43, P1129; ROBERTS JR, 1994, J BIOL CHEM, V269, P17841; Roberts JR, 1996, J BIOL CHEM, V271, P24604, DOI 10.1074/jbc.271.40.24604; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; WANG SP, 1993, MAMM GENOME, V4, P382, DOI 10.1007/BF00360589; Wang SP, 1996, GENOMICS, V33, P99, DOI 10.1006/geno.1996.0164	26	33	34	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1998	62	2					295	300		10.1086/301730	http://dx.doi.org/10.1086/301730			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA927	9463337	Green Published, Bronze			2022-12-18	WOS:000072416000012
J	Li, LY; Drayna, D; Hu, D; Hayward, A; Gahagan, S; Pabst, H; Cowan, MJ				Li, LY; Drayna, D; Hu, D; Hayward, A; Gahagan, S; Pabst, H; Cowan, MJ			The gene for severe combined immunodeficiency disease in Athabascan-speaking native Americans is located on chromosome 10p	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							V(D)J RECOMBINATION; DNA-REPAIR; HUMAN GENOME; LINKAGE; INTERLEUKIN-7; LOCALIZATION; MUTATION; KINASE; MICE; MAP	Severe combined immunodeficiency disease (SCID) consists of a group of heterogeneous genetic disorders. The most severe phenotype, T-B- SCID, is inherited as an autosomal recessive trait and is characterized by a profound deficiency of both T cell and B cell immunity. There is a uniquely high frequency of T-B- SCID among Athabascan-speaking Native Americans (A-SCID). To localize the A-SCID gene, we conducted a genomewide search, using linkage analysis of similar to 300 microsatellite markers in 14 affected Athabascan-speaking Native American families. We obtained conclusive evidence for linkage of the A-SCID locus to markers on chromosome 10p. The maximum pairwise LOD scores 4.53 and 4.60 were obtained from two adjacent markers, D10S191 and D10S1653, respectively, at a recombination fraction of theta = .00. Recombination events placed the gene in an interval of similar to 6.5 cM flanked by D10S1664 and D10S674. Multipoint analysis positioned the gene for the A-SCID phenotype between D10S191 and D10S1653, with a peak LOD score of 5.10 at D10S191. Strong linkage disequilibrium was found in five linked markers spanning similar to 6.5 cM in the candidate region, suggesting a founder effect with an ancestral mutation that occurred sometime before 1300 A.D.	Univ Calif San Francisco, Dept Pediat, Bone Marrow Transplant Div, San Francisco, CA 94143 USA; Natl Inst Deafness & Commun Disorders, NIH, Rockville, MD USA; Tuba City Indian Hlth Serv, Dept Pediat, Tuba City, AZ USA; Univ Colorado, Hlth Sci Ctr, Dept Pediat, Denver, CO 80262 USA; Univ Alberta, Dept Pediat, Edmonton, AB, Canada	University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Alberta	Cowan, MJ (corresponding author), Univ Calif San Francisco, Dept Pediat, Bone Marrow Transplant Div, 505 Parnassus Ave, San Francisco, CA 94143 USA.	mcowan@peds.ucsf.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028339] Funding Source: NIH RePORTER; NIAID NIH HHS [AI28339] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABE T, 1994, J IMMUNOL, V152, P5504; BLUNT T, 1995, CELL, V80, P813, DOI 10.1016/0092-8674(95)90360-7; CAI QQ, 1994, CYTOGENET CELL GENET, V65, P221, DOI 10.1159/000133635; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DROR Y, 1993, BLOOD, V81, P2021; ELDER ME, 1994, SCIENCE, V264, P1596, DOI 10.1126/science.8202712; FISCHER A, 1992, Immunodeficiency Reviews, V3, P83; FORD N, 1989, MOL CLONING LAB MANU; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HIRSCHHORN R, 1993, PEDIATR RES, V33, pS35; HU DC, 1988, PEDIATR RES, V24, P239; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; JEGGO PA, 1992, P NATL ACAD SCI USA, V89, P6423, DOI 10.1073/pnas.89.14.6423; JONES JF, 1991, HUM BIOL, V63, P669; KEHOE AB, 1981, N AM INDIANS COMPREH, P449; KEHOE AB, 1981, N AM INDIANS COMPREH, P133; KIRCHGESSNER CU, 1995, SCIENCE, V267, P1178, DOI 10.1126/science.7855601; KRAUSS ME, 1979, NATIVE LANGUAGES AM, P258; LEHESJOKI AE, 1993, HUM MOL GENET, V2, P1229, DOI 10.1093/hmg/2.8.1229; Li ZY, 1995, CELL, V83, P1079, DOI 10.1016/0092-8674(95)90135-3; LYNCH M, 1992, HUM GENET, V89, P566; MATHEWS DJ, 1995, BLOOD, V85, P38; MOMBAERTS O, 1992, CELL, V68, P859; MUEGGE K, 1993, SCIENCE, V261, P93, DOI 10.1126/science.7686307; MURPHY S, 1980, LANCET, V2, P502; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; OETTINGER MA, 1992, IMMUNOGENETICS, V35, P97, DOI 10.1007/BF00189518; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; OTEVREL T, 1995, GENOMICS, V27, P211, DOI 10.1006/geno.1995.1029; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; ROSEN FS, 1995, NEW ENGL J MED, V333, P431, DOI 10.1056/NEJM199508173330707; ROTBART HA, 1986, J PEDIATR-US, V109, P596, DOI 10.1016/S0022-3476(86)80219-0; RUSSELL SM, 1995, SCIENCE, V270, P797, DOI 10.1126/science.270.5237.797; Schwarz K, 1996, SCIENCE, V274, P97, DOI 10.1126/science.274.5284.97; SCHWARZ K, 1991, J EXP MED, V174, P1039, DOI 10.1084/jem.174.5.1039; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; TACCIOLI GE, 1995, CURR OPIN IMMUNOL, V7, P436, DOI 10.1016/0952-7915(95)80085-9; TACCIOLI GE, 1994, SCIENCE, V265, P1442, DOI 10.1126/science.8073286; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; WEBER JL, 1989, AM J HUM GENET, V44, P388	42	33	33	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1998	62	1					136	144		10.1086/301688	http://dx.doi.org/10.1086/301688			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YY246	9443881	Green Published, Bronze			2022-12-18	WOS:000072127900019
J	Altheide, TK; Hammer, MF				Altheide, TK; Hammer, MF			Evidence for a possible Asian origin of YAP(+) Y chromosomes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							MITOCHONDRIAL-DNA; HAPLOTYPES; POPULATION		UNIV ARIZONA,DEPT EEB,TUCSON,AZ 85821; UNIV ARIZONA,LAB MOL SYSTEMAT & EVOLUT,TUCSON,AZ 85821	University of Arizona; University of Arizona					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM053566, R01GM053566] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM53566] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Armour JAL, 1996, NAT GENET, V13, P154, DOI 10.1038/ng0696-154; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; HAMMER MF, 1994, MOL BIOL EVOL, V11, P749; HAMMER MF, 1995, AM J HUM GENET, V56, P951; Hammer MF, 1997, GENETICS, V145, P787; HAMMER MF, 1995, NATURE, V378, P376, DOI 10.1038/378376a0; Hammer Michael F., 1996, Evolutionary Anthropology, V5, P116, DOI 10.1002/(SICI)1520-6505(1996)5:4<116::AID-EVAN2>3.0.CO;2-E; Harding RM, 1997, AM J HUM GENET, V60, P772; Jorde LB, 1997, P NATL ACAD SCI USA, V94, P3100, DOI 10.1073/pnas.94.7.3100; Karafet T, 1997, AM J PHYS ANTHROPOL, V102, P301, DOI 10.1002/(SICI)1096-8644(199703)102:3<301::AID-AJPA1>3.0.CO;2-Y; RELETHFORD JH, 1994, AM J PHYS ANTHROPOL, V95, P249; Santos FR, 1996, GENOME RES, V6, P601, DOI 10.1101/gr.6.7.601; SANTOS FR, 1995, GENE, V165, P191, DOI 10.1016/0378-1119(95)00501-V; SPURDLE AB, 1994, ANN HUM GENET, V58, P251, DOI 10.1111/j.1469-1809.1994.tb01889.x; SPURDLE AB, 1994, AM J HUM GENET, V54, P319; TEMPLETON AR, 1995, GENETICS, V140, P767; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; WHITFIELD LS, 1995, NATURE, V378, P379, DOI 10.1038/378379a0	18	33	42	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1997	61	2					462	466						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XX701	9311756				2022-12-18	WOS:A1997XX70100029
J	Mitchell, LE				Mitchell, LE			Differentiating between fetal and maternal genotypic effects, using the transmission test for linkage disequilibrium	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter											Mitchell, LE (corresponding author), CHILDRENS HOSP PHILADELPHIA,DIV HUMAN GENET & MOL BIOL,ABRAMSON RES BLDG,ROOM 1002A,PHILADELPHIA,PA 19104, USA.							Ou CY, 1996, AM J MED GENET, V63, P610, DOI 10.1002/(SICI)1096-8628(19960628)63:4<610::AID-AJMG15>3.3.CO;2-Y; Posey DL, 1996, LANCET, V347, P686, DOI 10.1016/S0140-6736(96)91236-2; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; VANDERPUT NMJ, 1995, LANCET, V346, P1070, DOI 10.1016/S0140-6736(95)91743-8; WHITEHEAD AS, 1995, QJM-MON J ASSOC PHYS, V88, P763	5	33	33	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1997	60	4					1006	1007						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WT614	9106551				2022-12-18	WOS:A1997WT61400035
J	Krakowiak, PA; OQuinn, JR; Bohnsack, JF; Watkins, WS; Carey, JC; Jorde, LB; Bamshad, M				Krakowiak, PA; OQuinn, JR; Bohnsack, JF; Watkins, WS; Carey, JC; Jorde, LB; Bamshad, M			A variant of Freeman-Sheldon syndrome maps to 11p15.5-pter	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISTAL ARTHROGRYPOSIS; HUMAN GENOME; GENE; REGION; LINKAGE; 11P15	Distal arthrogryposis type 1 (DA1) and Freeman-Sheldon syndrome (FSS) are the two most common known causes of inherited multiple congenital contractures. We recently have characterized a new disorder (DA2B) with a phenotype intermediate between DA1 and FSS. We report the mapping of a gene that causes DA2B to chromosome 11p15.5-pter. Linkage analysis in a single kindred generated a positive LOD score of 5.31 at theta = 0 with the marker D11S922, and recombinants localize the gene to an similar to 3.5-6.5-cM region between the marker TH and the telomere. Analysis of additional families improves the LOD score to 6.45 at theta = 0 and suggests linkage homogeneity for DA2B.	UNIV UTAH,HLTH SCI CTR,ECCLES INST HUMAN GENET,DEPT HUMAN GENET,SALT LAKE CITY,UT 84112; UNIV UTAH,HLTH SCI CTR,ECCLES INST HUMAN GENET,DEPT PEDIAT,SALT LAKE CITY,UT 84112	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah								ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; BAMSHAD M, 1994, AM J HUM GENET, V55, P1153; Bamshad M, 1996, AM J MED GENET, V65, P277, DOI 10.1002/(SICI)1096-8628(19961111)65:4<277::AID-AJMG6>3.0.CO;2-M; Bamshad M, 1996, AM J MED GENET, V65, P282, DOI 10.1002/(SICI)1096-8628(19961111)65:4<282::AID-AJMG7>3.0.CO;2-R; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; CAREY JC, 1993, AM J HUM GENET, V53, P413; Fain PR, 1996, HUM MOL GENET, V5, P1631, DOI 10.1093/hmg/5.10.1631; Freeman E A, 1938, Arch Dis Child, V13, P277; GESSLER M, 1990, HUM GENET, V86, P135; Hall J, 1992, PRINCIPLES PRACTICE, P989; HALL JG, 1982, AM J MED GENET, V11, P185, DOI 10.1002/ajmg.1320110208; HALL JG, 1985, CLIN ORTHOP RELAT R, V194, P44; HIGGINS MJ, 1994, GENOMICS, V23, P211, DOI 10.1006/geno.1994.1479; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; KAWIRA EL, 1985, AM J MED GENET, V20, P425, DOI 10.1002/ajmg.1320200302; KLEMP P, 1995, AM J MED GENET, V5, P414; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MOORE CA, 1989, AM J MED GENET, V33, P231, DOI 10.1002/ajmg.1320330218; PUTNAM EA, 1995, NAT GENET, V11, P456, DOI 10.1038/ng1295-456; Russell MW, 1996, GENOMICS, V35, P353, DOI 10.1006/geno.1996.0367; SACCONE S, 1992, P NATL ACAD SCI USA, V89, P4913, DOI 10.1073/pnas.89.11.4913; STUBBS L, 1994, GENOMICS, V24, P324, DOI 10.1006/geno.1994.1623; TSIPOURAS P, 1992, NEW ENGL J MED, V326, P905, DOI 10.1056/NEJM199204023261401; WEITZEL JN, 1992, GENOMICS, V14, P309, DOI 10.1016/S0888-7543(05)80221-6	24	33	35	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1997	60	2					426	432						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WE931	9012416				2022-12-18	WOS:A1997WE93100022
J	Petronis, A; Bassett, AS; Honer, WG; Vincent, JB; Tatuch, Y; Sasaki, T; Ying, DJ; Klempan, TA; Kennedy, JL				Petronis, A; Bassett, AS; Honer, WG; Vincent, JB; Tatuch, Y; Sasaki, T; Ying, DJ; Klempan, TA; Kennedy, JL			Search for unstable DNA in schizophrenia families with evidence for genetic anticipation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BIPOLAR AFFECTIVE-DISORDER; EXPANDED CAG REPEATS; TRINUCLEOTIDE REPEATS; TRIPLET REPEAT; DISEASE; EXPANSION; AGE	Evidence for genetic anticipation has recently become an important subject of research in clinical psychiatric genetics. Renewed interest in anticipation was evoked by molecular genetic findings of a novel type of mutation termed ''unstable DNA.'' The unstable DNA model can be construed as the ''best fit'' for schizophrenia twin and family epidemiological data. We have performed a large-scale Southern blot hybridization, asymmetrical PCR-based, and repeat expansion-detection screening for (CAG)(n)/(CTG)(n) and (CCG)(n)/(CGG)(n) expansions in eastern Canadian schizophrenia multiplex families demonstrating genetic anticipation. There were no differences in (CAG)(n)/(CTG)(n), and (CCG)(n)/(CGG)(n) pattern distribution either between affected and unaffected individuals or across generations. Our findings do not support the hypothesis that large (CAG)(n)/(CTG)(n) or (CCG)(n)/(CGG)(n) expansions are the major etiologic factor in schizophrenia. A separate set of experiments directed to the analysis of small (30-130 trinucleotides), Huntington disease-type expansions in individual genes is required in order to fully exclude the presence of (CAG)(n)/(CTG)(n)- or (CCG)(n)/(CGG)(n)-type unstable mutation.	CLARKE INST PSYCHIAT,NEUROGENET SECT,TORONTO,ON M5T 1R8,CANADA; QUEEN ST MENTAL HLTH CTR,SCHIZOPHRENIA RES UNIT,TORONTO,ON,CANADA; UNIV BRITISH COLUMBIA,DEPT PSYCHIAT,JACK BELL RES CTR,VANCOUVER,BC,CANADA	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of British Columbia			Petronis, Art/AAD-4491-2019					ASHERSON P, 1994, BRIT J PSYCHIAT, V164, P619, DOI 10.1192/bjp.164.5.619; BASSETT AS, 1993, SCHIZOPHR RES, V11, P9, DOI 10.1016/0920-9964(93)90033-F; BASSETT AS, 1994, AM J HUM GENET, V54, P864; CASKEY CT, 1992, SCIENCE, V256, P784, DOI 10.1126/science.1589758; DAI ZH, 1991, CHIN J NEUROL PSYCHI, V24, P111; DEIGHTON C, 1994, ANN RHEUM DIS, V53, P833, DOI 10.1136/ard.53.12.833; GINDILIS VM, 1979, THESIS I MED GENETIC; GOLDSTEIN AM, 1994, J NATL CANCER I, V86, P1385, DOI 10.1093/jnci/86.18.1385; Gregor P, 1992, Cor Vasa, V34, P218; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; LI SH, 1993, GENOMICS, V16, P572, DOI 10.1006/geno.1993.1232; LINDBLAD K, 1995, NEUROBIOL DIS, V2, P55, DOI 10.1006/nbdi.1995.0006; MCINNIS MG, 1993, AM J HUM GENET, V53, P385; MORRIS AG, 1995, HUM MOL GENET, V4, P1957, DOI 10.1093/hmg/4.10.1957; Mott FW, 1911, LANCET, V1, P1251; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; NYLANDER PO, 1994, J MED GENET, V31, P686, DOI 10.1136/jmg.31.9.686; ODONOVAN MC, 1995, NAT GENET, V10, P380, DOI 10.1038/ng0895-380; ONEIL J, 1993, PSYCHIAT GENET, V3, P151; Paterson AD, 1996, AM J HUM GENET, V59, P264; PAYAMI H, 1995, NEUROLOGY, V45, P135, DOI 10.1212/WNL.45.1.135; PENROSE LS, 1948, ANN EUGENIC, V14, P125; PENROSE LS, 1971, MODERN PERSPECTIVES, P3; Petronis A, 1996, AM J MED GENET, V67, P85, DOI 10.1002/(SICI)1096-8628(19960216)67:1<85::AID-AJMG15>3.0.CO;2-L; PETRONIS A, 1995, CLIN NEUROSCI, V3, P76; PETRONIS A, 1995, AM J PSYCHIAT, V152, P164; RAPHAEL SA, 1993, AM J DIS CHILD, V147, P842, DOI 10.1001/archpedi.1993.02160320044017; RICHARDS RI, 1992, NAT GENET, V1, P7, DOI 10.1038/ng0492-7; RIGGINS GJ, 1992, NAT GENET, V2, P186, DOI 10.1038/ng1192-186; ROSS CA, 1993, TRENDS NEUROSCI, V16, P254, DOI 10.1016/0166-2236(93)90175-L; SCHALLING M, 1993, NAT GENET, V4, P135, DOI 10.1038/ng0693-135; SHARMA T, 1994, SCHIZOPHR RES, V11, P141; Sirugo G., 1994, American Journal of Human Genetics, V55, pA203; SIRUGO G, 1995, EPICENTRE FORUM, V2, P1; Sirugo Giorgio, 1995, American Journal of Human Genetics, V57, pA36; SUTHERLAND GR, 1992, CELL, V70, P709; VANDERMEY AGL, 1989, LANCET, V2, P1291; Vincent JB, 1996, MOL PSYCHIATR, V1, P141	39	33	33	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1996	59	4					905	911						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL283	8808607				2022-12-18	WOS:A1996VL28300021
J	Shenkar, R; Navidi, W; Tavare, S; Dang, MH; Chomyn, A; Attardi, G; Cortopassi, G; Arnheim, N				Shenkar, R; Navidi, W; Tavare, S; Dang, MH; Chomyn, A; Attardi, G; Cortopassi, G; Arnheim, N			The mutation rate of the human mtDNA deletion mtDNA(4977)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA DELETIONS; HUMAN BRAIN; INCREASE; DISEASE; TISSUES; AGE	The human mitochondrial mutation mtDNA(4977) is a 4,977-bp deletion that originates between two 13-bp direct repeats. We grew 220 colonies of cells, each from a single human cell. For each colony, we counted the number of cells and amplified the DNA by PCR to rest for the presence of a deletion. To estimate the mutation rate, we used a model that describes the relationship between the mutation rate and the probability that a colony of a given size will contain no mutants, taking into account such factors as possible mitochondrial turnover and mistyping due to PCR error. We estimate that the mutation rate for mtDNA(4977) in cultured human cells is 5.95 x 10(-8) per mitochondrial genome replication. This method can be applied to specific chromosomal, as well as mitochondrial, mutations.	UNIV SO CALIF,DEPT MATH,LOS ANGELES,CA 90089; UNIV COLORADO,HLTH SCI CTR,DIV PULM SCI & CRIT CARE MED,DENVER,CO; COLORADO SCH MINES,DEPT MATH & COMP SCI,GOLDEN,CO 80401; UNIV SO CALIF,DEPT BIOL SCI,LOS ANGELES,CA 90089; CALTECH,DIV BIOL,PASADENA,CA 91125; UNIV CALIF DAVIS,DEPT MOL BIOSCI,DAVIS,CA 95616	University of Southern California; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Colorado School of Mines; University of Southern California; California Institute of Technology; University of California System; University of California Davis			Shenkar, Robert/AAC-7065-2020	Arnheim, Norman/0000-0003-1247-1347				[Anonymous], MITOCHONDRIAL DNA HU; CORRALDEBRINSKI M, 1991, JAMA-J AM MED ASSOC, V266, P1812, DOI 10.1001/jama.266.13.1812; CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324; CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370; CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927; FLORY PJ, 1973, J MOL BIOL, V74, P81, DOI 10.1016/0022-2836(73)90100-9; Harris T. E., 1963, THEORY BRANCHING PRO; HATTORI K, 1991, AM HEART J, V121, P1735, DOI 10.1016/0002-8703(91)90020-I; KENDAL WS, 1988, CANCER RES, V48, P1060; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; LEEFLANG EP, 1994, CURRENT PROTOCOLS S, V3; Luria SE, 1943, GENETICS, V28, P491; SOONG NW, 1992, NAT GENET, V2, P318; WALLACE DC, 1994, P NATL ACAD SCI USA, V91, P8739, DOI 10.1073/pnas.91.19.8739; YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E; YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164; ZHANG C, 1992, FEBS LETT, V297, P34, DOI 10.1016/0014-5793(92)80321-7	17	33	35	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1996	59	4					772	780						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL283	8808591				2022-12-18	WOS:A1996VL28300005
J	Vance, JM; Speer, MC; Stajich, JM; West, S; Wolpert, C; Gaskell, P; Lennon, F; Tim, RM; Rozear, M; BenOthmane, K				Vance, JM; Speer, MC; Stajich, JM; West, S; Wolpert, C; Gaskell, P; Lennon, F; Tim, RM; Rozear, M; BenOthmane, K			Misclassification and linkage of hereditary sensory and autonomic neuropathy type 1 as Charcot-Marie-Tooth disease, type 2B	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							LOCALIZATION				Vance, JM (corresponding author), DUKE UNIV, MED CTR, DIV NEUROL, BOX 2900, DURHAM, NC 27710 USA.			Vance, Jeffery/0000-0003-3815-8199	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS026630] Funding Source: NIH RePORTER; NINDS NIH HHS [NS26630] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS RD, 1989, PRINCIPLES NEUROLOGY, P1055; BENOTHMANE K, 1992, NAT GENET, V2, P315, DOI 10.1038/ng1292-315; BENOTHMANE K, 1993, GENOMICS, V17, P370; BENOTHMANE K, 1990, THESIS U PARIS; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dyck P. J., 1993, PERIPHERAL NEUROPATH, V3rd, P1065; FISCHBECK KH, 1986, ANN NEUROL, V20, P527, DOI 10.1002/ana.410200414; KNOWLES JA, 1992, AM J HUM GENET, V51, P905; KWON JM, 1995, AM J HUM GENET, V57, P853; LOPREST LJ, 1992, NEUROLOGY, V42, P597, DOI 10.1212/WNL.42.3.597; OTHMANE KB, 1993, HUM MOL GENET, V2, P1625, DOI 10.1093/hmg/2.10.1625; Ott J., 1991, ANAL HUMAN GENETIC L; ROZEAR MP, 1987, NEUROLOGY, V37, P1460, DOI 10.1212/WNL.37.9.1460; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; VANCE JM, 1989, EXP NEUROL, V104, P186, DOI 10.1016/S0014-4886(89)80013-5; VANCE JM, 1991, GENOMICS, V9, P623, DOI 10.1016/0888-7543(91)90355-I	16	33	33	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1996	59	1					258	260						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL455	8659534				2022-12-18	WOS:A1996VL45500035
J	RAND, EB; SPINNER, NB; PICCOLI, DA; WHITINGTON, PF; TAUB, R				RAND, EB; SPINNER, NB; PICCOLI, DA; WHITINGTON, PF; TAUB, R			MOLECULAR ANALYSIS OF 24 ALAGILLE SYNDROME FAMILIES IDENTIFIES A SINGLE SUBMICROSCOPIC DELETION AND FURTHER LOCALIZES THE ALAGILLE REGION WITHIN 20P12	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYNDROME ARTERIOHEPATIC DYSPLASIA; PRADER-WILLI SYNDROME; DIGEORGE SYNDROME; BILE-DUCTS; POLYMORPHISMS; CYTOGENETICS; PAUCITY	Alagille syndrome (AGS) is a clinically defined disorder characterized by cholestatic liver disease with bile duct paucity, peculiar facies, structural heart defects, vertebral anomalies, and ocular abnormalities. Multiple patients with various cytogenetic abnormalities involving 20p12 have been identified, allowing the assignment of AGS to this region. The presence of interstitial deletions of varying size led to the hypothesis that AGS is a contiguous gene deletion syndrome. This molecular analysis of cytogenetically normal AGS patients was performed in order to test this hypothesis and to refine the localization of the known AGS region. Investigation of inheritance of simple tandem repeat polymorphism alleles in 67 members of 24 cytogenetically normal Alagille families led to the identification of a single submicroscopic deletion. The deletion included loci DZ0S61, D20S41, D20S186, and D20S188 and presumably intervening uninformative loci D20S189 and D20S27. The six deleted loci are contained in a single YAC of 1.9 Mb. The additional finding of multiple unrelated probands who are heterozygous at each locus demonstrates that microdeletions at known loci within the AGS region are rare in cytogenetically normal patients with this disorder. This suggests that the majority of cases of AGS may be the result of a single gene defect rather than a contiguous gene deletion syndrome.	CHILDRENS HOSP PHILADELPHIA,DIV HUMAN GENET & MOLEC BIOL,PHILADELPHIA,PA 19104; UNIV PENN,DEPT GENET,PHILADELPHIA,PA 19104; UNIV PENN,HOWARD HUGHES MED INST,PHILADELPHIA,PA 19104; WYLER CHILDRENS HOSP,GASTROENTEROL HEPATOL & NUTR SECT,CHICAGO,IL	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania	RAND, EB (corresponding author), CHILDRENS HOSP PHILADELPHIA,DIV GASTROENTEROL & NUTR,324 S 34TH ST,PHILADELPHIA,PA 19104, USA.				NICHD NIH HHS [K12-HD00850] Funding Source: Medline; PHS HHS [P30-28815] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000850] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALAGILLE D, 1987, J PEDIATR-US, V110, P195, DOI 10.1016/S0022-3476(87)80153-1; ALAGILLE D, 1975, J PEDIATR-US, V86, P63, DOI 10.1016/S0022-3476(75)80706-2; ANAD F, 1990, J MED GENET, V27, P729, DOI 10.1136/jmg.27.12.729; BYRNE JLB, 1986, AM J MED GENET, V24, P673, DOI 10.1002/ajmg.1320240411; COHEN D, 1993, NATURE, V3636, P698; DEPRETTERE A, 1987, J PEDIATR GASTR NUTR, V6, P865, DOI 10.1097/00005176-198711000-00008; DESMAZE C, 1993, HUM GENET, V90, P663, DOI 10.1007/BF00202489; DHORNEPOLLET S, 1994, J MOL GENET, V34, P453; DRISCOLL DA, 1992, AM J HUM GENET, V50, P924; EMANUEL BS, 1988, AM J HUM GENET, V43, P575; GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HAMABE J, 1991, AM J MED GENET, V41, P54, DOI 10.1002/ajmg.1320410116; HOL FA, 1995, HUM GENET, V95, P687; LEGIUS E, 1990, AM J MED GENET, V35, P532, DOI 10.1002/ajmg.1320350419; MELIS R, 1993, GENOMICS, V16, P56, DOI 10.1006/geno.1993.1140; MUELLER RF, 1987, J MED GENET, V24, P621, DOI 10.1136/jmg.24.10.621; NICHOLLS RD, 1989, AM J MED GENET, V33, P66, DOI 10.1002/ajmg.1320330109; OHAGI S, 1992, P NATL ACAD SCI USA, V89, P4977, DOI 10.1073/pnas.89.11.4977; POLLET N, 1995, GENOMICS, V27, P467, DOI 10.1006/geno.1995.1078; Sambrook J., 1989, MOL CLONING LAB MANU; SCHNITTGER S, 1989, HUM GENET, V83, P239, DOI 10.1007/BF00285164; SCHULMAN SA, 1984, AM J MED GENET, V19, P325; SPINNER NB, 1994, AM J HUM GENET, V55, P238; TEEBI AS, 1992, AM J MED GENET, V42, P35, DOI 10.1002/ajmg.1320420109; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WHITINGTON PF, 1988, GASTROENTEROLOGY, V95, P130, DOI 10.1016/0016-5085(88)90301-0; ZHANG FR, 1990, J PEDIATR-US, V116, P73, DOI 10.1016/S0022-3476(05)81648-8	29	33	34	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1995	57	5					1068	1073						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TA449	7485156				2022-12-18	WOS:A1995TA44900012
J	STEVANIN, G; CANCEL, G; DIDIERJEAN, O; DURR, A; ABBAS, N; CASSA, E; FEINGOLD, J; AGID, Y; BRICE, A				STEVANIN, G; CANCEL, G; DIDIERJEAN, O; DURR, A; ABBAS, N; CASSA, E; FEINGOLD, J; AGID, Y; BRICE, A			LINKAGE DISEQUILIBRIUM AT THE MACHADO-JOSEPH-DISEASE SPINAL CEREBELLAR-ATAXIA-3 LOCUS - EVIDENCE FOR A COMMON FOUNDER EFFECT IN FRENCH AND PORTUGUESE-BRAZILIAN FAMILIES AS WELL AS A 2ND ANCESTRAL PORTUGUESE-AZOREAN MUTATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							HUNTINGTONS-DISEASE; FRAGILE-X; GENE; EXPANSION		INSERM,U155,PARIS,FRANCE; UNIV SAO PAULO,HOSP CLIN,DEPT NEUROL,BR-05508 SAO PAULO,BRAZIL	Institut National de la Sante et de la Recherche Medicale (Inserm); Universidade de Sao Paulo	STEVANIN, G (corresponding author), HOP LA PITIE SALPETRIERE,INSERM,U289,47 BLVD HOP,PARIS 13,FRANCE.		Stevanin, Giovanni/E-5038-2016; Brice, Alexis/A-2170-2009; brice, alexis/AAE-8275-2019	Stevanin, Giovanni/0000-0001-9368-8657; brice, alexis/0000-0002-0941-3990; Cancel-Tassin, Geraldine/0000-0002-9583-6382				ALMQVIST E, 1995, HUM MOL GENET, V4, P207, DOI 10.1093/hmg/4.2.207; CANCEL G, 1995, AM J HUM GENET, V57, P809; DODE C, 1993, CR ACAD SCI III-VIE, V316, P1374; HARDING AE, 1993, ADV NEUROL, V61, P1; IMBERT G, 1993, NAT GENET, V4, P72, DOI 10.1038/ng0593-72; JACOBS PA, 1993, J MED GENET, V30, P454, DOI 10.1136/jmg.30.6.454; JODICE C, 1993, HUM MOL GENET, V2, P1383, DOI 10.1093/hmg/2.9.1383; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; LAVEDAN C, 1994, J MED GENET, V31, P33, DOI 10.1136/jmg.31.1.33; MACDONALD ME, 1992, NAT GENET, V1, P99, DOI 10.1038/ng0592-99; MORRISON PJ, 1993, J MED GENET, V30, P1018, DOI 10.1136/jmg.30.12.1018; MYERS RH, 1993, NAT GENET, V5, P168, DOI 10.1038/ng1093-168; NEVILLE CE, 1994, HUM MOL GENET, V3, P45; NOVELLETTO A, 1994, HUM MOL GENET, V3, P93, DOI 10.1093/hmg/3.1.93; OUDET C, 1993, AM J HUM GENET, V52, P297; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; ROSENBERG RN, 1995, NEUROLOGY, V45, P1; RUBINSZTEIN DC, 1995, HUM MOL GENET, V4, P203, DOI 10.1093/hmg/4.2.203; SQUITIERI F, 1994, HUM MOL GENET, V3, P2103, DOI 10.1093/hmg/3.12.2103; STEVANIN G, 1994, AM J HUM GENET, V54, P11; Stevanin G, 1994, Neurobiol Dis, V1, P79, DOI 10.1006/nbdi.1994.0010; STEVANIN G, 1995, AM J HUM GENET, V56, P193; STEVANIN G, IN PRESS J MED GENET; TAKIYAMA Y, 1993, NAT GENET, V4, P300, DOI 10.1038/ng0793-300; TAKIYAMA Y, 1995, HUM MOL GENET, V7, P1137; TWIST EC, 1995, J MED GENET, V32, P25, DOI 10.1136/jmg.32.1.25; ZHONG N, 1993, NAT GENET, V5, P248, DOI 10.1038/ng1193-248	27	33	33	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1995	57	5					1247	1250						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TA449	7485178				2022-12-18	WOS:A1995TA44900036
J	CROSBY, AH; SCHERPBIERHEDDEMA, T; WIJMENGA, C; ALTHERR, MR; MURRAY, JC; BUETOW, KH; DIXON, MJ				CROSBY, AH; SCHERPBIERHEDDEMA, T; WIJMENGA, C; ALTHERR, MR; MURRAY, JC; BUETOW, KH; DIXON, MJ			GENETIC-MAPPING OF THE DENTINOGENESIS IMPERFECTA TYPE-II LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS LINKAGE ANALYSIS; HUMAN CHROMOSOME-4; LOCALIZATION; RECOMBINATION; GENOME; GC	Dentinogenesis imperfecta type II (DGI-II) is an autosomal dominant disorder of dentin formation, which has previously been mapped to chromosome 4q12-21. In the current study, six novel short tandem-repeat polymorphisms (STRPs) have been isolated, five of which show significant evidence of linkage to DGI-II. To determine the order of the STRPs and define the genetic distance between them, nine loci (including polymorphisms for two known genes) were mapped through the CEPH reference pedigrees. The resulting genetic map encompasses 16.3 cM on the sex-averaged map. To combine this map with a physical map of the region, all of the STRPs were mapped through a somatic cell hybrid panel. The most likely location for the DGI-II locus within the fixed marker map is in the D4S2691-D4S2692 interval of 6.6 cM. The presence of a marker that shows no recombination with the DGI-II phenotype between the flanking markers provides an important anchor point for the creation of physical continuity across the DGI-II candidate region.	UNIV MANCHESTER,SCH BIOL SCI,MANCHESTER M13 9PT,LANCS,ENGLAND; UNIV MANCHESTER,DEPT DENT MED,MANCHESTER M13 9PT,LANCS,ENGLAND; UNIV MANCHESTER,DEPT SURG,MANCHESTER M13 9PT,LANCS,ENGLAND; FOX CHASE CANC CTR,DIV POPULAT SCI,PHILADELPHIA,PA 19111; LEIDEN UNIV,DEPT HUMAN GENET,2300 RA LEIDEN,NETHERLANDS; LOS ALAMOS NATL LAB,LOS ALAMOS,NM; UNIV IOWA HOSP & CLIN,DEPT PEDIAT & BIOL SCI,IOWA CITY,IA 52242	University of Manchester; University of Manchester; University of Manchester; Fox Chase Cancer Center; Leiden University; Leiden University - Excl LUMC; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Iowa			Crosby, Andrew H/E-2218-2015; Wijmenga, Cisca/D-2173-2009; Wijmenga, Cisca/AAE-7719-2019	Crosby, Andrew H/0000-0003-3667-9054; Wijmenga, Cisca/0000-0002-5635-1614	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG000835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE009170] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00835] Funding Source: Medline; NIDCR NIH HHS [DE09170] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Wellcome Trust(Wellcome TrustEuropean Commission)		ANAND R, 1990, NUCLEIC ACIDS RES, V18, P1951, DOI 10.1093/nar/18.8.1951; Bakker E, 1994, Eur J Hum Genet, V2, P210; BALL SP, 1982, ANN HUM GENET, V46, P35, DOI 10.1111/j.1469-1809.1982.tb00693.x; BOUGHMAN JA, 1986, J CRAN GENET DEV BIO, V6, P341; BUETOW KH, 1991, AM J HUM GENET, V48, P911; BUETOW KH, 1994, NAT GENET, V6, P391, DOI 10.1038/ng0494-391; BUTLER WT, 1989, CONNECT TISSUE RES, V23, P123, DOI 10.3109/03008208909002412; BUTLER WT, 1977, J DENT RES, V56, P228, DOI 10.1177/00220345770560030601; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; Crall M G, 1992, Proc Finn Dent Soc, V88 Suppl 1, P285; CROSBY AH, 1995, GENOMICS, V27, P155, DOI 10.1006/geno.1995.1018; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; Dixon Michael J., 1992, Human Molecular Genetics, V1, P249, DOI 10.1093/hmg/1.4.249; FORSMAN K, 1994, HUM MOL GENET, V3, P1621, DOI 10.1093/hmg/3.9.1621; GOOLD RD, 1993, HUM MOL GENET, V2, P1271, DOI 10.1093/hmg/2.8.1271; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MACDOUGALL M, 1992, AM J HUM GENET, V50, P190; MILLS KA, 1992, GENOMICS, V14, P209, DOI 10.1016/S0888-7543(05)80208-3; MURRAY JC, 1992, NAT GENET, V2, P46, DOI 10.1038/ng0992-46; TABAS JA, 1991, GENOMICS, V9, P283, DOI 10.1016/0888-7543(91)90254-C; WIJMENGA C, IN PRESS MUSCLE NERV; WITKOP C J, 1957, Acta Genet Stat Med, V7, P236	24	33	38	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1995	57	4					832	839						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RV793	7573043				2022-12-18	WOS:A1995RV79300013
J	BENOTHMANE, K; SPEER, MC; STAUFFER, J; BLEL, S; MIDDLETON, L; BENHAMIDA, C; ETRIBI, A; LOEB, D; HENTATI, F; ROSES, AD; BENHAMIDA, M; PERICAKVANCE, MA; VANCE, JM				BENOTHMANE, K; SPEER, MC; STAUFFER, J; BLEL, S; MIDDLETON, L; BENHAMIDA, C; ETRIBI, A; LOEB, D; HENTATI, F; ROSES, AD; BENHAMIDA, M; PERICAKVANCE, MA; VANCE, JM			EVIDENCE FOR LINKAGE DISEQUILIBRIUM IN CHROMOSOME 13-LINKED DUCHENNE-LIKE MUSCULAR-DYSTROPHY (LGMD2C)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							REGION		DUKE UNIV,MED CTR,DURHAM,NC 27710; NATL INST NEUROL,LA RABTA,TUNISIA	Duke University; Universite de Tunis-El-Manar; Institut National de Neurologie				Middleton, Lefkos/0000-0002-8615-3723	NINDS NIH HHS [P01 NS 26630] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS026630] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AZIBI K, 1993, HUM MOL GENET, V2, P1423; BENOTHMANE K, 1992, NAT GENET, V2, P315, DOI 10.1038/ng1292-315; BUSHBY K, IN PRESS NEUROMUSCUL; ROBERDS SL, 1994, CELL, V78, P625, DOI 10.1016/0092-8674(94)90527-4; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; WASHINGTON SS, 1995, CYTOGENET CELL GENET, V70, P2; Weir BS, 1990, GENETIC DATA ANAL	7	33	34	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1995	57	3					732	734						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR605	7668303				2022-12-18	WOS:A1995RR60500024
J	CHENEVIXTRENCH, G; KERR, J; FRIEDLANDER, M; HURST, T; SANDERSON, B; COGLAN, M; WARD, B; LEARY, J; KHOO, SK				CHENEVIXTRENCH, G; KERR, J; FRIEDLANDER, M; HURST, T; SANDERSON, B; COGLAN, M; WARD, B; LEARY, J; KHOO, SK			HOMOZYGOUS DELETIONS ON THE SHORT ARM OF CHROMOSOME-9 IN OVARIAN ADENOCARCINOMA CELL-LINES AND LOSS OF HETEROZYGOSITY IN SPORADIC TUMORS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FREQUENT LOSS; LENGTH POLYMORPHISMS; INTERFERON GENES; ALLELIC LOSS; CANCER; CARCINOMA; REGION; LOCUS; TRANSFORMATION; LOCALIZATION	Rat ovarian surface epithelial cells transformed spontaneously in vitro have been found to have homozygous deletions of the interferon alpha (IFNA) gene. This suggests that inactivation of a tumor-suppressor gene in this region may be crucial for the development of ovarian cancer. We therefore used microsatellite markers and Southern analysis to examine the homologous region in humans-the short arm of chromosome 9-for deletions in sporadic ovarian adenocarcinomas and ovarian tumor cell lines. Loss of heterozygosity occurred in 34 (37%) of 91 informative sporadic tumors, including some benign, low-malignant-potential and early-stage tumors, suggesting that it is an early event in the development of ovarian adenocarcinoma. Furthermore, homozygous deletions on 9p were found in 2 of 10 independent cell lines. Deletion mapping of the tumors and lines indicates that the candidate suppressor gene inactivated as a consequence lies between D9S171 and the IFNA locus, a region that is also deleted in several other tumors and that contains the melanoma predisposition gene, MLM.	UNIV QUEENSLAND, DEPT OBSTET & GYNECOL, BRISBANE, QLD, AUSTRALIA; PRINCE WALES HOSP, DEPT MED ONCOL, SYDNEY, NSW, AUSTRALIA; UNIV SYDNEY, WESTMEAD HOSP, DEPT OBSTET & GYNECOL, SYDNEY, NSW 2006, AUSTRALIA	University of Queensland; University of Sydney	CHENEVIXTRENCH, G (corresponding author), QUEENSLAND INST MED RES, QUEENSLAND CANC FUND, RES UNIT, 300 HERSTON RD, BRISBANE, QLD 4029, AUSTRALIA.		Chenevix-Trench, Georgia/AAV-2014-2020	Chenevix-Trench, Georgia/0000-0002-1878-2587				BELLO MJ, 1990, CANCER GENET CYTOGEN, V45, P223, DOI 10.1016/0165-4608(90)90086-P; BELLO MJ, 1990, INT J CANCER, V45, P50, DOI 10.1002/ijc.2910450111; BERTONCELLO I, 1985, AUST J EXP BIOL MED, V63, P241, DOI 10.1038/icb.1985.27; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; CANNONALBRIGHT LA, 1992, SCIENCE, V258, P1148, DOI 10.1126/science.1439824; CENTER R, 1993, GENE CHROMOSOME CANC, V7, P47, DOI 10.1002/gcc.2870070108; CHENEVIXTRENCH G, 1992, ONCOGENE, V7, P1059; CHENEVIXTRENCH G, 1993, AM J HUM GENET, V53, P760; CLIBY W, 1993, CANCER RES, V53, P2393; COLEMAN A, 1993, AM J HUM GENET, V53, P287; DIAZ MO, 1990, NEW ENGL J MED, V322, P77, DOI 10.1056/NEJM199001113220202; ECCLES DM, 1992, ONCOGENE, V7, P2069; FATHALLA MF, 1971, LANCET, V2, P163; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FOULKES WD, 1993, BRIT J CANCER, V67, P551, DOI 10.1038/bjc.1993.101; FOUNTAIN JW, 1992, P NATL ACAD SCI USA, V89, P10557, DOI 10.1073/pnas.89.21.10557; FOUNTAIN JW, 1993, AM J HUM GENET, V53, P170; FOUNTAIN JW, 1992, GENOMICS, V14, P105, DOI 10.1016/S0888-7543(05)80290-3; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; FUTREAL PA, 1992, CANCER RES, V52, P2624; GALLION HH, 1992, GYNECOL ONCOL, V47, P137, DOI 10.1016/0090-8258(92)90096-2; GODBOUT R, 1992, ONCOGENE, V7, P1879; GODWIN AK, 1992, J NATL CANCER I, V84, P592, DOI 10.1093/jnci/84.8.592; HALUSKA FG, 1993, AM J HUM GENET, V53, P306; ICKING D, 1985, CYTOGENET CELL GENET, V40, P659; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; KIWATOWSKI DJ, 1992, HUM MOL GENET, V1, P658; KUNZMANN R, 1987, CANCER GENET CYTOGEN, V28, P201, DOI 10.1016/0165-4608(87)90206-8; KWIATOWSKI DJ, 1993, CYTOGENET CELL GENET, V64, P63; LANGDON SP, 1988, CANCER RES, V48, P6166; LEE JH, 1990, CANCER RES, V50, P2724; LINNENBACH AJ, 1993, HUM MOL GENET, V2, P1407; MOK SCH, 1993, CANCER RES, V53, P1489; OLOPADE OI, 1992, GENOMICS, V14, P437, DOI 10.1016/S0888-7543(05)80238-1; OLOPADE OI, 1993, CANCER RES, V53, P2410; POWELL DE, 1992, HUM PATHOL, V23, P846, DOI 10.1016/0046-8177(92)90393-H; SAITO S, 1992, CANCER RES, V52, P5815; SATO T, 1991, CANCER RES, V51, P5118; TENERIELLO MG, 1993, CANCER RES, V53, P3103; VANDAMME B, 1992, CANCER RES, V52, P6646; VANHAAFTENDAY C, 1983, CANCER RES, V43, P3725; WARD BG, 1987, CANCER RES, V47, P2662; WEIL D, 1988, AM J HUM GENET, V42, P435; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WEITZEL JN, 1993, AM J HUM GENET, V53, P386; WILSON AP, 1987, BRIT J CANCER, V56, P763, DOI 10.1038/bjc.1987.285; WOLF CR, 1987, INT J CANCER, V39, P695, DOI 10.1002/ijc.2910390607; WOODS LK, 1979, CANCER RES, V39, P4449; YANGFENG TL, 1993, INT J CANCER, V54, P546, DOI 10.1002/ijc.2910540405; ZHENG J, 1993, HISTOLOGICALLY BENIG; [No title captured]	52	33	33	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1994	55	1					143	149						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NW461	8023842				2022-12-18	WOS:A1994NW46100020
J	ALBERTSEN, H; PLAETKE, R; BALLARD, L; FUJIMOTO, E; CONNOLLY, J; LAWRENCE, E; RODRIGUEZ, P; ROBERTSON, M; BRADLEY, P; MILNER, B; FUHRMAN, D; MARKS, A; SARGENT, R; CARTWRIGHT, P; MATSUNAMI, N; WHITE, R				ALBERTSEN, H; PLAETKE, R; BALLARD, L; FUJIMOTO, E; CONNOLLY, J; LAWRENCE, E; RODRIGUEZ, P; ROBERTSON, M; BRADLEY, P; MILNER, B; FUHRMAN, D; MARKS, A; SARGENT, R; CARTWRIGHT, P; MATSUNAMI, N; WHITE, R			GENETIC-MAPPING OF THE BRCA1 REGION ON CHROMOSOME 17Q21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMERASE CHAIN-REACTION; HUMAN GENOME; LINKAGE MAP; DNA; AMPLIFICATION	Chromosome 17q21 harbors a gene (BRCA1) associated with a hereditary form of breast cancer, As a step toward identification of this gene itself we developed a number of simple-sequence-repeat (SSR) markers for chromosome 17 and constructed a high-resolution genetic map of a 40-cM region around 17q21. As part of this effort we captured genotypes from five of the markers by using an ABI sequencing instrument and stored them in a locally developed database, as a step toward automated genotyping. In addition, YACs that physically link some of the SSR markers were identified. The results provided by this study should facilitate physical mapping of the BRCA1 region and isolation of the BRCA1 gene.	UNIV UTAH,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84112	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	ALBERTSEN, H (corresponding author), UNIV UTAH,ECCLES INST HUMAN GENET,BLDG 533,ROOM 2100,SALT LAKE CITY,UT 84112, USA.				NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000367] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG00367-04] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; BENTLEY KL, 1989, CYTOGENET CELL GENET, V51, P961; BLACK DM, 1993, AM J HUM GENET, V52, P702; BOWCOCK AM, 1993, AM J HUM GENET, V52, P718; CLARK JM, 1988, NUCLEIC ACIDS RES, V16, P9677, DOI 10.1093/nar/16.20.9677; CROPP CS, 1990, P NATL ACAD SCI USA, V87, P7737, DOI 10.1073/pnas.87.19.7737; DEVILEE P, 1993, AM J HUM GENET, V52, P730; EASTON DF, 1993, AM J HUM GENET, V52, P678; ECONOMOU EP, 1990, P NATL ACAD SCI USA, V87, P2951, DOI 10.1073/pnas.87.8.2951; GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213; GREEN P, 1987, CYTOGENET CELL GENET, V46, P623; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; JOSLYN G, 1991, CELL, V66, P601, DOI 10.1016/0092-8674(81)90022-2; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEMONS RS, 1990, GENE CHROMOSOME CANC, V2, P79, DOI 10.1002/gcc.2870020202; LITT M, 1989, AM J HUM GENET, V44, P397; MELIS R, 1993, GENOMICS, V16, P56, DOI 10.1006/geno.1993.1140; Nakamura Y, 1988, GENOMICS, V2, P302, DOI 10.1016/0888-7543(88)90018-3; OCONNELL P, 1993, GENOMICS, V15, P38, DOI 10.1006/geno.1993.1007; OCONNELL P, 1994, AM J HUM GENET, V54, P526; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SHEER D, 1985, ANN HUM GENET, V49, P17; SIMARD J, 1993, HUM MOL GENET, V2, P1193, DOI 10.1093/hmg/2.8.1193; SMITH SA, 1993, AM J HUM GENET, V52, P767; TAKEUCHI T, 1985, CYTOGENET CELL GENET, V40, P759; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; VARESCO L, 1992, GENE CHROMOSOME CANC, V4, P84, DOI 10.1002/gcc.2870040113; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; ZIEGLE JS, 1992, GENOMICS, V14, P1026, DOI 10.1016/S0888-7543(05)80126-0	31	33	34	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1994	54	3					516	525						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ158	8116621				2022-12-18	WOS:A1994MZ15800015
J	SCHORK, NJ; WEDER, AB; TREVISAN, M; LAURENZI, M				SCHORK, NJ; WEDER, AB; TREVISAN, M; LAURENZI, M			THE CONTRIBUTION OF PLEIOTROPY TO BLOOD-PRESSURE AND BODY-MASS INDEX VARIATION - THE GUBBIO STUDY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CARDIOVASCULAR RISK-FACTORS; VARIANCE-COMPONENTS; ESSENTIAL-HYPERTENSION; ENVIRONMENTAL SOURCES; PEDIGREE ANALYSIS; MODELS; POPULATION; FAMILIES; EXTENSIONS	Blood pressure (BP), body-mass index (BMI), and quantitative phenotypes thought to influence BP (e.g., lithium-sodium countertransport activity) were studied in 2,184 households comprising 5,376 people in Gubbio, Italy. Variance-components models were used to partition the variation of these phenotypes into components characterizing the effects of age-related, measured environmental, additive genetic, pleiotropic, unmeasured shared-household, and individual-specific (or random) factors. The goal of the investigation was to estimate the contribution of pleiotropy to variation in BP and BMI in population-based samples. Although our results suggest that numerous significant bivariate genetic correlations exist between BP and some of the traits investigated, they ultimately lead us to reject a prominent role for any individual bivariate pleiotropic system influencing the natural variation of BP. However, because we found evidence that many traits enter into small-impact pleiotropic relationships with BP, we cannot rule out the possibility that pleiotropic genes, when considered collectively, may contribute to BP variation at the population level. Similar results were obtained when BMI was taken as the primary variable of interest. We argue that the small but significant portion of BP variation explained by individual genes displaying bivariate pleiotropic effects is intuitive, in light of the relatively low heritabilities associated with quantitative cardiovascular phenotypes and the low phenotypic correlations between BP, BMI, and many other physiologically linked measures of cardiovascular function. Our results not only bear directly on both the nature of the multifactorial determinants of BP and the maintenance of BP variation in the population at large, but also emphasize the utility of variance-components models in epidemiologic and population genetics research. We discuss the implications of our results for genetic epidemiologists and medical researchers studying hypertension, as well as the limitations of our study and areas for future research.	UNIV MICHIGAN, SCH PUBL HLTH, DEPT EPIDEMIOL, ANN ARBOR, MI 48109 USA; SUNY BUFFALO, DEPT SOCIAL & PREVENT MED, BUFFALO, NY 14214 USA; UNIV NAPLES, INST INTERNAL MED & METAB DIS, NAPLES, ITALY; NORTHWESTERN UNIV, DEPT COMMUNITY HLTH & PREVENT MED, CHICAGO, IL USA; MERCK SHARP & DOHME LTD, CTR EPIDEMIOL RES, ROME, ITALY; CTR PREVENT MED, GUBBIO, ITALY	University of Michigan System; University of Michigan; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Naples Federico II; Northwestern University; Merck & Company	SCHORK, NJ (corresponding author), UNIV MICHIGAN, DEPT MED, DIV HYPERTENS, R6592 KRESGE I, ANN ARBOR, MI 48109 USA.			Schork, Nicholas/0000-0003-0920-5013	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R03HL048957, R01HL040397, K08HL002198] Funding Source: NIH RePORTER; NHLBI NIH HHS [NHLBI K04HL02198-01A1, NHLBI R01HL40397, NHLBI R03HL48957-01] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ASTEMBORSKI JA, 1985, AM J MED GENET, V21, P741, DOI 10.1002/ajmg.1320210417; BEATY TH, 1985, ANN HUM GENET, V49, P315, DOI 10.1111/j.1469-1809.1985.tb01707.x; BLANGERO J, 1991, GENET EPIDEMIOL, V8, P299, DOI 10.1002/gepi.1370080503; CAREY G, 1988, BEHAV GENET, V18, P329, DOI 10.1007/BF01260933; EAVES LJ, 1988, 2ND P INT C QUANT GE, P297; EFRON B, 1988, SIAM REV, V30, P421, DOI 10.1137/1030093; Falconer D. S., 1981, INTRO QUANTITATIVE G; HAFFNER SM, 1992, HYPERTENSION, V20, P38, DOI 10.1161/01.HYP.20.1.38; HANIS CL, 1983, AM J HUM GENET, V35, P1196; HOPPER JL, 1983, AM J EPIDEMIOL, V117, P344, DOI 10.1093/oxfordjournals.aje.a113547; Jacquard A., 1974, GENETIC STRUCTURE PO; JENNRICH RI, 1976, TECHNOMETRICS, V18, P11, DOI 10.2307/1267911; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; JULIUS S, 1971, CIRCULATION, V44, P413, DOI 10.1161/01.CIR.44.3.413; LANGE K, 1983, AM J MED GENET, V14, P513, DOI 10.1002/ajmg.1320140315; LANGE K, 1978, J MATH BIOL, V6, P59, DOI 10.1007/BF02478517; LANGE K, 1976, ANN HUM GENET, V4, P171; LAURENZI M, 1992, CLIN EXP HYPERTENS A, V14, P261, DOI 10.3109/10641969209036187; LAURENZI M, 1989, HYPERTENSION, V13, P408, DOI 10.1161/01.HYP.13.5.408; LEHMANN EL, 1975, NONPARAMETRICS; LEVER AF, 1992, J HYPERTENS, V10, P101, DOI 10.1097/00004872-199202000-00001; MOLL PP, 1991, AM J HUM GENET, V49, P1243; MOLL PP, 1979, ANN HUM GENET, V42, P343, DOI 10.1111/j.1469-1809.1979.tb00668.x; NETER J, 1985, APPLIED LINEAR STATI; PERUSSE L, 1989, AM J HUM GENET, V45, P240; PERUSSE L, 1991, AM J HUM GENET, V49, P94; SCHORK NJ, 1990, STAT MED, V9, P301, DOI 10.1002/sim.4780090313; SCHORK NJ, 1993, HUM HERED, V43, P1, DOI 10.1159/000154106; SCHORK NJ, 1993, BIOMETRICAL J, V35, P387, DOI 10.1002/bimj.4710350402; SCHORK NJ, IN PRESS AM J PHYSL; Searle SR, 1992, VARIANCE COMPONENTS; SPENCE MA, 1977, ANN HUM GENET, V41, P111, DOI 10.1111/j.1469-1809.1977.tb01968.x; THOMPSON EA, 1992, GENETICS, V131, P971; WARD R, 1990, HYPERTENSION PATHOPH, P81; WILLIAMS RR, 1988, JAMA-J AM MED ASSOC, V259, P3579, DOI 10.1001/jama.259.24.3579; WILLIAMS RR, 1990, J HYPERTENS, V8, pS39; WILLIAMS RR, 1989, J HYPERTENS, V7, pS8, DOI 10.1097/00004872-198900076-00003	37	33	33	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1994	54	2					361	373						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MU315	8304351				2022-12-18	WOS:A1994MU31500019
J	MCDOWELL, GA; MULES, EH; FABACHER, P; SHAPIRA, E; BLITZER, MG				MCDOWELL, GA; MULES, EH; FABACHER, P; SHAPIRA, E; BLITZER, MG			THE PRESENCE OF 2 DIFFERENT INFANTILE TAY-SACHS DISEASE MUTATIONS IN A CAJUN POPULATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							JEWISH CARRIERS; ASHKENAZI JEWS; DEFECT	A study was undertaken to characterize the mutation(s) responsible for Tay-Sachs disease (TSD) in a Cajun population in southwest Louisiana and to identify the origins of these mutations. Eleven of 12 infantile TSD alleles examined in six families had the beta-hexosaminidase A (Hex A) alpha-subunit exon 11 insertion mutation that is present in approximately 70% of Ashkenazi Jewish TSD heterozygotes. The mutation in the remaining allele was a single-base transition in the donor splice site of the alpha-subunit intron 9. To determine the origins of these two mutations in the Cajun population, the TSD carrier status was enzymatically determined for 90 members of four of the six families, and extensive pedigrees were constructed for all carriers. A single ancestral couple from France was found to be common to most of the carriers of the exon 11 insertion. Pedigree data suggest that this mutation has been in the Cajun population since its founding over 2 centuries ago and that it may be widely distributed within the population. In contrast, the intron 9 mutation apparently was introduced within the last century and probably is limited to a few Louisiana families.	UNIV MARYLAND,SCH MED,DEPT PEDIAT,DIV HUMAN GENET,655 W BALTIMORE ST,BRB 11037,BALTIMORE,MD 21201; UNIV MARYLAND,SCH MED,DEPT OBSTET & GYNECOL,BALTIMORE,MD 21201; KENNEDY KRIEGER INST,GENET LAB,BALTIMORE,MD; MATERNAL CHILD SECT,OFF PUBL HLTH,SHREVEPORT,LA; TULANE UNIV,SCH MED,HAYWARD GENET CTR,NEW ORLEANS,LA 70112	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Kennedy Krieger Institute; Tulane University					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024061] Funding Source: NIH RePORTER; NICHD NIH HHS [HD24061] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AKLI S, 1991, GENOMICS, V11, P124, DOI 10.1016/0888-7543(91)90109-R; Andermann E, 1977, Prog Clin Biol Res, V18, P161; CHASE GA, 1972, AM J HUM GENET, V24, P339; Conrad Glenn R., 1981, GERMAN COAST ABSTRAC; Deiler J. Hanno, 1908, SETTLEMENT GERMAN CO; HEBERT D, 1978, SO LOUISIANA RECORDS; Hebert Donald J, 1974, SW LOUISIANA RECORDS; JEHN J, 1980, ACADIAN DESCENDANTS, V4; KABACK MM, 1973, METHOD ENZYMOL, V28, P862; Mamelka P, 1987, PEDIGREE DRAW APPLE; MYEROWITZ R, 1988, P NATL ACAD SCI USA, V85, P3955, DOI 10.1073/pnas.85.11.3955; MYRIANTHOPOULOS NC, 1972, AM J HUM GENET, V24, P341; OKADA S, 1969, SCIENCE, V165, P698, DOI 10.1126/science.165.3894.698; PAW BH, 1990, AM J HUM GENET, V47, P698; PETERSEN GM, 1983, AM J HUM GENET, V35, P1258; ROBICHAUX AJ, 1981, ACADIAN EXILES ST MA; RUSHTON WF, 1979, CAJUNS ACADIA LOUISI; Sambrook J., 1989, MOL CLONING LAB MANU; SANDEFUR GL, 1982, LOUISIANA AHNENTAFEL; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHAPIRA E, 1989, BIOCH GENETICS LABOR; SHORE S, 1990, ANAL BIOCHEM, V186, P179, DOI 10.1016/0003-2697(90)90593-X; SMITH G, 1990, NATL GEOGR, V178, P40; SPYROPOULOS B, 1981, AM J HUM GENET, V33, P375; TANGUAY C, 1969, DICT GENEALOGIQUE FA; THURMON T F, 1974, Birth Defects Original Article Series, V10, P201; TRIGGSRAINE BL, 1990, NEW ENGL J MED, V323, P6, DOI 10.1056/NEJM199007053230102; VIDRINE JO, 1985, LOVES LEGACY MOBILE; 1978, RECORDS CATHOLIC DIO	29	33	35	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1992	51	5					1071	1077						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JU840	1307230				2022-12-18	WOS:A1992JU84000017
J	DEVLIN, B; RISCH, N				DEVLIN, B; RISCH, N			ETHNIC DIFFERENTIATION AT VNTR LOCI, WITH SPECIAL REFERENCE TO FORENSIC APPLICATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MEXICAN-AMERICANS; DNA; MUTATION; NUMBER	Allele-rich VNTR loci provide valuable information for forensic inference. Interpretation of this information is complicated by measurement error, which renders discrete alleles difficult to distinguish. Two methods have been used to circumvent this difficulty-i.e., binning methods and direct evaluation of allele frequencies, the latter achieved by modeling the data as a mixture distribution. We use this modeling approach to estimate the allele frequency distributions for two loci-D17S79 and D2S44-for black, Caucasian, and Hispanic samples from the Lifecodes and FBI data bases. The data bases are differentiated by the restriction enzyme used: PstI (Lifecodes) and HaeIII (FBI). Our results show that alleles common in one ethnic group are almost always common in all ethnic groups, and likewise for fare alleles; this pattern holds for both loci. Gene diversity, or heterozygosity, measured as one minus the sum of the squared allele frequencies, is greater for D2S44 than for D17S79, in both data bases. The average gene diversity across ethnic groups when PstI (HaeIII) is used is .918 (.918) for D17S79 and is .985 (.983) for D2S44. The variance in gene diversity among ethnic groups is greater for D17S79 than for D2S44. The number of alleles, like the gene diversity, is greater for D2S44 than for D17S79. The mean numbers of alleles across ethnic groups, estimated from the PstI (HaeIII) data, are 40.25 (41.5) for D17S79 and 104 (103) for D2S44. The number of alleles is correlated with sample size. We use the estimated allele frequency distributions for each ethnic group to explore the effects of unwittingly mixing populations and thereby violating independence assumptions. We show that, even in extreme cases of mixture, the estimated genotype probabilities are good estimates of the true probabilities, contradicting recent claims. Because the binning methods currently used for forensic inference show even less differentiation among ethnic groups, we conclude that mixture has little or no impact on the use of VNTR loci for forensics.	YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06510	Yale University	DEVLIN, B (corresponding author), YALE UNIV,SCH MED,DEPT EPIDEMIOL & PUBL HLTH,60 COLL ST,POB 3333,NEW HAVEN,CT 06510, USA.				NCI NIH HHS [CA45052] Funding Source: Medline; NHGRI NIH HHS [HG00648] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA045052] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000648] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BALAZS I, 1989, AM J HUM GENET, V44, P182; BUDOWLE B, 1991, AM J HUM GENET, V48, P137; BUDOWLE B, 1991, AM J HUM GENET, V48, P841; CERDAFLORES RM, 1992, ANN HUM BIOL, V19, P347, DOI 10.1080/03014469200002222; CHAKRABORTY R, 1986, GENET EPIDEMIOL, V3, P435, DOI 10.1002/gepi.1370030608; CHAKRABORTY R, 1992, HUM GENET, V88, P267, DOI 10.1007/BF00197257; COCKERHAM CC, 1984, P NATL ACAD SCI-BIOL, V81, P530, DOI 10.1073/pnas.81.2.530; COHEN JE, 1990, AM J HUM GENET, V46, P358; COHEN JE, 1991, SCIENCE, V243, P1037; DEVLIN B, 1990, SCIENCE, V249, P1416, DOI 10.1126/science.2205919; DEVLIN B, 1992, J AM STAT ASSOC, V87, P337; DEVLIN B, 1992, AM J HUM GENET, V51, P549; DEVLIN B, 1991, AM J HUM GENET, V48, P662; DEVLIN B, 1991, SCIENCE, V243, P1039; DEVLIN B, UNPUB STATISTICAL EV; EFRON B, 1991, SCIENCE, V253, P930; GOOD IJ, 1956, BIOMETRIKA, V43, P45; GREEN P, 1991, SCIENCE, V243, P1038; JEFFREYS AJ, 1988, NATURE, V332, P278, DOI 10.1038/332278a0; LANDER ES, 1991, AM J HUM GENET, V48, P819; LANDER ES, 1989, NATURE, V339, P501, DOI 10.1038/339501a0; LANDER ES, 1991, AM J HUM GENET, V49, P899; Lewontin R.C., 1972, J EVOLUTION BIOL, V14, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; LEWONTIN RC, 1991, SCIENCE, V254, P1745, DOI 10.1126/science.1845040; LI CC, 1969, ANN HUM GENET, V33, P23, DOI 10.1111/j.1469-1809.1969.tb01625.x; NEI M, 1982, EVOL BIOL, V14, P1; Nei M., 1987, MOL EVOLUTIONARY GEN; REED TE, 1974, SCIENCE, V185, P283, DOI 10.1126/science.185.4147.283; RICE JA, 1988, MATH STATISTICS DATA; RISCH NJ, 1992, SCIENCE, V255, P717, DOI 10.1126/science.1738844; SLATKIN M, 1973, GENETICS, V75, P733; SMOUSE PE, 1982, AM NAT, V119, P445, DOI 10.1086/283925; SMOUSE PE, 1986, AM J HUM GENET, V38, P918; WEIR B, 1992, IN PRESS AM J HUM GE, V51; WEIR BS, 1992, GENETICS, V130, P873	35	33	34	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1992	51	3					534	548						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JJ828	1496985				2022-12-18	WOS:A1992JJ82800010
J	SAITO, S; OKUI, K; TOKINO, T; OSHIMURA, M; NAKAMURA, Y				SAITO, S; OKUI, K; TOKINO, T; OSHIMURA, M; NAKAMURA, Y			ISOLATION AND MAPPING OF 68 RFLP MARKERS ON HUMAN CHROMOSOME-6	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SPINOCEREBELLAR ATAXIA; SHORT ARM; LOCALIZATION; GENE; LINKAGE; CONSTRUCTION; RESISTANCE; ANTIGEN; LOCUS; MAP	We have isolated 68 new RFLP markers on human chromosome 6. Of these, 64 were localized on chromosomal bands by the fluorescent in-situ hybridization (FISH) method, 25 on the short arm and 39 on the long arm. Their distribution was uneven; the markers were localized predominantly in regions of R-positive banding. Eleven markers defined VNTR loci. This expanded collection of DNA markers will contribute to high-resolution linkage mapping of genes causing inherited disorders and will provide useful reagents for isolation of putative tumor-suppressor genes on chromosome 6 that appear to be involved in malignancies. Furthermore, the new markers will be guideposts for detailed linkage and physical maps of this chromosome.	JAPANESE FDN CANC RES,INST CANC,DIV BIOCHEM,1-37-1 KAMI IKEBUKURO,TOSHIMA KU,TOKYO 170,JAPAN; TOTTORI UNIV,DEPT MOLEC CELL GENET,TOTTORI 680,JAPAN; SRL INC,TOKYO,JAPAN	Japanese Foundation for Cancer Research; Tottori University; SRL Inc.			Tokino, Takashi/AAI-9887-2021; Moosaei, Hossein/AAG-2289-2021	Moosaei, Hossein/0000-0002-0640-2161				BLANCHE H, 1991, GENOMICS, V9, P420, DOI 10.1016/0888-7543(91)90407-6; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; EDWARDS CQ, 1986, AM J HUM GENET, V38, P805; KOI M, 1989, JPN J CANCER RES, V80, P413, DOI 10.1111/j.1349-7006.1989.tb02329.x; LEACH R, 1986, P NATL ACAD SCI USA, V83, P3909, DOI 10.1073/pnas.83.11.3909; LEE JH, 1990, CANCER RES, V50, P2724; MORITA R, 1991, CANCER RES, V51, P820; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; RICH SS, 1987, AM J HUM GENET, V41, P524; ROBINSON MA, 1985, IMMUNOGENETICS, V21, P143, DOI 10.1007/BF00364866; SCHLOSSTEIN L, 1973, NEW ENGL J MED, V288, P704, DOI 10.1056/NEJM197304052881403; TAKAHASHI E, 1990, HUM GENET, V86, P14; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; TOKINO T, 1991, AM J HUM GENET, V48, P258; TRENT JM, 1990, SCIENCE, V247, P568, DOI 10.1126/science.2300817; YAMAKAWA K, 1991, GENOMICS, V9, P536, DOI 10.1016/0888-7543(91)90421-A; ZOGHBI HY, 1991, GENOMICS, V9, P713, DOI 10.1016/0888-7543(91)90365-L; ZOGHBI HY, 1990, GENOMICS, V6, P352, DOI 10.1016/0888-7543(90)90576-G; ZOGHBI HY, 1988, ANN NEUROL, V23, P580, DOI 10.1002/ana.410230609	19	33	33	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1992	50	1					65	70						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HA040	1346080				2022-12-18	WOS:A1992HA04000007
J	STAPLES, AJ; SUTHERLAND, GR; HAAN, EA; CLISBY, S				STAPLES, AJ; SUTHERLAND, GR; HAAN, EA; CLISBY, S			EPIDEMIOLOGY OF DOWN-SYNDROME IN SOUTH-AUSTRALIA, 1960-89	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MATERNAL AGE INTERVAL; DOWNS-SYNDROME; RATES	During 1960-89 687 Down syndrome live births and 46 Down syndrome pregnancy terminations were identified in South Australia. Ascertainment was estimated to be virtually complete. The sex distribution of Down syndrome live births was found to be statistically different from the non-Down syndrome live-birth sex distribution (P < .01). Smoothed maternal age-specific incidence was derived using both maternal age calculated to the nearest month and a discontinuous-slope regression model. The incidence of Down syndrome at birth for the study period was estimated to be 1.186 Down syndrome births/1,000 live births. Annual population incidence was shown to be correlated with trends in the maternal age distribution of confinements. If current trends in the maternal age distribution of confinements continue, the population incidence of Down syndrome in South Australia is predicted to exceed 1.5 Down syndrome births/1,000 live births during the 1990-94 quinquennium.	ADELAIDE CHILDRENS HOSP INC,DEPT CYTOGENET & MOLEC GENET,ADELAIDE,SA 5006,AUSTRALIA; ADELAIDE CHILDRENS HOSP INC,DEPT MED GENET & EPIDEMIOL,ADELAIDE,SA 5006,AUSTRALIA; INTELLECTUALLY DISABLED SERV COUNCIL INC,ADELAIDE,AUSTRALIA				Sutherland, Grant Robert/D-2606-2012					Hook E B, 1977, Birth Defects Orig Artic Ser, V13, P123; HOOK EB, 1978, TERATOLOGY, V17, P223, DOI 10.1002/tera.1420170303; HOOK EB, 1983, AM J HUM GENET, V35, P110; HOOK EB, 1978, AM J HUM GENET, V30, P19; HUETHER CA, 1981, AM J PUBLIC HEALTH, V71, P1367, DOI 10.2105/AJPH.71.12.1367; LAMSON SH, 1981, HUM GENET, V59, P232; NETER J, 1974, APPLIED LINEAR STATI; Penrose L.S., 1966, DOWNS ANOMALY; POLLARD JH, 1977, NUMERICAL STATISTICA; SUTHERLAND GR, 1979, MED J AUSTRALIA, V2, P58, DOI 10.5694/j.1326-5377.1979.tb112703.x; WALD NJ, 1988, BRIT MED J, V297, P883, DOI 10.1136/bmj.297.6653.883; 1989, S AUSTR YB, V23, P30	12	33	33	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1991	49	5					1014	1024						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GM873	1833972				2022-12-18	WOS:A1991GM87300012
J	MARTIN, RH				MARTIN, RH			CYTOGENETIC ANALYSIS OF SPERM FROM A MAN HETEROZYGOUS FOR A PERICENTRIC-INVERSION, INV (3) (P25Q21)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MALE CARRIER; SYNAPTONEMAL COMPLEXES; CHROMOSOME CONSTITUTION; HUMAN-SPERMATOZOA; DUPLICATION; SYNAPSIS; HETEROSYNAPSIS; FREQUENCY; BEHAVIOR; DELETION	Human sperm chromosomes were studied in a man heterozygous for a pericentric inversion of chromosome 3(p25q21). The pronuclear chromosomes were analyzed after in vitro penetration of golden hamster eggs. A total of 144 sperm were examined: 69.2% were chromosomally balanced and 30.8% were recombinant. Of the balanced complements, the proportion with a normal chromosome 3 (37.6%) was approximately equal to the proportion with an inverted 3 (31.6%). Of the recombinant complements, the proportion of sperm with a duplication q/deletion p (17.3%) was approximately equal to the reciprocal event of duplication p/deletion q (13.5%). The recombinant chromosome 3 with a duplication q and deletion p has been observed in several abnormal children, but the duplication p/deletion q has never been reported. My results demonstrate that both recombinant chromosomes are produced as expected from an unequal number of crossovers within an inversion loop. In all likelihood the duplication p/deletion q chromosome is an early embryonic lethal because of the amount of genetic material deleted. The proportions of X-bearing (48.9%) and Y-bearing sperm (51.1%) were not significantly different from the expected 1:1 ratio. There was no evidence for an interchromosomal effect. Of the three inversions studied by human sperm chromosome analysis, recombinant chromosomes have been observed only in this case.	UNIV CALGARY,FAC MED,DEPT PEDIAT,DIV MED GENET,CALGARY T2N 1N4,ALBERTA,CANADA; ALBERTA CHILDRENS PROV GEN HOSP,RES CTR,CALGARY,ALBERTA,CANADA	University of Calgary; Alberta Childrens Hospital; University of Calgary								ALDERDICE PW, 1975, AM J HUM GENET, V27, P699; ALLDERDICE PW, IN PRESS AM J MED GE; ASHLEY T, 1988, GENETICS, V118, P307; BALKAN W, 1983, CYTOGENET CELL GENET, V35, P295, DOI 10.1159/000131882; BATANIAN J, 1987, HUM GENET, V76, P81; BOUE A, 1984, PRENATAL DIAG, V4, P45, DOI 10.1002/pd.1970040705; Boue J, 1974, ANN PEDIATR, V21, P567; BRANDRIFF B, 1985, GAMETE RES, V11, P253, DOI 10.1002/mrd.1120110304; CHANDLEY AC, 1987, J MED GENET, V24, P325, DOI 10.1136/jmg.24.6.325; DELACHAPELLE A, 1974, AM J HUM GENET, V26, P746; DEPERDIGO A, 1989, HUM GENET, V83, P274, DOI 10.1007/BF00285171; FINEMAN RM, 1978, PEDIATRICS, V61, P611; GABRIELROBEZ O, 1988, CYTOGENET CELL GENET, V48, P84, DOI 10.1159/000132595; GABRIELROBEZ O, 1987, ANDROLOGIA, V19, P662; GABRIELROBEZ O, 1986, HUM GENET, V72, P148, DOI 10.1007/BF00283934; GUICHAOUA MR, 1986, ANN GENET-PARIS, V29, P207; KAISER P, 1984, HUM GENET, V68, P1, DOI 10.1007/BF00293869; LAURIE DA, 1985, ANN HUM GENET, V49, P189, DOI 10.1111/j.1469-1809.1985.tb01693.x; MARTIN RH, 1986, HUM GENET, V73, P97, DOI 10.1007/BF00291594; MARTIN RH, 1987, HUM GENET, V77, P108, DOI 10.1007/BF00272374; MARTIN RH, 1983, HUM GENET, V63, P305, DOI 10.1007/BF00274750; MARTIN RH, 1988, HUM GENET, V80, P357, DOI 10.1007/BF00273651; MARTIN RH, 1990, MOL REPROD DEV, V25, P101; RUDAK E, 1978, NATURE, V274, P911, DOI 10.1038/274911a0; SAADALLAH N, 1986, ANN HUM GENET, V50, P369, DOI 10.1111/j.1469-1809.1986.tb01758.x; SHERMAN SL, 1986, CLIN GENET, V30, P87; TRUNCA C, 1977, AM J MED GENET, V1, P217, DOI 10.1002/ajmg.1320010208; WINSOR EJT, 1978, CYTOGENET CELL GENET, V20, P169, DOI 10.1159/000130849	28	33	33	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1991	48	5					856	861						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK897	2018037				2022-12-18	WOS:A1991FK89700004
J	NAVON, R; PROIA, RL				NAVON, R; PROIA, RL			TAY-SACHS DISEASE IN MOROCCAN JEWS - DELETION OF A PHENYLALANINE IN THE ALPHA-SUBUNIT OF BETA-HEXOSAMINIDASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ASHKENAZI JEWS; EXTENSIVE HOMOLOGY; CHAIN; GENE; SEQUENCE; DEFECT; ACID; CDNA; MUTATION; CLONING	Tay-Sachs disease is an inherited lysosomal storage disorder caused by defects in the beta-hexosaminidase alpha-subunit gene. The carrier frequency for Tay-Sachs disease is significantly elevated in both the Ashkenazi Jewish and Moroccan Jewish populations but not in other Jewish groups. We have found that the mutations underlying Tay-Sachs disease in Ashkenazi and Moroccan Jews are different. Analysis of a Moroccan Jewish Tay-Sachs patient has revealed an in-frame deletion (DELTA-F) of one of the two adjacent phenylalanine codons that are present at positions 304 and 305 in the alpha-subunit sequence. The mutation impairs the subunit assembly of beta-hexosaminidase A, resulting in an absence of enzyme activity. The Moroccan patient was found also to carry, in the other alpha-subunit allele, a different, and as yet unidentified, mutation which causes a deficit of mRNA. Analysis of obligate carriers from six unrelated Moroccan Jewish families showed that three harbor the DELTA-F mutation, raising the possibility that this defect may be a prevalent mutation in this ethnic group.	NIDDKD,GENET & BIOCHEM BRANCH,BLDG 10,ROOM 9D-15,BETHESDA,MD 20892; SAPIR MED CTR,MOLEC GENET UNIT,KFAR SAVA,ISRAEL; TEL AVIV UNIV,SACKLER SCH MED,DEPT HUMAN GENET,TEL AVIV,ISRAEL	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine			Proia, Richard L/A-7908-2012	Proia, Richard/0000-0003-0456-1270				Andermann E, 1977, Prog Clin Biol Res, V18, P161; ARPAIA E, 1988, NATURE, V333, P85, DOI 10.1038/333085a0; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BACH G, 1976, ISRAEL J MED SCI, V12, P1432; BAPAT B, 1988, FEBS LETT, V237, P191, DOI 10.1016/0014-5793(88)80199-6; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; EFSTRATIADIS A, 1980, CELL, V21, P653, DOI 10.1016/0092-8674(80)90429-8; FARABAUGH PJ, 1978, J MOL BIOL, V126, P847, DOI 10.1016/0022-2836(78)90023-2; GRAHAM TR, 1988, J BIOL CHEM, V263, P16823; HECHTMAN P, 1989, American Journal of Human Genetics, V45, pA193; KADOWAKI T, 1990, P NATL ACAD SCI USA, V87, P658, DOI 10.1073/pnas.87.2.658; KORNELUK RG, 1986, J BIOL CHEM, V261, P8407; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; MYEROWITZ R, 1987, J BIOL CHEM, V262, P15396; MYEROWITZ R, 1988, J BIOL CHEM, V263, P18587; MYEROWITZ R, 1988, P NATL ACAD SCI USA, V85, P3955, DOI 10.1073/pnas.85.11.3955; MYEROWITZ R, 1985, P NATL ACAD SCI USA, V82, P7830, DOI 10.1073/pnas.82.23.7830; MYRIANTHOPOULOS NC, 1966, AM J HUM GENET, V18, P313; NAVON R, 1989, SCIENCE, V243, P1471, DOI 10.1126/science.2522679; NEUFELD EF, 1989, J BIOL CHEM, V264, P10927; OHNO K, 1988, BIOCHEM BIOPH RES CO, V153, P463, DOI 10.1016/S0006-291X(88)81247-6; PAW BH, 1990, AM J HUM GENET, V47, P698; PETERSEN GM, 1983, AM J HUM GENET, V35, P1258; PROIA RL, 1988, P NATL ACAD SCI USA, V85, P1883, DOI 10.1073/pnas.85.6.1883; PROIA RL, 1984, J BIOL CHEM, V259, P3350; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sandhoff KCE, 1989, METABOLIC BASIS INHE, V2, P1807; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TRIGGSRAINE BL, 1990, NEW ENGL J MED, V323, P6, DOI 10.1056/NEJM199007053230102; VECHT J, 1983, ISRAEL J MED SCI, V19, P67	30	33	33	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1991	48	2					412	419						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	EV744	1825014				2022-12-18	WOS:A1991EV74400026
J	HECHTMAN, P; KAPLAN, F; BAYLERAN, J; BOULAY, B; ANDERMANN, E; DEBRAEKELEER, M; MELANCON, S; LAMBERT, M; POTIER, M; GAGNE, R; KOLODNY, E; CLOW, C; CAPUA, A; PREVOST, C; SCRIVER, C				HECHTMAN, P; KAPLAN, F; BAYLERAN, J; BOULAY, B; ANDERMANN, E; DEBRAEKELEER, M; MELANCON, S; LAMBERT, M; POTIER, M; GAGNE, R; KOLODNY, E; CLOW, C; CAPUA, A; PREVOST, C; SCRIVER, C			MORE THAN ONE MUTANT ALLELE CAUSES INFANTILE TAY-SACHS DISEASE IN FRENCH-CANADIANS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV LAVAL, CTR HOSP, DEPT GENET MED, ST FOY, QUEBEC, CANADA; MCGILL UNIV, CTR HUMAN GENET, MONTREAL H3A 2T5, QUEBEC, CANADA; MCGILL UNIV, DEPT BIOL, MONTREAL H3A 2T5, QUEBEC, CANADA; MONTREAL NEUROL HOSP & INST, DEPT NEUROGENET, MONTREAL H3A 2B4, QUEBEC, CANADA; HOP ST JUSTINE, DEPT GENET MED, MONTREAL H3T 1C5, QUEBEC, CANADA; UNIV QUEBEC, SOREP, CHICOUTIMI G7H 2P9, QUEBEC, CANADA; HOP CHICOUTIMI, CHICOUTIMI, QUEBEC, CANADA; SHRIVER CTR MENTAL RETARDAT, WALTHAM, MA USA	Laval University; McGill University; McGill University; McGill University; Universite de Montreal; University of Quebec; University of Quebec Chicoutimi	HECHTMAN, P (corresponding author), MCGILL UNIV, MONTREAL CHILDRENS HOSP, RES INST, 2300 TUPPER ST, MONTREAL H3H 1P3, QUEBEC, CANADA.							Andermann E, 1977, Prog Clin Biol Res, V18, P161; ANDERMANN E, 1971, T AM NEUROL ASSOC, V98, P17; ARPAIA E, 1988, NATURE, V333, P85, DOI 10.1038/333085a0; BAYLERAN J, 1987, AM J HUM GENET, V41, P532; BAYLERAN J, 1984, CLIN CHIM ACTA, V143, P73, DOI 10.1016/0009-8981(84)90215-8; CHARBONNEAU M, 1987, HIST ATLAS CANDA, V1, P118; DAHLBERG GUNNAR, 1938, PROC ROY SOC EDINBURGH, V58, P213; DELVIN E, 1974, CLIN CHIM ACTA, V53, P135, DOI 10.1016/0009-8981(74)90361-1; HECHTMAN P, 1983, CLIN GENET, V24, P206; HECHTMAN P, 1989, American Journal of Human Genetics, V45, pA193; JETTE R, 1983, DICT GENEALOGIQUIE F; JOHN SWM, 1990, AM J HUM GENET, V46, P970; JOHN SWM, 1989, AM J HUM GENET, V45, P905; KAPLAN F, 1990, AM J HUM GENET, V46, P126; KYTZIA HJ, 1985, J BIOL CHEM, V260, P7568; MCDOWELL G A, 1989, American Journal of Human Genetics, V45, pA9; MYEROWITZ R, 1987, J BIOL CHEM, V262, P15396; MYEROWITZ R, 1988, J BIOL CHEM, V263, P18587; MYEROWITZ R, 1988, P NATL ACAD SCI USA, V85, P3955, DOI 10.1073/pnas.85.11.3955; MYEROWITZ R, 1986, SCIENCE, V232, P1646, DOI 10.1126/science.3754980; MYRIANTHOPOULOS NC, 1972, ADV EXP MED BIOL, V19, P561; NAVON R, 1989, SCIENCE, V243, P1471, DOI 10.1126/science.2522679; OHNO K, 1988, BIOCHEM BIOPH RES CO, V153, P463, DOI 10.1016/S0006-291X(88)81247-6; OKADA S, 1969, SCIENCE, V165, P698, DOI 10.1126/science.165.3894.698; PAW BH, 1989, P NATL ACAD SCI USA, V86, P2413, DOI 10.1073/pnas.86.7.2413; PROIA RL, 1982, P NATL ACAD SCI-BIOL, V79, P6360, DOI 10.1073/pnas.79.20.6360; PROIA RL, 1987, J BIOL CHEM, V262, P5677; Sandhoff KCE, 1989, METABOLIC BASIS INHE, V2, P1807; TANAKA A, 1990, AM J HUM GENET, V46, P329; ZOAKEEM G, 1987, AM J HUM GENET, V40, P537	30	33	34	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1990	47	5					815	822						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EE940	2220821				2022-12-18	WOS:A1990EE94000008
J	BORECKI, IB; LATHROP, GM; BONNEY, GE; YAOUANQ, J; RAO, DC				BORECKI, IB; LATHROP, GM; BONNEY, GE; YAOUANQ, J; RAO, DC			COMBINED SEGREGATION AND LINKAGE ANALYSIS OF GENETIC HEMOCHROMATOSIS USING AFFECTION STATUS, SERUM IRON, AND HLA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									WASHINGTON UNIV,SCH MED,DEPT PSYCHIAT,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT GENET,ST LOUIS,MO 63110; CTR ETUD POLYMORPHISME HUMAIN,PARIS,FRANCE; HOWARD UNIV,CTR CANC,DIV BIOSTAT,WASHINGTON,DC 20059; INSERM,U49,RENNES,FRANCE	Washington University (WUSTL); Washington University (WUSTL); Howard University; Institut National de la Sante et de la Recherche Medicale (Inserm)	BORECKI, IB (corresponding author), WASHINGTON UNIV,SCH MED,DIV BIOSTAT,BOX 8067,660 S EUCLID AVE,ST LOUIS,MO 63110, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028719, R29GM039573] Funding Source: NIH RePORTER; NICHD NIH HHS [HD 18281] Funding Source: Medline; NIGMS NIH HHS [GM 39573, GM 28719] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BASSETT ML, 1984, GASTROENTEROLOGY, V87, P628; BASSETT ML, 1981, HEPATOLOGY, V1, P120, DOI 10.1002/hep.1840010206; BEAUMONT C, 1979, NEW ENGL J MED, V301, P169, DOI 10.1056/NEJM197907263010401; BOMFORD A, 1976, Q J MED, V45, P611; BONNEY GE, 1988, AM J HUM GENET, V43, P29; BONNEY GE, 1986, BIOMETRICS, V42, P611, DOI 10.2307/2531211; BONNEY GE, 1984, AM J MED GENET, V18, P731, DOI 10.1002/ajmg.1320180420; BORECKI IB, 1989, AM J HUM GENET, V45, P465; BORECKI IB, 1990, HUM HERED, V40, P159, DOI 10.1159/000153924; BORECKI IB, 1989, AM J MED GENET, V34, P435, DOI 10.1002/ajmg.1320340321; BORECKI IB, 1990, IN PRESS AM J MED GE; BORWEIN ST, 1983, CLIN INVEST MED, V6, P171; CANNINGS C, 1977, CLIN GENET, V12, P208; CARTWRIGHT GE, 1979, NEW ENGL J MED, V301, P175, DOI 10.1056/NEJM197907263010402; CLERGETDARPOUX F, 1982, ANN HUM GENET, V46, P363, DOI 10.1111/j.1469-1809.1982.tb01587.x; DADONE MM, 1982, AM J CLIN PATHOL, V78, P196, DOI 10.1093/ajcp/78.2.196; DEMENAIS FM, IN PRESS GENET EPIDE; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; LALOUEL JM, 1985, AM J HUM GENET, V37, P700; LALOUEL JM, 1979, 14 U UT DEP MED BIOP; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEMIGNON L, 1983, CLIN GENET, V24, P171; LEMIGNON L, 1982, THESIS FM RENNES REN; OTT J, 1985, ANAL HUMAN GENETIC L; Simon M, 1980, Prog Med Genet, V4, P135; SIMON M, 1977, NEW ENGL J MED, V297, P1017, DOI 10.1056/NEJM197711102971901	26	33	33	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1990	47	3					542	550						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX223	2393027				2022-12-18	WOS:A1990DX22300019
J	XU, CF; NANJEE, MN; SAVILL, J; TALMUD, PJ; ANGELICO, F; DELBEN, M; ANTONINI, R; MAZZARELLA, B; MILLER, N; HUMPHRIES, SE				XU, CF; NANJEE, MN; SAVILL, J; TALMUD, PJ; ANGELICO, F; DELBEN, M; ANTONINI, R; MAZZARELLA, B; MILLER, N; HUMPHRIES, SE			VARIATION AT THE APOLIPOPROTEIN (APO) AI-CIII-AIV GENE-CLUSTER AND APO B-GENE LOCI IS ASSOCIATED WITH LIPOPROTEIN AND APOLIPOPROTEIN LEVELS IN ITALIAN CHILDREN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									WAKE FOREST UNIV,BOWMAN GRAY SCH MED,WINSTON SALEM,NC 27103; DEPT HLTH,MICROBIOL LAB,BRISBANE,QLD,AUSTRALIA; UNIV ROME LA SAPIENZA,IST TERAPIA MED SIST,I-00185 ROME,ITALY	Wake Forest University; Wake Forest Baptist Medical Center; Queensland Health; Sapienza University Rome	XU, CF (corresponding author), CHARING CROSS SUNLEY MED RES CTR,LURGAN AVE,LONDON W6 8LW,ENGLAND.		Angelico, Francesco/AAB-6585-2020; Talmud, Philippa J/C-4402-2008	Xu, Chun-Fang/0000-0002-8747-0683; Talmud, Philippa/0000-0002-5560-1933; Humphries, Stephen E/0000-0002-8221-6547				ABURATANI H, 1988, ATHEROSCLEROSIS, V72, P71, DOI 10.1016/0021-9150(88)90064-0; ANGELICO F, 1989, ATHEROSCLEROSIS CARD, V4, P569; AUSTIN MA, 1987, AM J EPIDEMIOL, V125, P308, DOI 10.1093/oxfordjournals.aje.a114531; AVOGARO P, 1980, ATHEROSCLEROSIS, V37, P69, DOI 10.1016/0021-9150(80)90094-5; BARNI N, 1986, HUM GENET, V73, P313, DOI 10.1007/BF00279093; BERG K, 1986, CLIN GENET, V30, P515; BERG K, 1984, ACTA GENET MED GEMEL, V33, P349, DOI 10.1017/S0001566000005808; BROWN MS, 1981, SCIENCE, V212, P628, DOI 10.1126/science.6261329; BROWN MS, 1984, SCI AM, V251, P58, DOI 10.1038/scientificamerican1184-58; BROWN MS, 1983, METABOLIC BASIS INHE, P655; CASTELLI WP, 1977, CIRCULATION, V55, P767, DOI 10.1161/01.CIR.55.5.767; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; COLEMAN RT, 1986, MOL BIOL MED, V3, P213; DARNFORS C, 1986, NUCLEIC ACIDS RES, V14, P7135, DOI 10.1093/nar/14.17.7135; EHNHOLM C, 1982, NEW ENGL J MED, V307, P850, DOI 10.1056/NEJM198209303071403; ELLEESON RD, 1978, MAYO CLIN PROC, V53, P307; FIDGE N, 1980, METABOLISM, V29, P643, DOI 10.1016/0026-0495(80)90109-2; FIELDING CJ, 1972, BIOCHIM BIOPHYS ACTA, V270, P513, DOI 10.1016/0005-2760(72)90116-6; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GIDEZ LI, 1982, J LIPID RES, V23, P1206; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; HAMSTEN A, 1986, ATHEROSCLEROSIS, V60, P199, DOI 10.1016/0021-9150(86)90166-8; HASSTEDT SJ, 1987, GENET EPIDEMIOL, V4, P67, DOI 10.1002/gepi.1370040202; HUANG LS, 1990, J LIPID RES, V31, P71; KANNEL WB, 1979, ANN INTERN MED, V90, P85, DOI 10.7326/0003-4819-90-1-85; KARATHANASIS SK, 1985, P NATL ACAD SCI USA, V82, P6374, DOI 10.1073/pnas.82.19.6374; KESSLING AM, 1986, CLIN GENET, V29, P485; KESSLING AM, 1988, AM J HUM GENET, V42, P458; KESSLING AM, 1988, HUM GENET, V78, P237, DOI 10.1007/BF00291668; KESSLING AM, 1985, CLIN GENET, V28, P296; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LAUER RM, 1975, J PEDIATR-US, V86, P697, DOI 10.1016/S0022-3476(75)80353-2; LAW A, 1986, LANCET, V1, P1301; LAW SW, 1984, BIOCHEM BIOPH RES CO, V118, P934, DOI 10.1016/0006-291X(84)91485-2; LEWIS B, 1987, ATHEROSCLEROSIS BIOL, P409; MACIEJKO JJ, 1983, NEW ENGL J MED, V309, P385, DOI 10.1056/NEJM198308183090701; MAGILL P, 1982, EUR J CLIN INVEST, V12, P113, DOI 10.1111/j.1365-2362.1982.tb00947.x; MILLER GJ, 1975, LANCET, V1, P16; MILLER NE, 1987, LIPOPROTEINS ATHEROS, P111; MORRISON JA, 1979, METABOLISM, V28, P641, DOI 10.1016/0026-0495(79)90017-9; MYANT NB, 1989, ATHEROSCLEROSIS, V77, P193, DOI 10.1016/0021-9150(89)90081-6; NEWMAN WP, 1986, NEW ENGL J MED, V314, P138, DOI 10.1056/NEJM198601163140302; NORDOY A, 1990, ARTERIOSCLEROSIS, V10, P149, DOI 10.1161/01.ATV.10.2.149; OETTGEN P, 1986, NUCLEIC ACIDS RES, V13, P5571; ORCHARD TJ, 1981, INT J EPIDEMIOL, V10, P161, DOI 10.1093/ije/10.2.161; ORDOVAS JM, 1986, NEW ENGL J MED, V314, P671, DOI 10.1056/NEJM198603133141102; PAIRITZ G, 1988, AM J HUM GENET, V43, P311; PRIESTLEY L, 1985, NUCLEIC ACIDS RES, V13, P6789, DOI 10.1093/nar/13.18.6789; REES A, 1985, J CLIN INVEST, V76, P1090, DOI 10.1172/JCI112062; SHOULDERS CC, 1985, ATHEROSCLEROSIS, V58, P277, DOI 10.1016/0021-9150(85)90073-5; SNIDERMAN A, 1980, P NATL ACAD SCI-BIOL, V77, P604, DOI 10.1073/pnas.77.1.604; SOKAL RR, 1983, BIOMETRY, P583; SORIA LF, 1989, P NATL ACAD SCI USA, V86, P587, DOI 10.1073/pnas.86.2.587; SRINIVASAN SR, 1976, CIRCULATION, V54, P309, DOI 10.1161/01.CIR.54.2.309; TALMUD PJ, 1985, CYTOGENET CELL GENET, V40, P759; TALMUD PJ, 1987, ATHEROSCLEROSIS, V67, P81, DOI 10.1016/0021-9150(87)90267-X; TALMUD PJ, 1988, J CLIN INVEST, V82, P1803, DOI 10.1172/JCI113795; TAMIR I, 1981, J CHRON DIS, V34, P27, DOI 10.1016/0021-9681(81)90079-5; TIKKANEN MJ, 1990, CLIN GENET, V37, P327, DOI 10.1111/j.1399-0004.1990.tb03514.x; TYBJAERGHANSEN A, 1990, ATHEROSCLEROSIS, V80, P235, DOI 10.1016/0021-9150(90)90031-D; WHAYNE TF, 1981, ATHEROSCLEROSIS, V39, P411, DOI 10.1016/0021-9150(81)90026-5; WILE DB, 1989, ATHEROSCLEROSIS, V78, P9, DOI 10.1016/0021-9150(89)90153-6; XU C, 1989, HUM GENET, V82, P322; 1981, AM J EPIDEMIOL, V113, P338; 1987, AM J EPIDEMIOL, V126, P95	65	33	35	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1990	47	3					429	439						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX223	1975478				2022-12-18	WOS:A1990DX22300007
J	OKANO, Y; WANG, T; EISENSMITH, RC; GUTTLER, F; WOO, SLC				OKANO, Y; WANG, T; EISENSMITH, RC; GUTTLER, F; WOO, SLC			RECURRENT MUTATION IN THE HUMAN PHENYLALANINE-HYDROXYLASE GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									BAYLOR UNIV,HOWARD HUGHES MED INST,DEPT CELL BIOL,ONE BAYLOR PLAZA,HOUSTON,TX 77030; BAYLOR UNIV,INST MOLEC GENET,HOUSTON,TX 77030; JOHN F KENNEDY INST,GLOSTRUP,DENMARK	Baylor University; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor University					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD017711, R01HD017711] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-17711] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AULEHLASCHOLZ C, 1988, HUM GENET, V78, P353, DOI 10.1007/BF00291734; CHAKRABORTY R, 1987, HUM GENET, V76, P40; CHEN SH, 1989, HUM GENET, V81, P226; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; DAIGER SP, 1989, AM J HUM GENET, V45, P319; DAIGER SP, 1989, AM J HUM GENET, V45, P310; DILELLA AG, 1987, METHOD ENZYMOL, V152, P447; DILELLA AG, 1988, LANCET, V1, P497; DILELLA AG, 1987, NATURE, V327, P333, DOI 10.1038/327333a0; DILELLA AG, 1986, NATURE, V322, P799, DOI 10.1038/322799a0; DILELLA AG, 1986, BIOCHEMISTRY-US, V25, P743, DOI 10.1021/bi00352a001; GUTTLER F, 1987, J PEDIATR-US, V110, P68, DOI 10.1016/S0022-3476(87)80290-1; GUTTLER F, 1980, ACTA PAEDIATR SC   S, V280, P1; HERRMANN FH, 1988, CLIN GENET, V34, P176; HERTZBERG M, 1989, AM J HUM GENET, V44, P382; JOHN SWM, 1989, AM J HUM GENET, V45, P905; KWOK SCM, 1985, BIOCHEMISTRY-US, V24, P556, DOI 10.1021/bi00324a002; LEDLEY FD, 1988, J PEDIATR-US, V113, P463, DOI 10.1016/S0022-3476(88)80629-2; LICHTERKONECKI U, 1989, HUM GENET, V81, P373, DOI 10.1007/BF00283695; LICHTERKONECKI U, 1988, HUM GENET, V78, P347, DOI 10.1007/BF00291733; LICHTERKONECKI U, 1988, BIOCHEMISTRY-US, V27, P2881, DOI 10.1021/bi00408a032; LIDSKY AS, 1985, LANCET, V1, P549; LIDSKY AS, 1985, AM J HUM GENET, V37, P619; LYONNET S, 1989, AM J HUM GENET, V44, P511; MARVIT J, 1987, NUCLEIC ACIDS RES, V15, P5613, DOI 10.1093/nar/15.14.5613; OKANO Y, 1990, AM J HUM GENET, V46, P18; ORKIN SH, 1984, ANNU REV GENET, V18, P131; REY F, 1988, AM J HUM GENET, V43, P914; RIESS O, 1988, HUM GENET, V78, P343, DOI 10.1007/BF00291732; ROBSON KJH, 1982, P NATL ACAD SCI-BIOL, V79, P4701, DOI 10.1073/pnas.79.15.4701; SILVA AJ, 1988, CELL, V54, P145, DOI 10.1016/0092-8674(88)90546-6; SULLIVAN SE, 1989, AM J HUM GENET, V44, P652; WANG T, 1990, SOMAT CELL MOLEC GEN, V16, P85, DOI 10.1007/BF01650483; WONG C, 1986, P NATL ACAD SCI USA, V83, P6529, DOI 10.1073/pnas.83.17.6529; WONG T, 1989, AM J HUM GENET, V45, P675; WOO SLC, 1983, NATURE, V306, P151, DOI 10.1038/306151a0; WOO SLC, 1988, BIOCHEMISTRY-US, V28, P1	37	33	34	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1990	46	5					919	924						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DD896	1971144				2022-12-18	WOS:A1990DD89600009
J	BIEBER, FR; HOFFMAN, EP; AMOS, JA				BIEBER, FR; HOFFMAN, EP; AMOS, JA			DYSTROPHIN ANALYSIS IN DUCHENNE MUSCULAR-DYSTROPHY - USE IN FETAL DIAGNOSIS AND IN GENETIC-COUNSELING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HARVARD UNIV, SCH MED, DEPT PATHOL, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DEPT PEDIAT, BOSTON, MA 02115 USA; MASSACHUSETTS GEN HOSP, CHILDRENS SERV, BOSTON, MA 02114 USA; MASSACHUSETTS GEN HOSP, GENET UNIT, BOSTON, MA 02114 USA; CHILDRENS HOSP MED CTR, HOWARD HUGHES MED INST, BOSTON, MA 02115 USA; EUNICE KENNEDY SHRIVER CTR MENTAL RETARDAT INC, DIV GENET, WALTHAM, MA USA; EUNICE KENNEDY SHRIVER CTR MENTAL RETARDAT INC, DEPT MOLEC NEUROGENET, WALTHAM, MA USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	BIEBER, FR (corresponding author), BRIGHAM & WOMENS HOSP, DEPT PATHOL, 75 FRANCIS ST, BOSTON, MA 02115 USA.		Bieber, Frederick/W-7764-2019	Hoffman, Eric/0000-0001-6470-5139; Bieber, Frederick/0000-0002-2120-9829	PHS HHS [251003-03-0] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AMOS JA, 1984, BIOCHIM BIOPHYS ACTA, V782, P247, DOI 10.1016/0167-4781(84)90059-9; ARAHATA K, 1988, NATURE, V333, P861, DOI 10.1038/333861a0; ARAHATA K, IN PRESS P NATL ACAD; BONILLA E, 1988, CELL, V54, P447, DOI 10.1016/0092-8674(88)90065-7; DARRAS BT, 1988, AM J HUM GENET, V43, P620; Dubowitz V., 1973, MUSCLE BIOPSY MODERN; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; HEJTMANCIK JF, 1989, MOL GENETICS DISEASE, P162; HOFFMAN EP, 1989, NEURON, V2, P1019, DOI 10.1016/0896-6273(89)90226-2; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HOFFMAN EP, 1988, NEW ENGL J MED, V318, P1363, DOI 10.1056/NEJM198805263182104; HOFFMAN EP, 1988, NEURON, V1, P411, DOI 10.1016/0896-6273(88)90191-2; HOFFMAN EP, IN PRESS NEUROLOGY; HOFKER MH, 1985, HUM GENET, V70, P148, DOI 10.1007/BF00273073; KAPRIELIAN Z, 1987, DEV BIOL, V124, P490, DOI 10.1016/0012-1606(87)90502-1; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; KOENIG M, IN PRESS AM J HUM GE; LEV AA, 1987, J BIOL CHEM, V262, P15817; MILLER JB, 1985, J CELL BIOL, V101, P1643, DOI 10.1083/jcb.101.5.1643; MIRANDA AF, 1988, AM J PATHOL, V132, P410; MONACO AP, 1985, NATURE, V316, P842, DOI 10.1038/316842a0; MONACO AP, 1988, ADV HUM GENET, V17, P61; Murphy EA, 1975, PRINCIPLES GENETIC C; PATEL K, 1988, J NEUROL SCI, V87, P315, DOI 10.1016/0022-510X(88)90256-0; RAY PN, 1985, NATURE, V318, P672, DOI 10.1038/318672a0; ZATZ M, 1989, AM J MED GENET, V32, P407, DOI 10.1002/ajmg.1320320328	26	33	33	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1989	45	3					362	367						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AN879	2672800				2022-12-18	WOS:A1989AN87900004
J	HU, XY; BURGHES, AHM; BULMAN, DE; RAY, PN; WORTON, RG				HU, XY; BURGHES, AHM; BULMAN, DE; RAY, PN; WORTON, RG			EVIDENCE FOR MUTATION BY UNEQUAL SISTER CHROMATID EXCHANGE IN THE DUCHENNE MUSCULAR-DYSTROPHY GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HOSP SICK CHILDREN,DEPT GENET,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA; HOSP SICK CHILDREN,RES INST,TORONTO M5G 1X8,ONTARIO,CANADA; UNIV TORONTO,DEPT MED GENET,TORONTO M5S 1A1,ONTARIO,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto				Burghes, Arthur/0000-0001-9031-1555				ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; BAKKER E, 1987, NATURE, V329, P554, DOI 10.1038/329554a0; BERTELSON CJ, 1986, J MED GENET, V23, P531, DOI 10.1136/jmg.23.6.531; BURGHES AHM, 1987, NATURE, V328, P434, DOI 10.1038/328434a0; BURGHES AHM, UNPUB AM J HUM GENET; DARRAS BT, 1987, NATURE, V329, P556, DOI 10.1038/329556a0; DENDUNNEN JT, 1987, NATURE, V329, P640, DOI 10.1038/329640a0; DORKINS H, 1985, HUM GENET, V71, P103, DOI 10.1007/BF00283362; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FORREST SM, 1987, LANCET, V2, P1294; HEARTLEIN MW, 1988, MOL CELL BIOL, V8, P3611, DOI 10.1128/MCB.8.9.3611; HOFKER MH, 1985, HUM GENET, V70, P148, DOI 10.1007/BF00273073; HORSTHEMKE B, 1987, EUR J BIOCHEM, V164, P77, DOI 10.1111/j.1432-1033.1987.tb10995.x; HU X-Y, 1987, American Journal of Human Genetics, V41, pA100; HU XY, 1988, J MED GENET, V25, P369, DOI 10.1136/jmg.25.6.369; JEFFREYS AJ, 1982, NATURE, V296, P9, DOI 10.1038/296009a0; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; KURNIT DM, 1979, HUM GENET, V47, P169, DOI 10.1007/BF00273199; LANMAN JT, 1987, AM J HUM GENET, V41, P138; LEHRMAN MA, 1985, SCIENCE, V227, P140, DOI 10.1126/science.3155573; LEHRMAN MA, 1987, CELL, V48, P827, DOI 10.1016/0092-8674(87)90079-1; MALHOTRA SB, 1988, SCIENCE, V242, P755, DOI 10.1126/science.3055295; MONACO AP, 1987, HUM GENET, V75, P221, DOI 10.1007/BF00281063; MONACO AP, 1985, NATURE, V316, P842, DOI 10.1038/316842a0; RAY PN, 1985, NATURE, V318, P672, DOI 10.1038/318672a0; SMITH GP, 1976, SCIENCE, V191, P528, DOI 10.1126/science.1251186; SZOSTAK JW, 1980, NATURE, V284, P426, DOI 10.1038/284426a0; VOGEL F, 1986, HUMAN GENETICS PROBL, P168; WAPENAAR M C, 1988, Genomics, V2, P101, DOI 10.1016/0888-7543(88)90090-0; WEATHERALL DJ, 1979, CELL, V16, P467, DOI 10.1016/0092-8674(79)90022-9; WILLARD HF, 1987, TRENDS GENET, V3, P192, DOI 10.1016/0168-9525(87)90232-0; WINTER RM, 1982, AM J MED GENET, V12, P437, DOI 10.1002/ajmg.1320120407; WOOD S, 1988, HUM GENET, V78, P282, DOI 10.1007/BF00291677; WORTON RG, 1988, INT REV NEUROBIOL, V29, P1, DOI 10.1016/S0074-7742(08)60083-5	35	33	33	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1989	44	6					855	863						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	U8549	2567117				2022-12-18	WOS:A1989U854900011
J	VANDERPLOEG, AT; HOEFSLOOT, LH; HOOGEVEENWESTERVELD, M; PETERSEN, EM; REUSER, AJJ				VANDERPLOEG, AT; HOEFSLOOT, LH; HOOGEVEENWESTERVELD, M; PETERSEN, EM; REUSER, AJJ			GLYCOGENESIS TYPE-II - PROTEIN AND DNA ANALYSIS IN 5 SOUTH-AFRICAN FAMILIES FROM VARIOUS ETHNIC-ORIGINS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CAPE TOWN,DEPT HUMAN GENET,CAPE TOWN,SOUTH AFRICA	University of Cape Town	VANDERPLOEG, AT (corresponding author), ERASMUS UNIV,DEPT CELL BIOL & GENET,POB 1738,3000 DR ROTTERDAM,NETHERLANDS.							AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BLOM W, 1983, CLIN CHIM ACTA, V134, P221, DOI 10.1016/0009-8981(83)90200-0; BONNICI F, 1980, S AFR MED J, V58, P860; ELFERINK RPJO, 1985, EUR J BIOCHEM, V153, P55, DOI 10.1111/j.1432-1033.1985.tb09266.x; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GALJAARD H, 1980, GENETIC METABOLIC DI; HASILIK A, 1980, J BIOL CHEM, V255, P4946; HASILIK A, 1980, J BIOL CHEM, V255, P4937; HERS HG, 1963, BIOCHEM J, V86, P11, DOI 10.1042/bj0860011; HERS HG, 1973, LYSOSOMES STORAGE DI, P197; HOEFSLOOT LH, 1988, EMBO J, V7, P1697, DOI 10.1002/j.1460-2075.1988.tb02998.x; HOWELL RR, 1983, METABOLIC BASIS INHE, P141; KOSTER JF, 1972, EUR J CLIN INVEST, V2, P467, DOI 10.1111/j.1365-2362.1972.tb00678.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maniatis T., 1982, MOL CLONING; MARTINIUK F, 1986, P NATL ACAD SCI USA, V83, P9641, DOI 10.1073/pnas.83.24.9641; REUSER AJJ, 1978, AM J HUM GENET, V30, P132; REUSER AJJ, 1985, J BIOL CHEM, V260, P8336; REUSER AJJ, 1987, J CLIN INVEST, V79, P1689, DOI 10.1172/JCI113008; REUSER AJJ, 1982, FEBS LETT, V146, P361, DOI 10.1016/0014-5793(82)80953-8; RIGAUD G, 1987, NUCLEIC ACIDS RES, V15, P857, DOI 10.1093/nar/15.2.857; SEWELL AC, 1979, CLIN CHIM ACTA, V92, P411, DOI 10.1016/0009-8981(79)90221-3; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANDERHORST GTJ, 1987, BIOCHIM BIOPHYS ACTA, V910, P123, DOI 10.1016/0167-4781(87)90064-9; VANDERPLOEG, 1988, PEDIATR RES, V24, P90; VANDERPLOEG AT, 1988, J NEUROL, V235, P392; VANDERPLOEG AT, 1987, J NEUROL SCI, V79, P327, DOI 10.1016/0022-510X(87)90239-5	29	33	34	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1989	44	6					787	793						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	U8549	2658562				2022-12-18	WOS:A1989U854900002
J	LLOP, E; ROTHHAMMER, F; ACUNA, M; APT, W				LLOP, E; ROTHHAMMER, F; ACUNA, M; APT, W			HLA ANTIGENS IN CARDIOMYOPATHIC CHILEAN CHAGASICS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CHILE,DEPT MED EXPTL,UNIDAD PARASITOL,SANTIAGO 7,CHILE	Universidad de Chile	LLOP, E (corresponding author), UNIV CHILE,FAC MED,DEPT BIOL CELULAR & GENET,CASILLA 70061,SANTIAGO 7,CHILE.							APT W, 1983, J TROP MED HYG, V86, P217; ARNAIZVILLENA A, 1981, HUM GENET, V58, P344, DOI 10.1007/BF00294935; Arturo A C, 1986, Bull Pan Am Health Organ, V20, P245; Bernstein F., 1931, COMITATO ITALIANO ST, P227; HAAS EJC, 1985, HUM HERED, V35, P306, DOI 10.1159/000153568; Hidalgo J., 1972, CULTURAS PROTOHISTOR; Kierszenbaum F, 1985, Parasitol Today, V1, P4, DOI 10.1016/0169-4758(85)90098-5; MATTIUZ PL, 1970, HISTOCOMPATIBILITY T, P193; Neghme A, 1982, CRECES, V3, P23; Nunez L., 1983, OCUPACION PALEOINDIO; ROTHHAMMER F, 1985, AM J PHYS ANTHROPOL, V68, P495, DOI 10.1002/ajpa.1330680405; Rothhammer F, 1986, Parasitol Today, V2, P76, DOI 10.1016/0169-4758(86)90160-2; ROTHHAMMER F, 1987, HUM GENET, P590; SCHOFIELD C J, 1982, Ecology of Disease, V1, P117; SVEJGAAR.A, 1974, TISSUE ANTIGENS, V4, P95; TERASAKI PI, 1964, NATURE, V204, P998, DOI 10.1038/204998b0; TIWARI JL, 1985, HLA DISEASE ASS	17	33	33	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1988	43	5					770	773						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q9336	3189340				2022-12-18	WOS:A1988Q933600026
J	DARRAS, BT; FRANCKE, U				DARRAS, BT; FRANCKE, U			MYOPATHY IN COMPLEX GLYCEROL KINASE-DEFICIENCY PATIENTS IS DUE TO 3' DELETIONS OF THE DYSTROPHIN GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									YALE UNIV,SCH MED,DEPT HUMAN GENET,POB 3333,NEW HAVEN,CT 06510	Yale University				Darras, Basil/0000-0002-1536-8145				DARRAS BT, 1987, NEW ENGL J MED, V316, P985, DOI 10.1056/NEJM198704163161604; DARRAS BT, 1988, AM J MED GENET, V29, P713, DOI 10.1002/ajmg.1320290341; FRANCKE U, 1987, AM J HUM GENET, V40, P212; FRANKE U, 1986, HUM GENET, P201; GUGGENHEIM MA, 1980, ANN NEUROL, V7, P441, DOI 10.1002/ana.410070509; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; KOHLSCHUTTER A, 1987, EUR J PEDIATR, V146, P575, DOI 10.1007/BF02467357; SAITO F, 1986, CLIN GENET, V29, P92; van Ommen G J, 1987, Genomics, V1, P329, DOI 10.1016/0888-7543(87)90032-2; WISE JE, 1987, AM J DIS CHILD, V141, P744, DOI 10.1001/archpedi.1987.04460070046020	11	33	33	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1988	43	2					126	130						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	P6084	2840818				2022-12-18	WOS:A1988P608400003
J	LITT, M; BUROKER, NE; KONDOLEON, S; DOUGLASS, J; LISTON, D; SHEEHY, R; MAGENIS, RE				LITT, M; BUROKER, NE; KONDOLEON, S; DOUGLASS, J; LISTON, D; SHEEHY, R; MAGENIS, RE			CHROMOSOMAL LOCALIZATION OF THE HUMAN PROENKEPHALIN AND PRODYNORPHIN GENES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									OREGON HLTH SCI UNIV,DEPT MED GENET,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,VOLLUM INST ADV BIOMED RES,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DIV CRIPPLED CHILDRENS,PORTLAND,OR 97201	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	LITT, M (corresponding author), OREGON HLTH SCI UNIV,DEPT BIOCHEM,PORTLAND,OR 97201, USA.				NIGMS NIH HHS [R01-GM32500] Funding Source: Medline; CIT NIH HHS [MCT920] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032500] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); CIT NIH HHS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKIL H, 1984, ANNU REV NEUROSCI, V7, P223, DOI 10.1146/annurev.ne.07.030184.001255; BAAS F, 1985, HUM GENET, V69, P138, DOI 10.1007/BF00293284; BREAKEFIELD XO, 1987, ANNU REV NEUROSCI, V10, P535; BUFTON L, 1986, AM J HUM GENET, V38, P447; BUROKER NE, 1986, HUM GENET, V72, P86, DOI 10.1007/BF00278825; CICERO TJ, 1980, FED PROC, V39, P2551; CIVELLI O, 1985, P NATL ACAD SCI USA, V82, P4291, DOI 10.1073/pnas.82.12.4291; COMB M, 1982, P NATL ACAD SCI-BIOL, V79, P360, DOI 10.1073/pnas.79.2.360; COMB M, 1982, NATURE, V295, P663, DOI 10.1038/295663a0; COMB M, 1983, DNA-J MOLEC CELL BIO, V2, P213, DOI 10.1089/dna.1983.2.213; DOUGLASS J, 1984, ANNU REV BIOCHEM, V53, P665; DOUGLASS J, 1987, ENDOCRINOLOGY, V120, P707, DOI 10.1210/endo-120-2-707; FEDER J, 1985, AM J HUM GENET, V37, P286; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; HALUSKA FG, 1987, NUCLEIC ACIDS RES, V15, P865, DOI 10.1093/nar/15.2.865; HOLADAY JW, 1983, ANNU REV PHARMACOL, V23, P541, DOI 10.1146/annurev.pa.23.040183.002545; HORIKAWA S, 1983, NATURE, V306, P611, DOI 10.1038/306611a0; KAKIDANI H, 1982, NATURE, V298, P245, DOI 10.1038/298245a0; KANAMATSU T, 1986, J NEUROSCI, V6, P644; LAWN RM, 1978, CELL, V15, P1157, DOI 10.1016/0092-8674(78)90043-0; LITT M, 1985, P NATL ACAD SCI USA, V82, P6206, DOI 10.1073/pnas.82.18.6206; NAKANISHI S, 1979, NATURE, V278, P423, DOI 10.1038/278423a0; OWERBACH D, 1981, SOMAT CELL GENET, V7, P359, DOI 10.1007/BF01538860; PLOTNIKOFF NP, 1983, INT J IMMUNOPHARMACO, V5, P437, DOI 10.1016/0192-0561(83)90020-6; PRZEWLOCKI R, 1979, BRAIN RES, V174, P357, DOI 10.1016/0006-8993(79)90862-X; PUIG MM, 1977, SCIENCE, V195, P419, DOI 10.1126/science.188138; SEALEY PG, 1985, NUCLEIC ACIDS RES, V13, P1905, DOI 10.1093/nar/13.6.1905; SIMON P, 1987, NUCLEIC ACIDS RES, V15, P373, DOI 10.1093/nar/15.1.373; WOOD S, 1986, AM J HUM GENET, V39, P744; ZABEL BU, 1982, AM J HUM GENET, V33, pA153	30	33	34	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1988	42	2					327	334						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M3133	2893547				2022-12-18	WOS:A1988M313300015
J	SPECTOR, EB; RICE, SCH; KERN, RM; HENDRICKSON, R; CEDERBAUM, SD				SPECTOR, EB; RICE, SCH; KERN, RM; HENDRICKSON, R; CEDERBAUM, SD			COMPARISON OF ARGINASE ACTIVITY IN RED-BLOOD-CELLS OF LOWER MAMMALS, PRIMATES, AND MAN - EVOLUTION TO HIGH-ACTIVITY IN PRIMATES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF LOS ANGELES,CTR HLTH SCI,DEPT PEDIAT,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,CTR HLTH SCI,MENTAL RETARDAT RES CTR,LOS ANGELES,CA 90024; UNIV CALIF DAVIS,REG PRIMATE CTR,DAVIS,CA 95616	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Davis	SPECTOR, EB (corresponding author), UNIV CALIF LOS ANGELES,CTR HLTH SCI,DEPT PSYCHIAT,LOS ANGELES,CA 90024, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD006576] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-11298, HD-05615, HD-06576] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BARY W, 1970, Q J EXP PHYSL, V55, P64; CEDERBAUM SD, 1979, PEDIATR RES, V13, P827, DOI 10.1203/00006450-197907000-00007; DIZIKES G J, 1984, American Journal of Human Genetics, V36, p135S; MICHELS VV, 1978, CLIN GENET, V13, P61; OSAWA W, 1980, TERATOLOGY, V22, pA29; SHIH VE, 1972, PEDIATR RES, V6, P548, DOI 10.1203/00006450-197206000-00003; SPECTOR EB, 1980, AM J HUM GENET, V32, P79; SPECTOR EB, 1983, PEDIATR RES, V17, P941, DOI 10.1203/00006450-198312000-00003; TERASAKI K, 1980, BIOCHEM GENET, V18, P829, DOI 10.1007/BF00500116; Wintrobe MM, 1974, CLIN HEMATOLOGY, P114	10	33	33	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1985	37	6					1138	1145						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AXE36	3936352				2022-12-18	WOS:A1985AXE3600010
J	OLAISEN, B; GEDDEDAHL, T; TEISBERG, P; THORSBY, E; SIVERTS, A; JONASSEN, R; WILHELMY, MC				OLAISEN, B; GEDDEDAHL, T; TEISBERG, P; THORSBY, E; SIVERTS, A; JONASSEN, R; WILHELMY, MC			A STRUCTURAL LOCUS FOR COAGULATION FACTOR-XIIIA (F13A) IS LOCATED DISTAL TO THE HLA REGION ON CHROMOSOME 6P IN MAN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Note									NATL HOSP NORWAY,TISSUE TYPING LAB,OSLO,NORWAY; RADIUMHOSP,NHIK,DEPT GENET,OSLO,NORWAY	University of Oslo; National Hospital Norway; University of Oslo	OLAISEN, B (corresponding author), UNIV OSLO,RIKSHOSP,INST FORENS MED,OSLO,NORWAY.							BOARD PG, 1979, AM J HUM GENET, V31, P116; BOHN H, 1972, BLUT, V25, P235, DOI 10.1007/BF01632188; DEGROUCH.J, 1968, AM J DIS CHILD, V115, P93, DOI 10.1001/archpedi.1968.02100010095019; GEDDEDAHL T, 1984, CYTOGENET CELL GENET, V37, P475; LEACH R, 1984, CYTOGENET CELL GENET, V37, P521; Lorand L, 1980, Prog Hemost Thromb, V5, P245; MORTON NE, 1982, HUM GENET, V62, P266, DOI 10.1007/BF00333534; ONEILL GJ, 1978, P NATL ACAD SCI USA, V75, P5165, DOI 10.1073/pnas.75.10.5165; PEARSON PL, 1982, CYTOGENET CELL GENET, V32, P309; ROBSON EB, 1984, CYTOGENET CELL GENET, V37, P47, DOI 10.1159/000132004; SCHWARTZ ML, 1973, J BIOL CHEM, V248, P1395; WEITKAMP LR, 1982, CYTOGENET CELL GENET, V32, P130, DOI 10.1159/000131693; WHITEHOUSE DB, 1983, ANN HUM GENET, V47, P1, DOI 10.1111/j.1469-1809.1983.tb00964.x	13	33	35	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1985	37	1					215	220						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AGY57	2858156				2022-12-18	WOS:A1985AGY5700022
J	HOOK, EB				HOOK, EB			DOWN SYNDROME RATES AND RELAXED SELECTION AT OLDER MATERNAL AGES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNION UNIV ALBANY MED COLL,DEPT PEDIAT,ALBANY,NY 12208	Albany Medical College	HOOK, EB (corresponding author), NEW YORK STATE DEPT HLTH,BUR MATERNAL & CHILD HLTH,ALBANY,NY 12237, USA.							AYME S, 1982, AM J HUM GENET, V34, P558; BORICELLI L, 1982, OBSTET GYNECOL S, V6, pS13; DELMAZO J, 1982, HUM GENET, V62, P316, DOI 10.1007/BF00304546; ERICKSON JD, 1978, ANN HUM GENET, V41, P289, DOI 10.1111/j.1469-1809.1978.tb01896.x; HASSOLD T, 1980, ANN HUM GENET, V44, P151, DOI 10.1111/j.1469-1809.1980.tb00955.x; HASSOLD T, 1980, ANN HUM GENET, V44, P29, DOI 10.1111/j.1469-1809.1980.tb00943.x; Hook E B, 1977, Birth Defects Orig Artic Ser, V13, P123; HOOK EB, 1983, AM J HUM GENET, V35, P110; HOOK EB, 1978, AM J HUM GENET, V30, P19; HOOK EB, 1981, TRISOMY, V21, P24; MAGENIS RE, 1981, TRISOMY, V21, P77; MANNING CH, 1981, HUM GENET, V59, P101, DOI 10.1007/BF00293054; MARTIN RH, 1982, AM J HUM GENET, V34, P459; MATSUNAGA E, 1972, ANN HUM GENET, V36, P209, DOI 10.1111/j.1469-1809.1972.tb00770.x; MATTEI JF, 1980, J MED GENET, V17, P368, DOI 10.1136/jmg.17.5.368; MIKKELSEN M, 1980, ANN HUM GENET, V44, P17, DOI 10.1111/j.1469-1809.1980.tb00942.x; SVED JA, 1981, TRISOMY, V21, P95; WAGENBICHLER P, 1976, HUM GENET, V32, P13, DOI 10.1007/BF00569971; WARBURTON D, 1980, HUMAN EMBRYONIC FETA, P261; 1981, STATISTICAL REPORT 1, P17	20	33	33	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	6					1307	1313						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RU705	6228139				2022-12-18	WOS:A1983RU70500025
J	LATHROP, GM; HOOPER, AB; HUNTSMAN, JW; WARD, RH				LATHROP, GM; HOOPER, AB; HUNTSMAN, JW; WARD, RH			EVALUATING PEDIGREE DATA .1. THE ESTIMATION OF PEDIGREE ERROR IN THE PRESENCE OF MARKER MISTYPING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV BRITISH COLUMBIA,DEPT MED GENET,VANCOUVER V6T 1W5,BC,CANADA; UNIV AUCKLAND,DEPT ANTHROPOL,AUCKLAND,NEW ZEALAND	University of British Columbia; University of Auckland	LATHROP, GM (corresponding author), UNIV WASHINGTON,BIOMATH GRP,SEATTLE,WA 98195, USA.				NHLBI NIH HHS [R01-HL20159] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ASHTON GC, 1980, AM J HUM GENET, V32, P601; BOYD WC, 1954, AM J HUM GENET, V6, P426; CANNINGS C, 1976, ADV APPL PROBAB, V8, P622, DOI 10.2307/1425918; CHAKRABO.R, 1974, AM J HUM GENET, V26, P477; Cotterman CW, 1941, SCI MON, V53, P227; COTTERMAN CW, 1951, AM J HUM GENET, V3, P362; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; FISHER RA, 1951, HEREDITY, V5, P95, DOI 10.1038/hdy.1951.5; Fisher RA, 1940, ANN EUGENIC, V10, P160, DOI 10.1111/j.1469-1809.1940.tb02245.x; HOOPER A, 1973, J POLYNESIAN SOC, V82, P366; LALOUEL JM, 1980, HUM HERED, V30, P320, DOI 10.1159/000153150; LANGANEY A, 1974, GENEALOGICAL MATH, P127; LATHROP GM, UNPUB EVALUATING PED, V2; LATHROP GM, 1980, THESIS U WASHINGTON; LATHROP GM, UNPUB EVALUATING PED, V3; Li C, 1961, HUMAN GENETICS PRINC; MACCLUER JW, 1963, AM J HUM GENET, V15, P191; NEEL JV, 1964, AM J HUM GENET, V16, P52; NEEL JV, 1975, AM J PHYS ANTHROPOL, V42, P25, DOI 10.1002/ajpa.1330420105; PERITZ E, 1972, AM J HUM GENET, V24, P46; POTTHOFF BF, 1965, AM J HUM GENET, V17, P480; PRIOR IAM, 1974, INT J EPIDEMIOL, V3, P225, DOI 10.1093/ije/3.3.225; SALMON DB, 1978, AM J HUM GENET, V30, P65; SCHACHT LE, 1963, 2ND P INT C HUM GEN, P894; SELVIN S, 1976, HUM HERED, V30, P89; SING CF, 1971, AM J HUM GENET, V23, P164; THOMPSON EA, 1975, ANN HUM GENET, V39, P173, DOI 10.1111/j.1469-1809.1975.tb00120.x; THOMPSON EA, 1976, SOC SCI INFORM, V15, P477, DOI 10.1177/053901847601500214; VALENTIN J, 1980, AM J HUM GENET, V32, P420; WARD RH, 1980, POPULATION STRUCTURE, P301; WEINER AS, 1931, Z INDUCT ABSTAMM VER, V59, P227	31	33	38	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	2					241	262						22	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QJ265	6573130				2022-12-18	WOS:A1983QJ26500008
J	JUBERG, RC; HANEY, NR; STALLARD, R				JUBERG, RC; HANEY, NR; STALLARD, R			NEW DELETION SYNDROME - 1Q43	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									WRIGHT STATE UNIV,SCH MED,DEPT PEDIATR,DAYTON,OH 45404	Wright State University Dayton	JUBERG, RC (corresponding author), CHILDRENS MED CTR,DEPT MED GENET & BIRTH DEFECTS,DAYTON,OH 45404, USA.							ANDRLE M, 1978, HUM GENET, V41, P115; DIGNAN PSJ, 1979, HUM GENET, V48, P151, DOI 10.1007/BF00286898; FRIEDRICH U, 1973, CLIN GENET, V4, P333; KESSEL E, 1978, HUM GENET, V42, P333, DOI 10.1007/BF00291316; KESSLER KK, 1979, AM J HUM GENET, V31, pA100; Mankinen C B, 1976, Birth Defects Orig Artic Ser, V12, P131; MOLINA M, 1978, AN ESP PEDIATR, V11, P729; SMITH DW, 1976, RECOGNIZABLE PATTERN, P82; STENCHEVER MA, 1977, AM J OBSTET GYNECOL, V127, P143, DOI 10.1016/S0002-9378(16)33240-9	9	33	33	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1981	33	3					455	463						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LT725	7246546				2022-12-18	WOS:A1981LT72500013
J	PEMBREY, ME; PERRINE, RP; WOOD, WG; WEATHERALL, DJ				PEMBREY, ME; PERRINE, RP; WOOD, WG; WEATHERALL, DJ			SICKLE-BETA 0 THALASSEMIA IN EASTERN SAUDI-ARABIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									GUYS HOSP,SCH MED,DEPT MED,LONDON SE1 9RT,ENGLAND; ARABIAN AMER OIL CO,DHAHRAN,SAUDI ARABIA; UNIV OXFORD,NUFFIELD DEPT CLIN MED,MRC,MOLEC HAEMATOL UNIT,OXFORD,ENGLAND	Guy's & St Thomas' NHS Foundation Trust; Saudi Aramco; University of Oxford	PEMBREY, ME (corresponding author), GUYS HOSP,SCH MED,PAEDIAT RES UNIT,LONDON SE1 9RT,ENGLAND.							ALTER BP, 1976, BLOOD, V48, P843; BETKE K, 1959, NATURE, V184, P1877, DOI 10.1038/1841877a0; CLARKE BJ, 1978, BLOOD             S1, V52, P201; DESIMONE J, 1978, P NATL ACAD SCI USA, V75, P2937, DOI 10.1073/pnas.75.6.2937; DOVER GJ, 1979, J CLIN INVEST, V63, P173, DOI 10.1172/JCI109286; HUISMAN THJ, 1977, HEMOGLOBINS TECHNIQU; KIDOGUCHI K, 1978, BLOOD, V52, P1115; PAPAYANNOPOULOU T, 1978, SCIENCE, V199, P1349, DOI 10.1126/science.628844; PAPAYANNOPOULOU T, 1976, P NATL ACAD SCI USA, V73, P2033, DOI 10.1073/pnas.73.6.2033; PAPAYANNOPOULOU T, 1977, P NATL ACAD SCI USA, V74, P2923, DOI 10.1073/pnas.74.7.2923; PEMBREY ME, 1975, BRIT J HAEMATOL, V29, P221, DOI 10.1111/j.1365-2141.1975.tb01816.x; PEMBREY ME, 1972, J CLIN PATHOL, V25, P738, DOI 10.1136/jcp.25.8.738; PEMBREY ME, 1978, BRIT J HAEMATOL, V40, P415, DOI 10.1111/j.1365-2141.1978.tb05813.x; PEMBREY ME, 1977, THESIS U LONDON; PERRINE RP, 1978, ANN INTERN MED, V88, P1, DOI 10.7326/0003-4819-88-1-1; PERRINE RP, 1972, LANCET, V2, P1163; PERRINE RP, UNPUBLISHED; SERJEANT GR, 1979, BRIT J HAEMATOL, V41, P83, DOI 10.1111/j.1365-2141.1979.tb03684.x; SERJEANT GR, 1973, BRIT J HAEMATOL, V24, P19, DOI 10.1111/j.1365-2141.1973.tb05723.x; SEWELL A, 1978, RED CELL, P93; SHERIDAN BL, 1976, BRIT J HAEMATOL, V32, P487, DOI 10.1111/j.1365-2141.1976.tb00952.x; STAMATOYANNOPOU.G, 1979, P C CELLULAR MOL REG; STAMATOYANNOPOULOS G, 1975, BLOOD, V46, P683; WEATHERALL DJ, 1974, CLIN HAEMATOL, V3, P467; Weatherall DJ, 1972, THALASSAEMIA SYNDROM; WOOD WG, 1977, BRIT J HAEMATOL, V36, P461, DOI 10.1111/j.1365-2141.1977.tb00986.x; WOOD WG, 1975, BLOOD, V46, P671; WOOD WG, 1976, NATURE, V264, P247, DOI 10.1038/264247a0; 1978, LANCET, V1, P971	29	33	33	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1980	32	1					26	41						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JH296	6153864				2022-12-18	WOS:A1980JH29600004
J	JACOBS, PA; MATSUYAMA, AM; BUCHANAN, IM; WILSON, C				JACOBS, PA; MATSUYAMA, AM; BUCHANAN, IM; WILSON, C			LATE REPLICATING X-CHROMOSOMES IN HUMAN TRIPLOIDY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											JACOBS, PA (corresponding author), UNIV HAWAII,JOHN A BURNS SCH MED,DEPT ANAT & REPROD BIOL,HONOLULU,HI 96822, USA.							BOUE JG, 1970, PRESSE MED, V78, P635; CARR DH, 1971, J MED GENET, V8, P164, DOI 10.1136/jmg.8.2.164; COUILLIN P, 1978, HUM GENET, V41, P35; FRYNS JP, 1977, HUM GENET, V38, P147, DOI 10.1007/BF00527396; HARNDEN DG, 1961, LANCET, V2, P488; HASSOLD TJ, 1978, ANN HUM GENET, V41, P443, DOI 10.1111/j.1469-1809.1978.tb00914.x; HENRIKSSON P, 1974, ACTA PAEDIATR SCAND, V63, P447, DOI 10.1111/j.1651-2227.1974.tb04827.x; Jacobs P., 1978, GENETIC EPIDEMIOLOGY, P463; JACOBS PA, 1978, ANN HUM GENET, V42, P49, DOI 10.1111/j.1469-1809.1978.tb00930.x; JUNIEN C, 1976, HUM GENET, V33, P61, DOI 10.1007/BF00447287; KLINGER HP, 1967, CYTOGENETICS, V6, P1, DOI 10.1159/000129926; LEISTI J, 1970, SCANDINAVIAN J CLI S, V25, P113; NIEBUHR E, 1972, ACTA PAEDIATR SCAND, V61, P203, DOI 10.1111/j.1651-2227.1972.tb15925.x; NIEBUHR E, 1974, HUMANGENETIK, V21, P103, DOI 10.1007/BF00281030; PRATS J, 1971, HELVETICA PAEDIATRIC, V2, P164; SCHMICKEL RD, 1971, J PEDIATR-US, V79, P97, DOI 10.1016/S0022-3476(71)80065-3; SCHMID W, 1967, CYTOGENETICS, V6, P145, DOI 10.1159/000129935; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; THERKELS.AJ, 1966, EXP CELL RES, V44, P636, DOI 10.1016/0014-4827(66)90472-1; WAKE N, 1976, NATURE, V262, P580, DOI 10.1038/262580a0; WEAVER DD, 1975, HUMANGENETIK, V28, P39, DOI 10.1007/BF00272480; WEST JD, 1977, CELL, V12, P873, DOI 10.1016/0092-8674(77)90151-9; WILLARD HF, 1976, AM J HUM GENET, V28, P213; WILLARD HF, 1977, AM J HUM GENET, V29, pA114	24	33	34	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1979	31	4					446	457						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HM222	484553				2022-12-18	WOS:A1979HM22200006
J	REED, T; EVANS, MM; NORTON, JA; CHRISTIAN, JC				REED, T; EVANS, MM; NORTON, JA; CHRISTIAN, JC			MATERNAL EFFECTS ON FINGERTIP DERMATOGLYPHICS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									INDIANA UNIV,SCH MED,DEPT PSYCHIAT,BIOSTAT GRP,INDIANAPOLIS,IN 46223	Indiana University System; Indiana University-Purdue University Indianapolis	REED, T (corresponding author), INDIANA UNIV,SCH MED,DEPT MED GENET,INDIANAPOLIS,IN 46223, USA.							BONNE B, 1971, HUM HERED, V21, P478, DOI 10.1159/000152440; Christian J C, 1978, Birth Defects Orig Artic Ser, V14, P167; CHRISTIAN JC, 1977, AM J HUM GENET, V29, P462; CHRISTIAN JC, 1976, ACTA GENET MED GEMEL, V25, P145, DOI 10.1017/S000156600001401X; CHRISTIAN JC, 1974, AM J HUM GENET, V26, P154; CHRISTIAN JC, 1976, AM J HUM GENET, V28, P174; CHRISTIAN JC, 1976, EXCERPTA MEDICA  397, P28; CHRISTIAN JC, 1975, CLIN RES, V22, pA372; COREY LA, 1976, AM J HUM GENET, V28, P433; HOLT SB, 1968, GENETICS DERMAL RIDG; LOESCH D, 1971, ANN HUM GENET, V34, P277, DOI 10.1111/j.1469-1809.1971.tb00240.x; MATSUDA E, 1973, JPN J HUM GENET, V17, P293; MI MP, 1975, HUM HERED, V25, P249, DOI 10.1159/000152732; MULVIHIL.JJ, 1969, J PEDIATR, V75, P579, DOI 10.1016/S0022-3476(69)80453-1; NANCE WE, 1976, ACTA GENET MED GEMEL, V25, P103, DOI 10.1017/S0001566000013933; NANCE WE, 1976, GENETICS, V83, P811; NANCE WE, 1974, CONGENITAL DEFECTS N, P23; Penrose L S, 1971, Ann Hum Genet, V34, P291, DOI 10.1111/j.1469-1809.1971.tb00241.x; REED T, 1978, HUM HERED, V28, P351, DOI 10.1159/000152977; REED T, 1978, AM J HUM GENET, V30, P383; REED T, 1975, HUM HERED, V25, P263, DOI 10.1159/000152734; Sokal Robert R., 1969, BIOMETRY; WENINGER M, 1976, HUM BIOL, V48, P713	23	33	33	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1979	31	3					315	323						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HE538	463880				2022-12-18	WOS:A1979HE53800007
J	EMANUEL, BS				EMANUEL, BS			COMPOUND LATERAL ASYMMETRY IN HUMAN CHROMOSOME-6 - BRDU-DYE STUDIES OF 6Q12-]6Q14	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV PENN,SCH MED,CTR HUMAN GENET,PHILADELPHIA,PA 19174; CHILDRENS HOSP,PHILADELPHIA,PA 19104	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	EMANUEL, BS (corresponding author), UNIV PENN,SCH MED,DEPT PEDIAT,PHILADELPHIA,PA 19174, USA.							ANGELL RR, 1975, CHROMOSOMA, V51, P301, DOI 10.1007/BF00326317; BARONOVSKAYA LT, 1974, HUMANGENETIK, V23, P131; CORNEO G, 1970, J MOL BIOL, V48, P319, DOI 10.1016/0022-2836(70)90163-4; EMANUEL BS, 1977, PEDIATR RES, V11, P454, DOI 10.1203/00006450-197704000-00509; EMANUEL BS, 1977, AM J HUM GENET, V30, pA39; EPPLEN JT, 1975, CYTOGENET CELL GENET, V15, P177, DOI 10.1159/000130516; FLAMM WG, 1967, P NATL ACAD SCI USA, V57, P1729, DOI 10.1073/pnas.57.6.1729; GRESZCHIK KD, 1974, HUMANGENETIK, V29, P41; JONES KW, 1971, NATURE NEW BIOL, V233, P286; KIM MA, 1975, HUMANGENETIK, V28, P57, DOI 10.1007/BF00272483; LATT SA, 1974, EXP CELL RES, V87, P425, DOI 10.1016/0014-4827(74)90510-2; LATT SA, 1973, P NATL ACAD SCI USA, V70, P3395, DOI 10.1073/pnas.70.12.3395; LATT SA, 1975, SOMAT CELL GENET, V1, P293, DOI 10.1007/BF01538452; LATT SA, 1974, SCIENCE, V185, P74, DOI 10.1126/science.185.4145.74; LIN MS, 1974, EXP CELL RES, V86, P392, DOI 10.1016/0014-4827(74)90727-7; MOORHEAD PS, 1960, EXP CELL RES, V20, P613, DOI 10.1016/0014-4827(60)90138-5; WOLFF S, 1974, CHROMOSOMA, V48, P341, DOI 10.1007/BF00290991; ZAKHAROV AF, 1972, CHROMOSOMA, V38, P341, DOI 10.1007/BF00320156	18	33	33	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1978	30	2					153	159						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EV595	17948543				2022-12-18	WOS:A1978EV59500006
J	FERRELL, RE; BERTIN, T; YOUNG, R; BARTON, SA; MURILLO, F; SCHULL, WJ				FERRELL, RE; BERTIN, T; YOUNG, R; BARTON, SA; MURILLO, F; SCHULL, WJ			AYMARA OF WESTERN BOLIVIA .4. GENE-FREQUENCIES FOR 8 BLOOD-GROUPS AND 19 PROTEIN AND ERYTHROCYTE ENZYME-SYSTEMS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV SAN ANDRES,LA PAZ,BOLIVIA	Universidad Mayor de San Andres	FERRELL, RE (corresponding author), UNIV TEXAS,HLTH SCI CTR,CTR DEMOG & POPULAT GENET,HOUSTON,TX 77030, USA.			Barton, Sara Ann/0000-0002-6196-3324				BLANCO R, 1975, HUM HERED, V25, P177, DOI 10.1159/000152725; Brewer G. J., 1970, INTRO ISOZYME TECHNI; DIAZ B, B PAN AM HLTH ORGAN; FERRELL RA, UNPUBLISHED; FERRELL RE, 1978, AM J PHYS ANTHROPOL, V48, P269, DOI 10.1002/ajpa.1330480302; GEERDINK RA, 1974, AM J HUM GENET, V26, P581; GIBLETT ER, 1961, NATURE, V192, P1300, DOI 10.1038/1921300a0; HARRISON GA, 1969, PHILOS T ROY SOC B, V256, P147, DOI 10.1098/rstb.1969.0040; KIRK RL, 1974, AM J PHYS ANTHROPOL, V41, P301, DOI 10.1002/ajpa.1330410213; MATSON GA, 1966, AM J PHYS ANTHROPOL, V24, P51, DOI 10.1002/ajpa.1330240107; MATSON GA, 1966, AM J PHYS ANTHROPOL, V24, P325, DOI 10.1002/ajpa.1330240306; MATSON GA, 1966, AM J PHYS ANTHROPOL, V25, P13, DOI 10.1002/ajpa.1330250104; MESTRINER MA, 1976, AM J HUM GENET, V28, P257; MODIANO G, 1972, AM J HUM GENET, V24, P111; MOURANT AE, 1976, PROC R SOC SER B-BIO, V194, P17, DOI 10.1098/rspb.1976.0062; Mourant AE, 1976, DISTRIBUTION HUMAN B; MURILLO F, BOL SANIT PANAM; Nei M., 1973, Genetic structure of populations. Proceedings of a conference sponsored by the University of Hawaii, 1973., P45; Nei M., 1975, MOL POPULATION GENET; PUTTEE R, 1939, U MIAMI HIS AM STUD, V1, P168; QUILICI JC, 1973, DEFINITION ANAL BIOL, P247; Race R. R, 1968, BLOOD GROUPS MAN; REED TE, 1968, AM J HUM GENET, V20, P579; RIPPY JF, 1921, J NEGRO HIST, V16, P183; SALZANO FM, 1972, HUM BIOL, V44, P443; SCHULL WJ, 1977, GENETIC NONGENETIC C, V18; SHAW CR, 1970, BIOCHEM GENET, V4, P297, DOI 10.1007/BF00485780; SPENCER N, 1968, ANN HUM GENET, V32, P9, DOI 10.1111/j.1469-1809.1968.tb00044.x; TANIS RJ, 1973, AM J HUM GENET, V25, P655; TILLS D, 1970, HUM HERED, V20, P523, DOI 10.1159/000152354; VERGNES H, 1967, NOUV REV FR HEMATOL, V7, P124; WEITKAMP LR, 1969, HUM HERED, V19, P159, DOI 10.1159/000152212; WEITKAMP LR, 1973, ANN HUM GENET, V38, P219; YEN FI, 1972, ARCH I BIOL ANDINA, V5, P1; 1975, USAID MISSION BOLIVI; 1974, TECHNICAL METHODS PR	36	33	33	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1978	30	5					539	549						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	GA288	736042				2022-12-18	WOS:A1978GA28800007
J	YOSHIDA, A; EWING, C; WESSELS, M; LIEBERMAN, J; GAIDULIS, L				YOSHIDA, A; EWING, C; WESSELS, M; LIEBERMAN, J; GAIDULIS, L			MOLECULAR ABNORMALITY OF PI S VARIANT OF HUMAN ALPHA1-ANTITRYPSIN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CITY HOPE NATL MED CTR,DEPT BIOCHEM GENET,DUARTE,CA 91010; CITY HOPE NATL MED CTR,DEPT RESP DIS,DUARTE,CA 91010	City of Hope; City of Hope								BROEK WGM, 1976, ANN HUM GENET, V34, P17; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; ERIKSSON S, 1964, ACTA MED SCAND, V175, P197; ERIKSSON S, 1965, ACTA MED SCAND     S, V177, P8; FAGERHOL MAGNE K., 1968, SER HAEMATOL, V1, P153; FAGERHOL MK, 1967, CLIN CHIM ACTA, V16, P199, DOI 10.1016/0009-8981(67)90181-7; FRANTS RR, 1976, EXCERPTA MEDICA  397, P31; Goodwin T. W., 1946, BIOCHEM JOUR, V40, P628; JEPPSSON JO, 1976, FEBS LETT, V65, P195, DOI 10.1016/0014-5793(76)80478-4; JONES RT, 1964, COLD SPRING HARB SYM, V29, P297, DOI 10.1101/SQB.1964.029.01.032; KUEPPERS F, 1976, AM J HUM GENET, V28, P370; LAURELL CB, 1963, SCAND J CLIN LAB INV, V15, P132, DOI 10.3109/00365516309051324; LIEBERMA.J, 1969, NEW ENGL J MED, V281, P279, DOI 10.1056/NEJM196908072810601; LOWRY OH, 1951, J BIOL CHEM, V193, P265; OWEN MC, 1976, BRIT MED J, V1, P130; Segrest JP, 1972, METHOD ENZYMOL, V28, P54, DOI DOI 10.1016/0076-6879(72)28007-7; SHARP HL, 1969, J LAB CLIN MED, V73, P934; WARREN L, 1959, J BIOL CHEM, V234, P1971; WINZLER R J, 1955, Methods Biochem Anal, V2, P279, DOI 10.1002/9780470110188.ch10; YOSHIDA A, 1976, P NATL ACAD SCI USA, V73, P1324, DOI 10.1073/pnas.73.4.1324	20	33	34	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1977	29	3					233	239						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DG794	301355				2022-12-18	WOS:A1977DG79400002
J	KUEPPERS, F				KUEPPERS, F			ALPHA-1 ANTITRYPSIN M1 - NEW COMMON GENETICALLY DETERMINED VARIANT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MAYO CLIN & MAYO FDN,ROCHESTER,MN 55901	Mayo Clinic								ALLEN RC, 1974, AM J CLIN PATHOL, V62, P732; ARNAUD P, 1975, LKB185 APPL NOT; FAGERHOL MK, 1970, PROG MED GENET, V7, P96; FAGERHOL MK, 1968, ACTA PATHOL MIC SC, V72, P601; JOHNSON AM, 1976, J LAB CLIN MED, V87, P152; KARLSSON C, 1973, LKB75 APPL NOT; KUEPPERS F, 1974, AM REV RESPIR DIS, V110, P176; KUEPPERS F, IN PRESS; LOWRY OH, 1951, J BIOL CHEM, V193, P265; SOBER HA, 1956, J AM CHEM SOC, V78, P756, DOI 10.1021/ja01585a017; 1975, LANCET, V1, P118	11	33	33	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1976	28	4					370	377						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	BX345	1085106				2022-12-18	WOS:A1976BX34500007
J	MIGEON, BR; KENNEDY, JF				MIGEON, BR; KENNEDY, JF			EVIDENCE FOR INACTIVATION OF AN X-CHROMOSOME EARLY IN DEVELOPMENT OF HUMAN FEMALE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT OBSTET & GYNECOL,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University								DAVIDSON RG, 1963, P NATL ACAD SCI USA, V50, P481, DOI 10.1073/pnas.50.3.481; DEOL MS, 1972, NATURE-NEW BIOL, V240, P277, DOI 10.1038/newbio240277a0; DEOL MS, 1972, NATURE-NEW BIOL, V238, P159, DOI 10.1038/newbio238159a0; ELLIS N, 1972, AM J CLIN PATHOL, V57, P534; GARDNER RL, 1971, NATURE, V231, P385, DOI 10.1038/231385a0; Gartler S M, 1972, Cell Differ, V1, P215, DOI 10.1016/0045-6039(72)90039-5; GARTLER SM, 1973, EXP CELL RES, V82, P464, DOI 10.1016/0014-4827(73)90368-6; LYON MF, 1972, BIOL REV, V47, P1; MARKS PA, 1959, NATURE, V183, P1266, DOI 10.1038/1831266b0; MIGEON BR, 1974, P NATL ACAD SCI USA, V71, P937, DOI 10.1073/pnas.71.3.937; MIGEON BR, 1971, AM J HUM GENET, V23, P199; PARK WW, 1957, J ANAT, V91, P369; SPARKES RS, 1969, J LAB CLIN MED, V73, P531; STEELE MW, 1973, BIOCHEM GENET, V9, P163, DOI 10.1007/BF00487445; STREETER GL, 1921, CONTR EMBRYOL, V11, P145	15	33	33	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1975	27	2					233	239						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	V9467	1124767				2022-12-18	WOS:A1975V946700010
J	GALL, JC; GARN, SM; WEINSTEIN, ED; STERN, AM; HAYWARD, JR; POZNANSKI, AK				GALL, JC; GARN, SM; WEINSTEIN, ED; STERN, AM; HAYWARD, JR; POZNANSKI, AK			OTO-PALATO-DIGITAL SYNDROME - COMPARISON OF CLINICAL AND RADIOGRAPHIC MANIFESTATIONS IN MALES AND FEMALES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		AASE J M, 1969, Birth Defects Original Article Series, V5, P43; CHRISTIAN J C, 1969, Birth Defects Original Article Series, V5, P82; DUDDING BA, 1967, AM J DIS CHILD, V113, P214, DOI 10.1001/archpedi.1967.02090170078006; GORLIN RJ, 1970, AM J DIS CHILD, V119, P377, DOI 10.1001/archpedi.1970.02100050379023; GORLIN RJ, 1966, 3 P INT C HUM GEN CH, P42; JAGER J, 1968, Z ORTHOP, V105, P196; LANGER LO, 1967, AMER J ROENTGENOL RA, V100, P63, DOI 10.2214/ajr.100.1.63; POZNANSKI AK, 1970, INVEST RADIOL, V5, P289, DOI 10.1097/00004424-197007000-00067; POZNANSKI AK, 1970, SEMIN ROENTGENOL, V5, P354, DOI 10.1016/S0037-198X(70)80005-0; TAYBI H, 1962, AMER J ROENTGENOL RA, V88, P450; WEINSTEIN E. DAVID, 1966, J MED GENET, V3, P17, DOI 10.1136/jmg.3.1.17	11	33	33	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1972	24	1					24	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	L6958	5012690				2022-12-18	WOS:A1972L695800004
J	MIGEON, BR				MIGEON, BR			STUDIES OF SKIN FIBROBLASTS FROM 10 FAMILIES WITH HGPRT DEFICIENCY, WITH REFERENCE TO X-CHROMOSOMAL INACTIVATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALBERTINI RJ, 1970, SCIENCE, V169, P482, DOI 10.1126/science.169.3944.482; DANCIS J, 1968, LIFE SCI PT 1 PHYSI, V7, P587, DOI 10.1016/0024-3205(68)90079-9; DANES BS, 1967, J EXP MED, V126, P509, DOI 10.1084/jem.126.3.509; DAVIDSON RG, 1963, P NATL ACAD SCI USA, V50, P481, DOI 10.1073/pnas.50.3.481; EMMERSON BT, 1969, SCIENCE, V166, P1533, DOI 10.1126/science.166.3912.1533; FELIX JS, 1969, P NATL ACAD SCI USA, V62, P536, DOI 10.1073/pnas.62.2.536; FUJIMOTO WY, 1970, P NATL ACAD SCI USA, V65, P577, DOI 10.1073/pnas.65.3.577; GARTLER SM, 1964, COLD SPRING HARB SYM, V29, P253, DOI 10.1101/SQB.1964.029.01.028; HOEFNAGEL D, 1965, NEW ENGL J MED, V273, P130, DOI 10.1056/NEJM196507152730303; LESCH M, 1964, AM J MED, V36, P561, DOI 10.1016/0002-9343(64)90104-4; LINDER D, 1965, AM J HUM GENET, V17, P212; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; MCKUSICK VA, 1962, Q REV BIOL, V37, P69, DOI 10.1086/403631; MIGEON BR, 1970, BIOCHEM GENET, V4, P377, DOI 10.1007/BF00485754; MIGEON BR, 1968, SCIENCE, V160, P425, DOI 10.1126/science.160.3826.425; NANCE WE, 1964, COLD SPRING HARB SYM, V29, P415, DOI 10.1101/SQB.1964.029.01.043; NYHAN WL, 1967, PEDIATR RES, V1, P5, DOI 10.1203/00006450-196701000-00001; NYHAN WL, 1970, P NATL ACAD SCI USA, V65, P214, DOI 10.1073/pnas.65.1.214; NYHAN WL, 1965, J PEDIATR-US, V67, P257, DOI 10.1016/S0022-3476(65)80249-9; RUSSELL LB, 1963, SCIENCE, V140, P976, DOI 10.1126/science.140.3570.976; SALZMANN J, 1968, P NATL ACAD SCI USA, V60, P545, DOI 10.1073/pnas.60.2.545	21	33	33	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1971	23	2					199	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	J1653	5092480				2022-12-18	WOS:A1971J165300007
J	ELANDTJOHNSON, RC				ELANDTJOHNSON, RC			SEGREGATION ANALYSIS FOR COMPLEX MODES OF INHERITANCE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BARRAI I, 1965, AM J HUM GENET, V17, P221; CHUNG CS, 1959, ANN HUM GENET, V23, P357, DOI 10.1111/j.1469-1809.1959.tb01479.x; DEWEY WJ, 1965, AM J HUM GENET, V17, P237; MI MP, 1967, AM J HUM GENET, V19, P313; MORTON NE, 1959, AM J HUM GENET, V11, P1; MORTON NE, 1963, GENETICS TODAY, V3, P935; MORTON NE, 1962, METHODOLOGY HUMAN GE, P17; OBRIEN WM, 1965, J CHRON DIS, V18, P675, DOI 10.1016/0021-9681(65)90069-X; PERITZ E, 1966, ANN HUM GENET, V30, P183, DOI 10.1111/j.1469-1809.1966.tb00017.x; STEINBERG AG, 1951, AM J HUM GENET, V3, P267; STEVENSON AC, 1953, ANN EUGENIC, V17, P177	11	33	33	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1970	22	2					129	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	F9213	5435639				2022-12-18	WOS:A1970F921300002
J	WOOLF, CM; WOOLF, RM				WOOLF, CM; WOOLF, RM			A GENETIC STUDY OF POLYDACTYLY IN UTAH	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ADAMS MS, 1968, EUGEN QUART, V15, P227, DOI 10.1080/19485565.1968.9987781; CHUNG CS, 1968, AM J HUM GENET, V20, P44; EDWARDS J. H., 1960, ACTA GENET ET STATIST MED, V10, P63; EDWARDS JH, 1969, BRIT MED BULL, V25, P58, DOI 10.1093/oxfordjournals.bmb.a070672; FRAZIER TM, 1960, AM J OBSTET GYNECOL, V80, P184; Gates Reginald Ruggles, 1946, HUMAN GENETICS; Manoiloff EO, 1931, AM J PHYS ANTHROPOL, V15, P503, DOI 10.1002/ajpa.1330150307; McKusick V.A., 1968, MENDELIAN INHERITANC; NEEL JV, 1958, AM J HUM GENET, V10, P398; SMITH D W, 1963, J Pediatr, V62, P326, DOI 10.1016/S0022-3476(63)80129-8; Sverdrup A, 1922, J GENET, V12, P217, DOI 10.1007/BF02983978; WOOLF C M, 1965, Plast Reconstr Surg, V35, P543, DOI 10.1097/00006534-196505000-00011; WOOLF CM, 1963, AM J HUM GENET, V15, P209; WOOLF CM, 1968, AM J HUM GENET, V20, P430; Wright S, 1934, GENETICS, V19, P0537	15	33	33	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1970	22	1					75	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	F4294	5411649				2022-12-18	WOS:A1970F429400006
J	HENDERSON, JF; KELLEY, WN; ROSENBLOOM, FM; SEEGMILLER, JE				HENDERSON, JF; KELLEY, WN; ROSENBLOOM, FM; SEEGMILLER, JE			INHERITANCE OF PURINE PHOSPHORIBOSYLTRANSFERASES IN MAN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		HENDERSON JF, 1968, CAN J BIOCHEM CELL B, V46, P703, DOI 10.1139/o68-108; HOEFNAGEL D, 1965, NEW ENGL J MED, V273, P130, DOI 10.1056/NEJM196507152730303; KELLEY WN, 1967, P NATL ACAD SCI USA, V57, P1735, DOI 10.1073/pnas.57.6.1735; KELLEY WN, IN PRESS; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; MIGEON BR, 1968, SCIENCE, V160, P425, DOI 10.1126/science.160.3826.425; NANCE WE, 1964, COLD SPRING HARB SYM, V29, P415, DOI 10.1101/SQB.1964.029.01.043; NYHAN WL, 1967, PEDIATR RES, V1, P5, DOI 10.1203/00006450-196701000-00001; ROSENBLOOM FM, 1967, LANCET, V2, P305; ROSENBLOOM FM, 1967, J AMER MED ASSOC, V202, P175, DOI 10.1001/jama.202.3.175; SEEGMILLER JE, 1967, SCIENCE, V155, P1682, DOI 10.1126/science.155.3770.1682; SHAPIRO SL, 1966, P SOC EXP BIOL MED, V122, P609; STAMATOYANNOPOULOS G, 1967, BLOOD-J HEMATOL, V29, P87, DOI 10.1182/blood.V29.1.87.87	13	33	33	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1969	21	1					61	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	D0848	5763607				2022-12-18	WOS:A1969D084800005
J	BARRAI, I; CANN, HM; CAVALLIS.LL; DENICOLA, P				BARRAI, I; CANN, HM; CAVALLIS.LL; DENICOLA, P			EFFECT OF PARENTAL AGE ON RATES OF MUTATION FOR HEMOPHILIA AND EVIDENCE FOR DIFFERING MUTATION RATES FOR HEMOPHILIA A AND B	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		AGGELER PM, 1952, P SOC EXP BIOL MED, V79, P692; Andreassen Mogens, 1943, OPERA EX DOMO BIOL HEREDITARIAE HUMANAE UNIV HAFNIENSIS, V6, P1; BARRAI I, 1965, AM J HUM GENET, V17, P221; BARROW EM, 1960, J LAB CLIN MED, V55, P936; BIGGS R, 1952, BRIT MED J, V2, P1378, DOI 10.1136/bmj.2.4799.1378; BRINKHOUS KM, 1964, HEMOPHILIAS       ED, P263; BURDETTE WJ, 1962, METHODOLOGY HUMAN ED, P17; CANN HM, IN PRESS; CAVALLISFORZA LL, 1961, ATTI ASSOC GENET IT, V6, P151; CAVALLISFORZA LL, 1962, INDAGINE SPECIALE AL; GRAHAM JB, 1964, HEMOPHILIAS, P263; HALDANE JBS, 1947, ANN EUGENIC, V13, P262; KOSOWER N, 1962, AM J HUM GENET, V14, P159; KREHBIEL EL, 1966, AM J HUM GENET, V18, P127; LEJEUNE J, 1957, CR HEBD ACAD SCI, V244, P1833; MORTON NE, 1959, AM J HUM GENET, V11, P1; MORTON NE, 1959, AM J HUM GENET, V11, P360; MORTON NE, 1962, METHODOLOGY HUMAN GE, P17; NOVITSKI E, 1958, AM J HUM GENET, V10, P268; NOVITSKI E, 1956, ANN HUM GENET, V21, P123, DOI 10.1111/j.1469-1809.1971.tb00271.x; NOVITSKI E, 1953, SCIENCE, V117, P531, DOI 10.1126/science.117.3046.531; PENROSE LS, 1955, LANCET, V2, P312; PENROSE LS, 1957, AM J HUM GENET, V9, P167; RAPAPORT SI, 1960, J CLIN INVEST, V39, P1619, DOI 10.1172/JCI104184; 1965, 1000 PUBL HEALTH   4; 1962, 1960 CAN DOM BUR STA; 1963, STATISTICAL ABSTRACT	27	33	33	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1968	20	3					175	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	B8693	5657359				2022-12-18	WOS:A1968B869300001
J	NEVO, SS; SUTTON, HE				NEVO, SS; SUTTON, HE			ASSOCIATION BETWEEN RESPONSE TO TYPHOID VACCINATION AND KNOWN GENETIC MARKERS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BENENSON A. S., 1964, BULL WORLD HEALTH ORGAN, V30, P653; BLUMBERG BS, 1961, P C GENETIC POLYM ED, P132; CLEVE H, 1966, PROTIDES BIOLOGICAL, P379; CLEVE HARTWIG, 1962, PROGR MED GENET, V2, P64; CVJETANO.B, 1965, B WORLD HEALTH ORGAN, V32, P29; Ford E. B., 1940, NEW SYSTEMATICS, P493; Ford E.B., 1965, GENETIC POLYMORPHISM; GAINES S, 1961, J EXP MED, V114, P327, DOI 10.1084/jem.114.3.327; GIBLETT ER, 1961, P C GENETIC POLYMORP, P132; HEJFEC LB, 1966, B WORLD HEALTH ORGAN, V34, P321; HUXLEY J, 1940, NEW SYSTEMATICS   ED, P493; JAYLE MF, 1954, PRESSE MED, V62, P1752; LAURELL CB, 1957, BLOOD, V12, P493, DOI 10.1182/blood.V12.6.493.493; NYMAN M, 1958, CLIN CHIM ACTA, V3, P111, DOI 10.1016/0009-8981(58)90067-6; PEETERS H, 1966, PROTIDES BIOLOGIC ED, P379; Siegel S, 1956, NONPARAMETRIC STATIS; SPRINGER GF, 1956, 2 MAC C POL BIOL  ED, P115; WESTPHAL O, 1956, 2 T C POLYS BIOL, P115	18	33	33	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1968	20	5					461	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	B8383	5701617				2022-12-18	WOS:A1968B838300005
J	WOOLF, CM; KOEHN, JH; COLEMAN, SS				WOOLF, CM; KOEHN, JH; COLEMAN, SS			CONGENITAL HIP DISEASE IN UTAH - INFLUENCE OF GENETIC AND NONGENETIC FACTORS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ANDREN L, 1961, ACTA ENDOCRINOL-COP, V37, P423, DOI 10.1530/acta.0.0370423; ANDREN L, 1961, ACTA ENDOCRINOL-COP, V37, P427, DOI 10.1530/acta.0.0370427; ANDREN L, 1960, Acta Orthop Scand, V30, P169; ANDREN LARS, 1963, ACTA ORTHOPAED SCAND, V33, P127, DOI 10.3109/17453676308999841; BAILAR JC, 1965, EUGEN QUART, V12, P146, DOI 10.1080/19485565.1965.9987622; BARLOW TG, 1962, J BONE JT SURG, VB 44, P292; Carter C O, 1964, Clin Orthop Relat Res, V33, P119; Carter CO, 1964, 2 INT C CONG MALF, P306; COLEMAN SS, 1956, JAMA-J AM MED ASSOC, V162, P548, DOI 10.1001/jama.1956.02970230020007; CORRIGAN C, 1950, CAN MED ASSOC J, V62, P535; EDWARDS J. H., 1960, ACTA GENET ET STATIST MED, V10, P63; FISHBEIN M, 1964, 2 INT C CONG MALF ED, P306; FISHBEIN M, 1964, 2 INT C CONG MALF ED, P345; MCINTOSH R, 1954, PEDIATRICS, V14, P505; MEDALIE JH, 1966, ISRAEL J MED SCI, V2, P212; NEWCOMBE HB, 1964, 2 INT C CONG MALF, P345; RABIN DL, 1965, AM J PUBLIC HEALTH N, V55, P1; RECORD RG, 1958, BRIT J PREV SOC MED, V17, P8; VONROSEN S, 1962, J BONE JOINT SURG BR, V44, P284, DOI 10.1302/0301-620X.44B2.284; WILKINSON JA, 1963, J BONE JOINT SURG BR, V45, P268, DOI 10.1302/0301-620X.45B2.268; WOOLF CM, 1963, AM J HUM GENET, V15, P209	21	33	33	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1968	20	5					430	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	B8383	5701615				2022-12-18	WOS:A1968B838300003
J	LISKER, R; GIBLETT, ER				LISKER, R; GIBLETT, ER			STUDIES ON SEVERAL GENETIC HEMATOLOGICAL TRAITS OF MEXICANS .11. RED CELL ACID PHOSPHATASE AND PHOSPHOGLUCOMUTASE IN 3 INDIAN GROUPS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article													Lisker, Ruben/N-3094-2013	Lisker, Ruben/0000-0003-4272-5766				CORDOVA MS, IN PRESS; GIBLETT ER, 1965, AM J HUM GENET, V17, P425; GIBLETT ER, IN PRESS; GREENWALT TJ, IN PRESS          ED; HOPKINSO.DA, 1965, NATURE, V208, P410, DOI 10.1038/208410a0; HOPKINSON DA, 1964, AM J HUM GENET, V16, P141; LAI L, 1964, SCIENCE, V145, P1187, DOI 10.1126/science.145.3637.1187; LAI LYC, 1966, ACTA GENET STAT MED, V16, P313; LIEINJO LE, 1966, NATURE, V210, P1183; SCOTT EM, 1966, AM J HUM GENET, V18, P408; SPENCER N, 1964, NATURE, V204, P742, DOI 10.1038/204742a0	11	33	33	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1967	19	2					174	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	91653	6022240				2022-12-18	WOS:A19679165300009
J	JENKINS, T; STEINBERG, AG				JENKINS, T; STEINBERG, AG			SOME SERUM PROTEIN POLYMORPHISMS IN KALAHARI BUSHMEN AND BANTU - GAMMA GLOBULINS HAPTOGLOBINS AND TRANSFERRINS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALLISON AC, 1958, P ROY SOC MED, V51, P641; ALLISON AC, 1958, NATURE, V181, P824, DOI 10.1038/181824a0; BARNICOT NA, 1960, ANN HUM GENET, V24, P171; BARNICOT NA, 1959, NATURE, V184, P2042, DOI 10.1038/1842042a0; BARNICOT NA, 1961, GENETICAL VARIATION, P41; BLEAK D, 1937, FETSCHRIFT MEINHOF, P55; GIBLETT ER, 1960, AM J HUM GENET, V12, P160; GORDON H., 1964, S AFRICAN MED J, V38, P734; HARRISON GA, 1961, GENETICAL VARIATI ED, P41; HOOTON EA, 1949, UP FROM APE; JENKINS T, IN PRESS; NEEL JV, 1961, AM J HUM GENET, V13, P262; PARKER WC, 1961, ANN HUM GENET, V25, P227; POULIK MD, 1957, NATURE, V180, P1477, DOI 10.1038/1801477a0; ROPARTZ C, 1960, REV FR ETUD CLIN BIO, V5, P814; SCHAPERA I, 1930, KHOISAN PEOPLES SOUT; SILBERBAUER GB, 1965, REP GOVERNMENT BECHU, P127; SINGER RONALD, 1961, S AFRICAN MED JOUR, V35, P520; STEINBERG AG, 1965, AM J HUM GENET, V17, P133; STEINBERG AG, 1966, AM J HUM GENET, V18, P109; STEINBERG AG, 1962, VOX SANG, V7, P151, DOI 10.1111/j.1423-0410.1962.tb03239.x; STEINBERG ARTHUR G., 1962, PROGR MED GENET, V2, P1; STERN J, 1962, J MENT DEFIC RES, V6, P13; TOBIAS P. V., 1957, MAN, V57, P33, DOI 10.2307/2794792; WEINER JS, 1959, NATURE, V183, P843, DOI 10.1038/183843a0; Zoutendyk A, 1955, AM J PHYS ANTHROP-NE, V13, P691, DOI 10.1002/ajpa.1330130410; Zoutendyk A, 1953, AM J PHYS ANTHROP-NE, V11, P361, DOI 10.1002/ajpa.1330110311	27	33	33	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1966	18	4					399	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	81309	4161543				2022-12-18	WOS:A19668130900006
J	REED, TE; FALLS, HF				REED, TE; FALLS, HF			PEDIGREE OF ANIRIDIA WITH A DISCUSSION OF GERMINAL MOSAICISM IN MAN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		AUERBACH C, 1950, AGENTI MUTAGENI    S, V22; Auerbach Charlotte, 1946, PROC ROY SOC EDINBURGH, V62B, P211; BEATTIE PH, 1947, BRIT J OPHTH, V31, P651; BELL J, 1932, TREASURY HUMAN INHER, V2; BORBERG A, 1951, OPERA EX DOMO BIOL H, V23; BORBERG A, 1953, COMMUNICATION; BRIDGES CB, 1919, P SOC EXP BIOL MED, V17, P1; BROOKS HL, 1935, EYE EAR MONTH, V14, P62; CALLAHAN A, 1949, AM J OPHTHALMOL, V32, P28, DOI 10.1016/S0002-9394(14)78355-2; DETROY L, 1938, ECHO MED NORD, V9, P465; DUNN LC, 1953, GENETICS, V38, P261; FALLS HF, 1951, AMA ARCH OPHTHALMOL, V46, P367; Finney DJ, 1940, ANN EUGENIC, V10, P171, DOI 10.1111/j.1469-1809.1940.tb02246.x; FINNEY DJ, 1942, ANN EUGEN LOND, V11, P224; GRUNEBERG H, 1952, BIBLIOGR GENET GRAVE, V15; HALDANE JBS, 1949, HEREDITAS          S, P267; Harris BB, 1929, J HERED, V20, P299, DOI 10.1093/oxfordjournals.jhered.a103201; Hollander WF, 1944, Q REV BIOL, V19, P285, DOI 10.1086/394697; Hutt F.B., 1949, GENETICS OF THE FOWL; KOMAI T, 1934, CONTRIBUTIONS GENETI, V1; KRIZ R, 1951, Vojen Zdrav Listy, V20, P223; MACKENZIE HJ, 1951, ANN EUGENIC, V16, P88, DOI 10.1111/j.1469-1809.1951.tb02460.x; MOHR J, 1953, OPERA EX DOMO BIOL H, V33; Mohr OL, 1923, HEREDITAS, V4, P142; Mollenbach CJ, 1947, OPERA EX DOMO BIOL H, V15; MORCH ET, 1941, OPERA EX DOMO BIOL H, V5; Morgan T. H., 1925, Bibliographia Genetica The Hague, V2, P1; Muller HJ, 1920, J EXP ZOOL, V31, P443, DOI 10.1002/jez.1400310405; NEHER E. M., 1938, AMER JOUR OPHTHALMOL, V21, P293; PINCUS MH, 1948, ARCH OPHTHALMOL-CHIC, V39, P60, DOI 10.1001/archopht.1948.00900020063006; REESE AB, 1949, ARCH OPHTHALMOL-CHIC, V42, P119; SCHACHTER M, 1948, ARCH OPHTAL, V8, P382; SEEDORFF KS, 1949, OPERA EX DOMO BIOL H, V20; SORSBY A, 1951, GENETICS OPHTHALMOLO; VOGT A, 1941, SCHWEIZ MED WSCHR, V71, P432; WAARDENBURG PJ, 1932, MENSCHLICHE AUGE SEI; Wright S, 1926, GENETICS, V11, P333; Zlotnikoff M., 1945, JOUR HEREDITY, V36, P163	38	33	33	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1955	7	1					28	38						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA210	14361391				2022-12-18	WOS:A1955WA21000004
J	de Bruijn, SE; Fiorentino, A; Ottaviani, D; Fanucchi, S; Melo, US; Corral-Serrano, JC; Mulders, T; Georgiou, M; Rivolta, C; Pontikos, N; Arno, G; Roberts, L; Greenberg, J; Albert, S; Gilissen, C; Aben, M; Rebello, G; Mead, S; Raymond, FL; Corominas, J; Smith, CEL; Kremer, H; Downes, S; Black, GC; Webster, AR; Inglehearn, CF; van den Born, LI; Koenekoop, RK; Michaelides, M; Ramesar, RS; Hoyng, CB; Mundlos, S; Mhlanga, MM; Cremers, FPM; Cheetham, ME; Roosing, S; Hardcastle, AJ				de Bruijn, Suzanne E.; Fiorentino, Alessia; Ottaviani, Daniele; Fanucchi, Stephanie; Melo, Uira S.; Corral-Serrano, Julio C.; Mulders, Timo; Georgiou, Michalis; Rivolta, Carlo; Pontikos, Nikolas; Arno, Gavin; Roberts, Lisa; Greenberg, Jacquie; Albert, Silvia; Gilissen, Christian; Aben, Marco; Rebello, George; Mead, Simon; Raymond, F. Lucy; Corominas, Jordi; Smith, Claire E. L.; Kremer, Hannie; Downes, Susan; Black, Graeme C.; Webster, Andrew R.; Inglehearn, Chris F.; van den Born, L. Ingeborgh; Koenekoop, Robert K.; Michaelides, Michel; Ramesar, Raj S.; Hoyng, Carel B.; Mundlos, Stefan; Mhlanga, Musa M.; Cremers, Frans P. M.; Cheetham, Michael E.; Roosing, Susanne; Hardcastle, Alison J.			Structural Variants Create New Topological-Associated Domains and Ectopic Retinal Enhancer-Gene Contact in Dominant Retinitis Pigmentosa	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTOSOMAL-DOMINANT; CHROMATIN; MUTATION; REARRANGEMENTS; MECHANISM; DISEASE; GENOME; RP17; MAP	The cause of autosomal-dominant retinitis pigmentosa (adRP), which leads to loss of vision and blindness, was investigated in families lacking a molecular diagnosis. A refined locus for adRP on Chr17q22 (RP17) was delineated through genotyping and genome sequencing, leading to the identification of structural variants (SVs) that segregate with disease. Eight different complex SVs were characterized in 22 adRP-affected families with >300 affected individuals. All RP17 SVs had breakpoints within a genomic region spanning YPEL2 to LINC01476. To investigate the mechanism of disease, we reprogrammed fibroblasts from affected individuals and controls into induced pluripotent stem cells (iPSCs) and differentiated them into photoreceptor precursor cells (PPCs) or retinal organoids (ROs). Hi-C was performed on ROs, and differential expression of regional genes and a retinal enhancer RNA at this locus was assessed by qPCR. The epigenetic landscape of the region, and Hi-C RO data, showed that YPEL2 sits within its own topologically associating domain (TAD), rich in enhancers with binding sites for retinal transcription factors. The Hi-C map of RP17 ROs revealed creation of a neo-TAD with ectopic contacts between GDPD1 and retinal enhancers, and modeling of all RP17 SVs was consistent with neo-TADs leading to ectopic retinal-specific enhancer-GDPD1 accessibility. qPCR confirmed increased expression of GDPD1 and increased expression of the retinal enhancer that enters the neo-TAD. Altered TAD structure resulting in increased retinal expression of GDPD1 is the likely convergent mechanism of disease, consistent with a dominant gain of function. Our study highlights the importance of SVs as a genomic mechanism in unsolved Mendelian diseases.	[de Bruijn, Suzanne E.; Albert, Silvia; Gilissen, Christian; Aben, Marco; Corominas, Jordi; Kremer, Hannie; Mhlanga, Musa M.; Cremers, Frans P. M.; Roosing, Susanne] Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [de Bruijn, Suzanne E.; Mulders, Timo; Kremer, Hannie; Hoyng, Carel B.; Cremers, Frans P. M.; Roosing, Susanne] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [Fiorentino, Alessia; Ottaviani, Daniele; Corral-Serrano, Julio C.; Georgiou, Michalis; Pontikos, Nikolas; Arno, Gavin; Webster, Andrew R.; Michaelides, Michel; Cheetham, Michael E.; Hardcastle, Alison J.] UCL Inst Ophthalmol, London EC1V 9EL, England; [Fiorentino, Alessia; Pontikos, Nikolas; Arno, Gavin; Downes, Susan; Black, Graeme C.; Webster, Andrew R.; Inglehearn, Chris F.; Michaelides, Michel; Cheetham, Michael E.; Hardcastle, Alison J.] UK Inherited Retinal Dis Consortium, London, England; [Fiorentino, Alessia; Pontikos, Nikolas; Arno, Gavin; Downes, Susan; Black, Graeme C.; Webster, Andrew R.; Inglehearn, Chris F.; Michaelides, Michel; Cheetham, Michael E.; Hardcastle, Alison J.] Genom England Clin Interpretat Partnership, London, England; [Fanucchi, Stephanie; Mhlanga, Musa M.] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med,Gene Express & Biophys, Dept Integrat Biomed Sci,Div Chem Syst & Synthet, ZA-7935 Cape Town, South Africa; [Melo, Uira S.; Mundlos, Stefan] Max Planck Inst Mol Genet, RG Dev & Dis, D-14195 Berlin, Germany; [Melo, Uira S.; Mundlos, Stefan] Charite, Inst Med & Human Genet, D-10117 Berlin, Germany; [Mulders, Timo; Hoyng, Carel B.] Radboud Univ Nijmegen, Dept Ophthalmol, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [Georgiou, Michalis; Arno, Gavin; Webster, Andrew R.; Michaelides, Michel] Moorfields Eye Hosp, London EC1V 2PD, England; [Rivolta, Carlo] Univ Leicester, Dept Genet & Genome Biol, Leicester LE1 7RH, Leics, England; [Rivolta, Carlo] Inst Mol & Clin Ophthalmol Basel IOB, Clin Res Ctr, CH-4031 Basel, Switzerland; [Rivolta, Carlo] Univ Hosp Basel, Dept Ophthalmol, CH-4001 Basel, Switzerland; [Roberts, Lisa; Greenberg, Jacquie; Rebello, George; Ramesar, Raj S.] Univ Cape Town, MRC Genom & Precis Med Res Unit, Fac Hlth Sci, Inst Infect Dis & Mol Med,Div Human Genet,Dept Pa, ZA-7935 Cape Town, South Africa; [Mead, Simon] UCL Inst Prion Dis, MRC Prion Unit UCL, London W1W 7FF, England; [Raymond, F. Lucy] Cambridge Univ Hosp, NIHR BioResource, Cambridge CB2 0QQ, England; [Raymond, F. Lucy] Univ Cambridge, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 0XY, England; [Smith, Claire E. L.; Inglehearn, Chris F.] Univ Leeds, Leeds Inst Med Res, Div Mol Med, Leeds LS2 9JT, W Yorkshire, England; [Kremer, Hannie] Radboud Univ Nijmegen, Dept Otorhinolaryngol, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [Downes, Susan] Oxford Univ Hosp NHS Trust, Oxford Eye Hosp, Oxford OX3 9DU, England; [Downes, Susan] Univ Oxford, Nuffield Lab Ophthalmol, Oxford OX3 9DU, England; [Black, Graeme C.] St Marys Hosp, Manchester Ctr Genom Med, Manchester M13 9WL, Lancs, England; [van den Born, L. Ingeborgh] Rotterdam Eye Hosp, NL-3011 BH Rotterdam, Netherlands; [Koenekoop, Robert K.] McGill Univ, Dept Paediat Surg Human Genet & Ophthalmol, Montreal, PQ H4A 3J1, Canada; [Mhlanga, Musa M.] Univ Lisbon, Inst Med Mol, Gene Express & Biophys Unit, Fac Med, P-1649028 Lisbon, Portugal; [Mhlanga, Musa M.] Radboud Univ Nijmegen, Radboud Inst Mol Life Sci RIMLS, Epigen & Single Cell Biophys Grp, NL-6525 GA Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; University of London; University College London; University of Cape Town; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Radboud University Nijmegen; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Leicester; University of Basel; University of Cape Town; University of London; University College London; University of Cambridge; University of Cambridge; University of Leeds; Radboud University Nijmegen; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Manchester; Rotterdam Eye Hospital; McGill University; Universidade de Lisboa; Radboud University Nijmegen	Roosing, S (corresponding author), Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, NL-6500 HB Nijmegen, Netherlands.; Roosing, S (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Med Ctr, NL-6500 HB Nijmegen, Netherlands.	susanne.roosing@radboudumc.nl	Inglehearn, Chris/GYD-9783-2022; Roosing, Susanne/ABF-9604-2021; Roberts, Lisa Jane/GQA-4854-2022; Kremer, Hannie/F-5126-2010; Roosing, Susanne/F-1616-2018; Koenekoop, Robert/AAT-6676-2021; Mundlos, Stefan/ABH-9585-2020; Pontikos, Nikolas/U-3642-2018; Black, Graeme/K-7374-2015	Roosing, Susanne/0000-0001-9038-0067; Roberts, Lisa Jane/0000-0001-6766-0255; Kremer, Hannie/0000-0002-0841-8693; Roosing, Susanne/0000-0001-9038-0067; Pontikos, Nikolas/0000-0003-1782-4711; Melo, Uira/0000-0003-4065-8635; Smith, Claire/0000-0001-8320-5105; Rivolta, Carlo/0000-0002-0733-9950; Cheetham, Michael/0000-0001-6429-654X; de Bruijn, Suzanne/0000-0003-2912-9265; Mundlos, Stefan/0000-0002-9788-3166; Ottaviani, Daniele/0000-0002-1946-7351; Mead, Simon/0000-0002-4326-1468; Black, Graeme/0000-0001-8727-6592; Hardcastle, Alison/0000-0002-0038-6770; Corral Serrano, Julio Cesar/0000-0002-4277-4931; Michaelides, Michel/0000-0002-1552-7046; Albert, Silvia/0000-0002-6921-0351	Retina UK; Fight for Sight; Moorfields Eye Charity; National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital National Health Service Foundation Trust; UCL Institute of Ophthalmology; GOSH; Cambridge; Wellcome Trust [205041/Z/16/Z, 538842]; DCN Radboudumc grant; Foundation Fighting Blindness [PPA0517-0717-RAD]; ANVTVVB; Oogfonds; LSBS; Rotterdamse Stichting Blindenbelangen; Stichting Blindenhulp; Stichting tot Verbetering van het Lot der Blinden; Stichting Blinden-Penning; Foundation Fighting Blindness; Reseau de Vision; MCH Foundation; Swiss National Science Foundation [176097]; MRC (UK); Retina South Africa; South African Medical Research Council; National Institute for Health Research; NHS England; Wellcome Trust; Cancer Research UK; Medical Research Council; Medical Research Council [MC_U123160651, MC_UU_00024/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0617-10175] Funding Source: researchfish; MRC [MC_UU_00024/1, MC_U123160651] Funding Source: UKRI	Retina UK; Fight for Sight; Moorfields Eye Charity; National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital National Health Service Foundation Trust; UCL Institute of Ophthalmology; GOSH; Cambridge; Wellcome Trust(Wellcome Trust); DCN Radboudumc grant; Foundation Fighting Blindness(European Commission); ANVTVVB; Oogfonds; LSBS; Rotterdamse Stichting Blindenbelangen; Stichting Blindenhulp; Stichting tot Verbetering van het Lot der Blinden; Stichting Blinden-Penning; Foundation Fighting Blindness(European Commission); Reseau de Vision; MCH Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); MRC (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Retina South Africa; South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); NHS England; Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the affected individuals and their families for participating in this study and our funding bodies. We thank Saskia D. van de Velde-Visser for cell culture work; Marijke N. ZonneveldVrieling, Mubeen Khan, Rolph Pfundt, and M. Imran Khan for experimental contributions; Alex Hoischen for expert contribution; Galuh Dyah Nur Astuti for bioinformatics support; Edward Bloch for taking skin biopsies; and KarinW. Littink, Suzanne IJzer, Irma Lopez, Anneke I. den Hollander, and Samantha Malka for their effort in sample collection. This research was supported by Retina UK; Fight for Sight; Moorfields Eye Charity; the National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital National Health Service Foundation Trust; UCL Institute of Ophthalmology; GOSH; Cambridge; The Wellcome Trust (205041/Z/16/Z grant 538842); a DCN Radboudumc grant (to F.P.M.C. and H.K.); Foundation Fighting Blindness (PPA0517-0717-RAD to S.R. and F.P.M.C.); ANVTVVB, Oogfonds, and LSBS; Rotterdamse Stichting Blindenbelangen, Stichting Blindenhulp, Stichting tot Verbetering van het Lot der Blinden, and Stichting Blinden-Penning (to S.R. and F.P.M.C.); Foundation Fighting Blindness, Reseau de Vision and MCH Foundation (to R.K.K.); Swiss National Science Foundation (176097 to C.R.); the MRC (UK to S.M.); and Retina South Africa and the South African Medical Research Council (to L.R.). The Steunfonds RP17 financially supported experiments for this project (to S.R. and F.P.M.C.). This research accessed 100,000 Genomes Project data, managed by Genomics England Limited (a wholly owned company of the Department of Health). The 100,000 Genomes Project is funded by the National Institute for Health Research and NHS England. The Wellcome Trust, Cancer Research UK, and the Medical Research Council have also funded research infrastructure.	Albert S, 2018, AM J HUM GENET, V102, P517, DOI 10.1016/j.ajhg.2018.02.008; BARDIEN S, 1995, HUM MOL GENET, V4, P1459, DOI 10.1093/hmg/4.8.1459; Cherry TJ, 2020, P NATL ACAD SCI USA, V117, P9001, DOI 10.1073/pnas.1922501117; Conrad DF, 2010, NAT GENET, V42, P385, DOI 10.1038/ng.564; Daiger SP, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a017129; den Hollander A, 1999, HUM GENET, V104, P73, DOI 10.1007/s004390050912; Diaz N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06961-0; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Durand NC, 2016, CELL SYST, V3, P95, DOI 10.1016/j.cels.2016.07.002; Fishilevich S., 2017, DATABASE, V2017, P2017, DOI DOI 10.1093/DATABASE/BAX028; Franke M, 2016, NATURE, V538, P265, DOI 10.1038/nature19800; Friedman JS, 2010, P NATL ACAD SCI USA, V107, P15523, DOI 10.1073/pnas.1002897107; Golovleva I, 2010, ADV EXP MED BIOL, V664, P255, DOI 10.1007/978-1-4419-1399-9_29; Gu S, 2015, HUM MOL GENET, V24, P4061, DOI 10.1093/hmg/ddv146; Haer-Wigman L, 2017, EUR J HUM GENET, V25, P591, DOI 10.1038/ejhg.2017.9; Hamel C, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-40; Ibrahim DM, 2020, CURR OPIN CELL BIOL, V64, P1, DOI 10.1016/j.ceb.2020.01.003; Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7; Kmoch S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6614; Koehn L, 2008, INVEST OPHTH VIS SCI, V49, P3172, DOI 10.1167/iovs.07-1664; Lidgerwood GE, 2018, BBA-MOL CELL BIOL L, V1863, P750, DOI 10.1016/j.bbalip.2018.04.007; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lohan S, 2014, CLIN GENET, V86, P318, DOI 10.1111/cge.12352; Lukowski SW, 2019, EMBO J, V38, DOI 10.15252/embj.2018100811; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; Melo US, 2020, AM J HUM GENET, V106, P872, DOI 10.1016/j.ajhg.2020.04.016; Ngcungcu T, 2017, AM J HUM GENET, V100, P737, DOI 10.1016/j.ajhg.2017.03.012; Ohshima N, 2015, J BIOL CHEM, V290, P4260, DOI 10.1074/jbc.M114.614537; Peng YR, 2019, CELL, V176, P1222, DOI 10.1016/j.cell.2019.01.004; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rebello G, 2004, P NATL ACAD SCI USA, V101, P6617, DOI 10.1073/pnas.0401529101; Sangermano R, 2016, OPHTHALMOLOGY, V123, P1375, DOI 10.1016/j.ophtha.2016.01.053; Schwarz N, 2017, HUM MOL GENET, V26, P2480, DOI 10.1093/hmg/ddx143; Spielmann M, 2018, NAT REV GENET, V19, P453, DOI 10.1038/s41576-018-0007-0; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; Sullivan LS, 2013, INVEST OPHTH VIS SCI, V54, P6255, DOI 10.1167/iovs.13-12605; Tsuboi K, 2015, BBA-MOL CELL BIOL L, V1851, P537, DOI 10.1016/j.bbalip.2015.01.002; Verbakel SK, 2018, PROG RETIN EYE RES, V66, P157, DOI 10.1016/j.preteyeres.2018.03.005; Zhang F, 2009, NAT GENET, V41, P849, DOI 10.1038/ng.399	41	32	32	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 5	2020	107	5					802	814		10.1016/j.ajhg.2020.09.002	http://dx.doi.org/10.1016/j.ajhg.2020.09.002			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	OP1QL	33022222	Green Published, Green Accepted, hybrid			2022-12-18	WOS:000587855200003
J	LoPresti, M; Beck, DB; Duggal, P; Cummings, DAT; Solomon, BD				LoPresti, Marissa; Beck, David B.; Duggal, Priya; Cummings, Derek A. T.; Solomon, Benjamin D.			The Role of Host Genetic Factors in Coronavirus Susceptibility: Review of Animal and Systematic Review of Human Literature	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							RESPIRATORY SYNDROME CORONAVIRUS; FELINE INFECTIOUS PERITONITIS; MOUSE HEPATITIS-VIRUS; GENOME-WIDE ASSOCIATION; AMINOPEPTIDASE-N; FUNCTIONAL RECEPTOR; BRONCHITIS VIRUS; L-SIGN; SARS; RESISTANCE	The SARS-CoV-2 pandemic raises many scientific and clinical questions. These include how host genetic factors affect disease susceptibility and pathogenesis. New work is emerging related to SARS-CoV-2; previous work has been conducted on other coronaviruses that affect different species. We reviewed the literature on host genetic factors related to coronaviruses, systematically focusing on human studies. We identified 1,832 articles of potential relevance. Seventy-five involved human host genetic factors, 36 of which involved analysis of specific genes or loci; aside from one meta-analysis, all were candidate-driven studies, typically investigating small numbers of research subjects and loci. Three additional case reports were described. Multiple significant loci were identified, including 16 related to susceptibility (seven of which identified protective alleles) and 16 related to outcomes (three of which identified protective alleles). The types of cases and controls used varied considerably; four studies used traditional replication/validation cohorts. Among other studies, 30 involved both human and non-human host genetic factors related to coronavirus, 178 involved study of non-human (animal) host genetic factors related to coronavirus, and 984 involved study of non-genetic host factors related to coronavirus, including involving immunopathogenesis. Previous human studies have been limited by issues that may be less impactful now, including low numbers of eligible participants and limited availability of advanced genomic methods; however, these may raise additional considerations. We outline key genes and loci from animal and human host genetic studies that may bear investigation in the study of COVID-19. We also discuss how previous studies may direct current lines of inquiry.	[LoPresti, Marissa] Univ Florida, Coll Vet Med, Gainesville, FL 32611 USA; [Beck, David B.] NHGRI, Inflammatory Dis Sect, NIH, Bethesda, MD 20892 USA; [Duggal, Priya] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Cummings, Derek A. T.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Cummings, Derek A. T.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA; [Solomon, Benjamin D.] NHGRI, Off Clin Director, NIH, Bethesda, MD 20892 USA	State University System of Florida; University of Florida; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; State University System of Florida; University of Florida; State University System of Florida; University of Florida; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Solomon, BD (corresponding author), NHGRI, Off Clin Director, NIH, Bethesda, MD 20892 USA.	solomonb@mail.nih.gov		Duggal, Priya/0000-0001-5809-2081; Solomon, Benjamin/0000-0002-8826-1023	Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health; US National Institutes of Health [R01-AI114703-01, 2R01AI148049-21A1]	Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported in part by the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health. B.D.S. and D.B.B. are National Institutes of Health employees. P.D. was supported by the US National Institutes of Health award 2R01AI148049-21A1. D.A.T.C. was supported by the US National Institutes of Health award R01-AI114703-01.	Abbott TR, 2020, CELL, V181, P865, DOI 10.1016/j.cell.2020.04.020; Addie DD, 2004, J FELINE MED SURG, V6, P59, DOI 10.1016/j.jfms.2003.12.010; Asselta R, 2020, AGING-US, V12, P10087, DOI 10.18632/aging.103415; Bacon LD, 2004, AVIAN PATHOL, V33, P605, DOI 10.1080/03079450400013147; Bakkers MJG, 2016, P NATL ACAD SCI USA, V113, pE3111, DOI 10.1073/pnas.1519881113; BANG FB, 1982, ADV EXP MED BIOL, V142, P359; Barquera R, 2020, HLA, V96, P277, DOI 10.1111/tan.13956; Basit A, 2021, J BIOMOL STRUCT DYN, V39, P3605, DOI 10.1080/07391102.2020.1768150; Bell ET, 2006, AUST VET J, V84, P2, DOI 10.1111/j.1751-0813.2006.tb13114.x; Benbacer L, 1997, J VIROL, V71, P734, DOI 10.1128/JVI.71.1.734-737.1997; Broughton JP, 2020, NAT BIOTECHNOL, V38, P870, DOI 10.1038/s41587-020-0513-4; BUMSTEAD N, 1989, BRIT POULTRY SCI, V30, P39, DOI 10.1080/00071668908417123; Bunyavanich S, 2020, JAMA-J AM MED ASSOC, V323, P2427, DOI 10.1001/jama.2020.8707; Cao YN, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0147-1; Casanova JL, 2020, CELL, V181, P1194, DOI 10.1016/j.cell.2020.05.016; Chai PW, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-00883-5; Chan JFW, 2020, CLIN INFECT DIS, V71, P2428, DOI 10.1093/cid/ciaa325; Chan KCA, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-26; Chan VSF, 2006, NAT GENET, V38, P38, DOI 10.1038/ng1698; Chen JW, 2019, ANIM SCI J, V90, P366, DOI 10.1111/asj.13163; Chu YK, 2008, VIROLOGY, V374, P151, DOI 10.1016/j.virol.2007.12.032; Cruz JD, 2021, J MED VIROL, V93, P71, DOI 10.1002/jmv.26126; Cui J, 2007, EMERG INFECT DIS, V13, P1526, DOI 10.3201/eid1310.070448; Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9; Cui J, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-304; Cui TT, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12040402; Curtis J, 2015, NAT GENET, V47, P523, DOI 10.1038/ng.3248; da Silva AP, 2017, AVIAN DIS, V61, P358, DOI 10.1637/11666-050117-RegR; Daley GQ, 2019, NEW ENGL J MED, V380, P897, DOI 10.1056/NEJMp1900504; DAMY SB, 1992, BRAZ J MED BIOL RES, V25, P1025; Dawes ME, 2014, POULTRY SCI, V93, P830, DOI 10.3382/ps.2013-03511; DAYA M, 1990, ADV EXP MED BIOL, V276, P59; de Groot NG, 2020, IMMUNOGENETICS, V72, P275, DOI 10.1007/s00251-020-01165-7; Debnath M, 2020, FASEB J, V34, P8787, DOI 10.1096/fj.202001115R; DELMAS B, 1992, NATURE, V357, P417, DOI 10.1038/357417a0; Dobrynin P, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0837-4; Doganay L, 2020, NORTH CLIN ISTANB, V7, P311, DOI 10.14744/nci.2020.30075; Faiq M.A., 2020, MED HYPOTHESES, V144; Fan CM, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.132796; Fish I, 2015, IMMUNOGENETICS, V67, P487, DOI 10.1007/s00251-015-0855-0; Foley JE, 1997, J AM VET MED ASSOC, V210, P1313; Fresard L, 2019, NAT MED, V25, P911, DOI 10.1038/s41591-019-0457-8; Fukuma A, 2015, ARCH VIROL, V160, P2293, DOI 10.1007/s00705-015-2506-z; GALLILY R, 1964, P NATL ACAD SCI USA, V51, P1158, DOI 10.1073/pnas.51.6.1158; Gaunt ER, 2010, J CLIN MICROBIOL, V48, P2940, DOI 10.1128/JCM.00636-10; Giudicessi JR, 2020, HEART RHYTHM, V17, P1487, DOI 10.1016/j.hrthm.2020.04.045; GLEDHILL AW, 1951, BRIT J EXP PATHOL, V32, P559; Golovko L, 2013, VIRUS RES, V175, P58, DOI 10.1016/j.virusres.2013.04.006; Gordon DE, 2020, NATURE, V583, P459, DOI 10.1038/s41586-020-2286-9; Gralinski LE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005504; Guenet Jean-Louis, 2005, Briefings in Functional Genomics & Proteomics, V4, P225, DOI 10.1093/bfgp/4.3.225; Hofmann H, 2005, P NATL ACAD SCI USA, V102, P7988, DOI 10.1073/pnas.0409465102; Hou YX, 2010, ARCH VIROL, V155, P1563, DOI 10.1007/s00705-010-0729-6; Hsieh LE, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-57; Hussain M, 2020, J MED VIROL, V92, P1580, DOI 10.1002/jmv.25832; Ignjatovic J, 2003, J COMP PATHOL, V128, P92, DOI 10.1053/jcpa.2002.0609; Inoue Y, 2007, J VIROL, V81, P8722, DOI 10.1128/JVI.00253-07; Jeffers SA, 2004, P NATL ACAD SCI USA, V101, P15748, DOI 10.1073/pnas.0403812101; KANTOCH M, 1963, J EXP MED, V117, P781, DOI 10.1084/jem.117.5.781; Karnam G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002710; Kim YI, 2020, CELL HOST MICROBE, V27, P704, DOI 10.1016/j.chom.2020.03.023; Kyuwa S, 2002, VIRUS RES, V83, P169, DOI 10.1016/S0168-1702(01)00432-4; Le owitz, 2012, 9 INT COMM TAX VIR, P806, DOI [10.1016/B978-0-12-384684-6.00068-9, DOI 10.1016/B978-0-12-384684-6.00068-9]; Le Poder S, 2011, ADV VIROL, V2011, DOI 10.1155/2011/609465; Lei Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005466; Leopardi S, 2018, INFECT GENET EVOL, V58, P279, DOI 10.1016/j.meegid.2018.01.012; LEVYLEBLOND E, 1979, J IMMUNOL, V122, P1359; Li F, 2008, J VIROL, V82, P6984, DOI 10.1128/JVI.00442-08; Li K K B, 2012, Hong Kong Med J, V18 Suppl 3, P35; Li WT, 2017, VIRUS RES, V235, P6, DOI 10.1016/j.virusres.2017.03.018; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Liang LC, 2005, DNA CELL BIOL, V24, P485, DOI 10.1089/dna.2005.24.485; Liu BM, 2014, J VIROL, V88, P13821, DOI 10.1128/JVI.02505-14; Luo CL, 2014, INFECT GENET EVOL, V21, P351, DOI 10.1016/j.meegid.2013.12.004; Manrai AK, 2016, NEW ENGL J MED, V375, P655, DOI 10.1056/NEJMsa1507092; Martina BEE, 2003, NATURE, V425, P915, DOI 10.1038/425915a; McAuliffe J, 2004, VIROLOGY, V330, P8, DOI 10.1016/j.virol.2004.09.030; Miguel E, 2017, EUROSURVEILLANCE, V22, P15, DOI 10.2807/1560-7917.ES.2017.22.13.30498; Mihm S, 2020, J INNATE IMMUN, V12, P273, DOI 10.1159/000508076; Nagata N, 2007, J VIROL, V81, P1848, DOI 10.1128/JVI.01967-06; Nguyen A, 2020, J VIROL, V94, DOI 10.1128/JVI.00510-20; Norris JM, 2005, AUST VET J, V83, P666, DOI 10.1111/j.1751-0813.2005.tb13044.x; OBRIEN SJ, 1985, SCIENCE, V227, P1428, DOI 10.1126/science.2983425; Patarcic I, 2015, SCI REP-UK, V5, DOI 10.1038/srep16119; Pedersen NC, 2014, VET IMMUNOL IMMUNOP, V162, P33, DOI 10.1016/j.vetimm.2014.09.001; Perricone C, 2020, CLIN EXP RHEUMATOL, V38, P580; Pesteanu-Somogyi LD, 2006, J FELINE MED SURG, V8, P1, DOI 10.1016/j.jfms.2005.04.003; Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005; Rehman SU, 2020, CLIN SCI, V134, P1143, DOI 10.1042/CS20200419; Schaefer GO, 2020, VACCINE, V38, P5085, DOI 10.1016/j.vaccine.2020.06.007; Schickli JH, 2004, J VIROL, V78, P9073, DOI 10.1128/JVI.78.17.9073-9083.2004; Shi JZ, 2020, SCIENCE, V368, P1016, DOI 10.1126/science.abb7015; Shivarov V, 2020, INT J IMMUNOGENET, V47, P329, DOI 10.1111/iji.12503; SMITH MS, 1984, J IMMUNOL, V133, P428; Smits SL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000756; Song HD, 2005, P NATL ACAD SCI USA, V102, P2430, DOI 10.1073/pnas.0409608102; Stergachis AB, 2020, NAT MED, V26, P991, DOI 10.1038/s41591-020-0953-x; Tresnan DB, 1996, J VIROL, V70, P8669, DOI 10.1128/JVI.70.12.8669-8674.1996; Tu CF, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217236; Tusell SM, 2007, J VIROL, V81, P1261, DOI 10.1128/JVI.01510-06; UYSAL BB, 2020, J MED VIROL, DOI DOI 10.1002/JMV.26106; Van den Brand JMA, 2008, VET PATHOL, V45, P551, DOI 10.1354/vp.45-4-551; van Doremalen N, 2016, J VIROL, V90, P5499, DOI 10.1128/JVI.03267-15; van Doremalen N, 2014, J VIROL, V88, P9220, DOI 10.1128/JVI.00676-14; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; von Brunn A, 2015, CURR OPIN VIROL, V14, P56, DOI 10.1016/j.coviro.2015.08.004; Wang P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36226; Wang WH, 2015, J APPL GENET, V56, P365, DOI 10.1007/s13353-014-0269-y; Wang YT, 2014, VET RES, V45, DOI 10.1186/s13567-014-0123-6; Whitworth KM, 2019, TRANSGENIC RES, V28, P21, DOI 10.1007/s11248-018-0100-3; WILLIAMS RK, 1991, P NATL ACAD SCI USA, V88, P5533, DOI 10.1073/pnas.88.13.5533; WILSON GAR, 1988, J VIROL, V62, P3371, DOI 10.1128/JVI.62.9.3371-3377.1988; Woo PCY, 2009, EXP BIOL MED, V234, P1117, DOI 10.3181/0903-MR-94; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; YEAGER CL, 1992, NATURE, V357, P420, DOI 10.1038/357420a0; Yousefzadegan S, 2020, AM J TROP MED HYG, V102, P1203, DOI 10.4269/ajtmh.20-0240; Zhang G, 2017, NEW ENGL J MED, V377, P1156, DOI 10.1056/NEJMoa1612665; Zhang XN, 2020, NATURE, V583, P437, DOI [10.1038/s41586-020-2355-0, 10.1007/s00521-020-05117-w]; Zhao XS, 2018, J VIROL, V92, DOI 10.1128/JVI.01535-17; Zhao XS, 2014, P NATL ACAD SCI USA, V111, P6756, DOI 10.1073/pnas.1320856111	120	32	32	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 3	2020	107	3					381	402		10.1016/j.ajhg.2020.08.007	http://dx.doi.org/10.1016/j.ajhg.2020.08.007			22	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NJ2TF	32814065	Bronze, Green Published, Green Submitted			2022-12-18	WOS:000565899700002
J	Motta, M; Pannone, L; Pantaleoni, F; Bocchinfuso, G; Radio, FC; Cecchetti, S; Ciolfi, A; Di Rocco, M; Elting, MW; Brilstra, EH; Boni, S; Mazzanti, L; Tamburrino, F; Walsh, L; Payne, K; Fernandez-Jaen, A; Ganapathi, M; Chung, WK; Grange, DK; Dave-Wala, A; Reshmi, SC; Bartholomew, DW; Mouhlas, D; Carpentieri, G; Bruselles, A; Pizzi, S; Bellacchio, E; Piceci-Sparascio, F; Lissewski, C; Brinkmann, J; Waclaw, RR; Waisfisz, Q; van Gassen, K; Wentzensen, IM; Morrow, MM; Alvarez, S; Martinez-Garcia, M; De Luca, A; Memo, L; Zampino, G; Rossi, C; Seri, M; Gelb, BD; Zenker, M; Dallapiccola, B; Stella, L; Prada, CE; Martinelli, S; Flex, E; Tartaglia, M				Motta, Marialetizia; Pannone, Luca; Pantaleoni, Francesca; Bocchinfuso, Gianfranco; Radio, Francesca Clementina; Cecchetti, Serena; Ciolfi, Andrea; Di Rocco, Martina; Elting, Mariet W.; Brilstra, Eva H.; Boni, Stefania; Mazzanti, Laura; Tamburrino, Federica; Walsh, Larry; Payne, Katelyn; Fernandez-Jaen, Alberto; Ganapathi, Mythily; Chung, Wendy K.; Grange, Dorothy K.; Dave-Wala, Ashita; Reshmi, Shalini C.; Bartholomew, Dennis W.; Mouhlas, Danielle; Carpentieri, Giovanna; Bruselles, Alessandro; Pizzi, Simone; Bellacchio, Emanuele; Piceci-Sparascio, Francesca; Lissewski, Christina; Brinkmann, Julia; Waclaw, Ronald R.; Waisfisz, Quinten; van Gassen, Koen; Wentzensen, Ingrid M.; Morrow, Michelle M.; Alvarez, Sara; Martinez-Garcia, Monica; De Luca, Alessandro; Memo, Luigi; Zampino, Giuseppe; Rossi, Cesare; Seri, Marco; Gelb, Bruce D.; Zenker, Martin; Dallapiccola, Bruno; Stella, Lorenzo; Prada, Carlos E.; Martinelli, Simone; Flex, Elisabetta; Tartaglia, Marco			Enhanced MAPK1 Function Causes a Neurodevelopmental Disorder within the RASopathy Clinical Spectrum	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OF-FUNCTION MUTATIONS; CAUSE NOONAN; GENETIC-VARIATION; KINASE ERK2; ELEGANS; PATHWAY; GERMLINE; PROTEINS; PATHOGENICITY; SPECIFICITY	Signal transduction through the RAF-MEK-ERK pathway, the first described mitogen-associated protein kinase (MAPK) cascade, mediates multiple cellular processes and participates in early and late developmental programs. Aberrant signaling through this cascade contributes to oncogenesis and underlies the RASopathies, a family of cancer-prone disorders. Here, we report that de novo missense variants in MAPK1, encoding the mitogen-activated protein kinase 1 (i.e., extracellular signal-regulated protein kinase 2, ERK2), cause a neurodevelopmental disease within the RASopathy phenotypic spectrum, reminiscent of Noonan syndrome in some subjects. Pathogenic variants promote increased phosphorylation of the kinase, which enhances translocation to the nucleus and boosts MAPK signaling in vitro and in vivo. Two variant classes are identified, one of which directly disrupts binding to MKP3, a dual-specificity protein phosphatase negatively regulating ERK function. Importantly, signal dysregulation driven by pathogenic MAPK1 variants is stimulus reliant and retains dependence on MEK activity. Our data support a model in which the identified pathogenic variants operate with counteracting effects on MAPK1 function by differentially impacting the ability of the kinase to interact with regulators and substrates, which likely explains the minor role of these variants as driver events contributing to oncogenesis. After nearly 20 years from the discovery of the first gene implicated in Noonan syndrome, PTPN11, the last tier of the MAPK cascade joins the group of genes mutated in RASopathies.	[Motta, Marialetizia; Pannone, Luca; Pantaleoni, Francesca; Radio, Francesca Clementina; Ciolfi, Andrea; Carpentieri, Giovanna; Pizzi, Simone; Bellacchio, Emanuele; Dallapiccola, Bruno; Tartaglia, Marco] Osped Pediat Bambino Gesu, IRCCS, Genet & Rare Dis Res Div, I-00146 Rome, Italy; [Pannone, Luca; Di Rocco, Martina; Carpentieri, Giovanna; Bruselles, Alessandro; Martinelli, Simone; Flex, Elisabetta] Ist Super Sanita, Dept Oncol & Mol Med, I-00161 Rome, Italy; [Bocchinfuso, Gianfranco; Stella, Lorenzo] Univ Roma Tor Vergata, Dept Chem Sci & Technol, I-00133 Rome, Italy; [Cecchetti, Serena] Ist Super Sanita, Core Facil, Microscopy Area, I-00161 Rome, Italy; [Di Rocco, Martina] Sapienza Univ Rome, Dept Biochem Sci A Rossi Fanelli, I-00185 Rome, Italy; [Elting, Mariet W.; Waisfisz, Quinten] Vrije Univ, Dept Clin Genet, Amsterdam UMC, NL-1117 Amsterdam, Netherlands; [Brilstra, Eva H.; van Gassen, Koen] Univ Med Ctr Utrecht, Dept Genet, NL-3584 CX Utrecht, Netherlands; [Boni, Stefania] San Martino Hosp, Med Genet Unit, I-32100 Belluno, Italy; [Mazzanti, Laura; Tamburrino, Federica] Univ Bologna, Policlin S Orsola Malpighi Hosp, Dept Med & Surg Sci, I-40138 Bologna, Italy; [Walsh, Larry; Payne, Katelyn] Indiana Univ Hlth Riley Hosp Children, Indianapolis, IN 46202 USA; [Fernandez-Jaen, Alberto] Univ Europea Madrid, Hosp Univ Quiron Madrid, Dept Pediat Neurol, Madrid 28223, Spain; [Ganapathi, Mythily] Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY 10032 USA; [Chung, Wendy K.] Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10032 USA; [Chung, Wendy K.] Columbia Univ, Dept Med, Med Ctr, New York, NY 10032 USA; [Grange, Dorothy K.] Washington Univ, Dept Pediat, Div Genet & Genom Med, Sch Med, St Louis, MO 63110 USA; [Dave-Wala, Ashita; Reshmi, Shalini C.; Bartholomew, Dennis W.; Mouhlas, Danielle] Nationwide Childrens Hosp, Inst Genom Med, Columbus, OH 43215 USA; [Reshmi, Shalini C.] Nationwide Childrens Hosp, Dept Pediat, Columbus, OH 43215 USA; [Piceci-Sparascio, Francesca; De Luca, Alessandro] Fdn IRCCS Casa Sollievo della Sofferenza, Med Genet Div, I-71013 San Giovanni Rotondo, Italy; [Lissewski, Christina; Brinkmann, Julia; Zenker, Martin] Univ Hosp Magdeburg, Inst Human Genet, D-39120 Magdeburg, Germany; [Waclaw, Ronald R.; Prada, Carlos E.] Univ Cincinnati, Dept Pediat, Coll Med, Cincinnati, OH 45229 USA; [Wentzensen, Ingrid M.; Morrow, Michelle M.] GeneDx, Gaithersburg, MD 20877 USA; [Alvarez, Sara; Martinez-Garcia, Monica] NimGenetics, Med Dept, Madrid 28049, Spain; [Memo, Luigi] Osped San Bortolo, Ambulatorio Genet Clin, I-36100 Vicenza, Italy; [Zampino, Giuseppe] Univ Cattolica Sacro Cuore, Fdn Policlin Univ Gemelli, Ctr Rare Dis & Congenital Defects, I-00168 Rome, Italy; [Rossi, Cesare; Seri, Marco] Univ Bologna, Med Genet Unit, Policlin S Orsola Malpighi, I-40138 Bologna, Italy; [Gelb, Bruce D.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA; [Gelb, Bruce D.] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA; [Prada, Carlos E.] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA	IRCCS Bambino Gesu; Istituto Superiore di Sanita (ISS); University of Rome Tor Vergata; Istituto Superiore di Sanita (ISS); Sapienza University Rome; Vrije Universiteit Amsterdam; Utrecht University; Utrecht University Medical Center; ULSS 1 Dolomiti; Ospedale di Belluno; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; European University of Madrid; Columbia University; Columbia University; Columbia University; Washington University (WUSTL); University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University Hospital Magdeburg; University System of Ohio; University of Cincinnati; ULSS 8 Berica; Ospedale San Bortolo di Vicenza; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Cincinnati Children's Hospital Medical Center	Tartaglia, M (corresponding author), Osped Pediat Bambino Gesu, IRCCS, Genet & Rare Dis Res Div, I-00146 Rome, Italy.	marco.tartaglia@opbg.net	Tartaglia, Marco/K-2955-2018; PANNONE, LUCA/AAC-1528-2021; Carpentieri, Giovanna/AAT-9814-2021; Di Rocco, Martina/AAB-3317-2022; Bruselles, Alessandro/M-6012-2019; Flex, Elisabetta/A-5958-2017; Cecchetti, Serena/N-1061-2015; Bocchinfuso, Gianfranco/E-9014-2011; Ciolfi, Andrea/J-4954-2018; Rossi, Cesare/AAC-2083-2022; Martinelli, Simone/J-9432-2018; Martinez, Monica/ABE-7034-2021; Martinez, Monica/HDM-9565-2022; Brilstra, Eva/AAT-3092-2021; Stella, Lorenzo/A-7996-2010; De Luca, Alessandro/B-2179-2017	Tartaglia, Marco/0000-0001-7736-9672; PANNONE, LUCA/0000-0001-7027-8196; Carpentieri, Giovanna/0000-0001-5526-6015; Bruselles, Alessandro/0000-0002-1556-4998; Flex, Elisabetta/0000-0002-6802-1356; Cecchetti, Serena/0000-0002-3601-176X; Bocchinfuso, Gianfranco/0000-0002-5556-7691; Ciolfi, Andrea/0000-0002-6191-0978; Rossi, Cesare/0000-0003-1826-615X; Martinelli, Simone/0000-0002-5843-419X; Stella, Lorenzo/0000-0002-5489-7381; Waisfisz, Quinten/0000-0002-7384-9182; Di Rocco, Martina/0000-0002-6666-1819; piceci sparascio, francesca/0000-0002-6920-8841; Prada, Carlos/0000-0003-3348-3531; De Luca, Alessandro/0000-0002-4408-8062	NIH Office of Research Infrastructure Programs [P40 OD010440]; EJP-RD (NSEuroNet); AIRC [IG 21614]; Ministero della Salute; JPB Foundation	NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EJP-RD (NSEuroNet); AIRC(Fondazione AIRC per la ricerca sul cancro); Ministero della Salute(Ministry of Health, Italy); JPB Foundation	The authors thank the subjects and their families for participating in this study. We are grateful to Shin Takagi (University of Nagoya, Japan) and James D. McGhee (University of Calgary, Canada) for providing the original plasmids used for C. elegans studies, and Serenella Venanzi (Istituto Superiore di Sanita`, Rome, Italy) and Rosalba Carrozzo (Ospedale Pediatrico Bambino Gesu`, Rome, Italy) for technical assistance. C. elegans strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). This work was supported by grants from EJP-RD (NSEuroNet) to M.Z. and M.T. and by AIRC (IG 21614) and Ministero della Salute (Ricerca Corrente 2019, 2020) to M.T. Funding from the JPB Foundation was provided to W.K.C.	Aoki Y, 2016, J HUM GENET, V61, P33, DOI 10.1038/jhg.2015.114; Aoki Y, 2013, AM J HUM GENET, V93, P173, DOI 10.1016/j.ajhg.2013.05.021; AROIAN RV, 1991, GENETICS, V128, P251; AROIAN RV, 1994, EMBO J, V13, P360, DOI 10.1002/j.1460-2075.1994.tb06269.x; Bauer CK, 2018, AM J HUM GENET, V103, P621, DOI 10.1016/j.ajhg.2018.09.001; Brenan L, 2016, CELL REP, V17, P1171, DOI 10.1016/j.celrep.2016.09.061; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Dunnett-Kane V, 2020, ANN ONCOL, V31, P873, DOI 10.1016/j.annonc.2020.03.291; Emrick MA, 2006, P NATL ACAD SCI USA, V103, P18101, DOI 10.1073/pnas.0608849103; Flex E, 2019, AM J HUM GENET, V105, P493, DOI 10.1016/j.ajhg.2019.07.007; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; Gilmartin AG, 2011, CLIN CANCER RES, V17, P989, DOI 10.1158/1078-0432.CCR-10-2200; Hayashi S, 2020, CURR OPIN GENET DEV, V63, P9, DOI 10.1016/j.gde.2020.01.004; Ioannidis NM, 2016, AM J HUM GENET, V99, P877, DOI 10.1016/j.ajhg.2016.08.016; Johnston JJ, 2018, GENET MED, V20, P1175, DOI 10.1038/gim.2017.249; Kaboord Barbara, 2008, V424, P349, DOI 10.1007/978-1-60327-064-9_27; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Kratz CP, 2015, BRIT J CANCER, V112, P1392, DOI 10.1038/bjc.2015.75; Krens SFG, 2006, FEBS LETT, V580, P4984, DOI 10.1016/j.febslet.2006.08.025; Lackner MR, 1998, GENETICS, V150, P103; LACKNER MR, 1994, GENE DEV, V8, P160, DOI 10.1101/gad.8.2.160; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li Q, 2017, AM J HUM GENET, V100, P267, DOI 10.1016/j.ajhg.2017.01.004; Magini P, 2019, AM J HUM GENET, V105, P689, DOI 10.1016/j.ajhg.2019.08.006; Maik-Rachline G, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051194; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; Martinelli S, 2008, HUM MOL GENET, V17, P2018, DOI 10.1093/hmg/ddn099; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miller CR, 2020, CSH MOL CASE STUD, V6, DOI 10.1101/mcs.a005231; Motta M, 2019, HUM MOL GENET, V28, P1007, DOI 10.1093/hmg/ddy412; Motta M, 2016, HUM MOL GENET, V25, P3824, DOI 10.1093/hmg/ddw229; Paix A, 2015, GENETICS, V201, P47, DOI 10.1534/genetics.115.179382; Pandit B, 2007, NAT GENET, V39, P1007, DOI 10.1038/ng2073; Peti W, 2013, PROTEIN SCI, V22, P1698, DOI 10.1002/pro.2374; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plotnikov Alexander, 2019, Cell Physiol Biochem, V53, P366, DOI 10.33594/000000144; Rauen KA, 2013, ANNU REV GENOM HUM G, V14, P355, DOI 10.1146/annurev-genom-091212-153523; Razzaque MA, 2007, NAT GENET, V39, P1013, DOI 10.1038/ng2078; Retterer K, 2016, GENET MED, V18, P696, DOI 10.1038/gim.2015.148; Roberts AE, 2007, NAT GENET, V39, P70, DOI 10.1038/ng1926; Roberts AE, 2013, LANCET, V381, P333, DOI 10.1016/S0140-6736(12)61023-X; Rodriguez C, 2019, J NEUROCHEM, V151, P103, DOI 10.1111/jnc.14828; Roskoski R, 2015, PHARMACOL RES, V100, P1, DOI 10.1016/j.phrs.2015.07.010; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Samatar AA, 2014, NAT REV DRUG DISCOV, V13, P928, DOI 10.1038/nrd4281; Sammons RM, 2019, MOL CARCINOGEN, V58, P1551, DOI 10.1002/mc.23047; Shapovalov MV, 2011, STRUCTURE, V19, P844, DOI 10.1016/j.str.2011.03.019; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Simanshu DK, 2017, CELL, V170, P17, DOI 10.1016/j.cell.2017.06.009; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Sternberg PW., 2005, VULVAL DEV, DOI 10.1895/wormbook.1.6.1; Sulston J.E., 1988, NEMATODE CAENORHABDI, P587; Sundaram M.V, 2013, CANONICAL RTK RAS ER; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2007, NAT GENET, V39, P75, DOI 10.1038/ng1939; Tartaglia M, 2010, ANN NY ACAD SCI, V1214, P99, DOI 10.1111/j.1749-6632.2010.05790.x; Thevenon J, 2016, CLIN GENET, V89, P700, DOI 10.1111/cge.12732; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Villani A, 2017, CLIN CANCER RES, V23, pE83, DOI 10.1158/1078-0432.CCR-17-0631; Wiel L, 2017, HUM MUTAT, V38, P1454, DOI 10.1002/humu.23313; WU Y, 1994, GENE DEV, V8, P147, DOI 10.1101/gad.8.2.147; Yamamoto GL, 2015, J MED GENET, V52, P413, DOI 10.1136/jmedgenet-2015-103018; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; ZHANG FM, 1994, NATURE, V367, P704, DOI 10.1038/367704a0; Zhang JL, 2003, J BIOL CHEM, V278, P29901, DOI 10.1074/jbc.M303909200	67	32	33	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 3	2020	107	3					499	513		10.1016/j.ajhg.2020.06.018	http://dx.doi.org/10.1016/j.ajhg.2020.06.018			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NJ2TF	32721402	Bronze, Green Published			2022-12-18	WOS:000565899700010
J	Hunter-Zinck, H; Shi, YL; Li, M; Gorman, BR; Ji, SG; Sun, N; Webster, T; Liem, A; Hsieh, P; Devineni, P; Karnam, P; Gong, X; Radhakrishnan, L; Schmidt, J; Assimes, TL; Huang, J; Pan, CP; Humphries, D; Brophy, M; Moser, J; Muralidhar, S; Huang, GD; Przygodzki, R; Concato, J; Gaziano, JM; Gelernter, J; O'Donnell, CJ; Hauser, ER; Zhao, HY; O'Leary, TJ; Tsao, PS; Pyarajan, S				Hunter-Zinck, Haley; Shi, Yunling; Li, Man; Gorman, Bryan R.; Ji, Sun-Gou; Sun, Ning; Webster, Teresa; Liem, Andrew; Hsieh, Paul; Devineni, Poornima; Karnam, Purushotham; Gong, Xin; Radhakrishnan, Lakshmi; Schmidt, Jeanette; Assimes, Themistocles L.; Huang, Jie; Pan, Cuiping; Humphries, Donald; Brophy, Mary; Moser, Jennifer; Muralidhar, Sumitra; Huang, Grant D.; Przygodzki, Ronald; Concato, John; Gaziano, John M.; Gelernter, Joel; O'Donnell, Christopher J.; Hauser, Elizabeth R.; Zhao, Hongyu; O'Leary, Timothy J.; Tsao, Philip S.; Pyarajan, Saiju		VA Million Vet Program	Genotyping Array Design and Data Quality Control in the Million Veteran Program	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC EPIDEMIOLOGY RESEARCH; ADULT HEALTH; UK BIOBANK; ANCESTRY; RESOURCE	The Million Veteran Program (MVP), initiated by the Department of Veterans Affairs (VA), aims to collect biosamples with consent from at least one million veterans. Presently, blood samples have been collected from over 800,000 enrolled participants. The size and diversity of the MVP cohort, as well as the availability of extensive VA electronic health records, make it a promising resource for precision medicine. MVP is conducting array-based genotyping to provide a genome-wide scan of the entire cohort, in parallel with wholegenome sequencing, methylation, and other 'omics assays. Here, we present the design and performance of the MVP 1.0 custom Axiom array, which was designed and developed as a single assay to be used across the multi-ethnic MVP cohort. A unified genetic quality-control analysis was developed and conducted on an initial tranche of 485,856 individuals, leading to a high-quality dataset of 459,777 unique individuals. 668,418 genetic markers passed quality control and showed high-quality genotypes not only on common variants but also on rare variants. We confirmed that, with non-European individuals making up nearly 30%, MVP's substantial ancestral diversity surpasses that of other large biobanks. We also demonstrated the quality of the MVP dataset by replicating established genetic associations with height in European Americans and African Americans ancestries. This current dataset has been made available to approved MVP researchers for genome-wide association studies and other downstream analyses. Further data releases will be available for analysis as recruitment at the VA continues and the cohort expands both in size and diversity.	[Hunter-Zinck, Haley; Shi, Yunling; Li, Man; Gorman, Bryan R.; Ji, Sun-Gou; Liem, Andrew; Hsieh, Paul; Devineni, Poornima; Karnam, Purushotham; Gong, Xin; Huang, Jie; Humphries, Donald; Brophy, Mary; Gaziano, John M.; O'Donnell, Christopher J.; Pyarajan, Saiju] VA Boston Healthcare Syst, VA Cooperat Studies Program, Boston, MA 02130 USA; [Li, Man] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT 84132 USA; [Gorman, Bryan R.; Liem, Andrew] Booz Allen Hamilton, Mclean, VA 22102 USA; [Ji, Sun-Gou] Seven Bridges, Boston, MA 02129 USA; [Sun, Ning; Concato, John; Gelernter, Joel; Zhao, Hongyu] VA Connecticut Healthcare Syst, VA Cooperat Studies Program, West Haven, CT 06516 USA; [Sun, Ning; Concato, John; Gelernter, Joel; Zhao, Hongyu] Yale Univ, Sch Med, New Haven, CT 06510 USA; [Webster, Teresa; Radhakrishnan, Lakshmi; Schmidt, Jeanette] Thermo Fisher Sci, Santa Clara, CA 95054 USA; [Assimes, Themistocles L.; Pan, Cuiping; Tsao, Philip S.] VA Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; [Assimes, Themistocles L.; Pan, Cuiping; Tsao, Philip S.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Moser, Jennifer; Muralidhar, Sumitra; Huang, Grant D.; Przygodzki, Ronald; O'Leary, Timothy J.] Vet Hlth Adm, Off Res & Dev, Washington, DC 20571 USA; [Gaziano, John M.; Pyarajan, Saiju] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Gaziano, John M.; Pyarajan, Saiju] Harvard Sch Med, Boston, MA 02115 USA; [Hauser, Elizabeth R.] Durham VA Hlth Syst, Durham, NC 27705 USA; [Hauser, Elizabeth R.] Duke Univ, Dept Med, Durham, NC 27617 USA; [Ji, Sun-Gou] Bridgebio Pharma, Palo Alto, CA USA; [Concato, John] Yale Univ, Dept Med, New Haven, CT 06520 USA; [Concato, John] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Utah System of Higher Education; University of Utah; Booz Allen Hamilton Holding Corporation; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; Thermo Fisher Scientific; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Duke University; Yale University; US Food & Drug Administration (FDA)	Pyarajan, S (corresponding author), VA Boston Healthcare Syst, VA Cooperat Studies Program, Boston, MA 02130 USA.; Pyarajan, S (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.; Pyarajan, S (corresponding author), Harvard Sch Med, Boston, MA 02115 USA.	saiju.pyarajan@va.gov	Oleary, Timothy/AAF-2829-2021; Oleary, Timothy/AAE-5219-2021; Assimes, Themistocles Leonard/D-9696-2015	Assimes, Themistocles Leonard/0000-0003-2349-0009; Hauser, Elizabeth/0000-0003-0367-9189; Pan, Cuiping/0000-0002-8152-2489; O'LEARY, TIMOTHY/0000-0002-2435-9136; Przygodzki, Ronald/0000-0002-1238-262X; Ji, Sun-Gou/0000-0001-8652-6318	United States Veterans Administration (VA) Office of Research and Development (ORD), Million Veteran Program [MVP000]; VA Special Fellowship in Medical Informatics	United States Veterans Administration (VA) Office of Research and Development (ORD), Million Veteran Program; VA Special Fellowship in Medical Informatics	This work was funded by the United States Veterans Administration (VA) Office of Research and Development (ORD), Million Veteran Program Grant number MVP000 to S.P. and the VA Special Fellowship in Medical Informatics to H.H.-Z. We would like to thank all Veteran participants in the MVP for donating their samples, information, and time to this project. We additionally thank Anoop Sendamarai and Frederick Dong for critical discussions and providing editorial assistance and review. The content of this manuscript reflects the views of the authors and does not represent the views of the Department of Veterans Affairs, FDA, or the United States Government.	Affimetrix, 2016, AX GEN SOL DAT AN GU; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Banda Y, 2015, GENETICS, V200, P1285, DOI 10.1534/genetics.115.178616; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; C.I.A, 2017, CENTR INT AG WORLD F; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Dai C.L., 2019, BIORXIV, DOI [10.1101/57741, DOI 10.1101/57741]; Diaz-Papkovich A., 2018, BIORXIV, DOI [10.1101/423632, DOI 10.1101/423632]; Galinsky KJ, 2016, AM J HUM GENET, V99, P1130, DOI 10.1016/j.ajhg.2016.09.014; Gaziano JM, 2016, J CLIN EPIDEMIOL, V70, P214, DOI 10.1016/j.jclinepi.2015.09.016; Gelernter J, 2019, NAT NEUROSCI, V22, P1394, DOI 10.1038/s41593-019-0447-7; Klarin D, 2018, NAT GENET, V50, P1514, DOI 10.1038/s41588-018-0222-9; Kranzler HR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09480-8; Kvale MN, 2015, GENETICS, V200, P1051, DOI 10.1534/genetics.115.178905; Loh PR, 2018, NAT GENET, V50, P906, DOI 10.1038/s41588-018-0144-6; Mackun Paul, 2011, CENSUS BRIEFS, V2010, P1; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Manrai AK, 2016, NEW ENGL J MED, V375, P655, DOI 10.1056/NEJMsa1507092; Martin AR, 2019, NAT GENET, V51, P584, DOI 10.1038/s41588-019-0379-x; National Center for Veterans Analysis and Statistics, 2014, TABL 3L LIV VET RAC, P2013; Noel PH, 2010, J GEN INTERN MED, V25, P510, DOI 10.1007/s11606-010-1279-z; Padhukasahasram B, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00204; Petrovski S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1016-y; Popejoy AB, 2016, NATURE, V538, P161, DOI 10.1038/538161a; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Weedon MN, 2019, VERY RARE PATHOGENIC, DOI [10.1101/696799, DOI 10.1101/696799]; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823	32	32	32	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 2	2020	106	4					535	548		10.1016/j.ajhg.2020.03.004	http://dx.doi.org/10.1016/j.ajhg.2020.03.004			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KZ5MJ	32243820	Bronze, Green Published			2022-12-18	WOS:000523306000010
J	Turner, TN; Wilfert, AB; Bakken, TE; Bernier, RA; Pepper, MR; Zhang, ZC; Torene, RI; Retterer, K; Eichler, EE				Turner, Tychele N.; Wilfert, Amy B.; Bakken, Trygve E.; Bernier, Raphael A.; Pepper, Micah R.; Zhang, Zhancheng; Torene, Rebecca I.; Retterer, Kyle; Eichler, Evan E.			Sex-Based Analysis of De Novo Variants in Neurodevelopmental Disorders	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INTELLECTUAL DISABILITY; DEVELOPMENTAL DELAY; MUTATIONS; AUTISM; SPECTRUM; GENES; FRAMEWORK; FORM; ARCHITECTURE; IDENTIFY	While genes with an excess of de novo mutations (DNMs) have been identified in children with neurodevelopmental disorders (NDDs), few studies focus on DNM patterns where the sex of affected children is examined separately. We considered similar to 8,825 sequenced parent-child trios (n similar to 26,475 individuals) and identify 54 genes with a DNM enrichment in males (n = 18), females (n = 17), or overlapping in both the male and female subsets (n = 19). A replication cohort of 18,778 sequenced parent-child trios (n = 56,334 individuals) confirms 25 genes (n = 3 in males, n = 7 in females, n = 15 in both male and female subsets). As expected, we observe significant enrichment on the X chromosome for females but also find autosomal genes with potential sex bias (females, CDK13, ITPR1; males, CHD8, MBDs, SYNGAP1); 6.5% of females harbor a DNM in a female-enriched gene, whereas 2.7% of males have a DNM in a male-enriched gene. Sex-biased genes are enriched in transcriptional processes and chromatin binding, primarily reside in the nucleus of cells, and have brain expression. By down-sampling, we find that DNM gene discovery is greatest when studying affected females. Finally, directly comparing de novo allele counts in NDD-affected males and females identifies one replicated genome-wide significant gene (DDX3X) with locus-specific enrichment in females. Our sex-based DNM enrichment analysis identifies candidate NDD genes differentially affecting males and females and indicates that the study of females with NDDs leads to greater gene discovery consistent with the female-protective effect.	[Turner, Tychele N.; Wilfert, Amy B.; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Bakken, Trygve E.] Allen Inst Brain Sci, Seattle, WA 98109 USA; [Bernier, Raphael A.; Pepper, Micah R.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Zhang, Zhancheng; Torene, Rebecca I.; Retterer, Kyle] GeneDx, 207 Perry Pkwy, Gaithersburg, MD 20877 USA; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Allen Institute for Brain Science; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.; Eichler, EE (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	eee@gs.washington.edu		Turner, Tychele/0000-0001-8246-6477	US National Institutes of Health [NIH R01MH101221]; Autism Science Foundation [16-008]; National Institute of Mental Health [1K99MH117165]; Common Fund of the Office of the Director of the National Institutes of Health; NCI; NHGRI; NHLBI; NIDA; NIMH; NINDS; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101221] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Autism Science Foundation; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Common Fund of the Office of the Director of the National Institutes of Health; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Tonia Brown for assistance in editing this manuscript. This research was supported, in part, by the US National Institutes of Health (NIH R01MH101221) to E.E.E. This work was also supported by a postdoctoral fellowship grant from the Autism Science Foundation (#16-008, T.N.T.) and a grant from the National Institute of Mental Health (1K99MH117165, T.N.T.). E.E.E. is an investigator of the Howard Hughes Medical Institute. The GenotypeTissue Expression (GTEx) Project was supported by the Common Fund of the Office of the Director of the National Institutes of Health, and by NCI, NHGRI, NHLBI, NIDA, NIMH, and NINDS. The data used for the analyses described in this manuscript were obtained from the GTEx Portal on 04/11/2018. Single-nucleus RNA-seq data from human temporal cortex was obtained from the Allen Cell Types Database.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Bernier R, 2014, CELL, V158, P263, DOI 10.1016/j.cell.2014.06.017; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Berryer MH, 2013, HUM MUTAT, V34, P385, DOI 10.1002/humu.22248; Blok LS, 2015, AM J HUM GENET, V97, P343, DOI 10.1016/j.ajhg.2015.07.004; Chakravarti A, 2016, BIOESSAYS, V38, P578, DOI 10.1002/bies.201500203; Coe BP, 2019, NAT GENET, V51, P106, DOI 10.1038/s41588-018-0288-4; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; Feliciano P, 2018, NEURON, V97, P488, DOI 10.1016/j.neuron.2018.01.015; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Fombonne E, 2003, J AUTISM DEV DISORD, V33, P365, DOI 10.1023/A:1025054610557; Geisheker MR, 2017, NAT NEUROSCI, V20, P1043, DOI 10.1038/nn.4589; Gerber S, 2016, AM J HUM GENET, V98, P971, DOI 10.1016/j.ajhg.2016.03.004; Guo H, 2018, MOL AUTISM, V9, DOI 10.1186/s13229-018-0247-z; Haack TB, 2012, AM J HUM GENET, V91, P1144, DOI 10.1016/j.ajhg.2012.10.019; Hamilton MJ, 2018, J MED GENET, V55, P28, DOI 10.1136/jmedgenet-2017-104620; Hashimoto R, 2016, J HUM GENET, V61, P199, DOI 10.1038/jhg.2015.141; Hodge RD, 2019, NATURE, V573, P61, DOI 10.1038/s41586-019-1506-7; Hughes JF, 2015, ANNU REV GENET, V49, P507, DOI 10.1146/annurev-genet-112414-055311; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Jacquemont S, 2014, AM J HUM GENET, V94, P415, DOI 10.1016/j.ajhg.2014.02.001; Kaiser FJ, 2014, HUM MOL GENET, V23, P2888, DOI 10.1093/hmg/ddu002; Kennedy P.J., 2015, UND MENT DIS YOUR GU; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Krumm N, 2015, NAT GENET, V47, P582, DOI 10.1038/ng.3303; Lehnhardt FG, 2016, J AUTISM DEV DISORD, V46, P139, DOI 10.1007/s10803-015-2558-7; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H., 2013, ARXIV13033997; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Mcrae JF, 2017, NATURE, V542, P433, DOI 10.1038/nature21062; Migeon B, 2014, GENDER MED, V4, P97; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; O'Roak BJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6595; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Ober C, 2008, NAT REV GENET, V9, P911, DOI 10.1038/nrg2415; Piton A, 2011, MOL PSYCHIATR, V16, P867, DOI 10.1038/mp.2010.54; Piton A, 2013, AM J HUM GENET, V93, P368, DOI 10.1016/j.ajhg.2013.06.013; Polyak A, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0216-5; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reijnders MRF, 2016, AM J HUM GENET, V98, P373, DOI 10.1016/j.ajhg.2015.12.015; Retterer K, 2016, GENET MED, V18, P696, DOI 10.1038/gim.2015.148; Robinson EB, 2013, P NATL ACAD SCI USA, V110, P5258, DOI 10.1073/pnas.1211070110; Rope AF, 2011, AM J HUM GENET, V89, P28, DOI 10.1016/j.ajhg.2011.05.017; Sarachana T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017116; Smyth G.K, 1998, NUMERICAL INTEGRATIO; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Talkowski ME, 2011, AM J HUM GENET, V89, P551, DOI 10.1016/j.ajhg.2011.09.011; Tukiainen T, 2017, NATURE, V550, P244, DOI 10.1038/nature24265; Turner TN, 2017, NUCLEIC ACIDS RES, V45, pD804, DOI 10.1093/nar/gkw865; Turner TN, 2016, AM J HUM GENET, V98, P58, DOI 10.1016/j.ajhg.2015.11.023; Turner TN, 2015, NATURE, V520, P51, DOI 10.1038/nature14186; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; van de Leemput J, 2007, PLOS GENET, V3, P1076, DOI 10.1371/journal.pgen.0030108; Vollger MR, 2020, ANN HUM GENET, V84, P125, DOI 10.1111/ahg.12364; Vollger MR, 2019, NAT METHODS, V16, P88, DOI 10.1038/s41592-018-0236-3; Ware J.S., 2015, CURR PROTOC HUM GENE, V87; Werling DM, 2013, CURR OPIN NEUROL, V26, P146, DOI 10.1097/WCO.0b013e32835ee548; Yuen RKC, 2017, NAT NEUROSCI, V20, P602, DOI 10.1038/nn.4524	65	32	33	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 5	2019	105	6					1274	1285		10.1016/j.ajhg.2019.11.003	http://dx.doi.org/10.1016/j.ajhg.2019.11.003			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JT4BB	31785789	Green Published, Bronze			2022-12-18	WOS:000500935400016
J	Keppler-Noreuil, KM; Sapp, JC; Lindhurst, MJ; Darling, TN; Burton-Akright, J; Bagheri, M; Dombi, E; Gruber, A; Jarosinski, PF; Martin, S; Nathan, N; Paul, SM; Savage, RE; Wolters, PL; Schwartz, B; Widemann, BC; Biesecker, LG				Keppler-Noreuil, Kim M.; Sapp, Julie C.; Lindhurst, Marjorie J.; Darling, Thomas N.; Burton-Akright, Jasmine; Bagheri, Mohammadhadi; Dombi, Eva; Gruber, Ashlyn; Jarosinski, Paul F.; Martin, Staci; Nathan, Neera; Paul, Scott M.; Savage, Ronald E.; Wolters, Pamela L.; Schwartz, Brian; Widemann, Brigitte C.; Biesecker, Leslie G.			Pharmacodynamic Study of Miransertib in Individuals with Proteus Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PAIN; MUTATION; AKT1	Proteus syndrome is a life-threatening segmental overgrowth syndrome caused by a mosaic gain-of-function AKT1 variant. There are no effective treatments for Proteus syndrome. Miransertib is an AKT1 inhibitor that, prior to this study, has been evaluated only in adult oncology trials. We designed a non-randomized, phase 0/1 pilot study of miransertib in adults and children with Proteus syndrome to identify an appropriate dosage starting point for a future efficacy trial using a pharmacodynamic endpoint. The primary endpoint was a 50% reduction in the tissue levels of AKT phosphorylation from biopsies in affected individuals. We also evaluated secondary efficacy endpoints. We found that a dose of 5 mg/m(2)/day (1/7 the typical dose used in oncology) led to a 50% reduction in phosphorylated AKT (pAKT) in affected tissues from five of six individuals. This dose was well tolerated. Two of the six efficacy endpoints (secondary objectives) suggested that this agent may be efficacious. We observed a decrease in a cerebriform connective tissue nevus and a reduction in pain in children. We conclude that 5 mg/m(2)/day of miransertib is an appropriate starting point for future efficacy trials and that this agent shows promise of therapeutic efficacy in children with Proteus syndrome.	[Keppler-Noreuil, Kim M.; Sapp, Julie C.; Lindhurst, Marjorie J.; Burton-Akright, Jasmine; Gruber, Ashlyn; Biesecker, Leslie G.] NHGRI, Med Genom & Metab Genet Branch, NIH, Bethesda, MD 20892 USA; [Darling, Thomas N.; Nathan, Neera] Uniformed Serv Univ Hlth Sci, Dept Dermatol, Bethesda, MD 20814 USA; [Bagheri, Mohammadhadi] NIH, Clin Ctr, Radiol Dept, Bethesda, MD 20892 USA; [Dombi, Eva; Wolters, Pamela L.; Widemann, Brigitte C.] NCI, Pediat Oncol Branch, NIH, Bethesda, MD 20892 USA; [Jarosinski, Paul F.] NIH, Pharm Dept, Clin Ctr, Bethesda, MD 20892 USA; [Martin, Staci] NCI, Hlth Psychol & Neurobehav Res Grp, NIH, Bethesda, MD 20892 USA; [Paul, Scott M.] NIH, Phys Med Sect, Clin Ctr, Bethesda, MD 20892 USA; [Savage, Ronald E.; Schwartz, Brian] ArQule Inc, Burlington, MA 01803 USA; [Keppler-Noreuil, Kim M.] Childrens Natl Med Ctr, Genet Div, Washington, DC 20010 USA; [Gruber, Ashlyn] Duke Univ, Dept Community & Family Med, Sch Med, Durham, NC 27710 USA; [Nathan, Neera] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Uniformed Services University of the Health Sciences - USA; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Children's National Health System; Duke University; Harvard University; Massachusetts General Hospital	Biesecker, LG (corresponding author), NHGRI, Med Genom & Metab Genet Branch, NIH, Bethesda, MD 20892 USA.	lesb@mail.nih.gov	Lindhurst, Marjorie/AHD-3412-2022	Sapp, Julie/0000-0002-4003-258X; Darling, Thomas/0000-0002-5161-1974	NIH National Human Genome Research Institute Intramural Research Program [HG200328, HG200388]; ArQule Inc.; NATIONAL CANCER INSTITUTE [ZIABC010801] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200388] Funding Source: NIH RePORTER	NIH National Human Genome Research Institute Intramural Research Program; ArQule Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors thank the individuals for participating in this trial. We also thank Claire Driscoll, Julia Fekecs, Hanna Hildenbrandt, Lenita Smith, Anjali Taneja, Evrim Turkbey, and Francine Thomas for their important contributions to the study. This study was supported by the NIH National Human Genome Research Institute Intramural Research Program grants HG200328 and HG200388. ArQule Inc. supported the study through in-kind contributions of miransertib and drug concentration assays via Covance, Inc. through a Clinical Trials Agreement with NHGRI. The trial design was registered prior to participant enrollment at ClinicalTrials.gov NCT02594215	Biesecker L. G, 2010, MANAGEMENT GENETIC S, P651, DOI DOI 10.1002/9780470893159.CH43; Biesecker L, 2006, EUR J HUM GENET, V14, P1151, DOI 10.1038/sj.ejhg.5201638; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; DeWitt EM, 2011, J CLIN EPIDEMIOL, V64, P794, DOI 10.1016/j.jclinepi.2010.10.012; DOWNIE WW, 1978, ANN RHEUM DIS, V37, P378, DOI 10.1136/ard.37.4.378; Hyman D. M., 2018, AM ASS CANC RES AACR; Iqbal J, 2006, ANN CLIN LAB SCI, V36, P469; Irwin DE, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-22; Keppler-Noreuil KM, 2017, AM J MED GENET A, V173, P2359, DOI 10.1002/ajmg.a.38311; Lakhani N., 2017, AM SOC CLIN ONC ASCO; Lindhurst MJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17162; Lindhurst MJ, 2012, NAT GENET, V44, P928, DOI 10.1038/ng.2332; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Martin S, 2015, PAIN MED, V16, P367, DOI 10.1111/pme.12620; Miro J, 2009, EUR J PAIN, V13, P1089, DOI 10.1016/j.ejpain.2009.07.002; Nathan NR, 2018, J AM ACAD DERMATOL, V78, P725, DOI 10.1016/j.jaad.2017.10.018; Oliver RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136514; Robles-Diaz M, 2014, GASTROENTEROLOGY, V147, P109, DOI 10.1053/j.gastro.2014.03.050; Rose M, 2014, J CLIN EPIDEMIOL, V67, P516, DOI 10.1016/j.jclinepi.2013.10.024; Sapp JC, 2017, GENET MED, V19, P1376, DOI 10.1038/gim.2017.65; Wicksell RK, 2009, PAIN, V141, P248, DOI 10.1016/j.pain.2008.11.006; Wolters P., 2010, CHILDR TUM FDN NEUR; Wolters P. S. M., 2013, NAT C PED PSYCH	23	32	33	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 7	2019	104	3					484	491		10.1016/j.ajhg.2019.01.015	http://dx.doi.org/10.1016/j.ajhg.2019.01.015			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HN9SY	30803705	Green Published, Bronze			2022-12-18	WOS:000460541200013
J	Machol, K; Rousseau, J; Ehresmann, S; Garcia, T; Nguyen, TTM; Spillmann, RC; Sullivan, JA; Shashi, V; Jiang, YH; Stong, N; Fiala, E; Willing, M; Pfundt, R; Kleefstra, T; Cho, MT; McLaughlin, H; Piera, MR; Orellana, C; Martinez, F; Caro-Llopis, A; Monfort, S; Roscioli, T; Nixon, CY; Buckley, MF; Turner, A; Jones, WD; van Hasseit, PM; Hofstede, FC; van Gassen, KLI; Brooks, AS; van Slegtenhorst, MA; Lachlan, K; Sebastian, J; Madan-Khetarpal, S; Sonal, D; Sakkubai, N; Thevenon, J; Faivre, L; Maurel, A; Petrovski, S; Krantz, ID; Tarpinian, JM; Rosenfeld, JA; Lee, BH; Campeau, PM; Adams, DR; Alejandro, ME; Allard, P; Azamian, MS; Bacino, CA; Balasubramanyam, A; Barseghyan, H; Batzli, GF; Beggs, AH; Behnam, B; Bican, A; Bick, DP; Birch, CL; Bonner, D; Boone, BE; Bostwick, BL; Briere, LC; Brown, DM; Brush, M; Burke, EA; Burrage, LC; Chen, S; Clark, GD; Coakley, TR; Cogan, JD; Cooper, CM; Cope, H; Craigen, WJ; D'Souza, P; Davids, M; Dayal, JG; Dell'Angelica, EC; Dhar, SU; Dillon, A; Dipple, KM; Donnell-Fink, LA; Dorrani, N; Dorset, DC; Douine, ED; Draper, DD; Eckstein, DJ; Emrick, LT; Eng, CM; Eskin, A; Esteves, C; Estwick, T; Ferreira, C; Fogel, BL; Friedman, ND; Gahl, WA; Glanton, E; Godfrey, RA; Goldstein, DB; Gould, SE; Gourdine, JPF; Groden, CA; Gropman, AL; Haendel, M; Hamid, R; Hanchard, NA; Handley, LH; Herzog, MR; Holm, IA; Hom, J; Howerton, EM; Huang, Y; Jacob, HJ; Jain, M; Johnston, JM; Jones, AL; Kohane, IS; Krasnewich, DM; Krieg, EL; Krier, JB; Lalani, SR; Lalani; Lau, CC; Lazar, J; Lee, H; Levy, SE; Lewis, RA; Lincoln, SA; Lipson, A; Loo, SK; Loscalzo, J; Maas, RL; Macnamara, EF; MacRae, CA; Maduro, VV; Majcherska, MM; Malicdan, MCV; Mamounas, LA; Manolio, TA; Markello, TC; Marom, R; Martinez-Agosto, JA; Marwaha, S; May, T; McConkie-Rosell, A; McCormack, CE; McCray, AT; Might, M; Moretti, PM; Morimoto, M; Mulvihill, JJ; Murphy, JL; Muzny, DM; Nehrebecky, ME; Nelson, SF; Newberry, JS; Newman, JH; Nicholas, SK; Novacic, D; Orange, JS; Pallais, JC; Palmer, CGS; Papp, JC; Parker, NH; Pena, LDM; Phillips, JA; Posey, JE; Postlethwait, JH; Potocki, L; Pusey, BN; Reuter, CM; Robertson, AK; Rodan, LH; Sampson, JB; Samson, SL; Schoch, K; Schroeder, MC; Scott, DA; Sharma, P; Signer, R; Silverman, EK; Sinsheimer, JS; Smith, KS; Splinter, K; Stoler, JM; Sweetser, DA; Tifft, CJ; Toro, C; Tran, AA; Urv, TK; Valivullah, ZM; Vilain, E; Vogel, TP; Wahl, CE; Walley, NM; Walsh, CA; Ward, PA; Waters, KM; Westerfield, M; Wise, AL; Wolfe, LA; Worthey, EA; Yamamoto, S; Yang, YP; Yu, GY; Zastrow, DB; Zheng, A				Machol, Keren; Rousseau, Justine; Ehresmann, Sophie; Garcia, Thomas; Thi Tuyet Mai Nguyen; Spillmann, Rebecca C.; Sullivan, Jennifer A.; Shashi, Vandana; Jiang, Yong-hui; Stong, Nicholas; Fiala, Elise; Willing, Marcia; Pfundt, Rolph; Kleefstra, Tjitske; Cho, Megan T.; McLaughlin, Heather; Rosello Piera, Monica; Orellana, Carmen; Martinez, Francisco; Caro-Llopis, Alfonso; Monfort, Sandra; Roscioli, Tony; Nixon, Cheng Yee; Buckley, Michael F.; Turner, Anne; Jones, Wendy D.; van Hasseit, Peter M.; Hofstede, Floris C.; van Gassen, Koen L., I; Brooks, Alice S.; van Slegtenhorst, Marjon A.; Lachlan, Katherine; Sebastian, Jessica; Madan-Khetarpal, Suneeta; Sonal, Desai; Sakkubai, Naidu; Thevenon, Julien; Faivre, Laurence; Maurel, Alice; Petrovski, Slave; Krantz, Ian D.; Tarpinian, Jennifer M.; Rosenfeld, Jill A.; Lee, Brendan H.; Campeau, Philippe M.; Adams, David R.; Alejandro, Mercedes E.; Allard, Patrick; Azamian, Mahshid S.; Bacino, Carlos A.; Balasubramanyam, Ashok; Barseghyan, Hayk; Batzli, Gabriel F.; Beggs, Alan H.; Behnam, Babak; Bican, Anna; Bick, David P.; Birch, Camille L.; Bonner, Devon; Boone, Braden E.; Bostwick, Bret L.; Briere, Lauren C.; Brown, Donna M.; Brush, Matthew; Burke, Elizabeth A.; Burrage, Lindsay C.; Chen, Shan; Clark, Gary D.; Coakley, Terra R.; Cogan, Joy D.; Cooper, Cynthia M.; Cope, Heidi; Craigen, William J.; D'Souza, Precilla; Davids, Mariska; Dayal, Jyoti G.; Dell'Angelica, Esteban C.; Dhar, Shweta U.; Dillon, Ani; Dipple, Katrina M.; Donnell-Fink, Laurel A.; Dorrani, Naghmeh; Dorset, Daniel C.; Douine, Emilie D.; Draper, David D.; Eckstein, David J.; Emrick, Lisa T.; Eng, Christine M.; Eskin, Ascia; Esteves, Cecilia; Estwick, Tyra; Ferreira, Carlos; Fogel, Brent L.; Friedman, Noah D.; Gahl, William A.; Glanton, Emily; Godfrey, Rena A.; Goldstein, David B.; Gould, Sarah E.; Gourdine, Jean-Philippe F.; Groden, Catherine A.; Gropman, Andrea L.; Haendel, Melissa; Hamid, Rizwan; Hanchard, Neil A.; Handley, Lori H.; Herzog, Matthew R.; Holm, Ingrid A.; Hom, Jason; Howerton, Ellen M.; Huang, Yong; Jacob, Howard J.; Jain, Mahim; Johnston, Jean M.; Jones, Angela L.; Kohane, Isaac S.; Krasnewich, Donna M.; Krieg, Elizabeth L.; Krier, Joel B.; Lalani, Seema R.; Lalani; Lau, C. Christopher; Lazar, Jozef; Lee, Hane; Levy, Shawn E.; Lewis, Richard A.; Lincoln, Sharyn A.; Lipson, Allen; Loo, Sandra K.; Loscalzo, Joseph; Maas, Richard L.; Macnamara, Ellen F.; MacRae, Calum A.; Maduro, Valerie V.; Majcherska, Marta M.; Malicdan, May Christine, V; Mamounas, Laura A.; Manolio, Teri A.; Markello, Thomas C.; Marom, Ronit; Martinez-Agosto, Julian A.; Marwaha, Shruti; May, Thomas; McConkie-Rosell, Allyn; McCormack, Colleen E.; McCray, Alexa T.; Might, Matthew; Moretti, Paolo M.; Morimoto, Marie; Mulvihill, John J.; Murphy, Jennifer L.; Muzny, Donna M.; Nehrebecky, Michele E.; Nelson, Stan F.; Newberry, J. Scott; Newman, John H.; Nicholas, Sarah K.; Novacic, Donna; Orange, Jordan S.; Pallais, J. Carl; Palmer, Christina G. S.; Papp, Jeanette C.; Parker, Neil H.; Pena, Loren D. M.; Phillips, John A., III; Posey, Jennifer E.; Postlethwait, John H.; Potocki, Lorraine; Pusey, Barbara N.; Reuter, Chloe M.; Robertson, Amy K.; Rodan, Lance H.; Sampson, Jacinda B.; Samson, Susan L.; Schoch, Kelly; Schroeder, Molly C.; Scott, Daryl A.; Sharma, Prashant; Signer, Rebecca; Silverman, Edwin K.; Sinsheimer, Janet S.; Smith, Kevin S.; Splinter, Kimberly; Stoler, Joan M.; Sweetser, David A.; Tifft, Cynthia J.; Toro, Camilo; Tran, Alyssa A.; Urv, Tiina K.; Valivullah, Zaheer M.; Vilain, Eric; Vogel, Tiphanie P.; Wahl, Colleen E.; Walley, Nicole M.; Walsh, Chris A.; Ward, Patricia A.; Waters, Katrina M.; Westerfield, Monte; Wise, Anastasia L.; Wolfe, Lynne A.; Worthey, Elizabeth A.; Yamamoto, Shinya; Yang, Yaping; Yu, Guoyun; Zastrow, Diane B.; Zheng, Allison		Undiagnosed Dis Network	Expanding the Spectrum of BAF-Related Disorders: De Novo Variants in SMARCC2 Cause a Syndrome with Intellectual Disability and Developmental Delay	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COFFIN-SIRIS SYNDROME; GATED CALCIUM-CHANNELS; SWI/SNF COMPLEX; NEURODEVELOPMENTAL DISORDER; GENE-TRANSCRIPTION; MSWI/SNF COMPLEXES; GENOTYPE-PHENOTYPE; MISSENSE MUTATIONS; NEURAL DEVELOPMENT; REGULATOR	SMARCC2 (BAF170) is one of the invariable core subunits of the ATP-dependent chromatin remodeling BAF (BRG1-associated factor) complex and plays a crucial role in embryogenesis and corticogenesis. Pathogenic variants in genes encoding other components of the BAF complex have been associated with intellectual disability syndromes. Despite its significant biological role, variants in SMARCC2 have not been directly associated with human disease previously. Using whole-exome sequencing and a web-based gene-matching program, we identified 15 individuals with variable degrees of neurodevelopmental delay and growth retardation harboring one of 13 heterozygous variants in SMARCC2, most of them novel and proven de novo. The clinical presentation overlaps with intellectual disability syndromes associated with other BAF subunits, such as Coffin-Siris and Nicolaides-Baraitser syndromes and includes prominent speech impairment, hypotonia, feeding difficulties, behavioral abnormalities, and dysmorphic features such as hypertrichosis, thick eyebrows, thin upper lip vermilion, and upturned nose. Nine out of the fifteen individuals harbor variants in the highly conserved SMARCC2 DNA-interacting domains (SANT and SWIRM) and present with a more severe phenotype. Two of these individuals present cardiac abnormalities. Transcriptomic analysis of fibroblasts from affected individuals highlights a group of differentially expressed genes with possible roles in regulation of neuronal development and function, namely H19, SCRG1, RELN, and CACNB4. Our findings suggest a novel SMARCC2-related syndrome that overlaps with neurodevelopmental disorders associated with variants in BAF-complex subunits.	[Machol, Keren; Rosenfeld, Jill A.; Lee, Brendan H.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Rousseau, Justine; Ehresmann, Sophie; Garcia, Thomas; Thi Tuyet Mai Nguyen; Campeau, Philippe M.] CHU St Justine, Dept Pediat, Res Ctr, Montreal, PQ H3T 1C5, Canada; [Rousseau, Justine; Ehresmann, Sophie; Garcia, Thomas; Thi Tuyet Mai Nguyen; Campeau, Philippe M.] Univ Montreal, Montreal, PQ H3T 1C5, Canada; [Spillmann, Rebecca C.; Sullivan, Jennifer A.; Shashi, Vandana] Duke Univ, Dept Pediat, Sch Med, Durham, NC 27710 USA; [Jiang, Yong-hui] Duke Univ, Dept Pediat & Neurobiol, Program Genet & Genom, Sch Med, Durham, NC 27710 USA; [Stong, Nicholas] Columbia Univ, Inst Genom Med, New York, NY 10032 USA; [Fiala, Elise; Willing, Marcia] Washington Univ, Dept Pediat, Sch Med, St Louis, MO 63110 USA; [Pfundt, Rolph; Kleefstra, Tjitske] Radboud Univ Nijmegen, Human Genet Dept, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [Cho, Megan T.; McLaughlin, Heather] GeneDx, Gaithersburg, MD 20877 USA; [Rosello Piera, Monica; Orellana, Carmen; Martinez, Francisco; Caro-Llopis, Alfonso; Monfort, Sandra] Hosp Univ Politecn La Fe, Unidad Genet, Valencia 46026, Spain; [Roscioli, Tony; Nixon, Cheng Yee] Univ New South Wales, Neurosci Res Australia NeuRA, Sydney, NSW 2031, Australia; [Roscioli, Tony; Buckley, Michael F.] New South Wales Hlth Pathol, Randwick, NSW 2217, Australia; [Roscioli, Tony; Turner, Anne] Sydney Childrens Hosp, Ctr Clin Genet, Sydney, NSW 2031, Australia; [Jones, Wendy D.] Great Ormond St Hosp Children NHS Fdn Trust, North East Thames Reg Genet serv, London WC1N 3JH, England; [van Hasseit, Peter M.; Hofstede, Floris C.; van Gassen, Koen L., I] Univ Med Ctr, Wilhelmina Childrens Hosp, Dept Metab Dis, NL-3584 EA Utrecht, Netherlands; [Brooks, Alice S.; van Slegtenhorst, Marjon A.] Erasmus MC, Dept Clin Genet, NL-3015 GD Rotterdam, Netherlands; [Lachlan, Katherine] Univ Hosp Southampton NHS Fdn Trust, Wessex Clin Genet Serv, Southampton SO16 5YA, Hants, England; [Sebastian, Jessica; Madan-Khetarpal, Suneeta] UPMC, Dept Med Genet, Childrens Hosp Pittsburgh, Pittsburgh, PA 15224 USA; [Sonal, Desai; Sakkubai, Naidu] Kennedy Krieger Inst, Dept Neurogenet, Baltimore, MD 21205 USA; [Thevenon, Julien; Faivre, Laurence; Maurel, Alice] CHU Dijon, Ctr Reference Anomalies Dev & Syndromes Malformat, Ctr Genet, F-21079 Dijon, France; [Petrovski, Slave] AstraZeneca, IMED Biotech Unit, AstraZeneca Ctr Genom Res Precis Med & Genom, Cambridge CB2 0AA, England; [Krantz, Ian D.; Tarpinian, Jennifer M.] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; [Krantz, Ian D.; Tarpinian, Jennifer M.] Univ Penn, Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Krantz, Ian D.; Tarpinian, Jennifer M.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Lachlan, Katherine] Univ Southampton, Fac Med, Human Genet & Genom Med, Southampton SO17 1BJ, Hants, England	Baylor College of Medicine; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Duke University; Duke University; Columbia University; Washington University (WUSTL); Radboud University Nijmegen; Hospital Universitari i Politecnic La Fe; Neuroscience Research Australia; University of New South Wales Sydney; University of Sydney; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Erasmus University Rotterdam; Erasmus MC; University of Southampton; University Hospital Southampton NHS Foundation Trust; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kennedy Krieger Institute; CHU Dijon Bourgogne; AstraZeneca; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Southampton	Campeau, PM (corresponding author), CHU St Justine, Dept Pediat, Res Ctr, Montreal, PQ H3T 1C5, Canada.	p.campeau@umontreal.ca	Orellana, Carmen/B-1925-2009; Hanchard, Neil/AAY-9075-2021; Caro-Llopis, Alfonso/D-7865-2019; Campeau, Philippe/J-8614-2015; Urv, Tiina/AAW-9336-2021; Stong, Nicholas/ABB-7516-2021; Loscalzo, Joseph/ABD-8980-2021; Sharma, Prashant/ABH-2407-2021; Monfort, Sandra/D-8801-2019; Yamamoto, Shinya/ABB-2837-2021; Lalani, Seema/AAI-5090-2020; Malicdan, May Christine/AAK-7422-2021; Nelson, Stanley F/D-4771-2009; Sweetser, David/ABB-9347-2021; Martinez, Francisco/A-2543-2009; LACHLAN, KATHERINE/ABH-6991-2020; Goldstein, David/AAY-8125-2020; , WaNgtJ/AAR-7045-2020	Orellana, Carmen/0000-0003-4271-5859; Hanchard, Neil/0000-0003-1925-2665; Campeau, Philippe/0000-0001-9713-7107; Monfort, Sandra/0000-0003-2016-1410; Yamamoto, Shinya/0000-0003-2172-8036; Nelson, Stanley F/0000-0002-2082-3114; Sweetser, David/0000-0002-1621-3284; Martinez, Francisco/0000-0002-0589-2584; LACHLAN, KATHERINE/0000-0002-3816-7346; Faivre, Laurence/0000-0001-9770-444X; Caro-Llopis, Alfonso/0000-0003-4187-2748; Rousseau, Justine/0000-0002-3554-2673; Urv, Tiina/0000-0002-2040-4972; Douine, Emilie/0000-0002-6048-2887; orange, jordan/0000-0001-7117-7725; Haendel, Melissa/0000-0001-9114-8737; Machol, Keren/0000-0003-0356-6889; Murphy, Jennifer Louise Patrick/0000-0003-1586-0890; Ehresmann, Sophie/0000-0002-4171-7222; Stong, Nicholas/0000-0002-0678-637X; Behnam, Babak/0000-0002-1266-1602; Brown, Donna/0000-0002-8805-7225; Azamian, Mahshid/0000-0002-8543-8284	CIHR; Fonds de recherche du Quebec - Sante (FRQS), Canada; Instituto de Salud Carlos III - Accion Estrategica en Salud 2013-2016; FEDER -Fondo Europeo de Desarrollo Regional [PI14/00350]; Duke University Health system; NIH Common Fund, through the Office of Strategic Coordination/Office of the NIH Director [U01HG007672, U01HG007942]; UCB Cell-tech; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007672, U01HG007942] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); Fonds de recherche du Quebec - Sante (FRQS), Canada; Instituto de Salud Carlos III - Accion Estrategica en Salud 2013-2016; FEDER -Fondo Europeo de Desarrollo Regional; Duke University Health system; NIH Common Fund, through the Office of Strategic Coordination/Office of the NIH Director; UCB Cell-tech(UCB Pharma SA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the affected individuals and their families for their participation in this study. We thank Xinyu Cao from Duke for technical support for the mRNA expression analysis. We thank the CIHR and Fonds de recherche du Quebec - Sante (FRQS), Canada for clinician-scientist awards to P.M.C. Spanish individuals' study was supported by grant PI14/00350 (Instituto de Salud Carlos III - Accion Estrategica en Salud 2013-2016; FEDER -Fondo Europeo de Desarrollo Regional). Individual 10 was evaluated through the Duke Genome Sequencing Clinic, supported by the Duke University Health system, and partially funded by UCB Cell-tech. Partial research reported in this manuscript was supported by the NIH Common Fund, through the Office of Strategic Coordination/Office of the NIH Director under award numbers U01HG007672 (Duke University) and U01HG007942 (Baylor College of Medicine-Sequencing). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aomatsu E, 2014, SCI REP-UK, V4, DOI 10.1038/srep03652; Aravind L, 2002, GENOME BIOL, V3; Barutcu AR, 2016, GENOME RES, V26, P1188, DOI 10.1101/gr.201624.115; Ben-David E, 2013, MOL PSYCHIATR, V18, P1054, DOI 10.1038/mp.2012.148; Bogershausen N, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00252; Boyer LA, 2004, NAT REV MOL CELL BIO, V5, P158, DOI 10.1038/nrm1314; Bramswig NC, 2017, HUM GENET, V136, P297, DOI 10.1007/s00439-017-1757-z; Breitenkamp AF, 2015, CURR MOL PHARMACOL, V8, P123, DOI 10.2174/1874467208666150507105235; Campeau PM, 2014, AM J MED GENET C, V166, P327, DOI 10.1002/ajmg.c.31412; Chesi A, 2013, NAT NEUROSCI, V16, P851, DOI 10.1038/nn.3412; Dron M, 1998, J BIOL CHEM, V273, P18015, DOI 10.1074/jbc.273.29.18015; Gabory A, 2010, BIOESSAYS, V32, P473, DOI 10.1002/bies.200900170; Gazdagh G., 2018, EUR J MED GENET; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Halgren C, 2012, CLIN GENET, V82, P248, DOI 10.1111/j.1399-0004.2011.01755.x; Han CL, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1139-z; Helsmoortel C, 2014, NAT GENET, V46, P380, DOI 10.1038/ng.2899; Hempel A, 2016, J MED GENET, V53, P152, DOI 10.1136/jmedgenet-2015-103393; Hodges HC, 2018, NAT STRUCT MOL BIOL, V25, P61, DOI 10.1038/s41594-017-0007-3; Hoyer J, 2012, AM J HUM GENET, V90, P565, DOI 10.1016/j.ajhg.2012.02.007; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Nguyen H, 2018, STEM CELL REP, V10, P1734, DOI 10.1016/j.stemcr.2018.04.014; Kashevarova AA, 2014, GENE, V536, P145, DOI 10.1016/j.gene.2013.11.029; Kazantseva A, 2009, J NEUROCHEM, V109, P807, DOI 10.1111/j.1471-4159.2009.06005.x; Khan U, 2018, CLEFT PALATE-CRAN J, V55, P456, DOI 10.1177/1055665617739312; Kosho T, 2014, AM J MED GENET C, V166, P241, DOI 10.1002/ajmg.c.31415; Kosho T, 2014, AM J MED GENET C, V166, P262, DOI 10.1002/ajmg.c.31407; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lelieveld SH, 2017, AM J HUM GENET, V101, P478, DOI 10.1016/j.ajhg.2017.08.004; Loe-Mie Y, 2010, HUM MOL GENET, V19, P2841, DOI 10.1093/hmg/ddq184; Marom R, 2017, HUM MUTAT, V38, P1365, DOI 10.1002/humu.23282; Martinez F, 2017, J MED GENET, V54, P87, DOI 10.1136/jmedgenet-2016-103964; Mochida S, 2018, NEUROSCI RES, V127, P33, DOI 10.1016/j.neures.2017.09.012; Mulligan KA, 2012, J NEUROIMMUNE PHARM, V7, P774, DOI 10.1007/s11481-012-9404-x; Narayanan R, 2015, CELL REP, V13, P1842, DOI 10.1016/j.celrep.2015.10.046; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Nicolaides P, 1993, Clin Dysmorphol, V2, P232; Ninkovic J, 2013, CELL STEM CELL, V13, P403, DOI 10.1016/j.stem.2013.07.002; Petrovski S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005492; Pinggera A, 2016, J PHYSIOL-LONDON, V594, P5839, DOI 10.1113/JP270672; Pretegiani E, 2016, J NEUROL, V263, P1659, DOI 10.1007/s00415-016-8194-0; Quinodoz M, 2017, AM J HUM GENET, V101, P623, DOI 10.1016/j.ajhg.2017.09.001; Raab JR, 2017, EPIGENET CHROMATIN, V10, DOI 10.1186/s13072-017-0167-8; Raveh E, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0458-2; Rima M, 2017, MOL BIOL CELL, V28, P3699, DOI 10.1091/mbc.E17-01-0076; Ring HZ, 1998, GENOMICS, V51, P140, DOI 10.1006/geno.1998.5343; Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413; Ronjat M, 2013, CHANNELS, V7, P119, DOI 10.4161/chan.23895; Santen GWE, 2013, HUM MUTAT, V34, P1519, DOI 10.1002/humu.22394; Santen GWE, 2012, EPIGENETICS-US, V7, P1219, DOI 10.4161/epi.22299; Schrier SA, 2012, AM J MED GENET A, V158A, P1865, DOI 10.1002/ajmg.a.35415; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Sokpor G, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00243; Soldatov NM, 2015, CURR MOL PHARMACOL, V8, P32, DOI 10.2174/1874467208666150507093258; Son EY, 2014, AM J MED GENET C, V166, P333, DOI 10.1002/ajmg.c.31416; Sousa SB, 2014, AM J MED GENET C, V166, P302, DOI 10.1002/ajmg.c.31409; Tadmouri A, 2012, EMBO J, V31, P3730, DOI 10.1038/emboj.2012.226; Tuoc TC, 2013, DEV CELL, V25, P256, DOI 10.1016/j.devcel.2013.04.005; Tuoc T, 2017, MOL NEUROBIOL, V54, P4618, DOI 10.1007/s12035-016-9948-5; Tsurusaki Y, 2012, NAT GENET, V44, P376, DOI 10.1038/ng.2219; Van Houdt JKJ, 2012, NAT GENET, V44, P445, DOI 10.1038/ng.1105; Vandeweyer G, 2014, AM J MED GENET C, V166, P315, DOI 10.1002/ajmg.c.31413; Vasileiou G, 2018, AM J HUM GENET, V102, P468, DOI 10.1016/j.ajhg.2018.01.014; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Wang XF, 2017, NAT GENET, V49, P289, DOI 10.1038/ng.3746; Wasser CR, 2017, J BIOL CHEM, V292, P1330, DOI 10.1074/jbc.R116.766782; Yoneyama M, 2007, J MOL BIOL, V369, P222, DOI 10.1016/j.jmb.2007.03.027; Zamponi GW, 2016, NAT REV DRUG DISCOV, V15, P19, DOI 10.1038/nrd.2015.5; Zarate YA, 2016, AM J MED GENET A, V170, P1967, DOI 10.1002/ajmg.a.37722; Zhu XL, 2015, GENET MED, V17, P774, DOI 10.1038/gim.2014.191; Zweier C, 2014, AM J MED GENET C, V166, P290, DOI 10.1002/ajmg.c.31408	71	32	32	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 3	2019	104	1					164	178		10.1016/j.ajhg.2018.11.007	http://dx.doi.org/10.1016/j.ajhg.2018.11.007			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HG2EH	30580808	Bronze, Green Published			2022-12-18	WOS:000454775500015
J	Dobyns, WB; Aldinger, KA; Ishak, GE; Mirzaa, GM; Timms, AE; Grout, ME; Dremmen, MHG; Schot, R; Vandervore, L; van Slegtenhorst, MA; Wilke, M; Kasteleijn, E; Lee, AS; Barry, BJ; Chao, KR; Szczaluba, K; Kobori, J; Hanson-Kahn, A; Bernstein, JA; Carr, L; D'Arco, F; Miyana, K; Okazaki, T; Saito, Y; Sasaki, M; Das, S; Wheeler, MM; Bamshad, MJ; Nickerson, DA; Engle, EC; Verheijen, FW; Doherty, D; Mancini, GMS				Dobyns, William B.; Aldinger, Kimberly A.; Ishak, Gisele E.; Mirzaa, Ghayda M.; Timms, Andrew E.; Grout, Megan E.; Dremmen, Marjolein H. G.; Schot, Rachel; Vandervore, Laura; van Slegtenhorst, Marjon A.; Wilke, Martina; Kasteleijn, Esmee; Lee, Arthur S.; Barry, Brenda J.; Chao, Katherine R.; Szczaluba, Krzysztof; Kobori, Joyce; Hanson-Kahn, Andrea; Bernstein, Jonathan A.; Carr, Lucinda; D'Arco, Felice; Miyana, Kaori; Okazaki, Tetsuya; Saito, Yoshiaki; Sasaki, Masayuki; Das, Soma; Wheeler, Marsha M.; Bamshad, Michael J.; Nickerson, Deborah A.; Engle, Elizabeth C.; Verheijen, Frans W.; Doherty, Dan; Mancini, Grazia M. S.		Univ Washington Ctr Mendelian; Ctr Mendelian Genomics Broad Inst	MACF1 Mutations Encoding Highly Conserved Zinc-Binding Residues of the GAR Domain Cause Defects in Neuronal Migration and Axon Guidance	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							F-ACTIN; GENE; SCHIZOPHRENIA; ASSOCIATION; DYNAMICS; RISK; LINK	To date, mutations in 15 actin- or microtubule-associated genes have been associated with the cortical malformation lissencephaly and variable brainstem hypoplasia. During a multicenter review, we recognized a rare lissencephaly variant with a complex brainstem malformation in three unrelated children. We searched our large brain-malformation databases and found another five children with this malformation (as well as one with a less severe variant), analyzed available whole-exome or -genome sequencing data, and tested ciliogenesis in two affected individuals. The brain malformation comprised posterior predominant lissencephaly and midline crossing defects consisting of absent anterior commissure and a striking W-shaped brainstem malformation caused by small or absent pontine crossing fibers. We discovered heterozygous de novo missense variants or an in-frame deletion involving highly conserved zinc-binding residues within the GAR domain of MACF1 in the first eight subjects. We studied cilium formation and found a higher proportion of mutant cells with short cilia than of control cells with short cilia. A ninth child had similar lissencephaly but only subtle brainstem dysplasia associated with a heterozygous de novo missense variant in the spectrin repeat domain of MACF1. Thus, we report variants of the microtubule-binding GAR domain of MACF1 as the cause of a distinctive and most likely pathognomonic brain malformation. A gain-of-function or dominant-negative mechanism appears likely given that many heterozygous mutations leading to protein truncation are included in the ExAC Browser. However, three de novo variants in MACF1 have been observed in large schizophrenia cohorts.	[Dobyns, William B.; Mirzaa, Ghayda M.; Grout, Megan E.; Bamshad, Michael J.; Doherty, Dan] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Dobyns, William B.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Dobyns, William B.; Aldinger, Kimberly A.; Ishak, Gisele E.; Mirzaa, Ghayda M.; Doherty, Dan] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA 98101 USA; [Ishak, Gisele E.] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Timms, Andrew E.] Seattle Childrens Res Inst, Ctr Dev Biol & Regenerat Med, Seattle, WA 98101 USA; [Dremmen, Marjolein H. G.] Erasmus MC Univ, Dept Radiol, Med Ctr, NL-3015 CN Rotterdam, Netherlands; [Dremmen, Marjolein H. G.] Sophia Childrens Univ Hosp, Div Pediat Radiol, NL-3015 CN Rotterdam, Netherlands; [Schot, Rachel; Vandervore, Laura; van Slegtenhorst, Marjon A.; Wilke, Martina; Kasteleijn, Esmee; Verheijen, Frans W.; Mancini, Grazia M. S.] Erasmus MC Univ, Dept Clin Genet, Med Ctr, NL-3015 CN Rotterdam, Netherlands; [Lee, Arthur S.; Barry, Brenda J.; Engle, Elizabeth C.] Childrens Hosp Boston, Dept Neurol, Boston, MA 02115 USA; [Lee, Arthur S.; Barry, Brenda J.; Engle, Elizabeth C.] Harvard Med Sch, Boston, MA 02115 USA; [Lee, Arthur S.; Chao, Katherine R.; Ctr Mendelian Genomics Broad Inst] Broad Inst MIT & Harvard, Ctr Mendelian Genom, Cambridge, MA 02142 USA; [Szczaluba, Krzysztof] Med Univ Warsaw, Dept Med Genet, PL-02106 Warsaw, Poland; [Kobori, Joyce] Permanente Med Grp Inc, Dept Genet, San Jose, CA 95123 USA; [Hanson-Kahn, Andrea] Stanford Sch Med, Dept Genet, Stanford, CA 94305 USA; [Hanson-Kahn, Andrea; Bernstein, Jonathan A.] Stanford Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Carr, Lucinda; D'Arco, Felice] Great Ormond St Hosp Children NHS Fdn Trust, Dept Neuroradiol, London WC1N 3JH, England; [Miyana, Kaori] Japanese Red Cross Med Ctr, Dept Pediat, Shibuya Ku, Tokyo, Japan; [Okazaki, Tetsuya; Saito, Yoshiaki] Tottori Univ, Fac Med, Dept Brain & Neurosci, Div Child Neurol, Yonago, Tottori, Japan; [Sasaki, Masayuki] Natl Ctr Neurol & Psychiat, Natl Ctr Hosp, Dept Child Neurol, Tokyo, Japan; [Das, Soma] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Wheeler, Marsha M.; Bamshad, Michael J.; Nickerson, Deborah A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Wheeler, Marsha M.; Bamshad, Michael J.; Nickerson, Deborah A.; Univ Washington Ctr Mendelian] Univ Washington, Ctr Mendelian Genom, Seattle, WA 98195 USA; Childrens Hosp, Dept Ophthalmol, Boston, MA 02115 USA; Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Seattle Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Medical University of Warsaw; Permanente Medical Groups; Stanford University; Stanford University; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Japanese Red Cross Medical Center; Tottori University; National Center for Neurology & Psychiatry - Japan; University of Chicago; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Dobyns, WB (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.; Dobyns, WB (corresponding author), Univ Washington, Dept Neurol, Seattle, WA 98195 USA.; Dobyns, WB (corresponding author), Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA 98101 USA.; Mancini, GMS (corresponding author), Erasmus MC Univ, Dept Clin Genet, Med Ctr, NL-3015 CN Rotterdam, Netherlands.	wbd@uw.edu; g.mancini@erasmusmc.nl	Vandervore, Laura V/Q-3209-2018; Aldinger, Kimberly/ABB-1561-2020; D'Arco, Felice/AAE-6902-2019; Dobyns, William Brian/ABC-6525-2021; Dobyns, William/AAI-2768-2020	Vandervore, Laura V/0000-0002-7293-8677; Aldinger, Kimberly/0000-0002-5406-8911; D'Arco, Felice/0000-0001-7396-591X; Dobyns, William/0000-0002-7681-2844; Blue, Elizabeth/0000-0002-0633-0305; Grout Vandenberg, Megan/0000-0001-7704-2100; Das, Soma/0000-0003-0387-6801; Szczaluba, Krzysztof/0000-0001-8803-646X	US National Institutes of Health under National Institute of Neurological Disorders and Stroke [5R01NS050375, 1R01NS058721, K08NS092898]; National Eye Institute (NEI) [R01EY027421]; National Heart, Lung, and Blood Institute (NHLBI) [X01HL132377, UM1HG008900]; Netherlands ErasmusMC Mrace grant [104673]; National Human Genome Research Institute (NHGRI) [U54HG006493]; NHGRI [U54HG006493]; University of Washington IDDRC Genetics Core; Center for Mendelian Genomics at the Broad Institute of MIT and Harvard; NEI; NHLBI [UM1HG008900]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY027421] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG008900, U54HG006493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058721, K08NS092898, R01NS092772, R01NS050375] Funding Source: NIH RePORTER	US National Institutes of Health under National Institute of Neurological Disorders and Stroke; National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Netherlands ErasmusMC Mrace grant; National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); University of Washington IDDRC Genetics Core; Center for Mendelian Genomics at the Broad Institute of MIT and Harvard; NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the families and their referring physicians for their important contributions to our ongoing work on these disorders. This study was funded by the US National Institutes of Health under National Institute of Neurological Disorders and Stroke grants 5R01NS050375 and 1R01NS058721 to W.B.D. and K08NS092898 to G.M.M., National Eye Institute (NEI) grant R01EY027421, and National Heart, Lung, and Blood Institute (NHLBI) grant X01HL132377 to E.C.E. and by Netherlands ErasmusMC Mrace grant 104673 to G.M.S.M. Sequencing and/or data analysis was provided by the University of Washington Center for Mendelian Genomics with support from National Human Genome Research Institute (NHGRI) grant U54HG006493 to D.A.N. and M.J.B., the Center for Mendelian Genomics at the Broad Institute of MIT and Harvard with support from NHGRI, NEI, and NHLBI grant UM1HG008900 to Daniel MacArthur and Heidi Rehm, and the University of Washington IDDRC Genetics Core with support from NHGRI grant U54HG006493 to D.D. Additional funding came from private donations to W.B.D. and D.D. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding sources. Please note that the authors cite OMIM according to journal editorial policy but do not endorse the referenced OMIM data.	Chen HJ, 2006, GENE DEV, V20, P1933, DOI 10.1101/gad.1411206; Di Donato N, 2017, AM J MED GENET A, V173, P1473, DOI 10.1002/ajmg.a.38245; Ekelund J, 2000, HUM MOL GENET, V9, P1049, DOI 10.1093/hmg/9.7.1049; Goryunov D, 2016, METHOD ENZYMOL, V569, P331, DOI 10.1016/bs.mie.2015.05.022; Goryunov D, 2010, MOL CELL NEUROSCI, V44, P1, DOI 10.1016/j.mcn.2010.01.010; Hackenberg A, 2017, NEUROPEDIATRICS, V48, P57, DOI 10.1055/s-0036-1597610; Hodgkinson CA, 2004, AM J HUM GENET, V75, P862, DOI 10.1086/425586; Irahara K, 2014, PEDIATR NEUROL, V50, P384, DOI 10.1016/j.pediatrneurol.2013.12.013; Jamuar SS, 2017, NAT GENET, V49, P606, DOI 10.1038/ng.3804; Jen JC, 2004, SCIENCE, V304, P1509, DOI 10.1126/science.1096437; Jorgensen LH, 2014, SCI REP-UK, V4, DOI 10.1038/srep05180; Ka MH, 2017, CEREB CORTEX, V27, P5525, DOI 10.1093/cercor/bhw319; Ka MH, 2014, DEV BIOL, V395, P4, DOI 10.1016/j.ydbio.2014.09.009; Kenny EM, 2014, MOL PSYCHIATR, V19, P872, DOI 10.1038/mp.2013.127; Kia SK, 2012, AM J HUM GENET, V91, P533, DOI 10.1016/j.ajhg.2012.07.008; Lane TR, 2017, STRUCTURE, V25, P1130, DOI 10.1016/j.str.2017.05.006; Lee S, 2002, DEVELOPMENT, V129, P1195; Lee S, 2007, DEVELOPMENT, V134, P1767, DOI 10.1242/dev.02842; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li DW, 2006, HUM MOL GENET, V15, P1995, DOI 10.1093/hmg/ddl122; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Lu IL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04880-8; May-Simera HL, 2016, CELL REP, V17, P1399, DOI 10.1016/j.celrep.2016.09.089; Moffat JJ, 2017, SEMIN CELL DEV BIOL, V69, P9, DOI 10.1016/j.semcdb.2017.05.020; Muraki K, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00074; Ravindran E, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006746; Reiter JF, 2017, NAT REV MOL CELL BIO, V18, P533, DOI 10.1038/nrm.2017.60; Shifman S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040028; Sicotte NL, 2006, NEUROLOGY, V67, P519, DOI 10.1212/01.wnl.0000227960.38262.0c; Wang Q, 2015, SCI REP-UK, V5, DOI 10.1038/srep18209; Wang X, 2017, MOL NEUROBIOL, V54, P2878, DOI 10.1007/s12035-016-9861-y; Wu XY, 2008, CELL, V135, P137, DOI 10.1016/j.cell.2008.07.045; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446; Yang Y, 2011, BIOL PSYCHIAT, V69, P63, DOI 10.1016/j.biopsych.2010.08.020	34	32	33	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 6	2018	103	6					1009	1021		10.1016/j.ajhg.2018.10.019	http://dx.doi.org/10.1016/j.ajhg.2018.10.019			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HD4YX	30471716	Bronze, Green Published			2022-12-18	WOS:000452535600014
J	Nguyen, TTM; Murakami, Y; Wigby, KM; Baratang, NV; Rousseau, J; St-Denis, A; Rosenfeld, JA; Laniewski, SC; Jones, J; Iglesias, AD; Jones, MC; Masser-Frye, D; Scheuerle, AE; Perry, DL; Taft, RJ; Le Deist, F; Thompson, M; Kinoshita, T; Campeau, PM				Thi Tuyet Mai Nguyen; Murakami, Yoshiko; Wigby, Kristen M.; Baratang, Nissan V.; Rousseau, Justine; St-Denis, Anik; Rosenfeld, Jill A.; Laniewski, Stephanie C.; Jones, Julie; Iglesias, Alejandro D.; Jones, Marilyn C.; Masser-Frye, Diane; Scheuerle, Angela E.; Perry, Denise L.; Taft, Ryan J.; Le Deist, Francoise; Thompson, Miles; Kinoshita, Taroh; Campeau, Philippe M.			Mutations in PIGS, Encoding a GPI Transamidase, Cause a Neurological Syndrome Ranging from Fetal Akinesia to Epileptic Encephalopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HYPOTONIA-SEIZURES SYNDROME; MENTAL-RETARDATION SYNDROME; ANCHOR-SYNTHESIS PATHWAY; CONGENITAL-ANOMALIES; INTELLECTUAL DISABILITY; MABRY SYNDROME; DEVELOPMENTAL DELAY; CAUSE HYPERPHOSPHATASIA; GERMLINE MUTATION; GLYCOSYLPHOSPHATIDYLINOSITOL	Inherited GPI deficiencies (IGDs) are a subset of congenital disorders of glycosylation that are increasingly recognized as a result of advances in whole-exome sequencing (WES) and whole-genome sequencing (WGS). IGDs cause a series of overlapping phenotypes consisting of seizures, dysmorphic features, multiple congenital malformations, and severe intellectual disability. We present a study of six individuals from three unrelated families in which WES or WGS identified bi-allelic phosphatidylinositol glycan class S (PIGS) biosynthesis mutations. Phenotypes included severe global developmental delay, seizures (partly responding to pyridoxine), hypotonia, weakness, ataxia, and dysmorphic facial features. Two of them had compound-heterozygous variants c.108G>A (p.Trp36*) and c.101T>C (p.Leu34Pro), and two siblings of another family were homozygous for a deletion and insertion leading to p.Thr439_Lys451delinsArgLeuLeu. The third family had two fetuses with multiple joint contractures consistent with fetal akinesia. They were compound heterozygous for c.923A>G (p.G1u308Gly) and c.468+1G>C, a splicing mutation. Flow-cytometry analyses demonstrated that the individuals with PIGS mutations show a GPI-AP deficiency profile. Expression of the p.Trp36* variant in PIGS-deficient HEK293 cells revealed only partial restoration of cell-surface GPI-APs. In terms of both biochemistry and phenotype, loss of function of PIGS shares features with PIGT deficiency and other IGDs. This study contributes to the understanding of the GPI-AP biosynthesis pathway by describing the consequences of PIGS disruption in humans and extending the family of IGDs.	[Thi Tuyet Mai Nguyen; Baratang, Nissan V.; Rousseau, Justine; St-Denis, Anik; Le Deist, Francoise; Campeau, Philippe M.] Univ Montreal, Ctr Hosp Univ St Justine, Res Ctr, Montreal, PQ H3T 1C5, Canada; [Murakami, Yoshiko; Kinoshita, Taroh] Osaka Univ, Res Inst Microbial Dis, Osaka 5650871, Japan; [Wigby, Kristen M.; Jones, Marilyn C.; Thompson, Miles] Univ Calif San Diego, Dept Pediat, San Diego, CA 92093 USA; [Rosenfeld, Jill A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Laniewski, Stephanie C.] Univ Rochester, Med Ctr, New York, NY 14642 USA; [Jones, Julie] Greenwood Genet Ctr, Greenwood, SC 29646 USA; [Iglesias, Alejandro D.] NewYork Presbyterian Morgan Stanley Childrens Hos, New York, NY 10032 USA; [Masser-Frye, Diane] Rady Childrens Hosp, San Diego, CA 92123 USA; [Scheuerle, Angela E.] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Perry, Denise L.; Taft, Ryan J.] Illumina Inc, San Diego, CA 92121 USA	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Osaka University; University of California System; University of California San Diego; Baylor College of Medicine; University of Rochester; Greenwood Genetic Center; NewYork-Presbyterian Hospital; Morgan Stanley Children's Hospital; Rady Childrens Hospital San Diego; University of Texas System; University of Texas Southwestern Medical Center Dallas; Illumina	Campeau, PM (corresponding author), Univ Montreal, Ctr Hosp Univ St Justine, Res Ctr, Montreal, PQ H3T 1C5, Canada.	p.campeau@umontreal.ca	Campeau, Philippe/J-8614-2015; Kinoshita, Taroh/C-7353-2009	Campeau, Philippe/0000-0001-9713-7107; Rousseau, Justine/0000-0002-3554-2673	Canadian Institutes of Health Research [RN 324373]; Fonds de Recherche en Sante Quebec [30647]; Fondation du Grand Defi Pierre Lavoie; Illumina iHope program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche en Sante Quebec; Fondation du Grand Defi Pierre Lavoie; Illumina iHope program	We acknowledge funding by the Canadian Institutes of Health Research (grant RN 324373), the Fonds de Recherche en Sante Quebec (award 30647), and the Fondation du Grand Defi Pierre Lavoie. Whole-genome sequencing of family 2 was supported by the Illumina iHope program.	Almeida AM, 2006, NAT MED, V12, P846, DOI 10.1038/nm1410; Barone R, 2012, ANN NEUROL, V72, P550, DOI 10.1002/ana.23632; Brady PD, 2014, EUR J MED GENET, V57, P487, DOI 10.1016/j.ejmg.2014.05.001; Chiyonobu T, 2014, J MED GENET, V51, P203, DOI 10.1136/jmedgenet-2013-102156; Cole DEC, 2015, SUBCELL BIOCHEM, V76, P343, DOI 10.1007/978-94-017-7197-9_16; Couser NL, 2015, AM J MED GENET A, V167, P2176, DOI 10.1002/ajmg.a.37129; Edvardson S, 2017, J MED GENET, V54, P196, DOI 10.1136/jmedgenet-2016-104202; Fauth C, 2016, AM J MED GENET A, V170, P392, DOI 10.1002/ajmg.a.37452; Fleming L, 2016, AM J MED GENET A, V170, P77, DOI 10.1002/ajmg.a.37369; Fujiwara I, 2015, AM J MED GENET A, V167, P777, DOI 10.1002/ajmg.a.36987; Granzow M, 2015, MOL CELL PROBE, V29, P323, DOI 10.1016/j.mcp.2015.05.012; Hansen L, 2013, AM J HUM GENET, V92, P575, DOI 10.1016/j.ajhg.2013.03.008; Horn D, 2011, AM J MED GENET A, V155A, P1917, DOI 10.1002/ajmg.a.34102; Howard MF, 2014, AM J HUM GENET, V94, P278, DOI 10.1016/j.ajhg.2013.12.012; Ilkovski B, 2015, HUM MOL GENET, V24, P6146, DOI 10.1093/hmg/ddv331; Jezela-Stanek A, 2016, EUR J PAEDIATR NEURO, V20, P462, DOI 10.1016/j.ejpn.2016.01.007; Johnston JJ, 2012, AM J HUM GENET, V90, P295, DOI 10.1016/j.ajhg.2011.11.031; Johnstone DL, 2017, HUM MOL GENET, V26, P1706, DOI 10.1093/hmg/ddx077; Joshi C, 2016, BRAIN DEV-JPN, V38, P848, DOI 10.1016/j.braindev.2016.04.004; Kato M, 2014, NEUROLOGY, V82, P1587, DOI 10.1212/WNL.0000000000000389; Khayat M, 2016, AM J MED GENET A, V170, P176, DOI 10.1002/ajmg.a.37375; Kinoshita T, 2008, J BIOCHEM, V144, P287, DOI 10.1093/jb/mvn090; Kinoshita T, 2014, P JPN ACAD B-PHYS, V90, P130, DOI 10.2183/pjab.90.130; Knaus A, 2016, HUM MUTAT, V37, P737, DOI 10.1002/humu.23006; Krawitz PM, 2013, AM J HUM GENET, V92, P584, DOI 10.1016/j.ajhg.2013.03.011; Krawitz PM, 2012, AM J HUM GENET, V91, P146, DOI 10.1016/j.ajhg.2012.05.004; Krawitz PM, 2010, NAT GENET, V42, P827, DOI 10.1038/ng.653; Kuki I, 2013, NEUROLOGY, V81, P1467, DOI 10.1212/WNL.0b013e3182a8411a; Kvarnung M, 2013, J MED GENET, V50, P521, DOI 10.1136/jmedgenet-2013-101654; Lam C, 2015, MOL GENET METAB, V115, P128, DOI 10.1016/j.ymgme.2015.04.007; Makrythanasis P, 2016, AM J HUM GENET, V98, P615, DOI 10.1016/j.ajhg.2016.02.007; Martin HC, 2014, HUM MOL GENET, V23, P3200, DOI 10.1093/hmg/ddu030; Maydan G, 2011, J MED GENET, V48, P383, DOI 10.1136/jmg.2010.087114; McInerney-Leo AM, 2016, HUM MUTAT, V37, P695, DOI 10.1002/humu.22994; Murakami Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004320; Nakamura K, 2014, EPILEPSIA, V55, pE13, DOI 10.1111/epi.12508; Nakashima M, 2014, NEUROGENETICS, V15, P193, DOI 10.1007/s10048-014-0408-y; Ng BG, 2012, AM J HUM GENET, V90, P685, DOI 10.1016/j.ajhg.2012.02.010; Nicklas JA, 2015, ENVIRON MOL MUTAGEN, V56, P663, DOI 10.1002/em.21953; Ohba C, 2014, NEUROGENETICS, V15, P85, DOI 10.1007/s10048-013-0384-7; Ohishi K, 2001, EMBO J, V20, P4088, DOI 10.1093/emboj/20.15.4088; Pagnamenta AT, 2017, EUR J HUM GENET, V25, P669, DOI 10.1038/ejhg.2017.32; QAZI QH, 1984, J PEDIATR-US, V104, P391, DOI 10.1016/S0022-3476(84)81101-4; Tarailo-Graovac M, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0243-8; Thompson MD, 2006, PEDIATR NEUROL, V34, P303, DOI 10.1016/j.pediatrneurol.2005.08.020; Thompson MD, 2012, AM J MED GENET A, V158A, P553, DOI 10.1002/ajmg.a.35202; Traynelis J, 2017, GENOME RES, V27, P1715, DOI 10.1101/gr.226589.117; Williams C, 2015, CLIN GENET, V88, P597, DOI 10.1111/cge.12581; Xue J, 2016, BRAIN DEV-JPN, V38, P807, DOI 10.1016/j.braindev.2016.04.008	49	32	33	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 4	2018	103	4					602	611		10.1016/j.ajhg.2018.08.014	http://dx.doi.org/10.1016/j.ajhg.2018.08.014			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GV7MS	30269814	Bronze, Green Published			2022-12-18	WOS:000446312200012
J	Staples, J; Maxwell, EK; Gosalia, N; Gonzaga-Jauregui, C; Snyder, C; Hawes, A; Penn, J; Ulloa, R; Bai, XD; Lopez, AE; Van Hout, CV; O'Dushlaine, C; Teslovich, TM; McCarthy, SE; Balasubramanian, S; Kirchner, HL; Leader, JB; Murray, MF; Ledbetter, DH; Shuldiner, AR; Yancoupolos, GD; Dewey, FE; Carey, DJ; Overton, JD; Baras, A; Habegger, L; Reid, JG				Staples, Jeffrey; Maxwell, Evan K.; Gosalia, Nehal; Gonzaga-Jauregui, Claudia; Snyder, Christopher; Hawes, Alicia; Penn, John; Ulloa, Ricardo; Bai, Xiaodong; Lopez, Alexander E.; Van Hout, Cristopher V.; O'Dushlaine, Colm; Teslovich, Tanya M.; McCarthy, Shane E.; Balasubramanian, Suganthi; Kirchner, H. Lester; Leader, Joseph B.; Murray, Michael F.; Ledbetter, David H.; Shuldiner, Alan R.; Yancoupolos, George D.; Dewey, Frederick E.; Carey, David J.; Overton, John D.; Baras, Aris; Habegger, Lukas; Reid, Jeffrey G.			Profiling and Leveraging Relatedness in a Precision Medicine Cohort of 92,455 Exomes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; DE-NOVO MUTATIONS; LINKAGE ANALYSIS; CRYPTIC RELATEDNESS; GENETIC-VARIATION; ARCHITECTURE; MODEL; POPULATIONS; AGE	Large-scale human genetics studies are ascertaining increasing proportions of populations as they continue growing in both number and scale. As a result, the amount of cryptic relatedness within these study cohorts is growing rapidly and has significant implications on downstream analyses. We demonstrate this growth empirically among the first 92,455 exomes from the DiscovEHR cohort and, via a custom simulation framework we developed called SimProgeny, show that these measures are in line with expectations given the underlying population and ascertainment approach. For example, within DiscovEHR we identified similar to 66,000 close (first-and second-degree) relationships, involving 55.6% of study participants. Our simulation results project that >70% of the cohort will be involved in these close relationships, given that DiscovEHR scales to 250,000 recruited individuals. We reconstructed 12,574 pedigrees by using these relationships (including 2,192 nuclear families) and leveraged them for multiple applications. The pedigrees substantially improved the phasing accuracy of 20,947 rare, deleterious compound heterozygous mutations. Reconstructed nuclear families were critical for identifying 3,415 de novo mutations in similar to 1,783 genes. Finally, we demonstrate the segregation of known and suspected disease-causing mutations, including a tandem duplication that occurs in LDLR and causes familial hypercholesterolemia, through reconstructed pedigrees. In summary, this work highlights the prevalence of cryptic relatedness expected among large healthcare population-genomic studies and demonstrates several analyses that are uniquely enabled by large amounts of cryptic relatedness.	[Staples, Jeffrey; Maxwell, Evan K.; Gosalia, Nehal; Gonzaga-Jauregui, Claudia; Hawes, Alicia; Penn, John; Ulloa, Ricardo; Bai, Xiaodong; Lopez, Alexander E.; Van Hout, Cristopher V.; O'Dushlaine, Colm; Teslovich, Tanya M.; McCarthy, Shane E.; Balasubramanian, Suganthi; Shuldiner, Alan R.; Yancoupolos, George D.; Dewey, Frederick E.; Carey, David J.; Overton, John D.; Baras, Aris; Habegger, Lukas; Reid, Jeffrey G.] Regeneron Pharmaceut, Regeneron Genet Ctr, Tarrytown, NY 10591 USA; [Snyder, Christopher] Rochester Inst Technol, Rochester, NY 14623 USA; [Kirchner, H. Lester; Leader, Joseph B.; Murray, Michael F.; Ledbetter, David H.] Geisinger Hlth Syst, Danville, PA 17822 USA	Regeneron; Rochester Institute of Technology; Geisinger Health System	Reid, JG (corresponding author), Regeneron Pharmaceut, Regeneron Genet Ctr, Tarrytown, NY 10591 USA.	jeffrey.reid@regeneron.com	Van Hout, Cristopher V./AAQ-3494-2021; Gonzaga-Jauregui, Claudia/H-4752-2019	Van Hout, Cristopher V./0000-0001-9689-5344; Gonzaga-Jauregui, Claudia/0000-0002-4667-3679				Abul-Husn NS, 2016, SCIENCE, V354, DOI 10.1126/science.aaf7000; Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bouchard-Cote A., 2016, ARXIV 1602 07956 Q B; Bycroft C., 2017, 166298101101 BIORXIV; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Day-Williams AG, 2011, GENET EPIDEMIOL, V35, P360, DOI 10.1002/gepi.20584; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dewey FE, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6814; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Fuchsberger C, 2016, NATURE, V536, P41, DOI 10.1038/nature18642; Gusev A, 2012, MOL BIOL EVOL, V29, P473, DOI 10.1093/molbev/msr133; Han EJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14238; Henn BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034267; Hu H, 2014, NAT BIOTECHNOL, V32, P663, DOI 10.1038/nbt.2895; Huff CD, 2011, GENOME RES, V21, P768, DOI 10.1101/gr.115972.110; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Ko A, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006963; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Loh PR, 2016, NAT GENET, V48, P1443, DOI 10.1038/ng.3679; Malinowski J, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00317; Maxwell E.K., 2017, BIORXIV 119461 10 11; MCKUSICK VA, 1964, B JOHNS HOPKINS HOSP, V115, P203; Mcrae JF, 2017, NATURE, V542, P433, DOI 10.1038/nature21062; Narasimhan VM, 2016, SCIENCE, V352, P474, DOI 10.1126/science.aac8624; Ober C, 2001, AM J HUM GENET, V69, P1068, DOI 10.1086/324025; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Rahbari R, 2016, NAT GENET, V48, P126, DOI 10.1038/ng.3469; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Saleheen D, 2017, NATURE, V544, P235, DOI 10.1038/nature22034; Santorico SA, 2014, GENET EPIDEMIOL, V38, pS92, DOI 10.1002/gepi.21832; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Staples J, 2016, AM J HUM GENET, V99, P154, DOI 10.1016/j.ajhg.2016.05.020; Staples J, 2014, AM J HUM GENET, V95, P553, DOI 10.1016/j.ajhg.2014.10.005; Staples J, 2013, GENET EPIDEMIOL, V37, P136, DOI 10.1002/gepi.21684; Stevens EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049575; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Sun Lei, 2012, Methods Mol Biol, V850, P47, DOI 10.1007/978-1-61779-555-8_4; Surendran P, 2016, NAT GENET, V48, P1151, DOI 10.1038/ng.3654; Voight BF, 2005, PLOS GENET, V1, P302, DOI 10.1371/journal.pgen.0010032; Wei Q, 2015, BIOINFORMATICS, V31, P1375, DOI 10.1093/bioinformatics/btu839; Wong WSW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10486; Yang J, 2014, NAT GENET, V46, P100, DOI 10.1038/ng.2876; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546	50	32	32	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 3	2018	102	5					874	889		10.1016/j.ajhg.2018.03.012	http://dx.doi.org/10.1016/j.ajhg.2018.03.012			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GG1IH	29727688	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000432440100012
J	Liskova, P; Dudakova, L; Evans, CJ; Lopez, KER; Pontikos, N; Athanasiou, D; Jama, H; Sach, J; Skalicka, P; Stranecky, V; Kmoch, S; Thaung, C; Filipec, M; Cheetham, ME; Davidson, AE; Tuft, SJ; Hardcastle, AJ				Liskova, Petra; Dudakova, Lubica; Evans, Cerys J.; Lopez, Karla E. Rojas; Pontikos, Nikolas; Athanasiou, Dimitra; Jama, Hodan; Sach, Josef; Skalicka, Pavlina; Stranecky, Viktor; Kmoch, Stanislav; Thaung, Caroline; Filipec, Martin; Cheetham, Michael E.; Davidson, Alice E.; Tuft, Stephen J.; Hardcastle, Alison J.			Ectopic GRHL2 Expression Due to Non-coding Mutations Promotes Cell State Transition and Causes Posterior Polymorphous Corneal Dystrophy 4	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; ENDOTHELIAL-CELLS; STEM-CELLS; GENE; ZEB1; GRAINYHEAD-LIKE-2; IDENTIFICATION; FRAMEWORK; PROJECT; CANCER	In a large family of Czech origin, we mapped a locus for an autosomal-dominant corneal endothelial dystrophy, posterior polymorphous corneal dystrophy 4 (PPCD4), to 8q22.3-q24.12. Whole-genome sequencing identified a unique variant (c.20+544G>T) in this locus, within an intronic regulatory region of GRHL2. Targeted sequencing identified the same variant in three additional previously unsolved PPCD-affected families, including a de novo occurrence that suggests this is a recurrent mutation. Two further unique variants were identified in intron 1 of GRHL2 (c.20+257delT and c.20+133delA) in unrelated PPCD-affected families. GRHL2 is a transcription factor that suppresses epithelial-to-mesenchymal transition (EMT) and is a direct transcriptional repressor of ZEB1. ZEB1 mutations leading to haploinsufficiency cause PPCD3. We previously identified promoter mutations in OVOL2, a gene not normally expressed in the corneal endothelium, as the cause of PPCD1. OVOL2 drives mesenchymal-to-epithelial transition (MET) by directly inhibiting EMT-inducing transcription factors, such as ZEB1. Here, we demonstrate that the GRHL2 regulatory variants identified in PPCD4-affected individuals induce increased transcriptional activity in vitro. Furthermore, although GRHL2 is not expressed in corneal endothelial cells in control tissue, we detected GRHL2 in the corneal "endothelium'' in PPCD4 tissue. These cells were also positive for epithelial markers E-Cadherin and Cytokeratin 7, indicating they have transitioned to an epithelial-like cell type. We suggest that mutations inducing MET within the corneal endothelium are a convergent pathogenic mechanism leading to dysfunction of the endothelial barrier and disease.	[Liskova, Petra; Dudakova, Lubica; Skalicka, Pavlina; Stranecky, Viktor; Kmoch, Stanislav] Charles Univ Prague, Fac Med 1, Dept Paediat & Adolescent Med, Res Unit Rare Dis, Ke Karlovu 2, Prague 12808, Czech Republic; [Liskova, Petra; Dudakova, Lubica; Skalicka, Pavlina; Stranecky, Viktor; Kmoch, Stanislav] Gen Univ Hosp Prague, Ke Karlovu 2, Prague 12808, Czech Republic; [Liskova, Petra; Skalicka, Pavlina; Filipec, Martin] Charles Univ Prague, Fac Med 1, Dept Ophthalmol, U Nemocnice 2, Prague 12808, Czech Republic; [Liskova, Petra; Skalicka, Pavlina; Filipec, Martin] Gen Univ Hosp Prague, U Nemocnice 2, Prague 12808, Czech Republic; [Liskova, Petra; Evans, Cerys J.; Lopez, Karla E. Rojas; Pontikos, Nikolas; Athanasiou, Dimitra; Jama, Hodan; Thaung, Caroline; Cheetham, Michael E.; Davidson, Alice E.; Hardcastle, Alison J.] UCL, UCL Inst Ophthalmol, London EC1V 9EL, England; [Sach, Josef] Charles Univ Prague, Fac Hosp Kralovske Vinohrady, Fac Med 3, Inst Pathol, Srobarova 50, Prague 10034, Czech Republic; [Thaung, Caroline; Tuft, Stephen J.; Hardcastle, Alison J.] Moorfields Eye Hosp, London EC1V 2PD, England	Charles University Prague; Charles University Prague; General University Hospital Prague; Charles University Prague; General University Hospital Prague; University of London; University College London; Charles University Prague; University Hospital Vinohrady; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Liskova, P (corresponding author), Charles Univ Prague, Fac Med 1, Dept Paediat & Adolescent Med, Res Unit Rare Dis, Ke Karlovu 2, Prague 12808, Czech Republic.; Liskova, P (corresponding author), Gen Univ Hosp Prague, Ke Karlovu 2, Prague 12808, Czech Republic.; Liskova, P (corresponding author), Charles Univ Prague, Fac Med 1, Dept Ophthalmol, U Nemocnice 2, Prague 12808, Czech Republic.; Liskova, P (corresponding author), Gen Univ Hosp Prague, U Nemocnice 2, Prague 12808, Czech Republic.; Liskova, P; Hardcastle, AJ (corresponding author), UCL, UCL Inst Ophthalmol, London EC1V 9EL, England.; Hardcastle, AJ (corresponding author), Moorfields Eye Hosp, London EC1V 2PD, England.	petra.liskova@lf1.cuni.cz; a.hardcastle@ucl.ac.uk	Liskova, Petra/C-9680-2011; Dudakova, Lubica/F-4781-2017; Pontikos, Nikolas/U-3642-2018; Stranecky, Viktor/I-8524-2017; Thaung, Caroline/C-2180-2008	Liskova, Petra/0000-0001-7834-8486; Dudakova, Lubica/0000-0003-4718-8955; Pontikos, Nikolas/0000-0003-1782-4711; Hardcastle, Alison/0000-0002-0038-6770; Stranecky, Viktor/0000-0002-2599-6479; Skalicka, Pavlina/0000-0002-7403-3433; Thaung, Caroline/0000-0002-8318-046X; Evans, Cerys/0000-0001-6989-889X; Cheetham, Michael/0000-0001-6429-654X	GACR [17-12355S]; Fight for Sight; Rosetrees Trust; Moorfields Eye Charity; Academy of Medical Sciences; Wellcome Trust; National Institute for Health Research Biomedical Research Centre based at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology; UNCE [204064]; GAUK [250361/2017]; SVV [260367/2017]; Ministry of Health of the Czech Republic [15-28208A]; Ministry of Education, Youth, and Sports of the Czech Republic [LQ1604 NPU II]; National Center for Medical Genomics [LM2015091, CZ.02.1.01/0.0/0.0/16_013/0001634]; Academy of Medical Sciences (AMS) [SBF001\\1010] Funding Source: researchfish; Rosetrees Trust [M311-F1] Funding Source: researchfish; Fight for Sight [1415/16, 1588/89] Funding Source: researchfish	GACR(Grant Agency of the Czech Republic); Fight for Sight; Rosetrees Trust(Rosetrees Trust); Moorfields Eye Charity; Academy of Medical Sciences(Academy of Medical Sciences (AMS)); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research Biomedical Research Centre based at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology; UNCE; GAUK; SVV; Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); National Center for Medical Genomics; Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Rosetrees Trust(Rosetrees Trust); Fight for Sight	We thank all the families for participating in this research. This work was funded by awards from GACR 17-12355S (P.L., L.D., P.S.), Fight for Sight, the Rosetrees Trust, Moorfields Eye Charity (A.J.H., S.J.T., A.E.D., K.E.R.L., and C.J.E.), The Academy of Medical Sciences (A.E.D.), and the Wellcome Trust (M.E.C.). S.J.T., N.P., and A.J.H. were supported by the National Institute for Health Research Biomedical Research Centre based at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology. Institutional support was provided by UNCE 204064 (P.L., L.D., S.K., V.S.) and Progres-Q26/LF1. P.S. was also funded by GAUK 250361/2017 and SVV 260367/2017 and S.K. and V.S. by grant 15-28208A from the Ministry of Health of the Czech Republic and the project LQ1604 NPU II from the Ministry of Education, Youth, and Sports of the Czech Republic.; We thank The National Center for Medical Genomics (LM2015091) for providing allele frequencies in an ethnically matched population (project CZ.02.1.01/0.0/0.0/16_013/0001634). This study was performed within the framework of ERN-EYE. The pGL3-Control vector was a kind gift from Dr. Stephanie Halford. We would like to thank Ales Horinek for paternity testing and Erik Kykal for basic bioinformatic analysis.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Aue A, 2015, J AM SOC NEPHROL, V26, P2704, DOI 10.1681/ASN.2014080759; Bath C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064244; Boivin FJ, 2017, ANN NY ACAD SCI, V1397, P80, DOI 10.1111/nyas.13367; BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chen T, 2017, J CELL PHYSIOL, V232, P3261, DOI 10.1002/jcp.25797; Chen YY, 2013, HUM MOL GENET, V22, P1271, DOI 10.1093/hmg/dds527; Chung DD, 2017, INVEST OPHTH VIS SCI, V58, P3202, DOI 10.1167/iovs.17-21423; Chung DD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169215; Cieply B, 2012, CANCER RES, V72, P2440, DOI 10.1158/0008-5472.CAN-11-4038; Davidson AE, 2016, AM J HUM GENET, V98, P75, DOI 10.1016/j.ajhg.2015.11.018; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Eghrari AO, 2015, PROG MOL BIOL TRANSL, V134, P7, DOI 10.1016/bs.pmbts.2015.04.001; Eng L, 2004, HUM MUTAT, V23, P67, DOI 10.1002/humu.10295; Evans CJ, 2015, ANN HUM GENET, V79, P1, DOI 10.1111/ahg.12090; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Frisch SM, 2017, ONCOGENE, V36, P6067, DOI 10.1038/onc.2017.178; Grabe Niels, 2002, In Silico Biology, V2, pS1; Harikumar A, 2015, EMBO REP, V16, P1609, DOI 10.15252/embr.201541011; He ZG, 2016, SCI REP-UK, V6, DOI 10.1038/srep29047; HENRIQUEZ AS, 1984, SURV OPHTHALMOL, V29, P139, DOI 10.1016/0039-6257(84)90171-1; Hong T, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004569; Jirsova K, 2007, EXP EYE RES, V84, P680, DOI 10.1016/j.exer.2006.12.006; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim YR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119443; Kitazawa K, 2016, CELL REP, V15, P1359, DOI 10.1016/j.celrep.2016.04.020; Krachmer J H, 1985, Trans Am Ophthalmol Soc, V83, P413; Krafchak CM, 2005, AM J HUM GENET, V77, P694, DOI 10.1086/497348; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Liskova P, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9495; Liskova P, 2016, EUR J HUM GENET, V24, P985, DOI 10.1038/ejhg.2015.232; Liskova P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045495; Massie I, 2015, METHODS MOL BIOL, V1235, P179, DOI 10.1007/978-1-4939-1785-3_15; McCarey BE, 2008, CORNEA, V27, P1, DOI 10.1097/ICO.0b013e31815892da; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Merjava S, 2011, HISTOCHEM CELL BIOL, V136, P93, DOI 10.1007/s00418-011-0830-2; Nakahashi H, 2013, CELL REP, V3, P1678, DOI 10.1016/j.celrep.2013.04.024; Petrof G, 2014, AM J HUM GENET, V95, P308, DOI 10.1016/j.ajhg.2014.08.001; Plagnol V, 2012, BIOINFORMATICS, V28, P2747, DOI 10.1093/bioinformatics/bts526; Pontikos N, 2017, BIOINFORMATICS, V33, P2421, DOI 10.1093/bioinformatics/btx147; Pradella D, 2017, MOL CANCER, V16, DOI 10.1186/s12943-016-0579-2; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; RODRIGUES MM, 1980, INVEST OPHTH VIS SCI, V19, P832; Singh A.J., 2017, CELL MOL LIFE SCI; Srinivas SP, 2012, EXP EYE RES, V95, P8, DOI 10.1016/j.exer.2011.09.009; Valtink M, 2008, CELLS TISSUES ORGANS, V187, P286, DOI 10.1159/000113406; Van Laer L, 2008, HUM MOL GENET, V17, P159, DOI 10.1093/hmg/ddm292; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Vona B, 2013, AM J MED GENET A, V161, P2060, DOI 10.1002/ajmg.a.36017; Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013; Weiss JS, 2015, CORNEA, V34, P117, DOI 10.1097/ICO.0000000000000307; Wingender E, 2008, BRIEF BIOINFORM, V9, P326, DOI 10.1093/bib/bbn016; Xiang J, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2016.83; Zakharevich M, 2017, MOL VIS, V23, P740	56	32	32	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 1	2018	102	3					447	459		10.1016/j.ajhg.2018.02.002	http://dx.doi.org/10.1016/j.ajhg.2018.02.002			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FX9ZL	29499165	hybrid, Green Published, Green Submitted			2022-12-18	WOS:000426469600015
J	Myers, CT; Stong, N; Mountier, EI; Helbig, KL; Freytag, S; Sullivan, JE; Ben Zeev, B; Nissenkorn, A; Tzadok, M; Heimer, G; Shinde, DN; Rezazadeh, A; Regan, BM; Oliver, KL; Ernst, ME; Lippa, NC; Mulhern, MS; Ren, Z; Poduri, A; Andrade, DM; Bird, LM; Bahlo, M; Berkovic, SF; Lowenstein, DH; Scheffer, IE; Sadleir, LG; Goldstein, DB; Mefford, HC; Heinzen, EL				Myers, Candace T.; Stong, Nicholas; Mountier, Emily I.; Helbig, Katherine L.; Freytag, Saskia; Sullivan, Joseph E.; Ben Zeev, Bruria; Nissenkorn, Andreea; Tzadok, Michal; Heimer, Gali; Shinde, Deepali N.; Rezazadeh, Arezoo; Regan, Brigid M.; Oliver, Karen L.; Ernst, Michelle E.; Lippa, Natalie C.; Mulhern, Maureen S.; Ren, Zhong; Poduri, Annapurna; Andrade, Danielle M.; Bird, Lynne M.; Bahlo, Melanie; Berkovic, Samuel F.; Lowenstein, Daniel H.; Scheffer, Ingrid E.; Sadleir, Lynette G.; Goldstein, David B.; Mefford, Heather C.; Heinzen, Erin L.			De Novo Mutations in PPP3CA Cause Severe Neurodevelopmental Disease with Seizures	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE; ENCEPHALOPATHY; CALCINEURIN; FRAMEWORK; PROTEIN; STXBP1; GENOME; COEXPRESSION; DISCOVERY; DYNAMIN	Exome sequencing has readily enabled the discovery of the genetic mutations responsible for a wide range of diseases. This success has been particularly remarkable in the severe epilepsies and other neurodevelopmental diseases for which rare, often de novo, mutations play a significant role in disease risk. Despite significant progress, the high genetic heterogeneity of these disorders often requires large sample sizes to identify a critical mass of individuals with disease-causing mutations in a single gene. By pooling genetic findings across multiple studies, we have identified six individuals with severe developmental delay (6/6), refractory seizures (5/6), and similar dysmorphic features (3/6), each harboring a de novo mutation in PPP3CA. PPP3CA encodes the alpha isoform of a subunit of calcineurin. Calcineurin encodes a calcium-and calmodulin-dependent serine/threonine protein phosphatase that plays a role in a wide range of biological processes, including being a key regulator of synaptic vesicle recycling at nerve terminals. Five individuals with de novo PPP3CA mutations were identified among 4,760 trio probands with neurodevelopmental diseases; this is highly unlikely to occur by chance (p = 1.2 x 10(-8)) given the size and mutability of the gene. Additionally, a sixth individual with a de novo mutation in PPP3CA was connected to this study through GeneMatcher. Based on these findings, we securely implicate PPP3CA in early-onset refractory epilepsy and further support the emerging role for synaptic dysregulation in epilepsy.	[Myers, Candace T.; Mefford, Heather C.] Univ Washington, Dept Pediat, Div Med Genet, Seattle, WA 98195 USA; [Stong, Nicholas; Ernst, Michelle E.; Lippa, Natalie C.; Mulhern, Maureen S.; Ren, Zhong; Goldstein, David B.; Heinzen, Erin L.] Columbia Univ, Med Ctr, Inst Genom Med, New York, NY 10032 USA; [Mountier, Emily I.; Sadleir, Lynette G.] Univ Otago, Dept Paediat & Child Hlth, Wellington 6242, New Zealand; [Helbig, Katherine L.; Shinde, Deepali N.] Ambry Genet, Aliso Viejo, CA 92656 USA; [Freytag, Saskia; Oliver, Karen L.; Bahlo, Melanie] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Freytag, Saskia; Bahlo, Melanie] Univ Melbourne, Dept Med Biol, Parkville, Vic 3050, Australia; [Sullivan, Joseph E.] Univ Calif San Francisco, Dept Neurol & Pediat, San Francisco, CA 94143 USA; [Ben Zeev, Bruria; Nissenkorn, Andreea; Tzadok, Michal; Heimer, Gali] Sheba Med Ctr, Ramat Gan, Israel; [Ben Zeev, Bruria; Nissenkorn, Andreea; Tzadok, Michal; Heimer, Gali] Tel Aviv Univ, Sackler Sch Med, IL-6997801 Tel Aviv, Israel; [Rezazadeh, Arezoo; Regan, Brigid M.; Andrade, Danielle M.] Univ Toronto, Krembil Neurosci Ctr, Toronto Western Hosp, Div Neurol,Epilepsy Genet Res Program, Toronto, ON M5T 2S8, Canada; [Oliver, Karen L.; Berkovic, Samuel F.] Univ Melbourne, Austin Hlth, Epilepsy Res Ctr, Dept Med, Heidelberg, Vic 3084, Australia; [Poduri, Annapurna] Harvard Med Sch, Boston Childrens Hosp, Dept Neurol, Epilepsy Genet Program, Boston, MA 02115 USA; [Poduri, Annapurna] Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA; [Bird, Lynne M.] Univ Calif San Diego, Dept Pediat, San Diego, CA 92037 USA; [Bird, Lynne M.] Rady Childrens Hosp, San Diego, CA 92037 USA; [Lowenstein, Daniel H.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Scheffer, Ingrid E.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia; [Scheffer, Ingrid E.] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Parkville, Vic 3050, Australia; [Heinzen, Erin L.] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA	University of Washington; University of Washington Seattle; Columbia University; University of Otago; Walter & Eliza Hall Institute; University of Melbourne; University of California System; University of California San Francisco; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; University of California System; University of California San Francisco; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; Columbia University	Mefford, HC (corresponding author), Univ Washington, Dept Pediat, Div Med Genet, Seattle, WA 98195 USA.; Heinzen, EL (corresponding author), Columbia Univ, Med Ctr, Inst Genom Med, New York, NY 10032 USA.; Heinzen, EL (corresponding author), Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA.	hmefford@uw.edu; eh2682@cumc.columbia.edu	Oliver, Karen Louise/O-6159-2018; Goldstein, David/AAY-8125-2020; Scheffer, Ingrid E/G-1668-2013; jiang, yu/HGU-0029-2022; Bird, Lynne/AAG-9533-2021; Stong, Nicholas/ABB-7516-2021; Helbig, Katherine/B-7454-2012	Oliver, Karen Louise/0000-0001-5188-6153; Scheffer, Ingrid E/0000-0002-2311-2174; Sadleir, Lynette/0000-0002-5355-7115; Helbig, Katherine/0000-0001-8249-0549; Stong, Nicholas/0000-0002-0678-637X; Berkovic, Samuel/0000-0003-4580-841X; Bahlo, Melanie/0000-0001-5132-0774; Bird, Lynne/0000-0003-4833-3747; Andrade, Danielle/0000-0003-0953-2698	Lennox-Gaustaut Syndrome Foundation; American Epilepsy Society; NIH National Institute of Neurological Disorders and Stroke [RO1 NS069605, U01NS077303, U01NS053998]; Health Research Council of New Zealand; Cure Kids New Zealand; Australian National Health and Medical Research Council [APP1054618, APP1102971]; Victorian State Government Operational Infrastructure Support; Australian Government NHMRC IRIISS funding; Janssen; Gilead; Biogen; AstraZeneca; UCB; Eisai; Athena Diagnostics; GlaxoSmithKline; Nutricia; Transgenomics; Biocodex; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069605, U01NS053998, U01NS077303] Funding Source: NIH RePORTER	Lennox-Gaustaut Syndrome Foundation; American Epilepsy Society; NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Health Research Council of New Zealand(Health Research Council of New Zealand); Cure Kids New Zealand; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government Operational Infrastructure Support; Australian Government NHMRC IRIISS funding(National Health and Medical Research Council (NHMRC) of Australia); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Gilead(Gilead Sciences); Biogen(Biogen); AstraZeneca(AstraZeneca); UCB(UCB Pharma SA); Eisai(Eisai Co Ltd); Athena Diagnostics; GlaxoSmithKline(GlaxoSmithKline); Nutricia(Danone Nutricia); Transgenomics; Biocodex; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank all individuals and their families. We also thank individuals and groups who contributed exome sequence samples for analysis, including the Epi4K Consortium, the Epilepsy Phenome Genome Project (EPGP), the Epilepsy Genetics Initiative (EGI) - a signature program of Citizens United for Research in Epilepsy (CURE), EuroEPINOMICS-RES Consortium, and Dr. Vandana Shashi and Dr. Ann Bergin. C.T.M. is supported by postdoctoral fellowships from the Lennox-Gaustaut Syndrome Foundation and the American Epilepsy Society. This study was supported by the NIH National Institute of Neurological Disorders and Stroke (RO1 NS069605 to H.C.M.; U01NS077303; U01NS053998), the Health Research Council of New Zealand, Cure Kids New Zealand, the Australian National Health and Medical Research Council (APP1054618, APP1102971); Victorian State Government Operational Infrastructure Support, Australian Government NHMRC IRIISS funding, as well as additional sources that are listed in the Supplemental Data. K.L.H. and D.N.S. are full-time employees of Ambry Genetics, Inc. Exome sequencing is one of Ambry's commercially available tests. D.B.G. is a founder and holds equity in Pairnomix and Praxis, and has research funding from Janssen, Gilead, Biogen, AstraZeneca, and UCB. I.E.S. received support from and/or has served as a paid consultant for UCB, Eisai, Athena Diagnostics, GlaxoSmithKline, Nutricia, Transgenomics, and Biocodex.	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; AITKEN A, 1984, EUR J BIOCHEM, V139, P663, DOI 10.1111/j.1432-1033.1984.tb08055.x; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Appenzeller S, 2014, AM J HUM GENET, V95, P360, DOI 10.1016/j.ajhg.2014.08.013; Arendt KL, 2015, P NATL ACAD SCI USA, V112, pE5744, DOI 10.1073/pnas.1510239112; Berkovic S, 2012, EPILEPSIA, V53, P1457, DOI 10.1111/j.1528-1167.2012.03511.x; Boumil RM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001046; Carvill GL, 2014, NEUROLOGY, V82, P1245, DOI 10.1212/WNL.0000000000000291; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cohen P T, 1996, Adv Pharmacol, V36, P67; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dhindsa RS, 2015, NEUROL-GENET, V1, DOI 10.1212/01.NXG.0000464295.65736.da; Farwell KD, 2015, GENET MED, V17, P578, DOI 10.1038/gim.2014.154; Freytag S, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0444-y; Freytag S, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0745-3; Hamdan FF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004772; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Heine M, 2012, ADV EXP MED BIOL, V970, P197, DOI 10.1007/978-3-7091-0932-8_9; Hiatt JB, 2013, GENOME RES, V23, P843, DOI 10.1101/gr.147686.112; Jiang Y, 2015, AM J HUM GENET, V97, P272, DOI 10.1016/j.ajhg.2015.06.013; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lemke JR, 2014, ANN NEUROL, V75, P147, DOI 10.1002/ana.24073; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; LIEBERMAN DN, 1994, NATURE, V369, P235, DOI 10.1038/369235a0; MACKINTOSH RW, 1990, FEBS LETT, V276, P156, DOI 10.1016/0014-5793(90)80531-M; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Martin HC, 2014, HUM MOL GENET, V23, P3200, DOI 10.1093/hmg/ddu030; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mcrae JF, 2017, NATURE, V542, P433, DOI 10.1038/nature21062; Michaud JL, 2014, HUM MOL GENET, V23, P4846, DOI 10.1093/hmg/ddu199; Myers CT, 2016, AM J HUM GENET, V99, P287, DOI 10.1016/j.ajhg.2016.06.003; O'Brien Janelle E., 2013, Frontiers in Genetics, V4, P213, DOI 10.3389/fgene.2013.00213; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; Oliver KL, 2016, NEUROL-GENET, V2, DOI 10.1212/NXG.0000000000000051; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Poduri A, 2013, ANN NEUROL, V74, P873, DOI 10.1002/ana.23998; Rickman C, 2007, J BIOL CHEM, V282, P12097, DOI 10.1074/jbc.M700227200; Rohena L, 2013, RARE DIS, V1, DOI 10.4161/rdis.26314; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Saitsu H, 2008, NAT GENET, V40, P782, DOI 10.1038/ng.150; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Scheffer IE, 2017, EPILEPSIA, V58, P512, DOI 10.1111/epi.13709; Schubert J, 2014, NAT GENET, V46, P1327, DOI 10.1038/ng.3130; Shen XM, 2014, NEUROLOGY, V83, P2247, DOI 10.1212/WNL.0000000000001079; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Staley K, 2015, NAT NEUROSCI, V18, P367, DOI 10.1038/nn.3947; Stamberger H, 2016, NEUROLOGY, V86, P954, DOI 10.1212/WNL.0000000000002457; Suls A, 2013, AM J HUM GENET, V93, P967, DOI 10.1016/j.ajhg.2013.09.017; Torkamani A, 2014, ANN NEUROL, V76, P529, DOI 10.1002/ana.24263; Van der Auwera GA, 2002, CURR PROTOC BIOINFOR, V43; Winder DG, 1998, CELL, V92, P25, DOI 10.1016/S0092-8674(00)80896-X; Zhu XL, 2015, GENET MED, V17, P774, DOI 10.1038/gim.2014.191	55	32	34	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 5	2017	101	4					516	524		10.1016/j.ajhg.2017.08.013	http://dx.doi.org/10.1016/j.ajhg.2017.08.013			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FI8UJ	28942967	Green Published, Bronze			2022-12-18	WOS:000412277300003
J	Yang, JJ; Fritsche, LG; Zhou, X; Abecasis, G				Yang, Jingjing; Fritsche, Lars G.; Zhou, Xiang; Abecasis, Goncalo		Int Age-Related Macular Degene	A Scalable Bayesian Method for Integrating Functional Information in Genome-wide Association Studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PARTITIONING HERITABILITY; LINKAGE DISEQUILIBRIUM; VARIABLE SELECTION; HAPLOTYPE BLOCKS; HIGH-RISK; VARIANTS; DISEASES; LOCI; IDENTIFICATION; ANNOTATION	Genome-wide association studies (GWASs) have identified many complex loci. However, most loci reside in noncoding regions and have unknown biological functions. Integrative analysis that incorporates known functional information into GWASs can help elucidate the underlying biological mechanisms and prioritize important functional variants. Hence, we develop a flexible Bayesian variable selection model with efficient computational techniques for such integrative analysis. Different from previous approaches, our method models the effect-size distribution and probability of causality for variants with different annotations and jointly models genome-wide variants to account for linkage disequilibrium (LD), thus prioritizing associations based on the quantification of the annotations and allowing for multiple associated variants per locus. Our method dramatically improves both computational speed and posterior sampling convergence by taking advantage of the block-wise LD structures in human genomes. In simulations, our method accurately quantifies the functional enrichment and performs more powerfully for prioritizing the true associations than alternative methods, where the power gain is especially apparent when multiple associated variants in LD reside in the same locus. We applied our method to an in-depth GWAS of age-related macular degeneration with 33,976 individuals and 9,857,286 variants. We find the strongest enrichment for causality among non-synonymous variants (543 more likely to be causal, 1.43 larger effect sizes) and variants in transcription, repressed Polycomb, and enhancer regions, as well as identify five additional candidate loci beyond the 32 known AMD risk loci. In conclusion, our method is shown to efficiently integrate functional information in GWASs, helping identify functional associated-variants and underlying biology.	[Yang, Jingjing; Fritsche, Lars G.; Zhou, Xiang; Abecasis, Goncalo] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ctr Stat Genet, 1415 Washington Hts, Ann Arbor, MI 48109 USA; [Fritsche, Lars G.] Norwegian Univ Sci & Technol, NTNU, Dept Publ Hlth & Nursing, KG Jebsen Ctr Genet Epidemiol, N-7491 Trondheim, Norway	University of Michigan System; University of Michigan; Norwegian University of Science & Technology (NTNU)	Zhou, X; Abecasis, G (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Biostat, Ctr Stat Genet, 1415 Washington Hts, Ann Arbor, MI 48109 USA.	xzhousph@umich.edu; goncalo@umich.edu	Yang, Jingjing/X-5013-2019; Fritsche, Lars G/AAF-9387-2019	Yang, Jingjing/0000-0002-4191-4138; Fritsche, Lars G/0000-0002-2110-1690	NIH [R01HG009124, R01GM126553, R01HG007022, R01EY022005]; National Science Foundation (NSF) [DMS1712933]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG009124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM126553] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	X.Z. is supported by NIH grants R01HG009124 and R01GM126553 and the National Science Foundation (NSF) grant DMS1712933. J.Y. and G.A. are supported by NIH grants R01HG007022 and R01EY022005. The authors would like to thank the Michigan Genomics Initiative (MGI) for allowing us to use the GWAS data about the skin cancer phenotype.	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Berisa T, 2016, BIOINFORMATICS, V32, P283, DOI 10.1093/bioinformatics/btv546; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carbonetto P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003770; Carbonetto P, 2012, BAYESIAN ANAL, V7, P73, DOI 10.1214/12-BA703; Carithers LJ, 2015, BIOPRESERV BIOBANK, V13, P307, DOI 10.1089/bio.2015.29031.hmm; Chipman H, 2001, MODEL SELECTION, V38, P65, DOI DOI 10.1214/LNMS/1215540964; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Fransen E, 2015, EUR J HUM GENET, V23, P110, DOI 10.1038/ejhg.2014.56; Fritsche LG, 2016, NAT GENET, V48, P134, DOI 10.1038/ng.3448; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Guan YT, 2011, ANN APPL STAT, V5, P1780, DOI 10.1214/11-AOAS455; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Helgason H, 2013, NAT GENET, V45, P1371, DOI 10.1038/ng.2740; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Jordan MI, 1999, MACH LEARN, V37, P183, DOI 10.1023/A:1007665907178; Kellis M, 2014, P NATL ACAD SCI USA, V111, P6131, DOI 10.1073/pnas.1318948111; Kettunen J, 2012, NAT GENET, V44, P269, DOI 10.1038/ng.1073; Kichaev G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004722; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lea AJ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005650; Loh PR, 2015, NAT GENET, V47, P1385, DOI 10.1038/ng.3431; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Masson D, 2009, J LIPID RES, V50, pS201, DOI 10.1194/jlr.R800061-JLR200; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; McVicker G, 2013, SCIENCE, V342, P747, DOI 10.1126/science.1242429; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Pickrell JK, 2014, AM J HUM GENET, V94, P559, DOI 10.1016/j.ajhg.2014.03.004; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Schork AJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003449; Seddon JM, 2013, NAT GENET, V45, P1366, DOI 10.1038/ng.2741; Singh S.W.M., 2012, MONTE CARLO MCMC EFF; Tung J., 2015, ELIFE, V25, P4; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wall JD, 2003, NAT REV GENET, V4, P587, DOI 10.1038/nrg1123; Wen XQ, 2014, ANN APPL STAT, V8, P176, DOI 10.1214/13-AOAS695; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhan XW, 2013, NAT GENET, V45, P1375, DOI 10.1038/ng.2758; Zhou X., 2017, UNIFIED FRAMEWORK VA; Zhou X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003264; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	58	32	32	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 7	2017	101	3					404	416		10.1016/j.ajhg.2017.08.002	http://dx.doi.org/10.1016/j.ajhg.2017.08.002			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FG1CS	28844487	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000409530900007
J	Osborn, DPS; Pond, HL; Mazaheri, N; Dejardin, J; Munn, CJ; Mushref, K; Cauley, ES; Moroni, I; Pasanisi, MB; Sellars, EA; Hill, RS; Partlow, JN; Willaert, RK; Bharj, J; Malamiri, RA; Galehdari, H; Shariati, G; Maroofian, R; Mora, M; Swan, LE; Voit, T; Conti, FJ; Jamshidi, Y; Manzini, MC				Osborn, Daniel P. S.; Pond, Heather L.; Mazaheri, Neda; Dejardin, Jeremy; Munn, Christopher J.; Mushref, Khaloob; Cauley, Edmund S.; Moroni, Isabella; Pasanisi, Maria Barbara; Sellars, Elizabeth A.; Hill, R. Sean; Partlow, Jennifer N.; Willaert, Rebecca K.; Bharj, Jaipreet; Malamiri, Reza Azizi; Galehdari, Hamid; Shariati, Gholamreza; Maroofian, Reza; Mora, Marina; Swan, Laura E.; Voit, Thomas; Conti, Francesco J.; Jamshidi, Yalda; Manzini, M. Chiara			Mutations in INPP5K Cause a Form of Congenital Muscular Dystrophy Overlapping Marinesco-Sjogren Syndrome and Dystroglycanopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SKELETAL-MUSCLE; ENDOPLASMIC-RETICULUM; GENETIC-VARIATION; DISEASE GENE; ZEBRAFISH; IDENTIFICATION; SKIP; PHOSPHATASE; NEUROLOGY; CATARACT	Congenital muscular dystrophies display a wide phenotypic and genetic heterogeneity. The combination of clinical, biochemical, and molecular genetic findings must be considered to obtain the precise diagnosis and provide appropriate genetic counselling. Here we report five individuals from four families presenting with variable clinical features including muscular dystrophy with a reduction in dystroglycan glycosylation, short stature, intellectual disability, and cataracts, overlapping both the dystroglycanopathies and Marinesco-Sjogren syndrome. Whole-exome sequencing revealed homozygous missense and compound heterozygous mutations in INPPSK in the affected members of each family. INPPSK encodes the inositol polyphosphate-5-phosphatase K, also known as SKIP (skeletal muscle and kidney enriched inositol phosphatase), which is highly expressed in the brain and muscle. INPPSK localizes to both the endoplasmic reticulum and to actin ruffles in the cytoplasm. It has been shown to regulate myoblast differentiation and has also been implicated in protein processing through its interaction with the ER chaperone HSPAS/BiP. We show that morpholino-mediated inpp5k loss of function in the zebrafish results in shortened body axis, microphthalmia with disorganized lens, microcephaly, reduced touch-evoked motility, and highly disorganized myofibers. Altogether these data demonstrate that mutations in INPPSK cause a congenital muscular dystrophy syndrome with short stature, cataracts, and intellectual disability.	[Osborn, Daniel P. S.; Dejardin, Jeremy; Bharj, Jaipreet; Maroofian, Reza; Jamshidi, Yalda] St Georges Univ London, Cardiovasc & Cell Sci Inst, Cranmer Terrace, London SW17 0RE, England; [Pond, Heather L.; Mushref, Khaloob; Cauley, Edmund S.; Manzini, M. Chiara] George Washington Univ, Sch Med & Hlth Sci, Dept Pharmacol & Physiol, Washington, DC 20037 USA; [Mazaheri, Neda; Galehdari, Hamid] Shahid Chamran Univ Ahvaz, Dept Genet, Ahvaz 6135783151, Iran; [Mazaheri, Neda; Galehdari, Hamid; Shariati, Gholamreza] Narges Med Genet & Prenatal Diag Lab, East Mihan Ave, Kianpars 6155689467, Ahvaz, Iran; [Munn, Christopher J.; Swan, Laura E.] Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Liverpool L69 3BX, Merseyside, England; [Moroni, Isabella; Pasanisi, Maria Barbara] Fdn IRCCS Ist Neurol C Besta, Pediat Neurol Unit, I-20133 Milan, Italy; [Pasanisi, Maria Barbara; Mora, Marina] Fdn IRCCS Ist Neurol C Besta, Div Neuromuscular Dis & Neuroimmunol, I-20126 Milan, Italy; [Sellars, Elizabeth A.] Univ Arkansas Med Sci, Arkansas Childrens Hosp, Sect Genet & Metab, Dept Pediat, Little Rock, AR 72202 USA; [Hill, R. Sean; Partlow, Jennifer N.] Boston Childrens Hosp, Program Genet & Genom, Boston, MA 02115 USA; [Hill, R. Sean; Partlow, Jennifer N.] Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; [Willaert, Rebecca K.] GeneDX, Gaithersburg, MD 20877 USA; [Malamiri, Reza Azizi] Ahvaz Jundishapur Univ Med Sci, Dept Paediat Neurol, Golestan Med Educ & Res Ctr, Ahvaz 6163764648, Iran; [Shariati, Gholamreza] Ahvaz Jundishapur Univ Med Sci, Fac Med, Dept Med Genet, Ahvaz 6135715794, Iran; [Maroofian, Reza] Univ Exeter, Sch Med, RILD Wellcome Wolfson Ctr, Royal Devon & Exeter NHS Fdn Trust, Exeter EX1 2LU, Devon, England; [Voit, Thomas; Conti, Francesco J.] UCL, Great Ormond St Inst Child Hlth, NIHR GOSH Biomed Res Ctr, London WC1N 1EH, England	St Georges University London; George Washington University; Shahid Chamran University of Ahvaz; University of Liverpool; IRCCS Istituto Neurologico Besta; IRCCS Istituto Neurologico Besta; Arkansas Children's Hospital; University of Arkansas System; University of Arkansas Medical Sciences; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Ahvaz Jundishapur University of Medical Sciences (AJUMS); Ahvaz Jundishapur University of Medical Sciences (AJUMS); University of Exeter; University of London; University College London	Jamshidi, Y (corresponding author), St Georges Univ London, Cardiovasc & Cell Sci Inst, Cranmer Terrace, London SW17 0RE, England.; Manzini, MC (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Dept Pharmacol & Physiol, Washington, DC 20037 USA.	yjamshid@sgul.ac.uk; cmanzini@gwu.edu	Malamiri, Reza Azizi/B-9306-2008; Jamshidi, Yalda/AAL-1377-2020; Osborn, Daniel/ABG-6699-2020; Shariati, Gholamreza/AAE-2798-2019; Moroni, Isabella/AAL-1336-2021; Mora, Marina/J-2883-2018	Malamiri, Reza Azizi/0000-0001-5423-6375; Jamshidi, Yalda/0000-0003-0151-6482; Moroni, Isabella/0000-0002-3322-1681; Mora, Marina/0000-0002-5765-2320; Manzini, M. Chiara/0000-0001-7175-1096; Shariati, Gholamreza/0000-0002-6295-127X; Cauley, Edmund/0000-0002-8968-6621; Dejardin, Jeremy Thomas/0000-0001-6460-7969; Osborn, Daniel/0000-0002-5266-404X; Swan, Laura/0000-0002-6312-6263	Telethon Network Genetic Biobanks [GTB12001F]; Manton Center for Orphan Disease Research; Muscular Dystrophy Association [293587]; March of Dimes [6-FY14-422]; Wellcome Trust Institutional Strategic Support Fund [105616/Z/14/Z]; Medical Research Council [MRC/N010035/1]; ZebSolutions; NIH National Center for Advancing Translational Sciences [UL1TR001876]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001876] Funding Source: NIH RePORTER; Medical Research Council [MR/N010035/1] Funding Source: researchfish; MRC [MR/N010035/1] Funding Source: UKRI	Telethon Network Genetic Biobanks(Fondazione Telethon); Manton Center for Orphan Disease Research; Muscular Dystrophy Association(Muscular Dystrophy Association); March of Dimes(March of Dimes); Wellcome Trust Institutional Strategic Support Fund(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ZebSolutions; NIH National Center for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	First and foremost, we thank the families who enrolled in our studies and the physicians who have contributed families. The EuroBioBank and Telethon Network Genetic Biobanks (project no. GTB12001F) are acknowledged for providing biological samples. We are also grateful to Meghan Cho (GeneDX) for coordinating release of sequencing information, Chris Walsh (Boston Children's Hospital) for logistical help in sample collection, and Jan Senderek (Universitat Munchen) for providing plasmids for protein function studies. This work was supported by the Manton Center for Orphan Disease Research (M.C.M.), the Muscular Dystrophy Association (research grant 293587 to M.C.M.), the March of Dimes (research grant 6-FY14-422 to M.C.M), the Wellcome Trust Institutional Strategic Support Fund (105616/Z/14/Z to L.E.S.), and the Medical Research Council (MRC/N010035/1 to L.E.S.). Zebrafish work was supported by ZebSolutions. This publication was also supported by Award Number UL1TR001876 from the NIH National Center for Advancing Translational Sciences. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Center for Advancing Translational Sciences or the NIH.	Behnke J, 2015, J MOL BIOL, V427, P1589, DOI 10.1016/j.jmb.2015.02.011; Bonnemann CG, 2014, NEUROMUSCULAR DISORD, V24, P289, DOI 10.1016/j.nmd.2013.12.011; Carss KJ, 2013, AM J HUM GENET, V93, P29, DOI 10.1016/j.ajhg.2013.05.009; Chen DY, 2011, NATURE, V469, P491, DOI 10.1038/nature09667; Ezgu F, 2014, CLIN GENET, V86, P74, DOI 10.1111/cge.12230; Greiling TMS, 2009, DEV DYNAM, V238, P2254, DOI 10.1002/dvdy.21997; Gupta V, 2011, HUM MOL GENET, V20, P1712, DOI 10.1093/hmg/ddr047; Gurung R, 2003, J BIOL CHEM, V278, P11376, DOI 10.1074/jbc.M209991200; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Ijuin T, 2000, J BIOL CHEM, V275, P10870, DOI 10.1074/jbc.275.15.10870; Ijuin T, 2016, GENES CELLS, V21, P457, DOI 10.1111/gtc.12353; Ijuin T, 2015, BBA-MOL CELL RES, V1853, P3192, DOI 10.1016/j.bbamcr.2015.09.009; Ijuin T, 2012, J BIOL CHEM, V287, P31330, DOI 10.1074/jbc.M112.388785; Kang PB, 2015, NEUROLOGY, V84, P1369, DOI 10.1212/WNL.0000000000001416; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Krieger M, 2013, BRAIN, V136, P3634, DOI 10.1093/brain/awt283; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lipton JO, 2014, NEURON, V84, P275, DOI 10.1016/j.neuron.2014.09.034; Lizio M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0560-6; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Manzini MC, 2012, AM J HUM GENET, V91, P541, DOI 10.1016/j.ajhg.2012.07.009; Manzini MC, 2011, CURR OPIN GENET DEV, V21, P333, DOI 10.1016/j.gde.2011.01.006; Mercuri E, 2009, NEUROLOGY, V72, P1802, DOI 10.1212/01.wnl.0000346518.68110.60; Mercuri E, 2012, ANN NEUROL, V72, P9, DOI 10.1002/ana.23548; Paolini C, 2007, J PHYSIOL-LONDON, V583, P767, DOI 10.1113/jphysiol.2007.138024; Reed UC, 1999, BRAIN DEV-JPN, V21, P274, DOI 10.1016/S0387-7604(98)00100-4; Reinhold A, 2003, AM J NEURORADIOL, V24, P825; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Scott EM, 2016, NAT GENET, V48, P1071, DOI 10.1038/ng.3592; Senderek J, 2005, NAT GENET, V37, P1312, DOI 10.1038/ng1678; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Sobreira N, 2015, HUM MUTAT, V36, P425, DOI 10.1002/humu.22769; Topaloglu H, 1997, Eur J Paediatr Neurol, V1, P127, DOI 10.1016/S1090-3798(97)80045-1; Wells L, 2013, J BIOL CHEM, V288, P6930, DOI 10.1074/jbc.R112.438978	34	32	36	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 2	2017	100	3					537	545		10.1016/j.ajhg.2017.01.019	http://dx.doi.org/10.1016/j.ajhg.2017.01.019			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EN2PH	28190459	Bronze, Green Accepted, Green Published			2022-12-18	WOS:000395851900017
J	Ordulu, Z; Kammin, T; Brand, H; Pillalamarri, V; Redin, CE; Collins, RL; Blumenthal, I; Hanscom, C; Pereira, S; Bradley, I; Crandall, BF; Gerrol, P; Hayden, MA; Hussain, N; Kanengisser-Pines, B; Kantarci, S; Levy, B; Macera, MJ; Quintero-Rivera, F; Spiegel, E; Stevens, B; Ulm, JE; Warburton, D; Wilkins-Haug, LE; Yachelevich, N; Gusella, JF; Talkowski, ME; Morton, CC				Ordulu, Zehra; Kammin, Tammy; Brand, Harrison; Pillalamarri, Vamsee; Redin, Claire E.; Collins, Ryan L.; Blumenthal, Ian; Hanscom, Carrie; Pereira, Shahrin; Bradley, India; Crandall, Barbara F.; Gerrol, Pamela; Hayden, Mark A.; Hussain, Naveed; Kanengisser-Pines, Bibi; Kantarci, Sibel; Levy, Brynn; Macera, Michael J.; Quintero-Rivera, Fabiola; Spiegel, Erica; Stevens, Blair; Ulm, Janet E.; Warburton, Dorothy; Wilkins-Haug, Louise E.; Yachelevich, Naomi; Gusella, James F.; Talkowski, Michael E.; Morton, Cynthia C.			Structural Chromosomal Rearrangements Require Nucleotide-Level Resolution: Lessons from Next-Generation Sequencing in Prenatal Diagnosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							APPARENTLY BALANCED TRANSLOCATIONS; CRYPTIC GENOMIC IMBALANCES; DE-NOVO; DEVELOPMENTAL DELAY; TRANSCRIPTION FACTOR; MENTAL-RETARDATION; DECIPHER DATABASE; SONIC HEDGEHOG; ARRAY CGH; GENE	In this exciting era of "next-gen cytogenetics," integrating genomic sequencing into the prenatal diagnostic setting is possible within an actionable time frame and can provide precise delineation of balanced chromosomal rearrangements at the nucleotide level. Given the increased risk of congenital abnormalities in newborns with de novo balanced chromosomal rearrangements, comprehensive interpretation of breakpoints could substantially improve prediction of phenotypic outcomes and support perinatal medical care. Herein, we present and evaluate sequencing results of balanced chromosomal rearrangements in ten prenatal subjects with respect to the location of regulatory chromatin domains (topologically associated domains [TADS]). The genomic material from all subjects was interpreted to be "normal" by microarray analyses, and their rearrangements would not have been detected by cell-free DNA (cfDNA) screening. The findings of our systematic approach correlate with phenotypes of both pregnancies with untoward outcomes (5/10) and with healthy newborns (3/10). Two pregnancies, one with a chromosomal aberration predicted to be of unknown clinical significance and another one predicted to be likely benign, were terminated prior to phenotype-genotype correlation (2/10). We demonstrate that the clinical interpretation of structural rearrangements should not be limited to interruption, deletion, or duplication of specific genes and should also incorporate regulatory domains of the human genome with critical ramifications for the control of gene expression. As detailed in this study, our molecular approach to both detecting and interpreting the breakpoints of structural rearrangements yields unparalleled information in comparison to other commonly used first-tier diagnostic methods, such as non-invasive cfDNA screening and microarray analysis, to provide improved genetic counseling for phenotypic outcome in the prenatal setting.	[Ordulu, Zehra; Kammin, Tammy; Pereira, Shahrin; Gerrol, Pamela; Hayden, Mark A.; Wilkins-Haug, Louise E.; Morton, Cynthia C.] Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, 75 Francis St, Boston, MA 02115 USA; [Ordulu, Zehra; Redin, Claire E.; Wilkins-Haug, Louise E.; Talkowski, Michael E.; Morton, Cynthia C.] Harvard Med Sch, Boston, MA 02115 USA; [Brand, Harrison; Pillalamarri, Vamsee; Redin, Claire E.; Collins, Ryan L.; Blumenthal, Ian; Hanscom, Carrie; Gusella, James F.; Talkowski, Michael E.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Brand, Harrison; Redin, Claire E.; Gusella, James F.; Talkowski, Michael E.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Brand, Harrison; Redin, Claire E.; Gusella, James F.; Talkowski, Michael E.] Harvard Med Sch, Boston, MA 02114 USA; [Brand, Harrison; Redin, Claire E.; Gusella, James F.; Talkowski, Michael E.; Morton, Cynthia C.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Bradley, India; Crandall, Barbara F.] Univ Calif Los Angeles, David Geffen Sch Med, Prenatal Diag Ctr, Dept Psychiat, Med Plaza, Los Angeles, CA 90095 USA; [Hussain, Naveed] Univ Connecticut, Connecticut Childrens Med Ctr, Dept Pediat, Farmington, CT 06030 USA; [Kanengisser-Pines, Bibi] Kaplan Med Ctr, Dept Obstet & Gynecol, IL-76100 Rehovot, Israel; [Kantarci, Sibel; Quintero-Rivera, Fabiola] Univ Calif Los Angeles, David Geffen Sch Med, UCLA Clin Genom Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Levy, Brynn] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Macera, Michael J.] Columbia Univ, New York Presbyterian Hosp, Med Ctr, New York, NY 10032 USA; [Spiegel, Erica] Columbia Univ, Dept Maternal Fetal Med, Med Ctr, New York, NY 10032 USA; [Stevens, Blair] Univ Texas Med Sch Houston, Dept Obstet Gynecol & Reprod Sci, Houston, TX 77030 USA; [Ulm, Janet E.] Reg Obstetr Consultants, Chattanooga, TN 37403 USA; [Warburton, Dorothy] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; [Warburton, Dorothy] Columbia Univ, Dept Pediat, New York, NY 10032 USA; [Yachelevich, Naomi] NYU, Sch Med, Dept Pediat, Clin Genet Serv, New York, NY 10003 USA; [Gusella, James F.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Talkowski, Michael E.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Talkowski, Michael E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Morton, Cynthia C.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Morton, Cynthia C.] Univ Manchester, Div Evolut & Genom Sci, Sch Biol Sci, Manchester Acad Hlth Sci Ctr, Manchester 03101, Lancs, England	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Connecticut Children's Medical Center; University of Connecticut; Hebrew University of Jerusalem; Kaplan Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Columbia University; Columbia University; NewYork-Presbyterian Hospital; Columbia University; University of Texas System; University of Texas Health Science Center Houston; Columbia University; Columbia University; New York University; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; University of Manchester	Morton, CC (corresponding author), Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, 75 Francis St, Boston, MA 02115 USA.; Morton, CC (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Morton, CC (corresponding author), Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA.; Morton, CC (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.; Morton, CC (corresponding author), Univ Manchester, Div Evolut & Genom Sci, Sch Biol Sci, Manchester Acad Hlth Sci Ctr, Manchester 03101, Lancs, England.	cmorton@partners.org	Hussain, Naveed/ABD-2342-2021; Ordulu, Zehra/ABI-6638-2020	Ordulu, Zehra/0000-0002-3218-1075; Talkowski, Michael/0000-0003-2889-0992; Collins, Ryan/0000-0003-1268-9995	NIH [GM061354, HD081256]; NIH (March of Dimes) [6-FY15-255]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD085857, R01HD081256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061354] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH (March of Dimes); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the families of the subjects for their participation. We thank Christina Jabbour, Amelia Lindgren, Samantha Schilit, and Drs. Ozden Altiok Clark and Frederick Bieber for their contributions. We dedicate this article in loving memory of Dorothy Warburton, a co-author on this study and the author of an article also published in The Journal,<SUP>4</SUP> which has served as a foundation for the Developmental Genome Anatomy Project. This study was funded by the NIH (GM061354 to C.C.M., M.E.T., and J.F.G.; HD081256 and March of Dimes 6-FY15-255 to M.E.T.).	Alvarez JD, 2000, GENE DEV, V14, P521; Amarillo IE, 2013, AM J MED GENET A, V161A, P1167, DOI 10.1002/ajmg.a.35847; Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205; American College of Obstetricians and Gynecologists Committee on Genetics, 2013, Obstet Gynecol, V122, P1374, DOI 10.1097/01.AOG.0000438962.16108.d1; Anderson E, 2014, DEVELOPMENT, V141, P3934, DOI 10.1242/dev.108480; [Anonymous], 2016, Obstet Gynecol, V127, P976, DOI 10.1097/AOG.0000000000001438; Arbabi A, 2016, BIOINFORMATICS, V32, P1662, DOI 10.1093/bioinformatics/btw178; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Balamotis MA, 2012, MOL CELL BIOL, V32, P333, DOI 10.1128/MCB.05917-11; Baptista J, 2008, AM J HUM GENET, V82, P927, DOI 10.1016/j.ajhg.2008.02.012; Barbosa AC, 2008, P NATL ACAD SCI USA, V105, P9391, DOI 10.1073/pnas.0802679105; Begemann M, 2015, NEW ENGL J MED, V373, P349, DOI 10.1056/NEJMoa1415227; Belloni E, 1996, NAT GENET, V14, P353, DOI 10.1038/ng1196-353; Benko S, 2009, NAT GENET, V41, P359, DOI 10.1038/ng.329; Bhatia S, 2014, HUM GENET, V133, P815, DOI 10.1007/s00439-014-1424-6; Bhatia S, 2013, AM J HUM GENET, V93, P1126, DOI 10.1016/j.ajhg.2013.10.028; Bianchi DW, 2014, NEW ENGL J MED, V370, P799, DOI 10.1056/NEJMoa1311037; Bragin E, 2014, NUCLEIC ACIDS RES, V42, pD993, DOI 10.1093/nar/gkt937; Brand H, 2015, AM J HUM GENET, V97, P170, DOI 10.1016/j.ajhg.2015.05.012; Brand H, 2014, AM J HUM GENET, V95, P454, DOI 10.1016/j.ajhg.2014.09.005; Buj-Bello A, 1999, HUM MUTAT, V14, P320, DOI 10.1002/(SICI)1098-1004(199910)14:4<320::AID-HUMU7>3.0.CO;2-O; Cai JL, 2003, HUM GENET, V114, P68, DOI 10.1007/s00439-003-1012-7; Castermans D, 2003, J MED GENET, V40, P352, DOI 10.1136/jmg.40.5.352; Chen HM, 1996, GENOMICS, V38, P30, DOI 10.1006/geno.1996.0588; Choucair N, 2015, MOL CYTOGENET, V8, DOI 10.1186/s13039-015-0149-0; Close J, 2012, J NEUROSCI, V32, P17690, DOI 10.1523/JNEUROSCI.3583-12.2012; De Gregori M, 2007, J MED GENET, V44, P750, DOI 10.1136/jmg.2007.052787; deKok YJM, 1996, HUM MOL GENET, V5, P1229, DOI 10.1093/hmg/5.9.1229; Di Meglio T, 2013, SCIENCE, V339, P204, DOI 10.1126/science.1229326; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Drury S, 2015, PRENATAL DIAG, V35, P1010, DOI 10.1002/pd.4675; Feenstra I, 2011, EUR J HUM GENET, V19, P1152, DOI 10.1038/ejhg.2011.120; Fernandez BA, 2005, CLIN GENET, V68, P349, DOI 10.1111/j.1399-0004.2005.00498.x; Fernandez T, 2004, AM J HUM GENET, V74, P1286, DOI 10.1086/421474; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Gicquel C, 2005, NAT GENET, V37, P1003, DOI 10.1038/ng1629; Gijsbers ACJ, 2010, EUR J MED GENET, V53, P227, DOI 10.1016/j.ejmg.2010.06.003; Gordon CT, 2009, J MED GENET, V46, P649, DOI 10.1136/jmg.2009.068361; Gordon CT, 2014, HUM MUTAT, V35, P1011, DOI 10.1002/humu.22606; Gribble SM, 2005, J MED GENET, V42, P8, DOI 10.1136/jmg.2004.024141; Higgins AW, 2008, AM J HUM GENET, V82, P712, DOI 10.1016/j.ajhg.2008.01.011; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Janssen N, 2012, HUM MUTAT, V33, P1149, DOI 10.1002/humu.22086; Jeong YS, 2006, DEVELOPMENT, V133, P761, DOI 10.1242/dev.02239; JOSEPH M, 1995, AM J MED GENET, V59, P168, DOI 10.1002/ajmg.1320590211; Jungbluth H, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-26; Kawabe H, 2003, GENES CELLS, V8, P537, DOI 10.1046/j.1365-2443.2003.00655.x; Kearney HM, 2011, GENET MED, V13, P680, DOI 10.1097/GIM.0b013e3182217a3a; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Kohwi-Shigematsu T, 2012, METHODS, V58, P243, DOI 10.1016/j.ymeth.2012.06.019; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lauren J, 2003, GENOMICS, V81, P411, DOI 10.1016/S0888-7543(03)00030-2; Le Meur N, 2010, J MED GENET, V47, P22, DOI 10.1136/jmg.2009.069732; Lee S, 2000, GENE, V245, P253, DOI 10.1016/S0378-1119(00)00031-7; Lehnhardt A, 2015, CLIN J AM SOC NEPHRO, V10, P825, DOI 10.2215/CJN.10141014; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Macera MJ, 2015, PRENATAL DIAG, V35, P299, DOI 10.1002/pd.4456; Middendorp S, 1997, P NATL ACAD SCI USA, V94, P9141, DOI 10.1073/pnas.94.17.9141; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Norton ME, 2015, NEW ENGL J MED, V372, P1589, DOI 10.1056/NEJMoa1407349; Nuytens K, 2013, NEUROBIOL DIS, V51, P144, DOI 10.1016/j.nbd.2012.11.004; Ordulu Z, 2014, AM J HUM GENET, V94, P695, DOI 10.1016/j.ajhg.2014.03.020; Pangalos C, 2016, PEERJ, V4, DOI 10.7717/peerj.1955; Rose NC, 2016, OBSTET GYNECOL, V127, pE123; Rutsch F, 2009, NAT GENET, V41, P234, DOI 10.1038/ng.294; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schluth-Bolard C, 2009, EUR J MED GENET, V52, P291, DOI 10.1016/j.ejmg.2009.05.011; Senderek J, 2011, AM J HUM GENET, V88, P162, DOI 10.1016/j.ajhg.2011.01.008; Sexton T, 2015, CELL, V160, P1049, DOI 10.1016/j.cell.2015.02.040; Shiratsuchi T, 1997, CYTOGENET CELL GENET, V79, P103, DOI 10.1159/000134693; Sismani C, 2008, MOL CYTOGENET, V1, DOI 10.1186/1755-8166-1-15; STARR J, 1990, J MED GENET, V27, P281, DOI 10.1136/jmg.27.5.281; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; Talkowski ME, 2012, NEW ENGL J MED, V367, P2226, DOI 10.1056/NEJMoa1208594; Talkowski ME, 2011, AM J HUM GENET, V88, P469, DOI 10.1016/j.ajhg.2011.03.013; Uetani N, 2000, EMBO J, V19, P2775, DOI 10.1093/emboj/19.12.2775; Wapner RJ, 2012, NEW ENGL J MED, V367, P2175, DOI 10.1056/NEJMoa1203382; WARBURTON D, 1991, AM J HUM GENET, V49, P995; Wise A, 2015, J NEUROGENET, V29, P135, DOI 10.3109/01677063.2015.1064916; Yamamoto T, 2014, AM J MED GENET A, V164, P634, DOI 10.1002/ajmg.a.36325; Yu ZK, 1998, P NATL ACAD SCI USA, V95, P11324, DOI 10.1073/pnas.95.19.11324; Zweier C, 2007, AM J HUM GENET, V80, P994, DOI 10.1086/515583; Zweier C, 2009, AM J HUM GENET, V85, P655, DOI 10.1016/j.ajhg.2009.10.004	84	32	35	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 3	2016	99	5					1015	1033		10.1016/j.ajhg.2016.08.022	http://dx.doi.org/10.1016/j.ajhg.2016.08.022			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EB6XT	27745839	Green Published, Bronze			2022-12-18	WOS:000387529600002
J	Ongen, H; Dermitzakis, ET				Ongen, Halit; Dermitzakis, Emmanouil T.			Alternative Splicing QTLs in European and African Populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN GENOME; CELL-TYPE; TRANSCRIPTOME; ANNOTATION; MUTATIONS; REVEALS; CANCER	With the advent of RNA-sequencing technology, we can detect different types of alternative splicing and determine how DNA variation regulates splicing. However, given the short read lengths used in most population-based RNA-sequencing experiments, quantifying transcripts accurately remains a challenge. Here we present a method, Altrans, for discovery of alternative splicing quantitative trait loci (asQTLs). To assess the performance of Altrans, we compared it to Cufflinks and MISO in simulations and Cufflinks for asQTL discovery. Simulations show that in the presence of unannotated transcripts, Altrans performs better in quantifications than Cufflinks and MISO. We have applied Altrans and Cufflinks to the Geuvadis dataset, which comprises samples from European and African populations, and discovered (FDR = 1%) 1,427 and 166 asQTLs with Altrans and 1,737 and 304 asQTLs with Cufflinks for Europeans and Africans, respectively. We show that, by discovering a set of asQTLs in a smaller subset of European samples and replicating these in the remaining larger subset of Europeans, both methods achieve similar replication levels (95% for both methods). We find many Altrans-specific asQTLs, which replicate to a high degree (93%). This is mainly due to junctions absent from the annotations and hence not tested with Cufflinks. The asQTLs are significantly enriched for biochemically active regions of the genome, functional marks, and variants in splicing regions, highlighting their biological relevance. We present an approach for discovering asQTLs that is a more direct assessment of splicing compared to other methods and is complementary to other transcript quantification methods.	[Ongen, Halit; Dermitzakis, Emmanouil T.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Ongen, Halit; Dermitzakis, Emmanouil T.] Univ Geneva, Inst Genet & Genom Geneva iGE3, CH-1211 Geneva, Switzerland; [Ongen, Halit; Dermitzakis, Emmanouil T.] Swiss Inst Bioinformat, CH-1211 Geneva, Switzerland; [Dermitzakis, Emmanouil T.] King Abdulaziz Univ, Ctr Excellence Genom Med Res, Jeddah 21589, Saudi Arabia; [Dermitzakis, Emmanouil T.] Acad Athens, Biomed Res Fdn, Athens 11527, Greece	University of Geneva; University of Geneva; Swiss Institute of Bioinformatics; King Abdulaziz University; Academy of Athens	Ongen, H (corresponding author), Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland.	halit.ongen@unige.ch; emmanouil.dermitzakis@unige.ch		Ongen, Halit/0000-0002-4197-5790	European Commission SYSCOL FP7 [UE7-SYSCOL-258236]; European Research Council; Louis Jeantet Foundation; Swiss National Science Foundation; NIH-NIMH (GTEx)	European Commission SYSCOL FP7; European Research Council(European Research Council (ERC)European Commission); Louis Jeantet Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NIH-NIMH (GTEx)	This research is supported by grants from European Commission SYSCOL FP7 (UE7-SYSCOL-258236), European Research Council, Louis Jeantet Foundation, Swiss National Science Foundation, and the NIH-NIMH (GTEx). We thank Alfonso Buil for statistical support. The computations were performed at the Vital-IT Swiss Institute of Bioinformatics.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Barnett DW, 2011, BIOINFORMATICS, V27, P1691, DOI 10.1093/bioinformatics/btr174; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Griebel T, 2012, NUCLEIC ACIDS RES, V40, P10073, DOI 10.1093/nar/gks666; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Khurana E, 2013, SCIENCE, V342, P84, DOI 10.1126/science.1235587; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Marco-Sola S, 2012, NAT METHODS, V9, P1185, DOI [10.1038/NMETH.2221, 10.1038/nmeth.2221]; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Nica AC, 2013, GENOME RES, V23, P1554, DOI 10.1101/gr.150706.112; Ongen H., 2015, BIORXIV; Ongen H, 2014, NATURE, V512, P87, DOI 10.1038/nature13602; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Schneider GF, 2012, NAT BIOTECHNOL, V30, P326, DOI 10.1038/nbt.2181; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang Yong-chuan, 2012, Cancer Biology Medicine, V9, P128, DOI 10.3969/j.issn.2095-3941.2012.02.009; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496	26	32	33	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 1	2015	97	4					567	575		10.1016/j.ajhg.2015.09.004	http://dx.doi.org/10.1016/j.ajhg.2015.09.004			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CT2FL	26430802	Green Published, hybrid			2022-12-18	WOS:000362617300007
J	Brand, H; Pillalamarri, V; Collins, RL; Eggert, S; O'Dushlaine, C; Braaten, EB; Stone, MR; Chambert, K; Doty, ND; Hanscom, C; Rosenfeld, JA; Ditmars, H; Blais, J; Mills, R; Lee, C; Gusella, JF; McCarroll, S; Smoller, JW; Talkowski, ME; Doyle, AE				Brand, Harrison; Pillalamarri, Vamsee; Collins, Ryan L.; Eggert, Stacey; O'Dushlaine, Colm; Braaten, Ellen B.; Stone, Matthew R.; Chambert, Kimberly; Doty, Nathan D.; Hanscom, Carrie; Rosenfeld, Jill A.; Ditmars, Hillary; Blais, Jessica; Mills, Ryan; Lee, Charles; Gusella, James F.; McCarroll, Steven; Smoller, Jordan W.; Talkowski, Michael E.; Doyle, Alysa E.			Cryptic and Complex Chromosomal Aberrations in Early-Onset Neuropsychiatric Disorders	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COPY NUMBER VARIATION; AUTISM SPECTRUM DISORDERS; STRUCTURAL VARIATION; BIPOLAR-DISORDER; HUMAN GENOME; SCHIZOPHRENIA; VARIANTS; DELETION; RISK; REARRANGEMENTS	Structural variation (SV) is a significant component of the genetic etiology of both neurodevelopmental and psychiatric disorders; however, routine guidelines for clinical genetic screening have been established only in the former category. Genome-wide chromosomal microarray (CMA) can detect genomic imbalances such as copy-number variants (CNVs), but balanced chromosomal abnormalities (BCAs) still require karyotyping for clinical detection. Moreover, submicroscopic BCAs and subarray threshold CNVs are intractable, or cryptic, to both CMA and karyotyping. Here, we performed whole-genome sequencing using large-insert jumping libraries to delineate both cytogenetically visible and cryptic SVs in a single test among 30 clinically referred youth representing a range of severe neuropsychiatric conditions. We detected 96 SVs per person on average that passed filtering criteria above our highest-confidence resolution (6,305 bp) and an additional 111 SVs per genome below this resolution. These SVs rearranged 3.8 Mb of genomic sequence and resulted in 42 putative loss-of-function (LoF) or gain-of-function mutations per person. We estimate that 80% of the LoF variants were cryptic to clinical CMA. We found myriad complex and cryptic rearrangements, including a "paired" duplication (360 kb, 169 kb) that flanks a 5.25 Mb inversion that appears in 7 additional cases from clinical CNV data among 47,562 individuals. Following convergent genomic profiling of these independent clinical CNV data, we interpreted three SVs to be of potential clinical significance. These data indicate that sequence-based delineation of the full SV mutational spectrum warrants exploration in youth referred for neuropsychiatric evaluation and clinical diagnostic SV screening more broadly.	[Brand, Harrison; Pillalamarri, Vamsee; Collins, Ryan L.; Eggert, Stacey; Stone, Matthew R.; Hanscom, Carrie; Ditmars, Hillary; Blais, Jessica; Gusella, James F.; Smoller, Jordan W.; Talkowski, Michael E.; Doyle, Alysa E.] Massachusetts Gen Hosp, Ctr Human Genet Res, Mol Neurogenet Unit, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Brand, Harrison; Eggert, Stacey; Gusella, James F.; Talkowski, Michael E.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Brand, Harrison; Eggert, Stacey; Braaten, Ellen B.; Doty, Nathan D.; Gusella, James F.; Smoller, Jordan W.; Talkowski, Michael E.; Doyle, Alysa E.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Eggert, Stacey; Gusella, James F.; McCarroll, Steven] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [O'Dushlaine, Colm; Chambert, Kimberly; Gusella, James F.; McCarroll, Steven; Smoller, Jordan W.; Talkowski, Michael E.; Doyle, Alysa E.] Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA 02141 USA; [O'Dushlaine, Colm; Chambert, Kimberly; Gusella, James F.; McCarroll, Steven; Smoller, Jordan W.; Talkowski, Michael E.; Doyle, Alysa E.] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02141 USA; [Braaten, Ellen B.; Doty, Nathan D.; Smoller, Jordan W.; Talkowski, Michael E.; Doyle, Alysa E.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Rosenfeld, Jill A.] PerkinElmer Inc, Signature Genom Labs, Spokane, WA 99207 USA; [Mills, Ryan] Univ Michigan, Med Ctr, Dept Computat Med, Ann Arbor, MI 48109 USA; [Mills, Ryan] Univ Michigan, Med Ctr, Dept Bioinformat & Human Genet, Ann Arbor, MI 48109 USA; [Lee, Charles] Jackson Lab Genom Med, Farmington, CT 06030 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Jackson Laboratory	Talkowski, ME (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Mol Neurogenet Unit, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA.	talkowski@chgr.mgh.harvard.edu; doylea@helix.mgh.harvard.edu	Doyle, Alysa/GVR-7637-2022; Mills, Ryan/F-4225-2010	Mills, Ryan/0000-0003-3425-6998; Collins, Ryan/0000-0003-1268-9995; Ditmars, Hillary/0000-0002-5066-9103; Talkowski, Michael/0000-0003-2889-0992	National Institute of Mental Health [MH095867]; Simons Foundation for Autism Research; Nancy Lurie Marks Family Foundation; March of Dimes; Charles Hood Foundation; Brain and Behavioral Research Foundation (NARSAD); Stanley Center for Psychiatric Research; David Judah Foundation; NIMH [K24MH094614]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH095867, R00MH095867, K24MH094614] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Simons Foundation for Autism Research; Nancy Lurie Marks Family Foundation; March of Dimes(March of Dimes); Charles Hood Foundation; Brain and Behavioral Research Foundation (NARSAD); Stanley Center for Psychiatric Research; David Judah Foundation; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The genomic studies were supported by funds from the National Institute of Mental Health (MH095867), the Simons Foundation for Autism Research, the Nancy Lurie Marks Family Foundation, the March of Dimes, the Charles Hood Foundation, and the Brain and Behavioral Research Foundation (NARSAD) to M.E.T. The LOGIC study and affiliated personnel were supported by funds from the Stanley Center for Psychiatric Research and the David Judah Foundation to A.E.D. J.W.M. is supported in part by NIMH grant K24MH094614.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bhalla K, 2004, J HUM GENET, V49, P308, DOI 10.1007/s10038-004-0145-4; Blumenthal I, 2014, AM J HUM GENET, V94, P870, DOI 10.1016/j.ajhg.2014.05.004; Chiang C, 2012, NAT GENET, V44, P390, DOI 10.1038/ng.2202; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Costain G, 2013, HUM MOL GENET, V22, P4485, DOI 10.1093/hmg/ddt297; Davis LK, 2012, AM J MED GENET A, V158A, P1654, DOI 10.1002/ajmg.a.35396; Dittwald P, 2013, GENOME RES, V23, P1395, DOI 10.1101/gr.152454.112; Doshi-Velez F, 2014, PEDIATRICS, V133, pE54, DOI 10.1542/peds.2013-0819; Elia J, 2010, MOL PSYCHIATR, V15, P637, DOI 10.1038/mp.2009.57; Gehman LT, 2011, NAT GENET, V43, P706, DOI 10.1038/ng.841; Gershon ES, 2013, AM J PSYCHIAT, V170, P968, DOI 10.1176/appi.ajp.2013.12121558; Grozeva D, 2010, ARCH GEN PSYCHIAT, V67, P318, DOI 10.1001/archgenpsychiatry.2010.25; Hanscom C., 2014, CURR PROTOC HUM GENE, V80, P1; Harrison FE, 2009, FREE RADICAL BIO MED, V46, P719, DOI 10.1016/j.freeradbiomed.2008.12.018; Kamien B, 2014, AM J MED GENET A, V164, P1411, DOI 10.1002/ajmg.a.36458; Kearney HM, 2011, GENET MED, V13, P676, DOI 10.1097/GIM.0b013e31822272ac; Klambauer G, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks003; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Malhotra D, 2011, NEURON, V72, P951, DOI 10.1016/j.neuron.2011.11.007; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Miller DT, 2009, J MED GENET, V46, P242, DOI 10.1136/jmg.2008.059907; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Nag A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059061; Neill NJ, 2010, MOL CYTOGENET, V3, DOI 10.1186/1755-8166-3-11; Noh HJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003523; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Piven J, 2013, J NEURODEV DISORD, V5, DOI 10.1186/1866-1955-5-30; Qiu S, 2007, J NEUROSCI RES, V85, P1046, DOI 10.1002/jnr.21204; Rosenfeld JA, 2010, GENET MED, V12, P694, DOI 10.1097/GIM.0b013e3181f0c5f3; Savini I, 2008, AMINO ACIDS, V34, P347, DOI 10.1007/s00726-007-0555-7; Schaefer GB, 2013, GENET MED, V15, P669, DOI 10.1038/gim.2013.32; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shea L, 2014, HUM GENET, V133, P111, DOI 10.1007/s00439-013-1362-8; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Sullivan PF, 2012, NAT REV GENET, V13, P537, DOI 10.1038/nrg3240; Szafranski P, 2010, HUM MUTAT, V31, P840, DOI 10.1002/humu.21284; Talkowski ME, 2012, NEW ENGL J MED, V367, P2226, DOI 10.1056/NEJMoa1208594; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Talkowski ME, 2011, AM J HUM GENET, V88, P469, DOI 10.1016/j.ajhg.2011.03.013; van Bon BWM, 2009, J MED GENET, V46, P511, DOI 10.1136/jmg.2008.063412; Wapner RJ, 2012, NEW ENGL J MED, V367, P2175, DOI 10.1056/NEJMoa1203382; Zhao WW, 2013, MOL CYTOGENET, V6, DOI 10.1186/1755-8166-6-26	49	32	33	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 2	2014	95	4					454	461		10.1016/j.ajhg.2014.09.005	http://dx.doi.org/10.1016/j.ajhg.2014.09.005			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AQ2XW	25279985	Bronze, Green Published			2022-12-18	WOS:000342654300010
J	Yamamoto, GL; Baratela, WAR; Almeida, TF; Lazar, M; Afonso, CL; Oyamada, MK; Suzuki, L; Oliveira, LAN; Ramos, ES; Kim, CA; Passos-Bueno, MR; Bertola, DR				Yamamoto, Guilherme L.; Baratela, Wagner A. R.; Almeida, Tatiana F.; Lazar, Monize; Afonso, Clara L.; Oyamada, Maria K.; Suzuki, Lisa; Oliveira, Luiz A. N.; Ramos, Ester S.; Kim, Chong A.; Passos-Bueno, Maria Rita; Bertola, Debora R.			Mutations in PCYT1A Cause Spondylometaphyseal Dysplasia with Cone-Rod Dystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; NICOTINIC ACETYLCHOLINE-RECEPTORS; NONNEURONAL CHOLINERGIC SYSTEM; GROWTH-PLATE CHONDROCYTES; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; DEVELOPMENTAL TOXICITY; MUSCULAR-DYSTROPHY; SEQUENCING DATA; INSECTICIDES; CARTILAGE	Spondylometaphyseal dysplasia with cone-rod dystrophy is a rare autosomal-recessive disorder characterized by severe short stature, progressive lower-limb bowing, flattened vertebral bodies, metaphyseal involvement, and visual impairment caused by cone-rod dystrophy. Whole-exome sequencing of four individuals affected by this disorder from two Brazilian families identified two previously unreported homozygous mutations in PCYT1A. This gene encodes the alpha isoform of the phosphate cytidylyltransferase 1 choline enzyme, which is responsible for converting phosphocholine into cytidine diphosphate-choline, a key intermediate step in the phosphatidylcholine biosynthesis pathway. A different enzymatic defect in this pathway has been previously associated with a muscular dystrophy with mitochondrial structural abnormalities that does not have cartilage and/or bone or retinal involvement. Thus, the deregulation of the phosphatidylcholine pathway may play a role in multiple genetic diseases in humans, and further studies are necessary to uncover its precise pathogenic mechanisms and the entirety of its phenotypic spectrum.	[Yamamoto, Guilherme L.; Baratela, Wagner A. R.; Almeida, Tatiana F.; Kim, Chong A.; Bertola, Debora R.] Univ Sao Paulo, Fac Med, Hosp Clin, Unidade Genet,Inst Crianca, BR-05403000 Sao Paulo, Brazil; [Yamamoto, Guilherme L.; Lazar, Monize; Passos-Bueno, Maria Rita; Bertola, Debora R.] Univ Sao Paulo, Inst Biociencias, Ctr Estudos Genoma Humano, BR-05508090 Sao Paulo, Brazil; [Afonso, Clara L.; Oyamada, Maria K.] Univ Sao Paulo, Fac Med, Hosp Clin, Dept Oftalmol, BR-05403000 Sao Paulo, Brazil; [Suzuki, Lisa; Oliveira, Luiz A. N.] Univ Sao Paulo, Fac Med, Hosp Clin, Dept Radiol,Inst Crianca, BR-05403000 Sao Paulo, Brazil; [Ramos, Ester S.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Genet, BR-14049900 Ribeirao Preto, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Yamamoto, GL (corresponding author), Univ Sao Paulo, Fac Med, Hosp Clin, Unidade Genet,Inst Crianca, BR-05403000 Sao Paulo, Brazil.	guilherme.yamamoto@usp.br	Ramos, Ester Silveira/E-3200-2019; Bertola, Débora/I-5120-2016; Passos-Bueno, Maria Rita/I-6796-2016; Yamamoto, Guilherme/C-9973-2010	Ramos, Ester Silveira/0000-0001-7253-2143; Bertola, Débora/0000-0002-4701-6777; Passos-Bueno, Maria Rita/0000-0002-9248-3008; Yamamoto, Guilherme/0000-0002-0490-8257; Kim, Chong/0000-0002-1754-1300	CEPID/FAPESP [98/14254-2]; CNPq [590148/2011-7]	CEPID/FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors would like to thank the families for their cooperation. This study was financially supported by CEPID/FAPESP 98/14254-2 and CNPq 590148/2011-7. The content is solely the responsibility of the authors and has not been influenced by the sponsors.	Bogan MJ, 2005, J BIOL CHEM, V280, P19613, DOI 10.1074/jbc.M414028200; Chang B, 2006, HUM MOL GENET, V15, P1847, DOI 10.1093/hmg/ddl107; Chung MK, 2002, FOOD CHEM TOXICOL, V40, P723, DOI 10.1016/S0278-6915(01)00127-2; Clagett-Dame M, 2002, ANNU REV NUTR, V22, P347, DOI 10.1146/annurev.nutr.22.010402.102745E; CORNELL RB, 1995, BIOCHEM J, V310, P699, DOI 10.1042/bj3100699; Cui Z, 1996, J BIOL CHEM, V271, P14668, DOI 10.1074/jbc.271.25.14668; Cui Z, 2002, BBA-MOL CELL BIOL L, V1585, P87, DOI 10.1016/S1388-1981(02)00328-1; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Deng Y, 2013, TOXICOL APPL PHARM, V269, P25, DOI 10.1016/j.taap.2013.02.008; Duncan G, 2003, LIFE SCI, V72, P2013, DOI 10.1016/S0024-3205(03)00064-X; En-Nosse M, 2009, CELL TISSUE RES, V338, P203, DOI 10.1007/s00441-009-0871-1; Fucile S, 2004, CELL CALCIUM, V35, P1, DOI 10.1016/j.ceca.2003.08.006; Gu ZZ, 2013, VASC PHARMACOL, V58, P87, DOI 10.1016/j.vph.2012.08.003; Inoue K, 2004, NAT GENET, V36, P361, DOI 10.1038/ng1322; Kawakita A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003945; Kent C, 2005, BBA-MOL CELL BIOL L, V1733, P53, DOI 10.1016/j.bbalip.2004.12.008; Kitoh H, 2011, AM J MED GENET A, V155A, P845, DOI 10.1002/ajmg.a.33898; Lee JY, 2009, J BIOL CHEM, V284, P33535, DOI 10.1074/jbc.M109.053363; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Matsumoto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042841; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; MENEELY GA, 1989, J EXP ZOOL, V252, P60, DOI 10.1002/jez.1402520109; MISAWA M, 1982, J TOXICOL ENV HEALTH, V10, P551, DOI 10.1080/15287398209530276; Mitsuhashi S, 2011, AM J HUM GENET, V88, P845, DOI 10.1016/j.ajhg.2011.05.010; Ruiz M, 2013, FEBS J, V280, P3928, DOI 10.1111/febs.12394; Sher RB, 2006, J BIOL CHEM, V281, P4938, DOI 10.1074/jbc.M512578200; Sousa SB, 2008, AM J MED GENET A, V146A, P3186, DOI 10.1002/ajmg.a.32576; Teber I, 2004, MOL BRAIN RES, V121, P131, DOI 10.1016/j.molbrainres.2003.11.017; Tian Y, 2005, REPROD TOXICOL, V20, P267, DOI 10.1016/j.reprotox.2005.01.012; Vance DE, 2009, J LIPID RES, V50, pS132, DOI 10.1194/jlr.R800048-JLR200; Walters BA, 2004, AM J MED GENET A, V129A, P265, DOI 10.1002/ajmg.a.30145; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang LM, 2005, MOL CELL BIOL, V25, P3357, DOI 10.1128/MCB.25.8.3357-3363.2005; WANG Y, 1995, J BIOL CHEM, V270, P18948, DOI 10.1074/jbc.270.32.18948; WANG YL, 1995, J BIOL CHEM, V270, P17843, DOI 10.1074/jbc.270.30.17843; Warman ML, 2011, AM J MED GENET A, V155A, P943, DOI 10.1002/ajmg.a.33909; Wessler I, 2008, BRIT J PHARMACOL, V154, P1558, DOI 10.1038/bjp.2008.185; Westman M, 2010, CLIN EXP IMMUNOL, V162, P62, DOI 10.1111/j.1365-2249.2010.04204.x; Wu LNY, 2002, J BIOL CHEM, V277, P5126, DOI 10.1074/jbc.M107899200; YAO ZM, 1988, J BIOL CHEM, V263, P2998	40	32	32	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 2	2014	94	1					113	119		10.1016/j.ajhg.2013.11.022	http://dx.doi.org/10.1016/j.ajhg.2013.11.022			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	292FU	24387991	Bronze, Green Published			2022-12-18	WOS:000329888400012
J	Zahrani, F; Aldahmesh, MA; Ashammari, MJ; Al-Hazzaa, SAF; Alkuraya, FS				Zahrani, Fatema; Aldahmesh, Mohammed A.; Ashammari, Muneera J.; Al-Hazzaa, Selwa A. F.; Alkuraya, Fowzan S.			Mutations in C12orf57 Cause a Syndromic Form of Colobomatous Microphthalmia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VERTEBRATE EYE DEVELOPMENT; ANOPHTHALMIA; GENE	Microphthalmia is an important developmental eye disorder. Although mutations in several genes have been linked to this condition, they only account for a minority of cases. We performed autozygome analysis and exome sequencing on a multiplex consanguineous family in which colobomatous microphthalmia is associated with profound global developmental delay, intractable seizures, and corpus callosum abnormalities, and we identified a homozygous truncating mutation in C12orf57 [c.1A>G; p.Met1?]. In a simplex case with a similar phenotype, we identified compound heterozygosity for the same mutation and another missense mutation [c.152T>A; p.Leu51Gln]. Little is known about C12orf57 but we show that it is expressed in several mouse tissues, including the eye and brain. Our data strongly implicate mutations in C12orf57 in the pathogenesis of a clinically distinct autosomal-recessive syndromic form of colobomatous microphthalmia.	[Zahrani, Fatema; Aldahmesh, Mohammed A.; Ashammari, Muneera J.; Al-Hazzaa, Selwa A. F.; Alkuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Ashammari, Muneera J.] King Khalid Univ Hosp, Dept Pediat, Riyadh 11461, Saudi Arabia; [Ashammari, Muneera J.] King Saud Univ, Coll Med, Riyadh 11461, Saudi Arabia; [Al-Hazzaa, Selwa A. F.] King Faisal Specialist Hosp & Res Ctr, Dept Ophthalmol, Riyadh 11211, Saudi Arabia; [Alkuraya, Fowzan S.] Alfaisal Univ, Dept Anat & Cell Biol, Coll Med, Riyadh 11533, Saudi Arabia	King Faisal Specialist Hospital & Research Center; King Saud University; King Khalid University Hospital; King Saud University; King Faisal Specialist Hospital & Research Center; Alfaisal University	Alkuraya, FS (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia.	falkuraya@kfshrc.edu.sa		Aldahmesh, Mohammed Abdullah/0000-0003-0130-9029	King Abdulaziz City for Science and Technology grant [08-MED497-20]; Dubai-Harvard Foundation for Medical Research collaborative grant	King Abdulaziz City for Science and Technology grant; Dubai-Harvard Foundation for Medical Research collaborative grant	We thank the families for enthusiastic participation. Genotyping and sequencing were performed by the Genotyping and Sequencing Core Facilities at King Faisal Specialist Hospital and Research Center. This study was supported by King Abdulaziz City for Science and Technology grant 08-MED497-20 (F.S.A.) and a Dubai-Harvard Foundation for Medical Research collaborative grant (F.S.A.).	Aldahmesh MA, 2012, GENET MED, V14, P900, DOI 10.1038/gim.2012.71; Aldahmesh MA, 2011, GENET MED, V13, P978, DOI 10.1097/GIM.0b013e31822623d5; Alkuraya F.S., 2012, CURR PROTOC HUM GENE, V6, P612; Alkuraya FS, 2010, GENET MED, V12, P765, DOI 10.1097/GIM.0b013e3181fbfcc4; Bardakjian TM, 2011, CURR OPIN OPHTHALMOL, V22, P309, DOI 10.1097/ICU.0b013e328349b004; Carr IM, 2006, HUM MUTAT, V27, P1041, DOI 10.1002/humu.20383; Donner AL, 2004, INT J DEV BIOL, V48, P743, DOI 10.1387/ijdb.041877ad; Gilbert S.F., 2010, DEV BIOL, V9th; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Lachke SA, 2010, WIRES SYST BIOL MED, V2, P305, DOI 10.1002/wsbm.59; Morrison D, 2002, J MED GENET, V39, P16, DOI 10.1136/jmg.39.1.16; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Parker SE, 2010, BIRTH DEFECTS RES A, V88, P1008, DOI 10.1002/bdra.20735; Percin EF, 2000, NAT GENET, V25, P397, DOI 10.1038/78071; Traboulsi E.I., 2011, GENETIC DIS EYE; Valleix S, 2006, AM J HUM GENET, V79, P358, DOI 10.1086/505654; Verma AS, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-47; Voronina VA, 2004, HUM MOL GENET, V13, P315, DOI 10.1093/hmg/ddh025; Wawersik S, 2000, HUM MOL GENET, V9, P917, DOI 10.1093/hmg/9.6.917	19	32	34	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 7	2013	92	3					387	391		10.1016/j.ajhg.2013.01.008	http://dx.doi.org/10.1016/j.ajhg.2013.01.008			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106RF	23453665	Bronze, Green Published			2022-12-18	WOS:000316161700011
J	Poeta, L; Fusco, F; Drongitis, D; Shoubridge, C; Manganelli, G; Filosa, S; Paciolla, M; Courtney, M; Collombat, P; Lioi, MB; Gecz, J; Ursini, MV; Miano, MG				Poeta, Loredana; Fusco, Francesca; Drongitis, Denise; Shoubridge, Cheryl; Manganelli, Genesia; Filosa, Stefania; Paciolla, Mariateresa; Courtney, Monica; Collombat, Patrick; Lioi, Maria Brigida; Gecz, Jozef; Ursini, Matilde Valeria; Miano, Maria Giuseppina			A Regulatory Path Associated with X-Linked Intellectual Disability and Epilepsy Links KDM5C to the Polyalanine Expansions in ARX	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HOMEOBOX GENE ARX; MENTAL-RETARDATION; INFANTILE SPASMS; TRACT EXPANSION; ABNORMAL GENITALIA; BP DUPLICATION; POLYA TRACT; DNA-BINDING; STEM-CELLS; MUTATIONS	Intellectual disability (ID) and epilepsy often occur together and have a dramatic impact on the development and quality of life of the affected children. Polyalanine (polyA)-expansion-encoding mutations of aristaless-related homeobox (ARX) cause a spectrum of X-linked ID (XLID) diseases and chronic epilepsy, including infantile spasms. We show that lysine-specific demethylase 5C (KDM5C), a gene known to be mutated in XLID-affected children and involved in chromatin remodeling, is directly regulated by ARX through the binding in a conserved noncoding element. We have studied altered ARX carrying various polyA elongations in individuals with XLID and/or epilepsy. The changes in polyA repeats cause hypomorphic ARX alterations, which exhibit a decreased trans-activity and reduced, but not abolished, binding to the KDM5C regulatory region. The altered functioning of the mutants tested is likely to correlate with the severity of XLID and/or epilepsy. By quantitative RT-PCR, we observed a dramatic Kdm5c mRNA downregulation in murine Arx-knockout embryonic and neural stem cells. Such Kdm5c mRNA diminution led to a severe decrease in the KDM5C content during in vitro neuronal differentiation, which inversely correlated with an increase in H3K4me3 signal. We established that ARX polyA alterations damage the regulation of KDM5C expression, and we propose a potential ARX-dependent path acting via chromatin remodeling.	[Poeta, Loredana; Fusco, Francesca; Drongitis, Denise; Manganelli, Genesia; Filosa, Stefania; Paciolla, Mariateresa; Ursini, Matilde Valeria; Miano, Maria Giuseppina] CNR, Inst Genet & Biophys Adriano Buzzati Traverso, I-80131 Naples, Italy; [Poeta, Loredana; Paciolla, Mariateresa; Lioi, Maria Brigida] Univ Basilicata, I-85100 Potenza, Italy; [Shoubridge, Cheryl; Gecz, Jozef] Univ Adelaide, Dept Paediat, Adelaide, SA 5006, Australia; [Shoubridge, Cheryl; Gecz, Jozef] Dept Genet & Mol Pathol, Adelaide, SA 5006, Australia; [Manganelli, Genesia; Filosa, Stefania] Ist Ricovero & Cura Carattere Sci, I-86077 Pozzilli, Italy; [Courtney, Monica; Collombat, Patrick] Univ Nice Sophia Antipolis, F-06108 Nice, France; [Courtney, Monica; Collombat, Patrick] INSERM, U1091, Diabet Genet Team, Inst Biol Valrose, F-06108 Nice, France	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Basilicata; University of Adelaide; IRCCS Neuromed; UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Miano, MG (corresponding author), CNR, Inst Genet & Biophys Adriano Buzzati Traverso, I-80131 Naples, Italy.	miano@igb.cnr.it	Drongitis, Denise/AHI-1341-2022; Giuseppina, Miano Maria/B-9169-2015; Miano, Maria Giuseppina/E-9056-2011; Poeta, Loredana/AFE-8345-2022; Miano, Maria Giuseppina/AAX-8437-2020; Shoubridge, Cheryl/A-1571-2016; collombat, patrick/P-3741-2019; Gecz, Jozef/X-3469-2019; Filosa, Stefania/A-4609-2014; collombat, patrick/F-4495-2015	Miano, Maria Giuseppina/0000-0003-1396-9673; Poeta, Loredana/0000-0001-7272-1040; Miano, Maria Giuseppina/0000-0003-1396-9673; Shoubridge, Cheryl/0000-0002-0157-3084; collombat, patrick/0000-0001-8232-1438; Gecz, Jozef/0000-0002-7884-6861; collombat, patrick/0000-0001-8232-1438; Filosa, Stefania/0000-0003-2896-3362; Drongitis, Denise/0000-0001-5916-7006	Juvenile Diabetes Research Foundation [17-2011-16, 2-2010-567, 26-2008-639]; Institut National de la Sante et de la Recherche Medicale AVENIR program; European Research Council [StG-2011-281265]; National Health and Medical Research Council of Australia [1008077, 508043, 1002732]; Foundation Telethon grant; Fondation Jerome Lejeune grant	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Institut National de la Sante et de la Recherche Medicale AVENIR program; European Research Council(European Research Council (ERC)European Commission); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Foundation Telethon grant(Fondazione Telethon); Fondation Jerome Lejeune grant	The authors would like to thank G. Courtois for the Myc antibody, as well as the Institute of Genetics and Biophysics Consiglio Nazionale delle Ricerche Integrated Microscopy Facility for helping with the microscopy analysis. They also thank P. Miano for assistance with the graphics. This work was supported by the Juvenile Diabetes Research Foundation (17-2011-16, 2-2010-567, 26-2008-639), the Institut National de la Sante et de la Recherche Medicale AVENIR program, and the European Research Council (StG-2011-281265) to P.C.; by grants from the National Health and Medical Research Council of Australia to J.G. (project grant 1008077 and principal research fellowship 508043) and to C.S. (project grant 1002732 and the M.S. McLeod Fellowship); by a Foundation Telethon grant to M.V.U.; and by a Fondation Jerome Lejeune grant to M.G.M.	Abrajano JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007936; Bachetti T, 2005, HUM MOL GENET, V14, P1815, DOI 10.1093/hmg/ddi188; Beguin S., 2012, EPILEPSY RELATED ARX; Bienvenu T, 2002, HUM MOL GENET, V11, P981, DOI 10.1093/hmg/11.8.981; Biressi S, 2008, CELL DEATH DIFFER, V15, P94, DOI 10.1038/sj.cdd.4402230; Brown L, 2005, HUM MOL GENET, V14, P411, DOI 10.1093/hmg/ddi037; Castel AL, 2010, NAT REV MOL CELL BIO, V11, P165, DOI 10.1038/nrm2854; Chen SM, 2002, HUM MOL GENET, V11, P873, DOI 10.1093/hmg/11.8.873; Colasante G, 2009, DEV BIOL, V334, P59, DOI 10.1016/j.ydbio.2009.07.014; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; Conti V, 2011, AM J MED GENET A, V155A, P164, DOI 10.1002/ajmg.a.33753; Cossee M, 2011, AM J MED GENET A, V155A, P98, DOI 10.1002/ajmg.a.33785; Demos MK, 2009, AM J MED GENET A, V149A, P1482, DOI 10.1002/ajmg.a.32851; Fico A, 2008, STEM CELLS DEV, V17, P573, DOI 10.1089/scd.2007.0130; Friocourt G, 2008, J NEUROSCI, V28, P5794, DOI 10.1523/JNEUROSCI.1067-08.2008; Friocourt G, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00004; Fullston T, 2011, CLIN GENET, V80, P510, DOI 10.1111/j.1399-0004.2011.01685.x; Fulp CT, 2008, HUM MOL GENET, V17, P3740, DOI 10.1093/hmg/ddn271; Fusco F, 2006, GENE, V383, P99, DOI 10.1016/j.gene.2006.07.022; Galli R, 2002, DEVELOPMENT, V129, P1633; Gecz J, 2006, CURR OPIN GENET DEV, V16, P308, DOI 10.1016/j.gde.2006.04.003; Guerrini R, 2007, NEUROLOGY, V69, P427, DOI 10.1212/01.wnl.0000266594.16202.c1; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Jensen Lars R, 2010, Pathogenetics, V3, P2, DOI 10.1186/1755-8417-3-2; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; Kato M, 2005, J CHILD NEUROL, V20, P392, DOI 10.1177/08830738050200042001; Kato M, 2004, HUM MUTAT, V23, P147, DOI 10.1002/humu.10310; Kato M, 2007, AM J HUM GENET, V81, P361, DOI 10.1086/518903; Kitamura K, 2002, NAT GENET, V32, P359, DOI 10.1038/ng1009; Kitamura K, 2009, HUM MOL GENET, V18, P3708, DOI 10.1093/hmg/ddp318; Laperuta C, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-25; Liu HB, 2011, J BIOL CHEM, V286, P17029, DOI 10.1074/jbc.M111.234252; Miano M.G., 2007, FOCUS MED GENETICS D, P1; Miura H, 1997, MECH DEVELOP, V65, P99, DOI 10.1016/S0925-4773(97)00062-2; Nasrallah IM, 2004, J CELL BIOL, V167, P411, DOI 10.1083/jcb.200408091; Nasrallah MP, 2012, HUM MOL GENET, V21, P1090, DOI 10.1093/hmg/ddr538; Olivetti PR, 2012, CURR OPIN NEUROBIOL, V22, P859, DOI 10.1016/j.conb.2012.04.006; Paciolla M, 2011, HUM REPROD, V26, P1191, DOI 10.1093/humrep/der040; Partington MW, 2004, CLIN GENET, V66, P39, DOI 10.1111/j.0009-9163.2004.00268.x; Poirier K, 2005, HUM GENET, V118, P45, DOI 10.1007/s00439-005-0011-2; Poirier K, 2008, EPILEPSY RES, V80, P224, DOI 10.1016/j.eplepsyres.2008.03.019; Price MG, 2009, J NEUROSCI, V29, P8752, DOI 10.1523/JNEUROSCI.0915-09.2009; Quille ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025181; Reish O, 2009, AM J MED GENET A, V149A, P1655, DOI 10.1002/ajmg.a.32842; Shinozaki Y, 2009, BRAIN DEV-JPN, V31, P469, DOI 10.1016/j.braindev.2008.08.006; Shoubridge C, 2007, GENOMICS, V90, P59, DOI 10.1016/j.ygeno.2007.03.005; Shoubridge C, 2012, HUM MOL GENET, V21, P1639, DOI 10.1093/hmg/ddr601; Shoubridge C, 2010, HUM MUTAT, V31, P889, DOI 10.1002/humu.21288; Shoubridge C, 2010, NAT GENET, V42, P486, DOI 10.1038/ng.588; Stepp ML, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-16; Stromme P, 2002, NAT GENET, V30, P441, DOI 10.1038/ng862; Stromme P, 2002, BRAIN DEV-JPN, V24, P266, DOI 10.1016/S0387-7604(02)00079-7; Tahiliani M, 2007, NATURE, V447, P601, DOI 10.1038/nature05823; TAKEUCHI T, 1995, GENE DEV, V9, P1211, DOI 10.1101/gad.9.10.1211; Van Esch H, 2004, CLIN GENET, V65, P503, DOI 10.1111/j.1399-0004.2004.00256.x; WILSON D, 1993, GENE DEV, V7, P2120, DOI 10.1101/gad.7.11.2120; Xu J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002553	57	32	34	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 10	2013	92	1					114	125		10.1016/j.ajhg.2012.11.008	http://dx.doi.org/10.1016/j.ajhg.2012.11.008			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	073RA	23246292	Green Published, Bronze			2022-12-18	WOS:000313759000012
J	Bourassa, CV; Meijer, IA; Merner, ND; Grewal, KK; Stefanelli, MG; Hodgkinson, K; Ives, EJ; Pryse-Phillips, W; Jog, M; Boycott, K; Grimes, DA; Goobie, S; Leckey, R; Dion, PA; Rouleau, GA				Bourassa, Cynthia V.; Meijer, Inge A.; Merner, Nancy D.; Grewal, Kanwal K.; Stefanelli, Mark G.; Hodgkinson, Kathleen; Ives, Elizabeth J.; Pryse-Phillips, William; Jog, Mandar; Boycott, Kym; Grimes, David A.; Goobie, Sharan; Leckey, Richard; Dion, Patrick A.; Rouleau, Guy A.			VAMP1 Mutation Causes Dominant Hereditary Spastic Ataxia in Newfoundland Families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MEMBRANE PROTEIN-1 VAMP-1; TARGETING SIGNAL; RAT-BRAIN; IDENTIFICATION; EXPRESSION; GENES	Our group previously described and mapped to chromosomal region 12p13 a form of dominantly inherited hereditary spastic ataxia (HSA) in three large Newfoundland (Canada) families. This report identifies vesicle-associated membrane protein 1 (VAMP1), which encodes a critical protein for synaptic exocytosis, as the responsible gene. In total, SO affected individuals from these families and three independent probands from Ontario (Canada) share the disease phenotype together with a disruptive VAMP1 mutation that affects a critical donor site for the splicing of VAMP1 isoforms. This mutation leads to the loss of the only VAMP1 isoform (VAMP1A) expressed in the nervous system, thus highlighting an association between the well-studied VAMP1 and a neurological disorder. Given the variable phenotype seen in the affected individuals examined here, we believe that VAMP1 should be tested for mutations in patients with either ataxia or spastic paraplegia.	[Bourassa, Cynthia V.; Meijer, Inge A.; Merner, Nancy D.; Dion, Patrick A.; Rouleau, Guy A.] Univ Montreal, Ctr Excellence Neurosci, Ctr Hosp Univ Montreal Res Ctr, Montreal, PQ H2L 2W5, Canada; [Bourassa, Cynthia V.; Meijer, Inge A.; Merner, Nancy D.; Dion, Patrick A.; Rouleau, Guy A.] Univ Montreal, Dept Med, Montreal, PQ H2L 2W5, Canada; [Grewal, Kanwal K.; Stefanelli, Mark G.; Ives, Elizabeth J.] Mem Univ Newfoundland, Discipline Med Genet, Fac Med, Hlth Sci Ctr, St John, NF A1B 3V6, Canada; [Grewal, Kanwal K.; Stefanelli, Mark G.; Ives, Elizabeth J.] Mem Univ Newfoundland, Div Neurol, Fac Med, Hlth Sci Ctr, St John, NF A1B 3V6, Canada; [Hodgkinson, Kathleen] Mem Univ Newfoundland, Dept Clin Epidemiol, Fac Med, St John, NF A1B 3V6, Canada; [Pryse-Phillips, William] Mem Univ Newfoundland, Dept Med, Fac Med, St John, NF A1B 3V6, Canada; [Jog, Mandar] Univ Western Ontario, Dept Clin Neurol Sci, London Hlth Sci Ctr Univ Hosp, London, ON N6A 5A5, Canada; [Boycott, Kym] Childrens Hosp Eastern Ontario, Dept Genet, Ottawa, ON K1H 8L1, Canada; [Grimes, David A.] Ottawa Hosp, Dept Neurol, Ottawa, ON K1Y 4E9, Canada; [Goobie, Sharan] Univ Western Ontario, Med Genet Program, SW Ontario Childrens Hosp, London Hlth Sci Ctr Univ Hosp, London, ON N6A 5A5, Canada; [Leckey, Richard] Dalhousie Univ, Dept Med, Fac Med, Halifax, NS B3H 2Y9, Canada; [Rouleau, Guy A.] Hop St Justine, Montreal, PQ H3T 1C5, Canada	Universite de Montreal; Universite de Montreal; Memorial University Newfoundland; University of Manitoba; Children's Hospital Research Institute of Manitoba; Memorial University Newfoundland; University of Manitoba; Children's Hospital Research Institute of Manitoba; Memorial University Newfoundland; Memorial University Newfoundland; London Health Sciences Centre; Western University (University of Western Ontario); University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Ottawa Hospital Research Institute; London Health Sciences Centre; Western University (University of Western Ontario); Dalhousie University; Universite de Montreal	Rouleau, GA (corresponding author), Univ Montreal, Ctr Excellence Neurosci, Ctr Hosp Univ Montreal Res Ctr, Montreal, PQ H2L 2W5, Canada.	guy.rouleau@umontreal.ca	Meijer, Inge/AAL-5157-2020	Merner, Nancy/0000-0002-8954-0155	Canadian Institutes for Health Research	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	The authors would like to thank the family members and the volunteer controls, as well as Roger Green for kindly providing the latter ones. We also thank Weichun Lin for information about the heterozygous mouse. Special thanks to Loubna Jouan and Anna Szuto for their technical assistance. C.V.B. is supported by the Canadian Institutes for Health Research through the Master's Award: Frederick Banting and Charles Best Canada Graduate Scholarships. G.A.R. holds the Canada Research Chair and a Jeanne et J. Louis Levesque Chair for the Genetics of Brain Diseases.	BAUMERT M, 1989, EMBO J, V8, P379, DOI 10.1002/j.1460-2075.1989.tb03388.x; Berglund L, 1999, BIOCHEM BIOPH RES CO, V264, P777, DOI 10.1006/bbrc.1999.1588; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Dion PA, 2009, NAT REV GENET, V10, P769, DOI 10.1038/nrg2680; Durr A, 2010, LANCET NEUROL, V9, P885, DOI 10.1016/S1474-4422(10)70183-6; ELFERINK LA, 1989, J BIOL CHEM, V264, P11061; Friedland DR, 2008, HEARING RES, V243, P105, DOI 10.1016/j.heares.2008.06.009; Green RC, 2007, FAM CANCER, V6, P53, DOI 10.1007/s10689-006-9104-x; Grewal KK, 2004, AM J MED GENET A, V131A, P249, DOI 10.1002/ajmg.a.30397; Isenmann S, 1998, MOL BIOL CELL, V9, P1649, DOI 10.1091/mbc.9.7.1649; Kim PK, 1999, J BIOL CHEM, V274, P36876, DOI 10.1074/jbc.274.52.36876; Lin V. W., 2003, SPINAL CORD MED PRIN; Liu Y, 2011, J PHYSIOL-LONDON, V589, P1603, DOI 10.1113/jphysiol.2010.201939; Mandic R, 1997, GENE, V199, P173, DOI 10.1016/S0378-1119(97)00244-8; Meijer IA, 2002, AM J HUM GENET, V70, P763, DOI 10.1086/338933; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Nystuen AM, 2007, NEUROGENETICS, V8, P1, DOI 10.1007/s10048-006-0068-7; Pagon RA., 1993, GENEREVIEWS; Purves D., 2001, NEUROSCIENCE; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; TRIMBLE WS, 1990, J NEUROSCI, V10, P1380; TRIMBLE WS, 1988, P NATL ACAD SCI USA, V85, P4538, DOI 10.1073/pnas.85.12.4538; YAMASAKI S, 1994, J BIOL CHEM, V269, P12764	26	32	33	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP 7	2012	91	3					548	552		10.1016/j.ajhg.2012.07.018	http://dx.doi.org/10.1016/j.ajhg.2012.07.018			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	004LL	22958904	Bronze, Green Published			2022-12-18	WOS:000308683100016
J	Feenstra, I; Vissers, LELM; Pennings, RJE; Nillessen, W; Pfundt, R; Kunst, HP; Admiraal, RJ; Veltman, JA; van Ravenswaaij-Arts, CMA; Brunner, HG; Cremers, CWRJ				Feenstra, Ilse; Vissers, Lisenka E. L. M.; Pennings, Ronald J. E.; Nillessen, Willy; Pfundt, Rolph; Kunst, Henricus P.; Admiraal, Ronald J.; Veltman, Joris A.; van Ravenswaaij-Arts, Conny M. A.; Brunner, Han G.; Cremers, Cor W. R. J.			Disruption of Teashirt Zinc Finger Homeobox 1 Is Associated with Congenital Aural Atresia in Humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMOSOME 18Q; GENE; DROSOPHILA; DELETIONS; MUTATIONS; MICROTIA; FAMILY; REGION; PALATE; HOXA2	Congenital aural atresia (CAA) can occur as an isolated congenital malformation or in the context of a number of monogenic and chromosomal syndromes. CAA is frequently seen in individuals with an 18q deletion, which is characterized by intellectual disability, reduced white-matter myelination, foot deformities, and distinctive facial features. Previous work has indicated that a critical region for CAA is located in 18q22.3. We studied four individuals (from two families) with CAA and other features suggestive of an 18q deletion, and we detected overlapping microdeletions in 18q22.3 in both families. The minimal region of deletion overlap (72.9-73.4 Mb) contained only one known gene, TSHZ1, which was recently shown to be important for murine middle-ear development. Sequence analysis of the coding exons in TSHZ1 in a cohort of 11 individuals with isolated, nonsyndromic bilateral CAA revealed two mutations, c.723G>A (p.Trp241X) and c.946_947delinsA (p.Pro316ThrfsX16), and both mutations predicted a loss of function. Together, these results demonstrate that hemizygosity of TSHZ1 leads to congenital aural atresia as a result of haploinsufficiency.	[Feenstra, Ilse; Vissers, Lisenka E. L. M.; Nillessen, Willy; Pfundt, Rolph; Veltman, Joris A.; Brunner, Han G.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Vissers, Lisenka E. L. M.; Veltman, Joris A.; Brunner, Han G.] Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Vissers, Lisenka E. L. M.; Veltman, Joris A.; Brunner, Han G.] Inst Genet & Metab Dis, NL-6500 HB Nijmegen, Netherlands; [Pennings, Ronald J. E.; Kunst, Henricus P.; Admiraal, Ronald J.; Cremers, Cor W. R. J.] Radboud Univ Nijmegen, Med Ctr, Dept Otorhinolaryngol, NL-6500 HB Nijmegen, Netherlands; [Pennings, Ronald J. E.; Kunst, Henricus P.; Admiraal, Ronald J.; Cremers, Cor W. R. J.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands; [van Ravenswaaij-Arts, Conny M. A.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Groningen	Feenstra, I (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands.	i.feenstra@antrg.umcn.nl	Feenstra, I./L-4303-2015; Cremers, C.W.R.J./L-4254-2015; Vissers, Lisenka ELM/A-2598-2015; Brunner, Han/C-9928-2013; Pfundt, Rolph/L-4576-2015; Veltman, Joris A/F-5128-2010; Admiraal, R.J.C./L-4171-2015; Pennings, Ronald JE/J-6651-2012; Kunst, Henricus P.M./J-6456-2012	Vissers, Lisenka ELM/0000-0001-6470-5497; Veltman, Joris A/0000-0002-3218-8250; Pennings, Ronald JE/0000-0001-5517-9683; Kunst, Henricus P.M./0000-0003-1162-6394	Dutch Brain Foundation [12F04.25]; Netherlands Organization for Health Research and Development (ZonMW) [916-86-016, 907-00388]	Dutch Brain Foundation; Netherlands Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development)	This work was funded in part by grants from the Dutch Brain Foundation (project 12F04.25 to I.F. and C.M.A.v.R.), the Netherlands Organization for Health Research and Development (ZonMW grants 916-86-016 to L.E.L.M.V. and 907-00388 to R.J.E.P.).	Abdelhak S, 1997, NAT GENET, V15, P157, DOI 10.1038/ng0297-157; Alasti F, 2008, AM J HUM GENET, V82, P982, DOI 10.1016/j.ajhg.2008.02.015; ALTMANN F, 1955, Ann Otol Rhinol Laryngol, V64, P824; Caubit X, 2000, MECH DEVELOP, V91, P445, DOI 10.1016/S0925-4773(99)00318-4; CHISAKA O, 1991, NATURE, V350, P473, DOI 10.1038/350473a0; Cody JD, 2009, AM J MED GENET A, V149A, P1421, DOI 10.1002/ajmg.a.32899; Cody JD, 1999, AM J MED GENET, V85, P455, DOI 10.1002/(SICI)1096-8628(19990827)85:5<455::AID-AJMG5>3.0.CO;2-Z; Core N, 2007, DEV BIOL, V308, P407, DOI 10.1016/j.ydbio.2007.05.038; Cremers C W, 1988, Adv Otorhinolaryngol, V40, P9; CREMERS CWRJ, 1985, INT J PEDIATR OTORHI, V8, P211, DOI 10.1016/S0165-5876(85)80081-1; DE GROUCHY J, 1964, Pathol Biol, V12, P579; Dixon J, 1996, NAT GENET, V12, P130; Dostal A, 2006, OTOL NEUROTOL, V27, P427, DOI 10.1097/00129492-200604000-00022; Feenstra I, 2007, AM J MED GENET A, V143A, P1858, DOI 10.1002/ajmg.a.31850; GENDRONMAGUIRE M, 1993, CELL, V75, P1317, DOI 10.1016/0092-8674(93)90619-2; JAHRSDOERFER A, 1992, AM J OTOL, V13, P6; Jayarajan V, 2000, J LARYNGOL OTOL, V114, P963; Kohlhase J, 1999, AM J HUM GENET, V64, P435, DOI 10.1086/302238; McMullan DJ, 2009, HUM MUTAT, V30, P1082, DOI 10.1002/humu.21015; Monks DC, 2010, INT J PEDIATR OTORHI, V74, P878, DOI 10.1016/j.ijporl.2010.05.004; NAGER G T, 1971, Birth Defects Original Article Series, V7, P33; Nuijten I, 2003, OTOL NEUROTOL, V24, P900, DOI 10.1097/00129492-200311000-00014; PARK WJ, 1995, HUM MOL GENET, V4, P1229, DOI 10.1093/hmg/4.7.1229; Parrish M, 2004, MOL CELL BIOL, V24, P7102, DOI 10.1128/MCB.24.16.7102-7112.2004; RASMUSSEN N, 1979, ACTA OTO-LARYNGOL, V88, P296, DOI 10.3109/00016487909137172; RODER L, 1992, DEVELOPMENT, V115, P1017; Schinzel A., 2001, CATALOGUE UNBALANCED; SCHUKNECHT HF, 1989, LARYNGOSCOPE, V99, P908; STRATHDEE G, 1995, AM J MED GENET, V59, P476, DOI 10.1002/ajmg.1320590414; Veltman JA, 2003, AM J HUM GENET, V72, P1578, DOI 10.1086/375695	30	32	35	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC 9	2011	89	6					813	819		10.1016/j.ajhg.2011.11.008	http://dx.doi.org/10.1016/j.ajhg.2011.11.008			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	864AF	22152683	Bronze, Green Published			2022-12-18	WOS:000298208700014
J	Shah, AM; Tamang, R; Moorjani, P; Rani, DS; Govindaraj, P; Kulkarni, G; Bhattacharya, T; Mustak, MS; Bhaskar, LVKS; Reddy, AG; Gadhvi, D; Gai, PB; Chaubey, G; Patterson, N; Reich, D; Tyler-Smith, C; Singh, L; Thangaraj, K				Shah, Anish M.; Tamang, Rakesh; Moorjani, Priya; Rani, Deepa Selvi; Govindaraj, Periyasamy; Kulkarni, Gururaj; Bhattacharya, Tanmoy; Mustak, Mohammed S.; Bhaskar, L. V. K. S.; Reddy, Alla G.; Gadhvi, Dharmendra; Gai, Pramod B.; Chaubey, Gyaneshwer; Patterson, Nick; Reich, David; Tyler-Smith, Chris; Singh, Lalji; Thangaraj, Kumarasamy			Indian Siddis: African Descendants with Indian Admixture	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA POLYMORPHISMS; MAXIMUM-LIKELIHOOD-ESTIMATION; Y-CHROMOSOME; GENETIC AFFINITIES; POPULATION; MTDNA; ORIGIN; MIGRATION; SEQUENCE; INSIGHTS	The Siddis (Afro-Indians) are a tribal population whose members live in coastal Karnataka, Gujarat, and in some parts of Andhra Pradesh. Historical records indicate that the Portuguese brought the Siddis to India from Africa about 300-500 years ago; however, there is little information about their more precise ancestral origins. Here, we perform a genome-wide survey to understand the population history of the Siddis. Using hundreds of thousands of autosomal markers, we show that they have inherited ancestry from Africans, Indians, and possibly Europeans (Portuguese). Additionally, analyses of the uniparental (Y-chromosomal and mitochondrial DNA) markers indicate that the Siddis trace their ancestry to Bantu speakers from sub-Saharan Africa. We estimate that the admixture between the African ancestors of the Siddis and neighboring South Asian groups probably occurred in the past eight generations (similar to 200 years ago), consistent with historical records.	[Shah, Anish M.; Tamang, Rakesh; Rani, Deepa Selvi; Govindaraj, Periyasamy; Bhattacharya, Tanmoy; Bhaskar, L. V. K. S.; Reddy, Alla G.; Gadhvi, Dharmendra; Singh, Lalji; Thangaraj, Kumarasamy] CSIR, Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India; [Moorjani, Priya; Reich, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Moorjani, Priya; Patterson, Nick; Reich, David] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Kulkarni, Gururaj; Gai, Pramod B.] Karnatak Univ, Dept Appl Genet, Dharwad 580003, Karnataka, India; [Mustak, Mohammed S.] Mangalore Univ, Dept Zool, Mangalore 574119, India; [Chaubey, Gyaneshwer] Univ Tartu, Inst Mol & Cell Biol, Dept Evolutionary Biol, EE-51010 Tartu, Estonia; [Chaubey, Gyaneshwer] Estonian Bioctr, EE-51010 Tartu, Estonia; [Tyler-Smith, Chris] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Singh, Lalji] Genome Fdn, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Karnatak University; Mangalore University; University of Tartu; Estonian Biocentre; Wellcome Trust Sanger Institute	Thangaraj, K (corresponding author), CSIR, Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India.	thangs@ccmb.res.in	Chaubey, Gyaneshwer/AAC-6409-2019; Chaubey, Gyaneshwer/H-2753-2012; BHASKAR, Lakkakula VKS/E-5871-2013	Chaubey, Gyaneshwer/0000-0003-2899-3852; Chaubey, Gyaneshwer/0000-0003-2899-3852; BHASKAR, Lakkakula VKS/0000-0003-2977-6454; Bhattacharyya, Tanmoy/0000-0002-8355-4417; Thangaraj, Kumarasamy/0000-0002-0075-0106	UK-India Education and Research Initiative [RG-4772]; Indian Council of Medical Research; Council of Scientific and Industrial Research, Government of India; Wellcome Trust; Centre of Excellence of the Estonian Biocentre; National Science Foundation; Department of Science and Technology, Government of India	UK-India Education and Research Initiative; Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Wellcome Trust(Wellcome TrustEuropean Commission); Centre of Excellence of the Estonian Biocentre; National Science Foundation(National Science Foundation (NSF)); Department of Science and Technology, Government of India(Department of Science & Technology (India))	We thank all the donors, who have voluntarily donated their blood samples for this study. K.T. was supported by the UK-India Education and Research Initiative (RG-4772), the Indian Council of Medical Research, and the Council of Scientific and Industrial Research, Government of India. C.T.S. was supported by The Wellcome Trust, and G.C. was supported by the Centre of Excellence of the Estonian Biocentre. D.R. and P.M. were supported by the National Science Foundation. L.S. was supported by a Bose Fellowship from the Department of Science and Technology, Government of India and a Bhatnagar fellowship from the Council of Scientific and Industrial Research, Government of India. ROLLOFF software is available upon request from P.M.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Beerli P, 1999, GENETICS, V152, P763; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beleza S, 2005, HUM GENET, V117, P366, DOI 10.1007/s00439-005-1290-3; Berniell-Lee G, 2009, MOL BIOL EVOL, V26, P1581, DOI 10.1093/molbev/msp069; BHATTACHARYA DK, 1970, CAH ETUD AFR, V10, P579, DOI 10.3406/cea.1970.2823; Brehm A, 2002, ANN HUM GENET, V66, P49, DOI 10.1017/S0003480001001002; Chaubey G, 2007, BIOESSAYS, V29, P91, DOI 10.1002/bies.20525; Crispim D, 2006, ANN HUM GENET, V70, P488, DOI 10.1111/j.1469-1809.2005.00249.x; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; Gauniyal M, 2011, BIOCHEM GENET, V49, P427, DOI 10.1007/s10528-011-9419-7; Gauniyal M, 2008, HUM BIOL, V80, P251, DOI 10.3378/1534-6617-80.3.251; Gonder MK, 2007, MOL BIOL EVOL, V24, P757, DOI 10.1093/molbev/msl209; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Lodhi AY, 1992, NORDIC J AFRICAN STU, V1, P83; Luis JR, 2004, AM J HUM GENET, V74, P532, DOI 10.1086/382286; Moorjani P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001373; Nelson MR, 2008, AM J HUM GENET, V83, P347, DOI 10.1016/j.ajhg.2008.08.005; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Patterson N, 2010, HUM MOL GENET, V19, P411, DOI 10.1093/hmg/ddp505; Pereira L, 2001, ANN HUM GENET, V65, P439, DOI 10.1017/S0003480001008855; Plaza S, 2004, HUM GENET, V115, P439, DOI 10.1007/s00439-004-1164-0; Ramana GV, 2001, EUR J HUM GENET, V9, P695, DOI 10.1038/sj.ejhg.5200708; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Rootsi S, 2007, EUR J HUM GENET, V15, P204, DOI 10.1038/sj.ejhg.5201748; Salas A, 2004, AM J HUM GENET, V74, P454, DOI 10.1086/382194; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Scozzari R, 2001, HUM IMMUNOL, V62, P871, DOI 10.1016/S0198-8859(01)00286-5; SCOZZARI R, 1994, HUM BIOL, V66, P1; Scozzari R, 1997, AM J HUM GENET, V60, P241; Semino O, 2004, AM J HUM GENET, V74, P1023, DOI 10.1086/386295; Semino O, 2002, AM J HUM GENET, V70, P265, DOI 10.1086/338306; Thangaraj K, 1999, ELECTROPHORESIS, V20, P1743, DOI 10.1002/(SICI)1522-2683(19990101)20:8<1743::AID-ELPS1743>3.0.CO;2-V; Thangaraj K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015283; Thanseem I, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-42; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Tofanelli S, 2009, MOL BIOL EVOL, V26, P2109, DOI 10.1093/molbev/msp120; Trivedi R, 2008, INT J HUM GENET, V8, P97, DOI 10.1080/09723757.2008.11886023; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wood ET, 2005, EUR J HUM GENET, V13, P867, DOI 10.1038/sj.ejhg.5201408; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911	43	32	33	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 15	2011	89	1					154	161		10.1016/j.ajhg.2011.05.030	http://dx.doi.org/10.1016/j.ajhg.2011.05.030			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	796HF	21741027	Bronze, Green Published			2022-12-18	WOS:000293041700014
J	Emery, LS; Felsenstein, J; Akey, JM				Emery, Leslie S.; Felsenstein, Joseph; Akey, Joshua M.			Estimators of the Human Effective Sex Ratio Detect Sex Biases on Different Timescales	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POPULATION-SIZE CHANGES; X-CHROMOSOME; AVERAGED RECOMBINATION; MITOCHONDRIAL-DNA; GENETIC-EVIDENCE; MUTATION-RATES; DISPERSAL; MIGRATION; PATTERNS; DIVERSITY	Determining historical sex ratios throughout human evolution can provide insight into patterns of genomic variation, the structure and composition of ancient populations, and the cultural factors that influence the sex ratio (e.g., sex-specific migration rates). Although numerous studies have suggested that unequal sex ratios have existed in human evolutionary history, a coherent picture of sex-biased processes has yet to emerge. For example, two recent studies compared human X chromosome to autosomal variation to make inferences about historical sex ratios but reached seemingly contradictory conclusions, with one study finding evidence for a male bias and the other study identifying a female bias. Here, we show that a large part of this discrepancy can be explained by methodological differences. Specifically, through reanalysis of empirical data, derivation of explicit analytical formulae, and extensive simulations we demonstrate that two estimators of the effective sex ratio based on population structure and nucleotide diversity preferentially detect biases that have occurred on different timescales. Our results clarify apparently contradictory evidence on the role of sex-biased processes in human evolutionary history and show that extant patterns of human genomic variation are consistent with both a recent male bias and an earlier, persistent female bias.	[Emery, Leslie S.; Felsenstein, Joseph; Akey, Joshua M.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Felsenstein, Joseph] Univ Washington, Dept Biol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Akey, JM (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	akeyj@uw.edu	Felsenstein, Joseph/K-8255-2012	Akey, Joshua/0000-0002-4411-1330; Emery, Leslie/0000-0002-9070-9886	National Institutes of Health (NIH) [RO1GM078105]; NIH/National Human Genome Research Institute (NHGRI); National Science Foundation [0814322]; Department of Genome Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078105] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Science Foundation(National Science Foundation (NSF)); Department of Genome Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Mike Hammer and Alon Keinan for providing data from their previous studies and Alon Keinan, Abigail Bigham, and members of the Akey lab for helpful discussions. We also acknowledge two anonymous reviewers for their thoughtful comments. This research was supported in part by National Institutes of Health (NIH) grant RO1GM078105 and an NIH/National Human Genome Research Institute (NHGRI) Genome Training Grant. J.F.'s participation was funded by National Science Foundation grant 0814322 (P.I. Mary Kuhner) and by "life support" funding from the Department of Genome Sciences.	Begun DJ, 2000, P NATL ACAD SCI USA, V97, P5960, DOI 10.1073/pnas.97.11.5960; Bustamante CD, 2009, NAT GENET, V41, P8, DOI 10.1038/ng0109-8; Casto AM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r10; Douadi MI, 2007, MOL ECOL, V16, P2247, DOI 10.1111/j.1365-294X.2007.03286.x; Eriksson J, 2006, MOL ECOL, V15, P939, DOI 10.1111/j.1365-294X.2006.02845.x; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Goudet J, 2002, MOL ECOL, V11, P1103, DOI 10.1046/j.1365-294X.2002.01496.x; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Hamilton G, 2005, P NATL ACAD SCI USA, V102, P7476, DOI 10.1073/pnas.0409253102; Hammer MF, 2004, GENETICS, V167, P1841, DOI 10.1534/genetics.103.025361; Hammer MF, 2010, NAT GENET, V42, P830, DOI 10.1038/ng.651; Hammer MF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000202; HEDRICK P, 2005, GENETICS POPULATIONS, P323; Hedrick PW, 2007, EVOLUTION, V61, P2750, DOI 10.1111/j.1558-5646.2007.00250.x; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; HUDSON RR, 1992, GENETICS, V132, P583; Keinan A, 2010, MOL BIOL EVOL, V27, P2312, DOI 10.1093/molbev/msq117; Keinan A, 2009, NAT GENET, V41, P66, DOI 10.1038/ng.303; Labuda D, 2010, AM J HUM GENET, V86, P980, DOI 10.1016/j.ajhg.2010.05.013; Labuda D, 2010, AM J HUM GENET, V86, P353, DOI 10.1016/j.ajhg.2010.01.029; Lambert CA, 2010, AM J HUM GENET, V86, P34, DOI 10.1016/j.ajhg.2009.12.002; Langergraber KE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000973; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Lohmueller KE, 2010, AM J HUM GENET, V86, P978, DOI 10.1016/j.ajhg.2010.03.021; MELNICK DJ, 1992, INT J PRIMATOL, V13, P379, DOI 10.1007/BF02547824; Musters H, 2006, J MOL EVOL, V62, P693, DOI 10.1007/s00239-005-0165-5; Oota H, 2001, NAT GENET, V29, P20, DOI 10.1038/ng711; Polanski A, 1998, P NATL ACAD SCI USA, V95, P5456, DOI 10.1073/pnas.95.10.5456; Pool JE, 2007, EVOLUTION, V61, P3001, DOI 10.1111/j.1558-5646.2007.00238.x; Prugnolle F, 2002, HEREDITY, V88, P161, DOI 10.1038/sj.hdy.6800060; Quinlan RJ, 2008, EVOL ANTHROPOL, V17, P227, DOI 10.1002/evan.20191; Ramachandran Sohini, 2004, Human Genomics, V1, P87; Ramachandran S, 2008, THEOR POPUL BIOL, V74, P291, DOI 10.1016/j.tpb.2008.08.003; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Segurel L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000200; Seielstad MT, 1998, NAT GENET, V20, P278, DOI 10.1038/3088; Singh ND, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-202; Wall JD, 2008, GENOME RES, V18, P1354, DOI 10.1101/gr.075630.107; WEIR BS, 1996, GENETIC DATA ANAL, V2, P73; Wilder JA, 2004, MOL BIOL EVOL, V21, P2047, DOI 10.1093/molbev/msh214; Wilder JA, 2004, NAT GENET, V36, P1122, DOI 10.1038/ng1428; Wilkins JF, 2006, BIOESSAYS, V28, P290, DOI 10.1002/bies.20378	42	32	32	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 10	2010	87	6					848	856		10.1016/j.ajhg.2010.10.021	http://dx.doi.org/10.1016/j.ajhg.2010.10.021			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	698AT	21109223	Bronze, Green Published			2022-12-18	WOS:000285564600012
J	Feldshtein, M; Elkrinawi, S; Yerushalmi, B; Marcus, B; Vullo, D; Romi, H; Ofir, R; Landau, D; Sivan, S; Supuran, CT; Birk, OS				Feldshtein, Maya; Elkrinawi, Suliman; Yerushalmi, Baruch; Marcus, Barak; Vullo, Daniela; Romi, Hila; Ofir, Rivka; Landau, Daniel; Sivan, Sara; Supuran, Claudiu T.; Birk, Ohad S.			Hyperchlorhidrosis Caused by Homozygous Mutation in CA12, Encoding Carbonic Anhydrase XII	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSMEMBRANE ISOZYME-XII; CYSTIC-FIBROSIS; INHIBITORS; EXPRESSION; IDENTIFICATION; PATHWAY; GENES	Excessive chloride secretion in weat (hyperchlorhidrosis), leading to a positive sweat test, is most commonly indicative of cystic fibrosis yet is found also in conjunction with various metabolic endocrine, and dermatological disorders There is conflicting evidence regarding the existence of autosomal recessive hyperchlorhidrosis We now describe a consanguineous Israeli Bedouin kindred with autosomal recessive hyperchlorhidrosis whose sole symptoms are visible salt precipitates after sweating, a preponderance to hyponatremic dehydration, and poor feeding and slow weight gain at infancy Through genome wide linkage analysis, we demonstrate that the phenotype is due to a homozygous mutation in CA 12, encoding carbonic anhydrase XII The mutant (c 427G>A [p Glu143Lys]) protein showed 71% activity of the wild type enzyme for catalyzing the CO2 hydration to bicarbonate and H+, and it bound the clinically used sulfonamide inhibitor acetazolamide with high affinity (K-i of 10 nM) Unlike the wild type enzyme, which is not inhibited by chloride, bromide, or iodide (K(i)s of 73-215 mM) the mutant is inhibited in the submicromolar range by these anions (K(i)s of 0 37-0 73 mM)	[Feldshtein, Maya; Marcus, Barak; Romi, Hila; Ofir, Rivka; Sivan, Sara; Birk, Ohad S.] Ben Gurion Univ Negev, Morris Kahn Lab Human Genet, NIBN, IL-84105 Beer Sheva, Israel; [Elkrinawi, Suliman; Yerushalmi, Baruch; Landau, Daniel] Soroka Univ, Med Ctr, Div Pediat, IL-84101 Beer Sheva, Israel; [Vullo, Daniela; Supuran, Claudiu T.] Univ Florence, Lab Chim Bioinorgan, I-50019 Florence, Italy; [Birk, Ohad S.] Soroka Univ, Med Ctr, Genet Inst, IL-84101 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Soroka Medical Center; University of Florence; Ben Gurion University; Soroka Medical Center	Birk, OS (corresponding author), Ben Gurion Univ Negev, Morris Kahn Lab Human Genet, NIBN, IL-84105 Beer Sheva, Israel.		Supuran, Claudiu T/A-5151-2008	Birk, Ohad/0000-0003-1430-1296; Supuran, Claudiu/0000-0003-4262-0323; Romi, Hila/0000-0003-4071-4334				Ben-Zeev B, 2003, J CHILD NEUROL, V18, P254, DOI 10.1177/08830738030180041001; Birnbaum RY, 2006, NAT GENET, V38, P749, DOI 10.1038/ng1813; Casaulta C, 2008, ARCH DIS CHILD, V93, P878, DOI 10.1136/adc.2007.132688; Gefen A, 2010, HUM MUTAT, V31, P229, DOI 10.1002/humu.21171; GREENBERG F, 1979, AM J HUM GENET, V31, pA73; Haapasalo J, 2008, NEURO-ONCOLOGY, V10, P131, DOI 10.1215/15228517-2007-065; Innocenti A, 2007, BIOORG MED CHEM LETT, V17, P1532, DOI 10.1016/j.bmcl.2006.12.113; Jaron R, 2008, PEDIATR PULM, V43, P545, DOI 10.1002/ppul.20807; Kallio H, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-22; KHALIFAH RG, 1971, J BIOL CHEM, V246, P2561; Khateeb S, 2006, AM J HUM GENET, V79, P942, DOI 10.1086/508572; LeGrys VA, 2007, J PEDIATR-US, V151, P85, DOI 10.1016/j.jpeds.2007.03.002; Liao SY, 2003, J MED GENET, V40, P257, DOI 10.1136/jmg.40.4.257; Ma L, 2007, LIFE SCI, V80, P2461, DOI 10.1016/j.lfs.2007.04.018; Narkis G, 2007, AM J HUM GENET, V81, P530, DOI 10.1086/520771; Narkis G, 2007, AM J HUM GENET, V81, P589, DOI 10.1086/520770; Schnetkamp PPM, 2004, PFLUG ARCH EUR J PHY, V447, P683, DOI 10.1007/s00424-003-1069-0; Silberstein M, 2006, AM J HUM GENET, V78, P922, DOI 10.1086/504158; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Supuran CT, 2003, MED RES REV, V23, P146, DOI 10.1002/med.10025; Tureci O, 1998, P NATL ACAD SCI USA, V95, P7608, DOI 10.1073/pnas.95.13.7608; Vullo D, 2005, BIOORG MED CHEM LETT, V15, P963, DOI 10.1016/j.bmcl.2004.12.053	22	32	33	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 12	2010	87	5					713	720		10.1016/j.ajhg.2010.10.008	http://dx.doi.org/10.1016/j.ajhg.2010.10.008			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	686AE	21035102	Bronze, Green Published			2022-12-18	WOS:000284668400019
J	Sheridan, MB; Kato, T; Haldeman-Englert, C; Jalali, GR; Milunsky, JM; Zou, Y; Klaes, R; Gimelli, G; Gimelli, S; Gemmill, RM; Drabkin, HA; Hacker, AM; Brown, J; Tomkins, D; Shaikh, TH; Kurahashi, H; Zackai, EH; Emanuel, BS				Sheridan, Molly B.; Kato, Takema; Haldeman-Englert, Chad; Jalali, G. Reza; Milunsky, Jeff M.; Zou, Ying; Klaes, Ruediger; Gimelli, Georgio; Gimelli, Stefania; Gemmill, Robert M.; Drabkin, Harry A.; Hacker, April M.; Brown, Julia; Tomkins, David; Shaikh, Tamim H.; Kurahashi, Hiroki; Zackai, Elaine H.; Emanuel, Beverly S.			A Palindrome-Mediated Recurrent Translocation with 3:1 Meiotic Nondisjunction: The t(8;22)(q24.13;q11.21)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECEPTOR-GENE CLUSTERS; RENAL-CELL CARCINOMA; CONSTITUTIONAL T(11/22); CHROMOSOME 22Q11.2; TRISOMY; TRC8; REARRANGEMENTS; BREAKPOINTS; SEQUENCE; FAMILY	Palindrome-mediated genomic instability has been associated with chromosomal translocations, including the recurrent t(11;22) (q23;q11). We report a syndrome characterized by extremity anomalies, mild dysmorphia, and intellectual impairment caused by 3:1 meiotic segregation of a previously unrecognized recurrent palindrome-mediated rearrangement, the t(8;22)(q24.13;q11.21). There are at least ten prior reports of this translocation, and nearly identical PATRR8 and PATRR22 breakpoints were validated in several of these published cases. PCR analysis of sperm DNA from healthy males indicates that the t(8;22) arises de novo during gametogenesis in some, but not all, individuals. Furthermore, demonstration that de novo PATRR8-to-PATRR11 translocations occur in sperm suggests that palindrome-mediated translocation is a universal mechanism producing chromosomal rearrangements.	[Sheridan, Molly B.; Jalali, G. Reza; Hacker, April M.; Brown, Julia; Tomkins, David; Zackai, Elaine H.; Emanuel, Beverly S.] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Kato, Takema; Kurahashi, Hiroki] Fujita Hlth Univ, Div Mol Genet, Inst Comprehens Med Sci, Aichi 4701192, Japan; [Haldeman-Englert, Chad] Wake Forest Univ, Sch Med, Winston Salem, NC 27157 USA; [Milunsky, Jeff M.; Zou, Ying] Boston Univ, Sch Med, Boston, MA 02118 USA; [Klaes, Ruediger] Mannheim Ctr Human Genet, D-68165 Mannheim, Germany; [Gimelli, Georgio] Ist Giannina Gaslini, Lab Citogenet, I-16147 Genoa, Italy; [Gimelli, Stefania] Univ Hosp Geneva, Dept Med Genet, CH-1211 Geneva, Switzerland; [Gemmill, Robert M.; Drabkin, Harry A.] Med Univ S Carolina, Charleston, SC 29425 USA; [Shaikh, Tamim H.] Univ Colorado, Dept Pediat, Denver, CO 80045 USA; [Zackai, Elaine H.; Emanuel, Beverly S.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Fujita Health University; Wake Forest University; Boston University; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Geneva; Medical University of South Carolina; University of Colorado System; University of Colorado Denver; University of Pennsylvania	Emanuel, BS (corresponding author), Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA.	beverly@mail.med.upenn.edu		Zou, Ying/0000-0003-2787-1917	Charles E.H. Upham chair in pediatrics [CA39926, HD26979]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD026979] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA039926] Funding Source: NIH RePORTER	Charles E.H. Upham chair in pediatrics; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors wish to thank C. Coutifaris and E. Wigo for providing sperm samples from healthy males, E. Geiger and the Nucleic Acid and Protein Core at the Children's Hospital of Philadelphia for technical assistance, and the patients and their families for their willingness to participate in this study. This study was supported by grants CA39926 and HD26979 and funds from the Charles E.H. Upham chair in pediatrics (to B.S.E.).	Ashley T, 2006, AM J HUM GENET, V79, P524, DOI 10.1086/507652; Carter MT, 2009, AM J MED GENET A, V149A, P1712, DOI 10.1002/ajmg.a.32957; Cunningham LA, 2003, MOL CELL BIOL, V23, P8740, DOI 10.1128/MCB.23.23.8740-8750.2003; Edelmann L, 2001, AM J HUM GENET, V68, P1, DOI 10.1086/316952; Fert-Ferrer S, 2000, PRENATAL DIAG, V20, P511, DOI 10.1002/1097-0223(200006)20:6<511::AID-PD849>3.0.CO;2-B; FU WN, 1976, CLIN GENET, V10, P329; Gemmill RM, 2002, ONCOGENE, V21, P3507, DOI 10.1038/sj.onc.1205437; Gemmill RM, 1998, P NATL ACAD SCI USA, V95, P9572, DOI 10.1073/pnas.95.16.9572; Giglio S, 2002, AM J HUM GENET, V71, P276, DOI 10.1086/341610; Gimelli S, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-52; GODDESALZ E, 1982, AM J MED GENET, V11, P241, DOI 10.1002/ajmg.1320110209; Gotter AL, 2004, HUM MOL GENET, V13, P103, DOI 10.1093/hmg/ddh004; Gotter AL, 2007, GENOME RES, V17, P470, DOI 10.1101/gr.6130907; GUPTA S, 2004, ANN M AM SOC HUM GEN; Helbig I, 2006, AM J MED GENET A, V140A, P1658, DOI 10.1002/ajmg.a.31350; Kato T, 2006, SCIENCE, V311, P971, DOI 10.1126/science.1121452; KehrerSawatzki H, 1997, HUM GENET, V99, P237, DOI 10.1007/s004390050346; Keung YK, 2004, CANCER GENET CYTOGEN, V148, P87, DOI 10.1016/S0165-4608(03)00210-3; Kurahashi H, 2000, AM J HUM GENET, V67, P763, DOI 10.1086/303054; Kurahashi H, 2000, HUM MOL GENET, V9, P1665, DOI 10.1093/hmg/9.11.1665; Kurahashi H, 2003, AM J HUM GENET, V72, P733, DOI 10.1086/368062; Kurahashi H, 2001, NAT GENET, V29, P139, DOI 10.1038/ng1001-139; Kurahashi H, 2006, DNA REPAIR, V5, P1136, DOI 10.1016/j.dnarep.2006.05.035; Lee JP, 2010, MOL CANCER RES, V8, P93, DOI 10.1158/1541-7786.MCR-08-0491; LEJEUNE J, 1972, EXP CELL RES, V74, P293, DOI 10.1016/0014-4827(72)90510-1; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Lewis SM, 2006, DNA REPAIR, V5, P1146, DOI 10.1016/j.dnarep.2006.05.014; LINDENBAUM RH, 1975, J MED GENET, V12, P29, DOI 10.1136/jmg.12.1.29; Lisnic B, 2009, DNA REPAIR, V8, P383, DOI 10.1016/j.dnarep.2008.11.017; Maas NMC, 2007, GENET COUNSEL, V18, P357; Mark HFL, 2005, CLIN GENET, V68, P146, DOI 10.1111/j.1399-0004.2005.00466.x; Nimmakayalu MA, 2003, HUM MOL GENET, V12, P2817, DOI 10.1093/hmg/ddg301; Ohye T, 2010, EUR J HUM GENET, V18, P783, DOI 10.1038/ejhg.2010.20; Ounap K, 2002, AM J MED GENET, V108, P322, DOI 10.1002/ajmg.10284; Petit P, 1998, GENET COUNSEL, V9, P157; Petkovic I, 1996, CLIN GENET, V50, P515; Poland KS, 2007, GENE CHROMOSOME CANC, V46, P805, DOI 10.1002/gcc.20466; RETHORE MO, 1977, ANN GENET-PARIS, V20, P5; SANCHEZ O, 1974, HUMANGENETIK, V23, P297, DOI 10.1007/BF00272513; SATO H, 1989, J MED GENET, V26, P642, DOI 10.1136/jmg.26.10.642; SOH K, 1984, TOHOKU J EXP MED, V144, P151, DOI 10.1620/tjem.144.151; Spiteri E, 2003, HUM MOL GENET, V12, P1823, DOI 10.1093/hmg/ddg203; Tapia-Paez I, 2001, HUM GENET, V109, P167; Thomas NS, 2010, J MED GENET, V47, P112, DOI 10.1136/jmg.2009.069716; Thomas NS, 2006, HUM GENET, V119, P444, DOI 10.1007/s00439-006-0157-6; Tonnies H, 2001, J MED GENET, V38, P617, DOI 10.1136/jmg.38.9.617; TRANEBJAERG L, 1984, ANN GENET-PARIS, V27, P224; VANDYKE DL, 1983, AM J HUM GENET, V35, P301; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; WARBURTON D, 1991, AM J HUM GENET, V49, P995; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884	51	32	33	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 13	2010	87	2					209	218		10.1016/j.ajhg.2010.07.002	http://dx.doi.org/10.1016/j.ajhg.2010.07.002			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	641EG	20673865	Green Published, Bronze			2022-12-18	WOS:000281107000005
J	Gardner, JC; Webb, TR; Kanuga, N; Robson, AG; Holder, GE; Stockman, A; Ripamonti, C; Ebenezer, ND; Ogun, O; Devery, S; Wright, GA; Maher, ER; Cheetham, ME; Moore, AT; Michaelides, M; Hardcastle, AJ				Gardner, Jessica C.; Webb, Tom R.; Kanuga, Naheed; Robson, Anthony G.; Holder, Graham E.; Stockman, Andrew; Ripamonti, Caterina; Ebenezer, Neil D.; Ogun, Olufunmilola; Devery, Sophie; Wright, Genevieve A.; Maher, Eamonn R.; Cheetham, Michael E.; Moore, Anthony T.; Michaelides, Michel; Hardcastle, Alison J.			X-Linked Cone Dystrophy Caused by Mutation of the Red and Green Cone Opsins	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOMINANT RETINITIS-PIGMENTOSA; HUMAN COLOR-VISION; PROGRESSIVE CONE; GENE CONVERSION; MOLECULAR-GENETICS; SEQUENCE EXCHANGE; CRYSTAL-STRUCTURE; ISCEV STANDARD; ROD DYSTROPHY; BLUE	X-linked cone and cone-rod dystrophies (XLCOD and XLCORD) are a heterogeneous group of progressive disorders that solely or primarily affect cone photoreceptors. Mutations in exon ORF15 of the RPGR gene are the most common underlying cause. In a previous study, we excluded RPGR exon ORF15 in some families with XLCOD. Here, we report genetic mapping of XLCOD to Xq26.1-qter. A significant LOD score was detected with marker DXS8045 (Z(max) = 2.41 [theta = 0.0]). The disease locus encompasses the cone opsin gene array on Xq28. Analysis of the array revealed a missense mutation (c. 529T>C [p. W177R]) in exon 3 of both the long-wavelength-sensitive (LW, red) and medium-wavelength-sensitive (MW, green) cone opsin genes that segregated with disease. Both exon 3 sequences were identical and were derived from the MW gene as a result of gene conversion. The amino acid W177 is highly conserved in visual and nonvisual opsins across species. We show that W177R in MW opsin and the equivalent W161R mutation in rod opsin result in protein misfolding and retention in the endoplasmic reticulum. We also demonstrate that W177R misfolding, unlike the P23H mutation in rod opsin that causes retinitis pigmentosa, is not rescued by treatment with the pharmacological chaperone 9-cis-retinal. Mutations in the LW/MW cone opsin gene array can, therefore, lead to a spectrum of disease, ranging from color blindness to progressive cone dystrophy (XLCOD5).	[Gardner, Jessica C.; Webb, Tom R.; Kanuga, Naheed; Robson, Anthony G.; Holder, Graham E.; Stockman, Andrew; Ripamonti, Caterina; Ebenezer, Neil D.; Ogun, Olufunmilola; Cheetham, Michael E.; Moore, Anthony T.; Michaelides, Michel; Hardcastle, Alison J.] UCL Inst Ophthalmol, London EC1V 9EL, England; [Robson, Anthony G.; Holder, Graham E.; Devery, Sophie; Wright, Genevieve A.; Moore, Anthony T.; Michaelides, Michel] Moorfields Eye Hosp, London EC1V 2PD, England; [Maher, Eamonn R.] Birmingham Womens Hosp, W Midlands Reg Genet Serv, Birmingham B15 2TT, W Midlands, England	University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; Birmingham Women's Hospital	Michaelides, M (corresponding author), UCL Inst Ophthalmol, 11-43 Bath St, London EC1V 9EL, England.	michel.michaelides@ucl.ac.uk; a.hardcastle@ucl.ac.uk	Cheetham, Michael/B-4672-2011; OGUN, Olufunmilola Abimbola/AAI-2898-2020; Webb, Tom/C-6237-2011; MAHER, EAMONN R/A-9507-2008; Webb, Tom/GMW-5311-2022	OGUN, Olufunmilola Abimbola/0000-0001-6433-9300; MAHER, EAMONN R/0000-0002-6226-6918; Cheetham, Michael/0000-0001-6429-654X; Webb, Tom/0000-0001-5998-8226; Hardcastle, Alison/0000-0002-0038-6770; Robson, Anthony/0000-0002-8391-6123	Fight for Sight UK; Moorfields Special Trustees; National Institute for Health Research UK	Fight for Sight UK; Moorfields Special Trustees; National Institute for Health Research UK(National Institute for Health Research (NIHR))	This research was supported by funding from Fight for Sight UK, Moorfields Special Trustees and the National Institute for Health Research UK to the Biomedical Research Centre for Ophthalmology, based at Moorfields Eye Hospital NHS Foundation Trust and the UCL Institute of Ophthalmology (to A.J.H. and M.M.), The Wellcome Trust (065454/Z/01/Z to A.J.H., M.C., and A.T.M.), The British Retinitis Pigmentosa Society (to A.J.H.), Fight for Sight UK (to AS), and The Foundation Fighting Blindness USA (to A.T.M., G.E.H., and A.G.R.). We wish to thank the family for participating in this study. MW cone opsin 1D4 epitope-tagged construct was a kind gift from Harry Ostrer of New York University Medical School. 1D4 antibody was a kind gift from Bob Molday of the University of British Columbia.	Arden G, 1999, VISION RES, V39, P641, DOI 10.1016/S0042-6989(98)00182-5; Ayyagari R, 1999, MOL VIS, V5; Ayyagari R, 2000, HUM GENET, V107, P75; Bergen AAB, 1997, AM J HUM GENET, V60, P1468, DOI 10.1086/515458; Borhan B, 2000, SCIENCE, V288, P2209, DOI 10.1126/science.288.5474.2209; CARROLL J, 2009, P NATL ACAD SCI US; Carroll J, 2002, J VISION, V2, DOI 10.1167/2.8.1; Chen JM, 2007, NAT REV GENET, V8, P762, DOI 10.1038/nrg2193; Deeb SS, 2005, CLIN GENET, V67, P369, DOI 10.1111/j.1399-0004.2004.00343.x; DRUMMONDBORG M, 1989, P NATL ACAD SCI USA, V86, P983, DOI 10.1073/pnas.86.3.983; Ebenezer ND, 2005, INVEST OPHTH VIS SCI, V46, P1891, DOI 10.1167/iovs.04-1482; FLEISCHMAN JA, 1981, ARCH OPHTHALMOL-CHIC, V99, P468, DOI 10.1001/archopht.1981.03930010470016; Gardner JC, 2009, MOL VIS, V15, P876; GYLLENSTEN UB, 1991, P NATL ACAD SCI USA, V88, P3686, DOI 10.1073/pnas.88.9.3686; Hayashi T, 1999, NAT GENET, V22, P90, DOI 10.1038/8798; Hecht S, 1933, J GEN PHYSIOL, V17, P269, DOI 10.1085/jgp.17.2.269; Hecht S, 1936, J GEN PHYSIOL, V19, P965, DOI 10.1085/jgp.19.6.965; Holder GE, 2006, ESSENT OPHTHALMOL, P133; Holder GE, 2007, DOC OPHTHALMOL, V114, P111, DOI 10.1007/s10633-007-9053-1; Illing ME, 2002, J BIOL CHEM, V277, P34150, DOI 10.1074/jbc.M204955200; Innan H, 2003, P NATL ACAD SCI USA, V100, P8793, DOI 10.1073/pnas.1031592100; Jalkanen R, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.040741; JUDD DB, 1951, CIE P, V1, P11; Kazmi MA, 1997, INVEST OPHTH VIS SCI, V38, P1074; Kellner U, 2004, GRAEF ARCH CLIN EXP, V242, P729, DOI 10.1007/s00417-004-0921-z; Klein-Seetharaman J, 2004, P NATL ACAD SCI USA, V101, P3409, DOI 10.1073/pnas.0308713101; Kosmaoglou M, 2009, J CELL SCI, V122, P4465, DOI 10.1242/jcs.055228; LadekjaerMikkelsen AS, 1996, HUM GENET, V98, P403, DOI 10.1007/s004390050229; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lin SW, 1996, BIOCHEMISTRY-US, V35, P11149, DOI 10.1021/bi960858u; Mancuso K, 2009, NATURE, V461, P784, DOI 10.1038/nature08401; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007; Mendes HF, 2008, HUM MOL GENET, V17, P3043, DOI 10.1093/hmg/ddn202; Michaelides M, 2005, EYE, V19, P2, DOI 10.1038/sj.eye.6701391; Michaelides M, 2004, INVEST OPHTH VIS SCI, V45, P1975, DOI 10.1167/iovs.03-0898; Michaelides M, 2004, BRIT J OPHTHALMOL, V88, P291, DOI 10.1136/bjo.2003.027102; Michaelides M, 2006, SURV OPHTHALMOL, V51, P232, DOI 10.1016/j.survophthal.2006.02.007; NAKAYAMA TA, 1991, J BIOL CHEM, V266, P4269; Nakayama TA, 1998, BIOCHEMISTRY-US, V37, P17487, DOI 10.1021/bi982077u; NATHANS J, 1993, AM J HUM GENET, V53, P987; NATHANS J, 1989, SCIENCE, V245, P831, DOI 10.1126/science.2788922; NATHANS J, 1986, SCIENCE, V232, P203, DOI 10.1126/science.3485310; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; NEITZ M, 1991, SCIENCE, V252, P971, DOI 10.1126/science.1903559; Noorwez SM, 2004, J BIOL CHEM, V279, P16278, DOI 10.1074/jbc.M312101200; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; REYNIERS E, 1995, GENOMICS, V29, P323, DOI 10.1006/geno.1995.9998; Ruddle JB, 2009, BRIT J OPHTHALMOL, V93, P1151, DOI 10.1136/bjo.2008.153908; Saliba RS, 2002, J CELL SCI, V115, P2907; Stenkamp RE, 2002, BBA-BIOMEMBRANES, V1565, P168, DOI 10.1016/S0005-2736(02)00567-9; STOCKMAN A, 1991, VISION RES, V31, P189, DOI 10.1016/0042-6989(91)90111-H; Stockman A, 1998, VISION RES, V38, P3703, DOI 10.1016/S0042-6989(98)00049-2; Stockman A, 2000, VISION RES, V40, P1711, DOI 10.1016/S0042-6989(00)00021-3; STOCKMAN A, 1993, J OPT SOC AM A, V10, P1396, DOI 10.1364/JOSAA.10.001396; Stockman Andrew, 2007, J Vis, V7, P4; Stockman A, 2007, J VISION, V7, DOI 10.1167/7.4.8; Stockman A, 2008, J VISION, V8, DOI 10.1167/8.1.10; STOECKERT CJ, 1984, NUCLEIC ACIDS RES, V12, P4469, DOI 10.1093/nar/12.11.4469; THIADENS AA, 2010, OPHTHALMOLOGY, V117, pE1; Thiadens AAHJ, 2010, OPHTHALMOLOGY, V117, P825, DOI 10.1016/j.ophtha.2009.09.008; Thiadens AAHJ, 2009, AM J HUM GENET, V85, P240, DOI 10.1016/j.ajhg.2009.06.016; Verrelli BC, 2004, AM J HUM GENET, V75, P363, DOI 10.1086/423287; VOLLRATH D, 1988, SCIENCE, V240, P1669, DOI 10.1126/science.2837827; WINDERICKX J, 1993, HUM MOL GENET, V2, P1413, DOI 10.1093/hmg/2.9.1413; WINDERICKX J, 1992, P NATL ACAD SCI USA, V89, P9710, DOI 10.1073/pnas.89.20.9710; WINDERICKX J, 1992, NATURE, V356, P431, DOI 10.1038/356431a0; Yang ZL, 2002, HUM MOL GENET, V11, P605, DOI 10.1093/hmg/11.5.605; Yesim F, 2002, AM J HUM GENET, V70, P1049, DOI 10.1086/339620; YOSHIZAWA T, 1992, PHOTOCHEM PHOTOBIOL, V56, P859, DOI 10.1111/j.1751-1097.1992.tb09707.x	70	32	35	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 9	2010	87	1					26	39		10.1016/j.ajhg.2010.05.019	http://dx.doi.org/10.1016/j.ajhg.2010.05.019			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	627HD	20579627	hybrid, Green Published			2022-12-18	WOS:000280029200003
J	Labuda, D; Lefebvre, JF; Nadeau, P; Roy-Gagnon, MH				Labuda, Damian; Lefebvre, Jean-Francois; Nadeau, Philippe; Roy-Gagnon, Marie-Helene			Female-to-Male Breeding Ratio in Modern Humans-an Analysis Based on Historical Recombinations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN GENOME; ANCESTRAL POPULATION; DNA-SEQUENCES; COMPLEX SPECIATION; STATISTICAL-METHOD; GENETIC-EVIDENCE; HAPLOTYPE MAP; MUTATION; EVOLUTION; RATES	Was the past genetic contribution of women and men to the current human population equal? Was polygyny (excess of breeding women) present among hominid lineages? We addressed these questions by measuring the ratio of population recombination rates between the X chromosome and the autosomes, rho(X)/rho(A). The X chromosome recombines only in female meiosis, whereas autosomes undergo crossovers in both sexes; thus, rho(X)/rho(A) reflects the female-to-male breeding ratio, beta. We estimated beta from rho(X)/rho(A) inferred from genomic diversity data and calibrated with recombination rates derived from pedigree data. For the HapMap Populations, we obtained beta of 1.4 in the Yoruba from West Africa, 1.3 in Europeans, and 1.1 in East Asian samples. These values are consistent with a high prevalence of monogamy and limited polygyny in human Populations. More mutations Occur during male meiosis as compared to female meiosis at the rate ratio referred to as alpha. We show that at alpha not equal 1, the divergence rates and genetic diversities of the X chromosome relative to the autosomes are complex functions of both alpha and beta, making their independent estimation difficult. Because our estimator of beta does not require any knowledge of the Mutation rates, Our approach should allow us to dissociate the effects of alpha and beta on the genetic diversity and divergence rate ratios of the sex chromosomes to the autosomes.	[Labuda, Damian; Lefebvre, Jean-Francois; Nadeau, Philippe; Roy-Gagnon, Marie-Helene] Univ Montreal, Hop St Justine, Res Ctr, Montreal, PQ H3T 1C5, Canada; [Labuda, Damian] Univ Montreal, Dept Pediat, Montreal, PQ H3T 1C5, Canada; [Roy-Gagnon, Marie-Helene] Univ Montreal, Dept Social & Prevent Med, Montreal, PQ H3T 1C5, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Labuda, D (corresponding author), Univ Montreal, Hop St Justine, Res Ctr, 3175 Cote St Catherine, Montreal, PQ H3T 1C5, Canada.	damian.labuda@umontreal.ca		Roy-Gagnon, Marie-Helene/0000-0001-8747-0846	Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Brown GR, 2009, TRENDS ECOL EVOL, V24, P297, DOI 10.1016/j.tree.2009.02.005; Burgess R, 2008, MOL BIOL EVOL, V25, P1979, DOI 10.1093/molbev/msn148; Bustamante CD, 2009, NAT GENET, V41, P8, DOI 10.1038/ng0109-8; CABALLERO A, 1994, HEREDITY, V73, P657, DOI 10.1038/hdy.1994.174; Dupanloup I, 2003, J MOL EVOL, V57, P85, DOI 10.1007/s00239-003-2458-x; Ebersberger I, 2002, AM J HUM GENET, V70, P1490, DOI 10.1086/340787; Efron B., 1993, INTRO BOOTSTRAP; Ellegren H, 2007, P ROY SOC B-BIOL SCI, V274, P1, DOI 10.1098/rspb.2006.3720; Ellegren H, 2009, TRENDS GENET, V25, P278, DOI 10.1016/j.tig.2009.04.005; Fenner JN, 2005, AM J PHYS ANTHROPOL, V128, P415, DOI 10.1002/ajpa.20188; Fleagle JG, 1988, PRIMATE ADAPTATION E; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Frost P, 2008, J SOCIAL EVOLUTIONAR, V2, P169; Gage TB, 1998, ANNU REV ANTHROPOL, V27, P197, DOI 10.1146/annurev.anthro.27.1.197; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Goetting-Minesky MP, 2006, J MOL EVOL, V63, P537, DOI 10.1007/s00239-005-0308-8; Hammer MF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000202; Harding RM, 2004, CURR OPIN GENET DEV, V14, P667, DOI 10.1016/j.gde.2004.08.010; Hedrick PW, 2007, EVOLUTION, V61, P2750, DOI 10.1111/j.1558-5646.2007.00250.x; Hein J., 2005, GENE GENEALOGIES VAR; Hellenthal G, 2007, BIOINFORMATICS, V23, P520, DOI 10.1093/bioinformatics/btl622; Hobolth A, 2007, PLOS GENET, V3, P294, DOI 10.1371/journal.pgen.0030007; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; HUDSON RR, 1985, GENETICS, V111, P147; Innan H, 2006, MOL BIOL EVOL, V23, P1040, DOI 10.1093/molbev/msj109; Jones S., 1992, CAMBRIDGE ENCY HUMAN; Keinan A, 2009, NAT GENET, V41, P66, DOI 10.1038/ng.303; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong X, 2004, AM J HUM GENET, V75, P1143, DOI 10.1086/426405; Labuda D, 2000, GENETICS, V156, P799; Lefebvre JF, 2008, GENETICS, V178, P2069, DOI 10.1534/genetics.107.082255; Li J, 2006, AM J HUM GENET, V79, P628, DOI 10.1086/508066; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175831; LOVEJOY CO, 1981, SCIENCE, V211, P341, DOI 10.1126/science.211.4480.341; Low B. S., 2000, WHY SEX MATTERS; Makova KD, 2002, NATURE, V416, P624, DOI 10.1038/416624a; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; MIYATA T, 1987, COLD SPRING HARB SYM, V52, P863, DOI 10.1101/SQB.1987.052.01.094; Myers SR, 2003, GENETICS, V163, P375; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Pool JE, 2008, MOL BIOL EVOL, V25, P1728, DOI 10.1093/molbev/msn124; Pool JE, 2007, EVOLUTION, V61, P3001, DOI 10.1111/j.1558-5646.2007.00238.x; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Reno PL, 2003, P NATL ACAD SCI USA, V100, P9404, DOI 10.1073/pnas.1133180100; Rozen S, 2009, AM J HUM GENET, V85, P923, DOI 10.1016/j.ajhg.2009.11.011; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; SCHEIDEL W, 2009, PRINCETON STANFORD W, V1, P1; Segurel L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000200; Seielstad MT, 1998, NAT GENET, V20, P278, DOI 10.1038/3088; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stumpf MPH, 2003, NAT REV GENET, V4, P959, DOI 10.1038/nrg1227; TAJIMA F, 1989, GENETICS, V123, P585; Taylor F, 2006, MOL BIOL EVOL, V23, P565, DOI 10.1093/molbev/msj060; Thornton K, 2006, GENETICS, V172, P1607, DOI 10.1534/genetics.105.048223; Wakeley J, 2009, COALESCENT THEORY; Wakeley J, 2008, NATURE, V452, pE3, DOI 10.1038/nature06805; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wilder JA, 2004, NAT GENET, V36, P1122, DOI 10.1038/ng1428; Wilkins JF, 2006, BIOESSAYS, V28, P290, DOI 10.1002/bies.20378; Yotova V, 2007, HUM GENET, V122, P431, DOI 10.1007/s00439-007-0413-4; Zerjal T, 2003, AM J HUM GENET, V72, P717, DOI 10.1086/367774; Zietkiewicz E, 2003, AM J HUM GENET, V73, P994, DOI 10.1086/378777	65	32	32	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 12	2010	86	3					353	363		10.1016/j.ajhg.2010.01.029	http://dx.doi.org/10.1016/j.ajhg.2010.01.029			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	570LG	20188344	Green Published, Bronze			2022-12-18	WOS:000275678800007
J	Tycko, B				Tycko, Benjamin			Mapping Allele-Specific DNA Methylation: A New Tool for Maximizing Information from GWAS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN GENE-EXPRESSION; GENOME-WIDE ASSOCIATION; MONOALLELIC EXPRESSION; REGULATORY VARIATION; HUMAN HAPLOTYPES; HUMAN AUTOSOMES; CELLS; CANCER; COMMON; POLYMORPHISM	In this issue of The Journal, an article by Schalkwyk et at.(1) shows the landscape of allele-specific DNA methylation (ASM) in the human genome. ASM has long been studied as a hallmark of imprinted genes, and a chromosome-wide version of this phenomenon occurs, in a random fashion, during X chromosome inactivation in female cells. But the type of ASM motivating the study by Schalkwyk et al. is different. They used a high-resolution, methylation-sensitive SNP array (MSNP) method for genome-wide profiling of ASM in total peripheral-blood leukocytes (PBL) and buccal cells from a series of monozygotic twin pairs. Their data bring a new level of detail to Our knowledge of a newly recognized phenomenon-nonimprinted, sequence-dependent ASM. They document the widespread occurrence of this phenomenon among human genes and discuss its basic implications for gene regulation and genetic-epigenetic interactions. But this paper and recent work from other laboratories(2,3) raises the possibility of a more immediate and practical application for ASM mapping, namely to help extract maximum information from genome-wide association studies.	[Tycko, Benjamin] Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY 10032 USA; [Tycko, Benjamin] Columbia Univ, Med Ctr, Dept Pathol, Taub Inst, New York, NY 10032 USA	Columbia University; Columbia University	Tycko, B (corresponding author), Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY 10032 USA.	bt12@columbia.edu						Boumber YA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000162; Chan HW, 2003, J EXP MED, V197, P245, DOI 10.1084/jem.20021127; Dermitzakis ET, 2006, MAMM GENOME, V17, P503, DOI 10.1007/s00335-006-0005-y; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Doria A, 2008, CELL METAB, V8, P186, DOI 10.1016/j.cmet.2008.08.006; Easton DF, 2008, HUM MOL GENET, V17, pR109, DOI 10.1093/hmg/ddn287; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Forton JT, 2007, GENOME RES, V17, P82, DOI 10.1101/gr.5663007; Ge B, 2009, NAT GENET, V41, P1216, DOI 10.1038/ng.473; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Guo LY, 2005, IMMUNITY, V23, P89, DOI 10.1016/j.immuni.2005.05.008; Heap GA, 2010, HUM MOL GENET, V19, P122, DOI 10.1093/hmg/ddp473; Kang MY, 2008, CANCER-AM CANCER SOC, V112, P1699, DOI 10.1002/cncr.23335; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Lettre G, 2008, HUM MOL GENET, V17, pR116, DOI 10.1093/hmg/ddn246; Lo HS, 2003, GENOME RES, V13, P1855, DOI 10.1101/gr.1006603; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Murrell A, 2004, HUM MOL GENET, V13, P247, DOI 10.1093/hmg/ddh013; Nica AC, 2008, HUM MOL GENET, V17, pR129, DOI 10.1093/hmg/ddn285; Nutt SL, 1999, NAT GENET, V21, P390, DOI 10.1038/7720; Ohlsson R, 1998, TRENDS GENET, V14, P435, DOI 10.1016/S0168-9525(98)01583-2; Pastinen T, 2006, HUM MOL GENET, V15, pR9, DOI 10.1093/hmg/ddl044; Pastinen T, 2005, HUM MOL GENET, V14, P3963, DOI 10.1093/hmg/ddi420; Pastinen T, 2004, PHYSIOL GENOMICS, V16, P184, DOI 10.1152/physiolgenomics.00163.2003; Plagnol V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002966; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schalkwyk LC, 2010, AM J HUM GENET, V86, P196, DOI 10.1016/j.ajhg.2010.01.014; Schilling E, 2009, GENOME RES, V19, P2028, DOI 10.1101/gr.095562.109; Serre D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000006; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Torkamani A, 2008, BIOINFORMATICS, V24, P1787, DOI 10.1093/bioinformatics/btn311; Verlaan DJ, 2009, GENOME RES, V19, P118, DOI 10.1101/gr.084798.108; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545; Yang H, 2009, NAT METHODS, V6, P663, DOI [10.1038/NMETH.1359, 10.1038/nmeth.1359]; ZHANG YH, 1992, NAT GENET, V1, P40, DOI 10.1038/ng0492-40; Zhang YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r138	37	32	33	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB 12	2010	86	2					109	112		10.1016/j.ajhg.2010.01.021	http://dx.doi.org/10.1016/j.ajhg.2010.01.021			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	556ZS	20159108	Bronze, Green Published			2022-12-18	WOS:000274637200001
J	Oti, M; Huynen, MA; Brunner, HG				Oti, Martin; Huynen, Martijn A.; Brunner, Han G.			The Biological Coherence of Human Phenome Databases	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC-DISORDERS; DISEASE; NETWORK; PROTEIN; PHENOTYPE; ONTOLOGY; GENOME; INTERACTOME; SIMILARITY; FAMILIES	Disease networks are increasingly explored as a complement to networks centered around interactions between genes and proteins. The quality of disease networks is heavily dependent on the amount and quality of phenotype information in phenotype databases of human genetic diseases. We explored which aspects of phenotype database architecture and content best reflect the underlying biology of disease. We used the OMIM-based HPO, Orphanet, and POSSUM phenotype databases for this purpose and devised a biological coherence score based on the sharing of gene ontology annotation to investigate the degree to which phenotype similarity in these databases reflects related pathobiology. Our analyses support the notion that a fine-grained phenotype ontology enhances the accuracy of phenome representation. In addition, we find that the OMIM database that is most used by the human genetics community is heavily underannotated. We show that this problem can easily be overcome by simply adding data available in the POSSUM database to improve OMIM phenotype representations in the HPO. Also, we find that the use of feature frequency estimates-currently implemented only in the Orphanet database-significantly improves the quality of the phenome representation. Our data suggest that there is much to be gained by improving human phenome databases and that some of the measures needed to achieve this are relatively easy to implement. More generally, we propose that curation and more systematic annotation of human phenome databases can greatly improve the power of the phenotype for genetic disease analysis.	[Brunner, Han G.] Radboud Univ Nijmegen Med Ctr, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [Oti, Martin; Huynen, Martijn A.] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, Nijmegen Ctr Mol Life Sci, NL-6525 GA Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Brunner, HG (corresponding author), Radboud Univ Nijmegen Med Ctr, Dept Human Genet, Geert Grootepl 10, NL-6525 GA Nijmegen, Netherlands.	h.brunner@antrg.umcn.nl	Huynen, Martijn A/A-1530-2014; Oti, Martin/D-9385-2015; Huijnen, M.A./H-8051-2014; Brunner, Han/C-9928-2013	Huynen, Martijn A/0000-0001-6189-5491; Oti, Martin/0000-0002-1005-5801; 	BioRange program of the Netherlands Bioinformatics Centre; BSIK grant through the Netherlands Genomics Initiative; European Union's 6th Framework Program [LSHB-CF-2005-019067]	BioRange program of the Netherlands Bioinformatics Centre; BSIK grant through the Netherlands Genomics Initiative; European Union's 6th Framework Program	We would like to thank to A. Bankier, C. Rose, M. Black, and the rest of the POSSUM team at the Murdoch Children's Research Institute in Melbourne, Australia, for granting us access to the POSSUM data. We Would also like to thank S. Ayme, A. Rath, and the rest of the Orphanet team at the INSERM in Paris, France, for providing us with the Orphanet data. We would further like to express our gratitude to A. Hamosh and colleagues at Johns Hopkins University, Baltimore, MD, for making the OMIM data publicly available and P. Robinson, S. Mundlos, and the HPO team at Charite-Universitzitsmedizin in Berlin, Germany, for publicly releasing the HPO. Additionally, we are grateful to R Beales for providing us with a list of putative ciliopathies and I. Sama for allowing us to use his unpublished protein-protein interaction data. Finally, we would like to thank A. Schenk, H. van Bokhoven, and G. Vriend for critical reading of the manuscript and useful comments. This work was supported in part by the BioRange program of the Netherlands Bioinformatics Centre that is supported by a BSIK grant through the Netherlands Genomics Initiative and by the European Union's 6th Framework Program contract number LSHB-CF-2005-019067 (EPISTEM).	Allanson JE, 2009, AM J MED GENET A, V149A, P2, DOI 10.1002/ajmg.a.32601; Arts HH, 2007, NAT GENET, V39, P882, DOI 10.1038/ng2069; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ayme Segolene, 2003, Soins, P46; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; BANKIER A, 1989, OPHTHALMIC PAED GEN, V10, P51, DOI 10.3109/13816818909083773; Beales PL, 2007, NAT GENET, V39, P727, DOI 10.1038/ng2038; Biesecker LG, 2005, CLIN GENET, V68, P320, DOI 10.1111/j.1399-0004.2005.00509.x; Brunner HG, 2004, NAT REV GENET, V5, P545, DOI 10.1038/nrg1383; Butte AJ, 2006, NAT BIOTECHNOL, V24, P55, DOI 10.1038/nbt1150; Church GM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100040; Freimer N, 2003, NAT GENET, V34, P15, DOI 10.1038/ng0503-15; Freudenberg J, 2002, BIOINFORMATICS, V18, pS110, DOI 10.1093/bioinformatics/18.suppl_2.S110; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hall JG, 2003, NAT GENET, V33, P440, DOI 10.1038/ng0403-440; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jiang XP, 2008, FEBS LETT, V582, P2549, DOI 10.1016/j.febslet.2008.06.023; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Lee DS, 2008, P NATL ACAD SCI USA, V105, P9880, DOI 10.1073/pnas.0802208105; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Loscalzo J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100163; Mistry M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-327; Oti M, 2007, CLIN GENET, V71, P1, DOI 10.1111/j.1399-0004.2006.00708.x; Oti M, 2008, TRENDS GENET, V24, P103, DOI 10.1016/j.tig.2007.12.005; Robinson PN, 2008, AM J HUM GENET, V83, P610, DOI 10.1016/j.ajhg.2008.09.017; Schulze TG, 2004, HUM HERED, V58, P131, DOI 10.1159/000083539; Snyder M, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.32; van Driel MA, 2006, EUR J HUM GENET, V14, P535, DOI 10.1038/sj.ejhg.5201585; WINTER RM, 1987, J MED GENET, V24, P509, DOI 10.1136/jmg.24.8.509; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27; Wu XB, 2009, BIOINFORMATICS, V25, P98, DOI 10.1093/bioinformatics/btn593	35	32	34	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 11	2009	85	6					801	808		10.1016/j.ajhg.2009.10.026	http://dx.doi.org/10.1016/j.ajhg.2009.10.026			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	533BN	20004759	Bronze, Green Published			2022-12-18	WOS:000272797100004
J	Balikova, I; Martens, K; Melotte, C; Amyere, M; Van Vooren, S; Moreau, Y; Vetrie, D; Fiegler, H; Carter, NP; Liehr, T; Vikkula, M; Matthijs, G; Fryns, JP; Casteels, I; Devriendt, K; Vermeesch, JR				Balikova, Irina; Martens, Kevin; Melotte, Cindy; Amyere, Mustapha; Van Vooren, Steven; Moreau, Yves; Vetrie, David; Fiegler, Heike; Carter, Nigel P.; Liehr, Thomas; Vikkula, Miikka; Matthijs, Gert; Fryns, Jean-Pierre; Casteels, Ingele; Devriendt, Koen; Vermeesch, Joris Robert			Autosomal-dominant microtia linked to five tandem copies of a copy-number-variable region at chromosome 4p16	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEGMENTAL DUPLICATIONS; DNA AMPLIFICATION; POLYMORPHISM; MECHANISM; PCR	Recently, large-scale benign copy-number variations (CNVs)-encompassing over 12% of the genome and containing genes considered to be dosage tolerant for human development-were uncovered in the human population. Here we present a family with a novel autosomal-dominantly inherited syndrome characterized by microtia, eye coloboma, and imperforation of the nasolacrimal duct. This phenotype is linked to a cytogenetically visible alteration at 4pter consisting of five copies of a copy-number-variable region, encompassing a low-copy repeat (LCR)-rich sequence. We demonstrate that the similar to 750 kb amplicon occurs in exact tandem copies. This is the first example of an amplified CNV associated with a Mendelian disorder, a discovery that implies that genome screens for genetic disorders should include the analysis of so-called benign CNVs and LCRs.	[Balikova, Irina; Martens, Kevin; Melotte, Cindy; Matthijs, Gert; Fryns, Jean-Pierre; Devriendt, Koen; Vermeesch, Joris Robert] Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium; [Amyere, Mustapha; Vikkula, Miikka] Catholic Univ Louvain, Lab Human Mol Genet, B-1200 Brussels, Belgium; [Van Vooren, Steven; Moreau, Yves] Katholieke Univ Leuven, Dept Elect Engn, B-3000 Louvain, Belgium; [Vetrie, David; Fiegler, Heike; Carter, Nigel P.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Liehr, Thomas] Univ Jena, Inst Human Genet & Anthropol, D-07740 Jena, Germany; [Casteels, Ingele] Katholieke Univ Leuven, Dept Ophthalmol, B-3000 Louvain, Belgium	KU Leuven; Universite Catholique Louvain; KU Leuven; Wellcome Trust Sanger Institute; Friedrich Schiller University of Jena; KU Leuven	Vermeesch, JR (corresponding author), Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium.	joris.vernieesch@uz.kuleuven.ac.be	Melotte, Cindy/GXV-5465-2022; Liehr, Thomas/H-2852-2019; Vikkula, Miikka/Q-1038-2018	Liehr, Thomas/0000-0003-1672-3054; Vikkula, Miikka/0000-0002-6236-338X; Vermeesch, Joris/0000-0002-3071-1191; Moreau, Yves/0000-0002-4647-6560; Vetrie, David/0000-0003-2075-4662; Matthijs, Gert/0000-0001-6710-1912	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ballif BC, 2003, HUM MOL GENET, V12, P2153, DOI 10.1093/hmg/ddg231; Barber JCK, 2005, J MED GENET, V42, P609, DOI 10.1136/jmg.2004.026955; Burma S, 2006, DNA REPAIR, V5, P1042, DOI 10.1016/j.dnarep.2006.05.026; Bzymek M, 2001, P NATL ACAD SCI USA, V98, P8319, DOI 10.1073/pnas.111008398; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Fiegler H, 2003, GENE CHROMOSOME CANC, V36, P361, DOI 10.1002/gcc.10155; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Hastings PJ, 2004, PLOS BIOL, V2, P2220, DOI 10.1371/journal.pbio.0020399; Hollox EJ, 2003, AM J HUM GENET, V73, P591, DOI 10.1086/378157; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Inoue K, 2004, NAT GENET, V36, P361, DOI 10.1038/ng1322; Kleinjan DA, 2006, DEV BIOL, V299, P563, DOI 10.1016/j.ydbio.2006.08.060; Liehr T, 2002, CYTOGENET GENOME RES, V97, P43, DOI 10.1159/000064043; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McClintock B, 1941, GENETICS, V26, P234; PETIT MA, 1992, EMBO J, V11, P1317, DOI 10.1002/j.1460-2075.1992.tb05176.x; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rodriguez L, 2007, AM J MED GENET A, V143A, P995, DOI 10.1002/ajmg.a.31681; Romero D, 1997, ANNU REV GENET, V31, P91, DOI 10.1146/annurev.genet.31.1.91; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Schinzel A., 2001, CATALOGUE UNBALANCED; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Van Buggenhout G, 2004, J MED GENET, V41, P691, DOI 10.1136/jmg.2003.016865; Vermeesch JR, 2005, J HISTOCHEM CYTOCHEM, V53, P413, DOI 10.1369/jhc.4A6436.2005; YOUNG M, 1987, FEBS LETT, V212, P10, DOI 10.1016/0014-5793(87)81547-8; Yue Y, 2006, CYTOGENET GENOME RES, V112, P6, DOI 10.1159/000087507	32	32	80	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2008	82	1					181	187		10.1016/j.ajhg.2007.08.001	http://dx.doi.org/10.1016/j.ajhg.2007.08.001			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NM	18179897	Bronze, Green Published			2022-12-18	WOS:000253223800019
J	Plotnikova, OV; Kondrashov, FA; Vlasov, PK; Grigorenko, AP; Ginter, EK; Rogaev, EI				Plotnikova, Olga V.; Kondrashov, Fyodor A.; Vlasov, Peter K.; Grigorenko, Anastasia P.; Ginter, Evgeny K.; Rogaev, Evgeny I.			Conversion and compensatory evolution of the gamma-crystallin genes and identification of a cataractogenic mutation that reverses the sequence of the human CRYGD gene to an ancestral state	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MISSENSE MUTATION; JUVENILE-ONSET; CONGENITAL CATARACT; PROTEIN EVOLUTION; 5 MEMBERS; EYE LENS; FAMILY; SOLUBILITY; LAMELLAR; LINKAGE	We identified a mutation in the CRYGD gene (P23S) of the gamma-crystallin gene cluster that is associated with a polymorphic congenital cataract that occurs with frequency of similar to 0.3% in a human population. To gain insight into the molecular mechanism of the pathogenesis of gamma-crystallin isoforms, we undertook an evolutionary analysis of the available mammalian and newly obtained primate sequences of the gamma-crystallin genes. The cataract- associated serine at site 23 corresponds to the ancestral state, since it was found in CRYGD of a lower primate and all the surveyed nonprimate mammals. Crystallin proteins include two structurally similar domains, and substitutions in mammalian CRYGD protein at site 23 of the first domain were always associated with substitutions in the structurally reciprocal sites 109 and 136 of the second domain. These data suggest that the cataractogenic effect of serine at site 23 in the N-terminal domain of CRYGD may be compensated indirectly by amino acid changes in a distal domain. We also found that gene conversion was a factor in the evolution of the gamma-crystallin gene cluster throughout different mammalian clades. The high rate of gene conversion observed between the functional CRYGD gene and two primate gamma-crystallin pseudogenes (CRYGEP1 and CRYGFP1) coupled with a surprising finding of apparent negative selection in primate pseudogenes suggest a deleterious impact of recently derived pseudogenes involved in gene conversion in the gamma-crystallin gene cluster.	Univ Massachusetts, Sch Med, Brudnick Neuropsychiat Res Inst, Dept Psychiat, Worcester, MA 01604 USA; Russian Acad Sci, Lab Mol Brain Genet, Res Ctr Mental Hlth, Moscow 109017, Russia; Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow 109017, Russia; Russian Acad Sci, Res Ctr Med Genet, Moscow 109017, Russia; Russian Acad Sci, Vavilov Inst Gen Genet, Moscow 109017, Russia; Moscow MV Lomonosov State Univ, Moscow 117234, Russia; Univ Calif San Diego, Div Biol Sci, Sect Ecol Behav & Evolut, La Jolla, CA 92093 USA	University of Massachusetts System; University of Massachusetts Worcester; Russian Academy of Sciences; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Research Centre for Medical Genetics; Russian Academy of Sciences; Russian Academy of Sciences; Vavilov Institute of General Genetics; Lomonosov Moscow State University; University of California System; University of California San Diego	Rogaev, EI (corresponding author), Univ Massachusetts, Sch Med, Brudnick Neuropsychiat Res Inst, Dept Psychiat, 303 Belmont St, Worcester, MA 01604 USA.	Evgeny.Rogaev@umassmed.edu	Vlasov, Peter/O-6392-2015; Plotnikova, Olga/B-5592-2013; Rogaev, Evgeny/AAN-7662-2020; Grigorenko, Anastasia/AAN-8226-2020; Kondrashov, Fyodor Alexeevich/H-6331-2015	Vlasov, Peter/0000-0003-0489-4200; Kondrashov, Fyodor Alexeevich/0000-0001-8243-4694				AARTS HJM, 1988, J MOL EVOL, V27, P163, DOI 10.1007/BF02138377; BARTON NH, 1990, GENETICS, V124, P773; Basak A, 2003, J MOL BIOL, V328, P1137, DOI 10.1016/S0022-2836(03)00375-9; Bassnett S, 1999, J CELL SCI, V112, P2155; Benson DA, 2006, NUCLEIC ACIDS RES, V34, pD16, DOI 10.1093/nar/gkj157; Berry V, 2000, NAT GENET, V25, P15, DOI 10.1038/75538; Bischof JM, 2006, HUM MUTAT, V27, P545, DOI 10.1002/humu.20335; BLUNDELL T, 1981, NATURE, V289, P771, DOI 10.1038/289771a0; BRAKENHOFF RH, 1990, J MOL BIOL, V216, P519, DOI 10.1016/0022-2836(90)90380-5; BRAKENHOFF RH, 1994, HUM MOL GENET, V3, P279, DOI 10.1093/hmg/3.2.279; Bu L, 2002, NAT GENET, V31, P276, DOI 10.1038/ng921; Burdon KP, 2004, BRIT J OPHTHALMOL, V88, P79, DOI 10.1136/bjo.88.1.79; Conley YP, 2000, AM J HUM GENET, V66, P1426, DOI 10.1086/302871; DENDUNNEN JT, 1986, J MOL BIOL, V189, P37, DOI 10.1016/0022-2836(86)90379-7; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evans P, 2004, J MOL BIOL, V343, P435, DOI 10.1016/j.jmb.2004.08.050; Francis PJ, 2000, J MED GENET, V37, P481, DOI 10.1136/jmg.37.7.481; Francis PJ, 1999, TRENDS GENET, V15, P191, DOI 10.1016/S0168-9525(99)01738-2; Fukami-Kobayashi K, 2002, J MOL BIOL, V319, P729, DOI 10.1016/S0022-2836(02)00239-5; GINTER EK, 1991, GENETIKA+, V27, P1840; GINTER EK, 1983, GENETIKA+, V19, P1344; Graw J, 1997, BIOL CHEM, V378, P1331; Gu JZ, 2005, MOL VIS, V11, P971; Hejtmancik JF, 2003, DEV OPHTHALMOL, V37, P67; Heon E, 1999, AM J HUM GENET, V65, P1261, DOI 10.1086/302619; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Jamieson RV, 2002, HUM MOL GENET, V11, P33, DOI 10.1093/hmg/11.1.33; Kern AD, 2004, NAT GENET, V36, P1207, DOI 10.1038/ng1451; Kmoch S, 2000, HUM MOL GENET, V9, P1779, DOI 10.1093/hmg/9.12.1779; Kondrashov AS, 2002, P NATL ACAD SCI USA, V99, P14878, DOI 10.1073/pnas.232565499; Kondrashov FA, 2007, TRENDS GENET, V23, P215, DOI 10.1016/j.tig.2007.03.002; Li W.H., 1997, MOL EVOLUTION; Mackay DW, 2004, MOL VIS, V10, P155; MEAKIN SO, 1985, MOL CELL BIOL, V5, P1408, DOI 10.1128/MCB.5.6.1408; MEAKIN SO, 1987, MOL CELL BIOL, V7, P2671, DOI 10.1128/MCB.7.8.2671; Messina-Baas O, 2006, MOL VIS, V12, P995; Nandrot E, 2003, J MED GENET, V40, P262, DOI 10.1136/jmg.40.4.262; Pande A, 2005, BIOCHEMISTRY-US, V44, P2491, DOI 10.1021/bi0479611; Pande A, 2000, P NATL ACAD SCI USA, V97, P1993, DOI 10.1073/pnas.040554397; Perelygin AA, 2002, J MOL EVOL, V55, P202, DOI 10.1007/s00239-002-2318-0; Poon A, 2005, GENETICS, V170, P989, DOI 10.1534/genetics.104.039438; Reddy MA, 2004, SURV OPHTHALMOL, V49, P300, DOI 10.1016/j.survophthal.2004.02.013; Rogaev EI, 1996, HUM MOL GENET, V5, P699, DOI 10.1093/hmg/5.5.699; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SanGiovanni JP, 2002, ARCH OPHTHALMOL-CHIC, V120, P1559, DOI 10.1001/archopht.120.11.1559; Santhiya ST, 2002, J MED GENET, V39, P352, DOI 10.1136/jmg.39.5.352; Semina EV, 1998, NAT GENET, V19, P167, DOI 10.1038/527; Shentu XC, 2004, MOL VIS, V10, P233; Stephan DA, 1999, P NATL ACAD SCI USA, V96, P1008, DOI 10.1073/pnas.96.3.1008; Teshima KM, 2004, GENETICS, V166, P1553, DOI 10.1534/genetics.166.3.1553; Vanita, 2001, J MED GENET, V38, P392, DOI 10.1136/jmg.38.6.392; Xu WZ, 2004, CHINESE MED J-PEKING, V117, P727; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	53	32	36	0	11	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2007	81	1					32	43		10.1086/518616	http://dx.doi.org/10.1086/518616			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	175UO	17564961	Bronze, Green Published			2022-12-18	WOS:000247039700003
J	Wang, T; Zhu, XF; Elston, RC				Wang, Tao; Zhu, Xiaofeng; Elston, Robert C.			Improving power in contrasting linkage-disequilibrium patterns between cases and controls	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HASEMAN-ELSTON METHOD; BLOOD-PRESSURE; HUMAN GENOME; POPULATIONS; ACE; POLYMORPHISMS; ASSOCIATIONS; TRAIT	Genetic association studies offer an opportunity to find genetic variants underlying complex human diseases. The success of this approach depends on the linkage disequilibrium (LD) between markers and the disease variant(s) in a local region of the genome. Because, in the region with a disease mutation, the LD pattern among markers may differ between cases and controls, in some scenarios, it is useful to compare a measure of this LD, to map disease mutations. For example, using the composite correlation to characterize the LD among markers, Zaykin et al. recently suggested an "LD contrast" test and showed that it has high power under certain haplotype-driven disease models. Furthermore, it is likely that individual variants observed at different positions in a gene act jointly with each other to influence the phenotype, and the LD contrast test is also a useful method to detect such joint action. However, the LD among markers introduced by mutations and their joint action is usually confounded by background LD, which is measured at the population level, especially in a local region with disease mutations. Because the measures of LD that are usually used, such as the composite correlation, represent both effects, they may not be optimal for the purpose of detecting association when high background LD exists. Here, we describe a test that improves the LD contrast test by taking into account the background LD. Because the proposed test is developed in a regression framework, it is very flexible and can be extended to continuous traits and to incorporate covariates. Our simulation results demonstrate the validity and substantially higher power of the proposed method over current methods. Finally, we illustrate our new method by applying it to real data from the International Collaborative Study on Hypertension in Blacks.	Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA	Case Western Reserve University	Elston, RC (corresponding author), Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA.	rce@darwin.case.edu	Zhu, Xiaofeng/O-6874-2019	Zhu, Xiaofeng/0000-0003-0037-411X	NCRR NIH HHS [RR03655, P41 RR003655] Funding Source: Medline; NHGRI NIH HHS [HG003054, R01 HG003054] Funding Source: Medline; NIGMS NIH HHS [GM28356, R01 GM028356, R37 GM028356] Funding Source: Medline; PHS HHS [P30CAD43703] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028356, R01GM028356] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bouzekri N, 2004, EUR J HUM GENET, V12, P460, DOI 10.1038/sj.ejhg.5201166; Chen HS, 2003, ANN HUM GENET, V67, P250, DOI 10.1046/j.1469-1809.2003.00036.x; Cox R, 2002, HUM MOL GENET, V11, P2969, DOI 10.1093/hmg/11.23.2969; Crawford DC, 2004, AM J HUM GENET, V74, P610, DOI 10.1086/382227; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Elston RC, 2000, GENET EPIDEMIOL, V19, P1, DOI 10.1002/1098-2272(200007)19:1<1::AID-GEPI1>3.0.CO;2-E; LEWONTIN RC, 1964, GENETICS, V49, P49; Liang KY, 2001, AM J HUM GENET, V68, P937, DOI 10.1086/319504; Nielsen DM, 2004, GENETICS, V168, P1029, DOI 10.1534/genetics.103.022335; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Tao H, 2006, PLOS GENET, V2, P848, DOI 10.1371/journal.pgen.0020093; Wang T, 2004, HUM HERED, V57, P109, DOI 10.1159/000077548; WEIR BS, 1979, HEREDITY, V42, P105, DOI 10.1038/hdy.1979.10; Xu X, 2000, AM J HUM GENET, V67, P1025, DOI 10.1086/303081; Zaykin DV, 2006, AM J HUM GENET, V78, P737, DOI 10.1086/503710; Zaykin DV, 2004, GENET EPIDEMIOL, V27, P252, DOI 10.1002/gepi.20015; Zhang JH, 2003, AM J HUM GENET, V73, P1073, DOI 10.1086/379154; Zhao JY, 2006, AM J HUM GENET, V79, P831, DOI 10.1086/508571; Zhu XF, 2000, AM J HUM GENET, V67, P1144; Zhu XF, 2001, AM J HUM GENET, V68, P1139, DOI 10.1086/320104	21	32	32	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2007	80	5					911	920		10.1086/516794	http://dx.doi.org/10.1086/516794			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160WM	17436245	Green Published, Bronze			2022-12-18	WOS:000245973200009
J	Salviati, L; Patricelli, M; Guariso, G; Sturniolo, GC; Alaggio, R; Bernardi, F; Zuffardi, O; Tenconi, R				Salviati, Leonardo; Patricelli, Mariagrazia; Guariso, Graziella; Sturniolo, Giacomo Carlo; Alaggio, Rita; Bernardi, Franca; Zuffardi, Orsetta; Tenconi, Romano			Deletion of PTEN and BMPR1A on chromosome 10q23 is not always associated with juvenile polyposis of infancy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							GENE		Univ Padua, Genet Clin, Dept Pediat, I-35128 Padua, Italy; Univ Padua, Dept Surg, I-35128 Padua, Italy; Univ Padua, Dept Gastroenterol Sci, I-35128 Padua, Italy; Univ Padua, Dept Pathol, I-35128 Padua, Italy; Borgo Roma Hosp, Verona, Italy; Hosp San Raffaele, I-20132 Milan, Italy; Univ Pavia, I-27100 Pavia, Italy; IRCCS, Policlin San Matteo, Pavia, Italy	University of Padua; University of Padua; University of Padua; University of Padua; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Pavia; IRCCS Fondazione San Matteo; University of Pavia	Tenconi, R (corresponding author), Univ Padua, Genet Clin, Dept Pediat, Via Giustiniani 3, I-35128 Padua, Italy.	romano.tenconi@unipd.it	alaggio, rita/AAC-2348-2019	alaggio, rita/0000-0003-3915-3816; Guariso, Graziella/0000-0002-3120-5063; zuffardi, orsetta/0000-0002-1466-4559				Baldini A, 2002, HUM MOL GENET, V11, P2363, DOI 10.1093/hmg/11.20.2363; Delnatte C, 2006, AM J HUM GENET, V78, P1066, DOI 10.1086/504301; DESAI DC, 1995, BRIT J SURG, V82, P14, DOI 10.1002/bjs.1800820106; Digilio MC, 2003, CLIN GENET, V63, P308, DOI 10.1034/j.1399-0004.2003.00049.x; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; GOODSHIP J, 1995, J MED GENET, V32, P746, DOI 10.1136/jmg.32.9.746; Merg A, 2004, AM J MED GENET C, V129C, P44, DOI 10.1002/ajmg.c.30020; SACHATELLO CR, 1975, AM J SURG, V129, P198, DOI 10.1016/0002-9610(75)90298-6; Tsuchiya KD, 1998, GENE CHROMOSOME CANC, V21, P113, DOI 10.1002/(SICI)1098-2264(199802)21:2<113::AID-GCC6>3.0.CO;2-3; Vaishnaw AK, 1999, J CLIN INVEST, V103, P355, DOI 10.1172/JCI5121	10	32	32	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2006	79	3					593	596		10.1086/507151	http://dx.doi.org/10.1086/507151			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	074RY	16909400	Green Published, Bronze			2022-12-18	WOS:000239830700024
J	Nothnagel, M; Rohde, K				Nothnagel, M; Rohde, K			The effect of single-nucleotide polymorphism marker selection on patterns of haplotype blocks and haplotype frequency estimates	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; ASSOCIATION; RECOMBINATION; IDENTIFICATION; DIVERSITY; HISTORY	The definition of haplotype blocks of single-nucleotide polymorphisms (SNPs) has been proposed so that the haplotypes can be used as markers in association studies and to efficiently describe human genetic variation. The International Haplotype Map (HapMap) project to construct a comprehensive catalog of haplotypic variation in humans is underway. However, a number of factors have already been shown to influence the definition of blocks, including the population studied and the sample SNP density. Here, we examine the effect that marker selection has on the definition of blocks and the pattern of haplotypes by using comparable but complementary SNP sets and a number of block definition methods in various genomic regions and populations that were provided by the Encyclopedia of DNA Elements (ENCODE) project. We find that the chosen SNP set has a profound effect on the block-covered sequence and block borders, even at high marker densities. Our results question the very concept of discrete haplotype blocks and the possibility of generalizing block findings from the HapMap project. We comparatively apply the block-free tagging-SNP approach and discuss both the haplotype approach and the tagging-SNP approach as means to efficiently catalog genetic variation.	Univ Kiel, Fac Med, Inst Med Informat & Stat, D-24105 Kiel, Germany; Max Delbruck Ctr Mol Med, Dept Bioinformat, Berlin, Germany	University of Kiel; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Nothnagel, M (corresponding author), Univ Kiel, Fac Med, Inst Med Informat & Stat, Brunswicker Str10, D-24105 Kiel, Germany.	nothnagel@medinfo.uni-kiel.de	Nothnagel, Michael/G-6545-2014; Nothnagel, Michael/L-7187-2019; Nothnagel, Michael/H-6887-2012; Nothnagel, Michael/A-7759-2011	Nothnagel, Michael/0000-0001-8305-7114; 				Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Becker T, 2004, GENET EPIDEMIOL, V27, P21, DOI 10.1002/gepi.10323; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Crawford DC, 2004, AM J HUM GENET, V74, P610, DOI 10.1086/382227; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Dawson E, 2002, NATURE, V418, P544, DOI 10.1038/nature00864; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Goddard KAB, 2000, AM J HUM GENET, V66, P216, DOI 10.1086/302727; Goldstein DB, 2001, NAT GENET, V29, P109, DOI 10.1038/ng1001-109; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; HUDSON RR, 1985, GENETICS, V111, P147; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Ke XY, 2004, HUM MOL GENET, V13, P577, DOI 10.1093/hmg/ddh060; Kidd JR, 2000, AM J HUM GENET, V66, P1882, DOI 10.1086/302952; Knapp M, 2003, HUM HERED, V56, P2, DOI 10.1159/000073727; LEWONTIN RC, 1964, GENETICS, V49, P49; Liu NJ, 2004, GENET EPIDEMIOL, V27, P385, DOI 10.1002/gepi.20026; Morris RW, 2002, GENET EPIDEMIOL, V23, P221, DOI 10.1002/gepi.10200; Nothnagel M, 2002, HUM HERED, V54, P186, DOI 10.1159/000070664; NOTHNAGEL M, 2004, THESIS HUMBOLDT U BE; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Phillips MS, 2003, NAT GENET, V33, P382, DOI 10.1038/ng1100; R Development Core Team, 2004, R LANG ENV STAT COMP; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Sawyer SL, 2005, EUR J HUM GENET, V13, P677, DOI 10.1038/sj.ejhg.5201368; Subrahmanyan L, 2001, AM J HUM GENET, V69, P381, DOI 10.1086/321297; Sun Xiao, 2004, Human Genomics, V1, P179; Wang N, 2002, AM J HUM GENET, V71, P1227, DOI 10.1086/344398; Zhai WW, 2004, GENET EPIDEMIOL, V27, P80, DOI 10.1002/gepi.20014; Zhang K, 2002, AM J HUM GENET, V71, P1386, DOI 10.1086/344780; Zhang WH, 2002, P NATL ACAD SCI USA, V99, P17004, DOI 10.1073/pnas.012672899	34	32	36	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2005	77	6					988	998		10.1086/498175	http://dx.doi.org/10.1086/498175			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	983OE	16380910	Bronze, Green Published			2022-12-18	WOS:000233241200008
J	Wooding, S; Stone, AC; Dunn, DM; Mummidi, S; Jorde, LB; Weiss, RK; Ahuja, S; Bamshad, MJ				Wooding, S; Stone, AC; Dunn, DM; Mummidi, S; Jorde, LB; Weiss, RK; Ahuja, S; Bamshad, MJ			Contrasting effects of natural selection on human and chimpanzee CC chemokine receptor 5	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HIV-1 INFECTION; IMMUNODEFICIENCY-VIRUS; NUCLEOTIDE DIVERSITY; DEMOGRAPHIC HISTORY; GENETIC-DIFFERENCES; POPULATION-GROWTH; RESISTANCE ALLELE; DNA-SEQUENCES; EVOLUTION; PROGRESSION	Human immunodeficiency virus type 1 (HIV-1) evolved via cross-species transmission of simian immunodeficiency virus (SIVcpz) from chimpanzees (Pan troglodytes). Chimpanzees, like humans, are susceptible to infection by HIV-1. However, unlike humans, infected chimpanzees seldom develop immunodeficiency when infected with SIVcpz or HIV-1. SIVcpz and most strains of HIV-1 require the cell-surface receptor CC chemokine receptor 5 (CCR5) to infect specific leukocyte subsets, and, subsequent to infection, the level of CCR5 expression influences the amount of HIV-1 entry and the rate of HIV-1 replication. Evidence that variants in the 5' cis-regulatory region of CCR5 (5'CCR5) affect disease progression in humans suggests that variation in CCR5 might also influence the response of chimpanzees to HIV-1/SIVcpz. To determine whether patterns of genetic variation at 5'CCR5 in chimpanzees are similar to those in humans, we analyzed patterns of DNA sequence variation in 37 wild-born chimpanzees (26 P. t. verus, 9 P. t. troglodytes, and 2 P. t. schweinfurthii), along with previously published 5'CCR5 data from 112 humans and 50 noncoding regions in the human and chimpanzee genomes. These analyses revealed that patterns of variation in 5'CCR5 differ dramatically between chimpanzees and humans. In chimpanzees, 5'CCR5 was less diverse than 80% of noncoding regions and was characterized by an excess of rare variants. In humans, 5'CCR5 was more diverse than 90% of noncoding regions and had an excess of common variants. Under a wide range of demographic histories, these patterns suggest that, whereas human 5'CCR5 has been subject to balancing selection, chimpanzee 5'CCR5 has been influenced by a selective sweep. This result suggests that chimpanzee 5'CCR5 might harbor or be linked to functional variants that influence chimpanzee resistance to disease caused by SIVcpz/HIV-1.	Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; Univ Utah, Dept Pediat, Salt Lake City, UT 84112 USA; Arizona State Univ, Dept Anthropol, Tempe, AZ 85287 USA; Univ Texas, Hlth Sci Ctr, Dept Med, Vet Adm Res Ctr AIDS & HIV Infect, San Antonio, TX 78284 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Arizona State University; Arizona State University-Tempe; University of Texas System; University of Texas Health San Antonio	Bamshad, MJ (corresponding author), Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA.	mike@genetics.utah.edu	Mummidi, Srinivas/C-1004-2008; Mummidi, Srinivas/H-3335-2017; Stone, Anne C/B-5719-2009	Mummidi, Srinivas/0000-0002-4068-6380; Mummidi, Srinivas/0000-0002-4068-6380; Stone, Anne/0000-0001-8021-8314	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043279, R21AI046326, R37AI046326, R01AI046326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010058, F32ES012125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059290] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-00064, M01 RR000064] Funding Source: Medline; NIAID NIH HHS [R01 AI043279, AI43279, R01 AI046326, R21 AI046326, R37 AI046326, AI46326] Funding Source: Medline; NIEHS NIH HHS [F32 ES012125, ES-12125, ES-10058] Funding Source: Medline; NIGMS NIH HHS [R01 GM059290, GM-59290] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Bamshad MJ, 2002, P NATL ACAD SCI USA, V99, P10539, DOI 10.1073/pnas.162046399; Corbet S, 2000, J VIROL, V74, P529, DOI 10.1128/JVI.74.1.529-534.2000; Cunningham AL, 2000, J LEUKOCYTE BIOL, V68, P311; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Deinard A, 1999, J HUM EVOL, V36, P687, DOI 10.1006/jhev.1999.0298; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Excoffier L, 2002, CURR OPIN GENET DEV, V12, P675, DOI 10.1016/S0959-437X(02)00350-7; Fischer A, 2004, MOL BIOL EVOL, V21, P799, DOI 10.1093/molbev/msh083; Fu YX, 1997, GENETICS, V147, P915; Gagneux P, 1999, P NATL ACAD SCI USA, V96, P5077, DOI 10.1073/pnas.96.9.5077; Gagneux P, 2001, PHILOS T R SOC B, V356, P889, DOI 10.1098/rstb.2001.0865; Galvani AP, 2003, P NATL ACAD SCI USA, V100, P15276, DOI 10.1073/pnas.2435085100; Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130; Goldberg TL, 1997, MOL BIOL EVOL, V14, P976, DOI 10.1093/oxfordjournals.molbev.a025841; Gonzalez E, 1999, P NATL ACAD SCI USA, V96, P12004, DOI 10.1073/pnas.96.21.12004; Harpending H, 2000, ANNU REV GENOM HUM G, V1, P361, DOI 10.1146/annurev.genom.1.1.361; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Kaessmann H, 1999, SCIENCE, V286, P1159, DOI 10.1126/science.286.5442.1159; Kaessmann H, 2001, NAT GENET, V27, P155, DOI 10.1038/84773; Lalani AS, 1999, SCIENCE, V286, P1968, DOI 10.1126/science.286.5446.1968; Lin YL, 2002, P NATL ACAD SCI USA, V99, P15590, DOI 10.1073/pnas.242134499; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Martin MP, 1998, SCIENCE, V282, P1907, DOI 10.1126/science.282.5395.1907; Mecsas J, 2004, NATURE, V427, P606, DOI 10.1038/427606a; MORIN PA, 1994, SCIENCE, V265, P1193, DOI 10.1126/science.7915048; Mummidi S, 2000, J BIOL CHEM, V275, P18946, DOI 10.1074/jbc.M000169200; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; O'Neil SP, 2000, J INFECT DIS, V182, P1051, DOI 10.1086/315823; Ondoa P, 2002, J MED VIROL, V67, P301, DOI 10.1002/jmv.10078; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Santiago ML, 2002, SCIENCE, V295, P465, DOI 10.1126/science.295.5554.465; Schliekelman P, 2001, NATURE, V411, P545, DOI 10.1038/35079176; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stone AC, 2002, P NATL ACAD SCI USA, V99, P43, DOI 10.1073/pnas.012364999; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Tishkoff SA, 2003, ANNU REV GENOM HUM G, V4, P293, DOI 10.1146/annurev.genom.4.070802.110226; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wooding S, 2000, HUM BIOL, V72, P693; Wooding S, 2004, AM J HUM GENET, V74, P637, DOI 10.1086/383092; Yu N, 2003, GENETICS, V164, P1511; Yu N, 2002, GENETICS, V161, P269	48	32	34	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2005	76	2					291	301		10.1086/427927	http://dx.doi.org/10.1086/427927			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	886GO	15625621	Green Published, Bronze			2022-12-18	WOS:000226215100014
J	Hurles, ME; Maund, E; Nicholson, J; Bosch, E; Renfrew, C; Sykes, BC; Jobling, MA				Hurles, ME; Maund, E; Nicholson, J; Bosch, E; Renfrew, C; Sykes, BC; Jobling, MA			Native American Y chromosomes in Polynesia: The genetic impact of the Polynesian slave trade	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EVOLUTIONARY HISTORY; MITOCHONDRIAL DNAS; PACIFIC; ORIGINS; MTDNA; POPULATIONS	Since Thor Heyerdahl asserted that Polynesia was first colonized from the Americas ( Heyerdahl 1950), geneticists have sought - but have not found - any evidence to support his theories. Here, Native American Y chromosomes are detected on the Polynesian island of Rapa. However, this, together with other odd features of the island's Y-chromosomal gene pool, is best explained as the genetic impact of a 19th century Peruvian slave trade in Polynesia. These findings underscore the need to account for history before turning to prehistory and the value of archival research to understanding modern genetic diversity. Although the impact of the Atlantic slave trade on the distribution of modern genetic diversity has been well appreciated, this represents the first study investigating the impact of this underappreciated episode on genetic diversity in the Pacific.	Univ Cambridge, McDonald Inst Archaeol Res, Cambridge CB2 3ER, England; Univ Oxford, Weatherall Inst Mol Med, Oxford, England; Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England	University of Cambridge; University of Oxford; University of Leicester	Hurles, ME (corresponding author), Univ Cambridge, McDonald Inst Archaeol Res, Downing St, Cambridge CB2 3ER, England.		Bosch, Elena/D-8681-2014; Bosch, Elena/N-7603-2019	Bosch, Elena/0000-0003-2848-103X; Bosch, Elena/0000-0003-2848-103X; Jobling, Mark/0000-0002-8061-1308	Wellcome Trust [057559] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bonatto SL, 1996, AM J HUM GENET, V59, P253; Cann RL, 1996, AM J HUM GENET, V59, P256; GREEN JL, 1864, COMMUNICATION   0401; GREEN JL, 1865, COMMUNICATION   0608; Green RC, 2000, J POLYNESIAN SOC, V109, P191; HEYERDAHL T, 1950, KONTIKI PACIFIC RAFT; Hurles ME, 2002, GENETICS, V160, P289; Hurles ME, 1998, AM J HUM GENET, V63, P1793, DOI 10.1086/302147; KIRCH PV, 1999, LAPITA PEOPLES; Lum JK, 2000, AM J PHYS ANTHROPOL, V113, P151; LUM JK, 1994, HUM BIOL, V66, P567; Lum JK, 1998, AM J HUM GENET, V63, P613, DOI 10.1086/301949; MARTINSON JJ, 1993, HUM GENET, V91, P445, DOI 10.1007/BF00217769; Maude H. E., 1981, SLAVERS PARADISE PER; McArthur Norma, 1968, ISLAND POPULATIONS P; Murray-McIntosh RP, 1998, P NATL ACAD SCI USA, V95, P9047, DOI 10.1073/pnas.95.15.9047; REDD AJ, 1995, MOL BIOL EVOL, V12, P604; Rohl A, 2001, INT J LEGAL MED, V115, P29, DOI 10.1007/s004140100217; SAVILLE AT, 1871, S SEAS J; SERJEANTSON SW, 1989, COLONIZATION PACIFIC, P286; STOKES J, 1930, UNPUB ETHNOLOGY RAPA; SYKES B, 1995, AM J HUM GENET, V57, P1463; Tarazona-Santos E, 2001, AM J HUM GENET, V68, P1485, DOI 10.1086/320601; Tommaseo-Ponzetta M, 2002, AM J PHYS ANTHROPOL, V117, P49, DOI 10.1002/ajpa.10010; Underhill PA, 1996, P NATL ACAD SCI USA, V93, P196, DOI 10.1073/pnas.93.1.196; Underhill PA, 2001, HUM MUTAT, V17, P271, DOI 10.1002/humu.23; YEN DE, 1974, BP BISHOP MUSEUM B; Zeitoun Elizabeth, 1999, SELECTED PAPERS 8 IN, P31; 1863, MESSAGER TAHITI 0228, P36	29	32	32	0	9	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2003	72	5					1282	1287		10.1086/374827	http://dx.doi.org/10.1086/374827			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	671PZ	12644966	Green Published, Bronze			2022-12-18	WOS:000182474400020
J	Kaufmann, D; Muller, R; Bartelt, B; Wolf, M; Kunzi-Rapp, K; Hanemann, CO; Fahsold, R; Hein, C; Vogel, W; Assum, G				Kaufmann, D; Muller, R; Bartelt, B; Wolf, M; Kunzi-Rapp, K; Hanemann, CO; Fahsold, R; Hein, C; Vogel, W; Assum, G			Spinal neurofibromatosis without cafe-au-lait macules in two families with null mutations of the NF1 gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TYPE-1 NF1; MELANOCYTES; EXPRESSION	Spinal neurofibromatosis (SNF) is considered to be an alternative form of neurofibromatosis, showing multiple spinal tumors and cafe'-au-lait macules. Involvement of the neurofibromatosis type 1 (NF1) locus has been demonstrated, by linkage analysis, for three families with SNF. In one of them, a cosegregating frameshift mutation in exon 46 of the NF1 gene was identified. In the present study, we report four individuals from two families who carry NF1 null mutations that would be expected to cause NF1. Three patients have multiple spinal tumors and no cafe'-au-lait macules, and the fourth has no clinical signs of NF1. In the first family, a missense mutation (Leu2067Pro) in NF1 exon 33 was found, and, in the second, a splice-site mutation (IVS31-5A -->G) enlarging exon 32 by 4 bp at the 5' end was found. The latter mutation has also been observed in an unrelated patient with classical NF1. Both NF1 mutations cause a reduction in neurofibromin of similar to 50%, with no truncated protein present in the cells. This demonstrates that typical NF1 null mutations can result in a phenotype that is distinct from classical NF1, showing only a small spectrum of the NF1 symptoms, such as multiple spinal tumors, but not completely fitting the current clinical criteria for SNF. We speculate that this phenotype is caused by an unknown modifying gene that compensates for some, but not all, of the effects caused by neurofibromin deficiency.	Univ Ulm, Dept Human Genet, D-89070 Ulm, Germany; Univ Ulm, Dept Dermatol, D-89070 Ulm, Germany; Univ Ulm, Dept Neurol, D-89070 Ulm, Germany; Univ Ulm, Dept Neurosurg, D-89070 Ulm, Germany; Gemeinschaftspraxis Prager & Junge, Dresden, Germany	Ulm University; Ulm University; Ulm University; Ulm University	Kaufmann, D (corresponding author), Univ Ulm, Dept Human Genet, Albert Einstein Allee 11, D-89070 Ulm, Germany.		Hanemann, C Oliver/AAV-6257-2020	Hanemann, C Oliver/0000-0002-1951-1025; Bartelt-Kirbach, Britta/0000-0002-9374-4046				Ars E, 1998, AM J HUM GENET, V62, P834, DOI 10.1086/301803; Eisenbarth I, 2000, AM J HUM GENET, V66, P393, DOI 10.1086/302747; Fahsold R, 2000, AM J HUM GENET, V66, P790, DOI 10.1086/302809; GRIESSER J, 1995, BIOL CHEM H-S, V376, P91, DOI 10.1515/bchm3.1995.376.2.91; Griesser J, 1997, J INVEST DERMATOL, V108, P275, DOI 10.1111/1523-1747.ep12286456; HEIM RA, 1995, HUM MOL GENET, V4, P975, DOI 10.1093/hmg/4.6.975; HOFFMEYER S, 1995, HUM MOL GENET, V4, P1267, DOI 10.1093/hmg/4.8.1267; HUSON SM, 1988, BRAIN, V111, P1355, DOI 10.1093/brain/111.6.1355; Kaufmann D, 1999, DNA CELL BIOL, V18, P345, DOI 10.1089/104454999315240; KehrerSawatzki H, 1997, HUM GENET, V100, P67, DOI 10.1007/s004390050467; Klose A, 1998, HUM MOL GENET, V7, P1261, DOI 10.1093/hmg/7.8.1261; McGaughran JM, 1999, J MED GENET, V36, P197; Poyhonen M, 1997, J MED GENET, V34, P184, DOI 10.1136/jmg.34.3.184; PULST SM, 1991, NEUROLOGY, V41, P1923, DOI 10.1212/WNL.41.12.1923; STARK M, 1992, HUM GENET, V90, P356; Thakker SD, 1999, NEURORADIOLOGY, V41, P625, DOI 10.1007/s002340050814	16	32	34	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2001	69	6					1395	1400		10.1086/324648	http://dx.doi.org/10.1086/324648			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	491AY	11704931	Green Published, Bronze			2022-12-18	WOS:000172086900024
J	Kennerson, ML; Zhu, D; Gardner, RJM; Storey, E; Merory, J; Robertson, SP; Nicholson, GA				Kennerson, ML; Zhu, D; Gardner, RJM; Storey, E; Merory, J; Robertson, SP; Nicholson, GA			Dominant intermediate Charcot-Marie-Tooth neuropathy maps to chromosome 19p12-p13.2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEIN ZERO GENE; SENSORY NEUROPATHY; DISEASE TYPE-1A; HEREDITARY MOTOR; NERVE-CONDUCTION; LINKAGE ANALYSIS; POINT MUTATIONS; DUPLICATION; THR124MET; CANDIDATE	The hereditary disorders of peripheral nerve form one of the most common groups of human genetic diseases, collectively called Charcot-Marie-Tooth (CMT) neuropathy. Using linkage analysis we have identified a new locus for a form of CMT that we have called "(d) under bar ominant intermediate CMT" (DI-CMT). A genomewide screen using 383 microsatellite markers showed strong linkage to the short arm of chromosome 19 (maximum LOD score 4.3, with a recombination fraction (theta) of 0, at D19S221 and maximum LOD score 5.28, theta =0, at D19S226). Haplotype analysis performed with 14 additional markers placed the D1-CMT locus within a 16.8-cM region flanked by the markers D19S586 and D19S546. Multipoint linkage analysis suggested the most likely location at D19S226 (maximum multipoint LOD score 6.77), within a 10-cM confidence interval. This study establishes the presence of a locus for DI-CMT on chromosome 19p12-p13.2.	Univ Sydney, Neurobiol Lab, ANZAC Res Inst, Concord Hosp, Sydney, NSW 2139, Australia; Concord Hosp, Mol Med Lab, Concord, NSW, Australia; Monash Univ, Genet Hlth Serv Victoria, Royal Childrens Hosp, Melbourne, Vic, Australia; Monash Univ, Dept Neurosci, Melbourne, Vic, Australia; Austin & Repatriat Hosp, Melbourne, Vic, Australia	Concord Repatriation General Hospital; University of Sydney; ANZAC Research Institute; Concord Repatriation General Hospital; Monash University; Royal Children's Hospital Melbourne; Monash University; Austin Research Institute	Kennerson, ML (corresponding author), Univ Sydney, Neurobiol Lab, ANZAC Res Inst, Concord Hosp, Sydney, NSW 2139, Australia.		Research Institute, ANZAC/CAE-9030-2022; Ekanayake, Kanchana/P-8817-2016; Storey, Elsdon/A-9889-2013; Kennerson, Marina L/B-5058-2014	Robertson, Stephen/0000-0002-5181-7809; Nicholson, Garth/0000-0001-9694-066X; Kennerson, Marina/0000-0003-3332-5074				BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; Bodzioch M, 2001, HUM MUTAT, V17, DOI 10.1002/1098-1004(2001)17:1<72::AID-HUMU10>3.0.CO;2-X; Bolino A, 2000, NAT GENET, V25, P17, DOI 10.1038/75542; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DAVIS CJF, 1978, J GENET HUM, V26, P311; De Jonghe P, 1999, BRAIN, V122, P281, DOI 10.1093/brain/122.2.281; DYCK PJ, 1968, ARCH NEUROL-CHICAGO, V18, P619, DOI 10.1001/archneur.1968.00470360041003; Elson GCA, 1999, BIOCHEM BIOPH RES CO, V264, P55, DOI 10.1006/bbrc.1999.1481; Guilbot A, 2001, HUM MOL GENET, V10, P415, DOI 10.1093/hmg/10.4.415; HARDING AE, 1980, BRAIN, V103, P259, DOI 10.1093/brain/103.2.259; HAYASAKA K, 1993, GENOMICS, V17, P755, DOI 10.1006/geno.1993.1400; Houlden H, 2001, ANN NEUROL, V49, P521; Jodice C, 1997, HUM MOL GENET, V6, P1973, DOI 10.1093/hmg/6.11.1973; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kalaydjieva L, 2000, AM J HUM GENET, V67, P47, DOI 10.1086/302978; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEE SJ, 1991, P NATL ACAD SCI USA, V88, P4250, DOI 10.1073/pnas.88.10.4250; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Marrosu MG, 1998, NEUROLOGY, V50, P1397, DOI 10.1212/WNL.50.5.1397; Mastaglia FL, 1999, J NEUROL NEUROSUR PS, V67, P174, DOI 10.1136/jnnp.67.2.174; MATSUNAMI N, 1992, NAT GENET, V1, P176, DOI 10.1038/ng0692-176; Mersiyanova IV, 2000, AM J HUM GENET, V67, P37, DOI 10.1086/302962; Meuleman J, 2000, ACTA NEUROL BELG, V100, P171; NICHOLSON G, 1993, NEUROLOGY, V43, P2558, DOI 10.1212/WNL.43.12.2558; NICHOLSON GA, 1991, NEUROLOGY, V41, P547, DOI 10.1212/WNL.41.4.547; Nicholson GA, 1996, NAT GENET, V13, P101, DOI 10.1038/ng0596-101; Ophoff RA, 1996, EUR J HUM GENET, V4, P321; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; Reynolds DM, 2000, AM J HUM GENET, V67, P1598, DOI 10.1086/316904; ROSSI A, 1985, J NEUROL, V232, P91, DOI 10.1007/BF00313907; SALISACHS P, 1974, J NEUROL SCI, V23, P25, DOI 10.1016/0022-510X(74)90138-5; Senderek J, 2000, BRAIN PATHOL, V10, P235, DOI 10.1111/j.1750-3639.2000.tb00257.x; TIMMERMAN V, 1992, NAT GENET, V1, P171, DOI 10.1038/ng0692-171; VALENTIJN LJ, 1992, NAT GENET, V2, P288, DOI 10.1038/ng1292-288; VALENTIJN LJ, 1992, NAT GENET, V1, P166, DOI 10.1038/ng0692-166; Villanova M, 1998, NEUROMUSCULAR DISORD, V8, P392, DOI 10.1016/S0960-8966(98)00044-3; Warner LE, 1998, NAT GENET, V18, P382, DOI 10.1038/ng0498-382; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4	40	32	36	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2001	69	4					883	888		10.1086/323743	http://dx.doi.org/10.1086/323743			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	472WP	11533912	Green Published, Bronze			2022-12-18	WOS:000171008200021
J	Phornphutkul, C; Anikster, Y; Huizing, M; Braun, P; Brodie, C; Chou, JY; Gahl, WA				Phornphutkul, C; Anikster, Y; Huizing, M; Braun, P; Brodie, C; Chou, JY; Gahl, WA			The promoter of a lysosomal membrane transporter gene, CTNS, binds Sp-1, shares sequences with the promoter of an adjacent gene, carkl, and causes cystinosis if mutated in a critical region	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEPHROPATHIC CYSTINOSIS; CYSTEAMINE THERAPY; CORNEAL CRYSTALS; RENAL-FUNCTION; MUTATIONS; DISEASE; ACID; DELETION; CHILDREN; GROWTH	Although >55 CTNS mutations occur in patients with the lysosomal storage disorder cystinosis, no regulatory mutations have been reported, because the promoter has not been defined. Using CAT reporter constructs of sequences 5' to the CTNS coding sequence, we identified the CTNS promoter as the region encompassing nucleotides -316 to +1 with respect to the transcription start site. This region contains an Sp-1 regulatory element (GGCGGCG) at positions -299 to -293, which binds authentic Sp-1, as shown by electrophoretic-mobility-shift assays. Three patients exhibited mutations in the CTNS promoter. One patient with nephropathic cystinosis carried a -295 G -->C substitution disrupting the Sp-1 motif, whereas two patients with ocular cystinosis displayed a -303 G -->T substitution in one case and a -303 T insertion in the other case. Each mutation drastically reduced CAT activity when inserted into a reporter construct. Moreover, each failed either to cause a mobility shift when exposed to nuclear extract or to compete with the normal oligonucleotide's mobility shift. The CTNS promoter region shares 41 nucleotides with the promoter region of an adjacent gene of unknown function, CARKL, whose start site is 501 bp from the CTNS start site. However, the patients' CTNS promoter mutations have no effect on CARKL promoter activity. These findings suggest that the CTNS promoter region should be examined in patients with cystinosis who have fewer than two coding-sequence mutations.	NICHHD, Sect Human Biochem Genet, Heritable Disorders Branch, NIH, Bethesda, MD 20892 USA; Bar Ilan Univ, Ramat Gan, Israel	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Bar Ilan University	Gahl, WA (corresponding author), NICHHD, Sect Human Biochem Genet, Heritable Disorders Branch, NIH, 10 Ctr Dr,MSC 1830,Bldg 10,Room 9S-241, Bethesda, MD 20892 USA.		Huizing, Marjan/AAR-8860-2020					Ame JC, 2001, J BIOL CHEM, V276, P11092, DOI 10.1074/jbc.M007870200; Anikster Y, 1999, MOL GENET METAB, V66, P111, DOI 10.1006/mgme.1998.2790; Anikster Y, 2000, PEDIATR RES, V47, P17, DOI 10.1203/00006450-200001000-00007; Anikster Y, 1999, HUM MUTAT, V14, P454, DOI 10.1002/(SICI)1098-1004(199912)14:6<454::AID-HUMU2>3.0.CO;2-H; Attard M, 1999, HUM MOL GENET, V8, P2507, DOI 10.1093/hmg/8.13.2507; AULA P, 2001, METABOLIC MOL BASES, P5109; CHARNAS LR, 1991, NEW ENGL J MED, V324, P1318, DOI 10.1056/NEJM199105093241904; Forestier L, 1999, AM J HUM GENET, V65, P353, DOI 10.1086/302509; Gahl W, 2001, METABOLIC MOL BASES, P5085; GAHL WA, 1987, NEW ENGL J MED, V316, P971, DOI 10.1056/NEJM198704163161602; GAHL WA, 1987, PEDIATR NEPHROL, V1, P260, DOI 10.1007/BF00849221; GAHL WA, 1982, SCIENCE, V217, P1263, DOI 10.1126/science.7112129; Gahl WA, 2000, MOL GENET METAB, V71, P100, DOI 10.1006/mgme.2000.3062; KAISERKUPFER MI, 1987, NEW ENGL J MED, V316, P775, DOI 10.1056/NEJM198703263161304; KIMONIS VE, 1995, J CLIN ENDOCR METAB, V80, P3257, DOI 10.1210/jc.80.11.3257; KOIVISTO UM, 1994, P NATL ACAD SCI USA, V91, P10526, DOI 10.1073/pnas.91.22.10526; MARKELLO TC, 1993, NEW ENGL J MED, V328, P1157, DOI 10.1056/NEJM199304223281604; McGowan-Jordan J, 1999, EUR J HUM GENET, V7, P671, DOI 10.1038/sj.ejhg.5200349; RENLUND M, 1986, SCIENCE, V232, P759, DOI 10.1126/science.3961501; ROSENBLATT DS, 1985, SCIENCE, V228, P1319, DOI 10.1126/science.4001945; Shotelersuk V, 1998, AM J HUM GENET, V63, P1352, DOI 10.1086/302118; THEODOROPOULOS DS, 1993, JAMA-J AM MED ASSOC, V270, P2200, DOI 10.1001/jama.270.18.2200; Thoene J, 1999, MOL GENET METAB, V67, P283, DOI 10.1006/mgme.1999.2876; THOENE JG, 1992, PATHOPHYSIOLOGY LYSO; TIETZE F, 1989, J BIOL CHEM, V264, P15316; Touchman JW, 2000, GENOME RES, V10, P165, DOI 10.1101/gr.10.2.165; Town M, 1998, NAT GENET, V18, P319, DOI 10.1038/ng0498-319; Verheijen FW, 1999, NAT GENET, V23, P462, DOI 10.1038/70585	28	32	34	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2001	69	4					712	721		10.1086/323484	http://dx.doi.org/10.1086/323484			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	472WP	11505338	Green Published, Bronze			2022-12-18	WOS:000171008200005
J	Cervino, ACL; Hill, AVS				Cervino, ACL; Hill, AVS			Comparison of tests for association and linkage in incomplete families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSMISSION/DISEQUILIBRIUM TEST; NUCLEAR FAMILIES; PARENTAL DATA; SIBSHIP TEST; DISEQUILIBRIUM; TRANSMISSION; TDT	To analyze incomplete families, the following statistical tests can be used: LRAT-a simple likelihood-based association test, TRANSMIT, SIBASSOC/STDT, and RCTDT. We compared these four tests, for the diallelic case, on simulated data sets. The comparisons focused on the power to detect linkage and association when different familial structures, resistance to population stratification, resistance to misclassification of the disease status of the healthy sib, and the effect of nonpaternity were considered. The simulations lead to the following conclusions. The type I errors of TRANSMIT, STBASSOC/STDT, and RCTDT were not affected by population stratification. LRAT showed bias under strong population stratification. High nonpaternity rates can lead to inflated type I errors, highlighting the importance of identification of half sibs. Under different homogenous models, the power of TRANSMIT was very similar to that of LRAT, and, similarly, no difference in power was observed between SIBASSOC/ STDT and RCTDT Under various recessive and additive models, TRANSMIT was slightly more powerful than SIBASSOC/STDT when monoparental families with one affected and one unaffected sib were analyzed. Under various dominant models, SIBASSOC/STDT was slightly more powerful than TRANSMIT. Misclassification of the disease status of healthy sibs, as well as the discarding of incomplete families, resulted in a consistent loss of power.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	University of Oxford; Wellcome Centre for Human Genetics	Cervino, ACL (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.		HILL, Adrian V>S>/C-1306-2008					Boehnke M, 1998, AM J HUM GENET, V62, P950, DOI 10.1086/301787; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; Curtis D, 1997, ANN HUM GENET, V61, P319, DOI 10.1017/S000348009700626X; CURTIS D, 1995, AM J HUM GENET, V56, P811; EWENS WJ, 1995, AM J HUM GENET, V57, P455; Horvath S, 1998, AM J HUM GENET, V63, P1886, DOI 10.1086/302137; KNAPP M, 1993, AM J HUM GENET, V52, P1085; Knapp M, 1999, AM J HUM GENET, V64, P861, DOI 10.1086/302285; MEISNER S, 1999, THESIS OPEN U OXFORD; Monks SA, 1998, AM J HUM GENET, V63, P1507, DOI 10.1086/302104; Morris AP, 1997, ANN HUM GENET, V61, P49; Morris AP, 1997, ANN HUM GENET, V61, P335, DOI 10.1017/S0003480097006349; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; RUWENDE, 1996, THESIS OXFORD U OXFO; Schaid DJ, 1997, GENET EPIDEMIOL, V14, P1113, DOI 10.1002/(SICI)1098-2272(1997)14:6<1113::AID-GEPI92>3.0.CO;2-J; SCHAID DJ, 1994, AM J HUM GENET, V55, P402; Schaid DJ, 1996, GENET EPIDEMIOL, V13, P423, DOI 10.1002/(SICI)1098-2272(1996)13:5<423::AID-GEPI1>3.0.CO;2-3; SELF SG, 1991, BIOMETRICS, V47, P53, DOI 10.2307/2532495; Sham P., 1998, STAT HUMAN GENETICS; SHAM PC, 1995, ANN HUM GENET, V59, P323, DOI 10.1111/j.1469-1809.1995.tb00751.x; Spielman RS, 1996, AM J HUM GENET, V59, P983; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; Weinberg CR, 1999, AM J HUM GENET, V64, P1186, DOI 10.1086/302337	25	32	32	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2000	67	1					120	132		10.1086/302992	http://dx.doi.org/10.1086/302992			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	347JY	10841813	Bronze, Green Published			2022-12-18	WOS:000088926900015
J	Klutz, M; Horsthemke, B; Lohmann, DR				Klutz, M; Horsthemke, B; Lohmann, DR			RB1 gene mutations in peripheral blood DNA of patients with isolated unilateral retinoblastoma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							GERM-LINE MUTATIONS; HEREDITARY RETINOBLASTOMA; PENETRANCE		Univ Essen Gesamthsch Klinikum, Inst Humangenet, D-4300 Essen, Germany	University of Duisburg Essen	Lohmann, DR (corresponding author), Inst Humangenet, Hufelandstr 55, D-45122 Essen, Germany.		Lohmann, Dietmar R/B-4041-2013; Lohmann, Dietmar R./X-4895-2019	Lohmann, Dietmar R/0000-0002-2624-9889; Lohmann, Dietmar R./0000-0002-2624-9889				Bremner R, 1997, AM J HUM GENET, V61, P556, DOI 10.1086/515499; DRAPER GJ, 1992, BRIT J CANCER, V66, P211, DOI 10.1038/bjc.1992.244; Gallie BL, 1997, AM J HUM GENET, V61, P279, DOI 10.1086/514861; GREGER V, 1994, HUM GENET, V94, P491; HU QJ, 1990, EMBO J, V9, P1147, DOI 10.1002/j.1460-2075.1990.tb08221.x; Lohmann DR, 1996, AM J HUM GENET, V58, P940; Lohmann DR, 1997, AM J HUM GENET, V61, P282, DOI 10.1086/514845; Otterson GA, 1997, P NATL ACAD SCI USA, V94, P12036, DOI 10.1073/pnas.94.22.12036; Sippel KC, 1998, AM J HUM GENET, V62, P610, DOI 10.1086/301766; TOGUCHIDA J, 1993, GENOMICS, V17, P535, DOI 10.1006/geno.1993.1368; VOGEL F, 1979, HUM GENET, V52, P1; YANDELL DW, 1989, NEW ENGL J MED, V321, P1689, DOI 10.1056/NEJM198912213212501	12	32	34	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1999	64	2					667	668		10.1086/302254	http://dx.doi.org/10.1086/302254			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	169HA	9973307	Green Published, Bronze			2022-12-18	WOS:000078740600040
J	Loeben, GL; Marteau, TM; Wilfond, BS				Loeben, GL; Marteau, TM; Wilfond, BS			Mixed messages: Presentation of information in cystic fibrosis screening pamphlets	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRIMARY-CARE; POPULATION; PRACTITIONERS; PREFERENCES; CARRIERS; STEPWISE; IMPACT	Written pamphlets are an important source of information for individuals deciding whether to undergo carrier testing for cystic fibrosis (CF). Adequate understanding of the condition and reproductive options following the diagnosis of a fetus with CF are critical to informed decision making. The information given about CF and reproductive options in 28 pamphlets about carrier testing, from commercial and noncommercial organizations in the United States and the United Kingdom, aimed at prenatal and other populations, was assessed. The amount of information provided about CF showed a range of 1-37 sentences (median 6.5), with most being relatively neutral and with a minority conveying a positive or a negative image. Positive sentences were less common in British, U.S. commercial, and prenatal pamphlets. Statements about life expectancy also varied considerably, both in the ages provided and in the degree of optimism conveyed. In addition, the pamphlets varied in the amount of information they provided about reproductive options following the diagnosis of a fetus with CE Abortion was mentioned in just 15 pamphlets, more often in the United Kingdom than in the United States and more frequently in pamphlets from noncommercial than in those from commercial organizations. Wide variation in the descriptions of CF and the reproductive options presented raises concerns about the extent to which any one pamphlet may present balanced information. The choices about what information to include in educational materials need to be explicitly considered on the basis of the message intended to be sent.	Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA; Univ London, United Med & Dent Sch Guys & St Thomas Hosp, Psychol & Genet Res Grp, London, England; Univ Arizona, Dept Pediat, Tucson, AZ USA	University of Pennsylvania; Pennsylvania Medicine; University of London; King's College London; University of Arizona	Wilfond, BS (corresponding author), NHGRI, 9000 Rockville Pike,Bldg 10,Room 1C123, Bethesda, MD 20892 USA.	Wilfond@nhgri.nih.gov		Marteau, Theresa/0000-0003-3025-1129	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R29HS008570] Funding Source: NIH RePORTER; AHRQ HHS [R29 HS08570] Funding Source: Medline; Wellcome Trust Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Wellcome Trust(Wellcome TrustEuropean Commission)		Axworthy D, 1996, LANCET, V347, P1443; BEKKER H, 1993, BRIT MED J, V306, P1584, DOI 10.1136/bmj.306.6892.1584; BEKKER H, 1994, J MED GENET, V31, P364, DOI 10.1136/jmg.31.5.364; Bernhardt BA, 1996, ARCH FAM MED, V5, P336, DOI 10.1001/archfami.5.6.336; Bernstein T, 1994, RADON RENTAL HOUSING; Cho MK, 1997, AM J MED GENET, V73, P314, DOI 10.1002/(SICI)1096-8628(19971219)73:3<314::AID-AJMG16>3.0.CO;2-M; Clayton EW, 1996, AM J HUM GENET, V58, P617; CLAYTON EW, 1995, AM J HUM GENET, V57, P171; *CYST FIBR FDN, 1997, PAT REG 1996 ANN DAT; Doherty RA, 1996, PRENATAL DIAG, V16, P397, DOI 10.1002/(SICI)1097-0223(199605)16:5<397::AID-PD864>3.0.CO;2-I; FIGUEIRAS M, IN PRESS HLTH PSYCHO; Grody WW, 1997, AM J HUM GENET, V60, P935; HARRIS H, 1993, BRIT MED J, V306, P1580, DOI 10.1136/bmj.306.6892.1580; HOLTZMAN NA, 1997, PROMOTING SAFE EFFEC, P99; Holtzman NA, 1997, PROMOTING SAFE EFFEC; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Loader S, 1996, AM J HUM GENET, V59, P234; Marteau TM, 1998, BMJ-BRIT MED J, V316, P693, DOI 10.1136/bmj.316.7132.693; MCNEIL BJ, 1982, NEW ENGL J MED, V306, P1259, DOI 10.1056/NEJM198205273062103; MENNIE M, 1993, CLIN GENET, V44, P102; MENNIE ME, 1992, J MED GENET, V29, P308, DOI 10.1136/jmg.29.5.308; MENNIE ME, 1993, PRENATAL DIAG, V13, P807, DOI 10.1002/pd.1970130904; MIEDZYBRODZKA Z, 1995, J MED GENET, V32, P282, DOI 10.1136/jmg.32.4.282; MIEDZYBRODZKA ZH, 1995, BRIT MED J, V310, P353, DOI 10.1136/bmj.310.6976.353; NANCE WE, 1992, AM J HUM GENET, V51, P1443; *NAT I HLTH, 1997, STAT CONS DEV C GEN; Payne Y, 1997, CLIN GENET, V51, P153; *PC STUD ETH PROBL, 1983, SCREEN COUNS GEN CON; Sorenson JR, 1997, AM J MED GENET, V70, P121, DOI 10.1002/(SICI)1096-8628(19970516)70:2<121::AID-AJMG4>3.0.CO;2-0; TAMBOR ES, 1994, AM J HUM GENET, V55, P626; WATSON EK, 1992, LANCET, V340, P217, DOI 10.1016/0140-6736(92)90477-K; WILFOND BS, 1993, JAMA-J AM MED ASSOC, V270, P2948, DOI 10.1001/jama.270.24.2948; Witt DR, 1996, AM J HUM GENET, V58, P823; *WORKSH POP SCREEN, 1990, NEW ENGL J MED, V323, P70	34	32	32	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1998	63	4					1181	1189		10.1086/302036	http://dx.doi.org/10.1086/302036			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	131LP	9758594	hybrid, Green Published			2022-12-18	WOS:000076577800032
J	Germain, DP; Puech, JP; Caillaud, C; Kahn, A; Poenaru, L				Germain, DP; Puech, JP; Caillaud, C; Kahn, A; Poenaru, L			Exhaustive screening of the acid beta-glucosidase gene, by fluorescence-assisted mismatch analysis using universal primers: Mutation profile and genotype/phenotype correlations in Gaucher disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN GLUCOCEREBROSIDASE GENE; CHEMICAL CLEAVAGE; JEWISH; HETEROGENEITY; GENOTYPE; DNA; POPULATION; PSEUDOGENE; PHENOTYPES; DIAGNOSIS	Gaucher disease (GD) is one of the most prevalent lysosomal storage disorders and one of the rare genetic diseases now accessible to therapy. Outside the Ashkenazi Jewish community, a high molecular diversity is observed, leaving similar to 30% of alleles undetected. Nevertheless, very few exhaustive methods have been developed for extensive gene screening of a large series of patients. Our approach for a complete search of mutations was the association of fluorescent chemical cleavage of mismatches with a universal strand-specific labeling system. The glucocerebrosidase (GBA) gene was scanned by use of a set of six amplicons, comprising 11 exons, all exon/intron boundaries, and the promoter region. By use of this screening strategy, the difficulties due to the existence of a highly homologous pseudogene were easily overcome, and both GD mutant alleles were identified in all 25 patients studied, thus attesting to a sensitivity that approaches 100%. A total of 18 different mutations and a new glucocerebrosidase haplotype were detected. The mutational spectrum included eight novel acid beta-glucosidase mutations: IVS2 G(+1)-->T, I119T, R170P, N188K, S237P, K303I, L324P, and A446P. These data further indicate the genetic heterogeneity of the lesions causing GD. Established genotype/phenotype correlations generally were confirmed, but notable disparities were disclosed in several cases, thus underlining the limitation in the prognostic value of genotyping. The observed influence of multifactorial control on this monogenic disease is discussed.	Univ Paris 05, Hop Cochin, Inst Cochin Genet Mol, INSERM,U129, Paris, France; Univ Paris 05, Lab Genet & Pathol Metab, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Germain, DP (corresponding author), CHU Cochin Port Royal, INSERM, U129, 24 Rue Faubourg St Jacques, F-75014 Paris, France.	germain@cochin.inserm.fr	GERMAIN, Dominique P./AAD-6747-2020	GERMAIN, Dominique/0000-0002-8355-007X				ABRAHAMOV A, 1995, LANCET, V346, P1000, DOI 10.1016/S0140-6736(95)91688-1; AMARAL O, 1994, J MED GENET, V31, P401, DOI 10.1136/jmg.31.5.401; Beutler E, 1996, HUM MUTAT, V8, P207, DOI 10.1002/(SICI)1098-1004(1996)8:3<207::AID-HUMU2>3.0.CO;2-6; BEUTLER E, 1992, GENOMICS, V12, P795, DOI 10.1016/0888-7543(92)90311-F; BEUTLER E, 1993, BRIT J HAEMATOL, V85, P401, DOI 10.1111/j.1365-2141.1993.tb03185.x; BEUTLER E, 1993, AM J HUM GENET, V52, P85; Beutler E., 1995, METABOLIC MOL BASES, P2641; Boot RG, 1997, HUM MUTAT, V10, P348, DOI 10.1002/(SICI)1098-1004(1997)10:5<348::AID-HUMU3>3.0.CO;2-B; BRADY RO, 1993, ARCH NEUROL-CHICAGO, V50, P1212, DOI 10.1001/archneur.1993.00540110088009; Choy FYM, 1997, AM J MED GENET, V71, P172, DOI 10.1002/(SICI)1096-8628(19970808)71:2<172::AID-AJMG10>3.0.CO;2-B; CORMAND B, 1995, HUM MUTAT, V5, P303, DOI 10.1002/humu.1380050406; Cotton RGH, 1997, TRENDS GENET, V13, P43, DOI 10.1016/S0168-9525(97)01011-1; COTTON RGH, 1988, P NATL ACAD SCI USA, V85, P4397, DOI 10.1073/pnas.85.12.4397; Cuppens H, 1998, J CLIN INVEST, V101, P487, DOI 10.1172/JCI639; DANIELS LB, 1982, CLIN CHEM, V28, P569; DIANZANI I, 1991, AM J HUM GENET, V48, P423; Durand P, 1997, GLYCOBIOLOGY, V7, P277, DOI 10.1093/glycob/7.2.277; FEREC C, 1992, NAT GENET, V1, P188, DOI 10.1038/ng0692-188; Germain D, 1996, HUM GENET, V98, P719, DOI 10.1007/s004390050292; Grabowski GA, 1996, CRIT REV ONCOL HEMAT, V23, P25, DOI 10.1016/1040-8428(96)00199-0; Grace ME, 1997, J CLIN INVEST, V99, P2530, DOI 10.1172/JCI119437; GRIFFAIS R, 1991, NUCLEIC ACIDS RES, V19, P3887; GROMPE M, 1993, NAT GENET, V5, P111, DOI 10.1038/ng1093-111; HE GS, 1992, AM J HUM GENET, V51, P810; HENRISSAT B, 1995, P NATL ACAD SCI USA, V92, P7090, DOI 10.1073/pnas.92.15.7090; HOROWITZ M, 1993, AM J HUM GENET, V53, P921; HOROWITZ M, 1989, GENOMICS, V4, P87, DOI 10.1016/0888-7543(89)90319-4; IDA H, 1995, HUM GENET, V95, P717; KIESEWETTER S, 1993, NAT GENET, V5, P274, DOI 10.1038/ng1193-274; KWOK PY, 1994, GENOMICS, V23, P138, DOI 10.1006/geno.1994.1469; LATHAM T, 1990, AM J HUM GENET, V47, P79; LATHAM TE, 1991, DNA CELL BIOL, V10, P15, DOI 10.1089/dna.1991.10.15; leCoutre P, 1997, HUM GENET, V99, P816, DOI 10.1007/s004390050454; McCabe ERB, 1996, JAMA-J AM MED ASSOC, V275, P548, DOI 10.1001/jama.1996.03530310054033; MIAO SC, 1994, J BIOL CHEM, V269, P10975; Moran D, 1997, GENE, V194, P201, DOI 10.1016/S0378-1119(97)00148-0; ONEILL RR, 1989, P NATL ACAD SCI USA, V86, P5049, DOI 10.1073/pnas.86.13.5049; PasmanikChor M, 1997, HUM MOL GENET, V6, P887, DOI 10.1093/hmg/6.6.887; PHELPS RS, 1995, BIOTECHNIQUES, V19, P984; Rowley G, 1995, GENOMICS, V30, P574, DOI 10.1006/geno.1995.1279; Rozmahel R, 1996, NAT GENET, V12, P280, DOI 10.1038/ng0396-280; RUTLAND P, 1995, NAT GENET, V9, P173, DOI 10.1038/ng0295-173; SAVOV A, 1995, HUM MOL GENET, V4, P1169, DOI 10.1093/hmg/4.7.1169; Serjeant GR, 1997, LANCET, V350, P725, DOI 10.1016/S0140-6736(97)07330-3; SIBILLE A, 1993, AM J HUM GENET, V52, P1094; SIDRANSKY E, 1993, JAMA-J AM MED ASSOC, V269, P1154, DOI 10.1001/jama.269.9.1154; SORJE J, 1985, P NATL ACAD SCI USA, V82, P7289; Tayebi N, 1996, AM J HUM GENET, V59, P740; Verpy E, 1996, AM J HUM GENET, V59, P308; VERPY E, 1994, P NATL ACAD SCI USA, V91, P1873, DOI 10.1073/pnas.91.5.1873; WINFIELD SL, 1997, GENOME RES, V7, P10120; Wolf U, 1997, HUM GENET, V100, P305, DOI 10.1007/s004390050509; Zimran A, 1995, PRENATAL DIAG, V15, P1185, DOI 10.1002/pd.1970151219	53	32	35	0	2	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1998	63	2					415	427		10.1086/301969	http://dx.doi.org/10.1086/301969			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110CB	9683600	Green Published, Bronze			2022-12-18	WOS:000075360800017
J	Vieland, VJ; Huang, J				Vieland, VJ; Huang, J			Statistical evaluation of age-at-onset anticipation: A new test and evaluation of its behavior in realistic applications	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ASCERTAINMENT; DISORDER; DISEASE; MODELS; BIAS	The discovery that microsatellite repeat expansions can cause clinical disease has fostered renewed interest in testing for age-at-onset anticipation (AOA). A commonly used procedure is to sample affected parent-child pairs (APCPs) from available data sets and to test for a difference in mean age at onset between the parents and the children. However, standard statistical methods fail to take into account the right truncation of both the parent and child age-at-onset distributions under this design, with the result that type I error rates can be inflated substantially. Previously, we had introduced a new test, based on the correct, bivariate right-truncated, age-at-onset distribution. We showed that this test has the correct type I error rate for random APCPs, even for quite small samples. However, in that paper, we did not consider two key statistical complications that arise when the test is applied to realistic data. First, affected pairs usually are sampled from pedigrees preferentially selected for the presence of multiple affected individuals. In this paper, we show that this will tend to inflate the type I error rate of the test. Second, we consider the appropriate probability model under the alternative hypothesis of true AOA due to an expanding microsatellite mechanism, and we show that there is good reason to believe that the power to detect AOA may be quite small, even for substantial effect sizes. When the type I error rate of the test is high relative to the power, interpretation of test results becomes problematic. We conclude that, in many applications, AOA tests based on APCPs may not yield meaningful results.	Univ Iowa, Coll Med, Dept Prevent Med, Div Biostat & Psychiat, Iowa City, IA 52242 USA; Univ Iowa, Dept Stat & Actuarial Sci, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Vieland, VJ (corresponding author), Univ Iowa, Coll Med, Dept Prevent Med, Div Biostat & Psychiat, 2800 SB, Iowa City, IA 52242 USA.			HUANG, Jian/0000-0002-5218-9269	PHS HHS [K02-01432, R01-55378, R01-48858] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BASSETT AS, 1994, AM J HUM GENET, V54, P864; Bassett AS, 1997, AM J HUM GENET, V60, P630; BONIFATI V, 1995, CAN J NEUROL SCI, V22, P272, DOI 10.1017/S0317167100039469; Brinkman RR, 1997, AM J HUM GENET, V60, P1202; EWENS WJ, 1982, AM J HUM GENET, V34, P853; Heiman GA, 1996, PSYCHIAT GENET, V6, P61, DOI 10.1097/00041444-199622000-00005; HEIMBUCH RC, 1980, AM J HUM GENET, V32, P564; HODGE SE, 1988, AM J HUM GENET, V43, P364; Hodge SE, 1996, GENETICS, V144, P1215; HODGE SE, 1995, PSYCHIATR GENET, V5, P43, DOI 10.1097/00041444-199521000-00007; HODGE SE, 1985, AM J HUM GENET, V37, P166; Horwitz M, 1996, AM J HUM GENET, V59, P990; Huang JA, 1997, GENET EPIDEMIOL, V14, P1091, DOI 10.1002/(SICI)1098-2272(1997)14:6<1091::AID-GEPI88>3.0.CO;2-C; KALBFLEI.JD, 1970, J ROY STAT SOC B, V32, P175; MCINNIS MG, 1993, AM J HUM GENET, V53, P385; McInnis MG, 1996, AM J HUM GENET, V59, P973; MORTON NE, 1959, AM J HUM GENET, V11, P1; MYERS RH, 1985, AM J HUM GENET, V37, P511; Paterson AD, 1996, AM J HUM GENET, V59, P264; PENROSE LS, 1948, ANN EUGENIC, V14, P125; Slager SL, 1997, GENET EPIDEMIOL, V14, P1119, DOI 10.1002/(SICI)1098-2272(1997)14:6<1119::AID-GEPI93>3.0.CO;2-J; STENE J, 1977, BIOMETRICS, V33, P523, DOI 10.2307/2529367; Stuart A., 1991, KENDALLS ADV THEORY, V2; VIELAND VJ, 1995, AM J HUM GENET, V56, P33; Vieland VJ, 1996, AM J HUM GENET, V58, P1072; Wald A, 1943, T AM MATH SOC, V54, P426, DOI 10.2307/1990256; ZATZ M, 1995, AM J HUM GENET, V56, P99	27	32	32	0	2	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1998	62	5					1212	1227		10.1086/301823	http://dx.doi.org/10.1086/301823			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZL922	9545393	Green Published, Bronze			2022-12-18	WOS:000073487000026
J	Howard, TD; Guttmacher, AE; McKinnon, W; Sharma, M; McKusick, VA; Jabs, EW				Howard, TD; Guttmacher, AE; McKinnon, W; Sharma, M; McKusick, VA; Jabs, EW			Autosomal dominant postaxial polydactyly, nail dystrophy, and dental abnormalities map to chromosome 4p16, in the region containing the Ellis-van Creveld syndrome locus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GROWTH-FACTOR RECEPTOR-3; VANCREVELD-SYNDROME; EPIDERMOLYSIS-BULLOSA; MISSENSE MUTATION; CPG DINUCLEOTIDES; THYROID-HORMONE; HOMEOBOX GENE; VII COLLAGEN; BETA-GENE; DOMAIN	We have studied a four-generation family with features of Weyers acrofacial dysostosis, in which the proband has a more severe phenotype, resembling Ellis-van Creveld syndrome. Weyers acrofacial dysostosis is an autosomal dominant condition with dental anomalies, nail dystrophy, postaxial polydactyly, and mild short stature. Ellis-van Creveld syndrome is a similar condition, with autosomal recessive inheritance and the additional features of disproportionate dwarfism, thoracic dysplasia, and congenital heart disease. Linkage and haplotype analysis determined that the disease locus in this pedigree resides on chromosome 4p16, distal to the genetic marker D4S3007 and within a 17-cM region flanking the genetic locus D4S2366. This region includes the Ellis-van Creveld syndrome locus, which previously was reported to map within a 3-cM region between genetic markers D4S2957 and D4S827. Either the genes for the condition in our family and for Ellis-van Creveld syndrome are near one another or these two conditions are allelic with mutations in the same gene. These data also raise the possibility that Weyers acrofacial dysostosis is the heterozygous expression of a mutation that, in homozygous form, causes the autosomal recessive disorder Ellis-van Creveld syndrome.	Johns Hopkins Univ, Sch Med, Ctr Genet Med, Dept Pediat, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Ctr Genet Med, Dept Surg, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Ctr Genet Med, Dept Med, Baltimore, MD 21287 USA; Univ Vermont, Coll Med, Vermont Reg Genet Ctr, Dept Pediat, Burlington, VT USA; Univ Vermont, Coll Med, Vermont Reg Genet Ctr, Dept Med, Burlington, VT USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Vermont; University of Vermont	Jabs, EW (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Genet Med, Dept Pediat, 600 N Wolfe St, Baltimore, MD 21287 USA.			Jabs, Ethylin/0000-0001-8983-5466	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE011131, R01DE010180] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00722] Funding Source: Medline; NIDCR NIH HHS [DE10180, DE11131] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		BELLUS GA, 1995, NAT GENET, V10, P357, DOI 10.1038/ng0795-357; Bellus GA, 1996, NAT GENET, V14, P174, DOI 10.1038/ng1096-174; BIGGERSTAFF RH, 1968, J AM DENT ASSOC, V77, P1090, DOI 10.14219/jada.archive.1968.0342; CHRISTIANO AM, 1993, NAT GENET, V4, P62, DOI 10.1038/ng0593-62; CHRISTIANO AM, 1994, P NATL ACAD SCI USA, V91, P3549, DOI 10.1073/pnas.91.9.3549; Curry C J, 1979, Birth Defects Orig Artic Ser, V15, P253; DeBry RW, 1996, GENOMICS, V33, P337, DOI 10.1006/geno.1996.0209; DePaepe A, 1997, HUM GENET, V99, P478; ELLIS RICHARD W. B., 1940, ARCH DIS CHILDHOOD [LONDON], V15, P65; FRYNS JP, 1991, AM J MED GENET, V39, P500, DOI 10.1002/ajmg.1320390430; GOLDBLATT J, 1992, MED J AUSTRALIA, V157, P271, DOI 10.5694/j.1326-5377.1992.tb137137.x; Gorlin RJ, 1990, PLAST RECONSTR SURG; HAYASHI Y, 1994, J CLIN INVEST, V94, P607, DOI 10.1172/JCI117376; HEWITT JE, 1991, GENOMICS, V11, P670, DOI 10.1016/0888-7543(91)90074-O; Ide SE, 1996, HUM GENET, V98, P572, DOI 10.1007/s004390050261; JEUNE M, 1955, Arch Fr Pediatr, V12, P886; LANGER L O JR, 1969, Birth Defects Original Article Series, V5, P55; MacKenzie A, 1997, MECH DEVELOP, V62, P29, DOI 10.1016/S0925-4773(96)00646-6; MCKUSICK VA, 1964, B JOHNS HOPKINS HOSP, V115, P306; MEYERS GA, 1995, NAT GENET, V11, P462, DOI 10.1038/ng1295-462; Ott J., 1991, ANAL HUMAN GENETIC L; PIRNAR T, 1966, AMER J ROENTGENOL RA, V98, P358, DOI 10.2214/ajr.98.2.358; Polymeropoulos MH, 1996, GENOMICS, V35, P1, DOI 10.1006/geno.1996.0315; PRUCHNO CJ, 1991, HUM GENET, V87, P33, DOI 10.1007/BF01213088; Radhakrishna U, 1997, AM J HUM GENET, V60, P597; ROBERT B, 1989, EMBO J, V8, P91, DOI 10.1002/j.1460-2075.1989.tb03352.x; ROSENFELD PJ, 1992, NAT GENET, V1, P209, DOI 10.1038/ng0692-209; ROUBICEK M, 1984, CLIN GENET, V26, P587; Rousseau F, 1996, HUM MOL GENET, V5, P509, DOI 10.1093/hmg/5.4.509; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; SHAPIRO SD, 1984, AM J MED GENET, V17, P579, DOI 10.1002/ajmg.1320170305; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; SPRANGER S, 1995, CLIN GENET, V47, P217; TAKEDA K, 1992, J CLIN ENDOCR METAB, V74, P49, DOI 10.1210/jc.74.1.49; TAVORMINA PL, 1995, NAT GENET, V9, P321, DOI 10.1038/ng0395-321; TAYLOR GA, 1984, RADIOLOGY, V151, P393, DOI 10.1148/radiology.151.2.6709909; THEIN SL, 1990, P NATL ACAD SCI USA, V87, P3924, DOI 10.1073/pnas.87.10.3924; THOMPSON LM, 1991, GENOMICS, V11, P1133, DOI 10.1016/0888-7543(91)90041-C; Vastardis H, 1996, NAT GENET, V13, P417, DOI 10.1038/ng0896-417; WEYERS H, 1952, Fortschr Geb Rontgenstr, V77, P562; ZIMMERMAN TS, 1987, HUM PATHOL, V18, P140, DOI 10.1016/S0046-8177(87)80332-5	41	32	32	0	2	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1997	61	6					1405	1412		10.1086/301643	http://dx.doi.org/10.1086/301643			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YT019	9399901	Green Published, Bronze			2022-12-18	WOS:000071555900025
J	Marazita, ML; Neiswanger, K; Cooper, M; Zubenko, GS; Giles, DE; Frank, E; Kupfer, DJ; Kaplan, BB				Marazita, ML; Neiswanger, K; Cooper, M; Zubenko, GS; Giles, DE; Frank, E; Kupfer, DJ; Kaplan, BB			Genetic segregation analysis of early-onset recurrent unipolar depression	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AFFECTIVE-DISORDERS; PSYCHIATRIC-DISORDERS; MAJOR DEPRESSION; DIAGNOSTIC-CRITERIA; LINKAGE ANALYSES; BIPOLAR-I; FAMILY; PROBANDS; MODELS; TRANSMISSION	Major depression is a relatively common psychiatric disorder that can be quite debilitating. Family, twin, and adoption studies indicate that unipolar depression has both genetic and environmental components. Early age at onset and recurrent episodes in the proband each increase the familiality of the illness. To investigate the potential genetic underpinnings of the disease, we have performed a complex segregation analysis on 832 individuals from 50 multigenerational families ascertained through a proband with early-onset recurrent unipolar major depression. The analysis was conducted by use of regressive models, to test a variety of hypotheses to explain the familial aggregation of recurrent unipolar depression. Analyses were conducted under two alternative definitions of affection status for the relatives of probands: (1) "narrow," in which relatives were assumed to be affected only if they were diagnosed with recurrent unipolar depression; and (2) "broad," in which relatives were assumed to be affected if diagnosed with any major affective illness. Under the narrow-definition assumption, the model that best explains these family data is a transmitted (although non-Mendelian) recessive major effect with significant residual parental effects on affection status. Under the broad-definition assumption, the best-fitting model is a Mendelian codominant major locus with significant residual parental and spousal effects.	Univ Pittsburgh, Sch Dent Med, Cleft Palate Craniofacial Ctr, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Dept Oral Maxillofacial Surg, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Med Ctr, Dept Psychiat, Pittsburgh, PA 15261 USA; Univ Rochester, Dept Neurol, Rochester, NY USA; Univ Rochester, Dept Psychiat, Rochester, NY USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Rochester; University of Rochester	Marazita, ML (corresponding author), Univ Pittsburgh, Sch Dent Med, Cleft Palate Craniofacial Ctr, 317 Salk Hall,3501 Terr St, Pittsburgh, PA 15261 USA.	mlm3@vms.cis.pitt.edu			NCRR NIH HHS [1-P41-RR03655] Funding Source: Medline; NIMH NIH HHS [MH30915, MH29618] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH030915, P50MH030915, R37MH029618, R01MH029618] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Akaike H, 1974, IEEE T AUTOMATIC CON, V19, P616; American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; BLAND RC, 1986, ARCH GEN PSYCHIAT, V43, P1085; BONNEY GE, 1984, AM J MED GENET, V18, P731, DOI 10.1002/ajmg.1320180420; BONNEY GE, 1986, BIOMETRICS, V42, P348; BOYD JH, 1981, ARCH GEN PSYCHIAT, V38, P1039; CADORET R, 1978, AM J PSYCHIAT, V133, P463; CANNINGS C, 1978, ADV APPL PROBAB, V10, P26, DOI 10.2307/1426718; COX N, 1989, J PSYCHIAT RES, V23, P109, DOI 10.1016/0022-3956(89)90002-2; CROWE RR, 1981, NEUROPSYCHOBIOLOGY, V7, P20, DOI 10.1159/000117829; DEMENAIS FM, 1991, AM J HUM GENET, V49, P773; Endicott J, 1975, FAMILY HIST RES DIAG; ENGLUND SA, 1990, J AFFECT DISORDERS, V18, P247, DOI 10.1016/0165-0327(90)90075-J; GERSHON ES, 1982, ARCH GEN PSYCHIAT, V39, P1157; GILES DE, 1988, J AFFECT DISORDERS, V14, P51, DOI 10.1016/0165-0327(88)90071-7; GILES DE, 1989, PSYCHIAT RES, V27, P127, DOI 10.1016/0165-1781(89)90128-5; GO RCP, 1978, AM J HUM GENET, V30, P28; GOLDIN LR, 1983, AM J HUM GENET, V35, P274; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; KUPFER DJ, 1989, J AFFECT DISORDERS, V17, P113, DOI 10.1016/0165-0327(89)90033-5; LUSTBADER ED, 1992, AM J HUM GENET, V51, P344; PAULS DL, 1995, AM J MED GENET, V60, P290, DOI 10.1002/ajmg.1320600406; PRICE RA, 1985, J PSYCHIAT RES, V19, P533, DOI 10.1016/0022-3956(85)90071-8; PRICE RA, 1987, ARCH GEN PSYCHIAT, V44, P434; Puig-Antich J., 1980, SCHEDULE AFFECTIVE D; RICE J, 1987, ARCH GEN PSYCHIAT, V44, P441; *SAGE, 1994, STAT AN GEN EP REL 2; SHAM PC, 1991, PSYCHIAT GENET, V2, P175, DOI DOI 10.1097/00041444-199203000-00002; SHELINE YI, 1995, BIOL PSYCHIAT, V37, P442, DOI 10.1016/0006-3223(94)00160-5; SORANT AJM, 1994, STAT ANAL GENETIC EP; SPENCE MA, 1995, AM J MED GENET, V60, P370, DOI 10.1002/ajmg.1320600505; Spitzer R.L., 1975, SCHEDULE AFFECTIVE D; SPITZER RL, 1978, ARCH GEN PSYCHIAT, V35, P773, DOI 10.1001/archpsyc.1978.01770300115013; TORGERSEN S, 1986, ARCH GEN PSYCHIAT, V43, P222; TSUANG MT, 1985, J PSYCHIAT RES, V19, P23, DOI 10.1016/0022-3956(85)90065-2; WEISSMAN MM, 1986, ARCH GEN PSYCHIAT, V43, P430; WEISSMAN MM, 1984, ARCH GEN PSYCHIAT, V41, P1136; WEISSMAN MM, 1984, ARCH GEN PSYCHIAT, V41, P13; Weissman MM, 1991, PSYCHIAT DISORDERS A, P53; WENDER PH, 1986, ARCH GEN PSYCHIAT, V43, P923	40	32	35	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1997	61	6					1370	1378		10.1086/301627	http://dx.doi.org/10.1086/301627			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	YT019	9399885	Bronze, Green Published			2022-12-18	WOS:000071555900021
J	Duffy, DL				Duffy, DL			Sib-pair: a program for non-parametric linkage/association analysis.	AMERICAN JOURNAL OF HUMAN GENETICS			English	Meeting Abstract									Queensland Inst Med Res, Brisbane, Qld 4006, Australia	QIMR Berghofer Medical Research Institute			Duffy, David L/B-7392-2013	Duffy, David L/0000-0001-7227-632X					0	32	32	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1997	61	4		S		1140	A197	A197						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YQ995					2022-12-18	WOS:000071446001142
J	Dietz, HC				Dietz, HC			Nonsense mutations and altered splice-site selection	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									JOHNS HOPKINS UNIV,SCH MED,DEPT MED,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT MOL BIOL & GENET,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University	Dietz, HC (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,CTR MED GENET,ROSS 1170,720 RUTLAND AVE,BALTIMORE,MD 21205, USA.							Aoufouchi S, 1996, CELL, V85, P415, DOI 10.1016/S0092-8674(00)81119-8; DIETZ HC, 1994, NAT GENET, V8, P183, DOI 10.1038/ng1094-183; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; LOZANO F, 1994, EMBO J, V13, P4617, DOI 10.1002/j.1460-2075.1994.tb06783.x; Maquat LE, 1996, AM J HUM GENET, V59, P279; Perlick HA, 1996, P NATL ACAD SCI USA, V93, P10928, DOI 10.1073/pnas.93.20.10928	6	32	32	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1997	60	3					729	730						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK403	9042933				2022-12-18	WOS:A1997WK40300030
J	Bernhardt, BA				Bernhardt, BA			Empirical evidence that genetic counseling is directive: Where do we go from here?	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							ATTITUDES				Bernhardt, BA (corresponding author), JOHNS HOPKINS MED INST,550 N BROADWAY,SUITE 511,BALTIMORE,MD 21205, USA.							Brunger F, 1995, J Genet Couns, V4, P151, DOI 10.1007/BF01408406; BURKE BM, 1994, WOMEN HEALTH, V22, P31; CAPLAN AL, 1993, PRESCRIBING OUR FUTU, P149; CLARKE A, 1991, LANCET, V338, P998, DOI 10.1016/0140-6736(91)91849-P; FURU T, 1993, CLIN GENET, V43, P160, DOI 10.1111/j.1399-0004.1993.tb04463.x; GELLER G, 1995, QUAL HEALTH RES, V5, P97, DOI 10.1177/104973239500500107; Holtzman N. A., 1996, American Journal of Human Genetics, V59, pA56; Kessler Seymour, 1992, J Genet Couns, V1, P9, DOI 10.1007/BF00960080; MARINER WK, 1994, AM J LAW MED, V20, P37; Michie S, 1997, AM J HUM GENET, V60, P40; Pencarinha Deborah F, 1992, J Genet Couns, V1, P19, DOI 10.1007/BF00960081; ROTER D, 1987, PATIENT EDUC COUNS, V9, P25, DOI 10.1016/0738-3991(87)90106-6; Shiloh S, 1996, TROUBLED HELIX SOCIA, P82, DOI DOI 10.1017/CBO9780511570049; SHILOH S, 1989, PSYCHOL HEALTH, V3, P45, DOI DOI 10.1080/08870448908400365; THOMPSON SC, 1993, PATIENT EDUC COUNS, V22, P133, DOI 10.1016/0738-3991(93)90093-C; WERTZ DC, 1988, AM J HUM GENET, V42, P592; Wertz Dorothy C, 1987, Inf Behav, V2, P329; WOLFSON PS, 1995, J ENVIRON PERMITTING, V4, P3	18	32	33	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1997	60	1					17	20						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	WA818	8981942				2022-12-18	WOS:A1997WA81800005
J	LaBuda, MC; Maldonado, M; Marshall, D; Otten, K; Gerhard, DS				LaBuda, MC; Maldonado, M; Marshall, D; Otten, K; Gerhard, DS			A follow-up report of a genome search for affective disorder predisposition loci in the old order Amish	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BIPOLAR AFFECTIVE-DISORDER; MANIC-DEPRESSIVE ILLNESS; OXIDASE-A GENE; X-CHROMOSOME MARKERS; MONOAMINE-OXIDASE; LINKAGE ANALYSIS; DNA MARKERS; SEGREGATION ANALYSIS; SUSCEPTIBILITY GENE; FAMILY DATA	Progress of a full-genome scan for predisposition loci for affective disorder in the Old Order Amish is reported. LOD-score results have been previously published for 51 loci on chromosomes 1 and 11, collectively. The present report contains results for an additional 367 loci throughout the genome with extensive coverage on chromosomes 1, 2, 3, 4, 6, 7, 9, 10, 13, 14, 18, 19, and 21 (average marker density for these chromosomes = 10.7 cM). Analyses were conducted in a four-stage process: (1) two-point LOD scores were calculated for all loci under a dominant model with reduced penetrance, consistent with results of segregation analyses of these pedigrees; (2) a screen for the sharing of alleles in similarly affected individuals was used to highlight areas potentially important for further analysis; (3) the preceding areas and markers on densely covered chromosomes were analyzed using the affected-pedigree-member (APM) method; and (4) the sharing of extended haplotypes in affected individuals was examined in areas showing apparent clustering of significant allele sharing as assessed by the APM method. Of the 367 markers analyzed, no statistically significant LOD scores resulted. Some degree (P < .05) of allele sharing was found at 74 loci, and 3.8% of all markers analyzed (N = 14) passed more stringent significance criteria suggestive of linkage (P less than or equal to .001 for at least one of the weighting functions). Multilocus APM and detailed exploration of extended haplotype sharing in areas highlighted by the APM analyses provided methods for more informative exploration of potentially suggestive results but did not identify areas clearly involved in the etiology of affective disorder in this population.	WASHINGTON UNIV, SCH MED, DEPT GENET, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, DEPT PSYCHIAT, ST LOUIS, MO 63110 USA; JOHNS HOPKINS MED INST, DIV CHILD & ADOLESCENT & PSYCHIAT, BALTIMORE, MD 21205 USA	Washington University (WUSTL); Washington University (WUSTL); Johns Hopkins University; Johns Hopkins Medicine					NIMH NIH HHS [MH51673] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051673] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		[Anonymous], 1992, Science, V258, P67; BARON M, 1987, NATURE, V326, P289, DOI 10.1038/326289a0; BARON M, 1993, NAT GENET, V3, P49, DOI 10.1038/ng0193-49; BERRETTINI WH, 1994, P NATL ACAD SCI USA, V91, P5918, DOI 10.1073/pnas.91.13.5918; Blackwood DHR, 1996, NAT GENET, V12, P427, DOI 10.1038/ng0496-427; COON H, 1993, AM J HUM GENET, V52, P1234; Coon H, 1996, BIOL PSYCHIAT, V39, P689, DOI 10.1016/0006-3223(95)00292-8; CRADDOCK N, 1995, AM J MED GENET, V60, P322, DOI 10.1002/ajmg.1320600412; DAWSON E, 1995, AM J MED GENET, V60, P94, DOI 10.1002/ajmg.1320600203; Debruyn A, 1996, BIOL PSYCHIAT, V39, P679, DOI 10.1016/0006-3223(95)00293-6; DEBRUYN A, 1994, AM J MED GENET, V54, P411, DOI 10.1002/ajmg.1320540423; DeteraWadleigh SD, 1996, AM J HUM GENET, V58, P1279; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Dizier MH, 1996, AM J HUM GENET, V58, P1338; DIZIER MH, 1993, AM J HUM GENET, V53, P1338; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; EGELAND JA, 1987, NATURE, V325, P783, DOI 10.1038/325783a0; EGELAND JA, 1983, AM J PSYCHIAT, V140, P56; EGELAND JA, 1992, PUBLICATION NIH; EIBERG H, 1993, CLIN GENET, V44, P254; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; EWALD H, 1995, PSYCHIATR GENET, V5, pS25; Freimer NB, 1996, NAT GENET, V12, P436, DOI 10.1038/ng0496-436; GERHARD DS, 1994, AM J MED GENET, V54, P398, DOI 10.1002/ajmg.1320540421; Ginns EI, 1996, NAT GENET, V12, P431, DOI 10.1038/ng0496-431; GOODWIN DW, 1989, PSYCHIATRIC DIAGNOSI; GREEN ED, 1995, GENOMICS, V25, P170, DOI 10.1016/0888-7543(95)80123-4; GURLING H, 1995, NAT GENET, V10, P8, DOI 10.1038/ng0595-8b; GURLING HMD, 1995, PSYCHIATR GENET, V5, pS25; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HEUN R, 1993, ACTA PSYCHIAT SCAND, V87, P279, DOI 10.1111/j.1600-0447.1993.tb03372.x; HOUWEN RHJ, 1994, NAT GENET, V8, P380, DOI 10.1038/ng1294-380; JARRETT RB, 1990, J CLIN PSYCHIAT S, V5, P26; KAWADA Y, 1995, AM J HUM GENET, V56, P335; KELSOE JR, 1989, NATURE, V342, P238, DOI 10.1038/342238a0; KELSOE JR, 1995, PSYCHIATR GENET, V5, pS26; KIDD KK, 1984, AM J PSYCHIAT, V141, P1042; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEBOYER M, 1990, LANCET, V335, P1219, DOI 10.1016/0140-6736(90)92738-4; LIM LCC, 1994, AM J HUM GENET, V54, P1122; LIM LCC, 1995, AM J MED GENET, V60, P325, DOI 10.1002/ajmg.1320600413; MELONI R, 1995, LANCET, V345, P932, DOI 10.1016/S0140-6736(95)90053-5; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; NOTHEN MM, 1995, AM J HUM GENET, V57, P975; NURNBERGER J, 1993, PSYCHIAT GENET, V3, P207; PAULS DL, 1995, AM J MED GENET, V60, P290, DOI 10.1002/ajmg.1320600406; PAULS DL, 1992, ARCH GEN PSYCHIAT, V49, P703; PAULS DL, 1991, GENOMICS, V11, P730, DOI 10.1016/0888-7543(91)90081-O; RICE J, 1987, ARCH GEN PSYCHIAT, V44, P441; Risch N, 1996, NAT GENET, V12, P351, DOI 10.1038/ng0496-351; SHAH M, 1995, AM J MED GENET, V60, P150, DOI 10.1002/ajmg.1320600212; Sham Pak C., 1992, Psychiatric Genetics, V2, P175, DOI 10.1097/00041444-199203000-00002; Spence M. A., 1994, American Journal of Human Genetics, V55, pA166; SPITZER RL, 1978, ARCH GEN PSYCHIAT, V35, P773, DOI 10.1001/archpsyc.1978.01770300115013; STINE OC, 1995, AM J HUM GENET, V57, P1384; STRAUB RE, 1994, NAT GENET, V8, P291, DOI 10.1038/ng1194-291; Tsuang M, 1990, GENETICS MOOD DISORD; WEEKS DE, 1995, AM J HUM GENET, V56, P1506; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WILLIAMSON JA, 1995, GENET EPIDEMIOL, V12, P163, DOI 10.1002/gepi.1370120205	62	32	32	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1996	59	6					1343	1362						20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV315	8940281				2022-12-18	WOS:A1996VV31500022
J	Stringham, HM; Boehnke, M				Stringham, HM; Boehnke, M			Identifying marker typing incompatibilities in linkage analysis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PEDIGREE	A common problem encountered in linkage analyses is that execution of the computer program is halted because of genotype(s) in the data that are inconsistent with Mendelian inheritance. Such inconsistencies may arise because of pedigree errors or errors in typing. In some cases, the source of the inconsistencies is easily identified by examining the pedigree. In others, the error is not obvious, and substantial time and effort are required to identify the responsible genotype(s). We have developed two methods for automatically identifying those individuals whose genotypes are most likely the cause of the inconsistencies. First, we calculate the posterior probability of genotyping error for each member of the pedigree, given the marker data on all pedigree members and allowing anyone in the pedigree to have an error. Second, we identify those individuals whose genotypes could be solely responsible for the inconsistency in the pedigree. We illustrate these methods with two examples: one a pedigree error, the second a genotyping error. These methods have been implemented as a module of the pedigree analysis program package MENDEL.	UNIV MICHIGAN,SCH PUBL HLTH,DEPT BIOSTAT,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan					NHGRI NIH HHS [HG00376] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000376, R29HG000376] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Boehnke M., 1992, American Journal of Human Genetics, V51, pA183; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Ehm Margaret Gelder, 1995, Journal of Biological Systems, V3, P13, DOI 10.1142/S0218339095000034; Ehm MG, 1996, AM J HUM GENET, V58, P225; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LATHROP GM, 1983, AM J HUM GENET, V35, P241; LATHROP GM, 1983, HUM HERED, V33, P377; LINCOLN SE, 1992, GENOMICS, V14, P604, DOI 10.1016/S0888-7543(05)80158-2; OTT J, 1993, HUM HERED, V43, P25, DOI 10.1159/000154109	9	32	33	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1996	59	4					946	950						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL283	8808612				2022-12-18	WOS:A1996VL28300026
J	Walker, AP; Muscatelli, F; Stafford, AN; Chelly, J; Dahl, N; Blomquist, HK; Delanghe, J; Willems, PJ; Steinmann, B; Monaco, AP				Walker, AP; Muscatelli, F; Stafford, AN; Chelly, J; Dahl, N; Blomquist, HK; Delanghe, J; Willems, PJ; Steinmann, B; Monaco, AP			Mutations and phenotype in isolated glycerol kinase deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL ADRENAL HYPOPLASIA; GENE; XP21; HYPERGLYCEROLEMIA; TRANSCRIPTION; SEQUENCES; CLONING	We demonstrate that isolated glycerol kinase (GK) deficiency in three families results from mutation of the Xp21 GK gene. GK mutations were detected in four patients with widely differing phenotypes. Patient 1 had a splice-site mutation causing premature termination. His general health was good despite absent GK activity, indicating that isolated GK deficiency can be silent. Patient 2 had GK deficiency and a severe phenotype involving psychomotor retardation and growth delay, bone dysplasia, and seizures, similar to the severe phenotype of one of the first described cases of GK deficiency. His younger brother, patient 3, also had GK deficiency, but so far his development has been normal. GK exon 17 was deleted in both brothers, implicating additional factors in causation of the severe phenotype of patient 2. Patient 4 had both GK deficiency with mental retardation and a GK missense mutation (D440V). Possible explanations for the phenotypic variation of these four patients include ascertainment bias; metabolic or environmental stress as a precipitating factor in revealing GK-related changes, as has previously been described in juvenile GK deficiency; and interactions with functional polymorphisms in other genes that alter the effect of GK deficiency on normal development.	JOHN RADCLIFFE HOSP,INST MOLEC MED,IMPERIAL CANC RES FUND LABS,OXFORD OX3 9DU,ENGLAND; INST COCHIN GENET MOLEC,INSERM,U129,F-75014 PARIS,FRANCE; UNIV HOSP,DEPT CLIN GENET & PEDIAT,UPPSALA,SWEDEN; UMEA UNIV,DEPT PEDIAT,UMEA,SWEDEN; UNIV HOSP,DEPT CLIN CHEM,GHENT,BELGIUM; UNIV ANTWERP,DEPT MED GENET,B-2020 ANTWERP,BELGIUM; UNIV ZURICH,CHILDRENS HOSP,DEPT PAEDIAT,DIV METAB & MOL DIS,ZURICH,SWITZERLAND	Cancer Research UK; University of Oxford; Institut National de la Sante et de la Recherche Medicale (Inserm); Uppsala University; Uppsala University Hospital; Umea University; Ghent University; Ghent University Hospital; University of Antwerp; University Children's Hospital Zurich; University of Zurich			Muscatelli, Françoise/P-4650-2016; Chelly, Jamel/J-7528-2015; Monaco, Anthony P/A-4495-2010; Walker, Ann P/C-1628-2008	Muscatelli, Françoise/0000-0003-4001-6528; Chelly, Jamel/0000-0002-0939-8719; Monaco, Anthony P/0000-0001-7480-3197; 				BLOMQUIST HK, 1996, IN PRESS CLIN GENET; BONHAM JR, 1992, 5 INT C INB ERR MET; CHELLY J, 1988, NATURE, V333, P858, DOI 10.1038/333858a0; CHELLY J, 1989, P NATL ACAD SCI USA, V86, P2617, DOI 10.1073/pnas.86.8.2617; DAVIES KE, 1988, AM J MED GENET, V29, P557, DOI 10.1002/ajmg.1320290313; DELANGHE J, IN PRESS EUR J LAB I; ERIKSSON A, 1983, CLIN CHEM, V29, P718; FRANCKE U, 1987, AM J HUM GENET, V40, P212; FRIES MH, 1995, AM J MED GENET, V46, P363; GINNS EI, 1984, J PEDIATR-US, V104, P736, DOI 10.1016/S0022-3476(84)80956-7; GUGGENHEIM MA, 1980, ANN NEUROL, V7, P441, DOI 10.1002/ana.410070509; GUO WW, 1993, NAT GENET, V4, P367, DOI 10.1038/ng0893-367; GUOSSAULT Y, 1982, CLIN CHIM ACTA, V123, P269; HO MF, 1995, PULSED FIELD GEL ELE, P21; HOWELL R R, 1989, Brain Dysfunction, V2, P126; HULTMAN T, 1989, NUCLEIC ACIDS RES, V17, P4937, DOI 10.1093/nar/17.13.4937; IKUTA S, 1987, NUCLEIC ACIDS RES, V15, P797, DOI 10.1093/nar/15.2.797; KRAWCZAK M, 1992, HUM GENET, V90, P41; LEMNA WK, 1990, NEW ENGL J MED, V322, P291, DOI 10.1056/NEJM199002013220503; LEWIS B, 1994, J CHILD NEUROL, V9, P70, DOI 10.1177/088307389400900118; McCabe ER, 1995, METABOLIC BASIS INHE, P1631; MCCABE ERB, 1977, BIOCHEM BIOPH RES CO, V78, P1327, DOI 10.1016/0006-291X(77)91437-1; MCINTOSH I, 1993, NAT GENET, V4, P219, DOI 10.1038/ng0793-219; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; MUSCATELLI F, 1994, NATURE, V372, P672, DOI 10.1038/372672a0; POMETTA D, 1984, EUR J CLIN INVEST, V14, P103, DOI 10.1111/j.1365-2362.1984.tb02096.x; RECAN D, 1992, J CLIN INVEST, V89, P712, DOI 10.1172/JCI115640; ROSE CI, 1978, J CLIN INVEST, V61, P163, DOI 10.1172/JCI108914; Sambrook J, 1989, MOL CLONING LAB MANU; SARGENT CA, 1993, HUM MOL GENET, V2, P97, DOI 10.1093/hmg/2.2.97; SARGENT CA, 1994, HUM MOL GENET, V3, P1317, DOI 10.1093/hmg/3.8.1317; WALKER AP, 1992, HUM MOL GENET, V1, P579, DOI 10.1093/hmg/1.8.579; WALKER AP, 1993, HUM MOL GENET, V2, P107, DOI 10.1093/hmg/2.2.107; WIRTH A, 1985, DEUT MED WOCHENSCHR, V110, P843, DOI 10.1055/s-2008-1068916; WISE JE, 1987, AM J DIS CHILD, V141, P744, DOI 10.1001/archpedi.1987.04460070046020; ZANARIA E, 1994, NATURE, V372, P635, DOI 10.1038/372635a0	36	32	33	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1996	58	6					1205	1211						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UM271	8651297				2022-12-18	WOS:A1996UM27100013
J	Azen, EA; Amberger, E; Fisher, S; Prakobphol, A; Niece, RL				Azen, EA; Amberger, E; Fisher, S; Prakobphol, A; Niece, RL			PRB1, PRB2, and PRB4 coded polymorphisms among human salivary concanavalin-A binding, II-1, and Po proline-rich proteins	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN-PAROTID-SALIVA; GENE-COMPLEX; AMINO-ACID; GLYCOPROTEIN; NULL; DNA; RECOMBINATION; SEQUENCES; ALLELES; LINKAGE	Six closely linked PRP (proline-rich protein) genes code for many salivary PRPs that show frequent length and null variants. From determined protein sequences and DNA sequence analysis of variant alleles, we here report the coding and molecular basis for Con (concanavalin A-binding) and Po (parotid ''o'') protein polymorphisms. The Con1 glycoprotein is encoded in exon 3 of a PRB2 allele (PRB2L CON1+) with a potential N-linked glycosylation site. Because of a probable gene conversion encompassing greater than or equal to 684 bp of DNA, the ''PRB2-like'' Con2 glycoprotein is encoded in exon 3 of a PRB1 allele (PRB1M CON2+) with a potential glycosylation site. The PmF protein is also encoded in the PRB1M CON2+ allele, thus explaining the previously reported association between Con2 and PmF proteins. A PRB2L CON1- allele contains a single nt missense change [TCT(Ser)-->(C) under bar CT(Pro)] that abolishes the potential N-linked glycosylation site (NKS-->NKP) in the Con1 protein, and this explains the Con- type. The Po protein and a glycoprotein (II-1) are encoded in the PRB4 gene, and both proteins are absent in the presence of a mutation in the PRB4M PO- allele that contains a single nt change (G-->C) at the +1 invariant position of the intron 3 5' donor splice site. The genetically determined absence of the II-1 glycoprotein leads to altered in vitro binding of Streptococcus sanguis 10556 to salivary proteins, which suggests a biological consequence for null mutations of the PRB4 gene.	UNIV WISCONSIN, DEPT MED GENET, MADISON, WI 53706 USA; UNIV WISCONSIN, CTR BIOTECHNOL, MADISON, WI 53706 USA; UNIV CALIF SAN FRANCISCO, DEPT STOMATOL, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT ANAT, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT PHARMACEUT CHEM, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT OBSTET GYNECOL & REPROD SCI, SAN FRANCISCO, CA 94143 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Azen, EA (corresponding author), UNIV WISCONSIN, DEPT MED, 1300 UNIV AVE, MADISON, WI 53706 USA.				NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE003658, R37DE007244, R01DE007244] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE07244, 5-R37-DE03658-30] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		AUSUBEL FM, 1994, CURRENT PROTOCOL S21, V3; AZEN E, 1993, INFECT IMMUN, V61, P4434, DOI 10.1128/IAI.61.10.4434-4439.1993; AZEN E, 1984, P NATL ACAD SCI-BIOL, V81, P5561, DOI 10.1073/pnas.81.17.5561; AZEN EA, 1990, AM J HUM GENET, V47, P686; AZEN EA, 1993, CRIT REV ORAL BIOL M, V4, P479, DOI 10.1177/10454411930040033201; AZEN EA, 1987, AM J HUM GENET, V41, P1035; AZEN EA, 1988, ADV HUM GENET, V17, P141; AZEN EA, 1984, BIOCHEM GENET, V22, P1065, DOI 10.1007/BF00499632; AZEN EA, 1993, AM J HUM GENET, V53, P264; AZEN EA, 1984, BIOCHEM GENET, V22, P1, DOI 10.1007/BF00499283; AZEN EA, 1992, AM J HUM GENET, V50, P842; AZEN EA, 1989, HUMAN SALIVA CLIN CH, V1, P161; BOLLAG RJ, 1989, ANNU REV GENET, V23, P199, DOI 10.1146/annurev.ge.23.120189.001215; COOPER DN, 1993, HUMAN GENE MUTATION, P150; DUNN IS, 1987, NUCLEIC ACIDS RES, V15, P2677; GAVEL Y, 1990, PROTEIN ENG, V3, P433, DOI 10.1093/protein/3.5.433; GILLECECASTRO BL, 1991, J BIOL CHEM, V266, P17358; HAY DI, 1994, J DENT RES, V73, P1717, DOI 10.1177/00220345940730110701; KAUFFMAN DL, 1991, BIOCHEMISTRY-US, V30, P3351, DOI 10.1021/bi00228a001; KAUFFMAN DL, 1993, CRIT REV ORAL BIOL M, V4, P287, DOI 10.1177/10454411930040030501; KIM HS, 1990, GENOMICS, V6, P260, DOI 10.1016/0888-7543(90)90565-C; KIM HS, 1993, MAMM GENOME, V4, P3, DOI 10.1007/BF00364656; KRAWCZAK M, 1992, HUM GENET, V90, P41; LYONS KM, 1988, GENETICS, V120, P267; LYONS KM, 1988, GENETICS, V120, P255; MAEDA N, 1985, J BIOL CHEM, V260, P1123; MAEDA N, 1985, BIOCHEM GENET, V23, P455, DOI 10.1007/BF00499086; MINAGUCHI K, 1989, J DENT RES, V68, P2, DOI 10.1177/00220345890680010201; MURRAY PA, 1992, INFECT IMMUN, V60, P31, DOI 10.1128/IAI.60.1.31-38.1992; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHLUCKEBIER S K, 1992, Journal of Dental Research, V71, P762; SCHWARTZ TW, 1986, FEBS LETT, V200, P1, DOI 10.1016/0014-5793(86)80500-2; SHIMOMURA H, 1983, J BIOCHEM-TOKYO, V93, P857, DOI 10.1093/jb/93.3.857	33	32	35	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1996	58	1					143	153						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TL697	8554050				2022-12-18	WOS:A1996TL69700018
J	LAZARO, C; GAONA, A; LYNCH, M; KRUYER, H; RAVELLA, A; ESTIVILL, X				LAZARO, C; GAONA, A; LYNCH, M; KRUYER, H; RAVELLA, A; ESTIVILL, X			MOLECULAR CHARACTERIZATION OF THE BREAKPOINTS OF A 12-KB DELETION IN THE NF1 GENE IN A FAMILY SHOWING GERM-LINE MOSAICISM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEUROFIBROMATOSIS TYPE-1 NF1; LETHAL OSTEOGENESIS IMPERFECTA; I COLLAGEN; PARENTAL MOSAICISM; NONSENSE MUTATION; REPEAT; COLIAI; DNA; TRANSLOCATION; RECURRENCE	Neurofibromatosis type 1 (NF1) is caused by deletions, insertions, translocations, and point mutations in the NF1 gene, which spans 350 kb on the long arm of human chromosome 17. Although several point mutations have been described, large molecular abnormalities have rarely been characterized in detail. We describe here the molecular breakpoints of a 12-kb deletion of the NF1 gene, which is responsible for the NF1 phenotype in a kindred with two children affected because of germline mosaicism in the unaffected father, who has the mutation in 10% of his spermatozoa. The mutation spans introns 31-39, removing 12,021 nt and inserting 30 bp, of which 19 bp are a direct repetition of a sequence located in intron 31, just 4 bp before the 5' breakpoint. The 5' and 3' breakpoints contain the sequence TATTTTA, which could be involved in the generation of the deletion. The most plausible explanation for the mechanism involved in the generation of this 12-kb deletion is homologous/nonhomologous recombination. Since sperm of the father does not contain the corresponding insertion of the 12-kb deleted sequence, this deletion could have occurred within the NF1 chromosome through loop formation. RNA from lymphocytes of one of the NF1 patients showed similar levels of the mutated and normal transcripts, suggesting that the NF1-mRNA from mutations causing frame shifts of the reading frame or stop codons in this gene is not degraded during its processing. The mutation was not detected in fresh lymphocytes from the unaffected father by PCR analysis, supporting the case for true germ-line mosaicism.	HOSP DURAN & REYNALS, INST RECERCA ONCOL, DEPT GENET MOLEC, E-08907 BARCELONA, SPAIN; HOSP CREU ROJA DE BARCELONA, SERV DERMATOL, BARCELONA, SPAIN; HOSP CLIN BARCELONA, SERV GENET, BARCELONA, SPAIN	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; University of Barcelona; Hospital Clinic de Barcelona			Estivill, Xavier/A-3125-2013; GARCIA, CONXI LAZARO/Q-2410-2016	Estivill, Xavier/0000-0002-0723-2256; GARCIA, CONXI LAZARO/0000-0002-7198-5906				ANDERSEN LB, 1993, HUM MOL GENET, V2, P1083, DOI 10.1093/hmg/2.7.1083-a; [Anonymous], 1988, ARCH NEUROL-CHICAGO, V45, P575, DOI 10.1097/00005537-199606000-00007; BENZ EJ, 1978, CELL, V14, P299, DOI 10.1016/0092-8674(78)90116-2; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COHN DH, 1990, AM J HUM GENET, V46, P591; CONSTANTINOU CD, 1990, AM J HUM GENET, V47, P670; Cooper D. N., 1993, HUMAN GENE MUTATION; COOPER DN, 1991, HUM GENET, V87, P519; Edwards Matthew J., 1992, Human Mutation, V1, P47, DOI 10.1002/humu.1380010108; EFSTRATIADIS A, 1980, CELL, V21, P653, DOI 10.1016/0092-8674(80)90429-8; HEIM RA, 1995, HUM MOL GENET, V4, P975, DOI 10.1093/hmg/4.6.975; HOFFMEYER S, 1994, NAT GENET, V6, P331, DOI 10.1038/ng0494-331; JONES CT, 1992, HUM MOL GENET, V1, P11, DOI 10.1093/hmg/1.1.11; LAZARO C, 1993, HUM GENET, V92, P429, DOI 10.1007/BF01247353; LAZARO C, 1993, HUM MOL GENET, V2, P725, DOI 10.1093/hmg/2.6.725; LAZARO C, 1994, NEW ENGL J MED, V331, P1403, DOI 10.1056/NEJM199411243312102; LEDBETTER DH, 1989, AM J HUM GENET, V44, P20; LEHRMAN MA, 1987, J BIOL CHEM, V262, P401; LEHRMAN MA, 1986, P NATL ACAD SCI USA, V83, P3679, DOI 10.1073/pnas.83.11.3679; LI Y, 1995, GENOMICS, V25, P9, DOI 10.1016/0888-7543(95)80104-T; MILEWICZ DM, 1993, AM J HUM GENET, V53, P62; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Riccardi VM., 1993, PLASTIC RECONST SURG, V91, P561, DOI [10.1097/00006534-199303000-00029, DOI 10.1097/00006534-199303000-00029]; RODENHISER DI, 1993, J MED GENET, V30, P363, DOI 10.1136/jmg.30.5.363; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; VISKOCHIL D, 1990, CELL, V62, P187, DOI 10.1016/0092-8674(90)90252-A; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; WALLACE MR, 1991, NATURE, V353, P864, DOI 10.1038/353864a0; WALLIS GA, 1990, AM J HUM GENET, V46, P1034	30	32	35	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1995	57	5					1044	1049						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TA449	7485153				2022-12-18	WOS:A1995TA44900009
J	VUJIC, M; HALLSTENSSON, K; WAHLSTROM, J; LUNDBERG, A; LANGMAACK, C; MARTINSSON, T				VUJIC, M; HALLSTENSSON, K; WAHLSTROM, J; LUNDBERG, A; LANGMAACK, C; MARTINSSON, T			LOCALIZATION OF A GENE FOR AUTOSOMAL-DOMINANT LARSEN SYNDROME TO CHROMOSOME REGION 3P21.1-14.1 IN THE PROXIMITY OF, BUT DISTINCT FROM, THE COL7A1 LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							JOINT DISLOCATIONS; VII COLLAGEN; LINKAGE; FACIES	Larsen syndrome (LS) is a skeletal dysplasia (osteochondrodysplasia) in which multiple dislocations of the large joints are the major feature. Nosology in this group of diseases, which constitutes 8% of Mendelian disorders in man, is primarily based on clinical and radiographic features, Hopes for more accurate classification grounds are currently being met by progress in elucidation of underlying genetic defects. We have performed linkage analysis in a large Swedish kindred with autosomal dominant LS and found the gene (LAR1) to be strongly linked to chromosome 3p markers (Z(max) = 13.4 at (theta = .00). Recombination analysis indicates that the LAR1 locus is located in a region defined distally by D3S1581. and proximally by D3S1600, which cytogenetically maps to chromosome region 3p21.1-14.1. Linkage and recombination analysis of a COL7A1 PruII intragenic polymorphism versus LS and chromosome 3 markers indicate that COL7A1 is located close to, but distinct from, the LAR1 locus.	EAST HOSP,DEPT PEDIAT,S-41685 GOTHENBURG,SWEDEN		VUJIC, M (corresponding author), EAST HOSP,DEPT CLIN GENET,S-41685 GOTHENBURG,SWEDEN.		Martinsson, Tommy/J-4140-2013	Martinsson, Tommy/0000-0002-9403-3123; Ejeskar, Katarina/0000-0001-8962-0860				BONAVENTURE J, 1992, J MED GENET, V29, P465; CETTA G, 1979, INT ORTHOP, V3, P47, DOI 10.1007/BF00266325; CHEN H, 1982, AM J MED GENET, V13, P149, DOI 10.1002/ajmg.1320130207; CHRISTIANO AM, 1994, J BIOL CHEM, V269, P20256; CHRISTIANO AM, 1992, GENOMICS, V14, P827, DOI 10.1016/S0888-7543(05)80204-6; De Smet L., 1993, Genetic Counseling, V4, P157; EIFERMAN RA, 1993, AM J OPHTHALMOL, V115, P395, DOI 10.1016/S0002-9394(14)73598-6; FRANCOMANO CA, 1995, NAT GENET, V9, P6, DOI 10.1038/ng0195-6; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HARRIS R, 1971, Clinical Genetics, V2, P87; HENRIKSSONP, 1977, ACTA PAEDIATR, V66, P653; HOUSTON CS, 1981, J CAN ASSOC RADIOL, V32, P206; KIEL EA, 1983, PEDIATRICS, V71, P942; LARSEN LJ, 1950, J PEDIATR, V23, P574; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATTA RJ, 1971, J PEDIATR-US, V78, P291, DOI 10.1016/S0022-3476(71)80014-8; MAROTEAUX P, 1975, ARCH FR PEDIATR, V32, P597; MARQUES MDT, 1980, J GENET HUM, V28, P83; MCKUSICK VA, 1992, MENDELIAN INHERITANC, P651; MICHELI LJ, 1976, J BONE JOINT SURG AM, V58, P562, DOI 10.2106/00004623-197658040-00024; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; PARENTE MG, 1991, P NATL ACAD SCI USA, V88, P6931, DOI 10.1073/pnas.88.16.6931; PETRELLA R, 1993, AM J MED GENET, V47, P187, DOI 10.1002/ajmg.1320470212; PIERQUIN G, 1991, HUM GENET, V87, P587, DOI 10.1007/BF00209018; ROBERTSON FW, 1975, CLIN PEDIATR, V14, P53, DOI 10.1177/000992287501400106; ROCHELSON B, 1993, OBSTET GYNECOL, V81, P845; SALMON MA, 1973, LANCET, V1, P318; SAMUEL AW, 1981, INT ORTHOP, V5, P229; SILVERMAN FN, 1972, ANN RADIOL, V15, P297; STEEL HH, 1972, J BONE JOINT SURG AM, VA 54, P75, DOI 10.2106/00004623-197254010-00007; TAKASHI O, 1976, CLIN ORTHOP RELAT R, V119, P206; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; 1985, INT SSTEM HUMAN CYTO	33	32	34	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1995	57	5					1104	1113						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TA449	7485161				2022-12-18	WOS:A1995TA44900017
J	FEITOSA, MF; BORECKI, I; KRIEGER, H; BEIGUELMAN, B; RAO, DC				FEITOSA, MF; BORECKI, I; KRIEGER, H; BEIGUELMAN, B; RAO, DC			THE GENETIC EPIDEMIOLOGY OF LEPROSY IN A BRAZILIAN POPULATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MYCOBACTERIUM-LEPRAEMURIUM; SEGREGATION ANALYSIS; COMPLEX SEGREGATION; LEPROMATOUS LEPROSY; CARIBBEAN ISLAND; SUSCEPTIBILITY; RESISTANCE; HLA; INFECTION; MOUSE	Data on leprosy patients have been obtained from the Dispensary of Leprosy of Campinas, Sao Paulo, where records on practically all cases of leprosy in the Campinas area during the period 1960-70 are filed. The whole sample comprises 10,886 individuals, distributed among 1,568 families. Complex segregation analysis was utilized to determine the nature of the genetic factors that may operate on leprosy and its subtypes. The results suggest the presence of a recessive major gene controlling susceptibility to leprosy per se, with frequency of similar to.05, although there are deviations from the expected Mendelian segregation proportions. Possible etiologic heterogeneity was examined by considering two subtypes separately: for lepromatous leprosy and tuberculoid leprosy there are suggestions for a segregating major effect; however, Mendelian transmission could not be demonstrated in either case. Therefore, there is no evidence to suggest unique genetic determinants for leprosy subtypes.	UNIV WASHINGTON, SCH MED, DIV BIOSTAT, ST LOUIS, MO USA; UNIV ESTADUAL CAMPINAS, DEPT MED GENET, SAO PAULO, BRAZIL; UNIV SAO PAULO, DEPT PARASITOL, BR-05508 SAO PAULO, BRAZIL	Washington University (WUSTL); Universidade Estadual de Campinas; Universidade de Sao Paulo	FEITOSA, MF (corresponding author), FDN OSWALDO CRUZ, DEPT GENET, AVENIDA BRASIL 4365, BR-21045 MANGUINHO, BRAZIL.		Feitosa, Mary F/K-8044-2012	Feitosa, Mary F/0000-0002-0933-2410	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028719] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 28719] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABEL L, 1988, AM J HUM GENET, V42, P256; ABEL L, 1989, INT J LEPROSY, V57, P465; BEIGUELMAN B, 1983, REV BRAS GENET, V6, P109; Beiguelman B, 1968, Rev Paul Med, V72, P105; BEIGUELMAN B, 1972, ACTA GENET MED GEMEL, V51, pA335; BLACKWELL JM, 1992, PARASITOLOGY, V104, pS19, DOI 10.1017/S0031182000075223; BROWN IN, 1982, IMMUNOLOGY, V47, P149; CURTIS J, 1984, INFECT IMMUN, V46, P635, DOI 10.1128/IAI.46.3.635-638.1984; DEMENAIS F, 1986, GENET EPIDEMIOL, P49; DEMENAIS F, 1985, GENETIC CONTROL HOST, P319; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; FILHO FP, 1963, 8 ANN C INT LEPR RIO, V3, P30; HAILE RWC, 1985, HUM HERED, V35, P43, DOI 10.1159/000153514; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; Morgan K., 1994, American Journal of Human Genetics, V55, pA196; MORTON NE, 1974, AM J HUM GENET, V26, P489; OTTENHOFF THM, 1987, INT J LEPROSY, V55, P521; SERJEANTSON S, 1979, ANN HUM BIOL, V6, P375, DOI 10.1080/03014467900003761; SERJEANTSON SW, 1983, IMMUNOL REV, V70, P89, DOI 10.1111/j.1600-065X.1983.tb00711.x; SHAW MA, 1993, ANN HUM GENET, V57, P251, DOI 10.1111/j.1469-1809.1993.tb00899.x; SHIELDS ED, 1987, J CLIN INVEST, V79, P1139, DOI 10.1172/JCI112930; SKAMENE E, 1984, IMMUNOGENETICS, V19, P117, DOI 10.1007/BF00387854; SKAMENE E, 1982, NATURE, V297, P506, DOI 10.1038/297506a0; SMITH DG, 1979, HUM GENET, V50, P163, DOI 10.1007/BF00390238; VANEDEN W, 1985, J INFECT DIS, V151, P9, DOI 10.1093/infdis/151.1.9; VANEDEN W, 1984, LEPROSY REV, V55, P89; VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D; WAGENER DK, 1988, GENET EPIDEMIOL, V5, P95, DOI 10.1002/gepi.1370050205	28	32	34	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1995	56	5					1179	1185						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QU586	7726175				2022-12-18	WOS:A1995QU58600022
J	HONG, HK; FERRELL, RE; GORIN, MB				HONG, HK; FERRELL, RE; GORIN, MB			CLINICAL DIVERSITY AND CHROMOSOMAL LOCALIZATION OF X-LINKED CONE DYSTROPHY (COD-I)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROXIMAL SHORT ARM; RETINITIS-PIGMENTOSA; RDS GENE; LINKAGE RELATIONSHIPS; DINUCLEOTIDE REPEAT; LOCUS; DNA; POLYMORPHISM; L1.28; RECOMBINATION	X-linked progressive cone dystrophy (COD1) causes progressive deterioration of visual acuity, deepening of central scotomas, macular changes, and bull's-eye lesions. The cone electroretinography (ERG) is variably abnormal in affected males, and the rod ERG may also be abnormal. The clinical picture of heterozygous females ranges from asymptomatic to a widespread spectrum of cone-mediated dysfunction. A prior linkage study demonstrated linkage between the COD1 locus and the marker locus DXS84, assigned to Xp21.1, with no recombination. In the present study, we have clinically characterized a large four-generation family with COD1 and have performed a linkage analysis using seven polymorphic markers on the short arm of the X chromosome. No recombination was observed between the disease and the marker loci DXS7 and MAOA, suggesting that the location of COD1 is in the region Xp11.3, distal to DXS84 and proximal to ArAF1.	UNIV PITTSBURGH,GRAD SCH PUBL HLTH,DEPT HUMAN GENET,PITTSBURGH,PA; UNIV PITTSBURGH,SCH MED,DEPT OPHTHALMOL,PITTSBURGH,PA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh								ALDRED MA, 1991, NUCLEIC ACIDS RES, V19, P1165, DOI 10.1093/nar/19.5.1165-a; BARTLEY J, 1989, CYTOGENET CELL GENET, V51, P959; BERGEN AAB, 1993, GENOMICS, V18, P463, DOI 10.1006/geno.1993.1504; BHATTACHARYA SS, 1984, NATURE, V309, P253, DOI 10.1038/309253a0; COLEMAN M, 1990, AM J HUM GENET, V47, P935; DENTON MJ, 1988, HUM GENET, V78, P60, DOI 10.1007/BF00291236; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRIEDRICH U, 1985, HUM GENET, V71, P93; GOODFELLOW PN, 1985, CYTOGENET CELL GENET, V40, P296, DOI 10.1159/000132178; HARTLEY DA, 1984, NUCLEIC ACIDS RES, V12, P5277, DOI 10.1093/nar/12.13.5277; HECKENLIVELY JR, 1986, ARCH OPHTHALMOL-CHIC, V104, P1322, DOI 10.1001/archopht.1986.01050210076029; HONG HK, 1993, HUM MOL GENET, V2, P1078, DOI 10.1093/hmg/2.7.1078; HUMPHRIES P, 1992, SCIENCE, V256, P804, DOI 10.1126/science.1589761; JACOBSON DM, 1989, OPHTHALMOLOGY, V96, P885; KAJIWARA K, 1993, NAT GENET, V3, P208, DOI 10.1038/ng0393-208; KEUNEN JEE, 1990, ARCH OPHTHALMOL-CHIC, V108, P1713, DOI 10.1001/archopht.1990.01070140067031; KIRCHGESSNER CU, 1991, AM J HUM GENET, V49, P184; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEVY ER, 1989, GENOMICS, V5, P368, DOI 10.1016/0888-7543(89)90072-4; LUTY JA, 1989, CYTOGENET CELL GENET, V51, P1036; MCKUSICK VA, 1992, MENDELIAN INHERITANC, P1807; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MUKAI S, 1985, AM J OPHTHALMOL, V100, P225, DOI 10.1016/0002-9394(85)90786-X; MUSARELLA MA, 1988, AM J HUM GENET, V43, P484; NICHOLS BE, 1993, NAT GENET, V3, P202, DOI 10.1038/ng0393-202; NUSSBAUM RL, 1985, HUM GENET, V70, P45, DOI 10.1007/BF00389458; OTT J, 1990, P NATL ACAD SCI USA, V87, P701, DOI 10.1073/pnas.87.2.701; PINCKERS A, 1981, OPHTHALMIC PAED GEN, V1, P17, DOI 10.3109/13816818109036022; PINCKERS A, 1981, OPHTHALMIC PAED GEN, V1, P25, DOI 10.3109/13816818109036023; Pinckers A, 1982, DOC OPHTHALMOL P SER, V33, P399; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; WELLS J, 1993, NAT GENET, V3, P213, DOI 10.1038/ng0393-213; WIRTH B, 1988, Genomics, V2, P263, DOI 10.1016/0888-7543(88)90011-0; WRIGHT AF, 1987, AM J HUM GENET, V41, P635; 1989, ARCH OPHTHALMOL-CHIC, V107, P816	35	32	32	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1994	55	6					1173	1181						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB684	7977377				2022-12-18	WOS:A1994QB68400014
J	MORRAL, N; LLEVADOT, R; CASALS, T; GASPARINI, P; MACEK, M; DORK, T; ESTIVILL, X				MORRAL, N; LLEVADOT, R; CASALS, T; GASPARINI, P; MACEK, M; DORK, T; ESTIVILL, X			INDEPENDENT ORIGINS OF CYSTIC-FIBROSIS MUTATIONS R334W, R347P, R1162X, AND 3849+10KBC-]T PROVIDE EVIDENCE OF MUTATION RECURRENCE IN THE CFTR GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONDUCTANCE REGULATOR GENE; NUCLEOTIDE-BINDING FOLD; MOLECULAR CHARACTERIZATION; LINKAGE DISEQUILIBRIUM; DELTA-F508 MUTATION; REPEAT POLYMORPHISM; MARKER HAPLOTYPES; POINT MUTATIONS; IDENTIFICATION; CHROMOSOME	Microsatellite analysis of chromosomes carrying particular cystic fibrosis mutations has shown different haplotypes in four cases: R334W, R347P, R1162X, and 3849+10kbC-->T. To investigate the possibility of recurrence of these mutations, analysis of intra- and extragenic markers flanking these mutations has been performed. Recurrence is the most plausible explanation, as it becomes necessary to postulate either double recombinations or single recombinations in conjunction with slippage at one or more microsatellite loci, to explain the combination of mutations and microsatellites if the mutations arose only once. Also in support of recurrence, mutations R334W, R347P, R1162X, and 3849+10kbC-->T invohre CpG dinucleotides, which are known to have an increased mutation rate. Although only 15.7% of point mutations in the coding sequence of CFTR have occurred at CpG dinucleotides, approximately half of these CpG sites have mutated at least once. Specific nucleotide positions of the coding region of CFTR, distinct from CpG sequences, also seem to have a higher mutation rate, and so it is possible that the mutations observed are recurrent. G-->A transitions are the most common change found in those positions involved in more than one mutational event in CFTR.	HOSP DURAN I REYNALS,INST RECERCA ONCOL,DEPT MOLEC GENET,E-08907 LHOSPITALET LLOBR,SPAIN; IRCCS,OSPED CASA SOLLIEVO SOFFEREZA,SERV GENET MED,FOGGIA,ITALY; JOHNS HOPKINS MED INST,CTR MED GENET,BALTIMORE,MD 21205; CHARLES UNIV,FAC MED 1,PRAGUE,CZECH REPUBLIC; HANNOVER MED SCH,ZENTRUM BIOCHEM,HANNOVER,GERMANY	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; IRCCS Casa Sollievo Della Sofferenza; Johns Hopkins University; Johns Hopkins Medicine; Charles University Prague; Hannover Medical School			Dörk, Thilo/J-8620-2012; Morral, Nuria/AAC-7149-2020; Gasparini, Paolo/B-6173-2014; Estivill, Xavier/A-3125-2013	Dörk, Thilo/0000-0002-9458-0282; Estivill, Xavier/0000-0002-0723-2256; Morral, Nuria/0000-0002-8932-2887				ANDREZET MP, 1993, HUM MOL GENET, V2, P51; Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649; Bonizzato A., 1992, Human Mutation, V1, P432, DOI 10.1002/humu.1380010515; BOZON D, 1994, HUM MUTAT, V3, P330, DOI 10.1002/humu.1380030329; Cheadle Jeremy P., 1992, Human Molecular Genetics, V1, P123, DOI 10.1093/hmg/1.2.123; CHEHAB FF, 1991, AM J HUM GENET, V48, P223; CHEVALIERPORST F, 1994, J MED GENET, V31, P541, DOI 10.1136/jmg.31.7.541; CHILLON M, 1994, HUM GENET, V93, P447; CHILLON M, 1994, HUM MUTAT, V3, P223, DOI 10.1002/humu.1380030308; CHILLON M, 1991, NUCLEIC ACIDS RES, V19, P6343, DOI 10.1093/nar/19.22.6343; Cooper DN, 1993, HUMAN GENE MUTATION, P109; Cremonesi Laura, 1992, Human Mutation, V1, P314, DOI 10.1002/humu.1380010409; CUPPENS H, 1993, GENOMICS, V18, P693, DOI 10.1016/S0888-7543(05)80376-3; CUTTING GR, 1990, NATURE, V346, P366, DOI 10.1038/346366a0; Cystic Fibrosis Genetic Anal Consortium, 1990, AM J HUM GENET, V47, P354; DEAN M, 1990, CELL, V61, P863, DOI 10.1016/0092-8674(90)90196-L; DEVOTO M, 1991, AM J HUM GENET, V48, P1127; DORK T, 1994, HUM GENET, V93, P67; DORK T, 1993, GENOMICS, V15, P688, DOI 10.1006/geno.1993.1127; DORK T, 1991, HUM GENET, V87, P441; DORK T, 1991, NUCLEIC ACIDS RES, V19, P2517, DOI 10.1093/nar/19.9.2517-a; DORK T, 1992, HUM GENET, V88, P417, DOI 10.1007/BF00215676; DORK T, IN PRESS HUM GENET; ESTIVILL X, 1989, AM J HUM GENET, V44, P704; ESTIVILL X, 1987, Genomics, V1, P257, DOI 10.1016/0888-7543(87)90052-8; ESTIVILL X, 1987, NATURE, V326, P840, DOI 10.1038/326840a0; FANEN P, 1992, GENOMICS, V13, P770, DOI 10.1016/0888-7543(92)90152-I; FEREC C, 1992, NAT GENET, V1, P188, DOI 10.1038/ng0692-188; GASPARINI P, 1993, HUM MUTAT, V2, P389, DOI 10.1002/humu.1380020511; GASPARINI P, 1991, HUM GENET, V86, P625; GASPARINI P, 1991, GENOMICS, V10, P193, DOI 10.1016/0888-7543(91)90500-E; GASPARINI P, 1992, J MED GENET, V29, P558, DOI 10.1136/jmg.29.8.558; GHANEM N, 1994, GENOMICS, V21, P434, DOI 10.1006/geno.1994.1290; HIGHSMITH WE, IN PRESS N ENGL J ME; KADASI L, 1992, HUM GENET, V89, P305, DOI 10.1007/BF00220546; KEREM BS, 1990, P NATL ACAD SCI USA, V87, P8447, DOI 10.1073/pnas.87.21.8447; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KIESEWETTER S, 1993, NAT GENET, V5, P274, DOI 10.1038/ng1193-274; MACEK M, 1990, HUM GENET, V85, P417, DOI 10.1007/BF02428289; Macek Milan Jr., 1992, Human Mutation, V1, P501, DOI 10.1002/humu.1380010608; MERCIER B, 1993, GENOMICS, V16, P296, DOI 10.1006/geno.1993.1183; MERCIER B, IN PRESS HUM GENET; MORRAL N, 1992, GENOMICS, V13, P1362, DOI 10.1016/0888-7543(92)90071-Y; MORRAL N, 1994, NAT GENET, V7, P169, DOI 10.1038/ng0694-169; MORRAL N, 1992, HUM GENET, V88, P356; MORRAL N, 1993, HUM MOL GENET, V2, P1015, DOI 10.1093/hmg/2.7.1015; MORRAL N, 1991, GENOMICS, V10, P692, DOI 10.1016/0888-7543(91)90454-M; NANES V, 1993, HUM MOL GENET, V2, P79; OSBORNE L, 1991, AM J HUM GENET, V48, P608; REISS J, 1991, HUM GENET, V87, P457; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; SANGIUOLO F, 1993, HUM MUTAT, V2, P422, DOI 10.1002/humu.1380020517; SAVOV A, 1994, HUM MOL GENET, V3, P513, DOI 10.1093/hmg/3.3.513; SAVOV A, 1994, HUM MOL GENET, V3, P57; Strong Theresa V., 1992, Human Mutation, V1, P380, DOI 10.1002/humu.1380010506; VIDAUD M, 1990, HUM GENET, V85, P446, DOI 10.1007/BF02428305; WAINWRIGHT BJ, 1985, NATURE, V318, P384, DOI 10.1038/318384a0; WHITE R, 1985, NATURE, V318, P382, DOI 10.1038/318382a0; WILL K, 1994, J CLIN INVEST, V93, P1852, DOI 10.1172/JCI117172; ZIELENSKI J, 1991, GENOMICS, V10, P214, DOI 10.1016/0888-7543(91)90503-7; ZIELENSKI J, 1991, AM J HUM GENET, V49, P1256; ZIELENSKI J, 1993, AM J HUM GENET, V52, P609; ZIELENSKI J, IN PRESS HUM MUTAT; IN PRESS HUM MUTAT	65	32	33	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1994	55	5					890	898						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB682	7526685				2022-12-18	WOS:A1994QB68200007
J	BRANDI, ML; WEBER, G; SVENSSON, A; FALCHETTI, A; TONELLI, F; CASTELLO, R; FURLANI, L; SCAPPATICCI, S; FRACCARO, M; LARSSON, C				BRANDI, ML; WEBER, G; SVENSSON, A; FALCHETTI, A; TONELLI, F; CASTELLO, R; FURLANI, L; SCAPPATICCI, S; FRACCARO, M; LARSSON, C			HOMOZYGOTES FOR THE AUTOSOMAL-DOMINANT NEOPLASIA SYNDROME (MENI)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PARATHYROID TUMORS; GENE; TYPE-1; CHROMOSOME-11; RETINOBLASTOMA; CANCER; MUTATION; ALLELES; DISEASE; MAPS	Families in which both parents are heterozygotes for the same autosomal dominant neoplasia syndrome are extremely unusual. Recently, we had the unique opportunity to evaluate three symptomatic siblings from the union between two unrelated individuals affected by multiple endocrine neoplasia type 1 (MEN1). When the three siblings and their parents and relatives were genotyped for 12 markers tightly linked to the MEN1 locus, at 11q13, two of the siblings were found to be homozygotes, and one a heterozygote, for MEN1. With regard to the MEN1 syndrome, no phenotypic differencies were observed between the two homozygotes and the heterozygotes. However, the two homozygotes showed unexplained infertility, which was not the case for any of the heterozygotes. Thus, MEN1 appears to be a disease with complete dominance, and the presence of two MEN1 alleles with mutations of the type that occur constitutionally may be insufficient for tumor development.	KAROLINSKA HOSP, DEPT CLIN GENET, STOCKHOLM, SWEDEN; KAROLINSKA HOSP, DEPT SURG, STOCKHOLM, SWEDEN; HOSP VERONA, DIV ENDOCRINOL, VERONA, ITALY; UNIV PAVIA, DEPT HUMAN PATHOL & GENET, PAVIA, ITALY	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; University of Pavia	BRANDI, ML (corresponding author), UNIV FLORENCE, DEPT CLIN PHYSIOPATHOL, VIALE PIERACCINI 6, I-50139 FLORENCE, ITALY.		Weber, Günther/F-3410-2016; FALCHETTI, ALBERTO/Q-1787-2016	FALCHETTI, ALBERTO/0000-0002-6739-4417				BRANDI ML, 1987, ENDOCR REV, V8, P391, DOI 10.1210/edrv-8-4-391; BYSTROM C, 1990, P NATL ACAD SCI USA, V87, P1968, DOI 10.1073/pnas.87.5.1968; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; FARNDON JR, 1986, BRIT J SURG, V73, P278, DOI 10.1002/bjs.1800730411; FRIEDMAN E, 1989, NEW ENGL J MED, V321, P213, DOI 10.1056/NEJM198907273210402; FRIEDMAN E, 1992, CANCER RES, V52, P6804; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; FUJIMORI M, 1992, AM J HUM GENET, V50, P399; HALL JG, 1992, NEW ENGL J MED, V326, P827, DOI 10.1056/NEJM199203193261210; HENRY I, 1991, NATURE, V351, P665, DOI 10.1038/351665a0; HEUTINK P, 1992, HUM MOL GENET, V1, P7, DOI 10.1093/hmg/1.1.7; HUANG HJS, 1988, SCIENCE, V242, P1563, DOI 10.1126/science.3201247; IWASAKI H, 1992, GENOMICS, V13, P7, DOI 10.1016/0888-7543(92)90194-W; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; JULIER C, 1990, GENOMICS, V7, P335, DOI 10.1016/0888-7543(90)90167-S; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; LARSSON C, 1992, J CLIN INVEST, V89, P1344, DOI 10.1172/JCI115720; LARSSON C, 1988, NATURE, V332, P85, DOI 10.1038/332085a0; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; MARIMAN ECM, 1993, HUM GENET, V91, P357, DOI 10.1007/BF00217356; NORDSTROM S, 1980, CLIN GENET, V18, P211; SCAPPATICCI S, 1991, CANCER GENET CYTOGEN, V52, P85, DOI 10.1016/0165-4608(91)90057-2; SKOGSEID B, 1991, J CLIN ENDOCR METAB, V73, P281, DOI 10.1210/jcem-73-2-281; THAKKER RV, 1989, NEW ENGL J MED, V321, P218, DOI 10.1056/NEJM198907273210403; THAKKER RV, 1993, ANN HUM GENET, V57, P17, DOI 10.1111/j.1469-1809.1993.tb00883.x; WEXLER NS, 1987, NATURE, V326, P194, DOI 10.1038/326194a0	28	32	32	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1993	53	6					1167	1172						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MJ818	7902670				2022-12-18	WOS:A1993MJ81800002
J	AKSENTIJEVICH, I; PRAS, E; GRUBERG, L; SHEN, Y; HOLMAN, K; HELLING, S; PROSEN, L; SUTHERLAND, GR; RICHARDS, RI; RAMSBURG, M; DEAN, M; PRAS, M; AMOS, CI; KASTNER, DL				AKSENTIJEVICH, I; PRAS, E; GRUBERG, L; SHEN, Y; HOLMAN, K; HELLING, S; PROSEN, L; SUTHERLAND, GR; RICHARDS, RI; RAMSBURG, M; DEAN, M; PRAS, M; AMOS, CI; KASTNER, DL			REFINED MAPPING OF THE GENE CAUSING FAMILIAL MEDITERRANEAN FEVER, BY LINKAGE AND HOMOZYGOSITY STUDIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN CHROMOSOME-16; POLYMORPHIC LOCI; SHORT ARM; MAP; DNA; MARKERS; LOCALIZATION; ARMENIANS	Familial Mediterranean fever (FMF) is an autosomal recessive disease characterized by attacks of fever and serosal inflammation; the biochemical basis is unknown. We recently reported linkage of the gene causing FMF (designated ''MEF'') to two markers on chromosome 16p. To map MEF more precisely, we have now tested nine 16p markers. Two-point and multipoint linkage analysis, as well as a study of recombinant haplotypes, placed MEF between D16S94 and D16S80, a genetic interval of about 9 cM. We also examined rates of homozygosity for markers in this region, among offspring of consanguineous marriages. For eight of nine markers, the rate of homozygosity among 26 affected inbred individuals was higher than that among their 20 unaffected sibs. Localizing MEF more precisely on the basis of homozygosity rates alone would be difficult, for two reasons: First, the high FMF carrier frequency increases the chance that inbred offspring could have the disease without being homozygous by descent at MEF. Second, several of the markers in this region are relatively nonpolymorphic, with a high rate of homozygosity, regardless of their chromosomal location.	NIAMDD,ARTHRITIS & RHEUMATISM BRANCH,BLDG 6,ROOM 112,BETHESDA,MD 20892; CHAIM SHEBA MED CTR,DEPT MED F,IL-52621 TEL HASHOMER,ISRAEL; CHAIM SHEBA MED CTR,HELLER INST MED RES,IL-52621 TEL HASHOMER,ISRAEL; ADELAIDE CHILDRENS HOSP INC,DEPT CYTOGENET & MOLEC GENET,ADELAIDE,SA 5006,AUSTRALIA; NCI,FREDERIC CANC RES & DEV CTR,VIRAL CARCINOGENESIS LAB,FREDERICK,MD 21701; NIAMDD,SKIN BIOL LAB,BETHESDA,MD 20892	Chaim Sheba Medical Center; Chaim Sheba Medical Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)			Sutherland, Grant Robert/D-2606-2012; Dean, Michael/R-7501-2019; Richards, Robert/ABE-6423-2020; Aksentijevich, Ivona/AAF-1335-2019; Dean, Michael C/G-8172-2012	Dean, Michael C/0000-0003-2234-0631; Richards, Robert Ian/0000-0002-5978-6453				ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; BARAKAT MH, 1986, Q J MED, V60, P837; Battey, 1986, BASIC METHODS MOL BI; Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649; BREUNING MH, 1990, J MED GENET, V27, P603, DOI 10.1136/jmg.27.10.603; CAVENEE W, 1984, AM J HUM GENET, V36, P10; CECCHERINI I, 1992, P NATL ACAD SCI USA, V89, P104, DOI 10.1073/pnas.89.1.104; GERMINO GG, 1992, GENOMICS, V13, P144, DOI 10.1016/0888-7543(92)90214-D; GOTO M, 1992, NATURE, V355, P735, DOI 10.1038/355735a0; HARRIS PC, 1991, LANCET, V338, P1484, DOI 10.1016/0140-6736(91)92300-Q; Hartl DL., 1988, PRIMER POPULATION GE; HYLAND VJ, 1989, HUM GENET, V83, P61, DOI 10.1007/BF00274150; JULIER C, 1990, GENOMICS, V6, P419, DOI 10.1016/0888-7543(90)90471-6; KEITH TP, 1990, P NATL ACAD SCI USA, V87, P5754, DOI 10.1073/pnas.87.15.5754; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MCALPINE PJ, 1991, CYTOGENET CELL GENET, V58, P5, DOI 10.1159/000133160; OZDEMIR A I, 1969, American Journal of Gastroenterology, V51, P311; PRAS E, 1992, NEW ENGL J MED, V326, P1509, DOI 10.1056/NEJM199206043262301; PRAS M, 1982, JOHNS HOPKINS MED J, V150, P22; REED KC, 1985, NUCLEIC ACIDS RES, V13, P7207, DOI 10.1093/nar/13.20.7207; REEDERS ST, 1991, CYTOGENET CELL GENET, V58, P643, DOI 10.1159/000133176; RICHARDS RI, 1991, J MED GENET, V28, P818, DOI 10.1136/jmg.28.12.818; SCHWABE AD, 1974, MEDICINE, V53, P453, DOI 10.1097/00005792-197411000-00005; SHOHAT M, 1992, AM J HUM GENET, V51, P1349; SMITH CAB, 1953, J R STAT SOC B, V15, P153; SOHAR E, 1967, AM J MED, V43, P227, DOI 10.1016/0002-9343(67)90167-2; THOMPSON AD, 1992, GENOMICS, V13, P402, DOI 10.1016/0888-7543(92)90260-Y; WILIAMSON R, 1991, CYTOGENET CELL GENET, V58, P1190	30	32	39	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1993	53	2					451	461						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LN820	8328461				2022-12-18	WOS:A1993LN82000017
J	NAVARRO, J; BENET, J; MARTORELL, MR; TEMPLADO, C; EGOZCUE, J				NAVARRO, J; BENET, J; MARTORELL, MR; TEMPLADO, C; EGOZCUE, J			SEGREGATION ANALYSIS IN A MAN HETEROZYGOUS FOR A PERICENTRIC-INVERSION OF CHROMOSOME-7 (P13-Q36) BY SPERM CHROMOSOME-STUDIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ABNORMALITIES; ABERRATIONS; CHILD	We have analyzed 140 sperm chromosome complements from a subfertile man heterozygous for an inv(7)(p13;q36). Seventy-five percent of the chromosome complements were not recombinant: 37.9% contained the normal chromosome 7, and 37.1% contained the inverted chromosome 7. Twenty-five percent of the 140 were recombinant: 7.1% carried a recombinant chromosome 7 with a duplication p and deletion q, 17.1% carried a recombinant chromosome 7 with a duplication q and deletion p, and 0.7% carried both recombinant chromosomes. The frequency of structural chromosomal aberrations unrelated to the inversion was 11.4%, and the frequency of aneuploidy was 2.9%. Both frequencies were not significantly different from those in control donors. Two sperm complements with a second independent, contiguous inversion involving one of the original breakpoints (q36) were observed (1.4%). The risk of producing chromosomally abnormal offspring or spontaneous abortions would be 34.3%. The proportion of X-bearing and Y-bearing sperm was 46.8% and 53.2%, respectively, not significantly different from the expected 1:1 ratio.			NAVARRO, J (corresponding author), UNIV AUTONOMA BARCELONA,FAC MED,UNITAT BIOL,DEPT BIOL CELLULAR & FISIOL,EDIFICI M,E-08193 BARCELONA,SPAIN.		Benet, Jordi/I-1690-2017	Benet, Jordi/0000-0001-6185-2555; Templado, Cristina/0000-0002-4602-9488; Navarro, Joaquima/0000-0002-9245-2260				ASHLEY T, 1988, GENETICS, V118, P307; BALKAN W, 1983, CYTOGENET CELL GENET, V35, P295, DOI 10.1159/000131882; BENET J, 1992, HUM GENET, V89, P176; BENET J, 1991, HUM REPROD, V6, P369, DOI 10.1093/oxfordjournals.humrep.a137342; BENET J, 1986, HUM GENET, V73, P181, DOI 10.1007/BF00291611; BOUE A, 1984, PRENATAL DIAG, V4, P45, DOI 10.1002/pd.1970040705; BRANDRIFF BF, 1988, CYTOGENET CELL GENET, V47, P29, DOI 10.1159/000132500; DEBRAEKELEER M, 1991, HUM REPROD, V6, P245, DOI 10.1093/oxfordjournals.humrep.a137315; Gardner R. J. M., 1989, CHROMOSOME ABNORMALI; HANSTEEN IL, 1982, CLIN GENET, V21, P309; JENDERNY J, 1992, HUM GENET, V89, P117, DOI 10.1007/BF00207058; KAISER P, 1984, HUM GENET, V68, P1, DOI 10.1007/BF00293869; LAURIE DA, 1985, ANN HUM GENET, V49, P189, DOI 10.1111/j.1469-1809.1985.tb01693.x; MARTIN RH, 1991, AM J HUM GENET, V48, P856; MARTIN RH, 1992, BIOL REPROD, V47, P268, DOI 10.1095/biolreprod47.2.268; MARTIN RH, 1993, CYTOGENET CELL GENET, V62, P199, DOI 10.1159/000133475; MARTIN RH, 1990, MOL REPROD DEV, V25, P101; NIELSEN J, 1982, HUM GENET, V61, P98, DOI 10.1007/BF00274195; RAMER JC, 1991, CLIN GENET, V39, P442; SAVAGE JRK, 1990, MUTATION ENV B, P385; SHERMAN SL, 1986, CLIN GENET, V30, P87; SYME RM, 1992, HUM REPROD, V7, P825, DOI 10.1093/oxfordjournals.humrep.a137744; TEMPLADO C, 1980, HUM GENET, V53, P335, DOI 10.1007/BF00287052; TEMPLADO C, 1990, HUM GENET, V84, P159; VEJERSLEV LO, 1984, PRENATAL DIAG, V4, P181, DOI 10.1002/pd.1970040304; WINSOR EJT, 1978, CYTOGENET CELL GENET, V20, P169, DOI 10.1159/000130849; 1982, UNSCEAR E IX8 UN SCI; 1986, ANN GENET, V29, P129	28	32	33	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1993	53	1					214	219						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ385	8317486				2022-12-18	WOS:A1993LJ38500025
J	RACK, KA; HARRIS, PC; MACCARTHY, AB; BOONE, R; RAYNHAM, H; MCKINLEY, M; FITCHETT, M; TOWE, CM; RUDD, P; ARMOUR, AL; LINDENBAUM, RH; BUCKLE, VJ				RACK, KA; HARRIS, PC; MACCARTHY, AB; BOONE, R; RAYNHAM, H; MCKINLEY, M; FITCHETT, M; TOWE, CM; RUDD, P; ARMOUR, AL; LINDENBAUM, RH; BUCKLE, VJ			CHARACTERIZATION OF 3 DENOVO DERIVATIVE CHROMOSOMES-16 BY REVERSE CHROMOSOME PAINTING AND MOLECULAR ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INSITU SUPPRESSION HYBRIDIZATION; DNA CONTENT; GENE; LIBRARIES; MAP; ABERRATIONS; RESOLUTION; SEQUENCES; METAPHASE; DISEASE	We have analyzed three de novo chromosome 16 rearrangements-two with a 16p+ chromosome and one a 16q+-none of which could be fully characterized by conventional cytogenetics. In each case, flow karyotypes have been produced, and the aberrant chromosome has been isolated by flow sorting. The origin of the additional material has been ascertained by amplifying and labeling the DNA of the abnormal chromosome by degenerate-oligonucleotide-primer-PCR and hybridizing it in situ to normal metaphase spreads (reverse chromosome painting). Both 16p+ chromosomes contain more than 30 Mb of DNA from the short arm of chromosome 9 (9p21.2-pter), while the 16q+ contains approximately 9 Mb of DNA from 2q37. The breakpoints on chromosome 16 have been localized in each case; the two breakpoints on the short arm are at different points within the terminal band, 16p13.3. The breakpoint on the long arm of chromosome 16 is very close to (within 230 kb of the 16q telomere. Determination of the regions of monosomy and trisomy allowed the observed phenotypes to be compared with other reported cases involving aneuploidy for these regions.	JOHN RADCLIFFE HOSP,INST MOLEC MED,OXFORD OX3 9DU,ENGLAND; CHURCHILL HOSP,DEPT MOLEC GENET,OXFORD OX3 7LJ,ENGLAND; UNIV LEICESTER,DEPT GENET,LEICESTER LE1 7RH,ENGLAND; DIST HOSP,WESSEX REG GEN LAB,SALISBURY,ENGLAND; ROYAL UNITED HOSP,CTR CHILDRENS,BATH,ENGLAND	University of Oxford; University of Oxford; University of Leicester; Salisbury District Hospital				Armour, John/0000-0002-8558-8506				Armour John A. L., 1992, Human Molecular Genetics, V1, P319, DOI 10.1093/hmg/1.5.319; BARRIOS L, 1989, CANCER GENET CYTOGEN, V41, P61, DOI 10.1016/0165-4608(89)90108-8; BUCKLE VJ, 1986, HUMAN GENETIC DISEAS, P85; CARTER NP, 1990, CYTOMETRY, V11, P202, DOI 10.1002/cyto.990110123; CARTER NP, 1992, J MED GENET, V29, P299, DOI 10.1136/jmg.29.5.299; CASAMASSIMA AC, 1990, AM J MED GENET, V37, P504, DOI 10.1002/ajmg.1320370414; CENTERWALL WR, 1975, PEDIATRICS, V56, P748; COHENHAGUENAUER O, 1987, CYTOGENET CELL GENET, V46, P595; COLLINS C, 1991, GENOMICS, V11, P997, DOI 10.1016/0888-7543(91)90025-A; CREMER T, 1988, HUM GENET, V80, P235, DOI 10.1007/BF01790091; DAHOUNHADORN S, 1992, ANN GENET-PARIS, V35, P55; FRYNS JP, 1977, HUM GENET, V38, P343, DOI 10.1007/BF00402162; GERMINO GG, 1990, AM J HUM GENET, V46, P925; HALVERSON D, 1990, ONCOGENE, V5, P1085; HARRIS P, 1987, HUM GENET, V76, P129, DOI 10.1007/BF00284908; HARRIS PC, 1990, GENOMICS, V7, P195, DOI 10.1016/0888-7543(90)90541-2; HARRIS PC, 1992, CYTOGENET CELL GENET, V60, P171; HIRST MC, 1991, NUCLEIC ACIDS RES, V19, P3283, DOI 10.1093/nar/19.12.3283; JARMAN AP, 1986, EMBO J, V5, P1857, DOI 10.1002/j.1460-2075.1986.tb04437.x; JULIER C, 1990, GENOMICS, V6, P419, DOI 10.1016/0888-7543(90)90471-6; KEITH TP, 1990, P NATL ACAD SCI USA, V87, P5754, DOI 10.1073/pnas.87.15.5754; LAMB J, 1989, LANCET, V2, P819; LAMB J, 1993, AM J HUM GENET, V52, P668; LEE CLY, 1981, HUM GENET, V57, P380, DOI 10.1007/BF00281689; LENGAUER C, 1991, CYTOGENET CELL GENET, V56, P27, DOI 10.1159/000133039; LICHTER P, 1988, HUM GENET, V80, P224, DOI 10.1007/BF01790090; MELTZER PS, 1992, NAT GENET, V1, P24, DOI 10.1038/ng0492-24; MENDELSOHN ML, 1973, SCIENCE, V179, P1126, DOI 10.1126/science.179.4078.1126; PINKEL D, 1988, P NATL ACAD SCI USA, V85, P9138, DOI 10.1073/pnas.85.23.9138; RIED T, 1992, P NATL ACAD SCI USA, V89, P1388, DOI 10.1073/pnas.89.4.1388; ROYLE NJ, 1992, NUCLEIC ACIDS RES, V20, P1164, DOI 10.1093/nar/20.5.1164; SACCONE S, 1992, P NATL ACAD SCI USA, V89, P4913, DOI 10.1073/pnas.89.11.4913; SCHMICKEL RD, 1986, J PEDIATR-US, V109, P231, DOI 10.1016/S0022-3476(86)80377-8; SUIJKERBUIJK RF, 1992, GENOMICS, V13, P355, DOI 10.1016/0888-7543(92)90253-O; Taysi K, 1978, Birth Defects Orig Artic Ser, V14, P343; TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K; TRASK B, 1990, CYTOMETRY, V11, P184, DOI 10.1002/cyto.990110121; VANDENENGH G, 1988, CYTOMETRY, V9, P266; WILKIE AOM, 1990, AM J HUM GENET, V46, P1112; WOLFF E, 1988, NUCLEIC ACIDS RES, V16, P9885, DOI 10.1093/nar/16.20.9885; XIAO GH, 1987, CYTOGENET CELL GENET, V46, P721	41	32	34	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1993	52	5					987	997						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LB889	8488848				2022-12-18	WOS:A1993LB88900017
J	VERMA, RS; LUKE, S; BRENNAN, JP; MATHEWS, T; CONTE, RA; MACERA, MJ				VERMA, RS; LUKE, S; BRENNAN, JP; MATHEWS, T; CONTE, RA; MACERA, MJ			MOLECULAR TOPOGRAPHY OF THE SECONDARY CONSTRICTION REGION (QH) OF HUMAN CHROMOSOME-9 WITH AN UNUSUAL EUCHROMATIC BAND	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FLUORESCENCE INSITU HYBRIDIZATION; DICENTRIC CHROMOSOME; ALPHOID DNA; CENP-B; CENTROMERE; SATELLITE; HETEROCHROMATIN; ORGANIZATION; SEQUENCES	Heterochromatin confined to pericentromeric (c) and secondary constriction (qh) regions plays a major role in morphological variation of chromosome 9, because of its size and affinity for pericentric inversion. Consequently, pairing at pachytene may lead to some disturbances between homologous chromosomes having such extreme variations and may result in abnormalities involving bands adjacent to the qh region. We encountered such a case, where a G-positive band has originated de novo, suggesting a maternal origin from the chromosome 9 that has had a complete pericentric inversion. In previously reported cases, the presence of an extra G-positive band within the 9qh region has been familial, and in the majority of those cases it was not associated with any clinical consequences. Therefore, this anomaly has been referred to as a ''rare'' variant. The qh region consists of a mixture of various tandemly repeated DNA sequences, and routine banding techniques have failed to characterize the origin of this extra genetic material. By the chromosome in situ suppression hybridization technique using whole chromosome paint, the probe annealed with the extra G-band, suggesting a euchromatic origin from chromosome 9, presumably band p12. By the fluorescence in situ hybridization technique using alpha- and beta-satellite probes, the dicentric nature was further revealed, supporting the concept of unequal crossing-over during maternal meiosis I, which could account for a duplication of the h region. The G-positive band most likely became genetically inert when it was sandwiched between two blocks of heterochromatin, resulting in a phenotypically normal child. Therefore, an earlier hypothesis, suggesting its origin from heterochromatin through so-called euchromatinization, is refuted here. If the proband's progeny(ies) inherit this chromosome, it shall be envisaged as a rare familial variant whose clinical consequences remain obscure.			VERMA, RS (corresponding author), SUNY HLTH SCI CTR,LONG ISL COLL HOSP,DIV GENET,HICKS ST & ATLANTIC AVE,BROOKLYN,NY 11201, USA.							ADINOLFI M, 1992, ADV GENOME BIOL, V1, P301; ASHLEY T, 1988, GENETICS, V118, P307; AUSIO J, 1992, J CELL SCI, V102, P1; BABU A, 1987, INT REV CYTOL, V108, P1, DOI 10.1016/S0074-7696(08)61435-7; BABU A, 1988, AM J HUM GENET, V42, P60; BERG JM, 1980, J MED GENET, V17, P144, DOI 10.1136/jmg.17.2.144; BUHLER E, 1977, HEREDITAS, V86, P63; BURK RD, 1985, CHROMOSOMA, V92, P225, DOI 10.1007/BF00348698; CATTANACH BM, 1974, GENET RES, V23, P291, DOI 10.1017/S0016672300014932; DOCHERTY Z, 1985, J MED GENET, V22, P156, DOI 10.1136/jmg.22.2.156; DOCHERTY Z, 1993, AM J MED GENET, V45, P105, DOI 10.1002/ajmg.1320450125; DONLON TA, 1981, CHROMOSOMA, V84, P353, DOI 10.1007/BF00286025; EARNSHAW WC, 1989, CHROMOSOMA, V98, P1, DOI 10.1007/BF00293329; FELSENFELD G, 1992, NATURE, V355, P219, DOI 10.1038/355219a0; FOWLER JC, 1988, HUM GENET, V79, P265; FOWLER JCS, 1989, CHROMOSOMA, V98, P266, DOI 10.1007/BF00327312; GRIEG GM, 1992, GENOMICS, V12, P573; GRUNSTEIN M, 1992, SCI AM, V267, P68, DOI 10.1038/scientificamerican1092-68; GUANGHUI X, 1984, MAMMALIAN CHROMOSOME, V25, P72; HANSMANN I, 1976, HUM GENET, V31, P247, DOI 10.1007/BF00270855; HOO JJ, 1992, CLIN GENET, V41, P157; HOULE D, 1992, NATURE, V359, P58, DOI 10.1038/359058a0; JALAL SM, 1990, AM J MED GENET, V37, P155, DOI 10.1002/ajmg.1320370135; KORNBERG RD, 1992, ANNU REV CELL BIOL, V8, P563, DOI 10.1146/annurev.cb.08.110192.003023; LUCAS JN, 1989, INT J RADIAT BIOL, V56, P35, DOI 10.1080/09553008914551161; LUKE S, 1992, J CELL SCI, V103, P919; MADAN K, 1978, HUM GENET, V43, P259, DOI 10.1007/BF00278832; MASUMOTO H, 1989, J CELL BIOL, V109, P1963, DOI 10.1083/jcb.109.5.1963; MATHEWS T, 1991, CLIN GENET, V40, P190; NAKAGOME Y, 1986, JPN J HUM GENET, V31, P21, DOI 10.1007/BF01876798; PERREAULT SD, 1992, MUTAT RES, V296, P43, DOI 10.1016/0165-1110(92)90031-4; ROCCHI M, 1991, GENOMICS, V9, P517, DOI 10.1016/0888-7543(91)90419-F; ROLAND B, 1992, AM J MED GENET, V42, P137, DOI 10.1002/ajmg.1320420128; SCHEDL P, 1991, CELL, V64, P941; SHARMA V, 1991, NUCLEIC ACIDS RES, V19, P4023, DOI 10.1093/nar/19.14.4023-a; SINGER MF, 1982, INT REV CYTOL, V76, P67, DOI 10.1016/S0074-7696(08)61789-1; TAGARRO I, 1991, GENOME, V34, P251, DOI 10.1139/g91-039; THERMAN E, 1974, AM J HUM GENET, V26, P83; TKACHUK DC, 1991, GENET ANAL-BIOMOL E, V8, P67, DOI 10.1016/1050-3862(91)90051-R; VERMA RS, 1992, GENOMICS, V14, P113, DOI 10.1016/S0888-7543(05)80291-5; VERMA RS, 1978, AM J MED GENET, V2, P331, DOI 10.1002/ajmg.1320020403; VERMA RS, 1984, EXPERIENTIA, V40, P878, DOI 10.1007/BF01952006; VERMA RS, 1988, HETEROCHROMATIN MOL, P276; VIANNAMORGANTE AM, 1986, CYTOGENET CELL GENET, V42, P119, DOI 10.1159/000132263; VOGT P, 1992, CHROMOSOMA, V101, P585, DOI 10.1007/BF00360534; VREMA RS, 1989, HUMAN CHROMOSOMES MA; WEBB GC, 1989, HUM GENET, V82, P59, DOI 10.1007/BF00288273; Willard H F, 1989, Prog Clin Biol Res, V318, P9; WILLARD HF, 1987, TRENDS GENET, V3, P192, DOI 10.1016/0168-9525(87)90232-0; WILLARD HF, 1990, TRENDS GENET, V6, P410, DOI 10.1016/0168-9525(90)90302-M; WILSON C, 1990, ANNU REV CELL BIOL, V6, P679, DOI 10.1146/annurev.cb.06.110190.003335; YEN TJ, 1992, NATURE, V359, P536, DOI 10.1038/359536a0	52	32	32	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1993	52	5					981	986						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LB889	8488847				2022-12-18	WOS:A1993LB88900016
J	ZONANA, J; JONES, M; BROWNE, D; LITT, M; KRAMER, P; BECKER, HW; BROCKDORFF, N; RASTAN, S; DAVIES, KP; CLARKE, A; THOMAS, NST				ZONANA, J; JONES, M; BROWNE, D; LITT, M; KRAMER, P; BECKER, HW; BROCKDORFF, N; RASTAN, S; DAVIES, KP; CLARKE, A; THOMAS, NST			HIGH-RESOLUTION MAPPING OF THE X-LINKED HYPOHIDROTIC ECTODERMAL DYSPLASIA (EDA) LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; GENETIC-HETEROGENEITY; PRENATAL-DIAGNOSIS; CHROMOSOME; REGION; FEMALE; MAP; DNA; POLYMORPHISMS; LOCALIZATION	The X-linked hypohidrotic ectodermal dysplasia (EDA) locus has been previously localized to the subchromosomal region Xq11-q21.1. We have extended our previous linkage studies and analyzed linkage between the EDA locus and 10 marker loci, including five new loci, in 41 families. Four of the marker loci showed no recombination with the EDA locus, and six other loci were also linked to the EDA locus with recombination fractions of .009-.075. Multipoint analyses gave support to the placement of the PGK1P1 locus proximal to the EDA locus and the DXS453 and PGK1 loci distal to EDA. Further ordering of the loci could be inferred from a human/rodent somatic cell hybrid derived from an affected female with EDA and an X;9 translocation and from studies of an affected male with EDA and a submicroscopic deletion. Three of the proximal marker loci, which showed no recombination with the EDA locus, when used in combination, were informative in 92% of females. The closely linked flanking polymorphic loci DXS339 and DXS453 had heterozygosities of 72% and 76%, respectively, and when used jointly, they were doubly informative in 52% of females. The human DXS732 locus was defined by a conserved mouse probe pcos169E/4 (DXCrc169 locus) that cosegregates with the mouse tabby (Ta) locus, a potential homologue to the EDA locus. The absence of recombination between EDA and the DXS732 locus lends support to the hypothesis that the DXCrc169 locus in the mouse and the DXS732 locus in humans may contain candidate sequences for the Ta and EDA genes, respectively.	OREGON HLTH SCI UNIV,DEPT BIOCHEM & MOLEC BIOL,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT NEUROL,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT PEDIAT,PORTLAND,OR 97201; MED RES COUNCIL CLIN RES CTR,COMPARAT BIOL SECT,HARROW,ENGLAND	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	ZONANA, J (corresponding author), OREGON HLTH SCI UNIV,DEPT MED GENET L103,3181 SW SAM JACKSON PK RD,PORTLAND,OR 97201, USA.			Brockdorff, Neil/0000-0003-4838-2653	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040741] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00022] Funding Source: Medline; NIAMS NIH HHS [PHS RO1 AR40741] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Wellcome Trust(Wellcome TrustEuropean Commission)		BARKER DF, 1989, CYTOGENET CELL GENET, V51, P958; BLECHER SR, 1986, J INVEST DERMATOL, V87, P720, DOI 10.1111/1523-1747.ep12456718; BROCKDORFF N, 1991, MAMM GENOME, V1, P152, DOI 10.1007/BF00351061; BROCKDORFF N, 1990, GENOMICS, V7, P573, DOI 10.1016/0888-7543(90)90201-5; BROCKDORFF N, 1991, GENOMICS, V10, P17, DOI 10.1016/0888-7543(91)90478-W; BROWNE DL, 1992, NUCLEIC ACIDS RES, V20, P1169, DOI 10.1093/nar/20.5.1169-a; BROWNE DL, 1991, NUCLEIC ACIDS RES, V19, P1721, DOI 10.1093/nar/19.7.1721-a; CLARKE A, 1987, ARCH DIS CHILD, V62, P989, DOI 10.1136/adc.62.10.989; CRAWFORD PJM, 1991, J MED GENET, V28, P181, DOI 10.1136/jmg.28.3.181; CREMERS FPM, 1988, AM J HUM GENET, V43, P452; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; FREIREMAIA N, 1988, ECTODERMAL DYSPLASIA; GOLDGAR DE, 1989, CYTOGENET CELL GENET, V51, P1006; GOODSHIP J, 1990, J MED GENET, V27, P422, DOI 10.1136/jmg.27.7.422; HANAUER A, 1988, HUM GENET, V80, P177, DOI 10.1007/BF00702863; HODGE SE, 1983, AM J HUM GENET, V35, P1139; KEITH DH, 1986, MOL CELL BIOL, V6, P4122, DOI 10.1128/MCB.6.11.4122; KIDD KK, 1989, CYTOGENET CELL GENET, V51, P622, DOI 10.1159/000132810; KRUSE TA, 1989, CYTOGENET CELL GENET, V51, P1026; LAFRENIERE RG, 1991, GENOMICS, V11, P352, DOI 10.1016/0888-7543(91)90143-3; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LIMON J, 1991, HUM GENET, V87, P338; LUTY JA, 1990, AM J HUM GENET, V46, P776; MAHTANI MM, 1991, GENOMICS, V10, P849, DOI 10.1016/0888-7543(91)90172-B; MERETTE C, 1991, AM J HUM GENET, V49, P1381; NIZETIC D, 1991, P NATL ACAD SCI USA, V88, P3233, DOI 10.1073/pnas.88.8.3233; OTT J, 1983, ANN HUM GENET, V47, P311, DOI 10.1111/j.1469-1809.1983.tb01001.x; Ott J., 1991, ANAL HUMAN GENETIC L; SEARLE A G, 1987, Genomics, V1, P3, DOI 10.1016/0888-7543(87)90099-1; THOMAS N, 1991, AM J HUM GENET, V49, pA205; TURLEAU C, 1989, CLIN GENET, V35, P462; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4037, DOI 10.1093/nar/18.13.4037; ZONANA J, 1988, J MED GENET, V25, P383, DOI 10.1136/jmg.25.6.383; ZONANA J, 1989, J PEDIATR-US, V114, P392, DOI 10.1016/S0022-3476(89)80556-6; ZONANA J, 1988, AM J HUM GENET, V43, P75; ZONANA J, 1990, AM J MED GENET, V35, P132, DOI 10.1002/ajmg.1320350125	36	32	34	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1992	51	5					1036	1046						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JU840	1357963				2022-12-18	WOS:A1992JU84000013
J	KNOWLES, JA; VIELAND, VJ; GILLIAM, TC				KNOWLES, JA; VIELAND, VJ; GILLIAM, TC			PERILS OF GENE-MAPPING WITH MICROSATELLITE MARKERS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							DNA POLYMORPHISMS; LINKAGE ANALYSIS		NEW YORK STATE PSYCHIAT INST & HOSP,COLL PHYS & SURG,DEPT GENET,NEW YORK,NY 10032; COLUMBIA UNIV,DEPT BIOSTAT,NEW YORK,NY 10027	New York State Psychiatry Institute; Columbia University	KNOWLES, JA (corresponding author), NEW YORK STATE PSYCHIAT INST & HOSP,COLL PHYS & SURG,DEPT PSYCHIAT,NEW YORK,NY 10032, USA.							CLARK JM, 1988, NUCLEIC ACIDS RES, V16, P9677, DOI 10.1093/nar/16.20.9677; HAZEN J, 1992, GENOMICS, V12, P183; KWIATKOWSKI DJ, 1992, GENOMICS, V12, P229, DOI 10.1016/0888-7543(92)90370-8; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LITT M, 1989, AM J HUM GENET, V44, P397; LOHFF CJ, 1992, NUCLEIC ACIDS RES, V20, P144, DOI 10.1093/nar/20.1.144; Maniatis T., 1982, MOL CLONING; OTT J, 1992, AM J HUM GENET, V51, P283; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEBER JL, 1991, GENOMICS, V11, P695, DOI 10.1016/0888-7543(91)90077-R; WIJMENGA C, 1991, GENOMICS, V9, P570, DOI 10.1016/0888-7543(91)90348-I	11	32	32	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1992	51	4					905	909						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JQ667	1415237				2022-12-18	WOS:A1992JQ66700035
J	HENKE, A; WAPENAAR, M; VANOMMEN, GJ; MARASCHIO, P; CAMERINO, G; RAPPOLD, G				HENKE, A; WAPENAAR, M; VANOMMEN, GJ; MARASCHIO, P; CAMERINO, G; RAPPOLD, G			DELETIONS WITHIN THE PSEUDOAUTOSOMAL REGION HELP MAP 3 NEW MARKERS AND INDICATE A POSSIBLE ROLE OF THIS REGION IN LINEAR GROWTH	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN CHROMOSOME-X; SEX-DETERMINING REGION; DISTAL SHORT ARM; Y-CHROMOSOME; X/Y TRANSLOCATIONS; DNA-SEQUENCES; SHORT STATURE; CELL HYBRIDS; LINKAGE MAP; T-COMPLEX	Short stature is consistently found in individuals with terminal deletions of Xp. In order to refine the localization of a putative locus affecting height, we analyzed two patients with a partial monosomy of the pseudoautosomal region at the molecular level. Eight pseudoautosomal probes were used for the genetic deletion analysis through dose evaluation. Three of them represent new markers (DXS415, DXS419, and DXS406) which were positioned on the pseudoautosomal map by pulsed field gel electrophoresis. Our data suggest that a locus affecting height maps in a region of about 1.5 Mbp, distal to the DXS406 locus and proximal to the DXS415 locus, a region which includes two CpG islands, and rule out an involvement of very distal sequences at the X/Y telomeres.	INST HUMAN GENET & ANTHROPOL,HEIDELBERG,GERMANY; SYLVIUS LABS,DEPT HUMAN GENET,LEIDEN,NETHERLANDS; DIPARTIMENTO PATOL UMANA & EREDITARIA,PAVIA,ITALY									AFFARA NA, 1987, NUCLEIC ACIDS RES, V15, P7325, DOI 10.1093/nar/15.18.7325; BALLABIO A, 1990, GENOMICS, V8, P263, DOI 10.1016/0888-7543(90)90281-X; BALLABIO A, 1989, P NATL ACAD SCI USA, V86, P10001, DOI 10.1073/pnas.86.24.10001; Bernstein R., 1985, Y CHROMOSOME B, P171; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BROWN WRA, 1988, EMBO J, V7, P2377, DOI 10.1002/j.1460-2075.1988.tb03082.x; COOKE HJ, 1986, COLD SPRING HARB SYM, V51, P213, DOI 10.1101/SQB.1986.051.01.026; FERGUSON-SMITH M A, 1965, J Med Genet, V2, P142, DOI 10.1136/jmg.2.2.142; FISHER EMC, 1990, CELL, V63, P1205, DOI 10.1016/0092-8674(90)90416-C; FRYNS JP, 1983, CYTOGENETICS MAMMA B, P245; GELLER RL, 1986, AM J HUM GENET, V38, P884; GOODFELLOW P, 1983, NATURE, V302, P346, DOI 10.1038/302346a0; GOODFELLOW PJ, 1988, P NATL ACAD SCI USA, V85, P5605, DOI 10.1073/pnas.85.15.5605; GOUGH NM, 1990, NATURE, V345, P734, DOI 10.1038/345734a0; HERRMANN B, 1986, CELL, V44, P469, DOI 10.1016/0092-8674(86)90468-X; HERRMANN BG, 1987, CELL, V48, P813, DOI 10.1016/0092-8674(87)90078-X; KAFFE S, 1983, CYTOGENETICS MAMMA B, P341; KALOUSEK D, 1979, J PEDIATR-US, V94, P891, DOI 10.1016/S0022-3476(79)80208-5; LEVILLIERS J, 1989, P NATL ACAD SCI USA, V86, P2296, DOI 10.1073/pnas.86.7.2296; MONDELLO C, 1987, ANN HUM GENET, V51, P137, DOI 10.1111/j.1469-1809.1987.tb01055.x; PAGE DC, 1987, CELL, V51, P1091, DOI 10.1016/0092-8674(87)90595-2; PAGE DC, 1990, NATURE, V346, P279, DOI 10.1038/346279a0; PETIT C, 1990, HUM GENET, V85, P247; PETIT C, 1988, EMBO J, V7, P2369, DOI 10.1002/j.1460-2075.1988.tb03081.x; RAPPOLD GA, 1988, NUCLEIC ACIDS RES, V16, P5361, DOI 10.1093/nar/16.12.5361; ROUYER F, 1987, CELL, V51, P417, DOI 10.1016/0092-8674(87)90637-4; SIMMLER MC, 1985, NATURE, V317, P692, DOI 10.1038/317692a0; Turner HH, 1938, ENDOCRINOLOGY, V23, P566, DOI 10.1210/endo-23-5-566; VANDENBERGHE H, 1977, HUM GENET, V36, P129, DOI 10.1007/BF00273251; WAPENAAR MC, 1990, CYTOGENET CELL GENET, V54, P10, DOI 10.1159/000132945; WAPENAAR MC, 1989, CYTOGENET CELL GENET, V51, P1102; WIEACKER P, 1984, AM J HUM GENET, V36, P265; ZUFFARDI O, 1982, AM J MED GENET, V12, P175, DOI 10.1002/ajmg.1320120207	33	32	35	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1991	49	4					811	819						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GG665	1897527				2022-12-18	WOS:A1991GG66500013
J	KWIATKOWSKI, DJ; OZELIUS, L; KRAMER, PL; PERMAN, S; SCHUBACK, DE; GUSELLA, JF; FAHN, S; BREAKEFIELD, XO				KWIATKOWSKI, DJ; OZELIUS, L; KRAMER, PL; PERMAN, S; SCHUBACK, DE; GUSELLA, JF; FAHN, S; BREAKEFIELD, XO			TORSION DYSTONIA GENES IN 2 POPULATIONS CONFINED TO A SMALL REGION ON CHROMOSOME 9Q32-34	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTOSOMAL DOMINANT INHERITANCE; MULTILOCUS LINKAGE ANALYSIS; ASHKENAZI JEWS; POLYMORPHISMS	Idiopathic torsion dystonia (ITD) is characterized by sustained, involuntary muscle contractions, frequently causing twisting and repetitive movements or abnormal postures. Most familial forms of ITD display autosomal dominant inheritance with reduced penetrance. Linkage analysis has been previously used to localize a dystonia gene to the 9q32-34 region in a large non-Jewish family and in a group of Ashkenazi Jewish families. Utilizing GT repeat polymorphisms from this region, here we demonstrate that the gene causing dystonia in Ashkenazi Jews can be localized to the 11-cM interval between AK 1 and D9S10. Linkage analysis in the non-Jewish family is also consistent with occurrence of the gene in this region, although positive lod scores extend over a > 20-cM interval in that family. These results set the stage for positional cloning of the dystonia gene. Currently there are no known candidate genes in this region.	MASSACHUSETTS GEN HOSP, DEPT NEUROL, BOSTON, MA 02114 USA; HARVARD UNIV, SCH MED, NEUROSCI PROGRAM, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DEPT GENET, BOSTON, MA 02115 USA; COLUMBIA UNIV COLL PHYS & SURG, DYSTONIA CLIN RES CTR, NEW YORK, NY 10032 USA; COLUMBIA UNIV COLL PHYS & SURG, DEPT NEUROL, NEW YORK, NY 10032 USA; OREGON HLTH SCI UNIV, DEPT NEUROL, PORTLAND, OR 97201 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Columbia University; Columbia University; Oregon Health & Science University	KWIATKOWSKI, DJ (corresponding author), MASSACHUSETTS GEN HOSP, DEPT MED, HEMATOL UNIT, 8 W, BLDG 149, BOSTON, MA 02114 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026656, R01NS028384] Funding Source: NIH RePORTER; NINDS NIH HHS [NS28384, NS26656] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BECHHANSEN NT, 1989, NUCLEIC ACIDS RES, V17, P4004, DOI 10.1093/nar/17.10.4004; Bressman S B, 1988, Adv Neurol, V50, P45; BRESSMAN SB, 1989, ANN NEUROL, V26, P612, DOI 10.1002/ana.410260505; de Yebenes J G, 1988, Adv Neurol, V50, P101; ELDRIDGE R, 1970, NEUROLOGY, V20, P1; Fahn S, 1988, Adv Neurol, V50, P1; FAHN S, 1989, J NEUROL NEUROSURG S, V52, P96; Gimenez-Roldan S, 1988, Adv Neurol, V50, P73; HAINES JL, 1990, GENOMICS, V8, P1, DOI 10.1016/0888-7543(90)90218-J; Hodge SE, 1979, AM J HUM GENET, V31, P761; Kramer P L, 1988, Adv Neurol, V50, P57; KRAMER PL, 1990, ANN NEUROL, V27, P114, DOI 10.1002/ana.410270203; KUPKE KG, 1990, AM J MED GENET, V36, P237, DOI 10.1002/ajmg.1320360219; KWIATKOWSKI DJ, 1989, NUCLEIC ACIDS RES, V17, P4425, DOI 10.1093/nar/17.11.4425; KWIATKOWSKI DJ, 1988, AM J HUM GENET, V42, P565; KWIATKOWSKI DJ, 1991, AM J HUM GENET, V48, P121; KWIATKOWSKI DJ, 1991, NUCLEIC ACIDS RES, V19, P967, DOI 10.1093/nar/19.4.967; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LATHROP GM, 1988, AM J HUM GENET, V42, P498; LATHROP GM, 1988, GENOMICS, V3, P361; Lee L V, 1976, Adv Neurol, V14, P137; LITT M, 1989, AM J HUM GENET, V44, P397; MULLER U, 1990, HUM GENET, V84, P107; NORTHRUP H, 1989, GENOMICS, V5, P442, DOI 10.1016/0888-7543(89)90007-4; OTT J, 1976, AM J HUM GENET, V28, P528; OZELIUS L, 1989, NEURON, V2, P1427, DOI 10.1016/0896-6273(89)90188-8; OZELIUS L, IN PRESS CELL GENET; RISCH NJ, 1990, AM J HUM GENET, V46, P533; SCHUBACK D, IN PRESS HUM GENET; Segawa M, 1976, Adv Neurol, V14, P215; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; WEBER JL, 1989, AM J HUM GENET, V44, P388; Zeman W, 1967, Psychiatr Neurol Neurochir, V70, P77; ZILBER N, 1984, J MED GENET, V21, P13, DOI 10.1136/jmg.21.1.13; ZUFFARDI O, 1989, HUM GENET, V82, P17, DOI 10.1007/BF00288264	35	32	33	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1991	49	2					366	371						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GA866	1867195				2022-12-18	WOS:A1991GA86600012
J	NICKLAS, JA; HUNTER, TC; ONEILL, JP; ALBERTINI, RJ				NICKLAS, JA; HUNTER, TC; ONEILL, JP; ALBERTINI, RJ			FINE-STRUCTURE MAPPING OF THE HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE (HPRT) GENE REGION OF THE HUMAN X-CHROMOSOME (XQ26)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN LYMPHOCYTES-T; LOWE OCULOCEREBRORENAL SYNDROME; LINKED LYMPHOPROLIFERATIVE SYNDROME; FRAGMENT LENGTH POLYMORPHISMS; YEAST ARTIFICIAL CHROMOSOMES; RESISTANT MUTANT FREQUENCY; ATOMIC-BOMB SURVIVORS; SOMATIC-CELL HYBRIDS; FRAGILE-X; MOLECULAR ANALYSES	The Xq26-q27 region of the X chromosome is interesting, as an unusually large number of genes and anonymous RFLP probes have been mapped in this area. A number of studies have used classical linkage analysis in families to map this region. Here, we use mutant human T-lymphocyte clones known to be deleted for all or part of the hypoxanthine-guanine phosphoribosyltransferase (hprt) gene, to order anonymous probes known to map to Xq26. Fifty-seven T-cell clones were studied, including 44 derived from in vivo mutation and 13 from in vitro irradiated T-lymphocyte cultures. Twenty anonymous probes (DXS10, DXS11, DXS19, DXS37, DXS42, DXS51, DXS53, DXS59, DXS79, DXS86, DXS92, DXS99, DXS100d, DXS102, DXS107, DXS144, DXS172, DXS174, DXS177, and DNF1) were tested for codeletion with the hprt gene by Southern blotting methods. Five of these probes (DXS10, DXS53, DXS79, DXS86 and DXS177) showed codeletion with hprt in some mutants. The mutants established the following unambiguous ordering of the probes relative to the hprt gene: DXS53-DXS79-5'hprt3'-DXS86-DXS10-DXS177. The centromere appears to map proximal to DXS53. These mappings order several closely linked but previously unordered probes. In addition, these studies indicate that rather large deletions of the functionally haploid X chromosome can occur while still retaining T-cell viability.	UNIV VERMONT,DEPT MED,BURLINGTON,VT 05401	University of Vermont	NICKLAS, JA (corresponding author), UNIV VERMONT,VERMONT REG CANC CTR,GENET LAB,32 N PROSPECT ST,BURLINGTON,VT 05401, USA.				NATIONAL CANCER INSTITUTE [R01CA030688] Funding Source: NIH RePORTER; NCI NIH HHS [CA 30688] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALBERTINI RJ, 1988, MUTAT RES, V204, P481, DOI 10.1016/0165-1218(88)90043-2; ALBERTINI RJ, 1982, P NATL ACAD SCI-BIOL, V79, P6617, DOI 10.1073/pnas.79.21.6617; ANSON DS, 1988, EMBO J, V7, P2795, DOI 10.1002/j.1460-2075.1988.tb03134.x; ARVEILER B, 1988, AM J HUM GENET, V42, P380; BALAZS I, 1984, SOMAT CELL MOLEC GEN, V10, P385, DOI 10.1007/BF01535634; BOGGS BA, 1984, SOMAT CELL MOLEC GEN, V10, P607, DOI 10.1007/BF01535226; BRADLEY WEC, 1987, MOL CELL BIOL, V7, P956, DOI 10.1128/MCB.7.2.956; BRENNAND J, 1983, J BIOL CHEM, V258, P9593; BROWN CJ, 1989, CYTOGENET CELL GENET, V51, P970; BROWN WT, 1988, AM J MED GENET, V30, P551, DOI 10.1002/ajmg.1320300157; CAMERINO G, 1984, P NATL ACAD SCI-BIOL, V81, P498, DOI 10.1073/pnas.81.2.498; COLE J, 1988, MUTAT RES, V204, P493, DOI 10.1016/0165-1218(88)90044-4; COOKE H, 1983, CYTOGENET CELL GENET, V37, P607; DAVATELIS G, 1985, NUCLEIC ACIDS RES, V13, P7540, DOI 10.1093/nar/13.20.7540; DAVIES KE, 1987, CYTOGENET CELL GENET, V46, P277, DOI 10.1159/000132481; DEMPSEY JL, 1985, CANCER RES, V45, P2873; DRAYNA D, 1985, SCIENCE, V230, P753, DOI 10.1126/science.4059909; FEIL R, 1990, AM J HUM GENET, V46, P720; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GIRAUD F, 1976, HUM GENET, V34, P125, DOI 10.1007/BF00278880; HAKODA M, 1989, ENVIRON MOL MUTAGEN, V13, P25, DOI 10.1002/em.2850130103; HAKODA M, 1988, MUTAT RES, V201, P39, DOI 10.1016/0027-5107(88)90109-1; HARVEY J, 1977, J MED GENET, V14, P46, DOI 10.1136/jmg.14.1.46; HENDERSON L, 1986, MUTAGENESIS, V1, P195, DOI 10.1093/mutage/1.3.195; HIGGINS MJ, 1990, P NATL ACAD SCI USA, V87, P3415, DOI 10.1073/pnas.87.9.3415; HOFKER MH, 1987, AM J HUM GENET, V40, P312; HOFKER MH, 1986, AM J HUM GENET, V39, P438; HOLDEN JJA, 1984, AM J MED GENET, V17, P259, DOI 10.1002/ajmg.1320170118; KENWRICK S, 1989, AM J HUM GENET, V45, P873; LESKO JG, 1986, AM J HUM GENET, V39, P669; LIPPERT M J, 1990, Environmental and Molecular Mutagenesis Supplement, V15, P35; LITTLE RD, 1989, P NATL ACAD SCI USA, V86, P1598, DOI 10.1073/pnas.86.5.1598; LUDECKE HJ, 1990, HUM GENET, V84, P512; MANDEL JL, 1986, COLD SPRING HARB SYM, V51, P195, DOI 10.1101/SQB.1986.051.01.024; MANDEL JL, 1989, CYTOGENET CELL GENET, V51, P384, DOI 10.1159/000132801; MCGINNISS MJ, 1989, ENVIRON MOL MUTAGEN, V14, P229, DOI 10.1002/em.2850140404; MCGINNISS MJ, 1990, MUTAT RES, V240, P117, DOI 10.1016/0165-1218(90)90015-T; MESSING K, 1989, HEALTH PHYS, V57, P537, DOI 10.1097/00004032-198910000-00003; MORLEY AA, 1983, NATURE, V302, P155, DOI 10.1038/302155a0; MULLEY J, 1988, AM J MED GENET, V30, P567, DOI 10.1002/ajmg.1320300158; MULLIGAN L, 1987, HUM GENET, V75, P381, DOI 10.1007/BF00284113; MULLIGAN LM, 1985, AM J HUM GENET, V37, P463; MURPHY PD, 1985, NUCLEIC ACIDS RES, V13, P3015, DOI 10.1093/nar/13.8.3015; MURPHY PD, 1985, SOMAT CELL MOLEC GEN, V11, P433, DOI 10.1007/BF01534837; MURPHY PD, 1987, CYTOGENET CELL GENET, V46, P665; MURPHY PD, 1983, CYTOGENET CELL GENET, V37, P707; NGUYEN C, 1989, CYTOGENET CELL GENET, V51, P1052; NGUYEN C, 1988, AM J MED GENET, V30, P601, DOI 10.1002/ajmg.1320300161; NICKLAS JA, 1987, MUTAGENESIS, V2, P341, DOI 10.1093/mutage/2.5.341; NICKLAS JA, 1989, MUTAT RES, V215, P147, DOI 10.1016/0027-5107(89)90178-4; NICKLAS JA, 1990, MUTAGENESIS, V5, P461, DOI 10.1093/mutage/5.5.461; NUSSBAUM RL, 1985, AM J HUM GENET, V37, P473; OBERLE I, 1987, HUM GENET, V77, P60; OBERLE I, 1986, HUM GENET, V72, P43, DOI 10.1007/BF00278816; ONEILL JP, 1990, MUTAT RES, V240, P143, DOI 10.1016/0165-1218(90)90018-W; ONEILL JP, 1990, MUTAT RES, V240, P135, DOI 10.1016/0165-1218(90)90017-V; ONEILL JP, 1989, ENVIRON MOL MUTAGEN, V13, P289, DOI 10.1002/em.2850130403; ONEILL JP, 1987, MUTAGENESIS, V2, P87, DOI 10.1093/mutage/2.2.87; PAI GS, 1980, P NATL ACAD SCI-BIOL, V77, P2810, DOI 10.1073/pnas.77.5.2810; PATTERSON M, 1988, AM J MED GENET, V30, P581, DOI 10.1002/ajmg.1320300159; POUSTKA AM, 1989, CYTOGENET CELL GENET, V51, P1060; REILLY DS, 1988, AM J HUM GENET, V42, P748; REILLY DS, 1990, GENOMICS, V8, P62, DOI 10.1016/0888-7543(90)90226-K; SEIFERT AM, 1987, MUTAT RES, V191, P57, DOI 10.1016/0165-7992(87)90171-0; SHILOH Y, 1990, AM J HUM GENET, V47, P20; SILVER DN, 1987, J CLIN INVEST, V79, P282, DOI 10.1172/JCI112795; SKARE JC, 1989, HUM GENET, V82, P354; SKARE JC, 1989, HUM GENET, V82, P349; SUTHERS GK, 1989, CYTOGENET CELL GENET, V51, P1087; SYLLA BS, 1989, CLIN GENET, V36, P459; TATES AD, 1989, MUTAT RES, V213, P73, DOI 10.1016/0027-5107(89)90033-X; TATSUMI K, 1985, J RADIAT RES, V26, P89; THAKKER RV, 1989, CYTOGENET CELL GENET, V51, P1089; TURNER DR, 1985, NATURE, V315, P343, DOI 10.1038/315343a0; TURNER G, 1989, AM J MED GENET, V34, P463, DOI 10.1002/ajmg.1320340402; WADA M, 1990, AM J HUM GENET, V46, P95; WADELIUS C, 1989, AM J HUM GENET, V44, P241; WIEACKER P, 1984, AM J HUM GENET, V36, P265	78	32	32	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1991	49	2					267	278						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GA866	1678246				2022-12-18	WOS:A1991GA86600003
J	REBBECK, TR; TURNER, ST; MICHELS, VV; MOLL, PP				REBBECK, TR; TURNER, ST; MICHELS, VV; MOLL, PP			GENETIC AND ENVIRONMENTAL EXPLANATIONS FOR THE DISTRIBUTION OF SOLDIUM-LITHIUM COUNTERTRANSPORT IN PEDIGREES FROM ROCHESTER, MN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BLOOD-PRESSURE; HYPERTENSION; PLASMA; SAMPLE; MODEL; POPULATION	An elevated level of erythrocyte sodium-lithium (Na-Li) countertransport has been suggested as a predictor of predisposition to essential hypertension. In order to evaluate whether a single genetic or environmental factor with large effects explains the mixture of distributions in Na-Li countertransport in the general population, complex segregation analyses were conducted by using 1,273 individuals more than age 20 years from 276 pedigrees selected without respect to disease risk factors or health status. Either a single genetic locus or a single environmental factor with large gender-specific effects explained the mixture of distributions for Na-Li countertransport in this sample equally well. In the subsample of pedigrees supporting a single-locus etiology, the single genetic locus explained 29.0% of the variability in adjusted Na-Li countertransport in males and 16.6% of that in females. In a subsample of pedigrees supporting an environmental factor etiology, the environmental factor explained 35.2% of the adjusted Na-Li countertransport in males and 20.5% of that in females. These results suggest that there are at least two different explanations for the mixture of distributions in Na-Li countertransport in the general population. Attempts to relate genetic variation in Na-Li countertransport to risk of essential hypertension must consider that the factor with large phenotypic effects on this trait is gender specific and may not be a single major locus in all pedigrees.	UNIV MICHIGAN,DEPT HUMAN GENET,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT EPIDEMIOL,ANN ARBOR,MI 48109; MAYO CLIN & MAYO FDN,DEPT INTERNAL MED,DIV HYPERTENS,ROCHESTER,MN 55905; MAYO CLIN & MAYO FDN,DEPT MED GENET,ROCHESTER,MN 55905	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Mayo Clinic; Mayo Clinic			Turner, Stephen/GXM-4654-2022; Rebbeck, Timothy/GLU-8348-2022	Rebbeck, Timothy/0000-0002-4799-1900	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007544] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL39107, HL 30438] Funding Source: Medline; NIGMS NIH HHS [5T32GM07544-11] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; AU YPT, 1986, CLIN CHEM, V32, P1394; AU YPT, 1986, BIOCHEM BIOPH RES CO, V138, P455, DOI 10.1016/0006-291X(86)90302-5; BARR SI, 1981, CLIN CHEM, V27, P1142; BEATY TH, 1980, AM J MED GENET, V6, P229, DOI 10.1002/ajmg.1320060307; BOEKNKE M, 1989, AM J HUM GENET, V44, P216; BOERWINKLE E, 1986, GENET EPIDEMIOL, V3, P365, DOI 10.1002/gepi.1370030509; BOERWINKLE E, 1984, RED CELL, P479; CANESSA M, 1979, LITHIUM CONTROVERSIE, P978; CANESSA M, 1980, INTRACELLULAR ELECTR, P239; CANNINGS C, 1978, ADV APPL PROBAB, V10, P26, DOI 10.2307/1426718; DADONE MM, 1984, AM J MED GENET, V17, P565, DOI 10.1002/ajmg.1320170304; DAY NE, 1969, BIOMETRIKA, V56, P463, DOI 10.1093/biomet/56.3.463; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; HASSTEDT SJ, 1982, COMPUT BIOMED RES, V15, P295, DOI 10.1016/0010-4809(82)90064-7; HASSTEDT SJ, 1988, AM J HUM GENET, V43, P14; Hasstedt SJ, 1981, 13 U UT DEP MED BIOP; IZZO C, 1981, CLIN CHEM, V27, P371; KOTTKE BA, 1986, MAYO CLIN PROC, V61, P313, DOI 10.1016/S0025-6196(12)61947-8; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; LALOUEL JM, 1979, 14 U UT DEP MED BIOP; MOLL PP, 1989, AM J HUM GENET, V44, P124; NETER J, 1985, APPLIED LINEAR STATI; SING CF, 1986, CLIN EXP HYPERTENS A, V8, P623, DOI 10.3109/10641968609046580; TURNER ST, 1985, HYPERTENSION, V7, P955, DOI 10.1161/01.HYP.7.6.955; TURNER ST, 1989, HYPERTENSION, V13, P378, DOI 10.1161/01.HYP.13.4.378	26	32	33	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1991	48	6					1092	1104						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FP092	2035530				2022-12-18	WOS:A1991FP09200010
J	BERTENSHAW, R; TAKEDA, K; REFETOFF, S				BERTENSHAW, R; TAKEDA, K; REFETOFF, S			SEQUENCING OF THE VARIANT THYROXINE-BINDING GLOBULIN (TBG) QUEBEC REVEALS 2 NUCLEOTIDE SUBSTITUTIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE; DNA	Thyroxine-binding globulin (TBG) is a liver glycoprotein that transports thyroid hormone in serum. In 1987 a variant TBG was discovered in an infant born in Quebec, following an investigation prompted by the finding of low blood thyroxine (T4) level on screening for neonatal hypothyroidism. This variant, TBG-Quebec, has cathodal shift on isoelectric focusing, reduced affinity for thyroxine, and markedly reduced stability. The latter property of the variant molecule is probably responsible for the partial TBG deficiency. We now report the results of sequencing of the entire coding region and exon-intron junctions of TBG-Quebec, which revealed two nucleotide substitutions; one, located in exon 3, changes the normal codon 283 of TTG (leucine) to that of TTT (phenylalanine), and the other, in exon 4, results in the replacement of the normal histidine-331 (CAT) by tyrosine (TAT). Allele-specific amplification (ASA) confirmed the cosegregation of the two nucleotide substitutions with the TBG-Quebec phenotype in individual members of this family. The substitution in codon 283, but not that in codon 331, has been previously described and, when occurring alone, does not alter the properties of the gene product. Thus, it appears that the replacement of histidine-331 by tyrosine is responsible for the observed altered properties of TBG-Quebec. However, the question of whether substitution of both amino acids is necessary for expression of the variant phenotype has yet to be answered.	UNIV CHICAGO,DEPT PEDIAT,THYROID STUDY UNIT,BOX 138,5841 S MARYLAND AVE,CHICAGO,IL 60637; UNIV CHICAGO,DEPT MED,CHICAGO,IL 60637; UNIV CHICAGO,DIV BIOL SCI,CHICAGO,IL 60637	University of Chicago; University of Chicago; University of Chicago			Refetoff, Samuel/ABB-1263-2021	Refetoff, Samuel/0000-0003-0164-8231	NIDDK NIH HHS [DK-07011, DK-15070] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007011, R01DK015070, R37DK015070] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BURR WA, 1980, Q J MED, V49, P295; MORI Y, 1990, J CLIN ENDOCR METAB, V70, P804, DOI 10.1210/jcem-70-3-804; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; REFETOFF S, 1979, ENDOCRINOLOGY, V1, P387; TAKAMATSU J, 1987, J CLIN INVEST, V79, P833, DOI 10.1172/JCI112891; TAKEDA K, 1989, J CLIN INVEST, V83, P1344, DOI 10.1172/JCI114021; TRENT JM, 1987, AM J HUM GENET, V41, P428; WALTZ MR, 1990, J ENDOCRINOL INVEST, V13, P343, DOI 10.1007/BF03349576	9	32	33	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1991	48	4					741	744						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK478	1901689				2022-12-18	WOS:A1991FK47800013
J	SHILOH, Y; LITVAK, G; ZIV, Y; LEHNER, T; SANDKUYL, L; HILDESHEIMER, M; BUCHRIS, V; CREMERS, FPM; SZABO, P; WHITE, BN; HOLDEN, JJA; OTT, J				SHILOH, Y; LITVAK, G; ZIV, Y; LEHNER, T; SANDKUYL, L; HILDESHEIMER, M; BUCHRIS, V; CREMERS, FPM; SZABO, P; WHITE, BN; HOLDEN, JJA; OTT, J			GENETIC-MAPPING OF X-LINKED ALBINISM-DEAFNESS SYNDROME (ADFN) TO XQ26.3-Q27.1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									TEL AVIV UNIV,SACKLER SCH MED,INST COMMUN DISORDERS,IL-69978 TEL AVIV,ISRAEL; COLUMBIA UNIV,DEPT PSYCHIAT,NEW YORK,NY 10027; CORNELL UNIV,MED CTR,NEW YORK HOSP,DEPT MED,NEW YORK,NY 10021; CATHOLIC UNIV NIJMEGEN,DEPT HUMAN GENET,NIJMEGEN,NETHERLANDS; QUEENS UNIV,DEPT BIOL,KINGSTON K7L 3N6,ONTARIO,CANADA	Tel Aviv University; Sackler Faculty of Medicine; Columbia University; Cornell University; NewYork-Presbyterian Hospital; Radboud University Nijmegen; Queens University - Canada	SHILOH, Y (corresponding author), TEL AVIV UNIV,SACKLER SCH MED,DEPT HUMAN GENET,IL-69978 TEL AVIV,ISRAEL.		Cremers, Frans/A-5625-2014	Cremers, Frans/0000-0002-4954-5592				ARIAS S, 1971, Birth Defects Original Article Series, V7, P87; ARVEILER B, 1988, AM J HUM GENET, V42, P380; BEIGHTON P, 1983, PRINCIPLES PRACTICE, P562; BRADLEY WG, 1974, BRAIN, V97, P521, DOI 10.1093/brain/97.1.521; BROWN KS, 1982, HDB CLIN NEUROLOGY 2, V43, P3; BROWN WT, 1988, AM J MED GENET, V30, P551, DOI 10.1002/ajmg.1320300157; BRUNNER HG, 1988, HUM GENET, V80, P337, DOI 10.1007/BF00273647; BUCHANAN JA, 1987, HUM GENET, V76, P165, DOI 10.1007/BF00284915; CARTER NL, 1980, AUDIOLOGY, V19, P86; CREEL D, 1980, SCIENCE, V209, P1253, DOI 10.1126/science.7403883; CREMERS FPM, 1988, AM J HUM GENET, V43, P452; DAVATELIS G, 1985, NUCLEIC ACIDS RES, V13, P7539, DOI 10.1093/nar/13.20.7539; DEOL MS, 1970, PROC R SOC SER B-BIO, V175, P201, DOI 10.1098/rspb.1970.0019; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FISCH L, 1959, J Laryngol Otol, V73, P355, DOI 10.1017/S0022215100055420; Fried K, 1969, J Med Genet, V6, P132, DOI 10.1136/jmg.6.2.132; GARBER SR, 1982, EAR HEARING, V3, P207, DOI 10.1097/00003446-198207000-00004; HAMANO K, 1986, NEUROPEDIATRICS, V17, P53, DOI 10.1055/s-2008-1052500; HILDING DA, 1977, ACTA OTO-LARYNGOL, V84, P24, DOI 10.3109/00016487709123939; JERGER J, 1959, ARCHIV OTOLARYNGOL, V69, P200; KAPLAN P, 1988, AM J MED GENET, V31, P679, DOI 10.1002/ajmg.1320310324; Klein D, 1950, HELV PAEDIATR ACTA, V5, P38; LAFERRIE.KA, 1974, ANN OTO RHINOL LARYN, V83, P685, DOI 10.1177/000348947408300518; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEWIS RA, 1978, AM J HUM GENET, V30, pA57; MANDEL JL, 1989, CYTOGENET CELL GENET, V51, P384, DOI 10.1159/000132801; Maniatis T., 1982, MOL CLONING; MARGOLIS E, 1962, ACTA GENET STAT MED, V12, P12; MCGINNESS J, 1974, SCIENCE, V183, P853, DOI 10.1126/science.183.4127.853; MCKUSICK VA, 1988, MENDELIAN INHERITANC; MULLIGAN LM, 1985, AM J HUM GENET, V37, P463; NGUYEN C, 1989, GENOMICS, V5, P298, DOI 10.1016/0888-7543(89)90061-X; OBERLE I, 1987, HUM GENET, V77, P60; ORKIN SH, 1986, CELL, V47, P845, DOI 10.1016/0092-8674(86)90799-3; OTT J, 1976, AM J HUM GENET, V28, P528; OTT J, 1985, ANAL HUMAN GENETIC L; PUJOL R, 1977, ACTA OTO-LARYNGOL, V83, P59, DOI 10.3109/00016487709128813; REED WB, 1967, ARCH DERMATOL, V95, P176, DOI 10.1001/archderm.95.2.176; ROSENBERG PE, 1969, MAICO AUDIOLOGIC LIB, V7; SCHONK D, 1989, GENOMICS, V4, P384, DOI 10.1016/0888-7543(89)90346-7; SHILOH Y, 1986, CANCER RES, V46, P5297; SORSBY A, 1954, J GENET, V52, P425, DOI 10.1007/BF02981535; SUGIURA A, 1970, Acta Oto-Laryngologica, V69, P126, DOI 10.3109/00016487009123345; TIETZ W, 1963, AM J HUM GENET, V15, P259; VEENEMA H, 1987, J MED GENET, V24, P413, DOI 10.1136/jmg.24.7.413; WAARDENBURG PJ, 1951, AM J HUM GENET, V3, P195; WALLIS C, 1988, GENOMICS, V3, P299, DOI 10.1016/0888-7543(88)90119-X; WIEACKER P, 1984, AM J HUM GENET, V36, P265; Wilber LA, 1976, ACOUSTIC IMPEDANCE A, P197; WINSHIP I, 1984, AM J MED GENET, V19, P797, DOI 10.1002/ajmg.1320190421; WISNIEWSKI KE, 1985, ACTA NEUROPATHOL, V66, P68, DOI 10.1007/BF00698297; WITKOP CJ, 1983, PRINCIPLES PRACTICE, P622; WOOLF CM, 1965, ARCHIV OTOLARYNGOL, V82, P244; WOOLF CM, 1965, AM J HUM GENET, V17, P23; ZIPRKOWSKI L, 1964, ARCH DERMATOL, V89, P151, DOI 10.1001/archderm.1964.01590250157028; ZIPRKOWSKI L, 1962, ARCH DERMATOL, V86, P530, DOI 10.1001/archderm.1962.01590100144027	56	32	32	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1990	47	1					20	27						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DK482	2349949				2022-12-18	WOS:A1990DK48200004
